The Value Set is used for the standard laboratory codes.
This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
Azithromycin+Ethambutol [Susceptibility]
Clarithromycin+Ethambutol [Susceptibility]
Erythromycin+Ethambutol [Susceptibility]
Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
Taenia solium larva Ab bands panel - Serum by Immunoblot
Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
DBG Ab [Presence] in Serum or Plasma from Blood product unit
Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
Trypanosoma cruzi Ab bands panel - Serum by Immunoblot
Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
Fasciola sp IgG Ab [Presence] in Serum by Immunoassay
Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
Filaria IgG Ab [Presence] in Serum by Immunoassay
Leishmania sp IgG Ab [Presence] in Serum by Immunoassay
Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
Leishmania sp Ab bands panel - Serum by Immunoblot
Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
Fasciola sp Ab bands panel - Serum by Immunoblot
Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
Chlamydophila pneumoniae Ab panel - Serum
Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis Ab.IgG panel - Serum
Schistosoma sp Ab [Titer] in Serum by Hemagglutination
Schistosoma mansoni Ab [Presence] in Serum by Immunoblot
Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
Toxoplasma gondii Ab bands panel - Serum by Immunoblot
Schistosoma sp Ab bands panel - Serum by Immunoblot
6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
Microalbumin [Mass/volume] in Urine collected for unspecified duration
DBG Ab [Presence] in Serum or Plasma from Donor
Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method
IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
Rubella virus IgG Ab index [Units/volume] in Serum and CSF
Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG
Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG
Sesamum indicum 1 IgE Ab [Units/volume] in Serum
Pioglitazone [Presence] in Serum or Plasma
Rosiglitazone [Presence] in Serum or Plasma
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection
Naloxone [Presence] in Cord tissue by Screen method
Phentermine [Presence] in Cord tissue by Screen method
Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay
Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS
Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection
Titin Ab [Units/volume] in Serum by Immunoassay
Abiraterone [Mass/volume] in Serum or Plasma
Aloe vera IgG Ab [Units/volume] in Serum
Bambusa vulgaris IgG Ab [Units/volume] in Serum
Goat cheese IgG Ab [Units/volume] in Serum
Sheep cheese IgG Ab [Units/volume] in Serum
Red cabbage IgG Ab [Units/volume] in Serum
Mentha balsamea Wild IgG Ab [Units/volume] in Serum
Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection
Corn salad IgG Ab [Units/volume] in Serum
Poppy Seed IgG Ab [Units/volume] in Serum
Pistachio IgG Ab [Units/volume] in Serum
Sunflower Seed IgG Ab [Units/volume] in Serum
Duck meat IgG Ab [Units/volume] in Serum
Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum
Astacoidea IgG Ab [Units/volume] in Serum
Brassica napus IgG Ab [Units/volume] in Serum
Goat Meat IgG Ab [Units/volume] in Serum
Goose meat IgG Ab [Units/volume] in Serum
Ostrich meat IgG Ab [Units/volume] in Serum
Quail meat IgG Ab [Units/volume] in Serum
Rabbit meat IgG Ab [Units/volume] in Serum
Venison meat IgG Ab [Units/volume] in Serum
Guineafowl IgG Ab [Units/volume] in Serum
Horse meat IgG Ab [Units/volume] in Serum
Camembert cheese IgG Ab [Units/volume] in Serum
Emmental cheese IgG Ab [Units/volume] in Serum
Processed cheese IgG Ab [Units/volume] in Serum
Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
Curd cheese IgG Ab [Units/volume] in Serum
Sugar Beet IgG Ab [Units/volume] in Serum
Chinese cabbage IgG Ab [Units/volume] in Serum
Fennel Fresh IgG Ab [Units/volume] in Serum
Savoy cabbage IgG Ab [Units/volume] in Serum
Vitis sp leaf IgG Ab [Units/volume] in Serum
Liquorice IgG Ab [Units/volume] in Serum
Fava bean IgG Ab [Units/volume] in Serum
Chick Pea IgG Ab [Units/volume] in Serum
Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum
8(9)-Cholestenol [Mass/volume] in Serum or Plasma
DiHydro T-Mas [Mass/volume] in Serum or Plasma
Squalene [Mass/volume] in Serum or Plasma
Stigmasterol [Mass/volume] in Serum or Plasma
Carnitine free and total and acylcarnitine panel - Urine
Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection
Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay
Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay
Norsufentanil [Mass/volume] in Urine by Confirmatory method
Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
Cortisol free and total panel - Serum or Plasma
TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method
NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus
Aspergillus sp DNA [Presence] in Blood by NAA with probe detection
Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection
Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection
BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection
Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection
Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection
SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method
Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative
CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal
Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection
Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection
Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection
Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection
Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection
Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection
Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection
Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count
Plasma cells/100 leukocytes in Synovial fluid
Hepatocellular carcinoma risk [Score] by GAAD
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection
Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay
Brexpiprazole [Mass/volume] in Serum or Plasma
Cariprazine [Mass/volume] in Serum or Plasma
Guanfacine [Mass/volume] in Serum or Plasma
Prothipendyl [Mass/volume] in Serum or Plasma
Prostate specific Ag [Mass/volume] in DBS
FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method
Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum
Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a)
traMADol and Metabolites Panel - Urine by Confirmatory method
Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes
Acylcarnitine Analysis Post Mortem in Specimen Document
Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma
Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma
Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma
Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
Amylase.macromolecular [Presence] in Serum or Plasma
Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma
Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma
Lipase.macromolecular [Presence] in Serum or Plasma
Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis
Chloride [Moles/volume] in Mixed venous blood
Glucose [Moles/volume] in Mixed venous blood
Legionella spp [Presence] in Specimen by NAA with probe detection
Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection
Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection
Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma
Platelet disorders multigene analysis in Blood or Tissue by Sequencing
Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing
Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing
PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method
Mycobacterium sp comparative reaction interpretation Narrative
Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal
Homocysteine and methylmalonate and methylcitrate panel - DBS
Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum
Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum
Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum
Hamster epithelium IgG Ab [Mass/volume] in Serum
Forsythia IgE Ab [Units/volume] in Serum
Testosterone [Mass/volume] in Body fluid
Follitropin [Units/volume] in Body fluid
S100 calcium binding protein B [Mass/volume] in Body fluid
Thyroglobulin [Mass/volume] in Body fluid
Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge
Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge
21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge
21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge
21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge
21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge
Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Renin [Mass/volume] in Plasma --1st specimen post XXX challenge
Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge
Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge
Renin [Mass/volume] in Plasma --4th specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma
Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot
Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
Liver fibrosis score in Serum or Plasma by Calculated.Agile3+
Liver fibrosis score in Serum or Plasma by Calculated.Agile4
Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC)
Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
Cell count and Differential panel - Amniotic fluid by Manual count
Leukocytes [#/volume] in Amniotic fluid by Manual count
Neutrophils [#/volume] in Amniotic fluid by Manual count
Other cells [#/volume] in Amniotic fluid by Manual count
Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method
Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection
Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay
Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method
Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method
Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method
Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method
Bacteria producing polysaccharide from sucrose [Presence] in Isolate
Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method
Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection
Orf virus DNA [Presence] in Specimen by NAA with probe detection
Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection
Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection
Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection
Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma
Rickettsia conorii IgG and IgM [Interpretation] in Serum
Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge
Staphylococcus aureus [Presence] in Specimen by Organism specific culture
Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture
Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture
Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture
Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture
Yeast and Candida sp identification panel - Specimen by Organism specific culture
Urinary tract pathogens panel - Urine by Culture
Gram positive bacteria identified in Isolate by Organism specific culture
Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture
Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture
Cronobacter sakazakii [Presence] by Organism specific culture
Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture
Campylobacter sp [Presence] in Stool by Organism specific culture
Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel
Staph aureus and MRSA screening panel - Specimen by Organism specific culture
Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Burr cells [Presence] in Body fluid by Light microscopy
Dengue virus Ab.IgG Panel - Serum, Plasma or Blood
Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood
Bovine tuberculosis comparative cervical test panel - Skin
Pathology report additional specified observation in Specimen Narrative
Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection
Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection
Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection
Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma
JC virus Ab Index in Serum or Plasma by Immunoassay
Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay
Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection
BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
HIV reverse transcriptase failed codons [Identifier] by Genotype method
HIV 1 group M RNA genotype [Identifier] by Genotype method
HIV protease failed codons [Identifier] by Genotype method
HIV integrase failed codons [Identifier] by Genotype method
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid
Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast
Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes
CD52 cell expression evaluation in Specimen Document by Flow cytometry (FC)
CD20 cell expression evaluation in Specimen Document by Flow cytometry (FC)
CD49d cell expression evaluation in Specimen Document by Flow cytometry (FC)
B-cell CD19 and CD20 subsets panel - Blood by Flow cytometry (FC)
Laceyella sacchari IgG Ab [Presence] in Serum
Neurofilament light chain [Mass/volume] in Cerebral spinal fluid
Respiratory Allergen Panel, Area 5 - Serum
Cortisol post dose insulin IV panel - Serum or Plasma
Somatotropin post dose insulin IV panel - Serum or Plasma
Monkeypox virus sequencing panel - Specimen by Sequencing
Monkeypox virus clade [Type] in Specimen by Sequencing
Monkeypox virus lineage [Type] in Specimen by Sequencing
Crawford Ab [Presence] in Serum or Plasma
E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit
Jo sup(a) Ab [Presence] in Serum or Plasma
Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine
THSD7A Ag [Presence] in Tissue by Immunofluorescence
Sezary syndrome monitoring in Blood Document by Flow cytometry (FC)
Sezary syndrome diagnosis in Blood Document by Flow cytometry (FC)
Leukemia and lymphoma immunophenotyping in Specimen Document by Flow cytometry (FC)
Candida glabrata+krusei DNA [Presence] in Blood by NAA with probe detection
Candida albicans and tropicalis DNA [Presence] in Blood by NAA with probe detection
Mephobarbital [Mass/volume] in Blood by Confirmatory method
Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method
Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method
Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method
Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes [Presence] by Molecular method
Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method
Theoretical limit of detection [#] in Specimen by calculation
Mast cells/100 cells in Bone marrow by Flow cytometry (FC)
B-cell precursors in Bone marrow by Flow cytometry (FC)
Glucose post XXX challenge panel - Serum or Plasma
Salmonella sp Ag [Presence] in Stool by Rapid immunoassay
NAT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Ustekinumab and Ustekinumab Ab panel - Serum or Plasma
Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay --trough
Monocyte subsets panel - Blood by Flow cytometry (FC)
Monocytes/100 leukocytes in Blood by Flow cytometry (FC)
CD14+CD16- (Classical) Monocytes/100 Monocytes in Blood
Borrelia burgdorferi IgM Ab index [Units/volume] in Serum and CSF
Mitochondria whole genome analysis in Blood or Tissue by Molecular genetics method
Chemokine (C-C motif) ligand 14 [Mass/volume] in Urine by Immunoassay
Calprotectin [Mass/volume] in Serum or Plasma
Alpha hydroxyetizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Alpha hydroxyetizolam [Presence] in Urine by Confirmatory method
Flualprazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Flualprazolam [Presence] in Urine by Confirmatory method
Flubromazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
E sup(w) Ab [Presence] in Serum or Plasma from Donor
Flubromazolam [Presence] in Urine by Confirmatory method
p-Fluorofentanyl/Creatinine [Mass Ratio] in Urine by Confirmatory method
p-Fluorofentanyl [Presence] in Urine by Confirmatory method
Brorphine [Mass/volume] in Urine by Confirmatory method
Brorphine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Brorphine [Presence] in Urine by Confirmatory method
Metonitazene [Mass/volume] in Urine by Confirmatory method
Metonitazene/Creatinine [Mass Ratio] in Urine by Confirmatory method
Metonitazene [Presence] in Urine by Confirmatory method
2-methyl AP-237 [Mass/volume] in Urine by Confirmatory method
Soluble urokinase plasminogen activator receptor [Mass/volume] in Serum or Plasma
2-methyl AP-237/Creatinine [Mass Ratio] in Urine by Confirmatory method
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen by NAA with probe detection
Melatonin [Moles/volume] in Saliva (oral fluid)
17-Hydroxyprogesterone [Mass/volume] in Saliva (oral fluid)
3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma
Normetanephrine Free/Creatinine [Molar ratio] in Serum or Plasma
Metanephrine Free/Creatinine [Molar ratio] in Serum or Plasma
Pneumocystis jiroveci DNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Immunoglobulin light chains.free/Protein.total in 24 hour Urine
2-methyl AP-237 [Presence] in Urine by Confirmatory method
MDMB-4en-PINACA [Mass/volume] in Urine by Confirmatory method
MDMB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method
MDMB-4en-PINACA [Presence] in Urine by Confirmatory method
4F-MDMB-BINACA [Mass/volume] in Urine by Confirmatory method
4F-MDMB-BINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method
4F-MDMB-BINACA [Presence] in Urine by Confirmatory method
ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method
ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method
ADB-BUTINACA [Presence] in Urine by Confirmatory method
5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method
5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method
5F-MDMB-PICA [Presence] in Urine by Confirmatory method
Sphincter excision plane [Anatomy] in Colorectal cancer specimen
Mesocolic excision plane [Anatomy] in Colorectal cancer specimen
Depth of invasion beyond muscularis propria [Length] in Colorectal cancer specimen
Inflammatory cell infiltrate in Colorectal cancer specimen
Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen
Albumin [Mass/volume] in Serum or Plasma by Nephelometry
Protein.monoclonal band 5/Protein.total in Serum or Plasma by Electrophoresis
Protein.monoclonal band 6/Protein.total in Serum or Plasma by Electrophoresis
Measles virus IgG Ab index [Units/volume] in Serum and CSF
Mumps virus IgG Ab index [Units/volume] in Serum and CSF
Herpes simplex virus 1+2 IgG Ab index [Units/volume] in Serum and CSF
Varicella zoster virus IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Plasmodium sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Dengue virus NS1 Ag [Units/volume] in Serum or Plasma by Immunoassay
Hepatitis E virus IgG Ab [Presence] in Serum or Plasma by Line blot
Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Line blot
Hantavirus IgG panel - Serum or Plasma by Line blot
Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Line blot
Hantavirus sin nombre IgG Ab [Presence] in Serum or Plasma by Line blot
Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Line blot
Hantavirus dobrava [Presence] in Serum or Plasma by Line blot
Hantavirus IgM panel - Serum or Plasma by Line blot
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Line blot
Hantavirus sin nombre IgM Ab [Presence] in Serum or Plasma by Line blot
Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Line blot
Hantavirus dobrava IgM Ab [Presence] in Serum or Plasma by Line blot
Legionella sp DNA [Presence] in Specimen by NAA with probe detection
SUMO-activating enzyme subunit 1 IgG Ab [Units/volume] in Serum by Immunoassay
PM-SCL-100 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB)
Normorphine/Creatinine [Mass Ratio] in Urine
PKD1 and PKD2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
Hemosiderin [Presence] in Blood or Marrow by Prussian blue stain
Recoverin Ab [Presence] in Serum by Immunoblot
Recoverin Ab [Presence] in Cerebral spinal fluid by Immunoblot
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunoblot
Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum by Immunoblot
Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunoblot
Glutamate decarboxylase 65 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Glutamate decarboxylase 65 Ab [Presence] in Serum by Immunoblot
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Glial nuclear type 1 Ab [Presence] in Serum by Immunoblot
Titin Ab [Presence] in Cerebral spinal fluid by Immunoblot
Titin Ab [Presence] in Serum by Immunoblot
Spermatozoa Immotile/100 spermatozoa in Semen --post vasectomy
Mean chromosome banding resolution [#] in Blood or Tissue by Banding
E sup(w) Ab [Presence] in Serum or Plasma
Contactin-associated protein 2 Ab [Presence] in Serum or Plasma by Immunofluorescence
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum or Plasma by Immunofluorescence
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Serum or Plasma by Immunofluorescence
NMDAR Ab [Presence] in Serum or Plasma by Immunofluorescence
NMDAR Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Pathologic casts [Presence] in Urine sediment by Light microscopy
Delta-8-tetrahydrocannabinol [Mass/volume] in Urine by LC/MS/MS
Aspergillus fumigatus [Presence] in Isolate
Dense fine speckled 70 protein Ab [Presence] in Serum or Plasma
Thrombin generation test [Interpretation] in Platelet poor plasma Narrative
Herpes virus 6 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 6 DNA [Units/volume] (viral load) in Blood by NAA with probe detection
Silica clotting time of Platelet poor plasma
Silica clotting time W excess phospholipid actual/normal of Platelet poor plasma
Neurofilament light chain [Mass/volume] in Serum or Plasma by Immunoassay
Speciociliatine [Presence] in Cord tissue
Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with non-probe detection
Pharyngeal pathogens DNA and RNA panel - Throat by NAA with non-probe detection
Adenovirus DNA [Presence] in Throat by NAA with non-probe detection
Chlamydophila pneumoniae DNA [Presence] in Throat by NAA with non-probe detection
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Throat by NAA with non-probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Throat by NAA with non-probe detection
Human metapneumovirus RNA [Presence] in Throat by NAA with non-probe detection
Rhinovirus+Enterovirus RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A H3 RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus B RNA [Presence] in Throat by NAA with non-probe detection
Mycoplasma pneumoniae DNA [Presence] in Throat by NAA with non-probe detection
Parainfluenza virus 1+2+3+4 RNA [Presence] in Throat by NAA with non-probe detection
Respiratory syncytial virus RNA [Presence] in Throat by NAA with non-probe detection
Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Throat by NAA with non-probe detection
Streptococcus pyogenes DNA [Presence] in Throat by NAA with non-probe detection
Leptospira sp DNA [Presence] in Blood by NAA with non-probe detection
Chikungunya virus RNA [Presence] in Blood by NAA with non-probe detection
Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with non-probe detection
Plasmodium sp DNA [Presence] in Blood by NAA with non-probe detection
Plasmodium falciparum DNA [Presence] in Blood by NAA with non-probe detection
Plasmodium vivax+ovale DNA [Presence] in Blood by NAA with non-probe detection
Glucose post arginine stimulation panel - Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose arginine
Somatotropin post insulin stimulation panel - Serum or Plasma
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma
17-Hydroxypregnenolone and 17-Hydroxyprogesterone p corticotropin stim panel - Serum or Plasma
Cortisol and 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Cortisol and Cortisone panel - 24 hour Urine
E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit
Etizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Etizolam [Presence] in Urine by Confirmatory method
Wr sup(b) Ag [Presence] on Red Blood Cells
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
Cholesterol [Presence] in Fibroblast by Filipin stain
Aeromonas sp DNA [Presence] in Stool by NAA with probe detection
BK virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
JC virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Erythrocytes.parasite sp infected/100 cells in Blood
Acute febrile illness global pathogens panel - Blood by NAA with non-probe detection
Candida krusei DNA [Presence] in Specimen by NAA with probe detection
Palmitoyl protein thioesterase and Tripeptidyl peptidase I panel - DBS
Borrelia burgdorferi Ab.IgG and IgM with reflex to immunoassay panel - Serum or Plasma
Borrelia burgdorferi Ab [Interpretation] in Serum Qualitative by IA.MTTT
Borrelia afzelii+burgdorferi+garinii IgG+IgM Ab [Presence] in Serum by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Immunoassay
Borrelia afzelii+burgdorferi+garinii Ab [Interpretation] in Serum by IA.MTTT
Borrelia burgdorferi.VlsE+OspC IgG+IgM Ab [Presence] in Serum by Immunoassay
Borrelia burgdorferi Ab [Interpretation] in Serum by IA.MTTT
Bioterrorism agent panel - Specimen by NAA with non-probe detection
Bacillus anthracis plasmid pXO1 DNA [Presence] in Blood by NAA with non-probe detection
Bacillus anthracis plasmid pXO2 DNA [Presence] in Blood by NAA with non-probe detection
Bacillus anthracis DNA [Presence] in Blood by NAA with non-probe detection
Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection
Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection
Coxiella burnetii DNA [Presence] in Blood by NAA with non-probe detection
Ebola virus RNA [Presence] in Blood by NAA with non-probe detection
Marburg virus RNA [Presence] in Blood by NAA with non-probe detection
Bacillus anthracis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Bacillus anthracis plasmid pXO1 DNA [Presence] by NAA with non-probe detection in Positive blood culture
Bacillus anthracis plasmid pXO2 DNA [Presence] by NAA with non-probe detection in Positive blood culture
Yersinia pestis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Yersinia pestis DNA [Presence] in Sputum by NAA with non-probe detection
Francisella tularensis DNA [Presence] in Sputum by NAA with non-probe detection
Troponin I.cardiac [Mass concentration difference] in Serum or Plasma by Calculation --2H post baseline measurement
Megakaryocytes [Presence] in Blood by Light microscopy
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Marrow by Molecular genetics method
Lung cancer targeted gene fusion transcript analysis in Tissue by Sequencing
DDIT3 gene rearrangement in Blood or Tissue by FISH
ETV6 gene rearrangements in Tissue by FISH
BAP1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
FH gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
FUS gene rearrangements in Blood or Tissue by FISH
MYC gene amplification in Tissue by FISH
NF1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
RET gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Molecular genetics method
GP1BB full mutation analysis in Blood or Tissue by Molecular genetics method
GP1BA gene full mutation analysis in Blood or Tissue by Molecular genetics method
GP9 gene full mutation analysis in Blood or Tissue by Molecular genetics method
PAH gene full mutation analysis in Blood or Tissue by Molecular genetics method
ADA gene full mutation analysis in Blood or Tissue by Molecular genetics method
CLCN7 gene full mutation analysis in Blood or Tissue by Molecular genetics method
Sex [Type] in Embryo by Molecular genetics method
Translocation analysis in Embryo by Molecular genetics method
Preimplantation multigene analysis in Embryo by Molecular genetics method
Copy number variation analysis in Blood or Tissue by Sequencing
Monkeypox virus and Orthopoxvirus.non-variola DNA panel - Specimen
Monkeypox virus and Orthopoxvirus.non-variola DNA [Identifier] in Specimen by NAA with probe detection
E sup(w) Ag [Presence] on Red Blood Cells from Donor
Metanephrine, Normetanephrine, 3-Methoxytyramine panel - 24 hour Urine
Tapentadol and Nortapentadol panel - Urine
Phenylalanine and Tyrosine panel - Serum or Plasma
Borrelia burgdorferi.VlsE1+pepC10 IgG+IgM Ab [Presence] in Serum by Immunoassay
Borrelia afzelii+burgdorferi+garinii Ab.IgG and IgM panel - Serum or Plasma by Immunoassay
Sudan virus RNA [Presence] in Blood by NAA with probe detection
Laceyella sacchari IgG Ab [Units/volume] in Serum
Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum
C peptide post XXX challenge panel - Serum
Dupilumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
Dolutegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
Bictegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
Lymphocyte TCR alpha beta double negative subsets panel - Blood
Blastomyces sp and Blastomyces dermatitidis Ag panel
Pediatric autoimmune central nervous system disorders evaluation panel - Cerebral spinal fluid
Pediatric autoimmune central nervous system disorders evaluation panel - Serum or Plasma
Microorganism level similarity to reference sample [Score] in Isolate or Specimen by MS.MALDI-TOF
Human coronavirus 229E RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human coronavirus HKU1 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human coronavirus NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human coronavirus OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Respiratory syncytial virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection
Respiratory syncytial virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection
Shigella sp DNA [Presence] in Stool by NAA with probe detection
Varicella zoster virus DNA [Presence] in Respiratory system specimen by NAA with probe detection
Bacterial vaginosis score in Vaginal fluid Qualitative by Nugent
2-Ketobutyrate [Moles/volume] in Serum or Plasma
Soluble urokinase plasminogen activator receptor [Mass/volume] in Plasma
Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify XL2
Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify CDT
Creatine kinase.MB [Moles/volume] in Serum or Plasma by Immunoassay
Contactin-associated protein 1 Ab.IgG and Neurofascin155 Ab.IgG4 panel - Serum or Plasma
Contactin-associated protein 1 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Neurochondrin Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Neurochondrin Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Neurochondrin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neurochondrin Ab [Presence] in Serum or Plasma by Immunofluorescence
Neurochondrin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neurochondrin Ab [Titer] in Serum or Plasma by Immunofluorescence
Mitochondrial metabolites panel - Serum or Plasma
Septin-7 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Septin-7 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Septin-5 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Septin-5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Septin-5 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Septin-5 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Septin-7 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Septin-7 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
HBA1+2 gene FIL deletion [Presence] in Blood by Molecular genetics method
HBA1+2 gene THAI deletion [Presence] in Blood by Molecular genetics method
Alpha globin gene deletion panel - Blood
Gas and electrolytes panel - Venous blood
Adenovirus DNA and Human Metapneumovirus and Rhinovirus RNA panel - Respiratory specimen by NAA with probe detection
Creatinine [Moles/volume] in Venous blood
Fasting glucose [Moles/volume] in Venous blood
Ampicillin [Susceptibility] by MIC.VOC detection in Positive blood culture
Ampicillin+Sulbactam [Susceptibility] by MIC.VOC detection in Positive blood culture
Cefotaxime [Susceptibility] by MIC.VOC detection in Positive blood culture
Cefotaxime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture
cefTAZidime [Susceptibility] by MIC.VOC detection in Positive blood culture
cefTAZidime+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture
cefTAZidime+Avibactam [Susceptibility] by MIC.VOC detection in Positive blood culture
Ceftolozane+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood culture
cefTRIAXone [Susceptibility] by MIC.VOC detection in Positive blood culture
Ertapenem [Susceptibility] by MIC.VOC detection in Positive blood culture
Imipenem [Susceptibility] by MIC.VOC detection in Positive blood culture
Meropenem [Susceptibility] by MIC.VOC detection in Positive blood culture
Meropenem+Vaborbactam [Susceptibility] by MIC.VOC detection in Positive blood culture
Piperacillin [Susceptibility] by MIC.VOC detection in Positive blood culture
Piperacillin+Tazobactam [Susceptibility] by MIC.VOC detection in Positive blood culture
cefOXitin [Susceptibility] by MIC.VOC detection in Positive blood culture
Amikacin [Susceptibility] by MIC.VOC detection in Positive blood culture
Gentamicin [Susceptibility] by MIC.VOC detection in Positive blood culture
Trimethoprim+Sulfamethoxazole [Susceptibility] by MIC.VOC detection in Positive blood culture
Tobramycin [Susceptibility] by MIC.VOC detection in Positive blood culture
Aztreonam [Susceptibility] by MIC.VOC detection in Positive blood culture
Amoxicillin+Clavulanate [Susceptibility] by MIC.VOC detection in Positive blood culture
Tigecycline [Susceptibility] by MIC.VOC detection in Positive blood culture
Ciprofloxacin [Susceptibility] by MIC.VOC detection in Positive blood culture
levoFLOXacin [Susceptibility] by MIC.VOC detection in Positive blood culture
Cefepime [Susceptibility] by MIC.VOC detection in Positive blood culture
Cefuroxime [Susceptibility] by MIC.VOC detection in Positive blood culture
Tetracycline [Susceptibility] by MIC.VOC detection in Positive blood culture
Bacterial susceptibility panel by Minimum inhibitory concentration VOC detection
Salmonella serogroup D1 [Presence] in Specimen by Immunoassay
Colony count [#/volume] in Specimen by Culture Standard Plate Count
Porcine DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Salmonella enterica serotype 1,4,[5],12:i:- [Cycle Threshold #] in Specimen by NAA with probe detection
Salmonella typhimurium DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma flocculare DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Equine herpesvirus 1 neuropathogenic G2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Salmonella dublin Ab in Specimen by Immunoassay
Canine parvovirus DNA VP2 gene [Presence] in Isolate by Sequencing
Canine Parvovirus 2 DNA [Presence] in Specimen by NAA with probe detection
Hemorrhagic enteritis virus Ab [Titer] in Serum by Immunoassay
Avian reovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Hemorrhagic enteritis virus Ab/Positive control in Serum by Immunoassay
Porcine deltacoronavirus S gene [Nucleotide sequence] in Isolate by Sequencing
Bovine parainfluenza virus 3 neutralizing antibody [Titer] in Serum by Neutralization test
Mycoplasma hyopneumoniae [Titer] in Specimen
Valnemulin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tylvalosin [Susceptibility] by Minimum inhibitory concentration (MIC)
Porcine epidemic diarrhea virus S1 gene [Identifier] in Isolate by Sequencing
Mycoplasma sp DNA [Identifier] in Isolate by Sequencing
Mycoplasma sp DNA [Nucleotide sequence] in Isolate by Sequencing
Porcine epidemic diarrhea virus IgG Ab [Units/volume] in Specimen by Immunoassay
Porcine epidemic diarrhea virus S1 gene IgA Ab [Units/volume] in Saliva (oral fluid) by Immunoassay
Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS in Isolate by Sequencing
Fungal 18s rRNA gene [Identifier] in Specimen by Sequencing
Fungal 18s rRNA gene [Nucleotide sequence] in Specimen by Sequencing
Salmonella sp whole genome [Nucleotide sequence] in Isolate by Sequencing
SMA residual risk [Interpretation] in Blood by Molecular genetics method Narrative
AGA gene [Likelihood] in Serum by Calculation
Bacterial versus viral etiology indicator panel - Serum, Plasma or Blood
Tumor necrosis factor ligand superfamily member 10 [Mass/volume] in Serum, Plasma or Blood
Bacterial versus viral infection likelihood [Score] by calculation
FCGR3A gene.p.Phe158 [Identifier] in Blood by Molecular genetics method Nominal
FCGR3A gene.p.Val158 [Identifier] in Blood by Molecular genetics method Nominal
Hepatocyte Ag by paraffin 1 in Blood or Tissue Qualitative by Immune stain
P63 protein [Interpretation] in Blood or Tissue Qualitative
Campylobacter coli DNA [Presence] in Stool by NAA with probe detection
Aeromonas hydrophila DNA [Presence] in Stool by NAA with probe detection
Campylobacter jejuni DNA [Presence] in Stool by NAA with probe detection
Campylobacter upsaliensis DNA [Presence] in Stool by NAA with probe detection
Candida krusei DNA [Presence] in Urine by NAA with probe detection
Clostridioides difficile DNA [Presence] in Stool by NAA with probe detection
Escherichia coli enteroinvasive DNA [Presence] in Stool by NAA with probe detection
Listeria monocytogenes DNA [Presence] in Stool by NAA with probe detection
Rotavirus B RNA [Presence] in Stool by NAA with probe detection
Rotavirus C RNA [Presence] in Stool by NAA with probe detection
Sapovirus genogroups I+II+IV RNA [Presence] in Stool by NAA with probe detection
Sapovirus genogroup V RNA [Presence] in Stool by NAA with probe detection
Gliadin peptide IgA+IgG Ab [Units/volume] in Serum by Immunoassay
Human coronavirus RNA in Specimen Document
Parainfluenza virus RNA in Specimen Document
Thyroglobulin and Thyroglobulin Ab panel - Tissue fine needle aspirate
Semen and urine analysis fertility panel - Specimen
E sup(w) Ag [Presence] on Red Blood Cells
Spermatozoa Normal chromatin/100 spermatozoa in Semen
Candida glabrata+krusei DNA [Presence] in Vaginal fluid by NAA with probe detection
Bacterial gyrB gene drug resistance mutation [Identifier] by Molecular method
ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative
Bacterial Vaginosis Associated Bacteria-2+Atopobium vaginae+Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection
Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Stool by NAA with probe detection
Cortisol [Moles/volume] in Serum or Plasma by LC/MS/MS
Histoplasma capsulatum+Blastomyces dermatitidis Ag panel - Serum or Plasma
Histoplasma capsulatum+Blastomyces dermatitidis Ag [Presence] in Serum or Plasma by Immunoassay
Histoplasma capsulatum+Blastomyces dermatitidis Ag [Mass/volume] in Serum or Plasma by Immunoassay
VKORC1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Cefoperazone [Susceptibility] by Disk diffusion (KB)
Semen [Volume] in Urine by Light microscopy --post ejaculation
Spermatozoa Agglutinated [Score] in Urine Qualitative by Light microscopy --post ejaculation
Spermatozoa.motility [Score] in Semen Qualitative by Light microscopy
Thyroglobulin heterophile Ab interference panel - Serum
Thyroglobulin heterophile Ab interference [Presence] in Serum
Thyroglobulin heterophile Ab interference [Interpretation] in Serum Narrative
Hypoglycemia evaluation panel - Serum or Plasma
JAK2 gene rearrangements in Blood or Marrow by FISH
JAK2 gene rearrangements in Blood or Tissue by FISH
MT-RNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HBB gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
USP6 gene rearrangements in Blood or Tissue by FISH
TCRB gene and TCRG gene rearrangements in Bone marrow by Molecular genetics method
TCRB gene and TCRG gene rearrangements in Blood or Tissue by Molecular genetics method
TCRB gene and TCRG gene rearrangements in Specimen by Molecular genetics method
PDGFB gene rearrangements in Blood or Tissue by FISH
NUTM1 gene rearrangements in Blood or Tissue by FISH
Myeloid sarcoma analysis in Blood or Tissue by FISH
Cardiovascular risk panel - Serum or Plasma
CD3+CD4+ (T4 helper) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection
Ehrlichiosis and Anaplasmosis and Babesiosis and Borrelia miyamotoi DNA panel - Serum, Plasma or Blood by NAA with probe detection
14-3-3 Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay
Tau protein [Mass/volume] in Cerebral spinal fluid by Immunoassay
E Ab [Presence] in Serum or Plasma from Blood product unit
Prion disease risk [Interpretation] in Cerebral spinal fluid by Immunoassay Narrative
MYC and BCL2 rearrangements in Tissue by FISH
Somatotropin and glucose post glucose stimulation panel - Serum or Plasma
Prenatal hepatitis B and C panel - Serum or Plasma
Neonatal ABO, Rh and DAT panel - Blood from Newborn
Basic metabolic and hematocrit panel - Blood
Lactate and pyruvate panel - Serum, Plasma or Blood
Abnormal Prion Protein [Presence] in Cerebral spinal fluid by RT-QuIC
T-Cell acute lymphoblastic leukemia in Blood or Tissue by FISH
Protein electrophoresis and M protein isotype panel - 24 hour Urine
Protein.monoclonal isotype [Identifier] in 24 hour Urine by MS.MALDI-TOF
Protein.monoclonal [Presence] in 24 hour Urine by MS.MALDI-TOF
Protein electrophoresis and M protein isotype panel - Urine
Protein.monoclonal isotype [Identifier] in Urine by MS.MALDI-TOF
Protein.monoclonal [Presence] in Urine by MS.MALDI-TOF
Hereditary Wilms tumor multigene analysis in Blood or Tissue by Molecular genetics method
Carbapenemase enzyme panel - Isolate by Rapid immunoassay
KPC carbapenemase [Presence] in Isolate by Rapid immunoassay
OXA-48-like carbapenemase [Presence] in Isolate by Rapid immunoassay
IMP Carbapenemase [Presence] in Isolate by Rapid immunoassay
VIM Carbapenemase [Presence] in Isolate by Rapid immunoassay
NDM Carbapenemase [Presence] in Isolate by Rapid immunoassay
Blood group antibody screen [Presence] in Blood from Newborn
Neonate blood type and indirect antibody screen panel - Specimen
Neonatal ABORh and Ab antibody panel - Blood from Newborn
T-cell lymphoma in Blood or Tissue Document by FISH
Chlamydia trachomatis rRNA and Neisseria gonorrhoeae rRNA and Trichomonas vaginalis RNA and Candida sp RNA panel
Certolizumab Ab [Mass/volume] in Serum or Plasma by SPR
JC virus DNA [log units/volume] (viral load) in Urine by NAA with probe detection
JC virus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection
E Ab [Presence] in Serum or Plasma from Donor
JC virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
JC virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
JC virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
Sodium Urate crystals [Energy Difference] in 24 hour Urine
Urate crystals [Energy Difference] in 24 hour Urine
Calcium hydrogen phosphate dihydrate (CHPD) in 24 hour Urine
Platelet aggregation ristocetin induced in Platelet rich plasma --250 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --125 ug/mL
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab in Serum by Immunoassay
Nonspermatozoal cells [#/area] in Semen by Microscopy high power field
Mitochondria M2-3E Ab [Presence] in Serum
Toxoplasma gondii DNA [Presence] in Plasma by NAA with probe detection
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum by Cell binding immunofluorescent assay
PCA-Tr Ab [Presence] in Serum by Cell binding immunofluorescent assay
PCA-Tr Ab [Titer] in Serum by Cell binding immunofluorescent assay
Maraviroc anticipated activity in Blood Qualitative by RT-PCR
Borrelia miyamotoi DNA [Presence] in Blood by NAA with probe detection
Adeno-associated virus (AAV) serotype Rh74 [Presence] in Serum by Immunoassay
Lithium [Moles/volume] in Blood by Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES)
Tau protein/Tau protein.phosphorilated 181 [Mass Ratio] in Cerebral spinal fluid
Dermatophytes DNA [Presence] in Specimen by NAA with probe detection
Trichophyton tonsurans DNA [Presence] in Specimen by NAA with probe detection
Trichophyton equinum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton interdigitale DNA [Presence] in Specimen by NAA with probe detection
Trichophyton mentagrophytes DNA [Presence] in Specimen by NAA with probe detection
Trichophyton quinckeanum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton schoenleinii DNA [Presence] in Specimen by NAA with probe detection
Trichophyton simii DNA [Presence] in Specimen by NAA with probe detection
Trichophyton concentricum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton bullosum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton benhamiae (Afr.) DNA [Presence] in Specimen by NAA with probe detection
Trichophyton benhamiae (white) DNA [Presence] in Specimen by NAA with probe detection
Trichophyton benhamiae (yellow) DNA [Presence] in Specimen by NAA with probe detection
Trichophyton erinacei DNA [Presence] in Specimen by NAA with probe detection
Trichophyton verrucosum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton eriotrephon DNA [Presence] in Specimen by NAA with probe detection
Trichophyton rubrum DNA [Presence] in Specimen by NAA with probe detection
Trichophyton violaceum DNA [Presence] in Specimen by NAA with probe detection
Epidermophyton floccosum DNA [Presence] in Specimen by NAA with probe detection
Microsporum canis DNA [Presence] in Specimen by NAA with probe detection
Microsporum audouinii DNA [Presence] in Specimen by NAA with probe detection
Microsporum ferrugineum DNA [Presence] in Specimen by NAA with probe detection
Nannizzia fulva DNA [Presence] in Specimen by NAA with probe detection
Nannizzia gypsea DNA [Presence] in Specimen by NAA with probe detection
Nannizzia incurvata DNA [Presence] in Specimen by NAA with probe detection
Nannizzia persicolor DNA [Presence] in Specimen by NAA with probe detection
Candida guilliermondii DNA [Presence] in Specimen by NAA with probe detection
Fusarium solani DNA [Presence] in Specimen by NAA with probe detection
Fusarium oxysporum DNA [Presence] in Specimen by NAA with probe detection
Scopulariopsis brevicaulis DNA [Presence] in Specimen by NAA with probe detection
CYP2C Cluster Allele [Genotype] in Blood or Tissue by Molecular genetics method
Toxoplasma gondii DNA [Presence] in Serum by RT-PCR
B-cell lymphoma chromosome analysis in Tissue by FISH
Chronic lymphocytic leukemia gene rearrangements in Blood or Marrow by FISH
Corynebacterium diphtheriae and Clostridium tetani toxoid Ab Panel - Serum or Plasma
Tianeptine [Mass/volume] in Urine by Confirmatory method
Tianeptine [Presence] in Urine by Confirmatory method
Tianeptine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Psilocin/Creatinine [Mass Ratio] in Urine by Confirmatory method
8-Aminoclonazolam [Presence] in Urine by Confirmatory method
8-Aminoclonazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method
Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Confirmatory method
Beta-Amyloid [Ratio] in Plasma by LC/MS/MS
Xylazine [Mass/volume] in Urine by Confirmatory method
Xylazine [Presence] in Urine by Confirmatory method
Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method
2,6-dimethylaniline [Presence] in Urine by Confirmatory method
2,6-dimethylaniline/Creatinine [Mass Ratio] in Urine by Confirmatory method
2,6-dimethylaniline [Mass/volume] in Urine by Confirmatory method
BK virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Cytomegalovirus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Cytomegalovirus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
Epstein Barr virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Herpes virus 6 DNA [Units/volume] in Cerebral spinal fluid by NAA with probe detection
Preimplantation targeted mutation analysis in Embryo by Molecular genetics method
Human papilloma virus cytology and high-risk genotypes panel - Cervix
Apolipoprotein C-III [Presence] in Serum or Plasma by Isoelectric focusing
Aspartylglucosaminidase [Enzymatic activity/mass] in Serum or Plasma
Brushite crystals [Saturation Fraction] in 24 hour Urine
Sodium Urate crystals [Saturation Fraction] in 24 hour Urine
Urate crystals [Saturation Fraction] in 24 hour Urine
Synthetic glucocorticoid panel - Serum or Plasma
Tetrazepam [Mass/volume] in Serum or Plasma
Medazepam [Mass/volume] in Serum or Plasma
Beclomethasone dipropionate [Moles/volume] in Serum or Plasma
Betamethasone [Moles/volume] in Serum or Plasma
Budesonide [Moles/volume] in Serum or Plasma
Dexamethasone [Moles/volume] in Serum or Plasma
Fludrocortisone [Moles/volume] in Serum or Plasma
Flunisolide [Moles/volume] in Serum or Plasma
Fluorometholone [Moles/volume] in Serum or Plasma
Fluticasone propionate [Moles/volume] in Serum or Plasma
Megestrol acetate [Moles/volume] in Serum or Plasma
Methylprednisolone [Moles/volume] in Serum or Plasma
prednisoLONE [Moles/volume] in Serum or Plasma
Triamcinolone [Moles/volume] in Serum or Plasma
Triamcinolone acetonide [Moles/volume] in Serum or Plasma
Sweat analysis specialist review of results
Beclomethasone dipropionate [Moles/volume] in Urine
Fluticasone propionate [Moles/volume] in Urine
Megestrol acetate [Moles/volume] in Urine
Methylprednisolone [Moles/volume] in Urine
Triamcinolone acetonide [Moles/volume] in Urine
4F-MDMB-BUTICA [Mass/volume] in Urine by Confirmatory method
4F-MDMB-BUTICA/Creatinine [Mass Ratio] in Urine by Confirmatory method
4F-MDMB-BUTICA [Presence] in Urine by Confirmatory method
Complement factor H Ab [Units/volume] in Serum or Plasma by Immunoassay
Troponin T. cardiac 2H and 6H 5th generation panel in Serum or Plasma by High sensitivity method
Gas and electrolytes point of care panel - Venous blood
Ma2 Antibody [Presence] in Cerebral spinal fluid by Immunoassay
Ma2 Antibody [Presence] in Serum or Plasma by Immunoassay
GABAAR IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
GABAAR IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
GABAAR IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
IgLON5 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Osmolality of Arterial blood by calculation
Osmolality of Venous blood by calculation
little c Ag [Presence] on Red Blood Cells from Fetus
K Ag [Presence] on Red Blood Cells from Fetus
Follitropin and lutropin post leuprolide stimulation panel - Serum
Noninvasive esophageal cancer DNA and esophageal cell screening [Presence] in Esophagus by Sequencing
AP-3 complex IgG Ab [Presence] in Specimen
Troponin T. cardiac [Mass/volume] in 2 hour 5th generation Serum or Plasma
Troponin T.cardiac delta [Mass concentration difference] in 2 hour Serum or Plasma
Troponin T.cardiac delta/Troponin T.cardiac in 2 hour Serum or Plasma --baseline
Troponin T.cardiac delta [Interpretation] in 2 hour Serum or Plasma Qualitative
Troponin T.cardiac [Mass/volume] in 6 hour Serum or Plasma
Troponin T.cardiac delta [Mass concentration difference] in 6 hour Serum or Plasma
Troponin T.cardiac delta/Troponin T.cardiac in 6 hour Serum or Plasma --baseline
Troponin T.cardiac delta [Interpretation] in 6 hour Serum or Plasma Qualitative
Iohexol disappearance panel - Urine and Serum or Plasma
Chronic lymphocytic leukemia gene targeted rearrangements in Blood or Marrow by FISH
Iohexol renal clearance in Serum or Plasma or Urine
Transforming growth factor beta 1 [Mass/volume] in Urine by Immunoassay
Epidermal growth factor [Mass/volume] in Urine by Immunoassay
Connective tissue growth factor [Mass/volume] in Serum by Immunoassay
Calbindin D28K [Mass/volume] in Urine by Immunoassay
SARS-CoV-2 Ag [Presence] in Nasopharynx by Immunofluorescence
Calcium oxalate crystals [Energy Difference] in Urine
Calcium hydrogen phosphate dihydrate crystals [Energy Difference] in Urine
Hydroxyapatite crystals [Energy Difference] in Urine
Urate crystals [Energy Difference] in Urine
Sodium urate crystals [Energy Difference] in Urine
Candida albicans DNA [Presence] in Specimen by NAA with probe detection
Candida albicans+glabrata+tropicalis+parapsilosis DNA [Presence] in Specimen by NAA with probe detection
Candida dubliniensis DNA [Presence] in Specimen by NAA with probe detection
Candida dubliniensis+lusitaniae+krusei+auris DNA [Presence] in Specimen by NAA with probe detection
Candida glabrata DNA [Presence] in Specimen by NAA with probe detection
Candida glabrata DNA [Presence] in Urine by NAA with probe detection
Candida lusitaniae DNA [Presence] in Specimen by NAA with probe detection
Candida parapsilosis DNA [Presence] in Specimen by NAA with probe detection
Candida parapsilosis DNA [Presence] in Urine by NAA with probe detection
Candida tropicalis DNA [Presence] in Specimen by NAA with probe detection
Candida tropicalis DNA [Presence] in Urine by NAA with probe detection
Cytomegalovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection
Cytomegalovirus DNA [Presence] in Stool by NAA with probe detection
Mycoplasma genitalium+hominis DNA [Presence] in Wound by NAA with probe detection
Streptococcus pyogenes DNA [Presence] in Wound by NAA with probe detection
MTTP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
COL4A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SLC35A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DNAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
COQ4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RTEL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ADAMTS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TCIRG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PEX2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PHGDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DHDDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SLC1A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HPS3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NDUFAF5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing
Voltage-gated calcium channel P/Q type binding Ab [Mass/volume] in Serum by Immunoassay
Cortisol, glucose and somatotropin post glucagon stimulation panel - Serum or Plasma
Glucose and somatotropin post glucagon stimulation panel - Serum or Plasma
Cortisol post arginine stimulation panel - Serum or Plasma
Glucose, somatotropin and cortisol post insulin administration in Serum or Plasma
Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG
Influenza virus A+B RNA [Presence] in Respiratory system specimen by NAA with probe detection
Candida albicans DNA [Presence] in Body fluid by Probe.amp.tar
Candida parapsilosis DNA [Presence] in Body fluid by Probe.amp.tar
Candida krusei DNA [Presence] in Body fluid by Probe.amp.tar
Candida glabrata DNA [Presence] in Body fluid by Probe.amp.tar
Candida tropicalis DNA [Presence] in Body fluid by Probe.amp.tar
Candida dubliniensis DNA [Presence] in Body fluid by Probe.amp.tar
E Ag [Presence] on Red Blood Cells from Blood product unit
3-hydroxypropyl mercapturate [Mass Ratio] in Urine
Foundation pain index Document by based on lab data
Erythrocytes.Plasmodium falciparum infected/100 erythrocytes in Blood by Microscopy
Clot initiation.kaolin induced [Time] in Blood by Thromboelastography
Clot formation.kaolin induced [Time] in Blood by Thromboelastography
Maximum amplitude kaolin induced [Length] in Blood by Thromboelastography
Clot initiation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase
Clot formation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase
Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase
Clot angle.kaolin induced in Blood by Thromboelastography^after addition of heparinase
Chromium IgE Ab RAST class [Presence] in Serum
von Willebrand factor.platelet binding activity without ristocetin [Units/volume] in Platelet poor plasma by Latex agglutination
Heterophile ACTH Interpretation in Plasma Narrative
ACTH heterophile Ab interference panel - Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucagon
Cortisol [[Mass/volume] in Serum or Plasma --30 minutes post dose glucagon
Cortisol [Moles/volume] in Serum or Plasma --60M post dose glucagon
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon
Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose glucagon
Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon
Cortisol [Mass/volume] in Serum or Plasma --3 hours post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --Fasting post dose insulin IV
Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Body fluid by Immune stain
Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Cervix by Immune stain
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV
Pathology report microscopic observation in Specimen
Anti-hypertensive and Anti-thrombotic drug [Presence] in Serum by LC/MS/MS
Abnormal Prion Protein [Interpretation] in Cerebral spinal fluid Document by RT-QuIC
ROS proto-oncogene 1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MET gene amplification in Blood or Tissue by Molgen
Carboxy tetrahydrocannabinol Delta 9/Creatinine [Mass Ratio] in Urine
SARS coronavirus 2 and Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence
Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS
1-deoxysphinganine [Mass/volume] in Serum by LC/MS/MS
1-Deoxysphingosine [Mass/volume] in Serum by LC/MS/MS
1-deoxymethylsphinganine [Mass/volume] in Serum by LC/MS/MS
1-deoxymethylsphingosine [Mass/volume] in Serum by LC/MS/MS
Sphinganine [Mass/volume] in Serum by LC/MS/MS
Sphingosine [Mass/volume] in Serum by LC/MS/MS
Perfluorohexanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluorobutane Sulfonic Acid [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluoroheptanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
4,8-Dioxa-3H-perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
Branched PFOA isomers [Mass/volume] in Serum or Plasma by LC/MS/MS
Linear PFOA Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS
Total perfluorohexanoic acid isomers [Mass/volume] in Serum or Plasma
Perfluorohexane sulfonate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluoroheptane sulfonate [Mass/volume] in Serum or Plasma
Perfluoroundecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluorodecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
E Ag [Presence] on Red Blood Cells from Donor
Branched PFOS Isomers [Mass/volume] in Serum or Plasma by LC/MS/MS
Linear PFOS Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS
2-N-Methyl-perfluorooctanesulfonamide acetate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluorododecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS
Perfluorooctane Sulfonamide [Mass/volume] in Serum or Plasma by LC/MS/MS
NASEM Summation Value [Mass/volume] in Serum or Plasma
Insulin [Units/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO
CAR-T cells total [#] in Blood product unit
Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma
Arginine stimulation challenge panel - Serum or Plasma by Immunoassay
B-Cell lymphoblastic leukemia monitoring minimal residual disease detection in Blood or Marrow by Flow cytometry (FC)
CNS Demyelinating Disease Panel - Serum or Plasma by Flow cytometry (FC)
Endometrial stromal tumor in Tissue Document by FISH
Secretin stimulation/Gastrin XXX challenge panel
Ceruloplasmin [Mass/volume] in 24 hour Urine
HBA1 and HBA2 gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
HLA-ABDR typing panel - Blood or Tissue from Donor
HLA-DQA1 SSO panel - Blood or Tissue by NAA with probe detection
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine, Cystatin C and Urea-based formula (CKiD)
Acute myeloid leukemia minimal residual disease in Bone marrow by Flow cytometry (FC) Narrative
B-cell acute lymphocytic leukemia in Blood or Tissue by FISH
B-cell acute lymphoblastic leukemia in Blood or Tissue by FISH
Acute myeloid leukemia in Blood or Tissue by FISH
Vitamin B3 and metabolites panel - Serum or Plasma by LC/MS/MS
Acute myeloid leukemia panel - Blood or Tissue by FISH
Streptococcus agalactiae [Susceptibility] in Urine by Culture
Pecan or Hickory Tree IgG Ab [Mass/volume] in Serum by Immunoassay
Glycolate [Moles/volume] in Serum or Plasma by Gas chromatography-mass spectrometry
Oxalate and Glycolate and Glyoxylate and Glycerate [Interpretation] in Serum or Plasma
Glycerate [Moles/volume] in Urine by Gas chromatography-mass spectrometry
Oxalate and Glycolate and Glyoxylate and Citrate [Interpretation] in Urine
Gastrin 34 [Moles/volume] in Serum or Plasma by LC/MS/MS
Melatonin [Moles/volume] in Saliva (oral fluid) by LC/MS/MS
Epidermal Allergen Mix (Dog dander+Cat epithelium+Horse dander) Ab.IgE panel - Serum or Plasma
ESR1 gene mutation panel - Tissue by Molecular genetics method
Gastrointestinal stromal tumor multigene mutation panel - Tissue by Molecular genetics method
Rhabdomyolysis and Metabolic myopathy multigene panel - Blood or Tissue by Molecular genetics method
Skeletal muscle channelopathy multigene panel - Blood or Tissue by Molecular genetics method
Carbapenemase [Type] in Isolate by Immunoassay
Bacteria.extended spectrum beta lactamase (ESBL) [Presence] in Stool based on lab data
Oxygen/Gas total [Partial pressure] in Arterial blood and Inhaled gas
Oxygen/Gas total [Partial pressure] adjusted to patient's actual temperature in Arterial blood and Inhaled gas
Sesamum indicum 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Abalone IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wattle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Corticotropin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Smooth Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alfalfa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alkalase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Allspice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Almond IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Almond Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactalbumin alpha IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alternaria alternata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Amoxicillin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ampicillin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Anchovy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Anisakis IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Anise IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Imported Fire Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apple Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apricot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Arrowroot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Artichoke IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ascaris sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Arizona Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Asparagus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus niger IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Avocado IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Groundsel Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bamboo shoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Banana IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Barley IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Barley Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Basil IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bass, Black IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fivehook Bassia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bayberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bayleaf IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Castor Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Coffee Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Kidney Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lima Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pinto Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American Beech IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beef IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Berlin Beetle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactalbumin beta IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beta lactoglobulin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blackberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blomia tropicalis IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bloodworm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blueberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Botrytis cinerea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Boxelder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brazil Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Broccoli IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bromelin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brussel Sprouts IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bovine serum albumin (BSA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Buckwheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Budgerigar feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bumble Bee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Burrobrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Burweed marshelder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cabbage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cocoa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Canary feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Candida albicans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Starfruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Caraway IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Careless Weed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Carob IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Carrot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Casein IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cashew nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cat dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Catfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cauliflower IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Italian Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Japanese Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mountain Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saltcedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Celery IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Acremonium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chaetomium globosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chamomile IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cheese cheddar type IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cottage Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mozzarella Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parmesan Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Swiss Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cherry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Horse Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chestnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chinchilla IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chloramin T IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chortoglyphus arcuatus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chymopapain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cinnamon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cladosporium herbarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clam IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clove IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clover IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cocklebur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coconut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Codfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coffee IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cola IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Corn IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cultivated Corn IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cultivated Cotton IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cotton fibers IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cotton western IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cottonseed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Western Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Crab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cranberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Crawfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cryptococcus terreus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cucumber IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Curry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Curvularia lunata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Curvularia specifera IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Arizona Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bald Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Italian Cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Daisy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ox-eye daisy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dandelion IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Daphnia (fish feed) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Date Palm Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Deer epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American house dust mite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dermatophagoides microceras IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European house dust mite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dill IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yellow Dock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Duck feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Echinococcus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Egg white IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whole Egg IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Egg yolk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Eggplant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rough Marsh Elder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Elder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Elk or Moose Meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chinese Elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Endive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Epicoccum purpurascens IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Epidermophyton floccosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ethylene oxide IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gum-Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Euroglyphus maynei IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog Fennel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fennel Fresh IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fennel Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ferret epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Meadow Fescue IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Finch feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Douglas Fir IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Firebush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fiscus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ab [Presence] in Serum or Plasma from Donor
Flea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Flounder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Formaldehyde IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fox IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Meadow Foxtail IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium culmorum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium moniliforme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium solani IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Garlic IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Geotrichum candidum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gerbil IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ginger IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gluten IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Glycyphagus domesticus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Goat epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Goat milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Goldenrod IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Goose feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grape IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grapefruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bahia grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bermuda grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Canadian blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brome IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
False oat grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gramma grass (Bouteloua gracilis) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Johnson grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kentucky blue grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Koehlers grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cocksfoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Quack grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red top grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Perennial rye grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wild rye grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Salt grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sorghum grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sudan grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sweet Vernal grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Velvet grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Guar gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Guava IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Guinea pig epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gum arabic IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sweet gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hackberry tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Haddock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Halibut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hamster epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Helminthosporium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Setomelanomma rostrata IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Eastern Hemlock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Water Hemp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Herring IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pecan or Hickory Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pecan or Hickory Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Shellbark Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honeysuckle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horn beam IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whitefaced Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yellow Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horseradish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Greer IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Hausstaub IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Hollister Stier IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Insulin bovine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Insulin human IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Insulin porcine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Iodinebush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Isocyanate HDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oxygen content in Right ventricular outflow tract
Isocyanate MDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Isocyanate TDI IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ispaghula laxative IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kapok IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kiwifruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lamb IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Goosefoot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cefoperazone [Susceptibility] by Serum bactericidal titer
Latex IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex glove extract IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex glove extract ammoniated IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex glove extract buffered IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Legume IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lemon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lenscale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lentils IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lepidoglyphus destructor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lettuce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lilac IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Easter lily IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lime IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Linden IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Liver beef IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lobster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spiny lobster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Locust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lupin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lycopodium spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lysozyme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mackerel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chub Mackerel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Scad IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Malt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mango IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coastal Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maple sugar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mare milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Marjoram IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maxatase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whiff IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cajeput tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mesquite IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mexican tea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Nimitti IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow milk boiled IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Milk powder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common Millet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Foxtail Millet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cockspur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mink epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mint IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cheese mold type IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chrysonilia sitophila IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aedes mosquito IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Moth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mediterranean flour moth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mouse epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mouse serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mouse urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mucor racemosus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mugwort IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mushroom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blue mussel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mustard IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Nectarine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Nettle IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Nigrospora sphaerica IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Nutmeg IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
California Black Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coastal Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oxygen content in Right pulmonary artery
Gamble Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Jerusalem oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Virginia Live Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Valley Oak IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oat pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Octopus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oidiodendrum spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Okra IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Olive Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Onion IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Orange IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oregano IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Orris root IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ovalbumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ovomucoid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oyster IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Queen Palm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Papaya (Carica papaya) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Paprika IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parakeet feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Budgerigar droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ab [Presence] in Serum or Plasma
Budgerigar serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parrot droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parrot feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parrot serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parsley IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parsnip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Passion fruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black-eye pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chick Pea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pear IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillin G IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillin V IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillium frequentans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillium notatum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cayenne IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chili Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pepper tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Perch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phoma betae IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phospholipase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phthalic anhydride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pigeon droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pigeon feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rough Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spiny Pigweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Austrian Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Loblolly Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Long Leaf Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pine Nut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Short Leaf Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Slash Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Virginia Scrub Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Eastern White Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pineapple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pistachio IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Malassezia furfur IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Plaice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English plantain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Plum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Cottonwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Poppy Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pork IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Potato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sweet potato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Povertyweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Privet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Protamine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Prune IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Psyllium seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aureobasidium pullulans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pumpkin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pumpkin Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pyrethrum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rabbit meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rabbit Bush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rabbit epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rabbit serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rabbit urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Radish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Desert Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
False ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Giant Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Southern Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Western Ragweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rapeseed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Raspberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rat epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rat serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rat urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Redwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Canary grass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common Reed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Reindeer epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rhizopus nigricans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rhodotorula spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rhubarb IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wild Rice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rose Hip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cultivated Rye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Safflower IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common Sagebrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saline fish feed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Salmon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saltbush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sardine (pilchard) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Savinase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Scallop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Scotch broom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sericin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sesame Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sheep epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sheep Sorrel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sheep wool IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Shrimp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silk waste IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bermuda grass smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Johnson grass smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Escargot IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Snapper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sole IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spinach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spondylocladium citrovirens IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spruce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Squash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Squid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pacific Squid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Stemphylium botryosum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Stemphylium solani IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Acarus siro IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tyrophagus putrescentiae IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Strawberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Succinylcholine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sugar Cane IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sunflower Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sunflower Seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Swine epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Swine urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Swordfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American Sycamore IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mandarin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tapioca IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tarragon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tetramin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saltwort IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Thyme IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tobacco IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tomato IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tragacanth IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichoderma viride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichophyton sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichophyton rubrum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichosporon spp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trimellitic anhydride (TMA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trout IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tuna IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ag [Presence] on Red Blood Cells from Donor
Turkey meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Turnip IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ulocladium chartarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Barley smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Vanilla IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Veal IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wall pellitory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
California Walnut Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Paper wasp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yellow Jacket IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Watermelon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grain weevel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cultivated Wheat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat Stem Rust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow whey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whitefish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pussy Willow IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wingscale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wormwood IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Baker's yeast IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brewer's yeast IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fish Feed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Salmon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tuna IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grey Alder IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alfalfa IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Almond IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alternaria alternata IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Ant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apple IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apricot IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ascaris lumbricoides IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Asparagus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus terreus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Banana IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Barley IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Kidney Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mung Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pinto Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yellow Bean IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beef IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beta lactoglobulin IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blueberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat Bran IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Broccoli IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brussel Sprouts IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cabbage IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Carageenan IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cardamon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Carp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Carrot IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Casein IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cauliflower IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cefaclor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Celery IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cheese cheddar type IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cream Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Roquefort Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cherry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken meat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chocolate IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cinnamon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clam IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clove IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cockatiel droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cockatiel feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(a) Ag [Presence] on Red Blood Cells
Coconut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Codfish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coffee IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cilantro IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Corn IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cotton linters IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cottonseed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow milk IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Crab IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cucumber IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Deer hair IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Echinococcus granulosus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Egg white IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Egg yolk IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Eggplant IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Endive IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Erythromycin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fig IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fireweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Flax IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Flounder IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium oxysporum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Garlic IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bovine Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Porcine Gelatin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ginger IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gluten IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grain elevator dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grape IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Grapefruit IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Haddock IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Halibut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Helminthosporium sativum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Shagbark Hickory IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Greer IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Western Juniper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Karaya gum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactalbumin alpha IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Beta galactosidase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lamb IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lemon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lettuce IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Licorice IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lime IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lobster IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Macadamia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Malt IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saccharopolyspora rectivirgula IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Monkey epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Paper Mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red mulberry IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mushroom IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mustard IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Nutmeg IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Olive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Onion IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Orange IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Orange Tree IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oregano IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oyster IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Papain IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parsley IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pea IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peach IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pear IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Black Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cayenne IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chili Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Green Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Jalepeno Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Pepper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pheasant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pickleweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Walleye Pike IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lodgepole Pine+Pondersosa Pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pineapple IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Plum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Pollock IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pomegranate IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Poplar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pork IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Potato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Radish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rape Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rice IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Orange roughy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rye IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Safflower IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sage IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
California Sagebrush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Annual Saltbush IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Scallop IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Schistosoma sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sesame Seed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Shark IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Shrimp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Snapper IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sole IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spinach IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blue Spruce IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Summer Squash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Zucchini IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Zucchini IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Strawberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sugar Cane IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sulfamethoxazole IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sunflower Seed IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sweet potato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mandarin IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tea IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tomato IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tree of Heaven IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trout IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Turkey IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Turkey feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Barley smut+Wheat smut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Vanilla IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Venison IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English Walnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Watermelon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whitefish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Baker's yeast IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brewer's yeast IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yogurt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alternaria sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Canary droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Finch droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maple IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mattress dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wild Oats IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parakeet droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Parakeet serum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bell Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Pepper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Water Chestnut IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European Hornet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maple syrup IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Western wheatgrass IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus versicolor IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat Bran IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blue Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chocolate IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cow milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Duck meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fenugreek IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse Bot Fly IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactalbumin alpha IgA Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactoglobulin IgA Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactoglobulin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maleic anhydride IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Neurospora sitophila IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillium brevicompactum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Abachi Wood Dust IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saffron IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Seminal fluid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dry-rot Fungus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Swine serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Clostridium tetani toxoid IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Thermoactinomyces vulgaris IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mealworm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bougainvillea IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cat serum albumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chicken droppings IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cochineal extract IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oriental Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Smoky Brown Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Conalbumin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red Currant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Jackfruit IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Jujube IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Litchi IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Palo verde IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Quinoa IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Stachybotrys chartarum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichophyton mentagrophytes var interdigitale IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Blue vetch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus enterotoxin B IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus enterotoxin C IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus enterotoxin D IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillium roqueforti IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sheep milk IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sheep whey IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cladosporium cladosporioides IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hexahydrophthalic anhydride (HHPA) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactoferrin bovine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pepsin IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus enterotoxin A IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichophyton mentagrophytes var goetzii IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Canary serum proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cedar IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alternaria alternata IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat Bran IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Candida albicans IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Casein IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cladosporium herbarum IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American house dust mite IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European house dust mite IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Egg white IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactalbumin alpha IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rice IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wasp venom IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lactoglobulin IgG4 Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Eel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Stachybotrys chartarum IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lovage IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Persimmon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gerbil hair IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
London Plane IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pellitory (Parietaria judaica) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sardine (Sardinops melanosticta) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Australian pine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Gerbil epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Tilapia IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spelt IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kelp or Seaweed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Colby Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Provolone Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Romano Cheese IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aureobasidium pullulans IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Curvularia specifera IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Catfish IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium moniliforme IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Helminthosporium sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kiwifruit IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mucor racemosus IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phthalic anhydride IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phoma betae IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Penicillium notatum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Perch IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rhizopus nigricans IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Stemphylium botryosum IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichophyton sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Miscellaneous allergen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wasp venom IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog dander+Dog epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bean string IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dermatophagoides sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Rat epithelium, serum proteins + urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pellitory (Parietaria officinalis) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dates IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fusarium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White Birch IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(b) Ab [Presence] in Serum or Plasma from Donor
Aspergillus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Whitefaced Hornet IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse hair+Horse dander IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Hollister Stier IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Japanese hop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Acremonium sp IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cephalosporine mold IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Red dye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yellow dye IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dipyrone IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
American Cockroach IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Spondylocladium sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mouse epithelium, serum proteins + urine proteins IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chinchilla epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fox epithelium IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mace IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hake IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy native (nPhl p) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 11 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 12 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Timothy recombinant (rPhl p) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ficus sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Amylase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Trichosporon pullulans IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch recombinant (rBet v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch recombinant (rBet v) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch recombinant (rBet v) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Oil palm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus TSST-1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Malassezia sp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Sugar Beet IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cantaloupe IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honeydew melon IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cantaloupe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honeydew melon IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Coffee bean IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
White mulberry IgG Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cottonwood IgG Ab [Presence] in Serum or Plasma by Radioallergosorbent test (RAST)
Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European Ash IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common wasp recombinant (rVes v) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Annatto seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Monosodium glutamate (MSG) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Codfish recombinant (rGad c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common wasp recombinant (rVes v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chlorhexidine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lupin seed IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Olive pollen native (nOle e) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Japanese cypress IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Olive pollen recombinant (rOle e) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
London Plane recombinant (rPla a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Common ragweed native (nAmb a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mugwort native (nArt v) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Saltwort native (nSal k) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mugwort native (nArt v) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English plantain recombinant (rPla l) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Codeine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Pholcodine IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European house dust mite native (nDer p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European house dust mite recombinant (rDer p) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European house dust mite recombinant (rDer p) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog recombinant (rCan f) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog recombinant (rCan f) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog recombinant 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Horse recombinant (rEqu c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Fy sup(b) Ab [Presence] in Serum or Plasma
Cat recombinant (rFel d) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cat recombinant (rFel d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Conalbumin native (nGal d) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean recombinant (rGly m) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Brazil Nut recombinant (rBer e) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cyprinus carpio recombinant (rCyp c) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat recombinant (rTri a) 19 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peach recombinant (rPru p) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peach recombinant (rPru p) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peach recombinant (rPru p) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut recombinant (rCor a) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut recombinant (rCor a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kiwi recombinant (rAct d) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean native (nGly m) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Soybean native (nGly m) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat recombinant (rTri a) 14 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apple recombinant (rMal d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Kiwi native (nAct d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut native (nCor a) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Yam IgE Ab in Serum by Radioallergosorbent test (RAST)
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bermuda grass native (nCyn d) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
House dust Bencard IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Paper wasp recombinant (rPol d) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
European paper wasp IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 6.01 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 6.02 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 8 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 9 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 11 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Lipolase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Termamyl IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Aspergillus flavus IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phadiatop IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Phadiatop infant IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Giant grouper IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Bromelin MUXF3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cedar elm IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Russian olive IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Olive pollen native (nOle e) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Arizona Cypress native (nCup a) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Alaska pollock roe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Apple recombinant (rMal d) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cashew nut recombinant (rAna o) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cetuximab IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog recombinant (rCan f) 4 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English walnut recombinant (rJug r) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
English walnut recombinant (rJug r) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Hazelnut recombinant (rCor a) 14 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Mahi mahi IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Silver Birch recombinant (rBet v) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Chum salmon roe IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Latex recombinant (rHev b) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Wheat native (nTri a) 19+20+21 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee recombinant (rApi m) 10 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee recombinant (rApi m) 2 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Peanut recombinant (rAra h) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Staphylococcus aureus enterotoxin E IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Maltose binding protein IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Celery recombinant (rApi g) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Ascorbate oxidase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Dog recombinant 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Cat recombinant (rFel d) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Systemic lupus Ab panel - Serum or Plasma
Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Staphylococcus aureus MLVA complex [Type] in Isolate or Specimen by Molecular genetics method
Cell-free DNA.donor/Cell-free DNA.total in Blood by Sequencing --post transplant
Genetic disease DNA and RNA analysis [Presence] in Blood or Tissue by Molecular genetics method
Steroid drug screening panel - Serum or Plasma by LC/MS/MS
Total perfluorooctane sulfonic acid isomers [Mass/volume] in Serum or Plasma
Kidney transplant acute cellular rejection risk [Score] in Plasma cell-free DNA by Calculated by AlloMap
Bone marrow transplant chimerism panel - Plasma cell-free DNA by Sequencing
Single nucleotide polymorphisms.recipient derived cf.dna/Single nucleotide polymorphisms.total cf dna in Plasma cell-free DNA by Sequencing --post bone marrow transplant
Single nucleotide polymorphisms.donor derived cf.dna/Single nucleotide polymorphisms.total cf dna in Blood from Donor
CD3 cells recipient derived/Cells.CD3 in Blood by Molecular genetics method --post bone marrow transplant
CD3 cells [#/volume] in Blood from Donor
Cells.CD15.recipient derived/Cells.CD15 in Blood --post bone marrow transplant
CD15 cells [#/volume] in Blood from Donor
Cells.CD33.recipient derived/Cells.CD33 in Blood --post bone marrow transplant
CD33 cells [#/volume] in Blood from Donor
Escherichia coli enteropathogenic DNA [Presence] in Wound by NAA with probe detection
Staphylococcus aureus enterotoxin A + Staphylococcus aureus enterotoxin B DNA [Presence] in Wound by NAA with probe detection
Cryptococcus neoformans DNA [Presence] in Specimen by NAA with probe detection
Adenovirus 1 and 2 Alpha DNA [Presence] in Respiratory system specimen by NAA with probe detection
Adenovirus 1 and 2 Beta DNA [Presence] in Respiratory system specimen by NAA with probe detection
Blastomyces dermatitidis DNA [Presence] in Specimen by NAA with probe detection
Campylobacter coli+jejuni DNA [Presence] in Wound by NAA with probe detection
Citrobacter freundii DNA [Presence] in Wound by NAA with probe detection
Clostridium botulinum DNA [Presence] in Wound by NAA with probe detection
Clostridioides difficile toxin A+B DNA [Presence] in Wound by NAA with probe detection
Clostridium perfringens DNA [Presence] in Wound by NAA with probe detection
Enterobacter aerogenes+Enterobacter cloacae DNA [Presence] in Specimen by NAA with probe detection
Enterobacter spp DNA [Presence] in Wound by NAA with probe detection
Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Wound by NAA with probe detection
Escherichia coli enteroinvasive DNA [Presence] in Wound by NAA with probe detection
Escherichia coli enterotoxigenic DNA [Presence] in Wound by NAA with probe detection
Enterovirus D68 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Haemophilus ducreyi DNA [Presence] in Urine by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Urine by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Urine by NAA with probe detection
Human papilloma virus 16 DNA [Presence] in Urine by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Urine by NAA with probe detection
Human Rhinovirus 1 and 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human Rhinovirus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Klebsiella pneumoniae oxytoca DNA [Presence] in Wound by NAA with probe detection
Klebsiella pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection
Morganella morganii DNA [Presence] in Wound by NAA with probe detection
Mycobacterium abscessus DNA [Presence] in Wound by NAA with probe detection
Mycobacterium fortuitum+chelonae DNA [Presence] in Wound by NAA with probe detection
Mycobacterium kansasii DNA [Presence] in Wound by NAA with probe detection
Mycobacterium marinum DNA [Presence] in Wound by NAA with probe detection
Mycobacterium ulcerans DNA [Presence] in Wound by NAA with probe detection
Proteus mirabilis DNA [Presence] in Urine by NAA with probe detection
Proteus vulgaris DNA [Presence] in Specimen by NAA with probe detection
Proteus vulgaris DNA [Presence] in Urine by NAA with probe detection
Sarcoptes scabiei DNA [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus DNA [Presence] in Respiratory system specimen by NAA with probe detection
Treponema pallidum DNA [Presence] in Urine by Probe with amplification
Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Wound by NAA with probe detection
Yersinia enterocolitica DNA [Presence] in Wound by NAA with probe detection
Cells.CD65/100 cells in Blood or Marrow by Flow cytometry (FC)
Fy sup(b) Ag [Presence] on Red Blood Cells from Donor
Enterovirus RNA [Log #/volume] (viral load) in Serum by NAA with probe detection
Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination
Testosterone Free [Mass/volume] in Serum or Plasma by Calculation
Eosinophils/100 leukocytes in Sputum by Manual count
Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Fy sup(b) Ag [Presence] on Red Blood Cells
Monocytes/100 leukocytes in Body fluid by Manual count
Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
Cancer Ag 125 [Units/volume] in Serum or Plasma
Gonadotropin peptide [Mass/volume] in Urine
Procollagen type I [Mass/volume] in Serum
Barbiturates [Mass/volume] in Serum or Plasma
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
Molindone [Mass/volume] in Serum or Plasma
Norpropoxyphene [Mass/volume] in Serum or Plasma
Sulfamethoxazole [Mass/volume] in Serum or Plasma
Temazepam [Mass/volume] in Serum or Plasma
Tranylcypromine [Mass/volume] in Serum or Plasma
Hemoglobin A [Units/volume] in Blood by Electrophoresis
Babesia microti identified in Blood by Light microscopy
Fetal cell screen [Interpretation] in Blood
Bordetella parapertussis Ab [Presence] in Serum
Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
Bacteria identified in Genital specimen by Aerobe culture
Bacteria identified in Nose by Aerobe culture
Tubular reabsorption of phosphorus/Glomerular filtration rate [Mass/volume] in Urine and Serum or Plasma
Bacteria identified in Urethra by Culture
Escherichia coli O157:H7 DNA [Presence] in Wound by NAA with probe detection
Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain
PLA2G7 and PLAC8 gene expression level [Score] in Blood by Molecular genetics method
SARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal
NR4A3 gene rearrangements in Blood or Tissue by FISH
Rhinovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection
Aldosterone/Renin [Ratio] in Serum or Plasma
AB-Fubinaca metabolite 3 [Mass/volume] in Urine by Confirmatory method
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection
AAV serotype rh74 Ab [Presence] in Serum or Plasma by Immunoassay
Microscopic observation [Identifier] in Wound by Gram stain
Cat epithelium IgE panel - Serum or Plasma
Horse dander IgE panel - Serum or Plasma
Albumin [Mass/volume] in Serum by Immunoassay
Teichoate Ab [Titer] in Serum by Immune diffusion (ID)
Etizolam [Presence] in Cord tissue by Confirmatory method
Flualprazolam [Presence] in Cord tissue by Confirmatory method
Bacterial vaginosis RNA [Presence] in Vagina by Probe with amplification
Cell growth [Presence] of Amniocytes Qualitative by Tissue culture
Acetyl norfentanyl [Mass/volume] in Cord tissue by Confirmatory method
Asialoganglioside GM1 IgM Ab [Titer] in Serum
Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells from Fetus
Baclofen [Mass/volume] in Urine by LC/MS/MS
Staphylococcus aureus MLVA type in Isolate or Specimen by Molecular genetics method
6-Hydroxychlorzoxazone [Mass/volume] in Urine
Carbamazepine 10,11-Epoxide [Mass/volume] in Urine
Paroxetine metabolite I [Mass/volume] in Urine by Confirmatory method
DNA single strand IgG Ab [Units/volume] in Serum
Paroxetine M-II [Mass/volume] in Urine by Confirmatory method
Paroxetine metabolite III [Mass/volume] in Urine by Confirmatory method
Sulbactam+Durlobactam [Susceptibility] by Gradient strip
Imatinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
Pazopanib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
Sunitinib total [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
DNA single strand IgM Ab [Units/volume] in Serum
Gefitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose
Creatinine [Moles/volume] in Serum or Plasma by LC/MS/MS
Helicobacter pylori IgG Ab [Presence] in Blood by Immunoassay
Hepatitis B virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay
Lupus anticoagulant aPTT screening panel - Platelet poor plasma by Coagulation assay
Small lymphocytic lymphoma chromosome deletions AndOr rearrangements in Blood or Tissue by FISH
Enterobacter spp DNA [Presence] in Specimen by NAA with probe detection
Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection
Klebsiella pneumoniae oxytoca DNA [Presence] in Specimen by NAA with probe detection
Mycobacterium marinum DNA [Presence] in Specimen by NAA with probe detection
Mycobacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection
Streptococcus pyogenes DNA [Presence] in Specimen by NAA with probe detection
Monkeypox virus neutralizing antibody [Titer] in Serum by Immunoassay
Monkeypox virus IgG Ab [Titer] in Serum by Immunoassay
G Ab [Presence] in Serum or Plasma from Blood product unit
Monkeypox virus IgM Ab [Titer] in Serum by Immunoassay
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis [Presence] in Genital fluid by NAA with probe detection
Coccidioides sp IgG and IgM [Units/volume] in Serum and CSF Qualitative by Immunoassay
Atlantic wreckfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Atlantic wreckfish IgE Ab [Units/volume] in Serum
4-hydroxy Xylazine [Mass/volume] in Urine by Confirmatory method
4-hydroxy Xylazine [Presence] in Urine by Confirmatory method
4-hydroxy Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Herpes virus 6A DNA [#/volume] (viral load) in Serum or Plasma by NAA with non-probe detection
Herpes virus 6B DNA [Units/volume] (viral load) in Serum or Plasma by NAA with non-probe detection
Iloperidone [Mass/volume] in Urine by Confirmatory method
N-Desmethylasenapine [Mass/volume] in Urine by Confirmatory method
Asenapine [Mass/volume] in Urine by Confirmatory method
clozapine N-oxide [Mass/volume] in Urine by Confirmatory method
Cortisol [Mass/volume] in Serum or Plasma --2 hour post dose corticotropin
Follitropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --10 minutes post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone
Atomoxetine [Presence] in Urine by Confirmatory method
4-Hydroxyatomoxetine [Mass/volume] in Urine by Confirmatory method
Ciprofloxacin [Susceptibility] for meningitis
Meropenem [Susceptibility] for meningitis
Cotinine [Mass/volume] in Serum or Plasma
Cells.chromosome Y deletion/Cells counted in Blood or Marrow by FISH
Entamoeba coli DNA [Presence] in Stool by NAA with probe detection
Campylobacter and Salmonella and Shigella sp identified in Stool by Organism specific culture
Campylobacter and Salmonella and Shigella and Yersinia sp identified in Stool by Organism specific culture
Salmonella and Shigella and Campylobacter and E. coli sp identified in Stool by Organism specific culture
Dehydronorketamine [Mass/volume] in Urine by LC/MS/MS
CD4+ CD26- Cells/100 CD4 cells in Blood by Flow cytometry (FC)
Cells.CD200/100 cells in Bone marrow by Flow cytometry (FC)
Cells.chromosome region 1p32 deletion/Cells counted in Blood or Marrow by FISH
Gabapentin [Presence] in Cord tissue by Screen method
Mitragynine [Presence] in Cord tissue by Screen method
Gabapentin [Presence] in Cord tissue by Confirmatory method
Mitragynine [Presence] in Cord tissue by Confirmatory method
Amoxicillin+Clavulanate [Susceptibility] for UTI
Isavuconazole [Susceptibility] in Isolate by Gradient strip
Cells.chromosome region 1q21 duplication in Blood or Marrow by FISH
Phosphorylated tau 181 [Mass/volume] in Plasma by Immunoassay
Soluble triggering receptor expressed on myeloid cells-1 [Mass/volume] in Serum or Plasma by Immunoassay
HMEP-Hemiplegic migraine multigene analysis in Blood or Tissue by Molecular genetics method
CTNNB1 gene targeted mutation analysis in Tumor by Molecular genetics method
TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method
Vortioxetine [Presence] in Urine by LC/MS/MS
Citalopram [Mass/volume] in Urine by LC/MS/MS
Pneumocystis jiroveci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Coccidioides sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Blastomyces sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Histoplasma sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Fungal pathogens panel - Cerebral spinal fluid by NAA with probe detection
MDA5 Ab [Units/volume] in Serum by Immunoassay
G Ab [Presence] in Serum or Plasma from Donor
Chenodeoxycholate+Cholate/Bile acid.total in Stool
Nickel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
Entamoeba hartmanni DNA [Presence] in Stool by NAA with probe detection
Bite cells [Presence] in Blood by Light microscopy
Cell growth [Presence] of Chorionic villus sample Qualitative by Tissue culture
Karyotype [Identifier] in Tissue from Fetus Narrative
GABAAR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Yersina pestis DNA [Presence] in Blood by NAA with non-probe detection
Crimean-Congo hemorrhagic fever virus RNA [Presence] in Blood by NAA with non-probe detection
Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA [Presence] in Blood by NAA with non-probe detection
Lassa virus RNA [Presence] in Blood by NAA with non-probe detection
Blister cells [Presence] in Blood by Light microscopy
West Nile virus RNA [Presence] in Blood by NAA with non-probe detection
Yellow fever virus RNA [Presence] in Blood by NAA with non-probe detection
Leishmania spp DNA [Presence] in Blood by NAA with non-probe detection
Suvorexant [Presence] in Urine by LC/MS/MS
Suvorexant [Mass/volume] in Urine by LC/MS/MS
Cells.chromosome region 20q12 deletion/Cells counted in Blood or Marrow by FISH
Hereditary Motor Neuropathy multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary motor and sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary spastic paraplegia multigene analysis in Blood or Tissue by Molecular genetics method
Distal weakness multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary congenital myasthenic syndrome multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary emery dreifuss multigene analysis in Blood or Tissue by Molecular genetics method
Dyserythropoietic anemia multigene analysis in Specimen by Sequencing
Erythrocytosis multigene analysis in Specimen by Sequencing
Erythrocytosis focused multigene analysis in Specimen by Sequencing
CYB5 and CYB5 Reductase multigene analysis in Specimen by Sequencing
RBC membrane multigene analysis in Specimen by Sequencing
Fragments [Presence] in Blood by Light microscopy
EBV Lymphoproliferation multigene analysis in Blood or Tissue by Molecular genetics method
Hyper igE syndrome multigene analysis in Specimen by Molecular genetics method
Dysregulation autoimmune multigene analysis in Specimen by Molecular genetics method
Viral Susceptibility multigene analysis in Specimen by Molecular genetics method
Autoimmune lymphoproliferative syndrome multigene analysis in Specimen by Molecular genetics method
Other cells/100 leukocytes in Bronchoalveolar lavage by Manual count
Time interval between troponin I.high-sensitivity assays
Human papilloma virus 16 and 18+45 mRNA [Presence] in Anorectal by NAA with probe detection
Helmet cells [Presence] in Blood by Light microscopy
Hemoglobin [Moles/volume] in Venous cord blood
Irregularly contracted cells [Presence] in Blood by Light microscopy
Oval macrocytes [Presence] in Blood by Light microscopy
Pencil cells [Presence] in Blood by Light microscopy
Chemokine (C-C motif) ligand 26 [Mass/volume] in Serum or Plasma by Immunoassay
Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) [Mass/volume] in Serum or Plasma by Immunoassay
Macrophage derived chemokine [Mass/volume] in Serum or Plasma by Immunoassay
Influenza A H3N2V RNA [Presence] in Specimen by NAA with probe detection
Polychromasia [Presence] in Blood by Light microscopy
Bacteria Identification and Susceptibilty in Positive blood culture Document
Aeromonas and plesiomonas sp identified in Stool by Organism specific culture
Renal calculus risk assessment [Likelihood] in 24 hour Urine Narrative
Infliximab and Infliximab Ab Panel - Serum or Plasma
Erythrocytes.dual population [Presence] in Blood by Light microscopy
Stomatocytes [Presence] in Blood by Light microscopy
Target cells [Presence] in Blood by Light microscopy
1-Hydroxymidazolam [Presence] in Meconium
O-desmethyltraMADol [Presence] in Meconium
Phosphodiesterase 10A Ab [Presence] in Specimen by Immunofluorescence
Tripartite motif containing 46 [Presence] in Specimen by Immunofluorescence
HBA1 and HBA2 gene deletion in Amniotic fluid or Chorionic villus sample by Molecular genetics method
Fat/Total solids [Mass Ratio] in 72 hour Stool
Blood product special preparation [Type]
Cytomegalovirus immune globulin given [Volume]
NOTCH3 gene full mutation analysis in Specimen by Molecular genetics method
Motor neuron disease multigene analysis in Specimen by Molecular genetics method
Muscular dystrophy multigene analysis in Specimen by Molecular genetics method
HIF2A gene targeted mutation analysis in Blood by Molecular genetics method
Peripheral neuropathy multigene analysis in Specimen by Molecular genetics method
KRAS Somatic mutation analysis in Tumor by Molecular genetics method
Parkinson Disease multigene analysis in Specimen by Molecular genetics method
Neuromuscular multigene analysis in Specimen by Molecular genetics method
Ofloxacin [Susceptibility] by Genotype method
cycloSERINE [Susceptibility] by Genotype method
Prothionamide [Susceptibility] by Genotype method
Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11-Ketotestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS
Zika virus lineage [Identifier] in Specimen by Molecular genetics method
G Ag [Presence] on Red Blood Cells from Blood product unit
Hepatitis B immune globulin given [Volume]
I Ag [Presence] on Red Blood Cells from Blood product unit
I Ag [Presence] on Red Blood Cells from Donor
Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)
G Ag [Presence] on Red Blood Cells from Donor
Inject varicella zoster virus immune globulin [Volume]
HISGT Histone genes targeted mutation analysis in Tumor by Molecular genetics method
little i Ag [Presence] on Red Blood Cells from Blood product unit
Mucopolysaccharidosis enzymes panel - Leukocytes
Multiple sulfatase deficiency enzymes panel - Leukocytes
little i Ag [Presence] on Red Blood Cells from Donor
Basic metabolic with hemoglobin and hematocrit panel - Blood
little i Ag [Presence] on Red Blood Cells
Ethyl glucuronide [Presence] in Serum or Plasma
Pregabalin [Presence] in Serum or Plasma
Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection
Legionella pneumophila DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection
Mucopolysaccharidosis [Enzymatic activity/volume] in DBS
Heparan-N-sulfatase [Enzymatic activity/volume] in DBS
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in DBS
heparan-alpha-glucosaminide N-acetyltransferase [Enzymatic activity/volume] in DBS
Multiple sulfatase deficiency [Enzymatic activity/volume] in DBS
11-Hydroxytestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS
CD34 recipient derived/CD34 cells in Bone marrow by Molecular genetics method --post stem cell transplant
Breast Cancer recurrence risk multigene analysis [Presence] in Tissue by Molecular genetics method
Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection
Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detection
Dementia evaluation panel - Cerebral spinal fluid
Transfuse blood exchange transfusion [Volume]
Apolipoprotein E phenotype [Identifier] in Plasma by LC/MS/MS
TRCA+TCRD gene rearrangements in Bone marrow by FISH
TCL-1A gene rearrangements in Bone marrow by FISH
Human papilloma virus 31+33+52+58 DNA [Presence] in Cervix by NAA with probe detection
DPYD gene.c.2846A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
DPYD gene.c.1236G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
DPYD gene.c.1905+1G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
DPYD gene.c.1679T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with non-probe detection
Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with probe detection
Clostridium tetani toxin [Presence] in Specimen by Mouse bioassay neutralization
Clostridium tetani toxin [Presence] in Specimen by Immunoassay
Clostridium tetani toxin [Presence] in Specimen by Endopeptidase Assay
Clostridium tetani toxin [Presence] in Serum or Plasma by Endopeptidase Assay
Clostridium tetani toxin [Presence] in Serum or Plasma by Mouse bioassay
Clostridium tetani toxin [Presence] in Serum or Plasma by Immunoassay
Adenovirus DNA [Presence] in Conjunctival specimen by NAA with probe detection
Mucopolysaccharidosis type II newborn screening panel
Mucopolysaccharidosis type II newborn screen interpretation newborn screen interpretation
Mucopolysaccharidosis type II comment [Text] in DBS Narrative
Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel
Guanidinoacetate methyltransferase deficiency newborn screen interpretation
Guanidinoacetate methyltransferase deficiency comment [Text] in DBS Narrative
Guanidinoacetate/Creatinine [Molar ratio] in DBS
Creatine/Creatinine [Molar ratio] in DBS
Immunoglobulin lambda light chain gene 22q11.22 rearrangement in Specimen by FISH
Immunoglobulin kappa light chain gene 2p11.2 rearrangement in Specimen by FISH
CRLF2 gene rearrangements in Blood or Marrow by FISH
Eszopiclone and Zopiclone [Mass/volume] in Urine by LC/MS/MS
Transfuse immune serum globulin [Volume]
H Ab [Presence] in Serum or Plasma from Blood product unit
Additional treatment [Identifier] in Urine
Spermatozoa Nonprogressive/100 spermatozoa in Urine --post ejaculation
Spermatozoa Immotile/100 spermatozoa in Urine --post ejaculation
Spermatozoa Viable/100 spermatozoa in Urine --post ejaculation
Spermatozoa.progressive.rapid/100 spermatozoa in Urine --post ejaculation
Spermatozoa.progressive.slow/100 spermatozoa in Urine --post ejaculation
Spermatozoa.progressive.slow+rapid/100 spermatozoa in Urine --post ejaculation
HLA-DPB1+DPA1 Typing panel - Blood or Tissue from Donor
HLA-DPB1+DPA1 Typing panel - Blood or Tissue
Rizatriptan [Mass/volume] in Urine by Confirmatory method
Alpha-Pyrrolidinoisohexanophenone [Mass/volume] in Urine by Confirmatory method
Carfentanil [Mass/volume] in Urine by Confirmatory method
MDMB-Fubinaca [Mass/volume] in Urine by Confirmatory method
N-Ethylpentylone [Mass/volume] in Urine by Confirmatory method
Naproxen [Mass/volume] in Urine by Confirmatory method
Norcocaine [Mass/volume] in Urine by Confirmatory method
Atomoxetine [Mass/volume] in Urine by Confirmatory method
Dibutylone [Mass/volume] in Urine by Confirmatory method
3-fluorophenmetrazine [Mass/volume] in Urine by Confirmatory method
Zopiclone [Mass/volume] in Urine by Confirmatory method
Chronic and low grade B cell lymphoid neoplasm multigene analysis in Blood or Tissue by Molecular genetics method
B cell non hodgkin Lymphoma multigene analysis in Blood or Tissue by Molecular genetics method
Histiocytic neoplasm multigene analysis in Blood or Tissue by Molecular genetics method
Plasma cell myeloma multigene analysis in Bone marrow by Molecular genetics method
T cell lymphoma multigene analysis in Blood or Tissue by Molecular genetics method
Pepsinogen I/Pepsinogen II [Mass Ratio] in Serum
Platelet aggregation ADP induced ATP secretion in Blood --2 umol/L
Platelet aggregation collagen induced in Platelet rich plasma --2 ug/mL
Fibroblast growth factor 23 [Presence] in Tissue by FISH
Hepatitis A virus cellular receptor 1 [Ratio] in Urine by Calculation
Eosinophil derived neurotoxin [Mass/volume] in Serum by Immunoassay
Galactosylceramidase [Enzymatic activity/volume] in Serum by LC/MS/MS
Galactosylceramidase [Enzymatic activity/volume] in Cerebral spinal fluid by LC/MS/MS
Ethanol cutoff [Volume Fraction] in Exhaled gas
Immunoglobulins and heavy-light chain panel - Serum or Plasma
Protein.glycosylated [Presence] in Serum or Plasma
UBA1 gene mutation in Specimen by Molecular genetics method
V gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal
J gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal
Primer set [Identifier] in Specimen by Molecular genetics method
IgH and IgK gene rearrangement status [Identifier] in Specimen by Molecular genetics method Nominal
Transfuse whole blood autologous [Volume]
Clonal cells rearrangements/Cells counted in Specimen by Molecular genetics method
Abnormal clonal sequences [Nucleotide sequence] in Specimen by Molecular genetics method Nominal
Hematopoietic progenitor cells/Cells.total in Blood by Automated count
ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
BRAF gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ERBB2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ABCG2 gene.p.Q141K [Presence] in Blood or Tissue by Molecular genetics method
Varicella zoster virus immune globulin given [Volume]
ABCB1 gene.c.1236C>T [Presence] in Blood or Tissue by Molecular genetics method
ABCB1 gene.c.2677G>T [Presence] in Blood or Tissue by Molecular genetics method
DPYD gene.c.2846A>T [Presence] in Blood or Tissue by Molecular genetics method
DPYD gene.c.1679T>G [Presence] in Blood or Tissue by Molecular genetics method
UGT1A1 gene.p.G71R [Presence] in Blood or Tissue by Molecular genetics method
UGT1A1 gene.p.P229Q [Presence] in Blood or Tissue by Molecular genetics method
SLCO1B1 gene.c.521T>C [Presence] in Blood or Tissue by Molecular genetics method
HLA-B gene.g.31431780T>G [Presence] in Blood or Tissue by Molecular genetics method
Chromosome 5 and 9 and 15 aneuploidy in Bone marrow by FISH
ROS proto-oncogene 1 mutations tested for in Blood or Tissue by Molecular genetics method Nominal
KIT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PDGFRA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PDGFRA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CDH1 gene rearrangements [Interpretation] in Blood or Tissue by Molecular genetics method Narrative
ESR1 gene mutation [Identifier] in Blood or Tissue by Molecular genetics method Nominal
DPYD gene.c.1905+1G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP3A4 gene c.6C>T [Presence] in Blood or Tissue by Molecular genetics method
CYP3A4 gene.c.IVS10+12G>A [Presence] in Blood or Tissue by Molecular genetics method
AE 1 Ag [Presence] in Tissue by Immune stain
UGT1A9 gene.1b-118(dT)9>10 [Presence] in Blood or Tissue by Molecular genetics method
UGT1A9 gene.p.M33T [Presence] in Blood or Tissue by Molecular genetics method
UGT1A9 gene.c.-2152C>T [Presence] in Blood or Tissue by Molecular genetics method
UGT1A9 gene.c.-275T>A [Presence] in Blood or Tissue by Molecular genetics method
N-Desmethyl imatinib [Mass/volume] in Serum or Plasma
Regorafenib [Mass/volume] in Serum or Plasma
Regorafenib N-oxide [Mass/volume] in Serum or Plasma
Sorafenib N-Oxide [Mass/volume] in Serum or Plasma
AE 3 Ag [Presence] in Tissue by Immune stain
Letrozole [Mass/volume] in Serum or Plasma
Palbociclib [Mass/volume] in Serum or Plasma
Ribociclib [Mass/volume] in Serum or Plasma
Abemaciclib [Mass/volume] in Serum or Plasma
Olaparib [Mass/volume] in Serum or Plasma
Rucaparib [Mass/volume] in Serum or Plasma
Niraparib [Mass/volume] in Serum or Plasma
Lenvatinib [Mass/volume] in Serum or Plasma
B-cell Ag [Presence] in Tissue by Immune stain
Sunitinib [Mass/volume] in Serum or Plasma
N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma
Common myeloid progenitor cell [#/volume] in Blood by Visual count
Common myeloid progenitor cell [#/mass] in Blood
Burst forming unit erythroid [#/volume] in Blood by Visual count
Burst forming unit erythroid [#/mass] in Blood
CXCR4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Lambda lymphocytes/100 lymphocytes in Bone marrow
CD30 Ag [Presence] in Tissue by Immune stain
IDH1 and IDH2 gene full mutation analysis in Blood or Tissue by Molecular genetics method
Acinetobacter sp identified [Type] in Specimen by Sequencing
Adenovirus sp identified [Type] in Specimen by Sequencing
Bacillus anthracis Ab [Titer] in Serum by Immunoassay --1st specimen
Bacillus anthracis Ab [Titer] in Serum by Immunoassay --2nd specimen
Bacillus anthracis protective antigen Ab [Presence] in Serum by Immunoassay
BR-2 Ag [Presence] in Tissue by Immune stain
Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --1st specimen
Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --2nd specimen
Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Borna disease virus RNA [Presence] in Brain tissue by NAA with probe detection
Borna disease virus RNA [Presence] in Brain tissue by Probe
Borna disease virus RNA [Presence] in Brain tissue by Sequencing
Borna disease virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Borna disease virus [Presence] in Specimen
Borna disease virus RNA [Presence] in Specimen by NAA with probe detection
Borna disease virus [Presence] in Specimen by Organism specific culture
Borna disease virus RNA [Presence] in Specimen by Sequencing
Borna disease virus Ag [Presence] in Brain tissue by Immune stain
Borna disease virus Ag [Presence] in Specimen by Immune stain
Borrelia recurrentis [Presence] in Cerebral spinal fluid by Organism specific culture
Borrelia recurrentis [Presence] in Blood by Microscopy
Complement C3 Ag [Presence] in Tissue by Immune stain
Borrelia recurrentis [Presence] in Blood by Organism specific culture
Borrelia recurrentis [Presence] in Specimen by Microscopy
Borrelia recurrentis [Presence] in Specimen by Organism specific culture
Borrelia recurrentis DNA [Presence] in Blood by NAA with probe detection
Borrelia recurrentis DNA [Presence] in Blood by Sequencing
Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by Sequencing
C5B-9 Ag [Presence] in Tissue by Immune stain
Borrelia recurrentis DNA [Presence] in Specimen by NAA with probe detection
Borrelia recurrentis DNA [Presence] in Specimen by Sequencing
Spirochete [Identifier] in Specimen by Microscopy
Brucella melitensis DNA [Presence] in Specimen by NAA with non-probe detection
Brucella sp Ab [Titer] in Serum by Immunoassay --1st specimen
Brucella sp Ab [Titer] in Serum by Immunoassay --2nd specimen
Brucella sp DNA [Identifier] in Specimen by NAA with non-probe detection
CD15 Ag [Presence] in Tissue by Immune stain
Chikungunya virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --1st specimen
Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --2nd specimen
Clostridium baratii [Presence] in Specimen
Clostridium butyricum [Presence] in Specimen
Corynebacterium pseudotuberculosis [Presence] in Specimen by Organism specific culture
CD16 Ag [Presence] in Tissue by Immune stain
Corynebacterium pseudotuberculosis [Presence] in Upper respiratory specimen by Organism specific culture
Corynebacterium ulcerans [Presence] in Specimen by Organism specific culture
Corynebacterium ulcerans [Presence] in Upper respiratory specimen by Organism specific culture
Corynebacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection
Diphtheria toxin DNA [Presence] in Specimen by NAA with probe detection
Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
CD20 Ag [Presence] in Tissue by Immune stain
Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --2nd specimen
Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --1st specimen
Dengue virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Dengue virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Dengue virus IgM Ab [Titer] in Serum by Immunoassay --1st specimen
Dengue virus IgM Ab [Titer] in Serum by Immunoassay --2nd specimen
Ebola virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
H Ab [Presence] in Serum or Plasma from Donor
Ebola virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Echinococcus sp [Identifier] in Specimen
European tick borne encephalitis virus IgA Ab index in Serum and CSF
European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
European tick borne encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
CD3 Ag [Presence] in Tissue by Immune stain
European tick borne encephalitis virus IgM Ab [Titer] in Serum by Immunoassay
European tick borne encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
European tick borne encephalitis virus RNA [Presence] in Tissue postmortem by NAA with probe detection
Francisella tularensis Ab [Titer] in Serum by Immunoassay --1st specimen
Francisella tularensis Ab [Titer] in Serum by Immunoassay --2nd specimen
Giardia lamblia cysts [Presence] in Stool by Microscopy
Giardia lamblia trophozoites [Presence] in Stool by Microscopy
Hantavirus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Hantavirus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Hepatitis A virus IgM Ab [Titer] in Serum
Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
CD34 Ag [Presence] in Tissue by Immune stain
Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Lassa virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Lassa virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Legionella sp Ab [Titer] in Serum Qualitative by Immunoassay --1st specimen
Legionella sp Ag [Identifier] in Urine by Immunoassay
CD56 Ag [Presence] in Tissue by Immune stain
Leptospira sp Ab [Titer] in Serum by Immunoassay --2nd specimen
Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --1st specimen
Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --2nd specimen
Measles virus genotype [Identifier] in Specimen by Sequencing
Measles virus IgG Ab avidity [Ratio] in Serum by Immunoassay
Measles virus IgM Ab [Ratio] in Serum by Immunoassay
CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain
Middle East respiratory syndrome coronavirus (MERS-CoV) [Presence] in Specimen by Neutralization test
Mumps virus IgM Ab [Units/volume] in Serum and CSF
Mycobacterium leprae Ab. anti-PGL-1 Ab [Titer] in Serum
Mycobacterium leprae DNA [Presence] in Specimen by NAA with probe detection
Norovirus genogroup II Ag [Presence] in Stool
Polio virus 1 Ab [Titer] in Serum by Immunoassay --1st specimen
Polio virus 1 Ab [Titer] in Serum by Immunoassay --2nd specimen
Polio virus 3 Ab [Titer] in Serum by Immunoassay --1st specimen
Polio virus 3 Ab [Titer] in Serum by Immunoassay --2nd specimen
Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Rubella virus IgM Ab index [Units/volume] in Serum and CSF
Salmonella paratyphi DNA [Presence] in Isolate by NAA with probe detection
CD57 Ag [Presence] in Tissue by Immune stain
Salmonella paratyphi [Identifier] in Isolate by Agglutination
Salmonella paratyphi DNA [Presence] in Blood by NAA with probe detection
Salmonella typhi DNA [Presence] in Isolate by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoblot
Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
CD11c Ag [Presence] in Tissue by Immune stain
Varicella zoster virus Ab.IgA index in Serum and CSF
Varicella zoster virus IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay
Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay
Leukocyte common Ag [Presence] in Tissue by Immune stain
Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
Yersinia enterocolitica biotype [Presence] in Stool
Yersinia enterocolitica O:3 Ab [Presence] in Stool
Yersinia enterocolitica O:5 Ab [Presence] in Stool
Yersinia enterocolitica O:8 Ab [Presence] in Stool
Yersinia enterocolitica O:9 Ab [Presence] in Stool
Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
M-5 Ag [Presence] in Tissue by Immune stain
Yersinia pseudotuberculosis 1 Ab [Presence] in Stool
Yersinia pseudotuberculosis 2 Ab [Presence] in Stool
Yersinia pseudotuberculosis 3 Ab [Presence] in Stool
Zika virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen
Zika virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
T-cell Ag [Presence] in Tissue by Immune stain
Glucose [Mass/volume] in Serum or Plasma --1 hour post meal
Glucose [Mass/volume] in Serum or Plasma --10 hours fasting
Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting
Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO
Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --6 hours fasting
Actin Ag [Presence] in Tissue by Immune stain
Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain
Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain
Lactalbumin alpha Ag [Presence] in Tissue by Immune stain
Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain
Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain
Amyloid A component Ag [Presence] in Tissue by Immune stain
Amyloid P component Ag [Presence] in Tissue by Immune stain
Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain
Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain
Calcitonin Ag [Presence] in Tissue by Immune stain
Carcinoembryonic Ag [Presence] in Tissue by Immune stain
Choriogonadotropin Ag [Presence] in Tissue by Immune stain
Chromogranin A Ag [Presence] in Tissue by Immune stain
Chromogranin Ag [Presence] in Tissue by Immune stain
Chymotrypsin Ag [Presence] in Tissue by Immune stain
Collagen type 4 Ag [Presence] in Tissue by Immune stain
Corticotropin Ag [Presence] in Tissue by Immune stain
Desmin Ag [Presence] in Tissue by Immune stain
Enolase.neuron specific Ag [Presence] in Tissue by Immune stain
Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain
CD227 Ag [Presence] in Tissue by Immune stain
Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain
Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain
Gastrin Ag [Presence] in Tissue by Immune stain
Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain
Glucagon Ag [Presence] in Tissue by Immune stain
Hemoglobin Ag [Presence] in Tissue by Immune stain
HMB-45 Ag [Presence] in Tissue by Immune stain
IgA Ag [Presence] in Tissue by Immune stain
IgA.heavy chain Ag [Presence] in Tissue by Immune stain
IgE Ag [Presence] in Tissue by Immune stain
IgG Ag [Presence] in Tissue by Immune stain
IgG.heavy chain Ag [Presence] in Tissue by Immune stain
IgM Ag [Presence] in Tissue by Immune stain
IgM.heavy chain Ag [Presence] in Tissue by Immune stain
Insulin Ag [Presence] in Tissue by Immune stain
Kappa light chains Ag [Presence] in Tissue by Immune stain
Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain
Keratin Ag [Presence] in Tissue by Immune stain
Lambda light chains Ag [Presence] in Tissue by Immune stain
Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain
Lutropin [Units/volume] in Serum or Plasma
Lutropin Ag [Presence] in Tissue by Immune stain
Lysozyme Ag [Presence] in Tissue by Immune stain
Myelin basic protein Ag [Presence] in Tissue by Immune stain
Myoglobin Ag [Presence] in Tissue by Immune stain
Peanut agglutinin Ag [Presence] in Tissue by Immune stain
Prolactin Ag [Presence] in Tissue by Immune stain
Prostate specific Ag [Presence] in Tissue by Immune stain
Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain
S-100 Ag [Presence] in Tissue by Immune stain
Serotonin Ag [Presence] in Tissue by Immune stain
Hemolytic disease of newborn screen [Interpretation] in Blood
Somatostatin Ag [Presence] in Tissue by Immune stain
Somatotropin Ag [Presence] in Tissue by Immune stain
Synaptophysin Ag [Presence] in Tissue by Immune stain
Thyroglobulin Ag [Presence] in Tissue by Immune stain
Thyrotropin Ag [Presence] in Tissue by Immune stain
Trypsin Ag [Presence] in Tissue by Immune stain
Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain
Vimentin Ag [Presence] in Tissue by Immune stain
Coagulation factor VI Ag [Presence] in Tissue by Immune stain
Coagulation factor VIII Ag [Presence] in Tissue by Immune stain
Coagulation factor XIII Ag [Presence] in Tissue by Immune stain
Fibrinogen Ag [Presence] in Tissue by Immune stain
Microscopic observation [Identifier] in Cervix by Cyto stain
Microscopic observation [Identifier] in Specimen by Cyto stain
Microscopic observation [Identifier] in Sputum by Cyto stain
Microscopic observation [Identifier] in Tissue by Cyto stain
Acetophenazine [Mass/volume] in Serum or Plasma
Amoxapine metabolite [Mass/volume] in Serum or Plasma
Aprobarbital [Mass/volume] in Serum or Plasma
Bretylium [Mass/volume] in Serum or Plasma
Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma
Diazoxide [Mass/volume] in Serum or Plasma
Digoxin [Mass/volume] in Serum or Plasma
Dipyridamole [Mass/volume] in Serum or Plasma
glipiZIDE [Mass/volume] in Serum or Plasma
glyBURIDE [Mass/volume] in Serum or Plasma
Mepivacaine [Mass/volume] in Serum or Plasma
Metharbital [Mass/volume] in Serum or Plasma
Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma
Normeperidine [Presence] in Serum or Plasma
Normephenytoin [Mass/volume] in Serum or Plasma
Normethsuximide [Mass/volume] in Serum or Plasma
Primidone+PHENobarbital [Mass/volume] in Serum or Plasma
Phenytoin Free/Phenytoin.total in Serum or Plasma
Pirmenol [Mass/volume] in Serum or Plasma
Triamterene [Mass/volume] in Serum or Plasma
Tricyclic antidepressants [Mass/volume] in Serum or Plasma
Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid
Acrosin [Entitic Catalytic Activity] in Spermatozoa
Adenosine triphosphate [Moles/volume] in Semen
Carcinoembryonic Ag [Units/volume] in Semen
Cells other than spermatozoa [#/volume] in Semen
Choriogonadotropin [Units/volume] in Semen
Ceforanide [Susceptibility] by Disk diffusion (KB)
Glucosidase [Enzymatic activity/volume] in Seminal plasma
Glycerophosphocholine [Moles/volume] in Seminal plasma
Prostaglandin F1 alpha [Moles/volume] in Semen
I Ab [Presence] in Serum or Plasma from Blood product unit
Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB)
Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB)
Primary Spermatocytes [#/volume] in Semen
Secondary Spermatocytes [#/volume] in Semen
Spermatozoa Pyriform Head/100 spermatozoa in Semen
Spermatozoa Tapering Head/100 spermatozoa in Semen
I Ab [Presence] in Serum or Plasma from Donor
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus
Spermatozoa Abnormal Head/100 spermatozoa in Semen
Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen
Spermatozoa Abnormal Tail/100 spermatozoa in Semen
Spermatozoa Agglutinated/100 spermatozoa in Semen
Spermatozoa Amorphous Head/100 spermatozoa in Semen
Spermatozoa Coiled Tail/100 spermatozoa in Semen
Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen
Spermatozoa Duplicate Head/100 spermatozoa in Semen
Spermatozoa Duplicate Tail/100 spermatozoa in Semen
Spermatozoa Immotile/100 spermatozoa in Semen
Spermatozoa Large Oval Head/100 spermatozoa in Semen
Spermatozoa Viable/100 spermatozoa in Semen
Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead
Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction
Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead
Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction
Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead
Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction
Spermatozoa Nonprogressive/100 spermatozoa in Semen
Spermatozoa Normal Head/100 spermatozoa in Semen
Spermatozoa Normal/100 spermatozoa in Semen
Spermatozoa Pin Head/100 spermatozoa in Semen
Spermatozoa Rapid/100 spermatozoa in Semen
Spermatozoa Round Head/100 spermatozoa in Semen
Spermatozoa Slow/100 spermatozoa in Semen
Spermatozoa Small Oval Head/100 spermatozoa in Semen
Spermatozoa Tail Swelling/100 spermatozoa in Semen
Spermatozoa Vacuolated Head/100 spermatozoa in Semen
Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
Acanthamoeba sp identified in Eye by Organism specific culture
Acanthamoeba sp identified in Eye by Wet preparation
Microscopic observation [Identifier] in Tissue by Night blue stain
Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture
Thermophilic Actinomycetes identified in Specimen by Organism specific culture
Amoeba identified in Aspirate by Immune stain
Amoeba identified in Aspirate by Wet preparation
Amoeba identified in Stool by Organism specific culture
Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence
Astrovirus [Identifier] in Stool by Electron microscopy
Babesia sp identified in Blood by Thick film
Babesia sp identified in Blood by Thin film
Calicivirus [Identifier] in Stool by Electron microscopy
Ceforanide [Susceptibility] by Serum bactericidal titer
Candida sp DNA [Presence] in Blood by Probe with amplification
Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial
Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification
Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)
Coccidia identified in Duodenal fluid by Acid fast stain
Coccidia identified in Stool by Acid fast stain
Cyanobacterium identified in Water by Light microscopy
Cyclospora sp identified in Stool by Acid fast stain
Cytomegalovirus Ag [Presence] in Tissue by Immune stain
Dinoflagellate identified in Water by Light microscopy
Filaria identified in Blood by Concentration
Filaria identified in Blood by Thick film
Filaria identified in Blood by Thin film
Fungus colony count [#/volume] in Specimen by Environmental culture
Fungus identified in Tissue by Fontana-Masson stain
Fungus identified in Specimen by Animal inoculation
Fungus identified in Specimen by Environmental culture
Fungus identified in Specimen by Sticky tape for environmental fungus
Giardia lamblia [Presence] in Stool by Organism specific culture
Helminth+Arthropod identified in Specimen
Hepatitis B virus core Ag [Presence] in Tissue by Immune stain
Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain
Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain
Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain
Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain
Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy
Herpes simplex virus identified in Tissue by Electron microscopy
Hydatid cyst identified in Aspirate by Immune stain
Hydatid cyst identified in Liver by Wet preparation
Hydatid cyst identified in Lung tissue by Wet preparation
Jk sup(a) Ab [Presence] in Serum or Plasma from Donor
Leishmania sp identified in Tissue by Giemsa stain
Leishmania sp identified in Tissue by Organism specific culture
Microscopic observation [Identifier] in Hair by KOH preparation
Microscopic observation [Identifier] in Nail by KOH preparation
Microsporidia identified in Duodenal fluid by Trichrome stain modified
Mushroom.toxic identified in Food by Light microscopy
Mushroom.toxic identified in Vomitus by Light microscopy
Jk sup(a) Ab [Presence] in Serum or Plasma
Naegleria sp identified in Tissue by Organism specific culture
Naegleria sp identified in Tissue by Wet preparation
Norovirus [Identifier] in Stool by Electron microscopy
Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)
Nystatin [Susceptibility] by Minimum lethal concentration (MLC)
Onchocerca sp identified in Tissue by Wet preparation
Orthopoxvirus [Identifier] in Skin by Electron microscopy
Ova and parasites identified in Stool by Concentration
Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Ova and parasites identified in Stool by Immune stain
Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain
Ova and parasites identified in Stool by Light microscopy
Human papilloma virus Ag [Presence] in Tissue by Immune stain
Picornavirus [Identifier] in Stool by Electron microscopy
Toxic Plant identified in Plant specimen by Inspection
Toxic Plant identified in Vomitus by Light microscopy
Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence
Jk sup(a) Ag [Presence] on Red Blood Cells from Donor
Plasmodium sp identified in Blood by Thin film
Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence
Pneumocystis sp identified in Lung tissue
Prototheca identified in Specimen by Culture
Schistosoma sp identified in Urine sediment by Light microscopy
Schistosoma sp identified in Specimen by Organism specific culture
Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination
Strongyloides sp Ab [Units/volume] in Serum by Immunoassay
Taenia solium adult Ab [Units/volume] in Serum by Immunoblot
Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)
Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)
Torovirus [Identifier] in Stool by Electron microscopy
Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay
Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay
Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification
Toxoplasma gondii [Presence] in Tissue by Giemsa stain
Jk sup(a) Ag [Presence] on Red Blood Cells
Trichomonas sp identified in Genital specimen by Organism specific culture
Trypanosoma sp identified in Blood by Light microscopy
Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)
Trypanosoma sp identified in Blood by Organism specific culture
Trypanosoma sp identified in Blood by Thick film
Trypanosoma sp identified in Blood by Thin film
Trypanosoma sp identified in Blood by Wet preparation
Varicella zoster virus identified in Skin by Electron microscopy
Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Virus identified in Cerebral spinal fluid by Electron microscopy
Virus identified in Stool by Electron microscopy
Virus identified in Tissue by Electron microscopy
Virus identified in Specimen by Electron microscopy
Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain
Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain
Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified
Amyloid.microscopic observation [Identifier] in Tissue by Highman stain
Jk sup(b) Ab [Presence] in Serum or Plasma from Donor
Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain
Bile.microscopic observation [Identifier] in Tissue by Fouchet stain
Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain
Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain
Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain
Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain
Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson
Jk sup(b) Ab [Presence] in Serum or Plasma
Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain
Fat.microscopic observation [Identifier] in Milk by Sudan IV stain
Fat.microscopic observation [Identifier] in Stool by Sudan IV stain
Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain
Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott
Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain
Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald
Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain
Iron.microscopic observation [Identifier] in Sputum by Gomori stain
Iron.microscopic observation [Identifier] in Tissue by Gomori stain
Iron.microscopic observation [Identifier] in Tissue by Other stain
Microscopic observation [Identifier] in Blood by Hemosiderin stain
Microscopic observation [Identifier] in Body fluid by Sudan black stain
Microscopic observation [Identifier] in Sputum by Silver stain
Microscopic observation [Identifier] in Tissue by Acetate esterase stain
Microscopic observation [Identifier] in Tissue by Alcian blue stain
Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated
Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff
Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Microscopic observation [Identifier] in Tissue by Alizarin red S stain
Microscopic observation [Identifier] in Tissue by Argentaffin stain
Microscopic observation [Identifier] in Tissue by Azure-eosin stain
Microscopic observation [Identifier] in Tissue by Basic fuchsin stain
Microscopic observation [Identifier] in Tissue by Bielschowsky stain
Microscopic observation [Identifier] in Tissue by Bleach stain
Microscopic observation [Identifier] in Tissue by Bodian stain
Jk sup(b) Ag [Presence] on Red Blood Cells from Donor
Microscopic observation [Identifier] in Tissue by Brown and Brenn stain
Microscopic observation [Identifier] in Tissue by Butyrate esterase stain
Microscopic observation [Identifier] in Tissue by Carmine stain.Best
Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain
Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain
Microscopic observation [Identifier] in Tissue by Congo red stain
Microscopic observation [Identifier] in Tissue by Crystal violet stain
Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific
Jk sup(b) Ag [Presence] on Red Blood Cells
Microscopic observation [Identifier] in Tissue by Fite-Faraco stain
Microscopic observation [Identifier] in Tissue by Gridley stain
Microscopic observation [Identifier] in Tissue by Hansel stain
Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain
Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain
Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain
Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones
Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Microscopic observation [Identifier] in Tissue by Methyl green stain
Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain
Microscopic observation [Identifier] in Tissue by Methyl violet stain
Microscopic observation [Identifier] in Tissue by Mucicarmine stain
Microscopic observation [Identifier] in Tissue by Neutral red stain
Microscopic observation [Identifier] in Tissue by Oil red O stain
Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat
Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion
Js sup(a) Ab [Presence] in Serum or Plasma from Donor
Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain
Microscopic observation [Identifier] in Tissue by Prussian blue stain
Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain
Microscopic observation [Identifier] in Tissue by Reticulin stain
Microscopic observation [Identifier] in Tissue by Safranin stain
Microscopic observation [Identifier] in Tissue by Schmorl stain
Microscopic observation [Identifier] in Tissue by Sevier-Munger stain
Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle
Microscopic observation [Identifier] in Tissue by Silver nitrate stain
Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson
Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius
Microscopic observation [Identifier] in Tissue by Steiner stain
Microscopic observation [Identifier] in Tissue by Sudan black stain
Microscopic observation [Identifier] in Tissue by Supravital stain
Microscopic observation [Identifier] in Tissue by Tetrachrome stain
Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley
Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified
Js sup(a) Ab [Presence] in Serum or Plasma
Microscopic observation [Identifier] in Tissue by Wade stain
Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer
Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale
Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain
Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain
Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain
Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain
Urate crystals.microscopic observation [type] in Tissue by De Galantha stain
Silicon [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO
Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO
Globulin [Mass/volume] in Serum by calculation
Js sup(a) Ag [Presence] on Red Blood Cells from Donor
Lipoprotein a [Mass/volume] in Serum or Plasma
Organic acids [Presence] in Serum or Plasma
Phosphoserine [Mass/volume] in Serum or Plasma
Troponin I.cardiac [Mass/volume] in Serum or Plasma
methazolAMIDE [Mass/volume] in Serum or Plasma
Js sup(a) Ag [Presence] on Red Blood Cells
Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification
Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification
Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence
Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Cyclospora cayetanensis [Presence] in Specimen
Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture
Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified
Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy
Microscopic observation [Identifier] in Genital mucus by Gram stain
Microsporidia identified in Specimen by Light microscopy
Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain
Varicella zoster virus [Presence] in Specimen by Organism specific culture
Progesterone receptor [Mass/mass] in Tissue
Immune complex [Units/volume] in Serum or Plasma by Raji cell assay
Intercellular substance Ab [Presence] in Serum
Js sup(b) Ab [Presence] in Serum or Plasma from Donor
Bacitracin [Susceptibility] by Disk diffusion (KB)
Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO
Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO
Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO
Xylose [Mass/volume] in Blood --baseline
Beta-2-Microglobulin [Mass/time] in 24 hour Urine
Js sup(b) Ab [Presence] in Serum or Plasma
Iodine.protein bound [Mass/volume] in Serum or Plasma
Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells
Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma
Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
Lipase [Enzymatic activity/volume] in Urine
Js sup(b) Ag [Presence] on Red Blood Cells from Donor
Pentoxifylline [Mass/volume] in Serum or Plasma
Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID)
Clostridioides difficile toxin B [Presence] in Stool
Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Amdinocillin [Susceptibility] by Serum bactericidal titer
Js sup(b) Ag [Presence] on Red Blood Cells
Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay
HIV 2 gp125 Ab [Presence] in Serum by Immunoblot
HIV 2 gp36 Ab [Presence] in Serum by Immunoblot
La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence
La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence
Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence
Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence
Dichlorobenzidine [Mass/volume] in Urine
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine
K Ab [Presence] in Serum or Plasma from Blood product unit
Bamboo shoot IgE Ab [Units/volume] in Serum
Blomia tropicalis IgE Ab [Units/volume] in Serum
Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum
Starfruit IgE Ab [Units/volume] in Serum
Chub Mackerel IgE Ab [Units/volume] in Serum
K Ab [Presence] in Serum or Plasma from Donor
Deer epithelium IgE Ab [Units/volume] in Serum
Elk or Moose Meat IgE Ab [Units/volume] in Serum
Fennel Fresh IgE Ab [Units/volume] in Serum
Fennel Seed IgE Ab [Units/volume] in Serum
Fish Feed IgE Ab [Units/volume] in Serum
Daphnia (fish feed) IgE Ab [Units/volume] in Serum
Horse serum proteins IgE Ab [Units/volume] in Serum
Mare milk IgE Ab [Units/volume] in Serum
Mediterranean flour moth IgE Ab [Units/volume] in Serum
Cow milk boiled IgE Ab [Units/volume] in Serum
Milk powder IgE Ab [Units/volume] in Serum
K Ag [Presence] on Red Blood Cells from Blood product unit
Mink epithelium IgE Ab [Units/volume] in Serum
Passion fruit IgE Ab [Units/volume] in Serum
Persimmon IgE Ab [Units/volume] in Serum
Pigeon feather IgE Ab [Units/volume] in Serum
Malassezia furfur IgE Ab [Units/volume] in Serum
Reindeer epithelium IgE Ab [Units/volume] in Serum
Swine urine proteins IgE Ab [Units/volume] in Serum
Long Leaf Pine IgE Ab [Units/volume] in Serum
Short Leaf Pine IgE Ab [Units/volume] in Serum
Slash Pine IgE Ab [Units/volume] in Serum
Virginia Scrub Pine IgE Ab [Units/volume] in Serum
K Ag [Presence] on Red Blood Cells from Donor
Rabbit serum proteins IgE Ab [Units/volume] in Serum
Rabbit urine proteins IgE Ab [Units/volume] in Serum
Spondylocladium citrovirens IgE Ab [Units/volume] in Serum
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO
Cystine+Homocysteine [Presence] in Urine
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood
3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma
Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine
6-Monoacetylmorphine (6-MAM) [Presence] in Urine
Amitriptyline+Nortriptyline [Mass/volume] in Urine
Cephapirin [Mass/volume] in Serum or Plasma
Demeclocycline [Mass/volume] in Serum or Plasma
Kp sup(a) Ab [Presence] in Serum or Plasma from Donor
Norparamethadione [Mass/volume] in Serum or Plasma
Dicloxacillin [Mass/volume] in Serum or Plasma
Doxapram [Mass/volume] in Serum or Plasma
Doxycycline [Mass/volume] in Serum or Plasma
Fluconazole [Mass/volume] in Serum or Plasma
fluvoxaMINE [Mass/volume] in Serum or Plasma
Itraconazole [Mass/volume] in Serum or Plasma
Cefotaxime [Susceptibility] by Disk diffusion (KB)
Ketoconazole [Mass/volume] in Serum or Plasma
Kp sup(a) Ab [Presence] in Serum or Plasma
metroNIDAZOLE [Mass/volume] in Serum or Plasma
Norclozapine [Mass/volume] in Serum or Plasma
Nafcillin [Mass/volume] in Serum or Plasma
Naltrexone [Mass/volume] in Serum or Plasma
Neomycin [Mass/volume] in Serum or Plasma
Normeperidine [Mass/volume] in Serum or Plasma
O-desmethylencainide [Mass/volume] in Serum or Plasma
Paramethadione [Mass/volume] in Serum or Plasma
Pyrazinamide [Mass/volume] in Serum or Plasma
Ticlopidine [Mass/volume] in Serum or Plasma
Tricyclic antidepressants [Presence] in Urine
Trimethoprim [Mass/volume] in Serum or Plasma
Borrelia burgdorferi Ab [Presence] in Serum
Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Borrelia burgdorferi Ag [Units/volume] in Urine
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Reovirus Ab [Titer] in Serum by Complement fixation
Somatotropin Ab [Titer] in Serum or Plasma
Kp sup(a) Ag [Presence] on Red Blood Cells from Donor
Somatotropin binding protein [Moles/volume] in Serum or Plasma
Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific
Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain
Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain
Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain
Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain
Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain
Kp sup(a) Ag [Presence] on Red Blood Cells
Benzodiazepines [Mass/volume] in Serum or Plasma
Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum
Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Lymphocytes/100 leukocytes in Body fluid
Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO
Acetylcholine receptor binding Ab [Moles/volume] in Serum
Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma
Beta+gamma tocopherol [Mass/volume] in Serum or Plasma
C reactive protein [Presence] in Serum or Plasma
Creatinine [Mass/volume] in Serum or Plasma --post dialysis
Creatinine [Mass/volume] in Serum or Plasma --pre dialysis
Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells
Enolase [Enzymatic activity/volume] in Red Blood Cells
Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
Kp sup(b) Ab [Presence] in Serum or Plasma from Donor
Kappa light chains [Mass/volume] in Serum or Plasma
Lambda light chains [Mass/volume] in Serum or Plasma
Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
Melatonin [Mass/volume] in Serum or Plasma
Kp sup(b) Ab [Presence] in Serum or Plasma
Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells
Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells
Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells
11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine
Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma
Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells
Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis
Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells
Microscopic observation [Identifier] in Body fluid by Cyto stain
Microscopic observation [Identifier] in Gastric fluid by Cyto stain
Cefotaxime [Susceptibility] by Serum bactericidal titer
Microscopic observation [Identifier] in Urine by Cyto stain
Kp sup(b) Ag [Presence] on Red Blood Cells from Donor
Despropionylfentanyl [Mass/volume] in Serum or Plasma
Despropionylfentanyl [Mass/volume] in Urine
Norfentanyl [Mass/volume] in Serum or Plasma
Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot
HIV 2 gp80 Ab [Presence] in Serum by Immunoblot
HIV 2 p26 Ab [Presence] in Serum by Immunoblot
Kp sup(b) Ag [Presence] on Red Blood Cells
HIV 2 p53 Ab [Presence] in Serum by Immunoblot
HIV 2 p56 Ab [Presence] in Serum by Immunoblot
HIV 2 p68 Ab [Presence] in Serum by Immunoblot
Human papilloma virus identified in Cervix
Schistosoma sp identified in Stool by Concentration
Streptococcus pneumoniae Ag [Presence] in Serum
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid
Smith extractable nuclear Ab [Units/volume] in Serum
Alpha chlordane [Mass/volume] in Serum or Plasma
Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma
Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma
Dieldrin [Mass/volume] in Serum or Plasma
Gamma chlordane [Mass/volume] in Serum or Plasma
Lindane [Mass/volume] in Serum or Plasma
Malaoxon [Mass/volume] in Serum or Plasma
Methoxychlor [Mass/volume] in Serum or Plasma
Tetrachloroethylene [Mass/volume] in Blood
Bacteria [#/area] in Synovial fluid by Microscopy high power field
Charcot-leyden crystals [type] in Specimen by Trichrome stain
Band form neutrophils/100 cells in Bone marrow by Manual count
Normoblasts Basophilic/100 cells in Bone marrow by Manual count
Basophils/100 cells in Bone marrow by Manual count
Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Eosinophils/100 cells in Bone marrow by Manual count
Variant lymphocytes/100 cells in Bone marrow by Manual count
Lymphocytes/100 cells in Bone marrow by Manual count
Mast cells/100 cells in Bone marrow by Manual count
Megakaryocytes/100 cells in Bone marrow by Manual count
Metamyelocytes/100 cells in Bone marrow by Manual count
Monocytes/100 cells in Bone marrow by Manual count
Myeloblasts/100 cells in Bone marrow by Manual count
Le sup(a) Ab [Presence] in Serum or Plasma from Donor
Myelocytes/100 cells in Bone marrow by Manual count
Neutrophils/100 cells in Bone marrow by Manual count
Normoblasts Orthochromic/100 cells in Bone marrow by Manual count
Plasma cells immature/100 cells in Bone marrow by Manual count
Plasma cells/100 cells in Bone marrow by Manual count
Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count
Promyelocytes/100 cells in Bone marrow by Manual count
Prolymphocytes/100 cells in Bone marrow by Manual count
Le sup(a) Ab [Presence] in Serum or Plasma
Promonocytes/100 cells in Bone marrow by Manual count
Pronormoblasts/100 cells in Bone marrow by Manual count
Platelet morphology finding [Identifier] in Blood
Erythrocytes [Morphology] in Bone marrow
Segmented neutrophils/100 cells in Bone marrow
Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Catecholamines Free [Mass/volume] in Urine
Appearance of Spun Cerebral spinal fluid
Myeloid cells/Erythroid cells [# Ratio] in Bone marrow
Metanephrine [Moles/time] in 24 hour Urine
Phosphate/Creatinine [Mass Ratio] in Urine
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine
Homovanillate/Creatinine [Mass Ratio] in Urine
Myoglobin/Creatinine [Mass Ratio] in Urine
Le sup(a) Ag [Presence] on Red Blood Cells from Donor
cefoTEtan [Susceptibility] by Minimum lethal concentration (MLC)
Hematocrit [Volume Fraction] of Cord blood
Hematocrit [Volume Fraction] of Body fluid
Cholinesterase [Enzymatic activity/volume] in Blood
Le sup(a) Ag [Presence] on Red Blood Cells
Cortisol/Creatinine [Mass Ratio] in Urine
Leukocyte morphology finding [Identifier] in Blood
Beta lactoglobulin IgG Ab [Units/volume] in Serum
Wheat Bran IgE Ab [Units/volume] in Serum
Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Carageenan IgE Ab [Units/volume] in Serum
Cream Cheese IgE Ab [Units/volume] in Serum
Chinchilla IgE Ab [Units/volume] in Serum
Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum
Cockatiel feather IgE Ab [Units/volume] in Serum
Arizona Cypress IgE Ab [Units/volume] in Serum
Deer hair IgE Ab [Units/volume] in Serum
Dematiaceae IgE Ab [Units/volume] in Serum
Le sup(b) Ab [Presence] in Serum or Plasma from Donor
Erythromycin IgE Ab [Units/volume] in Serum
Ferret epithelium IgE Ab [Units/volume] in Serum
Grain weevel IgE Ab [Units/volume] in Serum
Helminthosporium sativum IgE Ab [Units/volume] in Serum
Lactalbumin alpha IgG Ab [Units/volume] in Serum
Lactalbumin beta IgE Ab [Units/volume] in Serum
Beta galactosidase IgE Ab [Units/volume] in Serum
Lycopodium spp IgE Ab [Units/volume] in Serum
Macadamia IgE Ab [Units/volume] in Serum
Foxtail Millet IgE Ab [Units/volume] in Serum
Penicillium frequentans IgE Ab [Units/volume] in Serum
Le sup(b) Ab [Presence] in Serum or Plasma
Jalepeno Pepper IgE Ab [Units/volume] in Serum
Protamine IgE Ab [Units/volume] in Serum
Pumpkin Seed IgE Ab [Units/volume] in Serum
Rape Pollen IgE Ab [Units/volume] in Serum
Orange roughy IgE Ab [Units/volume] in Serum
Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Sardine (pilchard) IgE Ab [Units/volume] in Serum
Succinylcholine IgE Ab [Units/volume] in Serum
Trichosporon pullulans IgE Ab [Units/volume] in Serum
Ulocladium chartarum IgE Ab [Units/volume] in Serum
Le sup(b) Ag [Presence] on Red Blood Cells from Donor
18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma
Alpha-1-Fetoprotein [Mass/volume] in Body fluid
Atrial natriuretic factor [Mass/volume] in Plasma
Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid
Cancer Ag 125 [Units/volume] in Body fluid
Carbon dioxide, total [Moles/volume] in Body fluid
Le sup(b) Ag [Presence] on Red Blood Cells
Corticotropin releasing hormone [Mass/volume] in Serum or Plasma
Delta aminolevulinate [Mass/volume] in Urine
Microalbumin [Mass/volume] in Urine by Test strip
Immunoglobulin light chains [Presence] in Serum
Iodine Free [Mass/time] in 24 hour Urine
Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit
Pentacarboxylporphyrins [Mass/volume] in Urine
Pentacarboxylporphyrins [Presence] in Urine
Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid
3-O-Methyldopa [Mass/volume] in Serum or Plasma
cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC)
Astemizole [Mass/volume] in Serum or Plasma
Bromocriptine [Mass/volume] in Serum or Plasma
Brompheniramine [Mass/volume] in Serum or Plasma
Gemfibrozil [Mass/volume] in Serum or Plasma
hydrALAZINE [Mass/volume] in Serum or Plasma
Hydroxyalprazolam [Mass/volume] in Urine
Le sup(x) Ab [Presence] in Serum or Plasma from Donor
Hyoscyamine [Mass/volume] in Serum or Plasma
Mercaptopurine [Mass/volume] in Serum or Plasma
Morphine Free [Mass/volume] in Serum or Plasma
Le sup(x) Ab [Presence] in Serum or Plasma
Pergolide [Mass/volume] in Serum or Plasma
Phenacemide [Mass/volume] in Serum or Plasma
Phenylethylmalonate [Mass/volume] in Serum or Plasma
Piroxicam [Mass/volume] in Serum or Plasma
Scopolamine [Mass/volume] in Serum or Plasma
Le Ab [Presence] in Serum or Plasma from Blood product unit
Chlamydophila pneumoniae Ab [Titer] in Serum
Haemophilus ducreyi [Presence] in Specimen by Organism specific culture
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay
Hepatitis B virus DNA [Units/volume] in Serum
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
HTLV I Ab [Presence] in Serum by Immunoassay
Bacteria identified in Vaginal fluid by Aerobe culture
Le Ab [Presence] in Serum or Plasma from Donor
Parainfluenza virus 3 IgG Ab [Titer] in Serum
Parainfluenza virus 3 IgM Ab [Titer] in Serum
Salmonella paratyphi A Ab [Presence] in Serum by Agglutination
Salmonella paratyphi B Ab [Presence] in Serum by Agglutination
Streptococcus agalactiae Ag [Presence] in Specimen
Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture
Streptococcus pyogenes [Presence] in Throat by Organism specific culture
Streptococcus pyogenes Ag [Presence] in Serum by Agglutination
Viral inclusion bodies [Identifier] in Specimen by Cyto stain
Hematocrit [Volume Fraction] of Cord blood by Automated count
MCV [Entitic volume] in Cord blood by Automated count
Erythrocytes [Morphology] in Blood by Automated count
Elliptocytes [Presence] in Blood by Light microscopy
Large granular lymphocytes/100 leukocytes in Blood by Manual count
Tubular cells [Presence] in Urine sediment by Light microscopy
Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field
Bladder cells [#/area] in Urine sediment by Microscopy high power field
Urine sediment comments by Light microscopy Narrative
Cabot rings [Presence] in Blood by Light microscopy
Auer rods [Presence] in Blood by Light microscopy
cefoTEtan [Susceptibility] by Disk diffusion (KB)
Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Lu sup(a) Ab [Presence] in Serum or Plasma from Donor
Lu sup(a) Ab [Presence] in Serum or Plasma
Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Lu sup(a) Ag [Presence] on Red Blood Cells from Donor
Lu sup(a) Ag [Presence] on Red Blood Cells
Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit
Lu sup(ab) Ab [Presence] in Serum or Plasma from Donor
Lu sup(ab) Ab [Presence] in Serum or Plasma
Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Lu sup(b) Ab [Presence] in Serum or Plasma from Donor
Lu sup(b) Ab [Presence] in Serum or Plasma
Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Lu sup(b) Ag [Presence] on Red Blood Cells from Donor
Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot
Bacillus anthracis Ab [Units/volume] in Specimen by Immunofluorescence
Bacillus anthracis [Presence] in Specimen by Organism specific culture
Clostridium botulinum toxin [Units/volume] in Stool
Hydatid cyst identified in Specimen by Wet preparation
Microorganism identified in Specimen by Culture
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain
Microscopic observation [Identifier] in Sputum by Acid fast stain
Lu sup(b) Ag [Presence] on Red Blood Cells
Microscopic observation [Identifier] in Stool by Acid fast stain
Microscopic observation [Identifier] in Tissue by Acid fast stain
Microscopic observation [Identifier] in Urine by Acid fast stain
Human papilloma virus identified in Specimen
Rickettsia rickettsii RNA [Presence] in Tissue by NAA with probe detection
Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
Virus identified in Amniotic fluid by Culture
cefoTEtan [Susceptibility] by Serum bactericidal titer
little c Ab [Presence] in Serum or Plasma from Blood product unit
Microscopic observation [Identifier] in Specimen by Acid fast stain
Microscopic observation [Identifier] in Specimen by Other stain
Borrelia burgdorferi [Presence] in Specimen by Organism specific culture
little c Ab [Presence] in Serum or Plasma from Donor
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification
Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology
Microscopic exam [Interpretation] of Sputum by Cytology
Carbon dioxide [Partial pressure] in Blood
cefOXitin [Susceptibility] by Minimum lethal concentration (MLC)
Acetylcholine receptor binding Ab [Units/volume] in Serum
Acetylcholine receptor blocking Ab [Units/volume] in Serum
Acetylcholine receptor modulation Ab [Units/volume] in Serum
Intrinsic factor Ab [Units/volume] in Serum
Jo-1 extractable nuclear Ab [Units/volume] in Serum
Liver kidney microsomal Ab [Units/volume] in Serum
Phosphatidylserine IgG Ab [Presence] in Serum
little c Ab [Presence] in Serum or Plasma
Phosphatidylserine IgM Ab [Presence] in Serum
Rheumatoid arthritis nuclear Ab [Units/volume] in Serum
Rheumatoid factor [Units/volume] in Serum or Plasma
Rheumatoid factor IgM [Units/volume] in Serum
Cefmetazole [Susceptibility] by Gradient strip
Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip
little c Ag [Presence] on Red Blood Cells from Blood product unit
Sulfamethoxazole [Susceptibility] by Gradient strip
sulfiSOXAZOLE [Susceptibility] by Gradient strip
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L
Wuchereria bancrofti Ab [Units/volume] in Serum
Aspergillus fumigatus 1 Ab [Presence] in Serum
Aureobasidium pullulans Ab [Presence] in Serum
little c Ag [Presence] on Red Blood Cells from Donor
Bordetella pertussis Ab [Units/volume] in Serum
Brucella abortus Ab [Units/volume] in Serum
Brucella canis Ab [Units/volume] in Serum
Brucella melitensis Ab [Units/volume] in Serum
Brucella suis Ab [Units/volume] in Serum
Coxsackievirus A10 Ab [Units/volume] in Serum
Coxsackievirus A2 Ab [Units/volume] in Serum
Aspergillus fumigatus 6 Ab [Presence] in Serum
little c Ag [Presence] on Red Blood Cells
Coxsackievirus A4 Ab [Units/volume] in Serum
Shigella dysenteriae Ab [Units/volume] in Serum
Treponema pallidum Ab [Units/volume] in Serum
Toxoplasma gondii Ab [Units/volume] in Serum
Coxsackievirus A21 Ab [Units/volume] in Serum
Shigella flexneri Ab [Units/volume] in Serum
little e Ab [Presence] in Serum or Plasma from Blood product unit
Shigella boydii Ab [Units/volume] in Serum
Salmonella sp Ab [Units/volume] in Serum
Burkholderia pseudomallei Ab [Units/volume] in Serum
Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum
Leptospira interrogans Ab [Units/volume] in Serum
Japanese encephalitis virus Ab [Units/volume] in Serum
Shigella sonnei Ab [Units/volume] in Serum
little e Ab [Presence] in Serum or Plasma from Donor
little e Ab [Presence] in Serum or Plasma
little e Ag [Presence] on Red Blood Cells from Blood product unit
cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC)
little e Ag [Presence] on Red Blood Cells from Donor
little e Ag [Presence] on Red Blood Cells
little f Ab [Presence] in Serum or Plasma from Blood product unit
little f Ab [Presence] in Serum or Plasma from Donor
little f Ab [Presence] in Serum or Plasma
little f Ag [Presence] on Red Blood Cells from Blood product unit
Amikacin [Susceptibility] by Minimum lethal concentration (MLC)
little f Ag [Presence] on Red Blood Cells from Donor
little f Ag [Presence] on Red Blood Cells
cefOXitin [Susceptibility] by Disk diffusion (KB)
cefOXitin [Susceptibility] by Serum bactericidal titer
little i Ab [Presence] in Serum or Plasma from Blood product unit
little i Ab [Presence] in Serum or Plasma from Donor
little i Ab [Presence] in Serum or Plasma
little k Ab [Presence] in Serum or Plasma from Blood product unit
little k Ab [Presence] in Serum or Plasma from Donor
little k Ab [Presence] in Serum or Plasma
little k Ag [Presence] on Red Blood Cells from Blood product unit
little k Ag [Presence] on Red Blood Cells from Donor
little k Ag [Presence] on Red Blood Cells
Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)
Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
little s Ab [Presence] in Serum or Plasma from Blood product unit
little s Ab [Presence] in Serum or Plasma from Donor
little s Ab [Presence] in Serum or Plasma
little s Ag [Presence] on Red Blood Cells from Blood product unit
little s Ag [Presence] on Red Blood Cells from Donor
little s Ag [Presence] on Red Blood Cells
Cefpodoxime [Susceptibility] by Disk diffusion (KB)
LW Ab [Presence] in Serum or Plasma from Blood product unit
LW Ab [Presence] in Serum or Plasma from Donor
5-Hydroxyindoleacetate [Presence] in 24 hour Urine
Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma
Albumin/Globulin [Mass Ratio] in Body fluid
Amino acids [Moles/volume] in Serum or Plasma
Bacteria [Presence] in Genital specimen by Wet preparation
LW Ag [Presence] on Red Blood Cells from Blood product unit
Basophils/100 leukocytes in Body fluid by Manual count
Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
Cells [#/volume] in Body fluid by Manual count
Choriogonadotropin [Presence] in Body fluid
aPTT in Control Blood by Coagulation assay
Colloid oncotic pressure [Partial pressure] in Plasma
LW Ag [Presence] on Red Blood Cells from Donor
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation
Creatinine [Mass/volume] in Peritoneal fluid
Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis
Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis
Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis
Creatinine renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma
Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation
Cryofibrinogen [Presence] in Plasma by 1 day cold incubation
Cryofibrinogen [Presence] in Plasma by 2 day cold incubation
Cryofibrinogen [Presence] in Plasma by 3 day cold incubation
Cryoglobulin [Presence] in Serum by 4 hour cold incubation
Cryoglobulin [Presence] in Serum by 1 day cold incubation
Cryoglobulin [Presence] in Serum by 2 day cold incubation
Mg Ab [Presence] in Serum or Plasma from Blood product unit
Cryoglobulin [Presence] in Serum by 3 day cold incubation
Cryoglobulin [Presence] in Serum by 4 day cold incubation
Cryoglobulin [Presence] in Serum by 5 day cold incubation
Cryoglobulin [Presence] in Serum by 6 day cold incubation
Cryoglobulin [Presence] in Serum by 1 week cold incubation
Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count
Eosinophils/100 leukocytes in Body fluid by Manual count
Eosinophils/100 leukocytes in Urine sediment by Manual count
Mg Ab [Presence] in Serum or Plasma from Donor
Epithelial cells [Presence] in Vaginal fluid by Wet preparation
Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence
Fatty acids.very long chain [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis
Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis
Cefpodoxime [Susceptibility] by Serum bactericidal titer
Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis
Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination
Human papilloma virus Ag [Presence] in Genital specimen
Human papilloma virus 16+18 Ag [Presence] in Genital specimen
Leukocytes [#/area] in Nose by Microscopy high power field
Leukocytes [#/area] in Sputum by Microscopy high power field
Leukocytes [Presence] in Vaginal fluid by Wet preparation
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood
Triglyceride [Mass/volume] in Body fluid
Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count
Macrophages/100 leukocytes in Body fluid by Manual count
Prolactin [Mass/volume] in Serum or Plasma --baseline
Measles virus Ag [Presence] in Specimen by Immunofluorescence
Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count
Mesothelial cells/100 leukocytes in Body fluid by Manual count
Microscopic observation [Identifier] in Urine sediment by Light microscopy
Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count
Mg Ag [Presence] on Red Blood Cells from Blood product unit
Mumps virus Ag [Presence] in Specimen by Immunofluorescence
Neutrophils/100 leukocytes in Body fluid by Manual count
Osmotic fragility of Red Blood Cells by Diluted RBC
Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count
Mg Ag [Presence] on Red Blood Cells from Donor
Porphobilinogen [Presence] in 24 hour Urine
Pyruvate [Mass/volume] in Serum or Plasma
Epithelial cells.renal [Presence] in Urine sediment by Light microscopy
Rubella virus Ag [Presence] in Specimen by Immunofluorescence
Somatotropin [Mass/volume] in Serum or Plasma --baseline
Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy
Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy
Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination
M Ab [Presence] in Serum or Plasma from Blood product unit
Sucrose hemolysis [Presence] of Red Blood Cells
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay
Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay
Urea nitrogen [Mass/volume] in Peritoneal fluid
Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis
Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis
Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis
Urobilinogen [Presence] in 24 hour Urine
Uroporphyrin [Presence] in 24 hour Urine
Varicella zoster virus Ab [Presence] in Serum by Latex agglutination
Virus identified in Specimen by Immunofluorescence
Xanthochromia [Presence] of Body fluid Qualitative
Yeast [Presence] in Genital specimen by Wet preparation
DNA double strand Ab [Presence] in Serum by Farr method
M Ab [Presence] in Serum or Plasma from Donor
Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count
Bacteria identified in Cervix by Anaerobe culture
Drugs identified in Urine by Screen method
Drugs identified in Gastric fluid by Screen method
Drugs identified in Vitreous fluid by Screen method
M Ag [Presence] on Red Blood Cells from Blood product unit
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)
M Ag [Presence] on Red Blood Cells from Donor
Theobromine [Presence] in Serum or Plasma
Benzyl alcohol [Presence] in Serum or Plasma
Diamorphine [Presence] in Unknown substance
Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Hypoglycemics.oral [Identifier] in Urine
Mi sup(a) Ag [Presence] on Red Blood Cells from Donor
hydrALAZINE [Presence] in Serum or Plasma
Dimethylsulfoxide [Presence] in Serum or Plasma
Pentachlorophenol [Presence] in Serum or Plasma
oxyMORphone [Presence] in Serum or Plasma
Mi sup(a) Ag [Presence] on Red Blood Cells
Antipsychotics [Identifier] in Serum or Plasma
Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Tetrahydrocannabinol [Presence] in Stool
Benzodiazepines [Presence] in Gastric fluid
Mi sup(a) Ab [Presence] in Serum or Plasma from Donor
Dimethylacetamide [Mass/volume] in Urine
cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma
Mi sup(a) Ab [Presence] in Serum or Plasma
Demoxepam [Mass/volume] in Serum or Plasma
Halazepam [Mass/volume] in Serum or Plasma
Phenylethylmalonamide [Mass/volume] in Serum or Plasma
OLANZapine [Mass/volume] in Serum or Plasma
sulfaSALAzine [Mass/volume] in Serum or Plasma
dimenhyDRINATE [Mass/volume] in Serum or Plasma
Butorphanol [Mass/volume] in Serum or Plasma
Colchicine [Mass/volume] in Serum or Plasma
Diphenoxylate [Mass/volume] in Serum or Plasma
Emetine [Mass/volume] in Serum or Plasma
Ethinamate [Mass/volume] in Serum or Plasma
Griseofulvin [Mass/volume] in Serum or Plasma
Nitroglycerin [Mass/volume] in Serum or Plasma
Nabumetone [Mass/volume] in Serum or Plasma
Nadolol [Mass/volume] in Serum or Plasma
Oxybutynin [Mass/volume] in Serum or Plasma
Pimozide [Mass/volume] in Serum or Plasma
Promazine [Mass/volume] in Serum or Plasma
Pyridine [Mass/volume] in Serum or Plasma
Resperine [Mass/volume] in Serum or Plasma
Selegiline [Mass/volume] in Serum or Plasma
Sotalol [Mass/volume] in Serum or Plasma
Sulindac [Mass/volume] in Serum or Plasma
Terfenadine [Mass/volume] in Serum or Plasma
Triflupromazine [Mass/volume] in Serum or Plasma
Trimeprazine [Mass/volume] in Serum or Plasma
Triprolidine [Mass/volume] in Serum or Plasma
Chlorzoxazone [Mass/volume] in Serum or Plasma
Brodifacoum [Mass/volume] in Serum or Plasma
Chlormezanone [Mass/volume] in Serum or Plasma
Flurbiprofen [Mass/volume] in Serum or Plasma
Norfenfluramine [Mass/volume] in Serum or Plasma
Bufotenine [Mass/volume] in Serum or Plasma
predniSONE [Mass/volume] in Serum or Plasma
Naphthalene [Mass/volume] in Serum or Plasma
Naphthol [Mass/volume] in Serum or Plasma
traMADol [Mass/volume] in Serum or Plasma
Nortramadol [Mass/volume] in Serum or Plasma
Tolmetin [Mass/volume] in Serum or Plasma
M1 Ab [Presence] in Serum or Plasma from Blood product unit
Halogenated organic molecules [Identifier] in Urine
Ketones [Mass/volume] in Urine by Test strip --fasting
Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge
M1 Ab [Presence] in Serum or Plasma from Donor
Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge
Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge
Epithelial cells [Presence] in Semen by Light microscopy
Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy
Urate crystals amorphous [Presence] in Urine sediment by Light microscopy
Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid
Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid
Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge
Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry
Amino acids [Identifier] in Serum or Plasma
Cystine crystals [type] in Stone by Light microscopy
M1 Ag [Presence] on Red Blood Cells from Blood product unit
Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct
Dextromethamphetamine [Mass/volume] in Urine
Levomethamphetamine [Mass/volume] in Urine
Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
Arsenic.inorganic [Mass/volume] in Urine
M1 Ag [Presence] on Red Blood Cells from Donor
PHENobarbital [Presence] in Gastric fluid
Butabarbital [Presence] in Gastric fluid
PENTobarbital [Presence] in Gastric fluid
Secobarbital [Presence] in Gastric fluid
Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma
Methohexital [Presence] in Serum or Plasma
Hexobarbital [Mass/volume] in Serum or Plasma
Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen
Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen
Cadmium [Mass/volume] in Red Blood Cells
Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy
Bicarbonate [Moles/volume] in Dialysis fluid
Carcinoembryonic Ag [Mass/volume] in Body fluid
Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge
Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge
Major crossmatch [Interpretation] by Immediate spin
Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge
Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge
Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge
Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge
Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge
Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge
Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge
Major crossmatch [Interpretation] --post immediate spin
Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge
Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge
Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge
EPINEPHrine [Mass/volume] in Plasma --2 hours post XXX challenge
Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine
Major crossmatch [Interpretation] by Prewarmed
Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine
Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine
Major crossmatch.re-crossmatch [Interpretation]
N-methylacetamide [Mass/volume] in Urine
Nefazodone [Mass/volume] in Serum or Plasma
Zomepirac [Mass/volume] in Serum or Plasma
Quinethazone [Presence] in Serum or Plasma
Phorate [Mass/volume] in Serum or Plasma
Tybamate [Mass/volume] in Serum or Plasma
Turpentine [Mass/volume] in Serum or Plasma
Cefprozil [Susceptibility] by Disk diffusion (KB)
Papaverine [Mass/volume] in Serum or Plasma
Isocarboxazid [Mass/volume] in Serum or Plasma
Propylene glycol [Mass/volume] in Serum or Plasma
Narcotics and opioids [Identifier] in Urine
Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
N Ab [Presence] in Serum or Plasma from Blood product unit
Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge
Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen
N Ab [Presence] in Serum or Plasma from Donor
Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline
Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen
Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen
Creatinine [Mass/volume] in Vitreous fluid
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
N Ag [Presence] on Red Blood Cells from Blood product unit
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma
Fluoride [Mass/volume] in Dialysis fluid
Hydroxyethylflurazepam [Mass/volume] in Urine
N-desalkylflurazepam [Presence] in Stool
Hydroxyethylflurazepam [Presence] in Stool
Dolichol [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis
Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
N Ag [Presence] on Red Blood Cells from Donor
Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --4 hour specimen
Glucose [Mass/volume] in Dialysis fluid --2 hour specimen
Glucose [Mass/volume] in Dialysis fluid --4 hour specimen
Glucose [Mass/volume] in Serum or Plasma --7 hours post meal
Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge
Glucose [Mass/volume] in Peritoneal dialysis fluid
Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid
Cefprozil [Susceptibility] by Serum bactericidal titer
Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen
Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge
Gallium [Mass/volume] in Serum or Plasma
Tellurium [Mass/volume] in Serum or Plasma
Thorium [Mass/volume] in Serum or Plasma
Unidentified Ab [Presence] in Serum or Plasma
Norastemizole [Mass/volume] in Serum or Plasma
Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)
Hemoglobin pattern [Interpretation] in Blood
Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
N-methylhistamine [Mass/volume] in Urine
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Hydroxyproline [Mass/volume] in 2 hour Urine
Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma
Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma
Voltage-gated calcium channel IgG Ab [Units/volume] in Serum
IgA.secretory [Units/volume] in Serum or Plasma
Leucine-enkephalin [Units/volume] in Serum or Plasma
prednisoLONE [Mass/volume] in Serum or Plasma
Alpha subunit [Units/volume] in Serum or Plasma
Interferon gamma [Units/volume] in Serum or Plasma
Interferon beta [Units/volume] in Serum or Plasma
Interferon alpha [Units/volume] in Serum or Plasma
Tryptase [Enzymatic activity/volume] in Serum or Plasma
Soluble liver Ab [Units/volume] in Serum
Hyaluronate [Mass/volume] in Serum or Plasma
Endothelin [Units/volume] in Serum or Plasma
Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge
Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge
Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge
Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge
17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine
Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis
Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis
P Ab [Presence] in Serum or Plasma from Blood product unit
Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis
Mercury [Mass/volume] in Red Blood Cells
Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma
P Ab [Presence] in Serum or Plasma from Donor
Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis
Oligoclonal bands [Interpretation] in Serum or Plasma
Codeine Free [Mass/volume] in Serum or Plasma
Dihydrocodeine Free [Mass/volume] in Serum or Plasma
HYDROcodone Free [Mass/volume] in Serum or Plasma
HYDROmorphone Free [Mass/volume] in Serum or Plasma
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma
oxyCODONE Free [Mass/volume] in Serum or Plasma
Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge
Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge
Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge
Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge
Methdilazine [Mass/volume] in Serum or Plasma
Propiomazine [Mass/volume] in Serum or Plasma
Phenylalanine [Presence] in Blood by Guthrie test
Acid phosphatase [Enzymatic activity/volume] in Body fluid
Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma
Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma
Phosphoserine [Mass/volume] in Cerebral spinal fluid
Porphobilinogen deaminase [Enzymatic activity/volume] in Blood
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood
Potassium [Moles/volume] in Serum or Plasma --2nd specimen
Potassium [Moles/volume] in Serum or Plasma --3rd specimen
Potassium [Moles/volume] in Vitreous fluid
Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Progesterone [Mass/volume] in 24 hour Urine
Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Prostaglandin E2 [Mass/volume] in 24 hour Urine
Prostaglandin E1 [Mass/volume] in 24 hour Urine
Prostaglandin D2 [Mass/volume] in Serum or Plasma
Prostaglandin F2 alpha [Moles/volume] in Urine
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
Protein [Mass/volume] in Peritoneal dialysis fluid
Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen
Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis
Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot
Purkinje cells Ab [Presence] in Serum by Immunoblot
Neuronal nuclear type 1 Ab [Units/volume] in Serum
HIV 1 p23 Ab [Presence] in Serum by Immunoblot
HIV 1 p65 Ab [Presence] in Serum by Immunoblot
HIV 1 p28 Ab [Presence] in Serum by Immunoblot
HIV 1 p32 Ab [Presence] in Serum by Immunoblot
HIV 1 p18 Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
P1 Ab [Presence] in Serum or Plasma from Blood product unit
Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
HIV 1 gp34 Ab [Presence] in Serum by Immunoblot
HIV 1 p26 Ab [Presence] in Serum by Immunoblot
P1 Ab [Presence] in Serum or Plasma from Donor
HIV 1 p15 Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot
HIV 1 p64 Ab [Presence] in Serum by Immunoblot
HIV 1 p53 Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot
Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)
Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot
HIV 1 gp105 Ab [Presence] in Serum by Immunoblot
HIV 1 p68 Ab [Presence] in Serum by Immunoblot
HIV 1 p58 Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot
P1 Ag [Presence] on Red Blood Cells from Blood product unit
Chloride [Moles/volume] in Vitreous fluid
Acetylene [Mass/volume] in Serum or Plasma
Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge
P1 Ag [Presence] on Red Blood Cells from Donor
Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge
Sodium [Moles/volume] in Red Blood Cells
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum or Plasma
Beta galactosidase [Enzymatic activity/volume] in Leukocytes
Porphobilinogen synthase [Enzymatic activity/volume] in Blood
Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma
Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma
Monoamine oxidase [Enzymatic activity/volume] in Blood
Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
Triglyceride [Mass/volume] in Serum or Plasma by calculation
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Urea nitrogen [Mass/volume] in Arterial blood
Urea nitrogen [Mass/volume] in Venous blood
Urea nitrogen [Mass/volume] in Peripheral blood
Urea nitrogen [Mass/volume] in Blood --baseline
Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen
Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen
Urea nitrogen [Mass/volume] in 24 hour Urine
Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline
Cefsulodin [Susceptibility] by Disk diffusion (KB)
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen
Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis
Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge
Volatiles and gases [Identifier] in Urine
2,4 toluenediamine [Mass/volume] in Blood
2,6 toluenediamine [Mass/volume] in Blood
Allyl alcohol [Mass/volume] in Serum or Plasma
Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma
Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma
Hydrocarbons.chlorinated [Identifier] in Blood
Dichlorodifluoroethane [Mass/volume] in Blood
1,4-Dioxane [Mass/volume] in Serum or Plasma
Methylene chloride [Mass/volume] in Blood
Epichlorohydrin [Mass/volume] in Serum or Plasma
Mandelate/Creatinine [Mass Ratio] in Urine
Halogenated organic molecules [Identifier] in Blood
Hydrocarbons.halogenated.volatile [Identifier] in Blood
2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma
1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma
Methyl propyl ketone [Mass/volume] in Blood
Methyl ethyl ketone [Mass/volume] in Urine
Methyl amyl ketone [Mass/volume] in Blood
Methyl ethyl ketone [Mass/volume] in Blood
Methyl isoamyl ketone [Mass/volume] in Blood
Methyl isobutyl ketone [Mass/volume] in Blood
Methyl butyl ketone [Mass/volume] in Blood
Pesticides [Identifier] in Serum or Plasma
Pesticides [Identifier] in Gastric fluid
Trichlorofluoromethane [Mass/volume] in Blood
Trichlorofluoroethane [Mass/volume] in Blood
Trichlorotrifluoroethane [Mass/volume] in Blood
Ethyl acetate [Mass/volume] in Serum or Plasma
Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --fasting
C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Variant lymphocytes/100 leukocytes in Blood
Sezary cells [Presence] in Blood by Light microscopy
Cefsulodin [Susceptibility] by Serum bactericidal titer
Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma
Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay
Kaolin activated time [Units/volume] in Platelet poor plasma
Fibrin+Fibrinogen fragments [Units/volume] in Urine
Platelets [#/volume] in Plasma by Automated count
Platelets [Units/volume] in Dialysis fluid
aPTT in Platelet poor plasma by Coagulation assay --2nd specimen
aPTT in Platelet poor plasma by Coagulation assay --3rd specimen
aPTT in Platelet poor plasma by Coagulation assay --4th specimen
Drug induced platelet Ab [Units/volume] in Serum
Platelet associated IgA Ab [Units/volume] in Blood
Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence
Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence
Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence
Phosphatidylserine IgA Ab [Units/volume] in Serum
Phosphatidate IgG Ab [Units/volume] in Serum
Phosphatidate IgM Ab [Units/volume] in Serum
Phosphatidate IgA Ab [Units/volume] in Serum
Phosphatidylcholine IgG Ab [Units/volume] in Serum
Phosphatidylcholine IgM Ab [Units/volume] in Serum
Phosphatidylcholine IgA Ab [Units/volume] in Serum
Phosphatidylethanolamine IgG Ab [Units/volume] in Serum
Phosphatidylethanolamine IgM Ab [Units/volume] in Serum
Phosphatidylethanolamine IgA Ab [Units/volume] in Serum
Phosphatidylglycerol IgG Ab [Units/volume] in Serum
Phosphatidylglycerol IgM Ab [Units/volume] in Serum
Phosphatidylglycerol IgA Ab [Units/volume] in Serum
Phosphatidylinositol IgG Ab [Units/volume] in Serum
Phosphatidylinositol IgM Ab [Units/volume] in Serum
Phosphatidylinositol IgA Ab [Units/volume] in Serum
C4 nephritic factor [Mass/volume] in Serum or Plasma
C3 nephritic factor [Mass/volume] in Serum or Plasma
Complement alternate pathway AH50 [Units/volume] in Serum or Plasma
Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
Deoxyribonucleoprotein Ab [Units/volume] in Serum
Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot
Cancer Ag DM/70K [Units/volume] in Serum or Plasma
Immunosuppressive acidic protein [Units/volume] in Serum or Plasma
Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma
Cefsulodin [Mass/volume] in Serum or Plasma
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum
Rh immune globulin dosage.vials recommended [#]
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum
Rh immune globulin screen [interpretation]
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --2nd specimen
S Ab [Presence] in Serum or Plasma from Blood product unit
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --2nd specimen
Human antimouse Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum
S Ab [Presence] in Serum or Plasma from Donor
Immunoelectrophoresis for Serum or Plasma
Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay
Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay
Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay
Fibronectin aggregate IgA Ab [Units/volume] in Serum
Immunofixation for Cerebral spinal fluid
Wasp venom IgE Ab [Units/volume] in Serum
Russian olive IgE Ab [Units/volume] in Serum
Wasp venom IgG Ab [Units/volume] in Serum
English Walnut IgG Ab [Units/volume] in Serum
Formaldehyde IgG Ab [Units/volume] in Serum
Bahia grass IgG Ab [Units/volume] in Serum
White Elm IgG Ab [Units/volume] in Serum
Cottonwood IgG Ab [Units/volume] in Serum
S Ag [Presence] on Red Blood Cells from Blood product unit
Yellow Dock IgG Ab [Units/volume] in Serum
False ragweed IgG Ab [Units/volume] in Serum
English plantain IgG Ab [Units/volume] in Serum
Formaldehyde IgM Ab [Units/volume] in Serum or Plasma
Adenovirus Ab [Units/volume] in Cerebral spinal fluid
S Ag [Presence] on Red Blood Cells from Donor
Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid
Aspergillus glaucus Ab [Units/volume] in Serum
Ehrlichia chaffeensis Ab [Units/volume] in Serum
Thermoactinomyces Ab [Units/volume] in Serum
Rickettsia conorii IgG Ab [Units/volume] in Serum
Rickettsia conorii IgM Ab [Units/volume] in Serum
Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot
Borrelia hermsii IgG Ab [Units/volume] in Serum
Borrelia hermsii IgM Ab [Units/volume] in Serum
cefTAZidime [Susceptibility] by Minimum lethal concentration (MLC)
Brucella sp IgG Ab [Units/volume] in Serum
Brucella sp IgA Ab [Units/volume] in Serum
Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid
Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid
Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid
Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid
Candida albicans immune complex [Units/volume] in Serum or Plasma
Chlamydia trachomatis B Ab [Units/volume] in Serum
Chlamydia trachomatis C Ab [Units/volume] in Serum
Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum
Chlamydia trachomatis C IgM Ab [Units/volume] in Serum
Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --1st specimen
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum
Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid
Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid
Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid
Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid
U Ab [Presence] in Serum or Plasma from Blood product unit
Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid
Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus Ab [Units/volume] in Serum
Phoma herbarum IgE Ab [Units/volume] in Serum
Sporothrix schenckii IgG Ab [Units/volume] in Serum
Sporothrix schenckii IgM Ab [Units/volume] in Serum
U Ab [Presence] in Serum or Plasma from Donor
Sporothrix schenckii IgA Ab [Units/volume] in Serum
Haemophilus influenzae B Ab [Units/volume] in Serum
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid
Hepatitis D virus Ab [Presence] in Serum
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid
Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid
Legionella non-pneumophila Ab [Presence] in Serum
Legionella pneumophila atypical Ab [Presence] in Serum
Legionella longbeachae 1+2 Ab [Presence] in Serum
Leishmania donovani IgG Ab [Units/volume] in Serum
Leishmania donovani IgM Ab [Units/volume] in Serum
Leishmania brasilensis IgG Ab [Units/volume] in Serum
Leishmania brasilensis IgM Ab [Units/volume] in Serum
Leishmania mexicana IgG Ab [Units/volume] in Serum
Leishmania mexicana IgM Ab [Units/volume] in Serum
Leishmania tropica IgG Ab [Units/volume] in Serum
Leishmania tropica IgM Ab [Units/volume] in Serum
Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid
Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid
U Ag [Presence] on Red Blood Cells from Blood product unit
Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen
Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen
Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum
Neisseria meningitidis serogroup A Ab [Units/volume] in Serum
Neisseria meningitidis serogroup C Ab [Units/volume] in Serum
Sporothrix schenckii Ab [Presence] in Serum
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid
Toxocara canis IgM Ab [Units/volume] in Serum
U Ag [Presence] on Red Blood Cells from Donor
Toxocara canis IgA Ab [Units/volume] in Serum
Schistosoma sp IgG Ab [Units/volume] in Serum
Schistosoma sp IgM Ab [Units/volume] in Serum
Rubella virus IgG Ab [Units/volume] in Serum --1st specimen
Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid
Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid
Salmonella typhi H D Ab [Presence] in Serum
Salmonella typhi O D Ab [Presence] in Serum
Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid
Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence
Hantavirus hantaan Ab [Units/volume] in Serum
Trypanosoma cruzi IgM Ab [Units/volume] in Serum
Trypanosoma cruzi IgG Ab [Units/volume] in Serum
V Ab [Presence] in Serum or Plasma from Blood product unit
Colorado tick fever virus IgG Ab [Units/volume] in Serum
Colorado tick fever virus IgM Ab [Units/volume] in Serum
Hepatitis E virus Ab [Presence] in Serum
Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A1 Ab [Units/volume] in Serum
Amikacin [Susceptibility] by Disk diffusion (KB)
V Ab [Presence] in Serum or Plasma from Donor
Duffy group Ag [Type] on Red Blood Cells
IgA IgG Ab [Units/volume] in Serum or Plasma
IgM IgM Ab [Units/volume] in Serum or Plasma
Bacteria identified in 24 hour Urine by Culture
Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
Escherichia coli enteroinvasive identified in Stool by Organism specific culture
Ova and parasites identified in Stool by Light microscopy--2nd specimen
Ova and parasites identified in Stool by Light microscopy--3rd specimen
Human papilloma virus IgG Ab [Presence] in Serum
Human papilloma virus IgM Ab [Presence] in Serum
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence
Bartonella sp identified in Blood by Light microscopy
V Ag [Presence] on Red Blood Cells from Blood product unit
Pneumocystis sp identified in Specimen by Light microscopy
Parainfluenza virus Ag [Presence] in Specimen by Immunofluorescence
Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence
Escherichia coli labile toxin [Presence] in Specimen
Barr bodies [Presence] in Cervix by Light microscopy
V Ag [Presence] on Red Blood Cells from Donor
RNA polymerase I+II+III Ab [Presence] in Serum
Monoclonal band observed [Identifier] in Serum or Plasma
Leukocytes [#/volume] in Stool by Manual count
Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count
Band form neutrophils/100 leukocytes in Body fluid by Manual count
Unspecified cells/100 leukocytes in Body fluid by Manual count
Synovial cells [Units/volume] in Body fluid
Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Cystine [Mass/volume] in Cerebral spinal fluid
Homocystine [Mass/volume] in Cerebral spinal fluid
Hydroxyproline [Mass/volume] in Cerebral spinal fluid
Xg sup(a) Ab [Presence] in Serum or Plasma from Donor
Lysine [Mass/volume] in Cerebral spinal fluid
Methionine [Mass/volume] in Cerebral spinal fluid
1-Methylhistidine [Mass/volume] in Cerebral spinal fluid
3-Methylhistidine [Mass/volume] in Cerebral spinal fluid
Ornithine [Mass/volume] in Cerebral spinal fluid
Tyrosine [Mass/volume] in Cerebral spinal fluid
Xg sup(a) Ab [Presence] in Serum or Plasma
cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)
Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Glutamate [Mass/volume] in Amniotic fluid
Glutamine [Mass/volume] in Amniotic fluid
Histidine [Mass/volume] in Amniotic fluid
Homocystine [Mass/volume] in Amniotic fluid
Hydroxyproline [Mass/volume] in Amniotic fluid
Isoleucine [Mass/volume] in Amniotic fluid
Methionine [Mass/volume] in Amniotic fluid
1-Methylhistidine [Mass/volume] in Amniotic fluid
3-Methylhistidine [Mass/volume] in Amniotic fluid
Ornithine [Mass/volume] in Amniotic fluid
Xg sup(a) Ag [Presence] on Red Blood Cells from Donor
Phenylalanine [Mass/volume] in Amniotic fluid
Phosphoethanolamine [Mass/volume] in Amniotic fluid
Phosphoserine [Mass/volume] in Amniotic fluid
Threonine [Mass/volume] in Amniotic fluid
Xg sup(a) Ag [Presence] on Red Blood Cells
Tyrosine [Mass/volume] in Amniotic fluid
Tryptophan [Mass/volume] in Amniotic fluid
EPINEPHrine [Mass/volume] in Plasma --2nd specimen post XXX challenge
EPINEPHrine [Mass/volume] in Plasma --3rd specimen post XXX challenge
EPINEPHrine [Mass/volume] in Plasma --4th specimen post XXX challenge
EPINEPHrine [Mass/volume] in Plasma --5th specimen post XXX challenge
EPINEPHrine [Mass/volume] in Plasma --6th specimen post XXX challenge
Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
EPINEPHrine [Mass/volume] in Plasma --7th specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge
Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Yt sup(a) Ab [Presence] in Serum or Plasma from Donor
DOPamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Protein Fractions [Interpretation] in Urine by Electrophoresis
Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis
Yt sup(a) Ab [Presence] in Serum or Plasma
Creatinine renal clearance in 4 hour Urine and Serum or Plasma
Creatinine renal clearance in 6 hour Urine and Serum or Plasma
Creatinine renal clearance in 8 hour Urine and Serum or Plasma
Calcium/Albumin [Mass Ratio] in Serum or Plasma
Creatinine renal clearance/1.73 sq M in 4 hour Urine and Serum or Plasma
Creatinine renal clearance/1.73 sq M in 6 hour Urine and Serum or Plasma
Calcium/Osmolality [Ratio] in Serum or Plasma
Creatinine renal clearance/1.73 sq M in 8 hour Urine and Serum or Plasma
Creatinine renal clearance/1.73 sq M in 12 hour Urine and Serum or Plasma
Iron/Transferrin [Mass Ratio] in Serum or Plasma
Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma
Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood
IgG synthesis rate [Units/volume] in Serum and CSF
Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation
Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation
Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma
Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma
Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma
Arsenic/Creatinine [Mass Ratio] in Urine
Chromium/Creatinine [Mass Ratio] in Urine
Mercury/Creatinine [Mass Ratio] in Urine
Yt sup(a) Ag [Presence] on Red Blood Cells from Donor
Selenium/Creatinine [Mass Ratio] in Urine
Thallium/Creatinine [Mass Ratio] in Urine
cefTAZidime [Susceptibility] by Disk diffusion (KB)
Aluminum/Creatinine [Mass Ratio] in Urine
Cadmium/Creatinine [Mass Ratio] in Urine
Yt sup(a) Ag [Presence] on Red Blood Cells
Magnesium/Creatinine [Mass Ratio] in Urine
Fluoride/Creatinine [Mass Ratio] in Urine
Orthocresol/Creatinine [Mass Ratio] in Urine
Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine
Benzoylecgonine/Creatinine [Mass Ratio] in Urine
18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine
Gonadotropin peptide/Creatinine [Mass Ratio] in Urine
Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Aldosterone/Creatinine [Mass Ratio] in Urine
Oxalate/Creatinine [Mass Ratio] in Urine
Creatine/Creatinine [Mass Ratio] in Urine
Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine
Testosterone/Creatinine [Mass Ratio] in Urine
aPTT in Control Platelet poor plasma by Coagulation assay
Yt sup(b) Ab [Presence] in Serum or Plasma from Donor
Triple phosphate crystals [type] in Stone by Light microscopy
Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine
Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine
HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot
Amino acid pattern [Interpretation] in Serum or Plasma
Herpes simplex virus 2 Ab pattern [Interpretation] in Serum
Borrelia burgdorferi IgG band pattern [Interpretation] in Serum by Immunoblot
Borrelia burgdorferi IgM band pattern [Interpretation] in Serum by Immunoblot
Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum
Urea nitrogen renal clearance in Urine and Serum or Plasma
Lupus erythematosus cells [Presence] in Blood
Yt sup(b) Ab [Presence] in Serum or Plasma
Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation
Microscopic observation [Identifier] in Blood by Crystal violet stain
Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain
Cyanide ascorbate screen [Presence] in Blood
Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain
Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative
Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative
Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count
Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Variant lymphocytes/100 leukocytes in Body fluid by Manual count
Basophils/100 leukocytes in Cerebral spinal fluid by Manual count
Blasts/100 leukocytes in Cerebral spinal fluid by Manual count
Blasts/100 leukocytes in Body fluid by Manual count
Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count
Yt sup(b) Ag [Presence] on Red Blood Cells from Donor
Leukocytes other/100 leukocytes in Body fluid by Manual count
Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count
Nonhematic cells/100 leukocytes in Body fluid by Manual count
Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count
Unidentified cells/100 leukocytes in Body fluid by Manual count
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count
Nucleated erythrocytes [#/volume] in Body fluid by Manual count
Fat.microscopic observation [Presence] in Sputum by Sudan III stain
Yt sup(b) Ag [Presence] on Red Blood Cells
Xanthochromia [Presence] of Cerebral spinal fluid Qualitative
Carbon dioxide, total [Moles/volume] in Urine
cefTAZidime [Susceptibility] by Serum bactericidal titer
11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyraPONE PO overnight
Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid
Phosphate [Mass/volume] in Cerebral spinal fluid
4-Hydroxyglutethimide [Presence] in Serum or Plasma
ALPRAZolam [Presence] in Serum or Plasma
Butriptyline [Presence] in Serum or Plasma
chlorproMAZINE [Presence] in Serum or Plasma
clomiPRAMINE [Presence] in Serum or Plasma
clonazePAM [Presence] in Serum or Plasma
Clorazepate [Presence] in Serum or Plasma
Cocaethylene [Presence] in Serum or Plasma
Cyclobenzaprine [Presence] in Serum or Plasma
D-pseudoephedrine [Presence] in Serum or Plasma
11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyraPONE PO overnight
Norsertraline [Presence] in Serum or Plasma
Disopyramide [Presence] in Serum or Plasma
Flecainide [Presence] in Serum or Plasma
fluvoxaMINE [Presence] in Serum or Plasma
Gentamicin [Mass/volume] in Cerebral spinal fluid
Glutethimide [Presence] in Serum or Plasma
11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO
Mesoridazine [Presence] in Serum or Plasma
Mexiletine [Presence] in Serum or Plasma
N-desalkylflurazepam [Presence] in Serum or Plasma
Norchlordiazepoxide [Presence] in Serum or Plasma
Norclomipramine [Presence] in Serum or Plasma
Norclozapine [Presence] in Serum or Plasma
Nordiazepam [Presence] in Serum or Plasma
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyraPONE q4h X 6
Nordoxepin [Presence] in Serum or Plasma
Norfluoxetine [Presence] in Serum or Plasma
Normaprotiline [Presence] in Serum or Plasma
PARoxetine [Presence] in Serum or Plasma
Sertraline [Presence] in Serum or Plasma
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV
Theophylline [Mass/volume] in Cerebral spinal fluid
Theophylline [Mass/volume] in Body fluid
Thioridazine [Presence] in Serum or Plasma
Trifluoperazine [Presence] in Serum or Plasma
Vancomycin [Mass/volume] in Cerebral spinal fluid
Venlafaxine [Presence] in Serum or Plasma
Activated protein C resistance [Presence] in Blood by NAA with probe detection
Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay
Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay
Platelet aggregation XXX induced in Platelet rich plasma
Platelet aggregation prostaglandin induced in Platelet rich plasma
Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma
Histiocytes [Presence] in Nose by Light microscopy
Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV
Promonocytes/100 leukocytes in Blood by Manual count
11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO
Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV
Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO
Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO
3-Beta-Androstanediol [Mass/volume] in Serum or Plasma
6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine
Ethanolamine [Mass/volume] in Cerebral spinal fluid
Etiocholanolone [Mass/volume] in Serum or Plasma
Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV
Tetrahydroaldosterone [Mass/time] in 24 hour Urine
Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)
Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV
Dextromethorphan [Mass/volume] in Serum or Plasma
DOXOrubicin [Mass/volume] in Serum or Plasma
Methoxsalen [Mass/volume] in Serum or Plasma
Mitotane [Mass/volume] in Serum or Plasma
Erythrocytes [Presence] in Semen by Light microscopy
Interleukin 1 beta [Mass/volume] in Serum or Plasma
Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV
Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay
Rheumatoid factor [Units/volume] in Synovial fluid
Trichloroethane [Mass/volume] in Serum or Plasma
Chlordecone [Mass/volume] in Serum or Plasma
Codeine [Presence] in Urine by SAMHSA confirm method
1,3-Dimethylbenzene [Mass/volume] in Blood
Morphine [Presence] in Urine by SAMHSA confirm method
Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV
1,2-Dimethylbenzene [Mass/volume] in Blood
1,4-Dimethylbenzene [Mass/volume] in Blood
Epithelial cells.renal [#/volume] in Urine sediment
Epithelial cells.squamous [#/volume] in Urine sediment
Leukocytes [Presence] in Stool by Light microscopy
Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV
Phosphate crystals amorphous [#/volume] in Urine sediment
Urate crystals amorphous [#/volume] in Urine sediment
Epidermal growth factor receptor [Mass/mass] in Tissue
Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma
Ganglioside GD1b IgM Ab [Titer] in Serum
Ganglioside GD1b IgG Ab [Titer] in Serum
Asialoganglioside GM1 IgG Ab [Titer] in Serum
Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum
1-Methylhistidine/Creatinine [Mass Ratio] in Urine
Alpha aminoadipate/Creatinine [Mass Ratio] in Urine
Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine
Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine
Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV
Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine
Corticotropin [Mass/volume] in Plasma --pre dose insulin IV
3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine
Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine
3-Methylhistidine/Creatinine [Mass Ratio] in Urine
Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine
Ascorbate [Mass/time] in 24 hour Urine --post dose PO
5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine
Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
5-Oxoproline/Creatinine [Mass Ratio] in Urine
Acetoacetate/Creatinine [Mass Ratio] in Urine
Aconitate/Creatinine [Mass Ratio] in Urine
Adipate/Creatinine [Mass Ratio] in Urine
Albumin/Creatinine [Mass Ratio] in 24 hour Urine
Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly
Amylase/Creatinine [Mass Ratio] in Urine
Anserine/Creatinine [Mass Ratio] in Urine
Arginine/Creatinine [Mass Ratio] in Urine
Argininosuccinate/Creatinine [Mass Ratio] in Urine
Asparagine/Creatinine [Mass Ratio] in Urine
Aspartate/Creatinine [Mass Ratio] in Urine
Azelate/Creatinine [Mass Ratio] in Urine
Bromsulphthalein [Mass/volume] in Serum or Plasma
C peptide/Creatinine [Mass Ratio] in 24 hour Urine
C peptide/Creatinine [Mass Ratio] in Urine
Calcium/Creatinine [Mass Ratio] in 24 hour Urine
Carnosine/Creatinine [Mass Ratio] in Urine
Chloride/Creatinine [Mass Ratio] in 24 hour Urine
Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV
Citrate/Creatinine [Mass Ratio] in Urine
Cystine/Creatinine [Mass Ratio] in Urine
Delta aminolevulinate/Creatinine [Mass Ratio] in Urine
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV
Dodecanedioate/Creatinine [Mass Ratio] in Urine
DOPamine/Creatinine [Mass Ratio] in Urine
EPINEPHrine/Creatinine [Mass Ratio] in Urine
Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine
Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine
Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine
Estrogen/Creatinine [Mass Ratio] in 24 hour Urine
Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine
Ethanolamine/Creatinine [Mass Ratio] in Urine
Ethylmalonate/Creatinine [Mass Ratio] in Urine
Formate/Creatinine [Mass Ratio] in Urine
Galactose/Creatinine [Mass Ratio] in Urine
Glutamate/Creatinine [Mass Ratio] in Urine
Glutamine/Creatinine [Mass Ratio] in Urine
Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV
Glutarate/Creatinine [Mass Ratio] in Urine
Glycerate/Creatinine [Mass Ratio] in Urine
Glycine/Creatinine [Mass Ratio] in Urine
Glycolate/Creatinine [Mass Ratio] in Urine
Hexanoylglycine/Creatinine [Mass Ratio] in Urine
Hippurate/Creatinine [Mass Ratio] in Urine
Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV
Histamine/Creatinine [Mass Ratio] in Urine
Histamine/Creatinine [Mass Ratio] in 24 hour Urine
Histidine/Creatinine [Mass Ratio] in Urine
Homocystine/Creatinine [Mass Ratio] in Urine
Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV
Hydroxyproline/Creatinine [Mass Ratio] in Urine
Isoleucine/Creatinine [Mass Ratio] in Urine
Isovalerylglycine/Creatinine [Mass Ratio] in Urine
Lactate/Creatinine [Mass Ratio] in Urine
Leucine/Creatinine [Mass Ratio] in Urine
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV
Metanephrines/Creatinine [Mass Ratio] in Urine
Methionine/Creatinine [Mass Ratio] in Urine
Methylhippurate/Creatinine [Mass Ratio] in Urine
Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine
Methylmalonate/Creatinine [Mass Ratio] in Urine
Methylsuccinate/Creatinine [Mass Ratio] in Urine
N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine
N-methylhistamine/Creatinine [Mass Ratio] in Urine
Norepinephrine/Creatinine [Mass Ratio] in Urine
Normetanephrine/Creatinine [Mass Ratio] in Urine
Ornithine/Creatinine [Mass Ratio] in Urine
Orotate/Creatinine [Mass Ratio] in Urine
Oxalate/Creatinine [Mass Ratio] in 24 hour Urine
Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV
Phosphoethanolamine/Creatinine [Mass Ratio] in Urine
Para nitrophenol/Creatinine [Mass Ratio] in Urine
Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine
Phosphate/Creatinine [Mass Ratio] in 24 hour Urine
Phosphoserine/Creatinine [Mass Ratio] in Urine
Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV
Porphobilinogen/Creatinine [Mass Ratio] in Urine
Proline/Creatinine [Mass Ratio] in Urine
Protein/Creatinine [Mass Ratio] in 24 hour Urine
Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum
Pyruvate/Creatinine [Mass Ratio] in Urine
Suberylglycine/Creatinine [Mass Ratio] in Urine
Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV
Taurine/Creatinine [Mass Ratio] in Urine
Threonine/Creatinine [Mass Ratio] in Urine
Tryptophan/Creatinine [Mass Ratio] in Urine
Tyrosine/Creatinine [Mass Ratio] in Urine
Urate/Creatinine [Mass Ratio] in 24 hour Urine
Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV
Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine
Antimony/Creatinine [Mass Ratio] in Urine
Arsenic/Creatinine [Mass Ratio] in 24 hour Urine
Arsenic.inorganic/Creatinine [Mass Ratio] in Urine
Beryllium/Creatinine [Mass Ratio] in Urine
Cadmium/Creatinine [Mass Ratio] in 24 hour Urine
Phenylglyoxylate/Creatinine [Mass Ratio] in Urine
Vanadium/Creatinine [Mass Ratio] in Urine
Dimethylbenzene/Creatinine [Mass Ratio] in Urine
Finch feather IgE Ab [Units/volume] in Serum
Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST)
Monocytes/100 leukocytes in Peritoneal fluid by Manual count
Neutrophils/100 leukocytes in Peritoneal fluid by Manual count
Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV
Calcium [Moles/volume] in Blood --post calcium infusion
Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO
Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO
Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM
Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV
C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV
C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV
Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO
Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO
Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO
Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO
Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO
11-Deoxycortisol [Mass/time] in 24 hour Urine
Albumin.glycated/Albumin.total in Serum or Plasma
Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
Beta-2 transferrin [Presence] in Body fluid
Bilirubin.total [Presence] in Amniotic fluid
Collagen type 1 IgG Ab [Units/volume] in Serum
Collagen type 2 IgG Ab [Units/volume] in Serum
Ceftizoxime [Susceptibility] by Disk diffusion (KB)
Collagen type 4 IgG Ab [Units/volume] in Serum
Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine
Androstanolone Free/Androstanolone.total in Serum or Plasma
Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma
Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis
Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug cloNIDine PO
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis
Motilin [Mass/volume] in Serum or Plasma
Pregnenolone [Mass/time] in 24 hour Urine
Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day
Insulin-like growth factor-I [Units/volume] in Blood
Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma
Trichloroacetate [Mass/volume] in Serum or Plasma
Urate [Mass/volume] in Cerebral spinal fluid
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day
Meclizine [Mass/volume] in Serum or Plasma
Meclofenamate [Mass/volume] in Serum or Plasma
Norethindrone [Mass/volume] in Serum or Plasma
Oxipurinol [Mass/volume] in Serum or Plasma
Tamoxifen [Mass/volume] in Serum or Plasma
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Adenovirus Ab [Titer] in Serum by Immunofluorescence
Adenovirus IgG Ab [Units/volume] in Serum
Bordetella parapertussis Ag [Presence] in Specimen by Immunofluorescence
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence
Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
HIV 2 p41 Ab [Presence] in Serum by Immunoblot
Mumps virus [Presence] in Specimen by Organism specific culture
Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay
Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay
Glutamate decarboxylase 65 Ab [Units/volume] in Serum
Pancreatic islet cell Ab [Titer] in Serum
Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination
Rheumatoid factor [Titer] in Synovial fluid by Agglutination
Dichlorodifluoromethane [Mass/volume] in Blood
Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day
Lymphocytes/100 leukocytes in Body fluid by Manual count
Spermatozoa Motile [Presence] in Semen by Light microscopy
Leukocyte phosphatase [Enzymatic activity/volume] in Control Leukocytes by Light microscopy
Erythrocytes [#/area] in Urine sediment by Microscopy high power field
Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day
Complement+Immunoglobulin [Presence] in Red Blood Cells
Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay
Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Hepatitis A virus Ab [Presence] in Serum by Immunoassay
Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay
Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h
Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay
Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay
Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
Clostridioides difficile toxin A [Presence] in Stool by Immunoassay
Calcium.ionized [Moles/volume] in Serum or Plasma by calculation
Ceftizoxime [Susceptibility] by Serum bactericidal titer
Coproporphyrin [Presence] in 24 hour Urine
Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h
Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma
Methylmalonate [Moles/volume] in Serum or Plasma
Homocysteine [Moles/volume] in Serum or Plasma
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
Penicillin [Susceptibility] by Disk diffusion (KB)
Creatine kinase.MB [Mass/volume] in Serum or Plasma
Delta tocopherol [Mass/volume] in Serum or Plasma
Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay
Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis
Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis
Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting
Prealbumin/Protein.total in Serum or Plasma by Electrophoresis
Albumin/Protein.total in Serum or Plasma by Electrophoresis
Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis
Beta globulin/Protein.total in Serum or Plasma by Electrophoresis
Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis
Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis
Prealbumin/Protein.total in 24 hour Urine by Electrophoresis
Albumin/Protein.total in 24 hour Urine by Electrophoresis
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis
Beta globulin/Protein.total in 24 hour Urine by Electrophoresis
Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis
Alpha 1 globulin/Protein.total in Urine by Electrophoresis
Prealbumin/Protein.total in Urine by Electrophoresis
Albumin/Protein.total in Urine by Electrophoresis
Alpha 2 globulin/Protein.total in Urine by Electrophoresis
Beta globulin/Protein.total in Urine by Electrophoresis
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst
Gamma globulin/Protein.total in Urine by Electrophoresis
Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine
Neuronal nuclear type 1 Ab [Titer] in Serum
Neuronal nuclear type 2 Ab [Titer] in Serum
Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma
Urea nitrogen [Mass/volume] in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV
Carbon dioxide [Partial pressure] in Cord blood
Prostaglandin A [Mass/time] in 24 hour Urine
Prostaglandin E1 [Mass/time] in 24 hour Urine
Prostaglandin E2 [Mass/time] in 24 hour Urine
Prostaglandin F2 alpha [Mass/time] in 24 hour Urine
Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay
Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay
Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay
Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC)
Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC)
Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma
Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma
Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid
HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot
HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot
HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot
HTLV I+II p26 Ab [Presence] in Serum by Immunoblot
HTLV I+II p28 Ab [Presence] in Serum by Immunoblot
HTLV I+II p32 Ab [Presence] in Serum by Immunoblot
HTLV I+II p36 Ab [Presence] in Serum by Immunoblot
HTLV I+II p53 Ab [Presence] in Serum by Immunoblot
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid
HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Ciprofloxacin [Mass/volume] in Serum or Plasma --peak
Ciprofloxacin [Mass/volume] in Serum or Plasma --trough
1,4-Dioxane [Mass/volume] in Blood by Gas chromatography
Rheumatoid factor [Units/volume] in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Japanese Cedar IgE Ab [Units/volume] in Serum
Dermatophagoides microceras IgE Ab [Units/volume] in Serum
Pacific Squid IgE Ab [Units/volume] in Serum
Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy
cefTRIAXone [Susceptibility] by Minimum lethal concentration (MLC)
Carbon dioxide, total [Moles/volume] in Stool
Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid
Corticosterone [Mass/time] in 24 hour Urine
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV
Cortisol Free [Mass/time] in 12 hour Urine
D-Lactate [Moles/volume] in Serum or Plasma
Androstanolone Free [Mass/volume] in Serum or Plasma
Elastase.pancreatic [Mass/volume] in Serum
Epidermal growth factor [Mass/volume] in Serum or Plasma
Epidermal growth factor receptor [Moles/mass] in Tissue
Estrogen binding protein [Mass/volume] in Serum or Plasma
Prostaglandin D2 [Mass/time] in 24 hour Urine
Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma
carBAMazepine free [Mass/volume] in Saliva (oral fluid)
Dexamethasone [Mass/volume] in Serum or Plasma
Diethylstilbestrol [Mass/volume] in Serum or Plasma
Diflunisal [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV
Triamterene+hydroCHLOROthiazide [Mass/volume] in Serum or Plasma
Estazolam [Mass/volume] in Serum or Plasma
Monoacetyldapsone [Mass/volume] in Serum or Plasma
Phenytoin [Mass/volume] in Saliva (oral fluid)
Spironolactone [Mass/volume] in Serum or Plasma
Sulfapyridine [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID)
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence
Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot
Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day
Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence
Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM
HIV 1 Ab [Presence] in Serum by Immunofluorescence
Trypanosoma cruzi IgG Ab [Titer] in Serum
Fibronectin aggregate IgG Ab [Units/volume] in Serum
Intercalated disk Ab [Titer] in Serum by Immunofluorescence
Dimethylsulfoxide [Mass/volume] in Serum or Plasma
Amikacin [Susceptibility] by Serum bactericidal titer
Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Strychnine [Mass/volume] in Gastric fluid
Epithelial cells [Presence] in Stool by Light microscopy
Barley smut+Wheat smut IgE Ab [Units/volume] in Serum
Leukocytes [Presence] in Nose by Light microscopy
Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count
Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine
IgG synthesis rate [Mass/time] in Serum and CSF by calculation
IgG clearance/Albumin clearance [Ratio] in Serum and CSF
Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Lactate [Mass/volume] in Serum or Plasma
Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma
cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)
Pyruvate [Moles/volume] in Cerebral spinal fluid
Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma
Bacteria [Presence] in Semen by Light microscopy
Entamoeba histolytica [Presence] in Stool by Trichrome stain
Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot
Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture
Respiratory syncytial virus [Presence] in Nose by Organism specific culture
Estrogen receptor [Moles/mass] in Tissue
Silver Maple IgE Ab [Units/volume] in Serum
Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO
Ketones [Presence] in Urine --30 minutes post XXX challenge
Ketones [Presence] in Urine --4 hours post XXX challenge
Ketones [Presence] in Urine --5 hours post XXX challenge
Ketones [Presence] in Urine --6 hours post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
18-Hydroxycortisol [Mass/time] in 24 hour Urine
Corticotropin Big Fragment [Mass/volume] in Serum or Plasma
Bicarbonate [Moles/volume] in Cord blood
Bilirubin.direct [Mass/volume] in Body fluid
Cholesterol sulfate [Mass/volume] in Serum
Coproporphyrin [Mass/mass] in 24 hour Stool
Coproporphyrin [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV
Cortisone [Mass/volume] in Serum or Plasma
Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma
Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma
IgA.secretory [Mass/volume] in Serum or Plasma
Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid
N-methylimidazoleacetate [Mass/time] in 24 hour Urine
Palatinase [Enzymatic activity/mass] in Tissue
Peptide histidine isoleucine [Mass/volume] in Plasma
Pituitary glycoprotein hormone.alpha subunit [Mass/volume] in Serum
Potassium [Moles/volume] in Synovial fluid
Progesterone Free [Mass/time] in 24 hour Urine
Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid
Protoporphyrin [Mass/mass] in 24 hour Stool
Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma
Sucrase [Enzymatic activity/mass] in Tissue
Tissue polypeptide Ag [Mass/volume] in Serum or Plasma
Uroporphyrin [Mass/volume] in Red Blood Cells
Uroporphyrin [Mass/mass] in 24 hour Stool
Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
methIMAzole [Mass/volume] in Serum or Plasma
Methylprednisolone [Mass/volume] in Serum or Plasma
Omeprazole [Mass/volume] in Serum or Plasma
Phenytoin Free [Mass/volume] in Saliva (oral fluid)
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV
Prazosin [Mass/volume] in Serum or Plasma
Spermatozoa Progressive/100 spermatozoa in Semen
Complement C3b Inactive [Mass/volume] in Plasma
Blastomyces dermatitidis exoantigen [Identifier] in Isolate
Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence
cefTRIAXone [Susceptibility] by Disk diffusion (KB)
Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence
Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID)
Coccidioides immitis exoantigen [Identifier] in Isolate
Francisella tularensis IgA Ab [Presence] in Serum
Giardia lamblia Ag [Presence] in Stool by Immunofluorescence
Hepatitis E virus IgG Ab [Presence] in Serum
Hepatitis E virus IgM Ab [Presence] in Serum
Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence
Histoplasma capsulatum exoantigen [Identifier] in Isolate
Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day
Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM
Nocardia sp identified in Isolate by Organism specific culture
Salmonella typhi H D Ab [Titer] in Serum
Cells.estrogen receptor/100 cells in Tissue by Immune stain
P53 protein Ag [Presence] in Tissue by Immune stain
Cells.progesterone receptor/100 cells in Tissue by Immune stain
H2a-H2b DNA IgG Ab [Units/volume] in Serum
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV
Jo-1 extractable nuclear Ab [Titer] in Serum
Myelin basic protein IgA Ab [Units/volume] in Serum
Myelin basic protein IgG Ab [Units/volume] in Serum
Myelin basic protein IgM Ab [Units/volume] in Serum
Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV
Phosphatidylcholine IgA Ab [Presence] in Serum
Phosphatidylcholine IgG Ab [Presence] in Serum
Phosphatidylcholine IgM Ab [Presence] in Serum
Phosphatidylserine IgG Ab [Units/volume] in Serum
Phosphatidylserine IgM Ab [Units/volume] in Serum
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Purkinje cells Ab [Presence] in Serum by Immunofluorescence
Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence
Mitochondria M2 IgG Ab [Units/volume] in Serum
Somatotropin Ab [Presence] in Serum or Plasma
Ganglioside GQ1b IgG Ab [Titer] in Serum
Thyrotropin blocking Ab [Units/volume] in Serum
Tetrachlorodiphenylethane [Mass/mass] in Tissue
Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue
Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day
Methylenedioxymethamphetamine [Presence] in Urine
Sec-butyl acetate [Mass/volume] in Blood
Tert-butyl acetate [Mass/volume] in Blood
Liver kidney microsomal Ab [Presence] in Serum
Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Uroporphyrin [Mass/volume] in Serum or Plasma
Immune complex [Units/volume] in Serum or Plasma by C3b binding assay
Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Acylcarnitine [Moles/volume] in Serum or Plasma
Beta glucuronidase [Moles/volume] in Serum or Plasma
Carnitine free (C0) [Moles/volume] in Urine
Carnitine free (C0) [Moles/volume] in Serum or Plasma
Carnitine [Moles/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Insulin [Moles/volume] in Serum or Plasma --baseline
Lysosomal enzymes screen [Identifier] in Plasma and Urine
Organic acids/Creatinine [Molar ratio] in Urine
Platelet concentrate units available [#]
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day
Amphetamines [Presence] in Urine by Screen method >1000 ng/mL
Amphetamines [Presence] in Urine by Confirm method >200 ng/mL
Phencyclidine [Presence] in Urine by Screen method >25 ng/mL
Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL
Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL
Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
Benzoylecgonine [Presence] in Urine by Screen method
Benzoylecgonine [Presence] in Urine by Confirmatory method
Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV
Benzodiazepines [Presence] in Urine by Screen method
Microscopic observation [Identifier] in Genital specimen by Wet preparation
Microscopic observation [Identifier] in Cervix by Wet preparation
Microscopic observation [Identifier] in Vaginal fluid by Wet preparation
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Bacteria identified in Specimen by Environmental culture
Eosinophils/100 leukocytes in Stool by Manual count
Epithelial cells.squamous [Presence] in Sputum by Light microscopy
Leukocytes [Presence] in Sputum by Light microscopy
Mucus [Presence] in Sputum by Light microscopy
Polymorphonuclear cells/100 leukocytes in Stool by Manual count
Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)
Lithium [Moles/volume] in Serum or Plasma
Optical density of Amniotic fluid by Spectrophotometry
Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography
Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma
Prealbumin [Mass/volume] in Serum or Plasma
IgG/Protein.total in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight
Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis
Globulin/Protein.total in 24 hour Urine by Electrophoresis
Eosinophils/100 leukocytes in Peritoneal fluid by Manual count
Eosinophils/100 leukocytes in Pleural fluid by Manual count
Specific gravity of Amniotic fluid by Refractometry
Specific gravity of Cerebral spinal fluid by Refractometry
Specific gravity of Gastric fluid by Refractometry
Specific gravity of Peritoneal fluid by Refractometry
Specific gravity of Pleural fluid by Refractometry
Specific gravity of Synovial fluid by Refractometry
Specific gravity of Stool by Refractometry
Specific gravity of Water by Refractometry
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified
Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified
Microscopic observation [Identifier] in Cervix by KOH preparation
Microscopic observation [Identifier] in Vaginal fluid by KOH preparation
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain
Microscopic observation [Identifier] in Aspirate by Gram stain
Microscopic observation [Identifier] in Peritoneal fluid by Gram stain
Microscopic observation [Identifier] in Pleural fluid by Gram stain
Microscopic observation [Identifier] in Vaginal fluid by Gram stain
Microscopic observation [Identifier] in Throat by Gram stain
Microscopic observation [Identifier] in Synovial fluid by Gram stain
Microscopic observation [Identifier] in Eye by Gram stain
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyraPONE PO
Microscopic observation [Identifier] in Ear by Gram stain
Trichomonas vaginalis [Presence] in Cervix by Wet preparation
Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation
Trichomonas vaginalis [Presence] in Urethra by Wet preparation
Yeast [Presence] in Cervix by Wet preparation
Yeast [Presence] in Vaginal fluid by Wet preparation
Yeast [Presence] in Urethra by Wet preparation
Erythrocytes [#/volume] in Gastric fluid by Manual count
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Leukocytes [#/volume] in Gastric fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Semen by Manual count
Polymorphonuclear cells/100 leukocytes in Urine by Manual count
Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count
cefTRIAXone [Susceptibility] by Serum bactericidal titer
Mononuclear cells/100 leukocytes in Pleural fluid by Manual count
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day
Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count
Mononuclear cells/100 leukocytes in Synovial fluid by Manual count
Mononuclear cells/100 leukocytes in Semen by Manual count
Mononuclear cells/100 leukocytes in Urine sediment by Manual count
Mononuclear cells/100 leukocytes in Gastric fluid by Manual count
Amylase [Enzymatic activity/volume] in Synovial fluid
Amylase [Enzymatic activity/volume] in Cerebral spinal fluid
Amylase [Enzymatic activity/volume] in Dialysis fluid
Amylase [Enzymatic activity/volume] in Gastric fluid
Amylase [Enzymatic activity/volume] in Amniotic fluid
Urea nitrogen [Mass/volume] in Amniotic fluid
Urea nitrogen [Mass/volume] in Pleural fluid
Urea nitrogen [Mass/volume] in Synovial fluid
Urea nitrogen [Mass/volume] in Gastric fluid
Creatinine [Mass/volume] in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose
Creatinine [Mass/volume] in Pleural fluid
Creatinine [Mass/volume] in Synovial fluid
Creatinine [Mass/volume] in Gastric fluid
Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid
Phosphate [Mass/volume] in Pleural fluid
Phosphate [Mass/volume] in Peritoneal fluid
Phosphate [Mass/volume] in Synovial fluid
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight
Phosphate [Mass/volume] in Gastric fluid
Phosphate [Mass/volume] in Amniotic fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Urine
Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyraPONE PO overnight
Calcium [Moles/volume] in Amniotic fluid
Calcium [Moles/volume] in Peritoneal fluid
Calcium [Moles/volume] in Synovial fluid
Bilirubin.total [Mass/volume] in Dialysis fluid
Bilirubin.total [Mass/volume] in Pleural fluid
Bilirubin.total [Mass/volume] in Peritoneal fluid
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose
Bilirubin.total [Mass/volume] in Synovial fluid
Bilirubin.total [Mass/volume] in Gastric fluid
Globulin [Mass/volume] in Amniotic fluid
Globulin [Mass/volume] in Cerebral spinal fluid
Globulin [Mass/volume] in Peritoneal fluid
Globulin [Mass/volume] in Synovial fluid
Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV
Albumin/Globulin [Mass Ratio] in Amniotic fluid
Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid
Albumin/Globulin [Mass Ratio] in Pleural fluid
Albumin/Globulin [Mass Ratio] in Peritoneal fluid
Albumin/Globulin [Mass Ratio] in Synovial fluid
Cholesterol [Mass/volume] in Amniotic fluid
Cholesterol [Mass/volume] in Cerebral spinal fluid
Cholesterol [Mass/volume] in Peritoneal fluid
Cholesterol [Mass/volume] in Synovial fluid
Triglyceride [Mass/volume] in Amniotic fluid
Triglyceride [Mass/volume] in Cerebral spinal fluid
Triglyceride [Mass/volume] in Peritoneal fluid
Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast
Triglyceride [Mass/volume] in Synovial fluid
Virus identified in Vaginal fluid by Culture
Virus identified in Pleural fluid by Culture
Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight
Virus identified in Peritoneal fluid by Culture
Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)
Chlamydia trachomatis [Presence] in Blood by Organism specific culture
Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture
Chlamydia trachomatis [Presence] in Cervix by Organism specific culture
Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyraPONE PO overnight
Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture
Chlamydia trachomatis [Presence] in Urethra by Organism specific culture
Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture
Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay
Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay
Bacteria identified in Cervix by Aerobe culture
Bacteria identified in Urethra by Aerobe culture
Bacteria identified in Penis by Aerobe culture
Diphtheria identified in Throat by Organism specific culture
Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h
Diphtheria identified in Sputum by Organism specific culture
Diphtheria identified in Nose by Organism specific culture
Diphtheria identified in Skin by Organism specific culture
Diphtheria identified in Bronchial specimen by Organism specific culture
Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture
Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture
Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture
Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture
Virus identified in Cerebral spinal fluid by Immunofluorescence
Virus identified in Blood by Immunofluorescence
Virus identified in Semen by Immunofluorescence
Virus identified in Throat by Immunofluorescence
Virus identified in Eye by Immunofluorescence
Virus identified in Cervix by Immunofluorescence
Virus identified in Vaginal fluid by Immunofluorescence
Virus identified in Urine sediment by Immunofluorescence
Virus identified in Sputum by Immunofluorescence
Virus identified in Penis by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose
Virus identified in Urethra by Immunofluorescence
Human papilloma virus Ag [Presence] in Cervix
Human papilloma virus Ag [Presence] in Vaginal fluid
Human papilloma virus Ag [Presence] in Penis
Human papilloma virus Ag [Presence] in Urethra
Human papilloma virus 16+18 Ag [Presence] in Cervix
Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid
Human papilloma virus 16+18 Ag [Presence] in Penis
Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h
Human papilloma virus 16+18 Ag [Presence] in Urethra
Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV
Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence
Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence
Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Rubella virus Ag [Presence] in Throat by Immunofluorescence
Rubella virus Ag [Presence] in Skin by Immunofluorescence
Rubella virus Ag [Presence] in Eye by Immunofluorescence
Rubella virus Ag [Presence] in Nose by Immunofluorescence
Rubella virus Ag [Presence] in Sputum by Immunofluorescence
Rubella virus Ag [Presence] in Cervix by Immunofluorescence
Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day
Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence
Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence
Rubella virus Ag [Presence] in Penis by Immunofluorescence
Rubella virus Ag [Presence] in Urethra by Immunofluorescence
Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Measles virus Ag [Presence] in Throat by Immunofluorescence
Measles virus Ag [Presence] in Skin by Immunofluorescence
Measles virus Ag [Presence] in Eye by Immunofluorescence
Measles virus Ag [Presence] in Nose by Immunofluorescence
Measles virus Ag [Presence] in Sputum by Immunofluorescence
Measles virus Ag [Presence] in Cervix by Immunofluorescence
Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence
Measles virus Ag [Presence] in Urine sediment by Immunofluorescence
Measles virus Ag [Presence] in Penis by Immunofluorescence
Measles virus Ag [Presence] in Urethra by Immunofluorescence
Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Mumps virus Ag [Presence] in Throat by Immunofluorescence
Mumps virus Ag [Presence] in Skin by Immunofluorescence
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Mumps virus Ag [Presence] in Eye by Immunofluorescence
Mumps virus Ag [Presence] in Nose by Immunofluorescence
Mumps virus Ag [Presence] in Sputum by Immunofluorescence
Mumps virus Ag [Presence] in Cervix by Immunofluorescence
Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence
Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence
Mumps virus Ag [Presence] in Penis by Immunofluorescence
Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Mumps virus Ag [Presence] in Urethra by Immunofluorescence
Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Semen by NAA with probe detection
Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day
Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen
Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen
Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen
Calcitriol [Moles/volume] in Serum or Plasma
11-Deoxycortisol [Moles/volume] in Serum or Plasma
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
17-Hydroxyprogesterone [Moles/volume] in Urine
Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day
17-Hydroxyprogesterone [Moles/time] in 24 hour Urine
17-Ketosteroids [Moles/time] in 24 hour Urine
5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma
Blood group antibody investigation [Interpretation] in Plasma or RBC
Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review
ABO and Rh group [Type] in Blood from Donor
ABO group [Type] in Blood from Blood product unit
Acetaminophen [Moles/volume] in Serum or Plasma
Acetone [Moles/volume] in Serum or Plasma
Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine
Albumin/Creatinine [Molar ratio] in Urine
Aldosterone [Moles/volume] in Serum or Plasma
Aldosterone [Moles/time] in 24 hour Urine
Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma
Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h
Amylase isoenzymes [Interpretation] in Serum or Plasma
Alpha tocopherol [Moles/volume] in Serum or Plasma
ALPRAZolam [Moles/volume] in Serum or Plasma
Aluminum [Moles/volume] in 24 hour Urine
Aluminum [Moles/volume] in Serum or Plasma
Amitriptyline+Nortriptyline [Presence] in Gastric fluid
Amitriptyline+Nortriptyline [Presence] in Serum or Plasma
Amitriptyline+Nortriptyline [Presence] in Urine
Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h
Amitriptyline [Moles/volume] in Serum or Plasma
Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma
Amoxapine [Moles/volume] in Serum or Plasma
Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma
Androstenedione [Moles/volume] in Serum or Plasma
Blood group antibodies identified in Serum or Plasma from Blood product unit
Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin
Blood group antibodies identified in Serum or Plasma from Donor
Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed
Nuclear Ab [Presence] in Peritoneal fluid
Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)
Nuclear Ab pattern [Interpretation] in Serum
EPINEPHrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO
EPINEPHrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO
Ascorbate [Moles/volume] in Serum or Plasma
Barbiturates [Presence] in Gastric fluid
Basophils/100 leukocytes in Bronchial specimen by Manual count
Beta-2-Microglobulin [Moles/volume] in Serum
Bicarbonate [Moles/volume] in Venous blood
Bile acid [Moles/volume] in Serum or Plasma
Bilirubin.direct [Moles/volume] in Serum or Plasma
Bilirubin.indirect [Moles/volume] in Serum or Plasma
Bilirubin.total [Moles/volume] in Serum or Plasma
C peptide [Moles/volume] in Serum or Plasma
C reactive protein [Titer] in Serum or Plasma
25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma
Calculus analysis [Interpretation] in Stone
EPINEPHrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO
carBAMazepine [Moles/volume] in Serum or Plasma
Carbon dioxide, total [Moles/volume] in Dialysis fluid
Carotene [Moles/volume] in Serum or Plasma
Catecholamines Free [Moles/time] in 24 hour Urine
chlorproMAZINE [Presence] in Gastric fluid
chlorproMAZINE [Moles/volume] in Serum or Plasma
Cholesterol in HDL [Moles/volume] in Serum or Plasma
EPINEPHrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO
Cholesterol [Moles/volume] in Serum or Plasma
Chylomicrons [Moles/volume] in Serum or Plasma
cloBAZam [Moles/volume] in Serum or Plasma
clomiPRAMINE [Moles/volume] in Serum or Plasma
EPINEPHrine [Mass/volume] in Plasma --supine
clomiPRAMINE+Norclomipramine [Moles/volume] in Serum or Plasma
clonazePAM [Moles/volume] in Serum or Plasma
cloZAPine [Moles/volume] in Serum or Plasma
cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma
Cold agglutinin [Titer] in Serum or Plasma
Copper [Moles/volume] in Serum or Plasma
Coproporphyrin 1 [Moles/volume] in Serum or Plasma
Coproporphyrin 1 [Moles/volume] in Stool
Coproporphyrin 1 [Moles/volume] in Urine
Coproporphyrin 1/Porphyrins.total in Urine
Coproporphyrin 3 [Moles/volume] in Serum or Plasma
Coproporphyrin 3 [Moles/volume] in Stool
Coproporphyrin 3 [Moles/volume] in Urine
Cortisol [Moles/volume] in Serum or Plasma
Cortisol Free [Moles/time] in 24 hour Urine
Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen
Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
Creatinine [Moles/volume] in Peritoneal dialysis fluid
Creatinine [Moles/volume] in Serum or Plasma
Creatinine [Moles/time] in 24 hour Urine
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
Delta aminolevulinate [Moles/time] in 24 hour Urine
N-desalkylflurazepam [Moles/volume] in Serum or Plasma
Desipramine [Moles/volume] in Serum or Plasma
Norclobazam [Moles/volume] in Serum or Plasma
Norclomipramine [Moles/volume] in Serum or Plasma
Nordoxepin [Moles/volume] in Serum or Plasma
Deuteroporphyrin [Moles/volume] in Stool
diazePAM [Moles/volume] in Serum or Plasma
Digoxin [Moles/volume] in Serum or Plasma
diphenhydrAMINE+dimenhyDRINATE [Presence] in Gastric fluid
diphenhydrAMINE+dimenhyDRINATE [Presence] in Serum or Plasma
diphenhydrAMINE+dimenhyDRINATE [Presence] in Urine
Disopyramide [Moles/volume] in Serum or Plasma
DOPamine [Moles/volume] in Serum or Plasma
Doxepin [Moles/volume] in Serum or Plasma
Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma
Eosinophils/100 leukocytes in Bronchial specimen by Manual count
ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid
EPINEPHrine [Moles/time] in 24 hour Urine
Erythrocytes [#/volume] in Pericardial fluid by Manual count
Estradiol (E2) [Moles/volume] in Serum or Plasma
Estriol (E3) [Moles/volume] in Serum or Plasma
Estriol (E3) [Moles/time] in 24 hour Urine
Ethanol [Moles/volume] in Serum or Plasma
Ethosuximide [Moles/volume] in Serum or Plasma
Ethylene glycol [Moles/volume] in Serum or Plasma
Extractable nuclear Ab [Presence] in Serum
Ferritin [Moles/volume] in Serum or Plasma
Fluoride [Moles/volume] in Serum or Plasma
FLUoxetine [Moles/volume] in Serum or Plasma
Flurazepam [Moles/volume] in Serum or Plasma
Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma
Folate [Moles/volume] in Red Blood Cells
Folate [Moles/volume] in Serum or Plasma
Folate+Cyanocobalamin [Interpretation] in Serum or Blood
Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin
Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin
Glucose [Moles/volume] in Capillary blood by Glucometer
Glucose [Moles/volume] in Cerebral spinal fluid
Glucose [Moles/volume] in Peritoneal dialysis fluid
Glucose [Moles/volume] in Peritoneal fluid
Glucose [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Synovial fluid
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
Glucose [Moles/volume] in Capillary blood --2 hours post meal
Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --baseline
Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast
Fasting glucose [Moles/volume] in Capillary blood by Glucometer
Fasting glucose [Moles/volume] in Serum or Plasma
Granulocytes/100 leukocytes in Bronchial specimen by Manual count
Haloperidol [Moles/volume] in Serum or Plasma
Hemoglobin [Mass/volume] in Arterial blood by Oximetry
Heptacarboxylate [Moles/volume] in Plasma
Heptacarboxylate [Moles/volume] in Stool
Heptacarboxylate [Moles/volume] in Urine
Hexacarboxylate [Moles/volume] in Plasma
Homovanillate [Moles/time] in 24 hour Urine
Hydroxyproline Free [Moles/time] in 24 hour Urine
Hydroxyproline [Moles/time] in 24 hour Urine
Arthropod identified in Specimen by Permanent mount
Helminth+Arthropod identified in Specimen by Rearing/Culture
Helminth identified in Specimen by Macro/micro identification
Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer
Helminth identified in Specimen by Permanent mount
Imipramine+Desipramine [Presence] in Gastric fluid
Imipramine+Desipramine [Presence] in Serum or Plasma
Imipramine+Desipramine [Presence] in Urine
Imipramine+Desipramine [Moles/volume] in Serum or Plasma
Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO
Immunoglobulin light chains [Interpretation] in Urine
Insulin [Moles/volume] in Serum or Plasma
Iron [Interpretation] in Serum or Plasma
Iron binding capacity [Moles/volume] in Serum or Plasma
Iron saturation [Molar fraction] in Serum or Plasma
Isopropanol [Moles/volume] in Serum or Plasma
Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction
Leukocytes [#/volume] in Bronchial specimen by Manual count
Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO
Leukocytes [#/volume] in Pericardial fluid by Manual count
Lidocaine [Moles/volume] in Serum or Plasma
Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis
Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis
Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation
Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis
LORazepam [Moles/volume] in Serum or Plasma
Lymphocytes/100 leukocytes in Pericardial fluid by Manual count
Lymphocytes/100 leukocytes in Bronchial specimen by Manual count
Lymphocytes/100 leukocytes in Pleural fluid by Manual count
Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count
Lymphocytes/100 leukocytes in Synovial fluid by Manual count
Macrophages/100 leukocytes in Bronchial specimen by Manual count
Maprotiline [Moles/volume] in Serum or Plasma
Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count
Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO
Mesothelial cells/100 leukocytes in Pleural fluid by Manual count
Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count
Metanephrine/Creatinine [Molar ratio] in Urine
Metanephrines [Moles/time] in 24 hour Urine
Methamphetamine [Presence] in Gastric fluid
Methanol [Moles/volume] in Serum or Plasma
Methotrexate [Moles/volume] in Serum or Plasma
Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO
Methsuximide [Moles/volume] in Serum or Plasma
Toxoplasma gondii [Presence] in Tissue by Organism specific culture
Trypanosoma sp identified in Buffy Coat by Light microscopy
Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation
Microscopic observation [Identifier] in Specimen by Iron hematoxylin stain
Microscopic observation [Identifier] in Specimen by Kinyoun iron hematoxylin stain
6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin
N-acetylprocainamide [Moles/volume] in Serum or Plasma
Neutrophils/100 leukocytes in Pericardial fluid by Manual count
Neutrophils/100 leukocytes in Pleural fluid by Manual count
Nitrazepam [Moles/volume] in Serum or Plasma
Norclozapine [Moles/volume] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin
Norepinephrine [Moles/time] in 24 hour Urine
Norfluoxetine [Moles/volume] in Serum or Plasma
Nortriptyline [Moles/volume] in Serum or Plasma
Leukocytes other/100 leukocytes in Pericardial fluid by Manual count
Leukocytes other/100 leukocytes in Pleural fluid by Manual count
Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count
Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin
Leukocytes other/100 leukocytes in Synovial fluid by Manual count
Parathyrin [Interpretation] in Serum or Plasma
Parathyrin.intact [Moles/volume] in Serum or Plasma
PARoxetine [Moles/volume] in Serum or Plasma
Pathologist report of Plasma or RBC tests
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)
Pentacarboxylate [Moles/volume] in Plasma
Pentacarboxylate [Moles/volume] in Stool
Pentacarboxylate [Moles/volume] in Urine
PHENobarbital [Moles/volume] in Serum or Plasma
Phenylalanine [Moles/volume] in Serum or Plasma
Phenylpropanolamine [Presence] in Gastric fluid
Phenytoin [Moles/volume] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin
Phosphate [Moles/volume] in Serum or Plasma
Porphobilinogen [Moles/time] in 24 hour Urine
Porphyrins [Interpretation] in Serum or Plasma
Pregnanediol [Moles/time] in 24 hour Urine
Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin
Pregnanetriol [Moles/time] in 24 hour Urine
Primidone [Moles/volume] in Serum or Plasma
Procainamide [Moles/volume] in Serum or Plasma
Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma
Progesterone [Moles/volume] in Serum or Plasma
Propranolol [Moles/volume] in Serum or Plasma
Propranolol [Moles/time] in 24 hour Urine
Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin
Propylene glycol [Presence] in Serum or Plasma
Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation
Protein Fractions [Interpretation] in Urine by Immunofixation
Protriptyline [Moles/volume] in Serum or Plasma
quiNIDine [Moles/volume] in Serum or Plasma
raNITIdine [Presence] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin
Reagin Ab [Presence] in Specimen by VDRL
Retinol [Moles/volume] in Serum or Plasma
Rh [Type] in Blood from Blood product unit
Salicylates [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO
Sertraline [Moles/volume] in Serum or Plasma
Smudge cells/100 leukocytes in Blood by Manual count
Testosterone [Moles/volume] in Serum or Plasma
Testosterone Free [Moles/volume] in Serum or Plasma
Theophylline [Moles/volume] in Serum or Plasma
Thiocyanate [Moles/volume] in Serum or Plasma
Thioridazine [Moles/volume] in Serum or Plasma
Thyroglobulin [Moles/volume] in Serum or Plasma
Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
Thyroxine (T4) [Moles/volume] in Serum or Plasma
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay
Toxoplasma gondii Ab [Units/volume] in Specimen
Transfusion reaction [Interpretation] in Plasma or RBC Narrative
traZODone [Moles/volume] in Serum or Plasma
Triazolam [Moles/volume] in Serum or Plasma
Triglyceride [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma
Trimipramine [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid
Urea nitrogen [Moles/volume] in Serum or Plasma
Urea nitrogen [Moles/time] in 24 hour Urine
Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma
Uroporphyrin 1 isomer [Moles/volume] in Stool
Uroporphyrin 1 isomer [Moles/volume] in Urine
Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO
Uroporphyrin 3 isomer [Moles/volume] in Stool
Uroporphyrin 3 isomer [Moles/volume] in Urine
Valproate [Moles/volume] in Serum or Plasma
Vanillylmandelate [Moles/time] in 24 hour Urine
Vanillylmandelate/Creatinine [Molar ratio] in Urine
Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO
Volatile drugs positive [Identifier] in Serum or Plasma by Screen method
Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO
Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO
Xylose [Moles/time] in 5 hour Urine --post dose PO
Microalbumin [Mass/time] in 24 hour Urine
Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine
Microalbumin/Creatinine [Mass Ratio] in Urine
Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma
CD10 Abnormal blood cells/Abnormal blood cells.total in Blood
CD13 Abnormal blood cells/Abnormal blood cells.total in Blood
CD14 Abnormal blood cells/Abnormal blood cells.total in Blood
CD19 Abnormal blood cells/Abnormal blood cells.total in Blood
CD2 Abnormal blood cells/Abnormal blood cells.total in Blood
CD20 Abnormal blood cells/Abnormal blood cells.total in Blood
CD33 Abnormal blood cells/Abnormal blood cells.total in Blood
CD5 Abnormal blood cells/Abnormal blood cells.total in Blood
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO
CD7 Abnormal blood cells/Abnormal blood cells.total in Blood
Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma
Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma
Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection
Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection
Human antimouse Ab [Mass/volume] in Serum
Lecithin/Sphingomyelin [Ratio] in Amniotic fluid
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Immunoglobulin light chains.free [Type] in Urine
cycloSPORINE [Mass/volume] in Blood by Immunoassay
aPTT in Platelet poor plasma by Coagulation assay
A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit
A variant subtype Ab [Presence] in Serum or Plasma from Donor
A variant subtype Ab [Presence] in Serum or Plasma
I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit
I (intermediate) subtype [Presence] on Red Blood Cells from Donor
Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV
I (intermediate) subtype [Presence] on Red Blood Cells
little i-1 subtype [Presence] on Red Blood Cells from Blood product unit
little i-1 subtype [Presence] on Red Blood Cells from Donor
little i-1 subtype [Presence] on Red Blood Cells
little i-2 subtype [Presence] on Red Blood Cells from Blood product unit
little i-2 subtype [Presence] on Red Blood Cells from Donor
little i-2 subtype [Presence] on Red Blood Cells
O group [Presence] on Red Blood Cells from Blood product unit
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV
O group [Presence] on Red Blood Cells from Donor
Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV
Thyrotropin [Units/volume] in Serum or Plasma --baseline
Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV
Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO
Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO
11-Hydroxyandrosterone [Moles/time] in 24 hour Urine
11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine
11-Ketoandrosterone [Moles/time] in 24 hour Urine
11-Ketoetiocholanolone [Moles/time] in 24 hour Urine
2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum
5-Hydroxyindoleacetate [Moles/volume] in Urine
Aldosterone [Moles/volume] in Serum or Plasma --supine
Aldosterone [Moles/volume] in Serum or Plasma --upright
Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma
Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma
Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO
Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma
Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma
Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma
Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid
Amylase.P1/Amylase.total in Serum or Plasma
Amylase.P2/Amylase.total in Serum or Plasma
Amylase.P3/Amylase.total in Serum or Plasma
Amylase S1/Amylase.total in Serum or Plasma
Amylase S2/Amylase.total in Serum or Plasma
Amylase S3/Amylase.total in Serum or Plasma
Androstanediol [Moles/volume] in Serum or Plasma
Androstenedione [Moles/time] in 24 hour Urine
Androsterone [Moles/volume] in Serum or Plasma
Cephalexin [Susceptibility] by Disk diffusion (KB)
Androsterone [Moles/time] in 24 hour Urine
Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO
Bromide [Moles/volume] in Serum or Plasma
Calcitonin [Moles/volume] in Serum or Plasma
Catecholamines [Moles/time] in 24 hour Urine
Citrate [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO
Coproporphyrin [Moles/time] in 24 hour Stool
Coproporphyrin [Moles/time] in 24 hour Urine
Cortisol Free [Moles/volume] in Serum or Plasma
Creatine [Moles/volume] in Serum or Plasma
Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis
Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis
Creatinine [Moles/volume] in Amniotic fluid
Creatinine [Moles/volume] in Dialysis fluid
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma
Deoxypyridinoline [Moles/time] in 24 hour Urine
Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO
Androstanolone [Moles/volume] in Serum or Plasma
Enolase.neuron specific [Mass/volume] in Serum or Plasma
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine
Estriol (E3).conjugated [Moles/volume] in Serum or Plasma
Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO
Etiocholanolone [Moles/time] in 24 hour Urine
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
Follitropin [Units/volume] in Serum or Plasma
Fructosamine [Moles/volume] in Serum or Plasma
Gastrin [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO
Glucagon [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Dialysis fluid
Prolactin [Units/volume] in Serum or Plasma
Normetanephrine [Moles/time] in 24 hour Urine
Osteocalcin [Moles/volume] in Serum or Plasma
Oxalate [Moles/volume] in Serum or Plasma
Parathyrin related protein [Moles/volume] in Serum or Plasma
Parathyrin.C-terminal [Moles/volume] in Serum or Plasma
Phospholipid [Moles/volume] in Serum or Plasma
Porphyrins [Moles/time] in 24 hour Stool
Protoporphyrin Free [Moles/volume] in Blood
Testosterone [Moles/time] in 24 hour Urine
Uroporphyrin [Moles/time] in 24 hour Urine
Vanillylmandelate [Moles/volume] in Urine
Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO
Amiodarone [Moles/volume] in Serum or Plasma
Barbiturates [Moles/volume] in Serum or Plasma
Chloramphenicol [Moles/volume] in Serum or Plasma
Codeine [Moles/volume] in Serum or Plasma
Digitoxin [Moles/volume] in Serum or Plasma
Flecainide [Moles/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV
Imipramine [Moles/volume] in Serum or Plasma
Methadone [Moles/volume] in Serum or Plasma
Midazolam [Moles/volume] in Serum or Plasma
Cephalexin [Susceptibility] by Serum bactericidal titer
Morphine [Moles/volume] in Serum or Plasma
Tricyclic antidepressants [Moles/volume] in Serum or Plasma
Leukocyte phosphatase [Units/volume] in Leukocytes
Aluminum [Moles/volume] in Dialysis fluid
Lipoprotein.alpha/total Lipoprotein in Serum or Plasma
Lipoprotein.beta/total Lipoprotein in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV
Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma
Albumin/Protein.total in Synovial fluid by Electrophoresis
Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis
Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis
Beta globulin/Protein.total in Synovial fluid by Electrophoresis
Gamma globulin/Protein.total in Synovial fluid by Electrophoresis
Methionine+Tryptophan [Presence] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV
Isoleucine+Leucine [Presence] in Serum or Plasma
Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma
Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma
Alanine+Ethanolamine [Presence] in Serum or Plasma
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine
Beta aminoisobutyrate+Proline [Presence] in Urine
Alanine+Ethanolamine [Presence] in Urine
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine
Glutamate+Glutamine+Threonine [Presence] in Urine
Methionine+Tryptophan [Presence] in Urine
Alkaline phosphatase [Enzymatic activity/volume] in Body fluid
Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO
Anisocytosis [Presence] in Blood by Automated count
Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID)
Bilirubin.conjugated [Mass/volume] in Serum or Plasma
Blasts [Presence] in Blood by Automated count
Cancer Ag 125 [Units/volume] in Body fluid by Dilution
Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution
Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative
Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative
Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma
Complement C1q [Mass/volume] in Body fluid
Complement C2 [Mass/volume] in Body fluid
Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO
Complement C3 [Mass/volume] in Synovial fluid
Complement C4 [Mass/volume] in Synovial fluid
Complement C5 [Mass/volume] in Body fluid
Complement C6 [Mass/volume] in Body fluid
Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay
Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay
Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay
Cryoglobulin.IgA [Units/volume] in Serum
Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO
Cryoglobulin.IgG [Units/volume] in Serum
Cryoglobulin.IgM [Units/volume] in Serum
Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel
Cryoproteins identified in Serum or Plasma
DNA double strand Ab [Units/volume] in Body fluid
Complement factor B [Mass/volume] in Body fluid
Fibrin D-dimer [Presence] in Platelet poor plasma
Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO
Hypochromia [Presence] in Blood by Automated count
IgA [Presence] in Serum by Immunoelectrophoresis
IgG [Presence] in Serum by Immunoelectrophoresis
IgM [Presence] in Serum by Immunoelectrophoresis
Lambda light chains [Mass/volume] in 24 hour Urine
Kappa light chains [Mass/volume] in 24 hour Urine
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
Leukocytes other [Identifier] in Blood by Automated count
Variant lymphocytes [Presence] in Blood by Automated count
Lymphocytes clefted/100 leukocytes in Blood by Manual count
Macrocytes [Presence] in Blood by Automated count
Microcytes [Presence] in Blood by Automated count
Platelets Large Fragments [#/volume] in Blood by Manual count
Rheumatoid factor [Units/volume] in Body fluid by Nephelometry
Rheumatoid factor [Titer] in Serum by Nephelometry
Rheumatoid factor [Units/volume] in Serum by Nephelometry
Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO
Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry
Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID)
Biopsy [Interpretation] in Thyroid Narrative
Lipase [Enzymatic activity/volume] in Body fluid
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --2 hours post meal
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst
Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk
Regional Allergen Mix A (Common ragweed+Mugwort+Japanese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk
Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk
Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO
Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk
Horse Bot Fly IgE Ab [Units/volume] in Serum
Silver Birch IgE Ab [Units/volume] in Serum
Grey Alder IgE Ab [Units/volume] in Serum
London Plane IgE Ab [Units/volume] in Serum
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)
Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO
Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO
Other Antibiotic [Susceptibility] by Serum bactericidal titer
Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak
Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough
Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO
Berlin Beetle IgE Ab [Units/volume] in Serum
Italian Cedar IgE Ab [Units/volume] in Serum
Black Fly IgE Ab [Units/volume] in Serum
European Hornet IgE Ab [Units/volume] in Serum
Blood group antibody screen [Titer] in Serum or Plasma
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma
Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma
Amylase [Enzymatic activity/time] in 2 hour Urine
Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV
Bombesin Ag [Presence] in Tissue by Immune stain
Estrone sulfate [Mass/volume] in Serum or Plasma
Macroamylase [Presence] in Serum or Plasma
dRVVT actual/normal (normalized LA screen)
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV
aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay
Busulfan [Mass/volume] in Serum or Plasma
Dextroamphetamine [Mass/volume] in Urine
Ganciclovir [Mass/volume] in Serum or Plasma
Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma
Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO
Sulfonylurea [Presence] in Serum or Plasma
Valproate Free [Mass/volume] in Saliva (oral fluid)
Spermatozoa Abnormal/100 spermatozoa in Semen
Cytomegalovirus Ab [Presence] in Serum by Latex agglutination
Haemophilus influenzae B Ag [Presence] in Urine
Leishmania brasilensis IgG Ab [Titer] in Serum
Leishmania brasilensis IgM Ab [Titer] in Serum
Leishmania donovani IgG Ab [Titer] in Serum
Leishmania donovani IgM Ab [Titer] in Serum
Leishmania mexicana IgG Ab [Titer] in Serum
Leishmania mexicana IgM Ab [Titer] in Serum
Leishmania tropica IgG Ab [Titer] in Serum
Leishmania tropica IgM Ab [Titer] in Serum
Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO
Mycoplasma hominis [Presence] in Specimen by Organism specific culture
Parainfluenza virus 1 IgG Ab [Presence] in Serum
Parainfluenza virus 1 IgM Ab [Presence] in Serum
Parainfluenza virus 1 IgM Ab [Titer] in Serum
Parainfluenza virus 2 IgG Ab [Presence] in Serum
Parainfluenza virus 2 IgM Ab [Titer] in Serum
Parainfluenza virus 3 IgG Ab [Presence] in Serum
Parainfluenza virus 3 IgM Ab [Presence] in Serum
Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO
Trypanosoma cruzi IgM Ab [Titer] in Serum
Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence
Drugs identified in Blood by Screen method
Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO
Levomethamphetamine/Amphetamines.total in Urine
Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay
Ergosterol [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO
Testosterone Free/Testosterone.total in Serum or Plasma
Anaplasma marginale Ab [Presence] in Serum by Agglutination
Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID)
Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID)
Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay
Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID)
Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV
Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID)
Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID)
Avian leukosis virus Ag [Titer] in Serum by Immunoassay
Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO
Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay
Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay
Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition
Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition
Cephaloglycin [Susceptibility] by Disk diffusion (KB)
Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition
Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID)
Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID)
Avian reovirus Ab [Presence] in Serum by Immunoassay
Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay
Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID)
Bluetongue virus Ab [Presence] in Serum by Immunoassay
Bordetella avium Ab [Titer] in Serum by Agglutination
Bordetella avium Ab [Presence] in Serum by Immunoassay
Bovine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test
Bovine leukemia virus Ab [Presence] in Serum by Immunoassay
Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO
Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID)
Bovine diarrhea virus 1 neutralizing antibody [Titer] in Serum by Neutralization test
Bovine diarrhea virus 2 neutralizing antibody [Titer] in Serum by Neutralization test
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID)
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Equine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test
Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID)
Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition
Equine influenza virus A2 Ab [Presence] in Serum
Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition
Equine influenza virus Ag [Presence] in Nose by Immunoassay
Equine arteritis virus neutralizing antibody [Titer] in Serum by Neutralization test
Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay
Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination
Glucose [Mass/volume] in Serum or Plasma --baseline
Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID)
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay
Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination
Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay
Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe
Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV
Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay
Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination
Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay
Mycoplasma synoviae Ab [Presence] in Serum by Agglutination
Mycoplasma synoviae rRNA [Presence] in Serum by Probe
Neospora caninum Ab [Presence] in Serum by Immunoassay
Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition
Pasteurella multocida Ab [Presence] in Serum by Immunoassay
Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO
PRRSV Ab [Presence] in Serum by Immunoassay
PRRSV Ab [Presence] in Serum by Immunofluorescence
Pseudorabies virus Ab [Presence] in Serum by Immunoassay
Pseudorabies virus Ab [Presence] in Serum by Latex agglutination
Pseudorabies virus neutralizing antibody [Titer] in Serum by Neutralization test
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay
Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay
Salmonella arizonae Ab [Presence] in Serum by Agglutination
Salmonella pullorum Ab [Presence] in Serum by Agglutination
Salmonella typhimurium Ab [Presence] in Serum by Agglutination
Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO
Cephaloglycin [Susceptibility] by Serum bactericidal titer
Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV
Glucose [Mass/volume] in Serum or Plasma --12 hours fasting
Glucose [Mass/volume] in Urine --12 hours fasting
Fasting glucose [Mass/volume] in Capillary blood
Fasting glucose [Mass/volume] in Venous blood
Fasting glucose [Mass/volume] in Serum or Plasma
Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose TOLBUTamide IV
Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)
Insulin [Mass/volume] in Serum or Plasma --1 hour post dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --2 hours post dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --3 hours post dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --baseline
Insulin [Mass/volume] in Serum or Plasma --pre dose TOLBUTamide IV
Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO
Insulin [Mass/volume] in Serum or Plasma --12 hours fasting
17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h
17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)
17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h
17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h
Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO
Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO
Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO
Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast
Cephaloridine [Susceptibility] by Disk diffusion (KB)
Lead [Mass/volume] in Urine --post EDTA therapy
Cephaloridine [Susceptibility] by Serum bactericidal titer
Norepinephrine [Mass/volume] in Plasma --supine
Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)
Norepinephrine [Mass/volume] in Plasma --10 minutes post standing
Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO
Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug cloNIDine PO
Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug cloNIDine PO
Norepinephrine [Mass/volume] in Plasma --pre 300 ug cloNIDine PO
Osmolality of Urine--12 hours post fluid fast
Osmolality of Urine--8 hours post fluid fast
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)
Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)
Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)
Bovine Gelatin IgE Ab [Units/volume] in Serum
Porcine Gelatin IgE Ab [Units/volume] in Serum
Paper Mulberry IgE Ab [Units/volume] in Serum
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM
Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
11-Deoxycorticosterone [Mass/time] in 24 hour Urine
Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine
Estrogen receptor [Interpretation] in Tissue
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV
Progesterone receptor [Interpretation] in Tissue
Tetrahydrocortisone [Mass/time] in 24 hour Urine
Brucella abortus IgG Ab [Titer] in Serum
Brucella abortus IgM Ab [Titer] in Serum
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV
Colorado tick fever virus IgG Ab [Titer] in Serum
Colorado tick fever virus IgM Ab [Titer] in Serum
Cryptococcus sp Ab [Titer] in Cerebral spinal fluid
Helicobacter pylori IgA Ab [Presence] in Serum
Helicobacter pylori IgG Ab [Presence] in Serum
Helicobacter pylori IgM Ab [Presence] in Serum
Hepatitis C virus Ab [Presence] in Serum
Hepatitis C virus IgG Ab [Presence] in Serum
Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with probe detection
HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot
Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence
Neisseria meningitidis [Presence] in Specimen by Organism specific culture
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO
Neuronal nuclear Ab [Titer] in Cerebral spinal fluid
Droperidol [Presence] in Serum or Plasma
Mescaline [Mass/volume] in Serum or Plasma
Psilocin [Mass/volume] in Serum or Plasma
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV
Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma
Dechlorane [Presence] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV
Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge
Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10 AM specimen
Glucose [Mass/volume] in Serum or Plasma --11 AM specimen
Glucose [Mass/volume] in Serum or Plasma --2 PM specimen
Glucose [Mass/volume] in Serum or Plasma --3 PM specimen
Glucose [Mass/volume] in Serum or Plasma --4 PM specimen
Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO
Glucose [Mass/volume] in Serum or Plasma --5 PM specimen
Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid
Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid
Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid
Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid
Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue
Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
Hydroxyalprazolam [Mass/volume] in Stool
Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV
Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen
Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen
Amobarbital [Presence] in Urine by Confirmatory method
Butabarbital [Presence] in Urine by Confirmatory method
PHENobarbital [Presence] in Urine by Confirmatory method
PENTobarbital [Presence] in Urine by Confirmatory method
Secobarbital [Presence] in Urine by Confirmatory method
Benzodiazepines [Presence] in Urine by Confirmatory method
Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO
Morphine [Presence] in Urine by Confirmatory method
Codeine [Presence] in Urine by Confirmatory method
Diamorphine [Presence] in Urine by Confirmatory method
Methadone [Presence] in Urine by Confirmatory method
Propoxyphene [Presence] in Urine by Confirmatory method
Oxazepam [Mass/volume] in Urine by Confirmatory method
Nordiazepam [Presence] in Urine by Confirmatory method
ALPRAZolam [Presence] in Urine by Confirmatory method
Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV
clonazePAM [Presence] in Urine by Confirmatory method
LORazepam [Presence] in Urine by Confirmatory method
Temazepam [Presence] in Urine by Confirmatory method
Meperidine [Presence] in Urine by Confirmatory method
Buprenorphine [Presence] in Urine by Confirmatory method
Chlorpheniramine [Presence] in Urine by Confirmatory method
Diethylpropion [Presence] in Urine by Confirmatory method
Dihydrocodeine [Presence] in Urine by Confirmatory method
Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV
Ethylamphetamine [Presence] in Urine by Confirmatory method
Levorphanol [Presence] in Urine by Confirmatory method
Lysergate diethylamide [Presence] in Urine by Confirmatory method
Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method
MethylePHEDrine [Presence] in Urine by Confirmatory method
Methyprylon [Presence] in Urine by Confirmatory method
Nalbuphine [Presence] in Urine by Confirmatory method
Pentazocine [Presence] in Urine by Confirmatory method
Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO
Phenmetrazine [Presence] in Urine by Confirmatory method
Phenothiazines [Presence] in Urine by Confirmatory method
Phentermine [Presence] in Urine by Confirmatory method
Thiopental [Presence] in Urine by Confirmatory method
Triazolam [Presence] in Urine by Confirmatory method
Amitriptyline [Presence] in Urine by Confirmatory method
Benzoylecgonine [Mass/volume] in Urine by Confirmatory method
diazePAM [Mass/volume] in Urine by Confirmatory method
Nordiazepam [Mass/volume] in Urine by Confirmatory method
clonazePAM [Mass/volume] in Urine by Confirmatory method
N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method
Flurazepam [Mass/volume] in Urine by Confirmatory method
Triazolam [Mass/volume] in Urine by Confirmatory method
Midazolam [Mass/volume] in Urine by Confirmatory method
Amphetamine [Mass/volume] in Urine by Confirmatory method
Methamphetamine [Mass/volume] in Urine by Confirmatory method
Butabarbital [Mass/volume] in Urine by Confirmatory method
Butalbital [Mass/volume] in Urine by Confirmatory method
Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO
Secobarbital [Mass/volume] in Urine by Confirmatory method
Amobarbital [Mass/volume] in Urine by Confirmatory method
PENTobarbital [Mass/volume] in Urine by Confirmatory method
PHENobarbital [Mass/volume] in Urine by Confirmatory method
Propoxyphene [Mass/volume] in Urine by Confirmatory method
Cannabinoids [Mass/volume] in Blood by Confirmatory method
Methaqualone [Mass/volume] in Urine by Confirmatory method
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units
Methadone [Mass/volume] in Urine by Confirmatory method
Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method
6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method
oxyCODONE [Mass/volume] in Urine by Confirmatory method
Codeine [Mass/volume] in Urine by Confirmatory method
Morphine [Mass/volume] in Urine by Confirmatory method
HYDROcodone [Mass/volume] in Urine by Confirmatory method
Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units
Meperidine [Mass/volume] in Urine by Confirmatory method
Phencyclidine [Mass/volume] in Urine by Confirmatory method
Sodium urate crystals [Presence] in Stone by Infrared spectroscopy
Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy
Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy
Triamterene crystals [Presence] in Stone by Infrared spectroscopy
Retinol [Mass/volume] in Serum or Plasma --pre 5000 units
Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy
Newberyite crystals [Presence] in Stone by Infrared spectroscopy
Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy
Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy
Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy
Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy
Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy
Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy
Urate crystals [Presence] in Stone by Infrared spectroscopy
Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Bartonella sp DNA [Presence] in Blood by NAA with probe detection
Bartonella henselae DNA [Presence] in Blood by NAA with probe detection
Bartonella quintana DNA [Presence] in Blood by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Blood by NAA with probe detection
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection
Cephalothin [Susceptibility] by Disk diffusion (KB)
Human papilloma virus DNA [Presence] in Specimen by Probe with amplification
Escherichia coli verotoxin [Presence] in Specimen
Creatinine/Protein [Mass Ratio] in Urine
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO
Herpes simplex virus 1 [Presence] in Specimen by Organism specific culture
11-Deoxycorticosteroids [Mass/volume] in Plasma
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge
11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma
17-Hydroxypregnenolone [Mass/volume] in Urine
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
17-Ketogenic steroids [Mass/time] in 72 hour Urine
17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO
2-Hexanol/Creatinine [Mass Ratio] in Urine
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV
Acetonitrile [Mass/volume] in Serum or Plasma
Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood
Prostatic acid phosphatase [Presence] in Vaginal fluid
Acrylamide [Mass/volume] in Serum or Plasma
Acyclovir [Susceptibility] by Serum bactericidal titer
Biperiden [Mass/volume] in Serum or Plasma
Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells
Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO
Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Hydrocarbons Aliphatic [Identifier] in Blood
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV
Alkaline phosphatase [Enzymatic activity/volume] in Urine
Alpha aminoisobutyrate [Presence] in Urine
Alpha aminoisobutyrate [Mass/volume] in Urine
Alpha aminoisobutyrate [Presence] in Plasma
Alpha aminoisobutyrate [Mass/volume] in Plasma
Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid
Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid
Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO
Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method
Amantadine [Susceptibility] by Serum bactericidal titer
Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO
Amino beta guanidinopropionate [Presence] in Urine
Amino beta guanidinopropionate [Presence] in Plasma
Cephalothin [Susceptibility] by Serum bactericidal titer
Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO
Amitriptyline [Mass/volume] in Serum or Plasma --peak
Amitriptyline [Mass/volume] in Serum or Plasma --trough
Amobarbital [Mass/volume] in Gastric fluid
Diethylpropion [Mass/volume] in Serum or Plasma
Amphetamines [Presence] in Urine by Confirmatory method
Amyl nitrite [Mass/volume] in Serum or Plasma
Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV
Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM
Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Antidepressants [Identifier] in Serum or Plasma
Nuclear Ab [Presence] in Serum by Rodent substrate
Nuclear Ab [Units/volume] in Serum by Rodent substrate
Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM
Nuclear Ab [Presence] in Body fluid by Immunofluorescence
Arylamidase [Enzymatic activity/volume] in Urine
Asbestos identified in Sputum by Light microscopy
Ascorbate [Mass/volume] in Serum or Plasma --post dose
Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells
Aspergillus amstelodami Ab [Units/volume] in Serum
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid
Aspergillus terreus Ab [Units/volume] in Serum
Aspergillus versicolor Ab [Units/volume] in Serum
azaTHIOprine [Mass/volume] in Serum or Plasma
Azithromycin [Mass/volume] in Serum or Plasma
Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence
Bacitracin [Mass/volume] in Serum or Plasma
Barbiturates [Presence] in Urine by Confirmatory method
Basement membrane Ab [Presence] in Serum
Basement membrane Ab [Units/volume] in Serum by Immunofluorescence
Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)
Benzene ring IgE Ab [Units/volume] in Serum
Benzene ring IgG Ab [Units/volume] in Serum
Benzene ring IgM Ab [Units/volume] in Serum
Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting
Benzophenone [Mass/volume] in Serum or Plasma
Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method
Benzthiazide [Mass/volume] in Serum or Plasma
Benzylhydrazine [Mass/volume] in Serum or Plasma
Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO
Beta aminoisobutyrate [Presence] in Urine
Beta galactosidase [Enzymatic activity/volume] in Blood
Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid
Beta hydroxybutyrate [Moles/volume] in Urine
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes
Bethanechol [Mass/volume] in Serum or Plasma
Bicarbonate [Moles/volume] in Body fluid
Bicarbonate [Moles/volume] in Cerebral spinal fluid
Bicarbonate [Moles/volume] in Red Blood Cells
Bicarbonate [Moles/volume] in Amniotic fluid
Bile acid.dihydroxy [Mass/volume] in Serum or Plasma
Bile acid.trihydroxy [Mass/volume] in Serum or Plasma
Xylose [Mass/time] in 5 hour Urine --post dose PO
Bismuth/Creatinine [Mass Ratio] in Urine
Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation
Blastomyces dermatitidis Ab [Units/volume] in Serum
Blastomyces dermatitidis rRNA [Presence] in Serum by Probe
Bordetella parapertussis Ab [Units/volume] in Serum
Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay
Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal
Borrelia burgdorferi Ab [Presence] in Body fluid
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay
Borrelia hermsii [Presence] in Specimen by Organism specific culture
Boysenberry IgE Ab [Units/volume] in Serum
Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal
Bromodiphenhydramine [Mass/volume] in Urine
Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum
Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination
Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation
Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination
Brucella suis Ab [Units/volume] in Serum by Latex agglutination
Brush border Ab [Presence] in Serum by Immunofluorescence
Calcitriol [Mass/volume] in Serum or Plasma
Butabarbital [Mass/volume] in Gastric fluid
Butorphanol [Mass/volume] in Urine by Confirmatory method
1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes
C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
C reactive protein [Mass/volume] in Body fluid
Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)
Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
1-Methylhistidine [Presence] in Serum or Plasma
Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge
Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge
Calcium [Moles/volume] in Urine --4th specimen post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge
Calcium/Phosphate [Mass Ratio] in Serum or Plasma
Calcium/Protein [Mass Ratio] in Serum or Plasma
1-Methylhistidine [Mass/volume] in Serum or Plasma
Calcium/Sodium [Mass Ratio] in Serum or Plasma
Campylobacter coli rRNA [Units/volume] in Serum by Probe
Campylobacter jejuni rRNA [Units/volume] in Serum by Probe
Campylobacter jejuni rRNA [Presence] in Serum by Probe
Campylobacter lari rRNA [Units/volume] in Serum by Probe
Campylobacter lari rRNA [Presence] in Serum by Probe
Campylobacter sp rRNA [Presence] in Serum by Probe
1-Methylhistidine [Mass/volume] in Urine
Canary droppings IgE Ab [Units/volume] in Serum
Canary serum proteins Ab [Units/volume] in Serum
Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID)
Candida sp IgA Ab [Units/volume] in Saliva (oral fluid)
Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method
Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method
Capreomycin [Mass/volume] in Serum or Plasma
Captopril [Mass/volume] in Serum or Plasma
Carbon dioxide, total [Moles/volume] in Capillary blood
Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge
Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge
Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge
Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge
Cathartic laxatives [Identifier] in Urine
Cefaclor [Mass/volume] in Serum or Plasma
Cefadroxil [Mass/volume] in Serum or Plasma
Cefixime [Mass/volume] in Serum or Plasma
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma
Cefuroxime IgE Ab [Units/volume] in Serum
cefTRIAXone IgE Ab [Mass/volume] in Serum
Centromere Ab [Presence] in Serum by Immunofluorescence
Cephadrine [Mass/volume] in Serum or Plasma
Cephaloridine [Mass/volume] in Serum or Plasma
11-Deoxycortisol [Mass/volume] in Serum or Plasma
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma
Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe
Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid
Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence
Chlamydia sp Ab [Units/volume] in Serum by Complement fixation
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
11-Hydroxyandrosterone [Mass/volume] in Urine
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Chlamydia trachomatis B IgG Ab [Units/volume] in Serum
Chlamydia trachomatis C IgG Ab [Units/volume] in Serum
Chlamydia trachomatis DNA [Presence] in Blood by NAA with probe detection
Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
11-Hydroxyetiocholanolone [Mass/volume] in Serum
Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe
Chloramphenicol [Mass/volume] in Serum or Plasma --peak
Chloramphenicol [Mass/volume] in Serum or Plasma --trough
Chlorine [Mass/volume] in Dialysis fluid
Chlorthalidone [Mass/volume] in Serum or Plasma
Cholesterol crystals [Presence] in Stone by Infrared spectroscopy
Cholesterol crystals [Presence] in Body fluid by Light microscopy
Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma
Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma
Choriogonadotropin.intact [Moles/volume] in Semen
11-Ketoandrosterone [Mass/volume] in Serum
Cladosporium herbarum Ab [Units/volume] in Serum
Clarithromycin [Mass/volume] in Serum or Plasma
Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Clindamycin [Mass/volume] in Serum or Plasma --peak
Clindamycin [Mass/volume] in Serum or Plasma --trough
Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)
11-Ketoetiocholanolone [Mass/volume] in Serum
Cloxacillin [Mass/volume] in Serum or Plasma
aPTT in Control Blood by Coagulation 1:1 saline
Cocaethylene [Mass/volume] in Urine by Confirmatory method
11-Oxycorticosterone [Mass/volume] in Serum
Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid
Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay
Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid
Coccidioides immitis IgE Ab [Units/volume] in Serum
Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid
Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid
Cockatiel droppings Ab [Units/volume] in Serum
17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid
Cockatiel droppings IgG Ab [Units/volume] in Serum
Cockatoo droppings Ab [Units/volume] in Serum
Codeine Free [Presence] in Serum or Plasma by Confirmatory method
Colistin [Mass/volume] in Serum or Plasma
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells
Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge
Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA)
Corticotropin Canine [Mass/volume] in Plasma
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge
17-Hydroxycorticosteroids [Mass/volume] in Plasma
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma --9th specimen post XXX challenge
17-Hydroxycorticosteroids [Mass/volume] in Urine
Cortisol Free [Mass/time] in 48 hour Urine
Cortisol Free [Mass/time] in 72 hour Urine
Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge
17-Hydroxyketosteroids [Mass/volume] in Urine
Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge
Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture
Coxiella burnetii IgG Ab [Units/volume] in Serum
Coxiella burnetii IgM Ab [Units/volume] in Serum
Coxsackievirus A Ab [Units/volume] in Serum
Coxsackievirus A IgG Ab [Units/volume] in Serum
Coxsackievirus A IgM Ab [Units/volume] in Serum
Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma
Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B Ab [Units/volume] in Serum
Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test
Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test
Creatine [Mass/volume] in Vitreous fluid
Creatine kinase [Enzymatic activity/volume] in Body fluid
Cephapirin [Susceptibility] by Disk diffusion (KB)
Cryptococcus sp Ag [Presence] in Body fluid
Cobalamin (Vitamin B12) [Mass/volume] in Blood
Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge
Cyclohexanol/Creatinine [Mass Ratio] in Urine
Cyproheptadine [Mass/volume] in Serum or Plasma
Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid
Taenia solium larva IgM Ab [Units/volume] in Serum
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid
17-Hydroxyprogesterone [Mass/volume] in Urine
Cystine crystals [Presence] in Stone by Infrared spectroscopy
Cytomegalovirus Ab [Units/volume] in Body fluid
Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid
Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay --2nd specimen
17-Ketogenic steroids [Mass/volume] in Blood
Cytomegalovirus Ag [Presence] in Urine by Immunoassay
Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid)
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
17-Ketogenic steroids [Mass/time] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge
18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma
American house dust mite IgG Ab [Presence] in Blood
European house dust mite IgG Ab [Presence] in Blood
Nortrimipramine [Mass/volume] in Serum or Plasma
Dextromoramide [Presence] in Serum or Plasma
Propoxyphene [Presence] in Serum or Plasma by Confirmatory method
Dezocine [Mass/volume] in Serum or Plasma
Diamorphine [Mass/volume] in Unknown substance
Diamorphine [Mass/volume] in Urine by Confirmatory method
Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method
diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma
2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells
Dicamba [Mass/volume] in Serum or Plasma
Dichlorodiphenyldichloroethylene [Mass/volume] in Urine
Dichlorodiphenyldichloroethylene [Mass/volume] in Blood
Dichlorodiphenyltrichloroethane [Mass/volume] in Milk
2,3-Diphosphoglycerate [Mass/volume] in Serum
Cephapirin [Susceptibility] by Serum bactericidal titer
Dicyclomine [Mass/volume] in Serum or Plasma
Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
Diethylcarbamazepine [Mass/volume] in Serum or Plasma
Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method
Dinitrophenol [Presence] in Serum or Plasma
20-Hydroxyprogesterone [Mass/volume] in Serum
DOPamine [Mass/volume] in Urine --2nd specimen post XXX challenge
DOPamine [Mass/volume] in Urine --3rd specimen post XXX challenge
DOPamine [Mass/volume] in Urine --4th specimen post XXX challenge
DOPamine [Mass/volume] in Urine --5th specimen post XXX challenge
DOPamine [Mass/volume] in Urine --6th specimen post XXX challenge
DOPamine [Mass/volume] in Urine --7th specimen post XXX challenge
24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma
Doxylamine [Mass/volume] in Serum or Plasma
Drugs identified in Unknown substance by Screen method
Echinococcus sp IgM Ab [Units/volume] in Serum
Echovirus Ab [Units/volume] in Serum by Complement fixation
Echovirus 1 Ab [Units/volume] in Serum by Complement fixation
Echovirus 19 Ab [Units/volume] in Serum by Complement fixation
Echovirus 3 Ab [Units/volume] in Serum by Complement fixation
Echovirus 4 Ab [Units/volume] in Serum by Complement fixation
Echovirus 6 Ab [Units/volume] in Serum by Complement fixation
Echovirus 6+18+30 Ab [Units/volume] in Serum
Echovirus 9 Ab [Units/volume] in Serum by Complement fixation
Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum
Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum
Endomysium Ab [Presence] in Serum by Immunofluorescence
Endomysium Ab [Units/volume] in Serum by Immunofluorescence
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood
Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID)
Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid
Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence
Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation
EPINEPHrine [Mass/volume] in Plasma --4 hours post XXX challenge
Epithelial cells [Presence] in Nose by Light microscopy
Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid
Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid
Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid
Erythrocytes [#/volume] in Seminal plasma by Manual count
Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Escherichia coli enterotoxic identified in Stool by Organism specific culture
Escherichia coli K1 Ag [Presence] in Specimen by Immunoassay
Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination
Escherichia coli shiga-like toxin identified in Stool by Organism specific culture
Escherichia coli verotoxic identified in Stool by Organism specific culture
Estriol (E3) [Mass/volume] in Body fluid
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine
Ethacrynate [Mass/volume] in Serum or Plasma
Ethambutol+rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ethanol [Mass/volume] in Unknown substance
Ethinamate [Presence] in Serum or Plasma by Confirmatory method
Ethionamide [Mass/volume] in Serum or Plasma
Ethoheptazine [Presence] in Serum or Plasma
Ethoheptazine [Mass/volume] in Serum or Plasma
Cephradine [Susceptibility] by Minimum lethal concentration (MLC)
Etodolac [Mass/volume] in Serum or Plasma
Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain
3-Methylhistidine [Presence] in Serum or Plasma
Fibrinogen [Presence] in Platelet poor plasma
Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunoassay
Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay
3-Methylhistidine [Mass/volume] in Serum or Plasma
Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibronectin aggregate IgG Ab [Mass/volume] in Serum
Finch droppings IgE Ab [Presence] in Serum
Fluorocarbons [Identifier] in Serum or Plasma
3-Methylhistidine [Mass/volume] in Urine
Formate+Formaldehyde [Mass/volume] in Blood
Francisella tularensis Ab [Titer] in Serum
Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination
Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination
Francisella tularensis IgM Ab [Units/volume] in Serum
Francisella tularensis Ag [Presence] in Serum by Immunofluorescence
4-Pyridoxate [Mass/volume] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge
Giardia lamblia 65 Ag [Presence] in Stool
5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid
Giardia lamblia Ag [Presence] in Specimen
Gliadin Ab [Units/volume] in Saliva (oral fluid)
Glucose [Presence] in Urine --1st specimen post XXX challenge
Glucose [Presence] in Urine --2nd specimen post XXX challenge
Glucose [Presence] in Urine --3rd specimen post XXX challenge
5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma
Glucose [Presence] in Urine --4th specimen post XXX challenge
Glucose [Presence] in Urine --5th specimen post XXX challenge
Glucose [Presence] in Urine --6th specimen post XXX challenge
Glucose [Presence] in Urine --7th specimen post XXX challenge
Glucose [Presence] in Urine --8th specimen post XXX challenge
Glucose [Presence] in Urine --9th specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --post XXX challenge
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum
Glucose [Mass/volume] in Serum or Plasma --post meal
Glutathione [Mass/volume] in Serum or Plasma
Glycoproteins [Presence] in Serum or Plasma
St. Augustine grass IgE Ab [Units/volume] in Serum
Wild rye grass IgE Ab [Units/volume] in Serum
5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid
guaiFENesin [Mass/volume] in Serum or Plasma
Haemophilus influenzae IgG Ab [Units/volume] in Serum
Haemophilus influenzae A Ag [Presence] in Urine
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid
Haemophilus influenzae B IgG Ab [Units/volume] in Serum
Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum
Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence
Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)
5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma
Hematocrit/Hemoglobin [Ratio] of Blood by Automated count
Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis
Hepatitis B virus core Ab [Presence] in Serum
Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection
Hepatitis B virus surface Ab [Units/volume] in Serum
Hepatitis C virus IgG Ab [Units/volume] in Serum
Hepatitis G virus RNA [Presence] in Serum by NAA with probe detection
Heptacarboxylporphyrin [Mass/volume] in Stool
Heptachlorepoxide [Mass/volume] in Urine
Herpes simplex virus Ab [Presence] in Serum by Immunoblot
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid
Herpes simplex virus IgM Ab [Units/volume] in Serum
Herpes simplex virus Ag [Presence] in Specimen
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid
5-Hydroxyindoleacetate [Mass/volume] in Urine
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes simplex virus 2 Ab [Presence] in Serum
Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot
5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen
Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Heterophile Ab [Presence] in Synovial fluid by Latex agglutination
Hexacarboxylporphyrin [Mass/volume] in Blood
5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum
Hexacarboxylporphyrin [Mass/volume] in Stool
Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells
Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells
Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence
Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation
Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID)
6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID)
Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID)
HIV 1 Ab [Presence] in Cerebral spinal fluid
HIV 1 Ag [Presence] in Cerebral spinal fluid
HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid
8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
HTLV II DNA [Presence] in Specimen by NAA with probe detection
HTLV I DNA [Presence] in Specimen by NAA with probe detection
HTLV I+II Ab [Presence] in Serum by Immunoblot
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose
Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue
HYDROmorphone [Mass/volume] in Urine by Confirmatory method
Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method
IgA subclass 1 [Mass/volume] in Cerebral spinal fluid
IgA subclass 2 [Mass/volume] in Cerebral spinal fluid
Cephradine [Susceptibility] by Disk diffusion (KB)
Imipenem [Mass/volume] in Serum or Plasma
Acetaldehyde [Mass/volume] in Serum or Plasma
Influenza virus A Ab [Units/volume] in Cerebral spinal fluid
Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence
Influenza virus B Ab [Units/volume] in Cerebral spinal fluid
Influenza virus B IgG Ab [Units/volume] in Serum
Influenza virus B IgM Ab [Units/volume] in Serum
Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Intercellular substance Ab [Presence] in Serum by Immunofluorescence
Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence
Iodine.inorganic [Mass/volume] in Serum or Plasma
Isocyanate IgE Ab [Units/volume] in Serum
Isocyanate IgG Ab [Units/volume] in Serum
Isocyanate IgM Ab [Units/volume] in Serum
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence
Ketamine [Presence] in Urine by Confirmatory method
Ketoprofen [Mass/volume] in Serum or Plasma
Ketorolac [Mass/volume] in Serum or Plasma
La Crosse virus Ab [Titer] in Cerebral spinal fluid
Acetoacetate [Mass/volume] in Cerebral spinal fluid
Lactate dehydrogenase [Presence] in Urine
Lactoglobulin IgE Ab [Units/volume] in Serum
Lamellar bodies [Presence] in Amniotic fluid
Acetoacetate [Presence] in Serum or Plasma
Latex Bencard IgE Ab [Units/volume] in Serum
Latex glove extract IgE Ab [Units/volume] in Blood
Latex glove extract ammoniated IgE Ab [Units/volume] in Blood
Latex glove extract buffered IgE Ab [Units/volume] in Blood
Acetoacetate [Mass/volume] in Serum or Plasma
Legionella longbeachae 1 IgG Ab [Presence] in Serum
Legionella longbeachae 1 IgM Ab [Presence] in Serum
Legionella longbeachae 2 IgG Ab [Presence] in Serum
Legionella longbeachae 2 IgM Ab [Presence] in Serum
Legionella pneumophila Ag [Presence] in Specimen
Legionella pneumophila Ag [Presence] in Urine by Latex agglutination
Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence
Legionella pneumophila 1 Ab [Titer] in Serum
Legionella pneumophila 1 IgM Ab [Units/volume] in Serum
Legionella pneumophila 2 Ab [Titer] in Serum
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum
Legionella pneumophila 3 Ab [Titer] in Serum
Legionella pneumophila 3 IgM Ab [Units/volume] in Serum
Legionella pneumophila 4 Ab [Titer] in Serum
Legionella pneumophila 4 IgM Ab [Units/volume] in Serum
Legionella pneumophila 5 Ab [Titer] in Serum
Legionella pneumophila 5 IgM Ab [Units/volume] in Serum
Legionella pneumophila 6 Ab [Titer] in Serum
Legionella pneumophila 7 Ab [Presence] in Serum
Legionella pneumophila 8 Ab [Presence] in Serum
Legionella pneumophila 9 Ab [Presence] in Serum
Fatty acids.esterified [Mass/volume] in Serum or Plasma
Fatty acids.long chain [Identifier] in Serum or Plasma
Fatty acids.very long chain [Identifier] in Serum or Plasma
Lipoprotein.alpha [Mass/volume] in Body fluid
Lipoprotein.beta [Mass/volume] in Body fluid
Lipoprotein.pre-beta [Mass/volume] in Body fluid
Lipoproteins [Presence] in Serum or Plasma
Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid
Loperamide [Mass/volume] in Serum or Plasma
LORazepam [Mass/volume] in Urine by Confirmatory method
Lorcainide [Mass/volume] in Serum or Plasma
Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma
Lumpfish roe IgE Ab [Units/volume] in Serum
Lupus erythematosus factor [Presence] in Serum by Latex agglutination
Kappa lymphocytes/100 lymphocytes in Blood
Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma
Acid phosphatase [Enzymatic activity/volume] in Blood
Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid
Prostatic acid phosphatase [Enzymatic activity/volume] in Semen
Prostatic acid phosphatase [Enzymatic activity/volume] in Serum
Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma
CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood
Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum
Cephradine [Susceptibility] by Serum bactericidal titer
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells
Adenosine triphosphate [Mass/volume] in Blood
Cytoplasmic CD3 cells/100 cells in Blood
Cytoplasmic CD79 cells/100 cells in Blood
Cytoplasmic Ig mu cells/100 cells in Blood
HLE lymphocytes/100 lymphocytes in Blood
Lambda lymphocytes/100 lymphocytes in Blood
SMIg lymphocytes/100 lymphocytes in Blood
Lymphocytes/100 leukocytes in Synovial fluid by Automated count
Adenosine deaminase [Enzymatic activity/volume] in Blood
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid
Lysosomal enzymes [Identifier] in Plasma
Lysozyme [Enzymatic activity/volume] in Tear
Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood
Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge
Adenosine diphosphate [Mass/volume] in Serum
Mefenamate [Mass/volume] in Serum or Plasma
Mephobarbital [Mass/volume] in Urine by Confirmatory method
Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum
Mepivacaine [Presence] in Serum or Plasma
Mercaptopurine [Presence] in Serum or Plasma
Mesothelial cells [Presence] in Body fluid by Light microscopy
Metandienone [Mass/volume] in Serum or Plasma
Methadone.long acting metabolite [Mass/volume] in Serum or Plasma
Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Methemalbumin [Presence] in Serum or Plasma
Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma
Methyl isobutyl ketone [Mass/volume] in Urine
Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)
Methylacrylate [Mass/volume] in Serum or Plasma
Methylenedianiline [Mass/volume] in Blood
Methylergonovine [Mass/volume] in Serum or Plasma
Methylfentanyl [Mass/volume] in Serum or Plasma
Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine
metOLazone [Mass/volume] in Serum or Plasma
Miconazole [Mass/volume] in Serum or Plasma
Bacteria identified in Pleural fluid by Aerobe culture
Plasmodium sp identified in Tissue by Thick film
Microscopic observation [Identifier] in Sputum by KOH preparation
Minoxidil [Mass/volume] in Serum or Plasma
Mirtazapine [Mass/volume] in Serum or Plasma
Mitochondria Ab [Presence] in Serum by Immunofluorescence
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma
Mitochondria Ab [Units/volume] in Serum by Immunofluorescence
Monocytes/100 leukocytes in Synovial fluid by Manual count
Monocytes/100 leukocytes in Urine by Manual count
Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence
Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum
Morphine [Presence] in Serum or Plasma by Confirmatory method
Mumps virus Ab [Units/volume] in Cerebral spinal fluid
Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells
Mumps virus IgG+IgM Ab [Units/volume] in Serum
Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by Probe
Mycoplasma fermentans Ab [Presence] in Serum
Mycoplasma hominis Ab [Titer] in Serum by Complement fixation
Adenosine triphosphatase [Enzymatic activity/volume] in Semen
Mycoplasma hominis Ab [Presence] in Serum
Mycoplasma pneumoniae Ab [Presence] in Serum
Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot
Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence
Myelin associated glycoprotein IgA Ab [Units/volume] in Serum
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay
Myelin basic protein Ab [Mass/volume] in Serum
N-acetylprocainamide [Mass/volume] in Urine
Nalbuphine [Mass/volume] in Serum or Plasma
Adenylate kinase [Enzymatic activity/volume] in Serum
Nalidixate [Mass/volume] in Serum or Plasma
Neisseria meningitidis serogroups A+Y Ag [Presence] in Urine
Neisseria meningitidis Ab [Presence] in Serum
Neisseria meningitidis Ag [Presence] in Urine
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Urine
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Adenylosuccinate lyase [Enzymatic activity/volume] in Serum
Neisseria meningitidis serogroup B Ab [Units/volume] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Urine by Latex agglutination
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis polyvalent Ab [Units/volume] in Serum
Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma by Latex agglutination
Neopterin/Creatinine [Mass Ratio] in Urine
Neostigmine [Mass/volume] in Serum or Plasma
Neuronal Ab [Presence] in Serum by Immunofluorescence
Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neuronal Ab [Units/volume] in Serum by Immunofluorescence
Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Neuronal IgG Ab [Presence] in Body fluid by Immunoassay
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 2 Ab [Units/volume] in Serum
Aldosterone renal clearance in 24 hour Urine and Serum or Plasma
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid
Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence
Neutrophil Ab [Presence] in Serum by Immunofluorescence
Neutrophil Ab [Units/volume] in Serum by Immunofluorescence
Neutrophil IgA Ab [Units/volume] in Serum
Neutrophil IgG Ab [Units/volume] in Serum
Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
Neutrophil IgM Ab [Units/volume] in Serum
Neutrophil cytoplasmic Ab [Presence] in Serum
Neutrophil cytoplasmic Ab [Interpretation] in Serum
Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence
Neutrophil cytoplasmic IgA Ab [Presence] in Serum
Neutrophil cytoplasmic IgG Ab [Presence] in Serum
Neutrophil cytoplasmic IgM Ab [Presence] in Serum
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence
Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum
Neutrophils [#/volume] in Semen by Manual count
Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Nitroprusside [Mass/volume] in Serum or Plasma
Nizatidine [Mass/volume] in Serum or Plasma
Nomifensine [Mass/volume] in Serum or Plasma
Norepinephrine [Mass/volume] in Plasma --standing
Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge
Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge
Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge
Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge
Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge
Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge
Norpropoxyphene [Presence] in Urine by Confirmatory method
Norpropoxyphene [Mass/volume] in Urine by Confirmatory method
Novobiocin [Mass/volume] in Serum or Plasma
Nuclear Ab.histone reactive [Presence] in Serum
Uroporphyrin [Mass/time] in 24 hour Stool
Opiates [Mass/volume] in Urine by Confirmatory method
Organochlorine pesticides [Type] in Urine
oxyMORphone [Mass/volume] in Urine by Confirmatory method
Oxytetracycline [Mass/volume] in Serum or Plasma
Oxytriphylline [Mass/volume] in Serum or Plasma
Human papilloma virus 11 Ag [Presence] in Specimen
Human papilloma virus 16 Ag [Presence] in Specimen
Amoxicillin [Susceptibility] by Disk diffusion (KB)
Human papilloma virus 16+18 Ag [Presence] in Specimen
Human papilloma virus 18 Ag [Presence] in Specimen
Human papilloma virus 31 Ag [Presence] in Specimen
Human papilloma virus 31+33+35 Ag [Presence] in Specimen
Human papilloma virus 33 Ag [Presence] in Specimen
Human papilloma virus 42 Ag [Presence] in Specimen
Human papilloma virus 43 Ag [Presence] in Specimen
Human papilloma virus 44 Ag [Presence] in Specimen
Human papilloma virus 45 Ag [Presence] in Specimen
Human papilloma virus 5 Ag [Presence] in Specimen
Human papilloma virus 51 Ag [Presence] in Specimen
Human papilloma virus 6 Ag [Presence] in Specimen
Human papilloma virus 6+11 Ag [Presence] in Specimen
Papova virus SV 40 Ab [Units/volume] in Serum
Parainfluenza virus 1+2+3 Ag [Presence] in Specimen
Parainfluenza virus A Ab [Units/volume] in Serum
Parakeet droppings Ab [Units/volume] in Serum
Parakeet droppings IgG Ab [Units/volume] in Serum
Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid
Parakeet serum Ab [Units/volume] in Serum
Parrot droppings Ab [Units/volume] in Serum
Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum
1,4-Dichlorobenzene [Mass/volume] in Blood
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Penicillium roqueforti IgE Ab [Units/volume] in Serum
Penicillium sp Ab [Units/volume] in Serum
Pentacarboxylporphyrins [Mass/time] in 24 hour Stool
Pentachlorophenol [Mass/volume] in Blood
Chloramphenicol [Susceptibility] by Disk diffusion (KB)
PENTobarbital [Mass/volume] in Gastric fluid
Tetrachloroethylene [Mass/volume] in Serum or Plasma
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P
Phenazopyridine [Mass/volume] in Serum or Plasma
PHENobarbital [Mass/volume] in Gastric fluid
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P
Phenylephrine [Mass/volume] in Serum or Plasma
Phenylpropanolamine [Mass/volume] in Urine
Phoma herbarum IgG Ab [Units/volume] in Serum
Phosphatidylethanolamine IgA Ab [Presence] in Serum
Phosphatidylethanolamine IgG Ab [Presence] in Serum
Phosphatidylethanolamine IgM Ab [Presence] in Serum
Phosphatidylglycerol IgA Ab [Presence] in Serum
Phosphatidylglycerol IgG Ab [Presence] in Serum
Phosphatidylglycerol IgM Ab [Presence] in Serum
Phosphatidylinositol IgA Ab [Presence] in Serum
Phosphatidylinositol IgG Ab [Presence] in Serum
Phosphatidylinositol IgM Ab [Presence] in Serum
Phosphoethanolamine [Presence] in Serum or Plasma
Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay
Phosphoserine [Presence] in Serum or Plasma
Pigeon droppings Ab [Units/volume] in Serum
Pigeon feather IgE Ab [Presence] in Serum
Albumin [Mass/volume] in Cerebral spinal fluid
Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay
PM-1 Ab [Presence] in Serum by Immunofluorescence
PM-1 Ab [Units/volume] in Serum by Immunofluorescence
Polybrominated biphenyl [Mass/volume] in Serum or Plasma
Polymyxin B [Mass/volume] in Serum or Plasma
Porphobilinogen [Moles/volume] in Serum or Plasma
Prazepam [Mass/volume] in Urine by Confirmatory method
Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Albumin [Mass/volume] in Peritoneal fluid
Proinsulin [Mass/volume] in Serum or Plasma --baseline
Prostaglandin E [Mass/volume] in Serum or Plasma
Prostaglandin F2 alpha [Mass/volume] in Urine
Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis
Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis
Beta globulin [Mass/volume] in Body fluid by Electrophoresis
Gamma globulin [Mass/volume] in Body fluid by Electrophoresis
Chloramphenicol [Susceptibility] by Serum bactericidal titer
Protoporphyrin [Mass/volume] in Serum or Plasma
Pseudomonas aeruginosa Ab [Units/volume] in Serum
Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma
Quinacrine [Mass/volume] in Serum or Plasma
Marsh Ragweed IgE Ab [Units/volume] in Serum
Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --baseline
Renin [Enzymatic activity/volume] in Plasma --supine
Albumin [Mass/volume] in Serum or Plasma
Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid
Respiratory syncytial virus IgG Ab [Titer] in Serum
Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid
Respiratory syncytial virus identified in Specimen by Organism specific culture
Reticulin IgA Ab [Titer] in Serum by Immunofluorescence
Reticulin IgG Ab [Titer] in Serum by Immunofluorescence
Retinoate esters [Mass/volume] in Serum or Plasma
Retinyl esters [Mass/volume] in Serum or Plasma
Retinol Free [Mass/volume] in Serum or Plasma
Retinol [Mass/volume] in Serum or Plasma --3 hours post dose
Retinol [Mass/volume] in Serum or Plasma --6 hours post dose
Retrovirus identified in Specimen by Organism specific culture
Rheumatoid arthritis nuclear Ab [Presence] in Serum
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence
Rheumatoid factor [Units/volume] in Body fluid by Immunoassay
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence
Rickettsia spotted fever group RNA [Presence] in Serum by NAA with probe detection
Rickettsia spotted fever group RNA [Presence] in Serum by Probe
Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination
Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence
Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay
Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid
Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid
Bartonella quintana rRNA [Presence] in Specimen by Probe
Rotavirus RNA [Presence] in Specimen by Probe
Rubella virus Ab [Units/volume] in Cerebral spinal fluid
Rubella virus Ab [Units/volume] in Serum by Latex agglutination
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid
Measles virus Ab [Units/volume] in Cerebral spinal fluid
Measles virus IgA Ab [Units/volume] in Serum
Measles virus Ab [Units/volume] in Serum --1st specimen
Measles virus Ab [Units/volume] in Serum --2nd specimen
Saccharomonospora viridis IgG Ab [Units/volume] in Serum
Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid
Salmon roe IgE Ab [Units/volume] in Serum
Salmonella sp identified in Specimen by Organism specific culture
Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination
Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination
Albumin in CSF/Albumin in Serum or Plasma
Salmonella typhi O Ab [Presence] in Serum
Sasapyrine [Mass/volume] in Serum or Plasma
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence
SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay
Secobarbital [Mass/volume] in Gastric fluid
Albumin renal clearance in 24 hour Urine and Serum or Plasma
Shigella sp identified in Specimen by Organism specific culture
Ganglioside GQ1a IgM Ab [Presence] in Serum
Ganglioside GQ1b IgG Ab [Presence] in Serum
Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid
Ganglioside GQ1b IgM Ab [Presence] in Serum
Albumin.glycated [Mass/volume] in Serum or Plasma
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay
Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID)
Albumin/Globulin [Mass Ratio] in Serum or Plasma
Smith extractable nuclear Ab [Titer] in Serum by Immunoassay
Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence
Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge
Volume of 24 hour Peritoneal dialysis fluid
Alcohol dehydrogenase [Enzymatic activity/volume] in Serum
Spermatozoa Motile [Presence] in Semen --30 minutes post collection
Stimulants [Identifier] in Serum or Plasma
Aldolase [Enzymatic activity/volume] in Serum or Plasma
Aldosterone [Mass/volume] in Serum or Plasma
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen
Streptococcus pneumoniae Ab [Units/volume] in Serum
Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Ag [Presence] in Specimen by Latex agglutination
Streptococcus pyogenes [Presence] in Specimen by Organism specific culture
Aldosterone [Mass/time] in 24 hour Urine
Streptolysin O Ab [Units/volume] in Synovial fluid
Strontium/Creatinine [Mass Ratio] in Urine
Succinylcholine [Mass/volume] in Serum or Plasma
sulfADIAZINE IgE Ab [Units/volume] in Serum
Sulfalazine IgE Ab [Units/volume] in Serum
Sulfamedraxozole IgE Ab [Units/volume] in Serum
Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence
Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay
Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence
Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay
Aldosterone [Mass/volume] in Serum or Plasma --supine
sulfiSOXAZOLE IgE Ab [Units/volume] in Serum
Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma
Taurine [Presence] in Cerebral spinal fluid
Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)
Aldosterone [Mass/volume] in Serum or Plasma --upright
2-Methyl-2-Propanol [Mass/volume] in Blood
Testosterone Free [Mass/volume] in Dialysis fluid
Testosterone.weakly bound [Mass/volume] in Serum or Plasma
Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma
Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge
Tetrachlorodiphenylethane [Mass/volume] in Blood
Tetrachlorodiphenylethane [Mass/volume] in Urine
Tetrachloroethane [Mass/volume] in Blood
Fatty acids.nonesterified [Mass/volume] in Serum or Plasma
Thebaine [Mass/volume] in Serum or Plasma
Thyroglobulin IgM Ab [Units/volume] in Serum
Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination
Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma
Thyroid stimulating immunoglobulins [Presence] in Serum
Toluene diisocyanate [Mass/volume] in Blood
Topiramate [Mass/volume] in Serum or Plasma
Toxaphene [Mass/volume] in Serum or Plasma
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Toxoplasma gondii IgE Ab [Units/volume] in Serum
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum
traMADol [Presence] in Urine by Confirmatory method
Treponema pallidum Ab [Presence] in Serum by Immobilization
Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence
Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination
Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence
Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma
Trichinella spiralis Ab [Presence] in Serum by Latex agglutination
Trichinella spiralis IgA Ab [Presence] in Serum
Trichinella spiralis IgG Ab [Units/volume] in Serum
Trichinella spiralis IgM Ab [Presence] in Serum
Chloral hydrate [Presence] in Urine by Confirmatory method
Trichlorophenoxyacetate [Presence] in Blood
Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma
Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge
Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum
Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum
Trimeprazine [Presence] in Serum or Plasma
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma
Tromethamine [Mass/volume] in Serum or Plasma
Trypsinogen [Enzymatic activity/volume] in Serum or Plasma
Tryptamine [Mass/volume] in Serum or Plasma
Tungsten [Mass/volume] in Serum or Plasma
Alkaline phosphatase [Mass/volume] in Body fluid
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid
Urea nitrogen [Mass/volume] in Vitreous fluid
Urea nitrogen [Mass/volume] in Arterial blood --post dialysis
Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Urea nitrogen [Mass/volume] in Venous blood --pre dialysis
Urobilinogen [Mass/time] in 48 hour Stool
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence
Alkaline phosphatase [Mass/volume] in Urine
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid
Western equine encephalitis virus Ab [Titer] in Serum
Whitefish roe IgE Ab [Units/volume] in Serum
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
Yeast [Presence] in Stool by Light microscopy
Yellow dye IgE Ab [Units/volume] in Serum
Yersinia sp IgA Ab [Units/volume] in Serum
Yersinia sp IgG Ab [Units/volume] in Serum
Yersinia sp IgM Ab [Units/volume] in Serum
Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
Helicobacter pylori Ag [Presence] in Stool by Immunoassay
21-Hydroxylase Ab [Units/volume] in Serum
Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma
Hemosiderin [Presence] in Urine by Light microscopy
Parasite identified in Blood by Light microscopy
Radioactive iodine.thyroid/Radioactive iodine dose [Ratio]
Thyrotropin [Interpretation] in Specimen--post dose TRH
Large unstained cells/100 leukocytes in Blood by Automated count
Large unstained cells [#/volume] in Blood by Automated count
Leukocytes Left Shift [Presence] in Blood by Automated count
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
Immunoglobulin light chains [Mass/volume] in 24 hour Urine
Potassium [Moles/volume] in Hyperal solution
Sodium [Moles/volume] in Hyperal solution
Thyroid colloidal Ab [Units/volume] in Serum
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
Amikacin [Mass/volume] in Cerebral spinal fluid
Promyelocytes/100 leukocytes in Body fluid
Metamyelocytes/100 leukocytes in Body fluid
Prolymphocytes/100 leukocytes in Body fluid
Plasma cells/100 leukocytes in Body fluid
Promonocytes/100 leukocytes in Body fluid
Procainamide [Mass/volume] in Body fluid
Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma
N-acetylprocainamide [Mass/volume] in Body fluid
cycloSPORINE [Mass/volume] in Body fluid
Prealbumin/Protein.total in Body fluid by Electrophoresis
Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration
Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis
Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration
Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma
Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis
Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration
Beta globulin/Protein.total in Body fluid by Electrophoresis
Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration
Gamma globulin/Protein.total in Body fluid by Electrophoresis
Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration
Albumin/Protein.total in Body fluid by Electrophoresis
Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative
Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma
CD3+CD4+ (T4 helper) cells/100 cells in Body fluid
CD45 (Lymphs) cells/100 cells in Body fluid
CD3+CD8+ (T8 suppressor) cells/100 cells in Body fluid
Alkaline phosphatase [Enzymatic activity/volume] in Blood
Centromere Ab [Units/volume] in Body fluid
Basophils/100 leukocytes in Synovial fluid
Eosinophils/100 leukocytes in Synovial fluid
Monocytes/100 leukocytes in Synovial fluid
Neutrophils/100 leukocytes in Synovial fluid
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum
Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
Alpha fucosidase [Enzymatic activity/volume] in Blood
Chlortetracycline [Susceptibility] by Disk diffusion (KB)
Alpha-L-iduronidase [Enzymatic activity/volume] in Blood
Amylase [Enzymatic activity/time] in 12 hour Urine
Cancer Ag 27-29 [Units/volume] in Serum or Plasma
Cancer Ag 72-4 [Units/volume] in Serum or Plasma
Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma
Lipoprotein.alpha [Presence] in Serum or Plasma
Lipoprotein.beta [Presence] in Serum or Plasma
Lipoprotein.pre-beta [Presence] in Serum or Plasma
Alpha amino acid nitrogen [Mass/volume] in Plasma
Reticulocytes/100 erythrocytes in Blood by Automated count
Herpes simplex virus 1 IgG Ab [Presence] in Serum
Herpes simplex virus 2 IgG Ab [Presence] in Serum
Ureaplasma urealyticum [Presence] in Specimen by Organism specific culture
Ganglioside GM1b IgG Ab [Titer] in Serum
Ganglioside GM1b IgM Ab [Titer] in Serum
Alpha amino acid nitrogen [Mass/time] in 24 hour Urine
Hemoglobin A1c/Hemoglobin.total in Blood by calculation
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC
Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid
Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay
3-Methylhistidine [Mass/volume] in 24 hour Urine
Calcium [Mass/volume] in Serum or Plasma
Calcium.ionized [Mass/volume] in Serum or Plasma
Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
Glucose [Mass/volume] in Serum or Plasma --8 hours fasting
Carnitine free (C0)/Creatinine [Ratio] in Urine
Acylcarnitine/Creatinine [Ratio] in Urine
Orotate/Creatinine [Molar ratio] in Urine
Orotidine/Creatinine [Molar ratio] in Urine
Alpha aminobutyrate [Presence] in Serum or Plasma
Hemoglobin H [Presence] in Blood by Heat denaturation
Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL
Bacteria # 2 identified in Bone by Aerobe culture
Bacteria # 3 identified in Bone by Aerobe culture
Bacteria # 4 identified in Bone by Aerobe culture
Bacteria # 5 identified in Bone by Aerobe culture
Bacteria # 6 identified in Bone by Aerobe culture
Bacteria # 2 identified in Bronchial specimen by Aerobe culture
Bacteria # 3 identified in Bronchial specimen by Aerobe culture
Bacteria # 4 identified in Bronchial specimen by Aerobe culture
Bacteria # 5 identified in Bronchial specimen by Aerobe culture
Bacteria # 6 identified in Bronchial specimen by Aerobe culture
Bacteria # 2 identified in Genital specimen by Aerobe culture
Bacteria # 3 identified in Genital specimen by Aerobe culture
Bacteria # 4 identified in Genital specimen by Aerobe culture
Bacteria # 5 identified in Genital specimen by Aerobe culture
Bacteria # 6 identified in Genital specimen by Aerobe culture
Bacteria # 2 identified in Nose by Aerobe culture
Bacteria # 3 identified in Nose by Aerobe culture
Bacteria # 4 identified in Nose by Aerobe culture
Bacteria # 5 identified in Nose by Aerobe culture
Bacteria # 6 identified in Nose by Aerobe culture
Bacteria # 2 identified in Sputum by Aerobe culture
Bacteria # 3 identified in Sputum by Aerobe culture
Bacteria # 4 identified in Sputum by Aerobe culture
Bacteria # 5 identified in Sputum by Aerobe culture
Bacteria # 6 identified in Sputum by Aerobe culture
Bacteria identified in Throat by Aerobe culture
Bacteria # 2 identified in Throat by Aerobe culture
Bacteria # 3 identified in Throat by Aerobe culture
Bacteria # 4 identified in Throat by Aerobe culture
Bacteria # 5 identified in Throat by Aerobe culture
Bacteria # 6 identified in Throat by Aerobe culture
Bacteria # 2 identified in Tissue by Aerobe culture
Bacteria # 3 identified in Tissue by Aerobe culture
Bacteria # 4 identified in Tissue by Aerobe culture
Bacteria # 5 identified in Tissue by Aerobe culture
Bacteria # 6 identified in Tissue by Aerobe culture
Bacteria identified in Wound deep by Aerobe culture
Bacteria # 2 identified in Wound deep by Aerobe culture
Bacteria # 3 identified in Wound deep by Aerobe culture
Bacteria # 4 identified in Wound deep by Aerobe culture
Bacteria # 5 identified in Wound deep by Aerobe culture
Bacteria # 6 identified in Wound deep by Aerobe culture
Bacteria identified in Wound shallow by Aerobe culture
Bacteria # 2 identified in Wound shallow by Aerobe culture
Bacteria # 3 identified in Wound shallow by Aerobe culture
Bacteria # 4 identified in Wound shallow by Aerobe culture
Bacteria # 5 identified in Wound shallow by Aerobe culture
Chlortetracycline [Susceptibility] by Serum bactericidal titer
Bacteria # 6 identified in Wound shallow by Aerobe culture
Bacteria # 2 identified in Nose by Anaerobe culture
Bacteria # 3 identified in Nose by Anaerobe culture
Bacteria # 2 identified in Tissue by Anaerobe culture
Bacteria # 3 identified in Tissue by Anaerobe culture
Bacteria identified in Wound deep by Anaerobe culture
Bacteria # 2 identified in Wound deep by Anaerobe culture
Bacteria # 3 identified in Wound deep by Anaerobe culture
Bacteria identified in Blood by Aerobe culture
Bacteria # 2 identified in Blood by Aerobe culture
Bacteria # 3 identified in Blood by Aerobe culture
Bacteria # 4 identified in Blood by Aerobe culture
Bacteria # 5 identified in Blood by Aerobe culture
Bacteria # 6 identified in Blood by Aerobe culture
Bacteria identified in Blood by Anaerobe culture
Bacteria # 2 identified in Blood by Anaerobe culture
Bacteria # 3 identified in Blood by Anaerobe culture
Bacteria # 2 identified in Burn by Culture
Bacteria # 3 identified in Burn by Culture
Bacteria # 4 identified in Burn by Culture
Bacteria # 5 identified in Burn by Culture
Bacteria # 6 identified in Burn by Culture
Bacteria # 2 identified in Line specimen by IV Line culture
Bacteria # 3 identified in Line specimen by IV Line culture
Bacteria # 4 identified in Line specimen by IV Line culture
Bacteria # 5 identified in Line specimen by IV Line culture
Bacteria # 6 identified in Line specimen by IV Line culture
Amylase [Enzymatic activity/volume] in Duodenal fluid
Fungus # 2 identified in Specimen by Culture
Fungus # 3 identified in Specimen by Culture
Fungus # 4 identified in Specimen by Culture
Bacteria # 2 identified in Body fluid by Aerobe culture
Bacteria # 3 identified in Body fluid by Aerobe culture
Bacteria # 4 identified in Body fluid by Aerobe culture
Amylase [Enzymatic activity/volume] in Body fluid
Bacteria # 5 identified in Body fluid by Aerobe culture
Bacteria # 6 identified in Body fluid by Aerobe culture
Bacteria identified in Body fluid by Anaerobe culture
Bacteria # 2 identified in Body fluid by Anaerobe culture
Bacteria # 3 identified in Body fluid by Anaerobe culture
Bacteria # 2 identified in Peritoneal fluid by Culture
Bacteria # 3 identified in Peritoneal fluid by Culture
Bacteria # 4 identified in Peritoneal fluid by Culture
Amylase [Enzymatic activity/volume] in Pleural fluid
Bacteria # 5 identified in Peritoneal fluid by Culture
Bacteria # 6 identified in Peritoneal fluid by Culture
Bacteria # 2 identified in Stool by Culture
Bacteria # 3 identified in Stool by Culture
Bacteria # 4 identified in Stool by Culture
Bacteria # 5 identified in Stool by Culture
Bacteria # 6 identified in Stool by Culture
Amylase [Enzymatic activity/volume] in Peritoneal fluid
Bacteria # 2 identified in Urine by Culture
Bacteria # 3 identified in Urine by Culture
Bacteria # 4 identified in Urine by Culture
Bacteria # 5 identified in Urine by Culture
Bacteria # 6 identified in Urine by Culture
Virus # 2 identified in Specimen by Culture
Virus # 3 identified in Specimen by Culture
Amylase [Enzymatic activity/volume] in Serum or Plasma
Amylase [Enzymatic activity/volume] in Urine
Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)
Amylase [Enzymatic activity/time] in 24 hour Urine
Amylase renal clearance in 24 hour Urine and Serum or Plasma
Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma
Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma
Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
Amylase S1 [Enzymatic activity/volume] in Serum or Plasma
Amylase S2 [Enzymatic activity/volume] in Serum or Plasma
Amylase S3 [Enzymatic activity/volume] in Serum or Plasma
Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
Amylase/Creatinine [Mass Ratio] in Serum or Plasma
Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma
Alpha fucosidase [Enzymatic activity/mass] in Tissue
Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma
Acid alpha glucosidase [Enzymatic activity/volume] in Semen
Acid alpha glucosidase [Enzymatic activity/mass] in Tissue
Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes
Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Osmolality of Serum or Plasma by calculation
Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma
Erythrocyte sedimentation rate by 2H Westergren method
Acid phosphatase tartrate resistant [Presence] in Specimen
Amino acids [Identifier] in 24 hour Urine
Alpha mannosidase [Enzymatic activity/mass] in Tissue
Bacteria [Presence] in Nose by Light microscopy
Beta-N-acetylhexosaminidase.A [Presence] in Tissue
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid
Blastomyces dermatitidis IgE Ab [Presence] in Serum
Blastomyces dermatitidis IgG Ab [Presence] in Serum
Amoxicillin [Susceptibility] by Serum bactericidal titer
Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma
Blastomyces dermatitidis IgM Ab [Presence] in Serum
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot
Caffeine renal clearance in 24 hour Urine and Serum or Plasma
Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge
Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma
Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma
Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma
Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma
Delta 5-Pregnanetriol [Mass/volume] in Urine
Dezocine [Presence] in Urine by Confirmatory method
Alpha naphthylesterase [Enzymatic activity/volume] in Serum
EPINEPHrine [Mass/volume] in Urine --2nd specimen post XXX challenge
EPINEPHrine [Mass/volume] in Urine --3rd specimen post XXX challenge
EPINEPHrine [Mass/volume] in Urine --4th specimen post XXX challenge
EPINEPHrine [Mass/volume] in Urine --5th specimen post XXX challenge
EPINEPHrine [Mass/volume] in Urine --6th specimen post XXX challenge
EPINEPHrine [Mass/volume] in Urine --7th specimen post XXX challenge
Glucose-6-Phosphate dehydrogenase [Presence] in Tissue
Heparan sulfate [Presence] in Serum or Plasma
Histone H2a+H2b Ab [Units/volume] in Serum
Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence
Influenza virus Ab [Units/volume] in Cerebral spinal fluid
Alpha tocopherol [Mass/volume] in Serum or Plasma
Legionella pneumophila atypical IgM Ab [Presence] in Serum
Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination
1,3-Dichlorobenzene [Mass/volume] in Blood
cefOXitin IgE Ab [Units/volume] in Serum
Alpha-1-Antichymotrypsin [Mass/volume] in Serum
Methyprylon [Mass/time] in 24 hour Urine
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
Nitrogen [Mass/volume] in Dialysis fluid
Para aminobenzoate [Mass/volume] in Serum or Plasma
Pentacarboxylporphyrins [Mass/volume] in Blood
Polychlorinated biphenyl (PCB) [Presence] in Tissue
Sulfonylurea [Mass/volume] in Serum or Plasma
Trimethoprim IgE Ab [Units/volume] in Serum
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
Vasoactive intestinal peptide [Mass/time] in 24 hour Urine
Cinoxacin [Susceptibility] by Disk diffusion (KB)
Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay
Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid
Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma
CD16+CD56+ cells/100 cells in Body fluid
Immune complex [Units/volume] in Body fluid
Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma
Alpha 1 antitrypsin fecal clearance in 24 hour
Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit
Blood group antibody screen [Presence] in Serum or Plasma from Donor
Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma
Blood group antigens present [Identifier] on Red Blood Cells from Donor
Blood group antigens absent [Identifier] on Red Blood Cells from Donor
Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method
Hemoglobin F [Presence] in Meconium by Apt-Downey method
Background stain [Presence] in Blood by Light microscopy
Calcium [Moles/volume] corrected for total protein in Serum or Plasma
Cannabinoids [Presence] in Urine by Screen method
Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma
Donath Landsteiner Ab [Presence] in Blood
Donath Landsteiner Ab [Presence] in Control Serum and RBC
Donath Landsteiner Ab [Titer] in Control Serum and RBC
Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy
Erythrocytes [Morphology] in Synovial fluid by Light microscopy
Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma
Hemoglobin F/Hemoglobin.total in Blood from Newborn
Glucose [Interpretation] in Serum or Plasma--post dose glucose
High titer low avidity Ab [Presence] in Serum or Plasma
IgA [Presence] in Serum by Immunofixation
IgA [Presence] in Urine by Immunofixation
IgG [Presence] in Serum by Immunofixation
IgG [Presence] in Urine by Immunofixation
IgM [Presence] in Serum by Immunofixation
IgM [Presence] in Urine by Immunofixation
Amoeba identified in Aspirate by Iron hematoxylin stain
Hydatid cyst identified in Aspirate by Iron hematoxylin stain
Ova and parasites identified in Stool by Iron hematoxylin stain
Pneumocystis sp identified in Lung tissue by Immune stain
Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count
Pelger Huet cells [Presence] in Blood by Light microscopy
Platelet satellitism [Presence] in Blood by Light microscopy
Coagulation of Semen by Visual observation
Morphology [Interpretation] in Blood Narrative
Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma
Neutrophils.vacuolated [Presence] in Blood by Light microscopy
Globulin [Mass/volume] in Urine by calculation
Benzidine [Mass/volume] in Serum or Plasma
Smith extractable nuclear IgG Ab [Units/volume] in Serum
Cockatiel serum IgE Ab [Units/volume] in Serum
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid
oxyMORphone [Presence] in Urine by Confirmatory method
Microscopic observation [Identifier] in Cervix by Other stain
Microscopic observation [Identifier] in Duodenal fluid by Other stain
Microscopic observation [Identifier] in Body fluid by Other stain
Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum
Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum
Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma
Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid
Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid
Naltrexone [Presence] in Urine by Confirmatory method
Antihistamines [Presence] in Urine by Confirmatory method
Methyl tert-butyl ether [Mass/volume] in Blood
Hydroxyitraconazole [Mass/volume] in Serum or Plasma
Nortramadol [Presence] in Serum or Plasma by Confirmatory method
Cinoxacin [Susceptibility] by Serum bactericidal titer
Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets
Protein S Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO
Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO
Methylenedioxyamphetamine [Mass/volume] in Urine
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma
Methylenedioxymethamphetamine [Mass/volume] in Blood
Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma
Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method
Methylenedioxyamphetamine [Mass/volume] in Blood
8-Hydroxyamoxapine [Mass/volume] in Urine
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine
Retinol binding protein [Mass/time] in 24 hour Urine
Chondroitin sulfate [Mass/volume] in Serum
Cortisol Free [Mass/volume] in Saliva (oral fluid)
Retinol binding protein [Mass/volume] in Serum or Plasma
Cytochrome C oxidase [Enzymatic activity/mass] in Tissue
Iodine Free [Mass/volume] in Serum or Plasma
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma
Riboflavin [Mass/volume] in 24 hour Urine
Transcortin [Mass/volume] in Cerebral spinal fluid
Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue
Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method
Butalbital [Presence] in Urine by Confirmatory method
Chlorothiazide [Presence] in Serum or Plasma
Diamorphine [Mass/volume] in Serum or Plasma
diazePAM [Presence] in Urine by Confirmatory method
Methaqualone [Presence] in Urine by Confirmatory method
Opiates [Presence] in Urine by Confirmatory method
Phencyclidine [Presence] in Urine by Confirmatory method
Aspergillus niger Ab [Presence] in Cerebral spinal fluid
HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Spermatozoa IgA Ab [Units/volume] in Cervical mucus
Spermatozoa IgG Ab [Units/volume] in Cervical mucus
Spermatozoa IgA Ab [Units/volume] in Semen
Spermatozoa IgG Ab [Units/volume] in Semen
Spermatozoa IgM Ab [Units/volume] in Semen
Leukocytes in 12 hour Urine sediment by Light microscopy
Ammonia [Moles/volume] in Cerebral spinal fluid
Curvularia lunata IgG Ab [Units/volume] in Serum
Epicoccum purpurascens IgG Ab [Units/volume] in Serum
Rhizopus nigricans IgG Ab [Units/volume] in Serum
Stemphylium botryosum IgG Ab [Units/volume] in Serum
Aspergillus nidulans IgG Ab [Units/volume] in Serum
Black Bean IgG Ab [Units/volume] in Serum
Cephalosporine mold IgG Ab [Units/volume] in Serum
Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Chaetomium globosum IgG Ab [Units/volume] in Serum
Fusarium oxysporum IgG Ab [Units/volume] in Serum
Microcytes [Presence] in Urine by Light microscopy
Phthalic anhydride IgG Ab [Units/volume] in Serum
Phthalic anhydride IgM Ab [Units/volume] in Serum
Aspergillus sp Ab [Presence] in Cerebral spinal fluid
Epstein Barr virus early Ab [Presence] in Body fluid
Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid
Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid
Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid
Amphetamines [Presence] in Stool by Screen method
Ammonia nitrogen [Mass/time] in 24 hour Urine
Tetrahydrocannabinol [Presence] in Stool by Screen method
1,2-Dichlorobenzene [Mass/volume] in Blood
Ammonium ion [Moles/volume] in Arterial blood
Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid
Methyclothiazide [Mass/volume] in Serum or Plasma
Organophosphate pesticides [Identifier] in Urine
Amyloid associated protein [Mass/volume] in Serum
HYDROmorphone [Presence] in Urine by Confirmatory method
HER2 Ag [Presence] in Tissue by Immune stain
Phenylalanine/Creatinine [Molar ratio] in Urine
Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells
Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe
Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe
Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe
Androstanolone [Mass/volume] in Serum or Plasma
Streptococcus pyogenes Ag [Presence] in Throat
Yeast [Presence] in Specimen by Organism specific culture
Yeast [Presence] in Genital specimen by Organism specific culture
Broad casts [#/area] in Urine sediment by Microscopy low power field
Valproate.protein bound [Mass/volume] in Serum or Plasma
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence
Ova and parasites identified in Stool by Concentration--3rd specimen
Ova and parasites identified in Stool by Concentration--2nd specimen
Ova and parasites identified in Stool by Trichrome stain--3rd specimen
Ova and parasites identified in Stool by Trichrome stain--2nd specimen
Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Nipple discharge by Cyto stain
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
Microscopic observation [Identifier] in Buccal smear by Cyto stain
Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain
Androstenedione [Mass/volume] in Amniotic fluid
Androstenedione [Mass/volume] in Capillary blood
Androstenedione [Mass/volume] in Serum or Plasma
Androsterone [Mass/volume] in Serum or Plasma
Angiotensin converting enzyme [Enzymatic activity/volume] in Blood
Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Angiotensin II [Mass/volume] in Cerebral spinal fluid
Aniline [Mass/volume] in Serum or Plasma
Ciprofloxacin [Susceptibility] by Disk diffusion (KB)
Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Apolipoprotein A-I [Mass/volume] in Serum or Plasma
Apolipoprotein A-II [Mass/volume] in Serum or Plasma
Apolipoprotein B-100 [Mass/volume] in Serum or Plasma
Apolipoprotein B-150 [Mass/volume] in Serum or Plasma
Apolipoprotein B-48 [Mass/volume] in Serum or Plasma
Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma
Ciprofloxacin [Susceptibility] by Serum bactericidal titer
Apolipoprotein C-I [Mass/volume] in Serum or Plasma
Apolipoprotein C-II [Mass/volume] in Serum or Plasma
Apolipoprotein C-III [Mass/volume] in Serum or Plasma
Apolipoprotein A-III [Mass/volume] in Serum or Plasma
Apolipoprotein E2 [Mass/volume] in Serum or Plasma
Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma
Apolipoprotein LPA [Mass/volume] in Serum or Plasma
Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)
Apolipoprotein A [Mass/volume] in Serum or Plasma
Apolipoprotein B [Mass/volume] in Serum or Plasma
Apolipoprotein C [Mass/volume] in Serum or Plasma
Apolipoprotein E [Mass/volume] in Serum or Plasma
Amoxicillin+Clavulanate [Susceptibility]
Aquacobalamin [Mass/volume] in Serum or Plasma
Arginase [Enzymatic activity/volume] in Red Blood Cells
Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Erythromycin+Sulfisoxazole [Susceptibility]
Gentamicin.high potency [Susceptibility]
Piperacillin+Tazobactam [Susceptibility]
Argininosuccinate [Mass/volume] in Urine
Streptomycin.high potency [Susceptibility]
Argininosuccinate lyase [Enzymatic activity/volume] in Serum
Argininosuccinate synthase [Enzymatic activity/mass] in Tissue
Ticarcillin+Clavulanate [Susceptibility]
Trimethoprim+Sulfamethoxazole [Susceptibility]
Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)
Arylamidase [Enzymatic activity/volume] in Serum
Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Cerebral spinal fluid
Granulocytes/100 leukocytes in Blood by Automated count
Ascorbate [Mass/volume] in Serum or Plasma
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood
Metanephrine [Mass/time] in 24 hour Urine
Metanephrines [Mass/volume] in 24 hour Urine
Saquinavir [Mass/volume] in Serum or Plasma
Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification
Brucella sp Ab [Titer] in Serum by Agglutination
Mycoplasma pneumoniae [Presence] in Specimen by Organism specific culture
Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine
ABO and Rh group [Type] in Blood from Newborn
Amphetamines cutoff [Mass/volume] in Urine
Benzodiazepines cutoff [Mass/volume] in Urine
Benzoylecgonine cutoff [Mass/volume] in Urine
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
Cannabinoids cutoff [Mass/volume] in Urine
Carnitine esters [Moles/volume] in Serum or Plasma
Asparagine [Presence] in Serum or Plasma
Cells Counted Total [#] in Cerebral spinal fluid
Choriogonadotropin [Units/volume] in Serum or Plasma
Clarithromycin [Susceptibility] by Disk diffusion (KB)
Colony count [#] in Urine by Visual count
Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative
Erythrocytes [Presence] in Amniotic fluid
Fungus colony count [#/volume] in Specimen by Culture
Genetic screen in Specimen by Molecular genetics method Narrative
Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose
Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose
Herpes simplex virus IgG Ab [Presence] in Serum
Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA)
Histoplasma capsulatum Ag [Presence] in Serum
Histoplasma capsulatum Ag [Presence] in Specimen
HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot
Lamellar bodies [#/volume] in Amniotic fluid
Magnesium [Mass/volume] in Serum or Plasma
Bacteria identified in Bone marrow by Aerobe culture
Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture
Bacteria identified in Catheter tip by Culture
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot
Specimen creatinine acceptable [Presence] in Urine
Specimen drawn [Date and time] of Serum or Plasma
Specimen specific gravity acceptable [Presence] in Urine
Volume in Urine collected for unspecified duration
Susceptibility method [Identifier] in Specimen
Urea nitrogen comment - 24 hour Urine Narrative
Urobilinogen [Units/volume] in Urine by Test strip
Varicella zoster virus IgG Ab [Presence] in Serum
Cancer Ag 19-9 [Units/volume] in Pleural fluid
Cancer Ag 72-4 [Units/volume] in Pleural fluid
Cancer Ag 125 [Units/volume] in Pleural fluid
Aspartate aminotransferase/Alanine aminotransferase [Enzymatic activity ratio] in Serum or Plasma
Carcinoembryonic Ag [Units/volume] in Serum or Plasma
Carcinoembryonic Ag [Moles/volume] in Serum or Plasma
Carcinoembryonic Ag [Units/volume] in Pleural fluid
Carcinoembryonic Ag [Mass/volume] in Pleural fluid
Clarithromycin [Susceptibility] by Serum bactericidal titer
Carcinoembryonic Ag [Moles/volume] in Pleural fluid
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
Alpha-1-Fetoprotein [Units/volume] in Pleural fluid
Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid
Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid
Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid
Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma
Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid
Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid
Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma
Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid
Cytokeratin 19 [Units/volume] in Serum or Plasma
Cytokeratin 19 [Units/volume] in Pleural fluid
Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma
Tissue polypeptide specific Ag [Units/volume] in Pleural fluid
Cancer Ag 15-3 [Units/volume] in Pleural fluid
Cancer Ag 27-29 [Units/volume] in Pleural fluid
Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid
Cancer Ag 549 [Units/volume] in Serum or Plasma
Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid
Cancer Ag 549 [Units/volume] in Pleural fluid
Enolase.neuron specific [Units/volume] in Serum or Plasma
Enolase.neuron specific [Units/volume] in Pleural fluid
Prostate specific Ag [Units/volume] in Serum or Plasma
Prostate specific Ag [Moles/volume] in Serum or Plasma
Prostate specific Ag [Units/volume] in Semen
Prostate specific Ag [Mass/volume] in Semen
Prostate specific Ag [Moles/volume] in Semen
Prostate Specific Ag Free [Units/volume] in Serum or Plasma
Prostate Specific Ag Free [Moles/volume] in Serum or Plasma
Prostate Specific Ag Free [Units/volume] in Semen
Prostate Specific Ag Free [Mass/volume] in Semen
Prostate Specific Ag Free [Moles/volume] in Semen
Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma
Squamous cell carcinoma Ag [Units/volume] in Pleural fluid
Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid
Oxygen [Partial pressure] in Mixed venous blood
Carbon dioxide [Partial pressure] in Mixed venous blood
Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood
Oxygen [Partial pressure] saturation adjusted to 0.5 in Capillary blood
Atrial natriuretic factor [Mass/volume] in Arterial blood
Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood
Oxygen [Partial pressure] saturation adjusted to 0.5 in Mixed venous blood
Carbon dioxide, total [Moles/volume] in Mixed venous blood
Deoxyhemoglobin/Hemoglobin.total in Arterial blood
Deoxyhemoglobin/Hemoglobin.total in Capillary blood
Deoxyhemoglobin/Hemoglobin.total in Venous blood
Deoxyhemoglobin/Hemoglobin.total in Mixed venous blood
Bicarbonate [Moles/volume] in Mixed venous blood
Bicarbonate [Moles/volume] standard in Arterial blood
Bicarbonate [Moles/volume] standard in Capillary blood
Bicarbonate [Moles/volume] standard in Venous blood
Bicarbonate [Moles/volume] standard in Mixed venous blood
Base excess in Mixed venous blood by calculation
Base excess standard in Arterial blood by calculation
Base excess standard in Capillary blood by calculation
Base excess standard in Venous blood by calculation
Base excess standard in Mixed venous blood by calculation
Lactate [Moles/volume] in Capillary blood
Lactate [Moles/volume] in Mixed venous blood
Corticotropin [Mass/volume] in Plasma --post XXX challenge
Brucella abortus Ab [Units/volume] in Serum by Immunoassay
Doxepin+Metabolites [Mass/volume] in Urine
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
Lactose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO
Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)
Lipoprotein.alpha [Mass/volume] in Pleural fluid
Prolactin [Mass/volume] in Serum or Plasma --post XXX challenge
Trichinella spiralis Ab [Presence] in Serum by Immunoassay
Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Capillary blood
Base excess in Arterial blood by calculation
Oxygen [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen by Latex agglutination
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination
Amphetamines [Presence] in Urine by Screen method
Amphetamines tested for in Urine by Screen method Nominal
Amphetamines tested for in Urine by Screen method Narrative
Base excess in Capillary blood by calculation
Amphetamines [Identifier] in Urine by Confirmatory method
Amphetamines cutoff [Mass/volume] in Urine for Screen method
Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method
Amphetamines screen method [Identifier] in Urine
Amphetamines confirm method [Identifier] in Urine
Barbiturates [Presence] in Urine by Screen method
Barbiturates tested for in Urine by Screen method Nominal
Barbiturates tested for in Urine by Screen method Narrative
Base excess in Venous blood by calculation
Barbiturates positive [Identifier] in Urine by Confirmatory method
Barbiturates cutoff [Mass/volume] in Urine for Screen method
Barbiturates cutoff [Mass/volume] in Urine for Confirmatory method
Barbiturates screen method [Identifier] in Urine
Barbiturates confirm method [Identifier] in Urine
Benzodiazepines tested for in Urine by Screen method Nominal
Benzodiazepines tested for in Urine by Screen method Narrative
Immunoglobulin light chains [Presence] in Urine
Benzodiazepines positive [Identifier] in Urine by Confirmatory method
Benzodiazepines cutoff [Mass/volume] in Urine for Screen method
Benzodiazepines cutoff [Mass/volume] in Urine for Confirmatory method
Benzodiazepines screen method [Identifier] in Urine
Benzodiazepines confirm method [Identifier] in Urine
Cannabinoids tested for in Urine by Screen method Nominal
Cannabinoids tested for in Urine by Screen method Narrative
Cannabinoids [Presence] in Urine by Confirmatory method
Cannabinoids positive [Identifier] in Urine by Confirmatory method
Cannabinoids cutoff [Mass/volume] in Urine for Screen method
Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method
Cannabinoids screen method [Identifier] in Urine
Cannabinoids confirm method [Identifier] in Urine
Opiates [Presence] in Urine by Screen method
Opiates tested for in Urine by Screen method Nominal
Opiates tested for in Urine by Screen method Narrative
Opiates positive [Identifier] in Urine by Confirmatory method
Immunoglobulin light chains [Mass/volume] in Urine
Opiates cutoff [Mass/volume] in Urine for Screen method
Opiates cutoff [Mass/volume] in Urine for Confirmatory method
Opiates screen method [Identifier] in Urine
Opiates confirm method [Identifier] in Urine
Thiazides [Presence] in Urine by Screen method
Thiazides tested for in Urine by Screen method Nominal
Thiazides tested for in Urine by Screen method Narrative
Thiazides [Presence] in Urine by Confirmatory method
Benzoate [Mass/volume] in Serum or Plasma
Thiazides positive [Identifier] in Urine by Confirmatory method
Thiazides cutoff [Mass/volume] in Urine for Screen method
Thiazides cutoff [Mass/volume] in Urine for Confirmatory method
Thiazides screen method [Identifier] in Urine
Thiazides confirm method [Identifier] in Urine
Tricyclic antidepressants [Presence] in Urine by Screen method
Tricyclic antidepressants tested for in Urine by Screen method Nominal
Tricyclic antidepressants tested for in Urine by Screen method Narrative
Beta alanine [Presence] in Serum or Plasma
Tricyclic antidepressants [Presence] in Urine by Confirmatory method
Tricyclic antidepressants positive [Identifier] in Urine by Confirmatory method
Tricyclic antidepressants cutoff [Mass/volume] in Urine for Screen method
Tricyclic antidepressants cutoff [Mass/volume] in Urine for Confirmatory method
Tricyclic antidepressants screen method [Identifier] in Urine
Tricyclic antidepressants confirm method [Identifier] in Urine
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method
Beta alanine [Mass/volume] in Serum or Plasma
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method
Alpha hydroxyalprazolam [Presence] in Urine by Screen method
Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method
Alpha hydroxyalprazolam [Mass/volume] in Urine
Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method
Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Alpha hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method
Amitriptyline [Presence] in Urine by Screen method
Amitriptyline cutoff [Mass/volume] in Urine for Screen method
Amitriptyline cutoff [Mass/volume] in Urine for Confirmatory method
Amitriptyline+Nortriptyline [Presence] in Urine by Screen method
Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method
Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Screen method
Amitriptyline+Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method
Amobarbital [Presence] in Urine by Screen method
Amobarbital cutoff [Mass/volume] in Urine for Screen method
Amobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Amphetamine [Presence] in Urine by Screen method
Amphetamine [Presence] in Urine by Confirmatory method
Amphetamine cutoff [Mass/volume] in Urine for Screen method
Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Beta aminoisobutyrate [Presence] in Plasma
Aprobarbital [Presence] in Urine by Screen method
Aprobarbital [Presence] in Urine by Confirmatory method
Aprobarbital cutoff [Mass/volume] in Urine for Screen method
Aprobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Barbital [Presence] in Urine by Screen method
Barbital [Presence] in Urine by Confirmatory method
Barbital cutoff [Mass/volume] in Urine for Screen method
Barbital cutoff [Mass/volume] in Urine for Confirmatory method
Benzoylecgonine cutoff [Mass/volume] in Urine for Screen method
Benzoylecgonine cutoff [Mass/volume] in Urine for Confirmatory method
Cocaine [Presence] in Urine by Screen method
Cocaine [Presence] in Urine by Confirmatory method
Cocaine cutoff [Mass/volume] in Urine for Screen method
Cocaine cutoff [Mass/volume] in Urine for Confirmatory method
Bromazepam [Presence] in Urine by Screen method
Bromazepam [Presence] in Urine by Confirmatory method
Bromazepam cutoff [Mass/volume] in Urine for Screen method
Bromazepam cutoff [Mass/volume] in Urine for Confirmatory method
Butabarbital [Presence] in Urine by Screen method
Butabarbital cutoff [Mass/volume] in Urine for Screen method
Beta endorphin [Mass/volume] in Serum or Plasma
Butabarbital cutoff [Mass/volume] in Urine for Confirmatory method
Butalbital [Presence] in Urine by Screen method
Butalbital cutoff [Mass/volume] in Urine for Screen method
Butalbital cutoff [Mass/volume] in Urine for Confirmatory method
Butorphanol [Presence] in Urine by Screen method
Butorphanol [Presence] in Urine by Confirmatory method
Butorphanol cutoff [Mass/volume] in Urine for Screen method
Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells
Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method
Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method
Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method
Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method
Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method
chlordiazePOXIDE [Presence] in Urine by Screen method
chlordiazePOXIDE [Presence] in Urine by Confirmatory method
chlordiazePOXIDE cutoff [Mass/volume] in Urine for Screen method
chlordiazePOXIDE cutoff [Mass/volume] in Urine for Confirmatory method
Chlorpheniramine [Presence] in Urine by Screen method
Chlorpheniramine [Mass/volume] in Urine by Confirmatory method
Chlorpheniramine cutoff [Mass/volume] in Urine for Screen method
Chlorpheniramine cutoff [Mass/volume] in Urine for Confirmatory method
chlorproMAZINE [Presence] in Urine by Screen method
chlorproMAZINE [Presence] in Urine by Confirmatory method
chlorproMAZINE cutoff [Mass/volume] in Urine for Screen method
Beta fructofuranosidase [Enzymatic activity/volume] in Serum
chlorproMAZINE cutoff [Mass/volume] in Urine for Confirmatory method
clonazePAM [Presence] in Urine by Screen method
clonazePAM cutoff [Mass/volume] in Urine for Screen method
clonazePAM cutoff [Mass/volume] in Urine for Confirmatory method
Cocaethylene [Presence] in Urine by Screen method
Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells
Cocaethylene [Presence] in Urine by Confirmatory method
Cocaethylene cutoff [Mass/volume] in Urine for Screen method
Clindamycin [Susceptibility] by Disk diffusion (KB)
Cocaethylene cutoff [Mass/volume] in Urine for Confirmatory method
Codeine [Presence] in Urine by Screen method
Codeine cutoff [Mass/volume] in Urine for Screen method
Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma
Codeine cutoff [Mass/volume] in Urine for Confirmatory method
Tetrahydrocannabinol [Presence] in Urine by Screen method
Tetrahydrocannabinol [Presence] in Urine by Confirmatory method
Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method
Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method
Dextroamphetamine [Presence] in Urine by Screen method
Dextroamphetamine [Presence] in Urine by Confirmatory method
Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method
Beta galactosidase [Enzymatic activity/mass] in Tissue
Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Dextromethamphetamine [Presence] in Urine by Screen method
Dextromethamphetamine [Presence] in Urine by Confirmatory method
Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method
Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method
Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Propoxyphene [Presence] in Urine by Screen method
Glucosylceramidase [Enzymatic activity/volume] in Leukocytes
Propoxyphene cutoff [Mass/volume] in Urine for Screen method
Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method
Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine
Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method
Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
Diamorphine [Presence] in Urine by Screen method
Diamorphine cutoff [Mass/volume] in Urine for Screen method
Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method
diazePAM [Presence] in Urine by Screen method
diazePAM cutoff [Mass/volume] in Urine for Screen method
diazePAM cutoff [Mass/volume] in Urine for Confirmatory method
Dihydrocodeine [Presence] in Urine by Screen method
Beta glucuronidase [Enzymatic activity/mass] in Tissue
Dihydrocodeine [Mass/volume] in Urine by Confirmatory method
Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method
Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method
Dimetamphetamine [Presence] in Urine by Screen method
Dimetamphetamine [Presence] in Urine by Confirmatory method
Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method
Beta glucuronidase [Enzymatic activity/volume] in Urine
Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Ethylamphetamine [Presence] in Urine by Screen method
Ethylamphetamine [Mass/volume] in Urine by Confirmatory method
Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method
Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Ethylmorphine [Presence] in Urine by Screen method
Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid
Ethylmorphine [Presence] in Urine by Confirmatory method
Ethylmorphine cutoff [Mass/volume] in Urine for Screen method
Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method
Flunitrazepam [Presence] in Urine by Screen method
Flunitrazepam [Presence] in Urine by Confirmatory method
Flunitrazepam cutoff [Mass/volume] in Urine for Screen method
Flunitrazepam cutoff [Mass/volume] in Urine for Confirmatory method
FLUoxetine [Presence] in Urine by Screen method
Beta hydroxybutyrate [Mass/volume] in Urine
FLUoxetine [Presence] in Urine by Confirmatory method
FLUoxetine cutoff [Mass/volume] in Urine for Screen method
FLUoxetine cutoff [Mass/volume] in Urine for Confirmatory method
Flurazepam [Presence] in Urine by Screen method
Flurazepam [Presence] in Urine by Confirmatory method
Flurazepam cutoff [Mass/volume] in Urine for Screen method
Flurazepam cutoff [Mass/volume] in Urine for Confirmatory method
Haloperidol [Presence] in Urine by Screen method
Haloperidol [Presence] in Urine by Confirmatory method
Haloperidol cutoff [Mass/volume] in Urine for Screen method
Haloperidol cutoff [Mass/volume] in Urine for Confirmatory method
HYDROcodone [Presence] in Urine by Screen method
HYDROcodone [Presence] in Urine by Confirmatory method
HYDROcodone cutoff [Mass/volume] in Urine for Screen method
HYDROcodone cutoff [Mass/volume] in Urine for Confirmatory method
HYDROmorphone [Presence] in Urine by Screen method
HYDROmorphone cutoff [Mass/volume] in Urine for Screen method
HYDROmorphone cutoff [Mass/volume] in Urine for Confirmatory method
Hydroxyalprazolam [Presence] in Urine by Screen method
Hydroxyalprazolam [Presence] in Urine by Confirmatory method
Hydroxyalprazolam cutoff [Mass/volume] in Urine for Screen method
Hydroxyalprazolam cutoff [Mass/volume] in Urine for Confirmatory method
Hydroxyethylflurazepam [Presence] in Urine by Screen method
Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method
Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Screen method
Hydroxyethylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method
Beta lipotropin [Mass/volume] in Serum or Plasma
Hydroxytriazolam [Presence] in Urine by Screen method
Ketamine [Mass/volume] in Urine by Screen method
Ketamine cutoff [Mass/volume] in Urine for Confirmatory method
Ketamine cutoff [Mass/volume] in Urine for Screen method
Methotrimeprazine [Presence] in Urine by Screen method
Methotrimeprazine [Presence] in Urine by Confirmatory method
Methotrimeprazine cutoff [Mass/volume] in Urine for Screen method
Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma
Methotrimeprazine cutoff [Mass/volume] in Urine for Confirmatory method
Levomethamphetamine [Presence] in Urine by Screen method
Levomethamphetamine [Presence] in Urine by Confirmatory method
Levomethamphetamine [Mass/volume] in Urine by Confirmatory method
Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method
Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Levorphanol [Presence] in Urine by Screen method
Levorphanol cutoff [Mass/volume] in Urine for Screen method
Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method
LORazepam [Presence] in Urine by Screen method
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
LORazepam cutoff [Mass/volume] in Urine for Screen method
LORazepam cutoff [Mass/volume] in Urine for Confirmatory method
Lormetazepam [Presence] in Urine by Screen method
Lormetazepam [Presence] in Urine by Confirmatory method
Lormetazepam cutoff [Mass/volume] in Urine for Screen method
Lormetazepam cutoff [Mass/volume] in Urine for Confirmatory method
Lysergate diethylamide [Presence] in Urine by Screen method
Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method
Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method
Meperidine [Presence] in Urine by Screen method
Meperidine cutoff [Mass/volume] in Urine for Screen method
Meperidine cutoff [Mass/volume] in Urine for Confirmatory method
Mephobarbital [Presence] in Urine by Screen method
Mephobarbital [Presence] in Urine by Confirmatory method
Beta-2-Microglobulin [Mass/volume] in Urine
Mephobarbital cutoff [Mass/volume] in Urine for Screen method
Mephobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Mescaline [Presence] in Urine by Screen method
Mescaline [Presence] in Urine by Confirmatory method
Mescaline cutoff [Mass/volume] in Urine for Screen method
Mescaline cutoff [Mass/volume] in Urine for Confirmatory method
Mesoridazine [Presence] in Urine by Screen method
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma
Mesoridazine [Presence] in Urine by Confirmatory method
Mesoridazine cutoff [Mass/volume] in Urine for Screen method
Mesoridazine cutoff [Mass/volume] in Urine for Confirmatory method
Methadone [Presence] in Urine by Screen method
Methadone cutoff [Mass/volume] in Urine for Screen method
Methadone cutoff [Mass/volume] in Urine for Confirmatory method
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue
Methamphetamine [Presence] in Urine by Screen method
Methamphetamine [Presence] in Urine by Confirmatory method
Methamphetamine cutoff [Mass/volume] in Urine for Screen method
Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Methaqualone [Presence] in Urine by Screen method
Methaqualone cutoff [Mass/volume] in Urine for Screen method
Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method
Methylenediamine [Presence] in Urine by Screen method
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma
Methylenediamine [Presence] in Urine by Confirmatory method
Methylenediamine cutoff [Mass/volume] in Urine for Screen method
Methylenediamine cutoff [Mass/volume] in Urine for Confirmatory method
Methylenedioxyamphetamine [Presence] in Urine by Screen method
Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method
Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method
Methylenedioxymethamphetamine [Presence] in Urine by Screen method
Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method
Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma
Methylenedioxymethamphetamine [Mass/volume] in Urine
Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method
Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
MethylePHEDrine [Presence] in Urine by Screen method
MethylePHEDrine cutoff [Mass/volume] in Urine for Screen method
MethylePHEDrine cutoff [Mass/volume] in Urine for Confirmatory method
Methylphenidate [Presence] in Urine by Screen method
Methylphenidate [Presence] in Urine by Confirmatory method
Methylphenidate cutoff [Mass/volume] in Urine for Screen method
Clindamycin [Susceptibility] by Serum bactericidal titer
Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method
Methyprylon [Presence] in Urine by Screen method
Methyprylon cutoff [Mass/volume] in Urine for Screen method
Methyprylon cutoff [Mass/volume] in Urine for Confirmatory method
Midazolam [Presence] in Urine by Screen method
Midazolam [Presence] in Urine by Confirmatory method
Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum
Midazolam cutoff [Mass/volume] in Urine for Screen method
Midazolam cutoff [Mass/volume] in Urine for Confirmatory method
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method
Morphine [Presence] in Urine by Screen method
Morphine cutoff [Mass/volume] in Urine for Screen method
Morphine cutoff [Mass/volume] in Urine for Confirmatory method
Morphine Free [Presence] in Urine by Screen method
Morphine Free [Presence] in Urine by Confirmatory method
Morphine Free cutoff [Mass/volume] in Urine for Screen method
Bicarbonate [Moles/volume] in Arterial blood
Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method
Nalbuphine [Presence] in Urine by Screen method
Nalbuphine cutoff [Mass/volume] in Urine for Screen method
Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method
Naltrexone [Presence] in Urine by Screen method
Naltrexone [Mass/volume] in Urine by Confirmatory method
Bicarbonate [Moles/volume] in Capillary blood
Naltrexone cutoff [Mass/volume] in Urine for Screen method
Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method
N-desalkylflurazepam [Presence] in Urine by Screen method
N-desalkylflurazepam [Presence] in Urine by Confirmatory method
N-desalkylflurazepam [Mass/volume] in Urine
N-desalkylflurazepam cutoff [Mass/volume] in Urine for Screen method
N-desalkylflurazepam cutoff [Mass/volume] in Urine for Confirmatory method
Nitrazepam [Presence] in Urine by Screen method
Nitrazepam [Presence] in Urine by Confirmatory method
Nitrazepam cutoff [Mass/volume] in Urine for Screen method
Nitrazepam cutoff [Mass/volume] in Urine for Confirmatory method
Nordiazepam [Presence] in Urine by Screen method
Nordiazepam cutoff [Mass/volume] in Urine for Screen method
Nordiazepam cutoff [Mass/volume] in Urine for Confirmatory method
Norfluoxetine [Presence] in Urine by Screen method
Norfluoxetine [Presence] in Urine by Confirmatory method
Norfluoxetine cutoff [Mass/volume] in Urine for Screen method
Norfluoxetine cutoff [Mass/volume] in Urine for Confirmatory method
Norpropoxyphene [Presence] in Urine by Screen method
Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method
Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method
Bicarbonate [Moles/volume] in Serum or Plasma
Oxazepam [Presence] in Urine by Screen method
Oxazepam [Presence] in Urine by Confirmatory method
Oxazepam cutoff [Mass/volume] in Urine for Screen method
Oxazepam cutoff [Mass/volume] in Urine for Confirmatory method
oxyCODONE [Presence] in Urine by Screen method
oxyCODONE [Presence] in Urine by Confirmatory method
oxyCODONE cutoff [Mass/volume] in Urine for Screen method
oxyCODONE cutoff [Mass/volume] in Urine for Confirmatory method
oxyMORphone [Presence] in Urine by Screen method
oxyMORphone cutoff [Mass/volume] in Urine for Screen method
oxyMORphone cutoff [Mass/volume] in Urine for Confirmatory method
Para hydroxyamphetamine [Presence] in Urine by Screen method
Para hydroxyamphetamine [Presence] in Urine by Confirmatory method
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method
Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
PENTobarbital [Presence] in Urine by Screen method
PENTobarbital cutoff [Mass/volume] in Urine for Screen method
PENTobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Phencyclidine [Presence] in Urine by Screen method
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Phencyclidine cutoff [Mass/volume] in Urine for Screen method
Phencyclidine cutoff [Mass/volume] in Urine for Confirmatory method
Phenmetrazine [Presence] in Urine by Screen method
Phenmetrazine cutoff [Mass/volume] in Urine for Screen method
Phenmetrazine cutoff [Mass/volume] in Urine for Confirmatory method
PHENobarbital [Presence] in Urine by Screen method
PHENobarbital cutoff [Mass/volume] in Urine for Screen method
PHENobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Phenothiazines [Presence] in Urine by Screen method
Phenothiazines cutoff [Mass/volume] in Urine for Screen method
Phenothiazines cutoff [Mass/volume] in Urine for Confirmatory method
Phentermine [Presence] in Urine by Screen method
Phentermine cutoff [Mass/volume] in Urine for Screen method
Phentermine cutoff [Mass/volume] in Urine for Confirmatory method
Prazepam [Presence] in Urine by Screen method
Prazepam [Presence] in Urine by Confirmatory method
Prazepam cutoff [Mass/volume] in Urine for Screen method
Prazepam cutoff [Mass/volume] in Urine for Confirmatory method
Psilocin [Presence] in Urine by Screen method
Psilocin [Presence] in Urine by Confirmatory method
Psilocin cutoff [Mass/volume] in Urine for Screen method
Psilocin cutoff [Mass/volume] in Urine for Confirmatory method
Psilocybin [Presence] in Urine by Screen method
Bilirubin.direct [Mass/volume] in Serum or Plasma
Psilocybin [Presence] in Urine by Confirmatory method
Psilocybin [Mass/volume] in Urine by Confirmatory method
Psilocybin cutoff [Mass/volume] in Urine for Screen method
Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method
Secobarbital [Presence] in Urine by Screen method
Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma
Secobarbital cutoff [Mass/volume] in Urine for Screen method
Secobarbital cutoff [Mass/volume] in Urine for Confirmatory method
Temazepam [Presence] in Urine by Screen method
Temazepam cutoff [Mass/volume] in Urine for Screen method
Temazepam cutoff [Mass/volume] in Urine for Confirmatory method
Bilirubin.delta [Mass/volume] in Serum or Plasma
Thioridazine [Presence] in Urine by Screen method
Thioridazine [Presence] in Urine by Confirmatory method
Thioridazine cutoff [Mass/volume] in Urine for Screen method
Thioridazine cutoff [Mass/volume] in Urine for Confirmatory method
traMADol [Presence] in Urine by Screen method
Bilirubin.indirect [Mass/volume] in Serum or Plasma
traMADol cutoff [Mass/volume] in Urine for Screen method
traMADol cutoff [Mass/volume] in Urine for Confirmatory method
Triazolam [Presence] in Urine by Screen method
Triazolam cutoff [Mass/volume] in Urine for Screen method
Triazolam cutoff [Mass/volume] in Urine for Confirmatory method
Trichlorothiazide [Presence] in Urine by Screen method
Trichlorothiazide [Presence] in Urine by Confirmatory method
Trichlorothiazide [Mass/volume] in Urine by Confirmatory method
Trichlorothiazide [Mass/volume] in Urine
Trichlorothiazide cutoff [Mass/volume] in Urine for Screen method
Trichlorothiazide cutoff [Mass/volume] in Urine for Confirmatory method
Abachi Wood Dust IgE Ab [Units/volume] in Serum
Aspergillus flavus IgG Ab [Presence] in Serum
Aspergillus fumigatus IgG Ab [Presence] in Serum
Aspergillus niger IgG Ab [Presence] in Serum
Bilirubin.total [Mass/volume] in Amniotic fluid
Blue vetch IgE Ab [Units/volume] in Serum
Cat serum albumin IgE Ab [Units/volume] in Serum
Chicken droppings IgE Ab [Units/volume] in Serum
Coralbumin IgE Ab [Units/volume] in Serum
Bilirubin.total [Mass/volume] in Cerebral spinal fluid
Cotton fibers IgE Ab [Units/volume] in Serum
Dog serum albumin IgE Ab [Units/volume] in Serum
Fenugreek IgE Ab [Units/volume] in Serum
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Fox epithelium IgE Ab [Units/volume] in Serum
Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum
Horse meat IgE Ab [Units/volume] in Serum
Jackfruit IgE Ab [Units/volume] in Serum
Bilirubin.total [Mass/volume] in Body fluid
Maleic anhydride IgE Ab [Units/volume] in Serum
Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum
Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum
Bilirubin.total [Mass/volume] in Serum or Plasma
Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum
Red Currant IgE Ab [Units/volume] in Serum
Sheep milk IgE Ab [Units/volume] in Serum
Sheep whey IgE Ab [Units/volume] in Serum
Silk waste IgE Ab [Units/volume] in Serum
Swine serum albumin IgE Ab [Units/volume] in Serum
Clostridium tetani toxoid IgE Ab [Units/volume] in Serum
Thermoactinomyces vulgaris IgG Ab [Presence] in Serum
General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain
Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain
Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative
Cytologist who read Cyto stain of Cervical or vaginal smear or scraping
Reviewing cytologist who read Cyto stain of Cervical or vaginal smear or scraping
Pathologist who read Cyto stain of Cervical or vaginal smear or scraping
Screening techniques [Identifier] in Cervical or vaginal smear or scraping by Cyto stain
Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain
Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain
Cytology study comment Cervical or vaginal smear or scraping Cyto stain
Biopterin [Mass/volume] in 24 hour Urine
Cloxacillin [Susceptibility] by Disk diffusion (KB)
Biotinidase [Enzymatic activity/volume] in Serum or Plasma
Bradykinin [Mass/volume] in Serum or Plasma
Bromide [Mass/volume] in Serum or Plasma
C peptide [Mass/volume] in Serum or Plasma
C reactive protein [Mass/volume] in Serum or Plasma
25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma
Cloxacillin [Susceptibility] by Serum bactericidal titer
Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma
Calciferol binding proteins [Mass/volume] in Serum
Calcitonin [Mass/volume] in Serum or Plasma
Calcium renal clearance in 24 hour Urine and Serum or Plasma
Calcium.ionized [Moles/volume] in Serum or Plasma
Calcium [Moles/volume] in Cerebral spinal fluid
Calcium [Moles/volume] in Dialysis fluid
Calcium [Moles/volume] in Serum or Plasma
Calcium [Moles/time] in 2 hour Urine --12 hours fasting
Colistimethate by Minimum lethal concentration (MLC)
Cancer Ag 125 [Presence] in Serum or Plasma
Cancer Ag 15-3 [Presence] in Serum or Plasma
Cancer Ag 19-9 [Presence] in Serum or Plasma
Cancer Ag 242 [Presence] in Serum or Plasma
Cancer Ag 27-29 [Presence] in Serum or Plasma
Cancer Ag 50 [Presence] in Serum or Plasma
Colistimethate by Minimum inhibitory concentration (MIC)
Cancer Ag 549 [Presence] in Serum or Plasma
Cancer Ag 72-4 [Presence] in Serum or Plasma
Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum
Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue
Carbon dioxide [Partial pressure] in Amniotic fluid
Carbon dioxide [Partial pressure] in Arterial blood
Carbon dioxide [Partial pressure] in Capillary blood
Carbon dioxide [Partial pressure] in Venous blood
Carbon dioxide [Partial pressure] in Cerebral spinal fluid
Carbon dioxide [Partial pressure] in Body fluid
Carbon dioxide dissolved [Moles/volume] in Plasma
Carbon dioxide dissolved [Moles/volume] in Red Blood Cells
Carbon dioxide, total [Moles/volume] in Arterial blood
Carbon dioxide, total [Moles/volume] in Venous blood
Carbon dioxide, total [Moles/volume] in Serum or Plasma
Colistimethate [Susceptibility] by Serum bactericidal titer
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
Carboxyhemoglobin/Hemoglobin.total in Capillary blood
Carboxyhemoglobin/Hemoglobin.total in Venous blood
Carbonate [Mass/volume] in Arterial blood
Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells
Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid
Amikacin [Susceptibility] by Method for Slow-growing mycobacteria
Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria
Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria
Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria
Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria
Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria
Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria
Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria
Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria
Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria
Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria
Carcinoembryonic Ag [Mass/volume] in Semen
Sample icteric [Presence] of Serum or Plasma Qualitative
Sample hemolyzed [Presence] of Serum or Plasma Qualitative
Sample lipemic [Presence] of Serum or Plasma Qualitative
Sample integrity [Type] of Serum or Plasma
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Homogenous nuclear Ab pattern [Titer] in Serum
Nucleolar nuclear Ab pattern [Titer] in Serum
Smooth nuclear envelope nuclear Ab pattern [Titer] in Serum
Speckled nuclear Ab pattern [Titer] in Serum
Fibronectin.fetal [Mass/volume] in Vaginal fluid
Fibronectin.fetal [Presence] in Vaginal fluid
Urobilinogen [Mass/volume] in Urine by Test strip
Nitrite [Mass/volume] in Urine by Test strip
Leukocytes [#/volume] in Urine by Test strip
Erythrocytes [#/volume] in Urine by Test strip
Amphetamines [Mass/volume] in Urine by Confirmatory method
Barbiturates [Mass/volume] in Urine by Confirmatory method
Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma
Benzodiazepines [Mass/volume] in Urine by Confirmatory method
Cannabinoids [Mass/volume] in Urine by Confirmatory method
Thiazides [Mass/volume] in Urine by Confirmatory method
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum
Histoplasma capsulatum yeast phase Ab [Titer] in Serum
Lutropin [Units/volume] in Serum or Plasma by 1st IRP
Carnitine free (C0) [Presence] in Serum or Plasma
Prostatic acid phosphatase [Mass/volume] in Serum
Barbiturates [Presence] in Serum or Plasma by Screen method
Beta lactamase organism identified in Isolate
Cardiolipin IgG Ab [Interpretation] in Serum
Cardiolipin IgM Ab [Interpretation] in Serum
Alkaline phosphatase.bile [Enzymatic activity/volume] in Serum or Plasma
Acetylcholine receptor Ab [Moles/volume] in Serum
Microscopic observation [Identifier] in Specimen by Smear
Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP
Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucose
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --post 50 g glucose
Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe with signal amplification
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
Herpes virus identified in Specimen by Organism specific culture
Herpes simplex virus IgG Ab [Interpretation] in Serum by Immunoassay
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Insulin [Units/volume] in Serum or Plasma
Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay
Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma
Epithelial cells [Presence] in Urine sediment by Light microscopy
Protein [Presence] in Urine by Test strip
Leukocytes [Presence] in Urine sediment by Light microscopy
Fungi.yeastlike [Presence] in Urine sediment by Light microscopy
Fungi.filamentous [Presence] in Urine sediment by Light microscopy
Rubella virus IgG Ab [Interpretation] in Serum
Streptococcus agalactiae Ag [Presence] in Specimen by Latex agglutination
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)
Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria
Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria
Mycobacterium avium complex rRNA [Presence] in Specimen by NAA with probe detection
Toxoplasma gondii Ab [Interpretation] in Serum
Choriogonadotropin [Multiple of the median] in Serum or Plasma
Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma
Thiamine [Moles/volume] in Serum or Plasma
Acetone [Presence] in Serum or Plasma by Screen method
Ethanol [Presence] in Serum or Plasma by Screen method
Isopropanol [Presence] in Serum or Plasma by Screen method
Eosinophils [Presence] in Specimen by Wright stain
Polymorphonuclear cells [Presence] in Specimen by Wright stain
Bacteria identified in Tissue by Biopsy culture
Cytomegalovirus IgG Ab [Interpretation] in Serum or Plasma
Measles virus IgG Ab [Presence] in Serum
Colistin [Susceptibility] by Minimum lethal concentration (MLC)
Granulocytes [#/volume] in Blood by Automated count
Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid
Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid
Epstein Barr virus capsid IgG Ab [Titer] in Serum
Epstein Barr virus capsid IgM Ab [Titer] in Serum
Histiocytes/100 cells in Body fluid by Light microscopy
Gliadin IgA Ab [Units/volume] in Serum by Immunoassay
Gliadin IgG Ab [Units/volume] in Serum by Immunoassay
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation
Phosphatidylglycerol/Surfactant.total in Amniotic fluid
Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method
Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method
Clue cells [Presence] in Vaginal fluid by Wet preparation
Histiocytes/100 cells in Cerebral spinal fluid
Bilirubin.total [Mass/volume] in Urine by Test strip
Reagin Ab [Units/volume] in Serum or Plasma by RPR
Hemoglobin [Mass/volume] in Blood by calculation
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis
Turbidity [Presence] of Cerebral spinal fluid Qualitative
Turbidity [Presence] of Body fluid Qualitative
Amitriptyline [Mass/volume] in Urine by Confirmatory method
Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method
Aprobarbital [Mass/volume] in Urine by Confirmatory method
Barbital [Mass/volume] in Urine by Confirmatory method
Cocaine [Mass/volume] in Urine by Confirmatory method
Bromazepam [Mass/volume] in Urine by Confirmatory method
Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method
chlorproMAZINE [Mass/volume] in Urine by Confirmatory method
Dextroamphetamine [Mass/volume] in Urine by Confirmatory method
Dimetamphetamine [Mass/volume] in Urine by Confirmatory method
Ethylmorphine [Mass/volume] in Urine by Confirmatory method
Flunitrazepam [Mass/volume] in Urine by Confirmatory method
FLUoxetine [Mass/volume] in Urine by Confirmatory method
Haloperidol [Mass/volume] in Urine by Confirmatory method
Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method
Hydroxytriazolam [Presence] in Urine by Confirmatory method
Hydroxytriazolam cutoff [Mass/volume] in Urine for Confirmatory method
Hydroxytriazolam cutoff [Mass/volume] in Urine for Screen method
Carotene [Mass/volume] in Serum or Plasma
Ketamine [Mass/volume] in Urine by Confirmatory method
Methotrimeprazine [Mass/volume] in Urine by Confirmatory method
Levorphanol [Mass/volume] in Urine by Confirmatory method
Lormetazepam [Mass/volume] in Urine by Confirmatory method
Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method
Mescaline [Mass/volume] in Urine by Confirmatory method
Mesoridazine [Mass/volume] in Urine by Confirmatory method
Catalase [Enzymatic activity/volume] in Red Blood Cells
Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method
Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
MethylePHEDrine [Mass/volume] in Urine by Confirmatory method
Methylphenidate [Mass/volume] in Urine by Confirmatory method
Methyprylon [Mass/volume] in Urine by Confirmatory method
Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)
Morphine Free [Mass/volume] in Urine by Confirmatory method
Nalbuphine [Mass/volume] in Urine by Confirmatory method
Nitrazepam [Mass/volume] in Urine by Confirmatory method
Norfluoxetine [Mass/volume] in Urine by Confirmatory method
Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method
Phenmetrazine [Mass/volume] in Urine by Confirmatory method
Phenothiazines [Mass/volume] in Urine by Confirmatory method
Phentermine [Mass/volume] in Urine by Confirmatory method
Psilocin [Mass/volume] in Urine by Confirmatory method
Temazepam [Mass/volume] in Urine by Confirmatory method
Thioridazine [Mass/volume] in Urine by Confirmatory method
traMADol [Mass/volume] in Urine by Confirmatory method
Carboxyhemoglobin/Hemoglobin.total in Blood
Carbon dioxide, total [Moles/volume] in Blood
Colony count [#/volume] in Catheter tip by Culture
Ferritin [Mass/volume] in Serum or Plasma by Immunoassay
Prolactin [Mass/volume] in Serum or Plasma by Immunoassay
Creatine kinase.MB/Creatine kinase.total in Serum or Plasma
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification
Hemoglobin A/Hemoglobin.total in Blood by Electrophoresis
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation
Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation
Hepatitis A virus Ab [Presence] in Serum
Galactose 1 phosphate uridyl transferase [Presence] in Blood
Vancomycin [Mass/volume] in Serum or Plasma
Methanol [Presence] in Serum or Plasma by Screen method
Leukocytes [#/volume] in Specimen by Automated count
Lymphocytes [#/volume] in Specimen by Automated count
Catecholamines [Mass/time] in 24 hour Urine
Cerebroside sulfatase [Presence] in Serum or Plasma
Cerebroside sulfatase [Enzymatic activity/mass] in Tissue
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Specimen
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
Cerebroside sulfatase [Enzymatic activity/volume] in Urine
CD45 (Lymphs) cells/100 cells in Specimen
IgD lymphocytes/100 lymphocytes in Specimen
IgM lymphocytes/100 lymphocytes in Specimen
Kappa lymphocytes/100 lymphocytes in Specimen
Lambda lymphocytes/100 lymphocytes in Specimen
Lymphocytes/100 leukocytes in Specimen by Automated count
Albumin/Creatinine [Presence] in Urine by Test strip
Coproporphyrin [Mass/volume] in 24 hour Urine
Creatinine [Mass/volume] in 24 hour Urine
Reducing substances [Units/volume] in Urine by Test strip
Turbidity [Presence] of Urine Qualitative
Cerebroside sulfatase [Presence] in Leukocytes
Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Specimen by Immunoperoxidase stain
Colistin [Susceptibility] by Disk diffusion (KB)
Activated T cells lymphocytes/100 lymphocytes.small in Blood
Activated T cells lymphocytes/100 lymphocytes.small in Specimen
1-Methylhistidine [Moles/volume] in Serum or Plasma
Alpha aminobutyrate [Moles/volume] in Serum or Plasma
3-Methylhistidine [Moles/volume] in Serum or Plasma
Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes
Alanine [Moles/volume] in Serum or Plasma
Arginine [Moles/volume] in Serum or Plasma
Asparagine [Moles/volume] in Serum or Plasma
Aspartate [Moles/volume] in Serum or Plasma
Citrulline [Moles/volume] in Serum or Plasma
Cysteine [Moles/volume] in Serum or Plasma
Glutamate [Moles/volume] in Serum or Plasma
Glutamine [Moles/volume] in Serum or Plasma
Ceruloplasmin [Mass/volume] in Serum or Plasma
Glycine [Moles/volume] in Serum or Plasma
Histidine [Moles/volume] in Serum or Plasma
Homocystine [Moles/volume] in Serum or Plasma
Hydroxyproline [Moles/volume] in Serum or Plasma
Isoleucine [Moles/volume] in Serum or Plasma
Leucine [Moles/volume] in Serum or Plasma
Lysine [Moles/volume] in Serum or Plasma
Methionine [Moles/volume] in Serum or Plasma
Ornithine [Moles/volume] in Serum or Plasma
Phosphoserine [Moles/volume] in Serum or Plasma
Proline [Moles/volume] in Serum or Plasma
Serine [Moles/volume] in Serum or Plasma
Taurine [Moles/volume] in Serum or Plasma
Threonine [Moles/volume] in Serum or Plasma
Tryptophan [Moles/volume] in Serum or Plasma
Tyrosine [Moles/volume] in Serum or Plasma
Valine [Moles/volume] in Serum or Plasma
Tricyclic antidepressants [Mass/volume] in Urine by Screen method
Barbiturates [Mass/volume] in Urine by Screen method
Echovirus 14 neutralizing antibody [Titer] in Serum by Neutralization test
Chenodeoxycholylglycine [Mass/volume] in Serum
Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate
Actinobacillus pleuropneumoniae Ab [Presence] in Serum
Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID)
Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence
Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence
Chenodeoxycholylglycine.conjugated [Mass/volume] in Serum
Equine adenovirus Ag [Presence] in Lung by Immunofluorescence
Alkaloid identified in Urine by Thin layer chromatography (TLC)
Alkaloid identified in Plant by Thin layer chromatography (TLC)
Alkaloid identified in Ingesta by Thin layer chromatography (TLC)
Chloride [Moles/volume] in Amniotic fluid
Anaplasma marginale Ab [Presence] in Serum by Card agglutination
Anaplasma marginale Ab [Presence] in Serum by Complement fixation
Aspergillus sp identified in Litter by Organism specific culture
Babesia caballi Ab [Presence] in Serum by Complement fixation
Theileria equi Ab [Presence] in Serum by Complement fixation
Bacillus cereus [Presence] in Food by Culture FDA method
Bacteria identified in Litter by Aerobe culture
Bacteria identified in Embryo by Aerobe culture
Bifidobacterium sp [#/volume] in Milk by Organism specific culture
Bluetongue virus serotype [Identifier] in Isolate
Bluetongue virus Ab [Presence] in Serum by Complement fixation
Bluetongue virus RNA [Presence] in Tissue by NAA with probe detection
Chloride [Moles/volume] in Cerebral spinal fluid
Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence
Bluetongue virus [Presence] in Specimen by Organism specific culture
Border disease virus Ag [Presence] in Tissue by Immunofluorescence
Border disease virus Ag [Presence] in Blood by Immunofluorescence
Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation
Clostridium botulinum toxin [Identifier] in Specimen by Animal inoculation
Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence
Bovine diarrhea virus RNA [Presence] in Tissue by NAA with probe detection
Colistin [Susceptibility] by Serum bactericidal titer
Bovine diarrhea virus RNA [Presence] in Serum by NAA with probe detection
Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence
Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence
Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence
Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence
Bovine diarrhea virus Ag [Presence] in Serum by Immune stain
Bovine diarrhea virus [Presence] in Serum by Organism specific culture
Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence
Chloride [Moles/volume] in Dialysis fluid
Brucella abortus Ab [Titer] in Serum by Tube agglutination
Brucella abortus Ab [Presence] in Milk by Serial ring agglutination
Brucella abortus Ab [Presence] in Semen by Agglutination
Brucella abortus Ab [Titer] in Serum by Rivanol agglutination
Brucella abortus Ab [Presence] in Serum by Rapid agglutination
Brucella abortus Ab [Presence] in Whey by Ring agglutination
Brucella abortus Ab [Presence] in Milk by Ring agglutination
Brucella abortus Ab [Presence] in Serum by Card agglutination
Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination
Brucella abortus Ab [Presence] in Serum by Complement fixation
Brucella abortus Ab [Titer] in Serum by Plate agglutination
Brucella abortus Ab [Presence] in Serum by Immunoassay
Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST
Brucella ovis Ab [Presence] in Serum by Immunoassay
Brucella ovis Ab [Presence] in Serum by Complement fixation
Brucella sp identified in Tissue by Organism specific culture
Chloride [Moles/volume] in Red Blood Cells
Brucella sp identified in Milk by Organism specific culture
Cache valley virus neutralizing antibody [Presence] in Serum by Neutralization test
Campylobacter sp identified in Isolate by Organism specific culture
Campylobacter sp identified in Body fluid by Organism specific culture
Campylobacter sp identified in Tissue by Organism specific culture
Canarypox virus Ag [Presence] in Serum by Immunofluorescence
Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence
Chloride [Moles/volume] in Saliva (oral fluid)
Carbamates [Presence] in Gastric fluid by Screen method
Carbamates [Presence] in Specimen by Screen method
Carbamates [Presence] in Ingesta by Screen method
Carbamates [Presence] in Tissue by Screen method
Carbamates [Presence] in Feed by Screen method
Chloride [Moles/volume] in Serum or Plasma
Chicken anemia virus neutralizing antibody [Presence] in Serum by Neutralization test
Chicken anemia virus Ab [Presence] in Serum by Immunoassay
Chlamydophila psittaci [Presence] in Specimen by Organism specific culture
Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence
Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation
Chlamydia sp Ag [Presence] in Body fluid by Immunoassay
Chlamydia sp Ag [Presence] in Stool by Immunoassay
Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence
Cholinesterase [Enzymatic activity/mass] in Brain
Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence
Clostridioides difficile [Presence] in Stool by Agglutination
Clostridioides difficile [Presence] in Stool by Aerobe culture
Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence
Clostridium perfringens genotype [Identifier] in Isolate
Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence
Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence
Coccidioides immitis [Presence] in Isolate
Coccidioides immitis Ab [Presence] in Serum by Complement fixation
Coliform bacteria [#/volume] in Water by Viability count
Coliform bacteria [#/volume] by Viability count
Coliform bacteria [#/mass] in Egg by Viability count
Coliform colony count [#/volume] in Milk
Colony count [#/volume] in Milk by Culture Standard Plate Count
Colony count [Units/volume] in Specimen by Visual count
Colony count [Units/volume] in Specimen by Viability count FDA method
Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence
Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation
Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence
Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain
Cryptosporidium sp [Presence] in Stool by Acid fast stain
Cyanide [Units/mass] in Plant Qualitative
Drugs identified in Serum or Plasma by Screen method
Drugs identified in Tissue by Screen method
Drugs identified in Specimen by Screen method
Duck enteritis virus neutralizing antibody [Presence] in Serum by Neutralization test
Escherichia coli serotype [Identifier] in Isolate
Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition
Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation
Eastern equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Clostridium perfringens enterotoxin [Presence] in Tissue
Clostridium perfringens enterotoxin [Presence] in Body fluid
Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed
Encephalitozoon cuniculi Ab [Presence] in Serum
Epizootic hemorrhagic disease virus neutralizing antibody [Presence] in Serum by Neutralization test
Epizootic hemorrhagic disease virus Ab [Presence] in Serum
Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence
Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence
Saint Louis encephalitis virus Ab [Presence] in Serum
Equine arteritis virus [Presence] in Blood by Organism specific culture
Ergot alkaloid [Mass/volume] in Specimen
Escherichia coli [Presence] in Specimen by Culture FDA method
Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence
Escherichia coli F41 [Presence] in Isolate by Agglutination
Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence
Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination
Escherichia coli K88 [Presence] in Isolate by Agglutination
Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence
Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination
Escherichia coli K99 [Presence] in Isolate by Agglutination
Escherichia coli K99 [Presence] in Stool by Agglutination
Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence
Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture
Cholestanol [Mass/volume] in Serum or Plasma
Gallotannin [Mass/volume] in Serum or Plasma
Gallotannin [Mass/mass] in Gastric fluid
Haemophilus paragallinarum serotype [Identifier] in Isolate
Cholesterol esterase [Enzymatic activity/volume] in Serum
Herbicide [Presence] in Gastric fluid by Screen method
Herbicide [Presence] in Specimen by Screen method
Herbicide [Presence] in Ingesta by Screen method
Herbicide [Presence] in Tissue by Screen method
Cholesterol esters [Mass/volume] in Serum or Plasma
Herbicide [Presence] in Feed by Screen method
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence
Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence
Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence
Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence
Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence
Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence
Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence
Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence
Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence
IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID)
IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID)
IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID)
Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE)
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test
Infectious bronchitis virus [Presence] in Tissue by Organism specific culture
Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection
Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition
Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture
Leptospira sp [Presence] in Tissue by Immunofluorescence
Leptospira sp [Presence] in Tissue by Organism specific culture
Listeria sp [Presence] in Milk by Organism specific culture
Listeria sp [Presence] in Cheese by Organism specific culture
Alcelaphine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Cholesterol in IDL [Mass/volume] in Serum or Plasma
Bacteria identified in Isolate by Animal inoculation
Bacteria identified in Isolate by Anaerobe culture
Bacteria identified in Milk by Aerobe culture
Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion
Microscopic observation [Identifier] in Stool by Electron microscopy negative stain
Microscopic observation [Identifier] in Urine by Dark field examination
Microscopic observation [Identifier] in Stool by Dark field examination
Microscopic observation [Identifier] in Gastric fluid by Dark field examination
Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)
Cholesterol in LDL [Mass/volume] in Serum or Plasma
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation
Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain
Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan)
Mycoplasma sp serotype [Identifier] in Isolate
Mycoplasma sp [Presence] in Milk by Organism specific culture
Mycoplasma sp [Presence] in Exudate by Organism specific culture
Mycoplasma sp Ab [Presence] in Serum by Immunoassay
Mycoplasma sp Ag [Presence] in Isolate by Immune stain
Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture
Neospora caninum Ab [Presence] in Serum by Immunofluorescence
Organochlorine pesticides [Identifier] in Blood
Organochlorine pesticides [Identifier] in Specimen
Organochlorine pesticides [Identifier] in Gastric fluid
Organochlorine pesticides [Identifier] in Milk
Organochlorine pesticides [Identifier] in Tissue
Organochlorine pesticides [Presence] in Blood by Screen method
Organochlorine pesticides [Presence] in Specimen by Screen method
Organochlorine pesticides [Presence] in Gastric fluid by Screen method
Organochlorine pesticides [Presence] in Milk by Screen method
Organochlorine pesticides [Presence] in Tissue by Screen method
Cholesterol in VLDL [Mass/volume] in Serum or Plasma
Organophosphate pesticides [Presence] in Blood by Screen method
Organophosphate pesticides [Presence] in Specimen by Screen method
Organophosphate pesticides [Presence] in Gastric fluid by Screen method
Organophosphate pesticides [Presence] in Tissue by Screen method
Organophosphate pesticides [Identifier] in Specimen
Organophosphate pesticides [Identifier] in Gastric fluid
Organophosphate pesticides [Identifier] in Tissue
Ova and parasites identified in Stool by Parasite sedimentation
Ova and parasites identified in Stool by McMaster concentration
Ova and parasites identified in Stool by Baermann concentration
Parasite identified in Specimen by Inspection
Cholesterol [Mass/volume] in Serum or Plasma
Parasite identified in Serum by Light microscopy
Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence
Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID)
Phosphide [Mass/mass] in Gastrointestinal content
Cholesterol.non-esterified [Mass/volume] in Serum or Plasma
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence
Rickettsia sp [Presence] in Blood by Light microscopy
Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence
Salmonella sp serotype [Identifier] in Isolate by Agglutination
Salmonella sp identified in Egg by Organism specific culture
Salmonella sp identified in Tissue by Organism specific culture
Salmonella sp identified in Stool by Organism specific culture
Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot
Sarcocystis neurona Ab [Presence] in Serum by Immunoblot
Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma
Sarcocystis neurona Ab [Presence] in Blood by Immunoblot
Sarcocystis neurona Ag [Presence] in Tissue by Immune stain
Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture
Serpulina hyodysenteria [Presence] in Stool by Organism specific culture
Shigella sp identified in Feed by Organism specific culture
Cholesterol/Triglyceride [Mass Ratio] in Serum or Plasma
Staphylococcus sp identified in Specimen by Organism specific culture
Staphylococcus sp identified in Milk by Organism specific culture
Staphylococcus sp identified in Cheese by Organism specific culture
Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Cholinesterase [Enzymatic activity/volume] in Amniotic fluid
Sulfate [Mass/volume] in Serum or Plasma
Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture
Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma
Western equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation
Yersinia sp identified in Dairy product by Organism specific culture
Zinc phosphide [Mass/mass] in Gastrointestinal content
Cholinesterase [Enzymatic activity/volume] in Red Blood Cells
APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Antithrombin [Interpretation] in Platelet poor plasma
Bordetella pertussis Ab [Presence] in Specimen
Choriogonadotropin [Interpretation] in Serum or Plasma
Cortisol [Interpretation] in Serum or Plasma--1 hour post dose corticotropin
Coxsackievirus B1+B2+B3+B4+B5+B6 Ab [Interpretation] in Serum
Cell Fractions/Differential [Interpretation] in Cerebral spinal fluid
Cell Fractions/Differential [Interpretation] in Body fluid
Erythrocyte distribution width [Entitic volume] by Automated count
Coagulation factor VIII [Interpretation] in Specimen
Fibrinogen [Interpretation] in Platelet poor plasma
Fungus identified in Specimen by Fungus stain
Glucose tolerance [Interpretation] in Serum or Plasma
Hepatitis B virus core Ab [Units/volume] in Serum from Donor by Immunoassay
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor by Immunoassay
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe
Cholylglycine.conjugated [Mass/volume] in Serum
Metanephrine [Mass/volume] in 24 hour Urine
Bacteria identified in Specimen by Anaerobe+Aerobe culture
Microscopic observation [Identifier] in Bronchial specimen by Gram stain
Chondroitin sulfate [Mass/volume] in Urine
Microscopic observation [Identifier] in Dialysis fluid by Gram stain
Neutrophil cytoplasmic Ab [Titer] in Serum
Pathologist interpretation of Cerebral spinal fluid tests
Pathologist interpretation of Body fluid tests
Pathologist interpretation of Blood tests
Platelet aggregation [Interpretation] in Platelet poor plasma
Protein [Interpretation] in 24 hour Urine
Choriomammotropin [Mass/volume] in Amniotic fluid
Reagin Ab [Presence] in Serum from Donor by VDRL
Saint Louis encephalitis virus [Interpretation] in Specimen
Yeast.budding [Presence] in Urine sediment
11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen
11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine
17-Hydroxypregnenolone [Mass/time] in 24 hour Urine
17-Ketosteroids [Mass/volume] in 24 hour Urine
18-Hydroxycortisol [Mass/volume] in 24 hour Urine
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine
5-Hydroxytryptophan [Mass/time] in 24 hour Urine
7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma
8-Hydroxyloxapine [Mass/volume] in Urine
Choriomammotropin [Mass/volume] in Serum
Cyclacillin [Susceptibility] by Disk diffusion (KB)
Acrylaldehyde [Mass/volume] in Serum or Plasma
Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma
Choriogonadotropin [Moles/volume] in Semen
Adenovirus DNA [Presence] in Serum or Plasma by NAA with probe detection
Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine
Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma
Albumin [Mass/volume] in Serum or Plasma --2 hours post peritoneal dialysis
Allobarbital [Mass/volume] in Serum or Plasma
Choriogonadotropin (pregnancy test) [Presence] in Urine
Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid
Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)
Choriogonadotropin [Moles/volume] in Urine
Ascaris lumbricoides IgE Ab [Units/volume] in Serum
Black Ash IgE Ab [Units/volume] in Serum
Green Ash IgE Ab [Units/volume] in Serum
Asialoganglioside GM1 Ab [Titer] in Serum
ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma
Babesia microti DNA [Presence] in Blood by NAA with probe detection
Barbiturates present [Identifier] in Serum or Plasma by Screen method
Basement membrane IgG Ab [Interpretation] in Serum by Immunofluorescence
Basophils/100 leukocytes in Sputum by Manual count
BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
Black Bean IgE Ab [Units/volume] in Serum
Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Blood
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Serum or Plasma
Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma
Borrelia burgdorferi 66kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 93kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay
Borrelia burgdorferi DNA [Presence] in Urine by NAA with probe detection
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine
Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence
Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence
Brush border Ab [Titer] in Serum by Immunofluorescence
Cadmium [Mass/volume] in Serum or Plasma
Cyclacillin [Susceptibility] by Serum bactericidal titer
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --3 minutes post 0.5 ug/kg pentagastrin IV
Canrenone [Mass/volume] in Serum or Plasma
Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine
Choriogonadotropin.beta subunit [Moles/volume] in Urine
White Cedar IgE Ab [Units/volume] in Serum
Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
Choriogonadotropin.intact [Presence] in Serum or Plasma
Choriogonadotropin.intact [Moles/volume] in Serum or Plasma
Cephaeline [Mass/volume] in Serum or Plasma
Cerebroventricular lining cells [Presence] in Cerebral spinal fluid by Light microscopy
Chlamydophila pneumoniae [Presence] in Specimen by Organism specific culture
Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by NAA with probe detection
Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by Probe
Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection
Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection
chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma
Chloride [Moles/volume] in 24 hour Urine
Choriogonadotropin [Moles/volume] in Serum or Plasma
Cholesterol esters/Cholesterol.total in Serum or Plasma
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma
Chylomicrons [Mass/volume] in Serum or Plasma
Sweet Clover IgE Ab [Units/volume] in Serum
CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
cycloSERINE [Susceptibility] by Minimum lethal concentration (MLC)
Chylomicrons [Presence] in Serum or Plasma
Collagen crosslinked N-telopeptide [Moles/volume] in Serum
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine
Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid
Cortisol [Mass/volume] in Serum or Plasma --11 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --4 PM specimen
Creatinine [Mass/volume] in Arterial blood
Cryptosporidium sp Ag [Presence] in Stool
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chymotrypsin [Enzymatic activity/volume] in Body fluid
Desalkylhalazepam [Mass/volume] in Serum or Plasma
diazePAM+Nordiazepam [Mass/volume] in Urine
Protoporphyrin [Mass/time] in unspecified time Stool
Chymotrypsin [Mass/volume] in Serum or Plasma
DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Dobutamine [Mass/volume] in Serum or Plasma
Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot
Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination
Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence
Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay
Estradiol (E2) [Mass/time] in 24 hour Urine
Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine
Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone
Citrate [Mass/volume] in Serum or Plasma
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge
Ganglioside GD1a IgM Ab [Titer] in Serum by Immunoassay
Ganglioside GD1a IgG Ab [Titer] in Serum by Immunoassay
Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture
Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --1 hour post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --2 hours post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --3.5 hours post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --3 hours post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --40 minutes post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --45 minutes post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --4 hours post 0.2 U/kg secretin
Citrulline [Presence] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --50 minutes post 0.2 U/kg secretin
Gastrin [Mass/volume] in Serum or Plasma --7 minutes post 0.2 U/kg secretin
Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence
Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence
Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen
Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen
Glucose [Mass/volume] in Serum or Plasma --105 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge
Grepafloxacin [Susceptibility] by Gradient strip
Haemophilus influenzae B Ag [Presence] in Specimen by Latex agglutination
Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence
Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence
Herpes simplex virus 1 IgM Ab [Titer] in Serum
Herpes simplex virus 2 IgM Ab [Titer] in Serum
Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood
Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
HIV 1 p24 Ab [Titer] in Serum by Immunoblot
HIV 1 p41 Ab [Titer] in Serum by Immunoblot
HIV 2 gp105 Ab [Presence] in Serum by Immunoblot
HIV 2 gp120 Ab [Presence] in Serum by Immunoblot
HIV 2 gp15 Ab [Presence] in Serum by Immunoblot
Collagenase [Enzymatic activity/volume] in Serum
HIV 2 gp34 Ab [Presence] in Serum by Immunoblot
HIV 2 p31 Ab [Presence] in Serum by Immunoblot
HIV 2 p55 Ab [Presence] in Serum by Immunoblot
HIV 2 p58 Ab [Presence] in Serum by Immunoblot
Coproporphyrin [Moles/volume] in Red Blood Cells
HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot
HTLV I+II Ab band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
HTLV I+II Ab band pattern [Interpretation] in Serum by Immunoblot
HTLV I+II IgG Ab [Presence] in Serum by Immunoassay
IgA [Presence] in Cerebral spinal fluid by Immunofixation
IgG [Presence] in Cerebral spinal fluid by Immunofixation
IgM [Presence] in Cerebral spinal fluid by Immunofixation
Coproporphyrin [Mass/time] in 24 hour Stool
Intercellular substance IgG Ab [Interpretation] in Serum by Immunofluorescence
Ketones [Presence] in Urine --2.5 hours post XXX challenge
Ketones [Presence] in Urine --3.5 hours post XXX challenge
Ketones [Presence] in Urine --1.5 hours post XXX challenge
Laxatives present [Identifier] in Stool by Screen method
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
levoFLOXacin [Susceptibility] by Disk diffusion (KB)
levoFLOXacin [Mass/volume] in Serum or Plasma
Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Abnormal lymphocytes/100 leukocytes in Synovial fluid by Manual count
Kappa lymphocytes/Lymphocytes.lambda [# Ratio] in Blood
Coproporphyrin [Mass/time] in 24 hour Urine
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Manganese [Mass/volume] in 24 hour Urine
Mesothelial cells [Presence] in Peritoneal fluid by Light microscopy
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum
Methamphetamine [Presence] in Urine by SAMHSA confirm method
Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum
cycloSERINE [Susceptibility] by Minimum inhibitory concentration (MIC)
Microscopic observation [Identifier] in Bone by Acid phosphatase stain
Corticosterone [Mass/volume] in Serum or Plasma
Monocytes+Macrophages/100 leukocytes in Body fluid by Manual count
Monocytes+Macrophages/100 leukocytes in Synovial fluid by Manual count
Mononuclear cells [#/volume] in Cerebral spinal fluid by Manual count
Mononuclear cells [#/volume] in Body fluid by Manual count
Mononuclear cells [#/volume] in Synovial fluid by Manual count
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Corticotropin [Mass/volume] in Amniotic fluid
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Mycobacterium sp DNA [Presence] in Bronchial specimen by NAA with probe detection
Mycoplasma pneumoniae IgM Ab [Presence] in Serum
Myelin associated glycoprotein IgM Ab [Titer] in Serum
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum
Myocardium Ab pattern [Interpretation] in Serum
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine
Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
Neurokinin A [Units/volume] in Serum or Plasma
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence
Norketamine [Mass/volume] in Serum or Plasma
Normetanephrine [Mass/volume] in 24 hour Urine
Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver
Nuclear IgG Ab [Presence] in Serum by Immunofluorescence
Cortisol [Mass/volume] in Saliva (oral fluid)
Opiates [Presence] in Urine by Screen method >2000 ng/mL
Osteocalcin.bovine [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma
Ovary Ab [Presence] in Serum by Immunofluorescence
Oxychlordane [Mass/volume] in Serum or Plasma
Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe
Parainfluenza virus identified in Nose by Organism specific culture
Cortisol Free [Mass/volume] in Serum or Plasma
Phosphate [Mass/volume] in 24 hour Urine
Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum
Plasminogen activator urokinase type [Presence] in Tissue
Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence
Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence
Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence
Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence
cycloSERINE [Susceptibility] by Disk diffusion (KB)
Pomegranate IgE Ab [Units/volume] in Serum
White Poplar IgE Ab [Units/volume] in Serum
Potassium [Moles/volume] in 24 hour Urine
Cortisol Free [Mass/time] in 24 hour Urine
Propranolol [Mass/volume] in Gastric fluid
quiNIDine [Mass/volume] in Serum or Plasma --peak
Creatine [Mass/volume] in Serum or Plasma
Ribosomal P Ab [Units/volume] in Cerebral spinal fluid
Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination
Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination
Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination
Rickettsia conorii IgG Ab [Titer] in Serum
Rickettsia conorii IgM Ab [Titer] in Serum
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Orientia tsutsugamushi IgG Ab [Titer] in Serum
Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Measles virus IgG Ab [Titer] in Serum by Immunofluorescence
Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Measles virus IgM Ab [Presence] in Serum
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination
Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence
Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination
Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence
SCL-70 extractable nuclear IgG Ab [Presence] in Serum
Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum
Smith extractable nuclear IgG Ab [Presence] in Serum
Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
Spermatozoa Motile/100 spermatozoa in Semen --1 hour post ejaculation
Spermatozoa Motile/100 spermatozoa in Semen --2 hours post ejaculation
Spermatozoa Motile/100 spermatozoa in Semen --3 hours post ejaculation
Spermatozoa Motile/100 spermatozoa in Semen --4 hours post ejaculation
Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
Spermatozoa Motile/100 spermatozoa in Semen --6 hours post ejaculation
Acid sphingomyelinase [Enzymatic activity/volume] in Blood
cycloSERINE [Susceptibility] by Serum bactericidal titer
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
Sulfatide IgG Ab [Titer] in Cerebral spinal fluid
Sulfatide IgM Ab [Titer] in Cerebral spinal fluid
Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
Synovial lining cells [Presence] in Synovial fluid by Light microscopy
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Testosterone [Mass/volume] adjusted for sex hormone binding globulin in Serum or Plasma
Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL
Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL
Theophylline [Mass/volume] in Gastric fluid
Thermoactinomyces candidus Ab [Presence] in Serum
Laceyella sacchari Ab [Presence] in Serum
Thiocyanate/Creatinine [Mass Ratio] in Urine
Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells
Thiosulfate [Mass/volume] in Serum or Plasma
tiaGABine [Mass/volume] in Serum or Plasma
TOLAZamide [Presence] in Serum or Plasma
TOLBUTamide [Presence] in Serum or Plasma
Creatine kinase [Enzymatic activity/volume] in Amniotic fluid
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Transferrin.carbohydrate deficient.asialo/Transferrin.total in Serum or Plasma
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
Transferrin.carbohydrate deficient.monosialo/Transferrin.total in Serum or Plasma
Transferrin.carbohydrate deficient.pentasialo/Transferrin.total in Serum or Plasma
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
Transferrin.carbohydrate deficient.tetrasialo/Transferrin.total in Serum or Plasma
Transferrin.carbohydrate deficient.trisialo/Transferrin.total in Serum or Plasma
Trichloroethylene [Mass/volume] in Blood
Trimethobenzamide [Mass/volume] in Specimen
Tryptase [Mass/volume] in Serum or Plasma
Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
Valproate.bound/Valproate.total in Serum or Plasma
Creatinine [Mass/volume] in Amniotic fluid
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
Varicella zoster virus Ab [Titer] in Serum
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Varicella zoster virus IgM Ab [Presence] in Serum
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)
Creatinine [Mass/volume] in Serum or Plasma
Wheat dust IgE Ab [Units/volume] in Serum
Xylose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method
CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method
APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method
APC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)
STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method
ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method
ASPA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ATM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method
Creatinine renal clearance in 12 hour Urine and Serum or Plasma
ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method
ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method
BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method
BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method
BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method
CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Creatinine renal clearance in 24 hour Urine and Serum or Plasma
CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method
CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method
CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method
CACNA1S gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CBS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CCR5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CDH1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
COL2A1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CTNNB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method
CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
F5 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
F7 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
F8 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGFR2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method
FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method
FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method
G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
G6PD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Gaucher 1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Gaucher 2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Gaucher 3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HADHB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HBA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method
Cobalamin (Vitamin B12) renal clearance in 24 hour Urine and Serum or Plasma
HBB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method
HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method
HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Kallmann syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Kallmann syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method
MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method
MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MTHFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method
MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method
MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma
NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NF1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
OTC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method
Cystathionine [Presence] in Serum or Plasma
SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method
SERPINA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PMP22 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PSAP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RB1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method
SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method
SNCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TRAF3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
WT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method
FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method
FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method
FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method
HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics
Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics
Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics
Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics
Cystine [Mass/volume] in Serum or Plasma
Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(1;19)(q23.3;p13.3)(PBX1,TCF3) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(11;14)(q13;q32)(CCND1,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(11;19)(q23;p13.3)(MLL,MLLT1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(11;22)(q24;q12.2)(FLI1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(11;22)(p13;q12.2)(WT1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(12;16)(q13;p11.2)(DDIT3,FUS) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(12;21)(p13;q22.3)(ETV6,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(12;22)(q13;q12.2)(ATF1,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(2;13)(q36.1;q14.4)(PAX3,FOXO1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(2;5)(p23;q35.1)(ALK,NPM1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(21;22)(q22.3;q12.2)(ERG,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(4;11)(q21.3;q23)(AFF1,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(5;12)(q33.1;p13)(PDGFRB,ETV6) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(6;9)(p22;q34)(DEK,NUP214) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(8;14)(q24;q32)(MYC,IGH) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(9;11)(p22;q23)(MLLT3,MLL) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(9;22)(q22;q12.2)(NR4A3,EWSR1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(X;18)(q11.2;p11.23)(SS18,SSX1) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(X;18)(q11.2;p11.22)(SS18,SSX2) cells/Cells.total in Blood or Tissue by Molecular genetics method
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;19)(q23;p13.3)(MLL,MLLT1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;22)(q24;q12.2)(FLI1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;22)(p13;q12.2)(WT1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(12;16)(q13;p11.2)(DDIT3,FUS) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(12;22)(q13;q12.2)(ATF1,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Cystine+Cysteine [Mass/volume] in Serum or Plasma
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method
t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum
t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(6;9)(p22;q34)(DEK,NUP214) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(8;14)(q24;q32)(MYC,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;11)(p22;q23)(MLLT3,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method
Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid
t(9;22)(q22;q12.2)(NR4A3,EWSR1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(X;18)(q11.2;p11.23)(SS18,SSX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(X;18)(q11.2;p11.22)(SS18,SSX2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Cytochrome B5 reductase [Enzymatic activity/volume] in Serum
Cytochrome C oxidase [Enzymatic activity/volume] in Plasma
Cytochrome C oxidase [Enzymatic activity/volume] in Platelets
Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes
Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma
Demeclocycline [Susceptibility] by Disk diffusion (KB)
Cytosol aminopeptidase [Presence] in Urine
Cytosol aminopeptidase [Enzymatic activity/volume] in Urine
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma
Dehydroepiandrosterone (DHEA) [Presence] in Urine
Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine
Demeclocycline [Susceptibility] by Serum bactericidal titer
Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma
Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine
Delta aminolevulinate [Mass/volume] in Plasma
Delta aminolevulinate [Mass/volume] in Serum
Delta aminolevulinate [Mass/time] in 24 hour Urine
Deoxycholylglycine [Mass/volume] in Serum
Dermatan sulfate [Mass/volume] in Serum or Plasma
Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum
PRSS1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
NB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MXI1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MT-ATP6 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGFR3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
DMD gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid
Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine
Alcelaphine herpesvirus 1 Ab [Presence] in Serum
Anaplasma marginale Ab [Presence] in Serum
Aspergillus fumigatus 3 Ab [Presence] in Serum
Aspergillus niger Ab [Presence] in Serum
Diethyl ether [Mass/volume] in Serum or Plasma
Avian adenovirus 2 Ab [Presence] in Serum
Avian encephalomyelitis virus Ab [Presence] in Serum
Avian hemorrhagic enteritis virus Ab [Presence] in Serum
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum
Avian infectious laryngotracheitis virus Ab [Presence] in Serum
Influenza virus A Ab [Presence] in Serum
Avian paramyxovirus 1 Ab [Presence] in Serum
Avian paramyxovirus 1 Ab [Titer] in Serum
Avian paramyxovirus 2 Ab [Titer] in Serum
Avian paramyxovirus 3 Ab [Titer] in Serum
Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue
Reticuloendotheliosis virus Ab [Presence] in Serum
Babesia sp IgM Ab [Units/volume] in Serum
Bacillus anthracis Ab [Units/volume] in Specimen
Bartonella henselae IgG Ab [Titer] in Serum
Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue
Bartonella henselae IgM Ab [Titer] in Serum
Blastomyces dermatitidis Ab [Titer] in Serum
Bordetella pertussis Ab [Titer] in Serum
Bordetella pertussis Ab [Titer] in Specimen
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid
Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Borrelia burgdorferi Ab [Units/volume] in Body fluid
Borrelia burgdorferi Ab [Units/volume] in Serum
Borrelia burgdorferi Ab [Titer] in Serum
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid
Borrelia burgdorferi IgA Ab [Presence] in Serum
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid
Borrelia burgdorferi IgG Ab [Presence] in Serum
Dihydropteridine reductase [Enzymatic activity/volume] in Serum
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid
Borrelia burgdorferi IgG Ab [Titer] in Serum
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid
Borrelia burgdorferi IgM Ab [Presence] in Serum
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid
Dimethadione [Mass/volume] in Serum or Plasma
Borrelia burgdorferi IgM Ab [Titer] in Serum
Borrelia hermsii IgG Ab [Titer] in Serum
Borrelia hermsii IgM Ab [Titer] in Serum
Bovine diarrhea virus 1 Ab [Titer] in Serum
Bovine diarrhea virus 2 Ab [Titer] in Serum
Bovine herpesvirus 1 Ab [Presence] in Serum
Bovine herpesvirus 1 Ab [Titer] in Serum
Bovine leukemia virus Ab [Presence] in Serum
Brucella abortus IgM Ab [Units/volume] in Serum
Dipalmitoylphosphatidylcholine [Mass/volume] in Serum
Brucella canis IgG Ab [Units/volume] in Serum
Brucella canis IgM Ab [Units/volume] in Serum
DOPamine [Mass/volume] in Serum or Plasma
Cache valley virus Ab [Presence] in Serum
Candida albicans Ab [Units/volume] in Serum
Caprine arthritis encephalitis virus Ab [Presence] in Serum
Caprine parapoxvirus Ab [Presence] in Serum
Caprine parapoxvirus Ab [Presence] in Tissue
Chicken anemia virus Ab [Presence] in Serum
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid
Chlamydophila pneumoniae IgA Ab [Titer] in Serum
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
Chlamydophila pneumoniae IgG Ab [Titer] in Serum
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
Chlamydophila pneumoniae IgM Ab [Titer] in Serum
Chlamydophila psittaci Ab [Presence] in Serum
Chlamydophila psittaci Ab [Titer] in Serum
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid
Chlamydophila psittaci IgA Ab [Titer] in Serum
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid
Chlamydophila psittaci IgG Ab [Titer] in Serum
Chlamydophila psittaci IgM Ab [Titer] in Serum
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis Ab [Titer] in Serum
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid
Chlamydia trachomatis IgA Ab [Titer] in Serum
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis IgG Ab [Titer] in Serum
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis IgM Ab [Titer] in Serum
Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma
Chlamydia trachomatis B IgA Ab [Titer] in Serum
Chlamydia trachomatis B IgG Ab [Titer] in Serum
Chlamydia trachomatis B IgM Ab [Titer] in Serum
Chlamydia trachomatis C IgA Ab [Titer] in Serum
Chlamydia trachomatis C IgG Ab [Titer] in Serum
Chlamydia trachomatis C IgM Ab [Titer] in Serum
Dicloxacillin [Susceptibility] by Disk diffusion (KB)
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum
Elastase.pancreatic Free [Enzymatic activity/volume] in Serum
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid
Coccidioides immitis Ab [Presence] in Serum
Coccidioides immitis Ab [Units/volume] in Serum
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid
Coccidioides immitis Ab [Titer] in Serum
Coccidioides immitis IgG Ab [Presence] in Serum
Elastase.pancreatic [Enzymatic activity/volume] in Serum
Coccidioides immitis IgM Ab [Presence] in Serum
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B IgG Ab [Units/volume] in Serum
Coxsackievirus B IgM Ab [Units/volume] in Serum
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid
Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid
Elastase.leukocyte [Enzymatic activity/volume] in Plasma
Cryptococcus neoformans Ab [Titer] in Serum
Taenia solium larva Ab [Presence] in Serum
Cytomegalovirus Ab [Presence] in Serum or Plasma
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
Cytomegalovirus Ab [Titer] in Serum or Plasma
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid
Enolase [Enzymatic activity/volume] in Serum
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma
Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma
Duck enteritis virus Ab [Presence] in Serum
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid
Eastern equine encephalitis virus Ab [Presence] in Serum
Eastern equine encephalitis virus Ab [Titer] in Serum
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid
Eastern equine encephalitis virus IgG Ab [Titer] in Serum
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid
Eastern equine encephalitis virus IgM Ab [Titer] in Serum
Echinococcus granulosus IgG Ab [Presence] in Serum
Echinococcus sp IgG Ab [Units/volume] in Serum
Echovirus 11 Ab [Titer] in Cerebral spinal fluid
Echovirus 30 Ab [Titer] in Cerebral spinal fluid
Echovirus 4 Ab [Titer] in Cerebral spinal fluid
Enteropeptidase [Enzymatic activity/volume] in Plasma
Echovirus 9 Ab [Titer] in Cerebral spinal fluid
Ehrlichia chaffeensis IgG Ab [Presence] in Serum
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum
Entamoeba histolytica Ab [Presence] in Serum
Entamoeba histolytica Ab [Titer] in Serum
Entamoeba histolytica IgA Ab [Units/volume] in Serum
Entamoeba histolytica IgG Ab [Units/volume] in Serum
Entamoeba histolytica IgM Ab [Units/volume] in Serum
Epstein Barr virus capsid IgA Ab [Titer] in Serum
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid
Epiandrosterone [Mass/volume] in Serum or Plasma
Epstein Barr virus early Ab [Units/volume] in Serum
Epstein Barr virus early Ab [Titer] in Serum
Epstein Barr virus early IgG Ab [Presence] in Serum
Epstein Barr virus nuclear Ab [Presence] in Serum
Epstein Barr virus nuclear Ab [Titer] in Serum
Epstein Barr virus nuclear IgG Ab [Titer] in Serum
Equine arteritis virus Ab [Titer] in Serum
Equine herpesvirus 1 Ab [Titer] in Serum
Equine infectious anemia virus Ab [Presence] in Serum
Equine influenza virus A1 Ab [Titer] in Serum
Equine influenza virus A2 Ab [Titer] in Serum
Hantavirus puumala IgG Ab [Titer] in Serum
Hantavirus puumala IgM Ab [Titer] in Serum
Helicobacter pylori Ab [Presence] in Serum
Hepatitis A virus Ab [Units/volume] in Serum
Hepatitis A virus IgG Ab [Units/volume] in Serum
Hepatitis A virus IgM Ab [Presence] in Serum
Hepatitis A virus IgM Ab [Units/volume] in Serum
Hepatitis B virus core Ab [Units/volume] in Serum
Hepatitis B virus core Ab [Units/volume] in Serum from Donor
Hepatitis B virus core IgG Ab [Units/volume] in Serum
Hepatitis B virus core IgM Ab [Units/volume] in Serum
Hepatitis B virus e Ab [Presence] in Serum
Hepatitis B virus e Ab [Units/volume] in Serum
Hepatitis B virus surface Ab [Presence] in Serum
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor
Hepatitis C virus 100-3 Ab [Presence] in Serum
Hepatitis C virus 22-3 Ab [Presence] in Serum
Hepatitis C virus 5-1-1 Ab [Presence] in Serum
EPINEPHrine [Mass/time] in 24 hour Urine
Hepatitis C virus Ab [Units/volume] in Serum
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum
Hepatitis C virus c33c Ab [Presence] in Serum
Hepatitis D virus Ab [Units/volume] in Serum
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid
Epitestosterone [Mass/volume] in Serum or Plasma
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus Ab [Presence] in Serum
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus Ab [Titer] in Serum
Herpes simplex virus IgG Ab [Interpretation] in Serum
Herpes simplex virus IgM Ab [Titer] in Serum
Heterophile Ab after absorption [Titer] in Serum
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid
Histoplasma capsulatum Ab [Presence] in Serum
Histoplasma capsulatum Ab [Titer] in Serum
Histoplasma capsulatum IgA Ab [Presence] in Serum
Histoplasma capsulatum IgA Ab [Units/volume] in Serum
Histoplasma capsulatum IgE Ab [Presence] in Serum
Histoplasma capsulatum IgG Ab [Units/volume] in Serum
Histoplasma capsulatum IgM Ab [Presence] in Serum
Histoplasma capsulatum IgM Ab [Units/volume] in Serum
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum
HTLV I+II Ab [Presence] in Cerebral spinal fluid
Infectious bursal disease virus Ab [Presence] in Serum
Calciferol (Vit D2) [Mass/volume] in Serum or Plasma
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid
Japanese encephalitis virus Ab [Presence] in Serum
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid
Dicloxacillin [Susceptibility] by Serum bactericidal titer
Legionella pneumophila 1 IgG Ab [Titer] in Serum
Legionella pneumophila 1 IgM Ab [Titer] in Serum
Legionella pneumophila 2 IgG Ab [Titer] in Serum
Estradiol (E2) [Mass/volume] in Saliva (oral fluid)
Legionella pneumophila 2 IgM Ab [Titer] in Serum
Legionella pneumophila 3 IgG Ab [Titer] in Serum
Legionella pneumophila 3 IgM Ab [Titer] in Serum
Legionella pneumophila 4 IgG Ab [Titer] in Serum
Legionella pneumophila 4 IgM Ab [Titer] in Serum
Legionella pneumophila 5 IgG Ab [Titer] in Serum
Legionella pneumophila 5 IgM Ab [Titer] in Serum
Legionella pneumophila 6 IgG Ab [Titer] in Serum
Legionella pneumophila 6 IgM Ab [Titer] in Serum
Legionella pneumophila 7 Ab [Titer] in Serum
Legionella pneumophila 8 Ab [Titer] in Serum
Legionella pneumophila 9 Ab [Titer] in Serum
Legionella pneumophila Ab [Titer] in Serum
Legionella pneumophila IgG Ab [Titer] in Serum
Legionella pneumophila IgM Ab [Titer] in Serum
Amoxicillin+Clavulanate [Susceptibility] by Serum bactericidal titer
Estradiol (E2) Free [Mass/volume] in Serum or Plasma
Leptospira interrogans sv Bratislava Ab [Titer] in Serum
Leptospira interrogans sv Canicola Ab [Titer] in Serum
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum
Leptospira interrogans sv Hardjo Ab [Titer] in Serum
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum
Leptospira interrogans sv Pomona Ab [Titer] in Serum
Listeria monocytogenes Ab [Titer] in Serum
Lymphocytic choriomeningitis virus Ab [Titer] in Serum
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum
Saccharopolyspora rectivirgula Ab [Presence] in Serum
Mumps virus Ab [Titer] in Cerebral spinal fluid
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid
Estradiol (E2) Free [Moles/mass] in Tissue
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum
Mycoplasma gallisepticum Ab [Presence] in Serum
Mycoplasma meleagridis Ab [Presence] in Serum
Mycoplasma pneumoniae Ab [Titer] in Serum
Mycoplasma pneumoniae IgG Ab [Titer] in Serum
Mycoplasma pneumoniae IgM Ab [Titer] in Serum
Mycoplasma synoviae Ab [Presence] in Serum
Neisseria meningitidis serogroup Y Ab [Titer] in Specimen
Estradiol (E2) [Mass/volume] in Serum or Plasma
Human papilloma virus Ab [Presence] in Tissue
Paracoccidioides brasiliensis Ab [Titer] in Serum
Parainfluenza virus 1 Ab [Titer] in Serum
Parainfluenza virus 2 Ab [Titer] in Serum
Parainfluenza virus 3 Ab [Titer] in Serum
Pasteurella multocida Ab [Presence] in Serum
Plasmodium falciparum Ab [Titer] in Serum
Polio virus 1 Ab [Titer] in Cerebral spinal fluid
Polio virus 2 Ab [Titer] in Cerebral spinal fluid
Polio virus 3 Ab [Titer] in Cerebral spinal fluid
Pseudorabies virus Ab [Presence] in Serum
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum
Rabies virus Ab [Units/volume] in Tissue
Reagin Ab [Presence] in Cerebral spinal fluid
Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)
Reagin Ab [Units/volume] in Cerebral spinal fluid
Reagin Ab [Presence] in Serum from Donor
Respiratory syncytial virus Ab [Titer] in Serum
Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine
Respiratory syncytial virus IgM Ab [Titer] in Serum
Rickettsia (Proteus OX19) Ab [Presence] in Serum
Rickettsia (Proteus OX19) Ab [Titer] in Serum
Rickettsia (Proteus OX2) Ab [Presence] in Serum
Rickettsia (Proteus OX2) Ab [Titer] in Serum
Rickettsia (Proteus OXK) Ab [Presence] in Serum
Rickettsia (Proteus OXK) Ab [Titer] in Serum
Rickettsia spotted fever group Ab [Presence] in Serum
Estriol (E3).conjugated [Mass/volume] in Serum or Plasma
Rickettsia spotted fever group Ab [Titer] in Serum
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid
Rickettsia spotted fever group IgG Ab [Titer] in Serum
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid
Rickettsia spotted fever group IgM Ab [Titer] in Serum
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid
Rickettsia rickettsii IgG Ab [Titer] in Serum
Estriol (E3) [Mass/volume] in Amniotic fluid
Rickettsia rickettsii IgM Ab [Titer] in Serum
Orientia tsutsugamushi Ab [Titer] in Serum
Rickettsia typhi Ab [Units/volume] in Serum
Rickettsia typhi IgA Ab [Units/volume] in Serum
Rickettsia typhi IgG Ab [Presence] in Serum
Rickettsia typhi IgG Ab [Titer] in Serum
Rickettsia typhi IgM Ab [Titer] in Serum
Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid
Rickettsia typhus group Ab [Presence] in Serum
Rickettsia typhus group Ab [Titer] in Serum
Rickettsia typhus group IgG Ab [Titer] in Serum
Rickettsia typhus group IgM Ab [Titer] in Serum
Measles virus Ab [Titer] in Cerebral spinal fluid
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid
Measles virus IgG Ab [Titer] in Cerebral spinal fluid
Measles virus IgG Ab [Units/volume] in Serum --1st specimen
Measles virus IgG Ab [Units/volume] in Serum --2nd specimen
Measles virus IgM Ab [Titer] in Cerebral spinal fluid
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid
Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid
Saint Louis encephalitis virus Ab [Titer] in Serum
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid
Saint Louis encephalitis virus IgG Ab [Titer] in Serum
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid
Saint Louis encephalitis virus IgM Ab [Titer] in Serum
Salmonella arizonae Ab [Presence] in Serum
Salmonella paratyphi A Ab [Presence] in Serum
Estriol (E3) [Mass/volume] in Serum or Plasma
Salmonella paratyphi A H Ab [Presence] in Serum
Salmonella paratyphi A H Ab [Titer] in Serum
Salmonella paratyphi A O Ab [Presence] in Serum
Salmonella paratyphi B Ab [Presence] in Serum
Salmonella paratyphi B H Ab [Presence] in Serum
Salmonella paratyphi B H Ab [Titer] in Serum
Salmonella paratyphi B O Ab [Presence] in Serum
Salmonella paratyphi C H Ab [Presence] in Serum
Salmonella paratyphi C O Ab [Presence] in Serum
Salmonella pullorum Ab [Presence] in Serum
Salmonella typhi H Ab [Presence] in Serum
Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Salmonella typhimurium Ab [Presence] in Serum
Sarcocystis neurona Ab [Presence] in Blood
Estriol (E3) [Mass/time] in 24 hour Urine
Sarcocystis neurona Ab [Presence] in Body fluid
Sarcocystis neurona Ab [Presence] in Serum
Schistosoma japonicum Ab [Titer] in Serum
Schistosoma mansoni Ab [Presence] in Serum
Shigella dysenteriae Ab [Titer] in Serum
Estrogen [Mass/volume] in Serum or Plasma
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pyogenes enzyme Ab [Presence] in Serum
Streptococcus pyogenes enzyme Ab [Titer] in Serum
Saccharomonospora viridis Ab [Presence] in Serum
Thermoactinomyces vulgaris Ab [Presence] in Serum
Toxocara canis IgG Ab [Units/volume] in Serum
Toxoplasma gondii Ab [Presence] in Serum
Toxoplasma gondii IgA Ab [Units/volume] in Serum
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum
Toxoplasma gondii IgG Ab [Presence] in Serum
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid
Estrone (E1) [Mass/volume] in Serum or Plasma
Toxoplasma gondii IgG Ab [Titer] in Serum
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid
Toxoplasma gondii IgM Ab [Titer] in Serum
Treponema pallidum Ab [Units/volume] in Blood
Treponema pallidum Ab [Presence] in Cerebral spinal fluid
Treponema pallidum Ab [Presence] in Serum
Treponema pallidum IgG Ab [Units/volume] in Serum
Treponema pallidum IgM Ab [Units/volume] in Serum
Trichinella spiralis Ab [Presence] in Serum
Trichinella spiralis Ab [Titer] in Serum
Varicella zoster virus Ab [Presence] in Serum
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid
Varicella zoster virus IgG Ab [Titer] in Serum
Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen
Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid
Varicella zoster virus IgM Ab [Titer] in Serum
Venezuelan equine encephalitis virus Ab [Titer] in Serum
Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid
Escherichia coli verotoxin 1 Ab [Titer] in Stool
Escherichia coli verotoxin 2 Ab [Titer] in Stool
Doxycycline [Susceptibility] by Disk diffusion (KB)
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid
Western equine encephalitis virus Ab [Presence] in Serum
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid
Western equine encephalitis virus IgG Ab [Titer] in Serum
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid
Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma
Western equine encephalitis virus IgM Ab [Titer] in Serum
Wuchereria bancrofti Ab [Presence] in Serum
Yersinia enterocolitica IgA Ab [Units/volume] in Serum
Yersinia enterocolitica IgG Ab [Units/volume] in Serum
Yersinia enterocolitica IgM Ab [Units/volume] in Serum
Estrone (E1).unconjugated [Mass/time] in 24 hour Urine
Xylose [Moles/volume] in Blood --2 hours post 5 g xylose PO
Xylose [Moles/volume] in Blood --2 hours post dose xylose PO
Xylose [Mass/time] in 5 hour Urine --post 25 g xylose PO
Xylose [Mass/time] in 5 hour Urine --post 5 g xylose PO
Xylose [Moles/time] in 5 hour Urine --post 25 g xylose PO
Xylose [Moles/time] in 5 hour Urine --post 5 g xylose PO
Xylose/Xylose dose in 5 hour Urine --post 25 g xylose PO
Xylose/Xylose dose in 5 hour Urine --post 5 g xylose PO
Ethanolamine [Mass/volume] in Serum or Plasma
Xylose/Xylose dose in 5 hour Urine --post dose xylose PO
Glutamine [Moles/volume] in Cerebral spinal fluid
Tyrosine [Moles/volume] in Cerebral spinal fluid
Threonine [Moles/volume] in Cerebral spinal fluid
Serine [Moles/volume] in Cerebral spinal fluid
Proline [Moles/volume] in Cerebral spinal fluid
Phenylalanine [Moles/volume] in Cerebral spinal fluid
Ornithine [Moles/volume] in Cerebral spinal fluid
Methionine [Moles/volume] in Cerebral spinal fluid
Valine [Moles/volume] in Cerebral spinal fluid
Glycine [Moles/volume] in Cerebral spinal fluid
Lysine [Moles/volume] in Cerebral spinal fluid
Glutamate [Moles/volume] in Cerebral spinal fluid
Cystine [Moles/volume] in Cerebral spinal fluid
Citrulline [Moles/volume] in Cerebral spinal fluid
Aspartate [Moles/volume] in Cerebral spinal fluid
Arginine [Moles/volume] in Cerebral spinal fluid
Alanine [Moles/volume] in Cerebral spinal fluid
Alloisoleucine [Moles/volume] in Cerebral spinal fluid
Isoleucine [Moles/volume] in Cerebral spinal fluid
Homocystine [Moles/volume] in Cerebral spinal fluid
Coproporphyrin [Moles/volume] in Serum or Plasma
Uroporphyrin [Moles/volume] in Serum or Plasma
Estrone (E1) [Moles/volume] in Serum or Plasma
Bilirubin.delta [Moles/volume] in Serum or Plasma
Busulfan [Moles/volume] in Serum or Plasma
Propylene glycol [Moles/volume] in Serum or Plasma
Alloisoleucine [Moles/volume] in Serum or Plasma
Phytanate (C16:0(CH3)4) [Moles/volume] in Serum or Plasma
Cystine [Moles/volume] in Serum or Plasma
Transferrin [Moles/volume] in Serum or Plasma
7-Dehydrocholesterol [Presence] in Serum or Plasma
Lysine/Creatinine [Molar ratio] in Urine
Mercury/Creatinine [Molar ratio] in Urine
Etiocholanolone [Mass/time] in 24 hour Urine
Methionine/Creatinine [Molar ratio] in Urine
Ornithine/Creatinine [Molar ratio] in Urine
Serine/Creatinine [Molar ratio] in Urine
Tyrosine/Creatinine [Molar ratio] in Urine
Protoporphyrin [Moles/time] in 24 hour Urine
Cystine/Creatinine [Molar ratio] in Urine
Threonine/Creatinine [Molar ratio] in Urine
Proline/Creatinine [Molar ratio] in Urine
Aspartate/Creatinine [Molar ratio] in Urine
Valine/Creatinine [Molar ratio] in Urine
Leucine/Creatinine [Molar ratio] in Urine
Citrulline/Creatinine [Molar ratio] in Urine
Carnitine/Creatinine [Molar ratio] in Urine
Cadmium/Creatinine [Molar ratio] in Urine
Arginine/Creatinine [Molar ratio] in Urine
Alanine/Creatinine [Molar ratio] in Urine
Complement factor B [Mass/volume] in Serum or Plasma
Alloisoleucine/Creatinine [Molar ratio] in Urine
Ketones [Moles/volume] in Urine by Test strip
Histidine/Creatinine [Molar ratio] in Urine
Carnitine free (C0)/Creatinine [Molar ratio] in Urine
Glucose [Moles/volume] in Urine by Test strip
Isoleucine/Creatinine [Molar ratio] in Urine
Homocystine/Creatinine [Molar ratio] in Urine
Homovanillate/Creatinine [Molar ratio] in Urine
Glycine/Creatinine [Molar ratio] in Urine
Glutamine/Creatinine [Molar ratio] in Urine
Glutamate/Creatinine [Molar ratio] in Urine
Adenosine monophosphate.cyclic [Moles/volume] in Urine
Alloisoleucine [Moles/volume] in Specimen
Fatty acids.esterified [Mass/volume] in Blood
Ethylene glycol [Moles/volume] in Specimen
Acetaminophen [Moles/volume] in Specimen
Phenylalanine [Moles/volume] in Specimen
Propylene glycol [Moles/volume] in Specimen
Gentamicin [Moles/volume] in Serum or Plasma --peak
Gentamicin [Moles/volume] in Serum or Plasma --trough
Cholesterol in LDL [Moles/volume] in Serum or Plasma
Amylase.pancreatic [Enzymatic activity/volume] in Urine
Tobramycin [Moles/volume] in Serum or Plasma --peak
Tobramycin [Moles/volume] in Serum or Plasma --trough
Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma
Haemophilus influenzae B Ab [Mass/volume] in Serum
Fatty acids [Mass/volume] in Serum or Plasma
HLA-DR [Units/volume] in Cerebral spinal fluid
Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Pristanate (C15:0(CH3)4) [Moles/volume] in Serum or Plasma
Ferritin [Mass/volume] in Serum or Plasma
Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation
African horse sickness virus Ab [Presence] in Serum by Immunoassay
African horse sickness virus Ab [Presence] in Serum by Immunoblot
African horse sickness virus Ab [Presence] in Serum by Complement fixation
African horse sickness virus neutralizing antibody [Titer] in Serum by Neutralization test
African horse sickness virus Ab [Titer] in Serum
African horse sickness virus Ab [Presence] in Serum
Ferrochelatase [Enzymatic activity/volume] in Serum
African horse sickness virus Ag [Presence] in Tissue by Immunoassay
African horse sickness virus Ag [Presence] in Specimen by Immunoassay
African horse sickness virus RNA [Presence] in Tissue by NAA with probe detection
African horse sickness virus serotype [Identifier] in Serum by Neutralization test
African horse sickness virus serotype [Identifier] in Specimen by Neutralization test
African swine fever virus Ab [Presence] in Body fluid by Immunoassay
African swine fever virus Ab [Presence] in Body fluid
African swine fever virus Ab [Presence] in Serum
African swine fever virus Ab [Presence] in Serum by Immunoassay
African swine fever virus Ag [Presence] in Specimen by Agglutination
African swine fever virus Ag [Presence] in Tissue by Agglutination
African swine fever virus Ag [Presence] in Tissue by Immunofluorescence
African swine fever virus Ag [Presence] in Specimen by Immunofluorescence
African swine fever virus DNA [Presence] in Tissue by NAA with probe detection
Alcelaphine herpesvirus 1 Ab [Titer] in Serum
Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence
Alcelaphine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test
Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence
Doxycycline [Susceptibility] by Serum bactericidal titer
Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immune stain
Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection
Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE)
Aleutian disease virus Ab [Presence] in Serum
Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence
Anaplasma marginale Ab [Presence] in Serum by Immunoassay
Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence
Anaplasma marginale DNA [Presence] in Tissue by NAA with probe detection
Fibrinopeptide A [Mass/volume] in Peritoneal fluid
Anaplasma marginale rRNA [Presence] in Tissue by Probe
Anaplasma sp identified in Tissue by Modified Giemsa stain
Anaplasma sp identified in Blood by Modified Giemsa stain
Infectious bronchitis virus Ab [Titer] in Serum
Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition
Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay
Infectious bronchitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Infectious bronchitis virus Ag [Presence] in Specimen by Neutralization test
Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain
Infectious bronchitis virus Ag [Presence] in Specimen by Immunofluorescence
Infectious bronchitis virus [Presence] in Specimen by Electron microscopy
Infectious bronchitis virus RNA [Presence] in Specimen by Probe
Infectious bronchitis virus RNA [Presence] in Specimen by NAA with probe detection
Avian infectious laryngotracheitis virus [Presence] in Specimen by Electron microscopy
Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence
Flavin adenine dinucleotide [Mass/volume] in Serum
Avian infectious laryngotracheitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Avian infectious laryngotracheitis virus Ab [Titer] in Serum
Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Neutralization test
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID)
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay
Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Immune diffusion (ID)
Avian orthoreovirus Ag [Presence] in Specimen
Influenza virus A Ab [Presence] in Serum by Immunoassay
Influenza virus A Ab [Titer] in Serum by Agglutination
Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A Ag [Presence] in Specimen by Immune diffusion (ID)
Influenza virus A identified in Specimen by Bioassay
Influenza virus A subtype [Identifier] in Specimen by NAA with probe detection
Influenza virus A subtype [Identifier] in Specimen by Immune diffusion (ID)
Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition
Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination
Avian paramyxovirus 1 Ag [Presence] in Specimen by Hemagglutination inhibition
Avian paramyxovirus 1 identified in Specimen by Bioassay
Avian paramyxovirus 1 [Units/volume] in Specimen by Bioassay
Avian metapneumovirus Ab [Presence] in Serum
Avian pox virus [Presence] in Tissue by Electron microscopy
Avian pox virus Ab [Presence] in Serum by Agglutination
Avian pox virus Ab [Presence] in Serum by Immunofluorescence
Avian pox virus neutralizing antibody [Presence] in Serum by Neutralization test
Avian pox virus Ab [Presence] in Serum by Immune stain
Avian pox virus Ab [Presence] in Serum by Immunoassay
Avian pox virus DNA [Presence] in Tissue by NAA with probe detection
Avian pox virus DNA [Presence] in Tissue by Probe
Babesia bigemina Ab [Presence] in Serum by Immunofluorescence
Babesia bigemina Ab [Presence] in Serum by Immunoassay
Babesia bovis Ab [Presence] in Serum by Immunoassay
Babesia bovis Ab [Presence] in Serum by Immunofluorescence
Babesia caballi Ab [Presence] in Serum by Immunoassay
Babesia caballi Ab [Presence] in Serum by Immunofluorescence
Babesia caballi rRNA [Presence] in Blood by Probe
Babesia divergens Ab [Presence] in Serum by Immunofluorescence
Babesia divergens Ab [Presence] in Serum
Babesia sp rRNA [Presence] in Tissue by Probe
Babesia sp DNA [Presence] in Tissue by NAA with probe detection
Babesia sp identified in Tissue by Giemsa stain
Bacillus anthracis Ab [Presence] in Serum
Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID)
Bacillus anthracis Ab [Presence] in Serum by Agglutination
Bacillus anthracis Ab [Presence] in Serum by Immunoassay
Bacillus anthracis Ab [Presence] in Serum by Complement fixation
Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID)
Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence
Bacillus anthracis Ag [Presence] in Specimen by Immunofluorescence
Bluetongue virus neutralizing antibody [Presence] in Serum by Neutralization test
Bluetongue virus Ag [Presence] in Specimen by Immunofluorescence
Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)
Bluetongue virus Ag [Presence] in Specimen by Immunoassay
Bluetongue virus Ag [Presence] in Specimen by Neutralization test
Bluetongue virus Ag [Presence] in Specimen by Immune stain
Bluetongue virus serotype [Identifier] in Specimen by NAA with probe detection
Border disease virus Ab [Units/volume] in Serum by Immunoassay
Border disease virus Ab [Units/volume] in Serum
Border disease virus Ab [Titer] in Serum
Border disease virus neutralizing antibody [Titer] in Serum by Neutralization test
Border disease virus Ag [Presence] in Specimen by Immunofluorescence
Border disease virus Ag [Presence] in Specimen by Immune stain
Border disease virus Ag [Presence] in Tissue by Immunoassay
Border disease virus Ag [Presence] in Blood by Immunoassay
Border disease virus RNA [Presence] in Tissue from Fetus by NAA with probe detection
Border disease virus RNA [Presence] in Tissue by NAA with probe detection
Border disease virus RNA [Presence] in Blood by NAA with probe detection
Bordetella bronchiseptica Ab [Presence] in Serum
Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination
Bordetella bronchiseptica Ag [Presence] in Specimen by Agglutination
Bovine diarrhea virus Ab [Presence] in Milk
Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay
Bovine diarrhea virus Ab [Titer] in Serum
Bovine diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test
Bovine diarrhea virus neutralizing antibody [Presence] in Serum by Neutralization test
Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay
Bovine diarrhea virus Ab [Presence] in Serum
Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay
Bovine diarrhea virus Ag [Presence] in Specimen by Immune stain
Bovine diarrhea virus Ag [Presence] in Specimen by Immunofluorescence
Bovine diarrhea virus RNA [Presence] in Tissue by Probe
Bovine diarrhea virus RNA [Presence] in Specimen by NAA with probe detection
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence
Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID)
Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay
Bovine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Bovine herpesvirus 1 Ab [Presence] in Milk
Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunoassay
Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence
Bovine herpesvirus 1 Ag [Units/volume] in Specimen by Neutralization test
Bovine herpesvirus 1 Ag [Presence] in Specimen by Immune stain
Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence
Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain
Bovine herpesvirus 1 DNA [Presence] in Semen by NAA with probe detection
Bovine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection
Bovine leukemia virus Ab [Presence] in Milk
Bovine leukemia virus Ab [Presence] in Milk by Immunoassay
Bovine leukemia virus Ag [Presence] in Specimen
Bovine leukemia virus RNA [Presence] in Blood by NAA with probe detection
Bovine leukemia virus RNA [Presence] in Tissue by NAA with probe detection
Brucella abortus Ab [Presence] in Serum by Immunofluorescence
Formate [Mass/volume] in Serum or Plasma
Brucella abortus Ab [Units/volume] in Serum by Agglutination
Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay
Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay
Brucella abortus IgG1 Ab [Presence] in Serum
Brucella abortus IgG1 Ab [Presence] in Milk
Brucella abortus rRNA [Presence] in Specimen by Probe
Brucella abortus DNA [Presence] in Specimen by NAA with probe detection
Brucella canis Ab [Presence] in Serum by Immune diffusion (ID)
Brucella canis Ab [Presence] in Serum by Agglutination
Brucella melitensis Ab [Presence] in Serum
Brucella melitensis Ab [Presence] in Serum by Immunoassay
Brucella melitensis Ab [Presence] in Serum by Agglutination
Brucella melitensis Ab [Units/volume] in Serum by Complement fixation
Brucella melitensis Ab [Presence] in Serum by Complement fixation
Brucella melitensis DNA [Presence] in Specimen by NAA with probe detection
Brucella ovis Ab [Units/volume] in Serum by Complement fixation
Brucella ovis Ab [Presence] in Serum by Agglutination
Fructokinase [Enzymatic activity/volume] in Serum
Brucella ovis Ab [Units/volume] in Serum
Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID)
Brucella reaction wheal [Diameter] --2 days post 0.1 mL brucellin intradermal
Brucella reaction wheal [Diameter] --3 days post 0.1 mL brucellin intradermal
Brucella sp Ag [Presence] in Placenta by Immunofluorescence
Brucella sp Ag [Presence] in Vaginal fluid by Immune stain
Brucella sp Ag [Presence] in Tissue by Immune stain
Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence
Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence
Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain
Brucella sp Ag [Presence] in Placenta by Immune stain
Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Brucella suis Ab [Presence] in Serum by Plate agglutination
Brucella suis Ab [Presence] in Serum by Immunoassay
Brucella suis Ab [Units/volume] in Serum by Complement fixation
Brucella suis rRNA [Presence] in Specimen by Probe
Brucella suis DNA [Presence] in Specimen by NAA with probe detection
Burkholderia mallei Ab [Presence] in Serum
Burkholderia mallei Ab [Presence] in Serum by Immunoassay
Burkholderia mallei Ab [Presence] in Serum by Complement fixation
Burkholderia mallei reaction [Appearance] -1D post 0.1 mL mallein intradermal-
Burkholderia mallei reaction [Appearance] -2D post 0.1 mL mallein intradermal-
Campylobacter fetus Ab [Presence] in Genital mucus
Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination
Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence
Campylobacter fetus Ag [Presence] in Specimen by Immunofluorescence
Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus
Caprine arthritis encephalitis virus [Presence] in Specimen by Electron microscopy
Caprine arthritis encephalitis virus Ab [Presence] in Milk
Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination
Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immune stain
Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immunofluorescence
Caprine arthritis encephalitis virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE)
Caprine arthritis encephalitis virus DNA [Presence] in Specimen by NAA with probe detection
Caprine herpesvirus 1 Ab [Presence] in Serum
Caprine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Capripox virus [Presence] in Tissue by Animal inoculation
Capripox virus Ab [Presence] in Serum by Immunoblot
Capripox virus neutralizing antibody [Presence] in Serum by Neutralization test
Capripox virus Ag [Presence] in Specimen by Immune diffusion (ID)
Capripox virus Ag [Presence] in Tissue by Immune stain
Capripox virus Ag [Presence] in Specimen by Immunoassay
Capripox virus Ag [Presence] in Specimen by Immunofluorescence
Capripox virus Ag [Presence] in Tissue by Immunoassay
Capripox virus DNA [Presence] in Specimen by RFLP
Chlamydophila psittaci [Presence] in Specimen by Giemsa stain
Chlamydophila psittaci [Presence] in Placenta by Electron microscopy
Chlamydophila psittaci Ab [Presence] in Serum by Agglutination
Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID)
Aldolase [Enzymatic activity/volume] in Red Blood Cells
Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay
Chlamydophila psittaci Ag [Presence] in Specimen by Immune stain
Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain
Chlamydophila psittaci Ag [Presence] in Stool by Immune stain
Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain
Chlamydophila psittaci DNA [Presence] in Specimen by NAA with probe detection
Classical swine fever virus Ab [Presence] in Serum by Immunoassay
Classical swine fever virus neutralizing antibody [Presence] in Serum by Neutralization test
Classical swine fever virus Ab [Presence] in Serum
Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence
Classical swine fever virus Ag [Presence] in Specimen by Immunofluorescence
Classical swine fever virus Ag [Presence] in Tissue by Immune stain
Classical swine fever virus RNA [Presence] in Specimen by NAA with probe detection
Cowdria ruminantium [Presence] in Brain by Giemsa stain
Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence
Cowdria ruminantium Ab [Presence] in Serum by Immunoassay
Cowdria ruminantium Ab [Presence] in Serum
Cowdria ruminantium Ab [Presence] in Serum by Immunoblot
Cowdria ruminantium DNA [Presence] in Specimen by NAA with probe detection
Cowdria ruminantium rRNA [Presence] in Specimen by Probe
Coxiella burnetii [Presence] in Placenta by Light microscopy
Coxiella burnetii Ab [Presence] in Serum by Complement fixation
Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence
Coxiella burnetii Ab [Presence] in Serum by Immunoassay
Coxiella burnetii Ab [Presence] in Serum
Coxiella burnetii Ag [Presence] in Tissue by Immunoassay
Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence
Coxiella burnetii Ag [Presence] in Specimen by Immunofluorescence
Coxiella burnetii DNA [Presence] in Specimen by NAA with probe detection
Dermatophilus congolensis [Presence] in Skin by Giemsa stain
Dermatophilus congolensis Ab [Presence] in Serum
Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay
Fumarase [Enzymatic activity/volume] in Serum
Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence
Dirofilaria immitis Ag [Presence] in Blood
Enoxacin [Susceptibility] by Disk diffusion (KB)
Duck enteritis virus [Presence] in Tissue by Electron microscopy
Duck enteritis virus Ag [Presence] in Specimen by Neutralization test
Duck enteritis virus Ag [Presence] in Specimen by Agglutination
Duck hepatitis virus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Duck hepatitis virus 1 Ab [Presence] in Serum
Duck hepatitis virus 1 Ag [Presence] in Specimen by Neutralization test
Duck hepatitis virus 2 Ab [Presence] in Serum
Duck hepatitis virus 2 neutralizing antibody [Presence] in Serum by Neutralization test
Duck hepatitis virus 2 Ag [Presence] in Specimen by Neutralization test
Duck hepatitis virus 3 Ab [Presence] in Serum
Duck hepatitis virus 3 neutralizing antibody [Presence] in Serum by Neutralization test
Duck hepatitis virus 3 Ag [Presence] in Specimen by Immunofluorescence
Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition
Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination
Fumarylacetoacetate [Mass/volume] in Serum
Eastern equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test
Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
Eastern equine encephalitis virus IgM Ab [Presence] in Serum
Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation
Eastern equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence
Eastern equine encephalitis virus Ag [Presence] in Specimen by Complement fixation
Eastern equine encephalitis virus Ag [Presence] in Specimen by Neutralization test
Galactokinase [Enzymatic activity/volume] in Red Blood Cells
Eastern equine encephalitis virus RNA [Presence] in Tissue by NAA with probe detection
Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe
Echinococcus sp Ag [Presence] in Stool by Immunoassay
Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence
Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence
Ehrlichia risticii Ab [Presence] in Serum
Ephemeral fever virus neutralizing antibody [Presence] in Serum by Neutralization test
Ephemeral fever virus Ab [Presence] in Serum
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation
Epizootic hemorrhagic disease virus Ag [Presence] in Specimen
Epizootic hemorrhagic disease virus Ag [Presence] in Blood
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID)
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID)
Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection
Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID)
Equine arteritis virus Ab [Titer] in Serum by Complement fixation
Equine arteritis virus Ab [Presence] in Serum by Immunoassay
Equine arteritis virus neutralizing antibody [Presence] in Serum by Neutralization test
Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence
Equine arteritis virus Ab [Presence] in Serum
Equine arteritis virus Ag [Presence] in Specimen by Immunofluorescence
Equine arteritis virus Ag [Presence] in Specimen by Immune stain
Equine arteritis virus Ag [Presence] in Specimen by Neutralization test
Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence
Equine arteritis virus Ag [Presence] in Tissue by Immune stain
Equine arteritis virus RNA [Presence] in Specimen by NAA with probe detection
Equine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence
Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain
Equine herpesvirus 1 DNA [Presence] in Nose by NAA with probe detection
Equine herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection
Equine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection
Galactose [Mass/volume] in Serum or Plasma
Equine herpesvirus 1+4 neutralizing antibody [Presence] in Serum by Neutralization test
Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay
Equine herpesvirus 1+4 Ab [Presence] in Serum
Equine herpesvirus 1+4 Ab [Titer] in Serum
Equine herpesvirus 1+4 neutralizing antibody [Titer] in Serum by Neutralization test
Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation
Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence
Equine herpesvirus 4 Ag [Presence] in Specimen by Immunofluorescence
Equine herpesvirus 4 DNA [Presence] in Nose by NAA with probe detection
Equine herpesvirus 4 DNA [Presence] in Tissue by NAA with probe detection
Equine herpesvirus 4 DNA [Presence] in Specimen by NAA with probe detection
Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot
Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay
Equine infectious anemia virus Ag [Presence] in Specimen by Immunofluorescence
Equine infectious anemia virus Ag [Presence] in Specimen by Immunoassay
Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation
Equine influenza virus A1 Ab [Presence] in Serum
Equine influenza virus A1 Ag [Titer] in Specimen by Hemagglutination inhibition
Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation
Equine influenza virus A2 Ag [Titer] in Specimen by Hemagglutination inhibition
Foot and mouth disease virus Ab [Presence] in Serum
Foot and mouth disease virus neutralizing antibody [Presence] in Serum by Neutralization test
Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay
Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Enoxacin [Susceptibility] by Serum bactericidal titer
Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay
Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay
Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation
Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation
Foot and mouth disease virus RNA [Presence] in Tissue by Probe
Foot and mouth disease virus serotype [Identifier] in Specimen by Complement fixation
Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay
Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay
Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test
Galactose renal clearance in 24 hour Urine and Serum or Plasma
Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation
Foot and mouth disease virus serotype [Identifier] in Specimen by Immunoassay
Foot and mouth disease virus serotype [Identifier] in Tissue by NAA with probe detection
Francisella tularensis A DNA [Presence] in Tissue by NAA with probe detection
Francisella tularensis A rRNA [Presence] in Tissue by Probe
Francisella tularensis Ab [Presence] in Serum by Immunoassay
Francisella tularensis Ab [Titer] in Serum by Agglutination
Francisella tularensis Ag [Presence] in Tissue by Immune stain
Galactose 1 phosphate [Mass/volume] in Red Blood Cells
Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence
Francisella tularensis B DNA [Presence] in Tissue by NAA with probe detection
Francisella tularensis B rRNA [Presence] in Tissue by Probe
Francisella tularensis DNA [Presence] in Tissue by NAA with probe detection
Francisella tularensis rRNA [Presence] in Tissue by Probe
Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence
Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay
Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination
Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells
Histoplasma farciminosum Ab [Presence] in Serum
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --1 day post dose intradermal
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post dose intradermal
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --3 days post dose intradermal
Infectious bursal disease virus Ab [Titer] in Serum
Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID)
Infectious bursal disease virus neutralizing antibody [Titer] in Serum by Neutralization test
Infectious bursal disease virus Ag [Presence] in Specimen by Neutralization test
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells
Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID)
Japanese encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation
Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition
Japanese encephalitis virus Ab [Titer] in Serum
Japanese encephalitis virus Ag [Presence] in Specimen by Immunofluorescence
Japanese encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition
Galactosylceramidase [Enzymatic activity/mass] in Tissue
Leishmania donovani Ag [Presence] in Tissue by Immune stain
Leishmania reaction wheal [Diameter] --3 days post 0.1 mL leishmanin intradermal
Leishmania sp Ab [Presence] in Serum by Immunoassay
Leishmania sp Ab [Titer] in Serum by Hemagglutination
Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis
Leishmania sp Ab [Titer] in Serum by Immunofluorescence
Leishmania sp Ab [Presence] in Serum by Agglutination
Leishmania sp rRNA [Identifier] in Specimen by Probe
Leishmania sp DNA [Identifier] in Specimen by NAA with probe detection
Leishmania sp identified in Tissue by Immunofluorescence
Leishmania sp identified in Tissue by Electrophoresis
Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE)
Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Australis Ab [Presence] in Serum
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum
Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Bataviae Ab [Presence] in Serum
Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Bratislava Ab [Presence] in Serum
Leptospira interrogans sv Canicola Ab [Presence] in Serum
Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum
Gamma aminobutyrate [Presence] in Serum or Plasma
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Hardjo Ab [Presence] in Serum
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum
Leptospira interrogans Ab [Presence] in Serum by Immunoassay
Leptospira interrogans Ab [Presence] in Serum
Leptospira interrogans Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Mitis Ab [Presence] in Serum
Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Pomona Ab [Presence] in Serum
Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination
Leptospira sp Ab [Presence] in Serum by Immunoassay
Leptospira sp Ab [Presence] in Serum by Agglutination
Leptospira sp Ab [Titer] in Serum by Agglutination
Leptospira sp IgG Ab [Presence] in Serum by Immunoassay
Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells
Leptospira sp IgG Ab [Presence] in Serum
Leptospira sp IgM Ab [Presence] in Serum by Immunoassay
Leptospira sp IgM Ab [Presence] in Serum
Leptospira sp Ag [Presence] in Tissue by Immunofluorescence
Leptospira sp Ag [Presence] in Tissue by Immune stain
Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection
Leptospira sp DNA [Presence] in Tissue by NAA with probe detection
Leptospira subtype [Identifier] in Specimen
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination
Listeria sp Ab [Presence] in Serum by Agglutination
Lumpy skin disease virus [Presence] in Tissue by Electron microscopy
Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence
Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot
Lumpy skin disease virus neutralizing antibody [Presence] in Serum by Neutralization test
Lumpy skin disease virus Ab [Presence] in Serum
Lumpy skin disease virus Ab [Titer] in Serum
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum
Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay
Lumpy skin disease virus Ag [Presence] in Specimen by Immunoassay
Lumpy skin disease virus Ag [Presence] in Specimen
Lumpy skin disease virus Ag [Presence] in Specimen by Immunofluorescence
Lumpy skin disease virus Ag [Presence] in Specimen by Immune diffusion (ID)
Lumpy skin disease virus DNA [Presence] in Specimen by RFLP
Mareks disease virus Ab [Presence] in Serum
Mareks disease virus Ab [Presence] in Serum by Immunoassay
Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid
Mareks disease virus Ab [Presence] in Serum by Immunofluorescence
Mareks disease virus neutralizing antibody [Presence] in Serum by Neutralization test
Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Mareks disease virus Ag [Presence] in Specimen by Immunofluorescence
Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID)
Mareks disease virus DNA [Presence] in Specimen by NAA with probe detection
Mite identified in Skin by Parasite sedimentation
Gamma glutamyl transferase [Enzymatic activity/volume] in Semen
Mycobacterium avium ss avium Ab [Presence] in Blood
Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination
Mycobacterium avium ss avium rRNA [Presence] in Tissue by Probe
Mycobacterium avium ss avium identified in Specimen by Bioassay
Mycobacterium avium ss avium serotype [Identifier] in Specimen
Mycobacterium bovis Ab [Presence] in Serum
Mycobacterium bovis Ab [Presence] in Serum by Immunoassay
Mycobacterium bovis Ag [Presence] in Tissue by Immune stain
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
Mycobacterium bovis Ag [Presence] in Blood
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen
Mycobacterium avium ss paratuberculosis DNA [Presence] in Specimen by NAA with probe detection
Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by NAA with probe detection
Mycobacterium sp DNA [Presence] in Tissue by NAA with probe detection
Mycoplasma agalactiae neutralizing antibody [Presence] in Serum by Neutralization test
Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation
Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay
Mycoplasma agalactiae Ab [Presence] in Serum
Mycoplasma agalactiae DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma arginini Ab [Presence] in Serum
Mycoplasma arginini Ab [Presence] in Serum by Complement fixation
Mycoplasma bovis Ab [Presence] in Serum by Complement fixation
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation
Gamma glutamyl transferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation
Gastric inhibitory polypeptide [Mass/volume] in Plasma
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Neutralization test
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Immunofluorescence
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by Probe
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by NAA with probe detection
Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination
Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination
Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid
Mycoplasma gallisepticum Ab [Titer] in Serum
Mycoplasma gallisepticum Ag [Presence] in Specimen by Immunofluorescence
Mycoplasma gallisepticum Ag [Presence] in Specimen by Immune stain
Mycoplasma gallisepticum Ag [Presence] in Specimen by Neutralization test
Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by NAA with probe detection
Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination
Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation
Mycoplasma mycoides ss capri Ab [Presence] in Serum
Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immune diffusion (ID)
Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immunofluorescence
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain
Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay
Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation
Mycoplasma putrefaciens Ab [Presence] in Serum
Mycoplasma sp Ab [Presence] in Serum by Complement fixation
Mycoplasma sp Ag [Presence] in Specimen by Immunofluorescence
Mycoplasma sp rRNA [Presence] in Specimen by Probe
Mycoplasma sp DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination
Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID)
Myxoma virus Ab [Titer] in Serum by Immunofluorescence
Myxoma virus Ab [Presence] in Serum by Complement fixation
Myxoma virus neutralizing antibody [Presence] in Serum by Neutralization test
Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma
Myxoma virus Ab [Presence] in Serum by Immunofluorescence
Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID)
Myxoma virus Ag [Presence] in Specimen by Immunofluorescence
Nairobi sheep disease virus Ab [Titer] in Serum
Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID)
Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence
Nairobi sheep disease virus Ab [Presence] in Serum
Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma
Nairobi sheep disease virus Ag [Presence] in Specimen by Complement fixation
Nairobi sheep disease virus Ag [Presence] in Specimen by Immunofluorescence
Nairobi sheep disease virus Ag [Presence] in Specimen by Immunoassay
Ovine herpesvirus 2 Ab [Presence] in Serum
Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence
Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay
Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain
Ovine herpesvirus 2 DNA [Presence] in Tissue by NAA with probe detection
Ovine progressive pneumonia virus Ab [Presence] in Milk
Ovine progressive pneumonia virus Ab [Presence] in Serum
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID)
Gastrin [Mass/volume] in Serum or Plasma
Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay
Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immunofluorescence
Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immune stain
Ovine progressive pneumonia virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE)
Ovine progressive pneumonia virus DNA [Presence] in Specimen by NAA with probe detection
Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by NAA with probe detection
Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL avian tuberculin intradermal
Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL johnin intradermal
Hemoglobin.gastrointestinal [Presence] in Gastric fluid
Pasteurella multocida Ab [Titer] in Serum by Immunoassay
Pasteurella multocida Ab [Titer] in Serum
Pasteurella multocida Ag [Titer] in Specimen by Agglutination
Pasteurella multocida rRNA [Presence] in Specimen by Probe
Pasteurella multocida serotype [Identifier] in Specimen by Agglutination
Pasteurella multocida serotype [Identifier] in Specimen by Immunoelectrophoresis
Pasteurella multocida serotype [Identifier] in Specimen by Immunofluorescence
Pasteurella multocida toxin [Presence] in Specimen by Immunoassay
Peste des petits ruminants virus Ab [Titer] in Serum
Peste des petits ruminants virus Ab [Presence] in Serum
Peste des petits ruminants virus neutralizing antibody [Titer] in Serum by Neutralization test
Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis
Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID)
Hemoglobin.gastrointestinal [Presence] in Stool
Peste des petits ruminants virus RNA [Presence] in Tissue by Probe
Peste des petits ruminants virus RNA [Presence] in Tissue by NAA with probe detection
Porcine enterovirus Ag [Presence] in Specimen by Neutralization test
Porcine enterovirus Ab [Presence] in Serum
Porcine enterovirus neutralizing antibody [Presence] in Serum by Neutralization test
Porcine enterovirus Ab [Presence] in Serum by Immunoassay
Porcine enterovirus Ag [Presence] in Specimen by Immunofluorescence
Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition
Porcine parvovirus Ab [Presence] in Serum
PRRSV Ab [Presence] in Serum by Complement fixation
PRRSV neutralizing antibody [Presence] in Serum by Neutralization test
PRRSV Ag [Presence] in Specimen by Immune stain
Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
PRRSV Ag [Presence] in Tissue by Immune stain
PRRSV RNA [Presence] in Semen by NAA with probe detection
Porcine respiratory coronavirus Ab [Presence] in Serum
Porcine respiratory coronavirus neutralizing antibody [Presence] in Serum by Neutralization test
Glucagon [Mass/volume] in Amniotic fluid
Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay
Porcine respiratory coronavirus Ag [Presence] in Specimen by Immune stain
Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain
Porcine respiratory coronavirus RNA [Presence] in Specimen by Probe
Abnormal Prion Protein [Presence] in Brain by Immunoblot
Abnormal Prion Protein [Presence] in Brain by Immune stain
Abnormal Prion Protein [Presence] in Brain by Electron microscopy
Glucagon [Mass/volume] in Serum or Plasma
Pseudorabies virus neutralizing antibody [Presence] in Serum by Neutralization test
Pseudorabies virus Ag [Presence] in Specimen by Immune stain
Pseudorabies virus Ag [Presence] in Specimen by Immunoassay
Pseudorabies virus Ag [Presence] in Specimen by Immunofluorescence
Pseudorabies virus Ag [Presence] in Specimen by Neutralization test
Pseudorabies virus DNA [Presence] in Specimen by NAA with probe detection
Rabies virus [Presence] in Brain by Light microscopy
Rabies virus Ag [Presence] in Brain by Immunoassay
Rabies virus Ag [Presence] in Brain by Immune stain
Rabies virus Ag [Presence] in Specimen by Immune stain
Rift valley fever virus neutralizing antibody [Titer] in Serum by Neutralization test
Rift valley fever virus Ab [Presence] in Serum
Rift valley fever virus Ab [Presence] in Serum by Immunoassay
Rift valley fever virus Ab [Titer] in Serum
Rift valley fever virus Ag [Presence] in Tissue by Neutralization test
Rift valley fever virus Ag [Presence] in Blood by Neutralization test
Rift valley fever virus Ag [Presence] in Specimen by Immunofluorescence
Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence
Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID)
Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID)
Rinderpest virus neutralizing antibody [Presence] in Serum by Neutralization test
Glucose [Mass/volume] in Blood by Automated test strip
Rinderpest virus neutralizing antibody [Titer] in Serum by Neutralization test
Rinderpest virus Ab [Presence] in Serum by Immunoassay
Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay
Rinderpest virus Ag [Presence] in Specimen by Immunofluorescence
Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis
Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID)
Glucose [Mass/volume] in Blood by Test strip manual
Rinderpest virus Ag [Units/volume] in Specimen by Immunoassay
Rinderpest virus RNA [Presence] in Specimen by NAA with probe detection
Salmonella abortus equi Ab [Presence] in Serum by Agglutination
Salmonella abortus equi Ab [Presence] in Serum
Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation
Salmonella abortus ovis Ab [Presence] in Serum
Salmonella enteritidis IgG Ab [Presence] in Serum
Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay
Glucose [Mass/volume] in Cerebral spinal fluid
Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay
Salmonella enteritidis IgG Ab [Presence] in Egg yolk
Salmonella gallinarum Ab [Presence] in Blood by Agglutination
Salmonella gallinarum Ab [Presence] in Serum
Salmonella gallinarum Ab [Presence] in Serum by Immunoassay
Salmonella gallinarum Ab [Presence] in Serum by Agglutination
Salmonella gallinarum DNA [Presence] in Specimen by NAA with probe detection
Salmonella gallinarum rRNA [Presence] in Specimen by Probe
Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID)
Salmonella pullorum Ab [Presence] in Serum by Immunoassay
Salmonella pullorum DNA [Presence] in Specimen by NAA with probe detection
Salmonella pullorum rRNA [Presence] in Specimen by Probe
Swine influenza virus Ab [Presence] in Serum
Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition
Swine vesicular disease virus neutralizing antibody [Presence] in Serum by Neutralization test
Swine vesicular disease virus Ab [Presence] in Serum
Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay
Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis
Swine vesicular disease virus Ag [Presence] in Specimen by Immunoassay
Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation
Swine vesicular disease virus Ag [Presence] in Specimen by Complement fixation
Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay
Swine vesicular disease virus RNA [Presence] in Tissue by NAA with probe detection
Taenia hydatigena Ag [Presence] in Stool by Immunoassay
Erythromycin [Susceptibility] by Disk diffusion (KB)
Taenia sp Ag [Presence] in Stool by Immunoassay
Taenia sp eggs [Presence] in Stool by Probe
Taenia sp eggs [Presence] in Stool by NAA with probe detection
Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation
Taylorella equigenitalis Ab [Presence] in Serum
Taylorella equigenitalis Ag [Presence] in Specimen by Immunofluorescence
Taylorella equigenitalis Ag [Presence] in Specimen by Agglutination
Glucose [Mass/volume] in Serum or Plasma
Taylorella equigenitalis DNA [Presence] in Genital specimen by NAA with probe detection
Theileria annulata Ab [Presence] in Serum
Theileria annulata Ab [Presence] in Serum by Immunofluorescence
Theileria annulata Ab [Titer] in Serum by Immunofluorescence
Theileria annulata rRNA [Presence] in Serum by Probe
Theileria equi Ab [Presence] in Serum by Immunoassay
Theileria equi rRNA [Presence] in Blood by Probe
Theileria equi Ab [Presence] in Serum by Immunofluorescence
Theileria mutans Ab [Titer] in Serum by Immunofluorescence
Theileria mutans Ab [Presence] in Serum by Immunoassay
Theileria mutans Ab [Presence] in Serum by Immunofluorescence
Theileria mutans rRNA [Presence] in Serum by Probe
Glucose [Mass/volume] in Peritoneal fluid
Theileria mutans DNA [Presence] in Serum by NAA with probe detection
Theileria parva Ab [Presence] in Serum by Immunofluorescence
Theileria parva Ab [Titer] in Serum by Immunofluorescence
Theileria parva Ab [Presence] in Serum by Immunoassay
Theileria parva rRNA [Presence] in Serum by Probe
Theileria parva DNA [Presence] in Serum by NAA with probe detection
Theileria sp [Presence] in Blood by Giemsa stain
Theileria sp [Presence] in Tissue by Giemsa stain
Toxoplasma gondii Ab [Presence] in Serum by Agglutination
Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination
Transmissible gastroenteritis virus Ab [Presence] in Serum
Transmissible gastroenteritis virus neutralizing antibody [Presence] in Serum by Neutralization test
Transmissible gastroenteritis virus Ab [Titer] in Serum
Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay
Transmissible gastroenteritis virus neutralizing antibody [Titer] in Serum by Neutralization test
Transmissible gastroenteritis virus Ag [Presence] in Specimen by Neutralization test
Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay
Transmissible gastroenteritis virus Ag [Presence] in Specimen by Immune stain
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence
Transmissible gastroenteritis virus RNA [Presence] in Specimen by Probe
Trichinella spiralis [Presence] in Tissue by Light microscopy
Tritrichomonas foetus Ab [Presence] in Genital mucus
Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination
Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain
Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain
Tritrichomonas foetus DNA [Presence] in Specimen by NAA with probe detection
Tritrichomonas foetus DNA [Presence] in Genital fluid by NAA with probe detection
Tritrichomonas foetus reaction wheal [Diameter] --post 0.1 mL tricin intradermal
Trypanosoma brucei DNA [Presence] in Blood by NAA with probe detection
Trypanosoma congolense DNA [Presence] in Blood by NAA with probe detection
Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy
Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation
Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation
Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay
Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence
Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID)
Trypanosoma equiperdum Ab [Presence] in Serum
Trypanosoma equiperdum Ab [Titer] in Serum
Trypanosoma evansi [Presence] in Aspirate by Thick film
Trypanosoma evansi [Presence] in Aspirate by Thin film
Erythromycin [Susceptibility] by Serum bactericidal titer
Trypanosoma evansi [Presence] in Aspirate by Wet preparation
Trypanosoma evansi Ab [Units/volume] in Serum
Trypanosoma evansi Ab [Presence] in Serum
Trypanosoma evansi Ab [Presence] in Serum by Agglutination
Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay
Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence
Trypanosoma evansi Ag [Presence] in Blood by Immunoassay
Trypanosoma evansi DNA [Presence] in Specimen by NAA with probe detection
Trypanosoma evansi rRNA [Presence] in Specimen by Probe
Glucose phosphate isomerase [Enzymatic activity/volume] in Serum
Trypanosoma sp Ab [Presence] in Serum by Immunoassay
Trypanosoma sp Ab [Presence] in Serum by Agglutination
Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence
Trypanosoma sp Ag [Presence] in Blood by Immunoassay
Trypanosoma sp identified in Blood by Concentration
Tuberculosis reaction wheal [Diameter] --2 days post dose mammalian tuberculin intradermal
Tuberculosis reaction wheal [Diameter] --3 days post dose avian tuberculin intradermal
Tuberculosis reaction wheal [Diameter] --3 days post dose mammalian tuberculin intradermal
Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition
Venezuelan equine encephalitis virus Ab [Presence] in Serum
Venezuelan equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Neutralization test
Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum
Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence
Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition
Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Complement fixation
Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Neutralization test
Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by NAA with probe detection
Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Immunofluorescence
Vesicular stomatitis virus Ab [Presence] in Serum
Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue
Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay
Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay
Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation
Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation
Vesicular stomatitis Indiana virus Ab [Presence] in Serum
Vesicular stomatitis Indiana virus neutralizing antibody [Presence] in Serum by Neutralization test
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay
Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay
Vesicular stomatitis New Jersey virus neutralizing antibody [Presence] in Serum by Neutralization test
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation
Vesicular stomatitis virus serotype [Identifier] in Specimen by Complement fixation
Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation
Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
Vesicular stomatitis virus serotype [Identifier] in Specimen by Immunoassay
Rabbit hemorrhagic disease virus [Presence] in Tissue by Electron microscopy
Rabbit hemorrhagic disease virus Ab [Presence] in Serum
Rabbit hemorrhagic disease virus Ab [Titer] in Serum
Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay
Rabbit hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay
Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition
Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence
Glucose-6-Phosphate dehydrogenase [Presence] in Serum
Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay
Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination
Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain
Western equine encephalitis virus Ab [Presence] in Serum by Agglutination
Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition
Western equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test
Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition
Western equine encephalitis virus IgM Ab [Presence] in Serum
Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
Western equine encephalitis virus Ag [Presence] in Specimen by Neutralization test
Western equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence
Western equine encephalitis virus Ag [Presence] in Specimen by Complement fixation
African swine fever virus Ab [Presence] in Serum by Immune stain
Bovine leukemia virus [Presence] in Blood by Organism specific culture
Brucella sp identified in Semen by Organism specific culture
Dermatophilus congolensis [Presence] in Exudate by Giemsa stain
Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain
Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum
Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence
Leptospira sp identified in Tissue by Organism specific culture
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)
Leptospira sp identified in Milk by Organism specific culture
Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture
Salmonella enteritidis [Presence] in Stool by Organism specific culture
Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture
Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture
Tritrichomonas foetus [Presence] in Placenta by Organism specific culture
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes
Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture
Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria
cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria
Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria
Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria
Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria
Imipenem [Susceptibility] by Method for Slow-growing mycobacteria
Glucosylceramidase [Enzymatic activity/mass] in Tissue
Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria
Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria
Viomycin [Susceptibility] by Method for Slow-growing mycobacteria
Glutamate [Mass/volume] in Cerebral spinal fluid
Erythropoietin (EPO) given [Units/volume] of Dose
Erythropoietin (EPO) given [Units/mass] of Dose
Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)
Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Quinupristin+Dalfopristin [Susceptibility]
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum by Immunoassay
Glutamate [Mass/volume] in Serum or Plasma
Actinobacillus pleuropneumoniae Ab [Titer] in Serum
Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Specimen by Agglutination
Actinobacillus pleuropneumoniae serotype [Identifier] in Specimen by Agglutination
Actinobacillus suis serotype [Identifier] in Isolate by Agglutination
Aeromonas salmonicida DNA [Presence] in Tissue by NAA with probe detection
Anaplasma marginale Ab [Titer] in Serum by Complement fixation
Aspergillus sp Ab [Titer] in Serum by Immunoassay
Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay
Babesia bigemina Ab [Presence] in Serum by Complement fixation
Babesia bovis Ab [Presence] in Serum by Complement fixation
Babesia canis Ab [Titer] in Serum by Immunofluorescence
Babesia divergens Ab [Presence] in Serum by Complement fixation
Babesia sp Ab [Titer] in Serum by Complement fixation
Biochanin A [Mass/volume] in Serum or Plasma
Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
Bluetongue virus 10 neutralizing antibody [Titer] in Serum by Neutralization test
Bluetongue virus 11 neutralizing antibody [Titer] in Serum by Neutralization test
Bluetongue virus 13 neutralizing antibody [Titer] in Serum by Neutralization test
Bluetongue virus 17 neutralizing antibody [Titer] in Serum by Neutralization test
Bluetongue virus 2 neutralizing antibody [Titer] in Serum by Neutralization test
Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence
Bovine leukemia virus Ab [Titer] in Serum by Complement fixation
Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence
Bovine respiratory syncytial virus Ag [Presence] in Specimen
Brucella canis Ab [Presence] in Serum by Immunofluorescence
Brucella canis Ab [Titer] in Serum by Agglutination
Brucella canis Ab [Titer] in Serum by Immunofluorescence
Canine adenovirus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence
Canine coronavirus Ab [Presence] in Serum by Immunofluorescence
Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence
Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma
Canine distemper virus Ab [Presence] in Serum by Immunofluorescence
Canine distemper virus Ab [Titer] in Serum
Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence
Canine distemper virus IgG Ab [Titer] in Serum
Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence
Canine distemper virus IgM Ab [Titer] in Serum
Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence
Canine distemper virus Ag [Presence] in Conjunctival specimen
Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma
Canine herpesvirus neutralizing antibody [Presence] in Serum by Neutralization test
Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence
Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence
Canine parvovirus Ab [Presence] in Serum by Immunofluorescence
Canine parvovirus Ab [Presence] in Serum
Canine parvovirus IgG Ab [Titer] in Serum
Canine parvovirus IgM Ab [Titer] in Serum
Glutamine [Mass/volume] in Cerebral spinal fluid
Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence
Canine parvovirus Ag [Presence] in Stool by Immunofluorescence
Canine parvovirus DNA [Presence] in Stool by Probe
Caprine arthritis encephalitis virus Ag [Presence] in Specimen
Dirofilaria immitis Ag [Presence] in Serum by Immunoassay
Ethylene glycol [Presence] in Serum or Plasma
Feline coronavirus Ab [Presence] in Serum by Immunoassay
Feline coronavirus Ab [Presence] in Serum
Feline herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test
Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence
Glutamine [Mass/volume] in Serum or Plasma
Feline herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection
Feline herpesvirus neutralizing antibody [Titer] in Serum by Neutralization test
Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay
Feline immunodeficiency virus Ab [Presence] in Serum
Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence
Feline infectious peritonitis virus Ab [Presence] in Serum
Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence
Feline leukemia provirus [Presence] in Specimen
Feline leukemia virus Ab [Presence] in Serum by Immunoassay
Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence
Feline leukemia virus Ab [Presence] in Serum
Feline leukemia virus neutralizing antibody [Titer] in Serum by Neutralization test
Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence
Feline panleukopenia virus Ab [Titer] in Serum
Feline herpesvirus 1 Ab [Titer] in Serum
Feline syncytial virus Ab [Titer] in Serum
Francisella tularensis Ab [Titer] in Serum by Complement fixation
Genistein [Units/volume] in Serum or Plasma
Giardia lamblia Ag [Presence] in Specimen by Immunofluorescence
Leptospira sp Ag [Presence] in Urine by Immunofluorescence
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue
Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination
Neospora caninum Ab [Units/volume] in Serum by Immunoassay
Neospora caninum Ab [Titer] in Serum by Immunofluorescence
Neospora caninum Ag [Presence] in Tissue by Immune stain
Neospora caninum Ag [Presence] in Fixed tissue by Immune stain
Neutrophils/100 leukocytes in Blood by Manual count
Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma
Nitrate+Nitrite [Mass/volume] in Specimen
Pasteurella multocida serotype [Identifier] in Isolate
Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence
Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence
Porcine circovirus Ag [Presence] in Tissue by Immune stain
Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition
Porcine influenza virus A Ag [Presence] in Tissue by Immune stain
Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells
Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence
PRRSV Ab [Titer] in Serum by Immunofluorescence
Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence
Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence
Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence
Salmonella pullorum Ab [Titer] in Serum by Agglutination
Salmonella typhimurium Ab [Titer] in Serum by Agglutination
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence
Swine influenza virus Ag [Presence] in Tissue by Immune stain
Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation
Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination
Trypanosoma cruzi Ab [Presence] in Serum
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation
Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells
Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation
Vesicular stomatitis Indiana virus neutralizing antibody [Titer] in Serum by Neutralization test
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation
Vesicular stomatitis New Jersey virus neutralizing antibody [Titer] in Serum by Neutralization test
Western equine encephalitis virus Ab [Presence] in Specimen
Canine parvovirus Ag [Presence] in Stool by Immunoassay
Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk
Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk
Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk
Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells
5-Fluorocytosine [Mass/volume] in Specimen
Albumin [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis
Albumin [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis
Aldosterone free [Mass/time] in 24 hour Urine
Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma
Glutathione.oxidized [Mass/volume] in Red Blood Cells
Androstanediol [Mass/time] in 24 hour Urine
Other Antibiotic [Mass/volume] in Serum or Plasma
Antibody coated bacteria [Presence] in Urine by Immunofluorescence
Glutathione.reduced [Mass/volume] in Red Blood Cells
Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID)
Basophils/100 leukocytes in Specimen by Manual count
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Leukocytes
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum
Borrelia burgdorferi Ab index [Presence] in Serum and CSF
Carbon disulfide [Mass/volume] in Serum or Plasma
Glutathione [Mass/volume] in Red Blood Cells
Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe
Choriogonadotropin.beta subunit [Multiple of the median] adjusted in Serum or Plasma
Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID)
C3 nephritic factor [Units/volume] in Serum or Plasma
Coproporphyrin 1 [Mass/time] in 24 hour Stool
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum
Coproporphyrin 3 [Mass/time] in 24 hour Stool
Creosol [Mass/volume] in Serum or Plasma
Cyclohexanone [Mass/volume] in Serum or Plasma
Deuteroporphyrin [Mass/time] in unspecified time Stool
Dimethylformamide/Creatinine [Mass Ratio] in Urine
Echinococcus granulosus IgE Ab [Units/volume] in Serum
Epidermis Ab [Interpretation] in Tissue by Immunofluorescence
Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Erythrocytes [#/volume] in Specimen by Light microscopy
Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)
Erythrocytes [#/volume] in Body fluid by Automated count
Famotidine [Mass/volume] in Serum or Plasma
Flunitrazepam [Mass/volume] in Serum or Plasma
FLUoxetine+Norfluoxetine [Presence] in Urine
Hantavirus sin nombre IgG Ab [Titer] in Serum
Hantavirus sin nombre IgM Ab [Titer] in Serum
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe
Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot
Heptacarboxylporphyrin I [Mass/time] in unspecified time Stool
Heptacarboxylporphyrin III [Mass/time] in unspecified time Stool
Hexacarboxylporphyrin I [Mass/time] in unspecified time Stool
Hexacarboxylporphyrin III [Mass/time] in unspecified time Stool
HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification
Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence
Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence
Glycerol [Mass/volume] in Serum or Plasma
Immune complex [Units/volume] in Body fluid by C1q binding assay
Immune complex [Units/volume] in Body fluid by Raji cell assay
Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay
Immune complex [Units/volume] in Body fluid by Conglutinin assay
Inhibin A [Mass/volume] in Serum or Plasma
Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay
Isoheptacarboxylporphyrin [Mass/time] in unspecified time Stool
Isohexacarboxylporphyrin [Mass/time] in unspecified time Stool
Isopentacarboxylporphyrin [Mass/time] in unspecified time Stool
Isopropanol [Mass/volume] in Gastric fluid
Magnesium [Moles/volume] in 24 hour Stool
Glycine [Mass/volume] in Cerebral spinal fluid
Mesothelial cells [Presence] in Specimen by Light microscopy
Mesothelial cells [Presence] in Cerebral spinal fluid by Light microscopy
Microscopic observation [Identifier] in Body fluid by Wet preparation
Monocytes+Macrophages/100 leukocytes in Specimen by Manual count
Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count
Mycophenolate [Mass/volume] in Serum or Plasma
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum
Osmotic fragility of Red Blood Cells--0.0% sodium chloride
Glycine [Mass/volume] in Serum or Plasma
Osmotic fragility of Red Blood Cells--0.30% sodium chloride
Osmotic fragility of Red Blood Cells--0.35% sodium chloride
Osmotic fragility of Red Blood Cells--0.40% sodium chloride
Osmotic fragility of Red Blood Cells--0.45% sodium chloride
Osmotic fragility of Red Blood Cells--0.50% sodium chloride
Osmotic fragility of Red Blood Cells--0.55% sodium chloride
Osmotic fragility of Red Blood Cells--0.60% sodium chloride
Osmotic fragility of Red Blood Cells--0.60% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.65% sodium chloride
Osmotic fragility of Red Blood Cells--0.65% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.75% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.85% sodium chloride
Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum
Salmonella typhi O D Ab [Titer] in Serum by Agglutination
Salmonella typhi O D [Titer] in Serum by Immunofluorescence
Staphylococcus aureus enterotoxin B [Presence] in Specimen
Staphylococcus aureus enterotoxin B Ab [Presence] in Serum
Staphylococcus aureus toxic shock syndrome toxin 1 [Presence] in Specimen
Staphylococcus aureus toxic shock syndrome toxin 1 Ab [Presence] in Serum
Trans nonachlor [Mass/volume] in Serum or Plasma
Xylose [Mass/volume] in Blood --1 hour post 5 g xylose PO
Erythromycin+Sulfisoxazole [Susceptibility] by Serum bactericidal titer
Xylose [Mass/volume] in Blood --1 hour post dose xylose PO
Xylose [Mass/volume] in Blood --2 hours post 5 g xylose PO
Xylose [Mass/volume] in Blood --2 hours post dose xylose PO
Glycogen synthase [Enzymatic activity/volume] in Serum
Xylose [Moles/volume] in Blood --1 hour post 5 g xylose PO
Xylose [Moles/volume] in Blood --1 hour post dose xylose PO
Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Asialoganglioside GM1 IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay
Asialoganglioside GM1 IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Aspergillus sp Ab [Titer] in Cerebral spinal fluid
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid
Dengue virus IgG Ab [Units/volume] in Serum
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid
Burkholderia pseudomallei IgG Ab [Titer] in Serum
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid
Chlamydia sp Ab [Titer] in Cerebral spinal fluid
Dengue virus IgM Ab [Units/volume] in Serum
Echovirus 7 Ab [Titer] in Cerebral spinal fluid
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid
Epstein Barr virus early IgG Ab [Titer] in Serum
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid
Burkholderia pseudomallei IgM Ab [Titer] in Serum
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation
Borrelia burgdorferi Ag [Presence] in Specimen by Immunofluorescence
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Borrelia burgdorferi IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi IgG band pattern [Interpretation] in Body fluid by Immunoblot
Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot
Borrelia burgdorferi IgM band pattern [Interpretation] in Body fluid by Immunoblot
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Borrelia burgdorferi IgM band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence
Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation
Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay
Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay
Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Glycosaminoglycans [Mass/volume] in Urine
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Ganglioside GD1a IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1a IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay
Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)
Guanine deaminase [Enzymatic activity/volume] in Blood
Ganglioside GD1b IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
Ganglioside GQ1b IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay
Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain
Brucella sp identified in Bone marrow by Organism specific culture
Chlamydophila pneumoniae IgM Ab [Presence] in Serum
Chlamydia sp identified in Bronchial specimen by Organism specific culture
Eastern equine encephalitis virus IgG and IgM [Interpretation] in Serum
Epstein Barr virus early IgG Ab [Units/volume] in Serum
Echovirus 14 Ab [Titer] in Serum by Complement fixation
Fungus identified in Bronchial specimen by Culture
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid
Hepatitis C virus Ab band pattern [Interpretation] in Serum by Immunoblot
Herpes simplex virus 2 IgG Ab [Titer] in Serum
Influenza virus A+B Ag [Presence] in Specimen
La Crosse virus Ab [Interpretation] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid
Guanine deaminase [Enzymatic activity/volume] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Urine
Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)
Streptococcus agalactiae Ag [Presence] in Urine
Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma
Streptococcus pneumoniae Ag [Presence] in Urine
Toxocara canis IgA Ab [Presence] in Serum
Toxocara canis IgG Ab [Presence] in Serum
Toxocara canis IgM Ab [Presence] in Serum
14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot
Rifabutin [Mass/volume] in Serum or Plasma
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay
Borrelia sp Ag [Presence] in Specimen by Immunofluorescence
Cryoglobulin type [Identifier] in Serum by Electrophoresis
Taenia solium larva IgG band pattern [Interpretation] in Serum by Immunoblot
Taenia solium larva IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by Probe with signal amplification
Ehrlichia chaffeensis DNA [Presence] in Specimen by NAA with probe detection
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes
Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma
Alpha fucosidase [Enzymatic activity/mass] in Fibroblast
Alpha fucosidase [Enzymatic activity/mass] in Leukocytes
Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast
Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes
Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast
Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes
Alpha mannosidase [Enzymatic activity/mass] in Fibroblast
Alpha mannosidase [Enzymatic activity/mass] in Leukocytes
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes
Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast
Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes
Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast
Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes
Beta galactosidase [Enzymatic activity/mass] in Fibroblast
Beta galactosidase [Enzymatic activity/mass] in Leukocytes
Beta glucuronidase [Enzymatic activity/mass] in Fibroblast
Beta glucuronidase [Enzymatic activity/mass] in Leukocytes
Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma
Beta mannosidase [Enzymatic activity/mass] in Fibroblast
Beta mannosidase [Enzymatic activity/mass] in Leukocytes
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Fibroblast
Beta-N-acetylhexosaminidase.B/Beta-n-acetylhexosaminidase.total in Leukocytes
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast
Heptacarboxylporphyrin [Mass/volume] in Urine
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes
Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma
Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast
Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes
Cholesterol esterase [Enzymatic activity/mass] in Fibroblast
Cholesterol esterase [Enzymatic activity/mass] in Leukocytes
Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells
Galactosylceramidase [Enzymatic activity/mass] in Fibroblast
Galactosylceramidase [Enzymatic activity/mass] in Leukocytes
Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast
Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes
Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes
Hexokinase [Enzymatic activity/volume] in Plasma
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes
Sialidase [Enzymatic activity/mass] in Fibroblast
Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast
Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes
Corynebacterium toxin [Presence] in Specimen by Immune diffusion (ID)
Plasma cells [#/volume] in Blood by Manual count
Lymphoma cells/100 leukocytes in Blood by Manual count
Lymphoma cells [#/volume] in Blood by Manual count
Hairy cells/100 leukocytes in Blood by Manual count
Hairy cells [#/volume] in Blood by Manual count
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
Hexokinase [Enzymatic activity/volume] in Red Blood Cells
Progesterone [Moles/volume] in Saliva (oral fluid)
Treponema pallidum Ab [Presence] in Serum by Immunoassay
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay
Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Hexokinase 1/Hexokinase.total in Red Blood Cells
Ross River virus IgG Ab [Presence] in Serum by Immunoassay
Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Ross River virus IgM Ab [Presence] in Serum by Immunoassay
Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay
Leukocytes [#/volume] in Urine by Manual count
Epithelial cells [#/volume] in Urine by Manual count
Casts [Presence] in Urine sediment by Light microscopy
Hexokinase 3/Hexokinase.total in Red Blood Cells
Adenovirus type [Identifier] in Specimen by Neutralization test
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis secretory IgA Ab [Presence] in Specimen by Immunoassay
Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk
Hippuran renal clearance in 24 hour Urine and Serum or Plasma
Black Walnut IgG Ab [Units/volume] in Serum
White Hickory IgG Ab [Units/volume] in Serum
Johnson grass IgG Ab [Units/volume] in Serum
Cockroach IgG Ab [Units/volume] in Serum
White Ash IgG Ab [Units/volume] in Serum
Rough Marsh Elder IgG Ab [Units/volume] in Serum
Red mulberry IgG Ab [Units/volume] in Serum
Sheep Sorrel IgG Ab [Units/volume] in Serum
American Sycamore IgG Ab [Units/volume] in Serum
Western Water Hemp IgG Ab [Units/volume] in Serum
Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk
Kentucky blue grass IgG Ab [Units/volume] in Serum
Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk
Red Maple IgG Ab [Units/volume] in Serum
Giant Ragweed IgG Ab [Units/volume] in Serum
Kamut flour IgG Ab [Units/volume] in Serum
Goosefoot IgG Ab [Units/volume] in Serum
Maple syrup IgG Ab [Units/volume] in Serum
White+Black Pepper IgG Ab [Units/volume] in Serum
White+Black Pepper IgE Ab [Units/volume] in Serum
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk
Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum
Histamine [Mass/volume] in Serum or Plasma
Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen
Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen
Histidine [Mass/volume] in Serum or Plasma
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen
Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen
Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen
Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen
Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen
Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen
Mumps virus IgG Ab [Units/volume] in Serum --1st specimen
Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen
Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen
Polio virus 1 Ab [Titer] in Serum --1st specimen
Polio virus 1 Ab [Titer] in Serum --2nd specimen
Polio virus 2 Ab [Titer] in Serum --1st specimen
Polio virus 2 Ab [Titer] in Serum --2nd specimen
Polio virus 3 Ab [Titer] in Serum --1st specimen
Polio virus 3 Ab [Titer] in Serum --2nd specimen
Adenovirus Ab [Titer] in Serum --1st specimen
Adenovirus Ab [Titer] in Serum --2nd specimen
Coxsackievirus B1 Ab [Titer] in Serum --1st specimen
Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen
Coxsackievirus B2 Ab [Titer] in Serum --1st specimen
Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen
Histidine ammonia lyase [Enzymatic activity/volume] in Serum
Coxsackievirus B3 Ab [Titer] in Serum --1st specimen
Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen
Coxsackievirus B4 Ab [Titer] in Serum --1st specimen
Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen
Homocarnosine [Mass/volume] in Cerebral spinal fluid
Coxsackievirus B5 Ab [Titer] in Serum --1st specimen
Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen
Coxsackievirus B6 Ab [Titer] in Serum --1st specimen
Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen
Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen
Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen
Legionella pneumophila Ab [Titer] in Serum --1st specimen
Legionella pneumophila Ab [Titer] in Serum --2nd specimen
Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen
Ethambutol [Susceptibility] by Disk diffusion (KB)
Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen
Homocysteine [Mass/volume] in Serum or Plasma
Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen
Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen
La Crosse virus Ab [Titer] in Serum --1st specimen
La Crosse virus Ab [Titer] in Serum --2nd specimen
Western equine encephalitis virus Ab [Titer] in Serum --1st specimen
Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen
Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen
Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen
Influenza virus A Ab [Titer] in Serum --1st specimen
Influenza virus A Ab [Titer] in Serum --2nd specimen
Influenza virus B Ab [Titer] in Serum --1st specimen
Influenza virus B Ab [Titer] in Serum --2nd specimen
Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen
Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen
Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen
Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen
Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen
Respiratory syncytial virus Ab [Titer] in Serum --1st specimen
Homocystine [Presence] in Serum or Plasma
Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen
Coxsackievirus A10 Ab [Titer] in Serum --1st specimen
Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen
Coxsackievirus A16 Ab [Titer] in Serum --1st specimen
Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen
Coxsackievirus A7 Ab [Titer] in Serum --1st specimen
Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen
Coxsackievirus A9 Ab [Titer] in Serum --1st specimen
Homocystine [Mass/volume] in Serum or Plasma
Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen
Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen
Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen
Treponema pallidum Ab [Presence] in Serum by Agglutination
Cytomegalovirus IgG and IgM panel - Serum or Plasma
Epstein Barr virus capsid IgG and IgM panel - Serum
Basic metabolic 1998 panel - Serum or Plasma
Basic metabolic 2000 panel - Serum or Plasma
Comprehensive metabolic 1998 panel - Serum or Plasma
Comprehensive metabolic 2000 panel - Serum or Plasma
Hepatic function 1996 panel - Serum or Plasma
Hepatic function 2000 panel - Serum or Plasma
Electrolytes 1998 panel - Serum or Plasma
Alkaline phosphatase isoenz panel - Serum or Plasma
Amylase isoenzyme 3 panel - Serum or Plasma
Gas and Carbon monoxide panel - Arterial blood
Gas and Carbon monoxide panel - Capillary blood
Gas and Carbon monoxide panel - Venous blood
Parathyrin.intact and Calcium panel - Serum or Plasma
Parathyrin.mid molecule and Calcium panel - Serum or Plasma
Homovanillate [Mass/volume] in Cerebral spinal fluid
Protein electrophoresis panel - Serum or Plasma
Protein electrophoresis panel - Cerebral spinal fluid
Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma
Urinalysis macro (dipstick) panel - Urine
Ethambutol [Susceptibility] by Serum bactericidal titer
Renal function 2000 panel - Serum or Plasma
Homovanillate [Mass/time] in 24 hour Urine
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g glucose PO
Platelet associated Ab [Presence] in Blood
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay
Platelet aggregation ADP induced [Presence] in Platelet rich plasma
Platelet aggregation EPINEPHrine induced [Presence] in Platelet rich plasma
Platelet aggregation collagen induced [Presence] in Platelet rich plasma
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma
Platelet aggregation arachidonate induced [Presence] in Platelet rich plasma
Neutrophil associated Ab [Identifier] in Serum
Intrinsic factor Ab [Presence] in Serum by Immunoassay
little c Ab [Units/volume] in Serum or Plasma
Cardiolipin IgG Ab [Presence] in Serum by Immunoassay
Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
Brucella sp IgG Ab [Presence] in Serum by Immunoassay
Brucella sp IgM Ab [Presence] in Serum by Immunoassay
Cortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Cortisol [Moles/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight
Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight
Cortisol [Moles/volume] in Serum or Plasma --17 hours post 1 mg dexamethasone PO overnight
Cortisol [Moles/volume] in Serum or Plasma --24 hours post 1 mg dexamethasone PO overnight
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Specimen by Probe with amplification
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot
Aeromonas salmonicida [Presence] in Specimen
Hydroxocobalamin [Mass/volume] in Serum or Plasma
Aeromonas salmonicida serotype [Identifier] in Isolate
Androstenedione [Mass/volume] in Serum or Plasma --baseline
Babesia canis [Presence] in Blood by Giemsa stain
Brachyspira sp identified in Specimen by Organism specific culture
Brucella canis Ab [Presence] in Serum by Plate agglutination
Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition
Coccidia identified in Small intestine Tissue by Giemsa stain
Eperythrozoon sp [Presence] in Blood by Giemsa stain
Hydroxylysine [Presence] in Serum or Plasma
Estradiol (E2) [Mass/volume] in Serum or Plasma --baseline
Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence
Formononetin [Mass/volume] in Serum or Plasma
Haemobartonella felis [Presence] in Blood by Light microscopy
Hydroxylysine [Mass/volume] in Serum or Plasma
Hydrocarbons.chlorinated [Identifier] in Specimen
Mycobacterium avium ss paratuberculosis [Presence] in Specimen by Organism specific culture
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay
Streptococcus suis serotype [Identifier] in Isolate by Agglutination
IgA.canine [Mass/volume] in Serum by Immune diffusion (ID)
IgG.canine [Mass/volume] in Serum by Immune diffusion (ID)
IgM.canine [Mass/volume] in Serum by Immune diffusion (ID)
2-Methylbutyrylglycine/Creatinine [Molar ratio] in Urine
3-Methylcrotonylglycine/Creatinine [Molar ratio] in Urine
Butyrylglycine/Creatinine [Molar ratio] in Urine
Hexanoylglycine/Creatinine [Molar ratio] in Urine
Isobutyrylglycine/Creatinine [Molar ratio] in Urine
Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Isovalerylglycine/Creatinine [Molar ratio] in Urine
Phenylpropionylglycine/Creatinine [Molar ratio] in Urine
Propionylglycine/Creatinine [Molar ratio] in Urine
Suberylglycine/Creatinine [Molar ratio] in Urine
Tiglylglycine/Creatinine [Molar ratio] in Urine
Valerylglycine/Creatinine [Molar ratio] in Urine
Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum
Carnitine esters [Moles/volume] in Urine
Carnitine free (C0) [Moles/mass] in Tissue
Hydroxyproline [Presence] in Serum or Plasma
Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine
Interleukin 2 receptor [Mass/volume] in Serum or Plasma
Fatty acids [Moles/volume] in Serum or Plasma
Heptacarboxylporphyrin [Mass/time] in 24 hour Urine
Hydroxyproline [Mass/volume] in Serum or Plasma
Urea nitrogen [Mass/time] in 12 hour Urine
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
CD14+CD16+CD59+ cells [Presence] in Serum
Hemoglobin XXX/Hemoglobin.total in Blood by Electrophoresis
Hemoglobin A2+XXX/Hemoglobin.total in Blood by Electrophoresis
Hydroxyproline [Mass/time] in 24 hour Urine
Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood
Platelet function (closure time) collagen+ADP induced [Time] in Blood
Cancer associated serum Ag [Units/volume] in Serum
F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
F2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab RAST class [Presence] in Serum by Multidisk
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk
Hydroxyproline Free [Mass/volume] in Serum or Plasma
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk
Hydroxyproline Free [Mass/volume] in Urine
Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID)
Chicken serum Ab [Presence] in Serum by Immune diffusion (ID)
Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID)
Parrot serum Ab [Presence] in Serum by Immune diffusion (ID)
Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID)
Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID)
Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID)
Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID)
Hydroxyproline Free [Mass/time] in 24 hour Urine
Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID)
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab RAST class [Presence] in Serum by Multidisk
Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID)
Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Western wheatgrass IgE Ab [Units/volume] in Serum
Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk
Calcium/Creatinine [Molar ratio] in Urine
Phosphate [Moles/volume] in Red Blood Cells
Hypoxanthine [Mass/volume] in Body fluid
EPINEPHrine/Creatinine [Molar ratio] in Urine
Norepinephrine/Creatinine [Molar ratio] in Urine
DOPamine/Creatinine [Molar ratio] in Urine
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue
IgA [Mass/volume] in Cerebral spinal fluid
IgG [Mass/volume] in Cerebral spinal fluid
Floxacillin [Susceptibility] by Disk diffusion (KB)
IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
IgM [Mass/volume] in Cerebral spinal fluid
Floxacillin [Susceptibility] by Serum bactericidal titer
Inhibin [Mass/volume] in Serum or Plasma
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma
Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)
Insulin-like growth factor-II [Mass/volume] in Serum or Plasma
Inter alpha trypsin inhibitor [Mass/volume] in Serum
Intrinsic factor blocking Ab [Titer] in Serum
Inulin renal clearance in 24 hour Urine and Serum or Plasma
Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Iodohippuran renal clearance in 24 hour Urine and Serum or Plasma
Iron binding capacity [Mass/volume] in Serum or Plasma
Fluconazole [Susceptibility] by Disk diffusion (KB)
Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma
Iron saturation [Mass Fraction] in Serum or Plasma
Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
Isoleucine [Presence] in Serum or Plasma
Isoleucine [Mass/volume] in Serum or Plasma
2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in Urine
2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine
2-Oxoisocaproate/Creatinine [Molar ratio] in Urine
2-Oxoisovalerate/Creatinine [Molar ratio] in Urine
Beta aminoisobutyrate/Creatinine [Molar ratio] in Urine
3-Methylglutaconate/Creatinine [Molar ratio] in Urine
4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine
4-Hydroxyphenyllactate/Creatinine [Molar ratio] in Urine
Benzoate/Creatinine [Molar ratio] in Urine
C peptide/Creatinine [Molar ratio] in Urine
Cystathionine/Creatinine [Molar ratio] in Urine
Decadienediate/Creatinine [Molar ratio] in Urine
Decenedioate/Creatinine [Molar ratio] in Urine
Deoxypyridinoline/Creatinine [Molar ratio] in Urine
Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine
Dodecanedioate/Creatinine [Molar ratio] in Urine
Ethanolamine/Creatinine [Molar ratio] in Urine
Ethylmalonate/Creatinine [Molar ratio] in Urine
Formate/Creatinine [Molar ratio] in Urine
Fumarate/Creatinine [Molar ratio] in Urine
Galactose/Creatinine [Molar ratio] in Urine
Glutaconate/Creatinine [Molar ratio] in Urine
Glutarate/Creatinine [Molar ratio] in Urine
Glycerate/Creatinine [Molar ratio] in Urine
Glycolate/Creatinine [Molar ratio] in Urine
Glyoxylate/Creatinine [Molar ratio] in Urine
Hydroxydecanedioate/Creatinine [Molar ratio] in Urine
Hydroxylysine/Creatinine [Molar ratio] in Urine
Hydroxyproline/Creatinine [Molar ratio] in Urine
Isocitrate/Creatinine [Molar ratio] in Urine
Lactate/Creatinine [Molar ratio] in Urine
Malate/Creatinine [Molar ratio] in Urine
2-Methylcitrate/Creatinine [Molar ratio] in Urine
Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine
Methylmalonate/Creatinine [Molar ratio] in Urine
Methylsuccinate/Creatinine [Molar ratio] in Urine
Mevalonate/Creatinine [Molar ratio] in Urine
N-acetyltyrosine/Creatinine [Molar ratio] in Urine
Octanoate (C8:0)/Creatinine [Molar ratio] in Urine
Octenedioate (C8:1)/Creatinine [Molar ratio] in Urine
Phosphoethanolamine/Creatinine [Molar ratio] in Urine
Para nitrophenol/Creatinine [Molar ratio] in Urine
Phenylacetate/Creatinine [Molar ratio] in Urine
Phenyllactate/Creatinine [Molar ratio] in Urine
Phenylpyruvate/Creatinine [Molar ratio] in Urine
Phosphate/Creatinine [Molar ratio] in 24 hour Urine
Phosphoserine/Creatinine [Molar ratio] in Urine
Pyridinoline/Creatinine [Molar ratio] in Urine
Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine
Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine
Pyruvate/Creatinine [Molar ratio] in Urine
Sarcosine/Creatinine [Molar ratio] in Urine
Sebacate (C8)/Creatinine [Molar ratio] in Urine
Suberate/Creatinine [Molar ratio] in Urine
Succinate/Creatinine [Molar ratio] in Urine
Succinylacetone/Creatinine [Molar ratio] in Urine
Taurine/Creatinine [Molar ratio] in Urine
Tryptophan/Creatinine [Molar ratio] in Urine
Uracil/Creatinine [Molar ratio] in Urine
Carnitine esters/Creatinine [Molar ratio] in Urine
5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak
5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough
Ammonium urate crystals [#/area] in Urine sediment by Microscopy high power field
Bacteria [Presence] in Urine sediment by Light microscopy
Bilirubin crystals [#/area] in Urine sediment by Microscopy high power field
Calcium carbonate crystals [#/area] in Urine sediment by Microscopy high power field
Ketones [Presence] in Urine by Test strip
Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field
Calcium phosphate crystals [#/area] in Urine sediment by Microscopy high power field
Calcium sulfate crystals [#/area] in Urine sediment by Microscopy high power field
Cholesterol crystals [#/area] in Urine sediment by Microscopy high power field
Unidentified crystals [#/area] in Urine sediment by Microscopy high power field
Cystine crystals [#/area] in Urine sediment by Microscopy high power field
Eosinophils [Presence] in Urine sediment by Light microscopy
Epithelial casts [Presence] in Urine sediment by Light microscopy
Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy
Fatty casts [Presence] in Urine sediment by Light microscopy
Granular casts [Presence] in Urine sediment by Light microscopy
Hippurate crystals [#/area] in Urine sediment by Microscopy high power field
Hyaline casts [Presence] in Urine sediment by Light microscopy
L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid
Leucine crystals [#/area] in Urine sediment by Microscopy high power field
Perhexiline [Mass/volume] in Serum or Plasma
L-iditol dehydrogenase [Enzymatic activity/volume] in Serum
Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Lactate [Moles/volume] in Arterial blood
Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Fluconazole [Susceptibility] by Serum bactericidal titer
Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Lactate [Moles/volume] in Cerebral spinal fluid
Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
cefOXitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
sulfiSOXAZOLE 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Lactate [Moles/volume] in Peritoneal fluid
Cefuroxime Parenteral [Mass/volume] in Specimen
Lactate [Moles/volume] in Serum or Plasma
Chloramphenicol [Mass/volume] in Specimen
Clarithromycin [Mass/volume] in Specimen
Lactate [Moles/volume] in Synovial fluid
Oxytetracycline [Mass/volume] in Specimen
5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)
Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid
Sulfamethoxazole [Mass/volume] in Specimen
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen
Rubella virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Measles virus IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Toxoplasma gondii IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Alanine aminotransferase [Enzymatic activity/volume] in Body fluid
Alpha 1 antitrypsin [Mass/mass] in Stool
Alpha aminoadipate [Moles/time] in 24 hour Urine
Alpha aminobutyrate [Moles/time] in 24 hour Urine
Amobarbital [Moles/volume] in Serum or Plasma
Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria
Amylase [Enzymatic activity/volume] in 24 hour Urine
Amylase.pancreatic/Amylase.total in Serum or Plasma
Amylase.salivary/Amylase.total in Serum or Plasma
Androstenediol [Moles/time] in 24 hour Urine
11-Deoxycortisol [Moles/time] in 24 hour Urine
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma
17-Ketosteroids [Moles/volume] in 24 hour Urine
1-Methylhistidine [Moles/time] in 24 hour Urine
3-Methylhistidine [Moles/time] in 24 hour Urine
Antimony [Moles/volume] in Serum or Plasma
Arsenic [Moles/volume] in Serum or Plasma
Arsenic/Creatinine [Molar ratio] in Urine
Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay
Asparagine [Moles/time] in 24 hour Urine
Bordetella pertussis IgG Ab [Titer] in Serum
Bordetella pertussis IgM Ab [Titer] in Serum
Coxiella burnetii IgG Ab [Titer] in Serum
Coxiella burnetii IgM Ab [Titer] in Serum
Taenia solium larva IgG Ab [Units/volume] in Serum
Fasciola sp IgG Ab [Units/volume] in Serum
Lactate dehydrogenase [Enzymatic activity/volume] in Urine
Beta alanine [Moles/time] in 24 hour Urine
Beta aminoisobutyrate [Moles/time] in 24 hour Urine
Silver Birch IgG Ab [Units/volume] in Serum
5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)
Bismuth [Moles/volume] in Serum or Plasma
Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence
Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation
Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence
Wheat Bran IgG Ab [Units/volume] in Serum
Butabarbital [Moles/volume] in Serum or Plasma
Cadmium [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
Caffeine [Moles/volume] in Serum or Plasma
Campylobacter fetus Ab [Titer] in Serum by Complement fixation
Campylobacter jejuni Ab [Titer] in Serum by Complement fixation
cefOXitin [Susceptibility] by Method for Slow-growing mycobacteria
cefTRIAXone [Susceptibility] by Method for Slow-growing mycobacteria
Chlamydia sp IgA Ab [Units/volume] in Serum
Cholesterol in VLDL [Moles/volume] in Serum or Plasma
Choriogonadotropin [Units/volume] in Urine
Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
Chromium [Moles/volume] in Serum or Plasma
Chymotrypsin [Enzymatic activity/mass] in Stool
Citrulline [Moles/time] in 24 hour Urine
Recalcification time in Control Platelet poor plasma by Coagulation assay
Cobalt [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 1 [Enzymatic activity/volume] in Serum or Plasma
Corticosterone [Moles/volume] in Serum or Plasma
Cortisone [Moles/volume] in Serum or Plasma
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation
Cyanide [Moles/volume] in Serum or Plasma
Cystathionine [Moles/time] in 24 hour Urine
Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay
Cytokeratin 19 [Mass/volume] in Serum or Plasma
Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine
Dengue virus IgM Ab [Presence] in Serum by Immunoblot
Desethylamiodarone [Moles/volume] in Serum or Plasma
Nortrimipramine [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
Echinococcus sp Ab [Presence] in Serum by Immunoassay
Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE)
Endomysium Ab [Titer] in Serum by Immunofluorescence
Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence
Estradiol (E2) [Moles/time] in 24 hour Urine
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma
Ethambutol [Presence] in Serum or Plasma
Ethanolamine [Moles/time] in 24 hour Urine
Fasciola sp Ab [Titer] in Serum by Immunofluorescence
Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay
Filaria Ab [Titer] in Serum by Immunofluorescence
Filaria IgG Ab [Units/volume] in Serum by Immunoassay
Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation
Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Flunitrazepam [Moles/volume] in Serum or Plasma
Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence
Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence
Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay
Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay
Rubella virus IgM Ab [Presence] in Serum by Latex agglutination
Measles virus IgM Ab [Units/volume] in Serum by Immunoassay
Schistosoma sp Ab [Titer] in Serum by Immunofluorescence
Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay
Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence
Gabapentin [Moles/volume] in Serum or Plasma
Galactose [Moles/volume] in Serum or Plasma
Gamma aminobutyrate [Moles/time] in 24 hour Urine
Glucose [Presence] in Urine by Test strip
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB)
Haemophilus influenzae Ab [Mass/volume] in Serum
Free Hemoglobin [Moles/volume] in Plasma
Heptacarboxylporphyrin [Moles/time] in 24 hour Urine
Herpes simplex virus IgM Ab [Presence] in Serum
Lactate dehydrogenase 3 [Enzymatic activity/volume] in Serum or Plasma
Hexacarboxylporphyrin [Moles/time] in 24 hour Urine
Homocystine [Moles/time] in 24 hour Urine
Hydroxylysine [Moles/time] in 24 hour Urine
IgA [Presence] in Urine by Immunoelectrophoresis
Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation
IgG [Presence] in Urine by Immunoelectrophoresis
IgM [Presence] in Urine by Immunoelectrophoresis
Insulin Free [Moles/volume] in Serum or Plasma
Iodine [Moles/volume] in Serum or Plasma
Isoleucine [Moles/time] in 24 hour Urine
Isoniazid [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Lactalbumin alpha IgA Ab [Units/volume] in Serum
Lactoglobulin IgA Ab [Units/volume] in Serum
lamoTRIgine [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 4 [Enzymatic activity/volume] in Serum or Plasma
Lithium [Moles/volume] in Red Blood Cells
Manganese [Moles/volume] in Serum or Plasma
Mephenytoin [Moles/volume] in Serum or Plasma
Meprobamate [Moles/volume] in Serum or Plasma
Mercury [Moles/volume] in Saliva (oral fluid)
Mesoridazine [Moles/volume] in Serum or Plasma
Metanephrine [Moles/volume] in Serum or Plasma
Metanephrines [Moles/volume] in Serum or Plasma
Methaqualone [Moles/volume] in Serum or Plasma
Methionine [Moles/time] in 24 hour Urine
Methionine sulfoxide [Moles/time] in 24 hour Urine
Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma by Chemical separation
Methyprylon [Moles/volume] in Serum or Plasma
Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum
Molybdenum [Moles/volume] in Serum or Plasma
Nefazodone [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
Nickel [Moles/volume] in Serum or Plasma
Nicotinamide [Moles/volume] in Serum or Plasma
Normetanephrine [Moles/volume] in Serum or Plasma
Oxipurinol [Moles/volume] in Serum or Plasma
Lactate dehydrogenase 5 [Enzymatic activity/volume] in Serum or Plasma
Pentacarboxylporphyrins [Moles/time] in 24 hour Urine
Phenylalanine [Moles/time] in 24 hour Urine
Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma
Adrenal cortex Ab [Titer] in Serum by Immunofluorescence
5-Fluorocytosine [Susceptibility] by Serum bactericidal titer
Phenylbutazone [Moles/volume] in Serum or Plasma
Phosphoethanolamine [Moles/volume] in Urine
Phosphoserine [Moles/time] in 24 hour Urine
Pregnenolone [Moles/volume] in Serum or Plasma
Progesterone [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Propafenone [Moles/volume] in Serum or Plasma
Protoporphyrin [Moles/time] in 24 hour Stool
Renin [Enzymatic activity/volume] in Plasma --1st specimen post XXX challenge
Rubella virus IgG Ab [Presence] in Serum
Secobarbital [Moles/volume] in Serum or Plasma
Selenium [Moles/volume] in Serum or Plasma
Silicon [Moles/volume] in Serum or Plasma
Silver [Moles/volume] in Serum or Plasma
Lactose [Mass/volume] in Serum or Plasma
Insulin-like growth factor [Moles/volume] in Serum or Plasma
Streptococcus pneumoniae Ab [Mass/volume] in Serum
Teicoplanin [Moles/volume] in Serum or Plasma --peak
Teicoplanin [Moles/volume] in Serum or Plasma --trough
Thallium [Moles/volume] in Serum or Plasma
Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum
Topiramate [Moles/volume] in Serum or Plasma
Toxoplasma gondii IgM Ab [Presence] in Serum
Lipase [Enzymatic activity/time] in 24 hour Urine
Tryptophan [Moles/time] in 24 hour Urine
Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma
Uroporphyrin [Moles/time] in 24 hour Stool
Wuchereria bancrofti Ag [Presence] in Serum
Zolpidem [Moles/volume] in Serum or Plasma
Allobarbital [Moles/volume] in Serum or Plasma
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma
Angiotensin II [Moles/volume] in Plasma --supine
Angiotensin II [Moles/volume] in Plasma --upright
Bilirubin.direct [Moles/volume] in Body fluid
Bougainvillea IgE Ab [Units/volume] in Serum
C peptide [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Lecithin phosphorus [Mass/volume] in Amniotic fluid
C peptide [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid
C peptide [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Calcium [Moles/volume] in Red Blood Cells
Calcium [Moles/volume] in Urine --5 hours post 500 mg calcium PO
Chromogranin A [Moles/volume] in Serum or Plasma
Citalopram [Moles/volume] in Serum or Plasma
Cladosporium cladosporioides IgG Ab [Units/volume] in Serum
Rotavirus IgG Ab [Units/volume] in Serum
Rotavirus IgM Ab [Units/volume] in Serum
Leucine [Mass/volume] in Serum or Plasma
Rickettsia prowazekii IgG Ab [Titer] in Serum
Rickettsia prowazekii IgM Ab [Titer] in Serum
Cochineal extract IgE Ab [Units/volume] in Serum
Oriental Cockroach IgE Ab [Units/volume] in Serum
Smoky Brown Cockroach IgE Ab [Units/volume] in Serum
Conalbumin IgE Ab [Units/volume] in Serum
Cortisol [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h
Cortisol [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Leukocyte esterase [Enzymatic activity/volume] in Leukocytes
Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Eosinophil cationic protein (ECP) [Mass/volume] in Serum
Follitropin [Units/volume] in Urine by 2nd IRP
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug luteinizing releasing hormone IV
Follitropin [Units/volume] in Serum or Plasma --1 hour post 100 ug luteinizing releasing hormone IV
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --1st specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --2nd specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug luteinizing releasing hormone IV
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --3rd specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --4th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --5th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --6th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --7th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --8th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP --9th specimen post XXX challenge
Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Gastrin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucose
Glucose [Mass/volume] in Urine --1 hour post dose glucose
Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose
Glucose [Mass/volume] in Urine --2 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose
Glucose [Mass/volume] in Urine --30 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Glucose [Mass/volume] in Urine --4 hours post dose glucose
Phospholipid phosphorus [Mass/volume] in Serum
Glucose [Moles/volume] in Serum or Plasma --5.5 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --6 hours post dose glucose
Glucose [Mass/volume] in Urine --1.5 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre 50 g glucose PO
Kappa light chains [Presence] in Serum by Immunoelectrophoresis
Kappa light chains [Mass/time] in 24 hour Urine
Lambda light chains [Presence] in Serum by Immunoelectrophoresis
Phospholipid [Mass/volume] in Serum or Plasma
Lambda light chains [Mass/time] in 24 hour Urine
Insulin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --15th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Amphotericin B [Susceptibility] by Disk diffusion (KB)
Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)
Ketones [Presence] in Urine --1 hour post 50 g glucose PO
Ketones [Mass/volume] in Urine by Test strip --2 hours post dose glucose
Ketones [Mass/volume] in Urine by Test strip --4 hours post dose glucose
Leishmania donovani Ab [Titer] in Serum by Immunofluorescence
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation
Lutropin [Units/volume] in Urine by 1st IRP
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post 100 ug luteinizing releasing hormone IV
Triglyceride [Mass/volume] in Serum or Plasma
Lutropin [Units/volume] in Serum or Plasma --1 hour post 100 ug luteinizing releasing hormone IV
Lutropin [Units/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV
Lutropin [Units/volume] in Serum or Plasma --30 minutes post 100 ug luteinizing releasing hormone IV
Mianserin [Moles/volume] in Serum or Plasma
Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)
Ovary Ab [Titer] in Serum by Immunofluorescence
Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma
OXcarbazepine [Moles/volume] in Serum or Plasma
Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence
Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence
Plasmodium sp Ab [Titer] in Serum by Immunofluorescence
Pregnanetriolone [Moles/time] in 24 hour Urine
Procollagen type III [Units/volume] in Serum
Lipoprotein.alpha [Mass/volume] in Serum or Plasma
Prolactin [Mass/volume] in Serum or Plasma --10 minutes post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --1 hour post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --2 hours post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post 200 ug TRH IV
Prolactin [Mass/volume] in Serum or Plasma --50 minutes post 200 ug TRH IV
Lipoprotein.beta [Mass/volume] in Serum or Plasma
Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma
Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination
Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination
Ribosomal Ab [Presence] in Serum by Immunoassay
Ribosomal Ab [Titer] in Serum by Immunofluorescence
Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence
Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence
Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence
Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence
Rotavirus IgG Ab [Presence] in Serum by Immunoassay
Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay
Rotavirus IgM Ab [Presence] in Serum by Immunoassay
Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay
Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay
Insulin-like growth factor [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Lipoprotein.pre-beta [Mass/volume] in Serum or Plasma
Insulin-like growth factor [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge
Framycetin [Susceptibility] by Minimum lethal concentration (MLC)
Insulin-like growth factor [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --13th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --14th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Lipoproteins [Mass/volume] in Serum or Plasma
Insulin-like growth factor [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin-like growth factor [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Stachybotrys chartarum IgG Ab [Units/volume] in Serum
Streptolysin O Ab [Units/volume] in Serum by Latex agglutination
Thyrotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Thyroxine (T4) free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Tissue polypeptide specific Ag [Units/volume] in Urine
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria
Trichophyton mentagrophytes var interdigitale IgE Ab [Units/volume] in Serum
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma
Trypanosoma cruzi Ab [Titer] in Serum by Immunofluorescence
Vigabatrin [Moles/volume] in Serum or Plasma
Gonadotropin releasing hormone [Moles/volume] in Serum or Plasma
Xylose [Moles/volume] in Serum or Plasma --1.5 hours post dose xylose PO
Xylose [Moles/volume] in Serum or Plasma --1 hour post dose xylose PO
Xylose [Moles/volume] in Serum or Plasma --baseline
Staphylococcus aureus enterotoxin A IgE Ab [Units/volume] in Serum
Staphylococcus aureus enterotoxin B IgE Ab [Units/volume] in Serum
Staphylococcus aureus enterotoxin C IgE Ab [Units/volume] in Serum
Staphylococcus aureus enterotoxin D IgE Ab [Units/volume] in Serum
Palo verde IgE Ab [Units/volume] in Serum
Glucosylceramidase [Enzymatic activity/mass] in Fibroblast
Beta glucosidase activator [Interpretation] in Fibroblast
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Fibroblast
Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast
Cerebroside sulfatase activator [Interpretation] in Fibroblast
Cancer associated retinopathy Ab [Presence] in Serum by Immunoblot
HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection
HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes simplex virus 1 Ab [Titer] in Serum by Immunofluorescence
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 Ab [Titer] in Serum by Immunofluorescence
Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection
HIV 2 proviral DNA [Presence] in Specimen by NAA with probe detection
Alanine/Creatinine [Molar ratio] in 24 hour Urine
Aldosterone [Moles/volume] in 24 hour Urine
Alpha aminoadipate [Moles/volume] in 24 hour Urine
Alpha aminoadipate/Creatinine [Molar ratio] in 24 hour Urine
Alpha aminobutyrate [Moles/volume] in 24 hour Urine
Alpha aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine
Ammonia/Creatinine [Molar ratio] in 24 hour Urine
17-Hydroxycorticosteroids [Moles/volume] in 24 hour Urine
1-Methylhistidine [Moles/volume] in 24 hour Urine
1-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine
3-Alpha-Androstanediol glucuronide [Moles/time] in 24 hour Urine
3-Methylhistidine [Moles/volume] in 24 hour Urine
3-Methylhistidine/Creatinine [Molar ratio] in 24 hour Urine
Anserine [Moles/volume] in 24 hour Urine
Anserine/Creatinine [Molar ratio] in 24 hour Urine
Arginine [Moles/volume] in 24 hour Urine
Arginine/Creatinine [Molar ratio] in 24 hour Urine
Asparagine [Moles/volume] in 24 hour Urine
Asparagine/Creatinine [Molar ratio] in 24 hour Urine
Aspartate [Moles/volume] in 24 hour Urine
Aspartate/Creatinine [Molar ratio] in 24 hour Urine
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum
Beta alanine [Moles/volume] in 24 hour Urine
Beta alanine/Creatinine [Molar ratio] in 24 hour Urine
Beta aminoisobutyrate [Moles/volume] in 24 hour Urine
Beta aminoisobutyrate/Creatinine [Molar ratio] in 24 hour Urine
C peptide [Moles/volume] in 24 hour Urine
Calcium [Moles/volume] in Urine --pre 500 mg calcium PO
Carnosine [Moles/volume] in 24 hour Urine
Carnosine/Creatinine [Molar ratio] in 24 hour Urine
Citrulline [Moles/volume] in 24 hour Urine
Citrulline/Creatinine [Molar ratio] in 24 hour Urine
Copper/Creatinine [Molar ratio] in Urine
Coproporphyrin [Moles/volume] in 24 hour Urine
Lysolecithin acyltransferase [Enzymatic activity/volume] in Red Blood Cells
Cortisol Free [Moles/volume] in 24 hour Urine by Radioimmunoassay (RIA)
Cortisol Free [Moles/volume] in 24 hour Urine by HPLC
Cortisol Free [Moles/time] in 24 hour Urine by Radioimmunoassay (RIA)
Cortisol Free [Moles/time] in 24 hour Urine by HPLC
Creatinine [Moles/volume] in 24 hour Urine
Cystathionine [Moles/volume] in 24 hour Urine
Cystathionine/Creatinine [Molar ratio] in 24 hour Urine
Cysteate [Moles/volume] in 24 hour Urine
Lysozyme [Mass/volume] in Serum or Plasma
Cysteate/Creatinine [Molar ratio] in 24 hour Urine
Cysteine [Moles/volume] in 24 hour Urine
Cysteine/Creatinine [Molar ratio] in 24 hour Urine
Cystine/Creatinine [Molar ratio] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Moles/volume] in 24 hour Urine
Delta aminolevulinate [Moles/volume] in 24 hour Urine
Delta aminolevulinate/Creatinine [Molar ratio] in 24 hour Urine
Deoxypyridinoline [Moles/volume] in 24 hour Urine
D-Lactate [Moles/volume] in Serum or Plasma --1st specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --2nd specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --3rd specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --4th specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --5th specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --6th specimen post excercise
D-Lactate [Moles/volume] in Serum or Plasma --Pre excercise
DOPamine [Moles/volume] in 24 hour Urine
Elastase.pancreatic [Mass/mass] in Stool
EPINEPHrine [Moles/volume] in 24 hour Urine
EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine
Ethanolamine [Moles/volume] in 24 hour Urine
Ethanolamine/Creatinine [Molar ratio] in 24 hour Urine
Fluoride [Moles/volume] in 24 hour Urine
Fluoride/Creatinine [Molar ratio] in 24 hour Urine
Gamma aminobutyrate [Moles/volume] in 24 hour Urine
Gamma aminobutyrate/Creatinine [Molar ratio] in 24 hour Urine
Macroamylase [Enzymatic activity/volume] in Serum or Plasma
Glutamate [Moles/volume] in 24 hour Urine
Glutamate/Creatinine [Molar ratio] in 24 hour Urine
Glutamine [Moles/volume] in 24 hour Urine
Framycetin [Susceptibility] by Disk diffusion (KB)
Glutamine/Creatinine [Molar ratio] in 24 hour Urine
Glycine/Creatinine [Molar ratio] in 24 hour Urine
Heptacarboxylporphyrin [Moles/volume] in 24 hour Urine
Macroglobulin [Mass/volume] in Serum or Plasma
Hexacarboxylporphyrin [Moles/volume] in 24 hour Urine
Histamine/Creatinine [Molar ratio] in 24 hour Urine
Histidine [Moles/volume] in 24 hour Urine
Histidine/Creatinine [Molar ratio] in 24 hour Urine
Homocystine [Moles/volume] in 24 hour Urine
Homocystine/Creatinine [Molar ratio] in 24 hour Urine
Homovanillate [Moles/volume] in 24 hour Urine
Homovanillate/Creatinine [Molar ratio] in 24 hour Urine
Hydroxylysine [Moles/volume] in 24 hour Urine
Hydroxylysine/Creatinine [Molar ratio] in 24 hour Urine
Hydroxyproline [Moles/volume] in 24 hour Urine
Isoleucine [Moles/volume] in 24 hour Urine
Isoleucine/Creatinine [Molar ratio] in 24 hour Urine
Magnesium [Moles/volume] in Cerebral spinal fluid
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Complement fixation
Leucine/Creatinine [Molar ratio] in 24 hour Urine
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --1st specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --2nd specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --3rd specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --4th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --5th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --6th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --7th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --8th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma by 1st IRP --9th specimen post XXX challenge
Lysine/Creatinine [Molar ratio] in 24 hour Urine
Magnesium [Moles/volume] in 24 hour Urine
Metanephrine [Moles/volume] in 24 hour Urine
Methionine [Moles/volume] in 24 hour Urine
Magnesium [Moles/volume] in Dialysis fluid
Methionine sulfoxide [Moles/volume] in 24 hour Urine
Methionine sulfoxide/Creatinine [Molar ratio] in 24 hour Urine
Methionine/Creatinine [Molar ratio] in 24 hour Urine
Nickel/Creatinine [Molar ratio] in 24 hour Urine
Norepinephrine [Moles/volume] in 24 hour Urine
Normetanephrine [Moles/volume] in 24 hour Urine
Ornithine [Moles/volume] in 24 hour Urine
Ornithine/Creatinine [Molar ratio] in 24 hour Urine
Pentacarboxylporphyrins [Moles/volume] in 24 hour Urine
Phenylalanine [Moles/volume] in 24 hour Urine
Phenylalanine/Creatinine [Molar ratio] in 24 hour Urine
5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
Adenosine monophosphate.cyclic/Creatinine [Molar ratio] in 24 hour Urine
Magnesium [Moles/volume] in Red Blood Cells
Phosphate [Moles/volume] in 24 hour Urine
Phosphoserine/Creatinine [Molar ratio] in 24 hour Urine
Proline/Creatinine [Molar ratio] in 24 hour Urine
Pyridinoline [Moles/volume] in 24 hour Urine
Sarcosine/Creatinine [Molar ratio] in 24 hour Urine
Serine/Creatinine [Molar ratio] in 24 hour Urine
Serotonin [Moles/volume] in 24 hour Urine
Taurine/Creatinine [Molar ratio] in 24 hour Urine
Testosterone [Moles/volume] in 24 hour Urine
Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA)
Threonine [Moles/volume] in 24 hour Urine
Threonine/Creatinine [Molar ratio] in 24 hour Urine
Lipase [Enzymatic activity/volume] in 24 hour Urine
Trichinella spiralis Ab [Titer] in Serum by Immunofluorescence
Tryptophan/Creatinine [Molar ratio] in 24 hour Urine
Tyrosine [Moles/volume] in 24 hour Urine
Tyrosine/Creatinine [Molar ratio] in 24 hour Urine
Urea/Creatinine [Molar ratio] in 24 hour Urine
Almecillin [Susceptibility] by Minimum lethal concentration (MLC)
Framycetin [Susceptibility] by Serum bactericidal titer
Uroporphyrin [Moles/volume] in 24 hour Urine
Valine/Creatinine [Molar ratio] in 24 hour Urine
Vanillylmandelate [Moles/volume] in 24 hour Urine
Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine
Magnesium Ionized [Moles/volume] in Serum or Plasma
Xylose [Moles/volume] in Serum or Plasma --2 hours post dose xylose PO
Borrelia burgdorferi Ab [Presence] in Serum by Hemagglutination
Echinococcus sp Ab [Presence] in Serum by Hemagglutination
Echinococcus sp Ab [Titer] in Serum by Hemagglutination
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
Alkaline phosphatase.other fractions/Alkaline phosphatase.total in Serum or Plasma
Macroamylase/Amylase.total in Serum or Plasma
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --1 day post XXX challenge
Magnesium [Moles/volume] in Serum or Plasma
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --2 days post XXX challenge
Arbovirus NOS Ab [Titer] in Serum by Complement fixation
Cholesterol in HDL 2 [Moles/volume] in Serum or Plasma
Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma ultracentrifugate
Cholesterol in HDL 3 [Moles/volume] in Serum or Plasma
Creatine Kinase.macromolecular type 1/Creatine kinase.total in Serum or Plasma
Creatine Kinase.macromolecular type 2/Creatine kinase.total in Serum or Plasma
Malate dehydrogenase [Enzymatic activity/volume] in Serum
Nordiazepam [Moles/volume] in Serum or Plasma
Enterovirus NOS Ab [Titer] in Serum by Complement fixation
Extractable nuclear Ab identified in Serum
Gastrin [Moles/volume] in Serum or Plasma --post meal
Histiocytes [#/area] in Urine sediment by Microscopy high power field
HLA-B27 [Presence] by Flow cytometry (FC)
Lactoferrin bovine IgE Ab [Units/volume] in Serum
Sialate.lipid bound [Moles/volume] in Serum or Plasma
Trichophyton mentagrophytes var goetzii IgE Ab [Units/volume] in Serum
Norflunitrazepam [Moles/volume] in Serum or Plasma
Norcitalopram [Moles/volume] in Serum or Plasma
Normephenytoin [Moles/volume] in Serum or Plasma
Didesmethylcitalopram [Moles/volume] in Serum or Plasma
HLA-B27 [Presence] by NAA with probe detection
Pheneturide [Moles/volume] in Serum or Plasma
5-Hydroxypropafenone [Moles/volume] in Serum or Plasma
Mannitol renal clearance in 24 hour Urine and Serum or Plasma
Phytate [Moles/volume] in Serum or Plasma
Epithelial cells.extrarenal [#/area] in Urine sediment by Microscopy high power field
Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field
N-methylhistamine [Moles/time] in 24 hour Urine
Meat fibers [Presence] in Stool by Light microscopy
Pyridoxine [Moles/volume] in Serum or Plasma --pre 250 mg pyridoxine PO
Pyridoxine [Moles/volume] in Serum or Plasma --post 250 mg pyridoxine PO
Pyridoxine [Mass/volume] in Serum or Plasma --post pyridoxine PO
European tick borne encephalitis virus Ab [Titer] in Serum by Complement fixation
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum by Immunoassay
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum by Immunoassay
European tick borne encephalitis virus Ab [Titer] in Serum
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum
Metanephrines [Mass/time] in 24 hour Urine
Methcoproporphyrin [Mass/volume] in Serum or Plasma
Methemalbumin [Mass/volume] in Serum or Plasma
Methemoglobin/Hemoglobin.total in Arterial blood
Methemoglobin/Hemoglobin.total in Capillary blood
Methemoglobin/Hemoglobin.total in Venous blood
Fusidate [Susceptibility] by Minimum lethal concentration (MLC)
Methemoglobin/Hemoglobin.total in Red Blood Cells
Methemoglobin [Presence] in Red Blood Cells
Methionine [Presence] in Serum or Plasma
Methionine [Mass/volume] in Serum or Plasma
Methionine adenosyltransferase [Enzymatic activity/volume] in Serum
Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)
Methoxyacetate [Mass/volume] in Serum or Plasma
Methylenetetrahydrofolate dehydrogenase NAD [Enzymatic activity/volume] in Serum
Methylenetetrahydrofolate dehydrogenase NADP [Enzymatic activity/volume] in Serum
Methylmalonate [Mass/volume] in Serum or Plasma
Methylmalonyl CoA mutase [Enzymatic activity/volume] in Serum
Methyltestosterone [Mass/volume] in Urine
Fusidate [Susceptibility] by Disk diffusion (KB)
Methyltestosterone [Mass/time] in 24 hour Urine
Mianserin [Mass/volume] in Serum or Plasma
Myelin basic protein [Mass/volume] in Cerebral spinal fluid
Myoglobin [Mass/volume] in Serum or Plasma
Alternaria alternata IgG4 Ab [Units/volume] in Serum
Aspergillus fumigatus IgG4 Ab [Units/volume] in Serum
Honey bee IgG4 Ab [Units/volume] in Serum
Silver Birch IgG4 Ab [Units/volume] in Serum
Wheat Bran IgG4 Ab [Units/volume] in Serum
Candida albicans IgG4 Ab [Units/volume] in Serum
Cladosporium herbarum IgG4 Ab [Units/volume] in Serum
American house dust mite IgG4 Ab [Units/volume] in Serum
Fusidate [Susceptibility] by Serum bactericidal titer
European house dust mite IgG4 Ab [Units/volume] in Serum
Egg white IgG4 Ab [Units/volume] in Serum
Lactalbumin alpha IgG4 Ab [Units/volume] in Serum
Lactoglobulin IgG4 Ab [Units/volume] in Serum
Wasp venom IgG4 Ab [Units/volume] in Serum or Plasma
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Urine
Blasts/100 leukocytes in Cerebral spinal fluid
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic fluid
Eosinophils/100 leukocytes in Cerebral spinal fluid
Eosinophils/100 leukocytes in Body fluid
Erythrocytes [#/volume] in Cerebral spinal fluid
Erythrocytes [#/volume] in Pleural fluid
Erythrocytes [#/volume] in Peritoneal fluid
Erythrocytes [#/volume] in Synovial fluid
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid
Nucleated erythrocytes [#/volume] in Body fluid
Large unstained cells [#/volume] in Blood
Large unstained cells/100 leukocytes in Blood
Leukocytes [#/volume] in Cerebral spinal fluid
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum
Leukocytes [#/volume] in Peritoneal fluid
Leukocytes other [#/volume] in Cerebral spinal fluid
Leukocytes other/100 leukocytes in Blood
Leukocytes other/100 leukocytes in Cerebral spinal fluid
Leukocytes other/100 leukocytes in Body fluid
Lymphocytes [#/volume] in Cerebral spinal fluid
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue
Lymphocytes/100 leukocytes in Cerebral spinal fluid
Lymphocytes/100 leukocytes in Pericardial fluid
Lymphocytes/100 leukocytes in Pleural fluid
Lymphocytes/100 leukocytes in Peritoneal fluid
Lymphocytes/100 leukocytes in Synovial fluid
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes
Monocytes/100 leukocytes in Cerebral spinal fluid
Monocytes/100 leukocytes in Peritoneal fluid
Mononuclear cells [#/volume] in Cerebral spinal fluid
Mononuclear cells [#/volume] in Body fluid
Mononuclear cells [#/volume] in Synovial fluid
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue
Mononuclear cells/100 leukocytes in Cerebral spinal fluid
Mononuclear cells/100 leukocytes in Body fluid
Mononuclear cells/100 leukocytes in Pleural fluid
Mononuclear cells/100 leukocytes in Peritoneal fluid
Mononuclear cells/100 leukocytes in Semen
Mononuclear cells/100 leukocytes in Synovial fluid
Amphotericin B [Susceptibility] by Serum bactericidal titer
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum
Neutrophils [#/volume] in Cerebral spinal fluid
Neutrophils [#/volume] in Peritoneal fluid
Neutrophils [#/volume] in Synovial fluid
Segmented neutrophils/100 leukocytes in Blood
Segmented neutrophils/100 leukocytes in Cerebral spinal fluid
Band form neutrophils [#/volume] in Blood
Band form neutrophils/100 leukocytes in Blood
Band form neutrophils/100 leukocytes in Cerebral spinal fluid
Band form neutrophils/100 leukocytes in Body fluid
Neutrophils/100 leukocytes in Cerebral spinal fluid
Neutrophils/100 leukocytes in Body fluid
Neutrophils/100 leukocytes in Peritoneal fluid
Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid
NADH dehydrogenase [Enzymatic activity/volume] in Plasma
Polymorphonuclear cells/100 leukocytes in Body fluid
Polymorphonuclear cells/100 leukocytes in Pleural fluid
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid
Polymorphonuclear cells/100 leukocytes in Semen
Polymorphonuclear cells/100 leukocytes in Synovial fluid
Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post dose corticotropin
NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells
Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post dose corticotropin
Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --24 hours post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --32 hours post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --48 hours post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --56 hours post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --8 hours post dose corticotropin
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Glucose [Presence] in Urine by Test strip --2.5 hours post dose glucose
Glucose [Presence] in Urine by Test strip --3.5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose glucose
Glucose [Mass/volume] in Urine --3 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --4 hours post dose glucose
Neurophysin [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine --5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --6 hours post dose glucose
Glucose [Mass/volume] in Urine --6 hours post dose glucose
Glucose [Presence] in Urine by Test strip --1 hour post dose glucose
Glucose [Presence] in Urine by Test strip --2 hours post dose glucose
Glucose [Presence] in Urine by Test strip --30 minutes post dose glucose
Glucose [Presence] in Urine by Test strip --3 hours post dose glucose
Glucose [Presence] in Urine by Test strip --4 hours post dose glucose
Glucose [Presence] in Urine by Test strip --5 hours post dose glucose
Glucose [Presence] in Urine by Test strip --6 hours post dose glucose
Glucose [Presence] in Urine by Test strip --1.5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose
CD19+Lambda+ cells/100 cells in Specimen
IgA lymphocytes/100 lymphocytes in Specimen
1-Methylhistidine/Creatinine [Molar ratio] in Urine
3-Methylhistidine/Creatinine [Molar ratio] in Urine
Anserine/Creatinine [Molar ratio] in Urine
Asparagine/Creatinine [Molar ratio] in Urine
Beta alanine/Creatinine [Molar ratio] in Urine
Carnosine/Creatinine [Molar ratio] in Urine
Gamma aminobutyrate/Creatinine [Molar ratio] in Urine
Homocysteine/Creatinine [Molar ratio] in Urine
3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in Urine
1-Methylhistidine [Moles/volume] in Cerebral spinal fluid
3-Methylhistidine [Moles/volume] in Cerebral spinal fluid
Alpha aminobutyrate [Moles/volume] in Cerebral spinal fluid
Alpha aminoadipate [Moles/volume] in Cerebral spinal fluid
Anserine [Moles/volume] in Cerebral spinal fluid
Beta alanine [Moles/volume] in Cerebral spinal fluid
Beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid
Carnosine [Moles/volume] in Cerebral spinal fluid
Cystathionine [Moles/volume] in Cerebral spinal fluid
Ethanolamine [Moles/volume] in Cerebral spinal fluid
Gamma aminobutyrate [Moles/volume] in Cerebral spinal fluid
Hydroxylysine [Moles/volume] in Cerebral spinal fluid
Hydroxyproline [Moles/volume] in Cerebral spinal fluid
Phosphoethanolamine [Moles/volume] in Cerebral spinal fluid
Sarcosine [Moles/volume] in Cerebral spinal fluid
Anserine [Moles/volume] in Serum or Plasma
Alpha aminoadipate [Moles/volume] in Serum or Plasma
Alpha aminoadipate/Creatinine [Molar ratio] in Urine
Tryptophan [Moles/volume] in Cerebral spinal fluid
Asparagine [Moles/volume] in Cerebral spinal fluid
Beta alanine [Moles/volume] in Serum or Plasma
Beta aminoisobutyrate [Moles/volume] in Serum or Plasma
Carnosine [Moles/volume] in Serum or Plasma
Cystathionine [Moles/volume] in Serum or Plasma
Ethanolamine [Moles/volume] in Serum or Plasma
Gamma aminobutyrate [Moles/volume] in Serum or Plasma
Hydroxylysine [Moles/volume] in Serum or Plasma
Phosphoethanolamine [Moles/time] in 24 hour Urine
Phosphoethanolamine [Moles/volume] in Serum or Plasma
Sarcosine [Moles/volume] in Serum or Plasma
Taurine [Moles/volume] in Cerebral spinal fluid
Trypanosoma brucei gambiense Ab [Presence] in Serum
Trypanosoma brucei rhodesiense Ab [Presence] in Serum
Chikungunya virus Ab [Presence] in Serum
Rickettsia conorii Ab [Presence] in Serum
Nitrogen.nonprotein [Mass/volume] in Blood
Chlamydia trachomatis L2 Ab [Presence] in Serum
Legionella polyvalent A Ab [Presence] in Serum
Legionella polyvalent B Ab [Presence] in Serum
Legionella polyvalent C Ab [Presence] in Serum
Corynebacterium diphtheriae toxin Ab [Presence] in Serum
Legionella dumoffii Ab [Presence] in Serum
Nitrogen.nonprotein [Mass/volume] in Serum or Plasma
Legionella bozemaniae Ab [Presence] in Serum
Legionella gormanii Ab [Presence] in Serum
Legionella micdadei Ab [Presence] in Serum
Leishmania brasilensis Ab [Presence] in Serum
Leishmania donovani Ab [Presence] in Serum
Leishmania tropica Ab [Presence] in Serum
Paracoccidioides brasiliensis Ab [Presence] in Serum
Jamestown canyon virus Ab [Presence] in Serum
Clostridium tetani toxoid Ab [Presence] in Serum
Semliki Forest virus Ab [Presence] in Serum
Snowshoe hare virus Ab [Presence] in Serum
Hantavirus sin nombre IgM Ab [Presence] in Serum
Rhizopus arrhizus Ab [Presence] in Serum
Colorado tick fever virus Ab [Presence] in Serum
Hantavirus sin nombre IgG Ab [Presence] in Serum
Schistosoma haematobium Ab [Presence] in Serum
Chlamydia trachomatis D Ab [Presence] in Serum
Chlamydia trachomatis E Ab [Presence] in Serum
Chlamydia trachomatis F Ab [Presence] in Serum
Chlamydia trachomatis H Ab [Presence] in Serum
Chlamydia trachomatis I Ab [Presence] in Serum
Chlamydia trachomatis L1 Ab [Presence] in Serum
Absidia corymbifera Ab [Presence] in Serum
Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)
Rhizomucor pusillus Ab [Presence] in Serum
Echinococcus granulosus Ab [Presence] in Serum
Legionella longbeachae 1 Ab [Presence] in Serum
Legionella longbeachae 2 Ab [Presence] in Serum
Bartonella henselae Ab [Presence] in Serum
Bartonella quintana Ab [Presence] in Serum
Bartonella elizabethae Ab [Presence] in Serum
Secobarbital [Mass/volume] in Vitreous fluid
Norepinephrine [Mass/time] in 24 hour Urine
Estazolam [Mass/volume] in Vitreous fluid
Mycoplasma pneumoniae IgA Ab [Presence] in Serum by Immunoassay
3-Hydroxyisovalerate [Presence] in Urine
Triazolam [Mass/volume] in Vitreous fluid
Amobarbital [Mass/volume] in Vitreous fluid
Mercury/Creatinine [Mass Ratio] in 24 hour Urine
Butabarbital [Mass/volume] in Vitreous fluid
Normetanephrine [Mass/volume] in Serum or Plasma
Western equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe
Uroporphyrin 1 isomer [Mass/time] in 24 hour Stool
Clostridioides difficile IgM Ab [Units/volume] in Serum
Glucose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Clostridioides difficile IgA Ab [Units/volume] in Serum
Listeria monocytogenes IgG Ab [Units/volume] in Serum
Amino beta guanidinopropionate [Moles/time] in 24 hour Urine
Clostridioides difficile IgG Ab [Units/volume] in Serum
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Titer] in Serum by Immunoassay
Isospora belli [Presence] in Stool by Immunofluorescence
Epstein Barr virus nuclear IgM Ab [Titer] in Serum
Vanillylmandelate [Mass/volume] in 24 hour Urine
Xylose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Leucine [Moles/volume] in Amniotic fluid
Phenylpropanolamine [Mass/mass] in Meconium
Chlamydia trachomatis IgG Ab [Units/volume] in Serum by Immunoassay
Normetanephrine [Mass/time] in 24 hour Urine
Chlorphentermine [Mass/mass] in Meconium
Phosphoethanolamine [Moles/volume] in Blood
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Alpha aminoadipate [Moles/volume] in Urine
ePHEDrine+Pseudoephedrine [Mass/mass] in Meconium
Ovary IgG Ab [Titer] in Serum by Immunofluorescence
Isoleucine [Moles/volume] in Amniotic fluid
Tetrahydrocannabinol [Mass/mass] in Stool
Carboxy tetrahydrocannabinol [Mass/mass] in Stool
Rhodococcus equi Ab [Presence] in Serum by Immune diffusion (ID)
Promethazine [Presence] in Serum or Plasma
Phosphoserine [Moles/volume] in Cerebral spinal fluid
Xylose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Methylenedioxyamphetamine [Mass/volume] in Milk
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma
Opiates [Mass/mass] in Meconium by Screen method
Citrulline [Moles/volume] in Amniotic fluid
Magnesium [Mass/volume] in Red Blood Cells
Cannabinoids/Creatinine [Mass Ratio] in Urine
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2nd specimen
Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Carnosine [Moles/volume] in Amniotic fluid
Creatinine renal clearance in 2 hour Urine and Serum or Plasma
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum
Sodium renal clearance in 2 hour Urine and Serum or Plasma
Bacteroides fragilis IgG Ab [Units/volume] in Serum
Clostridium perfringens IgG Ab [Units/volume] in Serum
Clostridium perfringens IgM Ab [Units/volume] in Serum
Endothelin [Mass/volume] in Serum or Plasma
Trichloroacetate/Creatinine [Mass Ratio] in Urine
ePHEDrine+Pseudoephedrine [Mass/mass] in Stool
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoassay
QUEtiapine [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --4 hours post dose lactose PO
Glucose [Mass/volume] in Serum or Plasma --5 hours post dose lactose PO
diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine
Anserine [Moles/volume] in Amniotic fluid
Escherichia coli IgM Ab [Units/volume] in Serum
Methylenedioxyamphetamine [Mass/mass] in Stool
Methylenedioxymethamphetamine [Mass/mass] in Stool
Alpha aminobutyrate [Presence] in 24 hour Urine
Alpha hydroxybutyrate [Presence] in Urine
Ornithine [Mass/volume] in Serum or Plasma
Escherichia coli IgG Ab [Units/volume] in Serum
Ethanolamine [Presence] in 24 hour Urine
Gamma aminobutyrate [Presence] in 24 hour Urine
Hydroxyproline [Presence] in 24 hour Urine
Xylose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Acidity.titratable [Moles/volume] in Gastric fluid
Nordiazepam [Mass/volume] in Vitreous fluid
Glucose [Mass/volume] in Serum or Plasma --11 hour post XXX challenge
Campylobacter jejuni Ab [Units/volume] in Serum by Immunoassay
Alpha aminobutyrate [Moles/volume] in Amniotic fluid
Stachybotrys chartarum IgA Ab [Mass/volume] in Serum
Lipoprotein.beta [Presence] in Body fluid
Lipoprotein.alpha [Presence] in Body fluid
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Amniotic fluid
Phosphoserine [Moles/volume] in Amniotic fluid
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe
Testosterone [Mass/volume] in 24 hour Urine
Testosterone/Creatinine [Mass Ratio] in 24 hour Urine
Phencyclidine [Mass/mass] in Meconium by Screen method
Gentamicin [Susceptibility] by Disk diffusion (KB)
Prochlorperazine [Presence] in Serum or Plasma
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Serum
Hydroxyethylflurazepam [Mass/mass] in Hair
N-desalkylflurazepam [Mass/mass] in Hair
Methionine [Moles/volume] in Amniotic fluid
Sialate.lipid bound [Mass/volume] in Serum or Plasma
Perphenazine [Presence] in Serum or Plasma
Haloperidol [Presence] in Serum or Plasma
Interleukin 10 [Mass/volume] in Serum or Plasma
Alpha-1-acid glycoprotein [Mass/volume] in Cerebral spinal fluid
IgA.secretory [Mass/volume] in Saliva (oral fluid)
Oxazepam [Mass/volume] in Vitreous fluid
LORazepam [Mass/volume] in Vitreous fluid
Amino beta guanidinopropionate [Moles/volume] in Amniotic fluid
Parainfluenza virus Ab [Titer] in Serum by Immunofluorescence
Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma
Gamma aminobutyrate [Moles/volume] in Amniotic fluid
Sporothrix schenckii Ab [Units/volume] in Serum by Latex agglutination
N-desalkylflurazepam [Mass/mass] in Meconium
Ganglioside GD1b Ab [Units/volume] in Serum by Immunoassay
Orotate phosphoribosyltransferase [Enzymatic activity/volume] in Serum
ALPRAZolam [Mass/volume] in Vitreous fluid
Triiodothyronine (T3) [Mass/volume] in Saliva (oral fluid)
Orotidine-5'-Phosphate decarboxylase [Enzymatic activity/volume] in Serum
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay
Interleukin 6 [Mass/volume] in Serum or Plasma
Homocystine [Moles/volume] in Amniotic fluid
Ketones [Presence] in Urine by Test strip --3 hours post XXX challenge
Ova and parasites identified in Specimen by Concentration
Alpha hydroxyalprazolam [Mass/mass] in Hair
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Intrinsic factor blocking IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Tetrahydrocannabinol [Mass/mass] in Meconium
Glutamine [Moles/volume] in Amniotic fluid
Temazepam [Mass/volume] in Vitreous fluid
Midazolam [Mass/volume] in Vitreous fluid
chlordiazePOXIDE [Mass/volume] in Vitreous fluid
Flurazepam [Mass/volume] in Vitreous fluid
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
2-Methylcitrate [Moles/volume] in Serum or Plasma
Listeria sp Ab [Titer] in Cerebral spinal fluid
Alpha aminoadipate [Moles/volume] in Amniotic fluid
Gentamicin [Susceptibility] by Serum bactericidal titer
Alpha hydroxyalprazolam [Mass/mass] in Meconium
Hydroxytriazolam [Mass/mass] in Meconium
Cobalamin (Vitamin B12) [Presence] in Blood
Alpha aminobutyrate/Creatinine [Molar ratio] in Urine
Cancer Ag 19-9 [Units/volume] in Body fluid
Acetophenazine [Presence] in Serum or Plasma
Ganglioside GD1b Ab [Presence] in Serum by Immunoassay
Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence
Glycine [Moles/volume] in Amniotic fluid
Complement C4 [Units/volume] in Serum or Plasma
Sarcosine [Moles/volume] in Amniotic fluid
Hydroxyethylflurazepam [Mass/mass] in Meconium
chlordiazePOXIDE [Mass/mass] in Meconium
Mumps virus Ab [Presence] in Serum by Immunoassay
11-Ketoandrosterone [Mass/volume] in 24 hour Urine
11-Ketoandrosterone [Mass/volume] in Urine
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Saccharopolyspora rectivirgula IgG Ab [Mass/volume] in Serum
Thermoactinomyces IgG Ab [Mass/volume] in Serum
11-Hydroxyetiocholanolone [Mass/volume] in Urine
Alternaria alternata IgG Ab [Mass/volume] in Serum
Phoma herbarum IgG Ab [Mass/volume] in Serum
Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma
Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
Penicillium notatum IgG Ab [Mass/volume] in Serum
Parietal cell Ab [Presence] in Serum by Immunofluorescence
Reticulin IgG Ab [Presence] in Serum by Immunofluorescence
Osteocalcin [Mass/volume] in Serum or Plasma
Smooth muscle Ab [Presence] in Serum by Immunofluorescence
Herpes virus 7 IgG Ab [Titer] in Serum by Immunofluorescence
Beta aminoisobutyrate [Moles/volume] in Urine
Delta aminolevulinate [Mass/volume] in 24 hour Urine
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Coccidioides immitis Ab [Titer] in Serum by Immune diffusion (ID)
Phenylalanine [Moles/volume] in Amniotic fluid
Helicobacter pylori IgG Ab [Units/volume] in Saliva (oral fluid)
Arginine [Moles/volume] in Amniotic fluid
Trichoderma viride IgG Ab [Presence] in Serum
Pentachlorophenol/Creatinine [Mass Ratio] in Urine
18-Hydroxydeoxycorticosterone [Mass/time] in 24 hour Urine
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunofluorescence
Phenylpropanolamine [Mass/volume] in Milk
Carboxy tetrahydrocannabinol [Mass/volume] in Blood
Complement C7 [Units/volume] in Serum or Plasma
Oxalate [Mass/volume] in Serum or Plasma
Thyrotropin [Units/volume] in Saliva (oral fluid)
Thyroxine (T4) [Mass/volume] in Saliva (oral fluid)
Xylose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Xylose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Acetohexamide [Mass/volume] in Serum or Plasma
Xylose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Coccidioides sp IgG Ab [Units/volume] in Serum
Mesoporphyrin [Mass/time] in 24 hour Stool
Benzaldehyde [Presence] in Serum or Plasma
Alanine [Moles/volume] in Amniotic fluid
Polychlorinated biphenyl (PCB) [Mass/volume] in Body fluid
Xylose [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Allyl alcohol [Presence] in Serum or Plasma
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation
Para aminophenol/Creatinine [Mass Ratio] in Urine
Cystine [Moles/volume] in Amniotic fluid
Ketones [Presence] in Urine by Test strip --2 hours post XXX challenge
Oxalate renal clearance in 24 hour Urine and Serum or Plasma
Myelin associated glycoprotein IgM Ab [Units/volume] in Cerebral spinal fluid
Zirconium [Mass/volume] in Serum or Plasma
Proline [Moles/volume] in Amniotic fluid
Drugs identified in Hair by Screen method
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium
Norchlordiazepoxide [Mass/volume] in Urine
Oxygen [Partial pressure] in Arterial blood
Calcium/Creatinine [Mass Ratio] in 2 hour Urine
Endomysium IgA Ab [Titer] in Serum by Immunofluorescence
Ketones [Presence] in Urine by Test strip --1 hour post XXX challenge
Methohexital [Mass/volume] in Serum or Plasma
1-Methylhistidine [Moles/volume] in Urine
Oxygen [Partial pressure] in Capillary blood
Microscopic exam [Interpretation] of Urine by Cytology
3-Methylhistidine [Moles/volume] in Urine
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
Oxygen [Partial pressure] in Venous blood
Morphine [Mass/volume] in Cerebral spinal fluid
Morphine Free [Mass/volume] in Cerebral spinal fluid
Catecholamines Free [Mass/time] in 24 hour Urine
Beta alanine [Moles/volume] in Amniotic fluid
Melatonin [Presence] in Saliva (oral fluid)
Ketones [Presence] in Urine --1 hour post XXX challenge
Ketones [Presence] in Urine --2 hours post XXX challenge
Ketones [Presence] in Urine --3 hours post XXX challenge
Purkinje cells Ab [Units/volume] in Serum
Cisapride [Mass/volume] in Serum or Plasma
Loratadine [Mass/volume] in Serum or Plasma
14-3-3 Ag [Units/volume] in Cerebral spinal fluid by Immunoassay
Methylenedioxyethylamphetamine [Mass/volume] in Milk
Dextromethorphan+Levorphanol [Presence] in Urine
Enterococcus sp IgM Ab [Units/volume] in Serum
Methylenedioxyethylamphetamine [Mass/mass] in Stool
Methylenedioxyethylamphetamine [Mass/mass] in Meconium
Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma
Delavirdine [Mass/volume] in Serum or Plasma
7-Aminoflunitrazepam [Mass/volume] in Urine
Methylenedioxyethylamphetamine [Mass/volume] in Urine
Cannabinoids [Presence] in Vitreous fluid
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid
Asparagine [Moles/volume] in Amniotic fluid
Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)
Entamoeba histolytica IgA Ab [Presence] in Saliva (oral fluid)
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Parvovirus B19 IgG Ab [Titer] in Cerebral spinal fluid
2-Methylbutyrylglycine/Creatinine [Mass Ratio] in Urine
Probenecid [Mass/volume] in Serum or Plasma
Glutamate [Moles/volume] in Amniotic fluid
Histidine [Moles/volume] in Amniotic fluid
Microscopic observation [Identifier] in Body fluid by Gram stain
Parvovirus B19 IgM Ab [Titer] in Cerebral spinal fluid
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --2nd specimen
Magnesium [Mass/mass] in Red Blood Cells
Phosphate [Mass/mass] in Red Blood Cells
Phencyclidine [Presence] in Vitreous fluid
Tryptophan [Moles/volume] in Amniotic fluid
Oxygen saturation Calculated from oxygen partial pressure in Blood
Fractional oxyhemoglobin in Arterial blood
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --1st specimen
Fractional oxyhemoglobin in Capillary blood
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --1st specimen
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Hydrastine [Presence] in Serum or Plasma
Interleukin 4 [Mass/volume] in Serum or Plasma
1-Methylhistidine [Moles/volume] in Amniotic fluid
N-methylacetamide/Creatinine [Mass Ratio] in Urine
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Fractional oxyhemoglobin in Venous blood
Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)
Inhibin [Units/volume] in Serum or Plasma
3-Methylhistidine [Moles/volume] in Amniotic fluid
Herpes virus 7 IgM Ab [Titer] in Serum by Immunofluorescence
Phendimetrazine [Mass/volume] in Vitreous fluid
Threonine [Moles/volume] in Amniotic fluid
Hydroxyproline [Moles/volume] in Amniotic fluid
Oxytocin [Mass/volume] in Serum or Plasma
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid
Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid
Propoxyphene [Mass/volume] in Vitreous fluid
PHENobarbital [Mass/volume] in Vitreous fluid
diazePAM [Mass/volume] in Vitreous fluid
Tetrahydrocannabinol [Mass/volume] in Vitreous fluid
N-desalkylflurazepam [Mass/volume] in Vitreous fluid
Hydroxylysine [Moles/volume] in Amniotic fluid
HYDROmorphone Free [Mass/volume] in Vitreous fluid
Benzodiazepines [Presence] in Vitreous fluid
Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct
18-Hydroxycortisol/Creatinine [Mass Ratio] in 24 hour Urine
Palmitoylphosphatidyl choline [Mass/volume] in Plasma
Zinc/Creatinine [Mass Ratio] in 24 hour Urine
Follitropin [Units/volume] in 24 hour Urine
Amphetamines [Presence] in Vitreous fluid
Morphine Free [Mass/volume] in Vitreous fluid
Methadone [Mass/volume] in Vitreous fluid
Drugs identified in Stool by Screen method
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid by Complement fixation
Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid
Beta aminoisobutyrate [Moles/volume] in Amniotic fluid
Pancreatic polypeptide [Mass/volume] in Serum or Plasma
Ornithine [Moles/volume] in Amniotic fluid
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid by Complement fixation
Norepinephrine [Mass/volume] in 24 hour Urine
Barbiturates [Presence] in Vitreous fluid
Estriol (E3) [Mass/volume] in Saliva (oral fluid)
Cocaethylene [Mass/volume] in Serum or Plasma
Pantothenate [Mass/volume] in Serum, Plasma or Blood
Phentermine [Mass/volume] in Vitreous fluid
Para aminohippurate renal clearance in 24 hour Urine and Serum or Plasma
Azatadine [Mass/volume] in Serum or Plasma
Para aminohippurate [Mass/volume] in Urine
Methylenedioxyamphetamine [Mass/mass] in Meconium
Hydroxyethylflurazepam [Mass/mass] in Stool
Gramicidin D [Susceptibility] by Disk diffusion (KB)
Para methylhippurate [Mass/volume] in Urine
Phenmetrazine [Mass/volume] in Vitreous fluid
Phenylpropanolamine [Mass/volume] in Vitreous fluid
Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma
Chlorphentermine [Mass/volume] in Vitreous fluid
Amino beta guanidinopropionate/Creatinine [Molar ratio] in Urine
Aspartate [Moles/volume] in Amniotic fluid
Estriol (E3).unconjugated [Presence] in Serum or Plasma
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Polio virus Ab [Titer] in Serum by Complement fixation
Amphetamines [Mass/volume] in Vitreous fluid
Aluminum [Mass/volume] in Cerebral spinal fluid
Histoplasma capsulatum Ab [Titer] in Serum by Immune diffusion (ID)
4-Hydroxyphenylacetate [Presence] in Urine
3-Hydroxyisobutyrate [Presence] in Urine
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Methamphetamine [Mass/volume] in Vitreous fluid
Phosphoethanolamine [Moles/volume] in Amniotic fluid
Paraoxon [Mass/volume] in Serum or Plasma
Parathion [Mass/volume] in Serum or Plasma
Parathyrin related protein [Mass/volume] in Serum or Plasma
Leukocyte esterase [Units/volume] in Urine
Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid
Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)
Parathyrin.C-terminal [Mass/volume] in Serum or Plasma
Mephentermine [Mass/volume] in Vitreous fluid
Glutarate [Moles/volume] in Serum or Plasma
Testosterone [Presence] in Saliva (oral fluid)
Aspergillus flavus Ab [Titer] in Serum by Immune diffusion (ID)
Taurine [Moles/volume] in Amniotic fluid
Aspergillus niger Ab [Titer] in Serum by Immune diffusion (ID)
Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
Parathyrin.intact [Mass/volume] in Serum or Plasma
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Parathyrin.mid molecule [Mass/volume] in Serum or Plasma
Spermatozoa Motile/100 spermatozoa in Semen --12 hours post ejaculation
Somatotropin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Feline panleukopenia virus IgM Ab [Titer] in Serum
Gramicidin D [Susceptibility] by Serum bactericidal titer
Insulin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge
Feline panleukopenia virus IgG Ab [Titer] in Serum
Parathyrin.N-terminal [Mass/volume] in Serum or Plasma
Amino beta guanidinopropionate [Moles/volume] in Cerebral spinal fluid
2,4-Dichlorophenoxyacetate [Mass/volume] in Serum or Plasma
Cholesterol in HDL [Presence] in Serum or Plasma
Alpha aminobutyrate [Moles/volume] in Urine
Fasciola hepatica Ab [Titer] in Serum by Immunoassay
Molybdenum [Mass/mass] in Red Blood Cells
Aspartate aminotransferase [Presence] in Serum or Plasma
Hemoglobin A2 [Presence] in Blood by Electrophoresis
Benzfetamine [Mass/volume] in Vitreous fluid
Methaqualone [Mass/volume] in Vitreous fluid
DOPamine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Cystathionine [Presence] in 24 hour Urine
Pantothenate [Presence] in Serum, Plasma or Blood
Homocystine [Units/volume] in Serum or Plasma
Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin
Toxoplasma gondii IgE Ab [Presence] in Serum
Lipoprotein.pre-beta [Presence] in Pleural fluid
Phencyclidine [Mass/volume] in Vitreous fluid
HYDROcodone Free [Mass/volume] in Vitreous fluid
Benzoylecgonine [Mass/volume] in Vitreous fluid
Somatotropin [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge
Myelin basic protein Ab [Units/volume] in Serum
DOPamine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Aspergillus niger Ab [Presence] in Body fluid by Immune diffusion (ID)
Kappa light chains [Mass/volume] in Urine
Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen post XXX challenge
Pepsinogen I [Mass/volume] in Serum or Plasma
Manganese/Creatinine [Mass Ratio] in Urine
Chlamydia trachomatis B Ab [Titer] in Serum by Immunofluorescence
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Chlamydia trachomatis C Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis G+F+K Ab [Titer] in Serum by Immunofluorescence
Insulin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge
Aspergillus fumigatus Ab [Presence] in Body fluid by Immune diffusion (ID)
Aspergillus flavus Ab [Presence] in Body fluid by Immune diffusion (ID)
Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge
DOPamine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Porphobilinogen [Mass/volume] in 24 hour Urine
Pepsinogen II [Mass/volume] in Serum or Plasma
Feline herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Somatotropin [Mass/volume] in Serum or Plasma --18th specimen post XXX challenge
Blastomyces dermatitidis Ab [Presence] in Body fluid by Immune diffusion (ID)
Pepsinogen [Mass/volume] in Serum or Plasma
Candida sp IgM Ab [Units/volume] in Serum by Immunoassay
Lambda light chains [Mass/volume] in Urine
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
Hemoglobin.gastrointestinal [Mass/mass] in Stool
Hexacarboxylporphyrin [Mass/volume] in Urine
Hemoglobin.gastrointestinal [Presence] in Stool --6th specimen
Norparamethadione [Mass/volume] in Urine
Gamma glutamyl transferase [Enzymatic activity/volume] in Urine
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
C peptide [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Pepsins [Enzymatic activity/volume] in Gastric fluid
Methylenedianiline [Mass/volume] in Urine
Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)
Spermatozoa Motile/100 spermatozoa in Semen --24 hours post ejaculation
ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid
Interferon gamma [Mass/volume] in Serum or Plasma
SCL-70 extractable nuclear Ab [Units/volume] in Serum
Pepsins [Enzymatic activity/volume] in Urine
Candida sp IgA Ab [Units/volume] in Serum by Immunoassay
C peptide [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
1,4-Dioxane [Presence] in Serum or Plasma
Deoxypyridinoline [Moles/volume] in Urine
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Glucose [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
N-desalkylflurazepam [Mass/mass] in Stool
Protein C Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Immunoassay
Alpha hydroxyalprazolam [Mass/mass] in Stool
Candida sp Ag [Units/volume] in Serum or Plasma by Immunoassay
Phenylpropanolamine [Mass/mass] in Stool
DOPamine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Insulin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge
Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Phenolsulphonphthalein [Mass/volume] in Urine
Phenylalanine [Mass/volume] in Cerebral spinal fluid
Phenylalanine [Presence] in Serum or Plasma
Phenylalanine [Mass/volume] in Serum or Plasma
Hetacillin [Susceptibility] by Disk diffusion (KB)
Phenylalanine [Mass/time] in 24 hour Urine
Phenylalanine/Tyrosine [Mass Ratio] in Serum or Plasma
Hetacillin [Susceptibility] by Serum bactericidal titer
Phosphate [Mass/volume] in Dialysis fluid
Phosphate renal clearance in 24 hour Urine and Serum or Plasma
Phosphate [Mass/volume] in Serum or Plasma
Plasmin inhibitor actual/normal in Platelet poor plasma by Chromogenic method
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
Prothrombin Ag actual/normal in Platelet poor plasma by Immunoassay
Coagulation factor VII+Coagulation factor X actual/normal in Platelet poor plasma by Coagulation assay
Coagulation factor XIII activity actual/normal in Platelet poor plasma by Chromogenic method
von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
Beta 2 glycoprotein 1 Ab [Presence] in Serum by Immunoassay
Protein C actual/normal in Platelet poor plasma by Chromogenic method
Protein C actual/normal in Platelet poor plasma by Coagulation assay
Imipenem [Susceptibility] by Minimum lethal concentration (MLC)
Protein C Ag actual/normal in Platelet poor plasma by Immunoassay
Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
Protein S actual/normal in Platelet poor plasma by Coagulation assay
Protein S Ag actual/normal in Platelet poor plasma by Immunoassay
Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by Immunoassay
Insulin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge
Insulin [Units/volume] in Serum or Plasma --3 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --1 hour post 75 g glucose PO
Immune complex [Units/volume] in Serum or Plasma by C1q binding assay
Insulin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --7 hours post 75 g glucose PO
Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO
Somatotropin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --16th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --17th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --19th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --20th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --21st specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --24th specimen post XXX challenge
Phosphatidylcholine.saturated [Mass/volume] in Amniotic fluid
Somatotropin [Mass/volume] in Serum or Plasma --25th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --5 hours post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Phosphatidylglycerol [Presence] in Amniotic fluid
Lutropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid
Insulin [Units/volume] in Serum or Plasma --2 hours post 75 g glucose PO
Insulin [Units/volume] in Serum or Plasma --3 hours post 75 g glucose PO
Phosphatidylglycerol [Mass/volume] in Amniotic fluid
Insulin [Units/volume] in Serum or Plasma --4 hours post 75 g glucose PO
Insulin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
17-Ketogenic steroids [Mass/volume] in 24 hour Urine
Insulin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge
Phosphatidylinositol [Mass/volume] in Serum
Follitropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Interferon beta IgG Ab [Units/volume] in Serum or Plasma
Insulin [Units/volume] in Serum or Plasma --6 hours post 75 g glucose PO
Insulin [Units/volume] in Serum or Plasma --fasting
Insulin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma
Lutropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge
Phosphoenolpyruvate carboxykinase [Enzymatic activity/volume] in Serum
Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma --baseline
Butyrylglycine/Creatinine [Mass Ratio] in Urine
Sulfatide IgG Ab [Presence] in Serum by Immunoassay
Phosphoethanolamine [Mass/volume] in Serum or Plasma
Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Lactobacillus sp IgG Ab [Units/volume] in Serum
Lactobacillus sp IgM Ab [Units/volume] in Serum
Enterococcus sp IgG Ab [Units/volume] in Serum
Coxsackievirus B2 Ab [Presence] in Cerebral spinal fluid
Phosphoethanolamine [Mass/volume] in Urine
Bacteroides fragilis IgM Ab [Units/volume] in Serum
Immature lymphocytes/100 leukocytes in Amniotic fluid
Cryptosporidium sp [Identifier] in Stool by Organism specific culture
Coxsackievirus B1 Ab [Presence] in Cerebral spinal fluid
Calcium [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Gamma aminobutyrate [Moles/volume] in Urine
Phosphofructokinase [Enzymatic activity/volume] in Blood
Calcium [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Gamma aminoadipate [Moles/time] in 24 hour Urine
Alpha-1-Antichymotrypsin [Units/volume] in Stool
Calcium [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Coxsackievirus B3 Ab [Presence] in Cerebral spinal fluid
Coxsackievirus B4 Ab [Presence] in Cerebral spinal fluid
Calcium [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Phosphofructokinase [Enzymatic activity/volume] in Serum
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma
Echovirus 4 RNA [Presence] in Cerebral spinal fluid
Coenzyme Q10 [Mass/volume] in Serum or Plasma
Ascaris sp Ab [Titer] in Serum by Immunoassay
Hemoglobin.gastrointestinal [Presence] in Stool --7th specimen
Hemoglobin.gastrointestinal [Presence] in Stool --8th specimen
Butalbital [Mass/volume] in Vitreous fluid
Echovirus 30 RNA [Presence] in Cerebral spinal fluid by Probe
Neutrophils/100 leukocytes in Bronchial specimen
Bile acid [Moles/volume] in Serum --2 hours post meal
Calcium [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Echovirus 11 RNA [Presence] in Cerebral spinal fluid by Probe
Calcium [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Sporothrix schenckii Ab [Titer] in Serum
Phosphofructokinase F subunit/Phosphofructokinase.total in Platelets
Salmonella paratyphi B O Ab [Titer] in Serum by Agglutination
Collagen crosslinked N-telopeptide [Moles/volume] in Urine
Lactate [Mass/volume] in Cerebral spinal fluid
Interferon omega [Mass/volume] in Serum or Plasma
Coxiella burnetii phase 2 Ab [Titer] in Serum by Immunofluorescence
Phosphofructokinase F subunit/Phosphofructokinase.total in Leukocytes
Lactate [Mass/volume] in Blood --1 hour post XXX challenge
Coxsackievirus A7 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay
Lactate [Mass/volume] in Blood --4 hours post XXX challenge
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe
Coxiella burnetii phase 1 Ab [Titer] in Serum by Immunofluorescence
Phosphofructokinase L subunit/Phosphofructokinase.total in Red Blood Cells
Coxsackievirus B6 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe
Lactate [Mass/volume] in Blood --2 hours post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Pyruvate [Mass/volume] in Blood --4 hours post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Pyruvate [Mass/volume] in Blood --baseline
Coxsackievirus B5 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe
Phosphofructokinase M subunit/Phosphofructokinase.total in Red Blood Cells
Lactate [Mass/volume] in Blood --3 hours post XXX challenge
Pyruvate [Mass/volume] in Blood --1 hour post XXX challenge
Babesia microti IgM Ab [Presence] in Serum
Legionella pneumophila atypical Ab [Titer] in Serum by Immunofluorescence
Progesterone [Mass/volume] in Serum or Plasma --baseline
Pyruvate [Mass/volume] in Blood --2 hours post XXX challenge
Coxsackievirus A9 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe
Pyruvate [Mass/volume] in Blood --3 hours post XXX challenge
Catecholamines [Mass/volume] in Plasma --4 hours post XXX challenge
Histidine [Units/volume] in Serum or Plasma
Lactate [Mass/volume] in Blood --fasting
Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine
Metanephrines/Creatinine [Molar ratio] in 24 hour Urine
Phosphoglucomutase [Enzymatic activity/volume] in Serum
17-Ketogenic steroids [Moles/time] in 24 hour Urine
Thyroxine binding globulin [Moles/volume] in Serum or Plasma
2-Hydroxyisobutyrate [Presence] in Urine
Borrelia burgdorferi 66kD Ab [Presence] in Serum by Immunoblot
SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Borrelia burgdorferi 18kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 28kD Ab [Presence] in Serum by Immunoblot
Phosphoglycerate kinase [Enzymatic activity/volume] in Serum
Thyroxine (T4) free [Units/volume] in Serum or Plasma --baseline
Aldosterone [Mass/volume] in Serum or Plasma --baseline
Thyroxine (T4) free [Units/volume] in Serum or Plasma --1 hour post XXX challenge
Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination
Fibrinogen fragments [Mass/volume] in Urine by Latex agglutination
Borrelia burgdorferi 23kD Ab [Presence] in Cerebral spinal fluid by Immunoblot
Ehrlichia chaffeensis DNA [Presence] in Blood by NAA with probe detection
Phosphoglyceromutase [Enzymatic activity/volume] in Serum
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --baseline
Beta aminoadipate/Creatinine [Molar ratio] in Urine
Estrone (E1) [Mass/volume] in Saliva (oral fluid)
Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 39kD Ab [Presence] in Serum by Immunoblot
Sodium/Potassium [Molar ratio] in Serum or Plasma
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification
Escherichia coli shiga-like toxin [Units/volume] in Specimen by Immunoassay
Borrelia burgdorferi 39kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 39kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Gamma hydroxybutyrate [Mass/volume] in Blood
Borrelia burgdorferi 66kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 41kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma
Organophosphate pesticides [Mass/volume] in Urine by Screen method
Borrelia burgdorferi 41kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Gamma hydroxybutyrate [Mass/volume] in Urine
Cortisol [Presence] in Saliva (oral fluid) --1st specimen
Cortisol [Presence] in Saliva (oral fluid) --2nd specimen
Carbamate pesticides [Mass/volume] in Urine
Borrelia burgdorferi 58kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
1,2,4-Trichlorobenzene [Mass/volume] in Serum or Plasma
1,2,3-Trichlorobenzene [Mass/volume] in Serum or Plasma
1,3,5-Trichlorobenzene [Mass/volume] in Serum or Plasma
HIV 1 IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 30kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 45kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 28kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 23kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 21kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
7-Aminoclonazepam [Mass/volume] in Serum or Plasma
MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Naloxone [Mass/volume] in Serum or Plasma
Borrelia burgdorferi 23kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Mercury [Mass/volume] in Dentin --2nd specimen
amLODIPine [Mass/volume] in Serum or Plasma
Celecoxib [Mass/volume] in Serum or Plasma
Hemoglobin F [Presence] in Amniotic fluid
Beta aminobutyrate [Moles/volume] in Amniotic fluid
Meat fibers [#/area] in Stool by Light microscopy
Vegetable fibers [#/area] in Stool by Light microscopy
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool
7-Aminoclonazepam [Mass/volume] in Urine
Sildenafil citrate [Mass/volume] in Serum or Plasma
SUMAtriptan [Mass/volume] in Serum or Plasma
Hexachlorobutadiene [Presence] in Serum or Plasma
Bladder tumor Ag [Presence] in Urine by Immunoassay
Imipenem [Susceptibility] by Disk diffusion (KB)
Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Porphobilinogen [Mass/time] in 24 hour Urine
Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells
Porphobilinogen synthase [Enzymatic activity/volume] in Red Blood Cells
Porphyrins [Mass/volume] in Red Blood Cells
Porphyrins [Mass/volume] in Serum or Plasma
Imipenem [Susceptibility] by Serum bactericidal titer
Potassium [Moles/volume] in Cerebral spinal fluid
Potassium [Moles/volume] in Dialysis fluid
Potassium [Moles/volume] in Gastric fluid
Potassium [Moles/volume] in Serum or Plasma
Potassium [Moles/volume] in Red Blood Cells
Potassium [Moles/volume] in Saliva (oral fluid)
Potassium renal clearance in 24 hour Urine and Serum or Plasma
Pregnancy specific protein 1 [Mass/volume] in Serum
Pregnanediol [Mass/volume] in Amniotic fluid
Pregnanediol [Mass/time] in 24 hour Urine
Pregnanetriol [Mass/time] in 24 hour Urine
Pregnenolone [Mass/volume] in Serum or Plasma
Progesterone [Mass/volume] in Saliva (oral fluid)
Progesterone [Mass/volume] in Serum or Plasma
Proinsulin [Mass/volume] in Serum or Plasma
Prolactin [Mass/volume] in Serum or Plasma
Proline [Mass/volume] in Cerebral spinal fluid
Proline [Mass/volume] in Serum or Plasma
Proline dipeptidase [Enzymatic activity/mass] in Tissue
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Tissue
Prostaglandin E1 [Mass/volume] in Serum or Plasma
Prostaglandin E2 [Mass/volume] in Serum or Plasma
Platelet mean volume [Entitic volume] in Blood
Mesothelial cells/100 leukocytes in Body fluid
Mucus [#/area] in Urine sediment by Microscopy low power field
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum by Immunoassay
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum by Immunoassay
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Complement fixation
Yersinia sp identified in Stool by Organism specific culture
Bladder tumor Ag [Units/volume] in Urine by Immunoassay
Cladosporium herbarum IgM Ab [Units/volume] in Serum
Triglyceride [Presence] in Serum or Plasma
Prostaglandin F2 [Mass/volume] in Serum or Plasma
Nicotine+Cotinine [Presence] in Urine by Confirmatory method
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum by Immunofluorescence
Neuronal thread protein [Mass/volume] in Cerebral spinal fluid
Prostaglandin [Mass/volume] in Serum or Plasma
Prostate specific Ag [Mass/volume] in Serum or Plasma
2-Oxoadipate/Creatinine [Ratio] in Urine
4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine
4-Hydroxyphenyllactate/Creatinine [Ratio] in Urine
Beta alanine/Creatinine [Ratio] in Urine
Carnitine esters/Creatinine [Ratio] in Urine
Alpha aminobutyrate/Creatinine [Ratio] in Urine
Amino beta guanidinopropionate/Creatinine [Ratio] in Urine
Beta aminoadipate/Creatinine [Ratio] in Urine
Gamma aminobutyrate/Creatinine [Ratio] in Urine
3-Methylhistidine/Creatinine [Ratio] in Urine
Protein kinase [Enzymatic activity/volume] in Serum
Alpha aminoadipate/Creatinine [Ratio] in Urine
Cystathionine/Creatinine [Ratio] in Urine
Phosphoserine/Creatinine [Ratio] in Urine
Hydroxyproline/Creatinine [Ratio] in Urine
Beta aminoisobutyrate/Creatinine [Ratio] in Urine
Phosphoethanolamine/Creatinine [Ratio] in Urine
Protein nitrogen [Mass/time] in 24 hour Urine
Ethanolamine/Creatinine [Ratio] in Urine
1-Methylhistidine/Creatinine [Ratio] in Urine
Canine parvovirus Ab [Presence] in Stool by Hemagglutination inhibition
Alpha aminobutyrate/Creatinine [Ratio] in 24 hour Urine
Legionella sp IgM Ab [Titer] in Serum by Immunofluorescence
Albumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
Base excess in Arterial cord blood by calculation
Albumin [Mass/volume] in Synovial fluid by Electrophoresis
Base excess in Venous cord blood by calculation
Bicarbonate [Moles/volume] in Arterial cord blood
Bicarbonate [Moles/volume] in Venous cord blood
Oxygen saturation in Arterial cord blood
Carbon dioxide [Partial pressure] in Arterial cord blood
Carbon dioxide [Partial pressure] in Venous cord blood
Alpha 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Oxygen [Partial pressure] in Arterial cord blood
Oxygen [Partial pressure] in Venous cord blood
Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)
Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic method
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Coagulation factor X activated actual/normal in Platelet poor plasma by Chromogenic method
Plasmin inhibitor actual/normal in Platelet poor plasma by Immunoassay
Prekallikrein (Fletcher Factor) actual/normal in Platelet poor plasma by Chromogenic method
Plasminogen actual/normal in Platelet poor plasma by Chromogenic method
Alpha 1 globulin [Mass/volume] in Synovial fluid by Electrophoresis
Alpha 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Alpha 2 globulin [Mass/volume] in Synovial fluid by Electrophoresis
Beta globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Beta globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Beta globulin [Mass/volume] in Synovial fluid by Electrophoresis
Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)
Gamma globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Gamma globulin [Mass/volume] in Synovial fluid by Electrophoresis
Prealbumin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Prealbumin [Mass/volume] in Serum or Plasma by Electrophoresis
Protein [Presence] in Cerebral spinal fluid
Protein [Mass/volume] in Cerebral spinal fluid
Isoniazid [Susceptibility] by Disk diffusion (KB)
Protein [Mass/volume] in Peritoneal fluid
Protein [Mass/volume] in Serum or Plasma
Protein/Creatinine [Mass Ratio] in Urine
Protoporphyrin [Mass/time] in 24 hour Stool
Protoporphyrin Free [Mass/volume] in Blood
Protoporphyrin.zinc [Presence] in Red Blood Cells
Protoporphyrin.zinc [Mass/volume] in Red Blood Cells
Protoporphyrin [Presence] in Red Blood Cells
Protoporphyrin [Mass/volume] in Red Blood Cells
Isoniazid [Susceptibility] by Serum bactericidal titer
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Tissue
Pyridoxine [Mass/volume] in Serum or Plasma
Pyridoxine congeners [Mass/volume] in Serum or Plasma
Pyrimidine-5'-Nucleotidase [Presence] in Blood
Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood
Pyrophosphate crystals [#/volume] in Synovial fluid
Pyruvate [Mass/volume] in Arterial blood
Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)
Pyruvate [Mass/volume] in Cerebral spinal fluid
Pyruvate carboxylase [Enzymatic activity/mass] in Tissue
Pyruvate dehydrogenase.cytochrome [Enzymatic activity/volume] in Serum or Plasma
Pyruvate dehydrogenase.lipoamide [Enzymatic activity/mass] in Tissue
Pyruvate kinase [Enzymatic activity/volume] in Red Blood Cells
Zalcitabine [Units/volume] in Serum or Plasma
Pyruvate kinase [Enzymatic activity/volume] in Serum or Plasma
Pyruvate oxidase [Enzymatic activity/volume] in Serum or Plasma
Metanephrine [Mass/volume] in Serum or Plasma
Metanephrines [Mass/volume] in Serum or Plasma
1,4-Dimethylbenzene [Mass/volume] in Serum or Plasma
1,2-Dimethylbenzene [Mass/volume] in Serum or Plasma
1,3-Dimethylbenzene [Mass/volume] in Serum or Plasma
Alpha 1 antitrypsin [Mass/volume] in Body fluid
Carbamazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma
carBAMazepine.bound [Mass/volume] in Serum or Plasma
Mefloquine [Mass/volume] in Serum or Plasma
Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Somatotropin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
Cancer Ag 15-3 [Units/volume] in Body fluid
Choriogonadotropin.beta subunit [Units/volume] in Body fluid
Follitropin/Creatinine [Ratio] in 24 hour Urine
Lutropin [Units/volume] in 24 hour Urine
Renin [Enzymatic activity/volume] in Plasma
Lutropin/Creatinine [Ratio] in 24 hour Urine
Renin renal clearance in 24 hour Urine and Serum or Plasma
Renin [Enzymatic activity/volume] in Plasma --upright
Streptolysin O Ab [Units/volume] in Body fluid
Benzodiazepines [Mass/volume] in Body fluid
Bilirubin.indirect [Mass/volume] in Body fluid
carBAMazepine [Mass/volume] in Body fluid
Ceruloplasmin [Mass/volume] in Body fluid
Chloramphenicol [Mass/volume] in Body fluid
Retinoate [Mass/volume] in Serum or Plasma
Disopyramide [Mass/volume] in Body fluid
Ethosuximide [Mass/volume] in Body fluid
PHENobarbital [Mass/volume] in Body fluid
Tricyclic antidepressants [Mass/volume] in Body fluid
Kanamycin [Susceptibility] by Disk diffusion (KB)
Coxsackievirus B1 Ab [Titer] in Body fluid
Retinol [Mass/volume] in Serum or Plasma
Coxsackievirus B2 Ab [Titer] in Body fluid
Coxsackievirus B3 Ab [Titer] in Body fluid
Coxsackievirus B4 Ab [Titer] in Body fluid
Coxsackievirus B5 Ab [Titer] in Body fluid
Coxsackievirus B6 Ab [Titer] in Body fluid
Herpes simplex virus 2 Ab [Units/volume] in Body fluid
Herpes simplex virus 1 Ab [Units/volume] in Body fluid
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
Mumps virus IgG Ab [Units/volume] in Body fluid
Measles virus IgG Ab [Units/volume] in Body fluid
Thiodiglycolate/Creatinine [Mass Ratio] in Urine
Varicella zoster virus DNA [Presence] in Blood by NAA with probe detection
Riboflavin [Mass/volume] in Serum or Plasma
Varicella zoster virus IgG Ab [Units/volume] in Body fluid
Brucella sp Ab [Titer] in Serum --1st specimen
Brucella sp Ab [Titer] in Serum --2nd specimen
Alpha-1-Fetoprotein [Multiple of the median] adjusted in Amniotic fluid
Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)
Linezolid [Susceptibility] by Disk diffusion (KB)
Ribonuclease [Enzymatic activity/volume] in Serum
Fat.microscopic observation [Identifier] in Urine sediment by Sudan IV stain
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
Monocytes Abnormal/100 leukocytes in Blood by Manual count
Monocytes Abnormal [#/volume] in Blood by Manual count
Abnormal lymphocytes/100 leukocytes in Blood by Manual count
Abnormal lymphocytes [#/volume] in Blood by Manual count
Fibrin degradation products [Presence] in Blood by Agglutination
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination
Glutathione reductase [Presence] in Red Blood Cells
Glutethimide [Presence] in Gastric fluid
Phenylethylmalonamide [Presence] in Urine
Glutethimide [Mass/volume] in Gastric fluid
Methadone [Mass/volume] in Gastric fluid
Phenylethylmalonamide [Mass/volume] in Urine
Kanamycin [Susceptibility] by Serum bactericidal titer
Treponema pallidum [Presence] in Specimen by Immunofluorescence
Adenovirus Ab [Titer] in Body fluid by Complement fixation
Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge
Rickettsia typhi IgG Ab [Presence] in Body fluid
Rickettsia typhi IgM Ab [Presence] in Body fluid
Cocaethylene [Mass/volume] in Gastric fluid
Cocaethylene [Mass/volume] in Vitreous fluid
Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid
Xylose [Mass/volume] in Blood --2.5 hours post dose xylose PO
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Aspergillus fumigatus 2 Ab [Presence] in Serum
Mexiletine [Mass/volume] in Gastric fluid
Morphine Free [Mass/volume] in Gastric fluid
Flecainide [Mass/volume] in Gastric fluid
Methylmalonate [Mass/time] in 24 hour Urine
Rubella virus IgG Ab [Units/volume] in Body fluid
LORazepam [Mass/volume] in Gastric fluid
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium
Chloramphenicol [Mass/volume] in Gastric fluid
Serine [Mass/volume] in Cerebral spinal fluid
ALPRAZolam [Mass/volume] in Gastric fluid
Potassium [Moles/volume] in Serum or Plasma --post dialysis
Rheumatoid factor [Presence] in Cerebral spinal fluid
Salicylates [Mass/volume] in Gastric fluid
17-Ketosteroids.total neutral [Mass/time] in 12 hour Urine
Reovirus Ab [Titer] in Cerebral spinal fluid
Reovirus Ab [Titer] in Body fluid by Complement fixation
Cortisol [Mass/volume] in Serum or Plasma --pre XXX challenge
Parainfluenza virus 2 Ab [Titer] in Body fluid
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Magnesium [Mass/volume] in Cerebral spinal fluid
Parainfluenza virus 1 Ab [Titer] in Body fluid by Complement fixation
Parainfluenza virus 2 Ab [Titer] in Body fluid by Complement fixation
Parainfluenza virus 3 Ab [Titer] in Body fluid by Complement fixation
N-acetylprocainamide/Procainamide [Mass Ratio] in Serum or Plasma
cloZAPine [Mass/volume] in Serum or Plasma --trough
cloZAPine [Mass/volume] in Serum or Plasma --peak
Ethchlorvynol [Presence] in Gastric fluid
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
Methanol [Mass/volume] in Unknown substance
Narcotics and opioids [Identifier] in Blood
Narcotics and opioids [Identifier] in Gastric fluid
Insulin [Units/volume] in Serum or Plasma --4 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --6 hours post XXX challenge
chlordiazePOXIDE [Mass/volume] in Gastric fluid
Meprobamate [Mass/volume] in Gastric fluid
Nordiazepam [Mass/volume] in Gastric fluid
chlorproMAZINE [Mass/volume] in Gastric fluid
Norpropoxyphene [Mass/volume] in Gastric fluid
Methaqualone [Mass/volume] in Gastric fluid
Acetaminophen [Presence] in Gastric fluid
Parathyrin.mid molecule [Moles/volume] in Serum or Plasma
Gastrin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --fasting
Gastrin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --1 minute pre XXX challenge
clonazePAM [Mass/volume] in Gastric fluid
Meperidine [Mass/volume] in Gastric fluid
Disopyramide [Mass/volume] in Gastric fluid
Trimipramine [Mass/volume] in Gastric fluid
Thiothixene [Mass/volume] in Gastric fluid
Maprotiline [Mass/volume] in Gastric fluid
Amitriptyline [Mass/volume] in Gastric fluid
Nortriptyline [Mass/volume] in Gastric fluid
Imipramine [Mass/volume] in Gastric fluid
Desipramine [Mass/volume] in Gastric fluid
Nordoxepin [Mass/volume] in Gastric fluid
Glucose [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Reovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Parainfluenza virus 3 Ab [Titer] in Body fluid
Parainfluenza virus 1 Ab [Titer] in Body fluid
Sex hormone binding globulin [Mass/volume] in Serum or Plasma
Sialidase [Enzymatic activity/volume] in Serum
Sialidase [Enzymatic activity/mass] in Tissue
Sodium [Moles/volume] in Cerebral spinal fluid
Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)
Demeclocycline [Mass/volume] in Specimen
Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
Platelet associated IgA Ab [Presence] in Blood by Flow cytometry (FC)
Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC)
Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC)
2-Hydroxyadipate/Creatinine [Molar ratio] in Urine
2-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine
2-Hydroxyglutarate/Creatinine [Molar ratio] in Urine
2-Hydroxyisocaproate/Creatinine [Molar ratio] in Urine
2-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine
2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in Urine
2-Oxoadipate/Creatinine [Molar ratio] in Urine
Alpha ketoglutarate/Creatinine [Molar ratio] in Urine
3-Hydroxyadipate/Creatinine [Molar ratio] in Urine
Beta hydroxybutyrate/Creatinine [Molar ratio] in Urine
3-Hydroxyglutarate/Creatinine [Molar ratio] in Urine
3-Hydroxyisobutyrate/Creatinine [Molar ratio] in Urine
Sodium [Moles/volume] in Serum or Plasma
Beta hydroxybutyrate [Mass/volume] in Serum or Plasma
3-Hydroxyisovalerate/Creatinine [Molar ratio] in Urine
3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in Urine
3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine
3-Methylglutarate/Creatinine [Molar ratio] in Urine
4-Hydroxyphenylpyruvate/Creatinine [Molar ratio] in Urine
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine
5-Hydroxyhexanoate/Creatinine [Molar ratio] in Urine
5-Oxoproline/Creatinine [Molar ratio] in Urine
2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in Urine
Acetoacetate/Creatinine [Molar ratio] in Urine
Aconitate/Creatinine [Molar ratio] in Urine
Azelate/Creatinine [Molar ratio] in Urine
Citrate/Creatinine [Molar ratio] in Urine
Hippurate/Creatinine [Molar ratio] in Urine
Cryptococcus sp Ag [Presence] in Specimen
West Nile virus IgG Ab [Units/volume] in Serum
West Nile virus IgM Ab [Units/volume] in Serum
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid
HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification
E-cadherin [Presence] in Tissue by Immune stain
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Amniotic fluid cells
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Amniotic fluid cells
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Haemophilus ducreyi DNA [Presence] in Specimen by NAA with probe detection
Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Anaplasma phagocytophilum DNA [Presence] in Specimen by NAA with probe detection
Jamestown canyon virus IgG Ab [Titer] in Serum by Immunofluorescence
Jamestown canyon virus neutralizing antibody [Titer] in Serum by Neutralization test
La Crosse virus neutralizing antibody [Titer] in Serum by Neutralization test
Powassan virus IgG Ab [Titer] in Serum by Immunofluorescence
Powassan virus IgM Ab [Titer] in Serum by Immunofluorescence
West Nile virus IgG Ab [Presence] in Serum by Immunoassay
West Nile virus IgM Ab [Presence] in Serum by Immunoassay
West Nile virus neutralizing antibody [Titer] in Serum by Neutralization test
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
West Nile virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Sodium renal clearance in 24 hour Urine and Serum or Plasma
Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria
Differential panel - Cerebral spinal fluid
Cytomegalovirus DNA [Mass/volume] (viral load) in Blood by Probe
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain
CD45RO Ag [Presence] in Tissue by Immune stain
Alpha-1-Fetoprotein [Multiple of the median] in Amniotic fluid
CD25 Ag [Presence] in Tissue by Immune stain
Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Benzfetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method
CD5 Ag [Presence] in Tissue by Immune stain
Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection
Tropheryma whipplei DNA [Presence] in Tissue by NAA with probe detection
Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification
Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma by Confirmatory method
Phendimetrazine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Phenmetrazine [Mass/volume] in Serum or Plasma by Confirmatory method
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Stachybotrys chartarum IgE Ab [Units/volume] in Serum
CD23 Ag [Presence] in Tissue by Immune stain
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method
Zonisamide [Mass/volume] in Serum or Plasma
Beta hydroxybutyrate [Presence] in Urine
3-Hydroxydodecanoate (3-OH-C12:0) [Presence] in Urine
3-Hydroxypropionate (3-OH-C3) [Presence] in Urine
3-Hydroxysebacate ( 3-OH-C8) [Presence] in Urine
3-Methylcrotonylglycine [Presence] in Urine
Somatotropin [Mass/volume] in Amniotic fluid
CD122 Ag [Presence] in Tissue by Immune stain
Somatotropin [Mass/volume] in Serum or Plasma
Alkaline phosphatase [Enzymatic activity/mass] in Tissue
Ketoconazole [Susceptibility] by Disk diffusion (KB)
Isomaltase [Enzymatic activity/mass] in Tissue
Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence
Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence
Myeloperoxidase Ab [Presence] in Serum by Immunoassay
Proteinase 3 [Presence] in Serum by Immunoassay
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum by Immunoassay
Parainfluenza virus 2 IgM Ab [Presence] in Serum by Immunoassay
Interferon beta Ab [Presence] in Serum or Plasma
Rickettsia australis Ab [Titer] in Serum by Immunofluorescence
Rickettsia australis Ab [Presence] in Serum by Immunofluorescence
Rickettsia honei Ab [Titer] in Serum by Immunofluorescence
Rickettsia honei Ab [Presence] in Serum by Immunofluorescence
Dothiepin [Mass/volume] in Serum or Plasma
Dothiepin [Moles/volume] in Serum or Plasma
Temazepam [Moles/volume] in Serum or Plasma
Oxazepam [Moles/volume] in Serum or Plasma
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoassay
Bordetella pertussis IgM Ab [Presence] in Serum by Immunoassay
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay
Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay
Dengue virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
Dengue virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Chlamydia sp IgA Ab [Presence] in Serum by Immunoassay
Rickettsia conorii Ab [Titer] in Serum by Immunofluorescence
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum
Parainfluenza virus 2 IgM Ab [Presence] in Serum
Rickettsia australis Ab [Titer] in Serum
Rickettsia australis Ab [Presence] in Serum
Bordetella pertussis IgA Ab [Presence] in Serum
Bordetella pertussis IgM Ab [Presence] in Serum
Bordetella pertussis IgG Ab [Presence] in Serum
Parvovirus B19 IgG Ab [Presence] in Serum
Starch granules [Presence] in Stool by Light microscopy
Rickettsia prowazekii Ab [Titer] in Serum
Rickettsia prowazekii Ab [Presence] in Serum
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum
Orientia tsutsugamushi Karp Ab [Titer] in Serum
Orientia tsutsugamushi Karp Ab [Presence] in Serum
Orientia tsutsugamushi Kato Ab [Titer] in Serum
Orientia tsutsugamushi Kato Ab [Presence] in Serum
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum
Leptospira interrogans sv Celledoni Ab [Presence] in Serum
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum
Leptospira interrogans sv Djasiman Ab [Presence] in Serum
Leptospira interrogans sv Javanica Ab [Presence] in Serum
Leptospira interrogans sv Panama Ab [Presence] in Serum
Leptospira interrogans sv Shermani Ab [Presence] in Serum
Leptospira interrogans sv Zanoni Ab [Presence] in Serum
Streptomyces proteinase [Presence] in Serum
Rickettsia conorii Ab [Presence] in Serum by Immunofluorescence
Rickettsia sibirica Ab [Titer] in Serum by Immunofluorescence
Rickettsia sibirica Ab [Presence] in Serum by Immunofluorescence
Rickettsia rickettsii Ab [Titer] in Serum by Immunofluorescence
Rickettsia rickettsii Ab [Presence] in Serum by Immunofluorescence
Rickettsia akari Ab [Titer] in Serum by Immunofluorescence
Rickettsia akari Ab [Presence] in Serum by Immunofluorescence
Rickettsia prowazekii Ab [Titer] in Serum by Immunofluorescence
Substance P [Mass/volume] in Serum or Plasma
Rickettsia prowazekii Ab [Presence] in Serum by Immunofluorescence
Rickettsia typhi Ab [Titer] in Serum by Immunofluorescence
Rickettsia typhi Ab [Presence] in Serum by Immunofluorescence
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum by Immunofluorescence
Orientia tsutsugamushi Karp Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Karp Ab [Presence] in Serum by Immunofluorescence
Orientia tsutsugamushi Kato Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Kato Ab [Presence] in Serum by Immunofluorescence
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum by Immunofluorescence
Ketoconazole [Susceptibility] by Serum bactericidal titer
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum by Immunofluorescence
Influenza virus C Ag [Presence] in Specimen by Immunofluorescence
Chlamydophila pneumoniae Ag [Presence] in Specimen by Immunofluorescence
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
Leptospira interrogans sv Celledoni Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Djasiman Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Javanica Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Panama Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Shermani Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Zanoni Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Kremastos Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum by Agglutination
Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination
Rickettsia sibirica Ab [Presence] in Serum
Rickettsia rickettsii Ab [Titer] in Serum
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum
Leptospira interrogans sv Kremastos Ab [Presence] in Serum
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum
Leptospira interrogans sv Medanensis Ab [Presence] in Serum
Cryofibrinogen [Presence] in Plasma by 3 day RT incubation
Cryofibrinogen [Presence] in Plasma by 3 day 37 degree C incubation
Cryoglobulin [Presence] in Serum by 3 day RT incubation
Cryoglobulin [Presence] in Serum by 3 day 37 degree C incubation
Tocopherols [Moles/volume] in Serum or Plasma
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
Protoporphyrin.zinc [Molar ratio] in Red Blood Cells
Cholesterol [Moles/volume] in Body fluid
Triglyceride [Moles/volume] in Body fluid
Bilirubin.total [Moles/volume] in Body fluid
Sulfate.inorganic [Mass/volume] in Serum or Plasma
Karyotype [Identifier] in Blood or Tissue Nominal
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay
Coxiella burnetii phase 2 Ab [Titer] in Serum by Complement fixation
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunoassay
Coxiella burnetii phase 1 Ab [Titer] in Serum by Complement fixation
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
Microscopic observation [Identifier] in Blood by Brilliant cresyl blue
Sulfite oxidase [Enzymatic activity/volume] in Plasma
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay
West Nile virus IgM Ab [Presence] in Specimen by Immunoassay
West Nile virus neutralizing antibody [Titer] in Specimen by Neutralization test
West Nile virus IgM Ab [Presence] in Specimen
Trivittatus virus neutralizing antibody [Titer] in Specimen by Neutralization test
Saint Louis encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Highlands J virus neutralizing antibody [Titer] in Specimen by Neutralization test
Superoxide dismutase [Enzymatic activity/volume] in Plasma
Eastern equine encephalitis virus IgG Ab [Presence] in Specimen by Immunofluorescence
Jamestown canyon virus IgM Ab [Units/volume] in Specimen by Immunofluorescence
Jamestown canyon virus IgM Ab [Presence] in Specimen by Immunofluorescence
Jamestown canyon virus IgG Ab [Units/volume] in Specimen by Immunofluorescence
La Crosse virus IgG Ab [Presence] in Specimen by Immunofluorescence
La Crosse virus IgM Ab [Presence] in Specimen by Immunofluorescence
Powassan virus IgG Ab [Presence] in Specimen by Immunofluorescence
Powassan virus IgM Ab [Presence] in Specimen by Immunofluorescence
Taurine [Mass/volume] in Cerebral spinal fluid
Anaplasma phagocytophilum IgG Ab [Presence] in Specimen by Immunoblot
Anaplasma phagocytophilum IgM Ab [Presence] in Specimen by Immunoblot
Trivittatus virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Saint Louis encephalitis virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Highlands J virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Trivittatus virus neutralizing antibody [Titer] in Serum by Neutralization test
Saint Louis encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test
Highlands J virus neutralizing antibody [Titer] in Serum by Neutralization test
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunofluorescence
Jamestown canyon virus IgM Ab [Units/volume] in Serum by Immunofluorescence
Jamestown canyon virus IgM Ab [Presence] in Serum by Immunofluorescence
Jamestown canyon virus IgG Ab [Units/volume] in Serum by Immunofluorescence
La Crosse virus IgG Ab [Presence] in Serum by Immunofluorescence
La Crosse virus IgM Ab [Presence] in Serum by Immunofluorescence
Powassan virus IgG Ab [Presence] in Serum by Immunofluorescence
Powassan virus IgM Ab [Presence] in Serum by Immunofluorescence
Taurine [Mass/volume] in Serum or Plasma
Anaplasma phagocytophilum IgG Ab [Presence] in Serum by Immunoblot
Anaplasma phagocytophilum IgM Ab [Presence] in Serum by Immunoblot
Trivittatus virus Ab [Titer] in Specimen
Saint Louis encephalitis virus Ab [Titer] in Specimen
Highlands J virus Ab [Titer] in Specimen
Eastern equine encephalitis virus IgG Ab [Presence] in Specimen
Jamestown canyon virus IgM Ab [Units/volume] in Specimen
Jamestown canyon virus IgM Ab [Presence] in Specimen
Jamestown canyon virus IgG Ab [Units/volume] in Specimen
La Crosse virus IgG Ab [Presence] in Specimen
La Crosse virus IgM Ab [Presence] in Specimen
Powassan virus IgG Ab [Presence] in Specimen
Powassan virus IgM Ab [Presence] in Specimen
Anaplasma phagocytophilum IgG Ab [Presence] in Specimen
Anaplasma phagocytophilum IgM Ab [Presence] in Specimen
Trivittatus virus Ab [Titer] in Cerebral spinal fluid
Terminal deoxyribonucleotidyl transferase [Enzymatic activity/volume] in Plasma
Highlands J virus Ab [Titer] in Cerebral spinal fluid
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid
Testosterone [Mass/volume] in Saliva (oral fluid)
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid
Eastern equine encephalitis virus IgG Ab [Presence] in Serum
Jamestown canyon virus IgM Ab [Units/volume] in Serum
Jamestown canyon virus IgM Ab [Presence] in Serum
Jamestown canyon virus IgG Ab [Units/volume] in Serum
La Crosse virus IgG Ab [Presence] in Serum
La Crosse virus IgM Ab [Presence] in Serum
Powassan virus IgG Ab [Presence] in Serum
Powassan virus IgM Ab [Presence] in Serum
Anaplasma phagocytophilum IgG Ab [Presence] in Serum
Anaplasma phagocytophilum IgM Ab [Presence] in Serum
Alpha hydroxybutyrate/Creatinine [Molar ratio] in Urine
Adipate/Creatinine [Molar ratio] in Urine
IgD Ag [Presence] in Tissue by Immune stain
2-Oxo,3-Methylvalerate [Presence] in Urine
3-Hydroxy,3-Methylglutarate [Presence] in Urine
Testosterone [Mass/volume] in Serum or Plasma
Gamma hydroxybutyrate [Presence] in Urine
4-Hydroxycyclohexylacetate [Presence] in Urine
4-Hydroxyphenyllactate [Presence] in Urine
4-Hydroxyphenylpyruvate [Presence] in Urine
Argininosuccinate/Creatinine [Molar ratio] in Urine
Dehydroepiandrosterone (DHEA)/Creatinine [Mass Ratio] in 24 hour Urine
2-Hydroxy-3-Methylvalerate [Presence] in Urine
2-Hydroxyisovalerate [Presence] in Urine
2-Hydroxyphenylacetate [Presence] in Urine
2-Methylbutyrylglycine [Presence] in Urine
Actinobacillus sp identified in Specimen by Organism specific culture
Encephalomyocarditis virus neutralizing antibody [Titer] in Serum by Neutralization test
Pasteurella multocida type [Identifier] in Isolate
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum by Immunoassay
Encephalomyocarditis virus Ab [Titer] in Serum
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum
Helicobacter pylori [Presence] in Stomach by urea breath test
Testosterone [Mass/time] in 24 hour Urine
HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi IgG Ab [Presence] in Specimen by Immunoblot
Gamma globulin [Presence] in 24 hour Urine
Ampicillin [Susceptibility] by Disk diffusion (KB)
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification
HTLV I+II Ab [Presence] in Serum by Immunoassay
Cryptococcus sp Ag [Presence] in Serum by Immunoassay
Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
Entamoeba histolytica Ag [Presence] in Stool by Immunoassay
Haemophilus influenzae A DNA [Presence] in Specimen by NAA with probe detection
Haemophilus influenzae B DNA [Presence] in Specimen by NAA with probe detection
Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
Xylose [Mass/volume] in Serum or Plasma --2 hours post 5 g xylose PO
Selenium/Creatinine [Mass Ratio] in 24 hour Urine
Testosterone Free [Mass/volume] in Serum or Plasma
Chromium/Creatinine [Mass Ratio] in 24 hour Urine
Beryllium/Creatinine [Mass Ratio] in 24 hour Urine
Boron/Creatinine [Mass Ratio] in 24 hour Urine
Scandium/Creatinine [Mass Ratio] in 24 hour Urine
Testosterone [Mass/volume] in Amniotic fluid
Beryllium [Mass/volume] in 24 hour Urine
Titanium/Creatinine [Mass Ratio] in 24 hour Urine
Vanadium/Creatinine [Mass Ratio] in 24 hour Urine
Cobalt/Creatinine [Mass Ratio] in 24 hour Urine
Manganese/Creatinine [Mass Ratio] in 24 hour Urine
Aluminum/Creatinine [Mass Ratio] in 24 hour Urine
Thallium/Creatinine [Mass Ratio] in 24 hour Urine
Tellurium/Creatinine [Mass Ratio] in 24 hour Urine
Bismuth/Creatinine [Mass Ratio] in 24 hour Urine
Antimony/Creatinine [Mass Ratio] in 24 hour Urine
Copper/Creatinine [Mass Ratio] in 24 hour Urine
Lead/Creatinine [Mass Ratio] in 24 hour Urine
Alpha-2-Macroglobulin [Mass/volume] in Specimen
Alpha 1 globulin [Presence] in 24 hour Urine by Electrophoresis
Albumin [Presence] in 24 hour Urine by Electrophoresis
Alpha 2 globulin [Presence] in 24 hour Urine by Electrophoresis
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID)
Sjogrens syndrome-B extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID)
Nuclear IgG Ab [Presence] in Serum by Immunoassay
Beta globulin [Presence] in 24 hour Urine
Borrelia burgdorferi Ag [Mass/volume] in Urine by Immunoassay
Extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Legionella pneumophila IgG Ab [Units/volume] in Serum by Immunoassay
Herpes simplex virus Ag [Presence] in Serum by Immunoblot
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Tetrahydrocortisol [Mass/time] in 24 hour Urine
Ganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay
Ganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay
Asialoganglioside GM1 IgG Ab [Mass/volume] in Serum by Immunoassay
Asialoganglioside GM1 IgM Ab [Mass/volume] in Serum by Immunoassay
Parietal cell IgG Ab [Presence] in Serum by Immunofluorescence
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Centromere IgG Ab [Titer] in Serum by Immunofluorescence
Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine
Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence
Rubidium/Creatinine [Mass Ratio] in 24 hour Urine
Strontium [Mass/volume] in 24 hour Urine
Strontium/Creatinine [Mass Ratio] in 24 hour Urine
Molybdenum [Mass/volume] in 24 hour Urine
Tetrahydrofolate [Mass/volume] in Plasma
Molybdenum/Creatinine [Mass Ratio] in 24 hour Urine
Silver/Creatinine [Mass Ratio] in 24 hour Urine
Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tin/Creatinine [Mass Ratio] in 24 hour Urine
Cesium/Creatinine [Mass Ratio] in 24 hour Urine
Barium/Creatinine [Mass Ratio] in 24 hour Urine
Gold/Creatinine [Mass Ratio] in 24 hour Urine
Uranium/Creatinine [Mass Ratio] in 24 hour Urine
Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy
Thiamine [Mass/volume] in Serum or Plasma
Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination
Eosinophils [Presence] in Nose by Wright stain
Eosinophils [Presence] in Sputum by Wright stain
Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence
Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence
Histone IgG Ab [Units/volume] in Serum by Immunoassay
Basement membrane IgG Ab [Units/volume] in Serum by Immunoassay
Striated muscle IgG Ab [Titer] in Serum by Immunofluorescence
Microalbumin/Creatinine [Ratio] in Urine
Microalbumin/Creatinine [Ratio] in Urine by Test strip
Creatinine [Moles/volume] in Urine by Test strip
Microalbumin [Mass/volume] in 24 hour Urine
Creatinine [Mass/volume] in Urine by Test strip
CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Thiamine pyrophosphate [Mass/volume] in Serum
Transfuse cryoprecipitate poor plasma [Volume]
Blood group antibody screen [Titer] in Serum or Plasma by Albumin technique
Fibrin+Fibrinogen fragments [Mass/volume] in Serum
Borrelia burgdorferi 93kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 45kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 28kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 23kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 21kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 41kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 66kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 58kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 30kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 41kD IgM Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 39kD IgM Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 23kD IgM Ab [Presence] in Synovial fluid by Immunoblot
Botrytis cinerea IgG Ab [Units/volume] in Serum
Thiocyanate [Mass/volume] in Serum or Plasma
Bacillus subtilis IgE Ab [Units/volume] in Serum
Carbophenothion [Mass/volume] in Serum or Plasma
Coumaphos [Mass/volume] in Serum or Plasma
Dichlorvos [Mass/volume] in Serum or Plasma
Dimethoate [Mass/volume] in Serum or Plasma
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Serum or Plasma
Thiocyanate [Presence] in Serum or Plasma
Alternaria alternata+American house dust mite IgG Ab [Presence] in Serum by Multidisk
Phoma betae IgG Ab [Units/volume] in Serum
Bovine herpesvirus 1 Ab [Presence] in Serum by Complement fixation
Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID)
Alternaria alternata+American house dust mite IgE Ab [Presence] in Serum by Multidisk
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Anaplasma phagocytophilum DNA [Presence] in Blood by NAA with probe detection
Lincomycin [Susceptibility] by Disk diffusion (KB)
Dirofilaria immitis Ab [Units/volume] in Serum
Vigabatrin [Mass/volume] in Serum or Plasma
Mycobacterium sp identified in Dialysis fluid by Organism specific culture
Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay
Hydroxylysine/Creatinine [Ratio] in Urine
Phenylalanine/Creatinine [Ratio] in Urine
Thiosulfate renal clearance in 24 hour Urine and Serum or Plasma
Amino beta guanidinopropionate [Moles/volume] in Serum or Plasma
Threonine [Mass/volume] in Cerebral spinal fluid
Tyrosine [Moles/volume] in Amniotic fluid
Cystathionine [Moles/volume] in Amniotic fluid
Trichoderma viride IgG Ab [Units/volume] in Serum
Cortisone [Mass/volume] in 24 hour Urine by HPLC
Voltage-gated calcium channel Ab [Presence] in Serum
Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
Amylase/Creatinine renal clearance [Ratio] in Urine and Serum or Plasma
Renal tubular casts [#/area] in Urine by Light microscopy
Threonine [Mass/volume] in Serum or Plasma
Cathepsin D [Presence] in Tissue by Immune stain
IgD [Presence] in Serum by Immunofixation
IgE [Presence] in Serum by Immunofixation
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
Legionella pneumophila IgG Ab [Units/volume] in Serum
Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Cow hair+Cow dander IgE Ab [Units/volume] in Serum
Horse hair+Horse dander IgE Ab [Units/volume] in Serum
Transitional cells [#/area] in Urine sediment by Microscopy high power field
Burkholderia pseudomallei IgG Ab [Titer] in Specimen by Immunofluorescence
Burkholderia pseudomallei IgM Ab [Titer] in Specimen by Immunofluorescence
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Latex agglutination
Neisseria meningitidis serogroup B Ag [Presence] in Specimen by Latex agglutination
Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Latex agglutination
Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen by Latex agglutination
Neisseria meningitidis serogroup Y Ag [Presence] in Specimen by Latex agglutination
Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture
Yersinia enterocolitica O:3 Ab [Titer] in Specimen
Yersinia enterocolitica O:5 Ab [Titer] in Specimen
Yersinia enterocolitica O:8 Ab [Titer] in Specimen
Yersinia enterocolitica O:9 Ab [Titer] in Specimen
Trypanosoma cruzi IgG Ab [Titer] in Specimen
Trypanosoma cruzi IgM Ab [Titer] in Specimen
Acetylcholinesterase [Presence] in Amniotic fluid
Ecgonine methyl ester [Mass/volume] in Serum or Plasma
Ecgonine methyl ester [Mass/mass] in Meconium
Ecgonine methyl ester [Mass/volume] in Gastric fluid
Ecgonine methyl ester [Mass/volume] in Vitreous fluid
Thermoactinomyces vulgaris 2 Ab [Presence] in Serum
Amphetamine [Mass/volume] in Serum or Plasma
IgG lymphocytes [#/volume] in Leukocytes
Thromboxane alpha 2 [Mass/volume] in Serum
Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Immunoperoxidase stain
Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen by Immunoperoxidase stain
IgA lymphocytes [#/volume] in Leukocytes
IgM lymphocytes [#/volume] in Leukocytes
Lincomycin [Susceptibility] by Serum bactericidal titer
IgD lymphocytes [#/volume] in Leukocytes
Colony count [#/volume] in Dialysis fluid
Thromboxane beta 2 [Mass/volume] in Serum or Plasma
Aeromonas sp [Presence] in Specimen by Organism specific culture
Testosterone.bound [Mass/volume] in Serum or Plasma
Amylase [Enzymatic activity/time] in 1 hour Urine
Gerbil hair IgE Ab [Units/volume] in Serum
Borrelia burgdorferi Ab [Units/volume] in Serum --2nd specimen
Brucella sp Ab [Presence] in Serum --1st specimen
Thyroglobulin [Mass/volume] in Serum or Plasma
Brucella sp Ab [Presence] in Serum --2nd specimen
Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma
Coxsackievirus Ab [Presence] in Serum --1st specimen
Coxsackievirus Ab [Presence] in Serum --2nd specimen
Echovirus Ab [Presence] in Serum --1st specimen
Echovirus Ab [Presence] in Serum --2nd specimen
Epstein Barr virus capsid IgG Ab [Presence] in Serum --2nd specimen
Epstein Barr virus capsid IgM Ab [Presence] in Serum --2nd specimen
Epstein Barr virus nuclear Ab [Presence] in Serum --2nd specimen
Hydroxyproline Free [Presence] in 24 hour Urine
IgA [Presence] in 24 hour Urine by Immunoelectrophoresis
IgG [Presence] in 24 hour Urine by Immunoelectrophoresis
IgM [Presence] in 24 hour Urine by Immunoelectrophoresis
Legionella sp Ab [Presence] in Serum --1st specimen
Legionella sp Ab [Presence] in Serum --2nd specimen
Monocytes [#/volume] in Synovial fluid by Manual count
Mumps virus Ab [Presence] in Serum --2nd specimen
Respiratory syncytial virus Ab [Presence] in Serum --1st specimen
Respiratory syncytial virus Ab [Presence] in Serum --2nd specimen
Streptolysin O Ab [Units/volume] in Serum --1st specimen
Streptolysin O Ab [Units/volume] in Serum --2nd specimen
Thyrotropin.long acting [Units/volume] in Serum or Plasma
Mannose-binding protein [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
Protein/Creatinine [Mass Ratio] in Serum or Plasma
Reticulocytes.punctate/100 erythrocytes in Blood
Reticulocytes.aggregate/100 erythrocytes in Blood
HTLV I+II DNA [Presence] in Blood by NAA with probe detection
Tau protein [Mass/volume] in Cerebral spinal fluid
Artichoke IgG Ab [Units/volume] in Serum
Thyrotropin [Units/volume] in Serum or Plasma
Sweat Bee IgE Ab [Units/volume] in Serum
Nut Allergen Mix (Cashew+Pecan or Hickory nut+English walnut) IgE Ab [Presence] in Serum by Multidisk
Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid
Thyroid stimulating immunoglobulins actual/normal in Serum
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
Oneseed Juniper IgE Ab [Units/volume] in Serum
Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay
American Cockroach IgE Ab [Units/volume] in Serum
Cortisol Free/Creatinine [Molar ratio] in 24 hour Urine
Cortisol Free/Creatinine [Molar ratio] in Urine
Jamestown canyon virus IgG Ab [Titer] in Specimen by Immunofluorescence
Jamestown canyon virus neutralizing antibody [Presence] in Specimen by Neutralization test
La Crosse virus neutralizing antibody [Presence] in Specimen by Neutralization test
Powassan virus IgG Ab [Titer] in Specimen by Immunofluorescence
West Nile virus IgG Ab [Presence] in Specimen by Immunoassay
Powassan virus IgM Ab [Titer] in Specimen by Immunofluorescence
Lymphocytes clefted [#/volume] in Blood by Manual count
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Units/volume] in Serum by Multidisk
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Units/volume] in Serum by Multidisk
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk
Thyrotropin releasing hormone [Mass/volume] in Plasma
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Units/volume] in Serum by Multidisk
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma
Acetylcarnitine (C2) [Moles/volume] in Serum or Plasma
Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum
Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Fatty acids.very long chain C22:0 (Docosanoate) [Moles/volume] in Serum or Plasma
Fatty acids.very long chain C24:0 (Tetracosanoate) [Moles/volume] in Serum or Plasma
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma
Thyrotropin.long acting [Presence] in Serum or Plasma
Fatty acids.very long chain C26:0 (Hexacosanoate) [Moles/volume] in Serum or Plasma
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma
Alpha subunit [Mass/volume] in Serum or Plasma
Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Asialoganglioside GM1 IgM Ab [Presence] in Serum
Candida albicans reaction wheal [Diameter] --2 days post 0.1 mL Candida albicans intradermal
Chlamydia trachomatis Ab [Presence] in Serum
Thyroxine binding globulin [Mass/volume] in Blood
Chlamydophila pneumoniae Ab [Presence] in Serum
Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid
Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Complement fixation
Coccidioides reaction wheal [Diameter] --2 days post 0.1 mL coccidioidin intradermal
Coxiella burnetii IgG Ab [Presence] in Serum
Thyroxine binding globulin [Mass/volume] in Serum or Plasma
Coxiella burnetii IgM Ab [Presence] in Serum
Coxsackievirus A10 Ab [Presence] in Serum
Coxsackievirus A16 Ab [Presence] in Serum
Coxsackievirus A2 Ab [Presence] in Serum
Coxsackievirus A4 Ab [Presence] in Serum
Coxsackievirus A7 Ab [Presence] in Serum
Coxsackievirus A9 Ab [Presence] in Serum
Coxsackievirus B1 Ab [Presence] in Serum
Coxsackievirus B2 Ab [Presence] in Serum
Coxsackievirus B3 Ab [Presence] in Serum
Coxsackievirus B4 Ab [Presence] in Serum
Coxsackievirus B5 Ab [Presence] in Serum
Coxsackievirus B6 Ab [Presence] in Serum
Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post 0.1 mL histoplasmin intradermal
Mumps reaction wheal [Diameter] --2 days post 0.1 mL mumps intradermal
Band form neutrophils [#/volume] in Blood by Automated count
Segmented neutrophils/100 leukocytes in Body fluid by Manual count
Rheumatoid factor [Units/volume] in Body fluid
Trichophyton reaction wheal [Diameter] --2 days post 0.1ml trichophyton intradermal
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Serum or Plasma
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Serum or Plasma
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Serum or Plasma
3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Serum or Plasma
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Serum or Plasma
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Serum or Plasma
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P
Choriogonadotropin.intact [Units/volume] in Serum or Plasma
Acetylcholinesterase [Enzymatic activity/volume] in Blood
Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection
Thyroxine (T4) free [Mass/volume] in Serum or Plasma
Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
Barbiturates [Mass/volume] in Serum or Plasma by Screen method
Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method
Glucose [Moles/volume] in Serum or Plasma --2.6 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --3.3 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --3.6 hours post dose glucose
Insulin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge
Insulin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
Insulin [Units/volume] in Serum or Plasma --1.3 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --1.6 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --2.3 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --2.6 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --3.3 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --3.5 hours post XXX challenge
Thyroxine (T4) [Mass/volume] in Serum or Plasma
Insulin [Units/volume] in Serum or Plasma --3.6 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --1.6 hours post dose glucose
Glucose [Moles/volume] in Serum or Plasma --2.3 hours post dose glucose
Zidovudine [Susceptibility] by Phenotype method
lamiVUDine [Susceptibility] by Phenotype method
Thyroxine (T4)/Thyroxine binding globulin [Mass Ratio] in Serum or Plasma
Didanosine [Susceptibility] by Phenotype method
Zalcitabine [Susceptibility] by Phenotype method
Stavudine [Susceptibility] by Phenotype method
Abacavir [Susceptibility] by Phenotype method
Adefovir [Susceptibility] by Phenotype method
Nevirapine [Susceptibility] by Phenotype method
Delavirdine [Susceptibility] by Phenotype method
Efavirenz [Susceptibility] by Phenotype method
Indinavir [Susceptibility] by Phenotype method
Ritonavir [Susceptibility] by Phenotype method
Nelfinavir [Susceptibility] by Phenotype method
Saquinavir [Susceptibility] by Phenotype method
Zidovudine [Susceptibility] by Genotype method
lamiVUDine [Susceptibility] by Genotype method
Didanosine [Susceptibility] by Genotype method
Zalcitabine [Susceptibility] by Genotype method
Stavudine [Susceptibility] by Genotype method
Abacavir [Susceptibility] by Genotype method
Adefovir [Susceptibility] by Genotype method
Nevirapine [Susceptibility] by Genotype method
Delavirdine [Susceptibility] by Genotype method
Efavirenz [Susceptibility] by Genotype method
Indinavir [Susceptibility] by Genotype method
Ritonavir [Susceptibility] by Genotype method
Nelfinavir [Susceptibility] by Genotype method
Saquinavir [Susceptibility] by Genotype method
Amprenavir [Susceptibility] by Phenotype method
Amprenavir [Susceptibility] by Genotype method
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Serum or Plasma
Hemoglobin [Mass/volume] in Arterial blood
Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue
Alpha subunit free [Mass/volume] in Serum or Plasma
Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1 hour post incubation
aPTT.factor substitution in Platelet poor plasma --1 hour post incubation
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma
Cryptococcus sp Ag [Presence] in Serum by Latex agglutination
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Decanoylcarnitine (C10) [Moles/volume] in Serum or Plasma
Decenoylcarnitine (C10:1) [Moles/volume] in Serum or Plasma
Dodecanoylcarnitine (C12) [Moles/volume] in Serum or Plasma
Dodecenoylcarnitine (C12:1) [Moles/volume] in Serum or Plasma
Echovirus 11 Ab [Presence] in Serum by Complement fixation
Echovirus 30 Ab [Presence] in Serum by Complement fixation
Echovirus 4 Ab [Presence] in Serum by Complement fixation
Echovirus 7 Ab [Presence] in Serum by Complement fixation
Echovirus 9 Ab [Presence] in Serum by Complement fixation
Anaplasma phagocytophilum Ab [Titer] in Serum by Immunofluorescence
Epstein Barr virus capsid IgG Ab [Presence] in Serum
Epstein Barr virus capsid IgM Ab [Presence] in Serum
Extractable nuclear Ab [Units/volume] in Serum
Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay
Glucose [Mass/volume] in Serum or Plasma --1 hour post 1.2 g/kg lactose PO
Glucose [Mass/volume] in Serum or Plasma --2 hours post 1.2 g/kg lactose PO
Transferrin [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --3 hours post 1.2 g/kg lactose PO
Glutamate decarboxylase 65 Ab [Moles/volume] in Serum
Glutarylcarnitine (C5-DC) [Moles/volume] in Serum or Plasma
Hemoglobin [Mass/volume] in Venous blood
Hemoglobin [Mass/volume] in Mixed venous blood
Hemoglobin [Mass/volume] in Capillary blood
Hemoglobin [Mass/volume] in Venous cord blood
Hemoglobin [Mass/volume] in Arterial cord blood
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunofluorescence
Palmitoylcarnitine (C16) [Moles/volume] in Serum or Plasma
Palmitoleylcarnitine (C16:1) [Moles/volume] in Serum or Plasma
Hexanoylcarnitine (C6) [Moles/volume] in Serum or Plasma
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Complement fixation
Transketolase [Enzymatic activity/volume] in Serum
HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay
Insulin [Units/volume] in Serum or Plasma --30 minutes post 75 g glucose PO
Insulin [Units/volume] in Serum or Plasma --12 hours fasting
Lymphocytes [#/volume] in Blood by Flow cytometry (FC)
Lymphocytes/100 leukocytes in Blood by Flow cytometry (FC)
Metamyelocytes/100 leukocytes in Cerebral spinal fluid
Myelocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Fractional oxyhemoglobin in Venous cord blood
Fractional oxyhemoglobin in Arterial cord blood
Promyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Sucrase [Enzymatic activity/mass] in Small intestine Tissue
Basophils/100 leukocytes in Bronchial specimen
Basophils/100 leukocytes in Cerebral spinal fluid
Eosinophils/100 leukocytes in Bronchial specimen
Eosinophils/100 leukocytes in Pleural fluid
Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Eosinophils/100 leukocytes in Peritoneal fluid
Erythrocyte distribution width [Entitic volume]
Erythrocyte mean corpuscular diameter [Length]
Trehalase [Enzymatic activity/volume] in Urine
Erythrocytes [#/volume] in Gastric fluid
Erythrocytes [#/volume] in Pericardial fluid
Erythrocytes [#/volume] in Seminal plasma
Nucleated erythrocytes [#/volume] in Blood
Lipase [Enzymatic activity/volume] in Amniotic fluid
Granulocytes/100 leukocytes in Bronchial specimen
Hematocrit [Volume Fraction] of Cerebral spinal fluid
Leukocytes [#/volume] in Bronchial specimen
Lipase [Enzymatic activity/volume] in Serum or Plasma
Leukocytes [#/volume] in Pericardial fluid
Leukocytes other/100 leukocytes in Pericardial fluid
Leukocytes other/100 leukocytes in Pleural fluid
Leukocytes other/100 leukocytes in Peritoneal fluid
Leukocytes other/100 leukocytes in Synovial fluid
Leukocytes Left Shift [Presence] in Blood
Abnormal lymphocytes [#/volume] in Blood
Abnormal lymphocytes/100 leukocytes in Blood
Abnormal lymphocytes/100 leukocytes in Cerebral spinal fluid
Abnormal lymphocytes/100 leukocytes in Synovial fluid
Variant lymphocytes/100 leukocytes in Cerebral spinal fluid
Variant lymphocytes/100 leukocytes in Body fluid
Lymphocytes clefted/100 leukocytes in Blood
Large granular lymphocytes/100 leukocytes in Blood
Lymphocytes/100 leukocytes in Bronchial specimen
Macrophages/100 leukocytes in Bronchial specimen
Macrophages/100 leukocytes in Cerebral spinal fluid
Macrophages/100 leukocytes in Body fluid
Chloral hydrate [Mass/volume] in Serum or Plasma
Mesothelial cells/100 leukocytes in Cerebral spinal fluid
Mesothelial cells/100 leukocytes in Pericardial fluid
Mesothelial cells/100 leukocytes in Pleural fluid
Mesothelial cells/100 leukocytes in Peritoneal fluid
Monocytes+Macrophages/100 leukocytes in Cerebral spinal fluid
Monocytes+Macrophages/100 leukocytes in Body fluid
Monocytes+Macrophages/100 leukocytes in Synovial fluid
Monocytes+Macrophages/100 leukocytes in Specimen
Monocytes Abnormal/100 leukocytes in Blood
Mononuclear cells/100 leukocytes in Gastric fluid
Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma
Myelocytes/100 leukocytes in Cerebral spinal fluid
Neutrophils.hypersegmented [#/volume] in Blood
Neutrophils.hypersegmented/100 leukocytes in Blood
Segmented neutrophils [#/volume] in Blood
Triglyceride+ester in IDL [Mass/volume] in Serum or Plasma
Segmented neutrophils [#/volume] in Body fluid
Segmented neutrophils/100 leukocytes in Body fluid
Neutrophils/100 leukocytes in Pericardial fluid
Neutrophils/100 leukocytes in Pleural fluid
Nonhematic cells/100 leukocytes in Cerebral spinal fluid
Nonhematic cells/100 leukocytes in Body fluid
Platelet mean diameter [Entitic length] in Blood
Lomefloxacin [Susceptibility] by Disk diffusion (KB)
Triglyceride+ester in LDL [Mass/volume] in Serum or Plasma
Polymorphonuclear cells/100 leukocytes in Gastric fluid
Polymorphonuclear cells/100 leukocytes in Stool
Polymorphonuclear cells/100 leukocytes in Urine
Promyelocytes/100 leukocytes in Cerebral spinal fluid
Unidentified cells/100 leukocytes in Cerebral spinal fluid
Unspecified cells/100 leukocytes in Body fluid
levETIRAcetam [Mass/volume] in Serum or Plasma
Triglyceride+ester in VLDL [Mass/volume] in Serum or Plasma
Triglyceride [Mass/volume] in Serum or Plasma --fasting
Catecholamines [Mass/volume] in Plasma --baseline
Catecholamines [Mass/volume] in Plasma --1 hour post XXX challenge
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --2nd specimen
Phosphatidylserine IgA Ab [Presence] in Serum
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --1st specimen
Triiodothyronine resin uptake (T3RU) in Serum or Plasma
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --2nd specimen
Etiocholanolone/Creatinine [Mass Ratio] in Urine
Androsterone/Creatinine [Mass Ratio] in Urine
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma
Estriol (E3)/Creatinine [Mass Ratio] in Urine
Cortisone/Creatinine [Mass Ratio] in Urine
Pregnanetriol/Creatinine [Mass Ratio] in Urine
Pregnanetriolone/Creatinine [Mass Ratio] in Urine
Tetrahydrocortisone/Creatinine [Mass Ratio] in Urine
Tetrahydroaldosterone/Creatinine [Mass Ratio] in Urine
Bromodiphenhydramine [Mass/volume] in Serum or Plasma
Carbinoxamine [Mass/volume] in Serum or Plasma
Cholate [Moles/volume] in Serum or Plasma
Chenodeoxycholate [Moles/volume] in Serum or Plasma
Deoxycholate [Moles/volume] in Serum or Plasma
Inhibin B [Units/volume] in Serum or Plasma
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection
Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunofluorescence
Calcium [Mass/volume] in Total parental nutrition
Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma
Heptacarboxylporphyrin [Presence] in Urine
Hexacarboxylporphyrin [Presence] in Urine
Lomefloxacin [Susceptibility] by Serum bactericidal titer
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Serum or Plasma
levoFLOXacin [Mass/volume] in Serum or Plasma --peak
levoFLOXacin [Mass/volume] in Serum or Plasma --trough
Linoleoylcarnitine (C18:2) [Moles/volume] in Serum or Plasma
Liver kidney microsomal 1 Ab [Presence] in Serum
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma
Magnesium [Mass/volume] in Total parental nutrition
Neutrophil cytoplasmic Ab.classic [Presence] in Serum
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum
Octanoylcarnitine (C8) [Moles/volume] in Serum or Plasma
Octenoylcarnitine (C8:1) [Moles/volume] in Serum or Plasma
Oleoylcarnitine (C18:1) [Moles/volume] in Serum or Plasma
Osmotic fragility of Red Blood Cells--0.75% sodium chloride
Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma
Phosphate [Mass/volume] in Total parental nutrition
Potassium [Moles/volume] in Total parental nutrition
Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Molar ratio] in Serum or Plasma
Propionylcarnitine (C3) [Moles/volume] in Serum or Plasma
Pyridoxal phosphate [Mass/volume] in Serum or Plasma
HIV reverse transcriptase gene mutations detected [Identifier]
Rickettsia typhus group IgG Ab [Presence] in Serum
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Titer] in Serum by Immunofluorescence
Smooth muscle IgG Ab [Presence] in Serum
Sodium [Moles/volume] in Total parental nutrition
Spermatozoa Ab [Units/volume] in Specimen
Stearoylcarnitine (C18) [Moles/volume] in Serum or Plasma
Surfactant/Albumin [Mass Ratio] in Amniotic fluid
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Serum or Plasma
Tetradecanoylcarnitine (C14) [Moles/volume] in Serum or Plasma
Tetradecenoylcarnitine (C14:1) [Moles/volume] in Serum or Plasma
Thyroid stimulating immunoglobulins [Units/volume] in Serum
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Vanillylmandelate/Creatinine [Mass Ratio] in 24 hour Urine
Pyridoxal [Mass/volume] in Serum or Plasma
Acetoacetate+Acetone [Mass/volume] in Serum or Plasma
Xylose [Mass/volume] in Serum or Plasma --baseline
2-Ethyl-3-Hydroxypropionate [Presence] in Urine
Triokinase [Enzymatic activity/volume] in Plasma
2-methyl-3-hydroxybutyrate (C5-OH) [Presence] in Urine
Triosephosphate isomerase [Enzymatic activity/volume] in Serum
Trypsin [Enzymatic activity/volume] in Duodenal fluid
Trypsin [Enzymatic activity/volume] in Serum or Plasma
Loracarbef [Susceptibility] by Minimum lethal concentration (MLC)
Trypsin [Enzymatic activity/time] in 24 hour Stool
Trypsin [Enzymatic activity/volume] in Stool
Trypsin+Trypsinogen [Mass/volume] in Serum or Plasma
Trypsinogen [Presence] in Serum or Plasma
Trypsinogen [Mass/volume] in Serum or Plasma
Trypsinogen I Free [Mass/volume] in Serum or Plasma
Tryptophan [Mass/volume] in Cerebral spinal fluid
Tryptophan [Presence] in Serum or Plasma
Ampicillin [Susceptibility] by Serum bactericidal titer
Tryptophan [Mass/volume] in Serum or Plasma
Tryptophan Free [Mass/volume] in Serum or Plasma
Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
Tyramine [Mass/volume] in Cerebral spinal fluid
Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)
Tyrosine [Mass/volume] in Serum or Plasma
Loracarbef [Susceptibility] by Disk diffusion (KB)
Urate renal clearance in 24 hour Urine and Serum or Plasma
Total Erythrocyte Volume by Scintigraphy
Cold agglutinin [Titer] in Serum or Plasma by Adult RBC Agglutination
Cold agglutinin [Titer] in Serum or Plasma by Cord RBC agglutination
Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation
Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC)
Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin
Cobalamin (Vitamin B12) [Ratio] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor/post dose cyanocobalamin
Cobalamin (Vitamin B12) [Units/volume] in 24 hour Urine --post dose cyanocobalamin+intrinsic factor
DNA ploidy [Identifier] in Specimen by Flow cytometry (FC) Nominal
DNA index in Specimen by Flow cytometry (FC)
S-phase cells/100 cells in Specimen by Flow cytometry (FC)
Hyperdiploid cells/100 cells in Specimen by Flow cytometry (FC)
Aneuploid cells/100 cells in Specimen by Flow cytometry (FC)
Euploid+Aneuploid cells/100 cells in Specimen
DNA ploidy [Interpretation] in Specimen by Flow cytometry (FC) Narrative
Gold [Mass/volume] in Urine collected for unspecified duration
Iron [Mass/volume] in Urine collected for unspecified duration
Copper [Mass/volume] in Urine collected for unspecified duration
Mercury [Mass/volume] in Urine collected for unspecified duration
Magnesium [Mass/volume] in Urine collected for unspecified duration
Chromium [Mass/volume] in Urine collected for unspecified duration
Arsenic [Mass/volume] in Urine collected for unspecified duration
Cadmium [Mass/volume] in Urine collected for unspecified duration
Aluminum [Mass/volume] in Urine collected for unspecified duration
Selenium [Mass/volume] in Urine collected for unspecified duration
Silver [Mass/volume] in Urine collected for unspecified duration
Thallium [Mass/volume] in Urine collected for unspecified duration
Zinc [Mass/volume] in Urine collected for unspecified duration
Lead [Mass/volume] in Urine collected for unspecified duration
Urea nitrogen [Mass/volume] in Body fluid
Manganese [Mass/volume] in Urine collected for unspecified duration
Nickel [Mass/volume] in Urine collected for unspecified duration
Natriuretic peptide B [Mass/volume] in Serum or Plasma
Urea nitrogen [Mass/volume] in Serum or Plasma
Loracarbef [Susceptibility] by Serum bactericidal titer
Urea nitrogen [Mass/time] in 24 hour Urine
Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma
Urea renal clearance in 24 hour Urine and Serum or Plasma
Horse Chestnut IgE Ab [Presence] in Serum
Silver Birch recombinant (rBet v) 1 IgE Ab [Units/volume] in Serum
Silver Birch recombinant (rBet v) 2 IgE Ab [Units/volume] in Serum
Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Units/volume] in Serum
Chinchilla epithelium IgE Ab [Units/volume] in Serum
Sardine (Sardinops melanosticta) IgE Ab [Units/volume] in Serum
Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Units/volume] in Serum
Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Units/volume] in Serum
Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Units/volume] in Serum
Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 1 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 2 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 5 IgE Ab [Units/volume] in Serum
Timothy native (nPhl p) 4 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 6 IgE Ab [Units/volume] in Serum
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/volume] in Plasma
Timothy recombinant (rPhl p) 7 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 11 IgE Ab [Units/volume] in Serum
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk
Mold Allergen Mix 3 (Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) IgE Ab [Presence] in Serum by Multidisk
Uridyl transferase [Enzymatic activity/volume] in Red Blood Cells
Epidermal Allergen Mix B (Budgerigar feather+Canary feather+Parrot feather+Finch feather) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Presence] in Serum by Multidisk
Vancomycin [Moles/volume] in Serum or Plasma
Uridyl transferase [Enzymatic activity/mass] in Tissue
Dehydrochlormethyltestosterone [Mass/volume] in Urine
Corynebacterium diphtheriae Ab [Units/volume] in Serum --2nd specimen
Levoamphetamine/Amphetamines.total in Urine
Tissue transglutaminase IgA Ab [Units/volume] in Serum
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --2nd specimen
10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma
Dehydroepiandrosterone (DHEA) [Mass/volume] in Amniotic fluid
Interferon.beta 1 neutralizing antibody [Titer] in Serum or Plasma by Neutralization test
Filaria identified in Specimen by Concentration
Myelin associated glycoprotein IgM Ab [Presence] in Serum by Immunoblot
Voltage-gated calcium channel Ab [Moles/volume] in Serum
Dextroamphetamine/Amphetamines.total in Urine
Dextromethamphetamine/Amphetamines.total in Urine
Ritonavir [Mass/volume] in Serum or Plasma
Amprenavir [Mass/volume] in Serum or Plasma
Lymecycline [Susceptibility] by Minimum lethal concentration (MLC)
Testosterone/Epitestosterone [Mass Ratio] in Urine
Baker's yeast IgA Ab [Units/volume] in Serum
Indinavir [Mass/volume] in Serum or Plasma
Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Gatifloxacin [Susceptibility] by Disk diffusion (KB)
Moxifloxacin [Susceptibility] by Disk diffusion (KB)
Gatifloxacin [Susceptibility] by Gradient strip
Moxifloxacin [Susceptibility] by Gradient strip
Creatinine/Urea nitrogen [Mass Ratio] in Serum or Plasma
Rheumatoid factor [Presence] in Body fluid
Rubella virus IgM Ab [Units/volume] in Body fluid
Coccidioides immitis Ab [Presence] in Body fluid by Complement fixation
Coxsackievirus A7 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus A9 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus A10 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus A16 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B1 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B2 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B3 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B4 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B5 Ab [Titer] in Body fluid by Complement fixation
Coxsackievirus B6 Ab [Titer] in Body fluid by Complement fixation
Echovirus 4 Ab [Titer] in Body fluid by Complement fixation
Echovirus 9 Ab [Titer] in Body fluid by Complement fixation
Echovirus 11 Ab [Titer] in Body fluid by Complement fixation
Echovirus 30 Ab [Titer] in Body fluid by Complement fixation
Polio virus 1 Ab [Titer] in Body fluid by Complement fixation
Polio virus 2 Ab [Titer] in Body fluid by Complement fixation
Polio virus 3 Ab [Titer] in Body fluid by Complement fixation
Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid
Herpes simplex virus 2 IgG Ab [Units/volume] in Body fluid
Herpes simplex virus 1 IgM Ab [Units/volume] in Body fluid
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid by Immunofluorescence
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid by Complement fixation
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid by Complement fixation
HIV 1 p41 Ab [Presence] in Serum by Immunoblot
HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rickettsia typhi IgG Ab [Titer] in Body fluid
Rickettsia typhi IgM Ab [Titer] in Body fluid
Cannabinoids [Presence] in Meconium by Screen method
Benzodiazepines [Presence] in Meconium by Screen method
Ethylene glycol [Mass/volume] in Gastric fluid
Methaqualone [Mass/volume] in Bile fluid
Morphine Free [Mass/volume] in Bile fluid
Thioridazine [Mass/volume] in Gastric fluid
Urobilinogen [Mass/time] in 24 hour Urine
Narcotics and opioids [Identifier] in Bile fluid
Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing
Gentamicin [Mass/volume] in Serum or Plasma --trough post extended interval dosing
Gentamicin [Mass/volume] in Serum or Plasma --random post extended interval dosing
Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing
Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing
Urobilinogen [Mass/time] in 2 hour Urine
Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing
Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing
Amikacin [Mass/volume] in Serum or Plasma --trough post extended interval dosing
Amikacin [Mass/volume] in Serum or Plasma --random post extended interval dosing
Hematocrit [Volume Fraction] of Blood by Impedance
Creatinine [Mass/time] in 24 hour Body fluid
Protein S actual/normal in Platelet poor plasma by Chromogenic method
Osmotic fragility of Red Blood Cells--0.0% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.85% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.55% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.50% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.45% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.40% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.35% sodium chloride 24 hour 37 degree C incubation
Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Osmotic fragility of Red Blood Cells--0.30% sodium chloride 24 hour 37 degree C incubation
Uroporphyrin 1 isomer [Mass/volume] in Red Blood Cells
Reticulocytes/100 erythrocytes in Blood by Manual
Aneuploid cell population 1/100 cells in Specimen
Aneuploid cell population 2/100 cells in Specimen
Euploid+Aneuploid cells population 1/100 cells in Specimen
Euploid+Aneuploid cells population 2/100 cells in Specimen
Mumps virus particle-bound Ab [Titer] in Serum
Mumps virus soluble Ab [Titer] in Cerebral spinal fluid
Mumps virus particle-bound Ab [Titer] in Cerebral spinal fluid
Nuclear matrix protein 22 [Units/volume] in Urine
Cocaethylene [Mass/volume] in Bile fluid
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium
Uroporphyrin [Mass/time] in 24 hour Urine
Cefotaxime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Cefotaxime [Susceptibility] for meningitis by Gradient strip
cefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
cefTRIAXone [Susceptibility] for meningitis by Gradient strip
Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Cefepime [Susceptibility] for meningitis by Gradient strip
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Plasma
Reagin Ab [Titer] in Cerebral spinal fluid by VDRL
P53 protein Ag/100 cells in Tissue by Immune stain
ERBB2 gene duplication [Presence] in Tissue by FISH
Alpha-2-Microglobulin [Mass/volume] in 24 hour Urine
Immunoglobulin light chains [Presence] in 24 hour Urine
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Plasma
Coccidioides sp Ab [Presence] in Specimen by Immune diffusion (ID)
Coccidioides sp IgG Ab [Presence] in Specimen by Immunoassay
Borrelia burgdorferi Ab [Units/volume] in Specimen by Immunoassay
Hemoglobin Barts/Hemoglobin.total in Blood
Carboxyhemoglobin [Mass/volume] in Blood
Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasma
Heparin anti Xa [Units/volume] in Nonbiological fluid
Polymorphonuclear cells/100 leukocytes in Blood by Manual count
Valine [Mass/volume] in Cerebral spinal fluid
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk
Sulfate-3-Glucuronyl paragloboside Ab [Titer] in Serum
Methyl butyl ketone [Mass/volume] in Urine
Methyl isoamyl ketone [Mass/volume] in Urine
Methyl propyl ketone [Mass/volume] in Urine
Theobromine [Mass/volume] in Serum or Plasma
2,5-Hexanedione/Creatinine [Mass Ratio] in Urine
Estradiol (E2) [Mass/volume] in Amniotic fluid
Estrone (E1) [Mass/volume] in Amniotic fluid
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Lopinavir [Mass/volume] in Serum or Plasma
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
7-Aminonitrazepam [Mass/volume] in Serum or Plasma
Methyl amyl ketone [Mass/volume] in Urine
Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain
Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain
Histoplasma capsulatum IgG Ab [Presence] in Serum
HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay
Mycoplasma pneumoniae Ab [Titer] in Serum by Immunofluorescence
5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine
Hepatitis B virus core IgM Ab [Presence] in Serum
Progesterone receptor [Moles/mass] in Tissue
Islet cell 512 Ab [Units/volume] in Serum
Vanillylmandelate [Mass/volume] in Serum or Plasma
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum
Actinobacillus pleuropneumoniae Ab [Units/volume] in Serum
Adenovirus Ab [Units/volume] in Body fluid
Afipia felis IgG Ab [Units/volume] in Serum
Afipia felis IgM Ab [Units/volume] in Serum
African horse sickness virus Ab [Units/volume] in Serum
Alcelaphine herpesvirus 1 Ab [Units/volume] in Serum
Anaplasma marginale Ab [Units/volume] in Serum
Arbovirus NOS Ab [Units/volume] in Serum
Asialoganglioside GM1 Ab [Units/volume] in Serum
Asialoganglioside GM1 IgG Ab [Units/volume] in Serum
Asialoganglioside GM1 IgM Ab [Units/volume] in Serum
Aspergillus clavatus Ab [Presence] in Serum
Vanillylmandelate [Mass/time] in 24 hour Urine
Aspergillus flavus Ab [Presence] in Body fluid
Aspergillus flavus Ab [Units/volume] in Serum
Aspergillus nidulans Ab [Presence] in Serum
Aspergillus niger Ab [Presence] in Body fluid
Aspergillus sp Ab [Units/volume] in Cerebral spinal fluid
Aspergillus terreus Ab [Presence] in Serum
Aureobasidium pullulans IgG Ab [Units/volume] in Serum
Infectious bronchitis virus Ab [Units/volume] in Serum
Vanillylmandelate/Creatine [Mass Ratio] in Urine
Infectious bronchitis virus Ark-99 Ab [Units/volume] in Serum
Infectious bronchitis virus Conn-42 Ab [Units/volume] in Serum
Infectious bronchitis virus Mass-41 Ab [Units/volume] in Serum
Avian infectious laryngotracheitis virus Ab [Units/volume] in Serum
Avian paramyxovirus 1 Ab [Units/volume] in Serum
Avian paramyxovirus 2 Ab [Units/volume] in Serum
Babesia microti IgG Ab [Units/volume] in Serum
Vanillylmandelate/Creatinine [Mass Ratio] in Urine
Babesia microti IgM Ab [Units/volume] in Serum
Babesia sp IgG Ab [Units/volume] in Serum
Barmah forest virus IgG Ab [Presence] in Serum
Barmah forest virus IgM Ab [Presence] in Serum
Bartonella henselae Ab [Units/volume] in Serum
Bartonella henselae IgG Ab [Units/volume] in Cerebral spinal fluid
Bartonella henselae IgM Ab [Units/volume] in Cerebral spinal fluid
Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma
Basement membrane Ab [Units/volume] in Serum
Basement membrane IgA Ab [Presence] in Serum
Basement membrane IgG Ab [Units/volume] in Serum
Basement membrane IgG Ab [Presence] in Serum
Beta 2 glycoprotein 1 Ab [Presence] in Serum
Beta tubulin IgG Ab [Units/volume] in Serum
Beta tubulin IgM Ab [Units/volume] in Serum
Blastomyces dermatitidis Ab [Presence] in Body fluid
Vasopressin [Mass/volume] in Serum or Plasma
Bluetongue virus 10 Ab [Units/volume] in Serum
Bluetongue virus 11 Ab [Units/volume] in Serum
Bluetongue virus 13 Ab [Units/volume] in Serum
Bluetongue virus 17 Ab [Units/volume] in Serum
Bluetongue virus 2 Ab [Units/volume] in Serum
Bordetella avium Ab [Units/volume] in Serum
Bordetella pertussis Ab [Units/volume] in Specimen
Bordetella pertussis secretory IgA Ab [Presence] in Specimen
Borrelia burgdorferi IgG Ab [Presence] in Specimen
Borrelia burgdorferi IgM Ab [Presence] in Body fluid
Bovine diarrhea virus 1 Ab [Units/volume] in Serum
Bovine diarrhea virus 2 Ab [Units/volume] in Serum
Bovine diarrhea virus Ab [Units/volume] in Serum
Bovine herpesvirus 1 Ab [Units/volume] in Serum
Bovine leukemia virus Ab [Units/volume] in Serum
Burkholderia pseudomallei IgG Ab [Units/volume] in Specimen
Burkholderia pseudomallei IgM Ab [Units/volume] in Specimen
Campylobacter fetus Ab [Units/volume] in Serum
Campylobacter jejuni Ab [Units/volume] in Serum
Canary serum proteins Ab [Presence] in Serum
Cancer associated retinopathy Ab [Presence] in Serum
Canine adenovirus 1 Ab [Presence] in Serum
Canine coronavirus Ab [Presence] in Serum
Canine distemper virus Ab [Units/volume] in Serum
Canine distemper virus Ab [Presence] in Serum
Canine parvovirus Ab [Units/volume] in Serum
Canine parvovirus Ab [Presence] in Stool
Canine parvovirus IgG Ab [Units/volume] in Serum
Canine parvovirus IgM Ab [Units/volume] in Serum
Lymecycline [Susceptibility] by Disk diffusion (KB)
Centromere IgG Ab [Units/volume] in Serum
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis IgA Ab [Units/volume] in Serum
Menadione [Mass/volume] in Serum or Plasma
Chlamydia trachomatis B IgA Ab [Units/volume] in Serum
Chlamydia trachomatis B IgM Ab [Units/volume] in Serum
Chlamydia trachomatis D+K IgA Ab [Units/volume] in Serum
Chlamydia trachomatis D+K IgG Ab [Units/volume] in Serum
Chlamydia trachomatis D+K IgM Ab [Units/volume] in Serum
Chlamydophila pneumoniae IgA Ab [Units/volume] in Cerebral spinal fluid
Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum
Chlamydophila pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum
Chlamydophila psittaci IgA Ab [Units/volume] in Cerebral spinal fluid
Chlamydophila psittaci IgA Ab [Units/volume] in Serum
Chlamydophila psittaci IgG Ab [Units/volume] in Cerebral spinal fluid
Clostridioides difficile Ab [Units/volume] in Serum
Coccidioides immitis Ab [Presence] in Body fluid
Cockatiel droppings Ab [Presence] in Serum
Coxiella burnetii phase 1 Ab [Units/volume] in Serum
Coxiella burnetii phase 1 IgA Ab [Units/volume] in Serum
Coxiella burnetii phase 2 Ab [Units/volume] in Serum
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum
Coxiella burnetii phase 2 IgA Ab [Units/volume] in Serum
Coxsackievirus A10 Ab [Units/volume] in Body fluid
Coxsackievirus A16 Ab [Units/volume] in Body fluid
Coxsackievirus A7 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A7 Ab [Units/volume] in Body fluid
Coxsackievirus A9 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus A9 Ab [Units/volume] in Body fluid
Coxsackievirus B1 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B1 Ab [Units/volume] in Body fluid
Coxsackievirus B2 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B2 Ab [Units/volume] in Body fluid
Coxsackievirus B3 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B3 Ab [Units/volume] in Body fluid
Coxsackievirus B4 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B4 Ab [Units/volume] in Body fluid
Coxsackievirus B5 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B5 Ab [Units/volume] in Body fluid
Coxsackievirus B6 Ab [Units/volume] in Cerebral spinal fluid
Coxsackievirus B6 Ab [Units/volume] in Body fluid
Cryptococcus sp Ab [Units/volume] in Serum
Cryptostroma corticale Ab [Presence] in Serum
Cytotoxic percent reactive Ab [Presence] in Serum
Dengue virus 1 Ab [Units/volume] in Serum
Dengue virus 2 Ab [Units/volume] in Serum
Dengue virus 3 Ab [Units/volume] in Serum
Dengue virus 4 Ab [Units/volume] in Serum
Dengue virus Ab [Units/volume] in Specimen
Ganglioside GD1a Ab [Units/volume] in Serum
Ganglioside GD1b Ab [Units/volume] in Serum
Ganglioside GD1b IgG Ab [Units/volume] in Serum
Ganglioside GD1b IgM Ab [Units/volume] in Serum
DNA double strand Ab [Presence] in Serum
Echovirus 30 Ab [Units/volume] in Cerebral spinal fluid
Echovirus 30 Ab [Units/volume] in Body fluid
Echovirus 4 Ab [Units/volume] in Cerebral spinal fluid
Echovirus 4 Ab [Units/volume] in Body fluid
Echovirus 9 Ab [Units/volume] in Cerebral spinal fluid
Echovirus 9 Ab [Units/volume] in Body fluid
Ehrlichia canis Ab [Units/volume] in Serum
Ehrlichia chaffeensis IgM Ab [Units/volume] in Serum
Anaplasma phagocytophilum Ab [Units/volume] in Serum
Encephalomyocarditis virus Ab [Units/volume] in Serum
Endomysium IgA Ab [Units/volume] in Serum
Enterovirus NOS Ab [Units/volume] in Serum
Epstein Barr virus capsid IgA Ab [Units/volume] in Serum
Lymecycline [Susceptibility] by Serum bactericidal titer
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid
Epstein Barr virus early IgG Ab [Units/volume] in Cerebral spinal fluid
Epstein Barr virus nuclear Ab [Units/volume] in Serum
Epstein Barr virus nuclear IgG Ab [Units/volume] in Cerebral spinal fluid
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
Epstein Barr virus nuclear IgM Ab [Units/volume] in Serum
Equine arteritis virus Ab [Units/volume] in Serum
Equine herpesvirus 1 Ab [Units/volume] in Serum
Equine herpesvirus 1+4 Ab [Units/volume] in Serum
Equine influenza virus A1 Ab [Units/volume] in Serum
Equine influenza virus A2 Ab [Units/volume] in Serum
Escherichia coli verotoxin 1 Ab [Units/volume] in Stool
Escherichia coli verotoxin 2 Ab [Units/volume] in Stool
European tick borne encephalitis virus Ab [Units/volume] in Serum
Feline calicivirus Ab [Units/volume] in Serum
Feline coronavirus Ab [Units/volume] in Serum
Feline herpesvirus 1 Ab [Presence] in Serum
Feline herpesvirus Ab [Units/volume] in Serum
Feline immunodeficiency virus Ab [Units/volume] in Serum
Feline leukemia virus Ab [Units/volume] in Serum
Feline panleukopenia virus Ab [Units/volume] in Serum
Feline panleukopenia virus IgG Ab [Units/volume] in Serum
Feline panleukopenia virus IgM Ab [Units/volume] in Serum
Feline herpesvirus 1 Ab [Units/volume] in Serum
Feline syncytial virus Ab [Units/volume] in Serum
Francisella tularensis Ab [Units/volume] in Serum
Ganglioside GD1a IgG Ab [Units/volume] in Serum
Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid
Ganglioside GD1a IgM Ab [Units/volume] in Serum
Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid
Ganglioside GM1b IgG Ab [Units/volume] in Serum
Ganglioside GM1b IgM Ab [Units/volume] in Serum
Glomerular basement membrane IgG Ab [Units/volume] in Serum
Haemophilus somnus Ab [Units/volume] in Serum
Hantavirus sin nombre IgG Ab [Units/volume] in Serum
Hantavirus sin nombre IgM Ab [Units/volume] in Serum
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum
Herpes simplex virus 2 IgM Ab [Units/volume] in Body fluid
Herpes simplex virus Ab [Units/volume] in Cerebral spinal fluid
Herpes virus 6 IgG Ab [Units/volume] in Cerebral spinal fluid
Herpes virus 6 IgM Ab [Units/volume] in Cerebral spinal fluid
Herpes virus 7 IgG Ab [Units/volume] in Serum
Herpes virus 7 IgM Ab [Units/volume] in Serum
Heterophile Ab [Presence] in Synovial fluid
Highlands J virus Ab [Units/volume] in Cerebral spinal fluid
Highlands J virus Ab [Units/volume] in Serum
Highlands J virus Ab [Units/volume] in Specimen
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Cerebral spinal fluid
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Body fluid
Histoplasma capsulatum yeast phase Ab [Units/volume] in Cerebral spinal fluid
Histoplasma capsulatum yeast phase Ab [Units/volume] in Body fluid
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid
Hyaluronidase Ab [Units/volume] in Serum
Infectious bursal disease virus Ab [Units/volume] in Serum
Influenza virus A IgG Ab [Units/volume] in Serum
Influenza virus A IgM Ab [Units/volume] in Serum
Insulin receptor Ab [Units/volume] in Serum
Intercalated disk Ab [Units/volume] in Serum
Intercellular substance Ab [Units/volume] in Serum
Interferon.beta 1 Ab [Units/volume] in Serum or Plasma
Intrinsic factor blocking Ab [Units/volume] in Serum
Intrinsic factor blocking Ab [Presence] in Serum
Intrinsic factor blocking IgG Ab [Units/volume] in Serum
Jamestown canyon virus Ab [Units/volume] in Serum
La Crosse virus Ab [Units/volume] in Cerebral spinal fluid
La Crosse virus Ab [Presence] in Specimen
Meclocycline [Susceptibility] by Minimum lethal concentration (MLC)
La Crosse virus IgG Ab [Units/volume] in Cerebral spinal fluid
La Crosse virus IgM Ab [Units/volume] in Cerebral spinal fluid
Lassa virus IgG Ab [Units/volume] in Serum
Lassa virus IgM Ab [Units/volume] in Serum
Legionella pneumophila 1 Ab [Units/volume] in Serum
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum
Legionella pneumophila 1 IgM Ab [Units/volume] in Cerebral spinal fluid
Legionella pneumophila 2 Ab [Units/volume] in Serum
Legionella pneumophila 2 IgG Ab [Units/volume] in Serum
Legionella pneumophila 3 Ab [Units/volume] in Serum
Legionella pneumophila 3 IgG Ab [Units/volume] in Serum
Legionella pneumophila 4 Ab [Units/volume] in Serum
Legionella pneumophila 4 IgG Ab [Units/volume] in Serum
Legionella pneumophila 5 Ab [Units/volume] in Serum
Legionella pneumophila 5 IgG Ab [Units/volume] in Serum
Legionella pneumophila 6 Ab [Units/volume] in Serum
Legionella pneumophila 6 IgG Ab [Units/volume] in Serum
Legionella pneumophila 6 IgM Ab [Units/volume] in Serum
Legionella pneumophila 7 Ab [Units/volume] in Serum
Legionella pneumophila 8 Ab [Units/volume] in Serum
Legionella pneumophila 9 Ab [Units/volume] in Serum
Legionella pneumophila Ab [Units/volume] in Serum
Legionella pneumophila IgM Ab [Units/volume] in Serum
Legionella pneumophila atypical Ab [Units/volume] in Serum
Legionella sp IgM Ab [Units/volume] in Serum
Leishmania donovani Ab [Units/volume] in Serum
Oxygen [Partial pressure] in Exhaled gas
Leptospira borgpetersenii sv Sejroe Ab [Units/volume] in Serum
Leptospira interrogans sv Bratislava Ab [Units/volume] in Serum
Leptospira interrogans sv Canicola Ab [Units/volume] in Serum
Leptospira interrogans sv Grippotyphosa Ab [Units/volume] in Serum
Leptospira interrogans sv Hardjo Ab [Units/volume] in Serum
Leptospira interrogans sv Icterohaemorrhagiae Ab [Units/volume] in Serum
Leptospira interrogans sv Pomona Ab [Units/volume] in Serum
Leptospira sp Ab [Units/volume] in Serum
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid
Leptospira sp IgG Ab [Units/volume] in Serum
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid
Leptospira sp IgM Ab [Units/volume] in Serum
Listeria sp Ab [Units/volume] in Cerebral spinal fluid
Lumpy skin disease virus Ab [Units/volume] in Serum
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum
Lymphocytic choriomeningitis virus Ab [Units/volume] in Cerebral spinal fluid
Oxygen [Partial pressure] in Inhaled gas
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Serum
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Serum
Ganglioside GM1 Ab [Units/volume] in Serum
Ganglioside GM1 IgA Ab [Units/volume] in Serum
Ganglioside GM1 IgG Ab [Units/volume] in Serum
Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC)
Ganglioside GM1 IgG+IgM Ab [Units/volume] in Serum
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum
Ganglioside GM1 IgM Ab [Units/volume] in Serum
Mumps virus soluble Ab [Units/volume] in Cerebral spinal fluid
Mumps virus soluble Ab [Units/volume] in Serum
Mumps virus particle-bound Ab [Units/volume] in Cerebral spinal fluid
Mumps virus particle-bound Ab [Units/volume] in Serum
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood
Mycoplasma capricolum ss capripneumonia Ab [Units/volume] in Serum
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum
Mycoplasma gallisepticum Ab [Units/volume] in Serum
Mycoplasma hominis Ab [Units/volume] in Serum
Mycoplasma hyopneumoniae Ab [Presence] in Serum
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum
Mycoplasma pneumoniae IgA Ab [Presence] in Serum
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid
Mycoplasma sp Ab [Units/volume] in Serum
Mycoplasma synoviae Ab [Units/volume] in Serum
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid
Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Myelin associated glycoprotein Ab [Units/volume] in Serum
Myelin associated glycoprotein Ab [Presence] in Serum
Myelin associated glycoprotein IgM Ab [Presence] in Serum
Nairobi sheep disease virus Ab [Units/volume] in Serum
Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid
Neisseria meningitidis serogroup A IgG Ab [Units/volume] in Serum
Neisseria meningitidis serogroup C IgG Ab [Units/volume] in Serum
Neisseria meningitidis serogroup Y Ab [Units/volume] in Specimen
Neospora caninum Ab [Units/volume] in Serum
Neuronal Ab [Units/volume] in Cerebral spinal fluid
Neuronal Ab [Presence] in Cerebral spinal fluid
Neuronal IgG Ab [Presence] in Body fluid
Neuronal nuclear Ab [Units/volume] in Serum
Neuronal nuclear IgG Ab [Units/volume] in Serum
Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid
Neuronal nuclear type 2 Ab [Presence] in Serum
Nuclear Ab [Units/volume] in Pericardial fluid
Nuclear Ab [Units/volume] in Pleural fluid
Nuclear Ab [Units/volume] in Peritoneal fluid
Nuclear Ab [Units/volume] in Synovial fluid
Pancreatic islet cell Ab [Presence] in Serum
Parainfluenza virus 1 Ab [Units/volume] in Body fluid
Parainfluenza virus 1 IgM Ab [Units/volume] in Serum
Parainfluenza virus 2 Ab [Units/volume] in Body fluid
Parainfluenza virus 2 IgM Ab [Units/volume] in Serum
Parainfluenza virus 3 Ab [Units/volume] in Body fluid
Parainfluenza virus 3 IgG Ab [Units/volume] in Serum
Parainfluenza virus 3 IgM Ab [Units/volume] in Serum
Parainfluenza virus Ab [Units/volume] in Serum
Parietal cell IgG Ab [Presence] in Serum
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid
Pasteurella multocida Ab [Units/volume] in Serum
Peste des petits ruminants virus Ab [Units/volume] in Serum
Phospholipid IgA Ab [Units/volume] in Serum
PM-SCL extractable nuclear Ab [Units/volume] in Serum
PM-SCL extractable nuclear Ab [Presence] in Serum
Polio virus 1 Ab [Units/volume] in Cerebral spinal fluid
Polio virus 1 Ab [Units/volume] in Body fluid
Polio virus 2 Ab [Units/volume] in Cerebral spinal fluid
Polio virus 2 Ab [Units/volume] in Body fluid
Polio virus 3 Ab [Units/volume] in Cerebral spinal fluid
Polio virus 3 Ab [Units/volume] in Body fluid
Porcine influenza virus A Ab [Units/volume] in Serum
Porcine parvovirus Ab [Units/volume] in Serum
Powassan virus IgG Ab [Units/volume] in Serum
Powassan virus IgG Ab [Units/volume] in Specimen
Powassan virus IgM Ab [Units/volume] in Serum
Powassan virus IgM Ab [Units/volume] in Specimen
Pseudorabies virus Ab [Units/volume] in Serum
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid
Purkinje cells IgG Ab [Units/volume] in Serum
Reovirus Ab [Units/volume] in Cerebral spinal fluid
Reovirus Ab [Units/volume] in Body fluid
Volume [Mass/time] of 24 hour Body fluid
Respiratory syncytial virus IgG Ab [Units/volume] in Cerebral spinal fluid
Reticulin IgG Ab [Units/volume] in Serum
Rhodococcus equi Ab [Units/volume] in Serum
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum
Rickettsia (Proteus OX19) Ab [Units/volume] in Serum
Rickettsia (Proteus OXK) Ab [Units/volume] in Serum
Rickettsia akari Ab [Units/volume] in Serum
Rickettsia australis Ab [Units/volume] in Serum
Rickettsia conorii Ab [Units/volume] in Serum
Rickettsia honei Ab [Units/volume] in Serum
Rickettsia prowazekii IgG Ab [Units/volume] in Serum
Meclocycline [Susceptibility] by Disk diffusion (KB)
Rickettsia prowazekii IgM Ab [Units/volume] in Serum
Rickettsia spotted fever group IgM Ab [Units/volume] in Cerebral spinal fluid
Rickettsia typhus group IgM Ab [Units/volume] in Cerebral spinal fluid
Rickettsia rickettsii Ab [Units/volume] in Serum
Rickettsia rickettsii Ab [Presence] in Serum
Rickettsia sibirica Ab [Units/volume] in Serum
Orientia tsutsugamushi IgG Ab [Units/volume] in Serum
Orientia tsutsugamushi Gilliam Ab [Units/volume] in Serum
Orientia tsutsugamushi Karp Ab [Units/volume] in Serum
Orientia tsutsugamushi Kato Ab [Units/volume] in Serum
Orientia tsutsugamushi Litchfield Ab [Units/volume] in Serum
Rickettsia typhi IgM Ab [Units/volume] in Body fluid
Rift valley fever virus Ab [Units/volume] in Serum
Rinderpest virus Ab [Units/volume] in Serum
Ross River virus IgG Ab [Presence] in Serum
Ross River virus IgM Ab [Presence] in Serum
Rubella virus IgM Ab [Presence] in Serum
Saint Louis encephalitis virus Ab [Units/volume] in Specimen
Salmonella paratyphi B H Ab [Units/volume] in Serum
Salmonella paratyphi B O Ab [Units/volume] in Serum
Salmonella pullorum Ab [Units/volume] in Serum
Salmonella typhi H D Ab [Units/volume] in Serum
Salmonella typhi O D Ab [Units/volume] in Serum
Salmonella typhimurium Ab [Units/volume] in Serum
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum
Smith extractable nuclear Ab [Presence] in Serum
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum
Smooth muscle Ab [Units/volume] in Serum
Spermatozoa Ab [Presence] in Cervical mucus
Sporothrix schenckii Ab [Units/volume] in Cerebral spinal fluid
Stachybotrys chartarum IgA Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Units/volume] in Serum
Streptococcus pyogenes enzyme Ab [Units/volume] in Serum
Striated muscle Ab [Units/volume] in Serum
Striated muscle IgG Ab [Units/volume] in Serum
Sulfate-3-Glucuronyl paragloboside Ab [Presence] in Serum
Sulfate-3-Glucuronyl paragloboside Ab [Units/volume] in Serum
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Cerebral spinal fluid
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Cerebral spinal fluid
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Serum
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Serum
Sulfatide IgG Ab [Units/volume] in Serum
Sulfatide IgM Ab [Units/volume] in Serum
Taylorella equigenitalis Ab [Units/volume] in Serum
Ganglioside GQ1b Ab [Units/volume] in Serum
Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid
Ganglioside GQ1b IgG Ab [Units/volume] in Serum
Theileria annulata Ab [Units/volume] in Serum
Theileria mutans Ab [Units/volume] in Serum
Theileria parva Ab [Units/volume] in Serum
Thermoactinomyces IgG Ab [Units/volume] in Serum
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid
Transmissible gastroenteritis virus Ab [Units/volume] in Serum
Trichinella sp IgM Ab [Units/volume] in Serum
Trivittatus virus Ab [Units/volume] in Cerebral spinal fluid
Trivittatus virus Ab [Units/volume] in Serum
Trivittatus virus Ab [Units/volume] in Specimen
Trypanosoma cruzi IgG Ab [Units/volume] in Specimen
Trypanosoma equiperdum Ab [Units/volume] in Serum
Unidentified extractable nuclear Ab [Presence] in Serum
Varicella zoster virus Ab [Units/volume] in Cerebral spinal fluid
Varicella zoster virus IgM Ab [Units/volume] in Cerebral spinal fluid
Vesicular stomatitis Indiana virus Ab [Units/volume] in Serum
Vesicular stomatitis New Jersey virus Ab [Units/volume] in Serum
Vibrio cholerae Ab [Units/volume] in Serum
Rabbit hemorrhagic disease virus Ab [Units/volume] in Serum
West Nile virus Ab [Units/volume] in Specimen
West Nile virus IgG Ab [Presence] in Serum
West Nile virus IgG Ab [Presence] in Specimen
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid
West Nile virus IgM Ab [Presence] in Serum
Western equine encephalitis virus Ab [Units/volume] in Cerebral spinal fluid
Western equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid
Yersinia enterocolitica O:5 Ab [Units/volume] in Specimen
Yersinia enterocolitica Ab [Units/volume] in Serum
Adenovirus Ag [Presence] in Conjunctival specimen
African horse sickness virus Ag [Presence] in Specimen
African swine fever virus Ag [Presence] in Specimen
Alcelaphine herpesvirus 1 Ag [Presence] in Specimen
Infectious bronchitis virus Ag [Presence] in Specimen
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea
Avian infectious laryngotracheitis virus Ag [Presence] in Specimen
Avian leukosis virus Ag [Units/volume] in Egg yolk
Avian leukosis virus Ag [Units/volume] in Serum
Avian paramyxovirus 1 Ag [Presence] in Specimen
Bacillus anthracis Ag [Presence] in Specimen
Bacteroides fragilis Ag [Presence] in Specimen
Bacteroides melaninogenicus Ag [Presence] in Specimen
Bladder tumor Ag [Units/volume] in Urine
Blastomyces dermatitidis Ag [Presence] in Serum
Bluetongue virus Ag [Presence] in Specimen
Border disease virus Ag [Presence] in Blood
Border disease virus Ag [Presence] in Specimen
Bordetella bronchiseptica Ag [Presence] in Specimen
Bordetella parapertussis Ag [Presence] in Specimen
Bordetella pertussis Ag [Presence] in Specimen
Borrelia burgdorferi Ag [Presence] in Specimen
Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method
Bovine diarrhea virus Ag [Presence] in Blood
Bovine diarrhea virus Ag [Presence] in Nose
Bovine diarrhea virus Ag [Presence] in Stool
Bovine diarrhea virus Ag [Presence] in Specimen
Bovine herpesvirus 1 Ag [Presence] in Genital specimen
Bovine herpesvirus 1 Ag [Presence] in Nose
Bovine herpesvirus 1 Ag [Presence] in Specimen
Bovine herpesvirus 1 Ag [Units/volume] in Specimen
Bovine herpesvirus 2 Ag [Presence] in Exudate
Bovine herpesvirus 4 Ag [Presence] in Body fluid
Bovine inner ear Ag [Presence] in Serum or Plasma
Bovine respiratory syncytial virus Ag [Presence] in Lung
Brucella sp Ag [Presence] in Vaginal fluid
Campylobacter fetus Ag [Presence] in Genital fluid
Campylobacter fetus Ag [Presence] in Specimen
Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay
Candida albicans Ag [Units/volume] in Serum
Canine parvovirus Ag [Presence] in Stool
Capripox virus Ag [Presence] in Specimen
Chlamydia sp Ag [Presence] in Conjunctival specimen
Chlamydia sp Ag [Presence] in Body fluid
Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method
Chlamydia sp Ag [Presence] in Genital specimen
Chlamydia trachomatis Ag [Presence] in Blood
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid
Antithrombin Ag [Moles/volume] in Platelet poor plasma by Immunoassay
Chlamydia trachomatis Ag [Presence] in Stool
Chlamydia trachomatis Ag [Presence] in Urine sediment
Chlamydia trachomatis Ag [Presence] in Specimen
Chlamydophila pneumoniae Ag [Presence] in Specimen
Chlamydophila psittaci Ag [Presence] in Genital specimen
Meclocycline [Susceptibility] by Serum bactericidal titer
Chlamydophila psittaci Ag [Presence] in Specimen
Classical swine fever virus Ag [Presence] in Specimen
Coccidioides immitis Ag [Presence] in Isolate
Coxiella burnetii Ag [Presence] in Placenta
Coxiella burnetii Ag [Presence] in Specimen
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid
Cryptococcus sp Ag [Units/volume] in Cerebral spinal fluid
Cryptococcus sp Ag [Units/volume] in Serum
Cryptococcus sp Ag [Units/volume] in Specimen
Cryptosporidium sp Ag [Units/volume] in Stool
Cryptosporidium sp Ag [Presence] in Specimen
Cytomegalovirus Ag [Presence] in Serum or Plasma
Cytomegalovirus Ag [Presence] in Specimen
Dermatophilus congolensis Ag [Presence] in Exudate
Dirofilaria immitis Ag [Presence] in Serum
Duck enteritis virus Ag [Presence] in Specimen
Duck hepatitis virus 1 Ag [Presence] in Specimen
Duck hepatitis virus 2 Ag [Presence] in Specimen
Duck hepatitis virus 3 Ag [Presence] in Specimen
Eastern equine encephalitis virus Ag [Presence] in Brain
Cardiolipin Ab [Units/volume] in Serum by Immunoassay
Eastern equine encephalitis virus Ag [Presence] in Serum
Eastern equine encephalitis virus Ag [Presence] in Specimen
Entamoeba histolytica Ag [Units/volume] in Serum
Entamoeba histolytica Ag [Units/volume] in Stool
Entamoeba histolytica Ag [Units/volume] in Specimen
Epizootic hemorrhagic disease virus Ag [Presence] in Lung
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
Equine arteritis virus Ag [Presence] in Specimen
Equine herpesvirus 1 Ag [Presence] in Tracheal swab
Equine herpesvirus 1 Ag [Presence] in Specimen
Equine herpesvirus 1+4 Ag [Presence] in Body fluid
Equine herpesvirus 4 Ag [Presence] in Specimen
Equine infectious anemia virus Ag [Presence] in Specimen
Equine influenza virus A1 Ag [Units/volume] in Specimen
Equine influenza virus A2 Ag [Units/volume] in Specimen
Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay
Equine influenza virus Ag [Presence] in Nose
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid
Escherichia coli K1 Ag [Presence] in Specimen
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue
Foot and mouth disease virus Ag [Presence] in Throat
Francisella tularensis Ag [Presence] in Serum
Francisella tularensis Ag [Presence] in Specimen
Clotting time of Blood by Lee White method
Giardia lamblia Ag [Presence] in Stool --2nd specimen
Giardia lamblia Ag [Presence] in Stool --3rd specimen
Haemophilus influenzae A Ag [Presence] in Specimen
Haemophilus influenzae B Ag [Presence] in Specimen
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid
Haemophilus influenzae C Ag [Presence] in Specimen
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid
Haemophilus influenzae D Ag [Presence] in Specimen
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid
Haemophilus influenzae E Ag [Presence] in Specimen
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid
Haemophilus influenzae F Ag [Presence] in Specimen
Helicobacter pylori Ag [Presence] in Stool
Hepatitis B virus e Ag [Presence] in Serum
Hepatitis B virus e Ag [Units/volume] in Serum
Herpes simplex virus 1 Ag [Presence] in Genital specimen
Herpes simplex virus 1 Ag [Presence] in Skin
Herpes simplex virus 1 Ag [Presence] in Specimen
Activated clotting time (ACT) of Blood by Coagulation assay
Herpes simplex virus 2 Ag [Presence] in Genital specimen
Herpes simplex virus 2 Ag [Presence] in Skin
Herpes simplex virus 2 Ag [Presence] in Specimen
Herpes simplex virus Ag [Presence] in Genital specimen
Herpes simplex virus Ag [Presence] in Serum
Herpes simplex virus Ag [Presence] in Skin
Histoplasma capsulatum Ag [Units/volume] in Serum
Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Histoplasma capsulatum Ag [Units/volume] in Urine
Infectious bursal disease virus Ag [Presence] in Specimen
Influenza virus A Ag [Presence] in Throat
Influenza virus A Ag [Presence] in Specimen
Methacycline [Susceptibility] by Minimum lethal concentration (MLC)
Influenza virus A+B Ag [Presence] in Throat
Influenza virus A+B+C Ag [Presence] in Throat
Influenza virus A+B+C Ag [Presence] in Specimen
Influenza virus B Ag [Presence] in Throat
Coagulation factor IX activated [Units/volume] in Platelet poor plasma by Coagulation assay
Influenza virus B Ag [Presence] in Specimen
Influenza virus C Ag [Presence] in Specimen
Japanese encephalitis virus Ag [Presence] in Specimen
Legionella pneumophila 1 Ag [Presence] in Urine
Legionella pneumophila Ag [Presence] in Sputum
Legionella pneumophila Ag [Presence] in Urine
Leptospira interrogans Ag [Presence] in Specimen
Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
Mareks disease virus Ag [Presence] in Feather
Mareks disease virus Ag [Presence] in Specimen
Measles virus Ag [Presence] in Cerebral spinal fluid
Measles virus Ag [Presence] in Vaginal fluid
Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic method
Measles virus Ag [Presence] in Serum or Plasma
Measles virus Ag [Presence] in Urine sediment
Mumps virus Ag [Presence] in Cerebral spinal fluid
Mumps virus Ag [Presence] in Vaginal fluid
Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by Immunoassay
Mumps virus Ag [Presence] in Urine sediment
Mycoplasma gallisepticum Ag [Presence] in Specimen
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen
Nairobi sheep disease virus Ag [Presence] in Specimen
Coagulation factor IX Ag actual/normal in Platelet poor plasma by Immunoassay
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroup A Ag [Presence] in Specimen
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid
Neisseria meningitidis Ag [Presence] in Specimen
Neisseria meningitidis serogroup B Ag [Presence] in Specimen
Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroup C Ag [Presence] in Specimen
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma
Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen
Neisseria meningitidis serogroup Y Ag [Presence] in Specimen
Coagulation factor V activated [Units/volume] in Platelet poor plasma by Coagulation assay
Ovine progressive pneumonia virus Ag [Presence] in Specimen
Parainfluenza virus 1 Ag [Presence] in Throat
Parainfluenza virus 1 Ag [Presence] in Specimen
Parainfluenza virus 2 Ag [Presence] in Throat
Parainfluenza virus 2 Ag [Presence] in Specimen
Parainfluenza virus 3 Ag [Presence] in Throat
Parainfluenza virus 3 Ag [Presence] in Specimen
Parainfluenza virus Ag [Presence] in Specimen
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
Pasteurella multocida Ag [Units/volume] in Specimen
Plasmodium vivax Ag [Units/volume] in Blood
Pneumocystis jiroveci Ag [Presence] in Blood
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid
Pneumocystis jiroveci Ag [Presence] in Eye
Pneumocystis jiroveci Ag [Presence] in Nose
Pneumocystis jiroveci Ag [Presence] in Serum
Pneumocystis jiroveci Ag [Presence] in Semen
Pneumocystis jiroveci Ag [Presence] in Sputum
Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Pneumocystis jiroveci Ag [Presence] in Stool
Pneumocystis jiroveci Ag [Presence] in Throat
Pneumocystis jiroveci Ag [Presence] in Urine
Pneumocystis jiroveci Ag [Presence] in Specimen
Porcine enterovirus Ag [Presence] in Specimen
Pseudorabies virus Ag [Presence] in Specimen
Coagulation factor V Ag [Units/volume] in Platelet poor plasma by Immunoassay
Respiratory syncytial virus Ag [Presence] in Throat
Respiratory syncytial virus Ag [Presence] in Specimen
Rift valley fever virus Ag [Presence] in Specimen
Rinderpest virus Ag [Presence] in Exudate
Rinderpest virus Ag [Presence] in Specimen
Rinderpest virus Ag [Units/volume] in Specimen
Coagulation factor V Ag actual/normal in Platelet poor plasma by Immunoassay
Rubella virus Ag [Presence] in Cerebral spinal fluid
Rubella virus Ag [Presence] in Vaginal fluid
Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Rubella virus Ag [Presence] in Urine sediment
Streptococcus agalactiae Ag [Presence] in Throat
Streptococcus pneumoniae Ag [Presence] in Sputum
Streptococcus pneumoniae Ag [Presence] in Specimen
Streptococcus pyogenes Ag [Presence] in Serum
Coagulation factor VII activated [Units/volume] in Platelet poor plasma by Coagulation assay
Streptococcus pyogenes Ag [Presence] in Specimen
Swine vesicular disease virus Ag [Presence] in Skin
Swine vesicular disease virus Ag [Presence] in Specimen
Taenia hydatigena Ag [Presence] in Stool
Taylorella equigenitalis Ag [Presence] in Specimen
Transmissible gastroenteritis virus Ag [Presence] in Specimen
Trichomonas vaginalis Ag [Presence] in Genital specimen
Trypanosoma evansi Ag [Presence] in Blood
Varicella zoster virus Ag [Presence] in Skin
Varicella zoster virus Ag [Presence] in Specimen
Venezuelan equine encephalitis virus Ag [Presence] in Serum
Venezuelan equine encephalitis virus Ag [Presence] in Specimen
Vesicular stomatitis virus Ag [Presence] in Skin
Vesicular stomatitis virus Ag [Presence] in Throat
Western equine encephalitis virus Ag [Presence] in Serum
Western equine encephalitis virus Ag [Presence] in Specimen
Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
14-3-3 Ag [Presence] in Cerebral spinal fluid
14-3-3 Ag [Units/volume] in Cerebral spinal fluid
Acylcarnitine [Presence] in Serum or Plasma
Aldosterone [Mass/volume] in 24 hour Urine
Alpha-1-Fetoprotein [Presence] in Serum or Plasma
Basophils/100 leukocytes in Pericardial fluid by Manual count
Basophils/100 leukocytes in Pleural fluid by Manual count
Basophils/100 leukocytes in Peritoneal fluid by Manual count
Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method
Bordetella pertussis Ab [Presence] in Serum
Broad casts [Presence] in Urine sediment by Light microscopy
Catecholamines [Mass/volume] in 24 hour Urine
Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay
Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay
Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay
Chlamydia sp Ag [Presence] in Urine by Immunoassay
Chlamydia trachomatis B Ab [Titer] in Serum
Chlamydia trachomatis C Ab [Titer] in Serum
Chlamydia trachomatis G+F+K Ab [Titer] in Serum
Coproporphyrin/Creatinine [Molar ratio] in 24 hour Urine
Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine
Diuretics [Identifier] in Serum or Plasma by Screen method
Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay
Eosinophils/100 leukocytes in Pericardial fluid by Manual count
Eosinophils/100 leukocytes in Urine by Manual count
EPINEPHrine [Mass/volume] in 24 hour Urine
Glucose [Mass/volume] in Capillary blood
Hemoglobin.other/Hemoglobin.total in Blood by Electrophoresis
Hepatitis A virus IgG Ab [Presence] in Serum
Hepatitis B virus surface Ab [Titer] in Serum
Methacycline [Susceptibility] by Disk diffusion (KB)
HTLV I DNA [Presence] in Serum by NAA with probe detection
Hydroxyproline Free [Moles/volume] in 24 hour Urine
Insulin-like growth factor-I [Mass/volume] in Blood
Magnesium [Mass/volume] in 24 hour Urine
Microscopic observation [Identifier] in Nose by Gram stain
Monocytes+Macrophages/100 leukocytes in Pericardial fluid by Manual count
Monocytes+Macrophages/100 leukocytes in Pleural fluid by Manual count
Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay
Monocytes+Macrophages/100 leukocytes in Peritoneal fluid by Manual count
Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay
Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay
Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay
Polymorphonuclear cells [Presence] in Cerebral spinal fluid by Wright stain
Polymorphonuclear cells [Presence] in Body fluid by Wright stain
Polymorphonuclear cells [Presence] in Pericardial fluid by Wright stain
Coagulation factor VII+Acarboxy Ag activity actual/normal in Platelet poor plasma by Immunoassay
Polymorphonuclear cells [Presence] in Pleural fluid by Wright stain
Polymorphonuclear cells [Presence] in Peritoneal fluid by Wright stain
Polymorphonuclear cells [Presence] in Synovial fluid by Wright stain
Respiratory syncytial virus Ag [Presence] in Nose by Immunofluorescence
Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
Thyroperoxidase Ab [Presence] in Serum or Plasma
Uroporphyrin/Creatinine [Molar ratio] in 24 hour Urine
Volatiles and gases [Identifier] in Serum or Plasma
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe
Amitriptyline+Nortriptyline [Presence] in Specimen
Barbital [Moles/volume] in Serum or Plasma
Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by Immunoassay
Benzodiazepines [Moles/volume] in Serum or Plasma
Bupivacaine [Moles/volume] in Serum or Plasma
Butalbital [Moles/volume] in Serum or Plasma
carBAMazepine free [Moles/volume] in Serum or Plasma
chlordiazePOXIDE [Moles/volume] in Serum or Plasma
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Chloroquine [Moles/volume] in Serum or Plasma
chlorproPAMIDE [Moles/volume] in Serum or Plasma
Clorazepate [Moles/volume] in Serum or Plasma
Digoxin Free [Moles/volume] in Serum or Plasma
diphenhydrAMINE+dimenhyDRINATE [Presence] in Specimen
ePHEDrine+Pseudoephedrine [Presence] in Specimen
Ethchlorvynol [Moles/volume] in Serum or Plasma
fluvoxaMINE [Moles/volume] in Serum or Plasma
Glutethimide [Moles/volume] in Serum or Plasma
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method
glyBURIDE [Moles/volume] in Serum or Plasma
Ibuprofen [Moles/volume] in Serum or Plasma
Imipramine+Desipramine [Presence] in Specimen
Coagulation factor VIII activated [Units/volume] in Platelet poor plasma by Coagulation assay
Loxapine [Moles/volume] in Serum or Plasma
Mephobarbital [Moles/volume] in Serum or Plasma
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
Mexiletine [Moles/volume] in Serum or Plasma
6-Monoacetylmorphine (6-MAM) [Presence] in Specimen
Methacycline [Susceptibility] by Serum bactericidal titer
Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic method
PENTobarbital [Moles/volume] in Serum or Plasma
Phenytoin Free [Moles/volume] in Serum or Plasma
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation.2 stage
Procyclidine [Moles/volume] in Serum or Plasma
Theophylline [Moles/volume] in Serum or Plasma --peak
Theophylline [Moles/volume] in Serum or Plasma --trough
Thiopental [Moles/volume] in Serum or Plasma
TOLBUTamide [Moles/volume] in Serum or Plasma
Valproate Free [Moles/volume] in Serum or Plasma
Choriogonadotropin.beta subunit free [Multiple of the median] in Serum or Plasma
Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
Bromazepam [Moles/volume] in Serum or Plasma
Propoxyphene [Moles/volume] in Serum or Plasma
Propylene glycol [Moles/volume] in Urine
Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic method
risperiDONE [Presence] in Serum or Plasma
Lactate [Moles/volume] in Arterial plasma
Adenovirus+Rotavirus [Identifier] in Stool
Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma by Heat stability
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoassay
Haemophilus influenzae Ag [Presence] in Cerebral spinal fluid
Hemoglobin F [Presence] in Blood by Kleihauer-Betke method
Herpes simplex virus 1+2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Leukocytes [Presence] in Synovial fluid by Light microscopy
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoelectrophoresis
Pathologist review of serum or plasma results
Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy high power field
Platelets Large [Presence] in Blood by Light microscopy
Reducing substances [Mass/volume] in Urine
Urate crystals amorphous [#/area] in Urine sediment by Microscopy high power field
Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method
17-Hydroxyketosteroids [Mass/time] in 24 hour Urine
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma
Basophils+Eosinophils+Monocytes [#/volume] in Blood by Automated count
Basophils+Eosinophils+Monocytes/100 leukocytes in Blood by Automated count
Klebsiella granulomatis [Presence] in Genital specimen by Light microscopy
Carbonated calcium phosphate/Total in Stone
Carboxyhemoglobin [Presence] in Blood by Screen method
Catecholamines [Presence] in 24 hour Urine
Cells [#/volume] in Pleural fluid by Manual count
Cells [#/volume] in Peritoneal fluid by Manual count
Cells [#/volume] in Synovial fluid by Manual count
Cells Counted Total [#] in Pericardial fluid
Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Cytomegalovirus Ab [Titer] in Serum or Plasma by Immunofluorescence
Echinococcus sp IgG Ab [Presence] in Serum
Ehrlichia chaffeensis Ab [Presence] in Serum
Eosinophils [Presence] in Blood by Wright stain
Coarse Granular Casts [Presence] in Urine sediment by Light microscopy
Fine Granular Casts [Presence] in Urine sediment by Light microscopy
Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay
Granulocytes/100 leukocytes in Vaginal fluid
Heptacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine
Herpes simplex virus 1 Ab [Units/volume] in Synovial fluid
Herpes simplex virus 2 Ab [Units/volume] in Synovial fluid
Hydroxyproline Free [Moles/volume] in Urine
Itraconazole [Mass/volume] in Serum or Plasma --peak
Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
Itraconazole [Mass/volume] in Serum or Plasma --trough
Microscopic observation [Identifier] in Penis by Tzanck smear
Microscopic observation [Identifier] in Skin by Tzanck smear
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain
Microscopic observation [Identifier] in Body fluid by Acid fast stain
Microscopic observation [Identifier] in Cerebral spinal fluid
Monocytes+Macrophages [Presence] in Cerebral spinal fluid by Light microscopy
Monocytes+Macrophages [Presence] in Body fluid by Light microscopy
Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method
Monocytes+Macrophages [Presence] in Pericardial fluid by Light microscopy
Monocytes+Macrophages [Presence] in Pleural fluid by Light microscopy
Monocytes+Macrophages [Presence] in Peritoneal fluid by Light microscopy
Monocytes+Macrophages [Presence] in Synovial fluid by Light microscopy
Myoglobin [Mass/volume] in 24 hour Urine
Segmented neutrophils/100 leukocytes in Blood by Automated count
Coagulation factor X Ag [Units/volume] in Platelet poor plasma by Immunoassay
Unidentified cells [#/volume] in Cerebral spinal fluid by Manual count
Unidentified cells [#/volume] in Pericardial fluid by Manual count
Unidentified cells [#/volume] in Pleural fluid by Manual count
Unidentified cells [#/volume] in Peritoneal fluid by Manual count
Unidentified cells [#/volume] in Synovial fluid by Manual count
Plasmodium sp identified in Blood by Light microscopy
Platelet distribution width [Entitic volume] in Blood by Automated count
Platelets Small [Presence] in Blood by Light microscopy
Protein [Presence] in 24 hour Urine by Test strip
Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis
Reducing substances [Mass/volume] in Stool
Salmonella paratyphi A Ab [Titer] in Serum
Salmonella paratyphi B Ab [Titer] in Serum
Thyroxine (T4) free index in Serum or Plasma by calculation
Uroporphyrin [Mass/volume] in 24 hour Urine
von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma
Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay
Coagulation factor X Ag actual/normal in Platelet poor plasma by Immunoassay
Soluble liver Ab [Units/volume] in Serum by Immunoassay
Liver kidney microsomal 1 Ab [Units/volume] in Serum
Alanine [Moles/volume] in Vitreous fluid
Alpha aminobutyrate [Moles/volume] in Body fluid
Alpha aminobutyrate [Moles/volume] in Vitreous fluid
Arginine [Moles/volume] in Vitreous fluid
Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay
Argininosuccinate [Moles/volume] in Serum or Plasma
Argininosuccinate [Moles/volume] in Amniotic fluid
Argininosuccinate/Creatinine [Ratio] in Urine
Aspartate [Moles/volume] in Vitreous fluid
Carbamoyl phosphate synthetase [Enzymatic activity/mass] in Tissue
Citrulline [Moles/volume] in Vitreous fluid
Coagulation factor X+Acarboxy Ag actual/normal in Platelet poor plasma by Immunoassay
Cystathionine [Moles/volume] in Vitreous fluid
Cystine [Moles/volume] in Vitreous fluid
Ethanolamine [Moles/volume] in Amniotic fluid
Glutamate [Moles/volume] in Vitreous fluid
Glutamine [Moles/volume] in Vitreous fluid
Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Glycine [Moles/volume] in Vitreous fluid
Histidine [Moles/volume] in Vitreous fluid
Homocitrulline/Creatinine [Ratio] in Urine
Hydroxyproline [Moles/volume] in Body fluid
Hydroxyproline [Moles/volume] in Vitreous fluid
Isoleucine [Moles/volume] in Vitreous fluid
Leucine [Moles/volume] in Vitreous fluid
Methionine [Moles/volume] in Vitreous fluid
Methylmalonate [Mass/volume] in Cerebral spinal fluid
Ornithine [Moles/volume] in Vitreous fluid
Phenylalanine [Moles/volume] in Body fluid
Phenylalanine [Moles/volume] in Vitreous fluid
Phenylalanine/Tyrosine [Molar ratio] in Serum or Plasma
Proline [Moles/volume] in Vitreous fluid
Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
Threonine [Moles/volume] in Vitreous fluid
Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic method
Tyrosine [Moles/volume] in Vitreous fluid
Methicillin [Susceptibility] by Minimum lethal concentration (MLC)
Carnitine free (C0)/Carnitine.total in Serum or Plasma
Valproate Free/Valproate.total in Serum or Plasma
Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by Immunoassay
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --baseline
7-Dehydrocholesterol [Moles/volume] in Serum or Plasma
Coagulation factor XI Ag actual/normal in Platelet poor plasma by Immunoassay
Amino acid pattern [Interpretation] in Urine
Amylase [Enzymatic activity/volume] in Specimen
Androstenedione [Moles/volume] in Serum or Plasma --baseline
Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Base excess in Cord blood by calculation
Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid
Beta-2-Microglobulin [Moles/volume] in Urine
Bilirubin.total [Moles/volume] in Specimen
Carbon dioxide [Partial pressure] in Urine
Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma
Cortisol [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --baseline
Follitropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --baseline
Coagulation factor XII activated [Units/volume] in Platelet poor plasma by Coagulation assay
Glucose [Moles/volume] in Serum or Plasma --30 minutes post 75 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --4 hours post 75 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --5 hours post 75 g glucose PO
Lactate dehydrogenase [Enzymatic activity/volume] in Specimen
Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
Lutropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --baseline
Mercury [Moles/volume] in Serum or Plasma
Neopterin/Biopterin [Molar ratio] in Urine
Phenylpropanolamine [Presence] in Specimen
Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic method
Pipecolate [Moles/volume] in Serum or Plasma
Pyruvate [Moles/volume] in Serum or Plasma
Transcobalamin II [Moles/volume] in Serum
Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by Immunoassay
Uroporphyrin [Moles/volume] in Red Blood Cells
Xylose [Moles/volume] in Serum or Plasma
Zinc [Moles/volume] in Cerebral spinal fluid
Basophils+Eosinophils+Monocytes [#/volume] in Blood
Basophils+Eosinophils+Monocytes/100 leukocytes in Blood
Alkaline phosphatase.heat labile [Enzymatic activity/volume] in Serum or Plasma by Heat stability
Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability
Estriol (E3) [Multiple of the median] in Serum or Plasma
Hematocrit [Volume Fraction] of Arterial blood
Bacteria identified in Specimen by Respiratory culture
Yeast [Presence] in Urine sediment by Light microscopy
Oligoclonal bands [Presence] in Cerebral spinal fluid
Coagulation factor XII Ag actual/normal in Platelet poor plasma by Immunoassay
Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucose
Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Insulin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge
West Nile virus RNA [Presence] in Serum by NAA with probe detection
BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection
JC virus DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection
Torque teno virus DNA [Presence] in Serum or Plasma by NAA with probe detection
Hepatitis B virus genotype [Identifier] in Serum or Plasma by NAA with probe detection
Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Bacteria identified in Isolate by Aerobe culture
Ureaplasma sp identified in Specimen by Organism specific culture
Clostridium perfringens enterotoxin [Identifier] in Specimen
West Nile virus RNA [Presence] in Tissue by NAA with probe detection
West Nile virus Ag [Presence] in Tissue by Immune stain
Coagulation factor XIII activated [Units/volume] in Platelet poor plasma by Coagulation assay
Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by Immunoassay
Coagulation factor XIII Ag actual/normal in Platelet poor plasma by Immunoassay
Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assay
Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay
Recalcification time in Platelet poor plasma by Coagulation assay
Methicillin [Susceptibility] by Disk diffusion (KB)
Clot Lysis [Time] in Platelet poor plasma by Coagulation assay
Clot Retraction [Time] in Blood by Coagulation assay
Fibrin fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay
Fibrin fragments [Identifier] in Platelet poor plasma by Immunoelectrophoresis
CD10+CD19+ cells/100 cells in Bone marrow
CD13+CD33+ cells/100 cells in Bone marrow
Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutination
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Bone marrow
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Tissue
Methicillin [Susceptibility] by Serum bactericidal titer
CD5+CD19+ cells/100 cells in Bone marrow
CD3+CD4+ (T4 helper) cells [#/volume] in Specimen
Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination
CD3+CD4+ (T4 helper) cells/100 cells in Specimen
CD3+CD8+ (T8 suppressor) cells [#/volume] in Specimen
CD3+CD8+ (T8 suppressor) cells/100 cells in Specimen
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Specimen
CD7-CD13+CD33+ cells/100 cells in Specimen
Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination
CD3+CD25+ cells [#/volume] in Bone marrow
CD3+CD25+ cells/100 cells in Bone marrow
Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic method
CD3+CD4+ (T4 helper) cells [#/volume] in Bone marrow
CD3+CD4+ (T4 helper) cells/100 cells in Bone marrow
CD3+CD8+ (T8 suppressor) cells [#/volume] in Bone marrow
CD3+CD8+ (T8 suppressor) cells/100 cells in Bone marrow
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Bone marrow
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bone marrow
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Fibrin.soluble [Units/volume] in Serum by Coagulation assay
Glucosylceramidase [Enzymatic activity/mass] in Leukocytes
Calcium [Molar amount] in Urine collected for unspecified duration
Chloride [Molar amount] in Urine collected for unspecified duration
Creatinine [Molar amount] in Urine collected for unspecified duration
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells
Ketones [Moles/volume] in Serum or Plasma by Test strip
Nitroprusside reacting substances [Presence] in Urine
Norepinephrine/Creatinine [Molar ratio] in Urine collected for unspecified duration
Potassium [Molar amount] in Urine collected for unspecified duration
Protein [Mass] in Urine collected for unspecified duration
Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells
Sodium [Molar amount] in Urine collected for unspecified duration
Urate [Molar amount] in Urine collected for unspecified duration
Urea [Molar amount] in Urine collected for unspecified duration
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
Candida albicans reaction wheal [Diameter] --1 day post 50 ug Candida albicans intradermal
Mumps reaction wheal [Diameter] --1 day post 0.1 mL mumps intradermal
Trichophyton reaction wheal [Diameter] --2 days post 50 ug trichophyton intradermal
Tuberculosis reaction wheal [Diameter] --1 day post dose mammalian tuberculin intradermal
IgG lymphocytes/100 lymphocytes in Specimen
IgG lymphocytes/100 lymphocytes in Cerebral spinal fluid
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Coxiella burnetii Ab [Titer] in Cerebral spinal fluid
Candida albicans reaction wheal [Diameter] --2 days post 50 ug Candida albicans intradermal
Trichophyton reaction wheal [Diameter] --1 day post 50 ug trichophyton intradermal
Corynebacterium diphtheriae Ab [Units/volume] in Serum --1st specimen
Tetrahydroaldosterone/Creatinine [Mass Ratio] in 24 hour Urine
HIV 1 Ab [Presence] in Urine by Immunoblot
Zaleplon [Mass/volume] in Serum or Plasma
Bartonella henselae IgG Ab [Presence] in Serum
Bartonella henselae IgM Ab [Presence] in Serum
Bartonella quintana IgG Ab [Presence] in Serum
Bartonella quintana IgM Ab [Presence] in Serum
Phentermine [Mass/volume] in Serum or Plasma
Chromatin IgG Ab [Units/volume] in Serum or Plasma
Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain
Phenylpropionylglycine [Presence] in Urine
Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Follitropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge
Androstenedione [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Androstenedione [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Heavy metals [Presence] in 24 hour Urine
Cryoprecipitate poor plasma units available [#]
Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay
HIV 1+2 Ab [Presence] in Cerebral spinal fluid
Leptospira sp Ab [Titer] in Serum --1st specimen
Leptospira sp Ab [Titer] in Serum --2nd specimen
Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Amino acids [Moles/volume] in Body fluid
Amino acids [Moles/volume] in Cerebral spinal fluid
Amino acids [Moles/volume] in Amniotic fluid
Amino acids [Moles/volume] in Vitreous fluid
Carnitine free (C0)/Carnitine.total in Urine
Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Homocysteine cysteine disulfide [Moles/volume] in Serum or Plasma
Homocysteine cysteine disulfide/Creatinine [Ratio] in Urine
Ornithine carbamoyltransferase [Enzymatic activity/mass] in Tissue
3-Methoxytyramine [Mass/time] in 24 hour Urine
Biotinidase [Presence] in Serum or Plasma
Corynebacterium diphtheriae Ab [Presence] in Serum
Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Platelet mean volume [Entitic volume] in Blood by Automated count
Argininosuccinate lyase [Enzymatic activity/mass] in Red Blood Cells
ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method
Protein.monoclonal/Protein.total in Specimen by Immunofixation
MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Nitroblue Tetrazolium Test (NBT) [Presence] in Blood
HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Metanephrine Free [Mass/time] in 24 hour Urine
Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Blood group antibody screen [Presence] in Serum or Plasma by Saline method
FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma
Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum
Nevirapine [Mass/volume] in Serum or Plasma
Nelfinavir [Mass/volume] in Serum or Plasma
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma
Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Hydroxytriazolam [Mass/volume] in Serum or Plasma
Norflunitrazepam [Mass/volume] in Serum or Plasma
Fenthion [Mass/volume] in Serum or Plasma
DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6-Methylmercaptopurine [Entitic substance] in Red Blood Cells
Metanephrines/Creatinine [Mass Ratio] in 24 hour Urine
Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Aflatoxin IgG Ab [Units/volume] in Serum or Plasma
Aflatoxin IgA Ab [Units/volume] in Serum or Plasma
Aflatoxin IgM Ab [Units/volume] in Serum or Plasma
Aflatoxin IgE Ab [Units/volume] in Serum or Plasma
6-Thioguanine [Entitic substance] in Red Blood Cells
Anticonvulsants [Identifier] in Serum or Plasma
Borrelia burgdorferi 25kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi DNA [Presence] in Blood by NAA with probe detection
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Borrelia burgdorferi DNA [Presence] in Synovial fluid by NAA with probe detection
Cells Counted Total [#] in Amniotic fluid
Chlamydia sp Ag [Presence] in Vaginal fluid
Cold agglutinin [Presence] in Serum or Plasma
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid
Cytomegalovirus [Presence] in Bronchial specimen by Organism specific culture
DNA double strand Ab [Units/volume] in Serum by Immunoassay
Ehrlichia chaffeensis IgG Ab [Presence] in Cerebral spinal fluid
Ehrlichia chaffeensis IgM Ab [Presence] in Cerebral spinal fluid
Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Fine Granular Casts [#/area] in Urine sediment by Microscopy low power field
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis
Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis
Hemoglobin S/Hemoglobin.total in Blood by Electrophoresis
LMW Heparin [Units/volume] in Platelet poor plasma
Hepatitis B virus core IgG Ab [Presence] in Serum
Hepatitis B virus DNA [Mass/volume] in Serum
Herpes simplex virus 1 IgM Ab [Presence] in Serum
Herpes simplex virus 2 IgM Ab [Presence] in Serum
Herpes simplex virus identified in Eye by Organism specific culture
metroNIDAZOLE [Susceptibility] by Minimum lethal concentration (MLC)
Homocysteine [Moles/time] in 24 hour Urine
Anaplasma phagocytophilum IgG Ab [Titer] in Serum
Anaplasma phagocytophilum IgM Ab [Titer] in Serum
Legionella longbeachae 1+2 Ab [Titer] in Serum
Legionella pneumophila atypical Ab [Titer] in Serum
Legionella pneumophila 1+2+3+4+5+6 Ab [Titer] in Serum
Lymphocytes [#/volume] in Synovial fluid by Manual count
Heparin neutralization [Presence] in Platelet poor plasma
Magnesium Ionized [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Blood by Acid fast stain
Microscopic observation [Identifier] in Blood by Malaria smear
Microsporidia identified in Stool by Trichrome stain modified
Muscle sarcolemma Ab [Presence] in Serum
Cytochrome B5 reductase [Enzymatic activity/mass] in Red Blood Cells
Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection
LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assay
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine
Neutrophil cytoplasmic Ab.classic [Titer] in Serum
Giant platelets/100 leukocytes [Ratio] in Blood by Manual count
Potassium [Moles/volume] in Arterial blood
LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method
Rickettsia typhus group IgM Ab [Presence] in Serum
SCL-70 extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID)
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum
Tacrolimus [Mass/volume] in Serum or Plasma
LMW Heparin [Mass/time] in 24 hour Urine
Lipase [Enzymatic activity/volume] in Peritoneal fluid
Trichinella sp IgG Ab [Units/volume] in Serum by Immunoassay
Trichomonas sp [Presence] in Urine by Light microscopy
Trypanosoma cruzi IgG Ab [Presence] in Serum
Trypanosoma cruzi IgM Ab [Presence] in Serum
Beta 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Beta 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis
Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Beta 1 globulin/Protein.total in Serum or Plasma by Electrophoresis
Beta 2 globulin/Protein.total in Serum or Plasma by Electrophoresis
Beta 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
Beta 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis
Beta 1 globulin/Protein.total in Urine by Electrophoresis
Beta 2 globulin/Protein.total in Urine by Electrophoresis
Beta 1 globulin [Mass/volume] in Body fluid by Electrophoresis
Beta 2 globulin [Mass/volume] in Body fluid by Electrophoresis
Beta 1 globulin/Protein.total in Body fluid by Electrophoresis
Beta 2 globulin/Protein.total in Body fluid by Electrophoresis
Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method
CD3 cells/100 cells in Bronchial specimen
Heparin unfractionated [Mass/time] in 24 hour Urine
CD19 cells/100 cells in Bronchial specimen
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Bronchial specimen
Myeloperoxidase cells/100 cells in Specimen
Leukocytes [Presence] in Specimen by Wet preparation
Epithelial cells [Presence] in Specimen by Wet preparation
Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assay
Bacteria [Presence] in Specimen by Wet preparation
Clue cells [Presence] in Specimen by Wet preparation
Yeast [Presence] in Specimen by Wet preparation
Trichomonas vaginalis [Presence] in Specimen by Wet preparation
Trichinella sp IgG Ab [Units/volume] in Serum
Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma
metroNIDAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC)
Kininogen HMW [Mass/volume] in Platelet poor plasma by Immunoassay
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection
Clostridium tetani toxoid Ab [Units/volume] in Serum
Erythrocytes [Presence] in Urine sediment by Light microscopy
Escherichia coli O157:H7 Ag [Presence] in Stool
Fibrin strands [Presence] in Blood by Light microscopy
Glucose-6-Phosphatase [Enzymatic activity/volume] in Red Blood Cells
Leukocyte esterase+Nitrite [Presence] in Urine by Test strip
Leucine+Isoleucine+Valine [Identifier] in Serum or Plasma
Mean peroxidase activity index [Presence] in Blood
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
Thyroperoxidase Ab [Titer] in Serum or Plasma
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
Polymorphonuclear cells/Monocytes [Ratio] in Blood
Kininogen HMW actual/normal in Platelet poor plasma by Immunoassay
Herpes simplex virus 2 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma by Immunoassay --1st specimen/2nd specimen
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Parvovirus B19 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Parvovirus B19 IgM Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Kininogen LMW [Mass/volume] in Platelet poor plasma by Immunoassay
Drugs identified in Meconium by Screen method
Microscopic observation [Identifier] in Specimen by Oil red O stain
Glycosaminoglycans/Creatinine [Mass Ratio] in Urine
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen by Latex agglutination
Neutrophils/100 leukocytes in Bronchial specimen by Manual count
Kininogen LMW [Mass/volume] in Serum by Immunoassay
Variant lymphocytes/100 leukocytes in Bronchial specimen by Manual count
Monocytes+Macrophages/100 leukocytes in Bronchial specimen by Manual count
Mononuclear cells/100 leukocytes in Bronchial specimen
Leukocytes other/100 leukocytes in Bronchial specimen
Fungus identified in Bronchial specimen by Fungus stain
Bacteria identified in Bronchial specimen
Microscopic observation [Identifier] in Bronchial specimen by Iron hematoxylin stain
Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain
Pathologist interpretation of Bronchial specimen tests
Microscopic observation [Identifier] in Specimen by Chloracetate esterase stain
Microscopic observation [Identifier] in Specimen by Sudan black B stain
Microscopic observation [Identifier] in Specimen by Terminal deoxynucleotidyl transferase stain
Microscopic observation [Identifier] in Specimen by Myeloperoxidase stain
Microscopic observation [Identifier] in Specimen by Acetate esterase stain
Microsporidia identified in Stool by Trichrome stain
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose lactose PO
aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay
Epithelial cells.squamous/100 cells in Bronchial specimen by Light microscopy
Columnar cells/100 cells in Bronchial specimen
Microscopic observation [Identifier] in Specimen by Tartrate-resistant acid phosphatase stain
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
HIV 1 p17+p18 Ab [Presence] in Serum by Immunoblot
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Epstein Barr virus capsid IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Herpes simplex virus 1 IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Variant lymphocytes/100 leukocytes in Bronchial specimen
Monocytes+Macrophages/100 leukocytes in Bronchial specimen
Herpes simplex virus 2 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Cytomegalovirus IgG Ab [Ratio] in Serum or Plasma --1st specimen/2nd specimen
Parvovirus B19 IgG Ab [Units/volume] in Serum --1st specimen
Parvovirus B19 IgG Ab [Units/volume] in Serum --2nd specimen
Parvovirus B19 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Parvovirus B19 IgM Ab [Units/volume] in Serum --2nd specimen
Parvovirus B19 IgM Ab [Ratio] in Serum --1st specimen/2nd specimen
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --1st specimen
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --2nd specimen
Epstein Barr virus capsid IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Herpes simplex virus 1 IgG Ab [Ratio] in Serum --1st specimen/2nd specimen
Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen
metroNIDAZOLE [Susceptibility] by Disk diffusion (KB)
Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen by Latex agglutination
carBAMazepine free/carBAMazepine.total in Serum or Plasma
Neuronal Ab [Units/volume] in Serum by Immunoassay
Phospholipid Ab [Units/volume] in Serum by Immunoassay
17-Hydroxyprogesterone [Presence] in DBS
Cytoplasmic CD22 cells/100 cells in Specimen
Cytoplasmic CD3 cells/100 cells in Specimen
Multiple drug resistance cells/100 cells in Specimen
TCR alpha beta cells/100 cells in Specimen
TCR gamma delta cells/100 cells in Specimen
Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay
Osmotic fragility [Interpretation] of Red Blood Cells--Incubated
Osmotic fragility [Interpretation] of Red Blood Cells--fresh
Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay
Prothrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay
Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
2-Pyridone [Mass/volume] in Serum or Plasma
2-Pyridone/N'-methylnicotinamide [Mass Ratio] in Serum or Plasma
metroNIDAZOLE [Susceptibility] by Serum bactericidal titer
Acepromazine [Mass/volume] in Serum or Plasma
Acetaminophen [Presence] in Serum or Plasma
Acetaminophen [Mass/volume] in Serum or Plasma
Lutropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge
cycloSPORINE [Mass/volume] in Blood --2 hours post dose
Tissue transglutaminase IgG Ab [Units/volume] in Serum
Rickettsia spotted fever group IgG Ab [Presence] in Serum
Rickettsia spotted fever group IgM Ab [Presence] in Serum
Acetazolamide [Mass/volume] in Serum or Plasma
Rickettsia typhi IgM Ab [Presence] in Serum
Kelp or Seaweed IgE Ab [Units/volume] in Serum
Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Protoporphyrin.zinc [Mass/volume] in Blood
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot
Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC)
Colby Cheese IgE Ab [Units/volume] in Serum
Provolone Cheese IgE Ab [Units/volume] in Serum
Romano Cheese IgE Ab [Units/volume] in Serum
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma
Parasites [#/area] in Urine sediment by Microscopy low power field
Pseudocasts [#/area] in Urine sediment by Microscopy low power field
Triple phosphate crystals [#/area] in Urine sediment by Microscopy low power field
Tyrosine crystals [#/area] in Urine sediment by Microscopy low power field
CD34 cells/100 cells in Blood from Blood product unit
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 1.2 g/kg lactose PO
Hemoglobin [Mass/volume] in Venous cord blood by calculation
Hemoglobin [Mass/volume] in Arterial cord blood by calculation
Herpes simplex virus+Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
Leukocytes [#/volume] in Blood from Blood product unit
CD34 cells [#/volume] in Blood from Blood product unit
Sodium urate crystals [#/area] in Urine sediment by Microscopy low power field
Spermatozoa Progressive [Presence] in Semen
Acetazolamide [Mass/time] in 24 hour Urine
Fatty acids.very long chain C26:1 (Hexacosenoate) [Moles/volume] in Serum or Plasma
Candida sp identified in Vaginal fluid by Cyto stain
Fungus identified in Body fluid by Fungus stain
Hypnotics [Presence] in Serum or Plasma by Screen method
Hypnotics [Presence] in Urine by Screen method
Acetyldigitoxin [Mass/volume] in Serum or Plasma
Pyknosis [Presence] in Blood by Light microscopy
Respiratory syncytial virus Ag [Presence] in Nose
Tranquilizers [Presence] in Serum or Plasma by Screen method
Tranquilizers [Presence] in Urine by Screen method
Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC)
Hypertonic cryohemolysis of Red Blood Cells
Acetylsalicylate [Presence] in Serum or Plasma
Pseudocholinesterase phenotype [Identifier] in Serum or Plasma
Protoporphyrin [Molar ratio] in Red Blood Cells
BCL2 Ag [Presence] in Tissue by Immune stain
Ki-67 nuclear Ag [Presence] in Tissue by Immune stain
Sezary cells [Presence] in Specimen by Light microscopy
Heinz bodies/100 erythrocytes in Blood by Light microscopy
Ketones [Mass/volume] in Serum or Plasma
Fluorescence polarization [Presence] in Amniotic fluid
chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma
Blood group antigens tested for on Red Blood Cells
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Levamisole inhibition
Acetylsalicylate [Mass/volume] in Serum or Plasma
Alfentanil [Mass/volume] in Serum or Plasma
Alphaprodine [Mass/volume] in Serum or Plasma
Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Alphaprodine [Mass/time] in 24 hour Urine
ALPRAZolam [Mass/volume] in Serum or Plasma
Alprenolol [Mass/volume] in Serum or Plasma
Amantadine [Mass/volume] in Serum or Plasma
Amdinocillin [Mass/volume] in Serum or Plasma
Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Amikacin [Mass/volume] in Serum or Plasma --peak
Amyloid beta 42 peptide [Mass/volume] in Plasma
Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
Troponin T.cardiac [Presence] in Serum or Plasma
CD235a cells/100 cells in Peritoneal fluid
Transferrin receptor.soluble [Moles/volume] in Serum or Plasma
Interleukin 8 [Mass/volume] in Serum or Plasma
N-acetyl-L-aspartate [Mass/volume] in Body fluid
Taurine [Moles/volume] in Vitreous fluid
Neutrophils.agranular [Presence] in Blood by Light microscopy
Platelets agranular [Presence] in Blood by Light microscopy
Amikacin [Mass/volume] in Serum or Plasma --trough
Spermatozoa Agglutinated [Presence] in Semen
Bacteria [#/area] in Urine sediment by Automated count
Epithelial cells.squamous [#/area] in Urine sediment by Automated count
Transitional cells [#/area] in Urine by Computer assisted method
Epithelial cells.renal [#/area] in Urine by Computer assisted method
Oval fat bodies (globules) [#/area] in Urine sediment by Automated count
Hyaline casts [#/area] in Urine sediment by Automated count
Fine Granular Casts [#/area] in Urine sediment by Microscopy high power field
aMILoride [Mass/volume] in Serum or Plasma
Fine Granular Casts [#/area] in Urine sediment by Automated count
Coarse Granular Casts [#/area] in Urine sediment by Microscopy high power field
Coarse Granular Casts [#/area] in Urine sediment by Automated count
WBC casts [#/area] in Urine by Computer assisted method
RBC casts [#/area] in Urine by Computer assisted method
Waxy casts [#/area] in Urine by Computer assisted method
Fatty casts [#/area] in Urine by Computer assisted method
Spermatozoa [Presence] in Urine by Automated
Urate crystals [Presence] in Urine by Computer assisted method
Calcium oxalate crystals [Presence] in Urine by Computer assisted method
Calcium phosphate crystals [Presence] in Urine by Computer assisted method
Bilirubin crystals [Presence] in Urine by Computer assisted method
Sulfonamide crystals [Presence] in Urine by Computer assisted method
Triple phosphate crystals [Presence] in Urine by Computer assisted method
Ammonium urate crystals [Presence] in Urine by Computer assisted method
Cystine crystals [Presence] in Urine by Computer assisted method
Calcium carbonate crystals [Presence] in Urine by Computer assisted method
Fungi.filamentous [Presence] in Urine by Computer assisted method
Trichomonas vaginalis [Presence] in Urine by Computer assisted method
Guanidinoacetate [Moles/volume] in Serum or Plasma
Amylase [Catalytic Activity] in Urine collected for unspecified duration
Hyperchromia [Presence] in Blood by Light microscopy
Monocytes [#/volume] in Body fluid by Manual count
Monocytes [#/volume] in Cerebral spinal fluid by Manual count
Nuclear Ab [Titer] in Serum by Hep2 substrate
pH of Arterial blood adjusted to patient's actual temperature
Cell Fractions/Differential [Interpretation] in Blood
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood by Automated count
Cortisol [Mass/volume] in Cerebral spinal fluid
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH
Metamyelocytes/100 leukocytes in Cerebral spinal fluid by Manual count
Metamyelocytes/100 leukocytes in Body fluid by Manual count
Toxoplasma gondii IgA Ab [Units/volume] in Cerebral spinal fluid
Aminocaproate [Mass/volume] in Serum or Plasma --trough
Aspergillus sp IgG Ab [Presence] in Urine
Bordetella pertussis.pertussis toxin IgG Ab [Mass/volume] in Serum
Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH
Mezlocillin [Susceptibility] by Disk diffusion (KB)
Microscopic observation [Identifier] in Buffy Coat by Light microscopy
Microscopic observation [Identifier] in Blood by Malaria thin smear
3-Methylglutaconate [Moles/volume] in Serum or Plasma
Aminopyrine [Mass/volume] in Exhaled gas
5-Methyltetrahydrofolate [Presence] in Cerebral spinal fluid
7-Dehydrocholesterol [Mass/volume] in Serum or Plasma
Acetaminophen+Phenacetin [Presence] in Urine by Screen method
Acetylcholine receptor blocking Ab [Moles/volume] in Serum
Acetylcholine receptor modulation Ab [Moles/volume] in Serum
Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method
Aminopyrine [Mass/volume] in Serum or Plasma
Cannabinoids [Mass/mass] in Meconium by Confirmatory method
Cytomegalovirus IgM Ab [Units/volume] in Body fluid by Immunoassay
Glucose-6-Phosphate dehydrogenase [Presence] in DBS
Galactose 1 phosphate uridyl transferase [Presence] in DBS
Aminosalicylate [Mass/volume] in Serum or Plasma
Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
N-acetyl-L-aspartate [Presence] in Urine
Naproxen [Presence] in Urine by Screen method
Norchlordiazepoxide [Presence] in Urine by Screen method
Phosphatidylcholine Ab [Presence] in Serum
Amiodarone [Mass/volume] in Serum or Plasma
Phosphatidylethanolamine Ab [Presence] in Serum
Phosphatidylinositol Ab [Presence] in Serum
Phosphatidylserine Ab [Presence] in Serum
Porphyrins [Moles/volume] in Serum or Plasma
Rheumatoid factor IgA [Units/volume] in Serum
Rheumatoid factor IgG [Units/volume] in Serum
Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma
Salmonella paratyphi A O Ab [Titer] in Serum
Schistosoma sp IgG Ab [Presence] in Serum
Toxoplasma gondii IgG Ab [Units/volume] in Body fluid
Toxoplasma gondii IgM Ab [Units/volume] in Body fluid
Theophylline [Presence] in Urine by Screen method
Amitriptyline [Presence] in Serum or Plasma
Trypsin [Mass/volume] in Serum or Plasma
Turbidity [Presence] of Amniotic fluid Qualitative
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Complement fixation
West Nile virus IgG Ab [Titer] in Cerebral spinal fluid
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid
Amitriptyline [Mass/volume] in Serum or Plasma
Linezolid [Susceptibility] by Gradient strip
Colistin [Susceptibility] by Gradient strip
Quinupristin+Dalfopristin [Susceptibility] by Gradient strip
Diphenylmethoxyacetate [Presence] in Urine by Screen method
Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination
Granular casts [#/area] in Urine by Computer assisted method
Epithelial cells [#/area] in Urine sediment by Automated count
Leukotriene E4/Creatinine [Mass Ratio] in Urine
Cortisol Free [Mass/volume] in 24 hour Urine
17-Ketosteroids/Creatinine [Mass Ratio] in Urine
Pemoline [Mass/volume] in Urine by Screen method
Pemoline [Mass/volume] in Urine by Confirmatory method
Mezlocillin [Susceptibility] by Serum bactericidal titer
Lysergate diethylamide [Mass/volume] in Urine by Screen method
11-Dehydro thromboxane beta 2 [Mass/volume] in Urine
Glucose/Creatinine [Mass Ratio] in Urine
Alanine aminopeptidase [Enzymatic activity/volume] in Urine
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine
Urea nitrogen [Moles/volume] in 24 hour Urine
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma
Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1 hour post incubation
Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
Branched chain keto-acid dehydrogenase complex [Identifier] in Blood
Galactose 1 phosphate [Mass/mass] in Red Blood Cells
Band form neutrophils/100 leukocytes in Synovial fluid
Monocytes/100 leukocytes in Pleural fluid
Normocytic [Presence] in Blood by Light microscopy
Normochromic [Presence] in Blood by Light microscopy
Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose
Mesothelial cells/100 leukocytes in Synovial fluid
Chloride [Moles/volume] in Peritoneal fluid
Amylase [Enzymatic activity/volume] in Pericardial fluid
Variant lymphocytes/100 leukocytes in Peritoneal fluid
Variant lymphocytes/100 leukocytes in Pleural fluid
Variant lymphocytes/100 leukocytes in Synovial fluid
Blasts/100 leukocytes in Peritoneal fluid
Amobarbital [Presence] in Serum or Plasma
Chylomicrons [Presence] in Pleural fluid
Macrophages/100 leukocytes in Synovial fluid
Coccidioides sp Ab [Presence] in Serum by Complement fixation
Coccidioides sp Ab [Titer] in Serum by Complement fixation
Amobarbital [Mass/volume] in Serum or Plasma
Coccidioides sp Ab [Units/volume] in Serum
Respiratory syncytial virus Ab [Titer] in Cerebral spinal fluid
Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid
Segmented neutrophils/100 leukocytes in Peritoneal fluid
Segmented neutrophils/100 leukocytes in Pleural fluid
Segmented neutrophils/100 leukocytes in Synovial fluid
Segmented neutrophils/100 leukocytes in Pericardial fluid
Band form neutrophils/100 leukocytes in Pericardial fluid
Monocytes/100 leukocytes in Pericardial fluid
Respiratory syncytial virus Ab [Presence] in Serum
Coxsackievirus A8 Ab [Units/volume] in Serum
Coxsackievirus A8 Ab [Presence] in Serum
Coarse Granular Casts [#/area] in Urine sediment by Microscopy low power field
Myelin associated glycoprotein Ab [Titer] in Serum
Epstein Barr virus capsid Ab [Presence] in Serum
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum by Latex agglutination
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine by Latex agglutination
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination
Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/volume] in Serum or Plasma
Platelet associated IgG Ab/IgM Ab [Ratio] in Blood
Glucose [Mass/volume] in Pericardial fluid
Candida albicans Ab [Units/volume] in Serum by Complement fixation
Protein [Mass/volume] in Pericardial fluid
Complement C2 [Units/volume] in Serum or Plasma
Variant lymphocytes/100 leukocytes in Pericardial fluid
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay
Blasts/100 leukocytes in Pericardial fluid
Lipoprotein.beta/total Lipoprotein in Pleural fluid
Lipoprotein.pre-beta/total Lipoprotein in Pleural fluid
Amoxapine [Mass/volume] in Serum or Plasma
Coccidioides sp Ab [Presence] in Serum by Immunoassay
Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
Minocycline [Susceptibility] by Minimum lethal concentration (MLC)
Amoxicillin [Mass/volume] in Serum or Plasma
Bilirubin.conjugated [Mass/volume] in Body fluid
Toxoplasma gondii IgA Ab [Presence] in Serum
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum
Candida albicans Ab [Presence] in Cerebral spinal fluid
Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot
Hepatitis B virus e IgG Ab [Presence] in Serum by Immunoassay
Hepatitis D virus Ag [Presence] in Serum
Francisella tularensis IgG Ab [Titer] in Serum
Francisella tularensis IgM Ab [Titer] in Serum
West Nile virus Ab [Presence] in Specimen
Salmonella paratyphi A O Ab [Titer] in Serum by Agglutination
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post XXX challenge
Diethylpropion [Mass/time] in 24 hour Urine
Acylcarnitine pattern [Interpretation] in Urine
Bile acid pattern [Interpretation] in Urine
Glycosaminoglycans pattern [Interpretation] in Urine
Organic acids pattern [Interpretation] in Serum or Plasma
Organic acids pattern [Interpretation] in Cerebral spinal fluid
Organic acids pattern [Interpretation] in Urine
Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma
Epstein Barr virus early restricted Ab [Titer] in Serum
Amphetamines [Presence] in Serum or Plasma
Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO
Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO
Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO
Patient symptoms [Interpretation] --pre dose lactose PO
Patient symptoms [Interpretation] --30 minutes post dose lactose PO
Patient symptoms [Interpretation] --1 hour post dose lactose PO
Patient symptoms [Interpretation] --1.5 hours post dose lactose PO
Patient symptoms [Interpretation] --2 hours post dose lactose PO
Patient symptoms [Interpretation] --2.5 hours post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactose PO
Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO
Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO
Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO
Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactose PO
Hydrogen+Methane/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose lactose PO
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine
HIV 1 p65+p66 Ab [Presence] in Serum by Immunoblot
Coccidioides immitis IgM Ab [Presence] in Specimen by Immunoassay
Immature reticulocytes/Reticulocytes.total in Blood
Platelet aggregation ADP induced in Platelet rich plasma --High dose
Platelet aggregation ADP induced in Platelet rich plasma --Low dose
Platelet aggregation collagen induced in Platelet rich plasma --High dose
Platelet aggregation collagen induced in Platelet rich plasma --Low dose
Amphetaminil [Mass/time] in 24 hour Urine
Platelet aggregation ristocetin induced in Platelet rich plasma --High dose
Platelet aggregation ristocetin induced in Platelet rich plasma --Low dose
Clot Lysis [Time] in Control Platelet poor plasma by Coagulation assay
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
Methadone.long acting metabolite [Mass/volume] in Urine
Platelet aggregation ADP induced in Control Platelet rich plasma --High dose
Platelet aggregation ADP induced in Control Platelet rich plasma --Low dose
Amphotericin B [Mass/volume] in Cerebral spinal fluid
Platelet aggregation EPINEPHrine induced in Control Platelet rich plasma
Platelet aggregation arachidonate induced in Control Platelet rich plasma
Platelet aggregation ristocetin induced in Control Platelet rich plasma --High dose
Platelet aggregation ristocetin induced in Control Platelet rich plasma --Low dose
Coccidioides immitis IgM Ab [Presence] in Specimen
Influenza virus A+B Ag [Presence] in Nasopharynx
Creatine Kinase aberrant band/Creatine kinase.total in Serum or Plasma by Electrophoresis
Amphotericin B [Mass/volume] in Serum or Plasma
Abnormal lymphocytes/100 leukocytes in Body fluid by Manual count
Hantavirus sin nombre Ab [Presence] in Serum
Platelet aggregation ristocetin induced in Platelet rich plasma --1500 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --1200 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --900 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --600 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --300 ug/mL
Ampicillin [Mass/volume] in Serum or Plasma
Creatinine renal clearance in Urine and Serum or Plasma collected for unspecified duration
Kappa light chains/Lambda light chains [Mass Ratio] in Urine
Benzodiazepines [Mass/volume] in Gastric fluid
Cannabinoids [Mass/volume] in Gastric fluid
Ampicillin [Mass/volume] in Serum or Plasma --peak
Anileridine [Mass/volume] in Serum or Plasma
Pancreatic islet cell IgG Ab [Units/volume] in Serum
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoblot
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoblot
Jo-1 extractable nuclear IgG Ab [Units/volume] in Serum
Aureobasidium pullulans IgG Ab [Presence] in Serum
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum by Immunoassay
Chlamydia trachomatis I IgM Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis I Ab [Titer] in Serum by Immunofluorescence
Francisella tularensis IgA Ab [Titer] in Serum
Rheumatoid factor IgM [Titer] in Serum by Nephelometry
Dengue virus Ab [Titer] in Serum by Immunofluorescence
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot
Gastrin [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge
Uroporphyrin 3 isomer [Mass/time] in 24 hour Stool
Trichinella sp IgA Ab [Units/volume] in Serum
Phosphatidylethanolamine Ab [Units/volume] in Serum by Immunoassay
Phosphatidylinositol Ab [Units/volume] in Serum by Immunoassay
Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid
Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC)
Hemoglobin G - Coushatta/Hemoglobin.total in Blood
Platelet factor 4 [Presence] in Platelet poor plasma
Anileridine [Moles/volume] in 24 hour Urine
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot
Amylase [Enzymatic activity/volume] in Urine collected for unspecified duration
Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence
Myelin associated glycoprotein IgG Ab [Titer] in Serum
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum
Chlamydia trachomatis I IgM Ab [Titer] in Serum
Chlamydia trachomatis I Ab [Titer] in Serum
Anaplasma phagocytophilum Ab [Titer] in Serum
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum
Phosphatidylethanolamine Ab [Units/volume] in Serum
Phosphatidylinositol Ab [Units/volume] in Serum
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum
Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma
Neuronal nuclear type 1 Ab [Presence] in Serum
Cytomegalovirus early Ag [Presence] in Urine
Coproporphyrin 3/Coproporphyrin 1 [Mass Ratio] in 24 hour Stool
Deuteroporphyrin.semi-proto [Mass/time] in 24 hour Stool
Tricarboxylporphyrin 1 [Mass/time] in 24 hour Stool
Tricarboxylporphyrin 3 [Mass/time] in 24 hour Stool
Isotricarboxylporphyrin [Mass/time] in 24 hour Stool
Pentacarboxylporphyrin I [Mass/time] in 24 hour Stool
Pentacarboxylporphyrin III [Mass/time] in 24 hour Stool
Isocoproporphyrin [Mass/time] in 24 hour Stool
Hematoporphyrin [Mass/time] in 24 hour Stool
Hepatitis B virus sequencing [Identifier] in Serum by NAA with probe detection
HIV protease gene mutations detected [Identifier]
Cytomegalovirus UL54 gene mutations detected [Identifier]
Cytomegalovirus UL54+UL97 gene mutations detected [Identifier]
Hepatitis B virus precore TAG [Presence] in Serum by NAA with probe detection
Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detection
PM-SCL extractable nuclear Ab [Mass/volume] in Serum by Immune diffusion (ID)
IgA.secretory [Units/volume] in Saliva (oral fluid)
Phagocytic index of Blood by Flow cytometry (FC)
Lymphocyte proliferation stimulated by phytohemagglutinin [Mass/volume] in Blood
Anthraquinone [Mass/volume] in Serum or Plasma
Lymphocyte proliferation stimulated by Candida albicans [Units/volume] in Blood
Lymphocyte proliferation stimulated by tetanus toxoid [Units/volume] in Blood
Lymphocyte proliferation stimulated by tuberculin [Units/volume] in Blood
Lymphocyte Ab [Units/volume] in Serum by Flow cytometry (FC)
Limulus amebocyte lysate test [Units/volume] in Nonbiological fluid
Methylenedianiline [Mass/volume] in Serum or Plasma
Antipyrine [Mass/volume] in Serum or Plasma
Protein.monoclonal/Protein.total in Serum or Plasma by Electrophoresis
Cryoglobulin Rheumatoid Factor [Units/volume] in Serum
CD56 cells/CD38 Cells [# Ratio] in Blood
Beta galactosidase [Entitic Catalytic Activity] in Leukocytes
Antipyrine renal clearance in 24 hour Urine and Serum or Plasma
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Beta-N-acetylhexosaminidase [Moles/volume] in Leukocytes
Beta-N-acetylhexosaminidase.B [Moles/volume] in Leukocytes
Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
HIV 1 p24 Ag [Presence] in Serum or Plasma by Neutralization test
Glucosylceramidase [Entitic Catalytic Activity] in Leukocytes
Atenolol [Mass/volume] in Serum or Plasma
Erythrocytes.CD59 deficient/100 erythrocytes in Blood
HTLV I+II Ab band pattern [Interpretation] in Serum by Radioimmunoprecipitation assay (RIPA)
Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy
Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma
Atropine [Mass/volume] in Serum or Plasma
Platelet aggregation collagen induced lag [Time] in Platelet rich plasma --High dose
Platelet aggregation collagen induced lag [Time] in Control Platelet rich plasma --High dose
Platelet aggregation.ristocetin+Control PPP induced in Platelet rich plasma
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate
Platelet aggregation.ristocetin+Control PRP induced in Platelet poor plasma
Microscopic observation [Identifier] in Specimen by Esterase stain.combined
Francisella tularensis [Presence] in Specimen by Organism specific culture
Francisella tularensis [Presence] in Isolate by Organism specific culture
Francisella tularensis Ag [Presence] in Isolate by Immunofluorescence
Francisella tularensis DNA [Presence] in Specimen by NAA with probe detection
Minocycline [Susceptibility] by Disk diffusion (KB)
Francisella tularensis DNA [Presence] in Isolate by NAA with probe detection
Francisella tularensis [Presence] in Specimen by Cell wall fatty acid analysis
Francisella tularensis [Presence] in Isolate by Cell wall fatty acid analysis
Francisella tularensis Ab [Titer] in Serum by Microagglutination
Francisella tularensis Ab [Titer] in Serum by Tube agglutination
Yersinia pestis [Presence] in Specimen by Organism specific culture
Yersinia pestis [Presence] in Isolate by Organism specific culture
Yersinia pestis Ag [Presence] in Specimen by Immunofluorescence
Azlocillin [Mass/volume] in Serum or Plasma
Yersinia pestis Ag [Presence] in Isolate by Immunofluorescence
Yersinia pestis Ab [Presence] in Serum by Hemagglutination inhibition
Yersinia pestis Ab [Titer] in Serum by Immunoassay
Yersinia pestis DNA [Presence] in Specimen by NAA with probe detection
Yersinia pestis DNA [Presence] in Isolate by NAA with probe detection
Yersinia pestis [Presence] in Isolate by Phage lysis
Clostridium botulinum [Presence] in Specimen by Organism specific culture
Clostridium botulinum [Presence] in Isolate by Organism specific culture
Aztreonam [Mass/volume] in Serum or Plasma
Clostridium botulinum toxin [Presence] in Specimen by Mouse bioassay
Bacillus anthracis Ag [Presence] in Isolate by Immunofluorescence
Bacillus anthracis [Presence] in Isolate by Phage lysis
Microscopic observation [Identifier] in Specimen by Malachite green stain
Spore [Identifier] in Specimen by Malachite green stain
Clostridium botulinum toxin A [Presence] in Specimen by Mouse bioassay neutralization
Clostridium botulinum toxin E [Presence] in Specimen by Mouse bioassay neutralization
Clostridium botulinum toxin F [Presence] in Specimen by Mouse bioassay neutralization
Barbital [Mass/volume] in Serum or Plasma
Clostridium botulinum toxin A+B+E [Presence] in Specimen by Mouse bioassay neutralization
Clostridium botulinum toxin B [Presence] in Specimen by Mouse bioassay neutralization
Clostridium botulinum toxin [Presence] in Specimen
Clostridium botulinum toxin A [Presence] in Specimen
Clostridium botulinum toxin E [Presence] in Specimen
Clostridium botulinum toxin F [Presence] in Specimen
Clostridium botulinum toxin A+B+E [Presence] in Specimen
Clostridium botulinum toxin B [Presence] in Specimen
Francisella tularensis Ab [Presence] in Specimen by Slide agglutination
Francisella tularensis Ab [Presence] in Isolate by Slide agglutination
Cytology report of Tissue fine needle aspirate Cyto stain
Barbiturate screen absent [Identifier] in Urine
Resection completeness in Mesorectum Qualitative by Macroscopy
Histology type in Cancer specimen Narrative
Histology grade [Identifier] in Cancer specimen
Surgical margin tumor involvement.proximal by CAP cancer protocols
Surgical margin tumor involvement.distant by CAP cancer protocols
Surgical margin tumor involvement.circumferential by CAP cancer protocols
Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols
Venous.large vessel.invasion [Identifier] in Specimen by CAP cancer protocols
Tumor border configuration [Type] in Specimen
Barbiturate screen present [Identifier] in Urine
Surgical margin tumor involvement.lateral in Specimen by CAP cancer protocols
Distance of carcinoma from closest lateral margin [Length] in Specimen
Surgical margin tumor involvement.deep in Specimen by CAP cancer protocols Narrative
Distance of carcinoma from deep margin [Length] in Specimen
Polyp stalk length by CAP cancer protocols
Deepest extent of invasion [Type] in Specimen
Minocycline [Susceptibility] by Serum bactericidal titer
Surgical margin tumor involvement.mucosal in Specimen by CAP cancer protocols
Barbiturates [Presence] in Serum, Plasma or Blood
Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma
Shiga toxin stx gene [Identifier] in Specimen by NAA with probe detection
Leukocytes [#/volume] in Blood Product unit.platelet pheresis by Automated count
Radioactivity [Presence] in Urine --pre dose radioactive cyanocobalamin
Acidity.total [Moles/volume] in Gastric fluid
Leukocyte clumps [#/volume] in Urine by Automated count
Mucin clot [Appearance] in Synovial fluid Qualitative --15 minutes post incubation
Mucin clot [Appearance] in Synovial fluid Qualitative --30 minutes post incubation
Karyotype [Identifier] in Amniotic fluid Nominal
Karyotype [Identifier] in Chorionic villus sample Nominal
SmIg Ag [Presence] in Tissue by Immune stain
IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain
Galactose 1 phosphate uridyl transferase phenotype [Type] in Blood
Alpha-1-acid glycoprotein [Moles/volume] in Serum or Plasma
Retinol binding protein [Mass/volume] in Urine
Atrial natriuretic factor [Moles/volume] in Plasma
Bacterial casts [Presence] in Urine sediment by Light microscopy
Immature basophils [#/volume] in Blood by Manual count
Immature basophils/100 leukocytes in Blood by Manual count
Calcitonin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Calcium [Moles/volume] in Urine --10th specimen post XXX challenge
Calcium [Moles/volume] in Urine --1st specimen post XXX challenge
Calcium [Moles/volume] in Urine --5th specimen post XXX challenge
Calcium [Moles/volume] in Urine --6th specimen post XXX challenge
Calcium [Moles/volume] in Urine --7th specimen post XXX challenge
Calcium [Moles/volume] in Urine --8th specimen post XXX challenge
Bendroflumethiazide [Mass/volume] in Urine
Calcium [Moles/volume] in Urine --9th specimen post XXX challenge
DNA double strand IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
DNA double strand IgG Ab [Units/volume] in Serum
E selectin [Mass/volume] in Serum or Plasma
Immature eosinophils [#/volume] in Blood by Manual count
Bendroflumethiazide [Mass/time] in 24 hour Urine
Immature eosinophils/100 leukocytes in Blood by Manual count
RBC casts [Presence] in Urine sediment by Light microscopy
Fructosamine [Mass/volume] in Serum or Plasma
HIV 2 IgG Ab [Presence] in Serum by Immunoblot
Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma
Insulin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --11th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --12th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --13th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --14th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --15th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
Interferon alpha [Mass/volume] in Serum or Plasma
Interleukin 1 alpha [Mass/volume] in Serum or Plasma
Interleukin 13 [Mass/volume] in Serum or Plasma
Interleukin 18 [Mass/volume] in Serum or Plasma
WBC casts [Presence] in Urine sediment by Light microscopy
Lutropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
Lymphoblasts [#/volume] in Blood by Manual count
Lymphoblasts/100 leukocytes in Blood by Manual count
Lymphocytes Immunoblastic [#/volume] in Blood by Manual count
Lymphocytes Immunoblastic/100 leukocytes in Blood by Manual count
Lymphocytes Plasmacytoid [#/volume] in Blood by Manual count
Lymphocytes Plasmacytoid/100 leukocytes in Blood by Manual count
Malignant cells [#/volume] in Blood by Manual count
Malignant cells/100 leukocytes in Blood by Manual count
Mannitol [Moles/volume] in Serum or Plasma
Monoblasts [#/volume] in Blood by Manual count
Miocamycin [Susceptibility] by Minimum lethal concentration (MLC)
Monoblasts/100 leukocytes in Blood by Manual count
Immature monocytes [#/volume] in Blood by Manual count
Immature monocytes/100 leukocytes in Blood by Manual count
Norepinephrine [Moles/volume] in Plasma --standing
Norepinephrine [Moles/volume] in Plasma --supine
Benzfetamine [Mass/time] in 24 hour Urine
Parathyrin.intact [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Parathyrin.intact [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Parathyrin.intact [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Plasma cell precursor [#/volume] in Blood by Manual count
Plasma cell precursor/100 leukocytes in Blood by Manual count
Plasma cells immature [#/volume] in Bone marrow by Manual count
Progesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Benzodiazepines negative [Identifier] in Urine
Progesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Promonocytes [#/volume] in Blood by Manual count
Sezary cells [#/volume] in Blood by Manual count
Sezary cells/100 leukocytes in Blood by Manual count
Somatotropin [Units/volume] in Serum or Plasma
Somatotropin/Creatinine [Ratio] in 12 hour Urine
Somatotropin/Creatinine [Ratio] in 24 hour Urine
Starch granules [Presence] in Urine sediment by Light microscopy
Waxy casts [Presence] in Urine sediment by Light microscopy
Cystatin C [Mass/volume] in Serum or Plasma
Elastase.leukocyte [Mass/volume] in Plasma
Staphylococcus aureus enterotoxin [Identifier] in Specimen
HIV 1 Ab [Presence] in Capillary blood by Immunoassay
Xylose [Moles/volume] in Serum or Plasma --1 hour post 5 g xylose PO
DOPamine/Creatinine [Molar ratio] in Urine collected for unspecified duration
EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration
Oligosaccharides pattern [Interpretation] in Urine
Sulfocysteine/Creatinine [Molar ratio] in Urine
Benzodiazepines positive [Identifier] in Urine
Protein.monoclonal [Mass/volume] in Specimen by Immunofixation
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --2H post incubation with normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma
Karyotype [Identifier] in Bone marrow Nominal
Benzodiazepines [Presence] in Serum or Plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2 hours post incubation
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma by Immunoassay
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma
Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma
Bilirubin.conjugated+indirect [Moles/volume] in Serum or Plasma
Fetal cell screen [Presence] in Blood by Rosette test
Gestational age of fetus by Amniocentesis
Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by Probe
Trichomonas sp [#/area] in Urine sediment by Microscopy high power field
Prolactin [Moles/volume] in Serum or Plasma --30 minutes post 200 ug TRH IV
Prolactin [Moles/volume] in Serum or Plasma --1 hour post 200 ug TRH IV
Prolactin [Moles/volume] in Serum or Plasma --1.5 hours post 200 ug TRH IV
Prolactin [Moles/volume] in Serum or Plasma --2 hours post 200 ug TRH IV
Benzoylecgonine [Presence] in Serum or Plasma
Complement C1r actual/normal in Serum or Plasma
Complement C1s actual/normal in Serum or Plasma
Trans-3-Hydroxycotinine [Mass/volume] in Urine
Ampicillin [Mass/volume] in Serum or Plasma --trough
Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma
Neuronal nuclear type 3 Ab [Titer] in Serum
Benzoylecgonine [Mass/volume] in Serum or Plasma
Efavirenz [Mass/volume] in Serum or Plasma
Tacrolimus [Mass/volume] in Serum or Plasma --trough
aPTT W excess hexagonal phospholipid (StaClot LA confirm)
Lymphocyte proliferation stimulated by Borrelia burgdorferi [Ratio] in Blood
Borrelia burgdorferi Ab [Titer] in Cerebral spinal fluid
Glutaraldehyde IgE Ab [Units/volume] in Serum
Methylmethacrylate IgE Ab [Presence] in Serum
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma
Homocystine Free [Moles/volume] in Urine
Homocystine Free [Moles/volume] in Serum or Plasma
Interleukin 5 [Mass/volume] in Serum or Plasma
Interleukin 2 [Mass/volume] in Serum or Plasma
Herpes virus 6 DNA [Presence] in Tissue by NAA with probe detection
Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Lambda light chains.free [Mass/volume] in Serum or Plasma
Brucella abortus Ab [Titer] in Cerebral spinal fluid
Ziprasidone [Mass/volume] in Serum or Plasma
Clostridioides difficile toxin neutralizing antibody [Titer] in Serum by Neutralization test
Potassium/Creatinine [Molar ratio] in Urine
Magnesium/Creatinine [Molar ratio] in Urine
Sodium/Creatinine [Molar ratio] in Urine
Immune complex.IgM [Mass/volume] in Serum or Plasma
Immune complex IgA [Mass/volume] in Serum or Plasma
Immune complex.IgG [Mass/volume] in Serum or Plasma
cycloSPORINE.monoclonal [Mass/volume] in Blood
cycloSPORINE.polyclonal [Mass/volume] in Blood
Cholecalciferol (Vit D3) [Moles/volume] in Serum or Plasma
Procalcitonin [Mass/volume] in Serum or Plasma
Immune complex IgE [Units/volume] in Serum or Plasma
Sulthiame [Mass/volume] in Serum or Plasma
Melanoma inhibitory activity protein [Mass/volume] in Serum or Plasma
Granulocytes/100 leukocytes in Cerebral spinal fluid
SARS coronavirus Urbani RNA [Presence] in Specimen by NAA with probe detection
SARS coronavirus Urbani RNA [Presence] in Stool by NAA with probe detection
SARS coronavirus Urbani RNA [Presence] in Nose by NAA with probe detection
SARS coronavirus Urbani RNA [Presence] in Serum or Plasma by NAA with probe detection
SARS coronavirus Urbani Ab [Presence] in Serum by Immunoassay
Cocaine [Mass/volume] in Serum or Plasma
SARS coronavirus Urbani Ab [Units/volume] in Serum by Immunoassay
SARS coronavirus Urbani Ab [Presence] in Serum by Immunofluorescence
SARS coronavirus Urbani Ab [Titer] in Serum by Immunofluorescence
SARS coronavirus Urbani Ab [Presence] in Serum
SARS coronavirus Urbani Ab [Units/volume] in Serum
SARS coronavirus Urbani Ab [Titer] in Serum
SARS coronavirus Urbani RNA [Presence] in Sputum by NAA with probe detection
BK virus DNA [Presence] in Urine by NAA with probe detection
Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum
Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum
TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
California Walnut Pollen IgE Ab [Units/volume] in Serum
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum
Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic method
Bartonella henselae DNA [Presence] in Tissue by NAA with probe detection
Bartonella henselae DNA [Presence] in Specimen by NAA with probe detection
Heparin cofactor II actual/normal in Platelet poor plasma by Chromogenic method
Thymidine phosphorylase [Enzymatic activity/mass] in Leukocytes
quiNINE induced platelet Ab [Presence] in Serum
Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Miocamycin [Susceptibility] by Disk diffusion (KB)
Benzthiazide [Mass/time] in 24 hour Urine
Bolasterone [Mass/time] in 24 hour Urine
Xylose [Moles/volume] in Serum or Plasma --2 hours post 5 g xylose PO
Thyrotropin [Units/volume] in Serum or Plasma --pre or post dose TRH
Lutropin [Units/volume] in Serum or Plasma --pre or post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre or post dose arginine
Glucose [Moles/volume] in Serum or Plasma --pre or post dose cloNIDine
Bromazepam [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --pre or post dose glucose
Glucose [Moles/volume] in Serum or Plasma --pre or post dose insulin
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose insulin
Cortisol [Moles/volume] in Serum or Plasma --pre or post dose corticotropin
Brompheniramine [Presence] in Serum or Plasma
Bupivacaine [Mass/volume] in Serum or Plasma
Buprenorphine [Mass/volume] in Serum or Plasma
Paraneoplastic Ab [Presence] in Serum by Immunoblot
Human antichimeric Ab [Mass/volume] in Serum
Neopterin [Moles/volume] in Cerebral spinal fluid
Treponema pallidum IgG+IgM Ab [Presence] in Serum
Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum
N-acetyl-L-aspartate [Moles/volume] in Amniotic fluid
Mycoplasma fermentans DNA [Presence] in Blood by NAA with probe detection
Herpes simplex virus 1+2 IgM Ab [Titer] in Serum
Influenza virus A Ab [Units/volume] in Specimen
Influenza virus B Ab [Units/volume] in Specimen
Guanidinoacetate/Creatinine [Molar ratio] in Urine
Insulin.bound [Units/volume] in Serum or Plasma
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid
Creatine kinase [Presence] in Body fluid
Cancer Ag 72-4 [Units/volume] in Body fluid
Hepatitis C virus IgG band pattern [Interpretation] in Serum by Immunoblot
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue
Buprenorphine [Mass/time] in 24 hour Urine
Immature granulocytes [Presence] in Blood by Automated count
Microscopic observation [Identifier] in Specimen by Electron microscopy
Platelets Large [Presence] in Blood by Automated count
Sulfocysteine/Creatinine [Ratio] in Urine
Fatty acids.very long chain [Mass/volume] in Serum or Plasma
Histoplasma capsulatum Ag [Units/volume] in Specimen
Streptococcus pneumoniae Danish serotype 6B Ab [Mass/volume] in Serum
Butabarbital [Presence] in Serum or Plasma
Mixed cellular casts [Presence] in Urine sediment by Light microscopy
Hemoglobin casts [Presence] in Urine sediment by Light microscopy
Analgesics [Identifier] in Serum or Plasma
Tricyclic antidepressants [Presence] in Specimen
Herpes virus 6 IgG Ab [Titer] in Serum by Immunoassay
Miocamycin [Susceptibility] by Serum bactericidal titer
Ethanol [Presence] in Urine by Confirmatory method
Butabarbital [Mass/volume] in Serum or Plasma
Methanol [Presence] in Urine by Confirmatory method
Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method
Beta globulin/Protein.total in 24 hour Urine
Gamma globulin/Protein.total in 24 hour Urine
methIMAzole [Mass/time] in 24 hour Urine
Para aminobenzoate [Mass/time] in 24 hour Urine
DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae
Nucleated erythrocytes [Presence] in Blood
aPTT.factor substitution in Platelet poor plasma --30M post incubation with normal plasma
Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
Beta glucuronidase [Enzymatic activity/volume] in Specimen
Beta galactosidase [Presence] in Amniotic fluid cells
SMPD1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Salicylamide [Mass/volume] in Serum or Plasma --trough
Salicylamide [Mass/volume] in Serum or Plasma --peak
Neutrophils.hypersegmented [Presence] in Blood by Automated count
Nucleated erythrocytes [Presence] in Blood by Automated count
Cytomegalovirus [Presence] in Amniotic fluid by Organism specific culture
Linezolid [Mass/volume] in Serum or Plasma
SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
11-Deoxycortisol [Moles/volume] in 24 hour Urine
11-Deoxycortisol [Moles/volume] in Urine
11-Deoxycortisol/Creatinine [Molar ratio] in Urine
Butalbital [Presence] in Serum or Plasma
11-Hydroxyandrosterone [Moles/volume] in 24 hour Urine
11-Hydroxyandrosterone [Moles/volume] in Urine
11-Hydroxyandrosterone/Creatinine [Molar ratio] in Urine
11-Hydroxyetiocholanolone [Moles/volume] in 24 hour Urine
11-Hydroxyetiocholanolone [Moles/volume] in Urine
11-Hydroxyetiocholanolone/Creatinine [Molar ratio] in Urine
11-Ketoandrosterone [Moles/volume] in 24 hour Urine
11-Ketoandrosterone [Moles/volume] in Urine
11-Ketoandrosterone/Creatinine [Molar ratio] in Urine
11-Ketoetiocholanolone [Moles/volume] in 24 hour Urine
11-Ketoetiocholanolone [Moles/volume] in Urine
17-Hydroxycorticosteroids [Moles/volume] in Urine
17-Hydroxycorticosteroids/Creatinine [Molar ratio] in Urine
17-Hydroxyprogesterone [Moles/volume] in 24 hour Urine
17-Hydroxyprogesterone/Creatinine [Molar ratio] in Urine
Caffeine [Mass/volume] in Serum or Plasma
17-Ketosteroids/Creatinine [Molar ratio] in Urine
3-Alpha-Androstanediol glucuronide [Moles/volume] in 24 hour Urine
3-Alpha-Androstanediol glucuronide [Moles/volume] in Urine
3-Alpha-Androstanediol glucuronide/Creatinine [Molar ratio] in Urine
Acylcarnitine [Moles/time] in 24 hour Urine
Acylcarnitine [Moles/volume] in 24 hour Urine
Acylcarnitine/Creatinine [Molar ratio] in Urine
Adenosine monophosphate.cyclic [Moles/volume] in 24 hour Urine
Aldosterone/Creatinine [Molar ratio] in Urine
Pseudallescheria boydii IgG Ab [Presence] in Serum by Immune diffusion (ID)
Alternaria sp IgG Ab [Presence] in Serum by Immune diffusion (ID)
Ampicillin IgG Ab [Units/volume] in Serum
Androstenediol [Moles/volume] in 24 hour Urine
Androstenediol/Creatinine [Molar ratio] in Urine
Androstenedione [Moles/volume] in 24 hour Urine
Androstenedione/Creatinine [Molar ratio] in Urine
Androsterone [Moles/volume] in 24 hour Urine
Androsterone/Creatinine [Molar ratio] in Urine
Ascorbate [Moles/volume] in 24 hour Urine
Ascorbate/Creatinine [Molar ratio] in Urine
Asialoganglioside GM2 Ab [Units/volume] in Serum
Silver Birch recombinant (rBet v) 4 IgE Ab [Units/volume] in Serum
Borrelia garinii IgG Ab [Presence] in Serum by Immunoblot
Borrelia garinii IgM Ab [Presence] in Serum by Immunoblot
Cannabinoids [Presence] in Serum or Plasma
Cancer Ag 50 [Units/volume] in Serum or Plasma
Carnitine [Moles/volume] in 24 hour Urine
Carnitine free (C0) [Moles/volume] in 24 hour Urine
Carnitine free (C0) [Moles/time] in 24 hour Urine
Moxalactam [Susceptibility] by Minimum lethal concentration (MLC)
Catecholamines [Moles/volume] in 24 hour Urine
Catecholamines/Creatinine [Molar ratio] in Urine
Tetrahydrocannabinol [Presence] in Urine
Chlamydia sp IgA Ab [Titer] in Serum by Immunofluorescence
Chloride/Creatinine [Molar ratio] in Urine
Cladosporium sp IgG Ab [Presence] in Serum by Immune diffusion (ID)
Cobalt/Creatinine [Molar ratio] in Urine
Collagen crosslinked N-telopeptide [Mass/volume] in Urine
Collagen crosslinked N-telopeptide/Creatinine [Ratio] in Urine
Creatine [Moles/volume] in 24 hour Urine
Creatine/Creatinine [Molar ratio] in Urine
Dehydroepiandrosterone (DHEA) [Moles/volume] in Urine
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Urine
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in 24 hour Urine
Dehydroepiandrosterone sulfate (DHEA-S)/Creatinine [Molar ratio] in Urine
Dehydroepiandrosterone (DHEA)/Creatinine [Molar ratio] in Urine
Delta aminolevulinate [Moles/volume] in Urine
Ehrlichia sp Ab [Titer] in Serum by Complement fixation
Estradiol (E2) [Moles/volume] in 24 hour Urine
Estradiol (E2).unconjugated [Moles/volume] in 24 hour Urine
Estradiol (E2).unconjugated [Moles/volume] in Urine
Estradiol (E2).unconjugated/Creatinine [Molar ratio] in Urine
Estradiol (E2)/Creatinine [Molar ratio] in Urine
Estriol (E3) [Moles/volume] in 24 hour Urine
Estriol (E3)/Creatinine [Molar ratio] in Urine
Estrogen [Moles/volume] in 24 hour Urine
Estrogen/Creatinine [Molar ratio] in Urine
Estrone (E1) [Moles/volume] in 24 hour Urine
Estrone (E1) [Moles/time] in 24 hour Urine
Estrone (E1)/Creatinine [Molar ratio] in Urine
Etiocholanolone [Moles/volume] in 24 hour Urine
Etiocholanolone/Creatinine [Molar ratio] in Urine
Flupenthixol [Mass/volume] in Serum or Plasma
Follitropin [Units/volume] in 24 hour Urine by 2nd IRP
Fructose [Moles/volume] in 24 hour Urine
Fructose/Creatinine [Molar ratio] in Urine
Galactose [Moles/volume] in 24 hour Urine
Glucose/Creatinine [Molar ratio] in Urine
Heptacarboxylporphyrin [Mass/mass] in Stool
carBAMazepine [Presence] in Serum or Plasma
Heptacarboxylporphyrin [Moles/volume] in Urine
Hexacarboxylporphyrins [Mass/mass] in Stool
Histamine [Moles/volume] in Serum or Plasma
Histamine [Moles/volume] in 24 hour Urine
HTLV I+II Ab [Titer] in Serum by Complement fixation
Inhibin B [Mass/volume] in Serum or Plasma
Iodine/Creatinine [Molar ratio] in Urine
carBAMazepine [Mass/volume] in Serum or Plasma
Levodopa [Moles/volume] in Serum or Plasma
carBAMazepine free [Mass/volume] in Serum or Plasma
Lithium/Creatinine [Molar ratio] in Urine
Lormetazepam [Mass/volume] in Serum or Plasma
Lutropin [Units/volume] in 24 hour Urine by 1st IRP
Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Methionine sulfoxide [Moles/volume] in Urine
Mianserin+Normianserin [Mass/volume] in Serum or Plasma
Niacin [Moles/volume] in Serum or Plasma
N-methylhistamine [Moles/volume] in 24 hour Urine
N-methylhistamine [Moles/volume] in Urine
N-methylhistamine/Creatinine [Molar ratio] in Urine
Carbenicillin [Mass/volume] in Serum or Plasma
Normetanephrine/Creatinine [Molar ratio] in Urine
Oxalate/Creatinine [Molar ratio] in Urine
Pentacarboxylporphyrins [Mass/mass] in Stool
Pentacarboxylporphyrins [Moles/volume] in Urine
Pentacarboxylporphyrins/Creatinine [Molar ratio] in Urine
Phosphate/Creatinine [Molar ratio] in Urine
Carboxy tetrahydrocannabinol [Presence] in Urine
Phosphoethanolamine [Moles/volume] in 24 hour Urine
Porphobilinogen [Moles/volume] in 24 hour Urine
Porphobilinogen/Creatinine [Molar ratio] in Urine
Pregnanediol [Moles/volume] in 24 hour Urine
Pregnanediol/Creatinine [Molar ratio] in Urine
Pregnanetriol [Moles/volume] in 24 hour Urine
Pregnanetriol/Creatinine [Molar ratio] in Urine
Pregnanetriolone [Moles/volume] in 24 hour Urine
Carboxy tetrahydrocannabinol [Mass/volume] in Urine
Pregnanetriolone [Moles/volume] in Urine
Pregnanetriolone/Creatinine [Molar ratio] in Urine
Primidone+PHENobarbital [Moles/volume] in Serum or Plasma
Pyridinoline [Moles/time] in 24 hour Urine
Salmonella paratyphi C H Ab [Titer] in Serum by Agglutination
Salmonella paratyphi C O Ab [Titer] in Serum by Agglutination
Carisoprodol [Mass/volume] in Serum or Plasma
Salmonella typhi H Ab [Titer] in Serum by Agglutination
Salmonella typhi O Ab [Titer] in Serum by Agglutination
Serotonin/Creatinine [Molar ratio] in Urine
Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay
Sulthiame [Moles/volume] in Serum or Plasma
Teicoplanin [Mass/volume] in Serum or Plasma --peak
Teicoplanin [Mass/volume] in Serum or Plasma --trough
Testosterone/Creatinine [Molar ratio] in Urine
Thioguanine [Mass/volume] in Serum or Plasma
Treponema pallidum Ab [Titer] in Serum by Immunofluorescence
Trypanosoma brucei Ab [Titer] in Serum by Immunofluorescence
Venlafaxine [Moles/volume] in Serum or Plasma
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk
11-Ketoetiocholanolone/Creatinine [Molar ratio] in Urine
Amilsulpride [Mass/volume] in Serum or Plasma
Biotin [Moles/volume] in Serum or Plasma
Buccal mucosa Ab [Titer] in Serum by Immunofluorescence
Colon Ab [Titer] in Serum by Immunofluorescence
Complement C3d [Mass/volume] in Serum or Plasma
Coproporphyrin/Hemoglobin [Mass Ratio] in Red Blood Cells
Cytoskeleton Ab [Titer] in Serum by Immunofluorescence
Escitalopram [Mass/volume] in Serum or Plasma
Exocrine pancreas Ab [Titer] in Serum by Immunofluorescence
Interleukin 1 [Mass/volume] in Serum or Plasma
Keratin Ab [Titer] in Serum by Immunofluorescence
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Immune diffusion (ID)
Cefamandole [Mass/volume] in Serum or Plasma
Moclobemide [Moles/volume] in Serum or Plasma
Normianserin [Mass/volume] in Serum or Plasma
Normirtazapine [Mass/volume] in Serum or Plasma
Nucleosome Ab [Units/volume] in Serum by Immunoassay
Protoporphyrin.zinc [Mass/mass] in Red Blood Cells
Protoporphyrin [Mass/mass] in Red Blood Cells
Reticulocytes.mature/Reticulocytes.total in Blood
Moxalactam [Susceptibility] by Disk diffusion (KB)
Reticulocytes.mid/Reticulocytes.total in Blood
Salmonella enteritidis H Ab [Titer] in Serum
Salmonella typhimurium H Ab [Titer] in Serum
Silver Birch recombinant (rBet v) 1 + 2 IgE Ab [Units/volume] in Serum
cycloSPORINE.monoclonal [Mass/volume] in Serum or Plasma
Methadone.R [Mass/volume] in Serum or Plasma
Timothy recombinant (rPhl p) 12 IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Units/volume] in Serum
Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Units/volume] in Serum
Salmonella enteritidis H Ab [Titer] in Serum by Agglutination
Salmonella typhimurium H Ab [Titer] in Serum by Agglutination
Bartonella henselae Ab [Titer] in Serum by Flow cytometry (FC)
Lutropin/Follitropin [Ratio] in Serum or Plasma
Protein Fractions [Interpretation] in Specimen by Immunofixation
Diethylene glycol [Mass/volume] in Serum or Plasma
Apolipoprotein E phenotype [Identifier] in Blood
ceFAZolin [Mass/volume] in Serum or Plasma
Natural killer cell function [Units/volume] in Blood
Bilirubin.conjugated/Bilirubin.total in Serum or Plasma
ZOLMitriptan [Mass/volume] in Serum or Plasma
Acarboxyprothrombin [Mass/volume] in Serum or Plasma
Cefonicid [Mass/volume] in Serum or Plasma
Cache valley virus RNA [Presence] in Blood by NAA with probe detection
Cache valley virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Eastern equine encephalitis virus RNA [Presence] in Blood by NAA with probe detection
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Herpes simplex virus DNA [Presence] in Blood by NAA with probe detection
Jamestown canyon virus RNA [Presence] in Blood by NAA with probe detection
Jamestown canyon virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Cefoperazone [Mass/volume] in Serum or Plasma
La Crosse virus RNA [Presence] in Blood by NAA with probe detection
La Crosse virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Powassan virus RNA [Presence] in Blood by NAA with probe detection
Powassan virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Saint Louis encephalitis virus RNA [Presence] in Blood by NAA with probe detection
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
West Nile virus RNA [Presence] in Blood by NAA with probe detection
West Nile virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Cefotaxime [Mass/volume] in Serum or Plasma
California serogroup RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
California serogroup RNA [Presence] in Blood by NAA with probe detection
B Ab [Titer] in Serum or Plasma by Antihuman globulin
B Ab [Titer] in Serum or Plasma by Immediate spin
Cholesterol.in chylomicrons [Mass/volume] in Serum or Plasma
Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
Leukocytes [Presence] in Bile fluid by Light microscopy
cefoTEtan [Mass/volume] in Serum or Plasma
Giardia lamblia Ag [Presence] in Bile fluid
Calcium bilirubinate crystals [Presence] in Bile fluid by Light microscopy
Cholesterol crystals [Presence] in Bile fluid by Light microscopy
Neutrophils.vacuolated+Segmented [Presence] in Blood
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
Blood group antibodies identified in Serum or Plasma by Elution
Blood group antibodies identified in Blood by Chromogenic method
Blood group antibodies identified in Serum or Plasma by Cold absorption
Blood group antibodies identified in Serum or Plasma by Cold incubation
Blood group antibodies identified in Serum or Plasma by Warm incubation
Blood group antibodies identified in Serum or Plasma by Warm absorption
Avian paramyxovirus 1.exotic RNA [Presence] in Specimen by NAA with probe detection
Avian paramyxovirus 1 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
cefOXitin [Mass/volume] in Serum or Plasma
Avian paramyxovirus 1 subtype [Identifier] in Isolate by NAA with probe detection
TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method
MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method
SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method
TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
cefTAZidime [Mass/volume] in Serum or Plasma
Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics
SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative
VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics
Ceftizoxime [Mass/volume] in Serum or Plasma
GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
cefTRIAXone [Mass/volume] in Serum or Plasma
NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method
SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Cefuroxime Parenteral [Mass/volume] in Serum or Plasma
Carbon dioxide, total [Moles/volume] in Cord blood
Carnitine acyltransferase [Enzymatic activity/mass] in Tissue
Phosphorylase kinase [Enzymatic activity/volume] in Red Blood Cells
Succinate semialdehyde dehydrogenase [Enzymatic activity/mass] in Leukocytes
Band form neutrophils [Presence] in Blood by Automated count
Erythrocytes.lytic resistant [Presence] in Blood by Automated count
Sialooligosaccharides/Creatinine [Ratio] in Urine
PT panel - Platelet poor plasma by Coagulation assay
PT and aPTT panel - Platelet poor plasma by Coagulation assay
Blood type and Indirect antibody screen panel - Blood
Cephalexin [Mass/volume] in Serum or Plasma
Phenytoin free and total panel - Serum or Plasma
ACTH stimulation test using IM corticosteroids in Serum or Plasma
ACTH stimulation test using IV corticosteroids in Serum or Plasma
Bilirubin direct and total panel [Mass/volume] - Serum or Plasma
Complement C3 and C4 panel [Mass/volume] - Serum or Plasma
carBAMazepine free and total panel [Mass/volume] - Serum or Plasma
Cephalothin [Mass/volume] in Serum or Plasma
Protein and Glucose panel [Mass/volume] - Cerebral spinal fluid
Complement profile panel [Mass/volume] - Serum or Plasma
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
Follitropin and Lutropin panel [Units/volume] - Serum or Plasma
Immunoglobulin panel [Mass/volume] - Serum
Catecholamines 3 panel [Mass/volume] - Plasma
Chloramphenicol [Mass/volume] in Serum or Plasma
Electrolytes 1998 and Venous pH panel - Serum or Plasma + Blood venous
Cell count and Differential panel - Body fluid
Cell count and Differential panel - Synovial fluid
chlordiazePOXIDE [Presence] in Serum or Plasma
Cell count and Differential panel - Pleural fluid
Cell count panel - Cerebral spinal fluid
Cell count and Differential panel - Cerebral spinal fluid
Cell count and Differential panel - Peritoneal fluid
Alkaline phosphatase [Presence] in Body fluid
aPTT.lupus sensitive in Control Platelet poor plasma by Coagulation assay
8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood
Adenovirus Ab [Titer] in Cerebral spinal fluid
Barbiturates [Presence] in Meconium by Screen method
chlordiazePOXIDE [Mass/volume] in Serum or Plasma
Basophils [#/area] in Peritoneal fluid by Microscopy high power field
Calcium.ionized [Moles/volume] in Arterial blood
Inner ear 68kD Ab [Presence] in Serum or Plasma
JC virus DNA [Presence] in Tissue by NAA with probe detection
Palmitoyl protein thioesterase [Enzymatic activity/volume] in Serum or Plasma
von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasma
Moxalactam [Susceptibility] by Serum bactericidal titer
von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasma
HIV 1 Ab [Presence] in Body fluid by Immunoassay
HIV 1 Ab [Presence] in Body fluid by Immunoblot
Epstein Barr virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
3-O-Methyldopa [Moles/volume] in Cerebral spinal fluid
Hepatitis D virus IgM Ab [Presence] in Serum
Methotrexate [Mass/volume] in Body fluid
HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method
Collagen type 2 Ab [Units/volume] in Serum
Minocycline [Mass/volume] in Cerebral spinal fluid
Interferon beta Ab [Units/volume] in Serum or Plasma
Transketolase [Enzymatic activity/mass] in Blood
Chlormerodrin [Mass/volume] in 24 hour Urine
Prostate specific Ag [Mass/volume] in Urine
Herpes simplex virus 1+2 IgG Ab [Titer] in Serum
Spermatozoa IgM Ab [Units/volume] in Cervical mucus
Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain
Amino acids [Identifier] in Cerebral spinal fluid
Other Antibiotic [Mass/volume] in Specimen
Complement C1 esterase inhibitor.functional [Mass/volume] in Body fluid
Liver cytosol Ab [Units/volume] in Serum
Colorado tick fever virus Ab [Titer] in Serum
Cystine Free [Moles/volume] in Serum or Plasma
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum
2-Methylcitrate [Moles/volume] in Amniotic fluid
Methylmalonate [Moles/volume] in Amniotic fluid
Methotrexate [Moles/volume] in Cerebral spinal fluid
Substance P [Mass/volume] in Cerebral spinal fluid
Hypoglycemics.sulfonyluric [Identifier] in Urine
CD11+CD18+ cells [#/volume] in Leukocytes
Citalopram [Mass/volume] in Serum or Plasma
Ciprofloxacin [Mass/volume] in Cerebral spinal fluid
Chloroquine [Mass/volume] in Serum or Plasma
5-Methyltetrahydrofolate [Mass/volume] in Cerebral spinal fluid
Clarithromycin [Mass/volume] in Cerebral spinal fluid
Epstein Barr virus capsid IgA Ab [Titer] in Cerebral spinal fluid
Protein Fractions [Interpretation] in Serum or Plasma
Lopinavir [Susceptibility] by Phenotype method
Tenofovir [Susceptibility] by Phenotype method
Chlorothiazide [Mass/volume] in Serum or Plasma
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Chlorpheniramine [Presence] in Serum or Plasma
Pancreatic islet cell Ab [Moles/volume] in Serum
GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
KEL gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
Spermatozoa Immotile [#/volume] in Semen
MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Chlorpheniramine [Mass/volume] in Serum or Plasma
Hemoglobin A2/Hemoglobin.total in Blood by Chromatography column
Actin IgG Ab [Units/volume] in Serum or Plasma
Mephenytoin+Normephenytoin [Mass/volume] in Serum or Plasma
Hemoglobin S [Presence] in Amniotic fluid
Clostridium botulinum toxin A Ab [Presence] in Serum
Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma
Prilocaine [Mass/volume] in Serum or Plasma
Pyrimethamine [Mass/volume] in Serum or Plasma
Nafcillin [Susceptibility] by Minimum lethal concentration (MLC)
Choriogonadotropin [Mass/volume] in Serum or Plasma
8-Dehydrocholesterol [Mass/volume] in Serum or Plasma
Immunoelectrophoresis panel - 24 hour Urine
Propofol [Mass/volume] in Serum or Plasma
Tripeptide aminopeptidase [Enzymatic activity/volume] in Serum or Plasma
Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma
MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method
PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Ceramide trihexoside [Presence] in Urine
Biopsy [Interpretation] in Muscle Narrative
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor IX depleted plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XIII depleted plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor X depleted plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XI depleted plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor XII depleted plasma
Sulfatidase [Enzymatic activity/volume] in Leukocytes
Erythroamino alcohol [Mass/volume] in Serum or Plasma
Threoamino alcohol [Mass/volume] in Serum or Plasma
Vascular endothelial growth factor [Mass/volume] in Serum or Plasma
Cholesterol in VLDL/Triglyceride [Ratio] in Serum or Plasma
Alpha 1 antitrypsin actual/normal in Serum or Plasma
CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection
HIV reverse transcriptase+protease gene mutations tested for
Heparin induced platelet Ab [Presence] in Serum
Mycoplasma sp [Presence] in Specimen by Hoechst stain
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood
CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method
Chlamydophila pneumoniae rRNA [Presence] in Specimen by Probe
Chlamydia sp DNA [Presence] in Urine by NAA with probe detection
Chlamydia trachomatis Ag [Presence] in Nasopharynx
chlorproMAZINE [Mass/volume] in Serum or Plasma
Chlamydia trachomatis Ag [Presence] in Anal
Cholinesterase [Presence] in Serum or Plasma
Clostridioides difficile [Presence] in Stool
Clostridioides difficile toxin A+B [Presence] in Stool
Cocaine [Presence] in Hair by Screen method
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum by Immunofluorescence
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence
CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
Cytomegalovirus DNA [Presence] in Amniotic fluid by NAA with probe detection
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Dengue virus IgM Ab [Presence] in Cerebral spinal fluid
EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Eastern equine encephalitis virus Ab [Titer] in Cerebral spinal fluid
Echovirus 4 Ab [Presence] in Cerebral spinal fluid
Echovirus 7 Ab [Presence] in Cerebral spinal fluid
Eosinophils [#/area] in Peritoneal fluid by Microscopy high power field
DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Carbon dioxide, total [Moles/volume] in Blood by calculation
CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method
Chromosome breakage [Interpretation] in Specimen
APOE gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method
APOE gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method
Nuclear mitotic apparatus Ab [Interpretation] in Serum or Plasma
NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RHCE gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Chromosome breakage [Units/volume] in Blood by Diepoxybutane
Stable Hemoglobin [Presence] in Blood by Isopropanol stability
chlorproPAMIDE [Mass/volume] in Serum or Plasma
Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Chlorprothixene [Mass/volume] in Serum or Plasma
Chlorthalidone [Mass/time] in 24 hour Urine
Cimetidine [Presence] in Serum or Plasma
Cimetidine [Mass/volume] in Serum or Plasma
Nafcillin [Susceptibility] by Disk diffusion (KB)
Ciprofloxacin [Mass/volume] in Serum or Plasma
CISplatin [Mass/volume] in Serum or Plasma
Clindamycin [Mass/volume] in Serum or Plasma
cloBAZam [Mass/volume] in Serum or Plasma
Ethanol [Mass/volume] in Saliva (oral fluid)
Mycoplasma sp Ag [Presence] in Tissue by Immune stain
Haemophilus paragallinarum Ab [Units/volume] in Serum by Immunoassay
African horse sickness virus Ab [Presence] in Serum by Immunofluorescence
Rabbit hemorrhagic disease virus neutralizing antibody [Titer] in Serum by Neutralization test
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunofluorescence
Aino virus neutralizing antibody [Titer] in Serum by Neutralization test
Akabane virus neutralizing antibody [Titer] in Serum by Neutralization test
Coliform bacteria [#/volume] in Specimen by Viability count
Salmonella enteritidis [Presence] in Specimen by Organism specific culture
West Nile virus RNA [Presence] in Specimen by NAA with probe detection
Ampicillin+Sulbactam [Susceptibility] by Serum bactericidal titer
Clofibrate [Mass/volume] in Serum or Plasma
Calcium [Mass/volume] corrected for total protein in Serum or Plasma
Neopterin [Mass/volume] in Serum or Plasma
Cortisol Free [Mass/volume] in 24 hour Urine by HPLC
Nafcillin [Susceptibility] by Serum bactericidal titer
Immature basophils/100 leukocytes in Blood
Immature eosinophils [#/volume] in Blood
Immature eosinophils/100 leukocytes in Blood
Plasma cell precursor [#/volume] in Blood
Plasma cell precursor/100 leukocytes in Blood
clomiPRAMINE [Mass/volume] in Serum or Plasma
Lymphocytes Immunoblastic/100 leukocytes in Blood
Lymphocytes Plasmacytoid/100 leukocytes in Blood
Immature monocytes/100 leukocytes in Blood
Urobilinogen [Moles/volume] in Urine by Test strip
CD3+CD4+CD45RO+CD45RA- cells/100 cells in Blood
CD3+CD4+CD45RO+CD45RA+ cells/100 cells in Blood
CD3+CD4+CD45RO-CD45RA- cells/100 cells in Blood
CD3+CD4+CD45RO-CD45RA+ cells/100 cells in Blood
CD3+CD8+CD45RO+CD45RA- cells/100 cells in Blood
clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma
CD3+CD8+CD45RO+CD45RA+ cells/100 cells in Blood
CD3+CD8+CD45RO-CD45RA- cells/100 cells in Blood
CD3+CD8+CD45RO-CD45RA+ cells/100 cells in Blood
Phosphate [Moles/volume] in Dialysis fluid
Tumor necrosis factor.alpha [Moles/volume] in Serum or Plasma
Babesia microti IgG and IgM panel - Serum
Bordetella pertussis IgG and IgM panel - Serum
clonazePAM [Mass/volume] in Serum or Plasma
Borrelia burgdorferi IgG and IgM panel - Serum
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid
Cytomegalovirus IgG and IgM panel - Cerebral spinal fluid
Herpes virus 6 IgG and IgM panel - Serum
Herpes virus 6 IgG and IgM panel - Cerebral spinal fluid
Herpes virus 7 IgG and IgM panel - Serum
Measles virus IgG and IgM Qn panel - Serum
Measles virus IgG and IgM panel - Cerebral spinal fluid
Parvovirus B19 IgG and IgM panel - Serum
Phosphatidylserine IgG and IgM panel - Serum
Rubella virus IgG and IgM panel - Cerebral spinal fluid
Treponema pallidum IgG and IgM panel - Serum
Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid
Western equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid
Eosinophils [#/volume] in Cerebral spinal fluid by Manual count
Eosinophils [#/volume] in Cerebral spinal fluid
cloNIDine [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Blood by Myeloperoxidase stain
Rh [Type] in Blood by Confirmatory method
CD3+TCR alpha beta+ cells/100 cells in Blood
CD3+TCR alpha beta+ cells [#/volume] in Blood
Osmotic fragility [Interpretation] of Red Blood Cells
Osmotic fragility of Red Blood Cells--0.10% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.10% sodium chloride
Clopenthixol [Mass/volume] in Serum or Plasma
Osmotic fragility of Red Blood Cells--0.20% sodium chloride 24 hour 37 degree C incubation
Osmotic fragility of Red Blood Cells--0.20% sodium chloride
Fractional oxyhemoglobin in Mixed venous blood
Neutrophil associated Ab [Presence] in Blood
DNA index 3 in Specimen by Flow cytometry (FC)
DNA index 2 in Serum or Plasma by Flow cytometry (FC)
DNA index 3 in Serum or Plasma by Flow cytometry (FC)
DNA index in Serum or Plasma by Flow cytometry (FC)
DNA index 2 in Specimen by Flow cytometry (FC)
Unidentified cells/100 leukocytes in Peritoneal fluid
Clorazepate [Mass/volume] in Serum or Plasma
Unidentified cells/100 leukocytes in Pleural fluid
Unidentified cells/100 leukocytes in Synovial fluid
Unidentified cells/100 leukocytes in Body fluid
Unidentified cells [#/volume] in Pericardial fluid
Unidentified cells [#/volume] in Cerebral spinal fluid
Unidentified cells [#/volume] in Body fluid
Unidentified cells [#/volume] in Pleural fluid
Unidentified cells [#/volume] in Peritoneal fluid
Unidentified cells [#/volume] in Synovial fluid
Promyelocytes [#/volume] in Cerebral spinal fluid
Polymorphonuclear cells/100 leukocytes in Blood
Polymorphonuclear cells [#/volume] in Pleural fluid
Polymorphonuclear cells [#/volume] in Cerebral spinal fluid
Polymorphonuclear cells [#/volume] in Body fluid
Polymorphonuclear cells [#/volume] in Blood
Polymorphonuclear cells [#/volume] in Synovial fluid
Polymorphonuclear cells [#/volume] in Peritoneal fluid
Nonhematic cells [#/volume] in Cerebral spinal fluid
Nonhematic cells [#/volume] in Body fluid
Segmented neutrophils [#/volume] in Synovial fluid
Segmented neutrophils [#/volume] in Peritoneal fluid
Segmented neutrophils [#/volume] in Cerebral spinal fluid
Segmented neutrophils [#/volume] in Pleural fluid
Band form neutrophils [#/volume] in Synovial fluid
Clorprenaline [Mass/time] in 24 hour Urine
Band form neutrophils [#/volume] in Body fluid
Band form neutrophils [#/volume] in Cerebral spinal fluid
Myelocytes [#/volume] in Cerebral spinal fluid
Mononuclear cells [#/volume] in Pleural fluid
Monocytes+Macrophages/100 leukocytes in Peritoneal fluid
Monocytes+Macrophages/100 leukocytes in Pleural fluid
Monocytes+Macrophages [#/volume] in Pleural fluid
Monocytes+Macrophages [#/volume] in Peritoneal fluid
Monocytes+Macrophages [#/volume] in Synovial fluid
Monocytes+Macrophages [#/volume] in Cerebral spinal fluid
Monocytes [#/volume] in Cerebral spinal fluid
Monocytes [#/volume] in Peritoneal fluid
Metamyelocytes [#/volume] in Cerebral spinal fluid
Mesothelial cells [#/volume] in Peritoneal fluid
Mesothelial cells [#/volume] in Pleural fluid
Mesothelial cells [#/volume] in Cerebral spinal fluid
Mesothelial cells [#/volume] in Synovial fluid
Macrophages [#/volume] in Synovial fluid
Macrophages [#/volume] in Cerebral spinal fluid
Lymphocytes Plasmacytoid [#/volume] in Blood
Lymphocytes Immunoblastic [#/volume] in Blood
Variant lymphocytes [#/volume] in Peritoneal fluid
Variant lymphocytes [#/volume] in Pleural fluid
Variant lymphocytes [#/volume] in Cerebral spinal fluid
Variant lymphocytes [#/volume] in Synovial fluid
Variant lymphocytes [#/volume] in Body fluid
Abnormal lymphocytes [#/volume] in Body fluid
Abnormal lymphocytes [#/volume] in Cerebral spinal fluid
Abnormal lymphocytes [#/volume] in Synovial fluid
Lymphocytes [#/volume] in Synovial fluid
Leukocytes other [#/volume] in Body fluid
Leukocytes other [#/volume] in Pleural fluid
Leukocytes other [#/volume] in Synovial fluid
Leukocytes other [#/volume] in Peritoneal fluid
Histiocytes/100 leukocytes in Body fluid
Histiocytes [#/volume] in Cerebral spinal fluid
Granulocytes [#/volume] in Cerebral spinal fluid
Eosinophils [#/volume] in Synovial fluid
Eosinophils [#/volume] in Peritoneal fluid
Codeine [Mass/volume] in Serum or Plasma
Blasts [#/volume] in Cerebral spinal fluid
Basophils/100 leukocytes in Peritoneal fluid
Basophils/100 leukocytes in Pleural fluid
Basophils [#/volume] in Cerebral spinal fluid
Basophils [#/volume] in Peritoneal fluid
Abnormal lymphocytes/100 leukocytes in Body fluid
Unspecified cells [#/volume] in Body fluid
Mesothelial cells [#/volume] in Body fluid
Mononuclear cells [#/volume] in Peritoneal fluid
Lymphocytes+Monocytes [#/volume] in Blood
Large granular lymphocytes [#/volume] in Blood
Amino acids panel [Moles/volume] - Serum or Plasma
Second trimester triple maternal screen panel - Serum or Plasma
Nalidixate [Susceptibility] by Minimum lethal concentration (MLC)
Prochlorperazine [Mass/volume] in Serum or Plasma
Lymphocytes [#/volume] in Peritoneal fluid
Monocytes+Macrophages [#/volume] in Body fluid
Enterovirus IgM Ab [Units/volume] in Cerebral spinal fluid
Acenocoumarol [Mass/volume] in Serum or Plasma
Acyclovir [Mass/volume] in Serum or Plasma --trough
Acyclovir [Mass/volume] in Serum or Plasma --peak
Bromperidol [Mass/volume] in Serum or Plasma
Norcitalopram [Mass/volume] in Serum or Plasma
Norclobazam [Mass/volume] in Serum or Plasma
Normaprotiline [Mass/volume] in Serum or Plasma
Phenprocoumon [Mass/volume] in Serum or Plasma
Flecainide [Mass/volume] in Serum or Plasma --trough
Flecainide [Mass/volume] in Serum or Plasma --peak
Floxacillin [Mass/volume] in Serum or Plasma
Nelfinavir M8 [Mass/volume] in Serum or Plasma
Nordothiepin [Mass/volume] in Serum or Plasma
Pipamperone [Mass/volume] in Serum or Plasma
Sulforidazine [Mass/volume] in Serum or Plasma
Sulpiride [Mass/volume] in Serum or Plasma
Acetaldehyde [Presence] in Serum or Plasma
Chloral hydrate [Presence] in Serum or Plasma
Dothiepin sulfoxide [Mass/volume] in Serum or Plasma
E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma
MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics
Hemoglobin Lepore/Hemoglobin.total in Blood
Hemoglobin O - Arab/Hemoglobin.total in Blood
Hemoglobin A2.prime/Hemoglobin.total in Blood
Karyotype [Identifier] in Specimen Nominal
L-dopa decarboxylase [Enzymatic activity/volume] in Plasma
MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Glutarate [Mass/volume] in Serum or Plasma
Adenosine triphosphate/Adenosine diphosphate [Mass Ratio] in Blood
Patient symptoms [Interpretation] --3 hours post dose lactose PO
MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MEFV gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Cropropamide [Mass/time] in 24 hour Urine
Interferon beta Ab [Titer] in Serum or Plasma
Trans-3-Hydroxycotinine [Mass/volume] in Serum or Plasma
Purine nucleoside phosphorylase [Enzymatic activity/volume] in Cerebral spinal fluid
Amphiphysin Ab [Titer] in Cerebral spinal fluid
PCA-2 Ab [Titer] in Cerebral spinal fluid
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid
Octanoate (C8:0) [Moles/volume] in Serum or Plasma
Decanoate (C10:0) [Moles/volume] in Serum or Plasma
Decenoate (C10:1) [Moles/volume] in Serum or Plasma
Tetradecadienoate (C14:2) [Moles/volume] in Serum or Plasma
Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma
Laurate (C12:0) [Moles/volume] in Serum or Plasma
Lauroleate (C12:1) [Moles/volume] in Serum or Plasma
Hexadecadienoate (C16:2) [Moles/volume] in Serum or Plasma
Hexadecenoate (C16:1w9) [Moles/volume] in Serum or Plasma
Myristate (C14:0) [Moles/volume] in Serum or Plasma
Myristoleate (C14:1) [Moles/volume] in Serum or Plasma
Docosenoate (C22:1) [Moles/volume] in Serum or Plasma
Palmitate (C16:0) [Moles/volume] in Serum or Plasma
Crotethamide [Mass/time] in 24 hour Urine
Palmitoleate (C16:1w7) [Moles/volume] in Serum or Plasma
Gamma Linolenate (C18:3w6) [Moles/volume] in Serum or Plasma
Alpha linolenate (C18:3w3) [Moles/volume] in Serum or Plasma
Linoleate (C18:2w6) [Moles/volume] in Serum or Plasma
Oleate (C18:1w9) [Moles/volume] in Serum or Plasma
Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma
Arachidonate (C20:4w6) [Moles/volume] in Serum or Plasma
Arachidate (C20:0) [Moles/volume] in Serum or Plasma
Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)
Cyclacillin [Mass/volume] in Serum or Plasma
Nervonate (C24:1) [Moles/volume] in Serum or Plasma
Homo-gamma Linolenate (C20:3w6) [Moles/volume] in Serum or Plasma
Mead acid (C20:3w9) [Moles/volume] in Serum or Plasma
Eicosapentaenoate (C20:5w3) [Moles/volume] in Serum or Plasma
Docosahexaenoate (C22:6w3) [Moles/volume] in Serum or Plasma
Saturated fatty acids [Moles/volume] in Serum or Plasma
Monounsaturated fatty acids [Moles/volume] in Serum or Plasma
Polyunsaturated fatty acids [Moles/volume] in Serum or Plasma
Omega 3 fatty acids (w3) [Moles/volume] in Serum or Plasma
Omega 6 fatty acids (w6) [Moles/volume] in Serum or Plasma
Docosapentaenate (C22:5w3) [Moles/volume] in Serum or Plasma
Docosapentaenate (C22:5w6) [Moles/volume] in Serum or Plasma
Docosatetraenoate (C22:4w6) [Moles/volume] in Serum or Plasma
Cyclizine [Mass/volume] in Serum or Plasma
cycloSERINE [Mass/volume] in Serum or Plasma
cycloSPORINE+Metabolites [Mass/volume] in Blood
cycloSPORINE [Mass/volume] in Blood --12 hours post dose
Nalidixate [Susceptibility] by Disk diffusion (KB)
cycloSPORINE [Mass/volume] in Blood --24 hours post dose
Creatinine [Mass or Moles] in 24 hour Urine
Phosphate [Mass or Moles] in 24 hour Urine
Pathology report addendum in Specimen Narrative
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum by Immunoassay
Bartonella henselae Ab [Presence] in Serum by Immunofluorescence
Candida sp Ab [Presence] in Serum by Immune diffusion (ID)
Candida sp Ag [Presence] in Serum by Latex agglutination
Hepatitis D virus IgG Ab [Presence] in Serum by Immunoassay
Histone IgG Ab [Presence] in Serum by Immunoassay
Measles virus IgG Ab [Presence] in Serum by Immunoassay
Measles virus IgM Ab [Presence] in Serum by Immunoassay
Neuronal nuclear Ab [Presence] in Serum by Immunoblot
Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence
Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hepatitis D virus IgG Ab [Presence] in Serum
Tissue transglutaminase IgA Ab [Presence] in Serum
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma
Toxoplasma gondii HS Ab [Units/volume] in Serum by Agglutination
MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal
Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics
TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Transferrin.carbohydrate deficient.asialo [Presence] in Cerebral spinal fluid
HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Tetrahydrocannabinol [Mass/volume] in Urine
Glucosylceramidase [Enzymatic activity/mass] in Specimen
CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Toxoplasma gondii AC Ab [Units/volume] in Serum by Agglutination
TTR gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TTR gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Trypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide
Trypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide
Trypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide
Desipramine [Mass/volume] in Serum or Plasma
Trypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide
Trypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide
Lipase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide
Lipase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide
Lipase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide
Lipase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum by Immune diffusion (ID)
Laceyella sacchari Ab [Presence] in Serum by Immune diffusion (ID)
Protein [Mass/volume] in Body fluid --5th specimen post Sincalide
Protein [Mass/volume] in Body fluid --4th specimen post Sincalide
Protein [Mass/volume] in Body fluid --3rd specimen post Sincalide
Protein [Mass/volume] in Body fluid --2nd specimen post Sincalide
Protein [Mass/volume] in Body fluid --1st specimen post Sincalide
PMP22 gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method
PMP22 gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method
pH of Body fluid--5th specimen post Sincalide
pH of Body fluid--4th specimen post Sincalide
pH of Body fluid--3rd specimen post Sincalide
Desipramine [Presence] in Serum or Plasma
pH of Body fluid--2nd specimen post Sincalide
Nalidixate [Susceptibility] by Serum bactericidal titer
pH of Body fluid--1st specimen post Sincalide
OXcarbazepine [Mass/volume] in Serum or Plasma
Band form neutrophils/100 leukocytes in Blood by Automated count
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Collagen crosslinked N-telopeptide [Moles/volume] in 24 hour Urine
Chymotrypsin [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide
Chymotrypsin [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide
Chymotrypsin [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide
Chymotrypsin [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide
Chymotrypsin [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide
ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method
ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method
Amylase [Enzymatic activity/volume] in Body fluid --5th specimen post Sincalide
Amylase [Enzymatic activity/volume] in Body fluid --4th specimen post Sincalide
Amylase [Enzymatic activity/volume] in Body fluid --3rd specimen post Sincalide
Amylase [Enzymatic activity/volume] in Body fluid --2nd specimen post Sincalide
Amylase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide
Microscopic observation [Identifier] in Specimen by Immunofluorescence
Corynebacterium diphtheriae Ab [Titer] in Serum
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoblot
Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Desipramine [Mass/volume] in Serum or Plasma --trough
Mycobacterium tuberculosis genotype [Identifier] in Isolate
FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Norclomipramine [Mass/volume] in Serum or Plasma
Triglyceride in Lipoprotein a [Mass/volume] in Serum or Plasma
Triglyceride in Lipoprotein a [Presence] in Serum or Plasma
Triglyceride in Chylomicrons [Presence] in Serum or Plasma
Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma
Lipase [Enzymatic activity/volume] in Body fluid --1st specimen post Sincalide
Vitamin D+Metabolites [Mass/volume] in Serum or Plasma
SCA2 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA2 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA1 gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
SCA1 gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method
Platelet aggregation XXX induced in Platelet rich plasma from Donor
DMPK gene allele 2 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method
DMPK gene allele 1 CTG repeats [Presence] in Blood or Tissue by Molecular genetics method
MJD gene allele 2 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
MJD gene allele 1 CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Nordiazepam [Mass/volume] in Serum or Plasma
HNPCC genes mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method
HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method
HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method
Galactomannan Ag [Units/volume] in Serum or Plasma
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method
CV2 IgG Ab [Titer] in Cerebral spinal fluid
Dextromethorphan [Presence] in Serum or Plasma
Cholesterol. in Lipoprotein (a) [Presence] in Serum or Plasma
Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma
Cholesterol.in chylomicrons [Presence] in Serum or Plasma
Vaccinia virus DNA [Presence] in Specimen by NAA with probe detection
Taenia solium larva IgG Ab [Units/volume] in Cerebral spinal fluid
Hantavirus IgG Ab [Units/volume] in Serum
Hantavirus IgM Ab [Units/volume] in Serum
Legionella pneumophila 1 IgG Ab [Presence] in Serum
Legionella pneumophila 1 IgM Ab [Presence] in Serum
Enterovirus RNA [Presence] in Tissue by NAA with probe detection
Epstein Barr virus DNA [Presence] in Bone marrow by NAA with probe detection
Epstein Barr virus DNA [Presence] in Mouth by NAA with probe detection
Varicella zoster virus DNA [Presence] in Eye by NAA with probe detection
Varicella zoster virus DNA [Presence] in Tissue by NAA with probe detection
Cytomegalovirus DNA [Presence] in Bronchial specimen by NAA with probe detection
Leishmania donovani IgG Ab [Presence] in Serum
Leishmania donovani IgM Ab [Presence] in Serum
Leishmania brasilensis IgG Ab [Presence] in Serum
Leishmania brasilensis IgM Ab [Presence] in Serum
Leishmania mexicana IgG Ab [Presence] in Serum
Leishmania mexicana IgM Ab [Presence] in Serum
Leishmania tropica IgG Ab [Presence] in Serum
Leishmania tropica IgM Ab [Presence] in Serum
Neomycin [Susceptibility] by Minimum lethal concentration (MLC)
Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma
Chlamydia sp DNA [Presence] in Nose by NAA with probe detection
Coxsackievirus A4+A16 Ab [Titer] in Serum
Specific gravity of Body fluid by Refractometry
Oxytocin [Units/volume] in Serum or Plasma
Echinococcus granulosus Ab [Presence] in Serum by Immunoblot
Herpes simplex virus identified in Anal by Organism specific culture
Herpes simplex virus identified in Bronchial specimen by Organism specific culture
Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture
Herpes simplex virus identified in Cervix by Organism specific culture
Herpes simplex virus identified in Ear by Organism specific culture
Herpes simplex virus identified in Body fluid by Organism specific culture
Herpes simplex virus identified in Vaginal fluid by Organism specific culture
Herpes simplex virus identified in Penis by Organism specific culture
Herpes simplex virus identified in Placenta by Organism specific culture
Herpes simplex virus identified in Pleural fluid by Organism specific culture
Herpes simplex virus identified in Peritoneal fluid by Organism specific culture
Propoxyphene [Presence] in Serum or Plasma
Herpes simplex virus identified in Synovial fluid by Organism specific culture
Herpes simplex virus identified in Stool by Organism specific culture
Herpes simplex virus identified in Throat by Organism specific culture
Herpes simplex virus identified in Tissue by Organism specific culture
Herpes simplex virus identified in Urine by Organism specific culture
Herpes simplex virus identified in Urethra by Organism specific culture
Herpes simplex virus identified in Wound by Organism specific culture
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Complement fixation
Propoxyphene [Mass/volume] in Serum or Plasma
Spermatozoa [Presence] in Semen by Light microscopy --post reanastomosis
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay
HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 gp160 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 gp120 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p66 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p65 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p55 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p51 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 gp41 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p31 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p24 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p17 Ab [Presence] in Saliva (oral fluid) by Immunoblot
HIV 1 p18 Ab [Presence] in Saliva (oral fluid) by Immunoblot
Herpes simplex virus identified in Nasopharynx by Organism specific culture
HIV 1 gp40 Ab [Presence] in Serum by Immunoblot
ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MLL gene rearrangements in Blood or Tissue by Molecular genetics method
X chromosome inactivation [Identifier] in Blood or Tissue Narrative
Y chromosome deletion [Identifier] in Blood or Tissue Nominal
Maternal cell contamination [Identifier] in Amniotic fluid Nominal
Platelet genotype [Identifier] in Amniotic fluid
ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Telomere analysis [Identifier] in Blood or Tissue Nominal
CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
M-chlorophenylpiperazine [Presence] in Serum or Plasma
Transferrin.carbohydrate deficient.disialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma
Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method
HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method
Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method
Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma
OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC)
Ciliated columnar lining cells/100 leukocytes [# Ratio] in Body fluid
Cytosol aminopeptidase [Enzymatic activity/time] in 24 hour Urine
Terbufos [Mass/volume] in Serum or Plasma
Para nitrophenol [Mass/volume] in Serum or Plasma
Mevinphos [Mass/volume] in Serum or Plasma
Methyl parathion [Mass/volume] in Serum or Plasma
diazePAM [Mass/volume] in Serum or Plasma
Metasystox [Mass/volume] in Serum or Plasma
Fonofos [Mass/volume] in Serum or Plasma
Fenchlorphos [Mass/volume] in Serum or Plasma
Diazinon [Mass/volume] in Serum or Plasma
Chlorpyrifos [Mass/volume] in Serum or Plasma
Azinphos-methyl [Mass/volume] in Serum or Plasma
Leptospira sp DNA [Presence] in Specimen by NAA with probe detection
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection
Succinate dehydrogenase [Enzymatic activity/mass] in Tissue
Citrate synthase [Enzymatic activity/mass] in Tissue
NADH dehydrogenase [Enzymatic activity/mass] in Tissue
NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue
Succinate cytochrome C reductase [Enzymatic activity/mass] in Tissue
Pesticide and Insecticide panel [Mass/volume] - Serum or Plasma
Pesticide and Insecticide panel [Mass/volume] - Urine
Pesticide and Insecticide panel [Mass/volume] - Urine and Serum or Plasma
Mitochondrial myopathy enzyme panel [Enzymatic activity/mass] - Tissue
Para aminobenzoate in 6 hour Urine --6 hours post XXX bentiromide PO
Lipoprotein.beta.subparticle [Type] in Serum or Plasma
Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Amino acids panel [Moles/volume] - Cerebral spinal fluid
Amino acids panel [Moles/volume] - Amniotic fluid
Amino acids panel [Moles/time] - 24 hour Urine
diazePAM [Mass/volume] in Serum or Plasma --trough
Candida albicans IgG Ab [Mass/volume] in Serum
Sugar Cane IgG Ab [Mass/volume] in Serum
Baker's yeast IgG Ab [Mass/volume] in Serum
Fusarium moniliforme IgG Ab [Mass/volume] in Serum
Mucor racemosus IgG Ab [Mass/volume] in Serum
Phthalic anhydride IgG Ab [Mass/volume] in Serum
Phoma betae IgG Ab [Mass/volume] in Serum
Rhizopus nigricans IgG Ab [Mass/volume] in Serum
Stemphylium botryosum IgG Ab [Mass/volume] in Serum
Setomelanomma rostrata IgG Ab [Mass/volume] in Serum
Trichophyton rubrum IgG Ab [Mass/volume] in Serum
Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum
Cholinesterase panel [Enzymatic activity/volume] - Blood
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
Protein.monoclonal [Mass/volume] in Urine
Protein.monoclonal band 2 [Mass/volume] in Urine
Bile acid [Moles/volume] in Serum --fasting
Rickettsia rickettsii IgG and IgM panel - Serum
HIV 1 p31+p32 Ab [Presence] in Serum by Immunoblot
HIV 1 p40 Ab [Presence] in Serum by Immunoblot
Parathyrin [Mass/volume] in Serum or Plasma --baseline
Parathyrin [Mass/volume] in Serum or Plasma --10 minutes post excision
Oligoclonal bands [#] in Cerebral spinal fluid by Electrophoresis
Oligoclonal bands [#] in Serum or Plasma
Phenylalanine/Tyrosine [Molar ratio] in DBS
Procollagen+Collagen [Identifier] in Fibroblast by Electrophoresis
Fatty acid oxidation [Identifier] in Fibroblast
Dichlorphenamide [Mass/time] in 24 hour Urine
Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma
Hypersensitivity pneumonitis panel - Serum
1,2-Glyceryl dinitrate [Mass/volume] in Blood
Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Hydroxyethyl valine [Mass/volume] in Blood
Hydrazine/Creatinine [Mass Ratio] in Urine
Dicoumarol [Mass/volume] in Serum or Plasma
4-Tert-Butylphenol [Mass/volume] in Urine
Ethylene glycol dinitrate [Mass/volume] in Blood
Furoate/Creatinine [Mass Ratio] in Urine
Creatinine renal clearance predicted by Cockcroft-Gault formula
Digitoxin [Mass/volume] in Serum or Plasma
Creatinine renal clearance/1.73 sq M.predicted by Cockcroft-Gault formula, BSA formula
Creatinine renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration
Creatinine renal clearance/1.73 sq M in 2 hour Urine and Serum or Plasma
Acetaminophen [Mass/volume] in Serum or Plasma by Screen method
Theophylline [Mass/volume] in Serum or Plasma by Screen method
Salicylates [Mass/volume] in Serum or Plasma by Screen method
Butalbital [Mass/volume] in Serum or Plasma by Screen method
carBAMazepine [Mass/volume] in Serum or Plasma by Screen method
Azithromycin [Susceptibility] by Minimum lethal concentration (MLC)
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method
chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method
clomiPRAMINE [Mass/volume] in Serum or Plasma by Screen method
clonazePAM [Mass/volume] in Serum or Plasma by Screen method
Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method
Desipramine [Mass/volume] in Serum or Plasma by Screen method
diazePAM [Mass/volume] in Serum or Plasma by Screen method
diphenhydrAMINE [Mass/volume] in Serum or Plasma by Screen method
Doxepin [Mass/volume] in Serum or Plasma by Screen method
FLUoxetine [Mass/volume] in Serum or Plasma by Screen method
Flurazepam [Mass/volume] in Serum or Plasma by Screen method
fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method
Glutethimide [Mass/volume] in Serum or Plasma by Screen method
Ibuprofen [Mass/volume] in Serum or Plasma by Screen method
Lidocaine [Mass/volume] in Serum or Plasma by Screen method
LORazepam [Mass/volume] in Serum or Plasma by Screen method
Meperidine [Mass/volume] in Serum or Plasma by Screen method
Digitoxin>6h post dose [Mass/volume] in Serum or Plasma
Methadone [Mass/volume] in Serum or Plasma by Screen method
Methaqualone [Mass/volume] in Serum or Plasma by Screen method
Metoprolol [Presence] in Serum or Plasma by Screen method
Norclomipramine [Mass/volume] in Serum or Plasma by Screen method
Nordiazepam [Mass/volume] in Serum or Plasma by Screen method
Nordoxepin [Mass/volume] in Serum or Plasma by Screen method
Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method
Normeperidine [Mass/volume] in Serum or Plasma by Screen method
Digoxin Free [Mass/volume] in Serum or Plasma
Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method
Nortriptyline [Mass/volume] in Serum or Plasma by Screen method
Norverapamil [Presence] in Serum or Plasma by Screen method
Oxazepam [Mass/volume] in Serum or Plasma by Screen method
PENTobarbital [Mass/volume] in Serum or Plasma by Screen method
PHENobarbital [Mass/volume] in Serum or Plasma by Screen method
Phenytoin [Mass/volume] in Serum or Plasma by Screen method
Propranolol [Mass/volume] in Serum or Plasma by Screen method
Digoxin>12 hours post dose [Mass/volume] in Serum or Plasma
Secobarbital [Mass/volume] in Serum or Plasma by Screen method
traZODone [Mass/volume] in Serum or Plasma by Screen method
Amitriptyline [Mass/volume] in Serum or Plasma by Screen method
4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method
Borrelia burgdorferi DNA [Presence] in Tissue by NAA with probe detection
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Tissue by NAA with probe detection
Cotinine [Presence] in Urine by Confirmatory method
Collagen type 2 Ab [Presence] in Serum by Immunoassay
Metanephrine/Creatinine [Mass Ratio] in 24 hour Urine
NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method
Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration
Pyridinoline+Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration
C reactive protein [Quintile] in Serum or Plasma by High sensitivity method
Propoxyphene [Mass/volume] in Serum or Plasma by Screen method
Lymphocytic choriomeningitis virus IgG and IgM panel - Cerebral spinal fluid
Synovial lining cells/100 cells in Synovial fluid
Epithelial cells/100 cells in Body fluid
Creatinine/Body weight [Mass/kg/time] in 24 hour Urine
Butyrylcarnitine (C4) [Moles/volume] in Serum or Plasma
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Serum or Plasma
Urea nitrogen/Body weight [Mass/kg/time] in 24 hour Urine
Neomycin [Susceptibility] by Disk diffusion (KB)
JC virus DNA [Presence] in Urine by NAA with probe detection
Glucose [Mass/volume] in Urine collected for unspecified duration
Protein [Mass/volume] in Urine collected for unspecified duration
Ethanol [Mass/volume] in Urine collected for unspecified duration
Acetone [Mass/volume] in Urine collected for unspecified duration
Lymphocytic choriomeningitis virus IgG and IgM panel - Serum
Dimetamphetamine [Mass/time] in 24 hour Urine
Atomoxetine [Mass/volume] in Serum or Plasma
Gentamicin [Mass/volume] in Serum or Plasma
Amikacin [Mass/volume] in Serum or Plasma
Tobramycin [Mass/volume] in Serum or Plasma
Galactomannan Ag [Units/volume] in Specimen
Bilirubin.direct/Bilirubin.total in Serum or Plasma
Phosphate [Mass/volume] in Urine collected for unspecified duration
Creatinine [Mass/volume] in Urine collected for unspecified duration
Dimethyltryptamine [Mass/volume] in Serum or Plasma
Calcium [Mass/volume] in Urine collected for unspecified duration
Chloride [Moles/volume] in Urine collected for unspecified duration
Potassium [Moles/volume] in Urine collected for unspecified duration
Sodium [Moles/volume] in Urine collected for unspecified duration
Varicella zoster virus IgG and IgM panel - Cerebral spinal fluid
Tissue transglutaminase Ab panel - Serum
Trypanosoma cruzi IgG and IgM panel - Serum
Dimethyltryptamine [Mass/volume] in Urine
Burkholderia pseudomallei IgG and IgM panel - Serum
Colorado tick fever virus IgG and IgM panel - Serum
Carbon dioxide [Moles/volume] in Urine collected for unspecified duration
GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method
GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method
GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method
GBA gene c.84insG [Presence] in Blood or Tissue by Molecular genetics method
GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method
diphenhydrAMINE [Presence] in Serum or Plasma
XXX microorganism DNA [Presence] in Specimen by NAA with probe detection
G0+G1 phase cells/100 cells in Specimen by Flow cytometry (FC)
GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
California encephalitis virus IgG Ab [Titer] in Serum
California encephalitis virus IgM Ab [Titer] in Serum
California encephalitis virus Ab [Titer] in Cerebral spinal fluid
La Crosse virus Ab [Titer] in Serum by Complement fixation
metFORMIN [Mass/volume] in Serum or Plasma
Anti-hyperglycemics [Identifier] in Serum or Plasma by Screen method
Acetaminophen [Mass/volume] in Gastric fluid
Acetylcholinesterase [Enzymatic activity/volume] in Specimen
Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
Albumin/Protein.total in Serum or Plasma
Alkaline phosphatase.macrohepatic/Alkaline phosphatase.total in Serum or Plasma
Alpha 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis
diphenhydrAMINE [Mass/volume] in Serum or Plasma
La Crosse virus Ab [Titer] in Body fluid
Chlamydia sp DNA [Presence] in Conjunctival specimen by NAA with probe detection
Chlamydia sp DNA [Presence] in Anal by NAA with probe detection
Chlamydia sp rRNA [Presence] in Conjunctival specimen by Probe
Chlamydia sp DNA [Presence] in Cervix by NAA with probe detection
Chlamydia sp rRNA [Presence] in Cervix by Probe
Chlamydia sp rRNA [Presence] in Genital specimen by Probe
Chlamydia sp DNA [Presence] in Vaginal fluid by NAA with probe detection
Chlamydia sp rRNA [Presence] in Vaginal fluid by Probe
Chlamydia sp rRNA [Presence] in Nose by Probe
Chlamydia sp rRNA [Presence] in Anal by Probe
Chlamydia sp DNA [Presence] in Serum by NAA with probe detection
Chlamydia sp rRNA [Presence] in Serum by Probe
Chlamydia sp DNA [Presence] in Throat by NAA with probe detection
Chlamydia sp rRNA [Presence] in Throat by Probe
Chlamydia sp rRNA [Presence] in Urine by Probe
Chlamydia sp DNA [Presence] in Urethra by NAA with probe detection
Chlamydia sp rRNA [Presence] in Urethra by Probe
Chlamydia sp DNA [Presence] in Specimen by NAA with probe detection
Chlamydia sp rRNA [Presence] in Specimen by Probe
Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID)
Histoplasma capsulatum M Ab [Presence] in Serum by Immune diffusion (ID)
Histoplasma capsulatum Ag [Presence] in Urine
Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by NAA with probe detection
Chlamydia sp rRNA [Presence] in Nasopharynx by Probe
Microscopic observation [Identifier] in Amniotic fluid by Nile blue prusside
Inhibin A [Multiple of the median] in Serum or Plasma
Neomycin [Susceptibility] by Serum bactericidal titer
Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL
SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Eastern equine encephalitis virus IgG and IgM panel - Specimen
TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hyperchromia [Presence] in Blood by Automated count
Hydrogen ion [Moles/volume] in Arterial blood
Hydrogen ion [Moles/volume] adjusted to patient's actual temperature in Arterial blood
DMPK phenotype [Type] in Blood or Tissue by Molecular genetics method
DMPK gene allele 2 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
DMPK gene allele 1 CTG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Escherichia coli O157:H7 IgG and IgM panel - Serum
Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Avilamycin [Susceptibility] by Disk diffusion (KB)
Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefdinir [Susceptibility] by Gradient strip
Cefdinir [Susceptibility] by Disk diffusion (KB)
Cefditoren [Susceptibility] by Disk diffusion (KB)
Cefditoren [Susceptibility] by Gradient strip
Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefepime+Clavulanate [Susceptibility] by Gradient strip
Cefetamet [Susceptibility] by Disk diffusion (KB)
Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)
Disopyramide [Mass/volume] in Serum or Plasma
Cefixime [Susceptibility] by Gradient strip
Cefoperazone [Susceptibility] by Gradient strip
Cefoperazone+Sulbactam [Susceptibility] by Gradient strip
Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB)
Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefotiam [Susceptibility] by Disk diffusion (KB)
Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)
Disulfiram [Mass/volume] in Serum or Plasma
cefTAZidime+Clavulanate [Susceptibility] by Disk diffusion (KB)
cefTAZidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
cefTAZidime+Clavulanate [Susceptibility]
Ceftibuten [Susceptibility] by Disk diffusion (KB)
Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)
Ceftiofur [Susceptibility] by Disk diffusion (KB)
Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefuroxime Oral [Susceptibility] by Disk diffusion (KB)
Cephalexin [Susceptibility] by Gradient strip
Clinafloxacin [Susceptibility] by Disk diffusion (KB)
Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
DAPTOmycin [Susceptibility] by Disk diffusion (KB)
DAPTOmycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Doxepin [Mass/volume] in Serum or Plasma
Difloxacin [Susceptibility] by Disk diffusion (KB)
Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Dirithromycin [Susceptibility] by Disk diffusion (KB)
Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Enrofloxacin [Susceptibility] by Gradient strip
Enrofloxacin [Susceptibility] by Disk diffusion (KB)
Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ertapenem [Susceptibility] by Disk diffusion (KB)
Ertapenem [Susceptibility] by Gradient strip
Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Bambermycins [Susceptibility] by Disk diffusion (KB)
Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)
Fleroxacin [Susceptibility] by Disk diffusion (KB)
Florfenicol [Susceptibility] by Disk diffusion (KB)
Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
Fosfomycin [Susceptibility] by Gradient strip
Fosfomycin [Susceptibility] by Disk diffusion (KB)
Garenoxacin [Susceptibility] by Disk diffusion (KB)
Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Gemifloxacin [Susceptibility] by Disk diffusion (KB)
Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Gentamicin.high potency [Susceptibility] by Gradient strip
Grepafloxacin [Susceptibility] by Disk diffusion (KB)
Imipenem+EDTA [Susceptibility] by Gradient strip
Netilmicin [Susceptibility] by Minimum lethal concentration (MLC)
Isepamicin [Susceptibility] by Disk diffusion (KB)
Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Mupirocin [Susceptibility] by Disk diffusion (KB)
Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)
Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma
Nystatin [Susceptibility] by Disk diffusion (KB)
Orbifloxacin [Susceptibility] by Disk diffusion (KB)
Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Pefloxacin [Susceptibility] by Disk diffusion (KB)
Pirlimycin [Susceptibility] by Disk diffusion (KB)
Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Doxepin+Metabolites [Mass/volume] in Serum or Plasma
Polymyxin B [Susceptibility] by Gradient strip
Pristinamycin [Susceptibility] by Disk diffusion (KB)
Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB)
Salinomycin [Susceptibility] by Disk diffusion (KB)
Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Sparfloxacin [Susceptibility] by Disk diffusion (KB)
Doxepin [Mass/volume] in Serum or Plasma --trough
Spectinomycin [Susceptibility] by Gradient strip
Streptomycin.high potency [Susceptibility] by Gradient strip
Sulfonamide [Susceptibility] by Gradient strip
Telithromycin [Susceptibility] by Disk diffusion (KB)
Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tiamulin [Susceptibility] by Disk diffusion (KB)
Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tilmicosin [Susceptibility] by Disk diffusion (KB)
Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)
Trospectinomycin [Susceptibility] by Disk diffusion (KB)
Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Trovafloxacin [Susceptibility] by Disk diffusion (KB)
Tylosin [Susceptibility] by Disk diffusion (KB)
Doxylamine [Presence] in Serum or Plasma
Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)
Virginiamycin [Susceptibility] by Disk diffusion (KB)
Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Voriconazole [Susceptibility] by Gradient strip
Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Chronic lymphocytic leukemia gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Lipoprotein.intermediate density [Presence] in Serum or Plasma
Acetoacetate [Moles/volume] in Serum or Plasma
2-Oxoisovalerate [Moles/volume] in Serum or Plasma
2-Oxo,3-Methylvalerate [Moles/volume] in Serum or Plasma
2-Oxoisocaproate [Moles/volume] in Serum or Plasma
Succinate [Moles/volume] in Serum or Plasma
Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB)
Dyphylline [Mass/volume] in Serum or Plasma
Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)
Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid
Rickettsia sp IgM Ab [Units/volume] in Serum
Rickettsia sp IgG Ab [Units/volume] in Serum
Escherichia coli O157:H7 IgM Ab [Units/volume] in Serum
Escherichia coli O157:H7 IgG Ab [Units/volume] in Serum
Tissue transglutaminase IgM Ab [Units/volume] in Serum
Encainide [Mass/volume] in Serum or Plasma
Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Enoxacin [Mass/volume] in Serum or Plasma
ePHEDrine [Mass/volume] in Serum or Plasma
ePHEDrine+Pseudoephedrine [Presence] in Serum or Plasma
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma
ePHEDrine+Pseudoephedrine [Presence] in Urine
Erythromycin [Mass/volume] in Serum or Plasma
Ethambutol [Mass/volume] in Serum or Plasma
Netilmicin [Susceptibility] by Disk diffusion (KB)
Ethchlorvynol [Presence] in Serum or Plasma
Ethchlorvynol [Mass/volume] in Serum or Plasma
Ethoheptazine [Mass/time] in 24 hour Urine
Netilmicin [Susceptibility] by Serum bactericidal titer
Ethosuximide [Mass/volume] in Serum or Plasma
Ethotoin [Mass/volume] in Serum or Plasma
N-ethylnicotinamide [Mass/volume] in Urine
Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC)
Fencamfamin [Mass/time] in 24 hour Urine
Fenetylline [Mass/time] in 24 hour Urine
Fenfluramine [Mass/volume] in Serum or Plasma
Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)
Fenoprofen [Mass/volume] in Serum or Plasma
Fenproporex [Mass/time] in 24 hour Urine
fentaNYL [Mass/volume] in Serum or Plasma
Flecainide [Mass/volume] in Serum or Plasma
5-Fluorocytosine [Mass/volume] in Serum or Plasma
Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Nitrofurantoin [Susceptibility] by Disk diffusion (KB)
Fluorouracil [Mass/volume] in Serum or Plasma
FLUoxetine [Presence] in Serum or Plasma
FLUoxetine [Mass/volume] in Serum or Plasma
Fluoxymesterone [Mass/time] in 24 hour Urine
fluPHENAZine [Mass/volume] in Serum or Plasma
Flurazepam [Presence] in Serum or Plasma
Flurazepam [Mass/volume] in Serum or Plasma
Nitrofurantoin [Susceptibility] by Serum bactericidal titer
Furosemide [Mass/volume] in Serum or Plasma
Gentamicin [Mass/volume] in Serum or Plasma --peak
Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Gentamicin [Mass/volume] in Serum or Plasma --trough
Glutethimide [Mass/volume] in Serum or Plasma
Haloperidol [Mass/volume] in Serum or Plasma
Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
hydroCHLOROthiazide [Mass/volume] in Serum or Plasma
hydroCHLOROthiazide [Mass/volume] in Urine
hydroCHLOROthiazide [Mass/time] in 24 hour Urine
HYDROcodone [Presence] in Serum or Plasma
HYDROcodone [Mass/volume] in Serum or Plasma
Norfloxacin [Susceptibility] by Disk diffusion (KB)
HYDROmorphone [Presence] in Serum or Plasma
HYDROmorphone [Mass/volume] in Serum or Plasma
Hydroxychloroquine [Mass/volume] in Serum or Plasma
Hydroxymethoxyphenamine [Mass/volume] in Urine
hydrOXYzine [Mass/volume] in Serum or Plasma
Ibuprofen [Mass/volume] in Serum or Plasma
Arbovirus Ab [Identifier] in Specimen by Immunofluorescence
West Nile virus polyvalent E Ab [Presence] in Specimen by Immunoassay
Imipramine [Presence] in Serum or Plasma
West Nile virus Ab [Presence] in Specimen by Immunoassay
West Nile virus NS5 Ab [Presence] in Specimen by Immunoassay
West Nile virus polyvalent E Ab [Presence] in Specimen
West Nile virus NS5 Ab [Presence] in Specimen
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection
Inhibin A [Multiple of the median] adjusted in Serum or Plasma
Imipramine [Mass/volume] in Serum or Plasma
Complement C1 esterase inhibitor [Mass/volume] in Body fluid
Chromosome 8 trisomy [Percentile] by Cytogenetics
Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CATCH22 syndrome gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FMR1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
AS+PWS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Kappa light chains.free [Mass/volume] in Serum
Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative
ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ELN gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum
TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Epstein Barr virus DNA [#/volume] (viral load) in Blood by NAA with probe detection
14-3-3 Ag [Mass/volume] in Cerebral spinal fluid
MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Imipramine [Mass/volume] in Serum or Plasma --trough
Indomethacin [Mass/volume] in Serum or Plasma
Insulin [Mass/volume] in Serum or Plasma
Isoniazid [Mass/volume] in Serum or Plasma
Kanamycin [Mass/volume] in Serum or Plasma --peak
Norfloxacin [Susceptibility] by Serum bactericidal titer
Kanamycin [Mass/volume] in Serum or Plasma --trough
Ketamine [Mass/volume] in Serum or Plasma
Labetalol [Mass/volume] in Serum or Plasma
Novobiocin [Susceptibility] by Minimum lethal concentration (MLC)
Methotrimeprazine [Mass/volume] in Urine
Levorphanol [Mass/volume] in Serum or Plasma
Levorphanol [Mass/time] in 24 hour Urine
Lidocaine [Mass/volume] in Serum or Plasma
Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)
Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose
Lithium [Mass/volume] in Serum or Plasma
Azithromycin [Susceptibility] by Disk diffusion (KB)
Lithium renal clearance in 24 hour Urine and Serum or Plasma
Novobiocin [Susceptibility] by Disk diffusion (KB)
Lithium [Mass/volume] in Serum or Plasma --trough
LORazepam [Mass/volume] in Serum or Plasma
Loxapine [Mass/volume] in Serum or Plasma
Lysergate diethylamide [Presence] in Serum or Plasma
Novobiocin [Susceptibility] by Serum bactericidal titer
Lysergate diethylamide [Mass/volume] in Serum or Plasma
Lysergate diethylamide [Presence] in Urine
Maprotiline [Presence] in Serum or Plasma
Maprotiline [Mass/volume] in Serum or Plasma
Perchlorate [Mass/volume] in Specimen by HPLC
Abnormal Prion Protein [Presence] in Brain by Immunoassay
Meperidine [Presence] in Serum or Plasma
Meperidine [Mass/volume] in Serum or Plasma
Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Mephenytoin [Mass/volume] in Serum or Plasma
Mephobarbital [Mass/volume] in Serum or Plasma
Meprobamate [Presence] in Serum or Plasma
Meprobamate [Mass/volume] in Serum or Plasma
Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Mesoridazine [Mass/volume] in Serum or Plasma
Mesterolone [Mass/time] in 24 hour Urine
Ofloxacin [Susceptibility] by Disk diffusion (KB)
Metandienone [Mass/time] in 24 hour Urine
Ofloxacin [Susceptibility] by Serum bactericidal titer
Methadone [Mass/volume] in Serum or Plasma
Methamphetamine [Presence] in Serum or Plasma
Methamphetamine [Mass/volume] in Serum or Plasma
Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC)
Methapyrilene [Presence] in Serum or Plasma
Methapyrilene [Mass/volume] in Serum or Plasma
Methaqualone [Presence] in Serum or Plasma
Methaqualone [Mass/volume] in Serum or Plasma
Methicillin [Mass/volume] in Serum or Plasma
Methocarbamol [Presence] in Serum or Plasma
Methocarbamol [Mass/volume] in Serum or Plasma
Methotrexate [Mass/volume] in Cerebral spinal fluid
Methotrexate [Mass/volume] in Serum or Plasma
Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose
Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose
Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose
Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose
Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Avian paramyxovirus [Presence] in Specimen by Organism specific culture
Eastern equine encephalitis virus RNA [Presence] in Specimen by Probe
Saint Louis encephalitis virus RNA [Presence] in Specimen by Probe
West Nile virus RNA [Presence] in Specimen by Probe
California serogroup RNA [Presence] in Specimen by Probe
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Units/volume] in Serum by Multidisk
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Presence] in Serum by Multidisk
Corticotropin releasing hormone [Moles/volume] in Serum or Plasma
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay
DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA)
Azithromycin [Susceptibility] by Serum bactericidal titer
Methoxyphenamine [Mass/time] in 24 hour Urine
Methsuximide [Mass/volume] in Serum or Plasma
Methyldopa [Mass/volume] in Serum or Plasma
MethylePHEDrine [Mass/time] in 24 hour Urine
Oleandomycin [Susceptibility] by Disk diffusion (KB)
Methylphenidate [Presence] in Serum or Plasma
Methylphenidate [Mass/volume] in Serum or Plasma
Methylphenidate [Mass/time] in 24 hour Urine
Methyprylon [Presence] in Serum or Plasma
Methyprylon [Mass/volume] in Serum or Plasma
Oleandomycin [Susceptibility] by Serum bactericidal titer
Parathyrin.intact [Mass/volume] in Serum or Plasma --5 minutes post excision
Metoprolol [Mass/volume] in Serum or Plasma
Parathyrin.intact [Mass/volume] in Serum or Plasma --baseline
Porphyrins/Creatinine [Mass Ratio] in Urine
Pentacarboxylporphyrins/Creatinine [Mass Ratio] in Urine
Coproporphyrin/Creatinine [Mass Ratio] in Urine
Heptacarboxylporphyrin/Creatinine [Mass Ratio] in Urine
Hexacarboxylporphyrin/Creatinine [Mass Ratio] in Urine
Uroporphyrin/Creatinine [Mass Ratio] in 24 hour Urine
West Nile virus IgM Ab [Units/volume] in Serum by Immunoassay
Major crossmatch [Interpretation] by Polyethylene glycol (PEG) method
Major crossmatch [Interpretation] by Low ionic strength saline (LISS)
Lambda light chains.free [Mass/time] in 24 hour Urine
Organic acids [Moles/volume] in Serum or Plasma
Borrelia burgdorferi C6 Ab [Units/volume] in Serum by Immunoassay
Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Heptacarboxylate/Creatinine [Molar ratio] in Urine
Kappa light chains.free [Mass/volume] in Urine
Kappa light chains.free [Mass/time] in 24 hour Urine
Lambda light chains.free [Mass/volume] in Urine
Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Parainfluenza virus 1 IgG Ab [Units/volume] in Serum
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum
Basophils/100 leukocytes in Amniotic fluid by Manual count
Beta globulin [Mass/volume] in 24 hour Urine by Electrophoresis
Bile acid.dihydroxy [Moles/volume] in Serum or Plasma
Bile acid.trihydroxy [Moles/volume] in Serum or Plasma
Alpha 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis
Mexiletine [Mass/volume] in Serum or Plasma
Alpha 2 globulin [Mass/volume] in Urine by Electrophoresis
Amylase [Enzymatic activity/volume] in 2 hour Urine
Amylase [Enzymatic activity/time] in Urine collected for unspecified duration
Antidepressants [Identifier] in Gastric fluid
Antihistamines [Presence] in Gastric fluid
Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence
Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence
Mezlocillin [Mass/volume] in Serum or Plasma
Midazolam [Mass/volume] in Serum or Plasma
Oxacillin [Susceptibility] by Minimum lethal concentration (MLC)
Minocycline [Mass/volume] in Serum or Plasma
CD3+TCR gamma delta+ cells [#/volume] in Blood
CD3+TCR gamma delta+ cells/100 cells in Specimen
Brucella abortus IgG Ab [Presence] in Serum
Brucella abortus IgM Ab [Presence] in Serum
Brucella canis IgG Ab [Presence] in Serum
Brucella canis IgM Ab [Presence] in Serum
C peptide [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Calcium oxalate [Mass/time] in 24 hour Urine
Calcium oxalate monohydrate/Total in Stone
Carbon dioxide, total [Moles/volume] in Specimen
Carbonated calcium phosphate [Presence] in Stone
Cells Counted Total [#] in Pleural fluid
Cells Counted Total [#] in Peritoneal fluid
Cells Counted Total [#] in Synovial fluid
Influenza virus A H7 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H6 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H5 RNA [Presence] in Specimen by NAA with probe detection
Morphine [Mass/volume] in Serum or Plasma
Influenza virus A Ab [Units/volume] in Serum by Immunoassay
Columbid circovirus DNA [Presence] in Specimen by NAA with probe detection
Transmissible spongiform encephalopathy [Presence] in Brain by Light microscopy
aPTT in Pooled Platelet poor plasma by Coagulation assay --1 hour post incubation
Lymphocyte proliferation stimulated by 0.5 ug/mL Candida albicans [Units/volume] in Blood
Lymphocyte proliferation stimulated by 1.0 ug/mL Candida albicans [Units/volume] in Blood
Lymphocyte proliferation stimulated by 2.5 ug/mL Candida albicans [Units/volume] in Blood
Lymphocyte proliferation stimulated by 5.0 ug/mL Candida albicans [Units/volume] in Blood
Lymphocyte proliferation stimulated by 2.41 ug/mL tetanus toxoid [Units/volume] in Blood
Lymphocyte proliferation stimulated by 4.83 ug/mL tetanus toxoid [Units/volume] in Blood
Lymphocyte proliferation stimulated by 9.67 ug/mL tetanus toxoid [Units/volume] in Blood
Lymphocyte proliferation stimulated by 19.3 ug/mL tetanus toxoid [Units/volume] in Blood
Erythrocytes [Presence] in Duodenal fluid
2,4-Dichlorophenoxyacetate [Mass/volume] in Water
2,2-Dichloropropionate [Mass/volume] in Water
1,2-Dibromo-3-Chloropropane [Mass/volume] in Water
1,2-Dichlorobenzene [Mass/volume] in Water
1,4-Dichlorobenzene [Mass/volume] in Water
1,2-Dichloroethane [Mass/volume] in Water
1,1-Dichloroethylene [Mass/volume] in Water
cis-1,2-Dichloroethylene [Mass/volume] in Water
Trans-1,2-Dichloroethylene [Mass/volume] in Water
Methylene chloride [Mass/volume] in Water
1,2-Dichloropropane [Mass/volume] in Water
Di(2-Ethylhexyl) phthalate [Mass/volume] in Water
Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ethylene dibromide [Mass/volume] in Water
Heptachlorepoxide [Mass/volume] in Water
Tetrachloroethylene [Mass/volume] in Water
Benzo alpha pyrene [Mass/volume] in Water
Carbon tetrachloride [Mass/volume] in Water
Pentachlorophenol [Mass/volume] in Water
Moxalactam [Mass/volume] in Serum or Plasma
2,4,5-Trichlorophenoxyacetate [Mass/volume] in Water
1,2,4-Trichlorobenzene [Mass/volume] in Water
1,1,2-Trichloroethane [Mass/volume] in Water
Hexachlorocyclopentadiene [Mass/volume] in Water
Hexachlorobenzene [Mass/volume] in Water
Trichloroethylene [Mass/volume] in Water
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid by Latex agglutination
XXX microorganism DNA [Identifier] in Specimen by NAA with probe detection
Herpes virus 6 DNA [Identifier] in Specimen by NAA with probe detection
N-acetylprocainamide [Mass/volume] in Serum or Plasma
Herpes virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Herpes virus 6 DNA panel - Specimen by NAA with probe detection
Interleukin 2 receptor [Units/volume] in Specimen
Streptococcus sp identified in Specimen by Organism specific culture
Bartonella sp identified in Specimen by Organism specific culture
Chitotriosidase [Enzymatic activity/volume] in Serum or Plasma
A Ab [Titer] in Serum or Plasma by Antihuman globulin
A Ab [Titer] in Serum or Plasma by Immediate spin
Isobutyrylglycine/Creatinine [Mass Ratio] in Urine
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG Ab [Mass/volume] in Serum by Multidisk
Muscle specific receptor tyrosine kinase Ab [Presence] in Serum
Cefepime [Mass/volume] in Serum or Plasma
Haloperidol reduced [Mass/volume] in Serum or Plasma
Hexadecadienoate (C16:2)/Creatinine [Mass Ratio] in Urine
Hypoxanthine/Creatinine [Molar ratio] in Urine
N-octanoylglycine/Creatinine [Mass Ratio] in Urine
Pigeon droppings IgG Ab [Mass/volume] in Serum
U1 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum
Voriconazole [Mass/volume] in Serum or Plasma
Xanthine/Creatinine [Molar ratio] in Urine
Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
Buprenorphine+Norbuprenorphine [Presence] in Urine
Tenofovir [Mass/volume] in Serum or Plasma
Adenovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Cryptococcus sp identified in Specimen by Organism specific culture
Cryptococcus neoformans [Presence] in Specimen by Organism specific culture
Mycobacterium tuberculosis complex DNA [Presence] in Specimen by NAA with probe detection
HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method
Influenza virus A cDNA [Presence] in Specimen by NAA with probe detection
Influenza virus B [Presence] in Specimen by Organism specific culture
Coccidioides immitis Ag [Presence] in Cerebral spinal fluid
C3 nephritic factor [Presence] in Serum or Plasma
Complement C3 [Presence] in Serum or Plasma
Coxiella burnetii phase 2 Ab [Titer] in Serum
Legionella sp identified in Pleural fluid by Organism specific culture
Legionella sp identified in Urine by Organism specific culture
Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence
Parainfluenza virus 1 Ag [Presence] in Nose by Immunofluorescence
Crystals [type] in Amniotic fluid by Light microscopy
Crystals [type] in Pericardial fluid by Light microscopy
Crystals [type] in Peritoneal fluid by Light microscopy
Parainfluenza virus 1+2+3 Ab [Presence] in Serum
Cyclospora sp Ag [Presence] in Stool by Immunoassay
CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Basement membrane zone Ab [Titer] in Serum
TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Parasite identified in Body fluid by Inspection
Trans-cinnamoylglycine/Creatinine [Mass Ratio] in Urine
Pigeon droppings IgG Ab [Presence] in Serum
Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay
C peptide [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Thiocyanate [Mass/time] in 24 hour Urine
Ibuprofen [Mass/volume] in Serum or Plasma --pre dose
Ibuprofen [Mass/volume] in Serum or Plasma --30 minutes post dose
Ibuprofen [Mass/volume] in Serum or Plasma --1 hour post dose
Ibuprofen [Mass/volume] in Serum or Plasma --1.5 hours post dose
Ibuprofen [Mass/volume] in Serum or Plasma --2 hours post dose
Ibuprofen [Mass/volume] in Serum or Plasma --2.5 hours post dose
Ibuprofen [Mass/volume] in Serum or Plasma --3 hours post dose
Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen
Colony count [#/mass] in Specimen by Visual count
Aspergillus fumigatus IgE Ab/IgE total in Serum
Barbiturates [Presence] in Meconium by Confirmatory method
Basement membrane zone Ab [Presence] in Serum
Benzodiazepines [Presence] in Meconium by Confirmatory method
Bilirubin crystals [#/area] in Urine sediment by Microscopy low power field
Blastomyces dermatitidis IgM Ab [Presence] in Serum by Immunoassay
Catecholamines [Mass/time] in 72 hour Urine
CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method
Immune complex.C3d+IgG [Units/volume] in Serum or Plasma
Crystals [Presence] in Synovial fluid by Light microscopy
Crystals [#/area] in Urine sediment by Microscopy high power field
Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence
Legionella sp Ag [Presence] in Pleural fluid by Immunofluorescence
Legionella sp Ag [Presence] in Sputum by Immunofluorescence
Naproxen [Mass/volume] in Serum or Plasma
Legionella sp Ag [Presence] in Urine by Immunofluorescence
Mountain Juniper IgE Ab/IgE total in Serum
Chicken serum proteins IgG Ab [Presence] in Serum
Chlamydia sp IgG Ab [Presence] in Body fluid
Chlamydia sp Ab [Presence] in Cerebral spinal fluid
Chlamydia trachomatis rRNA [Presence] in Blood by Probe
chlorproPAMIDE [Mass/volume] in 24 hour Urine
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in Urine
17-Hydroxyprogesterone [Mass/volume] in DBS
Acid alpha glucosidase [Enzymatic activity/volume] in Serum or Plasma
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
Glucosylceramidase [Enzymatic activity/volume] in Serum or Plasma
Branched chain keto-acid dehydrogenase complex [Presence] in DBS
Oxacillin [Susceptibility] by Disk diffusion (KB)
Carnitine free (C0) [Moles/volume] in DBS
Creatine kinase.MB [Presence] in Serum or Plasma
Galactose 1 phosphate [Moles/mass] in Red Blood Cells
Netilmicin [Mass/volume] in Serum or Plasma --peak
Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma
Insulin-like growth factor-I [Units/volume] in Serum or Plasma
Metanephrine Free [Mass/volume] in Serum or Plasma
Phenylalanine+Tyrosine [Presence] in Urine
Retinyl palmitate [Mass/volume] in Serum or Plasma
Spermatozoa Amorphous Head [Presence] in Semen
Spermatozoa Nonviable/100 spermatozoa in Semen
Spermatozoa Progressive [Presence] in Semen --4 hours post ejaculation
Spermatozoa Progressive Grade 1/100 spermatozoa in Semen
Spermatozoa Progressive Grade 2/100 spermatozoa in Semen
Spermatozoa Progressive Grade 4/100 spermatozoa in Semen
Spermatozoa Progressive Grade 3/100 spermatozoa in Semen
Thyroglobulin Ab [Titer] in Serum by Immunofluorescence
Netilmicin [Mass/volume] in Serum or Plasma --trough
Thyroglobulin recovery in Serum or Plasma
Uroporphyrin/Creatinine [Mass Ratio] in Urine
Viscosity of Semen Qualitative--30 minutes post collection
CD11b+CD11c+ cells/100 cells in Specimen
Cytoplasmic Ig mu cells [#/volume] in Blood
Terminal deoxyribonucleotidyl transferase cells/100 cells in Specimen by Immunoassay
aPTT.factor substitution in Platelet poor plasma --2 hours post incubation
Immature granulocytes/100 leukocytes in Blood
Microscopic observation [Identifier] in Blood or Marrow by Prussian blue stain
Coagulation factor VIII Ag actual/normal in Platelet poor plasma by Immunoassay
Complement C4b binding protein actual/normal in Serum or Plasma
Hemoglobin F/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9)
Oligoclonal bands [Mass/volume] in Urine by Electrophoresis
Protein.abnormal band [Mass/time] in 24 hour Urine
CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma
Nicotine [Mass/volume] in Serum or Plasma
Spermatozoa Motile/100 spermatozoa in Semen --post washing
Spermatozoa Motile/100 spermatozoa in Semen --pre washing
Spermatozoa Motile [Presence] in Semen --pre washing
Repaglinide [Mass/volume] in Serum or Plasma
Spermatozoa [#/volume] in Semen --post washing
Spermatozoa [#/volume] in Semen --pre washing
Oxacillin [Susceptibility] by Serum bactericidal titer
MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Cortisol [Mass/volume] in Serum or Plasma --pre or post dose dexamethasone
Acylcarnitine short chain [Moles/volume] in Serum or Plasma
Narcolepsy associated Ag [Presence] in Serum or Plasma
Spermatozoa.head Motile w IgA/100 spermatozoa in Semen by Immunobead
Spermatozoa.head Motile w IgG/100 spermatozoa in Semen by Immunobead
Spermatozoa.head Motile w IgM/100 spermatozoa in Semen by Immunobead
Spermatozoa.midpiece Motile w IgA/100 spermatozoa in Semen by Immunobead
Spermatozoa.midpiece Motile w IgG/100 spermatozoa in Semen by Immunobead
Spermatozoa.midpiece Motile w IgM/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail Motile w IgA/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail Motile w IgG/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail Motile w IgM/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail tip Motile w IgA/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail tip Motile w IgG/100 spermatozoa in Semen by Immunobead
Spermatozoa.tail Tip Motile w IgM/100 spermatozoa in Semen by Immunobead
Spermatozoa Motile [Presence] in Semen --post washing
Nikethamide [Mass/time] in 24 hour Urine
Carbon tetrachloride [Mass/volume] in Air
2,4-Dichlorophenoxyacetate [Mass/volume] in Air
1,2-Dibromo-3-Chloropropane [Mass/volume] in Air
Nitrazepam [Mass/volume] in Serum or Plasma
1,4-Dichlorobenzene [Mass/volume] in Air
Hexachlorobutadiene [Mass/volume] in Air
Nitrofurantoin [Mass/volume] in Serum or Plasma
Methyl tert-butyl ether [Mass/volume] in Air
Methyl isobutyl ketone [Mass/volume] in Air
1,2-Dichloropropane [Mass/volume] in Air
Nordoxepin [Mass/volume] in Serum or Plasma
Tetrachloroethylene [Mass/volume] in Air
1,2,4-Trichlorobenzene [Mass/volume] in Air
1,1,2-Trichloroethane [Mass/volume] in Air
Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC)
Di(2-Ethylhexyl) phthalate [Mass/volume] in Air
Bis(Chloromethyl) Ether [Mass/volume] in Air
Chloromethyl methyl ether [Mass/volume] in Air
2-Chloro-1,3-Butadiene [Mass/volume] in Air
Norethandrolone [Mass/time] in 24 hour Urine
2-Chloroacetophenone [Mass/volume] in Air
Bis(2-Chloroethyl) ether [Mass/volume] in Air
3,3'-Dimethoxybenzidine [Mass/volume] in Air
N,N-Dimethylaniline [Mass/volume] in Air
Dichlorodiphenyldichloroethylene [Mass/volume] in Air
Sperm Head IgA Ab/100 spermatozoa in Specimen by Immunobead
Sperm Midpiece IgA Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail Tip IgA Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail IgA Ab/100 spermatozoa in Specimen by Immunobead
Sperm Head IgG Ab/100 spermatozoa in Specimen by Immunobead
Norfloxacin [Mass/volume] in Serum or Plasma
Sperm Midpiece IgG Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail Tip IgG Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail IgG Ab/100 spermatozoa in Specimen by Immunobead
Sperm Head IgM Ab/100 spermatozoa in Specimen by Immunobead
Sperm Midpiece IgM Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail Tip IgM Ab/100 spermatozoa in Specimen by Immunobead
Sperm Tail IgM Ab/100 spermatozoa in Specimen by Immunobead
Spermatozoa IgA+IgG Ab/100 spermatozoa in Specimen by Immunobead
Norfluoxetine [Mass/volume] in Serum or Plasma
2-Acetylaminofluorene [Mass/volume] in Air
1,1-Dimethylhydrazine [Mass/volume] in Air
4,6-Dinitro-O-Cresol [Mass/volume] in Air
1,2-Diphenylhydrazine [Mass/volume] in Air
Hexachlorocyclopentadiene [Mass/volume] in Air
Hexamethylene diisocyanate [Mass/volume] in Air
Norpropoxyphene [Presence] in Serum or Plasma
Hexamethylphosphoramide [Mass/volume] in Air
Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
N-nitrosodimethylamine [Mass/volume] in Air
N-nitrosomorpholine [Mass/volume] in Air
Pentachloronitrobenzene [Mass/volume] in Air
1,3-Propane sultone [Mass/volume] in Air
Titanium tetrachloride [Mass/volume] in Air
Nortriptyline [Mass/volume] in Serum or Plasma
2,4,5-Trichlorophenol [Mass/volume] in Air
2,4,6-Trichlorophenol [Mass/volume] in Air
1,1-Dichloroethylene [Mass/volume] in Air
Animal hair+Epithelium [Mass/volume] in Air
Nortriptyline [Presence] in Serum or Plasma
1,3-Dichloropropene [Mass/volume] in Air
Dimethylcarbamoyl chloride [Mass/volume] in Air
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air
Polychlorinated biphenyl (PCB) [Mass/volume] in Air
2,4-Toluene diisocyanate [Mass/volume] in Air
1,2-Dimethylbenzene [Mass/volume] in Air
1,3-Dimethylbenzene [Mass/volume] in Air
1,4-Dimethylbenzene [Mass/volume] in Air
Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose
Eastern equine encephalitis virus IgM Ab [Units/volume] in Specimen
Eastern equine encephalitis virus IgG Ab [Units/volume] in Specimen
Ofloxacin [Mass/volume] in Serum or Plasma
Orphenadrine [Mass/volume] in Serum or Plasma
Ouabain [Mass/volume] in Serum or Plasma
Oxacillin [Mass/volume] in Serum or Plasma
Oxandrolone [Mass/time] in 24 hour Urine
Oxazepam [Mass/volume] in Serum or Plasma
INR in Platelet poor plasma or blood by Coagulation assay
Oxytetracycline [Susceptibility] by Disk diffusion (KB)
ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Oxprenolol [Mass/volume] in Serum or Plasma
ARIPiprazole [Mass/volume] in Serum or Plasma
ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Fibers [Presence] in Stool by Light microscopy
Fibrin D-dimer [Titer] in Platelet poor plasma
fluPHENAZine [Presence] in Serum or Plasma
HEXA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Leflunomide [Mass/volume] in Serum or Plasma
LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Lymphocytes [Presence] in Stool by Light microscopy
MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MLL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Poikilocytosis [Presence] in Blood by Automated count
PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Schistocytes [Presence] in Blood by Automated count
SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Succinylacetone [Moles/volume] in Amniotic fluid
TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum
Calicivirus RNA [Presence] in Specimen by NAA with probe detection
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Macroprolactin [Mass/volume] in Serum or Plasma
TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
oxyCODONE [Mass/volume] in Serum or Plasma
Oxymesterone [Mass/time] in 24 hour Urine
Oxytetracycline [Susceptibility] by Serum bactericidal titer
Clostridium botulinum toxin A+B+E+F+G [Presence] in Specimen by Mouse bioassay neutralization
Escherichia coli O157:H7 DNA [Presence] in Specimen by NAA with probe detection
Amylase [Enzymatic activity/volume] in 12 hour Urine
Oxymetholone [Mass/time] in 24 hour Urine
Calcium oxalate dihydrate crystals [Presence] in Urine sediment
Histiocytes [Presence] in Urine sediment by Light microscopy
Mixed cellular casts [#/area] in Urine sediment by Microscopy low power field
Neutrophils [Presence] in Urine by Light microscopy
West Nile virus IgG Ab [Units/volume] in Serum by Immunoassay
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma
Adipoylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma
Cytomegalovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Epidermal growth factor receptor Ag [Presence] in Tissue
Hepatitis B virus core Ab [Presence] in Body fluid
Hepatitis B virus e Ab [Presence] in Body fluid
Hepatitis B virus e Ag [Presence] in Specimen
Oxyphenbutazone [Mass/volume] in Serum or Plasma
Hepatitis C virus Ab [Presence] in Body fluid by Immunoblot
Isovalerylcarnitine (C5) [Moles/volume] in Serum or Plasma
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid
Mycoplasma pneumoniae Ab [Presence] in Body fluid
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid
Suberylcarnitine (C8-DC) [Moles/volume] in Serum or Plasma
Treponema pallidum Ab [Units/volume] in Body fluid by Hemagglutination
Para hydroxyamphetamine [Presence] in Urine
Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood
Coliform bacteria [#/mass] in Specimen by Viability count
Escherichia coli O157:H7 Ag [Presence] in Raw milk by Immunoassay
Abnormal Prion Protein [Presence] in Tissue by Immune stain
Abnormal Prion Protein [Presence] in Tissue by Immunoassay
Sarcocystis neurona Ab [Presence] in Serum by Immunofluorescence
Vesicular stomatitis Indiana virus RNA [Presence] in Specimen by NAA with probe detection
Para hydroxyamphetamine [Mass/volume] in Urine
Vesicular stomatitis New Jersey virus RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by Sequencing
Para hydroxyamphetamine [Mass/time] in 24 hour Urine
Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Paraldehyde [Mass/volume] in Serum or Plasma
Pefloxacin [Mass/volume] in Serum or Plasma
Pemoline [Mass/volume] in Serum or Plasma
EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gentamicin [Mass/volume] in Cerebral spinal fluid --peak
Rough Marsh Elder IgE Ab/IgE total in Serum
California Walnut Pollen IgE Ab/IgE total in Serum
Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep
Myelin associated glycoprotein IgM Ab [Titer] in Serum by Immunoassay
PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Vancomycin [Mass/volume] in Cerebral spinal fluid --peak
Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by NAA with probe detection
Influenza virus A neuraminidase cDNA [Identifier] in Specimen by NAA with probe detection
Penicillin [Mass/volume] in Serum or Plasma
Penicillin G [Susceptibility] by Minimum lethal concentration (MLC)
Penicillin G [Mass/volume] in Serum or Plasma
Penicillin V [Mass/volume] in Serum or Plasma
Pentazocine [Presence] in Serum or Plasma
Pentazocine [Mass/volume] in Serum or Plasma
Pentazocine [Mass/time] in 24 hour Urine
Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)
Pentetrazol [Mass/time] in 24 hour Urine
PENTobarbital [Presence] in Serum or Plasma
PENTobarbital [Mass/volume] in Serum or Plasma
Perphenazine [Mass/volume] in Serum or Plasma
Influenza virus A Ab [Presence] in Egg yolk by Immune diffusion (ID)
Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition
Phenacetin [Mass/volume] in Serum or Plasma
Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A N1 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N2 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N3 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N4 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N5 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N6 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N7 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N8 neutralizing antibody [Presence] in Serum by Neutralization test
Influenza virus A N9 neutralizing antibody [Presence] in Serum by Neutralization test
Abnormal Prion Protein [Presence] in Tissue by Immunoblot
Phenazocine [Mass/time] in 24 hour Urine
Phencyclidine [Mass/volume] in Serum or Plasma
Phencyclidine [Presence] in Serum or Plasma
Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase
Cholinesterase.fluoride inhibited/Cholinesterase in Serum or Plasma
Cholinesterase.scoline inhibited/Cholinesterase in Serum or Plasma
Cholinesterase.chloride inhibited/Cholinesterase in Serum or Plasma
Cholinesterase.RO 020683 inhibited/Cholinesterase in Serum or Plasma
Phendimetrazine [Mass/volume] in Serum or Plasma
Penicillin G [Susceptibility] by Disk diffusion (KB)
Phendimetrazine [Mass/time] in 24 hour Urine
Pheniramine [Mass/volume] in Serum or Plasma
Phenmetrazine [Mass/volume] in Serum or Plasma
9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma
Beta aminobutyrate [Moles/volume] in Serum or Plasma
Beta-2-Microglobulin [Moles/volume] in Body fluid
Bicarbonate [Moles/volume] standard in Venous cord blood
Bicarbonate [Moles/volume] standard in Arterial cord blood
Phenmetrazine [Mass/time] in 24 hour Urine
Bilirubin.total [Moles/volume] in Peritoneal fluid
Bilirubin.conjugated [Moles/volume] in Body fluid
Bilirubin.indirect [Moles/volume] in Body fluid
Carbon dioxide, total [Moles/volume] in Peritoneal dialysis fluid
Carbon dioxide, total [Moles/volume] in Venous cord blood
Carbon dioxide, total [Moles/volume] in Arterial cord blood
Chloride [Moles/volume] in Peritoneal dialysis fluid
Cholesterol [Moles/volume] in Pleural fluid
Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation
Penicillin G [Susceptibility] by Serum bactericidal titer
Prochlorperazine [Moles/volume] in Serum or Plasma
Creatinine [Moles/volume] in 24 hour Peritoneal dialysis fluid
Creatinine [Moles/volume] in 24 hour Dialysis fluid
Creatinine [Moles/volume] in 72 hour Urine
Creatinine [Moles/volume] in Peritoneal fluid
dimenhyDRINATE [Moles/volume] in Serum or Plasma
diphenhydrAMINE [Moles/volume] in Serum or Plasma
fluPHENAZine [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Vitreous fluid
PHENobarbital [Presence] in Serum or Plasma
Glucose [Moles/volume] in Pericardial fluid
Glucose [Moles/volume] in Arterial blood
Trimeprazine [Moles/volume] in Serum or Plasma
Normethsuximide [Moles/volume] in Serum or Plasma
OLANZapine [Moles/volume] in Serum or Plasma
pH of Capillary blood adjusted to patient's actual temperature
pH of Venous blood adjusted to patient's actual temperature
PHENobarbital [Mass/volume] in Serum or Plasma
Phensuximide [Moles/volume] in Serum or Plasma
PHENobarbital Free [Mass/volume] in Serum or Plasma
Adenovirus DNA [Presence] in Specimen by NAA with probe detection
Phenothiazines [Presence] in Serum or Plasma
Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence
Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA)
Influenza virus A Ab [Units/volume] in Serum by Complement fixation
Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition
Finch droppings IgG Ab [Presence] in Serum
Cockatiel droppings IgG Ab [Presence] in Serum
Penicillin V [Susceptibility] by Minimum lethal concentration (MLC)
Uranium/Creatinine [Mass Ratio] in Urine
Legionella sp Ag [Presence] in Specimen by Immunofluorescence
Phensuximide [Mass/volume] in Serum or Plasma
West Nile virus Ab [Units/volume] in Serum
Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assay
West Nile virus Ab [Presence] in Cerebral spinal fluid
Glucose [Mass/volume] in Serum or Plasma --1st specimen post dose lactose
Glucose [Mass/volume] in Serum or Plasma --2nd specimen post dose lactose
Glucose [Mass/volume] in Serum or Plasma --3rd specimen post dose lactose
Corticotropin [Mass/volume] in Plasma --1st specimen post XXX challenge
Complement C4d [Mass/volume] in Plasma by Immunoassay
Pregnanetriol/Creatinine [Mass Ratio] in 24 hour Urine
TOLAZamide [Mass/volume] in 24 hour Urine
TOLBUTamide [Mass/volume] in 24 hour Urine
Trichoderma viride Ab [Mass/volume] in Serum
Alternaria sp IgG Ab [Mass/volume] in Serum
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Hexacarboxylporphyrin [Mass/time] in 24 hour Stool
Fungus.microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain
Alternaria alternata Ab [Mass/volume] in Serum
Penicillium notatum Ab [Mass/volume] in Serum
Phoma herbarum Ab [Mass/volume] in Serum
Rubella virus Ab [Presence] in Cerebral spinal fluid
Amino beta guanidinopropionate/Creatinine [Molar ratio] in 24 hour Urine
Neutrophil Ab [Presence] in Serum by Immunoassay
Histoplasma capsulatum IgG Ab [Presence] in Serum by Immunoassay
HTLV I+II p19 Ab [Units/volume] in Serum
Phentermine [Mass/time] in 24 hour Urine
Pecan or Hickory Nut IgE Ab/IgE total in Serum
Curvularia lunata IgE Ab/IgE total in Serum
Epicoccum purpurascens IgE Ab/IgE total in Serum
Fusarium moniliforme IgE Ab/IgE total in Serum
Stemphylium botryosum IgE Ab/IgE total in Serum
Phenylbutazone [Mass/volume] in Serum or Plasma
Hamster epithelium IgE Ab/IgE total in Serum
Guinea pig epithelium IgE Ab/IgE total in Serum
Rabbit epithelium IgE Ab/IgE total in Serum
Spermatozoa Motile [#/area] in Semen by Microscopy high power field
Spermatozoa Immotile [#/area] in Semen by Microscopy high power field
Neisseria meningitidis serogroup w135 Ab [Mass/volume] in Serum
Silicone IgG Ab [Units/volume] in Serum by Immunoassay
Silicone IgA Ab [Units/volume] in Serum by Immunoassay
Silicone IgM Ab [Units/volume] in Serum by Immunoassay
Silicone IgE Ab [Units/volume] in Serum by Immunoassay
Benzoylcarnitine (BzCn) [Moles/volume] in Serum or Plasma
Neisseria meningitidis serogroup Y Ab [Mass/volume] in Serum
Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)
Phenylpropanolamine [Presence] in Serum or Plasma
Phenylpropanolamine [Mass/volume] in Serum or Plasma
Phenylpropanolamine [Mass/time] in 24 hour Urine
Phenytoin [Mass/volume] in Serum or Plasma
Phenytoin Free [Mass/volume] in Serum or Plasma
Penicillin V [Susceptibility] by Disk diffusion (KB)
Pindolol [Mass/volume] in Serum or Plasma
Piperacillin [Mass/volume] in Serum or Plasma
Sulfamethoxazole [Moles/volume] in Serum or Plasma
Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine
Protoporphyrin Free [Moles/volume] in Red Blood Cells
Prazepam [Mass/volume] in Serum or Plasma
Urea [Moles/volume] in Serum or Plasma --post dialysis
Urea [Moles/volume] in Serum or Plasma --pre dialysis
Urea [Moles/volume] in 24 hour Dialysis fluid
Urea [Moles/volume] in Peritoneal dialysis fluid
Delta aminolevulinate/Creatinine [Molar ratio] in Urine
Urea/Creatinine [Molar ratio] in Serum or Plasma
Primidone [Mass/volume] in Serum or Plasma
Porphyrins [Moles/volume] in Red Blood Cells
Potassium [Moles/volume] in Peritoneal dialysis fluid
Pyridoxine [Moles/volume] in Serum or Plasma
Sodium [Moles/volume] in Peritoneal dialysis fluid
Potassium [Moles/volume] in Venous blood
Potassium [Moles/volume] in Capillary blood
Sodium [Moles/volume] in Capillary blood
Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in 24 hour Urine
Tocainide [Moles/volume] in Serum or Plasma
Trifluoperazine [Moles/volume] in Serum or Plasma
Vancomycin [Moles/volume] in Serum or Plasma --peak
Vancomycin [Moles/volume] in Serum or Plasma --trough
Warfarin [Moles/volume] in Serum or Plasma
risperiDONE [Moles/volume] in Serum or Plasma
Azlocillin [Susceptibility] by Minimum lethal concentration (MLC)
risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma
Triglyceride [Moles/volume] in Pleural fluid
Creatinine in dialysis fluid/Creatinine in serum or plasma
inFLIXimab [Mass/volume] in Serum or Plasma
Lipoprotein associated phospholipase A2 [Mass/volume] in Serum or Plasma
Rabbit hair IgE Ab [Units/volume] in Serum
Procainamide [Mass/volume] in Serum or Plasma
Procainamide+N-acetylprocainamide [Mass/volume] in Serum or Plasma
Penicillin V [Susceptibility] by Serum bactericidal titer
Promethazine [Mass/volume] in Serum or Plasma
Propranolol [Mass/time] in 24 hour Urine
Propranolol [Presence] in Serum or Plasma
Propranolol [Mass/volume] in Serum or Plasma
Creatinine [Mass/volume] in Serum or Plasma --pre XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --1.5 hours pre XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --1 hour pre XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge
Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC)
Creatinine [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --3.75 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --5.25 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --9 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --10 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --12 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --16 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --18 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --2 days post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --4 days post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --7 days post XXX challenge
Creatinine [Mass/volume] in Urine --pre XXX challenge
Creatinine [Mass/volume] in Urine --2.25 hours pre XXX challenge
Creatinine [Mass/volume] in Urine --1.5 hours pre XXX challenge
Creatinine [Mass/volume] in Urine --1 hour pre XXX challenge
Creatinine [Mass/volume] in Urine --30 minutes pre XXX challenge
Propylhexedrine [Mass/time] in 24 hour Urine
Creatinine [Mass/volume] in Urine --baseline
Creatinine [Mass/volume] in Urine --30 minutes post XXX challenge
Creatinine [Mass/volume] in Urine --1 hour post XXX challenge
Creatinine [Mass/volume] in Urine --1.5 hours post XXX challenge
Creatinine [Mass/volume] in Urine --2 hours post XXX challenge
Creatinine [Mass/volume] in Urine --2.5 hours post XXX challenge
Creatinine [Mass/volume] in Urine --3 hours post XXX challenge
Creatinine [Mass/volume] in Urine --3.5 hours post XXX challenge
Protriptyline [Mass/volume] in Serum or Plasma
Creatinine [Mass/volume] in Urine --4 hours post XXX challenge
Creatinine [Mass/volume] in Urine --4.5 hours post XXX challenge
Creatinine [Mass/volume] in Urine --5 hours post XXX challenge
Creatinine [Mass/volume] in Urine --5.5 hours post XXX challenge
Creatinine [Mass/volume] in Urine --6 hours post XXX challenge
Creatinine [Mass/volume] in Urine --8 hours post XXX challenge
Creatinine [Mass/volume] in Urine --1 day post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --5 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --110 minutes post XXX challenge
Protriptyline [Presence] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --12.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --13 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --13.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --14 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --15.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --16 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --17.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --18 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --18.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --19.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --20 hours post XXX challenge
Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Serum or Plasma --20.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --21.5 hours post XXX challenge
Protriptyline [Mass/volume] in Serum or Plasma --trough
Glucose [Mass/volume] in Serum or Plasma --22 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --23.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --1 day post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --9 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --14 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --16 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --27 minutes post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --25 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --26 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --27 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --28 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --29 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --30 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --31 hour post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --36 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --2 days post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --pre XXX challenge
Albumin [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge
Albumin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Pseudoephedrine [Mass/time] in 24 hour Urine
Albumin [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --1 day post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --2 days post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --3 days post XXX challenge
Albumin [Mass/volume] in Serum or Plasma --4 days post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --pre XXX challenge
Calcium [Mass/volume] in Serum or Plasma --45 minutes pre XXX challenge
Calcium [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge
Calcium [Mass/volume] in Serum or Plasma --baseline
Calcium [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Pyrilamine [Presence] in Serum or Plasma
Calcium [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --12 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --13 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --14 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --16 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --20 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --1 day post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --36 hours post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --2 days post XXX challenge
Calcium [Mass/volume] in Serum or Plasma --3 days post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --baseline
Pyrilamine [Mass/volume] in Serum or Plasma
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 day post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --2 hours pre XXX challenge
Phenethicillin [Susceptibility] by Disk diffusion (KB)
aPTT in Platelet poor plasma by Coagulation assay --baseline
aPTT in Platelet poor plasma by Coagulation assay --30 minutes post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --1 hour post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --2 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --3 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --4 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --6 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --8 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --12 hours post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --1 day post XXX challenge
aPTT in Platelet poor plasma by Coagulation assay --18 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --pre XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --1.5 hours pre XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --8 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --9 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --10 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --12 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --16 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --18 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --2 days post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --4 days post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --7 days post XXX challenge
Creatinine [Moles/volume] in Urine --pre XXX challenge
Creatinine [Moles/volume] in Urine --1.5 hours pre XXX challenge
Creatinine [Moles/volume] in Urine --1 hour pre XXX challenge
Creatinine [Moles/volume] in Urine --30 minutes pre XXX challenge
Creatinine [Moles/volume] in Urine --baseline
Creatinine [Moles/volume] in Urine --30 minutes post XXX challenge
Creatinine [Moles/volume] in Urine --1 hour post XXX challenge
Creatinine [Moles/volume] in Urine --1.5 hours post XXX challenge
Creatinine [Moles/volume] in Urine --2 hours post XXX challenge
Creatinine [Moles/volume] in Urine --2.5 hours post XXX challenge
Pyrovalerone [Mass/time] in 24 hour Urine
Creatinine [Moles/volume] in Urine --3 hours post XXX challenge
Creatinine [Moles/volume] in Urine --3.5 hours post XXX challenge
Creatinine [Moles/volume] in Urine --4 hours post XXX challenge
Creatinine [Moles/volume] in Urine --4.5 hours post XXX challenge
Creatinine [Moles/volume] in Urine --5 hours post XXX challenge
Creatinine [Moles/volume] in Urine --5.5 hours post XXX challenge
Creatinine [Moles/volume] in Urine --6 hours post XXX challenge
Creatinine [Moles/volume] in Urine --8 hours post XXX challenge
Creatinine [Moles/volume] in Urine --1 day post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --50 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --70 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
quiNIDine+Quinine [Presence] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --6 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --7 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --8 hours post XXX challenge
quiNIDine [Mass/volume] in Serum or Plasma --trough
Glucose [Moles/volume] in Serum or Plasma --8.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --9 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --10 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --10.75 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --11.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --12 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --12.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --13 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --13.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --14 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --15.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --16 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --17.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --18 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --18.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --19.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --20 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --20.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --21.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --22 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --23.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --1 day post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre-meal
Glucose [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --13 minutes pre XXX challenge
quiNINE [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --8 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --3 minutes pre XXX challenge
Glucose [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --6 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --8 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --9 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --12 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --14 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --16 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --19 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --22 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --25 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --27 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge
rifAMPin [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --4.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --5.5 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --25 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --26 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --27 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --28 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --29 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --30 hours post XXX challenge
Salicylamide [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --31 hour post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --36 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --2 days post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --pre XXX challenge
Calcium [Moles/volume] in Serum or Plasma --45 minutes pre XXX challenge
Calcium [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge
Calcium [Moles/volume] in Serum or Plasma --baseline
Calcium [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --6.5 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --7.5 hours post XXX challenge
Salicylates [Presence] in Serum or Plasma
Calcium [Moles/volume] in Serum or Plasma --8 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --12 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --13 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --14 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --16 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --20 hours post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --1 day post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --36 hours post XXX challenge
Salicylates [Mass/volume] in Serum or Plasma
Calcium [Moles/volume] in Serum or Plasma --2 days post XXX challenge
Calcium [Moles/volume] in Serum or Plasma --3 days post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --baseline
Creatinine [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --2.25 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --5 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Creatinine [Mass/volume] in Serum or Plasma --1 day post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10.75 hours post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --13 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --3 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --baseline
Creatinine [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --6 hours post XXX challenge
Creatinine [Moles/volume] in Serum or Plasma --1 day post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO
Secobarbital [Presence] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO
Phenethicillin [Susceptibility] by Serum bactericidal titer
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose lactose PO
Lactose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO
Lactose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO
Lactose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO
Lactose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --75 minutes post dose glucose
Glucose [Moles/volume] in Serum or Plasma --105 minutes post dose glucose
Secobarbital [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --1 hour post meal
Insulin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --pre or post dose glucose
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Xylose [Moles/volume] in Serum or Plasma --fasting
Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --pre dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --pre dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --3.5 hours post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --4 hours post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --pre or post dose glucose
Cortisol [Moles/volume] in Serum or Plasma --pre dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus
Cortisol [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --pre dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus
Testosterone [Moles/volume] in Serum or Plasma --pre dose triple bolus
Testosterone [Moles/volume] in Serum or Plasma --3 hours post dose triple bolus
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre dose triple bolus
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --2 hours post dose triple bolus
Prolactin [Mass/volume] in Serum or Plasma --pre dose triple bolus
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose triple bolus
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus
Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --pre dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose triple bolus
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose triple bolus
MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method
MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method
MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method
MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method
MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method
MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method
MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method
MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method
MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method
MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method
Spironolactone [Mass/time] in 24 hour Urine
MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method
MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method
MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method
Creatinine [Moles/time] in 24 hour Dialysis fluid
Creatinine [Moles/time] in 24 hour Body fluid
Pipemidate [Susceptibility] by Minimum lethal concentration (MLC)
Follitropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus
Follitropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus
Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus
Follitropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus
Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus
Follitropin [Units/volume] in Serum or Plasma --pre dose triple bolus
Glucose [Moles/time] in 24 hour Body fluid
Heptacarboxylate [Moles/time] in 24 hour Urine
Hexacarboxylate [Moles/time] in 24 hour Urine
HYDROmorphone [Presence] in Gastric fluid
Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus
Lutropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus
Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus
Lutropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus
Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus
Lutropin [Units/volume] in Serum or Plasma --pre dose triple bolus
Methaqualone [Presence] in Gastric fluid
Nortriptyline [Presence] in Gastric fluid
Para aminobenzoate free [Mass/volume] in Serum or Plasma
Pentacarboxylate [Moles/time] in 24 hour Urine
Streptomycin [Mass/volume] in Serum or Plasma
Porphyrins [Moles/time] in 24 hour Urine
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus
Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus
Sulfonamide [Mass/volume] in Serum or Plasma
Trimipramine [Presence] in Gastric fluid
Tripelennamine [Presence] in Gastric fluid
Urea [Moles/time] in 24 hour Dialysis fluid
Uroporphyrin 1 isomer [Moles/time] in 24 hour Urine
Uroporphyrin 3 isomer [Moles/time] in 24 hour Urine
3-Methoxytyramine [Moles/time] in 24 hour Urine
Sulfonamide [Presence] in Serum or Blood
Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid
Amitriptyline [Presence] in Gastric fluid
Amphetamine+Methamphetamine [Presence] in Urine
Amphetamine+Methamphetamine [Presence] in Specimen
Amphetamine+Methamphetamine [Presence] in Serum or Plasma
Methotrimeprazine [Presence] in Specimen
Methotrimeprazine [Presence] in Serum or Plasma
CYP2D6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Osmotic fragility [Interpretation] of Red Blood Cells from Control--fresh
Osmotic fragility [Interpretation] of Red Blood Cells from Control--Incubated
Sucrose hemolysis of Red Blood Cells from Control
APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Teicoplanin [Mass/volume] in Serum or Plasma
Parainfluenza virus identified in Specimen by Organism specific culture
HIV 1 p24 Ab [Presence] in Serum or Plasma by Immunoassay
HIV 1 gp41 Ab [Presence] in Serum or Plasma by Immunoassay
HIV 1 gp120+gp160 Ab [Presence] in Serum or Plasma by Immunoassay
Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)
XXX microorganism serotype [Identifier] in Isolate by Agglutination
Tetracaine [Mass/volume] in Serum or Plasma
CMV gene mutations detected [Identifier]
Tetracycline [Mass/volume] in Serum or Plasma
Sialooligosaccharides [Presence] in Urine
Clot Lysis [Presence] in Platelet poor plasma by Coagulation assay
Ceruloplasmin actual/normal in Serum or Plasma
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum
Prothrombin Ab [Units/volume] in Serum or Plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor VIII depleted plasma
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum by Probe with signal amplification
Phenytoin.bound [Mass/volume] in Serum or Plasma
GJB1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GJB1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Drugs identified in Urine by Confirmatory method
Glimepride [Mass/volume] in Serum or Plasma
Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoblot
SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Tetrahydrocortisone [Mass/volume] in Urine
Lymphocytes [#/area] in Semen by Microscopy high power field
FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Tetradecadienoate (C14:2)/Creatinine [Mass Ratio] in Urine
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum
Volatiles and gases [Identifier] in Specimen
WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Virus identified in Body fluid by Culture
Virus identified in Genital specimen by Culture
Methylenedioxymethamphetamine [Presence] in Specimen
Unidentified crystals [#/area] in Urine sediment by Microscopy low power field
Phosphate crystals amorphous [#/area] in Urine sediment by Microscopy low power field
Urate crystals amorphous [#/area] in Urine sediment by Microscopy low power field
Theophylline [Mass/volume] in Saliva (oral fluid)
Urate crystals [#/area] in Urine sediment by Microscopy low power field
Protein/Creatinine [Ratio] in 24 hour Urine
Histiocytes/100 cells in Synovial fluid by Manual count
Macrophages/100 leukocytes in Synovial fluid by Manual count
Neutrophils/100 leukocytes in Synovial fluid by Manual count
Plasma cells/100 leukocytes in Synovial fluid by Manual count
Theophylline [Mass/volume] in Serum or Plasma
Methylenedioxymethamphetamine [Presence] in Serum or Plasma
Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
Yersinia pseudotuberculosis 2 Ab [Titer] in Serum
Yersinia pseudotuberculosis 1 Ab [Titer] in Serum
Yersinia enterocolitica Ab [Titer] in Serum by Agglutination
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay
Thiopental [Mass/volume] in Serum or Plasma
Candida sp Ab [Titer] in Serum by Latex agglutination
Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation
Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition
Powassan virus Ab [Titer] in Serum by Complement fixation
Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition
Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence
Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition
Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test
Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test
Pipemidate [Susceptibility] by Disk diffusion (KB)
Snowshoe hare virus Ab [Titer] in Serum by Immunofluorescence
Snowshoe hare virus Ab [Titer] in Serum by Hemagglutination inhibition
Semliki Forest virus Ab [Titer] in Serum by Hemagglutination inhibition
Powassan virus Ab [Titer] in Serum by Hemagglutination inhibition
Saint Louis encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition
Dengue virus Ab [Titer] in Serum by Complement fixation
Histiocytes/100 cells in Peritoneal fluid by Manual count
Macrophages/100 leukocytes in Peritoneal fluid by Manual count
Plasma cells/100 leukocytes in Peritoneal fluid by Manual count
Histiocytes/100 cells in Pleural fluid by Manual count
Macrophages/100 leukocytes in Pleural fluid by Manual count
Monocytes/100 leukocytes in Pleural fluid by Manual count
Plasma cells/100 leukocytes in Pleural fluid by Manual count
Histiocytes/100 cells in Pericardial fluid by Manual count
Macrophages/100 leukocytes in Pericardial fluid by Manual count
Monocytes/100 leukocytes in Pericardial fluid by Manual count
Plasma cells/100 leukocytes in Pericardial fluid by Manual count
Thioridazine [Mass/volume] in Serum or Plasma
Methylenedioxyamphetamine [Presence] in Gastric fluid
Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
Erythrocytes [#/volume] in Peritoneal dialysis fluid by Manual count
Leukocytes other/100 leukocytes in Peritoneal dialysis fluid by Manual count
Neutrophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
Monocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count
Lymphocytes/100 leukocytes in Peritoneal dialysis fluid by Manual count
Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
Basophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
Plasma cells/100 leukocytes in Cerebral spinal fluid by Microscopy
Rubella virus Ab [Titer] in Cerebral spinal fluid by Latex agglutination
Ticarcillin [Mass/volume] in Serum or Plasma
Leukocytes other/100 leukocytes in Bronchial specimen by Manual count
Monocytes/100 leukocytes in Bronchial specimen by Manual count
Hemoglobin C [Presence] in Blood by Electrophoresis
Hemoglobin E [Presence] in Blood by Electrophoresis
Mononuclear cells atypical [#/volume] in Blood by Manual count
Hemoglobin F [Mass/volume] in Blood by Electrophoresis
Hemoglobin H [Mass/volume] in Blood by Electrophoresis
CD10 Ag [Presence] in Tissue by Immune stain
CD117 Ag [Presence] in Tissue by Immune stain
CD19 Ag [Presence] in Tissue by Immune stain
CD45 Ag [Presence] in Tissue by Immune stain
CD66e Ag [Presence] in Tissue by Immune stain
Estrogen receptor Ag [Presence] in Tissue by Immune stain
Progesterone receptor Ag [Presence] in Tissue by Immune stain
Cytokeratin 20 Ag [Presence] in Tissue by Immune stain
Cytokeratin 7 Ag [Presence] in Tissue by Immune stain
Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain
Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain
Actin muscle specific Ag [Presence] in Tissue by Immune stain
Actin smooth muscle Ag [Presence] in Tissue by Immune stain
Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain
Promyelocytes [#/volume] in Body fluid by Manual count
Neutrophils [#/volume] in Body fluid by Manual count
Myelocytes [#/volume] in Body fluid by Manual count
Timolol [Mass/volume] in Serum or Plasma
Metamyelocytes [#/volume] in Body fluid by Manual count
Eosinophils [#/volume] in Body fluid by Manual count
Blasts [#/volume] in Body fluid by Manual count
Basophils [#/volume] in Body fluid by Manual count
Band form neutrophils [#/volume] in Body fluid by Manual count
Variant lymphocytes [#/volume] in Body fluid by Manual count
Platelets [#/volume] in Body fluid by Automated count
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum by Agglutination
Tobramycin [Mass/volume] in Serum or Plasma --peak
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Agglutination
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination
Cryoglobulin.IgM [Mass/volume] in Serum by Cold incubation
Cryoglobulin.IgG [Mass/volume] in Serum by Cold incubation
Cryoglobulin.IgA [Mass/volume] in Serum by Cold incubation
Cryoglobulin.IgM [Mass/volume] in Serum by 37 degree C incubation
Cryoglobulin.IgG [Mass/volume] in Serum by 37 degree C incubation
Invasive trophoblast Ag [Mass/volume] in Serum or Plasma
Drugs identified in Specimen by Confirmatory method
Tobramycin [Mass/volume] in Serum or Plasma --trough
Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --50 umol/L
Platelet aggregation EPINEPHrine induced [Units/volume] in Platelet rich plasma --100 umol/L
Prothrombin IgG Ab [Units/volume] in Serum or Plasma
Prothrombin IgM Ab [Units/volume] in Serum or Plasma
7-Dehydrocholesterol [Presence] in Amniotic fluid
Albumin [Mass/volume] in Peritoneal dialysis fluid
Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tocainide [Mass/volume] in Serum or Plasma
Alpha-1-acid glycoprotein [Presence] in Urine by Immunoelectrophoresis
Alpha-1-acid glycoprotein [Presence] in Serum or Plasma by Immunoelectrophoresis
Alpha 1 antitrypsin [Presence] in Urine by Immunoelectrophoresis
Alpha 1 antitrypsin [Presence] in Serum or Plasma by Immunoelectrophoresis
Alpha-2-Macroglobulin [Presence] in Urine by Immunoelectrophoresis
Alpha-2-Macroglobulin [Presence] in Serum by Immunoelectrophoresis
Ascaris lumbricoides IgG Ab [Units/volume] in Serum by Immunoassay
Ascaris lumbricoides IgM Ab [Units/volume] in Serum by Immunoassay
Beta-2 transferrin [Presence] in Cerebral spinal fluid
Borrelia burgdorferi IgM Ab [Presence] in Serum or Plasma by Immunoassay
Brucella sp Ab [Presence] in Serum by Complement fixation
Brucella sp Ab [Presence] in Serum by Agglutination
Campylobacter sp IgA Ab [Presence] in Serum by Immunoassay
Campylobacter sp IgG Ab [Presence] in Serum by Immunoassay
TOLBUTamide [Mass/volume] in Serum or Plasma
Cancer Ag 125 [Units/volume] in Peritoneal fluid
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous blood
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Capillary blood
Carcinoembryonic Ag [Mass/volume] in Pericardial fluid
Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid
CD3+CD4+ (T4 helper) cells/100 cells in Bronchial specimen
CD3+CD8+ (T8 suppressor) cells/100 cells in Bronchial specimen
Cryoglobulin.IgA [Mass/volume] in Serum by 37 degree C incubation
Nucleated erythrocytes [Presence] in Blood by Light microscopy
Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Manual count
Gamma globulin/Beta globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis
Kappa light chains [Presence] in Serum by Immunofixation
Kappa light chains [Presence] in Urine by Immunofixation
Kappa light chains.free [Presence] in Urine
Lambda light chains [Presence] in Urine by Immunofixation
Lambda light chains [Presence] in Serum by Immunofixation
Lambda light chains.free [Presence] in Urine
traZODone [Mass/volume] in Serum or Plasma
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum by Agglutination
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Agglutination
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum by Agglutination
Leukocytes other/100 leukocytes in Blood by Automated count
Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Mesothelial cells/100 leukocytes in Blood by Manual count
Myelocytes/100 leukocytes in Body fluid by Manual count
Neutrophils.hypogranulated [Presence] in Blood by Light microscopy
Nuclear Ab [Titer] in Serum by Immunoassay
Parasite identified in Blood by Thick film
Parvovirus B19 IgG Ab [Presence] in Serum by Immunofluorescence
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay
Parvovirus B19 IgM Ab [Presence] in Serum by Immunofluorescence
Promyelocytes/100 leukocytes in Body fluid by Manual count
Protein.monoclonal [Mass/volume] in Urine by Electrophoresis
Protein [Mass/time] in 12 hour Urine --resting
Protein [Mass/time] in 12 hour Urine --upright
Pyrophosphate crystals [Presence] in Body fluid
Reticulocytes [#/volume] in Blood by Manual count
Rubella virus Ab [Presence] in Cerebral spinal fluid by Latex agglutination
Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Smudge cells/100 leukocytes in Body fluid by Manual count
Thyrotropin binding inhibitory immunoglobulins [Units/volume] in Serum
Toxocara canis IgG Ab [Presence] in Serum by Immunoassay
Triamterene [Mass/time] in 24 hour Urine
Toxocara canis IgM Ab [Presence] in Serum by Immunoassay
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay
Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot
Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot
Turbidity [Presence] of Serum or Plasma Qualitative
Urate crystals [Presence] in Body fluid by Light microscopy
Acinetobacter sp multidrug resistant identified in Specimen by Organism specific culture
Immunoelectrophoresis for Cerebral spinal fluid
Platelet factor 3 [Units/volume] in Platelet rich plasma
Myeloid cells/100 cells in Bone marrow by Manual count
Megakaryocytes [Presence] in Bone marrow by Microscopy
Erythroid cells/100 cells in Bone marrow by Manual count
Pipemidate [Susceptibility] by Serum bactericidal titer
Triazolam [Mass/volume] in Serum or Plasma
RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Sulfamethoxazole IgE Ab [Presence] in Serum
Spermatozoa [#/volume] in Semen --post concentration
Spermatozoa Motile [#/volume] in Semen --post concentration
Toxoplasma gondii IgM Ab index [Units/volume] in Serum and CSF
Aromatic solvents [Identifier] in Serum or Plasma
Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
Lactoferrin [Presence] in Stool by Immunoassay
Maternal cell contamination [Identifier] in Blood Nominal
Amphotericin B [Mass/volume] in Serum or Plasma --peak
Polio virus IgG Ab [Titer] in Serum --2nd specimen
Polio virus Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis IgM Ab [Presence] in Serum by Immunoassay
Coccidioides immitis Ab [Presence] in Serum by Immunoassay
Giardia lamblia IgG Ab [Presence] in Serum by Immunoassay
Giardia lamblia IgM Ab [Presence] in Serum by Immunoassay
Immature granulocytes [Presence] in Blood
Hairy cells [Presence] in Blood by Light microscopy
Haptoglobin [Presence] in Serum or Plasma
Hemoglobin F [Presence] in Specimen by Apt-Downey method
Heparin Ab [Presence] in Platelet poor plasma by Platelet aggregation
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay
Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Hepatitis D virus Ab [Presence] in Serum by Immunoassay
Herpes simplex virus IgG Ab [Presence] in Serum by Immunoassay
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
Herpes virus 6 IgG Ab [Presence] in Serum by Immunoassay
Herpes virus 6 IgM Ab [Presence] in Serum by Immunoassay
HIV 1 IgG Ab [Presence] in Serum by Immunoblot
Tricyclic antidepressants [Presence] in Serum or Plasma
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay
HTLV I+II IgG Ab [Presence] in Serum by Immunoblot
La Crosse virus Ab [Presence] in Serum by Hemagglutination inhibition
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Osmotic fragility of Red Blood Cells--unincubated
Osmotic fragility of Red Blood Cells--Incubated
Trifluoperazine [Mass/volume] in Serum or Plasma
Platelet clump [Presence] in Blood by Automated count
Rabies virus IgG Ab [Presence] in Serum by Immunofluorescence
Plasma cells [Presence] in Blood by Light microscopy
Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assay
Fragments [Presence] in Blood by Automated count
Complement C2 [Presence] in Serum or Plasma
Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition
Echinococcus sp Ab [Presence] in Serum by Complement fixation
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence
17-Hydroxyprogesterone [Mass/volume] in Amniotic fluid
Amiodarone [Mass/volume] in Serum or Plasma --peak
Amiodarone [Mass/volume] in Serum or Plasma --trough
Amphotericin B [Mass/volume] in Serum or Plasma --trough
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid
Coxsackievirus A IgM Ab [Titer] in Serum --1st specimen
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid --2nd specimen
Coxsackievirus A Ab [Titer] in Serum --2nd specimen
Coxsackievirus A Ab [Titer] in Serum --1st specimen
Coxsackievirus B IgM Ab [Titer] in Serum --1st specimen
Coxsackievirus B IgG Ab [Titer] in Serum --2nd specimen
Coxsackievirus B Ab [Titer] in Cerebral spinal fluid
Coxsackievirus B IgM Ab [Titer] in Cerebral spinal fluid --1st specimen
Coxsackievirus B IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen
Ethosuximide [Mass/volume] in Serum or Plasma --peak
Piperacillin [Susceptibility] by Minimum lethal concentration (MLC)
Ethosuximide [Mass/volume] in Serum or Plasma --trough
Haemophilus influenzae Ag [Presence] in Urine
Histoplasma capsulatum IgM Ab [Titer] in Cerebral spinal fluid --1st specimen
Trimeperidine [Mass/time] in 24 hour Urine
Histoplasma capsulatum IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen
Histoplasma capsulatum IgM Ab [Titer] in Serum --1st specimen
Histoplasma capsulatum Ag [Presence] in Cerebral spinal fluid
Histoplasma capsulatum IgG Ab [Titer] in Serum --2nd specimen
Mexiletine [Mass/volume] in Serum or Plasma --trough
Mexiletine [Mass/volume] in Serum or Plasma --peak
Polio virus IgM Ab [Titer] in Serum --1st specimen
Trimethadione [Mass/volume] in Serum or Plasma
Polio virus IgM Ab [Titer] in Cerebral spinal fluid --1st specimen
Polio virus IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen
Streptococcus agalactiae Ag [Presence] in Vaginal fluid
Toxoplasma gondii IgM Ab [Titer] in Serum --1st specimen
Toxoplasma gondii IgG Ab [Titer] in Serum --2nd specimen
Calculus analysis [Interpretation] in Stone by Infrared spectroscopy
Japanese cypress IgE Ab [Units/volume] in Serum
Japanese hop IgE Ab [Units/volume] in Serum
Trimethoprim [Presence] in Serum or Plasma
Coproporphyrin 3 [Moles/time] in 24 hour Urine
Coproporphyrin 1 [Moles/time] in 24 hour Urine
Alkaline phosphatase.placental [Presence] in Serum or Plasma
Alkaline phosphatase.intestinal [Presence] in Serum or Plasma
Alkaline phosphatase.liver 2 [Presence] in Serum or Plasma
Alkaline phosphatase.liver 1 [Presence] in Serum or Plasma
Alkaline phosphatase.bone [Presence] in Serum or Plasma
Amphetamines [Presence] in Hair by Screen method
Amphetamines [Presence] in Saliva (oral fluid) by Screen method
Cannabinoids [Presence] in Hair by Screen method
Cannabinoids [Presence] in Saliva (oral fluid) by Screen method
Cocaine [Presence] in Saliva (oral fluid) by Screen method
Methamphetamine [Presence] in Hair by Screen method
Methamphetamine [Presence] in Saliva (oral fluid) by Screen method
Opiates [Presence] in Hair by Screen method
Opiates [Presence] in Saliva (oral fluid) by Screen method
Phencyclidine [Presence] in Hair by Screen method
Phencyclidine [Presence] in Saliva (oral fluid) by Screen method
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --baseline
11-Deoxycorticosterone [Presence] in Serum or Plasma
11-Hydroxyandrosterone/Creatinine [Mass Ratio] in 24 hour Urine
11-Hydroxyetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine
11-Ketoandrosterone/Creatinine [Mass Ratio] in 24 hour Urine
11-Ketoetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Tetrachlorodiphenylethane [Presence] in Serum or Plasma
11-Deoxycorticosterone [Moles/volume] in 24 hour Urine
Helicobacter pylori IgA Ab [Titer] in Serum
Helicobacter pylori IgM Ab [Titer] in Serum
HTLV I Ab [Presence] in Cerebral spinal fluid
HTLV II Ab [Presence] in Cerebral spinal fluid
Trimipramine [Presence] in Serum or Plasma
von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasma
Histoplasma capsulatum Ab [Presence] in Body fluid
Aspergillus fumigatus Ab [Presence] in Body fluid
Adenovirus+Rotavirus Ag [Presence] in Stool
Trimipramine [Mass/volume] in Serum or Plasma
SOD1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Herpes virus 8 IgG Ab [Presence] in Serum by Immunofluorescence
Strawberry IgG Ab [Mass/volume] in Serum
Sulfonamide crystals [#/area] in Urine sediment by Microscopy low power field
Alternaria sp IgG Ab [Presence] in Serum
Argininosuccinate [Moles/volume] in Cerebral spinal fluid
fentaNYL [Presence] in Urine by Confirmatory method
Legionella pneumophila 1 Ab [Presence] in Serum
Galactose 1 phosphate [Mass/volume] in DBS
Homovanillate [Moles/volume] in Cerebral spinal fluid
3-Methylcrotonylglycine [Mass/time] in 24 hour Urine
Glucose [Mass/volume] in Urine by Test strip --1st specimen post XXX challenge
Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Urine by Test strip --2nd specimen post XXX challenge
Normetanephrine Free [Moles/volume] in Serum or Plasma
Leishmania sp IgG Ab [Units/volume] in Serum
Leishmania sp IgG Ab [Units/volume] in Cerebral spinal fluid
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum
Tripelennamine [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Capillary blood --baseline
SOD1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Methylparaben IgE Ab [Units/volume] in Serum
Norovirus genogroup I Ag [Presence] in Stool
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma
Valproate [Mass/volume] in Serum or Plasma
11-Oxo-Androsterone [Mass/time] in 24 hour Urine
11-Oxo-Androsterone/Creatinine [Mass Ratio] in 24 hour Urine
11-Oxo-Etiocholanolone [Mass/time] in 24 hour Urine
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine
Carnitine esters/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Cystine Free [Presence] in Serum or Plasma
CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method
Valproate Free [Mass/volume] in Serum or Plasma
CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method
Glucose [Mass/volume] in Specimen --1st specimen
Glucose [Mass/volume] in Specimen --3rd specimen
AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method
CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method
CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method
Valproate [Mass/volume] in Serum or Plasma --trough
CD3-CD57+ cells/100 cells in Bone marrow
CD19+CD103+ cells/100 cells in Bone marrow
CD19+CD103+ cells/100 cells in Body fluid
CD11c+CD19+ cells/100 cells in Body fluid
CD25+CD19+ cells/100 cells in Body fluid
CD3-CD57+ cells [#/volume] in Body fluid
CD3-CD16+ cells/100 cells in Bone marrow
CD3+CD56+ cells [#/volume] in Bone marrow
CD3+CD56+ cells [#/volume] in Body fluid
CD3+CD4+ (T4 helper) cells [#/volume] in Tissue
Vancomycin Free [Mass/volume] in Serum or Plasma
CD3+CD8+ (T8 suppressor) cells [#/volume] in Tissue
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Tissue
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Vancomycin [Mass/volume] in Serum or Plasma --peak
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Vancomycin [Mass/volume] in Serum or Plasma --trough
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay
3-Methylcrotonylglycine [Moles/volume] in Blood
Cortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone
Parathyrin.intact [Mass/volume] in Serum or Plasma --10 minutes post excision
Piperacillin [Susceptibility] by Disk diffusion (KB)
PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method
Yersinia enterocolitica O:3 Ab [Presence] in Serum
Yersinia enterocolitica O:5 Ab [Presence] in Serum
Yersinia enterocolitica O:8 Ab [Presence] in Serum
Yersinia enterocolitica O:9 Ab [Presence] in Serum
Yersinia pseudotuberculosis Ab [Presence] in Serum
Yersinia sp IgG Ab [Units/volume] in Serum by Immunoassay
Yersinia sp IgM Ab [Units/volume] in Serum by Immunoassay
Yersinia enterocolitica Ab [Presence] in Serum
Yersinia sp IgM Ab [Titer] in Serum by Immunoassay
Yellow Jacket IgE Ab [Mass/volume] in Serum
Yohimbine [Mass/volume] in Serum or Plasma
Yersinia enterocolitica IgA Ab [Presence] in Serum
Yersinia enterocolitica IgG Ab [Presence] in Serum
Yersinia enterocolitica O:3 Ab [Presence] in Cerebral spinal fluid
Verapamil [Mass/volume] in Serum or Plasma
Yersinia enterocolitica O:5 Ab [Presence] in Cerebral spinal fluid
Yersinia enterocolitica O:8 Ab [Presence] in Cerebral spinal fluid
Yersinia enterocolitica O:9 Ab [Presence] in Cerebral spinal fluid
Yellow Jacket IgG4 Ab [Presence] in Serum
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Complement fixation
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Complement fixation
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Complement fixation
Yersinia sp Ab [Presence] in Serum by Complement fixation
Cryptosporidium parvum identified in Stool
MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Parietal cell IgG Ab [Units/volume] in Serum
SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Volatile drugs negative [Identifier] in Urine by Screen method
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum
VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
XXX microorganism DNA [Presence] in Urine by NAA with probe detection
Volatile drugs positive [Identifier] in Urine by Screen method
XXX microorganism DNA [Presence] in Serum or Plasma by NAA with probe detection
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum
Adenovirus DNA [Identifier] in Specimen by RFLP
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
Adenovirus IgG Ab [Presence] in Serum by Immunoassay
Human metapneumovirus RNA [Identifier] in Specimen by NAA with probe detection
Human metapneumovirus Ag [Presence] in Specimen by Immunofluorescence
Warfarin [Mass/volume] in Serum or Plasma
Human metapneumovirus IgG Ab [Presence] in Serum by Immunoassay
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
Parainfluenza virus 1 IgG Ab [Presence] in Serum by Immunoassay
Parainfluenza virus 2 IgG Ab [Presence] in Serum by Immunoassay
Parainfluenza virus 3 IgG Ab [Presence] in Serum by Immunoassay
Parainfluenza virus 4 Ag [Presence] in Specimen by Immunofluorescence
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
Respiratory syncytial virus IgG Ab [Presence] in Serum by Immunoassay
Rhinovirus RNA [Identifier] in Specimen by NAA with probe detection
Rhinovirus+Enterovirus RNA [Presence] in Specimen by NAA with probe detection
Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence
Rhinovirus Ag [Identifier] in Specimen by Neutralization test
CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Alternaria alternata IgE Ab/IgE total in Serum
Zimelidine [Mass/volume] in Serum or Plasma
Calcium hydrogen phosphate dihydrate/Total in Stone
Calcium hydrogen phosphate dihydrate [Mass/time] in 24 hour Urine
Human coronavirus RNA [Identifier] in Specimen by NAA with probe detection
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
Human coronavirus 229E IgG Ab [Presence] in Serum by Immunoassay
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
Human coronavirus 229E Ag [Presence] in Specimen by Immunofluorescence
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
Human coronavirus NL63 IgG Ab [Presence] in Serum by Immunoassay
Human coronavirus OC43 Ag [Presence] in Specimen by Immunofluorescence
Human coronavirus OC43 IgG Ab [Presence] in Serum by Immunoassay
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
Piperacillin [Susceptibility] by Serum bactericidal titer
Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
Human metapneumovirus IgG Ab [Presence] in Serum
Respiratory syncytial virus IgG Ab [Presence] in Serum
Human coronavirus 229E IgG Ab [Presence] in Serum
Human coronavirus NL63 IgG Ab [Presence] in Serum
Human coronavirus OC43 IgG Ab [Presence] in Serum
Bilirubin.total [Moles/volume] in Urine by Test strip
Protoporphyrin [Moles/volume] in Red Blood Cells
Testosterone.free+weakly bound [Moles/volume] in Serum or Plasma
Beta endorphin [Moles/volume] in Serum or Plasma
Citrate [Molar amount] in Urine collected for unspecified duration
Aldosterone [Molar amount] in Urine collected for unspecified duration
Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g glucose PO
Ribonucleoprotein extractable nuclear Ab [Mass/volume] in Serum
Fungus identified in Genital specimen by Culture
Tau protein/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid
Listeria monocytogenes O1 Ab [Titer] in Serum
Listeria monocytogenes H1 Ab [Titer] in Serum
Listeria monocytogenes O4b Ab [Titer] in Serum
Lopinavir [Susceptibility] by Genotype method
Uroporphyrin [Mass/time] in unspecified time Stool
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Norovirus RNA [Presence] in Specimen by Probe
Cocaine [Presence] in Blood by Confirmatory method
Cocaine [Presence] in Meconium by Confirmatory method
3-Methylcrotonylglycine [Moles/volume] in Serum or Plasma
Palmitoylcarnitine (C16) [Moles/volume] in Blood
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Blood
WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SHOX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal
NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
KEL gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal
HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method
GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GLA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Treponema pallidum Ab [Units/volume] in Specimen
Toxoplasma gondii HS Ab [Units/volume] in Serum
Toxoplasma gondii AC Ab [Units/volume] in Serum
Strongyloides sp IgG Ab [Units/volume] in Serum
Salmonella gallinarum Ab [Presence] in Blood
Parvovirus B19 IgM Ab [Units/volume] in Serum --1st specimen
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid
Measles virus IgG Ab [Presence] in Cerebral spinal fluid
Jamestown canyon virus Ab [Presence] in Specimen
Influenza virus A N9 Ab [Presence] in Serum
Influenza virus A N8 Ab [Presence] in Serum
Influenza virus A N7 Ab [Presence] in Serum
Influenza virus A N6 Ab [Presence] in Serum
Influenza virus A N5 Ab [Presence] in Serum
Influenza virus A N4 Ab [Presence] in Serum
Influenza virus A N3 Ab [Presence] in Serum
Influenza virus A N2 Ab [Presence] in Serum
Influenza virus A N1 Ab [Presence] in Serum
HIV 1 Ab [Units/volume] in Saliva (oral fluid)
HIV 1 Ab [Presence] in Saliva (oral fluid)
Herpes virus 8 IgG Ab [Presence] in Serum
Herpes virus 6 IgM Ab [Presence] in Serum
Herpes virus 6 IgG Ab [Presence] in Serum
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
Hepatitis B virus e IgG Ab [Presence] in Serum
Haemophilus paragallinarum Ab [Units/volume] in Serum
Giardia lamblia IgM Ab [Presence] in Serum
Giardia lamblia IgG Ab [Presence] in Serum
Cytomegalovirus IgM Ab [Units/volume] in Body fluid
Coccidioides sp IgG Ab [Presence] in Specimen
Chlamydia trachomatis IgM Ab [Presence] in Serum
Canine herpesvirus Ab [Presence] in Serum
Campylobacter sp IgG Ab [Presence] in Serum
Ascaris lumbricoides IgM Ab [Units/volume] in Serum
Ascaris lumbricoides IgG Ab [Units/volume] in Serum
Treponema pallidum DNA [Presence] in Specimen by NAA with probe detection
Uranium 235/Uranium 238 [Mass Ratio] in 24 hour Urine
Uranium depleted/Creatinine [Mass Ratio] in Urine
Listeria monocytogenes H Ab [Titer] in Serum
Phenylalanine+Tyrosine [Presence] in Blood
Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
Yeast.budding [#/area] in Urine sediment by Microscopy high power field
Xylose [Mass/volume] in Serum or Plasma --2 hours post dose xylose PO
Waxy Casts Broad [Presence] in Urine sediment by Light microscopy
Western equine encephalitis virus Ab [Titer] in Body fluid
Trichophyton reaction wheal [Diameter] --2 days post dose trichophyton intradermal
Trichophyton reaction wheal [Diameter] --1 day post dose trichophyton intradermal
Mumps reaction wheal [Diameter] --2 days post dose mumps intradermal
Mumps reaction wheal [Diameter] --1 day post dose mumps intradermal
Candida albicans reaction wheal [Diameter] --2 days post Candida albicans intradermal
Candida albicans reaction wheal [Diameter] --1 day post Candida albicans intradermal
Histoplasma capsulatum farciminosum reaction wheal [Diameter] --2 days post histoplasmin intradermal
Western equine encephalitis virus Ab [Titer] in Serum by Complement fixation
Xylose [Mass/volume] in Serum or Plasma --5 hours post dose xylose PO
Xylose [Mass/volume] in Serum or Plasma --fasting
Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC)
Waxy casts [Presence] in Urine by Computer assisted method
Xylose [Mass/time] in 2 hour Urine --2 hours post dose xylose PO
Yellow Hornet IgG4 Ab [Presence] in Serum
Whitefaced Hornet IgG4 Ab [Presence] in Serum
West Nile virus Ab [Units/volume] in Serum by Immunoassay
West Nile virus IgM Ab [Titer] in Body fluid
West Nile virus IgG Ab [Titer] in Body fluid
Xylose [Mass/volume] in Serum or Plasma --30 minutes post dose xylose PO
Voriconazole [Susceptibility] by Minimum lethal concentration (MLC)
Voriconazole [Susceptibility] by Disk diffusion (KB)
Voltage-gated calcium channel IgG Ab [Moles/volume] in Serum
Watermelon IgG Ab [Mass/volume] in Serum
West Nile virus Ab [Units/volume] in Cerebral spinal fluid
Viscosity+Liquefaction [Identifier] of Semen
VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method
VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method
West Nile virus IgG+IgM Ab [Presence] in Serum
West Nile virus RNA [Presence] in Serum from Donor by NAA with probe detection
Xanthan gum IgE Ab [Units/volume] in Serum
Volatiles and gases [Identifier] in Gastric fluid by Screen method
Yeast [#/area] in Urine sediment by Microscopy low power field
Yellow fever virus IgM Ab [Presence] in Serum
Yellow fever virus IgG Ab [Presence] in Serum
Paper wasp IgG Ab [Mass/volume] in Serum
Xanthurenate [Presence] in 24 hour Urine
Xanthurenate+Kynurenate [Mass/time] in 24 hour Urine
Yeast [Presence] in Body fluid by Light microscopy
Waxy casts [#/area] in Urine sediment by Microscopy high power field
West Nile virus Ab [Titer] in Cerebral spinal fluid
Yellow Jacket IgG Ab [Mass/volume] in Serum
Xanthurenate+Kynurenate [Presence] in 24 hour Urine
Paper wasp IgE Ab [Mass/volume] in Serum
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid
Xylose [Mass/volume] in Urine --5 hours post dose xylose PO
Yellow fever virus Ab [Presence] in Cerebral spinal fluid
Xanthurenate [Presence] in Serum or Plasma
Yeast [Presence] in Cerebral spinal fluid by Light microscopy
Yeast [#/area] in Body fluid by Microscopy high power field
Western equine encephalitis virus IgG Ab [Presence] in Serum
Viscosity of Pericardial fluid Qualitative
Yellow fever virus Ab [Titer] in Serum --2nd specimen
Yellow fever virus Ab [Titer] in Serum --1st specimen
Yellow fever virus Ab [Presence] in Serum
Xylose [Mass/volume] in Urine --baseline
Xylose [Mass/volume] in Urine --5 hours post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --5 hours post 25 g xylose PO
Xylose [Mass/volume] in Urine --4 hours post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --4 hours post 25 g xylose PO
Xylose [Mass/volume] in Urine --3 hours post 25 g xylose PO
Xylose [Mass/volume] in Serum or Plasma --3 hours post 25 g xylose PO
Xylose [Mass/volume] in Urine --2 hours post 25 g xylose PO
Xylose [Mass/volume] in Urine --1 hour post 25 g xylose PO
Western equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid
Western equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid
Voltage-gated calcium channel IgG Ab [Presence] in Serum
Viscosity of Peritoneal fluid Qualitative
Viscosity of Cerebral spinal fluid Qualitative
Volatiles and gases [Identifier] in Blood
Xylose [Mass/volume] in Serum or Plasma --post dose xylose PO
VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method
Beta hydroxybutyrate + Gamma aminobutyrate [Moles/volume] in Serum or Plasma
Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Dermatophagoides sp IgE Ab [Units/volume] in Serum
Alpha-1-Fetoprotein interpretation in Amniotic fluid
Alpha-1-Fetoprotein interpretation in Serum or Plasma
Amino acids intense band position [Identifier] in Urine
Gross blood [Presence] of Body fluid Qualitative
Gross blood [Presence] of Stool Qualitative
Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum
Burr cells [#/volume] in Cerebral spinal fluid by Manual count
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Manual count
Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy high power field
Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine
Uranium 235/Uranium 238 [Mass Ratio] in Urine
Epithelial cells.parabasal [Presence] in Vaginal fluid by Light microscopy
11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE
HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma
Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB)
Tenofovir [Susceptibility] by Genotype method
Beta lactoglobulin IgE Ab [Units/volume] in Serum
Alloisoleucine [Presence] in Serum or Plasma
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay
Azlocillin [Susceptibility] by Disk diffusion (KB)
Yersinia sp IgA Ab [Presence] in Serum by Immunoblot
Yersinia sp IgG Ab [Presence] in Serum by Immunoblot
Emtricitabine [Susceptibility] by Genotype method
Atazanavir [Susceptibility] by Genotype method
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in 24 hour Urine
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum by Immunoassay
Meropenem [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --pre dose corticotropin
Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Angiostrongylus cantonensis Ab [Presence] in Specimen by Immunoblot
Angiostrongylus costaricensis Ab [Presence] in Serum by Agglutination
Babesia divergens Ab [Titer] in Serum by Immunofluorescence
Babesia microti Ab [Titer] in Serum by Immunofluorescence
Babesia duncani Ab [Titer] in Serum by Immunofluorescence
Echinococcus sp Ab [Presence] in Serum by Immunoblot
Filaria Ab [Units/volume] in Serum by Immunoassay
Gnathostoma sp Ab [Presence] in Serum by Immunoblot
Leishmania brasilensis Ab [Titer] in Serum by Immunofluorescence
Leishmania tropica Ab [Titer] in Serum by Immunofluorescence
Paragonimus sp Ab [Presence] in Serum by Immunoblot
Schistosoma haematobium Ab [Presence] in Serum by Immunoblot
Schistosoma japonicum Ab [Presence] in Serum by Immunoblot
Schistosoma mansoni Ab [Presence] in Specimen by Immunoblot
Toxocara canis Ab [Titer] in Specimen by Immunoassay
Trichinella spiralis Ab [Units/volume] in Serum by Immunoassay
Trypanosoma brucei gambiense Ab [Presence] in Serum by Agglutination
Trypanosoma brucei rhodesiense Ab [Titer] in Serum by Immunofluorescence
Acanthamoeba sp DNA [Presence] in Specimen by NAA with probe detection
Piperacillin+Tazobactam [Susceptibility] by Serum bactericidal titer
Angiostrongylus cantonensis DNA [Presence] in Specimen by NAA with probe detection
Angiostrongylus costaricensis DNA [Presence] in Specimen by NAA with probe detection
Balamuthia mandrillaris DNA [Presence] in Specimen by NAA with probe detection
Cryptosporidium hominis DNA [Presence] in Specimen by NAA with probe detection
Cryptosporidium parvum DNA [Presence] in Specimen by NAA with probe detection
Cyclospora carcopitheci DNA [Presence] in Specimen by NAA with probe detection
Cyclospora cayetanensis DNA [Presence] in Specimen by NAA with probe detection
Cyclospora colobi DNA [Presence] in Specimen by NAA with probe detection
Cyclospora papionis DNA [Presence] in Specimen by NAA with probe detection
Encephalitozoon cuniculi DNA [Presence] in Specimen by NAA with probe detection
Encephalitozoon hellem DNA [Presence] in Specimen by NAA with probe detection
Encephalitozoon intestinalis DNA [Presence] in Specimen by NAA with probe detection
Entamoeba dispar DNA [Presence] in Specimen by NAA with probe detection
Enterocytozoon bieneusi DNA [Presence] in Specimen by NAA with probe detection
Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Parasite identified in Specimen by Culture
Plasmodium falciparum DNA [Presence] in Blood by NAA with probe detection
Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection
Plasmodium ovale DNA [Presence] in Blood by NAA with probe detection
Plasmodium vivax DNA [Presence] in Blood by NAA with probe detection
Plasmodium stage [Identifier] in Blood by Light microscopy
Human coronavirus Ag [Presence] in Specimen by Immunofluorescence
Human coronavirus identified in Specimen
SARS coronavirus RNA [Presence] in Specimen by NAA with probe detection
SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay
Taenia solium larva Ab [Presence] in Specimen by Immunoblot
Wuchereria bancrofti+Brugia malayi Ag [Presence] in Serum by Immunoassay
Amphetamines/Creatinine [Mass Ratio] in Urine
Opiates/Creatinine [Mass Ratio] in Urine
Methadone/Creatinine [Mass Ratio] in Urine
Benzodiazepines/Creatinine [Mass Ratio] in Urine
Barbiturates/Creatinine [Mass Ratio] in Urine
Ribavirin [Mass/volume] in Serum or Plasma
Atazanavir [Mass/volume] in Serum or Plasma
Phenethicillin [Mass/volume] in Serum or Plasma
Carbamazepine 10,11-Epoxide [Mass/volume] in DBS
Diethylcarbamazepine [Mass/volume] in DBS
Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay
Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay
Bacterial sialidase [Presence] in Specimen
Bartonella henselae IgG and IgM panel - Serum
BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
Chlamydia sp IgG and IgM panel [Titer] - Serum
Clostridium tetani toxoid Ab [Units/volume] in Serum by Immunoassay
Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation
Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation
Coxsackievirus B neutralizing Ab panel [Titer] - Serum by Neutralization test
Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay
Cryptosporidium sp [Presence] in Specimen by Acid fast stain
Echovirus 11 neutralizing antibody [Titer] in Serum by Neutralization test
Echovirus 16 neutralizing antibody [Titer] in Serum by Neutralization test
Echovirus 30 neutralizing antibody [Titer] in Serum by Neutralization test
Echovirus 7 neutralizing antibody [Titer] in Serum by Neutralization test
Febrile agglutinin Ab panel [Titer] - Serum
Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Haemophilus influenzae B Ag [Presence] in Body fluid
HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
HIV 1 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay
Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC)
Linezolid [Susceptibility] by Method for Slow-growing mycobacteria
Measles virus Ab [Titer] in Serum by Hemagglutination inhibition
Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Neisseria meningitidis serogroup B Ag [Presence] in Body fluid
Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
Parainfluenza virus Ag panel - Specimen by Immunofluorescence
Polio virus neutralizing Ab panel - Serum by Neutralization test
Rabies virus Ab [Presence] in Serum by Immunoassay
Streptococcus agalactiae Ag [Presence] in Body fluid
Trichomonas vaginalis Ag [Presence] in Vaginal fluid
Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 400 copies/mL
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 2.6 log copies/mL
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 75 copies/mL
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 1.9 log copies/mL
Bacteria [Presence] in Pericardial fluid by Light microscopy
Bacteria [Presence] in Body fluid by Light microscopy
Bacteria [Presence] in Synovial fluid by Light microscopy
Bacteria [Presence] in Peritoneal fluid by Light microscopy
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
Bacteria [Presence] in Pleural fluid by Light microscopy
Fasting glucose [Mass/volume] in Capillary blood by Glucometer
Lactose [Mass/volume] in Serum or Plasma --pre fast
Lactose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO
Methemoglobin/Hemoglobin.total in Mixed venous blood
Prolactin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Xanthurenate [Mass/volume] in Serum or Plasma
Platelet Ab [Presence] in Serum by Flow cytometry (FC)
Neutrophil Ab [Presence] in Serum by Flow cytometry (FC)
HLA Ab [Presence] in Serum by Flow cytometry (FC)
Unstable Hemoglobin [Presence] in Red Blood Cells by Isopropanol stability
Xylose [Moles/volume] in Urine --5 hours post 5 g xylose PO
Arenavirus RNA [Presence] in Specimen by NAA with probe detection
Bacillus anthracis DNA [Identifier] in Specimen by NAA with probe detection
Bacillus anthracis DNA [Presence] in Specimen by NAA with probe detection
Brucella sp Ag [Presence] in Specimen by Immunofluorescence
Brucella sp DNA [Identifier] in Specimen by NAA with probe detection
Brucella sp DNA [Presence] in Specimen by NAA with probe detection
Burkholderia sp Ag [Presence] in Specimen by Immunofluorescence
Burkholderia sp DNA [Presence] in Specimen by NAA with probe detection
Burkholderia sp DNA [Identifier] in Specimen by NAA with probe detection
Clostridium botulinum toxin A [Presence] in Specimen by Immunofluorescence
Clostridium botulinum toxin A botA gene [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin B [Presence] in Specimen by Immunofluorescence
Clostridium botulinum toxin B botB gene [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin E [Presence] in Specimen by Immunofluorescence
Clostridium botulinum toxin F [Presence] in Specimen by Immunofluorescence
Ebola virus RNA [Presence] in Specimen by NAA with probe detection
Ebola virus Ag [Presence] in Specimen by Immunofluorescence
Marburg virus RNA [Presence] in Specimen by NAA with probe detection
Ricin toxin IgM Ab [Presence] in Serum by Immunofluorescence
Ricin toxin IgG Ab [Presence] in Serum by Immunofluorescence
Ricin toxin [Presence] in Specimen by Immunofluorescence
West Nile virus IgM Ab [Presence] in Specimen by Immunofluorescence
West Nile virus Ag [Presence] in Specimen by Immunofluorescence
Calcium.ionized [Moles/volume] in Capillary blood
Calcium.ionized [Moles/volume] in Venous blood
Calcium.ionized [Moles/volume] in Mixed venous blood
Carbon dioxide, total [Moles/volume] in Arterial blood by calculation
Carboxyhemoglobin/Hemoglobin.total in Mixed venous blood
Chloride [Moles/volume] in Arterial blood
Glucose [Mass/volume] in Capillary blood by Glucometer
Hematocrit [Volume Fraction] of Venous blood
Hematocrit [Volume Fraction] of Mixed venous blood
Potassium [Moles/volume] in Mixed venous blood
Sodium [Moles/volume] in Mixed venous blood
ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC)
ABT492 [Susceptibility] by Disk diffusion (KB)
ABT492 [Susceptibility] by Gradient strip
Azlocillin [Susceptibility] by Gradient strip
Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB)
Aztreonam+Clavulanate [Susceptibility] by Gradient strip
Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Biapenem [Susceptibility] by Disk diffusion (KB)
Biapenem [Susceptibility] by Gradient strip
Carbenicillin [Susceptibility] by Gradient strip
Cefamandole [Susceptibility] by Gradient strip
ceFAZolin [Susceptibility] by Gradient strip
Cefotaxime+Clavulanate [Susceptibility] by Gradient strip
cefoTEtan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
cefoTEtan+Clavulanate [Susceptibility] by Disk diffusion (KB)
cefoTEtan+Clavulanate [Susceptibility] by Gradient strip
cefOXitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
cefOXitin+Clavulanate [Susceptibility] by Disk diffusion (KB)
cefOXitin+Clavulanate [Susceptibility] by Gradient strip
Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip
Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB)
cefTRIAXone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
cefTRIAXone+Clavulanate [Susceptibility] by Disk diffusion (KB)
cefTRIAXone+Clavulanate [Susceptibility] by Gradient strip
Cephaloridine [Susceptibility] by Gradient strip
Clavulanate [Susceptibility] by Gradient strip
Clavulanate [Susceptibility] by Disk diffusion (KB)
Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
Dalbavancin [Susceptibility] by Disk diffusion (KB)
Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
Dalbavancin [Susceptibility] by Gradient strip
DAPTOmycin [Susceptibility] by Gradient strip
Enoxacin [Susceptibility] by Gradient strip
Ethionamide [Susceptibility] by Disk diffusion (KB)
Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Everninomicin [Susceptibility] by Gradient strip
Everninomicin [Susceptibility] by Disk diffusion (KB)
Gemifloxacin [Susceptibility] by Gradient strip
Josamycine [Susceptibility] by Disk diffusion (KB)
Josamycine [Susceptibility] by Gradient strip
Lincomycin [Susceptibility] by Gradient strip
Lomefloxacin [Susceptibility] by Gradient strip
Mezlocillin [Susceptibility] by Gradient strip
Moxalactam [Susceptibility] by Gradient strip
Nafcillin [Susceptibility] by Gradient strip
Neomycin [Susceptibility] by Gradient strip
Novobiocin [Susceptibility] by Gradient strip
Oritavancin [Susceptibility] by Disk diffusion (KB)
Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
Oritavancin [Susceptibility] by Gradient strip
Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ramoplanin [Susceptibility] by Gradient strip
Ramoplanin [Susceptibility] by Disk diffusion (KB)
Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Rosamicin [Susceptibility] by Gradient strip
Rosamicin [Susceptibility] by Disk diffusion (KB)
Sulbactam [Susceptibility] by Disk diffusion (KB)
Sulbactam [Susceptibility] by Gradient strip
Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Tazobactam [Susceptibility] by Disk diffusion (KB)
Tazobactam [Susceptibility] by Gradient strip
Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Telithromycin [Susceptibility] by Gradient strip
Thiamphenicol [Susceptibility] by Disk diffusion (KB)
Thiamphenicol [Susceptibility] by Gradient strip
Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefpodoxime+Clavulanate [Susceptibility]
cefTRIAXone+Clavulanate [Susceptibility]
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk
BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Beclomethasone dipropionate [Mass/volume] in Serum or Plasma
Betamethasone [Mass/volume] in Serum or Plasma
Blastomyces dermatitidis Ag [Presence] in Urine by Immunoassay
Budesonide [Mass/volume] in Serum or Plasma
CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Ehrlichia chaffeensis Ab [Titer] in Serum
FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Fludrocortisone [Mass/volume] in Serum or Plasma
Flunisolide [Mass/volume] in Serum or Plasma
Fluorometholone [Mass/volume] in Serum or Plasma
Fluticasone propionate [Mass/volume] in Serum or Plasma
GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Urine
Pivampicillin [Susceptibility] by Disk diffusion (KB)
Interleukin 12 [Mass/volume] in Serum or Plasma
lamoTRIgine [Mass/volume] in Serum or Plasma by Screen method
Megestrol acetate [Mass/volume] in Serum or Plasma
SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Triamcinolone [Mass/volume] in Serum or Plasma
Triamcinolone acetonide [Mass/volume] in Serum or Plasma
VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot
Burkholderia pseudomallei IgG and IgM panel - Serum by Immunofluorescence
Pivampicillin [Susceptibility] by Serum bactericidal titer
Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum
Coxiella burnetii phase 1 and 2 IgM panel [Titer] - Serum
Herpes virus 7 IgG and IgM panel [Titer] - Serum by Immunofluorescence
Lymphocytic choriomeningitis virus IgG and IgM panel [Titer] - Cerebral spinal fluid by Immunofluorescence
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination
Horseradish IgG Ab [Units/volume] in Serum
Lidocaine IgE Ab [Units/volume] in Serum
Microorganism or agent identified in Specimen
Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection
Castor Bean DNA [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus enterotoxin B [Presence] in Specimen by Immunofluorescence
Variola virus DNA [Presence] in Specimen by NAA with probe detection
Vibrio parahaemolyticus DNA [Presence] in Specimen by NAA with probe detection
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Specimen
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma
Yeast.hyphae [#/area] in Urine sediment by Microscopy high power field
Viscosity of Semen--20 minutes post collection
Yeast.pseudohyphae [Presence] in Urine sediment by Light microscopy
Yeast.hyphae [Presence] in Urine by Computer assisted method
Yeast.hyphae [Presence] in Urine sediment by Light microscopy
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma
Waxy casts [#/volume] in Urine by Computer assisted method
Tryptase.mature [Enzymatic activity/volume] in Serum or Plasma
Voltage-gated potassium channel Ab [Moles/volume] in Serum
PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Smooth Alder IgG Ab [Units/volume] in Serum
White Birch IgE Ab [Units/volume] in Serum
Bordetella pertussis and Bordetella parapertussis DNA panel - Specimen by NAA with probe detection
Rickettsia typhi and Rickettsia spotted fever group IgG and IgM panel - Serum
Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay
Dengue virus IgG and IgM panel - Serum by Immunoassay
Vendor device model code of Glucose meter
Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC)
Parainfluenza virus 4 IgG Ab [Presence] in Serum by Immunoassay
SARS coronavirus IgM Ab [Presence] in Serum by Immunoassay
Arsenic.inorganic [Mass/volume] in 24 hour Urine
Heptacarboxylporphyrin [Mass/volume] in 24 hour Urine
Hexacarboxylporphyrin [Mass/volume] in 24 hour Urine
Lipoprotein.pre-beta [Presence] in Body fluid
Almecillin [Susceptibility] by Disk diffusion (KB)
Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)
Lopinavir+Ritonavir [Susceptibility] by Genotype method
Nickel/Creatinine [Mass Ratio] in 24 hour Urine
Pentacarboxylporphyrins [Mass/volume] in 24 hour Urine
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Saint Louis encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Lipoprotein.X [Presence] in Serum or Plasma
PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method
Polymyxin B [Susceptibility] by Disk diffusion (KB)
C peptide [Moles/volume] in Serum or Plasma --fasting
Myocardium Ab [Presence] in Serum by Immunofluorescence
Gossypol bound [Mass/volume] in Specimen
Gossypol negative isomer [Mass/volume] in Specimen
Gossypol posiitve isomer [Mass/volume] in Specimen
CD3+CD16+CD56+ cells [#/volume] in Blood
Hepatitis A and B and C 7a panel - Serum
CD3 cells/100 cells in Cerebral spinal fluid
Curvularia specifera IgE Ab [Units/volume] in Serum
Soluble liver Ab [Presence] in Serum by Immunoassay
Azlocillin [Susceptibility] by Serum bactericidal titer
DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay
Hairy cells/100 leukocytes in Bone marrow
Human antimouse IgG Ab [Mass/volume] in Serum
Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain
Microscopic observation [Identifier] in Bronchial specimen by Cyto stain
Myelin associated glycoprotein/Sulfated glucuronic paragloboside Ab [Titer] in Serum
Nucleolar nuclear Ab pattern [Titer] in Body fluid
Smooth nuclear envelope nuclear Ab pattern [Titer] in Body fluid
Speckled nuclear Ab pattern [Titer] in Body fluid
Nucleated erythrocytes/100 cells in Bone marrow by Manual count
Chromium/Creatinine [Molar ratio] in Urine
Manganese/Creatinine [Molar ratio] in Urine
Thallium/Creatinine [Molar ratio] in Urine
Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum
Alpha subunit free [Units/volume] in Serum or Plasma
Benzodiazepine metabolites [Presence] in Urine by Screen method
Borrelia burgdorferi DNA [Presence] in Tick by NAA with probe detection
Borrelia burgdorferi 18kD IgG Ab [Presence] in Synovial fluid by Immunoblot
Borrelia burgdorferi 23kD Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 39kD IgG Ab [Presence] in Synovial fluid by Immunoblot
CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Cocaine+Benzoylecgonine [Presence] in Urine by Screen method
Ethanol [Presence] in Urine by Screen method
Hemoglobin A/Hemoglobin.total in Blood by HPLC
Hemoglobin A2/Hemoglobin.total in Blood by HPLC
Hemoglobin F/Hemoglobin.total in Blood by HPLC
Hemoglobin pattern [Interpretation] in Blood by HPLC Narrative
Hemoglobin.other/Hemoglobin.total in Blood by HPLC
levETIRAcetam [Presence] in Urine by Screen method
Variant lymphocytes/100 leukocytes in Blood by Automated count
Methadone+Metabolite [Presence] in Urine by Screen method
Methaqualone+Metabolite [Presence] in Urine by Screen method
Methylenedioxyamphetamine [Presence] in Urine
Nuclear Ab [Presence] in Serum by Immunofluorescence
Salmonella and Shigella sp identified in Specimen by Organism specific culture
Shigella boydii Ag [Presence] in Isolate
Shigella dysenteriae Ag [Presence] in Isolate
Shigella flexneri Ag [Presence] in Isolate
Shigella sonnei Ag [Presence] in Isolate
Polymyxin B [Susceptibility] by Serum bactericidal titer
APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RHD gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal
Foscarnet [Susceptibility] by Genotype method
GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells
Glutathione reductase phenotype [Interpretation] in Red Blood Cells
HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hepatitis B virus S+pol gene [Identifier] in Serum or Plasma by NAA with probe detection
RHD and RHCE gene alleles [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Drugs identified in Mother's milk by Screen method
Leukocytes [Presence] in Stool by Methylene blue stain
Bordetella pertussis IgA Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis IgM Ab [Units/volume] in Serum by Immunoassay
Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay
Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC)
Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum
HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC)
HTLV I p42 Ab [Presence] in Serum by Immunoblot
Neisseria meningitidis serogroups A+w135 Ag [Presence] in Body fluid
Toxoplasma gondii identified in Specimen by Other stain
Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB)
Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
cefTAZidime+Clavulanate [Susceptibility] by Gradient strip
Tigecycline [Susceptibility] by Gradient strip
Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Tigecycline [Susceptibility] by Disk diffusion (KB)
Streptococcus pneumoniae 14 serotypes IgG panel B [Mass/volume] - Serum
Streptococcus pneumoniae 14 serotypes IgG panel A [Mass/volume] - Serum
Streptococcus pneumoniae 12 serotypes IgG panel [Mass/volume] - Serum
Streptococcus pneumoniae 7 serotypes IgG panel B [Mass/volume] - Serum
Streptococcus pneumoniae 7 serotypes IgG panel A [Mass/volume] - Serum
Streptococcus pneumoniae 6 serotypes IgG panel [Mass/volume] - Serum
Streptococcus pneumoniae 4 serotypes IgG panel [Mass/volume] - Serum
Streptococcus pneumoniae 23 serotypes IgG panel [Mass/volume] - Serum
Streptococcus pneumoniae Danish serotype 19B IgG Ab [Mass/volume] in Serum
Neisseria meningitidis serogroup w135 Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup A Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup B Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup C Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup D Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup X Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup Y Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup Z Ag [Presence] in Isolate by Agglutination
Neisseria meningitidis serogroup Z' Ag [Presence] in Isolate by Agglutination
Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification
Protein.monoclonal [Mass/time] in 24 hour Urine by Electrophoresis
Protein.monoclonal/Protein.total in Urine by Electrophoresis
Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis
Aspergillus fumigatus 1 Ab [Presence] in Cerebral spinal fluid
Aspergillus fumigatus 6 Ab [Presence] in Cerebral spinal fluid
Aspergillus sp Ab [Titer] in Pleural fluid by Complement fixation
Aureobasidium pullulans Ab [Presence] in Cerebral spinal fluid
Blastomyces dermatitidis Ab [Titer] in Pleural fluid by Complement fixation
Cannabinoids [Presence] in Blood by Screen method
Carboxy tetrahydrocannabinol [Presence] in Blood
Catecholamines Free fractionated [Mass/volume] in Plasma
Coccidioides immitis Ab [Titer] in Pleural fluid by Complement fixation
Cytomegalovirus IgG Ab [Presence] in Cerebral spinal fluid
Echinococcus sp Ab [Presence] in Cerebral spinal fluid
Epstein Barr virus early Ab [Titer] in Cerebral spinal fluid
Epstein Barr virus nuclear Ab [Titer] in Cerebral spinal fluid
Fibrin D-dimer [Presence] in Cerebral spinal fluid
Fosamprenavir [Susceptibility] by Phenotype method
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid
Glycolate [Moles/volume] in Serum or Plasma
Hepatitis B virus surface Ab [Presence] in Cerebral spinal fluid
Hepatitis B virus surface Ag [Presence] in Cerebral spinal fluid
Hepatitis C virus Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunofluorescence
Histoplasma capsulatum Ab [Presence] in Pleural fluid by Immune diffusion (ID)
IgD [Mass/volume] in Cerebral spinal fluid
IgE [Units/volume] in Cerebral spinal fluid
Inhibin Ag [Presence] in Tissue by Immune stain
Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection
Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination
Methylmalonate [Moles/volume] in 24 hour Urine
Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid
Mitochondria Ab [Titer] in Cerebral spinal fluid
Mucus [Presence] in Stool by Light microscopy
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid
Parietal cell Ab [Titer] in Cerebral spinal fluid
Phenothiazines [Mass/volume] in Serum or Plasma
Pigeon serum Ab [Presence] in Cerebral spinal fluid
Smooth muscle Ab [Titer] in Cerebral spinal fluid
Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid
Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid
Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid
Tropheryma whipplei DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid
Hydroxyperhexiline [Mass/volume] in Serum or Plasma
Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma
18-Hydroxycorticosterone [Mass/volume] in Urine
Amphetamine [Mass/volume] in Blood by Confirmatory method
Artifact [Presence] in Urine sediment by Light microscopy
Aspergillus fumigatus IgM Ab [Units/volume] in Serum
Barbiturates [Mass/volume] in Blood by Confirmatory method
Benzodiazepines [Mass/volume] in Blood by Confirmatory method
BK virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection
Borrelia burgdorferi DNA [Presence] in Body fluid by NAA with probe detection
Pyrazinamide [Susceptibility] by Disk diffusion (KB)
Botrytis cinerea IgG Ab [Mass/volume] in Serum
Brucella abortus IgG Ab [Presence] in Cerebral spinal fluid
Calcium [Moles/volume] in Capillary blood
Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Corticotropin [Mass/volume] in Plasma --30 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma --1.5 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma --baseline
Corticotropin [Mass/volume] in Plasma --1 hour post XXX challenge
HIV 1+2 Ab [Presence] in Specimen by Immunoassay
Immune complex.IgG [Units/volume] in Synovial fluid by C1q binding assay
Tropheryma whipplei DNA [Presence] in Blood by NAA with probe detection
Glucose [Mass/volume] in Urine --3 hours post dose lactose PO
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Prolactin monomeric [Mass/volume] in Serum or Plasma
CD10+CD20+ cells/100 cells in Bone marrow
Glucose [Mass/volume] in Urine --6 hours post dose lactose PO
Salicylurate [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine --1 hour post dose lactose PO
Glucose [Mass/volume] in Urine --2 hours post dose lactose PO
Colorado tick fever virus Ab [Titer] in Cerebral spinal fluid
Glucose [Mass/volume] in Urine --30 minutes post dose lactose PO
Magnesium [Mass/volume] in Dialysis fluid
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification
Naloxone [Presence] in Urine by Screen method
Terminal deoxyribonucleotidyl transferase cells/100 cells in Bone marrow
Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection
CD13+CD56+ cells/100 cells in Bone marrow
Gastrin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge
Toxoplasma gondii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Glucose [Mass/volume] in Urine --4 hours post dose lactose PO
Glucose [Mass/volume] in Urine --5 hours post dose lactose PO
1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method
Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method
Urease [Presence] in Tissue --3 hours post incubation
Natriuretic peptide B [Mass/volume] in Blood
Prothrombin time (PT) in Platelet poor plasma by Coagulation 1:1 saline
Immune complex.IgG [Units/volume] in Serum or Plasma by C1q binding assay
Urease [Presence] in Tissue --1 day post incubation
Babesia sp DNA [Presence] in Specimen by NAA with probe detection
Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Alpha 2 laminin [Presence] in Tissue by Immune stain
Bacteria identified in Isolate by Pulsed-Field Gel Electrophoresis (PFGE)
Fat.neutral [#/area] in Pleural fluid by Microscopy high power field
Pyrazinamide [Susceptibility] by Serum bactericidal titer
Calcium hydrogen phosphate dihydrate [Saturation Fraction] in 24 hour Urine
Fat.neutral [#/area] in Urine by Microscopy high power field
Spermatozoa Normal Motile [#/volume] in Semen
Urate [Saturation Fraction] in 24 hour Urine
Succinyladenosine [Moles/volume] in Cerebral spinal fluid
AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gonadotropin releasing hormone [Mass] of Dose
AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection
Mycobacterium tuberculosis complex genotype [Identifier] in Isolate
Alkaline phosphatase.heat labile/Alkaline phosphatase.total in Serum or Plasma by Heat stability
Clindamycin.induced [Susceptibility] by Disk diffusion (KB)
Oxacillin Resistant Staphylococcus sp isolate [Presence] in Isolate by Latex agglutination
OmpC Ab [Presence] in Serum by Immunoassay
Cerebroside sulfatase [Enzymatic activity/volume] in 24 hour Urine
Fibrin D-dimer DDU [Mass/volume] in Cerebral spinal fluid by Latex agglutination
Cardiolipin IgA Ab B2GP1 dependent [Multiple of the median] in Serum
Cardiolipin IgA Ab B2GP1 independent [Multiple of the median] in Serum
Cardiolipin IgG Ab B2GP1 dependent [Multiple of the median] in Serum
Cardiolipin IgG Ab B2GP1 independent [Multiple of the median] in Serum
Cardiolipin IgM Ab B2GP1 dependent [Multiple of the median] in Serum
Cardiolipin IgM Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylcholine IgA Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylcholine IgA Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylcholine IgG Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylcholine IgG Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylcholine IgM Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylcholine IgM Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylethanolamine IgA Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylethanolamine IgA Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylethanolamine IgG Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylethanolamine IgG Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylethanolamine IgM Ab B2GP1 dependent [Multiple of the median] in Serum
rifAMPin [Susceptibility] by Minimum lethal concentration (MLC)
Phosphatidylethanolamine IgM Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylserine IgA Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylserine IgA Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylserine IgG Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylserine IgG Ab B2GP1 independent [Multiple of the median] in Serum
Phosphatidylserine IgM Ab B2GP1 dependent [Multiple of the median] in Serum
Phosphatidylserine IgM Ab B2GP1 independent [Multiple of the median] in Serum
Troponin I.cardiac [Mass/volume] in Blood
Inflammatory bowel disease Ab panel - Serum
Crystals [type] in Vitreous fluid by Light microscopy
Aspergillus sp Ab [Interpretation] in Serum by Immune diffusion (ID) Narrative
Borrelia burgdorferi IgG and IgM [Interpretation] in Cerebral spinal fluid
HIV 1 and 2 Ab [Interpretation] in Serum Narrative
HTLV I+II Ab [Interpretation] in Serum Narrative
Human papilloma virus high and Low risk DNA panel - Cervix
Streptococcus pneumoniae serotype IgG Ab [Interpretation] in Serum Narrative
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Nephelometry
Multiple drug resistant organism identified in Urine
Multiple drug resistant organism identified in Wound
Multiple drug resistant organism identified in Sputum
AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BRCA1 Ag [Presence] in Tissue by Immune stain
BRCA2 Ag [Presence] in Tissue by Immune stain
CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain
ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HER3 Ag [Presence] in Tissue by Immune stain
HER4 Ag [Presence] in Tissue by Immune stain
Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain
Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain
Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain
Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain
Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain
MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Retinoblastoma protein [Presence] in Tissue by Immune stain
Hemoglobin [Entitic mass] in Reticulocytes
Stachybotrys chartarum IgE Ab [Mass/volume] in Serum
Stachybotrys chartarum IgG Ab [Mass/volume] in Serum
rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)
11-Deoxycorticosterone [Mass/volume] in Urine
Benzoylecgonine [Mass/volume] in Blood by Confirmatory method
CD11c+CD19+ cells/100 cells in Bone marrow
CD25+CD19+ cells/100 cells in Bone marrow
CD3-CD16+ cells [#/volume] in Body fluid
CD3-CD16+ cells [#/volume] in Bone marrow
CD3-CD57+ cells [#/volume] in Bone marrow
Myeloperoxidase cells/100 cells in Body fluid
Choriogonadotropin [Units/volume] in Body fluid
Cladosporium herbarum IgG Ab [Mass/volume] in Serum
Clindamycin IgE Ab [Units/volume] in Serum
Colorado tick fever virus IgG Ab [Presence] in Serum by Immunofluorescence
Colorado tick fever virus IgM Ab [Titer] in Serum by Immunofluorescence
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunofluorescence
Cyclic citrullinated peptide IgG Ab [Presence] in Serum
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Dihydrocodeine [Mass/volume] in Serum or Plasma
Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
Epicoccum purpurascens IgG Ab [Mass/volume] in Serum
Formate/Creatinine [Mass Ratio] in 24 hour Urine
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS
Helminthosporium sp IgG Ab [Mass/volume] in Serum
Hematocrit [Volume Fraction] of Capillary blood
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --1st specimen
rifAMPin [Susceptibility] by Disk diffusion (KB)
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --2nd specimen
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --3rd specimen
Hemoglobin.gastrointestinal [Presence] in Specimen --2nd specimen
Hemoglobin.gastrointestinal [Presence] in Specimen --1st specimen
HER2 [Mass/volume] in Serum by Immunoassay
Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
Histoplasma capsulatum Ag [Units/volume] in Specimen by Immunoassay
HIV 1 RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Hydroflumethiazide [Mass/volume] in Serum or Plasma
Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO
Isovalerylcarnitine (C5) [Moles/volume] in DBS
JC virus DNA [Presence] in Specimen by NAA with probe detection
Lactate dehydrogenase panel - Serum or Plasma
Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection
Intercellular substance IgA Ab [Presence] in Serum by Immunofluorescence
Acetylcholine receptor blocking Ab/Acetylcholine Ab.total in Serum
CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method
GALT gene allele 1 [Presence] in Blood by Molecular genetics method
GALT gene allele 2 [Presence] in Blood by Molecular genetics method
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum
Vesicular stomatitis Indiana virus Ab [Titer] in Serum
Trypanosoma brucei rhodesiense Ab [Titer] in Serum
Taylorella equigenitalis Ab [Titer] in Serum
Snowshoe hare virus IgM Ab [Titer] in Serum
Semliki Forest virus Ab [Titer] in Serum
SARS coronavirus IgM Ab [Presence] in Serum
SARS coronavirus IgG Ab [Presence] in Serum
Salmonella typhimurium Ab [Titer] in Serum
Salmonella paratyphi C O Ab [Titer] in Serum
Salmonella paratyphi C H Ab [Titer] in Serum
Salmonella paratyphi B O Ab [Titer] in Serum
Saint Louis encephalitis virus IgM Ab [Presence] in Serum
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid
Rubella virus Ab [Titer] in Cerebral spinal fluid
Rickettsia rickettsii IgG Ab [Presence] in Serum
Rickettsia rickettsii IgM Ab [Presence] in Serum
Pseudallescheria boydii IgG Ab [Presence] in Serum
Powassan virus IgM Ab [Titer] in Specimen
Powassan virus IgG Ab [Titer] in Specimen
Porcine influenza virus A Ab [Titer] in Serum
Parainfluenza virus 4 IgG Ab [Presence] in Serum
Parainfluenza virus 1 Ab [Titer] in Serum --2nd specimen
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid by Immunofluorescence
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid
Leptospira sp Ab [Titer] in Cerebral spinal fluid
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum
Leishmania sp Ab [Presence] in Cerebral spinal fluid
Aztreonam [Susceptibility] by Minimum lethal concentration (MLC)
Leishmania brasilensis Ab [Titer] in Serum
Legionella sp Ab [Titer] in Cerebral spinal fluid
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid
Jamestown canyon virus IgM Ab [Titer] in Serum
Jamestown canyon virus IgG Ab [Titer] in Specimen
Jamestown canyon virus IgG Ab [Titer] in Serum
Jamestown canyon virus Ab [Titer] in Serum
HIV 1 gp120+gp160 Ab [Presence] in Serum
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid
Histoplasma capsulatum Ab [Presence] in Pleural fluid
Herpes virus 8 IgG Ab [Units/volume] in Serum
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid
Herpes simplex virus 2 Ab [Titer] in Serum
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum
Herpes simplex virus 1 Ab [Titer] in Serum
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid
Feline leukemia virus Ab [Titer] in Serum
Feline immunodeficiency virus Ab [Titer] in Serum
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid
Coxsackievirus A16 Ab [Titer] in Body fluid
Coxsackievirus A7 Ab [Titer] in Body fluid
Coxsackievirus A9 Ab [Titer] in Body fluid
Coxsackievirus A10 Ab [Titer] in Body fluid
Coxiella burnetii phase 1 Ab [Titer] in Serum
Colorado tick fever virus IgG Ab [Presence] in Serum
Coccidioides sp Ab [Presence] in Specimen
Coccidioides immitis Ab [Titer] in Pleural fluid
Clostridioides difficile toxin Ab [Titer] in Serum
Cladosporium sp IgG Ab [Presence] in Serum
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid
Campylobacter sp IgA Ab [Presence] in Serum
Burkholderia pseudomallei IgM Ab [Titer] in Specimen
Burkholderia pseudomallei IgG Ab [Titer] in Specimen
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid
Bovine leukemia virus Ab [Titer] in Serum
Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid
Borrelia burgdorferi C6 Ab [Units/volume] in Serum
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid
Borrelia burgdorferi Ab [Units/volume] in Specimen
Blastomyces dermatitidis Ab [Titer] in Pleural fluid
Aspergillus sp Ab [Titer] in Pleural fluid
rifAMPin [Susceptibility] by Serum bactericidal titer
Angiostrongylus costaricensis Ab [Presence] in Serum
Angiostrongylus cantonensis Ab [Presence] in Specimen
Eastern equine encephalitis virus IgM Ab [Presence] in Specimen
COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Vanillylmandelate and Creatinine panel - 24 hour Urine
Sjogrens syndrome-A and B extractable nuclear Ab panel - Serum
Phosphatidylserine IgA and IgG and IgM panel - Serum
Neuronal nuclear type 3 Ab [Presence] in Serum
Acetaldehyde and Paraldehyde panel [Mass/volume] - Serum or Plasma
Amitriptyline and Nortriptyline panel - Serum or Plasma
Mycoplasma sp and Ureaplasma sp panel - Specimen by Organism specific culture
Metanephrine and Normetanephrine panel [Mass/volume] - Serum or Plasma
Immunoglobulin light chains panel - 24 hour Urine
Herpes simplex virus 1 Ab [Presence] in Serum
Hemoglobin electrophoresis panel in Blood
Porphyrin fractions [Interpretation] in 24 hour Urine
Hexacarboxylporphyrin [Presence] in 24 hour Urine
Porphyrin fractions panel - 24 hour Urine
FLUoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma
Doxepin and Nordoxepin panel - Serum or Plasma
Imipramine and Desipramine panel - Serum or Plasma
Nicotine and Metabolites panel [Mass/volume] - Urine
clomiPRAMINE and Norclomipramine panel - Serum or Plasma
Brucella abortus IgG and IgM panel - Serum
Bile acid fractions panel [Moles/volume] - Serum or Plasma
Bacterial Ag panel - Cerebral spinal fluid
California encephalitis virus Ab [Units/volume] in Serum Qualitative
Allopurinol and Oxipurinol panel [Mass/volume] - Serum or Plasma
Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma
17-Ketosteroids and 17-Ketogenic steroids panel - 24 hour Urine
Synthetic glucocorticoid panel [Mass/volume] - Serum or Plasma
Spermatozoa [Presence] in Semen by Light microscopy --post concentration
Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post concentration
Formaldehyde [Mass/volume] in Nonbiological fluid
Microorganism [#/volume] in Specimen by Viability count
Quaternary ammonium compound [Mass/volume] in Specimen
Carbon.organic [Mass/volume] in Specimen
Ristocetin [Susceptibility] by Minimum lethal concentration (MLC)
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification
Interleukin 2 receptor [Units/volume] in Serum or Plasma
Triiodothyronine (T3) Ab [Presence] in Serum
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum by Immunofluorescence
Lithium [Moles/volume] in Saliva (oral fluid)
Phenmetrazine [Presence] in Hair by Screen method
Phentermine [Presence] in Hair by Screen method
Asialoganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay
Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay
Arsenic organic [Mass/volume] in 24 hour Urine
Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Cyanide [Mass/volume] in Blood by Confirmatory method
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method
HIV 1 and 2 Ab band pattern [Interpretation] in Serum by Immunoblot
Acylcarnitine/Carnitine.free (C0) [Molar ratio] in Urine
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence
Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum by Immunoassay
FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum by Immunofluorescence
Legionella non-pneumophila Ab [Titer] in Serum by Immunofluorescence
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method
Nicotine [Presence] in Urine by Confirmatory method
Cotinine [Mass/volume] in Serum or Plasma by Confirmatory method
Gamma hydroxybutyrate [Presence] in Urine by Screen method
Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method
Norfentanyl [Presence] in Urine by Confirmatory method
BK virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Parainfluenza virus 2 Ab [Units/volume] in Cerebral spinal fluid
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid by Complement fixation
Tetrachloroethylene [Mass/volume] in Urine
Invasive trophoblast Ag [Presence] in Serum or Plasma
Invasive trophoblast Ag [Multiple of the median] in Serum or Plasma
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by Probe with signal amplification
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by NAA with probe detection
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe
Albumin [Mass/volume] in Body fluid by Electrophoresis
Polychlorinated biphenyl (PCB) [Mass/volume] in Blood
Bacteria identified in Nasopharynx by Culture
Cortisol [Mass/volume] in Serum or Plasma --baseline
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Throat by NAA with probe detection
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose corticotropin IM
Nucleated erythrocytes [#/volume] in Synovial fluid by Manual count
Coccidioides sp Ab [Units/volume] in Serum by Complement fixation
Toxocara sp Ab [Units/volume] in Serum by Immunoassay
2-Hydroxyisocaproate [Presence] in Urine
Ova and parasites identified in Stool by Trichrome stain
Cryptococcus sp Ag [Presence] in Specimen by Latex agglutination
Cryptococcus sp Ag [Titer] in Specimen by Latex agglutination
Benzoylecgonine [Mass/volume] in Specimen
Histone Ab [Units/volume] in Serum by Immunoassay
Saint Louis encephalitis virus IgG Ab [Presence] in Serum
OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Liver kidney microsomal 1 IgG Ab [Presence] in Serum
Acrylylcarnitine (C3:1) [Moles/volume] in Serum or Plasma
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum by Immunoassay
Thrombopoietin [Mass/volume] in Platelet poor plasma by Immunoassay
Treponema pallidum Ab [Presence] in Serum from Donor by Immunofluorescence
Norsildenafil [Mass/volume] in Serum or Plasma
Ganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay
Ganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay
ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma
Herpes virus 6 DNA [Presence] in Serum by NAA with probe detection
Erythrocytes [#/volume] in Semen by Light microscopy
PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Catecholamines/Creatinine [Mass Ratio] in 24 hour Urine
EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine
X ray dye crystals [Presence] in Urine sediment by Light microscopy
Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)
Xanthine derivatives [Presence] in Urine
Leishmania chagasi K39 Ab [Presence] in Serum
Uranium depleted cutoff [Mass/volume] in Urine
Ceftobiprole [Susceptibility] by Disk diffusion (KB)
Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC)
Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)
CD19+CD27+IgD+ cells/100 cells in Blood or Tissue
CD3 cells/CD4 cells [# Ratio] in Specimen
GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Glucose [Mass/volume] in Milk --2 hours post meal
Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection
Hepatitis D virus Ag [Mass/volume] in Urine
Hepatitis D virus Ag [Mass/volume] in Serum
Heterophile Ab [Presence] in Control Serum
Spermatozoa IgA binding location [Identifier] in Semen
Spermatozoa IgM Ab/100 spermatozoa in Serum
Spermatozoa IgG Ab/100 spermatozoa in Serum
Spermatozoa IgG binding location [Identifier] in Semen
Spermatozoa IgA Ab/100 spermatozoa in Serum
Methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma
Neutrophil oxidative burst/unstimulated in Blood
Platelet glycoprotein Ab [Presence] in Serum by Immunoassay
Immune Complex C3d [Units/volume] in Serum or Plasma
Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection
Chromosome 21 trisomy [Percentile] by Cytogenetics
Desmoglein 1 and Desmoglein 3 Ab panel [Units/volume] - Serum
FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Avian adenovirus 127 Ab [Titer] in Serum by Hemagglutination inhibition
Avian paramyxovirus 6 Ab [Titer] in Serum by Hemagglutination inhibition
Avian paramyxovirus 7 Ab [Titer] in Serum by Hemagglutination inhibition
Avian paramyxovirus 8 Ab [Titer] in Serum by Hemagglutination inhibition
Avian paramyxovirus 9 Ab [Titer] in Serum by Hemagglutination inhibition
Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence
Avian metapneumovirus A Ab [Titer] in Serum by Immunoassay
Avian metapneumovirus B Ab [Presence] in Serum by Immunofluorescence
Avian metapneumovirus B Ab [Titer] in Serum by Immunoassay
Avian metapneumovirus C Ab [Presence] in Serum by Immunofluorescence
Avian metapneumovirus C Ab [Titer] in Serum by Immunoassay
Avian reovirus Ab [Presence] in Serum by Immunofluorescence
Chicken anemia virus Ab [Presence] in Serum by Immunofluorescence
Classical swine fever virus neutralizing antibody [Titer] in Serum by Neutralization test
Classical swine fever virus Ag [Presence] in Specimen by Immune stain
Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence
Eastern equine encephalitis virus Ab [Titer] in Serum by Complement fixation
Ristocetin [Susceptibility] by Disk diffusion (KB)
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunoassay
Ehrlichia risticii Ab [Titer] in Serum by Immunofluorescence
Equine herpesvirus 1 neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Equine herpesvirus 2 neutralizing antibody [Titer] in Serum by Neutralization test
Equine herpesvirus 3 neutralizing antibody [Titer] in Serum by Neutralization test
Fowl adenovirus Ab [Presence] in Serum by Immune diffusion (ID)
Goose parvovirus Ab [Presence] in Serum by Immunofluorescence
Goose parvovirus RNA [Presence] in Specimen by NAA with probe detection
Infectious bronchitis virus JMK Ab [Titer] in Serum by Hemagglutination inhibition
Porcine adenovirus Ab [Presence] in Serum by Immunofluorescence
Psittacid herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Immunoassay
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
West Nile virus IgM Ab [Titer] in Serum by Immunoassay
Avian adenovirus 127 Ab [Titer] in Serum
Avian paramyxovirus 6 Ab [Titer] in Serum
Avian paramyxovirus 7 Ab [Titer] in Serum
Avian paramyxovirus 8 Ab [Titer] in Serum
Avian paramyxovirus 9 Ab [Titer] in Serum
Avian metapneumovirus A Ab [Presence] in Serum
Avian metapneumovirus A Ab [Titer] in Serum
Avian metapneumovirus B Ab [Presence] in Serum
Avian metapneumovirus B Ab [Titer] in Serum
Avian metapneumovirus C Ab [Presence] in Serum
Avian metapneumovirus C Ab [Titer] in Serum
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum by Immunofluorescence
UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine
Bordetella sp Ag [Presence] in Specimen by Immunofluorescence
Cardiolipin IgA Ab [Mass/volume] in Serum
Cardiolipin IgG Ab [Mass/volume] in Serum
Cardiolipin IgM Ab [Mass/volume] in Serum
Enterovirus identified in Specimen by Immunofluorescence
Nocardia sp identified in Specimen by Organism specific culture
Parainfluenza virus Ag [Identifier] in Specimen by Immunofluorescence
Trichomonas sp [#/area] in Urine sediment by Microscopy low power field
Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal
PlA1 Ab [Presence] in Platelet rich plasma
CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method
Salmonella and Shigella sp identified in Stool by Organism specific culture
Spermatozoa Progressive [Presence] in Semen --post washing
Spermatozoa Progressive [Presence] in Semen --pre washing
Spermatozoa Motile [#/volume] in Semen --post washing
Coccidioides immitis IgG Ab [Units/volume] in Specimen
Bordetella pertussis Ab [Presence] in Specimen by Immunofluorescence
Alkaline phosphatase.heat stable/Alkaline phosphatase.total in Serum or Plasma by Heat stability
Neisseria sp identified in Throat by Organism specific culture
Neisseria sp identified in Urethra by Organism specific culture
Neisseria sp identified in Cervix by Organism specific culture
Neisseria sp identified in Anal by Organism specific culture
Neisseria sp identified in Specimen by Organism specific culture
Streptococcus sp identified in Isolate by Organism specific culture
Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma
Cholesterol in VLDL acylated [Mass/volume] in Serum or Plasma
Cholesterol non HDL [Mass/volume] in Serum or Plasma
Gardnerella vaginalis+Prevotella sp morphotypes [Presence] in Vaginal fluid by Light microscopy
JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method
Lactobacillus sp morphotypes [Presence] in Vaginal fluid by Light microscopy
Cryofibrinogen [Presence] in Plasma by 1 week 37 degree C incubation
Erythrocyte sedimentation rate by 15 minute reading
Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification
Chlamydia trachomatis DNA [Presence] in Specimen by Probe with signal amplification
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by Probe with signal amplification
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification
Bacteria identified in Wound deep by Culture
Bacteria identified in Tissue by Culture
Bacteria identified in Isolate by Culture
Ristocetin [Susceptibility] by Serum bactericidal titer
Bacteria identified in Cervix by Culture
Bacteria identified in Aspirate by Culture
Unidentified cells/100 cells in Bone marrow
Hematocrit [Volume Fraction] of Stem cell product
Microscopic observation [Identifier] in Esophageal brushing by Cyto stain
Tuberculosis reaction wheal [Diameter] --3 days post 1 TU intradermal
Uranium dose assessment [Interpretation] in Urine
Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells
Rabbit dander IgE Ab [Units/volume] in Serum
Sodium urate [Saturation Fraction] in 24 hour Urine
Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid
Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid
Bacteria identified in Nasopharynx by Aerobe culture
Microscopic observation [Identifier] in Tissue by Rapid stain
Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain
Haemophilus influenzae B Ag [Presence] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Serum
Escherichia coli K1 Ag [Presence] in Serum
Escherichia coli K1 Ag [Presence] in Urine
Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid
Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid
Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid
Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum
Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum
Bartonella henselae and Bartonella quintana IgM panel [Titer] - Serum
Bacteria identified in Bronchoalveolar lavage by Aerobe culture
Bacteria identified in Bronchial brush by Aerobe culture
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoblot
Complement C3 [Mass/volume] in Pericardial fluid
Acylcarnitine/Carnitine.free (C0) [Ratio] in Urine
Complement C3 [Mass/volume] in Peritoneal fluid
Complement C3 [Mass/volume] in Pleural fluid
Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC)
Complement C4 [Mass/volume] in Pericardial fluid
Complement C4 [Mass/volume] in Peritoneal fluid
Complement C4 [Mass/volume] in Pleural fluid
Lipoprotein a [Moles/volume] in Serum or Plasma
Bizarre cells [Presence] in Blood by Light microscopy
TYMP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Yersinia pseudotuberculosis Ab [Presence] in Cerebral spinal fluid
Varicella zoster virus IgM Ab [Presence] in Serum by Immunofluorescence
Rabies virus Ab [Units/volume] in Serum by Immunoassay
Plasmodium malariae IgG Ab [Titer] in Serum
Inner ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot
HIV 1 Ab [Units/volume] in Serum by Immunofluorescence
Ganglioside GD1b IgM Ab [Presence] in Serum
Ganglioside GD1b IgG Ab [Presence] in Serum
Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay
Androstenedione [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Microalbumin [Mass/volume] in 4 hour Urine
Microalbumin [Mass/time] in 4 hour Urine
Microalbumin [Mass/time] in 12 hour Urine
Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence
Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence
Adenovirus Ag [Presence] in Nose by Immunofluorescence
Adenovirus Ag [Presence] in Trachea by Immunofluorescence
Adenovirus Ag [Presence] in Genital specimen
Adenovirus Ab [Presence] in Cerebral spinal fluid
Adenovirus Ab [Presence] in Serum by Complement fixation
Actinomyces israelii Ab [Presence] in Serum
Actinomyces bovis Ab [Presence] in Serum
Acetylcholine receptor blocking Ab [Presence] in Serum
Acetylcholine receptor binding Ab [Presence] in Serum
Acetylcholine receptor Ab [Presence] in Serum
Acetohexamide [Presence] in Serum or Plasma
Acetazolamide [Presence] in Serum or Plasma
Acetaminophen crystals [Presence] in Urine sediment by Light microscopy
8-Hydroxyamoxapine [Presence] in Serum or Plasma
6-Thioguanine [Presence] in Red Blood Cells
6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells
6-Methylmercaptopurine [Presence] in Red Blood Cells
5-Oxoproline [Presence] in 24 hour Urine
3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine
2-Hydroxyglutarate [Presence] in 24 hour Urine
Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method
Parrot droppings IgG Ab [Presence] in Serum
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Fatty acid comprehensive (C8-C26) panel - Serum or Plasma
Fatty acid mitochondrial (C8-C18) panel - Serum or Plasma
Fatty acid essential (C12-C22) panel - Serum or Plasma
Fatty acid very long chain (C22-C26) panel - Serum or Plasma
Salivary gland IgA Ab [Units/volume] in Saliva (oral fluid)
Powassan virus polyvalent E Ab [Presence] in Specimen by Immunoassay
16-Alpha hydroxypregnenolone/Creatinine [Mass Ratio] in Urine
Cladosporium sp IgE Ab [Presence] in Serum
Varicella zoster virus identified in Skin by Shell vial culture
Inner ear 68kD Ab [Presence] in Body fluid
Herpes virus identified in Specimen by Shell vial culture
Herpes simplex virus identified in Cerebral spinal fluid by Shell vial culture
Herpes simplex virus identified in Specimen by Shell vial culture
Enterovirus identified in Specimen by Shell vial culture
Enterovirus identified in Cerebral spinal fluid by Shell vial culture
Cytomegalovirus [Presence] in Urine by Shell vial culture
Cytomegalovirus [Presence] in Specimen by Shell vial culture
Cytomegalovirus [Presence] in Cerebral spinal fluid by Shell vial culture
Cytomegalovirus [Presence] in Blood by Shell vial culture
Cytomegalovirus [Presence] in Body fluid by Shell vial culture
Cytomegalovirus [Presence] in Bone marrow by Shell vial culture
Cytomegalovirus [Presence] in Anal by Shell vial culture
Cytomegalovirus [Presence] in Tissue by Shell vial culture
Alkaline phosphatase.liver+bone [Presence] in Serum or Plasma
Alkaline phosphatase.intestinal+renal [Presence] in Serum or Plasma
Alkaline phosphatase.heat stable [Presence] in Serum or Plasma by Heat stability
Albumin [Presence] in Cerebral spinal fluid
Prostatic acid phosphatase [Presence] in Serum
Acetaminophen+oxyCODONE [Presence] in Serum or Plasma
Acetaminophen+Codeine [Presence] in Serum or Plasma
Acetaldehyde+Paraldehyde [Presence] in Serum or Plasma
5-Ethyl-5-Phenylhydantoin [Presence] in Specimen
5,10-Methylenetetrahydrofolate reductase [Presence] in Serum
17-Ketogenic steroids [Presence] in 24 hour Urine
Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma
Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma
Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Alkaline phosphatase.fetal+lung+lymphocyte [Presence] in Serum or Plasma
4-Hydroxybenzoate [Presence] in 24 hour Urine
aPTT in Platelet poor plasma by Coagulation 1:1 saline
Fosamprenavir [Susceptibility] by Genotype method
Tipranavir [Susceptibility] by Genotype method
Blood group Ag [Interpretation] on Red Blood Cells from Blood product unit
Rolitetracycline [Susceptibility] by Disk diffusion (KB)
Glucose/Insulin [Mass Ratio] in Serum or Plasma
Variant lymphocytes [#/volume] in Blood by Automated count
COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Moxifloxacin [Mass/volume] in Serum or Plasma
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence
Spermatozoa IgM binding location [Identifier] in Semen
Sulfate [Mass/volume] in Urine collected for unspecified duration
Casts [#/area] in Urine sediment by Automated count
Alpha-1-Fetoprotein [Presence] in Amniotic fluid
Choriogonadotropin.beta subunit [Presence] in Specimen
Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid
Choriogonadotropin.intact [Units/volume] in Amniotic fluid
Estriol (E3) [Mass/volume] in 24 hour Urine
Estriol (E3) [Multiple of the median] adjusted in Serum or Plasma
Amino acid pattern [Interpretation] in Cerebral spinal fluid
Urease [Presence] in Tissue --1 hour post incubation
Urease [Presence] in Tissue --20 minutes post incubation
Urease [Presence] in Tissue --4 hours post incubation
Urease [Presence] in Tissue --30 minutes post incubation
Rubella virus Ab [Presence] in Serum by Immunoassay
Basement membrane IgG Ab [Presence] in Serum by Immunoassay
Androstenedione [Presence] in Serum or Plasma
Beta-2-Microglobulin [Presence] in Serum
Beta-2-Microglobulin [Presence] in Urine
Rolitetracycline [Susceptibility] by Serum bactericidal titer
Bilirubin.direct [Presence] in Serum or Plasma
Aspartate aminotransferase [Presence] in Body fluid
Aspergillus glaucus Ab [Presence] in Serum by Immune diffusion (ID)
Bilirubin.total [Presence] in Body fluid
Androstanolone [Presence] in Serum or Plasma
Tetrahydrocannabinol [Presence] in Specimen
Apolipoprotein E [Presence] in Serum or Plasma
Beta globulin [Presence] in Serum or Plasma by Electrophoresis
Influenza virus A IgG Ab [Presence] in Serum
Influenza virus A IgM Ab [Presence] in Serum
Influenza virus B IgG Ab [Presence] in Serum
Influenza virus B IgM Ab [Presence] in Serum
Borrelia burgdorferi Ab [Titer] in Serum by Immunoassay
Brucella abortus IgG Ab [Units/volume] in Serum by Immunoassay
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence
Chlamydophila pneumoniae Ab [Titer] in Serum by Immunofluorescence
Chlamydophila sp Ab [Interpretation] in Serum
Chlamydophila sp Ab [Presence] in Serum by Immunofluorescence
Chlamydia trachomatis IgG Ab [Presence] in Serum
Coccidioides sp IgG Ab [Presence] in Serum by Immunoassay
Coccidioides sp IgM Ab [Presence] in Serum by Immunoassay
Influenza virus A IgA Ab [Presence] in Serum
Influenza virus B IgA Ab [Presence] in Serum
Legionella pneumophila 1+3+4+5+6+8 IgM Ab [Presence] in Serum
Mycobacterium sp rRNA [Presence] in Specimen by Probe
Urease [Presence] in Tissue --2 hours post incubation
Benztropine [Presence] in Serum or Plasma
Beta-2 transferrin [Presence] in Specimen
Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method
Asialoganglioside GM1 Ab [Presence] in Serum
Benzthiazide [Presence] in 24 hour Urine
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Blastomyces dermatitidis IgG Ab [Presence] in Serum by Immunoassay
Chlamydophila psittaci IgG Ab [Presence] in Serum
Antithrombin Ag [Presence] in Platelet poor plasma by Immunoassay
Aspergillus sp Ab [Presence] in Serum by Complement fixation
Aspergillus sp IgA Ab [Presence] in Serum
Aspergillus sp IgG Ab [Presence] in Serum
Aspergillus sp IgM Ab [Presence] in Serum
Influenza virus A Ag [Presence] in Nasopharynx
Basement membrane IgM Ab [Presence] in Serum
Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture
Bordetella pertussis filamentous hemagglutinin IgA Ab [Presence] in Serum
Bordetella pertussis filamentous hemagglutinin IgG Ab [Presence] in Serum
Bordetella pertussis filamentous hemagglutinin IgM Ab [Presence] in Serum
Ampicillin [Presence] in Serum or Plasma
Bilirubin.total [Presence] in Amniotic fluid by Spectrophotometry direct
Bordetella pertussis [Presence] in Sputum by Organism specific culture
Bordetella pertussis Ag [Presence] in Sputum by Immunofluorescence
Babesia microti IgG Ab [Presence] in Serum
Influenza virus B Ag [Presence] in Nasopharynx
Bordetella pertussis [Presence] in Pleural fluid by Organism specific culture
Beta hydroxybutyrate [Presence] in 24 hour Urine
Beta lipotropin [Presence] in Serum or Plasma
Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC)
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Complement fixation
Azinphos-methyl [Presence] in Serum or Plasma
Argininosuccinate [Presence] in Serum or Plasma
Avian encephalomyelitis virus Ab [Presence] in Cerebral spinal fluid
Bordetella pertussis Ag [Presence] in Nasopharynx
Aspergillus versicolor Ab [Presence] in Serum
Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection
Beta 2 glycoprotein 1 IgG Ab [Presence] in Serum
Beta 2 glycoprotein 1 IgA Ab [Presence] in Serum
Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum
Beta-2-Microglobulin [Presence] in Cerebral spinal fluid
Bartonella sp IgG Ab [Presence] in Serum
Bartonella sp IgM Ab [Presence] in Serum
Beta endorphin [Presence] in Serum or Plasma
Beta hydroxybutyrate [Presence] in Serum or Plasma
azaTHIOprine [Presence] in Serum or Plasma
Bordetella parapertussis [Presence] in Specimen by Organism specific culture
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunofluorescence
Yersinia enterocolitica Ab [Presence] in Cerebral spinal fluid
California encephalitis virus Ab [Titer] in Serum
Amphetamines [Mass/mass] in Meconium by Confirmatory method
Alkaline phosphatase.liver [Presence] in Serum or Plasma
Kappa light chains.free [Mass/volume] in 24 hour Urine
Insulin Free [Mass/volume] in Serum or Plasma
CD4+CD45+ cells/100 cells in Bone marrow
CD4+CD45RO+ cells/100 cells in Body fluid
CD4+CD45RO+ cells/100 cells in Cerebral spinal fluid
CD2 cells [#/volume] in Cerebral spinal fluid
CD4+CD45RO+ cells [#/volume] in Bone marrow
CD4+CD45RO+ cells [#/volume] in Cerebral spinal fluid
CD4+CD45RO+ cells [#/volume] in Body fluid
CD4+CD45RO+ cells [#/volume] in Specimen
CD3+HLA-DR+ cells [#/volume] in Bone marrow
CD3+HLA-DR+ cells [#/volume] in Cerebral spinal fluid
CD3+HLA-DR+ cells [#/volume] in Body fluid
CD3+HLA-DR+ cells [#/volume] in Specimen
CD4+CD45RA+ cells/100 cells in Bone marrow
CD4+CD45RA+ cells/100 cells in Cerebral spinal fluid
CD4+CD45RA+ cells/100 cells in Body fluid
CD3+CD25+ cells/100 cells in Cerebral spinal fluid
CD3+HLA-DR+ cells/100 cells in Cerebral spinal fluid
CD3+CD4+ (T4 helper) cells/100 cells in Cerebral spinal fluid
CD3+CD8+ (T8 suppressor) cells/100 cells in Cerebral spinal fluid
CD19 cells [#/volume] in Cerebral spinal fluid
Coccidioides sp Ab [Presence] in Serum by Immune diffusion (ID)
Measles virus Ab [Presence] in Serum by Immunoassay
Varicella zoster virus Ab [Presence] in Serum by Immunoassay
Aspergillus sp identified in Specimen by Organism specific culture
Rabies virus neutralizing antibody [Titer] in Serum by Neutralization test
Choriogonadotropin.intact [Multiple of the median] adjusted in Serum or Plasma
Choriogonadotropin.intact [Multiple of the median] in Serum or Plasma
Amphetamines [Presence] in Urine by Screen method >500 ng/mL
Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL
Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL
Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Anaplasma phagocytophilum Ab [Interpretation] in Serum by Immunofluorescence
Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma
Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma
Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma
Choriogonadotropin [Multiple of the median] in Amniotic fluid
Choriogonadotropin [Units/volume] in Amniotic fluid
Choriogonadotropin [Units/volume] in Cerebral spinal fluid
Choriogonadotropin [Multiple of the median] adjusted in Amniotic fluid
Choriogonadotropin.beta subunit free [Multiple of the median] in Amniotic fluid
Estriol (E3).unconjugated [Multiple of the median] in Amniotic fluid
Chlamydia trachomatis D and K IgA and IgG and IgM [Interpretation] in Serum
Coxiella burnetii phase 1 and 2 IgG and IgM [Interpretation] in Serum
CD55 and CD59 RBC [Interpretation] in Blood
Herpes simplex virus 1 and 2 IgM Ab [Interpretation] in Serum
Herpes simplex virus 1 and 2 IgG Ab [Interpretation] in Serum by Immunoassay
Influenza virus A and B Ab [Interpretation] in Body fluid
Measles virus IgG and IgM [Interpretation] in Cerebral spinal fluid
Measles virus IgG and IgM [Interpretation] in Serum
Metanephrine and Normetanephrine [Interpretation] in Urine
Helicobacter pylori [Presence] in Gastric fluid by Organism specific culture
Blasts [Presence] in Blood by Light microscopy
Basophils [Presence] in Body fluid by Light microscopy
Bordetella parapertussis Ab [Presence] in Body fluid
Borrelia burgdorferi Ab [Presence] in Synovial fluid by Immunoblot
Coxiella burnetii Ab [Interpretation] in Serum
Bacteria [Presence] in Cervix by Wet preparation
Bacteria [Presence] in Vaginal fluid by Wet preparation
Aspergillus flavus B Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus flavus H Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus fumigatus B Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus fumigatus H Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus nidulans B Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus nidulans H Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus niger B Ab [Presence] in Serum by Immune diffusion (ID)
Aspergillus niger H Ab [Presence] in Serum by Immune diffusion (ID)
Bilirubin.total [Presence] in 24 hour Urine by Test strip
Analgesics Non-narcotic [Presence] in Serum or Plasma
Analgesics Non-narcotic [Presence] in Urine
Bacteria [Presence] in Eye by Light microscopy
Basophils [Presence] in Cerebral spinal fluid by Light microscopy
Basophils [Presence] in Synovial fluid by Light microscopy
Basophils [Presence] in Pericardial fluid by Light microscopy
Basophils [Presence] in Pleural fluid by Light microscopy
Basophils [Presence] in Peritoneal fluid by Light microscopy
Aspergillus fumigatus O Ab [Presence] in Serum
Bordetella pertussis Higashi-Hama Ab [Units/volume] in Serum
Bordetella pertussis Yamaguchi Ab [Presence] in Serum
Basophils [Presence] in Nose by Light microscopy
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method
Glucose phosphate isomerase [Enzymatic activity/mass] in Red Blood Cells
Adenylate kinase [Enzymatic activity/mass] in Red Blood Cells
Phosphofructokinase [Enzymatic activity/mass] in Blood
Phosphoglycerate kinase [Enzymatic activity/mass] in Red Blood Cells
Triosephosphate isomerase [Enzymatic activity/mass] in Red Blood Cells
Pyrimidine-5'-Nucleotidase [Enzymatic activity/mass] in Blood
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Bone marrow
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Cerebral spinal fluid
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Body fluid
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Tissue
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Specimen
CD20+FMC7+ cells/100 cells in Bone marrow
CD20+FMC7+ cells/100 cells in Cerebral spinal fluid
CD20+FMC7+ cells/100 cells in Body fluid
CD20+FMC7+ cells [#/volume] in Bone marrow
CD20+FMC7+ cells [#/volume] in Cerebral spinal fluid
CD20+FMC7+ cells [#/volume] in Body fluid
CD20+CD52+ cells/100 cells in Bone marrow
CD20+CD52+ cells/100 cells in Cerebral spinal fluid
CD20+CD52+ cells/100 cells in Body fluid
Arbovirus Ab [Interpretation] in Serum by Immunofluorescence
Bilirubin casts [Presence] in Urine sediment by Light microscopy
Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma
Brucella canis IgG and IgM [Interpretation] in Serum
Catecholamines [Interpretation] in Urine
Chlamydia trachomatis IgA and IgG and IgM [Interpretation] in Serum
Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Chlamydophila pneumoniae IgG and IgM [Interpretation] in Serum
Chlamydophila psittaci IgA and IgG and IgM [Interpretation] in Serum
Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum
Extractable nuclear Ab [Interpretation] in Serum
Fatty acids pattern [Interpretation] in Serum or Plasma
Xylose absorption [Interpretation] in Urine and Serum or Plasma
ABO and Rh group [Interpretation] in Blood from Newborn
Escherichia coli O157 Ag [Presence] in Specimen
Escherichia coli O157:H7 DNA [Identifier] in Specimen by NAA with probe detection
Escherichia coli O157:H7 [Identifier] in Specimen by Organism specific culture
Escherichia coli O157:H7 [Presence] in Isolate by Organism specific culture
Leukocytes [#/area] in Vaginal fluid by Wet preparation
Neisseria meningitidis [Identifier] in Isolate by Organism specific culture
Epithelial cells.squamous [#/area] in Vaginal fluid by Light microscopy
Unidentified cells/100 leukocytes in Blood by Manual count
Unidentified cells/100 leukocytes in Blood by Automated count
Unidentified cells/100 leukocytes in Blood
Microscopic observation [Identifier] in Specimen by Wayson stain
Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay
Rosoxacin [Susceptibility] by Disk diffusion (KB)
Rosoxacin [Susceptibility] by Serum bactericidal titer
Clue cells [#/area] in Vaginal fluid by Microscopy low power field
Erythrocytes [#/area] in Vaginal fluid by Wet preparation
Bacteria [#/area] in Vaginal fluid by Wet preparation
Trichomonas vaginalis [#/area] in Vaginal fluid by Wet preparation
Fungi.filamentous [#/area] in Vaginal fluid by Wet preparation
Yeast [#/area] in Vaginal fluid by Wet preparation
Spermatozoa Motile [#/area] in Vaginal fluid by Wet preparation
Spermatozoa Immotile [#/area] in Vaginal fluid
Influenza virus A RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A H5 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A H6 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A H7 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Avian paramyxovirus 1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Avian paramyxovirus 1.exotic RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Bacillus anthracis cell wall Ag [Presence] in Specimen by Immunofluorescence
Bacillus anthracis spore Ag [Presence] in Specimen by Immunofluorescence
Brucella sp Ag [Identifier] in Specimen by Immunofluorescence
Cache valley virus neutralizing antibody [Titer] in Serum by Neutralization test
Classical swine fever virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Clostridium botulinum toxin [Identifier] in Specimen by Immunoassay
Coxiella burnetii [Presence] in Specimen by Light microscopy
Equine adenovirus Ag [Titer] in Serum by Neutralization test
15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine [Mass Ratio] in Urine
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Mass Ratio] in Urine
16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone [Mass Ratio] in Urine
17 Alpha-hydroxypregnanolone/Creatinine [Mass Ratio] in Urine
17-Ketosteroids/Creatinine [Mass Ratio] in 24 hour Urine
2-Methylcitrate/Creatinine [Molar ratio] in 24 hour Urine
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine
3-Methylhistidine/Creatinine [Mass Ratio] in 24 hour Urine
5-Hydroxyhexanoate/Creatinine [Mass Ratio] in 24 hour Urine
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine
Adenovirus Ab [Units/volume] in Serum by Complement fixation
Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine
Albumin/Globulin [Mass Ratio] in Urine by Electrophoresis
Albumin/Globulin [Mass Ratio] in 24 hour Urine by Electrophoresis
Aldosterone/Creatinine [Mass Ratio] in 24 hour Urine
Alpha aminobutyrate/Creatinine [Mass Ratio] in 24 hour Urine
Androsterone/Creatinine [Mass Ratio] in 24 hour Urine
Arginine/Creatinine [Mass Ratio] in 24 hour Urine
Arsenic.inorganic/Creatinine [Mass Ratio] in 24 hour Urine
Asparagine/Creatinine [Mass Ratio] in 24 hour Urine
Aspartate/Creatinine [Mass Ratio] in 24 hour Urine
Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine
Carnosine/Creatinine [Mass Ratio] in 24 hour Urine
Chloral hydrate/Creatinine [Mass Ratio] in Urine
Citrate/Creatinine [Mass Ratio] in 24 hour Urine
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine by Immunoassay
Cortisol Free/Creatinine [Mass Ratio] in Urine
Cortisol/Creatinine [Mass Ratio] in 24 hour Urine
Cotinine/Creatinine [Mass Ratio] in Urine
Cystine/Creatinine [Mass Ratio] in 24 hour Urine
Delta aminolevulinate/Creatinine [Mass Ratio] in 24 hour Urine
D-Lactate/Creatinine [Molar ratio] in Urine
DOPamine/Creatinine [Mass Ratio] in 24 hour Urine
Insulin.bound [Presence] in Serum or Plasma
Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC)
Interferon alpha [Presence] in Serum or Plasma
Interleukin 5 [Presence] in Serum or Plasma
Interleukin 6 [Presence] in Serum or Plasma
Iodine.inorganic [Presence] in Serum or Plasma
Isoleucine/Creatinine [Mass Ratio] in 24 hour Urine
Isovalerylglycine/Creatinine [Mass Ratio] in 24 hour Urine
Jo-1 extractable nuclear IgG Ab [Presence] in Serum
Lactate/Creatinine [Mass Ratio] in 24 hour Urine
Leucine/Creatinine [Mass Ratio] in 24 hour Urine
Lysine/Creatinine [Mass Ratio] in 24 hour Urine
Magnesium/Creatinine [Mass Ratio] in 24 hour Urine
Metanephrine Free/Creatinine [Mass Ratio] in Urine
Methionine/Creatinine [Mass Ratio] in 24 hour Urine
N-methylhistamine/Creatinine [Mass Ratio] in 24 hour Urine
Norepinephrine/Creatinine [Mass Ratio] in 24 hour Urine
Normetanephrine/Creatinine [Mass Ratio] in 24 hour Urine
Ornithine/Creatinine [Mass Ratio] in 24 hour Urine
Orotate/Creatinine [Molar ratio] in 24 hour Urine
Phenol/Creatinine [Molar ratio] in Urine
Phenol/Creatinine [Molar ratio] in 24 hour Urine
Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine
Phenylalanine/Creatinine [Mass Ratio] in Urine
Phosphoethanolamine/Creatinine [Molar ratio] in 24 hour Urine
Phosphoethanolamine/Creatinine [Mass Ratio] in 24 hour Urine
Porphyrins/Creatinine [Mass Ratio] in 24 hour Urine
Ethylmalonate/Creatinine [Mass Ratio] in 24 hour Urine
Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine
Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay
Glutamate/Creatinine [Mass Ratio] in 24 hour Urine
Glutamate+Glutamine/Creatinine [Molar ratio] in Urine
Glutamate+Glutamine/Creatinine [Mass Ratio] in Urine
Glutamine/Creatinine [Mass Ratio] in 24 hour Urine
Glutarate/Creatinine [Mass Ratio] in 24 hour Urine
Glutarate/Creatinine [Molar ratio] in 24 hour Urine
Glycine/Creatinine [Mass Ratio] in 24 hour Urine
Glycosaminoglycans/Creatinine [Mass Ratio] in 24 hour Urine
Glycosaminoglycans/Creatinine [Molar ratio] in Urine
Hexanoylglycine/Creatinine [Mass Ratio] in 24 hour Urine
Hippurate/Creatinine [Mass Ratio] in 24 hour Urine
Histamine/Creatinine [Molar ratio] in Urine
Histidine/Creatinine [Mass Ratio] in 24 hour Urine
Homocysteine [Presence] in Serum or Plasma
Homocysteine/Creatinine [Molar ratio] in 24 hour Urine
Homocystine/Creatinine [Mass Ratio] in 24 hour Urine
Hyaline casts.broad [Presence] in Urine sediment by Light microscopy
hydroCHLOROthiazide [Presence] in 24 hour Urine
Hydroflumethiazide [Presence] in 24 hour Urine
Hydroxyproline/Creatinine [Mass Ratio] in 24 hour Urine
Hypnotics [Presence] in Gastric fluid by Screen method
IgA [Presence] in 24 hour Urine by Immunofixation
Immune complex [Presence] in Serum or Plasma by C1q binding assay
Immune complex [Presence] in Serum or Plasma by Raji cell assay
Immune complex [Presence] in Serum or Plasma
Kappa light chains [Presence] in 24 hour Urine
Lambda light chains [Presence] in 24 hour Urine
Proline/Creatinine [Mass Ratio] in 24 hour Urine
Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Pyruvate/Creatinine [Mass Ratio] in 24 hour Urine
Selenium/Creatinine [Molar ratio] in 24 hour Urine
Serine/Creatinine [Mass Ratio] in 24 hour Urine
Silicon/Creatinine [Mass Ratio] in Urine
Sodium/Creatinine [Molar ratio] in 24 hour Urine
Sodium/Potassium [Molar ratio] in 24 hour Urine
Somatotropin/Creatinine [Mass Ratio] in Urine
Suberate/Creatinine [Molar ratio] in 24 hour Urine
Succinate/Creatinine [Molar ratio] in 24 hour Urine
Superoxide dismutase [Presence] in Plasma
Taurine/Creatinine [Mass Ratio] in 24 hour Urine
Tetrahydrodeoxycortisol/Creatinine [Mass Ratio] in Urine
Threonine/Creatinine [Mass Ratio] in 24 hour Urine
Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine
Tyrosine/Creatinine [Mass Ratio] in 24 hour Urine
Urea nitrogen/Creatinine [Mass Ratio] in Urine
Valine/Creatinine [Mass Ratio] in 24 hour Urine
Vanillylmandelate/Creatine [Mass Ratio] in 24 hour Urine
CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Interleukin 2 receptor alpha chain soluble [Units/volume] in Serum or Plasma
Herpes virus 7 DNA [Presence] in Specimen by NAA with probe detection
Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine
3-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine
Adenosine monophosphate.cyclic.nephrogenous/Creatinine [Molar ratio] in Urine
Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis
Alpha cortolone/Creatinine [Mass Ratio] in Urine
Annexin V IgG Ab [Units/volume] in Serum or Plasma
Annexin V IgM Ab [Units/volume] in Serum or Plasma
Other Antibiotic [Mass/volume] in Serum or Plasma --peak
Other Antibiotic [Mass/volume] in Serum or Plasma --trough
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum by Immunoassay
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum by Immunoassay
Ascaris sp IgG Ab [Units/volume] in Serum
Aspergillus fumigatus 1 Ab [Units/volume] in Serum
Aspergillus fumigatus 3 Ab [Units/volume] in Serum
Aspergillus fumigatus 6 Ab [Units/volume] in Serum
Aspergillus niger Ab [Units/volume] in Serum by Complement fixation
Bartonella henselae Ab [Units/volume] in Serum by Immunoassay
Bartonella sp IgG Ab [Units/volume] in Serum by Immunoassay
Bartonella sp IgM Ab [Units/volume] in Serum by Immunoassay
Basement membrane IgA Ab [Units/volume] in Serum
Basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Beta cortolone/Creatinine [Mass Ratio] in Urine
Blastomyces dermatitidis Ab [Units/volume] in Serum by Complement fixation
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoblot
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi Ab [Units/volume] in Synovial fluid
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay --1st specimen
Borrelia burgdorferi Ab [Units/volume] in Serum --1st specimen
Brucella abortus IgG+IgM Ab [Units/volume] in Serum
C peptide/Creatinine [Mass Ratio] in Urine --2nd specimen post XXX challenge
Cladosporium herbarum Ab [Presence] in Serum by Immune diffusion (ID)
American house dust mite Ab [Presence] in Serum by Immune diffusion (ID)
Insulin Free+Bound [Presence] in Serum or Plasma
Herpes simplex virus 1 [Presence] in Vaginal fluid by Organism specific culture
Herpes simplex virus 1 [Presence] in Skin by Organism specific culture
Herpes simplex virus 1 [Presence] in Genital specimen by Organism specific culture
Herpes simplex virus 1 [Presence] in Throat by Organism specific culture
Herpes simplex virus 1 [Presence] in Cervix by Organism specific culture
Herpes simplex virus 1 [Presence] in Anal by Organism specific culture
Herpes simplex virus 1 Ab [Presence] in Body fluid
Herpes simplex virus 1 Ag [Presence] in Anal
Herpes simplex virus 1 Ag [Presence] in Cervix
Herpes simplex virus 1 Ag [Presence] in Eye
Herpes simplex virus 1 Ag [Presence] in Penis
Herpes simplex virus 1 Ag [Presence] in Throat
Herpes simplex virus 1 Ag [Presence] in Tissue
Herpes simplex virus 1 Ag [Presence] in Urethra
Herpes simplex virus 1 Ag [Presence] in Vaginal fluid
Herpes simplex virus 1 DNA [Presence] in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 1+2 Ab [Presence] in Serum
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 1+2 IgG Ab [Presence] in Body fluid
Herpes simplex virus 1+2 IgM Ab [Presence] in Body fluid
Herpes simplex virus 2 [Presence] in Specimen by Organism specific culture
Herpes simplex virus 2 [Presence] in Vaginal fluid by Organism specific culture
Herpes simplex virus 2 [Presence] in Skin by Organism specific culture
Herpes simplex virus 2 [Presence] in Genital specimen by Organism specific culture
Herpes simplex virus 2 [Presence] in Throat by Organism specific culture
Herpes simplex virus 2 [Presence] in Cervix by Organism specific culture
Herpes simplex virus 2 [Presence] in Anal by Organism specific culture
Herpes simplex virus 2 Ab [Presence] in Body fluid
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay
Herpes simplex virus 2 Ag [Presence] in Eye
Herpes simplex virus 2 Ag [Presence] in Penis
Herpes simplex virus 2 Ag [Presence] in Vaginal fluid
Herpes simplex virus 2 Ag [Presence] in Anal
Herpes simplex virus 2 Ag [Presence] in Urethra
Herpes simplex virus 2 Ag [Presence] in Cervix
Herpes simplex virus 2 Ag [Presence] in Throat
Herpes simplex virus 2 Ag [Presence] in Tissue
Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection
Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence
Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence
Herpes simplex virus Ag [Presence] in Cervix
Herpes simplex virus Ag [Presence] in Penis
Herpes simplex virus Ag [Presence] in Vaginal fluid
Herpes simplex virus Ag [Presence] in Eye
Herpes simplex virus Ag [Presence] in Nose
Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay
Herpes simplex virus Ag [Presence] in Cervix by Immunoassay
Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence
Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection
Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
Herpes virus 6 IgG Ab [Presence] in Serum by Immunofluorescence
Histoplasma capsulatum Ab [Presence] in Serum by Immunoassay
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Histoplasma capsulatum Ag [Presence] in Urine by Immunoassay
Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay
Histoplasma capsulatum H Ab [Presence] in Cerebral spinal fluid
Histoplasma capsulatum H Ab [Presence] in Serum
Histoplasma capsulatum M Ab [Presence] in Serum
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Immune diffusion (ID)
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Immune diffusion (ID)
HIV 1+2 Ab [Presence] in Serum from Donor
HTLV I Ab [Presence] in Serum from Donor
HTLV I DNA [Presence] in Blood by NAA with probe detection
HTLV I+II Ab [Presence] in Serum from Donor
HTLV II Ab [Presence] in Serum by Immunoassay
HTLV II IgG Ab [Presence] in Serum by Immunoassay
HTLV II DNA [Presence] in Blood by Probe
HTLV II DNA [Presence] in Blood by NAA with probe detection
Human papilloma virus 31+33 Ag [Presence] in Specimen
Human papilloma virus 35 Ag [Presence] in Specimen
Human papilloma virus DNA [Presence] in Urethra by Probe
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe
Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification
Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification
Human papilloma virus DNA [Presence] in Cervix by Probe
Human papilloma virus DNA [Presence] in Tissue by Probe
hydroCHLOROthiazide [Presence] in Serum or Plasma
Hydroxyitraconazole [Presence] in Serum or Plasma
Kappa light chains.free [Presence] in Serum by Immunofixation
Influenza virus A Ab [Presence] in Serum by Complement fixation
Influenza virus A Ab [Presence] in Body fluid
Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence
Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence
Influenza virus A Ag [Presence] in Nose by Immunofluorescence
Influenza virus A Ag [Presence] in Trachea by Immunofluorescence
Influenza virus A Ag [Presence] in Bronchial specimen
Influenza virus A Ag [Presence] in Nose by Immunoassay
Influenza virus A+B Ab [Presence] in Serum
Influenza virus A+B Ag [Presence] in Bronchial specimen
Influenza virus A+B Ag [Presence] in Nose
Influenza virus B Ab [Presence] in Serum by Complement fixation
Influenza virus B Ab [Presence] in Body fluid
Roxithromycin [Susceptibility] by Disk diffusion (KB)
Influenza virus B Ab [Presence] in Serum
Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence
Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence
Influenza virus B Ag [Presence] in Nose by Immunofluorescence
Influenza virus B Ag [Presence] in Trachea by Immunofluorescence
Influenza virus B Ag [Presence] in Nose by Immunoassay
Influenza virus B Ag [Presence] in Bronchial specimen
Influenza virus C Ab [Presence] in Serum by Complement fixation
Influenza virus C Ab [Presence] in Serum
HTLV I+II p21 env Ab [Presence] in Serum by Immunoblot
HTLV I+II p38 tax Ab [Presence] in Serum by Immunoblot
IgA [Presence] in Skin by Immunofluorescence
IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition
IgA IgG Ab [Presence] in Serum or Plasma
IgA IgM Ab [Presence] in Serum or Plasma
IgA.monoclonal [Presence] in Serum by Immunofixation
IgA.monoclonal [Presence] in Urine by Immunofixation
IgA.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation
IgA.secretory [Presence] in Saliva (oral fluid)
IgD [Presence] in Urine by Immunofixation
IgE [Presence] in Urine by Immunofixation
IgG [Presence] in 24 hour Urine by Immunofixation
IgG Ag [Presence] in Skin by Immunofluorescence
IgG.monoclonal [Presence] in Serum by Immunofixation
IgG.monoclonal [Presence] in Urine by Immunofixation
IgG.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation
IgM [Presence] in 24 hour Urine by Immunofixation
IgM.monoclonal [Presence] in Serum by Immunofixation
IgM.monoclonal [Presence] in Urine by Immunofixation
IgM.monoclonal [Presence] in Cerebral spinal fluid by Immunofixation
Kappa light chains.free [Presence] in Urine by Immunofixation
Kappa light chains [Presence] in Cerebral spinal fluid by Immunofixation
ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HIV 1 [Interpretation] in Serum or Plasma by Immunoassay
KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Additional pathological findings in Tumor
Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols
Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols
Extraprostatic extension by CAP cancer protocols
Reason specimen size cannot be determined in Breast tumor
Specimen size.maximum dimension in Breast tumor
Specimen size additional dimension 1 in Breast tumor
Specimen size additional dimension 2 in Breast tumor
Reason invasive component size cannot be determined in Breast tumor Narrative
Invasive component size.maximum dimension [Length] in Breast tumor
Invasive component size additional dimension 1 [Length] in Breast tumor
Invasive component size additional dimension 2 [Length] in Breast tumor
Gleason pattern.primary in Prostate tumor
Gleason pattern.secondary in Prostate tumor
Gleason pattern.tertiary in Prostate tumor
Cervical Mucus Penetration Test [Interpretation] in Semen
Nuclear pleomorphism in Breast tumor by Nottingham
Histologic grade [Score] in Breast cancer specimen by Nottingham
Roxithromycin [Susceptibility] by Serum bactericidal titer
Mitotic count per 10 HPF in Breast tumor
Hamster Ova Penetration Test [Interpretation] in Semen
Tissue cores.positive.carcinoma in Tissue core
Tumor quantitation.incidental in Prostate tumor by CAP cancer protocols
Tissue involved by tumor in Prostate tumor
Number of carcinoma positive tissue chips CAP cancer protocols
Number of tissue chips CAP cancer protocols
Dominant nodule.maximum.dimension in Prostate tumor
Dominant nodule additional dimension 1 in Prostate tumor
Dominant nodule additional dimension 2 in Prostate tumor
Tumor involvement by ulceration by CAP cancer protocols
Depth of invasion by tumor [Length] in Skin melanoma
Depth of invasion by tumor cannot be determined comment in Skin melanoma Narrative
Site of distant metastasis in Breast tumor
Margin involvement in Prostate tumor by CAP cancer protocols
Margin involvement by CAP cancer protocols
Invasive carcinoma uninvolved margin distance closest [Length] in Breast tumor
DCIS.uninvolved margin distance.closest in Breast tumor
Invasive carcinoma uninvolved margin closest in Breast tumor
DCIS.uninvolved margin.closest in Breast tumor
Margin(s) involved by invasive carcinoma in Breast tumor
Margin(s) involved by DCIS in Breast tumor
Margin(s) involved by invasive carcinoma in Prostate tumor
Margin(s) involved by invasive melanoma in Skin melanoma
Invasive melanoma.uninvolved margin.closest in Skin melanoma
Invasive melanoma in situ.uninvolved margin.closest in Skin melanoma
Distance of invasive melanoma to closest lateral margin [Length] in Skin melanoma
Distance of melanoma in situ to closest lateral margin
Distance of invasive melanoma to closest deep margin [Length] in Skin melanoma
Invasive melanoma.location relative to closest uninvolved lateral margin in Skin melanoma
Melanoma in situ.location relative to closest uninvolved lateral margin
Invasive melanoma.location relative to involved lateral margin in Skin melanoma
Melanoma in situ.location relative to involved lateral margin
Invasive melanoma.location relative to closest uninvolved deep margin in Skin melanoma
Invasive melanoma.location relative to involved deep margin in Skin melanoma
Cellano Ag [Presence] on Red Blood Cells
Tumor regression by CAP cancer protocols
Lesion size additional dimension 1 in Skin
ACTA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Complement C1q Ab [Units/volume] in Serum
MC4R gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NEB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Actin smooth muscle IgG Ab [Units/volume] in Serum
Albumin/Creatinine [Mass Ratio] in Cerebral spinal fluid
Asialoganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay
Asialoganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay
Carnitine/Acylcarnitine [Molar ratio] in Serum or Plasma
Cholesterol in LDL/Apolipoprotein B [Mass Ratio] in Serum or Plasma
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine by Immunoassay
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Specimen by Immunoassay
Complement C3/Protein [Mass Ratio] in Synovial fluid
Complement C4/Protein [Mass Ratio] in Synovial fluid
Creatinine/Calcium [Mass Ratio] in Urine
Lipoprotein.beta/Lipoprotein.alpha [Mass Ratio] in Serum or Plasma
Lipoprotein.pre-beta/Triglyceride [Mass Ratio] in Serum or Plasma
Complement Activity Cell Surface Induced [Units/volume] in Serum or Plasma
Methylmalonate/Homocysteine [Mass Ratio] in Serum or Plasma
Methylmalonate/Homocystine [Molar ratio] in Serum or Plasma
Histiocytes [Presence] in Blood by Light microscopy
Histiocytes [Presence] in Body fluid by Light microscopy
Histiocytes [Presence] in Bone marrow by Light microscopy
Progesterone/11-Deoxycorticosterone [Mass Ratio] in Serum or Plasma
Sisomicin [Susceptibility] by Minimum lethal concentration (MLC)
Progesterone/Estradiol (E2) [Mass Ratio] in Serum or Plasma
Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma
Transferrin.carbohydrate deficient.monosialo/Transferrin.carbohydrate deficient.disialo [Mass Ratio] in Serum or Plasma
Triglyceride/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
Urea nitrogen/Creatinine [Mass Ratio] in Blood
Urea nitrogen/Creatinine [Mass Ratio] in Body fluid
Asialoganglioside GM1 Ab [Presence] in Serum by Immunoassay
Asialoganglioside GM1 Ab [Units/volume] in Serum by Immunoassay
Asialoganglioside GM1 IgG Ab [Presence] in Serum
La Crosse virus Ab [Presence] in Serum by Immunofluorescence
La Crosse virus Ab [Presence] in Serum by Immunoassay
La Crosse virus Ab [Units/volume] in Serum by Immunofluorescence
La Crosse virus Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM1 IgA Ab [Presence] in Serum
Ganglioside GM1 IgM Ab [Presence] in Serum
Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney
Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney
Hepatitis D virus Ag [Presence] in Serum by Immunoassay
Hepatitis D virus Ag [Units/volume] in Serum by Immunoassay
Complement C1 esterase inhibitor.functional [Mass/volume] in Serum or Plasma
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence
Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence
Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
Sodium [Moles/volume] (Maximum value during study) in Serum or Plasma
Complement C1q [Mass/volume] in Serum or Plasma
Creatinine [Mass/volume] (Maximum value during study) in Serum or Plasma
Alanine aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma by No addition of P-5'-P
Aspartate aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma
Amylase and Creatinine clearance panel - Urine and Serum or Plasma
Menorrhagia coagulation panel - Platelet poor plasma
Complement C1q Ag [Moles/volume] in Serum or Plasma
Immunoglobulin light chains panel - Urine
Immunoglobulin light chains panel [Mass/volume] - Serum
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Influenza virus A H5 Asian RNA [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin [Identifier] in Specimen
Brucella sp [Presence] in Specimen by Organism specific culture
Burkholderia sp identified in Specimen by Organism specific culture
Coxiella burnetii [Presence] in Specimen by Organism specific culture
Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)
Burkholderia sp [Presence] in Specimen by Organism specific culture
Aldolase [Enzymatic activity/volume] in Pleural fluid
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid
GNE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Taenia solium IgG Ab [Units/volume] in Serum by Immunoblot
BK virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection
Histoplasma capsulatum H Ab band pattern [Interpretation] in Serum by Immunoblot
Histoplasma capsulatum M Ab band pattern [Interpretation] in Serum by Immunoblot
Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Coccidioides sp IgA Ab [Presence] in Serum by Immunoassay
Yeast.hyphae [Presence] in Specimen by Wet preparation
Hepatitis C virus c22p Ab [Presence] in Serum by Immunoblot
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum by Immunofluorescence
Brucella abortus IgM Ab [Units/volume] in Serum by Immunofluorescence
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunofluorescence
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Complement C1r [Mass/volume] in Serum or Plasma
Brucella abortus IgG Ab [Units/volume] in Serum by Immunofluorescence
Leishmania donovani IgM Ab [Titer] in Serum by Immunofluorescence
Leishmania brasilensis IgM Ab [Titer] in Serum by Immunofluorescence
Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence
La Crosse virus IgM Ab [Titer] in Serum by Immunoassay
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunofluorescence
Leishmania donovani IgG Ab [Titer] in Serum by Immunofluorescence
Bartonella quintana IgM Ab [Titer] in Serum by Immunofluorescence
Complement C1r2+C1s2 [Units/volume] in Serum or Plasma
Hepatitis D virus IgM Ab [Units/volume] in Serum by Immunoassay
Bartonella quintana IgG Ab [Titer] in Serum by Immunofluorescence
Teriflunomide [Mass/volume] in Serum or Plasma
Phosphorylase [Enzymatic activity/volume] in Blood
Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum
Glycogen synthase I/Glycogen synthase.total in Blood
Complement C1s [Mass/volume] in Serum or Plasma
Acid phosphatase tartrate resistant [Presence] in Bone marrow
Acid phosphatase tartrate resistant [Presence] in Blood
5-Hydroxymethyl-2-Furoate [Presence] in Urine
Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine
Catecholamines [Interpretation] in Plasma
Choriogonadotropin [Presence] in Control Serum
Fungus # 5 identified in Specimen by Culture
Bacteria # 2 identified in Specimen by Culture
Complement C2 [Mass/volume] in Serum or Plasma
Bacteria # 3 identified in Specimen by Culture
Bacteria # 2 identified in Specimen by Anaerobe culture
Bacteria # 4 identified in Specimen by Culture
Bacteria # 5 identified in Specimen by Culture
Bacteria # 6 identified in Specimen by Culture
Bacteria # 7 identified in Urine by Culture
Bacteria # 7 identified in Specimen by Culture
Bacteria # 8 identified in Urine by Culture
Bacteria # 8 identified in Specimen by Culture
Mycobacterium sp # 2 identified in Specimen by Organism specific culture
Mycobacterium sp # 3 identified in Specimen by Organism specific culture
Bacteria # 3 identified in Specimen by Anaerobe culture
Mycobacterium sp # 4 identified in Specimen by Organism specific culture
Mycobacterium sp # 5 identified in Specimen by Organism specific culture
Bacteria # 4 identified in Specimen by Anaerobe culture
Bacteria # 5 identified in Specimen by Anaerobe culture
Bacteria # 6 identified in Specimen by Anaerobe culture
Complement C3 [Mass/volume] in Serum or Plasma
Bacteria # 7 identified in Specimen by Anaerobe culture
Methoxyacetate/Creatinine [Mass Ratio] in Urine
5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine
6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine
Complement C3 fragment [Presence] in Red Blood Cells
Iron.microscopic observation [Presence] in Body fluid by Other stain
Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection
Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE)
Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA)
HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection
HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay
HIV 1+2 Ab [Presence] in Serum by Immunoblot
HTLV I+II RNA [Presence] in Serum by NAA with probe detection
Complement C3 fragment [Mass/volume] in Red Blood Cells
IgM Ag [Presence] in Skin by Immunofluorescence
Influenza virus A Ab [Presence] in Cerebral spinal fluid
Insulin dependent diabetes mellitus [Presence]
Staphylococcus aureus enterotoxin A sea gene [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus enterotoxin E see gene [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus enterotoxin B seb gene [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Specimen by NAA with probe detection
Malignant cells [#/volume] in Peritoneal fluid
Complement C3a [Mass/volume] in Serum or Plasma
Malignant cells [#/volume] in Cerebral spinal fluid by Manual count
Malignant cells [#/volume] in Pleural fluid by Manual count
Malignant cells [#/volume] in Synovial fluid by Manual count
Malignant cells [#/volume] in Pericardial fluid by Manual count
Malignant cells [#/volume] in Peritoneal fluid by Manual count
Malignant cells [#/volume] in Synovial fluid
Malignant cells [#/volume] in Pleural fluid
Malignant cells [#/volume] in Cerebral spinal fluid
Complement C3b [Mass/volume] in Serum or Plasma
Malignant cells [#/volume] in Pericardial fluid
Malignant cells/100 cells in Cerebral spinal fluid
Malignant cells/100 cells in Synovial fluid
Malignant cells/100 cells in Cerebral spinal fluid by Manual count
Malignant cells/100 cells in Pleural fluid by Manual count
Malignant cells/100 cells in Synovial fluid by Manual count
Malignant cells/100 cells in Pericardial fluid by Manual count
Malignant cells/100 cells in Peritoneal fluid by Manual count
Malignant cells/100 cells in Urine by Manual count
Malignant cells/100 cells in Bone marrow by Manual count
Malignant cells/100 cells in Liver by Manual count
Malignant cells/100 cells in Pleural fluid
Malignant cells/100 cells in Bone marrow
Malignant cells/100 cells in Pericardial fluid
Malignant cells/100 cells in Peritoneal fluid
5-Hydroxyindoleacetate panel - 24 hour Urine
Homovanillate and Creatinine [Interpretation] in Urine
Complement C3b-C4b receptor [Entitic number] in Red Blood Cells
5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine
Alpha-1-Fetoprotein [Units/volume] in Body fluid
Beta 2 globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Beta 2 globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis
Beta globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Beta globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis
Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma
Cortisol [Moles/volume] in Serum or Plasma --pre XXX challenge
Complement C3c [Mass/volume] in Serum or Plasma
Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone
DOPamine/Creatinine [Molar ratio] in 24 hour Urine
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post meal
Hemoglobin C/Hemoglobin.total in Blood by HPLC
Hemoglobin D/Hemoglobin.total in Blood by HPLC
Hemoglobin E/Hemoglobin.total in Blood by HPLC
Hemoglobin S/Hemoglobin.total in Blood by HPLC
Normetanephrine/Creatinine [Molar ratio] in 24 hour Urine
Complement C3d [Entitic number] in Red Blood Cells
Prolactin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --2 hours post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --pre dose TRH IV
Protein.monoclonal band 2/Protein.total in Serum or Plasma by Electrophoresis
Specific gravity of 24 hour Urine by Refractometry
Thymidine kinase [Enzymatic activity/volume] in Serum
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH IV
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH IV
Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay
Australian cervix cytology code [Interpretation] of Specimen
Borrelia burgdorferi 31kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 31kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 34kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 34kD IgG Ab [Presence] in Serum by Immunoblot
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma
Chlamydophila psittaci IgM Ab [Presence] in Serum
Chlamydophila psittaci IgA Ab [Presence] in Serum
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen
Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen
Chlamydophila pneumoniae IgG Ab [Presence] in Serum
Complement C4 [Mass/volume] in Serum or Plasma
Chlamydophila pneumoniae IgA Ab [Presence] in Serum
Chlamydia trachomatis L2 IgM Ab [Presence] in Serum
Chlamydia trachomatis L2 IgG Ab [Presence] in Serum
Chlamydia trachomatis L2 IgA Ab [Presence] in Serum
Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum
Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum
Chlamydia trachomatis D+K IgM Ab [Presence] in Serum
Chlamydia trachomatis D+K IgG Ab [Presence] in Serum
Sisomicin [Susceptibility] by Disk diffusion (KB)
Chlamydia trachomatis D+K IgA Ab [Presence] in Serum
Chlamydia trachomatis C IgM Ab [Presence] in Serum
Chlamydia trachomatis C IgG Ab [Presence] in Serum
Chlamydia trachomatis C IgA Ab [Presence] in Serum
Chlamydia trachomatis B IgM Ab [Presence] in Serum
Chlamydia trachomatis B IgG Ab [Presence] in Serum
Chlamydia trachomatis B IgA Ab [Presence] in Serum
Chlamydia trachomatis Ab [Units/volume] in Serum --2nd specimen
Chlamydia trachomatis Ab [Presence] in Serum --1st specimen
Chlamydia trachomatis IgM Ab [Presence] in Cerebral spinal fluid
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunoassay
Chlamydia trachomatis IgM Ab [Units/volume] in Serum by Immunoassay
Chlamydia trachomatis IgG Ab [Presence] in Cerebral spinal fluid
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunoassay
Chlamydia trachomatis IgA Ab [Presence] in Cerebral spinal fluid
Complement C4 CH50 [Mass/volume] in Cerebral spinal fluid
Chlamydia trachomatis IgA Ab [Presence] in Serum
Chlamydia trachomatis IgA Ab [Units/volume] in Serum by Immunoassay
Chlamydia trachomatis Ab [Units/volume] in Serum by Immunoassay
Chlamydia trachomatis Ab [Presence] in Serum by Complement fixation
Chlamydia trachomatis Ab [Presence] in Serum by Immunofluorescence
Chlamydia sp IgG Ab [Presence] in Cerebral spinal fluid
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Adenosine monophosphate.cyclic [Moles/volume] in Urine --2 hours post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --6 hours post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --baseline
Adenosine monophosphate.cyclic [Moles/volume] in Urine --4 hours post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --baseline
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6 hours post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2 hours post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4 hours post XXX challenge
Complement C4b binding protein [Units/volume] in Serum or Plasma
Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma
Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method
HLA typing for celiac disease panel - Blood or Tissue
Bacteria producing catalase [Presence] in Isolate
Bacterial virulence [Presence] in Specimen by Mouse bioassay
Bacteria producing oxidase [Presence] in Isolate
Bacteria producing urease [Presence] in Isolate
Bacteria producing arginine decarboxylase [Presence] in Isolate
Complement C4b binding protein [Mass/volume] in Serum or Plasma
Clostridium botulinum toxin [Presence] in Specimen by Immunoassay
Francisella tularensis Ab [Presence] in Serum by Microagglutination
Francisella tularensis Ag [Presence] in Specimen by Slide agglutination
XXX microorganism Ag [Identifier] in Specimen by Immunofluorescence
Microscopic observation [Identifier] in Specimen by Tzanck smear
Bacteria producing indole [Presence] in Isolate
Yersinia pestis Ab [Presence] in Specimen by Hemagglutination
Bacteria producing X and V factors [Presence] in Isolate
Complement C4d [Entitic number] in Red Blood Cells
Cortisol [Moles/volume] in Serum or Plasma --12 AM specimen
Cortisol [Moles/volume] in Serum or Plasma --12 PM specimen
Cortisol [Moles/volume] in Serum or Plasma --4 PM specimen
Cortisol [Moles/volume] in Serum or Plasma --8 AM specimen
Cortisol [Moles/volume] in Serum or Plasma --8 PM specimen
Glucose [Moles/volume] in Serum or Plasma --12 AM specimen
Glucose [Moles/volume] in Serum or Plasma --8 AM specimen
Complement C5 [Mass/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --12 PM specimen
Glucose [Moles/volume] in Serum or Plasma --4 PM specimen
Glucose [Moles/volume] in Serum or Plasma --8 PM specimen
Cardiolipin IgA and IgG and IgM panel - Serum
cycloSPORINE Monoclonal and Polyclonal panel [Mass/volume] - Blood
Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence
Protein and Glucose panel - Urine by Test strip
Spermatozoa IgA and IgG and IgM panel - Serum
C reactive protein [Mass/volume] in Cerebral spinal fluid
Varicella zoster virus IgG and IgM panel - Serum
Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe
Sisomicin [Susceptibility] by Serum bactericidal titer
Complement C6 [Mass/volume] in Serum or Plasma
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anal by Probe
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Tissue by Probe
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe
Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe
Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection
Complement C7 [Mass/volume] in Serum or Plasma
Chlamydia trachomatis rRNA [Presence] in Anal by Probe
Chlamydia trachomatis DNA [Presence] in Anal by NAA with probe detection
Chlamydia trachomatis Ag [Presence] in Genital specimen
Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay
Chlamydia trachomatis [Presence] in Anal by Organism specific culture
Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture
Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture
Complement C8 [Mass/volume] in Serum or Plasma
Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture
Chlamydia sp identified in Anal by Organism specific culture
Chlamydia sp identified in Cervix by Organism specific culture
Chlamydia sp identified in Body fluid by Organism specific culture
Chlamydia sp identified in Vaginal fluid by Organism specific culture
Chlamydia sp identified in Nasopharynx by Organism specific culture
Chlamydia sp Ag [Presence] in Anal by Immunofluorescence
Complement C9 [Mass/volume] in Serum or Plasma
Chlamydia sp Ag [Presence] in Anal by Immunoassay
Chlamydia sp Ag [Presence] in Cervix by Immunoassay
Chlamydia sp Ag [Presence] in Cervix by Immunofluorescence
Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence
Complement total hemolytic CH50 [Units/volume] in Body fluid
Chlamydia sp Ag [Presence] in Urine by Immunofluorescence
Chlamydia sp Ag [Presence] in Urethra by Immunoassay
Chlamydia sp Ag [Presence] in Urethra by Immunofluorescence
Mycobacterium gordonae rRNA [Presence] in Specimen by NAA with probe detection
Mycobacterium kansasii rRNA [Presence] in Specimen by NAA with probe detection
Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Complement fixation
Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Immunoassay
Cocal virus Ag [Presence] in Specimen by Complement fixation
Cocal virus Ag [Presence] in Specimen by Immunoassay
Cocal virus neutralizing antibody [Titer] in Serum by Neutralization test
Vesicular stomatitis Alagoas virus neutralizing antibody [Titer] in Serum by Neutralization test
Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Complement fixation
Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Immunoassay
Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Immunoassay
Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Complement fixation
Chlamydia trachomatis Ab [Presence] in Body fluid
Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence
Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay
Chlamydia sp Ag [Presence] in Nasopharynx
Campylobacter jejuni IgM Ab [Titer] in Serum
Chlamydia trachomatis IgG Ab [Presence] in Serum by Immunoassay
Endomysium IgG Ab [Units/volume] in Serum
IgA.secretory [Mass/volume] in Body fluid
Complement C1r2+C1s2 [Mass/volume] in Serum or Plasma
Listeria monocytogenes O4b IgG Ab [Titer] in Serum
Listeria monocytogenes O4b IgM Ab [Titer] in Serum
Platelet associated Ab [Presence] in Blood by Flow cytometry (FC)
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method
Methdilazine [Presence] in Serum or Plasma
Complement decay accelerating factor [Entitic number] in Red Blood Cells
Triflupromazine [Presence] in Serum or Plasma
Propiomazine [Presence] in Serum or Plasma
Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC)
Neutrophil Ab [Units/volume] in Serum by Immunoassay
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay
Phenylalanine hydroxylase Ab [Units/volume] in Serum
Heparin induced platelet Ab [Units/volume] in Serum
Rheumatoid factor [Presence] in Body fluid by Latex agglutination
U2 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum
Immune complex [Units/volume] in Serum or Plasma by C3d binding assay
Hepatitis B virus and Hepatitis D virus Ab [Interpretation] in Serum Narrative
Acremonium sp Ab [Presence] in Serum by Immune diffusion (ID)
Complement factor Ba [Mass/volume] in Serum or Plasma
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Escherichia coli O157 Ag [Presence] in Isolate by Latex agglutination
Alternaria alternata Ab [Presence] in Serum
Asialoganglioside GM2 Ab [Presence] in Serum
Borrelia burgdorferi IgA Ab [Units/volume] in Serum by Immunofluorescence
Corynebacterium diphtheriae IgG Ab [Presence] in Serum
Ganglioside GM1 IgG Ab [Presence] in Serum
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunofluorescence
Pancreatic islet cell Ab [Units/volume] in Serum by Immunofluorescence
Purkinje cells Ab [Units/volume] in Serum by Immunofluorescence
Thyrotropin.alpha subunit [Mass/volume] in Serum or Plasma
HIV nucleoside reverse transcriptase gene mutations detected [Identifier]
HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier]
Herpes gestationis IgG Ab non-complement fixing [Presence] in Serum by Immunofluorescence
Basement membrane zone IgG Ab [Presence] in Serum by Immunofluorescence
Complement factor Bb [Mass/volume] in Serum or Plasma
Herpes gestationis IgG Ab complement fixing [Presence] in Serum by Immunofluorescence
1p chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method
19q chromosome deletion [Presence] in Blood or Tissue by Molecular genetics method
Neisseria meningitidis [Identifier] in Isolate by Agglutination
11-Deoxycortisol/Cortisol [Mass Ratio] in Serum or Plasma
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine
Complement factor D [Mass/volume] in Serum or Plasma
Other Antibiotic [Susceptibility] by Disk diffusion (KB)
Basement membrane zone BP180 Ab [Units/volume] in Serum
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
CASR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CAPN3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS
Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma
Complement factor H [Mass/volume] in Serum or Plasma
Cow epithelium+Cow dander IgE Ab [Units/volume] in Serum
Decanoylcarnitine (C10) [Moles/volume] in DBS
Decenoylcarnitine (C10:1) [Moles/volume] in DBS
Dodecanoylcarnitine (C12) [Moles/volume] in DBS
Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS
Complement factor I [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine by Test strip --3rd specimen post XXX challenge
Glucose [Mass/volume] in Urine by Test strip --4th specimen post XXX challenge
Glucose [Mass/volume] in Urine by Test strip --5th specimen post XXX challenge
Glutarylcarnitine (C5-DC) [Moles/volume] in DBS
Hemoglobin A [Presence] in Blood by Electrophoresis
Heptacarboxylporphyrin [Moles/volume] in DBS
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence
Complement factor P [Mass/volume] in Plasma
Hexanoylcarnitine (C6) [Moles/volume] in DBS
HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot
Isobutyrylcarnitine (C4) [Moles/volume] in DBS
Isoleucine+Leucine [Moles/volume] in DBS
Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS
Linoleoylcarnitine (C18:2) [Moles/volume] in DBS
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Cerebral spinal fluid
Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay
Pancreatic islet cell complement fixing Ab [Titer] in Serum by Immunofluorescence
Streptolysin O Ab [Mass/volume] in Serum
Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Complement iC3b receptors [Entitic number] in Leukocytes
Complement membrane attack complex (C5b-C6-C7-C8-C9n) [Mass/volume] in Plasma
Complement membrane C3b-C4b cofactor protein [Entitic number] in Leukocytes
Immunodeficiency markers [Interpretation] in Specimen Narrative
Chronic leukemia markers [Interpretation] in Specimen Narrative
Acute leukemia markers [Interpretation] in Specimen Narrative
Immunodeficiency panel - Blood by Flow cytometry (FC)
Chronic leukemia panel - Specimen by Flow cytometry (FC)
Acute leukemia panel - Specimen by Flow cytometry (FC)
Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection
Sympathomimetics [Presence] in Urine by Confirmatory method
Pregnancy associated plasma protein A multiple of the median [Percentile]
Low molecular weight heparin induced platelet Ab [Presence] in Serum
Bacteria identified in Blood by Aerobe culture 25 degree C incubation
Bacteria identified in Blood by Anaerobe culture 25 degree C incubation
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Body fluid
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Body fluid
Influenza virus A+B Ab [Presence] in Body fluid
Echovirus 30 Ab [Presence] in Body fluid
Echovirus 11 Ab [Presence] in Body fluid
DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cytomegalovirus IgA Ab [Presence] in Body fluid
Coxsackievirus B6 Ab [Presence] in Body fluid
Coxsackievirus B5 Ab [Presence] in Body fluid
Coxsackievirus B4 Ab [Presence] in Body fluid
Coxsackievirus B3 Ab [Presence] in Body fluid
Coxsackievirus B2 Ab [Presence] in Body fluid
Coxsackievirus B1 Ab [Presence] in Body fluid
Choriogonadotropin.beta subunit.free multiple of the median [Percentile]
Bordetella bronchiseptica DNA [Presence] in Specimen by NAA with probe detection
Acetylcholinesterase/Cholinesterase [Enzymatic activity ratio] in Amniotic fluid
Cortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone
Glucose [Moles/volume] in 24 hour Dialysis fluid
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO
Glycerol [Moles/volume] in Serum or Plasma
Urea [Moles/volume] in Dialysis fluid --2 hour specimen
Urea [Moles/volume] in Dialysis fluid --4 hour specimen
Spectinomycin [Susceptibility] by Disk diffusion (KB)
Complement total hemolytic [Units/volume] in Blood
Uroporphyrin 3 isomer [Moles/mass] in Stool
Coproporphyrin 1/Creatinine [Molar ratio] in Urine
Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in Urine
Coproporphyrin 3/Creatinine [Molar ratio] in Urine
Hexacarboxylate/Creatinine [Molar ratio] in Urine
Pentacarboxylate/Creatinine [Molar ratio] in Urine
Uroporphyrin 3 isomer/Creatinine [Molar ratio] in Urine
Uroporphyrin/Creatinine [Molar ratio] in Urine
Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method
FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
FMR1 gene allele 2 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood
Ethyl glucuronide [Mass/volume] in Urine
Campylobacter jejuni IgG Ab [Titer] in Serum
FMR1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method
Complement total hemolytic CH50 [Units/volume] in Serum or Plasma
Glutathione peroxidase [Enzymatic activity/volume] in Blood
Glutathione reductase [Enzymatic activity/volume] in Serum
Leptospira interrogans IgG Ab [Titer] in Serum by Immunofluorescence
NF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
NF2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
Superoxide dismutase [Enzymatic activity/volume] in Blood
Bacteria Identification [Presence] in Isolate by Culture
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
Bacteria producing hemolysis [Presence] in Isolate
Bacterial biochemical profile [Identifier] in Isolate by Culture
Proinsulin/Insulin [Ratio] in Serum or Plasma
Cyanmethemoglobin/Hemoglobin.total in Blood
Cytotoxic percent reactive Ab [Presence] in Serum by Quick method
Date of analysis of unspecified specimen
Erythrocytes.filamented [Presence] in Blood by Light microscopy
Lymphocyte proliferation stimulated by 0.125 ug pokeweed mitogen in Blood
Lymphocyte proliferation stimulated by 0.25 ug pokeweed mitogen in Blood
Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen in Blood
Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin in Blood
Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen [Units/volume] in Blood
Lymphocyte proliferation stimulated by 10 ug concanavalin A in Blood
Lymphocyte proliferation stimulated by 2.0 ug phytohemagglutinin in Blood
Lymphocyte proliferation stimulated by 20 ug concanavalin A in Blood
Lymphocyte proliferation stimulated by 5 ug concanavalin A in Blood
Deoxyhemoglobin/Hemoglobin.total in Blood
Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin in Blood
Time of analysis of unspecified specimen
Erythrocyte sedimentation rate by Westergren method
Glutathione peroxidase [Enzymatic activity/mass] in Red Blood Cells
Eosinophils [Presence] in Stool by Light microscopy
Basophilic stippling fine [Presence] in Blood by Light microscopy
Basophilic stippling coarse [Presence] in Blood by Light microscopy
Leukocytes [#/area] in Urine sediment by Microscopy low power field
Leucine crystals [#/area] in Urine sediment by Microscopy low power field
Erythrocyte sedimentation rate by Wintrobe method
Hippurate crystals [#/area] in Urine sediment by Microscopy low power field
Epithelial casts [#/area] in Urine sediment by Microscopy high power field
Cystine crystals [#/area] in Urine sediment by Microscopy low power field
Calcium phosphate crystals [#/area] in Urine sediment by Microscopy low power field
Calcium carbonate crystals [#/area] in Urine sediment by Microscopy low power field
Epithelial cells.squamous [#/area] in Urine sediment by Microscopy low power field
Epithelial cells.renal [#/area] in Urine sediment by Microscopy low power field
Erythrocyte sedimentation rate Zeta by Zetafuge
Haptoglobin [Mass/volume] in Serum or Plasma
Haptoglobin [Mass/volume] in Serum or Plasma by Electrophoresis
Hematocrit [Volume Fraction] of Blood by Automated count
Hematocrit [Volume Fraction] of Blood by Centrifugation
Hemoglobin A1c/Hemoglobin.total in Blood
Spectinomycin [Susceptibility] by Serum bactericidal titer
Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis
Aztreonam [Susceptibility] by Disk diffusion (KB)
Hemoglobin A2 [Moles/volume] in Blood by Chromatography column
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin A2/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9)
Spiramycin [Susceptibility] by Minimum lethal concentration (MLC)
Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Abruzzo [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin Barts [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Barts [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin C/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9)
Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Hemoglobin C - Harlem [Presence] in Blood
Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Chesapeake [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Constant Spring [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin D - Punjab [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin D - Punjab [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9)
Spiramycin [Susceptibility] by Disk diffusion (KB)
Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin E/Hemoglobin.total in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin F - Texas [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin F - Texas [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9)
Spiramycin [Susceptibility] by Serum bactericidal titer
Hemoglobin G - Coushatta [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin G - Coushatta [Units/volume] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin G - Georgia [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin G - Philadelphia [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin H/Hemoglobin.total in Blood by Electrophoresis
Hemoglobin Hasharon [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Hasharon [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin Hope [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Hope [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin I [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin I [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin J - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin J - Capetown [Presence] in Blood
Streptomycin [Susceptibility] by Minimum lethal concentration (MLC)
Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin J - Oxford [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin Kempsey [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Kempsey [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin Lepore [Presence] in Blood by Electrophoresis acid (pH 6.3)
Hemoglobin Lepore [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Hemoglobin M - Boston [Presence] in Blood
Hemoglobin M - Hyde Park [Presence] in Blood
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
Immunoglobulin light chains [Mass/time] in 24 hour Urine
Gamma hydroxybutyrate [Presence] in Serum or Plasma
Hemoglobin M - Iwate [Presence] in Blood
Creatinine [Moles/volume] in Dialysis fluid --2 hour specimen
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --2nd tube
Leukocytes [#/volume] in Cerebral spinal fluid --2nd tube
Leukocytes [#/volume] in Cerebral spinal fluid --3rd tube
Leukocytes [#/volume] in Cerebral spinal fluid --4th tube
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --3rd tube
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --4th tube
Calcium.ionized [Moles/volume] in Dialysis fluid
Hemoglobin M - Milwaukee [Presence] in Blood
Plasmodium sp Ag [Presence] in Blood by Immunoassay
Anabolic steroids [Moles/volume] in Serum or Plasma
Calcium [Mass/volume] corrected for albumin in Serum or Plasma
Pregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
Hemoglobin M - Saskatoon [Presence] in Blood
18q chromosome deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Rubella virus IgM Ab [Titer] in Cerebral spinal fluid
Hemoglobin Malmo [Presence] in Blood by Electrophoresis acid (pH 6.3)
Rubella virus IgG Ab [Titer] in Cerebral spinal fluid
Mycoplasma sp DNA [Presence] in Body fluid by NAA with probe detection
Cardiolipin Ab [Presence] in Serum by Immunoassay
Endomysium IgA Ab [Presence] in Serum by Immunofluorescence
Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry
Hemoglobin Malmo [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay
Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry
Clostridioides difficile toxin B [Presence] in Stool by Cytotoxin tissue culture assay
Glycosaminoglycans/Creatinine [Ratio] in Urine
Epithelial cells [#/area] in Urine sediment by Microscopy low power field
Granular casts [#/area] in Urine sediment by Microscopy high power field
Hyaline casts [#/area] in Urine sediment by Microscopy high power field
Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis acid (pH 6.3)
Transitional cells [#/area] in Urine sediment by Microscopy low power field
Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field
Urate crystals [#/area] in Urine sediment by Microscopy high power field
Streptomycin [Susceptibility] by Disk diffusion (KB)
Hemoglobin N - Baltimore [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis acid (pH 6.3)
Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum
Aspergillus glaucus Ab [Presence] in Serum
Bartonella sp IgG Ab [Units/volume] in Serum
Bartonella sp IgM Ab [Units/volume] in Serum
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid
Hemoglobin N - Seattle [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Borrelia burgdorferi IgA Ab [Units/volume] in Serum
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum
Hemoglobin O - Arab [Presence] in Blood by Electrophoresis acid (pH 6.3)
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum
Classical swine fever virus Ab [Titer] in Serum
Coccidioides sp IgA Ab [Presence] in Serum
Coccidioides sp IgG Ab [Presence] in Serum
Coccidioides sp IgM Ab [Presence] in Serum
Echinococcus granulosus Ab [Units/volume] in Serum
Hemoglobin O - Arab [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid
Equine herpesvirus 2 Ab [Titer] in Serum
Equine herpesvirus 3 Ab [Titer] in Serum
Herpes simplex virus Ab [Presence] in Body fluid
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid
Infectious bronchitis virus JMK Ab [Titer] in Serum
Legionella non-pneumophila Ab [Titer] in Serum
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum
Leptospira interrogans IgG Ab [Titer] in Serum
Mycoplasma pneumoniae IgG Ab [Presence] in Serum
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid
Porcine adenovirus Ab [Presence] in Serum
Psittacid herpesvirus 1 Ab [Presence] in Serum
Reagin Ab [Titer] in Cerebral spinal fluid
Salmonella typhi O D Ab [Titer] in Serum
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum
Treponema pallidum Ab [Presence] in Serum from Donor
PKD1 gene+PKD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon [Units/volume] in Control Blood
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood
5-Fluorocytosine [Moles/volume] in Serum or Plasma
Creatinine [Moles/volume] in Dialysis fluid --4 hour specimen
Streptomycin [Susceptibility] by Serum bactericidal titer
Creatinine [Moles/volume] in Dialysis fluid --overnight
Glucose [Moles/volume] in Dialysis fluid --2 hour specimen
Glucose [Moles/volume] in Dialysis fluid --4 hour specimen
Glucose [Moles/volume] in Dialysis fluid --overnight
Thrombin time in Platelet poor plasma by Coagulation assay --after addition of heparinase
ABCA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SGCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Hemoglobin S [Presence] in Blood by Electrophoresis acid (pH 6.3)
DULoxetine [Mass/volume] in Serum or Plasma
Hemoglobin S [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Kappa lymphocytes/100 lymphocytes in Bone marrow
Kappa lymphocytes/100 lymphocytes in Body fluid
Urea [Moles/volume] in Dialysis fluid --overnight
Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation identified by Molecular method
Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation [Identifier] by Molecular method
Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation [Identifier] by Molecular method
Mycobacterium tuberculosis embB gene ethambutol resistance mutation [Identifier] by Molecular method
Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoassay
Acylcarnitine pattern [Interpretation] in Serum or Plasma
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunofluorescence
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunofluorescence
Methyl ethyl ketone [Mass/volume] in Serum or Plasma
oxyCODONE Free [Presence] in Serum or Plasma by Screen method
Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method
oxyMORphone Free [Presence] in Serum or Plasma by Screen method
Morphine Free [Presence] in Serum or Plasma by Screen method
HYDROmorphone Free [Presence] in Serum or Plasma by Screen method
HYDROcodone Free [Presence] in Serum or Plasma
Codeine Free [Presence] in Serum or Plasma by Screen method
6-monoacetylmorphine free [Presence] in Serum or Plasma
Cryofibrinogen [Presence] in Plasma by 1 week cold incubation
Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay
Proteinase 3 Ab [Units/volume] in Serum by Immunoassay
ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction
25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
ABO group [Type] in Blood--after transfusion reaction
Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction
Appearance of Urine--after transfusion reaction
Appearance of Serum--after transfusion reaction
Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells --after transfusion reaction
Major crossmatch [Interpretation] --after transfusion reaction
Hemoglobin Yoshizuka [Presence] in Blood
Rh [Type] in Blood--after transfusion reaction
Hemoglobin Ypsilanti [Presence] in Blood
Hemoglobin Zurich [Presence] in Blood by Electrophoresis acid (pH 6.3)
Aztreonam [Susceptibility] by Serum bactericidal titer
sulfADIAZINE [Susceptibility] by Minimum lethal concentration (MLC)
Hemoglobin Zurich [Presence] in Blood by Electrophoresis alkaline (pH 8.9)
Hemoglobin F [Presence] in Stool by Apt-Downey method
Hemoglobin F [Presence] in Blood by Alkali denaturation
Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method
Thermolabile hemoglobin/Hemoglobin.total in Red Blood Cells
Unstable Hemoglobin [Presence] in Red Blood Cells
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --15 minutes post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --2 hours post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre 1 g/kg glucose PO
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post 1 g/kg glucose PO
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post 1 g/kg glucose PO
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes pre dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine
Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV
Lutropin [Units/volume] in Serum or Plasma --15 minutes post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --45 minutes post dose gonadotropin releasing hormone
Cortisol [Mass/volume] in Serum or Plasma --8 hours post 8 mg dexamethasone PO overnight high dose
Prothrombin time (PT) in Capillary blood by Coagulation assay
INR in Capillary blood by Coagulation assay
Erythrocytes [#/area] in Urine sediment by Automated count
Leukocyte clumps [#/area] in Urine sediment by Microscopy high power field
Mucus [#/area] in Urine sediment by Microscopy high power field
Trichomonas vaginalis [#/area] in Urine sediment by Microscopy high power field
Hemoglobin distribution width [Mass/volume] in Blood
Hemolysis interference index of Serum or Plasma
Lipemic interference index of Serum or Plasma
Icteric interference index of Serum or Plasma
Beta fructofuranosidase [Enzymatic activity/mass] in Tissue
Xylose [Mass/volume] in Serum or Plasma --15 minutes post 25 g xylose PO
Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool
Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool
Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 50 g lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post 10 g lactulose PO
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Rheumatoid factor and Cyclic citrullinated peptide IgG Ab [Interpretation] in Serum
Rheumatoid Factor and Cyclic Citrullinated Peptide IgG panel [Units/volume] - Serum
Shigella sp [Presence] in Specimen by Organism specific culture
Shigella sp DNA [Presence] in Specimen by NAA with probe detection
sulfADIAZINE [Susceptibility] by Minimum inhibitory concentration (MIC)
sulfADIAZINE [Susceptibility] by Disk diffusion (KB)
Kallikrein [Enzymatic activity/volume] in Plasma
Kallikrein Tissue type [Units/volume] in Plasma
Leukocyte phosphatase [Enzymatic activity/volume] in Leukocytes
Lymphocytes+Monocytes/100 leukocytes in Blood
sulfADIAZINE [Susceptibility] by Serum bactericidal titer
Lysozyme [Enzymatic activity/volume] in Serum or Plasma
Plasminogen Ag [Mass/volume] in Platelet poor plasma
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma
Fibroblast growth factor 23 [Units/volume] in Plasma
7-Dehydrocholesterol [Moles/volume] in Amniotic fluid
Adenosine triphosphate [Moles/volume] in Red Blood Cells
Leukocytes [#/area] in Urine sediment by Automated count
Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method
Clostridium botulinum toxin gene [Identifier] in Specimen by NAA with probe detection
Clostridium perfringens toxin gene [Identifier] in Specimen by NAA with probe detection
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Mass/volume] in Serum by Multidisk
Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Units/volume] in Serum by Multidisk
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of bovine thrombin
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid
Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Barley smut IgE Ab [Units/volume] in Serum
Protein C Ag [Mass/volume] in Platelet poor plasma
Alpha-1-Microglobulin [Mass/volume] in Urine
CYP2C9 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Tropheryma whipplei DNA [Presence] in Specimen by NAA with probe detection
HTR2A gene+HTR2C gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Bacterial vaginosis whiff test [Presence] in Vaginal fluid
RHCE gene allele Cc [Genotype] in Amniotic fluid by Molecular genetics method Nominal
Francisella tularensis subtype [Identifier] in Specimen by NAA with probe detection
Amino acidemias newborn screen interpretation
Fatty acid oxidation defects newborn screen interpretation
Galactosemias newborn screen interpretation
Hemoglobin disorders newborn screen interpretation
Maple syrup urine disease newborn screen interpretation
Organic acidemias newborn screen interpretation
Other amino acidopathies newborn screen interpretation
Phenylketonuria and variants/Biopterin defects newborn screen interpretation
3-Methylcrotonic/Hydroxymethylglutaric/Methylglutaconic newborn screen interpretation
Other organic acidemias newborn screen interpretation
Medium chain acyl dehydrogenase Deficiency/Glutaric Acidemia type 2 newborn screen interpretation
Carnitine uptake defect/CPT1 deficiency newborn screen interpretation
Other fatty acid oxidation disorders newborn screen interpretation
Congenital adrenal hyperplasia newborn screen interpretation
Hb SS, Hb SC, Hb SB thal newborn screen interpretation
Other hemoglobinopathies newborn screen interpretation
Biotinidase deficiency newborn screen interpretation
Congenital hypothyroidism newborn screen interpretation
Cystic fibrosis newborn screen interpretation
Protein S Free Ag [Units/volume] in Platelet poor plasma by Immunoassay
Argininemia newborn screen interpretation
von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasma
Streptokinase [Enzymatic activity/volume] in Plasma
Sulfhemoglobin/Hemoglobin.total in Blood
Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Beclomethasone dipropionate [Mass/volume] in Urine
Fluticasone propionate [Mass/volume] in Urine
Megestrol acetate [Mass/volume] in Urine
Methylprednisolone [Mass/volume] in Urine
Triamcinolone acetonide [Mass/volume] in Urine
Synthetic glucocorticoid panel [Mass/volume] - Urine
TCR alpha beta Ag [Presence] in Tissue by Immune stain
TCR gamma delta Ag [Presence] in Tissue by Immune stain
Vasoactive intestinal peptide Ag [Presence] in Tissue by Immune stain
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Latex agglutination
MCOLN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Asialoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay
Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
BK virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method
oxyCODONE Free [Mass/volume] in Urine by Confirmatory method
oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method
oxyMORphone Free [Mass/volume] in Urine by Confirmatory method
Benzodiazepines [Presence] in Serum or Plasma by Screen method
Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method
Salicylates [Mass/volume] in Serum or Plasma by Confirmatory method
Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Liver kidney microsomal IgG Ab [Titer] in Serum by Immunofluorescence
Ethanol [Mass/volume] in Urine by Confirmatory method
Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma
Helicobacter pylori IgM Ab [Presence] in Serum by Immunoassay
GBA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method
ASPA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BLM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DYS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TCRB and HC gene rearrangements in Blood or Tissue by Molecular genetics method
Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by Probe
Candida sp rRNA [Presence] in Vaginal fluid by Probe
Brucella sp Ag [Presence] in Specimen by Agglutination
Varicella zoster virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method
Spermatozoa IgM Ab/100 spermatozoa in Serum by Immunobead
Spermatozoa IgG Ab/100 spermatozoa in Serum by Immunobead
Spermatozoa IgA Ab/100 spermatozoa in Serum by Immunobead
Platelet associated IgG Ab [Presence] in Serum by Immunoassay
BCL6 Ag [Presence] in Tissue by Immune stain
Ber-EP4 Ag [Presence] in Tissue by Immune stain
Calretinin Ag [Presence] in Tissue by Immune stain
Cancer Ag 72-4 [Presence] in Tissue by Immune stain
CD1a Ag [Presence] in Tissue by Immune stain
CD21 Ag [Presence] in Tissue by Immune stain
CD31 Ag [Presence] in Tissue by Immune stain
CD4 Ag [Presence] in Tissue by Immune stain
CD68 Ag [Presence] in Tissue by Immune stain
CD79a Ag [Presence] in Tissue by Immune stain
CD8 Ag [Presence] in Tissue by Immune stain
CD99 Ag [Presence] in Tissue by Immune stain
CDX2 Ag [Presence] in Tissue by Immune stain
Choriogonadotropin.beta subunit Ag [Presence] in Tissue by Immune stain
Cytokeratin 5/6 Ag [Presence] in Tissue by Immune stain
Cytoketatin HMW Ag [Presence] in Tissue by Immune stain
DBA44 Ag [Presence] in Tissue by Immune stain
Follitropin Ag [Presence] in Tissue by Immune stain
HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Phosphatidate IgA Ab [Units/volume] in Serum by Immunoassay
Melan-A Ag [Presence] in Tissue by Immune stain
MyoD1 Ag [Presence] in Tissue by Immune stain
Myogenin Ag [Presence] in Tissue by Immune stain
Neurofilament Ag [Presence] in Tissue by Immune stain
NKI/C3 Ag [Presence] in Tissue by Immune stain
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen
Villin Ag [Presence] in Tissue by Immune stain
Sulfamethoxazole [Susceptibility] by Serum bactericidal titer
Herpes virus 8 IgG Ab [Titer] in Serum by Immunofluorescence
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Chlamydophila pneumoniae Ab [Units/volume] in Serum by Immunofluorescence
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay
Legionella pneumophila 10 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 11 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 11 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 12 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 12 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 13 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 13 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 14 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 14 IgM Ab [Titer] in Serum by Immunofluorescence
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Babesia microti IgG Ab [Titer] in Cerebral spinal fluid
Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence
Babesia microti IgM Ab [Titer] in Cerebral spinal fluid
PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence
Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay
Plasmodium sp DNA [Presence] in Blood by NAA with probe detection
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma
Angiotensinogen [Moles/volume] in Plasma
Delta aminolevulinate [Moles/volume] in Serum
Indicans/Creatinine [Molar ratio] in 24 hour Urine
Methylmalonate [Moles/time] in 24 hour Urine
Natriuretic peptide B [Moles/volume] in Serum or Plasma
Calciferol (Vit D2) [Moles/volume] in Serum or Plasma
Acetaminophen [Moles/volume] in Gastric fluid
Aluminum [Moles/volume] in Red Blood Cells
Carbamazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma
Chromium [Moles/volume] in 24 hour Urine
Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC)
Copper [Moles/volume] in Red Blood Cells
Gentamicin [Moles/volume] in Serum or Plasma
Glutethimide [Moles/volume] in Gastric fluid
Gold/Creatinine [Molar ratio] in 24 hour Urine
LORazepam [Moles/volume] in Gastric fluid
Manganese [Moles/volume] in Gastric fluid
Maprotiline [Moles/volume] in Gastric fluid
Meprobamate [Moles/volume] in Gastric fluid
Methyprylon [Moles/volume] in Gastric fluid
PHENobarbital [Moles/volume] in Gastric fluid
Primidone [Moles/volume] in Gastric fluid
Protriptyline [Moles/volume] in Gastric fluid
Salicylates [Moles/volume] in Gastric fluid
sulfiSOXAZOLE [Susceptibility] by Minimum lethal concentration (MLC)
Thallium [Moles/volume] in Red Blood Cells
Thioridazine [Moles/volume] in Gastric fluid
Trimipramine [Moles/volume] in Gastric fluid
Ascorbate [Moles/volume] in Serum or Plasma --post dose
EPINEPHrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO
EPINEPHrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO
EPINEPHrine [Moles/volume] in Plasma --2 hours post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --2nd specimen post XXX challenge
EPINEPHrine [Moles/volume] in Urine --2nd specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO
EPINEPHrine [Moles/volume] in Plasma --3rd specimen post XXX challenge
EPINEPHrine [Moles/volume] in Urine --3rd specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --4 hours post XXX challenge
EPINEPHrine [Moles/volume] in Urine --4th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --4th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --5th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Urine --5th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --6th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Urine --6th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --7th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Urine --7th specimen post XXX challenge
EPINEPHrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO
Lead [Moles/volume] in Urine --post EDTA therapy
Norepinephrine [Moles/volume] in Plasma --10 minutes post standing
Norepinephrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO
Norepinephrine [Moles/volume] in Plasma --1 hour post XXX challenge
Norepinephrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO
Norepinephrine [Moles/volume] in Plasma --2 hours post XXX challenge
Norepinephrine [Moles/volume] in Plasma --2nd specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --2nd specimen post XXX challenge
Norepinephrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO
Norepinephrine [Moles/volume] in Plasma --3 hours post XXX challenge
Norepinephrine [Moles/volume] in Plasma --3rd specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --3rd specimen post XXX challenge
Norepinephrine [Moles/volume] in Plasma --4 hours post XXX challenge
Norepinephrine [Moles/volume] in Plasma --4th specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --4th specimen post XXX challenge
Norepinephrine [Moles/volume] in Plasma --5th specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --5th specimen post XXX challenge
Norepinephrine [Moles/volume] in Plasma --6th specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --6th specimen post XXX challenge
Catecholamines [Moles/volume] in Plasma --7th specimen post XXX challenge
Norepinephrine [Moles/volume] in Urine --7th specimen post XXX challenge
Norepinephrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO
Parathyrin.intact [Moles/volume] in Serum or Plasma --10 minutes post excision
Parathyrin.intact [Moles/volume] in Serum or Plasma --5 minutes post excision
Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline
Parathyrin [Moles/volume] in Serum or Plasma --10 minutes post excision
Parathyrin [Moles/volume] in Serum or Plasma --baseline
Progesterone [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --baseline
Proinsulin [Moles/volume] in Serum or Plasma --baseline
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Vasopressin [Mass/volume] in Plasma --1st specimen post XXX challenge
sulfiSOXAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC)
Triglyceride [Moles/volume] in Serum or Plasma --fasting
Chlamydia trachomatis L2 DNA [Presence] in Specimen by NAA with probe detection
Chlamydia trachomatis DNA [Identifier] in Specimen by NAA with probe detection
Cholesterol in LDL real size pattern [Identifier] in Serum or Plasma
Lipoprotein.beta.subparticle.medium [Entitic length] in Serum or Plasma
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 200 copies/ml
Immune Complex C3d [Mass/volume] in Serum or Plasma
Cholesterol in VLDL 3+4 [Mass/volume] in Serum or Plasma
Cholesterol in VLDL 5+6 [Mass/volume] in Serum or Plasma
Cholesterol in HDL 4+5 [Mass/volume] in Serum or Plasma
Cholesterol in HDL 1+2 [Mass/volume] in Serum or Plasma
Trisomy 21 risk based on maternal age+Alpha-1-Fetoprotein+Choriogonadotropin+Estriol.unconjugated [Likelihood] in Fetus
Fetal Trisomy 18 risk [Likelihood] Based on maternal age
Bilirubin.total [Interpretation] in Amniotic fluid
Fetal lung maturity [Interpretation] in Amniotic fluid
Blood.dried [Presence] of Stone Qualitative
Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid
Herpes simplex virus glycoprotein G IgG Ab [Presence] in Serum
Influenza virus A Ab [Presence] in Serum --1st specimen
Influenza virus A Ab [Presence] in Serum --2nd specimen
Chlamydia trachomatis Ag [Presence] in Body fluid
Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay
Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay
Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay
Adenosine monophosphate.cyclic [Moles/volume] in Urine --2nd specimen post XXX challenge
BK virus DNA [Presence] in Specimen by NAA with probe detection
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Coproporphyrin 1 [Mass/volume] in 24 hour Urine
Coproporphyrin 3 [Mass/volume] in 24 hour Urine
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
Creatinine [Mass/volume] in Urine --2nd specimen post XXX challenge
Creatinine [Mass/volume] in Urine --1st specimen post XXX challenge
Creatinine [Mass/volume] in Urine --3rd specimen post XXX challenge
Creatinine [Mass/volume] in Urine --4th specimen post XXX challenge
Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection
Creatinine [Mass/volume] in Urine --6th specimen post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --3rd specimen post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --1st specimen post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --4th specimen post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --5th specimen post XXX challenge
Adenosine monophosphate.cyclic [Moles/volume] in Urine --6th specimen post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --2nd specimen post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --3rd specimen post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --4th specimen post XXX challenge
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --5th specimen post XXX challenge
Creatinine [Mass/volume] in Urine --5th specimen post XXX challenge
S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid
S100 calcium binding protein B [Mass/volume] in Serum
Complement Sc5b-9 Ab [Presence] in Serum or Plasma
Erythrocyte distribution width [Ratio] in Cord blood
Platelet mean volume [Entitic volume] in Cord blood
Heparin cofactor II Ag [Units/volume] in Platelet poor plasma
IgG and IgG subclass panel [Mass/volume] - Serum
IgG subclass panel [Mass/volume] - Serum
Fungus # 6 identified in Specimen by Culture
Fungus # 7 identified in Specimen by Culture
Bacteria # 7 identified in Genital specimen by Aerobe culture
Bacteria # 7 identified in Wound shallow by Aerobe culture
Bacteria # 8 identified in Wound shallow by Aerobe culture
Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen
Corynebacterium diphtheriae Ab [Ratio] in Serum --2nd specimen/1st specimen
DNA double strand Ab [Units/volume] in Serum by Farr method
Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay
Ribosomal P Ab [Units/volume] in Serum by Immunoassay
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk
Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain
Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF
BRST 2 Ag [Presence] in Tissue by Immune stain
Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay
Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF
Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay
Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay
Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay
Inner ear 68kD Ab [Units/volume] in Serum or Plasma by Immunoassay
Interleukin 12 [Mass/volume] in Body fluid by Immunoassay
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum by Immunoassay
Myelin basic protein Ab [Units/volume] in Serum by Immunoassay
Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay
Baker's yeast IgG Ab [Units/volume] in Serum by Immunoassay
SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Hepatitis B virus core Ab [Presence] in Serum from Donor by Immunoassay
HIV 1 RNA [Presence] in Serum or Plasma from Donor by Probe with amplification
Reagin Ab [Presence] in Serum from Donor by RPR
Treponema pallidum IgG Ab [Presence] in Serum from Donor by Immunoassay
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection
Cytomegalovirus Ab [Presence] in Serum from Donor by Hemagglutination
Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay
Hepatitis C virus Ab [Presence] in Serum from Donor by Immunoassay
Nuclear Ab [Presence] in Serum by Immunoassay
Netilmicin [Mass/volume] in Serum or Plasma
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method
Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection
Salmonella typhi H D Ab [Titer] in Serum by Agglutination
sulfiSOXAZOLE [Susceptibility] by Disk diffusion (KB)
Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test
chlorproPAMIDE [Mass/volume] in Specimen
Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay
Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay
Kanamycin [Mass/volume] in Serum or Plasma
Babesia microti DNA [Presence] in Specimen by NAA with probe detection
BCS1L gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Beta mannosidase actual/normal in Leukocytes
Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method
CV2 IgG Ab [Presence] in Serum by Immunoblot
CV2 Ab [Presence] in Serum or Plasma by Immunoblot
CYP2D6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method
Ehrlichia chaffeensis IgG Ab [Titer] in Serum by Immunofluorescence
Entamoeba histolytica Ab [Presence] in Cerebral spinal fluid
Fibers [#/area] in Stool by Light microscopy
Fosphenytoin [Mass/volume] in Serum or Plasma
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 6 DNA [Identifier] in Serum or Plasma by NAA with probe detection
Methadone [Presence] in Serum or Plasma by Confirmatory method
Mumps virus Ab [Units/volume] in Serum by Immunoassay
Plasma cells/100 leukocytes in Cerebral spinal fluid
Pregabalin [Mass/volume] in Serum or Plasma
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method
RB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Lipase [Enzymatic activity/volume] in Pleural fluid
Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay
Aspergillus flavus B Ab [Presence] in Serum
Aspergillus flavus H Ab [Presence] in Serum
Aspergillus fumigatus B Ab [Presence] in Serum
Aspergillus fumigatus H Ab [Presence] in Serum
Aspergillus nidulans B Ab [Presence] in Serum
Aspergillus nidulans H Ab [Presence] in Serum
Aspergillus niger B Ab [Presence] in Serum
Aspergillus niger H Ab [Presence] in Serum
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --1st specimen
Cytomegalovirus Ab [Presence] in Serum or Plasma from Donor
Echinococcus granulosus IgG Ab [Units/volume] in Serum
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid
Epstein Barr virus early diffuse Ab [Presence] in Serum
Epstein Barr virus early IgA Ab [Titer] in Serum
Epstein Barr virus early IgG Ab [Titer] in Body fluid
Epstein Barr virus early restricted Ab [Presence] in Serum
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --1st specimen
Hepatitis B virus core Ab [Presence] in Serum from Donor
Hepatitis C virus Ab [Presence] in Serum from Donor
Influenza virus A Ab [Presence] in Egg yolk
Influenza virus A H1 Ab [Titer] in Serum
Influenza virus A H10 Ab [Titer] in Serum
Influenza virus A H11 Ab [Titer] in Serum
Influenza virus A H12 Ab [Titer] in Serum
Influenza virus A H13 Ab [Titer] in Serum
Influenza virus A H14 Ab [Titer] in Serum
Influenza virus A H15 Ab [Titer] in Serum
Influenza virus A H2 Ab [Titer] in Serum
Influenza virus A H3 Ab [Titer] in Serum
Influenza virus A H4 Ab [Titer] in Serum
Influenza virus A H5 Ab [Titer] in Serum
Influenza virus A H6 Ab [Titer] in Serum
Influenza virus A H7 Ab [Titer] in Serum
Influenza virus A H8 Ab [Titer] in Serum
Influenza virus A H9 Ab [Titer] in Serum
Legionella pneumophila 10 IgG Ab [Titer] in Serum
Legionella pneumophila 10 IgM Ab [Titer] in Serum
Legionella pneumophila 11 IgG Ab [Titer] in Serum
Legionella pneumophila 11 IgM Ab [Titer] in Serum
Legionella pneumophila 12 IgG Ab [Titer] in Serum
Legionella pneumophila 12 IgM Ab [Titer] in Serum
Legionella pneumophila 13 IgG Ab [Titer] in Serum
Legionella pneumophila 13 IgM Ab [Titer] in Serum
Legionella pneumophila 14 IgG Ab [Titer] in Serum
Legionella pneumophila 14 IgM Ab [Titer] in Serum
Legionella pneumophila 7 IgG Ab [Titer] in Serum
sulfiSOXAZOLE [Susceptibility] by Serum bactericidal titer
Legionella pneumophila 7 IgM Ab [Titer] in Serum
Legionella pneumophila 8 IgG Ab [Titer] in Serum
Legionella pneumophila 8 IgM Ab [Titer] in Serum
Legionella pneumophila 9 IgG Ab [Titer] in Serum
Legionella pneumophila 9 IgM Ab [Titer] in Serum
Powassan virus polyvalent E Ab [Presence] in Specimen
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --2nd specimen
Treponema pallidum Ab [Units/volume] in Body fluid
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid
Treponema pallidum IgG Ab [Presence] in Serum from Donor
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid
Vesicular stomatitis Alagoas virus Ab [Titer] in Serum
Yersinia pestis Ab [Presence] in Specimen
Cytology report of Breast fine needle aspirate Cyto stain
Cytology report of Nipple discharge Cyto stain
Cytology report of Body fluid Cyto stain
Cytology report of Thyroid fine needle aspirate Cyto stain
Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep
Cytology report of Cervical or vaginal smear or scraping Cyto stain
Cytology report of Breast ductal lavage Cyto stain
Mumps virus RNA [Presence] in Specimen by NAA with probe detection
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
2-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Plasma
3-Hydroxysebacate ( 3-OH-C8)/Creatinine [Molar ratio] in Urine
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Cerebral spinal fluid
Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC)
3-Methylhistidine [Moles/volume] in Body fluid
4-Hydroxybenzoate/Creatinine [Molar ratio] in Urine
Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine
4-Hydroxymandelate/Creatinine [Molar ratio] in Urine
5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine
5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid
5-Methyltetrahydrofolate [Moles/volume] in Cerebral spinal fluid
Adenosine deaminase [Enzymatic activity/mass] in Fibroblast
Adenosine deaminase [Enzymatic activity/mass] in Red Blood Cells
Adenosine deaminase [Entitic Catalytic Activity] in Leukocytes
Alanine/Amino acids.total in Cerebral spinal fluid
Alanine/Amino acids.total in Amniotic fluid
Alanine/Amino acids.total in Serum or Plasma
Microalbumin/Protein.total in 24 hour Urine
Alpha aminobutyrate [Moles/volume] in DBS
Androstenedione [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
Arginine/Amino acids.total in Serum or Plasma
Arginine/Amino acids.total in Cerebral spinal fluid
Arginine/Amino acids.total in Amniotic fluid
Argininosuccinate lyase [Enzymatic activity/mass] in Liver
Argininosuccinate lyase [Enzymatic activity/mass] in Fibroblast
Argininosuccinate synthase [Enzymatic activity/mass] in Fibroblast
Aspartate/Amino acids.total in Cerebral spinal fluid
Aspartate/Amino acids.total in Amniotic fluid
Aspartate/Amino acids.total in Serum or Plasma
Bicarbonate [Moles/time] in 24 hour Urine
Bicarbonate [Moles/volume] in 24 hour Urine
Biopterin [Moles/volume] in Cerebral spinal fluid
Biopterin/Creatinine [Molar ratio] in Urine
C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose
C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose
C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose
C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon
C peptide [Moles/volume] in Serum or Plasma --pre dose glucose
Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE)
Calcium [Moles/volume] corrected for total protein in Blood
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood
Ceruloplasmin [Moles/volume] in Serum or Plasma
Choriogonadotropin.beta subunit free [Units/volume] in Body fluid
Citrate synthase [Enzymatic activity/mass] in Leukocytes
Citrate synthase [Enzymatic activity/mass] in Fibroblast
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin
Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV
Crystals [type] in Tissue by Light microscopy
Decanoate (C10:0)/Creatinine [Molar ratio] in Urine
Decenoate (C10:1)/Creatinine [Molar ratio] in Urine
Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Estradiol (E2) [Mass/volume] in Serum or Plasma --pre dose corticotropin
Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV
Follitropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug luteinizing releasing hormone IV
Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
Glutamate/Amino acids.total in Cerebral spinal fluid
Glutamate/Amino acids.total in Amniotic fluid
Glutamate/Amino acids.total in Serum or Plasma
Glutathione.oxidized [Moles/mass] in Red Blood Cells
Glycerol/Creatinine [Molar ratio] in Urine
Glycine/Amino acids.total in Serum or Plasma
Glycine/Amino acids.total in Cerebral spinal fluid
Glycine/Amino acids.total in Amniotic fluid
Hematocrit [Volume Fraction] of Dialysis fluid
Palmitate (C16:0)/Creatinine [Molar ratio] in Urine
Hexadecenoate (C16:1w9)/Creatinine [Molar ratio] in Urine
Histidine/Amino acids.total in Cerebral spinal fluid
Histidine/Amino acids.total in Amniotic fluid
Histidine/Amino acids.total in Serum or Plasma
Homogentisate/Creatinine [Molar ratio] in Urine
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose
Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon
Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose
Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose
Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose
Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose
Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose
Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose
Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose
Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose
Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose
Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose
Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose
Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon
Insulin [Units/volume] in Serum or Plasma --pre dose glucose
Insulin [Units/volume] in Serum or Plasma --pre dose glucagon
Insulin [Units/volume] in Serum or Plasma --pre-meal
Isoleucine/Amino acids.total in Cerebral spinal fluid
Isoleucine/Amino acids.total in Amniotic fluid
Isoleucine/Amino acids.total in Serum or Plasma
Isoleucine/Amino acids.total in Specimen
Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine
Leucine/Amino acids.total in Cerebral spinal fluid
Leucine/Amino acids.total in Amniotic fluid
Leucine/Amino acids.total in Serum or Plasma
Linoleate (C18:2w6)/Creatinine [Molar ratio] in Urine
Lutropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV
Lutropin [Units/volume] in Serum or Plasma --pre 100 ug luteinizing releasing hormone IV
Lysine/Amino acids.total in Cerebral spinal fluid
Lysine/Amino acids.total in Amniotic fluid
Lysine/Amino acids.total in Serum or Plasma
Malonate/Creatinine [Molar ratio] in Urine
Mandelate/Creatinine [Molar ratio] in Urine
Mannitol/Creatinine [Molar ratio] in Urine
Metanephrine/Creatinine [Molar ratio] in 24 hour Urine
Sulfonamide [Susceptibility] by Disk diffusion (KB)
Methionine/Amino acids.total in Cerebral spinal fluid
Methionine/Amino acids.total in Amniotic fluid
Methionine/Amino acids.total in Serum or Plasma
Methionine/Amino acids.total in Specimen
Methylmalonate/Urea [Molar ratio] in Amniotic fluid
Methylmalonate/Urea [Molar ratio] in Serum or Plasma
Methylmalonate/Urea [Molar ratio] in Urine
Neopterin/Creatinine [Molar ratio] in Urine
Oleate (C18:1w9)/Creatinine [Molar ratio] in Urine
Oxalate [Moles/volume] in Dialysis fluid
Oxygen [Partial pressure] adjusted to patient's actual temperature in Cord blood
Parathyrin [Mass/volume] in Serum or Plasma --2 hours post dose calcium
Parathyrin [Mass/volume] in Serum or Plasma --4 hours post dose calcium
Parathyrin [Mass/volume] in Serum or Plasma --pre dose calcium
pH of Cord blood adjusted to patient's actual temperature
Phenylalanine/Amino acids.total in Cerebral spinal fluid
Phenylalanine/Amino acids.total in Amniotic fluid
Phenylalanine/Amino acids.total in Serum or Plasma
Phenylalanine/Amino acids.total in Specimen
Phytanate (C16:0(CH3)4)/Creatinine [Molar ratio] in Urine
Pipecolate/Creatinine [Molar ratio] in Urine
Procollagen type III/Creatinine [Ratio] in Urine
Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV
Prolactin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV
Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV
Proline/Amino acids.total in Amniotic fluid
Proline/Amino acids.total in Serum or Plasma
Prostate specific Ag [Mass/volume] in Body fluid
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells
Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes
Serine/Amino acids.total in Cerebral spinal fluid
Serine/Amino acids.total in Amniotic fluid
Serine/Amino acids.total in Serum or Plasma
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --10 minutes post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --10th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --pre dose glucose PO
Somatotropin [Units/volume] in Serum or Plasma --pre dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --pre dose TRH
Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine
Sulfocysteine [Moles/volume] in Amniotic fluid
Myristate (C14:0)/Creatinine [Molar ratio] in Urine
Threonine/Amino acids.total in Cerebral spinal fluid
Threonine/Amino acids.total in Amniotic fluid
Threonine/Amino acids.total in Serum or Plasma
Tocopherols [Mass/volume] in Serum or Plasma
Tyrosine/Amino acids.total in Cerebral spinal fluid
Tyrosine/Amino acids.total in Amniotic fluid
Tyrosine/Amino acids.total in Serum or Plasma
Valine/Amino acids.total in Cerebral spinal fluid
Valine/Amino acids.total in Amniotic fluid
Valine/Amino acids.total in Serum or Plasma
2-Deoxytetronate/Creatinine [Molar ratio] in Urine
2-Ethylhydracrylate/Creatinine [Molar ratio] in Urine
2-Hydroxysebacate/Creatinine [Molar ratio] in Urine
2-Methyl-3-Hydroxyvalerate [Moles/volume] in Plasma
2-Methyl-3-Oxobutyrate/Creatinine [Molar ratio] in Urine
2-Methylglutaconate/Creatinine [Molar ratio] in Urine
2-Methylglutarate/Creatinine [Molar ratio] in Urine
3,4-Hydroxymandelate/Creatinine [Molar ratio] in Urine
3-Deoxytetronate/Creatinine [Molar ratio] in Urine
3-Hydroxy,4-Methoxybenzoate/Creatinine [Molar ratio] in Urine
3-Hydroxyhexanoate (3-OH-C6:0)/Creatinine [Molar ratio] in Urine
3-Hydroxysuberate/Creatinine [Molar ratio] in Urine
3-Hydroxyvalerate [Moles/volume] in Plasma
3-Indolelactate/Creatinine [Molar ratio] in Urine
3-Methyladipate/Creatinine [Molar ratio] in Urine
4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molar ratio] in Urine
7-Hydroxyoctanoate/Creatinine [Molar ratio] in Urine
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
Adenosyl homocysteine hydrolase [Enzymatic activity/mass] in Red Blood Cells
Adiponectin [Mass/volume] in Serum or Plasma
Arabitol/Creatinine [Molar ratio] in Urine
Argininosuccinate synthase [Enzymatic activity/mass] in Chorionic villus sample
Argininosuccinate synthase [Enzymatic activity/mass] in Amniotic fluid cells
C peptide [Moles/volume] in Serum or Plasma --4 minutes post 1 mg glucagon
C peptide [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon
C peptide [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid cells
Corticotropin [Mass/volume] in Plasma --post dose dexamethasone
Cortisol [Mass/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h
Cortisol [Moles/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h
Cortisol [Mass/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h
Cortisol [Moles/volume] in Serum or Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h
Cortisol [Mass/volume] in Serum or Plasma --post dose corticotropin
Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin
Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells
Fibroblast growth factor 23.intact [Units/volume] in Plasma
Fibroblast growth factor 23.C-terminal [Units/volume] in Plasma
Follitropin [Units/volume] in Serum or Plasma --pre 100 ug luteinizing releasing hormone IV
Galactitol/Creatinine [Molar ratio] in Urine
Gentisate/Creatinine [Molar ratio] in Urine
Glucose [Moles/volume] in Serum or Plasma --5 minutes post dose glucose
Glutamate dehydrogenase [Enzymatic activity/mass] in Chorionic villus sample
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells
Insulin [Units/volume] in Serum or Plasma --post meal
Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine
Lutropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug luteinizing releasing hormone IV
Malondialdehyde [Moles/volume] in Plasma
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Fibroblast
Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose metoclopramide
Prolactin [Units/volume] in Serum or Plasma --1 hour post dose metoclopramide
Prolactin [Mass/volume] in Serum or Plasma --2.5 hours post dose TRH IV
Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose metoclopramide
Prolactin [Units/volume] in Serum or Plasma --pre dose metoclopramide
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Amniotic fluid cells
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Fibroblast
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Leukocytes
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Placenta
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Chorionic villus sample
Propionylglycine [Moles/volume] in Plasma
Pyruvate carboxylase [Enzymatic activity/mass] in Amniotic fluid cells
Sulfonamide [Susceptibility] by Serum bactericidal titer
Pyruvate carboxylase [Enzymatic activity/mass] in Fibroblast
Pyruvate carboxylase [Enzymatic activity/mass] in Leukocytes
Pyruvate carboxylase [Enzymatic activity/mass] in Placenta
Ribitol/Creatinine [Molar ratio] in Urine
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --1.75 hours post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --2 hours post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --2 hours pre dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --3 hours post dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --5 minutes post dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --pre dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --pre dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --pre dose growth hormone releasing factor
Somatotropin [Units/volume] in Serum or Plasma --pre dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --pre dose propranolol+glucagon
Specimen source [Identifier] of Body fluid
Sulfocysteine [Moles/volume] in Serum or Plasma
Testosterone [Mass/volume] in Serum or Plasma --12 hours post 5000 U HCG IM
Testosterone [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Testosterone [Mass/volume] in Serum or Plasma --1 day post 5000 U HCG IM
Testosterone [Mass/volume] in Serum or Plasma --2 days post 5000 U HCG IM
Testosterone [Mass/volume] in Serum or Plasma --4 hours post 5000 U HCG IM
Testosterone [Mass/volume] in Serum or Plasma --3 days post 5000 U HCG IM
Testosterone [Mass/volume] in Serum or Plasma --pre dose corticotropin
Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --2 hours post dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose luteinizing releasing hormone IV
Thyrotropin [Units/volume] in Serum or Plasma --pre dose luteinizing releasing hormone IV
EYA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Deoxyuridine [Moles/volume] in Serum or Plasma
FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GFAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Talampicillin [Susceptibility] by Minimum lethal concentration (MLC)
GLRA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ACVRL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
JAG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
JAK3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MVK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mycoplasma penetrans DNA [Presence] in Specimen by NAA with probe detection
NCF2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
PINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PTEN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SGCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SGSH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TGFBR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
THRB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
tiZANidine [Mass/volume] in Serum or Plasma
Tranylcypromine [Presence] in Serum or Plasma
Mirtazapine [Presence] in Serum or Plasma
Phenylalanine/Creatinine [Ratio] in 24 hour Urine
Epstein Barr virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Progesterone [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Progesterone [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Bilirubin.total [Moles/volume] in Cord blood
Adenosine deaminase binding protein [Units/volume] in Urine
Genetic variant clinical significance [Interpretation] in Blood or Tissue by Molecular genetics method
DNA sequence variation display name [Text] Narrative
Chromosome [Identifier] in Blood or Tissue by Molecular genetics method
DNA sequence variation identifier [Identifier]
Genetic variant allelic state [Type] in Blood or Tissue by Molecular genetics method
Genechip manufacturer ID [Identifier] in Blood or Tissue by Molecular genetics method
Genechip ID [Identifier] in Blood or Tissue by Molecular genetics method
Genechip version [Identifier] in Blood or Tissue by Molecular genetics method
Reference sequence [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal
Sequence variation panel - Blood or Tissue by Molecular genetics method
Genechip kit panel - Blood or Tissue by Molecular genetics method
Sequencing methodology panel - Blood or Tissue by Molecular genetics method
Forward primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal
Reverse primer [Nucleotide sequence] in Blood or Tissue by Molecular genetics method Nominal
aPTT.lupus sensitive actual/normal (normalized LA screen)
HIV 1 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection
AS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Gene mutations tested for [#] in Blood or Tissue by Molecular genetics method
ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MT-ND4 gene c.G15257A [Presence] in Blood or Tissue by Molecular genetics method
SERPINE1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PKLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RHCE gene allele Ee [Genotype] in Amniotic fluid by Molecular genetics method Nominal
SCA10 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
THRB gene p.Ala317Thr [Presence] in Blood or Tissue by Molecular genetics method
TTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Leukocytes [#/volume] corrected for nucleated erythrocytes in Cerebral spinal fluid
Hemoglobin [Presence] in Cerebral spinal fluid
Pathologist interpretation of Synovial fluid tests
Fibronectin.fetal [Presence] in Specimen
Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Manual count
Anthraquinone cutoff [Mass/mass] in Stool
Oxyphenisatin cutoff [Mass/mass] in Stool
Phenolphthalein cutoff [Mass/mass] in Stool
Hemoglobin.gastrointestinal [Presence] in Vomitus
Neutrophils [Presence] in Nose by Wright stain
Eosinophils [Presence] in Stool by Wright stain
Neutrophils [Presence] in Stool by Wright stain
Erythrocytes [Presence] in Vaginal fluid
Leukocytes [#/volume] corrected for nucleated erythrocytes in Body fluid
Turbidity [Presence] of Synovial fluid Qualitative
Kaolin activated time [Units/volume] in Blood
Pneumocystis jiroveci [Presence] in Specimen by Calcofluor white
Human bocavirus Ag [Presence] in Specimen by Immunofluorescence
Human bocavirus IgG Ab [Presence] in Specimen by Immunoassay
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunoassay
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay
Spherocytes.micro [Presence] in Blood by Light microscopy
Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay
Complement total hemolytic CH50 [Titer] in Serum or Plasma
Synthetic glucocorticoid drug [Mass/volume] in Unknown substance
Thyroxine binding globulin panel [Mass/volume] - Serum or Plasma by Electrophoresis
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose glucagon
Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post dose luteinizing releasing hormone IV
3,6-Epoxydecanedioate/Creatinine [Molar ratio] in Urine
3,6-Epoxydodecanedioate/Creatinine [Molar ratio] in Urine
3,6-Epoxyoctanedioate/Creatinine [Molar ratio] in Urine
3,6-Epoxytetradecanedioate/Creatinine [Molar ratio] in Urine
3-Hydroxyadipate 3,6-lactone/Creatinine [Molar ratio] in Urine
3-Hydroxydodecanedienedioate/Creatinine [Molar ratio] in Urine
3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Molar ratio] in Urine
3-Hydroxydodecenedioate/Creatinine [Molar ratio] in Urine
3-Hydroxytetradecadienedioate/Creatinine [Molar ratio] in Urine
3-Hydroxytetradecanedioate/Creatinine [Molar ratio] in Urine
3-Hydroxytetradecenedioate/Creatinine [Molar ratio] in Urine
Cholesterol/Apolipoprotein B [Molar ratio] in Serum or Plasma
Cholesterol in HDL/Cholesterol in HDL+VLDL [Molar ratio] in Serum or Plasma
Corticotropin [Mass/volume] in Plasma --12 AM specimen
Corticotropin [Mass/volume] in Plasma --12 PM specimen
Corticotropin [Mass/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --4 AM specimen
Corticotropin [Mass/volume] in Plasma --4 PM specimen
Corticotropin [Mass/volume] in Plasma --8 AM specimen
Corticotropin [Mass/volume] in Plasma --8 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --12 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --12 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --15 minutes pre 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --4 AM specimen
Cortisol [Moles/volume] in Serum or Plasma --4 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --8 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --8 PM specimen
4,5-Dihydroxyhexanolactone/Creatinine [Molar ratio] in Urine
Erythritol/Creatinine [Molar ratio] in Urine
Follitropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug luteinizing releasing hormone IV
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucose
Glutathione.oxidized/Glutathione.reduced [Molar ratio] in Red Blood Cells
Glutathione.reduced [Moles/mass] in Red Blood Cells
Glutathione.reduced [Units/mass] in Red Blood Cells
Heptadecenoate/Creatinine [Molar ratio] in Urine
Hexadecanedioate/Creatinine [Molar ratio] in Urine
Homocysteine.free/Creatinine [Molar ratio] in Urine
Insulin [Units/volume] in Serum or Plasma --10 minutes pre dose glucose
Isovalerylglycine/Urea [Molar ratio] in Plasma
Lutropin [Units/volume] in Serum or Plasma --15 minutes pre 100 ug luteinizing releasing hormone IV
Pentadecanoate/Creatinine [Molar ratio] in Urine
Talampicillin [Susceptibility] by Disk diffusion (KB)
Prolactin [Mass/volume] in Serum or Plasma --15 minutes pre dose TRH IV
Quinolinate/Creatinine [Molar ratio] in Urine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose glucagon
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose insulin IV
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose ornithine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre dose TRH
Somatotropin [Units/volume] in Serum or Plasma --1 hour post dose arginine+insulin
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose betaxolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose propranolol+glucagon
Somatotropin [Units/volume] in Serum or Plasma --30 minutes pre dose TRH
Xylitol/Creatinine [Molar ratio] in Urine
Alanine aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
Aspartate aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)
Erythro-4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine
Erythro-4-Deoxytetronate/Creatinine [Molar ratio] in Urine
Ferritin [Entitic mass] in Red Blood Cells
Indole-3-Acetate/Creatinine [Molar ratio] in Urine
Mevalonolactone/Creatinine [Molar ratio] in Urine
Oligosaccharides/Creatinine [Molar ratio] in Urine
Perseitol/Creatinine [Molar ratio] in Urine
Sedoheptitol/Creatinine [Molar ratio] in Urine
Sorbitol/Creatinine [Molar ratio] in Urine
Threitol/Creatinine [Molar ratio] in Urine
Threo-4,5-Dihydrohexanoate/Creatinine [Molar ratio] in Urine
Threo-4,5-Dihydrohexanolactone/Creatinine [Molar ratio] in Urine
Threo-4-Deoxytetronate/Creatinine [Molar ratio] in Urine
Thymine/Creatinine [Molar ratio] in Urine
Vanillate/Creatinine [Molar ratio] in Urine
Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay
HTLV I rgp21 Ab [Presence] in Serum by Immunoblot
PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Thymidine [Moles/volume] in Serum or Plasma
Cytokeratin 19 [Mass/volume] in Body fluid
Enolase.neuron specific [Mass/volume] in Body fluid
Squamous cell carcinoma Ag [Mass/volume] in Body fluid
Beta-2-Microglobulin [Mass/volume] in Body fluid
Prostate specific Ag/Creatinine [Mass Ratio] in Urine
5-Hydroxyindoleacetate [Presence] in Urine
Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by NAA with probe detection
Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Reference change value 0.99 [#] in unspecified time Population
Reference change value 0.99 in unspecified time Population
Reference change value 0.95 in unspecified time Population
Reference change value 0.95 [#] in unspecified time Population
European Hornet triggered leukotriene release [Mass/volume] by Leukocytes
Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes
Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes
Honey bee triggered leukotriene release [Mass/volume] by Leukocytes
Amylase triggered leukotriene release [Mass/volume] by Leukocytes
Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes
Latex triggered leukotriene release [Mass/volume] by Leukocytes
Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes
Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes
Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes
Sunset yellow FCF triggered leukotriene release [Mass/volume] by Leukocytes
Succinylcholine triggered leukotriene release [Mass/volume] by Leukocytes
Lidocaine triggered leukotriene release [Mass/volume] by Leukocytes
Trimethoprim triggered leukotriene release [Mass/volume] by Leukocytes
Cephalosporin C triggered leukotriene release [Mass/volume] by Leukocytes
Cefuroxime triggered leukotriene release [Mass/volume] by Leukocytes
Amoxicillin triggered leukotriene release [Mass/volume] by Leukocytes
Ampicillin triggered leukotriene release [Mass/volume] by Leukocytes
Talampicillin [Susceptibility] by Serum bactericidal titer
Penicillin V triggered leukotriene release [Mass/volume] by Leukocytes
Penicillin G triggered leukotriene release [Mass/volume] by Leukocytes
Short+Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes
Celery triggered leukotriene release [Mass/volume] by Leukocytes
Casein triggered leukotriene release [Mass/volume] by Leukocytes
Beta lactoglobulin triggered leukotriene release [Mass/volume] by Leukocytes
Lactalbumin alpha triggered leukotriene release [Mass/volume] by Leukocytes
Egg yolk triggered leukotriene release [Mass/volume] by Leukocytes
Baker's yeast triggered leukotriene release [Mass/volume] by Leukocytes
Orange triggered leukotriene release [Mass/volume] by Leukocytes
Carrot triggered leukotriene release [Mass/volume] by Leukocytes
Beef triggered leukotriene release [Mass/volume] by Leukocytes
Pork triggered leukotriene release [Mass/volume] by Leukocytes
Tomato triggered leukotriene release [Mass/volume] by Leukocytes
Shrimp triggered leukotriene release [Mass/volume] by Leukocytes
Crab triggered leukotriene release [Mass/volume] by Leukocytes
Hazelnut triggered leukotriene release [Mass/volume] by Leukocytes
Soybean triggered leukotriene release [Mass/volume] by Leukocytes
Peanut triggered leukotriene release [Mass/volume] by Leukocytes
Sesame Seed triggered leukotriene release [Mass/volume] by Leukocytes
Oat triggered leukotriene release [Mass/volume] by Leukocytes
Barley triggered leukotriene release [Mass/volume] by Leukocytes
Rye triggered leukotriene release [Mass/volume] by Leukocytes
Wheat triggered leukotriene release [Mass/volume] by Leukocytes
Codfish triggered leukotriene release [Mass/volume] by Leukocytes
Cow milk triggered leukotriene release [Mass/volume] by Leukocytes
Egg white triggered leukotriene release [Mass/volume] by Leukocytes
Human serum albumin triggered leukotriene release [Mass/volume] by Leukocytes
Bovine serum albumin (BSA) triggered leukotriene release [Mass/volume] by Leukocytes
Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes
Cat dander triggered leukotriene release [Mass/volume] by Leukocytes
Glycyphagus domesticus triggered leukotriene release [Mass/volume] by Leukocytes
Tyrophagus putrescentiae triggered leukotriene release [Mass/volume] by Leukocytes
Lepidoglyphus destructor triggered leukotriene release [Mass/volume] by Leukocytes
Acarus siro triggered leukotriene release [Mass/volume] by Leukocytes
American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes
European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes
Flea triggered leukotriene release [Mass/volume] by Leukocytes
Cockroach triggered leukotriene release [Mass/volume] by Leukocytes
Alternaria alternata triggered leukotriene release [Mass/volume] by Leukocytes
Candida albicans triggered leukotriene release [Mass/volume] by Leukocytes
Aspergillus fumigatus triggered leukotriene release [Mass/volume] by Leukocytes
Cladosporium herbarum triggered leukotriene release [Mass/volume] by Leukocytes
Penicillium notatum triggered leukotriene release [Mass/volume] by Leukocytes
Red Cedar triggered leukotriene release [Mass/volume] by Leukocytes
Japanese Cedar triggered leukotriene release [Mass/volume] by Leukocytes
Olive Pollen triggered leukotriene release [Mass/volume] by Leukocytes
White Oak triggered leukotriene release [Mass/volume] by Leukocytes
Hazelnut Pollen triggered leukotriene release [Mass/volume] by Leukocytes
Silver Birch triggered leukotriene release [Mass/volume] by Leukocytes
Pellitory (Parietaria judaica) triggered leukotriene release [Mass/volume] by Leukocytes
Pellitory (Parietaria officinalis) triggered leukotriene release [Mass/volume] by Leukocytes
Saltwort triggered leukotriene release [Mass/volume] by Leukocytes
English plantain triggered leukotriene release [Mass/volume] by Leukocytes
Mugwort triggered leukotriene release [Mass/volume] by Leukocytes
Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes
Common Ragweed triggered leukotriene release [Mass/volume] by Leukocytes
Velvet grass triggered leukotriene release [Mass/volume] by Leukocytes
Cultivated Rye triggered leukotriene release [Mass/volume] by Leukocytes
Kentucky blue grass triggered leukotriene release [Mass/volume] by Leukocytes
Timothy triggered leukotriene release [Mass/volume] by Leukocytes
Perennial rye grass triggered leukotriene release [Mass/volume] by Leukocytes
Meadow Fescue triggered leukotriene release [Mass/volume] by Leukocytes
Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes
Bermuda grass triggered leukotriene release [Mass/volume] by Leukocytes
Dust Allergen Mix B (Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) triggered leukotriene release [Mass/volume] by Leukocytes
Grass Allergen Mix E (Cocksfoot+Meadow Fescue+Velvet grass+Perennial rye grass+Timothy+Kentucky blue grass ) triggered leukotriene release [Mass/volume] by Leukocytes
Benzylpenicilloyl-polylysine triggered leukotriene release [Mass/volume] by Leukocytes
Minor determinant mixture triggered leukotriene release [Mass/volume] by Leukocytes
Cefamandole triggered leukotriene release [Mass/volume] by Leukocytes
ceFAZolin triggered leukotriene release [Mass/volume] by Leukocytes
Tetracycline triggered leukotriene release [Mass/volume] by Leukocytes
Ciprofloxacin triggered leukotriene release [Mass/volume] by Leukocytes
Lysine acetylsalicylate triggered leukotriene release [Mass/volume] by Leukocytes
Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes
Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes
Indomethacin triggered leukotriene release [Mass/volume] by Leukocytes
Acetaminophen triggered leukotriene release [Mass/volume] by Leukocytes
Mefenamate triggered leukotriene release [Mass/volume] by Leukocytes
Propyphenazone triggered leukotriene release [Mass/volume] by Leukocytes
Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes
Sulfamethoxazole triggered leukotriene release [Mass/volume] by Leukocytes
Atracurium triggered leukotriene release [Mass/volume] by Leukocytes
Mivacurium triggered leukotriene release [Mass/volume] by Leukocytes
Pancuronium triggered leukotriene release [Mass/volume] by Leukocytes
Propofol triggered leukotriene release [Mass/volume] by Leukocytes
Rocuronium triggered leukotriene release [Mass/volume] by Leukocytes
Vecuronium triggered leukotriene release [Mass/volume] by Leukocytes
Sodium benzoate triggered leukotriene release [Mass/volume] by Leukocytes
Sodium nitrite triggered leukotriene release [Mass/volume] by Leukocytes
Potassium metabisulfite triggered leukotriene release [Mass/volume] by Leukocytes
Sodium salicylate triggered leukotriene release [Mass/volume] by Leukocytes
Tartrazine triggered leukotriene release [Mass/volume] by Leukocytes
Food colorant mix I triggered leukotriene release [Mass/volume] by Leukocytes
Food colorant mix II triggered leukotriene release [Mass/volume] by Leukocytes
Quinoline yellow triggered leukotriene release [Mass/volume] by Leukocytes
Chromotrope 2B triggered leukotriene release [Mass/volume] by Leukocytes
Pigweed triggered leukotriene release [Mass/volume] by Leukocytes
New coccine triggered leukotriene release [Mass/volume] by Leukocytes
Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes
Patent blue V triggered leukotriene release [Mass/volume] by Leukocytes
Indigo carmine triggered leukotriene release [Mass/volume] by Leukocytes
Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes
Glutamate triggered leukotriene release [Mass/volume] by Leukocytes
Coproporphyrin 1/Creatinine [Mass Ratio] in Urine
Coproporphyrin 3/Creatinine [Mass Ratio] in Urine
Didanosine [Mass/volume] in Serum or Plasma
DNA double strand Ab [Units/volume] in Body fluid by Farr method
BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A [Presence] in Specimen by Organism specific culture
Lysosomal enzymes screen [Identifier] in Blood
Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination
Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence
Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence
Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence
Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence
Glimepride [Presence] in Serum or Plasma
Repaglinide [Presence] in Serum or Plasma
chlorproPAMIDE [Presence] in Serum or Plasma
MCOLN1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
BLM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Aspergillus sp Ag [Presence] in Tissue by Immune stain
Candida sp Ag [Presence] in Tissue by Immune stain
Histoplasma capsulatum Ag [Presence] in Tissue by Immune stain
Sporothrix schenckii Ag [Presence] in Tissue by Immune stain
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Ethanol+Methanol+Isopropyl alcohol+Acetone [Moles/volume] in Serum or Plasma
Hemoglobin.other/Hemoglobin.total in Blood
Activated clotting time.kaolin induced of Platelet poor plasma
HIV 1+O+2 Ab [Presence] in Serum or Plasma
HIV 1+O+2 Ab [Units/volume] in Serum or Plasma
levETIRAcetam [Moles/volume] in Serum or Plasma
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
Pregabalin [Moles/volume] in Serum or Plasma
Venlafaxine+O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma
Methotrimeprazine [Moles/volume] in Serum or Plasma
Reboxetine [Moles/volume] in Serum or Plasma
Chlorprothixene [Moles/volume] in Serum or Plasma
ARIPiprazole [Moles/volume] in Serum or Plasma
traMADol [Moles/volume] in Serum or Plasma
Prazepam [Moles/volume] in Serum or Plasma
Testosterone [Moles/volume] in Saliva (oral fluid)
Herpes virus 8 IgM Ab [Titer] in Serum by Immunofluorescence
Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination
Borrelia afzelii IgG Ab [Presence] in Serum by Immunoblot
Borrelia valaisiana IgG Ab [Presence] in Serum by Immunoblot
O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma
Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma
Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma
Methadone.R [Moles/volume] in Serum or Plasma
Pentadecanoate [Moles/volume] in Serum or Plasma
cis-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma
trans-Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma
trans-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma
Dihomogammalinolenate (C20:3n-6) [Moles/volume] in Serum or Plasma
Docosapentaenoate (C22:5 n-3) [Moles/volume] in Serum or Plasma
Spermatozoa Isolated Head/100 spermatozoa in Semen
Spermatozoa Angled Midpiece/100 spermatozoa in Semen
Spermatozoa Isolated Tail/100 spermatozoa in Semen
Spermatozoa Short Tail/100 spermatozoa in Semen
Collagen type 1 Ab [Units/volume] in Serum
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum
Zopiclone [Moles/volume] in Serum or Plasma
Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC)
3-Methoxytyramine [Moles/volume] in 24 hour Urine
3-Methoxytyramine/Creatinine [Molar ratio] in 24 hour Urine
Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Molar ratio] in Serum or Plasma
Collagen.bovine type 1 Ab [Units/volume] in Serum
Collagen.bovine type 2 Ab [Units/volume] in Serum
Collagen.injectable Ab [Units/volume] in Serum
Platelets Large/Platelets in Blood by Automated count
Thyroglobulin recovery [Presence] in Serum or Plasma
Macroprolactin/Prolactin [Moles] in Serum or Plasma
B cell crossmatch [Presence] in Blood from Donor
Carbon dioxide, total [Moles/volume] in Venous blood by calculation
Coccidioides immitis Ab [Titer] in Body fluid by Complement fixation
Coccidioides immitis IgM Ab [Units/volume] in Body fluid
Coccidioides sp Ab [Presence] in Body fluid by Immune diffusion (ID)
Coproporphyrin/Creatinine [Molar ratio] in Urine
Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immunofluorescence
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid
Methadone+Metabolite [Mass/volume] in Serum or Plasma
Myeloperoxidase IgG Ab [Units/volume] in Serum
Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence
Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma
Proteinase 3 IgG Ab [Units/volume] in Serum
T cell crossmatch [Presence] in Blood from Donor
Yersinia sp IgM Ab [Presence] in Serum by Immunoblot
Fungus identified in Tissue by Immune stain
Zygomycete sp Ag [Presence] in Tissue by Immune stain
Alpha-1-Microglobulin [Mass/volume] in Serum or Plasma
Alpha-1-Microglobulin [Mass/time] in 24 hour Urine
Alpha-1-Microglobulin/Creatinine [Mass Ratio] in Urine
Alpha-1-acid glycoprotein [Mass/volume] in Body fluid
Staphylolysin Ab [Units/volume] in Body fluid
Immune complex.IgG [Mass/volume] in Serum or Plasma by C1q binding assay
Complement C3c [Mass/volume] in Body fluid
C reactive protein [Mass/volume] in Capillary blood
Oligoclonal bands [Presence] in Serum or Plasma
Protein Fractions [Interpretation] in Body fluid by Electrophoresis
Protein Fractions [Interpretation] in Body fluid
Troponin T.cardiac [Mass/volume] in Blood
Erythrocytes.Plasmodium sp infected/1000 erythrocytes in Blood
Rumenate (C18:2 cis-9 trans-11) [Moles/volume] in Serum or Plasma
Carnitine [Molar amount] in unspecified time Semen
Zinc [Molar amount] in unspecified time Semen
Fructose [Molar amount] in unspecified time Semen
Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)
Beta-trace protein [Mass/volume] in Cerebral spinal fluid
Complement C1 esterase inhibitor actual/normal in Serum or Plasma
Transferrin.carbohydrate deficient/Transferrin.total in Serum or Plasma
Complement total hemolytic CH50 actual/normal in Serum or Plasma
Pro-hepcidin [Mass/volume] in Serum or Plasma
Amyloid A [Mass/volume] in Serum or Plasma
Beta-trace protein [Mass/volume] in Serum or Plasma
Borrelia burgdorferi 18kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
HLA Ab [Presence] in Serum by Immunoassay
Platelet glycoprotein Ia/IIa IgG Ab [Presence] in Blood by Immunoassay
Platelet glycoprotein Ib/Ix IgG Ab [Presence] in Blood by Immunoassay
Platelet glycoprotein IIb/IIIa IgG Ab [Presence] in Blood by Immunoassay
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum by Immunoassay
Platelet glycoprotein Ib/Ix Ab [Presence] in Serum by Immunoassay
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay
Measles virus RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A and B RNA [Identifier] in Specimen by NAA with probe detection
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL
Teicoplanin [Susceptibility] by Disk diffusion (KB)
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 400 copies/mL
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 2.6 log copies/mL
Muscle sarcolemma Ab [Units/volume] in Pleural fluid
Myocardium Ab [Titer] in Pleural fluid by Immunofluorescence
Fetal blood [Volume] by Kleihauer-Betke method
Erythrocytes.fetal/1000 erythrocytes [Ratio] in Blood by Kleihauer-Betke method
Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection
Bacteria # 2 identified in Specimen by Respiratory culture
Bacteria # 3 identified in Specimen by Respiratory culture
Bacteria # 4 identified in Specimen by Respiratory culture
Bacteria # 5 identified in Specimen by Respiratory culture
Bacteria # 6 identified in Specimen by Respiratory culture
Bacteria # 7 identified in Specimen by Respiratory culture
Bacteria # 3 identified in Specimen by Aerobe culture
Bacteria # 7 identified in Specimen by Aerobe culture
Bacteria # 8 identified in Specimen by Aerobe culture
Follitropin [Units/volume] in Serum or Plasma --on cycle day 10
Follitropin [Units/volume] in Serum or Plasma --on cycle day 11
Follitropin [Units/volume] in Serum or Plasma --on cycle day 21
Follitropin [Units/volume] in Serum or Plasma --on cycle day 3
Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection
Hepatitis C virus genotype [Identifier] in Specimen by NAA with probe detection
Hepatitis C virus RNA [Presence] in Specimen by Probe with signal amplification
HFE gene c.187G>C [Presence] in Blood or Tissue by Molecular genetics method
KCNQ1OT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Lutropin [Units/volume] in Serum or Plasma --on cycle day 11
Lutropin [Units/volume] in Serum or Plasma --on cycle day 3
Lutropin [Units/volume] in Serum or Plasma --on cycle day 21
Collagen crosslinked C-telopeptide [Mass/volume] in Urine
Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine
Coccidioides sp rRNA [Presence] in Specimen by NAA with probe detection
Coccidioides sp rRNA [Presence] in Isolate by NAA with probe detection
aPTT in Platelet poor plasma by Coagulation assay --after addition of APC
Activated protein C resistance [Interpretation] in Platelet poor plasma
Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutination
von Willebrand panel - Platelet poor plasma
Platelet glycoprotein IIb/IIIa Ab [Presence] in Blood by Immunoassay
von Willebrand evaluation [Interpretation] in Platelet poor plasma
Activated protein C resistance panel - Platelet poor plasma
cycloSPORINE [Mass/volume] in Blood by Immunoassay --trough
BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CLCN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
VPS13B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TGM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose fructose PO
Glucose [Mass/volume] in Serum or Plasma --pre dose fructose PO
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose fructose PO
Adenovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection
Teicoplanin [Susceptibility] by Serum bactericidal titer
7-Dehydrocholesterol [Mass/volume] in Amniotic fluid
Antibiotic tested [Identifier] against isolate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose lactose PO
Cryoglobulin [Presence] in Serum by Immune diffusion (ID)
Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma
Phosphate [Mass/volume] in Serum or Plasma --post dialysis
Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate
Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate
Hexacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine
Urea nitrogen [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis
Bilirubin.direct [Mass/volume] in Cord blood
Bilirubin.total [Mass/volume] in Cord blood
Choriogonadotropin.intact [Presence] in Body fluid
Creatinine [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis
Insulin-like growth factor binding protein 3 [Presence] in Urine
Urea nitrogen [Mass/volume] in Venous blood --post dialysis
Creatinine [Mass/volume] in Peritoneal fluid --pre dialysis
Bicarbonate [Moles/volume] in Serum --post dialysis
Heptacarboxylporphyrin [Mass/time] in 24 hour Stool
Coproporphyrin/Creatinine [Mass Ratio] in 24 hour Urine
Cholesterol in LDL pattern A [Presence] in Serum or Plasma
Cholesterol in LDL pattern BII [Presence] in Serum or Plasma by Electrophoresis
Cholesterol in LDL pattern BI [Presence] in Serum or Plasma by Electrophoresis
Cryoglobulin type [Identifier] in Serum by Immunofixation
Urea nitrogen [Mass/volume] in Peripheral blood --post dialysis
Phosphate [Mass/volume] in Serum or Plasma --pre dialysis
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
Vanillylmandelate, Homovanillate and Creatinine panel - 24 hour Urine
Pseudomonas sp DNA [Identifier] in Specimen by NAA with probe detection
Yersinia sp DNA [Identifier] in Specimen by NAA with probe detection
Ej Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA)
OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA)
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 copies/mL
Borrelia burgdorferi IgM Ab index [Units/volume] in Body fluid
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum by Immunoassay
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Ganglioside GD1a Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM2 Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM1 Ab [Units/volume] in Serum by Immunoassay
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --5 days post incubation
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived
IgA.intrathecally synthesized [Mass/volume] in Serum and CSF
IgG.intrathecally synthesized [Mass/volume] in Serum and CSF
IgM.intrathecally synthesized [Mass/volume] in Serum and CSF
Protein fractions.oligoclonal bands.intrathecal [Presence] in Serum and CSF
Albumin and Immunoglobulin Quotient [Interpretation] in Serum and CSF
IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Prostate cancer risk [Likelihood] by Estimated
Clinical cytogeneticist [Identifier] in Specimen
EBV-LMP Ag [Presence] in Tissue by Immune stain
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
Cancer Ag 125 [Presence] in Tissue by Immune stain
P57 Ag [Presence] in Tissue by Immune stain
Pancytokeratin Ag [Presence] in Tissue by Immune stain
PAX5 Ag [Presence] in Tissue by Immune stain
Plasma cell Ag [Presence] in Tissue by Immune stain
Smooth muscle myosin heavy chain Ag [Presence] in Tissue by Immune stain
Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection
X and Y chromosome [Interpretation] in Blood or Marrow by FISH--post bone marrow transplant
Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Salmonella paratyphi C Ab [Titer] in Serum
Thyrotropin releasing hormone [Mass] of Dose
Luteinizing releasing hormone [Mass] of Dose
Spermatozoa Immature/100 spermatozoa in Semen
Hematocrit [Volume Fraction] of Blood by Estimated
Leukocytes+Platelets [Morphology] in Blood
Reticulocyte mean volume [Entitic volume] in Reticulocytes
Hemoglobin C crystals [Presence] in Red Blood Cells by Light microscopy
Erythrocytes.fresh/100 erythrocytes in Cerebral spinal fluid by Manual count
Burr cells/100 erythrocytes in Cerebral spinal fluid by Manual count
Eosinophils [Presence] in Specimen by Light microscopy
Free Hemoglobin [Mass/volume] in Plasma --after transfusion reaction
Microscopic observation [Identifier] in Genital specimen by Gram stain
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence
Leishmania tropica IgM Ab [Units/volume] in Serum by Immunofluorescence
Leishmania tropica IgG Ab [Units/volume] in Serum by Immunofluorescence
La Crosse virus IgG Ab [Units/volume] in Serum by Immunoassay
Leishmania mexicana IgM Ab [Units/volume] in Serum by Immunofluorescence
Leishmania mexicana IgG Ab [Units/volume] in Serum by Immunofluorescence
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunofluorescence
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum by Immunofluorescence
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunofluorescence
Microscopic observation [Identifier] in Body fluid by Crystal violet stain
Epstein Barr virus Ab [Presence] in Serum by Immunofluorescence
Bacteria # 3 identified in Blood by Culture
Hemoglobin [Mass/volume] in Blood --pre therapeutic phlebotomy
JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Bacteria # 2 identified in Blood by Culture
NCF1+NCF2+CYBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CYBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative
Complement C4 [Presence] in Serum or Plasma
NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture
3-Hydroxy fatty acids pattern [Interpretation] in Serum or Plasma
3-Hydroxypalmitate.free (3-OH-C16:0) [Moles/volume] in Serum or Plasma
3-Hydroxymyristate.free (3-OH-C14:0) [Moles/volume] in Serum or Plasma
3-Hydroxydodecanoate.free (3-OH-C12:0) [Moles/volume] in Serum or Plasma
3-Hydroxydodecanoate (3-OH-C12:0) [Moles/volume] in Serum or Plasma
3-Hydroxydecanoate.free (3-OH-C10:0) [Moles/volume] in Serum or Plasma
3-Hydroxyoctanoate.free (3-OH-C8:0) [Moles/volume] in Serum or Plasma
3-Hydroxyoctanoate (3-OH-C8:0) [Moles/volume] in Serum or Plasma
3-Hydroxyhexanoate.free (3-OH-C6:0) [Moles/volume] in Serum or Plasma
3-Hydroxyhexanoate (3-OH-C6:0) [Moles/volume] in Serum or Plasma
3-Hydroxy fatty acid panel - Serum or Plasma
3-Hydroxypalmitate (3-OH-C16:0) [Moles/volume] in Serum or Plasma
3-Hydroxymyristate (3-OH-C14:0) [Moles/volume] in Serum or Plasma
3-Hydroxydecanoate (3-OH-C10:0) [Moles/volume] in Serum or Plasma
Kappa light chains [Mass/volume] in Cerebral spinal fluid
Lambda light chains [Mass/volume] in Cerebral spinal fluid
Kappa light chains/Lambda light chains [Mass Ratio] in Cerebral spinal fluid
Kappa light chains.free [Mass/volume] in Cerebral spinal fluid
Lambda light chains.free [Mass/volume] in Cerebral spinal fluid
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Cerebral spinal fluid
Kappa light chains.free/Albumin in Serum and CSF
Nucleated erythrocytes/100 cells in Cerebral spinal fluid
CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
Herpes simplex virus 2 Ab [Presence] in Serum by Immunoassay
Prostaglandin D2 [Mass/volume] in Body fluid
Renin [Enzymatic activity/volume] in Plasma --30 minutes pre XXX challenge
Glucose [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis
Creatinine peritoneal dialysis clearance
Creatinine peritoneal dialysis clearance/1.73 sq M
Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC)
Creatinine [Mass/time] in unspecified time Peritoneal dialysis fluid
Urea nitrogen peritoneal dialysis clearance/1.73 sq M
Hepatitis C virus FibroSURE panel - Serum or Plasma
First trimester maternal screen panel - Serum or Plasma
Second trimester penta maternal screen panel - Serum or Plasma
Second trimester quad maternal screen panel - Serum or Plasma
Alpha-1-Fetoprotein panel - Serum or Plasma
Neural tube defect risk [Likelihood] in Fetus
Platelet aggregation panel - Platelet rich plasma
Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified in Stool by Organism specific culture
Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g glucose PO
Protein fractions 3 panel - Serum or Plasma
Methicillin resistance mecA gene [Presence] by Molecular method
Vancomycin resistance vanA gene [Presence] by Molecular method
Staphylococcus aureus Panton-Valentine leukocidin gene [Presence] in Isolate or Specimen by Molecular genetics method
Donath Landsteiner Ab [Titer] in Control Serum
Karyotype [Identifier] in Blood or Tissue by High resolution Nominal
Karyotype [Identifier] in Tissue from Fetus Nominal
Karyotype [Identifier] in Cord blood Nominal
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence
Respiratory allergen panel, US - North Atlantic states a - Serum
Respiratory allergen panel, US - Mid Atlantic states - Serum
Respiratory allergen panel, US - South Atlantic states a - Serum
Respiratory allergen panel, US - Subtropical Florida - Serum
Respiratory allergen panel, US - Greater Ohio valley a - Serum
Respiratory allergen panel, US - South central states - Serum
Respiratory allergen panel, US - Northern midwest states a - Serum
Respiratory allergen panel, US - Central midwest a - Serum
Respiratory allergen panel, US - Great plains states a - Serum
Respiratory allergen panel, US - Southwestern grassland states - Serum
Respiratory allergen panel, US - Rocky mountain states a - Serum
Respiratory allergen panel, US - Arid southwest - Serum
Respiratory allergen panel, US - Southern coastal California - Serum
Respiratory allergen panel, US - California central valley - Serum
Respiratory allergen panel, US - Intermountain west a - Serum
Respiratory allergen panel, US - Inland northwest a - Serum
Respiratory allergen panel, US - Cascade Pacific northwest a - Serum
Respiratory allergen panel, US - Alaska a - Serum
Bartonella bacilliformis IgG Ab [Titer] in Serum by Immunofluorescence
Bartonella bacilliformis IgM Ab [Titer] in Serum by Immunofluorescence
Bartonella elizabethae IgG Ab [Titer] in Serum by Immunofluorescence
Bartonella elizabethae IgM Ab [Titer] in Serum by Immunofluorescence
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum by Immunofluorescence
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum by Immunofluorescence
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum by Immunofluorescence
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum by Immunofluorescence
Ehrlichia chaffeensis IgM Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum by Immunofluorescence
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum by Immunofluorescence
Rickettsia africae IgM Ab [Titer] in Serum by Immunofluorescence
Rickettsia africae IgG Ab [Titer] in Serum by Immunofluorescence
Rickettsia akari IgG Ab [Titer] in Serum by Immunofluorescence
Rickettsia akari IgM Ab [Titer] in Serum by Immunofluorescence
Rickettsia parkeri IgM Ab [Titer] in Serum by Immunofluorescence
Rickettsia parkeri IgG Ab [Titer] in Serum by Immunofluorescence
Rickettsia sp DNA [Identifier] in Specimen by RFLP
Bartonella sp DNA [Presence] in Specimen by NAA with probe detection
Ehrlichia ewingii DNA [Presence] in Specimen by NAA with probe detection
Ehrlichia sp DNA [Presence] in Specimen by NAA with probe detection
Orientia tsutsugamushi DNA [Presence] in Specimen by NAA with probe detection
Rickettsia rickettsii DNA [Presence] in Specimen by NAA with probe detection
Rickettsia sp DNA [Presence] in Specimen by NAA with probe detection
Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Rickettsia spotted fever group DNA [Presence] in Specimen by NAA with probe detection
Rickettsia typhus group DNA [Presence] in Specimen by NAA with probe detection
Anaplasma phagocytophilum [Presence] in Specimen by Organism specific culture
Ehrlichia sp identified in Specimen by Organism specific culture
Neorickettsia sp [Presence] in Specimen by Organism specific culture
Orientia tsutsugamushi [Presence] in Specimen by Organism specific culture
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid by Immunofluorescence
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid by Immunofluorescence
Bartonella bacilliformis IgG Ab [Titer] in Body fluid by Immunofluorescence
Bartonella bacilliformis IgM Ab [Titer] in Body fluid by Immunofluorescence
Bartonella elizabethae IgG Ab [Titer] in Body fluid by Immunofluorescence
Bartonella elizabethae IgM Ab [Titer] in Body fluid by Immunofluorescence
Bartonella henselae IgM Ab [Titer] in Body fluid by Immunofluorescence
Bartonella henselae IgG Ab [Titer] in Body fluid by Immunofluorescence
Bartonella quintana IgG Ab [Titer] in Body fluid by Immunofluorescence
Bartonella quintana IgM Ab [Titer] in Body fluid by Immunofluorescence
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid by Immunofluorescence
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid by Immunofluorescence
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid by Immunofluorescence
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid by Immunofluorescence
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid by Immunofluorescence
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid by Immunofluorescence
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid by Immunofluorescence
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid by Immunofluorescence
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid by Immunofluorescence
Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia africae IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia africae IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia akari IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia akari IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia conorii IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia conorii IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia parkeri IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia parkeri IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia prowazekii IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia prowazekii IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia rickettsii IgM Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia rickettsii IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia typhi IgG Ab [Titer] in Body fluid by Immunofluorescence
Rickettsia typhi IgM Ab [Titer] in Body fluid by Immunofluorescence
Respiratory allergen panel, US - North Atlantic states b - Serum
Respiratory allergen panel, US - South Atlantic states b - Serum
Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum
Respiratory allergen panel, US - Central Florida - Serum
Respiratory allergen panel, US - Southern Florida - Serum
Respiratory allergen panel, US - Southeast coast - Serum
Respiratory allergen panel, US - West south central states - Serum
Respiratory allergen panel, US - Greater Ohio valley b - Serum
Respiratory allergen panel, US - Northern midwest states b - Serum
Respiratory allergen panel, US - Central midwest b - Serum
Respiratory allergen panel, US - Great plains states b - Serum
Respiratory allergen panel, US - Rocky mountain states b - Serum
Respiratory allergen panel, US - Inland northwest b - Serum
Respiratory allergen panel, US - Cascade Pacific northwest b - Serum
Respiratory allergen panel, US - Intermountain west b - Serum
Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum
Respiratory allergen panel, US - Alaska b - Serum
Respiratory allergen panel, US - Hawaii - Serum
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Specimen
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Specimen
Acylcarnitine pattern [Interpretation] in Tissue
Alpha hydroxyalprazolam [Mass/volume] in Specimen
Benzodiazepines [Mass/volume] in Specimen by Confirmatory method
Benzodiazepines [Mass/volume] in Specimen
Cannabinoids [Presence] in Specimen by Confirmatory method
Carboxy tetrahydrocannabinol [Mass/volume] in Specimen
chlordiazePOXIDE [Mass/volume] in Specimen
Cocaine [Presence] in Specimen by Confirmatory method
Temafloxacin [Susceptibility] by Disk diffusion (KB)
Histoplasma capsulatum Ag [Mass/volume] in Urine
Hydroxyethylflurazepam [Mass/volume] in Specimen
Hydroxytriazolam [Mass/volume] in Specimen
Methadone [Mass/volume] in Specimen by Confirmatory method
Norpropoxyphene [Mass/volume] in Specimen
Propoxyphene [Mass/volume] in Specimen by Confirmatory method
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Card agglutination
PKHD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DCX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ELN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
EYA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Leukocytes [Presence] in Stool by Methylene blue stain --2nd specimen
MDCR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
GPR143 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
POLG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SGCG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CDKL5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Anaplasma sp [Presence] in Specimen by Light microscopy
Ehrlichia sp [Presence] in Specimen by Light microscopy
Glucose [Mass/volume] in Serum or Plasma --20 minutes pre XXX challenge
Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucose
Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucose
Glucose [Mass/volume] in Serum or Plasma --8 AM specimen
Pyridinoline.free/Creatinine [Molar ratio] in Urine
Glucose [Mass/volume] in Serum or Plasma --12 PM specimen
Glucose [Mass/volume] in Serum or Plasma --6 PM specimen
Glucose [Mass/volume] in Serum or Plasma --8 PM specimen
Glucose [Mass/volume] in Serum or Plasma --10 PM specimen
Glucose [Mass/volume] in Serum or Plasma --12 AM specimen
Glucose [Mass/volume] in Serum or Plasma --3 AM specimen
Glucose [Mass/volume] in Serum or Plasma --6 AM specimen
N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine
Amylase.pancreatic [Enzymatic activity/volume] in Body fluid
Immune complex.IgG [Mass/volume] in Body fluid by C1q binding assay
6-Phosphogluconate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells
Free Hemoglobin [Presence] in Cerebral spinal fluid
Albumin [Mass/time] in Urine collected for unspecified duration
Urate [Mass/volume] in Peritoneal dialysis fluid
Creatinine [Mass/volume] in Peritoneal dialysis fluid
Calcium [Moles/volume] in Peritoneal dialysis fluid
Phosphate [Moles/volume] in Peritoneal dialysis fluid
Magnesium [Moles/volume] in Peritoneal dialysis fluid
Clot Retraction [Volume Fraction] in Blood
Norepinephrine [Moles/volume] in Plasma --7th specimen post XXX challenge
Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma
Platelet aggregation arachidonate induced [Units/volume] in Platelet rich plasma
Influenza virus A and B identified in Specimen by Bioassay
Pancreastatin [Mass/volume] in Serum or Plasma
PAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SCA15 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Streptococcus sp exoenzyme Ab [Units/volume] in Serum
Respiratory allergen panel, US - North Atlantic states c - Serum
Respiratory allergen panel, US - Intermountain west c - Serum
Respiratory allergen panel, US - Puerto Rico - Serum
Respiratory allergen panel, US - Coastal California - Serum
Respiratory allergen panel, US - Greater Ohio valley c - Serum
Respiratory allergen panel, US - Northern midwest states c - Serum
Microalbumin [Mass/time] in Urine collected for unspecified duration
CD25+CD127Low cells/CD4 cells [# Ratio] in Specimen
Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal
Cortisol Free/Cortisone free [Mass Ratio] in Urine
Temafloxacin [Susceptibility] by Serum bactericidal titer
Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus
Second trimester penta maternal screen [Interpretation] in Serum or Plasma
Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain
Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision
Respiratory syncytial virus IgG and IgM panel [Units/volume] - Serum
Riboflavin [Moles/volume] in Serum or Plasma
Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal
Subtelomere analysis [Interpretation] in Blood or Tissue by FISH Narrative
Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL
Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL
Testosterone Free/Testosterone.total in Serum or Plasma by Detection limit <= 1.0 ng/dL
diazePAM and Nordiazepam panel - Serum or Plasma
PT and aPTT and Fibrinogen panel - Platelet poor plasma by Coagulation assay
Globulin [Mass/volume] in Urine by Electrophoresis
Microscopic observation [Identifier] in Endocervical brush by Cyto stain
25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma
Shigella sp serotype [Identifier] in Isolate by Agglutination
aPTT in Blood drawn from CRRT circuit by Coagulation assay
Trisomy 21+Trisomy 18 risk [Likelihood] in Fetus
Fondaparinux [Mass/volume] in Serum or Plasma
Microdeletion syndromes in Specimen by FISH Nominal
Gamma 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
Eastern equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid
Western equine encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid
La Crosse virus IgG and IgM [Interpretation] in Cerebral spinal fluid
Saint Louis encephalitis virus IgG and IgM [Interpretation] in Cerebral spinal fluid
Specimen drawn [Date and time] of Cerebral spinal fluid
Urea nitrogen [Mass ratio] in Serum or Plasma--post dialysis/pre dialysis
Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid
Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Beta-2-Microglobulin [Mass/volume] in Dialysis fluid
Western equine encephalitis virus IgG and IgM [Interpretation] in Serum
First and Second trimester integrated maternal screen panel
First trimester maternal screen with nuchal translucency panel
Maternal screen clinical predictors panel
Fetal Trisomy 21 risk [Likelihood] Based on maternal age
Fetal Neural tube defect risk [Likelihood] Based on maternal age
Second trimester quad maternal screen [Interpretation] in Serum or Plasma Narrative
Arbovirus IgG and IgM panel - Serum by Immunofluorescence
Arbovirus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence
Saint Louis encephalitis virus IgG and IgM [Interpretation] in Serum
Chlamydia trachomatis DNA [Units/volume] in Specimen by NAA with probe detection
Cryptococcus neoformans rRNA [Units/volume] in Specimen by NAA with probe detection
Helicobacter pylori DNA [Presence] in Specimen by NAA with probe detection
Herpes virus 8 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
WBC casts [#/area] in Urine sediment by Microscopy high power field
Mycoplasma pneumoniae DNA [Units/volume] in Blood by NAA with probe detection
Phenolphthalein [Mass/volume] in Specimen
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Temocillin [Susceptibility] by Minimum lethal concentration (MLC)
Mycoplasma sp identified in Urine by Organism specific culture
Spermatozoa [#/area] in Urine sediment by Microscopy high power field
Borna disease virus Ab [Units/volume] in Serum
ZAP70 Ag [Presence] in Tissue by Immune stain
Flavivirus rRNA [Units/volume] (viral load) in Blood by NAA with probe detection
Trichosporon sp DNA [Units/volume] in Serum by NAA with probe detection
Monosaccharides.sulfated [Presence] in Urine
Immunodeficiency follow-up panel - Specimen by Flow cytometry (FC)
Erythrocyte inclusion bodies [Identifier] in Blood
Anaplasma sp identified in Specimen by Sequencing
Bartonella sp identified in Specimen by Sequencing
Coxiella burnetii identified in Specimen by Sequencing
Ehrlichia sp identified in Specimen by Sequencing
Orientia tsutsugamushi identified in Specimen by Sequencing
Rickettsia sp identified in Specimen by Sequencing
Rickettsia typhus group identified in Specimen by Sequencing
Creatine kinase.MiMi/Creatine kinase.total in Serum or Plasma
Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis
Chylomicrons/total Lipoprotein in Serum or Plasma
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis
Cholesterol in VLDL [Mass/volume] in Serum or Plasma by Electrophoresis
Glucose [Mass/volume] in Blood --2 hours post dose glucose
Fractional excretion of sodium [Ratio] in Urine and Serum or Plasma
Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma
Hemoglobin [Mass/volume] in Urine by Test strip
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence
California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence
La Crosse virus IgG and IgM [Interpretation] in Serum
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid
Rickettsia rickettsii IgG Ab [Titer] in Body fluid
Rickettsia rickettsii IgM Ab [Titer] in Body fluid
Rickettsia prowazekii IgM Ab [Titer] in Body fluid
Rickettsia prowazekii IgG Ab [Titer] in Body fluid
Rickettsia parkeri IgG Ab [Titer] in Body fluid
Rickettsia parkeri IgM Ab [Titer] in Body fluid
Rickettsia parkeri IgG Ab [Titer] in Serum
Rickettsia parkeri IgM Ab [Titer] in Serum
Rickettsia conorii IgM Ab [Titer] in Body fluid
Rickettsia conorii IgG Ab [Titer] in Body fluid
Rickettsia akari IgM Ab [Titer] in Serum
Rickettsia akari IgM Ab [Titer] in Body fluid
Rickettsia akari IgG Ab [Titer] in Serum
Rickettsia akari IgG Ab [Titer] in Body fluid
Rickettsia africae IgG Ab [Titer] in Body fluid
Rickettsia africae IgM Ab [Titer] in Body fluid
Rickettsia africae IgG Ab [Titer] in Serum
Rickettsia africae IgM Ab [Titer] in Serum
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid
Human bocavirus IgG Ab [Presence] in Specimen
Hepatitis B virus surface IgG Ab [Presence] in Serum
Epstein Barr virus Ab [Presence] in Serum
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid
Echinococcus granulosus Ab [Titer] in Serum
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum
Coccidioides sp Ab [Presence] in Body fluid
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid
California encephalitis virus IgG Ab [Units/volume] in Serum
Brucella abortus Ab [Presence] in Cerebral spinal fluid
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum
Bartonella quintana IgM Ab [Titer] in Body fluid
Bartonella quintana IgG Ab [Titer] in Body fluid
Bartonella henselae IgG Ab [Titer] in Body fluid
Bartonella henselae IgM Ab [Titer] in Body fluid
Bartonella elizabethae IgM Ab [Titer] in Body fluid
Bartonella elizabethae IgG Ab [Titer] in Body fluid
Bartonella elizabethae IgM Ab [Titer] in Serum
Bartonella elizabethae IgG Ab [Titer] in Serum
Bartonella bacilliformis IgM Ab [Titer] in Body fluid
Bartonella bacilliformis IgG Ab [Titer] in Body fluid
Bartonella bacilliformis IgM Ab [Titer] in Serum
Bartonella bacilliformis IgG Ab [Titer] in Serum
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid
PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hexokinase [Enzymatic activity/mass] in Red Blood Cells
2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells
Phosphatidylinositol/Surfactant.total in Amniotic fluid
Galactose [Mass/volume] in Red Blood Cells
Catalase [Enzymatic activity/mass] in Red Blood Cells
Colony count [#/volume] in Specimen by Visual count
Leukocytes [#/area] in Semen by Microscopy high power field
Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine
lamiVUDine [Mass/volume] in Serum or Plasma
Stavudine [Mass/volume] in Serum or Plasma
Porphobilinogen deaminase [Enzymatic activity/mass] in Red Blood Cells
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid
Acetylcholinesterase [Enzymatic activity/mass] in Red Blood Cells
Cholinesterase [Enzymatic activity/mass] in Red Blood Cells
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Rapid, less than 30 minutes
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes
Patient symptoms [Interpretation] Narrative--1.5 hours post dose lactose PO
Patient symptoms [Interpretation] Narrative--1 hour post dose lactose PO
Patient symptoms [Interpretation] Narrative--2.5 hours post dose lactose PO
Patient symptoms [Interpretation] Narrative--2 hours post dose lactose PO
Patient symptoms [Interpretation] Narrative--30 minutes post dose lactose PO
Patient symptoms [Interpretation] Narrative--3 hours post dose lactose PO
Patient symptoms [Interpretation] Narrative--pre dose lactose PO
Xylose absorption [Interpretation] in Urine and Serum or Plasma Narrative
Acylcarnitine pattern [Interpretation] in Urine Narrative
Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma Narrative
Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative
Alpha tocopherol and Beta+gamma tocopherol [Interpretation] in Serum or Plasma Narrative
Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative
Amino acid pattern [Interpretation] in Serum or Plasma Narrative
Amino acid pattern [Interpretation] in Urine Narrative
Amylase isoenzymes [Interpretation] in Serum or Plasma Narrative
Calculus analysis [Interpretation] in Stone Narrative
Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood Narrative
Bile acid pattern [Interpretation] in Urine Narrative
Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy
Catecholamines [Interpretation] in Urine Narrative
Catecholamines [Interpretation] in Plasma Narrative
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis Narrative
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma Narrative
Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum Narrative
Cryoproteins [Interpretation] in Serum by Electrophoresis agarose gel Narrative
Fatty acids pattern [Interpretation] in Serum or Plasma Narrative
Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma Narrative
Folate+Cyanocobalamin [Interpretation] in Serum or Blood Narrative
Gammopathy [Interpretation] in Serum by Electrophoresis Narrative
Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells Narrative
Glutathione reductase phenotype [Interpretation] in Red Blood Cells Narrative
Glycosaminoglycans pattern [Interpretation] in Urine Narrative
Homovanillate and Creatinine [Interpretation] in Urine Narrative
Immunoglobulin light chains [Interpretation] in Urine Narrative
Immunofixation for Cerebral spinal fluid Narrative
Immunoelectrophoresis for Cerebral spinal fluid Narrative
Immunoelectrophoresis for Serum or Plasma Narrative
Immunofixation for Serum or Plasma Narrative
Immunofixation for 24 hour Urine Narrative
Immunoelectrophoresis for Urine Narrative
Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma Narrative
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative
Lipoprotein fractions [Interpretation] in Serum or Plasma Narrative
Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma Narrative
Metanephrine and Normetanephrine [Interpretation] in Urine Narrative
Oligosaccharides pattern [Interpretation] in Urine Narrative
Organic acids pattern [Interpretation] in Cerebral spinal fluid Narrative
Organic acids pattern [Interpretation] in Serum or Plasma Narrative
Organic acids pattern [Interpretation] in Urine Narrative
Parathyrin [Interpretation] in Serum or Plasma Narrative
Porphyrins [Interpretation] in Serum or Plasma Narrative
Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Porphyrins [Interpretation] in Stool Narrative
Porphyrins [Interpretation] in Urine Narrative
Porphyrin fractions [Interpretation] in 24 hour Urine Narrative
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative
Oligoclonal bands [Interpretation] in Serum or Plasma Narrative
Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative
Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation Narrative
Protein Fractions [Interpretation] in Serum or Plasma Narrative
Protein Fractions [Interpretation] in Urine by Electrophoresis Narrative
Protein Fractions [Interpretation] in Urine by Immunofixation Narrative
Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis Narrative
Protein Fractions [Interpretation] in Specimen by Immunofixation Narrative
Amino acid pattern [Interpretation] in Cerebral spinal fluid Narrative
Uranium dose assessment [Interpretation] in Urine Narrative
Cervical Mucus Penetration Test [Interpretation] in Semen Narrative
Hamster Ova Penetration Test [Interpretation] in Semen Narrative
Myocardium Ab pattern [Interpretation] in Serum Narrative
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative
Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence Narrative
Nuclear Ab pattern [Interpretation] in Serum Narrative
Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative
Acute leukemia markers [Interpretation] in Specimen
Chronic leukemia markers [Interpretation] in Specimen
Immunodeficiency markers [Interpretation] in Specimen
Hemolytic disease of newborn screen [Interpretation] in Blood Narrative
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis
Hemoglobin pattern [Interpretation] in Blood Narrative
Alpha-1-Fetoprotein interpretation in Amniotic fluid Narrative
Beta glucosidase activator [Interpretation] in Fibroblast Narrative
Beta-N-acetylhexosaminidase.A activator [Interpretation] in Fibroblast Narrative
Cerebroside sulfatase activator [Interpretation] in Fibroblast Narrative
Hemoglobin pattern [Interpretation] in Blood by HPLC
Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post dose metyraPONE
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Clavulanate IgE Ab [Units/volume] in Serum
Interferon alpha Ab [Presence] in Serum or Plasma by Immunoassay
Renin [Enzymatic activity/volume] in Plasma --3 hours post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --2 hours post XXX challenge
Vasopressin [Mass/volume] in Plasma --30 minutes post XXX challenge
Galactitol [Moles/volume] in Amniotic fluid
Adenovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Stool by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Blood by NAA with probe detection
BK virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Epstein Barr virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
Epstein Barr virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Epstein Barr virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Epstein Barr virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis B virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis B virus DNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis B virus DNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis B virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis B virus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis B virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis B virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis B virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis B virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis B virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis B virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis B virus DNA [Units/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Temocillin [Susceptibility] by Disk diffusion (KB)
Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis C virus RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis C virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 6 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Herpes virus 7 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Blood by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Tissue by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Serum or Plasma by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Specimen by NAA with probe detection
Pneumocystis jiroveci DNA [#/volume] in Bone marrow by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Urine by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Amniotic fluid by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Bone marrow by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Blood by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Specimen by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Serum or Plasma by NAA with probe detection
Temocillin [Susceptibility] by Serum bactericidal titer
Varicella zoster virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Alpha synuclein Ag [Presence] in Tissue by Immune stain
Androgen receptor Ag [Presence] in Tissue by Immune stain
Annexin 1 Ag [Presence] in Tissue by Immune stain
Alzheimer precursor protein Ag [Presence] in Tissue by Immune stain
Beta catenin Ag [Presence] in Tissue by Immune stain
C4d Ag [Presence] in Tissue by Immune stain
Calponin Ag [Presence] in Tissue by Immune stain
CD1 Ag [Presence] in Tissue by Immune stain
CD13 Ag [Presence] in Tissue by Immune stain
CD14 Ag [Presence] in Tissue by Immune stain
CD2 Ag [Presence] in Tissue by Immune stain
CD22 Ag [Presence] in Tissue by Immune stain
CD27 Ag [Presence] in Tissue by Immune stain
CD33 Ag [Presence] in Tissue by Immune stain
CD35 Ag [Presence] in Tissue by Immune stain
IgG subclass 4 Ag [Presence] in Tissue by Immune stain
Mammaglobin Ag [Presence] in Tissue by Immune stain
CD123 Ag [Presence] in Tissue by Immune stain
CD163 Ag [Presence] in Tissue by Immune stain
CD41-Bf Ag [Presence] in Tissue by Immune stain
Cyclooxygenase 2 Ag [Presence] in Tissue by Immune stain
CXCL13 Ag [Presence] in Tissue by Immune stain
CXCR5 Ag [Presence] in Tissue by Immune stain
FOXP3 Ag [Presence] in Tissue by Immune stain
Herpes virus 8 latent nuclear Ag [Presence] in Tissue by Immune stain
TCL-1A Ag [Presence] in Tissue by Immune stain
Vascular endothelial growth factor Ag [Presence] in Tissue by Immune stain
HIV 1 [Interpretation] in Serum or Plasma by Immunoassay Narrative
Platelet aggregation ristocetin induced in Platelet rich plasma --1800 ug/mL
Nateglinide [Presence] in Serum or Plasma
BCR-ABL1 b2a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method
BCR-ABL1 b3a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method
Leukemia markers [Interpretation] in Cerebral spinal fluid Narrative
Leukemia markers [Interpretation] in Blood Narrative
Leukemia markers [Interpretation] in Pleural fluid Narrative
Hepatitis B virus surface Ab actual/Negative control in Serum or Plasma
BCR-ABL1 e1a1 fusion protein [Presence] in Blood or Tissue by Molecular genetics method
Platelets [#/volume] in Blood by Estimate
Leukocytes [#/volume] in Blood by Estimate
Calcium oxalate dihydrate/Total in Stone by Infrared spectroscopy
Calcium oxalate monohydrate/Total in Stone by Infrared spectroscopy
Glucose-6-Phosphate dehydrogenase [Entitic Catalytic Activity] in Blood
Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence
CMT demyelinating gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Erythrocyte clumps [#/area] in Urine sediment by Automated count
MYOC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Acetaldehyde [Presence] in Gastric fluid
Topiramate [Mass/volume] in Serum or Plasma --peak
Topiramate [Mass/volume] in Serum or Plasma --trough
Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition
Tetracycline [Susceptibility] by Minimum lethal concentration (MLC)
Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H5 Ab [Presence] in Serum
Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H9 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A RNA [Presence] in Isolate by NAA with probe detection
Influenza virus B Ab [Presence] in Serum by Immunoassay
Influenza virus B Ag [Presence] in Isolate by Immunofluorescence
Influenza virus B RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection
Influenza virus identified in Specimen by Shell vial culture
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Acid citrate dextrose [Volume] in Blood product unit
Newborn screening recommended follow-up [Interpretation]
JC virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
JC virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
CD59 Deficient leukocytes/100 cells in Blood
Creatine kinase.MB [Mass/volume] in Blood
Epinephrine+Norepinephrine [Mass/volume] in Urine
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in 24 hour Urine
Beta F1 Ag [Presence] in Tissue by Immune stain
HLA-A+B+C (class I) Ag [Presence] in Tissue by Immune stain
p16INK4a Ag [Presence] in Tissue by Immune stain
PDGFR-beta Ag [Presence] in Tissue by Immune stain
TAU 3 Ag [Presence] in Tissue by Immune stain
TAU 4 Ag [Presence] in Tissue by Immune stain
Holoprosencephaly gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL
Epstein Barr virus band pattern [Interpretation] in Specimen by Immunoblot Narrative
Second trimester triple maternal screen [Interpretation] in Serum or Plasma Narrative
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative
Phosphatidylinositol+Phosphatidylserine/Surfactant.total in Amniotic fluid
Sphingomyelin/Surfactant.total in Amniotic fluid
Phosphatidylethanolamine/Surfactants.total in Amniotic fluid
Lecithin/Surfactant.total in Amniotic fluid
Aminocaproate cutoff [Mass/volume] in Serum or Plasma
Aminocaproate [Presence] in Serum or Plasma
HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay
Referral lab test identifier and name [Identifier]
Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma
First and Second trimester integrated maternal screen [Interpretation]
Protein.abnormal band [Mass/volume] in Serum
First trimester maternal screen with nuchal translucency [Interpretation] Narrative
Bacterial susceptibility panel by Gradient strip
Calcidiol and Calciferol panel - Serum or Plasma
Calcidiol and Calciferol [Interpretation] in Serum or Plasma Narrative
Satratoxin IgM Ab [Units/volume] in Serum by Immunoassay
Trichothecene IgA Ab [Units/volume] in Serum by Immunoassay
Trichothecene IgG Ab [Units/volume] in Serum by Immunoassay
Trichothecene IgM Ab [Units/volume] in Serum by Immunoassay
Uroporphyrinogen decarboxylase [Units/volume] in Red Blood Cells
Trichothecene IgE Ab [Units/volume] in Serum by Immunoassay
Natalizumab Ab [Presence] in Serum by Immunoassay
Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Hepatitis B virus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis B virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis B virus DNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection
Hepatitis C virus RNA [log units/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis B virus DNA [log units/volume] (viral load) in Tissue by NAA with probe detection
Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection
Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection
Vibrio sp DNA [Identifier] in Specimen by NAA with probe detection
Streptococcus pyogenes DNA [Identifier] in Specimen by NAA with probe detection
Salmonella sp DNA [Presence] in Specimen by NAA with probe detection
Campylobacter sp DNA [Identifier] in Specimen by NAA with probe detection
Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
Legionella sp DNA [Identifier] in Specimen by NAA with probe detection
Carbapenem resistance blaKPC gene [Presence] by Molecular method
Atazanavir+Ritonavir [Susceptibility] by Genotype method
Indinavir+Ritonavir [Susceptibility] by Genotype method
lamiVUDine or Emtricitabine [Susceptibility] by Genotype method
Saquinavir+Ritonavir [Susceptibility] by Genotype method
Tipranavir+Ritonavir [Susceptibility] by Genotype method
Amprenavir or Fosamprenavir [Susceptibility] by Genotype method
Cholesterol in VLDL 1+2 [Mass/volume] in Serum or Plasma
CD59 Granulocytes [Interpretation] in Blood Qualitative
Muscle sarcolemma Ab [Titer] in Pleural fluid by Immunofluorescence
Muscle sarcolemma Ab [Titer] in Serum by Immunofluorescence
Remnant lipoprotein [Mass/volume] in Serum or Plasma
Darunavir+Ritonavir [Susceptibility] by Genotype method
ATN1 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
ATN1 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
FXN gene allele 1.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method
FXN gene allele 2.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Ganglioside GM1 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
HTT gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
HTT gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasma
Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay
SCA1 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA1 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA10 gene allele 1.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA10 gene allele 2.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA2 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA2 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
MJD gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
MJD gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
CACNA1A gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
CACNA1A gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA7 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
SCA7 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
TPMT gene c.719A>G [Presence] in Blood or Tissue by Molecular genetics method
TPMT gene c.238G>C [Presence] in Blood or Tissue by Molecular genetics method
TPMT gene c.460G>A [Presence] in Blood or Tissue by Molecular genetics method
HIV protease gene mutations by Genotype method
HIV nonnucleoside reverse transcriptase susceptibility panel by Genotype method
HIV nucleoside reverse transcriptase susceptibility panel by Genotype method
HIV reverse transcriptase susceptibility panel by Genotype method
HIV susceptibility panel by Genotype method
HIV protease gene mutations by Phenotype method
HIV nonnucleoside reverse transcriptase susceptibility panel by Phenotype method
HIV nucleoside reverse transcriptase susceptibility panel by Phenotype method
HIV reverse transcriptase susceptibility panel by Phenotype method
HIV susceptibility panel by Phenotype method
Darunavir [Susceptibility] by Phenotype method
Tipranavir [Susceptibility] by Phenotype method
Atazanavir [Susceptibility] by Phenotype method
Emtricitabine [Susceptibility] by Phenotype method
Neisseria meningitidis DNA [Presence] in Specimen by NAA with probe detection
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --7 day post incubation
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Blood --5 days post incubation
Lymphocyte proliferation stimulated by 10 umol beryllium [Units/volume] in Blood --7 day post incubation
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --5 days post incubation
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --7 day post incubation
CPT2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood --3 days post incubation
ERBB2 gene copy number/Chromosome 17 copy number in Tissue by FISH
CPT2 gene p.Arg503Cys [Presence] in Blood by Molecular genetics method
CPT2 gene p.Arg631Cys [Presence] in Blood by Molecular genetics method
Trichoderma viride IgG Ab [Mass/volume] in Serum
Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO
Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 100 g glucose PO
Nortrimipramine [Presence] in Serum or Plasma
Striated muscle IgG Ab [Presence] in Serum by Immunofluorescence
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous cord blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous cord blood
pH of Arterial cord blood adjusted to patient's actual temperature
pH of Venous cord blood adjusted to patient's actual temperature
Bacampicillin [Susceptibility] by Disk diffusion (KB)
Metanephrine Free [Moles/volume] in Serum or Plasma
pH of Blood adjusted to patient's actual temperature
Nateglinide [Mass/volume] in Serum or Plasma
SH3TC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ARSA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
KCNQ2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
predniSONE [Presence] in Serum or Plasma
SOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Listeria sp Ab [Titer] in Serum by Complement fixation
Coccidioides sp Ab [Presence] in Serum by Latex agglutination
Parainfluenza virus Ab [Titer] in Serum by Complement fixation
Interleukin 8 [Mass/volume] in Body fluid
Dehydroepiandrosterone (DHEA) [Mass/volume] in Saliva (oral fluid)
Interleukin 1 beta [Mass/volume] in Body fluid
HIV 1 p24 Ag [Presence] in Cerebral spinal fluid
Kentucky blue grass IgG Ab [Mass/volume] in Serum
Meadow Fescue IgG Ab [Mass/volume] in Serum
Haemophilus influenzae type [Identifier] in Isolate
Aldolase [Enzymatic activity/volume] in Body fluid
Melatonin [Mass/volume] in Cerebral spinal fluid
Homocysteine [Moles/volume] in Cerebral spinal fluid
Neurokinin A [Mass/volume] in Serum or Plasma
Penicillin G IgG Ab [Mass/volume] in Serum
Aspergillus sp Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Interleukin 6 [Mass/volume] in Body fluid
Interleukin 10 [Mass/volume] in Body fluid
11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine
FBN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence
Yellow Hornet IgG Ab [Mass/volume] in Serum
Plasmodium malariae IgG Ab [Titer] in Serum by Immunofluorescence
Plasmodium vivax IgG Ab [Titer] in Serum by Immunofluorescence
Plasmodium falciparum IgG Ab [Titer] in Serum by Immunofluorescence
Plasmodium ovale IgG Ab [Titer] in Serum by Immunofluorescence
Whitefaced Hornet IgG Ab [Mass/volume] in Serum
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method
Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method
Lipoprotein.alpha [Moles/volume] in Serum or Plasma
6-monoacetylmorphine free [Mass/volume] in Serum or Plasma
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma
Norbuprenorphine [Mass/volume] in Urine by Confirmatory method
Buprenorphine [Mass/volume] in Urine by Confirmatory method
Crystals [Presence] in Urine sediment by Light microscopy
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid
Adenosine deaminase [Enzymatic activity/volume] in Pericardial fluid
Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid
Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid
Bilirubin.total [Mass/volume] in Pericardial fluid
Filaria IgG2 Ab [Units/volume] in Serum by Immunoassay
Filaria IgG3 Ab [Units/volume] in Serum by Immunoassay
Filaria IgG4 Ab [Units/volume] in Serum by Immunoassay
Filaria IgG1 Ab [Units/volume] in Serum by Immunoassay
Onchocerca sp IgG Ab [Units/volume] in Serum by Immunoassay
Galactitol [Moles/volume] in Serum or Plasma
Glomerular basement membrane Ab [Units/volume] in Serum
Hepatitis D virus IgG Ab [Units/volume] in Serum by Immunoassay
Hepatitis E virus Ab [Units/volume] in Serum by Immunoassay
Hepatitis G virus Ab [Units/volume] in Serum
Immune complex [Mass/volume] in Serum or Plasma
Tetracycline [Susceptibility] by Disk diffusion (KB)
Leishmania sp DNA [Presence] in Blood by NAA with probe detection
Mitochondria M2 Ab [Units/volume] in Serum
Mononuclear cells/100 leukocytes in Pericardial fluid
Onchocerca sp IgG4 Ab [Units/volume] in Serum by Immunoassay
Onchocerca sp IgG Ab [Units/volume] in Serum
Onchocerca sp IgG2 Ab [Units/volume] in Serum by Immunoassay
Onchocerca sp IgG3 Ab [Units/volume] in Serum by Immunoassay
Polymorphonuclear cells/100 leukocytes in Pericardial fluid
Potassium [Moles/volume] in Amniotic fluid
Potassium [Moles/volume] in Peritoneal fluid
Sodium [Moles/volume] in Peritoneal fluid
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Bone marrow by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Treponema pallidum DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Hemagglutination
Trypanosoma cruzi DNA [Presence] in Blood by NAA with probe detection
2-Ethyl-3-Hydroxypropionate/Creatinine [Molar ratio] in 24 hour Urine
2-Hydroxy-3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine
2-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine
2-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine
2-Hydroxyisocaproate/Creatinine [Molar ratio] in 24 hour Urine
2-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine
2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Molar ratio] in 24 hour Urine
2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in 24 hour Urine
2-Oxoisocaproate/Creatinine [Molar ratio] in 24 hour Urine
2-Oxoisovalerate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxyadipate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxyglutarate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxyisobutyrate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxyisovalerate/Creatinine [Molar ratio] in 24 hour Urine
3-Hydroxypropionate (3-OH-C3)/Creatinine [Molar ratio] in 24 hour Urine
16-Alpha hydroxyestrone [Mass/volume] in Serum or Plasma
2-Hydroxyestrone [Mass/volume] in Serum or Plasma
2-Hydroxyestrone/16-Alpha hydroxyestrone [Mass Ratio] in Serum or Plasma
2-Hydroxyestrone and 16-Alpha hydroxyestrone panel - Serum or Plasma
Norcodeine [Mass/volume] in Serum or Plasma
Specimen drawn [Date and time] of Serum or Plasma--1st specimen
Specimen drawn [Date and time] of Serum or Plasma--2nd specimen
Platelet function (closure time) [Interpretation] in Blood Narrative
Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic fluid
Neural tube defect risk [Likelihood] in Population
Eosinophils [Presence] in Urine sediment by Wright stain
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes
Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor
Enterovirus RNA [Presence] in Serum by NAA with probe detection
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot
Hydroxylysine.free/Creatinine [Molar ratio] in 24 hour Urine
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline
Cholinesterase [Enzymatic activity/volume] in Peritoneal fluid
Oligoclonal bands [#] in Cerebral spinal fluid by Isoelectric focusing
Transforming growth factor beta 1 [Mass/volume] in Serum or Plasma
COL5A1 gene+COL5A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Tetracycline IgE Ab [Units/volume] in Serum
Methyltestosterone [Presence] in Serum or Plasma
SMN1 gene+SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Peptide YY [Mass/volume] in Serum or Plasma
Amphotericin B [Mass/volume] in Specimen
Tetracycline [Susceptibility] by Serum bactericidal titer
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid by Latex agglutination
Toxocara canis Ab [Units/volume] in Specimen by Immunoassay
G6PC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Aspergillus sp DNA [Presence] in Specimen by NAA with probe detection
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic method
Endothelin I [Mass/volume] in Serum or Plasma
Ibuprofen IgE Ab [Units/volume] in Serum
Camel dander IgE Ab [Units/volume] in Serum
Coagulation factor VII Ag actual/normal in Platelet poor plasma by Immunoassay
FH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
POU3F4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ABCB4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
California juniper IgE Ab [Units/volume] in Serum
Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method
Hepatitis B virus codon 173 [Identifier] by Genotype method
Hepatitis B virus codon 180 [Identifier] by Genotype method
Hepatitis B virus codon 181 [Identifier] by Genotype method
Hepatitis B virus codon 204 [Identifier] by Genotype method
Hepatitis B virus codon 236 [Identifier] by Genotype method
Hepatitis B virus codon 80 [Identifier] by Genotype method
Hepatitis B virus resistance panel by Genotype method
Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation
Lymphocyte proliferation.beryllium stimulation panel - Blood
Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --1st specimen post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --pre dose corticotropin
HIV 1 RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
Somatotropin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Specimen by NAA with probe detection
Insulin [Units/volume] in Serum or Plasma --pre XXX challenge
Metabolic syndrome [Presence] in Serum or Plasma
Setomelanomma rostrata IgE Ab/IgE total in Serum
Heptacarboxylporphyrin I [Mass/time] in 24 hour Stool
Heptacarboxylporphyrin III [Mass/time] in 24 hour Stool
Hexanoylglycine/Creatinine [Molar ratio] in 24 hour Urine
Hippurate/Creatinine [Molar ratio] in 24 hour Urine
Histoplasma capsulatum M Ab [Presence] in Cerebral spinal fluid
HIV 1 Ab [Presence] in Specimen by Rapid immunoassay
Hydroxydecanedioate/Creatinine [Molar ratio] in 24 hour Urine
IgA Ag [Presence] in Tissue by Immunofluorescence
Blastomyces dermatitidis rRNA [Presence] in Specimen by Probe
Kappa light chains/Lambda light chains [Mass Ratio] in 24 hour Urine
Interleukin 10 [Mass/volume] in Cerebral spinal fluid
Isocitrate/Creatinine [Molar ratio] in 24 hour Urine
Isovalerylglycine/Creatinine [Molar ratio] in 24 hour Urine
Japanese encephalitis virus Ab [Titer] in Cerebral spinal fluid
Legionella pneumophila IgG Ab [Presence] in Serum
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum
Legionella sp IgG Ab [Presence] in Serum
Borrelia burgdorferi DNA [Presence] in Specimen by NAA with probe detection
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Leukocytes --6 days post incubation
Heptacarboxylporphyrin II [Mass/time] in unspecified time Stool
Interleukin 6 [Mass/volume] in Cerebral spinal fluid
Isopropyl ether [Presence] in Serum or Plasma
Lymphocyte proliferation stimulated by concanavalin A in Blood
Lymphocyte proliferation stimulated by phytohemagglutinin in Blood
Lymphocyte proliferation stimulated by pokeweed mitogen in Blood
Campylobacter sp rRNA [Presence] in Specimen by Probe
Alkaline phosphatase.macro/Alkaline phosphatase.total in Serum or Plasma
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by Glock and McLean
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by WHO method
Leukocytes [#/volume] in Peritoneal dialysis fluid
Protein in pleural fluid/Protein in serum
Lactate dehydrogenase in pleural fluid/Lactate dehydrogenase in serum
3-Hydroxysebacate (3-OH-C8) unsaturated/Creatinine [Molar ratio] in Urine
Chlamydia trachomatis rRNA [Presence] in Specimen by Probe
3-Hydroxysuberate.unsaturated/Creatinine [Molar ratio] in Urine
Adipate.unsaturated/Creatinine [Molar ratio] in Urine
Adipolactone/Creatinine [Molar ratio] in Urine
Calcium.ionized/Calcium.total corrected for albumin in Serum or Plasma
Calcium.ionized/Calcium.total corrected for albumin in Blood
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid
Dodecenedioate/Creatinine [Molar ratio] in Urine
Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC)
Coccidioides immitis rRNA [Presence] in Specimen by Probe
Glutamate dehydrogenase [Enzymatic activity/mass] in Leukocytes
Sepiapterin [Moles/volume] in Cerebral spinal fluid
Somatotropin [Units/volume] in Serum or Plasma --1 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --1:30 am specimen
Somatotropin [Units/volume] in Serum or Plasma --10 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --10:30 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --11 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --11:30 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --12 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --12:30 PM specimen
Somatotropin [Units/volume] in Serum or Plasma --2 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --2:30 am specimen
Somatotropin [Units/volume] in Serum or Plasma --3 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --3:30 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --4:30 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --5 AM specimen
Cryptococcus neoformans rRNA [Presence] in Specimen by Probe
Somatotropin [Units/volume] in Serum or Plasma --5:30 AM specimen
Somatotropin [Units/volume] in Serum or Plasma --6 AM specimen
Specific gravity of Urine adjusted to pH 7.4
Suberate.unsaturated/Creatinine [Molar ratio] in Urine
Urate renal clearance in Urine and Serum or Plasma collected for unspecified duration
Urate renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration
Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection
Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Manual count
Charcoal [Presence] in Urine sediment by Light microscopy
Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
Cytomegalovirus DNA [Presence] in Tissue by Probe
Borrelia burgdorferi 31kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 31kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 34kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 34kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 35kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 35kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 35kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 35kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Cytomegalovirus DNA [Presence] in Tissue by NAA with probe detection
Borrelia burgdorferi 37kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 37kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 37kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 37kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Herpes simplex virus 1 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 18/20kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 18/20kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi 83/93kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 83/93kD IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection
Platelet aggregation collagen induced [Identifier] in Platelet rich plasma
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post XXX challenge
Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
Methaqualone [Presence] in Body fluid by Screen method
Cytology report of Bronchoalveolar lavage Cyto stain
Mixing studies [Interpretation] in Platelet poor plasma Narrative
Fetal lung maturity panel - Amniotic fluid
Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method
Enterococcus sp rRNA [Presence] in Specimen by Probe
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post XXX challenge
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method
West Nile virus Ag [Presence] in Blood or Marrow from Donor
Hemoglobin.gastrointestinal [Presence] in Sputum or Gastric fluid
Cytomegalovirus IgG Ab [Presence] in Body fluid
Microdeletion syndromes in Blood or Tissue by FISH
Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method
Ethanol+Methanol+Isopropyl alcohol+Acetone [Presence] in Serum, Plasma or Blood
Hepatitis C virus RNA panel (viral load) in Serum or Plasma by NAA with probe detection
Virus identified in Specimen by Shell vial culture
Food Allergen Mix 30 (Peanut+White bean+Soybean+Lentil+ Peas) IgE Ab [Units/volume] in Serum by Multidisk
Narcissus IgE Ab [Units/volume] in Serum
Escherichia coli IgE Ab [Units/volume] in Serum
Mahogany wood dust IgE Ab [Units/volume] in Serum
Oak wood dust IgE Ab [Units/volume] in Serum
Sulfamethoxazole IgE Ab [Units/volume] in Serum
China aster IgE Ab [Units/volume] in Serum
Cephalosporin IgE Ab [Units/volume] in Serum
Arbovirus neutralizing antibody [Identifier] in Specimen by Neutralization test
Colorado tick fever virus neutralizing antibody [Presence] in Specimen by Neutralization test
Dengue virus neutralizing antibody [Presence] in Specimen by Neutralization test
Powassan virus neutralizing antibody [Presence] in Specimen by Neutralization test
Snowshoe hare virus neutralizing antibody [Presence] in Specimen by Neutralization test
Epstein Barr virus DNA [Presence] in Tissue by Probe
5-Methyltetrahydrofolate/Folate in Serum or Plasma
Advanced oxidation protein products [Moles/volume] in Serum or Plasma
Bilirubin+Urobilinogen [Presence] in Urine
Protein carbonyl/Protein [Ratio] in Serum or Plasma
Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
Hemicystine [Moles/volume] in Amniotic fluid
Hemicystine [Moles/volume] in Serum or Plasma
Epstein Barr virus DNA [Presence] in Tissue by NAA with probe detection
Hemicystine/Amino acids.total in Amniotic fluid
Hemicystine/Amino acids.total in Serum or Plasma
Hemicystine/Amino acids.total in Specimen
Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection
Hemicystine/Creatinine [Molar ratio] in Urine
Iohexol renal clearance in Urine and Serum or Plasma
Fractional excretion of phosphate [Ratio] in Urine and Serum or Plasma collected for unspecified duration
Phosphate renal clearance in Urine and Serum or Plasma collected for unspecified duration
Oligoclonal bands/Protein.total in Urine by Electrophoresis
Fatty acids.very long chain C24:0 (Tetracosanoate)/Creatinine [Molar ratio] in Urine
Tetradecanedioate/Creatinine [Molar ratio] in Urine
Haemophilus influenzae rRNA [Presence] in Specimen by Probe
Tetradecenedioate/Creatinine [Molar ratio] in Urine
Urea renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration
1-Methylhistidine [Moles/volume] in Body fluid
11-Hydroxyandrostenedione [Moles/volume] in Body fluid
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
Hepatitis B virus DNA [Presence] in Blood by NAA with probe detection
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
11-Deoxycortisol [Moles/volume] in Amniotic fluid
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
11-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
11-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
17-Ketosteroids [Mass/volume] in Urine --post dose dexamethasone
17-Ketosteroids [Mass/volume] in Urine --2 days post dose dexamethasone
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma
Alpha aminoadipate [Moles/volume] in DBS
Alpha aminoadipate [Moles/volume] in Body fluid
2-Methyl-3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in DBS
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid
Hepatitis B virus DNA [Presence] in Tissue by NAA with probe detection
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Urine
Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine
2-Methylcitrate [Moles/volume] in Cerebral spinal fluid
21-Deoxycortisol [Moles/volume] in Amniotic fluid
21-Deoxycortisol [Moles/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin
21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
Hepatitis B virus DNA [Presence] in Specimen by NAA with probe detection
21-Deoxycortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
3-Hydroxyvalerate [Moles/volume] in Cerebral spinal fluid
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Cerebral spinal fluid
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Amniotic fluid
Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Urine
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Urine
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Amniotic fluid
Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection
3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Amniotic fluid
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Urine
3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Urine
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Cerebral spinal fluid
Hepatitis C virus RNA [Presence] in Specimen by NAA with probe detection
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Amniotic fluid
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS
3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Urine
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Amniotic fluid
3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Cerebral spinal fluid
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Amniotic fluid
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Urine
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Amniotic fluid
3-Hydroxystearoylcarnitine (C18-OH)/Creatinine [Molar ratio] in Urine
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Serum or Plasma
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Urine
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
3-Methoxy-4-Hydroxyphenylglycol/Creatinine [Molar ratio] in Urine
3-Methoxytyramine [Moles/volume] in Cerebral spinal fluid
3-Methoxytyramine [Moles/volume] in Serum or Plasma
3-O-Methyldopa [Moles/volume] in Serum or Plasma
3-O-Methyldopa/Creatinine [Molar ratio] in Urine
3-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide
Herpes simplex virus DNA [Presence] in Specimen by NAA with probe detection
Gamma aminobutyrate [Moles/volume] in DBS
Gamma aminobutyrate [Moles/volume] in Body fluid
Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid
5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5-Hydroxytryptophan [Moles/volume] in Serum or Plasma
5-Hydroxytryptophan [Moles/volume] in Urine
5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine
Histoplasma capsulatum DNA [Presence] in Specimen by NAA with probe detection
5-Methyltetrahydrofolate [Moles/volume] in Serum or Plasma
Acetoacetate [Moles/volume] in Cerebral spinal fluid
Acetylcarnitine (C2) [Moles/volume] in Cerebral spinal fluid
Acetylcarnitine (C2) [Moles/volume] in Amniotic fluid
Acetylcarnitine (C2) [Moles/volume] in DBS
Acetylcarnitine (C2) [Moles/volume] in Urine
Acetylcarnitine (C2)/Creatinine [Molar ratio] in Urine
Histoplasma capsulatum rRNA [Presence] in Specimen by Probe
Organic acids pattern [Interpretation] in Specimen
Acylcarnitine [Moles/volume] in Amniotic fluid
Acylcarnitine [Moles/volume] in Cerebral spinal fluid
Acylcarnitine pattern [Interpretation] in Specimen
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma
Alanine aminotransferase [Enzymatic activity/volume] in Dialysis fluid
Aldosterone [Moles/volume] in Serum or Plasma --post XXX challenge
Ticarcillin [Susceptibility] by Disk diffusion (KB)
Aldosterone [Moles/volume] in Serum or Plasma --pre XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin IM
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM
Alloisoleucine [Moles/volume] in Amniotic fluid
Alloisoleucine [Moles/volume] in Body fluid
Alpha-2-Macroglobulin/Protein.total in Serum or Plasma
Hemicystine [Moles/volume] in Cerebral spinal fluid
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --6 days post incubation
HIV 1 RNA [Presence] in Blood by NAA with probe detection
Calcitonin Calcium and Pentagastrin challenge panel - Serum or Plasma
Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV
Calcitonin [Mass/volume] in Serum or Plasma --pre 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV
Wine vinegar IgE Ab [Units/volume] in Serum
HIV 1 RNA [Presence] in Specimen by NAA with probe detection
Neonatal bilirubin panel [Mass/volume] - Serum or Plasma
Iron and Iron binding capacity panel - Serum or Plasma
Cholesterol in VLDL 1+2+3 [Mass/volume] in Serum or Plasma
Cholesterol in LDL.narrow density [Mass/volume] in Serum or Plasma
Cholesterol in IDL+Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma
HTLV I+II RNA [Presence] in Specimen by NAA with probe detection
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue by Molecular genetics method
Iron [Mass/volume] in Serum or Plasma --1st specimen
Iron [Mass/volume] in Serum or Plasma --2nd specimen
Iron [Mass/volume] in Serum or Plasma --3rd specimen
Iron [Mass/volume] in Serum or Plasma --4th specimen
Iron [Mass/volume] in Serum or Plasma --5th specimen
Legionella sp rRNA [Presence] in Specimen by Probe
Iron [Mass/volume] in Serum or Plasma --6th specimen
Iron [Mass/volume] in Serum or Plasma --7th specimen
Iron [Mass/volume] in Serum or Plasma --8th specimen
Glucose [Mass/volume] in Serum or Plasma --1st specimen
Glucose [Mass/volume] in Serum or Plasma --7th specimen
Glucose [Mass/volume] in Serum or Plasma --10th specimen
Albumin [Mass/time] in Urine collected for unspecified duration --supine
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula
Listeria monocytogenes rRNA [Presence] in Specimen by Probe
Glucose [Mass/volume] in Serum or Plasma --2nd specimen
Glucose [Mass/volume] in Serum or Plasma --3rd specimen
Glucose [Mass/volume] in Serum or Plasma --4th specimen
Glucose [Mass/volume] in Serum or Plasma --5th specimen
Glucose [Mass/volume] in Serum or Plasma --6th specimen
Glucose [Mass/volume] in Serum or Plasma --8th specimen
Glucose [Mass/volume] in Serum or Plasma --9th specimen
Respiratory pathogens DNA and RNA 12a panel - Specimen by NAA with probe detection
Collection interval from baseline of Unspecified specimen
Bacteria [Presence] in Urine by Automated
Broad casts [Presence] in Urine by Computer assisted method
Cholesterol crystals [Presence] in Urine by Computer assisted method
Epithelial casts [Presence] in Urine by Computer assisted method
Epithelial cells.non-squamous [Presence] in Urine by Automated
Erythrocyte clumps [Presence] in Urine by Computer assisted method
Fat [Presence] in Urine by Computer assisted method
Oval fat bodies (globules) [Presence] in Urine by Computer assisted method
Mycobacterium avium complex rRNA [Presence] in Specimen by Probe
Fatty casts [Presence] in Urine by Computer assisted method
Granular casts [Presence] in Urine by Computer assisted method
Hyaline casts [Presence] in Urine by Automated
Leucine crystals [Presence] in Urine by Computer assisted method
Leukocyte clumps [#/area] in Urine sediment by Automated count
Mixed cellular casts [Presence] in Urine by Computer assisted method
Mucus [#/area] in Urine sediment by Automated count
Phosphate crystals amorphous [Presence] in Urine by Computer assisted method
Mycobacterium avium ss avium rRNA [Presence] in Specimen by Probe
Trichomonas sp [Presence] in Urine by Computer assisted method
Tyrosine crystals [Presence] in Urine by Computer assisted method
Urate crystals amorphous [Presence] in Urine by Computer assisted method
Yeast.budding [Presence] in Urine by Computer assisted method
17-Ketosteroids [Mass/volume] in 24 hour Urine --post high dose dexamethasone
17-Ketosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
17-Ketosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone
17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
Mycobacterium gordonae rRNA [Presence] in Specimen by Probe
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --post dose dexamethasone
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
Ticarcillin [Susceptibility] by Serum bactericidal titer
21-Deoxycortisol [Moles/volume] in Serum or Plasma
3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine
Mycobacterium intracellulare rRNA [Presence] in Specimen by Probe
3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --1st specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --2nd specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --3rd specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --4th specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --5th specimen fasting
Aldosterone [Moles/volume] in Serum or Plasma --post 25 mg captopril PO
Aldosterone [Moles/volume] in Serum or Plasma --pre 25 mg captopril PO
Mycobacterium kansasii rRNA [Presence] in Specimen by Probe
Prekeratocytes [Presence] in Blood by Light microscopy
17-Ketosteroids [Mass/time] in 24 hour Urine --post high dose dexamethasone
17-Ketosteroids [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
2-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Urine
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Amniotic fluid
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in DBS
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma
Mycobacterium tuberculosis rRNA [Presence] in Specimen by Probe
3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Urine
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Cerebral spinal fluid
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Amniotic fluid
3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine [Molar ratio] in Urine
3-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide
Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe
3-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide
3-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide
Neisseria meningitidis rRNA [Presence] in Specimen by Probe
4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide
4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide
6-Hydroxyheptanoate [Moles/volume] in Urine
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Urine
Parvovirus B19 RNA [Presence] in Blood by NAA with probe detection
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Amniotic fluid
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Cerebral spinal fluid
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine
BCL10 Ag [Presence] in Tissue by Immune stain
Caldesmon Ag [Presence] in Tissue by Immune stain
CD138 Ag [Presence] in Tissue by Immune stain
Parvovirus B19 RNA [Presence] in Tissue by NAA with probe detection
CD7 Ag [Presence] in Tissue by Immune stain
Chlamydia trachomatis DNA [Presence] in Specimen from Donor by NAA with probe detection
Clusterin Ag [Presence] in Tissue by Immune stain
Cyclospora sp identified in Stool by Safranin stain
Cytokeratin 19 Ag [Presence] in Tissue by Immune stain
Cytokeratin 5 Ag [Presence] in Tissue by Immune stain
Galectin 3 Ag [Presence] in Tissue by Immune stain
CD235a Ag [Presence] in Tissue by Immune stain
Granzyme B Ag [Presence] in Tissue by Immune stain
HBME-1 Ag [Presence] in Tissue by Immune stain
Helicobacter pylori Ag [Presence] in Tissue by Immune stain
Hepatocyte Ag [Presence] in Tissue by Immune stain
MLH-1 Ag [Presence] in Tissue by Immune stain
MSH-2 Ag [Presence] in Tissue by Immune stain
MSH-6 Ag [Presence] in Tissue by Immune stain
MUM-1 Ag [Presence] in Tissue by Immune stain
Neisseria gonorrhoeae DNA [Presence] in Specimen from Donor by NAA with probe detection
Neu-N Ag [Presence] in Tissue by Immune stain
Parvovirus B19 RNA [Presence] in Specimen by NAA with probe detection
PMS-2 Ag [Presence] in Tissue by Immune stain
Respiratory syncytial virus Ag [Presence] in Tissue by Immune stain
Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)
SLC6A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
WT-1 Ag [Presence] in Tissue by Immune stain
Hexadecanedioate/Creatinine [Mass Ratio] in Urine
Tetradecanedioate/Creatinine [Mass Ratio] in Urine
Alpha-beta crystallin Ag [Presence] in Tissue by Immune stain
Staphylococcus aureus rRNA [Presence] in Specimen by Probe
Beta cortolone/Cortisol [Mass Ratio] in Urine
carBAMazepine and metabolites panel - Serum or Plasma
Cannabinoids [Mass/volume] in Dialysis fluid
Eosinophils [Presence] in Nose by Hansel stain
Eosinophils [Presence] in Sputum by Hansel stain
Ependymal+Choroid plexus cells/100 leukocytes [Ratio] in Cerebral spinal fluid
Ethanol [Presence] in Saliva (oral fluid) by Screen method
Streptococcus agalactiae rRNA [Presence] in Specimen by Probe
Parvovirus B19 DNA [Presence] in Body fluid by NAA with probe detection
Parvovirus B19 DNA [Presence] in Urine by NAA with probe detection
Parvovirus B19 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Parvovirus B19 DNA [Presence] in Bone marrow by NAA with probe detection
Parvovirus B19 DNA [Presence] in Blood by NAA with probe detection
Parvovirus B19 DNA [Presence] in Amniotic fluid by NAA with probe detection
Streptococcus pneumoniae rRNA [Presence] in Specimen by Probe
Australian pine IgE Ab/IgE total in Serum
Parrot feather IgE Ab/IgE total in Serum
Phenolphthalein [Presence] in Serum or Plasma
Phenylacetate/Creatinine [Molar ratio] in 24 hour Urine
Phenyllactate/Creatinine [Molar ratio] in 24 hour Urine
Phenylpropionylglycine/Creatinine [Molar ratio] in 24 hour Urine
Phenylpyruvate/Creatinine [Molar ratio] in 24 hour Urine
Common Pigweed IgE Ab/IgE total in Serum
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum
Prolactin monomeric/Prolactin.total in Serum or Plasma
Propionylglycine/Creatinine [Molar ratio] in 24 hour Urine
Protoporphyrin [Mass/volume] in 24 hour Urine
Streptococcus pyogenes rRNA [Presence] in Specimen by Probe
Protoporphyrin [Mass/time] in 24 hour Urine
Eosinophils.band form/100 cells in Bone marrow by Manual count
Myelocytes.eosinophilic/100 cells in Bone marrow by Manual count
Nucleated cells [#/volume] in Bronchial specimen by Manual count
Acetylcholine receptor binding Ab [Titer] in Serum by Immunofluorescence
von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay
Creatinine dialysis fluid clearance/1.73 sq M
Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula
Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula
Glutathione reductase [Enzymatic activity/mass] in Red Blood Cells
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz)
Acetylcholine receptor blocking Ab [Titer] in Serum by Immunofluorescence
Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid
Parakeet+Parrot droppings IgE Ab/IgE total in Serum
Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection
Microscopic observation [Identifier] in Bronchial brush by Cyto stain.thin prep
Coagulation factor II circulating inhibitor [Presence] in Platelet poor plasma
PTT circulating inhibitor [Presence] in Platelet poor plasma
3-Keto n-Valerate [Moles/volume] in Cerebral spinal fluid
Acetylcholine receptor modulation Ab [Titer] in Serum by Immunofluorescence
3-Keto n-Valerate/Creatinine [Molar ratio] in Urine
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample
Adenosine deaminase [Enzymatic activity/mass] in Chorionic villus sample
Molecular diagnostic major findings for display [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Molecular diagnostic overall interpretation [Presence] in Blood or Tissue by Molecular genetics method
Narrative diagnostic report [Interpretation]
Actinomyces sp Ab [Titer] in Serum by Immunofluorescence
Blood group antibody titered [Identifier] in Serum or Plasma
Other cells/100 leukocytes [Identifier] in Synovial fluid
Patient symptoms [Interpretation] Narrative--after transfusion reaction
Cannabinoids [Presence] in Meconium by Confirmatory method
Other cells/100 leukocytes [Identifier] in Cerebral spinal fluid
Protein.abnormal band/Protein.total in Urine by Electrophoresis
Cholesterol in HDL 2+3 [Mass/volume] in Serum or Plasma
Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)
Chlamydia trachomatis rRNA [Presence] in Specimen from Donor by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection
Corticotropin [Mass/volume] in Plasma --pre 1 mg dexamethasone PO overnight
Corticotropin [Mass/volume] in Plasma --post 1 mg dexamethasone PO overnight
Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO overnight
Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO overnight
Corticotropin [Mass/volume] in Plasma --pre 2 mg dexamethasone PO overnight
Corticotropin [Mass/volume] in Plasma --post 2 mg dexamethasone PO overnight
Adenovirus Ab [Titer] in Serum by Complement fixation
Corticotropin [Mass/volume] in Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h
Corticotropin [Mass/volume] in Plasma --post 500 ug dexamethasone PO 2.5 day low dose q6h
Cortisol [Mass/volume] in Serum or Plasma --pre 100 ug CRH IV
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post 100 ug CRH IV
Cortisol [Mass/volume] in Serum or Plasma --40 minutes post 100 ug CRH IV
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 100 ug CRH IV
Corticotropin [Mass/volume] in Plasma --pre 100 ug CRH IV
Corticotropin [Mass/volume] in Plasma --20 minutes post 100 ug CRH IV
Adenovirus IgM Ab [Units/volume] in Serum
Corticotropin [Mass/volume] in Plasma --40 minutes post 100 ug CRH IV
Corticotropin [Mass/volume] in Plasma --1 hour post 100 ug CRH IV
Cortisol [Mass/volume] in Serum or Plasma --9 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --3 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --6 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --9 PM specimen
Cortisol [Mass/volume] in Serum or Plasma --3 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --6 AM specimen
Adrenal Ab [Titer] in Serum by Immunofluorescence
Corticotropin [Mass/volume] in Plasma --9 AM specimen
Corticotropin [Mass/volume] in Plasma --3 PM specimen
Corticotropin [Mass/volume] in Plasma --6 PM specimen
Corticotropin [Mass/volume] in Plasma --9 PM specimen
Corticotropin [Mass/volume] in Plasma --3 AM specimen
Corticotropin [Mass/volume] in Plasma --6 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre dose insulin IV
Cortisol [Mass/volume] in Serum or Plasma --20 minutes post dose insulin IV
Adrenal cortex Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes pre dose arginine
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post dose arginine
Corticotropin [Mass/volume] in Plasma --1st specimen
Corticotropin [Mass/volume] in Plasma --2nd specimen
Corticotropin [Mass/volume] in Plasma --3rd specimen
Corticotropin [Mass/volume] in Plasma --4th specimen
Corticotropin [Mass/volume] in Plasma --5th specimen
Ancylostoma sp Ab [Units/volume] in Serum
Corticotropin [Mass/volume] in Plasma --6th specimen
Corticotropin [Mass/volume] in Plasma --7th specimen
Corticotropin [Mass/volume] in Plasma --8th specimen
Cortisol [Mass/volume] in Serum or Plasma --1st specimen
Cortisol [Mass/volume] in Serum or Plasma --2nd specimen
Cortisol [Mass/volume] in Serum or Plasma --3rd specimen
Cortisol [Mass/volume] in Serum or Plasma --4th specimen
Cortisol [Mass/volume] in Serum or Plasma --5th specimen
Cortisol [Mass/volume] in Serum or Plasma --6th specimen
Cortisol [Mass/volume] in Serum or Plasma --7th specimen
Cortisol [Mass/volume] in Serum or Plasma --8th specimen
C peptide [Moles/volume] in Serum or Plasma --1st specimen
C peptide [Moles/volume] in Serum or Plasma --2nd specimen
C peptide [Moles/volume] in Serum or Plasma --3rd specimen
C peptide [Moles/volume] in Serum or Plasma --4th specimen
C peptide [Moles/volume] in Serum or Plasma --5th specimen
C peptide [Moles/volume] in Serum or Plasma --6th specimen
C peptide [Moles/volume] in Serum or Plasma --7th specimen
C peptide [Moles/volume] in Serum or Plasma --8th specimen
Calcitonin [Mass/volume] in Serum or Plasma --1st specimen
Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen
Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen
Calcitonin [Mass/volume] in Serum or Plasma --4th specimen
Calcitonin [Mass/volume] in Serum or Plasma --5th specimen
Calcitonin [Mass/volume] in Serum or Plasma --6th specimen
Calcitonin [Mass/volume] in Serum or Plasma --7th specimen
Nuclear Ab [Units/volume] in Serum by Immunoassay
Calcitonin [Mass/volume] in Serum or Plasma --8th specimen
Follitropin [Units/volume] in Serum or Plasma --1st specimen
Follitropin [Units/volume] in Serum or Plasma --2nd specimen
Follitropin [Units/volume] in Serum or Plasma --3rd specimen
Follitropin [Units/volume] in Serum or Plasma --4th specimen
Follitropin [Units/volume] in Serum or Plasma --5th specimen
Follitropin [Units/volume] in Serum or Plasma --6th specimen
Follitropin [Units/volume] in Serum or Plasma --7th specimen
Nuclear Ab [Titer] in Serum by Immunofluorescence
Follitropin [Units/volume] in Serum or Plasma --8th specimen
Gastrin [Mass/volume] in Serum or Plasma --1st specimen
Gastrin [Mass/volume] in Serum or Plasma --2nd specimen
Gastrin [Mass/volume] in Serum or Plasma --3rd specimen
Gastrin [Mass/volume] in Serum or Plasma --4th specimen
Gastrin [Mass/volume] in Serum or Plasma --5th specimen
Gastrin [Mass/volume] in Serum or Plasma --6th specimen
Gastrin [Mass/volume] in Serum or Plasma --7th specimen
Ascaris lumbricoides Ab [Units/volume] in Serum by Immunoassay
Gastrin [Mass/volume] in Serum or Plasma --8th specimen
Somatotropin [Mass/volume] in Serum or Plasma --1st specimen
Somatotropin [Mass/volume] in Serum or Plasma --2nd specimen
Somatotropin [Mass/volume] in Serum or Plasma --3rd specimen
Somatotropin [Mass/volume] in Serum or Plasma --4th specimen
Somatotropin [Mass/volume] in Serum or Plasma --5th specimen
Somatotropin [Mass/volume] in Serum or Plasma --6th specimen
Somatotropin [Mass/volume] in Serum or Plasma --7th specimen
Bacampicillin [Susceptibility] by Serum bactericidal titer
Aspergillus fumigatus Ab [Units/volume] in Serum
Somatotropin [Mass/volume] in Serum or Plasma --8th specimen
Insulin [Units/volume] in Serum or Plasma --1st specimen
Insulin [Units/volume] in Serum or Plasma --2nd specimen
Insulin [Units/volume] in Serum or Plasma --3rd specimen
Insulin [Units/volume] in Serum or Plasma --4th specimen
Insulin [Units/volume] in Serum or Plasma --5th specimen
Insulin [Units/volume] in Serum or Plasma --6th specimen
Insulin [Units/volume] in Serum or Plasma --7th specimen
Insulin [Units/volume] in Serum or Plasma --8th specimen
Lutropin [Units/volume] in Serum or Plasma --1st specimen
Lutropin [Units/volume] in Serum or Plasma --2nd specimen
Lutropin [Units/volume] in Serum or Plasma --3rd specimen
Lutropin [Units/volume] in Serum or Plasma --4th specimen
Lutropin [Units/volume] in Serum or Plasma --5th specimen
Lutropin [Units/volume] in Serum or Plasma --6th specimen
Lutropin [Units/volume] in Serum or Plasma --7th specimen
Lutropin [Units/volume] in Serum or Plasma --8th specimen
Prolactin [Mass/volume] in Serum or Plasma --1st specimen
Aspergillus niger Ab [Units/volume] in Serum
Prolactin [Mass/volume] in Serum or Plasma --2nd specimen
Prolactin [Mass/volume] in Serum or Plasma --3rd specimen
Prolactin [Mass/volume] in Serum or Plasma --4th specimen
Prolactin [Mass/volume] in Serum or Plasma --5th specimen
Prolactin [Mass/volume] in Serum or Plasma --6th specimen
Prolactin [Mass/volume] in Serum or Plasma --7th specimen
Prolactin [Mass/volume] in Serum or Plasma --8th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --1st specimen
Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID)
Parathyrin.intact [Mass/volume] in Serum or Plasma --2nd specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --3rd specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --4th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --5th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --6th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --7th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --8th specimen
Thyrotropin [Units/volume] in Serum or Plasma --1st specimen
Aspergillus sp Ab [Titer] in Serum by Complement fixation
Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen
Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen
Thyrotropin [Units/volume] in Serum or Plasma --4th specimen
Thyrotropin [Units/volume] in Serum or Plasma --5th specimen
Thyrotropin [Units/volume] in Serum or Plasma --6th specimen
Thyrotropin [Units/volume] in Serum or Plasma --7th specimen
Thyrotropin [Units/volume] in Serum or Plasma --8th specimen
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose TRH
Babesia sp Ab [Titer] in Serum by Immunofluorescence
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine
Tricyclic antidepressants [Mass/volume] in Urine
Bacterial susceptibility panel by Minimum inhibitory concentration (MIC)
Bacterial susceptibility panel by Disk diffusion (KB)
Eastern equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
Malondialdehyde.free [Moles/volume] in Plasma
Bilirubin.total [Presence] in Urine by Automated test strip
Clarity in Urine by Refractometry automated
Urinalysis microscopic panel [#/volume] - Urine by Automated count
Glucose [Presence] in Urine by Automated test strip
Urinalysis dipstick panel - Urine by Automated test strip
Ketones [Mass/volume] in Urine by Automated test strip
Nitrite [Presence] in Urine by Automated test strip
Bacillus anthracis Ab [Units/volume] in Serum by Hemagglutination
Hemoglobin [Mass/volume] in Urine by Automated test strip
Protein [Mass/volume] in Urine by Automated test strip
Specific gravity of Urine by Refractometry automated
Urobilinogen [Mass/volume] in Urine by Automated test strip
Basement membrane Ab [Presence] in Serum by Immunofluorescence
Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation
Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB)
Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel - Serum or Plasma
Adenosine monophosphate.cyclic stimulation panel - Urine
Glucose tolerance gestational panel - Urine and Serum or Plasma
Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID)
Glucose screen gestational panel - Urine and Serum or Plasma
Lactose challenge (hydrogen breath test) panel - Exhaled gas
Triple bolus stimulation panel - Serum or Plasma
Glucose tolerance 3 hours panel - Serum or Plasma
Glucose tolerance 4 hours panel - Serum or Plasma
Glucose tolerance 5 hours panel - Serum or Plasma
Glucose tolerance 6 hours panel - Serum or Plasma
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Trophoblasts
Bordetella pertussis Ab [Units/volume] in Serum by Immunoassay
Adenosine deaminase [Enzymatic activity/mass] in Trophoblasts
Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method
3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method
3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method
Pathologist interpretation of Specimen tests
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post XXX challenge
Neisseria meningitidis serogroups Ag panel - Specimen by Latex agglutination
Glucose tolerance 3 hours gestational panel - Serum or Plasma
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay
Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood
Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma
Felbamate [Mass/volume] in Serum or Plasma by Confirmatory method
Chlamydophila pneumoniae IgA and IgG and IgM [Interpretation] in Serum
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post XXX challenge
Borrelia burgdorferi Ab [Titer] in Serum by Immunofluorescence
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post XXX challenge
Phosphatidylcholine.saturated/Surfactant.total in Amniotic fluid
Karyotype [Identifier] in Blood or Tissue Narrative
Opiates cutoff [Mass/mass] in Meconium for Confirmatory method
HTT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Miscellaneous allergen IgG Ab [Identifier] in Serum
AS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HIV 1 RNA panel (viral load) in Cerebral spinal fluid by NAA with probe detection
Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay
Ova and parasites identified in Blood or Tissue by Wright stain
DMD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HC gene rearrangements in Blood or Tissue by Molecular genetics method Narrative
Heptacarboxylporphyrin/Creatinine [Molar ratio] in Urine
Liver kidney microsomal IgG Ab [Titer] in Serum
Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria
Cefepime [Susceptibility] by Method for Slow-growing mycobacteria
Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria
Borrelia burgdorferi IgG Ab [Titer] in Serum by Immunofluorescence
cefTRIAXone [Susceptibility] for meningitis
Balsam poplar IgE Ab [Units/volume] in Serum
Monterey cypress IgE Ab [Units/volume] in Serum
Giant Japanese spider crab IgE Ab [Units/volume] in Serum
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method
Annatto seed IgE Ab [Units/volume] in Serum
Asian ladybug IgE Ab [Units/volume] in Serum
Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe with signal amplification
Pregnanetriolone [Mass/time] in 24 hour Urine
Tetrahydrocorticosterone/Creatinine [Mass Ratio] in Urine
Tetrahydrocortisol/Creatinine [Mass Ratio] in Urine
Latex recombinant (rHev b) 1 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 11 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 6.01 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 6.02 IgE Ab [Units/volume] in Serum
Lupin seed IgE Ab [Units/volume] in Serum
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Units/volume] in Serum by Multidisk
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Units/volume] in Serum by Multidisk
Borrelia burgdorferi IgM Ab [Titer] in Serum by Immunofluorescence
Basophils.band form/100 leukocytes in Bone marrow
Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
Ticarcillin+Clavulanate [Susceptibility] by Serum bactericidal titer
Herpes simplex virus 1 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Urine by NAA with probe detection
Brucella abortus Ab [Presence] in Serum by Latex agglutination
Nuclear matrix protein 22 [Presence] in Urine
Glucose tolerance [Interpretation] in Serum or Plasma Narrative
Microscopic observation in Specimen by Electron microscopy Narrative
Erythrocyte agglutination [Presence] in Blood
Corticotropin releasing hormone [Mass] of Dose
Leukocyte toxic vacuoles [Presence] in Blood by Light microscopy
Brucella abortus Ab [Titer] in Serum by Latex agglutination
Spherocytes [Presence] in Cord blood by Light microscopy
Calcium-phosphorus product [(Mass/volume)*2] in Serum or Plasma
Calcium-phosphorus product panel - Serum or Plasma
First trimester maternal screen with nuchal translucency [Interpretation]
Paecilomyces variottii IgE Ab [Units/volume] in Serum
Thyroxine binding protein pattern [Interpretation] in Serum or Plasma by Electrophoresis
Brucella canis Ab [Titer] in Serum by Latex agglutination
PRKCG gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab [Presence] in Serum
Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative
Somatotropin [Mass/time] in 24 hour Urine
Plasmodium sp lactate dehydrogenase [Identifier] in Blood
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Hemagglutination
Brucella melitensis Ab [Titer] in Serum by Latex agglutination
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum by Complement fixation
Parainfluenza virus 1+2+3 Ab [Titer] in Serum by Complement fixation
Influenza virus A+B Ab [Titer] in Serum by Complement fixation
Rubella virus Ab [Titer] in Serum by Hemagglutination inhibition
Treponema pallidum Ab [Titer] in Cerebral spinal fluid by Hemagglutination
Influenza virus A neutralizing antibody [Identifier] in Serum by Neutralization test
Influenza virus A Ag [Identifier] in Isolate
Influenza virus A.adamantane resistance [Presence] by Phenotype method
Influenza virus A.adamantane resistance [Presence]
Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection
Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method
Brucella sp IgM Ab [Units/volume] in Serum
Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method
Bitter dock IgE Ab [Units/volume] in Serum
Brucella suis Ab [Titer] in Serum by Latex agglutination
11-Deoxycortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Lymphoblasts/100 leukocytes in Bone marrow by Manual count
Monoblasts/100 leukocytes in Bone marrow by Manual count
Reticulum cell/100 cells in Bone marrow by Gomori stain
Serotonin release 100 IU/mL heparin.unfractionated [Units/volume] in Serum
Serotonin release 0.1 IU/mL heparin.unfractionated [Units/volume] in Serum
La Crosse virus Ab [Units/volume] in Serum
Serotonin release interpretation in Serum
Serotonin release.heparin.porcine in Serum
Serotonin release.heparin.unfractionated panel - Serum
Serotonin release.heparin.porcine panel - Serum
Serotonin release.heparin.porcine and low molecular weight panel - Serum
Tobramycin [Susceptibility] by Minimum lethal concentration (MLC)
Candida albicans Ab [Presence] in Serum by Immune diffusion (ID)
Hirudin [Units/volume] in Platelet poor plasma by Chromogenic method
Platelet factor 4 Ag [Presence] in Platelet poor plasma by Immunoassay
Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine
F13A1 gene p.Val34Leu [Presence] in Blood or Tissue by Molecular genetics method
Glucose [Mass/volume] in Serum or Plasma --15 minutes post 0.1 U/kg insulin
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose insulin IV
aPTT in Pooled Platelet poor plasma by Coagulation assay
Candida albicans Ag [Titer] in Serum by Latex agglutination
Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Blood
Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Leukocytes
Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay
Hemoglobin Hasharon/Hemoglobin.total in Blood by Electrophoresis
Fungus # 8 identified in Specimen by Culture
Ganglioside GD1a IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Ganglioside GD1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Asialoganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Ganglioside GM1 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Ganglioside GM2 IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Ganglioside GQ1b IgG Ab/IgM Ab [Ratio] in Serum by Immunoassay
Centromere Ab [Titer] in Serum by Immunofluorescence
ABO and Rh group [Type] in Blood from Newborn--after transfusion reaction
Cancer Ag 125 [Units/volume] in Cerebral spinal fluid
Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid
Cancer Ag 15-3 [Units/volume] in Pericardial fluid
Cancer Ag 15-3 [Units/volume] in Peritoneal fluid
Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid
Cancer Ag 19-9 [Units/volume] in Pericardial fluid
Chlamydophila pneumoniae Ab [Units/volume] in Serum
Cancer Ag 19-9 [Units/volume] in Peritoneal fluid
Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis acid (pH 6.0)
Protein.monoclonal band 3/Protein.total in Serum or Plasma by Electrophoresis
Protein.monoclonal band 4/Protein.total in Serum or Plasma by Electrophoresis
Osmotic fragility beginning hemolysis of Red Blood Cells
Osmotic fragility full hemolysis of Red Blood Cells
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
17-Ketogenic steroids [Moles/volume] in 24 hour Urine
Chlamydophila psittaci Ab [Titer] in Serum by Complement fixation
7-Dehydrocholesterol [Moles/volume] in Body fluid
Amikacin [Moles/volume] in Serum or Plasma --peak
Amikacin [Moles/volume] in Serum or Plasma --trough
Amitriptyline [Moles/volume] in Gastric fluid
Chlamydophila psittaci IgG Ab [Units/volume] in Serum
Antimony [Moles/volume] in 24 hour Urine
Antimony [Moles/volume] in Red Blood Cells
Arsenic [Moles/volume] in Red Blood Cells
Arsenic.inorganic [Moles/volume] in Urine
Chlamydophila psittaci IgM Ab [Units/volume] in Serum
Arsenic.inorganic [Moles/time] in 24 hour Urine
Arsenic/Creatinine [Molar ratio] in 24 hour Urine
Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Base excess in Capillary blood from Fetus by calculation
Chlamydia sp Ab [Units/volume] in Serum by Immunoassay
Beta-2-Microglobulin [Moles/volume] in 24 hour Urine
Chlamydia sp Ab [Titer] in Serum by Complement fixation
Boron/Creatinine [Molar ratio] in 24 hour Urine
Cadmium [Moles/volume] in Red Blood Cells
Cadmium/Creatinine [Molar ratio] in 24 hour Urine
Calcium.ionized [Moles/volume] in Body fluid
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Body fluid
Calcium/Creatinine [Molar ratio] in 24 hour Urine
Cholesterol in HDL [Moles/volume] in Body fluid
Chromium [Moles/volume] in Red Blood Cells
Cobalt [Moles/volume] in Red Blood Cells
Cortisol [Moles/volume] in 24 hour Urine
Chlamydia sp Ab [Titer] in Serum by Immunofluorescence
diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma
Fluoride/Creatinine [Molar ratio] in Urine
Heptacarboxylporphyrin [Moles/mass] in Stool
Hexacarboxylporphyrin [Moles/mass] in Stool
Chlamydia sp IgG Ab [Units/volume] in Serum
Histamine [Moles/volume] in 3 hour Urine
Hydrogen ion [Moles/volume] in Mixed venous cord blood
Hydrogen ion [Moles/volume] in Venous cord blood
Hydrogen ion [Moles/volume] in Arterial cord blood
Hydrogen ion [Moles/volume] in Capillary blood
Hydrogen ion [Moles/volume] in Cord blood
Chlamydia sp IgM Ab [Units/volume] in Serum
Hydrogen ion [Moles/volume] in Venous blood
Hydrogen ion [Moles/volume] in Serum or Plasma
Indicans/Creatinine [Molar ratio] in Urine
Isopropanol [Moles/volume] in Body fluid
Chlamydia trachomatis Ab [Titer] in Serum by Complement fixation
Magnesium/Creatinine [Molar ratio] in 24 hour Urine
Manganese [Moles/volume] in Red Blood Cells
Mercury [Moles/volume] in Red Blood Cells
Methyl ethyl ketone [Moles/volume] in Body fluid
Chlamydia trachomatis Ab [Titer] in Serum by Immunofluorescence
Methyl ethyl ketone [Moles/volume] in Serum or Plasma
Molybdenum [Moles/volume] in Red Blood Cells
Molybdenum [Moles/time] in 24 hour Urine
Naproxen [Moles/volume] in Serum or Plasma
Nickel [Moles/volume] in Red Blood Cells
Nitrogen [Moles/time] in 24 hour Body fluid
Nitrogen [Moles/volume] in 24 hour Urine
Paraquat [Moles/volume] in Serum or Plasma
Pentacarboxylporphyrins [Moles/mass] in Stool
Chlamydia trachomatis IgG Ab [Units/volume] in Serum
Tobramycin [Susceptibility] by Disk diffusion (KB)
Porphyrins [Moles/volume] in 24 hour Urine
Chlamydia trachomatis IgM Ab [Units/volume] in Serum
Thallium [Moles/volume] in 24 hour Urine
Titanium [Moles/volume] in Serum or Plasma
Tobramycin [Moles/volume] in Serum or Plasma
Uroporphyrin 1 isomer [Moles/mass] in Stool
Uroporphyrin/Porphyrins.total in 24 hour Urine
Vanadium [Moles/volume] in Red Blood Cells
Zinc/Creatinine [Molar ratio] in 24 hour Urine
Mycobacterium sp [Presence] in Specimen by Organism specific culture
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --20 umol/L
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2 umol/L
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --4 umol/L
Platelet aggregation collagen induced [Presence] in Platelet rich plasma --190 ug/mL
Coccidioides immitis Ab [Units/volume] in Serum by Immunoassay
Vanillylmandelate and Creatinine [Interpretation] in 24 hour Urine Narrative
Albumin [Presence] in Urine by Test strip
Phosphoethanolamine IgA Ab [Presence] in Serum or Plasma
Phosphoserine IgA Ab [Presence] in Serum or Plasma
Phosphoserine IgG Ab [Presence] in Serum or Plasma
Phosphoethanolamine IgM Ab [Presence] in Serum or Plasma
Phosphoethanolamine IgG Ab [Presence] in Serum or Plasma
Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID)
Phosphoserine IgM Ab [Presence] in Serum or Plasma
Manual differential performed [Presence] in Blood
Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma --after transfusion
Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma
XXX blood group IgG Ab [Titer] in Serum or Plasma
Coccidioides immitis Ab [Titer] in Serum by Complement fixation
XXX blood group IgM Ab [Titer] in Serum or Plasma
Liley Zone [Presence] in Amniotic fluid by Spectrophotometry
Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma
Flunitrazepam [Presence] in Serum, Plasma or Blood
Hepatitis B virus surface Ag [Presence] in Blood from Donor by Neutralization test
Epstein Barr virus early diffuse IgG Ab [Units/volume] in Serum
XXX blood group Ab [Titer] in Serum or Plasma by Antihuman globulin
Cold agglutinin [Presence] in Serum or Plasma by Agglutination
Cytology report of Bronchial brush Cyto stain
TCR alpha beta cells [#/volume] in Blood
TCR gamma delta cells [#/volume] in Blood
Lambda light chains.free [Presence] in Serum by Immunofixation
CBir1 Ab [Units/volume] in Serum by Immunoassay
pH of Mixed venous blood adjusted to patient's actual temperature
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood
Horowitz index adjusted to patients actual temperature in Blood
Horowitz index adjusted to patients actual temperature in Capillary blood
Cold agglutinin [Titer] in Serum or Plasma by Agglutination
Horowitz index adjusted to patients actual temperature in Arterial blood
Horowitz index adjusted to patients actual temperature in Mixed venous blood
Horowitz index adjusted to patients actual temperature in Venous blood
CMT demyelinating gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Complement C8.functional [Units/volume] in Serum or Plasma
CFTR gene mutations tested for [#] in Blood or Tissue by Molecular genetics method
Leishmania donovani IgG and IgM [Interpretation] in Serum
Leishmania tropica IgG and IgM [Interpretation] in Serum Narrative
Lipoprotein midband A [Mass/volume] in Serum or Plasma
Coxiella burnetii Ab [Titer] in Serum by Complement fixation
Lipoprotein midband B [Mass/volume] in Serum or Plasma
Lipoprotein midband C [Mass/volume] in Serum or Plasma
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma by High sensitivity method
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --after transfusion
Wheat native (nTri a) 19 IgE Ab [Units/volume] in Serum
CD3-CD16+CD56+CD244+ cells/100 cells in Bone marrow
CD3-CD16+CD56+CD244+ cells/100 cells in Blood
Coxsackievirus A7 neutralizing antibody [Titer] in Serum by Neutralization test
CD3-CD16+CD56+CD244+ cells/100 cells in Specimen
Cytoplasmic CD117 blasts/100 cells in Bone marrow
Cytoplasmic CD117 blasts/100 cells in Blood
Cytoplasmic CD117 blasts/100 cells in Specimen
CD117 blasts [Units/volume] in Bone marrow
Coxsackievirus A9 neutralizing antibody [Titer] in Serum by Neutralization test
CD11a blasts [Units/volume] in Bone marrow
Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation
CD123 blasts [Units/volume] in Bone marrow
Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test
CD126 blasts [Units/volume] in Bone marrow
CD127 blasts [Units/volume] in Bone marrow
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation
Cytoplasmic CD13 blasts/100 blasts in Bone marrow
Cytoplasmic CD13 blasts/100 blasts in Blood
Cytoplasmic CD13 blasts/100 blasts in Specimen
CD13 blasts [Units/volume] in Bone marrow
CD135 blasts [Units/volume] in Bone marrow
CD14 blasts [Units/volume] in Bone marrow
Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test
Tobramycin [Susceptibility] by Serum bactericidal titer
CD15 blasts [Units/volume] in Bone marrow
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation
Cytoplasmic CD179a blasts/100 blasts in Bone marrow
Cytoplasmic CD179a blasts/100 blasts in Blood
Cytoplasmic CD179a blasts/100 blasts in Specimen
Cytoplasmic CD179a blasts [Units/volume] in Bone marrow
Cytoplasmic CD179a blasts [Units/volume] in Blood
Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test
Cytoplasmic CD179a blasts [Units/volume] in Specimen
CD179a blasts [Units/volume] in Bone marrow
CD179a blasts [Units/volume] in Specimen
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation
CD19 blasts [Units/volume] in Bone marrow
Cytoplasmic CD2 blasts/100 blasts in Specimen
Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test
CD2 blasts [Units/volume] in Bone marrow
Cytoplasmic CD22 blasts/100 blasts in Bone marrow
Cytoplasmic CD22 blasts/100 blasts in Blood
Cytoplasmic CD22 blasts/100 blasts in Specimen
Cytoplasmic CD22 blasts [Units/volume] in Bone marrow
Cytoplasmic CD22 blasts [Units/volume] in Blood
Cytoplasmic CD22 blasts [Units/volume] in Specimen
CD22 blasts [Units/volume] in Bone marrow
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation
Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test
Cytoplasmic CD3 blasts/100 blasts in Bone marrow
Cytoplasmic CD3 blasts/100 blasts in Blood
Cytoplasmic CD3 blasts/100 blasts in Specimen
Cytoplasmic CD3 blasts [Units/volume] in Bone marrow
Cytoplasmic CD3 blasts [Units/volume] in Blood
Cytoplasmic CD3 blasts [Units/volume] in Specimen
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation
CD3 blasts [Units/volume] in Bone marrow
CD3+CD16+CD56+ blasts/100 blasts in Bone marrow
CD3+CD16+CD56+ blasts/100 blasts in Blood
Corynebacterium diphtheriae Ab [Units/volume] in Serum
CD3+CD16+CD56+ blasts/100 blasts in Specimen
CD33 blasts [Units/volume] in Bone marrow
Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC)
CD33+CD34+ blasts/100 blasts in Specimen
Cytoplasmic CD34 blasts/100 blasts in Specimen
CD34 blasts [Units/volume] in Bone marrow
CD34+CD117+ blasts/100 blasts in Bone marrow
Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay
CD34+CD117+ blasts/100 blasts in Specimen
CD34+CD117+ blasts [Units/volume] in Bone marrow
CD34+CD117+ blasts [Units/volume] in Blood
CD36+CD235a+ blasts/100 blasts in Bone marrow
CD10 blasts [Units/volume] in Bone marrow
CD117 Ag [Presence] in Bone marrow by Immune stain
CD117 Ag [Presence] in Blood by Immune stain
CD117 Ag [Presence] in Specimen by Immune stain
CD15 Ag [Presence] in Bone marrow by Immune stain
CD15 Ag [Presence] in Blood by Immune stain
CD15 Ag [Presence] in Specimen by Immune stain
4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma
Albumin [Mass/volume] in 24 hour Urine by Electrophoresis
Desbutylbupivacaine [Mass/volume] in Serum or Plasma
Hemoglobin A1/Hemoglobin.total in Blood by Electrophoresis
Taenia solium larva Ab [Units/volume] in Serum by Hemagglutination
Ropivacaine [Mass/volume] in Serum or Plasma
Acetaminophen crystals [#/area] in Urine sediment by Microscopy high power field
CD10 cells/100 cells in Cerebral spinal fluid
CD10+CD19+ cells/100 cells in Cerebral spinal fluid
Cytomegalovirus Ab [Titer] in Serum or Plasma by Latex agglutination
CD10+CD19+ cells/100 cells in Body fluid
CD103 cells/100 cells in Cerebral spinal fluid
CD105 cells/100 cells in Cerebral spinal fluid
CD117 cells/100 cells in Cerebral spinal fluid
Cytomegalovirus Ab [Units/volume] in Serum or Plasma by Immunofluorescence
CD11b cells/100 cells in Cerebral spinal fluid
CD11c cells/100 cells in Cerebral spinal fluid
CD11c+CD19+ cells/100 cells in Cerebral spinal fluid
CD13 cells/100 cells in Cerebral spinal fluid
CD13+CD33+ cells/100 cells in Cerebral spinal fluid
Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)
CD13+CD33+ cells/100 cells in Body fluid
CD13+CD33+HLA-DR+ cells/100 cells in Tissue
CD13+CD33+HLA-DR+ cells/100 cells in Cerebral spinal fluid
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
CD13+CD33+HLA-DR+ cells/100 cells in Bone marrow
CD13+CD33+HLA-DR+ cells/100 cells in Body fluid
CD13+CD33+HLA-DR+ cells/100 cells in Blood
CD138 cells/100 cells in Cerebral spinal fluid
CD14 cells/100 cells in Cerebral spinal fluid
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
CD15 cells/100 cells in Cerebral spinal fluid
CD16+CD56+ cells/100 cells in Cerebral spinal fluid
CD16+CD56+ cells/100 cells in Bone marrow
CD16+CD57+ cells/100 cells in Cerebral spinal fluid
CD16+CD57+ cells/100 cells in Bone marrow
CD16+CD57+ cells/100 cells in Body fluid
CD16B cells/100 cells in Cerebral spinal fluid
CD19 cells/100 cells in Cerebral spinal fluid
CD23 cells/100 cells in Cerebral spinal fluid
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
CD25 cells/100 cells in Cerebral spinal fluid
CD25+CD19+ cells/100 cells in Cerebral spinal fluid
CD3+CD16+ cells/100 cells in Cerebral spinal fluid
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
CD3+CD16+ cells/100 cells in Bone marrow
CD3+CD56+ cells/100 cells in Cerebral spinal fluid
CD3+CD56+ cells/100 cells in Bone marrow
CD3+CD57+ cells/100 cells in Cerebral spinal fluid
Neutrophil cytoplasmic Ab [Units/volume] in Serum
CD3+CD57+ cells/100 cells in Bone marrow
CD30 cells/100 cells in Cerebral spinal fluid
Deoxyribonuclease Ab [Units/volume] in Serum
CD33 cells/100 cells in Cerebral spinal fluid
CD36 cells/100 cells in Cerebral spinal fluid
CD38 cells/100 cells in Cerebral spinal fluid
Butirosin [Susceptibility] by Minimum lethal concentration (MLC)
DNA double strand Ab [Units/volume] in Serum
CD3+CD4+ (T4 helper) cells/100 cells in Tissue
CD4+CD7- cells/100 cells in Cerebral spinal fluid
CD4+CD7-CD26- cells/100 cells in Cerebral spinal fluid
CD4+CD7-CD26- cells/100 cells in Bone marrow
CD4+CD7-CD26- cells/100 cells in Body fluid
CD4+CD7-CD49D- cells/100 cells in Tissue
CD4+CD7-CD49D- cells/100 cells in Cerebral spinal fluid
CD4+CD7-CD49D- cells/100 cells in Bone marrow
CD4+CD7-CD49D- cells/100 cells in Body fluid
DNA double strand Ab [Presence] in Serum by Immunofluorescence
CD41 cells/100 cells in Cerebral spinal fluid
Trimethoprim [Susceptibility] by Disk diffusion (KB)
CD42 cells/100 cells in Cerebral spinal fluid
DNA single strand Ab [Units/volume] in Serum
CD42b cells/100 cells in Cerebral spinal fluid
CD43 cells/100 cells in Cerebral spinal fluid
Streptococcal DNAse B [Units/volume] in Serum
CD19+CD43+ cells/100 cells in Cerebral spinal fluid
CD19+CD43+ cells/100 cells in Bone marrow
CD19+CD43+ cells/100 cells in Body fluid
CD45 (Lymphs) cells/100 cells in Cerebral spinal fluid
CD45 (Lymphs) cells/100 cells in Bone marrow
CD5+CD19+ cells/100 cells in Cerebral spinal fluid
Eastern equine encephalitis virus Ab [Units/volume] in Serum
CD55 cells/100 cells in Cerebral spinal fluid
CD56+CD57+ cells/100 cells in Cerebral spinal fluid
CD56+CD57+ cells/100 cells in Bone marrow
CD56+CD57+ cells/100 cells in Body fluid
CD57 cells/100 cells in Cerebral spinal fluid
CD19+CD58+ cells/100 cells in Cerebral spinal fluid
CD19+CD58+ cells/100 cells in Bone marrow
CD19+CD58+ cells/100 cells in Body fluid
CD59 cells/100 cells in Cerebral spinal fluid
Echinococcus sp Ab [Units/volume] in Serum by Hemagglutination
CD61 cells/100 cells in Cerebral spinal fluid
CD64 cells/100 cells in Cerebral spinal fluid
Echovirus 1 neutralizing antibody [Titer] in Serum by Neutralization test
CD79b cells/100 cells in Cerebral spinal fluid
CD8+HLA-DR+ cells/100 cells in Cerebral spinal fluid
CD8+HLA-DR+ cells/100 cells in Bone marrow
CD8+HLA-DR+ cells/100 cells in Body fluid
Echovirus 1 Ab [Titer] in Serum by Complement fixation
CD9 cells/100 cells in Cerebral spinal fluid
HLA-DR+ cells/100 cells in Cerebral spinal fluid
Erythrocytes [#/area] in Synovial fluid by Light microscopy
Echovirus 19 neutralizing antibody [Titer] in Serum by Neutralization test
Leukocytes other [#/volume] in Blood by Automated count
Mononuclear cells/100 leukocytes in Blood by Manual count
Plasma cells/100 leukocytes in Cerebral spinal fluid by Manual count
Plasma cells/100 leukocytes in Body fluid by Manual count
Echovirus 19 Ab [Titer] in Serum by Complement fixation
CD65w cells/100 cells in Cerebral spinal fluid
Trimethoprim [Susceptibility] by Serum bactericidal titer
CD81 cells/100 cells in Cerebral spinal fluid
Immunoglobulin light chains.free [Mass/time] in 24 hour Urine
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay
Echovirus 3 neutralizing antibody [Titer] in Serum by Neutralization test
Fosamprenavir+Ritonavir [Susceptibility] by Genotype method
3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma
Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma
Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma
Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma
Echovirus 3 Ab [Titer] in Serum by Complement fixation
Coproporphyrin/Porphyrins.total in 24 hour Urine
Domperidone [Moles/volume] in Body fluid
Sodium [Moles/volume] corrected for glucose in Serum or Plasma
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Testosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Corticotropin [Moles/volume] in Plasma --pre or post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Echovirus 4 neutralizing antibody [Titer] in Serum by Neutralization test
EPINEPHrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Lactate [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Norepinephrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --pre or post XXX challenge
Gastrin [Mass/volume] in Serum or Plasma --pre or post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --pre or post XXX challenge
Echovirus 4 Ab [Titer] in Serum by Complement fixation
Renin [Mass/volume] in Plasma --pre or post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --pre or post XXX challenge
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
Protein.monoclonal [Mass/volume] in 24 hour Urine by Electrophoresis
Protein.monoclonal band 2 [Mass/volume] in Urine by Electrophoresis
Protein.monoclonal band 2 [Mass/volume] in 24 hour Urine by Electrophoresis
Protein.monoclonal band 3 [Mass/volume] in 24 hour Urine by Electrophoresis
Protein.monoclonal band 3 [Mass/volume] in Urine by Electrophoresis
Echovirus 6 neutralizing antibody [Titer] in Serum by Neutralization test
Macroprolactin/Prolactin [Mass] in Serum or Plasma
Domperidone [Moles/volume] in Serum or Plasma
CD19+CD38+ cells [Units/volume] in Blood
Dihydrocodeine+Hydrocodol [Mass/volume] in Urine
Paragonimus sp Ab [Titer] in Serum by Immunoassay
Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma
Coccidioides immitis Ab [Titer] in Body fluid
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum
Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid
Echovirus 6 Ab [Titer] in Serum by Complement fixation
Hepatitis D virus IgG Ab [Units/volume] in Serum
Hepatitis E virus Ab [Units/volume] in Serum
Influenza virus A H16 Ab [Titer] in Serum
Onchocerca sp IgG2 Ab [Units/volume] in Serum
Onchocerca sp IgG3 Ab [Units/volume] in Serum
Onchocerca sp IgG4 Ab [Units/volume] in Serum
Paragonimus sp Ab [Titer] in Pleural fluid
Echovirus 9 neutralizing antibody [Titer] in Serum by Neutralization test
Parainfluenza virus 1+2+3 Ab [Titer] in Serum
Plasmodium falciparum IgG Ab [Titer] in Serum
Plasmodium ovale IgG Ab [Titer] in Serum
Plasmodium vivax IgG Ab [Titer] in Serum
Satratoxin IgM Ab [Units/volume] in Serum
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum
Echovirus 9 Ab [Titer] in Serum by Complement fixation
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid
Treponema pallidum Ab [Titer] in Cerebral spinal fluid
ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Coccidioides sp IgM Ab [Presence] in Specimen by Immune diffusion (ID)
Mucus [#/volume] in Urine by Automated count
Spermatozoa [#/volume] in Urine by Automated count
Bacteria [#/volume] in Urine by Automated count
Yeast [#/volume] in Urine by Automated count
Echovirus NOS neutralizing antibody [Titer] in Serum by Neutralization test
Crystals [#/volume] in Urine by Automated count
Casts [#/volume] in Urine by Automated count
Hyaline casts [#/volume] in Urine by Automated count
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
Epithelial cells.squamous [#/volume] in Urine by Automated count
Leukocytes [#/volume] in Urine by Automated count
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen post XXX challenge
Echovirus NOS Ab [Titer] in Serum by Complement fixation
Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --baseline
Estradiol (E2) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Penicillin G benzathine [Susceptibility]
Creatine kinase.BB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis
Creatine kinase.MB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis
Creatine kinase.MM [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis
Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis
Entamoeba histolytica Ab [Units/volume] in Serum by Hemagglutination
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Peritoneal fluid by Electrophoresis
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Pleural fluid by Electrophoresis
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Cerebral spinal fluid by Electrophoresis
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk
Epidermis Ab [Titer] in Serum by Immunofluorescence
Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Units/volume] in Serum
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Presence] in Serum by Multidisk
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Presence] in Serum by Multidisk
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Presence] in Serum by Multidisk
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Presence] in Serum by Multidisk
Lactalbumin alpha IgG Ab [Presence] in Serum
Beta lactoglobulin IgG Ab [Presence] in Serum
Epstein Barr virus early Ab [Presence] in Serum by Immunoassay
European house dust mite IgG Ab [Presence] in Serum
American house dust mite IgG Ab [Presence] in Serum
Cladosporium herbarum IgG Ab [Presence] in Serum
Candida albicans IgG Ab [Presence] in Serum
Epstein Barr virus early Ab [Presence] in Serum by Immunofluorescence
Alternaria alternata IgG Ab [Presence] in Serum
Stachybotrys chartarum IgG Ab [Presence] in Serum
Aspergillus versicolor IgG Ab [Presence] in Serum
Cladosporium cladosporioides IgG Ab [Presence] in Serum
Penicillium sp IgG Ab [Presence] in Serum
Budgerigar droppings IgG Ab [Presence] in Serum
Chicken feather IgG Ab [Presence] in Serum
Canary feather IgG Ab [Presence] in Serum
Parrot feather IgG Ab [Presence] in Serum
Pigeon feather IgG Ab [Presence] in Serum
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay
Chlamydia trachomatis DNA [Presence] in Semen by NAA with probe detection
Normoblasts/100 cells in Bone marrow by Manual count
Macrophages/100 leukocytes in Bone marrow by Manual count
Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence
Anisochromasia [Presence] in Blood by Light microscopy
Anulocytes [Presence] in Blood by Light microscopy
Immature granulocytes [#/volume] in Blood
Other cells [#/volume] in Blood by Manual count
Other cells/100 leukocytes in Blood by Manual count
Plasmodium sp [Presence] in Blood by Light microscopy
Granulocytes [#/volume] in Blood by Manual count
Dyserythropoiesis [Presence] in Blood by Light microscopy
Chloride [Moles/volume] in Capillary blood
Cholesterol [Moles/volume] in Synovial fluid
Creatinine [Moles/time] in 12 hour Urine
Glucose [Moles/volume] in Capillary blood
Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose
Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose
Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose
Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose
Cytochrome B5 reductase [Presence] in Red Blood Cells
Triglyceride [Moles/volume] in Synovial fluid
Xylose [Moles/volume] in Blood --3 hours post dose xylose PO
Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence
Xylose [Moles/volume] in Blood --3 hours post XXX challenge
Xylose [Moles/volume] in Blood --30 minutes post dose xylose PO
Xylose [Moles/volume] in Blood --30 minutes post XXX challenge
Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose
Hemoglobin A2+C/Hemoglobin.total in Blood
Hemoglobin A2+E/Hemoglobin.total in Blood
Potassium [Moles/volume] in Serum or Plasma --pre dialysis
Creatinine [Moles/volume] in Serum or Plasma --pre dialysis
Creatinine [Moles/volume] in Serum or Plasma --post dialysis
Macrophages/100 leukocytes in Dialysis fluid by Manual count
Mesothelial cells/100 leukocytes in Dialysis fluid by Manual count
Fasciola hepatica Ab [Units/volume] in Serum
Spermatozoa [#/volume] in Semen --post vasectomy
Malignant cells/100 cells in Dialysis fluid by Manual count
Malignant cells/100 cells in Body fluid by Manual count
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with 1:4 normal plasma 1H post incubation separate tubes
Lymphocytes [#/volume] in Peritoneal fluid by Manual count
Morphology [Interpretation] in Bone marrow Narrative
Macroblasts/100 cells in Bone marrow by Manual count
Schistocytes/1000 erythrocytes in Blood by Light microscopy
Platelet distribution width [Ratio] in Blood
Reticulocytes.mature [#/volume] in Blood
Immature reticulocytes [#/volume] in Blood
Erythrocyte aggregates [Presence] in Blood by Light microscopy
Acanthocytes/1000 erythrocytes in Blood by Light microscopy
Platelet anisocytosis [Presence] in Blood by Light microscopy
Mean sphered cell volume [Entitic volume] in Red Blood Cells
Reticulocytes.high light scatter/Reticulocytes.total in Blood
Reticulocytes.high light scatter [#/volume] in Blood
Megakaryocytic nuclei [Presence] in Blood by Light microscopy
Micromegakaryocytes [Presence] in Blood by Light microscopy
Rabies virus RNA [Presence] in Specimen by NAA with probe detection
Rabies virus RNA [Presence] in Specimen by Probe
Monocytoid cells/100 leukocytes in Cerebral spinal fluid by Manual count
Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum by Immunoblot
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
HLA-B [Interpretation] by NAA with probe detection
SLC14A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hepatitis E virus Ab [Presence] in Body fluid
Hepatitis D virus Ab [Presence] in Body fluid
Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection
Filaria Ab [Units/volume] in Serum by Hemagglutination
Hepatitis C virus Ab Signal/Cutoff in Body fluid
Hepatitis C virus Ab [Presence] in Body fluid
Hepatitis B virus core IgM Ab [Presence] in Body fluid
Hepatitis B virus surface Ag [Presence] in Body fluid
Hepatitis A virus IgM Ab [Presence] in Body fluid
Hepatitis A virus Ab [Presence] in Body fluid
Core respiratory allergens panel - Serum
Alphavirus RNA [Presence] in Specimen by NAA with probe detection
Francisella tularensis Ab [Presence] in Serum by Latex agglutination
Chikungunya virus RNA [Presence] in Specimen by NAA with probe detection
Flavivirus RNA [Presence] in Specimen by NAA with probe detection
Japanese encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Lymphocytic choriomeningitis virus RNA [Presence] in Specimen by NAA with probe detection
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Pseudomonas aeruginosa DNA [Identifier] in Unspecified specimen by NAA with probe detection
Parechovirus A RNA [Presence] in Specimen by NAA with probe detection
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --baseline
Brucella sp Ab [Titer] in Serum by Tube agglutination
Francisella tularensis Ab [Titer] in Serum by Latex agglutination
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Gall canaliculi Ab [Units/volume] in Serum
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --baseline
Pregnenolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Pregnenolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Amphetamines [Presence] in Blood by Screen method
Opiates [Presence] in Blood by Screen method
Phencyclidine [Presence] in Blood by Screen method
Albumin [Mass/volume] in Pericardial fluid
Corticotropin [Mass/volume] in Plasma --afternoon specimen
CV2 Ab [Titer] in Serum or Plasma by Immunofluorescence
Giardia lamblia Ab [Units/volume] in Serum
Endomysium IgG Ab [Titer] in Serum by Immunofluorescence
Microscopic observation [Identifier] in Specimen by Lactophenol blue
Ganglioside IgG Ab [Presence] in Serum by Immunoblot
Ganglioside IgM Ab [Presence] in Serum by Immunoblot
Ganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay
Herpes virus 6 Ab [Units/volume] in Serum by Immunoassay
Homogentisate [Mass/time] in 24 hour Urine
Hyaluronate [Mass/volume] in Pleural fluid
Inner ear 68kD Ab [Titer] in Serum or Plasma by Immunofluorescence
Intercellular substance Ab [Titer] in Serum by Immunofluorescence
Leishmania sp identified in Specimen by Giemsa stain
Leishmania sp identified in Specimen by Organism specific culture
Leishmania sp Ab [Presence] in Body fluid
Ma+Ta Ab [Titer] in Serum by Immunofluorescence
Microscopic observation [Identifier] in Blood by Giemsa stain
Mitochondria M2 Ab [Units/volume] in Serum by Immunoassay
Muscle specific receptor tyrosine kinase Ab [Moles/volume] in Serum
Normoblasts Orthochromic/100 cells in Blood by Microscopy
Normoblasts Polychromatophilic/100 cells in Blood by Microscopy
Purkinje cells Ab [Titer] in Serum by Immunofluorescence
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Latex agglutination
Reticulin Ab [Titer] in Serum by Immunofluorescence
Fungus [Presence] in Specimen by Organism specific culture
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --10 umol/L
Ganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay
Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
Streptococcus pyogenes enzyme Ab [Titer] in Serum by Latex agglutination
Herpes virus 6 IgG and IgM [Interpretation] in Serum Narrative
Oxygen saturation Calculated from oxygen partial pressure in Venous blood
Oxygen saturation Calculated from oxygen partial pressure in Capillary blood
Oxygen saturation Calculated from oxygen partial pressure in Arterial blood
Chlamydia trachomatis L2 IgA and IgG and IgM [Interpretation] in Serum
Urea nitrogen renal clearance in 24 hour Urine and Serum or Plasma
HYDROmorphone Free [Mass/volume] in Urine
6-monoacetylmorphine free [Mass/volume] in Urine
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum by Immunoassay
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum by Immunoassay
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum by Immunoassay
Borrelia burgdorferi G39/40 IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 49736 IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi IgA and IgG and IgM [Interpretation] in Serum by Immunoassay
Helicobacter pylori Ab [Units/volume] in Serum by Immunoassay
PCA-Tr Ab [Titer] in Cerebral spinal fluid
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid
Pyruvate [Moles/volume] in Arterial blood
Histoplasma capsulatum Ag [Mass/volume] in Serum by Immunoassay
Histoplasma capsulatum Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay
Helicobacter pylori Ab [Titer] in Serum by Latex agglutination
CD3+CD4-CD8-CD45+ cells/100 cells in Blood
ATP7B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
POMT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
POMT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Ehrlichia chaffeensis IgG+IgM Ab [Presence] in Serum or Plasma
Giardia lamblia IgA and IgG and IgM [Interpretation] in Serum or Plasma
Helicobacter pylori IgA and IgG and IgM [Interpretation] in Serum or Plasma
Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay
Muscle specific receptor tyrosine kinase Ab [Titer] in Serum or Plasma
Trypanosoma cruzi IgG and IgM [Interpretation] in Serum or Plasma
Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose fructose PO
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose fructose PO
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose fructose PO
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose fructose PO
Leukocytes [#/area] in Stool by Microscopy high power field
Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay
Histoplasma capsulatum DNA [#/volume] in Specimen by NAA with probe detection
F9 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
HEXA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Chromatin Ab [Units/volume] in Serum or Plasma
7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method
7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method
YY1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CFH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 0.5 log copies/mL
Carbon dioxide, total [Moles/volume] in Capillary blood by calculation
Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method
Reagin Ab [Presence] in Cord blood by VDRL
Dengue virus IgG and IgM [Interpretation] in Serum
HIV 2 Ab Signal/Cutoff in Serum or Plasma by Immunoassay
Blastomyces dermatitidis Ab [Titer] in Serum by Immune diffusion (ID)
Coccidioides sp Ab [Titer] in Serum by Immune diffusion (ID)
Haemophilus influenzae Ab [Units/volume] in Serum by Immunoassay
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Immune diffusion (ID)
RBC casts [#/area] in Urine sediment by Microscopy high power field
Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method
Citrate/Creatinine [Mass Ratio] in Urine collected for unspecified duration
Xylose [Mass/volume] in Serum or Plasma --1 hour post 5 g xylose PO
Mitochondria M2 Ab [Titer] in Serum by Immunofluorescence
Complement C1 esterase inhibitor bound Ab [Mass/volume] in Serum or Plasma
PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Hepatitis A virus IgG Ab [Units/volume] in Serum by Immunoassay
CV2 Ab [Units/volume] in Serum or Plasma
Hepatitis E virus IgM Ab [Units/volume] in Serum
Adenosine deaminase [Enzymatic activity/volume] in Synovial fluid
Homogentisate [Mass/volume] in 24 hour Urine
Myeloperoxidase Ab [Titer] in Serum by Immunofluorescence
Phosphatidylserine IgM Ab [Titer] in Serum by Immunofluorescence
Fibrillarin Ab [Titer] in Serum by Immunofluorescence
Rickettsia conorii IgG Ab [Units/volume] in Serum by Immunoassay
Hepatitis A virus IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Rickettsia conorii IgM Ab [Units/volume] in Serum by Immunoassay
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay
Chlamydophila psittaci IgG Ab [Units/volume] in Serum by Immunoassay
Chlamydophila psittaci IgM Ab [Units/volume] in Serum by Immunoassay
Trimethoprim+Sulfamethoxazole [Susceptibility] by Serum bactericidal titer
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunoassay
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum by Immunoassay
Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum by Immunoassay
Legionella pneumophila IgM Ab [Units/volume] in Serum by Immunoassay
Leptospira sp IgG Ab [Units/volume] in Serum by Immunoassay
Bartonella quintana IgG Ab [Units/volume] in Serum by Immunoassay
Coxsackievirus B IgG Ab [Units/volume] in Serum by Immunoassay
Coxsackievirus B IgM Ab [Units/volume] in Serum by Immunoassay
Leptospira sp IgM Ab [Units/volume] in Serum by Immunoassay
Listeria monocytogenes IgG Ab [Units/volume] in Serum by Immunoassay
Hepatitis A virus IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunoassay
Adenovirus IgG Ab [Units/volume] in Serum by Immunoassay
Adenovirus IgM Ab [Units/volume] in Serum by Immunoassay
Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay
Bordetella parapertussis Ab [Units/volume] in Serum by Immunoassay
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunoassay
Trypanosoma cruzi IgM Ab [Units/volume] in Serum by Immunoassay
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Units/volume] in Serum
Lactate [Mass/volume] in Capillary blood
Beta-2 transferrin [Mass/volume] in Body fluid
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Acidified buffered plate agglutination
Tryptase [Moles/volume] in Serum or Plasma
Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
Angiotensin II [Mass/volume] in Plasma --upright
Bordetella parapertussis IgG Ab [Titer] in Serum by Immunofluorescence
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay
Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay
Echovirus IgG Ab [Titer] in Serum by Immunofluorescence
Echovirus IgM Ab [Titer] in Serum by Immunofluorescence
Plasmodium falciparum IgM Ab [Titer] in Serum by Immunofluorescence
Malonate/Creatinine [Mass Ratio] in Urine
Cortisol [Moles/volume] in Saliva (oral fluid)
Hepatitis A virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Staphylococcus aureus TSST-1 IgE Ab [Units/volume] in Serum
Malassezia sp IgE Ab [Units/volume] in Serum
Budgerigar serum proteins+feathers+droppings IgG Ab [Presence] in Serum
Pigeon serum proteins+feathers+droppings IgG Ab [Presence] in Serum
Parrot serum proteins+feathers+droppings IgG Ab [Presence] in Serum
Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Presence] in Serum by Multidisk
Hepatitis B virus core IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Mold Allergen Mix 7 (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) IgG Ab [Presence] in Serum by Multidisk
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of XXX
Washed packed erythrocytes given [Volume]
Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay
Direct antiglobulin test.polyspecific reagent [presence] on Cord red blood cells
Transfuse platelet concentrate units [#]
Varicella zoster virus immune globulin ordered [#] in Blood product unit
Varicella zoster virus immune globulin units given [#]
Transfuse whole blood autologous units [#]
Hepatitis B virus core Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Transfuse cryoprecipitate poor plasma units [#]
Hepatitis B virus e Ab [Units/volume] in Serum by Immunoassay
Hepatitis B virus e Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Efavirenz [Mass/volume] in Serum or Plasma --trough
Efavirenz [Mass/volume] in Serum or Plasma --peak
Ependymal cells/100 cells in Cerebral spinal fluid
Erythrocytes [#/area] in Bronchoalveolar lavage by Microscopy high power field
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --3rd specimen
Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool --2nd specimen
Hepatitis A virus IgG+IgM Ab [Presence] in Serum
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum
Herpes simplex virus IgG Ab [Titer] in Serum by Immunoassay
Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
Indinavir [Mass/volume] in Serum or Plasma --trough
Hepatitis B virus e Ag [Presence] in Serum by Radioimmunoassay (RIA)
Legionella sp Ab [Titer] in Serum --2nd specimen
Lopinavir [Mass/volume] in Serum or Plasma --trough
Nelfinavir [Mass/volume] in Serum or Plasma --peak
Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence
Nevirapine [Mass/volume] in Serum or Plasma --peak
Nucleated cells [#/volume] in Peritoneal fluid by Manual count
Other cells/100 leukocytes in Bronchial specimen by Manual count
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay
Ritonavir [Mass/volume] in Serum or Plasma --peak
Ritonavir [Mass/volume] in Serum or Plasma --trough
Rubella virus Ab [Units/volume] in Serum by Immunoassay
Saquinavir [Mass/volume] in Serum or Plasma --trough
Spermatozoa Slow/100 spermatozoa in Semen --1 hour post ejaculation
Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay
Escherichia coli shiga-like toxin 2 [Presence] in Stool by Immunoassay
Escherichia coli shiga-like toxin 1 [Presence] in Stool by Immunoassay
Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Calcium [Mass/volume] in Serum or Plasma --post dialysis
UGT1A1 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
UGT1A1 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hepatitis B virus surface Ag [Presence] in Serum
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine
Placer DNA analysis test identifier [Identifier]
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay
Genetic variation's effect on drug efficacy
Drug efficacy analysis overall interpretation
Pharmacogenetic analysis report Document
Discrete variation analysis overall interpretation
Individual allele identifier [Identifier]
Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Bacillus anthracis capsule Ag [Presence] in Specimen by Immunofluorescence
Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA)
Donepezil [Mass/volume] in Serum or Plasma
Glomerular basement membrane Ab [Mass/volume] in Serum
lamoTRIgine [Presence] in Serum or Plasma
Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method
Modafinil [Mass/volume] in Serum or Plasma
niCARdipine [Presence] in Serum or Plasma
Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay
Coenzyme Q10 [Presence] in Serum or Plasma
Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection
Vasoactive intestinal peptide [Presence] in Serum or Plasma
Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC)
Metanephrine and Normetanephrine panel - Urine
Homovanillate/Creatinine [Mass Ratio] in Urine collected for unspecified duration
Hepatitis C virus Ab [Presence] in Serum by Immunoblot
Hepatitis D virus Ab [Units/volume] in Serum by Immunoassay
Hepatitis D virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay
Herpes simplex virus Ab [Units/volume] in Serum by Latex agglutination
Herpes simplex virus Ab [Titer] in Serum by Complement fixation
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunoassay
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay
Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunoassay
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay
Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay
Bacterial capsule [Identifier] in Specimen by Light microscopy
Co sup(b) Ab [Presence] in Serum or Plasma
Co sup(a) Ab [Presence] in Serum or Plasma
Blood product unit 4 expiration [Date and time]
Blood product unit 3 expiration [Date and time]
Blood product unit 2 expiration [Date and time]
Blood product unit 1 expiration [Date and time]
Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells
D Ab [Presence] in Serum or Plasma by Antihuman globulin
Herpes virus 6 IgG Ab [Units/volume] in Serum
Apheresis available [#] in Blood product unit
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 1H post incubation separate tubes
Biopsy [Interpretation] in Specimen Narrative
Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --post heparin neutralization
aPTT in Platelet poor plasma by Coagulation assay --post heparin neutralization
Osmotic fragility of Red Blood Cells--0.90% sodium chloride
Osmotic fragility of Red Blood Cells--0.90% sodium chloride 24 hour 37 degree C incubation
Herpes virus 6 IgM Ab [Units/volume] in Serum
Acid glycerol lysis [Time] in Red Blood Cells
Cefotaxime [Susceptibility] for meningitis
INR in Platelet poor plasma by Coagulation assay --post heparin neutralization
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Heterophile Ab [Presence] in Serum by Latex agglutination
t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method
Troleandomycin [Susceptibility] by Disk diffusion (KB)
Heterophile Ab [Titer] in Serum by Latex agglutination
Heterophile Ab after absorption [Titer] in Serum by Latex agglutination
Histone Ab [Presence] in Serum by Immunofluorescence
Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID)
Histoplasma capsulatum Ab [Titer] in Serum by Complement fixation
HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay
HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot
HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay
Troleandomycin [Susceptibility] by Serum bactericidal titer
HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay
HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay
HIV 2 Ab [Presence] in Serum by Immunoblot
HTLV I+II Ab [Units/volume] in Serum by Immunoassay
Streptococcal hyaluronidase Ab [Presence] in Serum
Immune complex [Units/volume] in Serum or Plasma
Influenza virus A Ab [Titer] in Serum by Complement fixation
Influenza virus B Ab [Titer] in Serum by Complement fixation
Vancomycin [Susceptibility] by Minimum lethal concentration (MLC)
Influenza virus C Ab [Titer] in Serum by Complement fixation
Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Intrinsic factor Ab [Presence] in Serum by Radioimmunoassay (RIA)
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay
Jo-1 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Legionella pneumophila Ab [Presence] in Serum by Immunofluorescence
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence
Leishmania sp Ab [Units/volume] in Serum
Leptospira sp Ab [Titer] in Serum by Latex agglutination
Listeria monocytogenes Ab [Units/volume] in Serum
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Complement fixation
Measles virus Ab [Units/volume] in Serum by Immunoassay
Measles virus Ab [Titer] in Serum by Complement fixation
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay
Measles virus IgM Ab [Titer] in Serum by Immunofluorescence
Saccharopolyspora rectivirgula Ab [Units/volume] in Serum
Mitochondria Ab [Titer] in Serum by Immunofluorescence
Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Mumps virus Ab [Titer] in Serum by Complement fixation
Mumps virus Ab [Titer] in Serum by Immunofluorescence
Muscle sarcolemma Ab [Units/volume] in Serum
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Latex agglutination
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
Vancomycin [Susceptibility] by Disk diffusion (KB)
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
Mycoplasma pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence
Myelin basic protein Ab [Titer] in Serum by Immunofluorescence
Myocardium Ab [Titer] in Serum by Immunofluorescence
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence
Vancomycin [Susceptibility] by Serum bactericidal titer
Onchocerca sp Ab [Units/volume] in Serum
Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence
Paracoccidioides brasiliensis Ab [Titer] in Serum by Complement fixation
Paragonimus sp Ab [Titer] in Serum by Complement fixation
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation
Parietal cell Ab [Titer] in Serum by Immunofluorescence
Viomycin [Susceptibility] by Minimum lethal concentration (MLC)
Parvovirus B19 Ab [Units/volume] in Serum by Immunoassay
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay
Etravirine [Susceptibility] by Genotype method
Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay
aPTT.factor sensitive in Platelet poor plasma by Coagulation assay
Prothrombin time (PT) PIVKA insensitive actual/normal in Capillary blood by Coagulation assay
PCNA extractable nuclear Ab [Presence] in Serum by Immunoassay
Prothrombin time (PT) PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assay
Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assay
SERPINE1 gene c.-675 4G+5G [Presence] in Blood or Tissue by Molecular genetics method
SERPINE1 gene c.-844A>G [Presence] in Blood or Tissue by Molecular genetics method
Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assay
Prothrombin time (PT) PIVKA sensitive actual/normal in Capillary blood by Coagulation assay
PCNA extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Prothrombin time (PT) PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assay
Intrinsic coagulation system thromboelastography panel - Blood
Extrinsic coagulation system thromboelastography panel - Blood
Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel - Blood
Thromboelastography without activation panel - Blood
aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTT
Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT)
Clot formation [Time] in Blood by Thromboelastography
Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed [Time] in Blood by Rotational TEG
Clot formation.extrinsic coagulation system activated [Time] in Blood by Rotational TEG
Clot formation.intrinsic coagulation system activated [Time] in Blood by Rotational TEG
Clot formation.intrinsic coagulation system activated.heparin insensitive [Time] in Blood by Rotational TEG
Clotting time.extrinsic coagulation system activated of Blood by Rotational TEG
Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed of Blood by Rotational TEG
Clotting time.intrinsic coagulation system activated.heparin insensitive of Blood by Rotational TEG
Clotting time.intrinsic coagulation system activated of Blood by Rotational TEG
Intrinsic coagulation system with heparin inhibition thromboelastography panel - Blood
Maximum clot firmness [Length] in Blood by Thromboelastography
Penicillium roqueforti Ab [Units/volume] in Serum
Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed [Length] in Blood by Rotational TEG
Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited [Length] in Blood by Rotational TEG
Maximum clot firmness.intrinsic coagulation system activated [Length] in Blood by Rotational TEG
Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive [Length] in Blood by Rotational TEG
Maximum clot firmness.extrinsic coagulation system activated [Length] in Blood by Rotational TEG
Maximum lysis [Length fraction] in Blood by Thromboelastography
Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed [Length fraction] in Blood by Rotational TEG
Maximum lysis.extrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG
Plasmodium falciparum Ab [Units/volume] in Serum
Maximum lysis.intrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG
Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG
Clot initiation [Time] in Blood by Thromboelastography
Ova and parasites identified in Specimen by Light microscopy--3rd specimen
Plasmodium sp Ab [Units/volume] in Serum
Ova and parasites identified in Specimen by Light microscopy--2nd specimen
Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Plasmodium vivax Ab [Units/volume] in Serum
Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test
Nucleated cells [#/volume] in Pericardial fluid by Automated count
Nucleated cells [#/volume] in Cerebral spinal fluid by Automated count
Nucleated cells [#/volume] in Dialysis fluid by Automated count
Nucleated cells [#/volume] in Peritoneal fluid by Automated count
Nucleated cells [#/volume] in Pleural fluid by Automated count
Saint Louis encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
La Crosse virus IgG Ab [Presence] in Serum by Immunoassay
La Crosse virus IgM Ab [Presence] in Serum by Immunoassay
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Polio virus 1 Ab [Titer] in Serum by Complement fixation
Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test
Polio virus 2 Ab [Titer] in Serum by Complement fixation
Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test
Polio virus 3 Ab [Titer] in Serum by Complement fixation
CD1a cells/100 cells in Cerebral spinal fluid
Cytoplasmic CD22 cells/100 cells in Blood
Burkholderia pseudomallei Ab [Units/volume] in Serum by Hemagglutination
Cytoplasmic CD22 cells/100 cells in Body fluid
Cytoplasmic CD22 cells/100 cells in Bone marrow
Cytoplasmic CD22 cells/100 cells in Cerebral spinal fluid
Cytoplasmic CD22 cells/100 cells in Tissue
Cytoplasmic CD3 cells/100 cells in Body fluid
Cytoplasmic CD3 cells/100 cells in Bone marrow
Cytoplasmic CD3 cells/100 cells in Cerebral spinal fluid
Cytoplasmic CD3 cells/100 cells in Tissue
Vanadium [Moles/volume] in Serum or Plasma
Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL
Titanium [Moles/volume] in Red Blood Cells
Silver [Moles/volume] in Red Blood Cells
Beryllium [Moles/volume] in Serum or Plasma
Vanadium/Creatinine [Molar ratio] in 24 hour Urine
Vanadium/Creatinine [Molar ratio] in Urine
Reagin Ab [Presence] in Cerebral spinal fluid by VDRL
Uranium/Creatinine [Molar ratio] in 24 hour Urine
Uranium/Creatinine [Molar ratio] in Urine
Silver/Creatinine [Molar ratio] in 24 hour Urine
Silver/Creatinine [Molar ratio] in Urine
Bismuth/Creatinine [Molar ratio] in 24 hour Urine
Bismuth/Creatinine [Molar ratio] in Urine
Reagin Ab [Units/volume] in Serum by VDRL
Selenium [Moles/volume] in Red Blood Cells
Tin/Creatinine [Molar ratio] in 24 hour Urine
Thallium/Creatinine [Molar ratio] in 24 hour Urine
Tellurium/Creatinine [Molar ratio] in Urine
Tellurium/Creatinine [Molar ratio] in 24 hour Urine
Strontium/Creatinine [Molar ratio] in 24 hour Urine
Strontium/Creatinine [Molar ratio] in Urine
Selenium/Creatinine [Molar ratio] in Urine
Platinum/Creatinine [Molar ratio] in 24 hour Urine
Platinum/Creatinine [Molar ratio] in Urine
Nickel/Creatinine [Molar ratio] in Urine
Molybdenum/Creatinine [Molar ratio] in 24 hour Urine
Molybdenum/Creatinine [Molar ratio] in Urine
Mercury/Creatinine [Molar ratio] in 24 hour Urine
Manganese/Creatinine [Molar ratio] in 24 hour Urine
Lead/Creatinine [Molar ratio] in 24 hour Urine
Copper/Creatinine [Molar ratio] in 24 hour Urine
Cobalt/Creatinine [Molar ratio] in 24 hour Urine
Chromium/Creatinine [Molar ratio] in 24 hour Urine
Beryllium/Creatinine [Molar ratio] in Urine
Beryllium/Creatinine [Molar ratio] in 24 hour Urine
Barium/Creatinine [Molar ratio] in 24 hour Urine
Barium/Creatinine [Molar ratio] in Urine
Arsenic.inorganic/Creatinine [Molar ratio] in Urine
Arsenic.inorganic/Creatinine [Molar ratio] in 24 hour Urine
Antimony/Creatinine [Molar ratio] in Urine
Antimony/Creatinine [Molar ratio] in 24 hour Urine
Aluminum/Creatinine [Molar ratio] in Urine
Aluminum/Creatinine [Molar ratio] in 24 hour Urine
Dextromethorphan [Presence] in Gastric fluid
chlordiazePOXIDE [Presence] in Gastric fluid
Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence
Tobramycin [Mass/volume] in Cerebral spinal fluid
cloBAZam [Moles/volume] in Gastric fluid
Bacteria identified in Gastric fluid by Culture
Streptococcus agalactiae [Presence] in Anal by Organism specific culture
Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
CV2 Ab [Units/volume] in Cerebral spinal fluid
Immune complex [Mass/volume] in Serum or Plasma by Immunoassay
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk
Bacteria identified in Sputum tracheal aspirate by Culture
Influenza virus B Ab [Units/volume] in Serum by Complement fixation
Cytomegalovirus Ab [Units/volume] in Serum by Complement fixation
Rheumatoid factor [Presence] in Serum by Latex agglutination
Herpes simplex virus Ab [Units/volume] in Serum by Complement fixation
Varicella zoster virus Ab [Units/volume] in Serum by Complement fixation
Trichinella spiralis IgG Ab [Titer] in Serum by Immunofluorescence
Viomycin [Susceptibility] by Disk diffusion (KB)
Plasmodium sp IgG Ab [Titer] in Serum by Immunofluorescence
Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
Echinococcus sp IgG1 Ab [Units/volume] in Serum by Immunoassay
Echinococcus sp IgG4 Ab [Units/volume] in Serum by Immunoassay
Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay
Rheumatoid factor [Presence] in Serum by Sheep Cell Agglutination
Leishmania sp IgG Ab [Titer] in Serum by Immunofluorescence
Rubella virus IgG Ab avidity [Ratio] in Serum by Immunoassay
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Complement fixation
Leptospira sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Leptospira sp DNA [Presence] in Blood by NAA with probe detection
Leptospira sp DNA [Presence] in Urine by NAA with probe detection
Cytoplasmic CD79a cells/100 cells in Blood
Cytoplasmic CD79a cells/100 cells in Body fluid
Rheumatoid factor [Titer] in Serum by Latex agglutination
Cytoplasmic CD79a cells/100 cells in Bone marrow
Cytoplasmic CD79a cells/100 cells in Cerebral spinal fluid
Cytoplasmic CD79a cells/100 cells in Tissue
Terminal deoxyribonucleotidyl transferase cells/100 cells in Blood by Flow cytometry (FC)
Terminal deoxyribonucleotidyl transferase cells/100 cells in Body fluid by Flow cytometry (FC)
Terminal deoxyribonucleotidyl transferase cells/100 cells in Tissue by Flow cytometry (FC)
Leukocytes.disintegrated [#/volume] in Blood
Mitochondria M4 Ab [Units/volume] in Serum
Mitochondria M9 Ab [Units/volume] in Serum
Fine speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma by Immunofluorescence
Mitotic spindle apparatus Ab [Presence] in Serum or Plasma by Immunofluorescence
Fibrillarin Ab [Presence] in Serum by Immunofluorescence
PCNA extractable nuclear Ab [Titer] in Serum by Immunofluorescence
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence
PM-SCL extractable nuclear Ab [Titer] in Serum by Immunofluorescence
Rheumatoid factor [Titer] in Serum by Sheep Cell Agglutination
Ribosomal Ab [Presence] in Serum by Immunofluorescence
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunofluorescence
Signal Recognition Particle (SRP) Ab [Titer] in Serum or Plasma by Immunofluorescence
Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence
Bactericidal permeability increasing protein Ab [Presence] in Serum
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
Salivary gland Ab [Titer] in Serum by Immunofluorescence
U1 small nuclear ribonucleoprotein Ab [Presence] in Serum
Tissue transglutaminase Ab [Presence] in Serum
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Tissue transglutaminase IgG Ab [Presence] in Serum
Cyclic citrullinated peptide Ab [Units/volume] in Serum
Cyclic citrullinated peptide Ab [Presence] in Serum
Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence
Liver kidney microsomal Ab [Presence] in Serum by Immunofluorescence
Signal Recognition Particle (SRP) Ab [Units/volume] in Serum or Plasma
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum
Rickettsia (Proteus OX19) Ab [Presence] in Serum by Latex agglutination
Filler DNA analysis test identifier [Identifier]
Genetic variation clinical significance [Imp]
Genetic disease analysis overall carrier interpretation
Genetic variation's effect on drug metabolism
Rickettsia (Proteus OX2) Ab [Presence] in Serum by Latex agglutination
Reference sequence alteration [Identifier]
Beta globulin+Gamma globulin [Mass/volume] in Body fluid by Electrophoresis
Chromogranin A [Mass/volume] in Body fluid
Glucose [Mass/volume] in Serum or Plasma --pre-meal
Glucose [Mass/volume] in Total parental nutrition
Beta globulin+Gamma globulin/Protein.total in Body fluid by Electrophoresis
Collagen crosslinked C-telopeptide [Mass/time] in 24 hour Urine
Carnitine [Moles/volume] in Amniotic fluid
Carnitine free (C0) [Moles/volume] in Amniotic fluid
Creatine [Moles/volume] in Amniotic fluid
Decanoylcarnitine (C10) [Moles/volume] in Amniotic fluid
Decenoylcarnitine (C10:1) [Moles/volume] in Amniotic fluid
Rickettsia (Proteus OXK) Ab [Presence] in Serum by Latex agglutination
Dodecanoylcarnitine (C12) [Moles/volume] in Amniotic fluid
Dodecenoylcarnitine (C12:1) [Moles/volume] in Amniotic fluid
Viomycin [Susceptibility] by Serum bactericidal titer
Butyrylcarnitine (C4) [Moles/volume] in Amniotic fluid
Beta aminoisobutyrate [Moles/volume] in DBS
Butyrylcarnitine (C4) [Moles/volume] in DBS
Rickettsia sp Ab [Titer] in Serum by Complement fixation
Argininosuccinate [Moles/volume] in Body fluid
Beta alanine [Moles/volume] in Body fluid
Cystathionine [Moles/volume] in Body fluid
Butyrylcarnitine (C4) [Moles/volume] in Cerebral spinal fluid
Carnitine [Moles/volume] in Cerebral spinal fluid
Carnitine free (C0) [Moles/volume] in Cerebral spinal fluid
Ceruloplasmin [Moles/volume] in Cerebral spinal fluid
Rickettsia rickettsii IgG Ab [Titer] in Serum by Immunofluorescence
Creatine [Moles/volume] in Cerebral spinal fluid
Decanoylcarnitine (C10) [Moles/volume] in Cerebral spinal fluid
Decenoylcarnitine (C10:1) [Moles/volume] in Cerebral spinal fluid
Levodopa [Moles/volume] in Cerebral spinal fluid
Dodecanoylcarnitine (C12) [Moles/volume] in Cerebral spinal fluid
Dodecenoylcarnitine (C12:1) [Moles/volume] in Cerebral spinal fluid
Cystine [Moles/mass] in Chorionic villus sample
Ammonia [Moles/volume] in Dialysis fluid
Rickettsia rickettsii IgM Ab [Titer] in Serum by Immunofluorescence
Cholesterol [Moles/volume] in Dialysis fluid
Bilirubin.conjugated [Moles/volume] in Dialysis fluid
Glucose [Moles/volume] in Nonbiological fluid
Base excess in Nonbiological fluid by calculation
Bicarbonate [Moles/volume] in Nonbiological fluid
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Nonbiological fluid
Calcium.ionized [Moles/volume] in Nonbiological fluid by Ion-selective membrane electrode (ISE)
Carbon dioxide, total [Moles/volume] in Nonbiological fluid by calculation
Rickettsia spotted fever group Ab [Units/volume] in Serum by Immunoassay
Carbon dioxide, total [Moles/volume] in Nonbiological fluid
Nitrogen.nonprotein [Moles/volume] in Serum or Plasma
Collagen crosslinked C-telopeptide [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --post meal
Carnitine free (C0)/Carnitine.total in DBS
Carnitine free (C0)/Carnitine.total in Cerebral spinal fluid
3-O-Methyldopa [Moles/time] in 24 hour Urine
3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in 24 hour Urine
Chloride [Moles/volume] in Total parental nutrition
Calcium [Moles/volume] in Total parental nutrition
Decanoylcarnitine (C10) [Moles/volume] in Urine
Decenoylcarnitine (C10:1) [Moles/volume] in Urine
Dodecenoylcarnitine (C12:1) [Moles/volume] in Urine
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Urine
Butyrylcarnitine (C4) [Moles/volume] in Urine
Kynurenate/Creatinine [Molar ratio] in Urine
Rickettsia spotted fever group Ab [Presence] in Serum by Latex agglutination
Decenoylcarnitine (C10:1)/Creatinine [Molar ratio] in Urine
Docosenoate (C22:1)/Creatinine [Molar ratio] in Urine
5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine
Butyrylcarnitine (C4)/Creatinine [Molar ratio] in Urine
Carnitine free (C0)/Carnitine.total in Amniotic fluid
Immature granulocytes [#/volume] in Blood by Automated count
Rickettsia spotted fever group Ab [Titer] in Serum by Immunofluorescence
Thermolabile hemoglobin [Presence] in Red Blood Cells
Sulfonamide crystals [#/area] in Urine sediment by Microscopy high power field
Tyrosine crystals [#/area] in Urine sediment by Microscopy high power field
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum by Immunoassay
Monocytes+Macrophages/100 leukocytes in Bone marrow
Monocytes+Macrophages/100 leukocytes in Blood
Monocytes+Macrophages/100 leukocytes in Tissue
Bacterial casts [#/area] in Urine sediment by Microscopy low power field
Sodium urate crystals [#/area] in Urine sediment by Microscopy high power field
Ammonium urate crystals [#/area] in Urine sediment by Microscopy low power field
Calcium oxalate crystals [#/area] in Urine sediment by Microscopy low power field
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence
Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy low power field
Cholesterol in LDL [Moles/volume] in Body fluid
Amylase isoenzymes [Interpretation] in Body fluid Narrative
Cholesterol in HDL [Moles/volume] in Dialysis fluid
Organic acids pattern [Interpretation] in Body fluid
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Arterial blood
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum by Immunoassay
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Venous blood
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Hydrogen ion [Moles/volume] in Mixed venous blood
Somatotropin [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
DNA double strand Ab [Presence] in Body fluid
Iron/Creatinine [Molar ratio] in 24 hour Urine
Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS
Valine/Phenylalanine [Molar ratio] in DBS
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS
Asparagine+Ornithine [Moles/volume] in DBS
Methionine/Phenylalanine [Molar ratio] in DBS
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence
Citrulline/Phenylalanine [Molar ratio] in DBS
Propionylcarnitine (C3) [Moles/volume] in DBS
Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS
Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Rickettsia typhus group Ab [Presence] in Serum by Immunoassay
Formiminoglutamate [Moles/volume] in DBS
Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS
Tiglylcarnitine (C5:1) [Moles/volume] in DBS
3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS
3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS
Rickettsia typhus group Ab [Presence] in Serum by Latex agglutination
3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS
Octenoylcarnitine (C8:1) [Moles/volume] in DBS
Octanoylcarnitine (C8) [Moles/volume] in DBS
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS
Decadienoylcarnitine (C10:2) [Moles/volume] in DBS
Rickettsia typhus group Ab [Titer] in Serum by Immunofluorescence
Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS
Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS
Tetradecanoylcarnitine (C14) [Moles/volume] in DBS
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS
Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS
Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS
Rickettsia typhus group IgG Ab [Units/volume] in Serum by Immunoassay
Palmitoylcarnitine (C16) [Moles/volume] in DBS
Argininosuccinate/Arginine [Molar ratio] in DBS
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Oleoylcarnitine (C18:1) [Moles/volume] in DBS
Hexenoylcarnitine (C6:1) [Moles/volume] in DBS
Heptanoylcarnitine (C7) [Moles/volume] in DBS
Phenylacetylcarnitine (PheC2) [Moles/volume] in DBS
Salicylylcarnitine (SalC) [Moles/volume] in DBS
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence
Nonanoylcarnitine (C9) [Moles/volume] in DBS
Decatrienoylcarnitine (C10:3) [Moles/volume] in DBS
Dehydrosuberylcarnitine (C8:1-DC) [Moles/volume] in DBS
Suberylcarnitine (C8-DC) [Moles/volume] in DBS
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in DBS
Sebacylcarnitine (C10-DC) [Moles/volume] in DBS
Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS
Rickettsia typhus group IgM Ab [Units/volume] in Serum by Immunoassay
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in DBS
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS
Mycobacterium sp identified in Aspirate by Organism specific culture
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS
dRVVT in Control Platelet poor plasma by Coagulation assay
Coagulation factor XI activated [Units/volume] in Platelet poor plasma by Coagulation assay
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence
Leukocytes [#/area] in Specimen by Wet preparation
Leukocytes [#/area] in Urethra by Wet preparation
Leukocytes [#/area] in Cervix by Wet preparation
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma
Orientia tsutsugamushi Ab [Titer] in Serum by Complement fixation
5-Oxoproline+Pipecolate [Moles/volume] in DBS
Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS
Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS
Acrylylcarnitine (C3:1) [Moles/volume] in DBS
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS
Stearoylcarnitine (C18) [Moles/volume] in DBS
Plasmodium sp lactate dehydrogenase [Presence] in Blood
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence
Human metapneumovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus B RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Parainfluenza virus 2 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Parainfluenza virus 3 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Mycoplasma pneumoniae DNA [#/volume] in Specimen by NAA with probe detection
Rickettsia typhi IgM Ab [Titer] in Serum by Immunofluorescence
Enterovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Mycobacterium tuberculosis DNA [#/volume] in Specimen by NAA with probe detection
Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
Glomerular basement membrane Ab [Presence] in Serum by Immunofluorescence
Urinalysis yeast variants panel - Urine by Computer assisted method
Bartonella henselae IgG Ab [Units/volume] in Serum
Urinalysis yeast variants panel [#/volume] - Urine by Computer assisted method
Yeast.hyphae [#/volume] in Urine by Computer assisted method
Yeast.budding [#/volume] in Urine by Computer assisted method
Urinalysis yeast variants panel [#/area] - Urine by Computer assisted method
Yeast.hyphae [#/area] in Urine by Computer assisted method
Yeast.budding [#/area] in Urine by Computer assisted method
Urinalysis type of non-squamous epithelial cells panel - Urine by Computer assisted method
Epithelial cells.renal [Presence] in Urine by Computer assisted method
Bartonella henselae IgM Ab [Units/volume] in Serum
Transitional cells [Presence] in Urine by Computer assisted method
Urinalysis type of non-squamous epithelial cells panel [#/volume] - Urine by Computer assisted method
Epithelial cells.renal [#/volume] in Urine by Computer assisted method
Transitional cells [#/volume] in Urine by Computer assisted method
Urinalysis type of non-squamous epithelial cells panel [#/area] - Urine by Computer assisted method
Urinalysis type of cast panel - Urine by Computer assisted method
RBC casts [Presence] in Urine by Computer assisted method
WBC casts [Presence] in Urine by Computer assisted method
Casts type not specified [Presence] in Urine by Computer assisted method
Urinalysis type of cast panel [#/volume] - Urine by Computer assisted method
Granular casts [#/volume] in Urine by Computer assisted method
Mixed cellular casts [#/volume] in Urine by Computer assisted method
Broad casts [#/volume] in Urine by Computer assisted method
RBC casts [#/volume] in Urine by Computer assisted method
WBC casts [#/volume] in Urine by Computer assisted method
Epithelial casts [#/volume] in Urine by Computer assisted method
Fatty casts [#/volume] in Urine by Computer assisted method
Mixed cellular casts [#/area] in Urine by Computer assisted method
Broad casts [#/area] in Urine by Computer assisted method
Epithelial casts [#/area] in Urine by Computer assisted method
Erythrocytes [Presence] in Urine by Automated
Urinalysis microscopic panel [#/area] - Urine sediment by Automated count
Epithelial cells.non-squamous [#/area] in Urine sediment by Automated count
Urinalysis type of crystal panel [#/volume] - Urine by Computer assisted method
Calcium oxalate crystals [#/volume] in Urine by Computer assisted method
Crystals unspecified [#/volume] in Urine by Computer assisted method
Triple phosphate crystals [#/volume] in Urine by Computer assisted method
Calcium phosphate crystals [#/volume] in Urine by Computer assisted method
Mycobacterium sp identified in Blood by Organism specific culture
Leucine crystals [#/volume] in Urine by Computer assisted method
Urate crystals [#/volume] in Urine by Computer assisted method
Calcium carbonate crystals [#/volume] in Urine by Computer assisted method
Cystine crystals [#/volume] in Urine by Computer assisted method
Tyrosine crystals [#/volume] in Urine by Computer assisted method
Urinalysis type of crystal panel [#/area] - Urine by Computer assisted method
Rubella virus Ab [Units/volume] in Serum by Hemagglutination inhibition
Calcium oxalate crystals [#/area] in Urine by Computer assisted method
Crystals unspecified [#/area] in Urine by Computer assisted method
Triple phosphate crystals [#/area] in Urine by Computer assisted method
Calcium phosphate crystals [#/area] in Urine by Computer assisted method
Leucine crystals [#/area] in Urine by Computer assisted method
Urate crystals [#/area] in Urine by Computer assisted method
Calcium carbonate crystals [#/area] in Urine by Computer assisted method
Cystine crystals [#/area] in Urine by Computer assisted method
Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition
Tyrosine crystals [#/area] in Urine by Computer assisted method
Urinalysis microscopic panel - Urine Qualitative by Automated
Leukocytes [Presence] in Urine by Automated
Leukocyte clumps [Presence] in Urine by Automated
Epithelial cells.squamous [Presence] in Urine by Automated
Crystals [Presence] in Urine by Automated
Rubella virus Ab [Presence] in Serum by Latex agglutination
Crystals [#/area] in Urine sediment by Automated count
Casts type not specified [#/volume] in Urine by Computer assisted method
Spermatozoa [#/area] in Urine sediment by Automated count
Urinalysis type of crystal panel - Urine by Computer assisted method
Specific gravity of Urine by Automated test strip
Bilirubin.total [Mass/volume] in Urine by Automated test strip
Glucose [Mass/volume] in Urine by Automated test strip
Crystals.amorphous [Presence] in Urine by Computer assisted method
Rubella virus Ab [Titer] in Serum by Latex agglutination
Urinalysis type of cast panel [#/area] - Urine by Computer assisted method
Crystals.amorphous [#/volume] in Urine by Computer assisted method
Crystals.amorphous [#/area] in Urine by Computer assisted method
Urinalysis other formed elements panel - Urine by Computer assisted method
Crystals unspecified [Presence] in Urine by Computer assisted method
Casts type not specified [#/area] in Urine by Computer assisted method
17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS
17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar ratio] in DBS
17-Hydroxyprogesterone [Moles/volume] in DBS
11-Deoxycorticosterone [Mass/volume] in DBS
Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
11-Deoxycorticosterone [Moles/volume] in DBS
Thyroxine (T4) free [Mass/volume] in DBS
Thyroxine (T4) free [Moles/volume] in DBS
Urinalysis other formed elements panel [#/volume] - Urine by Computer assisted method
Oval fat bodies (globules) [#/volume] in Urine by Computer assisted method
Urinalysis other formed elements panel [#/area] - Urine by Computer assisted method
Oval fat bodies (globules) [#/area] in Urine by Computer assisted method
Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay
Trichomonas sp [#/volume] in Urine by Computer assisted method
Fat [#/volume] in Urine by Computer assisted method
Trichomonas sp [#/area] in Urine by Computer assisted method
Erythrocyte clumps [#/area] in Urine by Computer assisted method
Fat [#/area] in Urine by Computer assisted method
Erythrocyte clumps [#/volume] in Urine by Computer assisted method
Bordetella parapertussis IgG Ab [Titer] in Serum
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum
Saccharomonospora viridis Ab [Units/volume] in Serum
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum
Coccidioides sp IgM Ab [Presence] in Specimen
Colorado tick fever virus Ab [Presence] in Specimen
Echinococcus sp IgG1 Ab [Units/volume] in Serum
Echinococcus sp IgG4 Ab [Units/volume] in Serum
Salivary gland Ab [Units/volume] in Serum
Francisella tularensis Ab [Presence] in Isolate
Francisella tularensis Ab [Presence] in Specimen
Hepatitis C virus IgM Ab [Units/volume] in Serum
Herpes simplex virus IgG Ab [Titer] in Serum
Herpes virus 6 Ab [Units/volume] in Serum
Influenza virus A Ab [Identifier] in Serum
Plasmodium falciparum IgM Ab [Titer] in Serum
Powassan virus Ab [Presence] in Specimen
Snowshoe hare virus Ab [Presence] in Specimen
Toxocara canis Ab [Units/volume] in Specimen
Trichinella spiralis IgG Ab [Titer] in Serum
Trichothecene IgA Ab [Units/volume] in Serum
Salmonella sp Ab [Titer] in Serum by Latex agglutination
Trichothecene IgE Ab [Units/volume] in Serum
Trichothecene IgG Ab [Units/volume] in Serum
Trichothecene IgM Ab [Units/volume] in Serum
Proline/Phenylalanine [Molar ratio] in DBS
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [Molar ratio] in DBS
5-Oxoproline+Pipecolate/Phenylalanine [Molar ratio] in DBS
Asparagine+Ornithine/Serine [Molar ratio] in DBS
Asparagine+Ornithine/Phenylalanine [Molar ratio] in DBS
Salmonella paratyphi A H Ab [Presence] in Serum by Latex agglutination
Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Molar ratio] in DBS
Arginine/Phenylalanine [Molar ratio] in DBS
Citrulline/Tyrosine [Molar ratio] in DBS
Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) [Molar ratio] in DBS
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS
Salmonella paratyphi A O Ab [Presence] in Serum by Latex agglutination
Salmonella paratyphi B H Ab [Presence] in Serum by Latex agglutination
Bilirubin.total [Presence] in Cerebral spinal fluid
Alpha naphthylesterase [Enzymatic activity/volume] in Blood
Alpha naphthylesterase [Enzymatic activity/volume] in Bone marrow
Fibroblast growth factor 23.intact [Mass/volume] in Plasma --pre XXX challenge
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --1st specimen post XXX challenge
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge
Salmonella paratyphi B O Ab [Presence] in Serum by Latex agglutination
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --4th specimen post XXX challenge
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --5th specimen post XXX challenge
Fibroblast growth factor 23.intact [Mass/volume] in Plasma by Immunoassay --6th specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --pre XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --1st specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --2nd specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --3rd specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --4th specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --5th specimen post XXX challenge
Fibroblast growth factor 23 [Units/volume] in Plasma by Immunoassay --6th specimen post XXX challenge
Gamma glutamyl transferase [Enzymatic activity/volume] in Dialysis fluid
Creatine kinase [Enzymatic activity/volume] in Dialysis fluid
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Amniotic fluid cells
Argininosuccinate lyase [Enzymatic activity/mass] in Chorionic villus sample
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Chorionic villus sample
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Fibroblast
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Fibroblast
Salmonella paratyphi C H Ab [Presence] in Serum by Latex agglutination
Argininosuccinate lyase [Enzymatic activity/mass] in Liver from Fetus
Argininosuccinate synthase [Enzymatic activity/mass] in Liver from Fetus
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Leukocytes
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Leukocytes
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Leukocytes
Citrate synthase [Enzymatic activity/mass] in Control Leukocytes
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Fibroblast
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Red Blood Cells
Salmonella paratyphi C O Ab [Presence] in Serum by Latex agglutination
Carboxymefloquine [Mass/volume] in Serum or Plasma
Cycloguanil [Mass/volume] in Serum or Plasma
Cyclophosphamide [Mass/volume] in Serum or Plasma
Cytarabine [Mass/volume] in Serum or Plasma
Uracil arabinoside [Mass/volume] in Serum or Plasma
Gamma 3 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Salmonella typhi H Ab [Presence] in Serum by Latex agglutination
Iron [Mass/volume] in Urine --post dose deferoxamine
Gamma 3 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Carbon dioxide [Partial pressure] in Nonbiological fluid
Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid
Sebacylcarnitine (C10-DC) [Moles/volume] in Amniotic fluid
Eicosanoylcarnitine (C20) [Moles/volume] in Amniotic fluid
Salmonella typhi O Ab [Presence] in Serum by Latex agglutination
Eicosanoylcarnitine (C20) [Moles/volume] in DBS
Beta aminoisobutyrate [Moles/volume] in Body fluid
Decadienoylcarnitine (C10:2) [Moles/volume] in Cerebral spinal fluid
Sebacylcarnitine (C10-DC) [Moles/volume] in Cerebral spinal fluid
Eicosanoylcarnitine (C20) [Moles/volume] in Cerebral spinal fluid
3-Keto n-Valerate [Moles/volume] in Serum or Plasma
Anthranilate [Moles/volume] in Serum or Plasma
Kynurenate [Moles/volume] in Serum or Plasma
Schistosoma sp Ab [Units/volume] in Serum
Kynurenin [Moles/volume] in Serum or Plasma
Decadienoylcarnitine (C10:2) [Moles/volume] in Serum or Plasma
Sebacylcarnitine (C10-DC) [Moles/volume] in Serum or Plasma
Eicosanoylcarnitine (C20) [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --4 AM specimen
Glucose [Moles/volume] in Serum or Plasma --pre dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose betaxolol
Levodopa/Tyrosine [Molar ratio] in Serum or Plasma
Anthranilate [Moles/time] in 24 hour Urine
Dihydroxycholestanoate [Moles/volume] in Serum or Plasma
Mycobacterium sp identified in Cerebral spinal fluid by Organism specific culture
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --30 minutes pre dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose betaxolol
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose betaxolol
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay
3-O-Methyldopa [Moles/volume] in 24 hour Urine
Kynurenate [Moles/time] in 24 hour Urine
Decadienoylcarnitine (C10:2) [Moles/volume] in Urine
Sebacylcarnitine (C10-DC) [Moles/volume] in Urine
Eicosanoylcarnitine (C20) [Moles/volume] in Urine
Iron [Moles/volume] in Urine --post dose deferoxamine
SCL-70 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in 24 hour Urine
5-Hydroxytryptophan [Moles/volume] in 24 hour Urine
Creatinine [Moles/volume] in 12 hour Urine
Decanoylcarnitine (C10)/Creatinine [Molar ratio] in Urine
Asparagine/Amino acids.total in Serum or Plasma
Kynurenin/Creatinine [Molar ratio] in Urine
Decadienoylcarnitine (C10:2)/Creatinine [Molar ratio] in Urine
Sebacylcarnitine (C10-DC)/Creatinine [Molar ratio] in Urine
Dodecanoylcarnitine (C12)/Creatinine [Molar ratio] in Urine
Dodecenoylcarnitine (C12:1)/Creatinine [Molar ratio] in Urine
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay
Eicosanoylcarnitine (C20)/Creatinine [Molar ratio] in Urine
Anthranilate/Creatinine [Molar ratio] in Urine
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Fibroblast
Citrate synthase [Enzymatic activity/mass] in Control Fibroblast
Basophils/100 leukocytes in Dialysis fluid by Manual count
Erythrocytes [#/volume] in Dialysis fluid by Manual count
Monocytes/100 leukocytes in Dialysis fluid
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Neutrophils/100 leukocytes in Dialysis fluid
Polymorphonuclear cells [#/volume] in Semen
Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain
Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
Alkaline phosphatase.bile/Alkaline phosphatase.total in Serum or Plasma
Protein [Presence] in Urine by SSA method
Triglyceride in VLDL [Moles/volume] in Serum or Plasma
Triglyceride in HDL 2 [Moles/volume] in Serum or Plasma
Triglyceride in HDL 3 [Moles/volume] in Serum or Plasma
Microalbumin [Mass/volume] in Body fluid by Detection limit <= 1.0 mg/L
Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L
Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L
Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L
Herpes simplex virus IgG Ab [Presence] in Body fluid by Immunoassay
Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay
Varicella zoster virus IgM Ab [Presence] in Body fluid by Immunoassay
Measles virus IgG Ab [Presence] in Body fluid by Immunoassay
Measles virus IgM Ab [Presence] in Body fluid by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay
Herpes simplex virus IgM Ab [Presence] in Body fluid by Immunoassay
Alpha globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Alpha globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Epithelial cells [Presence] in Blood by Light microscopy
Dodeicosanoylcarnitine (C22) [Moles/volume] in Amniotic fluid
Dodeicosanoylcarnitine (C22) [Moles/volume] in DBS
3,4-Dihydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid
Dodeicosanoylcarnitine (C22) [Moles/volume] in Cerebral spinal fluid
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Dodeicosanoylcarnitine (C22) [Moles/volume] in Serum or Plasma
3,4-Dihydroxyphenylacetate [Moles/volume] in Serum or Plasma
3,4-Dihydroxyphenylacetate [Moles/time] in 24 hour Urine
Dodeicosanoylcarnitine (C22) [Moles/volume] in Urine
Mycobacterium sp identified in Body fluid by Organism specific culture
Fructosamine/Protein [Ratio] in Serum or Plasma
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in 24 hour Urine
Dodeicosanoylcarnitine (C22)/Creatinine [Molar ratio] in Urine
Smith extractable nuclear Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE)
Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin
Erythrocytes.Plasmodium sp infected/100 erythrocytes in Blood
Nucleated cells [#/volume] in Synovial fluid by Manual count
Beta-2 transferrin [Mass/volume] in Cerebral spinal fluid
Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay
Smith extractable nuclear Ab [Presence] in Serum by Immunoassay
Lactate dehydrogenase/Creatinine [Ratio] in Urine
Rheumatoid factor [Units/volume] in Pleural fluid
Platelet aggregation ADP induced in Platelet rich plasma --20 umol/mL
Platelet aggregation ADP induced in Platelet rich plasma --50 umol/mL
Platelet aggregation ADP induced in Platelet rich plasma --100 umol/mL
Platelet aggregation collagen induced in Platelet rich plasma --8.0 ug/mL
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --0.1 ug/mL
Platelet aggregation arachidonate induced in Platelet rich plasma --500 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --800 ug/mL
aPTT.lupus insensitive in Platelet poor plasma by Coagulation assay
Yeast identified in Genital specimen by Organism specific culture
Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
cycloSPORINE [Mass/volume] in Blood --post dose
Lambda light chains.free [Mass/volume] in 24 hour Urine
Alkaline phosphatase.intestinal 2/Alkaline phosphatase.total in Serum or Plasma
Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Alkaline phosphatase.intestinal 3/Alkaline phosphatase.total in Serum or Plasma
Galactosylceramidase [Enzymatic activity/mass] in Amniotic fluid cells
Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid
Echovirus Ab [Units/volume] in Serum by Immunoassay
Echovirus IgM Ab [Units/volume] in Serum by Immunoassay
Loa loa DNA [Presence] in Blood by NAA with probe detection
Toxocara canis IgE Ab [Units/volume] in Serum
Smooth muscle Ab [Titer] in Serum by Immunofluorescence
Beta globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Beta globulin+Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Beta globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Gamma globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Gamma globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Gamma 2 globulin.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis
Gamma 2 globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Chitobioside IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Somatotropin Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA)
Homovanillate [Mass/volume] in 24 hour Urine
Laminaribioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Irritable bowel disease prognostic panel - Serum or Plasma by Immunoassay
HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay
Taenia solium larva Ag [Units/volume] in Serum
Spermatozoa Ab [Units/volume] in Cervical mucus
Mumps virus RNA [Presence] in Serum by NAA with probe detection
Brucella sp DNA [Identifier] in Serum by NAA with probe detection
Treponema pallidum DNA [Presence] in Blood by NAA with probe detection
Neisseria meningitidis DNA [Presence] in Blood by NAA with probe detection
Haemophilus influenzae B DNA [Presence] in Blood by NAA with probe detection
Rickettsia sp DNA [Presence] in Blood by NAA with probe detection
Parasite identified in Bone marrow by Light microscopy
Erythroid cells [#/volume] in Blood or Marrow
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Immunofluorescence
Benzoylcarnitine (BzCn) [Moles/volume] in DBS
Bacteria # 2 identified in Duodenal fluid by Aerobe culture
Bacteria # 3 identified in Duodenal fluid by Aerobe culture
Bacteria # 4 identified in Duodenal fluid by Aerobe culture
Bacteria identified in Duodenal fluid by Aerobe culture
KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method
HRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
Chloride [Moles/volume] in Pleural fluid
20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal
Alpha cortol [Mass/time] in 24 hour Urine
Mycobacterium sp identified in Bone marrow by Organism specific culture
Alpha cortol/Creatinine [Mass Ratio] in 24 hour Urine
Alpha cortol/Creatinine [Mass Ratio] in Urine
Breast Cancer Ag 225 [Presence] in Tissue by Immune stain
BCL1 Ag [Presence] in Tissue by Immune stain
Beta cortol [Mass/time] in 24 hour Urine
Beta cortol/Creatinine [Mass Ratio] in 24 hour Urine
Beta cortol/Creatinine [Mass Ratio] in Urine
Spirillum minus Ab [Units/volume] in Serum
BOB1 Ag [Presence] in Tissue by Immune stain
CD45RB Ag [Presence] in Tissue by Immune stain
CD52 Ag [Presence] in Tissue by Immune stain
Chloride/Creatinine [Ratio] in 24 hour Urine
OCT2 Ag [Presence] in Tissue by Immune stain
Glutathione.reduced/glutathione.oxidized [Molar ratio] in Blood
Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid
Sporothrix schenckii Ab [Units/volume] in Serum
Polio virus identified in Stool by Organism specific culture
Flavin adenine dinucleotide [Mass/volume] in Blood
Flavin mononucleotide [Mass/volume] in Blood
Parathion [Mass/volume] in Gastric fluid
Methyl parathion [Mass/volume] in Gastric fluid
Saint Louis encephalitis virus Ab [Units/volume] in Serum
Staphylolysin Ab [Units/volume] in Serum
Streptobacillus moniliformis Ab [Units/volume] in Serum
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
Streptokinase Ab [Units/volume] in Serum
Streptolysin O Ab [Units/volume] in Serum or Plasma
Mycobacterium bovis tuberculin stimulated gamma interferon-Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood
Mycobacterium bovis tuberculin stimulated gamma interferon panel - Blood
Mycobacterium bovis tuberculin stimulated gamma interferon-control stimulated gamma interferon [Units/volume] in Blood
Myasthenia gravis evaluation pediatric panel - Serum
Myasthenia grav eval adult rflx panel - Serum
CV2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid
Glial nuclear type 1 Ab [Titer] in Serum
Mycobacterium sp identified in Peritoneal fluid by Organism specific culture
Streptolysin O Ab [Titer] in Serum by Latex agglutination
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid
PCA-1 Ab [Titer] in Cerebral spinal fluid
Glial nuclear type 1 Ab [Titer] in Cerebral spinal fluid
Paraneoplastic Ab [Presence] in Cerebral spinal fluid by Immunoblot
levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria
Acylglycines [Interpretation] in Urine Narrative
SLC26A4 gene p.Glu384Gly [Presence] in Blood by Molecular genetics method
SLC26A4 gene.p.Leu236Pro [Presence] in Blood by Molecular genetics method
SLC26A4 gene p.Thr416Pro [Presence] in Blood by Molecular genetics method
SLC25A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
KCNC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SOS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Striated muscle Ab [Titer] in Serum by Immunofluorescence
WS2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Borrelia burgdorferi G39/40 IgG Ab [Units/volume] in Serum or Plasma
Posaconazole [Mass/volume] in Serum or Plasma
GCK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Barbiturates.other [Mass/volume] in Urine
Strongyloides sp Ab [Units/volume] in Serum by Hemagglutination
Benzodiazepines.other [Mass/volume] in Urine
Legionella pneumophila 2+3+4+5+6+8 Ab [Presence] in Serum
Cocaine metabolites.other [Mass/volume] in Urine
Taenia saginata Ab [Units/volume] in Serum by Immunoassay
Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells by 5 minute RT incubation
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post XXX challenge
Taenia solium adult Ab [Units/volume] in Serum by Immunoassay
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post XXX challenge
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post XXX challenge
HLA-DRB1 SBT [Type] in Specimen by High resolution
Natural killer cell panel - Blood by Flow cytometry (FC)
Cladosporium sp IgE Ab [Units/volume] in Serum
JAK2 gene.p.Val617Phe mutant/Normal in Blood or Tissue by Molecular genetics method
Cytomegalovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Prostate specific Ag panel - Serum or Plasma
Estrogen [Mass/volume] in Serum or Plasma by calculation
Estrogen fraction panel - Serum or Plasma
HLA-A+B+C SBT [Interpretation] by High resolution
Thermoactinomyces candidus Ab [Units/volume] in Serum
CD55+CD59 deficient RBC actual/normal in Blood
Legionella pneumophila 1+2+3+4+5+6 IgG Ab [Titer] in Serum
Alpha 2 globulin [Presence] in Urine by Electrophoresis
Beta globulin [Presence] in Urine by Electrophoresis
Gamma globulin [Presence] in Urine by Electrophoresis
Epstein Barr virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Hepatitis A virus Ab [Interpretation] in Serum
Laceyella sacchari Ab [Units/volume] in Serum
Arsenic.methylated [Mass/volume] in Urine
Acetaminophen and Propoxyphene panel [Mass/volume] - Urine
HTT gene CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method
HTT gene mutation panel - Blood or Tissue by Molecular genetics method
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Titer] in Serum
Thermoactinomyces vulgaris Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Urine by Wright stain
Microscopic observation [Identifier] in Stool by Wright stain
Zolpidem [Presence] in Urine by Confirmatory method
Sodium urate crystals [Presence] in Urine sediment by Light microscopy
CFTR gene.p.IVS8 polyT 7T/9T [presence] in Blood or Tissue by Molecular genetics method
CILD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PTPN11 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PTPN11 gene mutations tier 3 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RPS6KA3 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RPS6KA3 gene mutations tier 2 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
STK11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Neutrophils.immature/100 leukocytes in Blood
HIV reverse transcriptase+protease gene mutations detected [Identifier]
Major crossmatch [Interpretation] by Electronic
Platelets panel - Blood by Automated count
Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA)
Arbovirus IgG Ab [Interpretation] in Serum by Immunofluorescence Narrative
Transferrin.carbohydrate deficient panel - Serum or Plasma
Arbovirus IgG panel - Serum by Immunofluorescence
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Oligosaccharides pattern [Interpretation] in Serum or Plasma Narrative
Lymphocyte proliferation [Interpretation] in Blood
Triple phosphate [Saturation Fraction] in 24 hour Urine
Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)
Platelet aggregation ADP induced [Units/volume] in Blood
Platelet aggregation arachidonate induced [Units/volume] in Blood
Platelet glycoprotein IIb/IIIa Ab [Units/volume] in Blood
Alpha hydroxytriazolam [Mass/volume] in Serum
Carnosine [Presence] in Cerebral spinal fluid
Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Thyroglobulin Ab [Titer] in Serum by Latex agglutination
Thiopurine methyltransferase [Enzymatic activity/volume] in Blood
Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC)
Chloroamphetamine [Mass/volume] in Serum
Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC)
Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA)
cycloSPORINE [Mass/volume] in Blood --trough
CD55 deficient Granulocytes/100 cells in Blood
CD59 deficient Granulocytes/100 cells in Blood
CD55 deficient RBC/100 erythrocytes in Blood
cycloSPORINE [Mass/volume] in Blood --peak
Thyroperoxidase Ab [Titer] in Serum or Plasma by Latex agglutination
1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma
ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ACVRL1 gene+ENG gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Arsenic.inorganic [Mass/time] in 24 hour Urine
Arsenic organic [Mass/time] in 24 hour Urine
TGFB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ATRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Basement membrane zone BP180 IgG Ab [Units/volume] in Serum or Plasma
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma
BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BTD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method
CACT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mixed cellular casts [#/area] in Urine sediment by Microscopy high power field
HTC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Thyrotropin receptor Ab [Units/volume] in Serum
HTC2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
COL10A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
COL2A1 gene+COL11A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
COL4A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
DYSF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
EXT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/volume] in Serum or Plasma
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/volume] in Serum or Plasma
FKTN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FIG4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FLNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GAA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Galactomannan Ag [Units/volume] in Cerebral spinal fluid
GCH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GYS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Toxocara canis Ab [Units/volume] in Serum by Immunoassay
Glucose tetrasaccharide/Creatinine [Molar ratio] in Urine
HPRT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Iodine [Mass/volume] in Urine collected for unspecified duration
IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Jamestown canyon virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
LMX1B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Toxoplasma gondii Ab [Presence] in Serum by Sabin dye test
LRRK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection
Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method
Norbuprenorphine [Mass/volume] in Serum or Plasma
O-desmethylvenlafaxine [Mass/volume] in Urine
OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Parvovirus B19 IgG Ab [Units/volume] in Body fluid
Parvovirus B19 IgM Ab [Units/volume] in Body fluid
PCCA gene+PCCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mycobacterium sp identified in Synovial fluid by Organism specific culture
PLOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PNKD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunofluorescence
Ribosomal P IgG Ab [Units/volume] in Serum
RNA polymerase III Ab [Units/volume] in Serum
TRAPPC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SH3BP2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SMC1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SPAST gene + KIAA0196 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
KIAA0196 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TGFBR1 gene+TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Butirosin [Susceptibility] by Disk diffusion (KB)
Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay
C10orf2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
USH2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Voriconazole [Mass/volume] in Cerebral spinal fluid
Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Pleural fluid by Rhodamine-auramine fluorochrome stain
Bacteria identified in Esophageal brushing by Culture
Mycobacterium sp identified in Pleural fluid by Organism specific culture
Microscopic observation [Identifier] in Peritoneal fluid by Rhodamine-auramine fluorochrome stain
Bacteria identified in Bile fluid by Culture
Microscopic observation [Identifier] in Body fluid by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Synovial fluid by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Endometrium by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Pericardial fluid by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Gastric fluid by Rhodamine-auramine fluorochrome stain
Streptococcus pneumoniae DNA [Presence] in Blood by NAA with probe detection
Toxoplasma gondii IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
Microscopic observation [Identifier] in Bone marrow by Rhodamine-auramine fluorochrome stain
Thyroglobulin Ab [Units/volume] in Tissue fine needle aspirate
Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate
Thyroglobulin Ab [Units/volume] in Lymph node fine needle aspirate
Thyroglobulin [Mass/volume] in Tissue fine needle aspirate
HIV 1 tropism [Identifier] in Blood Narrative
Rheumatoid factor [Titer] in Synovial fluid by Latex agglutination
Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection
Treponema pallidum Ab [Units/volume] in Serum by Immobilization
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection
Glucose [Mass/volume] in Serum or Plasma --20 minutes post 50 g lactose PO
Glucose [Mass/volume] in Serum or Plasma --40 minutes post 50 g lactose PO
Histoplasma capsulatum Ag [Units/volume] in Bronchoalveolar lavage by Immunoassay
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid by Immunoassay
Streptococcus pneumoniae 14 serotypes and Corynebacterium diphtheriae toxin and Clostridium tetani toxin Ab.IgG panel - Serum
Lactate dehydrogenase in pericardial fluid/Lactate dehydrogenase in serum
Treponema pallidum Ab [Presence] in Serum by Immunofluorescence
Lactate dehydrogenase in peritoneal fluid/Lactate dehydrogenase in serum
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
CD4 stimulated ATP immune response [Mass/volume] in Blood
CD4 stimulated ATP immune response [Presence] in Blood
Vibrio cholerae toxin Ag [Presence] in Isolate
Treponema pallidum Ab [Titer] in Serum by Latex agglutination
Vibrio cholerae toxin ctx gene [Presence] in Specimen by NAA with probe detection
Bacterial cytolethal distending toxin cdt gene [Presence] in Specimen by NAA with probe detection
Escherichia coli enteroinvasive [Presence] in Isolate
Escherichia coli adherence pattern [Identifier] in Isolate by Hep2 substrate
Escherichia coli shiga-like toxin identified in Specimen
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 and H7 flagellar fliC genes [Identifier] in Specimen by NAA with probe detection
HPA 1a/1a+Gp IIb/IIIa [Presence] in Blood
HPA 1b/1b+Gp IIb/IIa [Presence] in Blood
Escherichia coli O157 identified in Isolate by Organism specific culture
Salmonella typhi [Identifier] in Isolate by Agglutination
Choriogonadotropin.tumor marker [Mass/volume] in Serum or Plasma
Choriogonadotropin.tumor marker [Moles/volume] in Serum or Plasma
Trichinella spiralis Ab [Titer] in Serum by Latex agglutination
Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma
Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma
Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma
Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma
Leukocytes [Presence] in Urine by Visual
Brickdust deposit [Presence] in Urine by Visual
Erythrocytes.dysmorphic G1/100 erythrocytes in Urine sediment by Light microscopy
Triiodothyronine (T3) Ab [Units/volume] in Serum
Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy
Erythrocytes.non-dysmorphic [Presence] in Urine sediment by Light microscopy
Microcytes [Presence] in Urine sediment by Light microscopy
Mycobacterium sp identified in Sputum by Organism specific culture
Macrocytes [Presence] in Urine sediment by Light microscopy
Spherocytes [Presence] in Urine sediment by Light microscopy
Burr cells [Presence] in Urine sediment by Light microscopy
Erythrocytes.ghost cells [Presence] in Urine sediment by Light microscopy
Erythrocyte morphology [Interpretation] in Urine sediment by Light microscopy Narrative
Trypanosoma brucei Ab [Units/volume] in Serum
Drug crystals [Presence] in Urine sediment by Light microscopy
Pseudocasts [Presence] in Urine sediment by Light microscopy
Dimagnesium phosphate crystals [Presence] in Urine sediment by Light microscopy
Epithelial cells.non-squamous [Presence] in Urine sediment by Light microscopy
Actin Ab [Presence] in Serum or Plasma by Immunofluorescence
Actin Ab [Titer] in Serum or Plasma by Immunofluorescence
Centromere protein B Ab [Presence] in Serum
Centromere protein B Ab [Units/volume] in Serum
Trypanosoma cruzi Ab [Titer] in Serum by Complement fixation
Homogenous nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Fine speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Coarse speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Coarse speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Atypic speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Atypic speckled nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Chromosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Chromosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Trypanosoma sp Ab [Units/volume] in Serum
Nucleolar nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Nucleolar nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Centrosomal nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Centrosomal nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Nuclear matrix Ab pattern [Titer] in Serum by Immunofluorescence
Nuclear matrix Ab pattern [Presence] in Serum by Immunofluorescence
Nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Multiple nuclear dots nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Multiple nuclear dots nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Centromere protein F Ab [Presence] in Serum by Immunofluorescence
Centromere protein F Ab [Titer] in Serum by Immunofluorescence
Human upstream binding factor Ab [Presence] in Serum by Immunofluorescence
Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence
Nuclear membrane pores nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Nuclear membrane pores nuclear Ab pattern [Titer] in Serum by Immunofluorescence
Vaccinia virus Ab [Units/volume] in Serum
Golgi apparatus Ab [Presence] in Serum by Immunofluorescence
Golgi apparatus Ab [Titer] in Serum by Immunofluorescence
Lysosome Ab [Presence] in Serum by Immunofluorescence
Lysosome Ab [Titer] in Serum by Immunofluorescence
Vimentin Ab [Presence] in Serum by Immunofluorescence
Vimentin Ab [Titer] in Serum by Immunofluorescence
Vinculin Ab [Presence] in Serum by Immunofluorescence
Vinculin Ab [Titer] in Serum by Immunofluorescence
Varicella zoster virus Ab [Titer] in Serum by Complement fixation
Actin.filamentous Ab [Presence] in Serum or Plasma
Actin.filamentous Ab [Units/volume] in Serum or Plasma
Mutated citrullinated vimentin Ab [Units/volume] in Serum
Varicella zoster virus Ab [Titer] in Serum by Latex agglutination
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum
Nuclear pore protein gp210 Ab [Presence] in Serum
Lamin Ab [Presence] in Serum by Immunofluorescence
Lamin Ab [Titer] in Serum by Immunofluorescence
Smith extractable nuclear B Ab [Presence] in Serum
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay
Smith extractable nuclear D Ab [Presence] in Serum
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum
Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain
Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain
Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain
Western equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay
Mycobacterium sp identified in Tissue by Organism specific culture
Vibrio cholerae Ab [Mass/volume] in Serum
Western equine encephalitis virus Ab [Units/volume] in Serum
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
Hemoglobin O - Arab/Hemoglobin.total in DBS
Hemoglobin Barts/Hemoglobin.total in DBS
Yersinia enterocolitica O:3 Ab [Units/volume] in Serum
Endocrine newborn screening panel (SI units)
Thyroid newborn screening panel (SI units)
Yersinia enterocolitica O:8 Ab [Units/volume] in Serum
Galactosemia newborn screening panel (SI units)
Hemoglobinopathies newborn screening panel
Infectious diseases newborn screening panel
CFTR gene mutations found [Identifier] in DBS by Molecular genetics method Nominal
Toxoplasma gondii IgG Ab [Presence] in DBS
Toxoplasma gondii IgM Ab [Presence] in DBS
Newborn screening panel American Health Information Community (AHIC)
Rubella virus RNA [Presence] in Specimen by NAA with probe detection
Citrulline/Arginine [Molar ratio] in DBS
Pesticides [Presence] in Gastric fluid by Screen method
Chemotherapy effectiveness panel [Identifier] - Blood or Tissue
Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative
Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine
Yersinia enterocolitica O:9 Ab [Units/volume] in Serum
Isopropyl methylphosphonate [Mass/volume] in Urine
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine
Monocyclohexyl methylphosphonate [Mass/volume] in Urine
2-Methylpropyl methylphosphonate [Mass/volume] in Urine
Monoethyl methylphosphonate [Mass/volume] in Urine
Yersinia pseudotuberculosis Ab [Units/volume] in Serum
Mycobacterium sp identified in Urine by Organism specific culture
Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification
Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification
Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay
Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) rat liver+stomach+kidney substrate Narrative
Autoantibodies [Interpretation] in Serum by Immunofluorescence (IF) Hep2 substrate Narrative
Homogenous nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence
Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence
Intercellular bridge nuclear Ab pattern [Presence] in Serum by Immunofluorescence
Intercellular bridge nuclear Ab pattern [Titer] in Serum by Immunofluorescence
RNA polymerase I Ab [Presence] in Serum by Immunofluorescence
RNA polymerase I Ab [Titer] in Serum by Immunofluorescence
Pancytokeratin Ab [Presence] in Serum by Immunofluorescence
Pancytokeratin Ab [Titer] in Serum by Immunofluorescence
Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence
Cytoplasmic Ab pattern.PL-7+PL-12 [Titer] in Serum by Immunofluorescence
Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml
Cytomegalovirus immediate-early Ag [Presence] in Blood
Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB)
Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC)
Imipenem+EDTA [Susceptibility] by Disk diffusion (KB)
Arbekacin [Susceptibility] by Disk diffusion (KB)
Cefmenoxime [Susceptibility] by Disk diffusion (KB)
Caspofungin [Susceptibility] by Disk diffusion (KB)
Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC)
Clotrimazole [Susceptibility] by Disk diffusion (KB)
Econazole [Susceptibility] by Disk diffusion (KB)
Itraconazole [Susceptibility] by Disk diffusion (KB)
Miconazole [Susceptibility] by Disk diffusion (KB)
Nitroxoline [Susceptibility] by Disk diffusion (KB)
Para aminosalicylate [Susceptibility] by Disk diffusion (KB)
Rifabutin [Susceptibility] by Disk diffusion (KB)
Thiacetazone [Susceptibility] by Disk diffusion (KB)
Caspofungin [Susceptibility] by Gradient strip
Posaconazole [Susceptibility] by Gradient strip
Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Posaconazole [Susceptibility] by Disk diffusion (KB)
Temocillin [Susceptibility] by Gradient strip
Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB)
Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC)
Griseofulvin [Susceptibility] by Disk diffusion (KB)
Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC)
Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum
Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of factor V depleted plasma+APC
Hemoglobin C - Harlem/Hemoglobin.total in Blood
Mycobacterium sp identified in Wound by Organism specific culture
Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection
Cortisol [Moles/volume] in Serum or Plasma --24 hours post dose dexamethasone
Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone
Cortisol [Moles/volume] in Serum or Plasma --4 days post dose corticotropin
Cortisol [Moles/volume] in Serum or Plasma --5 days post dose dexamethasone
Cortisol [Moles/volume] in Serum or Plasma --5 hours post dose corticotropin
Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma --pre or post XXX challenge
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma
Immune response markers [Interpretation] in Specimen Narrative
Lymphoma markers [Interpretation] in Specimen Narrative
Lymphoma - acute screen markers [Interpretation] in Specimen Narrative
Lymphoma - CLL screen markers [Interpretation] in Specimen Narrative
Lymphoma - T-cell markers [Interpretation] in Specimen Narrative
Immune response panel - Specimen by Flow cytometry (FC)
Lymphoma panel - Specimen by Flow cytometry (FC)
Lymphoma - acute screen panel - Specimen by Flow cytometry (FC)
Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC)
Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC)
Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid
Metabolic panel.large animal - Serum or Plasma
Metabolic panel.small animal - Serum or Plasma
Cell count and Diff panel with Gluc and Prot - Body fluid
Cortisol challenge panel - Saliva (oral fluid)
Cortisol [Mass/volume] in Serum or Plasma --9 AM 2nd day specimen
Corticotropin [Mass/volume] in Plasma --9 AM 2nd day specimen
LDL.oxidized [Units/volume] in Serum or Plasma
Cytopathic effect [Presence] in Specimen
Influenza virus Ag [Presence] in Specimen
Influenza virus B Ag [Presence] in Isolate
Influenza virus RNA [Identifier] in Specimen by Probe
Respiratory virus Ag [Identifier] in Specimen by Immunofluorescence
Protein and Glucose panel [Mass/volume] - Body fluid
Drug screen comment [Interpretation] in Urine
Glucose [Moles/volume] in Serum or Plasma --10 minutes pre dose glucagon
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose glucagon
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --2 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --4 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --5 minutes pre dose glucagon
Glucose [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon
Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose insulin IV
Glucose [Moles/volume] in Serum or Plasma --pre dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --2 hour post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --3 hours post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose ornithine alpha-ketoglutarate
Glucose [Moles/volume] in Serum or Plasma --1.5 hour post dose ornithine alpha-ketoglutarate
Glutarate [Moles/volume] in Cerebral spinal fluid
Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine
Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid
Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid
Glutarylcarnitine (C5-DC) [Moles/volume] in Urine
Glycolate [Moles/volume] in Cerebral spinal fluid
Guanidinoacetate [Moles/volume] in Cerebral spinal fluid
Guanidinoacetate [Moles/volume] in Amniotic fluid
Hemoglobin [Mass/volume] in Blood from Blood product unit
Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine
Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid
Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid
Heptanoylcarnitine (C7) [Moles/volume] in Urine
Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine
Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine
Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid
Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid
Hexanoylcarnitine (C6) [Moles/volume] in Urine
Homocitrulline [Moles/volume] in Amniotic fluid
Homocysteine [Moles/volume] in Amniotic fluid
Isobutyrylglycine [Moles/volume] in Urine
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine
Isovalerylglycine [Moles/volume] in Cerebral spinal fluid
Lactate/Pyruvate [Molar ratio] in Cerebral spinal fluid
Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine
Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid
Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid
Linoleoylcarnitine (C18:2) [Moles/volume] in Urine
Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine
Methylmalonate [Moles/volume] in Cerebral spinal fluid
Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine
Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine
Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid
Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid
Palmitoylcarnitine (C16)/Creatinine [Molar ratio] in Urine
Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid
Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid
Phosphoethanolamine [Moles/volume] in DBS
Pipecolate [Moles/volume] in Cerebral spinal fluid
Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine
Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid
Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid
Propionylglycine [Moles/volume] in Cerebral spinal fluid
Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine
Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid
Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid
Sulfocysteine [Moles/volume] in Cerebral spinal fluid
Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine
Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid
Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid
Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine
Tiglylglycine [Moles/volume] in Cerebral spinal fluid
3-Methoxytyramine/Creatinine [Mass Ratio] in 24 hour Urine
3-Methoxytyramine [Mass/volume] in 24 hour Urine
Acetylcarnitine (C2) [Moles/volume] in Semen
Albumin [Moles/volume] in Serum or Plasma
Alpha-1-Fetoprotein [Mass/volume] in Cord blood
Ascorbate+Dehydroascorbate [Moles/volume] in Serum or Plasma
Ascorbate+Dehydroascorbate [Mass/volume] in Serum or Plasma
Beta 1 globulin [Mass/volume] in Urine by Electrophoresis
Beta 2 globulin [Mass/volume] in Urine by Electrophoresis
Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum
Beta-2-Microglobulin [Mass/volume] in 24 hour Urine
Beta 2 globulin+Gamma globulin/Protein.total in Urine by Electrophoresis
Beta globulin/Protein.total in Dialysis fluid by Electrophoresis
Bicarbonate [Moles/volume] in Plasma --post dialysis
Bicarbonate [Moles/volume] in Peritoneal fluid
Bicarbonate [Moles/volume] in Pleural fluid
Bilirubin.total [Moles/volume] in Dialysis fluid
Calcium [Moles/volume] in Nonbiological fluid
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Cord blood
Calcium.ionized [Moles/volume] in Cord blood
Catalase [Enzymatic activity/volume] in Plasma
Chloride [Moles/volume] in Serum or Plasma --post dialysis
Cholesterol [Moles/volume] in Peritoneal fluid
Cholesterol in HDL [Mass/volume] in Body fluid
Cholesterol.non-esterified [Moles/volume] in Serum or Plasma
Creatinine/Body weight [Moles/kg/time] in 24 hour Urine
Creatinine [Moles/volume] in Pleural fluid
Cobalamin (Vitamin B12) [Moles/volume] in Body fluid
Cobalamin (Vitamin B12) [Mass/volume] in Body fluid
Cobalamin (Vitamin B12) [Moles/volume] in Urine
Cystatin C [Mass/volume] in 24 hour Urine
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid cells
Cytochrome C oxidase [Enzymatic activity/mass] in Fibroblast
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid
Dehydroascorbate/Ascorbate in Serum or Plasma
Dehydroascorbate [Moles/volume] in Serum or Plasma
Dihydroxycholestanoate [Moles/volume] in Body fluid
Dihydroxycholestanoate [Moles/volume] in Urine
Dodecanoylcarnitine (C12) [Moles/volume] in Urine
Mycobacterium sp identified in Specimen by Organism specific culture
Fibroblast growth factor 23.intact [Mass/volume] in Serum or Plasma
Gamma globulin/Protein.total in Dialysis fluid by Electrophoresis
Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon
Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucagon
4-Hydroxymidazolam [Mass/volume] in Serum or Plasma
Transfuse 5% plasma protein fraction units [#]
Pooled platelet concentrate units given [#]
Transfuse pooled cryoprecipitate units [#]
Transfuse pooled fresh frozen plasma units [#]
Pooled fresh frozen plasma units given [#]
Direct antiglobulin test.complement C3+C4 specific reagent [Presence] on Red Blood Cells
Direct antiglobulin test.complement C3 specific reagent [Presence] on Red Blood Cells
Cryoprecipitate poor plasma units given [#]
Transfuse leukocyte-poor plateletpheresis units [#]
Leukocyte-poor plateletpheresis units given [#]
Transfuse leukocyte-poor platelets units [#]
ABO and Rh group [Type] in Blood from Fetus
Transfuse fresh frozen plasma pediatric units [#]
Frozen erythrocytes newborn units given [#]
Transfuse frozen erythrocytes pediatric units [#]
Frozen erythrocytes pediatric units given [#]
Transfuse plateletpheresis half units [#]
Weak D Ag [Presence] on Red Blood Cells from Fetus
Fresh frozen plasma pediatric units given [#]
Transfuse frozen erythrocytes newborn units [Volume]
Frozen packed erythrocytes given [Volume]
5% plasma protein fraction given [Volume]
Pooled fresh frozen plasma given [Volume]
Lipoprotein.beta.subparticle [Moles/volume] in Serum or Plasma
Aspergillus fumigatus Ab [Titer] in Serum
Sodium urate/Total in Stone by Infrared spectroscopy
Carnitine esters/Carnitine.free (C0) [Molar ratio] in Urine
Fatty acids.very long chain.C22:1n9 (Erucate) [Mass/volume] in Serum or Plasma
Fatty acids.very long chain C26:1 (Hexacosenoate) [Mass/volume] in Serum or Plasma
FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
NPM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method
CYP2C9 and VKORC1 [Interpretation] in Blood or Tissue by Molecular genetics method Narrative
Blastomyces dermatitidis Ag [Units/volume] in Body fluid
Biotinidase [Enzymatic activity/volume] in Serum or Plasma from Normal control
Granulocyte colony stimulating factor [Mass/volume] in Serum or Plasma
Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine [Molar ratio] in Urine
Malonylcarnitine (C3-DC) [Moles/volume] in Cerebral spinal fluid
Malonylcarnitine (C3-DC) [Moles/volume] in Amniotic fluid
Malonylcarnitine (C3-DC) [Moles/volume] in DBS
Malonylcarnitine (C3-DC) [Moles/volume] in Urine
Albumin/Protein.total in Dialysis fluid by Electrophoresis
Alpha 1 globulin/Protein.total in Dialysis fluid by Electrophoresis
Alpha 2 globulin/Protein.total in Dialysis fluid by Electrophoresis
Cholesterol in HDL 2a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis
Cholesterol in HDL 2b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis
Cholesterol in HDL 3a/Cholesterol in total HDL in Serum or Plasma by Electrophoresis
Bacteroides fragilis Ag [Presence] in Specimen by Immunofluorescence
Cholesterol in HDL 3b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis
Cholesterol in HDL 3c/Cholesterol in total HDL in Serum or Plasma by Electrophoresis
Amylase.macromolecular/Amylase.total in Serum or Plasma
Pimeloylcarnitine (C7-DC) [Moles/volume] in Cerebral spinal fluid
Pimeloylcarnitine (C7-DC) [Moles/volume] in Amniotic fluid
Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS
Pimeloylcarnitine (C7-DC) [Moles/volume] in Urine
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Cerebral spinal fluid
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine
Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine
Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine
Pipecolate [Moles/volume] in Amniotic fluid
Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid
Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid
Allantoine [Moles/time] in 24 hour Urine by Electrophoresis
Glucose [Moles/volume] in Serum or Plasma --post dialysis
Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge
Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total in Serum or Plasma
Bacteroides melaninogenicus Ag [Presence] in Specimen by Immunofluorescence
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
Butirosin [Susceptibility] by Serum bactericidal titer
Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture
Bordetella pertussis [Presence] in Throat by Organism specific culture
Norovirus genogroup I RNA [Presence] in Stool by NAA with probe detection
Norovirus genogroup II RNA [Presence] in Stool by NAA with probe detection
Alkaline phosphatase [Enzymatic activity/volume] in Amniotic fluid
Culex mosquito IgE Ab [Units/volume] in Serum
DNA double strand Ab [Units/volume] in Serum by Immunofluorescence
Giant grouper IgE Ab [Units/volume] in Serum
Fosfomycin IgE Ab [Units/volume] in Serum
Gentamicin IgE Ab [Units/volume] in Serum
Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay
Ma+Ta Ab [Units/volume] in Serum by Immunoassay
Jumper ant IgE Ab [Units/volume] in Serum
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Propyphenazone IgE Ab [Units/volume] in Serum
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method
Tetranychus urticae IgE Ab [Units/volume] in Serum
Tissue transglutaminase Ab [Titer] in Serum by Immunofluorescence
Fava bean IgE Ab [Units/volume] in Serum
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine [Molar ratio] in Urine
Centers for Environmental Health abrine and ricinine panel [Mass/volume] - Urine
1,2-Dichloroethane [Mass/volume] in Serum or Plasma
Carbon tetrachloride [Mass/volume] in Serum or Plasma
Chloroform [Mass/volume] in Serum or Plasma
Ethyl benzene [Mass/volume] in Serum or Plasma
Meta methylhippurate+Para methylhippurate [Mass/volume] in Serum or Plasma
Styrene [Mass/volume] in Serum or Plasma
N-ethyldiethanolamine [Mass/volume] in Urine
N-methyldiethanolamine [Mass/volume] in Urine
Monofluoroacetate [Mass/volume] in Urine
Monochloroacetate [Mass/volume] in Urine
Bordetella pertussis [Presence] in Specimen by Organism specific culture
Bordetella pertussis Ag [Presence] in Specimen by Immunofluorescence
Darunavir [Susceptibility] by Genotype method
PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
Adenovirus [Presence] in Specimen by Organism specific culture
Parainfluenza virus 1 [Presence] in Specimen by Organism specific culture
Parainfluenza virus 2 [Presence] in Specimen by Organism specific culture
Parainfluenza virus 3 [Presence] in Specimen by Organism specific culture
Respiratory syncytial virus [Presence] in Specimen by Organism specific culture
Respiratory pathogens panel - Specimen by Organism specific culture
Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma
Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine
Centers for Environmental Health trace metals panel [Mass/volume] - Urine
Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine
Brucella sp identified in Blood by Organism specific culture
Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine
Multiple sclerosis panel - Serum and CSF
Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection
BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)
Penicillin Parenteral [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone PO overnight
SCN5A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Fc epsilon RI + RII Ab [Units/volume] in Serum
Cache valley virus RNA [Presence] in Specimen by NAA with probe detection
California serogroup RNA [Presence] in Specimen by NAA with probe detection
Powassan virus RNA [Presence] in Specimen by NAA with probe detection
Saint Louis encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Familial long QTS syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
BCR-ABL1 e1a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method
Anaplasma phagocytophilum IgG and IgM panel - Serum Qualitative
Aldosterone and renin activity panel - Plasma
Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma
Ethambutol+rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria
Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine
Minocycline [Susceptibility] by Method for Slow-growing mycobacteria
risperiDONE and 9-Hydroxyrisperidone panel - Serum or Plasma
Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria
Ursodeoxycholate [Moles/volume] in Serum or Plasma
Bordetella pertussis IgA and IgG panel - Serum by Immunoassay
Streptococcus pyogenes enzyme Ab panel - Serum Qualitative
Echinococcus sp IgG4 Ab [Presence] in Serum
Hepatitis G virus E2 Ab [Presence] in Serum
Mycoplasma sp Ab [Presence] in Cerebral spinal fluid
Cytoplasmic Ab [Titer] in Serum by Immunofluorescence
Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence
Calcium phosphate crystals [Presence] in Specimen by Light microscopy
Sodium urate crystals [Presence] in Specimen by Light microscopy
Human epididymis protein 4 [Moles/volume] in Serum or Plasma
Cefotaxime [Susceptibility] for meningitis by Disk diffusion (KB)
cefTRIAXone [Susceptibility] for meningitis by Disk diffusion (KB)
Chromosome analysis.interphase [Interpretation] in Amniotic fluid by FISH Narrative
Chromosome analysis.interphase [Interpretation] in Chorionic villus sample by FISH Narrative
Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
DHCR7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Zygosity [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cells karyotyped.total [#] in Blood or Tissue
Brucella sp identified in Specimen by Organism specific culture
KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --5 minutes post incubation after addition of normal plasma
Macroamylase [Presence] in Pleural fluid
Vasoactive intestinal peptide [Mass/volume] in Cerebral spinal fluid
DNA analysis discrete sequence variation panel
Antioxidants [Moles/volume] in Serum or Plasma
Asialoglycoprotein receptor Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Aspirate by Rhodamine-auramine fluorochrome stain
Mycobacterium tuberculosis A60 IgM Ab [Presence] in Serum by Immunoassay
Mycobacterium tuberculosis A60 Ab [Presence] in Serum by Immunoassay
Pancreatic polypeptide [Moles/volume] in Serum or Plasma
Alpha thalassemia gene panel - Blood by Molecular genetics method
Abnormal hemoglobin gene panel - Blood by Molecular genetics method
HBA2 gene alpha 4.2kb deletion [Presence] in Blood by Molecular genetics method
HBA2 gene c.427T>C [Presence] in Blood by Molecular genetics method
HBA2 gene c.429A>T [Presence] in Blood by Molecular genetics method
HBB gene c.441_442insAC [Presence] in Blood by Molecular genetics method
HBB gene c.251G>A [Presence] in Blood by Molecular genetics method
HBB gene c.19G>A [Presence] in Blood by Molecular genetics method
HBB gene c.20A>T [Presence] in Blood by Molecular genetics method
HBB gene c.364G>C [Presence] in Blood by Molecular genetics method
HPFH-6 gene [Presence] in Blood by Molecular genetics method
HBB gene c.220G>A [Presence] in Blood by Molecular genetics method
HBA2 gene c.84G>C [Presence] in Blood by Molecular genetics method
HBA1 gene c.223G>C [Presence] in Blood by Molecular genetics method
HBB gene c.79G>A [Presence] in Blood by Molecular genetics method
HBA2 gene SEA deletion [Presence] in Blood by Molecular genetics method
HBA2 gene THAI+FIL+MED+alpha 20.5 deletion [Presence] in Blood by Molecular genetics method
HBA2 gene alpha 3.7kb deletion [Presence] in Blood by Molecular genetics method
Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Sulopenem [Susceptibility] by Disk diffusion (KB)
Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB)
Protein electrophoresis and Immunoglobulins panel - Serum
CAV3 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Specimen by Probe with signal amplification
JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method
JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method
Fungus [Presence] in Skin by KOH preparation
Fungus [Presence] in Sputum by KOH preparation
Fungus [Presence] in Specimen by KOH preparation
Fungus [Presence] in Nail by KOH preparation
Fungus [Presence] in Vaginal fluid by KOH preparation
Yeast.pseudohyphae [Presence] in Specimen by KOH preparation
Yeast.pseudohyphae [Presence] in Sputum by KOH preparation
Yeast.pseudohyphae [Presence] in Nail by KOH preparation
Yeast.pseudohyphae [Presence] in Skin by KOH preparation
Yeast.pseudohyphae [Presence] in Vaginal fluid by KOH preparation
Yeast [Presence] in Vaginal fluid by KOH preparation
Yeast [Presence] in Nail by KOH preparation
Yeast [Presence] in Specimen by KOH preparation
Yeast [Presence] in Sputum by KOH preparation
Yeast [Presence] in Skin by KOH preparation
Fungus [Presence] in Bronchial specimen by KOH preparation
Yeast.pseudohyphae [Presence] in Bronchial specimen by KOH preparation
Yeast [Presence] in Bronchial specimen by KOH preparation
Sd sup(a) Ab [Presence] in Serum or Plasma
Sd sup(a) Ag [Presence] on Red Blood Cells
Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)
Platelet aggregation ristocetin induced in Platelet rich plasma --1000 ug/mL
VIM gene methylation [Presence] in Stool by Molecular genetics method
cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma
Ecarin clotting time (ECT) in Blood by Coagulation assay
Cortisol [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO
Glucose [Moles/volume] in Serum or Plasma --45 minutes post 75 g glucose PO
Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic method
Osmolality of Urine--4 hours post fluid fast
Osmolality of Urine--7 hours post fluid fast
Osmolality of Urine--5 hours post fluid fast
Osmolality of Urine--3 hours post fluid fast
Osmolality of Urine--2 hours post fluid fast
Osmolality of Urine--1 hour post fluid fast
Osmolality of Urine--6 hours post fluid fast
Thyrotropin [Units/volume] in Serum or Plasma --pre XXX challenge
Argatroban [Mass/volume] in Platelet poor plasma
Cholesterol crystals [#/area] in Urine by Computer assisted method
Crystals.amorphous [#/area] in Urine sediment by Microscopy high power field
Dengue virus Ab [Titer] in Serum by Hemagglutination inhibition
Hemoglobin A2+C+E+O/Hemoglobin.total in Blood
Hemoglobin A2+E+O/Hemoglobin.total in Blood
Hemoglobin Constant Spring/Hemoglobin.total in Blood
Hemoglobin D+G/Hemoglobin.total in Blood
Hemoglobin N+I/Hemoglobin.total in Blood
Megaloblasts [#/volume] in Blood by Manual count
Megaloblasts/100 leukocytes in Blood by Manual count
Mononuclear cells immature/100 leukocytes in Blood by Manual count
Phosphate crystals amorphous [#/area] in Urine by Computer assisted method
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay
Candida sp identified in Saliva (oral fluid) by Organism specific culture
West Nile virus Ab [Titer] in Serum by Hemagglutination inhibition
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO
Insulin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --6 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --4 minutes post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge
Protein and Glucose panel - Cerebral spinal fluid
Phospholipid IgA and IgG and IgM panel - Serum
Beta 2 glycoprotein 1 IgA and IgG panel - Serum
Short Fibrin D-dimer FEU and DDU panel - Platelet poor plasma
Capreomycin [Susceptibility] by Minimum lethal concentration (MLC)
Warfarin tracking panel - Platelet poor plasma
West Nile virus IgG and IgM panel - Serum
Drug test kit name [Identifier] in Urine
Insulin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge
Mononuclear cells immature [#/volume] in Blood by Manual count
Myeloblasts/100 leukocytes in Cerebral spinal fluid by Manual count
Neoplastic cells/100 leukocytes in Cerebral spinal fluid by Manual count
Dengue virus neutralizing antibody [Titer] in Serum by Neutralization test
Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP
Candida sp identified in Stool by Organism specific culture
Influenza virus A swine origin RNA [Identifier] in Specimen by NAA with probe detection
Influenza virus A swine origin RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA panel - Specimen by NAA with probe detection
11-Deoxycortisol [Moles/volume] in Serum or Plasma --baseline
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Cortisol [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --baseline
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Estradiol (E2) [Moles/volume] in Serum or Plasma --baseline
Estradiol (E2) [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge
Insulin [Moles/volume] in Serum or Plasma --7 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose
Insulin [Moles/volume] in Serum or Plasma --10 minutes pre dose glucose
Insulin [Moles/volume] in Serum or Plasma --4 hours post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --10 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --1 minute post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --1 hour post dose glucagon
Insulin [Moles/volume] in Serum or Plasma --1.5 hours post dose glucagon
Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucagon
Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucagon
Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --3 hours post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --5 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --45 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --2 hours post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --3 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --7 minutes pre dose glucose
Insulin [Moles/volume] in Serum or Plasma --15 minutes post dose glucose IV
Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucagon
Lutropin [Units/volume] in Serum or Plasma --4 hours post XXX challenge
Prolactin [Mass/volume] in Serum or Plasma --20 minutes post dose TRH IV
Prolactin [Mass/volume] in Serum or Plasma --40 minutes post dose TRH IV
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucose
Somatotropin [Mass/volume] in Serum or Plasma --10 minutes post exercise
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose glucose
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucose
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine
Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post exercise
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose glucagon
Testosterone [Moles/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone
Testosterone [Moles/volume] in Serum or Plasma --baseline
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine
Acetazolamide [Moles/volume] in Serum or Plasma
Anileridine [Moles/volume] in Serum or Plasma
Atropine [Moles/volume] in Serum or Plasma
Benzoylecgonine [Moles/volume] in Serum or Plasma
Brompheniramine [Moles/volume] in Serum or Plasma
buPROPion [Moles/volume] in Serum or Plasma
Chloral hydrate [Moles/volume] in Serum or Plasma
Clopenthixol [Moles/volume] in Serum or Plasma
Candida sp identified in Specimen by Organism specific culture
Cocaethylene [Moles/volume] in Serum or Plasma
Cyclobenzaprine [Moles/volume] in Serum or Plasma
Diethylpropion [Moles/volume] in Serum or Plasma
dilTIAZem [Moles/volume] in Serum or Plasma
Doxylamine [Moles/volume] in Serum or Plasma
ePHEDrine [Moles/volume] in Serum or Plasma
Fenoprofen [Moles/volume] in Serum or Plasma
fentaNYL [Moles/volume] in Serum or Plasma
Flupenthixol [Moles/volume] in Serum or Plasma
Flurbiprofen [Moles/volume] in Serum or Plasma
Furosemide [Moles/volume] in Serum or Plasma
hydroCHLOROthiazide [Moles/volume] in Serum or Plasma
Hydroxybupropion [Moles/volume] in Serum or Plasma
Hydroxychloroquine [Moles/volume] in Serum or Plasma
hydrOXYzine [Moles/volume] in Serum or Plasma
Indomethacin [Moles/volume] in Serum or Plasma
Ketoprofen [Moles/volume] in Serum or Plasma
Labetalol [Moles/volume] in Serum or Plasma
metFORMIN [Moles/volume] in Serum or Plasma
Methocarbamol [Moles/volume] in Serum or Plasma
Methsuximide+Normethsuximide [Moles/volume] in Serum or Plasma
Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma
Methylphenidate [Moles/volume] in Serum or Plasma
Metoprolol [Moles/volume] in Serum or Plasma
Mirtazapine [Moles/volume] in Serum or Plasma
Nadolol [Moles/volume] in Serum or Plasma
Nicotine [Moles/volume] in Serum or Plasma
Nicotine [Moles/volume] in Serum or Plasma by Screen method
Norpropoxyphene [Moles/volume] in Serum or Plasma
Orphenadrine [Moles/volume] in Serum or Plasma
Oxprenolol [Moles/volume] in Serum or Plasma
Oxyphenbutazone [Moles/volume] in Serum or Plasma
Paraldehyde [Moles/volume] in Serum or Plasma
Pentazocine [Moles/volume] in Serum or Plasma
Phenacetin [Moles/volume] in Serum or Plasma
Phenelzine [Moles/volume] in Serum or Plasma
Pheniramine [Moles/volume] in Serum or Plasma
Phenolphthalein [Moles/volume] in Serum or Plasma
Phentermine [Moles/volume] in Serum or Plasma
predniSONE [Moles/volume] in Serum or Plasma
Prilocaine [Moles/volume] in Serum or Plasma
Procaine [Moles/volume] in Serum or Plasma
Promethazine [Moles/volume] in Serum or Plasma
Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma
Pseudoephedrine [Moles/volume] in Serum or Plasma
QUEtiapine [Moles/volume] in Serum or Plasma
Salicylamide [Moles/volume] in Serum or Plasma
Sildenafil citrate [Moles/volume] in Serum or Plasma
Sotalol [Moles/volume] in Serum or Plasma
Sulfapyridine [Moles/volume] in Serum or Plasma
sulfaSALAzine [Moles/volume] in Serum or Plasma
Timolol [Moles/volume] in Serum or Plasma
Tranylcypromine [Moles/volume] in Serum or Plasma
Trimethoprim [Moles/volume] in Serum or Plasma
Tripelennamine [Moles/volume] in Serum or Plasma
Verapamil [Moles/volume] in Serum or Plasma
OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
Budgerigar feather IgE Ab [Presence] in Serum
Canary feather IgE Ab [Presence] in Serum
Chicken feather IgE Ab [Presence] in Serum
Cockatiel feather IgE Ab [Presence] in Serum
Creatinine [Moles/volume] in Urine collected for unspecified duration
Finch feather IgE Ab [Presence] in Serum
Goose feather IgE Ab [Presence] in Serum
Leukocytes.disintegrated/100 leukocytes in Body fluid by Manual count
Leukocytes.disintegrated/100 leukocytes in Cerebral spinal fluid by Manual count
Microscopic observation [Identifier] in Peritoneal fluid by Cyto stain
Microscopic observation [Identifier] in Pericardial fluid by Cyto stain
Microscopic observation [Identifier] in Pleural fluid by Cyto stain
Microscopic observation [Identifier] in Synovial fluid by Cyto stain
Microscopic observation [Identifier] in Endometrium by Cyto stain
Parakeet feather IgE Ab [Presence] in Serum
Parrot feather IgE Ab [Presence] in Serum
Triglyceride/Cholesterol in HDL [Molar ratio] in Serum or Plasma
Turkey feather IgE Ab [Presence] in Serum
Urea [Moles/volume] in Urine collected for unspecified duration
Chlamydia sp identified in Conjunctival specimen by Organism specific culture
Follitropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
Amoxicillin+Sulbactam [Susceptibility] by Gradient strip
Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Other Antibiotic [Susceptibility] by Gradient strip
Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC)
Avilamycin [Susceptibility] by Gradient strip
Bacampicillin [Susceptibility] by Gradient strip
Bambermycins [Susceptibility] by Gradient strip
Butirosin [Susceptibility] by Gradient strip
Capreomycin [Susceptibility] by Gradient strip
Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefacetrile [Susceptibility] by Disk diffusion (KB)
Cefacetrile [Susceptibility] by Gradient strip
Cefadroxil [Susceptibility] by Gradient strip
Cephaloglycin [Susceptibility] by Gradient strip
Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Cephalothin+Sulbactam [Susceptibility] by Gradient strip
Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB)
Cefamandole+Sulbactam [Susceptibility] by Gradient strip
Cephapirin [Susceptibility] by Gradient strip
Cefatrizine [Susceptibility] by Gradient strip
Cefetamet [Susceptibility] by Gradient strip
Cefmenoxime [Susceptibility] by Gradient strip
Cefonicid [Susceptibility] by Gradient strip
Ceforanide [Susceptibility] by Gradient strip
Cefotaxime+Sulbactam [Susceptibility] by Gradient strip
Cefotiam [Susceptibility] by Gradient strip
Cephradine [Susceptibility] by Gradient strip
Cefsulodin [Susceptibility] by Gradient strip
cefTAZidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
cefTAZidime+Sulbactam [Susceptibility] by Disk diffusion (KB)
cefTAZidime+Sulbactam [Susceptibility] by Gradient strip
Ceftiofur [Susceptibility] by Gradient strip
Cefuroxime Oral [Susceptibility] by Gradient strip
Cefuroxime [Susceptibility] by Gradient strip
Chlortetracycline [Susceptibility] by Gradient strip
Cinoxacin [Susceptibility] by Gradient strip
Terminal deoxyribonucleotidyl transferase [Units/volume] in Leukocytes
Clindamycin.high potency [Susceptibility]
Clindamycin.high potency [Susceptibility] by Gradient strip
Clindamycin.high potency [Susceptibility] by Disk diffusion (KB)
Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
Clofazimine [Susceptibility] by Disk diffusion (KB)
Clofazimine [Susceptibility] by Gradient strip
Clotrimazole [Susceptibility] by Gradient strip
Cloxacillin [Susceptibility] by Gradient strip
Cyclacillin [Susceptibility] by Gradient strip
cycloSERINE [Susceptibility] by Gradient strip
Dicloxacillin [Susceptibility] by Gradient strip
Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Dibekacin [Susceptibility] by Disk diffusion (KB)
Dibekacin [Susceptibility] by Gradient strip
Econazole [Susceptibility] by Gradient strip
Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC)
Flumequine [Susceptibility] by Disk diffusion (KB)
Flumequine [Susceptibility] by Gradient strip
Framycetin [Susceptibility] by Gradient strip
Isepamicin [Susceptibility] by Gradient strip
Acetone [Mass/volume] in Serum or Plasma
Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Isoconazole [Susceptibility] by Disk diffusion (KB)
Isoconazole [Susceptibility] by Gradient strip
Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Miconazole [Susceptibility] by Gradient strip
Miocamycin [Susceptibility] by Gradient strip
Nitroxoline [Susceptibility] by Gradient strip
Nystatin [Susceptibility] by Gradient strip
Oleandomycin [Susceptibility] by Gradient strip
Ornidazole [Susceptibility] by Gradient strip
Ornidazole [Susceptibility] by Disk diffusion (KB)
Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC)
Oxolinate [Susceptibility] by Disk diffusion (KB)
Oxolinate [Susceptibility] by Gradient strip
Oxytetracycline [Susceptibility] by Gradient strip
Paromomycin [Susceptibility] by Disk diffusion (KB)
Paromomycin [Susceptibility] by Gradient strip
Pipemidate [Susceptibility] by Gradient strip
Piperacillin+Sulbactam [Susceptibility] by Gradient strip
Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC)
Piromidate [Susceptibility] by Disk diffusion (KB)
Piromidate [Susceptibility] by Gradient strip
Pristinamycin [Susceptibility] by Gradient strip
Pyrazinamide [Susceptibility] by Gradient strip
Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Rosoxacin [Susceptibility] by Gradient strip
Sisomicin [Susceptibility] by Gradient strip
Spiramycin [Susceptibility] by Gradient strip
Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
Ticarcillin+Sulbactam [Susceptibility] by Gradient strip
Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Tinidazole [Susceptibility] by Disk diffusion (KB)
Tinidazole [Susceptibility] by Gradient strip
Aluminum [Mass/volume] in Dialysis fluid
Virginiamycin [Susceptibility] by Gradient strip
Apolipoprotein A-I and A-II and B and C panel [Mass/volume] - Serum or Plasma
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/volume] - Serum or Plasma
Borrelia burgdorferi IgA and IgG and IgM panel - Cerebral spinal fluid
Tissue transglutaminase IgA and IgG panel - Serum
Erythrocytes.fetal/100 erythrocytes [Ratio] in Blood by Flow cytometry (FC)
Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefotiam hexetil [Susceptibility] by Disk diffusion (KB)
Cefotiam hexetil [Susceptibility] by Gradient strip
Aluminum [Mass/volume] in Serum or Plasma
Aluminum [Mass/volume] in Red Blood Cells
EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene c.2156G>C+2155G>A+2155G>T [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene c.2573T>G [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene c.2582T>A [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene c.2303G>T [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene c.2369C>T [Presence] in Blood or Tissue by Molecular genetics method
EGFR gene exon 20 insertion [Presence] in Blood or Tissue by Molecular genetics method
Basophils [#] in Cerebral spinal fluid by Manual count
Cardiolipin IgG Ab [Multiple of the median] in Serum
Cardiolipin IgM Ab [Multiple of the median] in Serum
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
Direct antiglobulin test.IgA specific reagent [Presence] on Red Blood Cells
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
Direct antiglobulin test.IgM specific reagent [Presence] on Red Blood Cells
Eosinophils [#] in Cerebral spinal fluid by Manual count
Erythrocytes [#/volume] in Amniotic fluid
Nucleated erythrocytes [#] in Cerebral spinal fluid by Manual count
Hematocrit [Volume Fraction] of Bone marrow
Hemoglobin [Mass/volume] in Blood by Oximetry
Hemoglobin Barts [Presence] in Blood by HPLC
Leukocytes [#/volume] corrected for nucleated erythrocytes in Bone marrow
Lymphocytes [#] in Cerebral spinal fluid by Manual count
Mononuclear cells [#/volume] in Bone marrow
Myelocytes [#] in Cerebral spinal fluid by Manual count
Chlamydia sp identified in Genital specimen by Organism specific culture
Band form neutrophils [#] in Cerebral spinal fluid by Manual count
Neutrophils [#] in Cerebral spinal fluid by Manual count
Nucleated cells [#/volume] in Bone marrow
Nucleated cells [#/volume] in Body fluid
Other cells [#] in Cerebral spinal fluid by Manual count
Phosphatidylserine IgG Ab [Multiple of the median] in Serum
Phosphatidylserine IgM Ab [Multiple of the median] in Serum
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --2.5 umol/L
Platelet aggregation ADP induced [Presence] in Platelet rich plasma --5 umol/L
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1125 mg/L
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --1000 mg/L
Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma --500 mg/L
Platelets [#/volume] in Cord blood by Estimate
Promyelocytes [#] in Cerebral spinal fluid by Manual count
Leukocyte phosphatase [Presence] in Leukocytes
cycloSPORINE [Mass/volume] in Blood by LC/MS/MS
Antimony [Mass/volume] in Serum or Plasma
Mycophenolate [Mass/volume] in Serum or Plasma by LC/MS/MS
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma by LC/MS/MS
11-Deoxycorticosterone [Moles/time] in 24 hour Urine
11-Deoxycortisol [Mass/volume] in Amniotic fluid
18-Hydroxycortisol [Moles/volume] in Serum or Plasma
18-Hydroxycortisol [Moles/time] in 24 hour Urine
18-Hydroxycortisol [Moles/volume] in 24 hour Urine
Alpha aminobutyrate/Amino acids.total in Serum or Plasma
25-hydroxyvitamin D3 [Moles/volume] in Cord blood
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine
3,4-Dihydroxyphenylacetate [Moles/volume] in Urine
Adiponectin.high molecular weight [Mass/volume] in Serum or Plasma
Allo-pregnanediol [Mass/time] in 24 hour Urine
Allo-pregnanediol [Mass/volume] in 24 hour Urine
Allo-tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine
Allo-tetrahydrodeoxycortisol [Mass/volume] in 24 hour Urine
Allo-tetrahydrocorticosterone [Mass/time] in 24 hour Urine
Allo-tetrahydrocorticosterone [Mass/volume] in 24 hour Urine
Allo-tetrahydrocortisol [Mass/volume] in 24 hour Urine
Acid alpha glucosidase [Enzymatic activity/volume] in DBS
Aliphatic carboxylate, C14-C26.esters [Presence] in Stool
Catalase [Enzymatic activity/mass] in Tissue
Catecholamines [Moles/volume] in Cerebral spinal fluid
Catecholamines [Moles/volume] in Body fluid
Cathepsin K [Moles/volume] in Serum or Plasma
Cathepsin L [Mass/volume] in Serum or Plasma
Cathepsin S [Mass/volume] in Serum or Plasma
Vegetable fibers [Presence] in Stool by Light microscopy
Chitotriosidase [Enzymatic activity/volume] in DBS
Chloride [Moles/volume] in 24 hour Stool
Cholesterol/Phospholipid [Molar ratio] in Serum or Plasma
Cholesterol ester transfer protein [Units/volume] in Serum or Plasma
Cholesterol esters [Moles/volume] in Serum or Plasma
Corticosterone [Mass/volume] in 24 hour Urine
Corticosterone [Moles/time] in 24 hour Urine
Corticosterone [Moles/volume] in 24 hour Urine
Cortisol Free [Mass/time] in 24 hour Urine by Radioimmunoassay (RIA)
Cortisol Free [Mass/volume] in 24 hour Urine by Radioimmunoassay (RIA)
Cryoglobulin.IgA.monoclonal [Presence] in Serum
Cryoglobulin.IgG.monoclonal [Presence] in Serum
Cryoglobulin.IgM.monoclonal [Presence] in Serum
Cobalamin (Vitamin B12) [Mass/volume] in Urine
Androstenediol [Moles/volume] in Serum or Plasma
Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine [Molar ratio] in Urine
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Cerebral spinal fluid
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Amniotic fluid
Arsenic [Mass/volume] in Serum or Plasma
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Serum or Plasma
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Urine
Estradiol (E2) [Mass/volume] in Body fluid
Estradiol (E2) [Moles/volume] in Body fluid
Folate [Mass/volume] in Cerebral spinal fluid
Choriogonadotropin.beta subunit free [Mass/volume] in Cerebral spinal fluid
Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid
Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma
Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
Chlamydia sp identified in Throat by Organism specific culture
Choriogonadotropin [Units/volume] in Cord blood
Heptanoylcarnitine (C7) [Moles/volume] in Serum or Plasma
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Serum or Plasma
Palmitate (C16:0)/Laurate (C12:0) [Molar ratio] in Serum or Plasma
Homocitrulline [Moles/volume] in Cerebral spinal fluid
Homocitrulline [Moles/volume] in Serum or Plasma
Homocysteine [Moles/volume] in Body fluid
Homocysteine [Moles/volume] in 24 hour Urine
Homocystine [Moles/volume] in Body fluid
Hydroxocobalamin [Moles/volume] in Serum or Plasma
Hydroxocobalamin [Moles/volume] in Body fluid
Hydroxocobalamin [Mass/volume] in Body fluid
Hydroxocobalamin [Moles/volume] in Urine
3-Hydroxyanthranilate/Creatinine [Molar ratio] in Urine
3-Hydroxyanthranilate [Moles/volume] in Serum or Plasma
3-Hydroxyanthranilate [Moles/time] in 24 hour Urine
3-Hydroxyanthranilate [Moles/volume] in Urine
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Amniotic fluid cells
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Red Blood Cells
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Placenta
Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase [Enzymatic activity ratio] in Chorionic villus sample
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample
Immunoglobulin light chains.free [Presence] in Serum by Immunoelectrophoresis
Immunoglobulin light chains.free [Presence] in Serum by Immunofixation
Immunoglobulin light chains.free [Presence] in Urine by Electrophoresis
Immunoglobulin light chains.free [Presence] in Urine by Immunofixation
IgA.monoclonal [Presence] in Serum by Immunoelectrophoresis
IgA [Mass/volume] in Serum by Electrophoresis
IgD.monoclonal [Presence] in Serum by Immunoelectrophoresis
IgE.monoclonal [Presence] in Serum by Immunoelectrophoresis
Alpha cortol [Mass/volume] in 24 hour Urine
Alpha cortolone [Mass/time] in 24 hour Urine
Alpha cortolone [Mass/volume] in 24 hour Urine
Alpha galactosidase A [Enzymatic activity/volume] in DBS
Alpha-L-iduronidase [Enzymatic activity/volume] in DBS
Alpha mannosidase [Enzymatic activity/volume] in DBS
Arylsulfatase [Enzymatic activity/volume] in DBS
Beta 1 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Beta 2 globulin [Mass/volume] in Cerebral spinal fluid by Electrophoresis
Beta galactosidase [Enzymatic activity/volume] in DBS
Glucosylceramidase [Enzymatic activity/volume] in DBS
C peptide [Mass/volume] in Serum or Plasma --post meal
C peptide [Moles/volume] in Serum or Plasma --post meal
C peptide [Mass/volume] in 24 hour Urine
Benzene [Mass/volume] in Serum or Plasma
IgG.monoclonal [Presence] in Serum by Immunoelectrophoresis
IgG [Mass/volume] in Serum by Electrophoresis
IgM.monoclonal [Presence] in Serum by Immunoelectrophoresis
IgM [Mass/volume] in Serum by Electrophoresis
Interleukin 1 receptor alpha chain [Mass/volume] in Serum or Plasma
Interleukin 1 receptor alpha chain soluble [Mass/volume] in Serum or Plasma
Isovalerylglycine [Moles/volume] in Plasma
Lactate [Moles/volume] in Dialysis fluid
Lipase [Enzymatic activity/volume] in Dialysis fluid
Lysozyme [Mass/volume] in Cerebral spinal fluid
Magnesium [Moles/volume] in Serum or Plasma --post dialysis
Magnesium [Moles/volume] in Total parental nutrition
Malondialdehyde [Moles/mass] in Red Blood Cells
Malonylcarnitine (C3-DC) [Moles/volume] in Serum or Plasma
Methemoglobin/Hemoglobin.total in Cord blood
Neopterin [Moles/volume] in 24 hour Urine
Beryllium [Mass/volume] in Serum or Plasma
Nitrite [Moles/volume] in Serum or Plasma
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Serum or Plasma
Chlamydia sp identified in Urethra by Organism specific culture
Octanoylcarnitine (C8) [Moles/volume] in Urine
Octenoylcarnitine (C8:1)/Creatinine [Molar ratio] in Urine
Octenoylcarnitine (C8:1) [Moles/volume] in Cerebral spinal fluid
Octenoylcarnitine (C8:1) [Moles/volume] in Amniotic fluid
Octenoylcarnitine (C8:1) [Moles/volume] in Urine
Oleoylcarnitine (C18:1)/Creatinine [Molar ratio] in Urine
Oleoylcarnitine (C18:1) [Moles/volume] in Cerebral spinal fluid
Oleoylcarnitine (C18:1) [Moles/volume] in Amniotic fluid
Oleoylcarnitine (C18:1) [Moles/volume] in Urine
Ornithine/Amino acids.total in Serum or Plasma
Palmitoleylcarnitine (C16:1)/Creatinine [Molar ratio] in Urine
Palmitoleylcarnitine (C16:1) [Moles/volume] in Cerebral spinal fluid
Palmitoleylcarnitine (C16:1) [Moles/volume] in Amniotic fluid
Palmitoleylcarnitine (C16:1) [Moles/volume] in Urine
Palmitoylcarnitine (C16) [Moles/volume] in Urine
Bismuth [Mass/volume] in Serum or Plasma
Alkaline phosphatase [Enzymatic activity/volume] in Cord blood
Phosphate [Moles/volume] in Serum or Plasma --post dialysis
Phosphate [Moles/volume] in Peritoneal fluid
IgG [Mass/volume] in Serum by Immune diffusion (ID)
IgG [Mass/volume] in Body fluid by Immune diffusion (ID)
Platelet aggregation ADP induced ATP secretion in Blood --5 umol/L
Platelet aggregation ADP induced ATP secretion [Presence] in Blood --10 umol/L
Platelet aggregation ADP induced ATP secretion [Presence] in Blood --5 umol/L
Platelet aggregation ADP induced in Blood --5 umol/L
Platelet aggregation ADP induced in Blood --10 umol/L
Platelet aggregation arachidonate induced in Blood --500 umol/L
Platelet aggregation collagen induced in Blood --1 ug/mL
Platelet aggregation collagen induced in Blood --5 ug/mL
Platelet aggregation ristocetin induced in Blood --250 ug/mL
Platelet aggregation ADP induced ATP secretion in Blood --10 umol/L
Platelet aggregation arachidonate induced ATP secretion [Presence] in Blood --500 umol/L
Platelet aggregation arachidonate induced ATP secretion in Blood --500 umol/L
Platelet aggregation collagen induced ATP secretion in Blood --5 ug/mL
Platelet aggregation collagen induced ATP secretion in Blood --1 ug/mL
Platelet aggregation collagen induced ATP secretion [Presence] in Blood --1 ug/mL
Platelet aggregation collagen induced ATP secretion [Presence] in Blood --5 ug/mL
Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --5 U/mL
Platelet aggregation thrombin induced ATP secretion in Blood --1 U/mL
Platelet aggregation thrombin induced ATP secretion in Blood --5 U/mL
Platelet aggregation thrombin induced ATP secretion [Presence] in Blood --1 U/mL
ACE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Foot and mouth disease virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Influenza virus A N1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Platelet aggregation ristocetin induced in Blood --1.0 mg/mL
CD3-CD56+ cells/100 cells in Bone marrow
Chlamydia sp identified in Specimen by Organism specific culture
Karyotype [Identifier] in Urine by FISH Narrative
Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Androstenediol [Mass/time] in 24 hour Urine
Hydroxylysine [Moles/volume] in Body fluid
Apolipoprotein A-I/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
Apolipoprotein B/Cholesterol in LDL [Mass Ratio] in Serum or Plasma
Protein phosphatase 3 [Enzymatic activity/volume] in Leukocytes
Beta defensin [Mass/mass] in Stool.dried
Chlamydia sp Ag [Presence] in Specimen by Immunofluorescence
Cellular material [Mass/mass] of Stone by Estimated
Amphetamine+Methamphetamine [Mass/volume] in Urine
Glucose [Mass/volume] in Urine --1 hour post meal
Immunoglobulin light chains.free [Presence] in Serum
CD38 Ag [Presence] in Tissue by Immune stain
Chikungunya virus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Chikungunya virus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Cholesterol in HDL 2a [Moles/volume] in Serum or Plasma
Cholesterol in HDL 2b [Moles/volume] in Serum or Plasma
Cholesterol in IDL 1 [Moles/volume] in Serum or Plasma
Cholesterol in IDL 2 [Moles/volume] in Serum or Plasma
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Anal by Probe with signal amplification
MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method
MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method
Potassium/Creatinine [Molar ratio] in 24 hour Urine
CHIC2 gene 4q12 deletion in Blood or Tissue by FISH
CD55+CD59 deficient RBC+Granulocytes [Interpretation] in Blood Narrative
Parietal cell Ab [Units/volume] in Serum by Immunoassay
Smith extractable nuclear Ab and Ribonucleoprotein extractable nuclear Ab panel - Serum
Beta 2 glycoprotein and Cardiolipin Ab and Phosphatidylserine panel - Serum
Candida albicans IgM Ab [Units/volume] in Serum
Candida albicans IgA Ab [Units/volume] in Serum
Beta 2 glycoprotein 1 Ab IgA and IgG and IgM panel - Serum
Protein.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
Date referral lab test results received in unspecified time Referral lab test
Candida albicans IgA and IgG and IgM Ab panel - Serum
HOXB13 gene/IL17BR gene [Ratio] in Tissue by Molecular genetics method
PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hours post peritoneal dialysis
Calculus analysis with calculus photography [Interpretation] in Stone
CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal
CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal
Gum arabic IgG4 Ab [Mass/volume] in Serum
Corticotropin IgG4 Ab [Mass/volume] in Serum
Alternaria alternata IgG4 Ab [Mass/volume] in Serum
American Beech IgG4 Ab [Mass/volume] in Serum
American Cheese IgG4 Ab [Mass/volume] in Serum
American Cockroach IgG4 Ab [Mass/volume] in Serum
White Elm IgG4 Ab [Mass/volume] in Serum
American Sycamore IgG4 Ab [Mass/volume] in Serum
Artichoke IgG4 Ab [Mass/volume] in Serum
Asparagus IgG4 Ab [Mass/volume] in Serum
Aspergillus fumigatus IgG4 Ab [Mass/volume] in Serum
Aspergillus niger IgG4 Ab [Mass/volume] in Serum
Aspergillus versicolor IgG4 Ab [Mass/volume] in Serum
Australian pine IgG4 Ab [Mass/volume] in Serum
Bahia grass IgG4 Ab [Mass/volume] in Serum
Bermuda grass IgG4 Ab [Mass/volume] in Serum
Bass, Black IgG4 Ab [Mass/volume] in Serum
Black Willow IgG4 Ab [Mass/volume] in Serum
Blackberry IgG4 Ab [Mass/volume] in Serum
Black-eye pea IgG4 Ab [Mass/volume] in Serum
Blueberry IgG4 Ab [Mass/volume] in Serum
Insulin bovine IgG4 Ab [Mass/volume] in Serum
Brazil Nut IgG4 Ab [Mass/volume] in Serum
Brewer's yeast IgG4 Ab [Mass/volume] in Serum
Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Brussel Sprouts IgG4 Ab [Mass/volume] in Serum
Buckwheat IgG4 Ab [Mass/volume] in Serum
Candida albicans IgG4 Ab [Mass/volume] in Serum
Careless Weed IgG4 Ab [Mass/volume] in Serum
Cashew nut IgG4 Ab [Mass/volume] in Serum
Castor Bean IgG4 Ab [Mass/volume] in Serum
Cat dander IgG4 Ab [Mass/volume] in Serum
Cauliflower IgG4 Ab [Mass/volume] in Serum
Acremonium sp IgG4 Ab [Mass/volume] in Serum
Cheese cheddar type IgG4 Ab [Mass/volume] in Serum
Cheese mold type IgG4 Ab [Mass/volume] in Serum
Chick Pea IgG4 Ab [Mass/volume] in Serum
Chromium [Mass/volume] in Red Blood Cells
Chili Pepper IgG4 Ab [Mass/volume] in Serum
Chinese Elm IgG4 Ab [Mass/volume] in Serum
Chocolate IgG4 Ab [Mass/volume] in Serum
Cladosporium herbarum IgG4 Ab [Mass/volume] in Serum
Chromium [Mass/volume] in Serum or Plasma
Cocklebur IgG4 Ab [Mass/volume] in Serum
Common Reed IgG4 Ab [Mass/volume] in Serum
Corn smut IgG4 Ab [Mass/volume] in Serum
Cottonwood IgG4 Ab [Mass/volume] in Serum
Cranberry IgG4 Ab [Mass/volume] in Serum
American house dust mite IgG4 Ab [Mass/volume] in Serum
European house dust mite IgG4 Ab [Mass/volume] in Serum
Dandelion IgG4 Ab [Mass/volume] in Serum
Dog epithelium IgG4 Ab [Mass/volume] in Serum
Dog dander IgG4 Ab [Mass/volume] in Serum
Douglas Fir IgG4 Ab [Mass/volume] in Serum
Duck feather IgG4 Ab [Mass/volume] in Serum
Duck meat IgG4 Ab [Mass/volume] in Serum
Egg white IgG4 Ab [Mass/volume] in Serum
Whole Egg IgG4 Ab [Mass/volume] in Serum
English plantain IgG4 Ab [Mass/volume] in Serum
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG4 Ab [Mass/volume] in Serum
Red Imported Fire Ant IgG4 Ab [Mass/volume] in Serum
Glycyphagus domesticus IgG4 Ab [Mass/volume] in Serum
Cockroach IgG4 Ab [Mass/volume] in Serum
Goat milk IgG4 Ab [Mass/volume] in Serum
Hamster epithelium IgG4 Ab [Mass/volume] in Serum
Goldenrod IgG4 Ab [Mass/volume] in Serum
Goose feather IgG4 Ab [Mass/volume] in Serum
Grapefruit IgG4 Ab [Mass/volume] in Serum
Green Bean IgG4 Ab [Mass/volume] in Serum
Green Pepper IgG4 Ab [Mass/volume] in Serum
Guinea pig epithelium IgG4 Ab [Mass/volume] in Serum
Hazelnut Pollen IgG4 Ab [Mass/volume] in Serum
Honey bee IgG4 Ab [Mass/volume] in Serum
Horseradish IgG4 Ab [Mass/volume] in Serum
Clostridioides difficile [Presence] in Stool by Organism specific culture
House dust Greer IgG4 Ab [Mass/volume] in Serum
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgG4 Ab [Mass/volume] in Serum
Insulin human IgG4 Ab [Mass/volume] in Serum
Italian Cypress IgG4 Ab [Mass/volume] in Serum
Johnson grass IgG4 Ab [Mass/volume] in Serum
Karaya gum IgG4 Ab [Mass/volume] in Serum
Kentucky blue grass IgG4 Ab [Mass/volume] in Serum
Red Kidney Bean IgG4 Ab [Mass/volume] in Serum
Kiwifruit IgG4 Ab [Mass/volume] in Serum
Lepidoglyphus destructor IgG4 Ab [Mass/volume] in Serum
Lactalbumin alpha IgG4 Ab [Mass/volume] in Serum
Beta lactoglobulin IgG4 Ab [Mass/volume] in Serum
Goosefoot IgG4 Ab [Mass/volume] in Serum
Lima Bean IgG4 Ab [Mass/volume] in Serum
Locust tree IgG4 Ab [Mass/volume] in Serum
Maple syrup IgG4 Ab [Mass/volume] in Serum
Rough Marsh Elder IgG4 Ab [Mass/volume] in Serum
Meadow Fescue IgG4 Ab [Mass/volume] in Serum
Meadow Foxtail IgG4 Ab [Mass/volume] in Serum
Cajeput tree IgG4 Ab [Mass/volume] in Serum
Common Millet IgG4 Ab [Mass/volume] in Serum
Aedes mosquito IgG4 Ab [Mass/volume] in Serum
Mountain Juniper IgG4 Ab [Mass/volume] in Serum
Mucor racemosus IgG4 Ab [Mass/volume] in Serum
Blue mussel IgG4 Ab [Mass/volume] in Serum
Nectarine IgG4 Ab [Mass/volume] in Serum
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG4 Ab [Mass/volume] in Serum
Oat pollen IgG4 Ab [Mass/volume] in Serum
Olive Pollen IgG4 Ab [Mass/volume] in Serum
Cocksfoot IgG4 Ab [Mass/volume] in Serum
Ox-eye daisy IgG4 Ab [Mass/volume] in Serum
Papaya (Carica papaya) IgG4 Ab [Mass/volume] in Serum
Paper wasp IgG4 Ab [Mass/volume] in Serum
Parmesan Cheese IgG4 Ab [Mass/volume] in Serum
Parrot feather IgG4 Ab [Mass/volume] in Serum
Pecan or Hickory Nut IgG4 Ab [Mass/volume] in Serum
Pecan or Hickory Tree IgG4 Ab [Mass/volume] in Serum
Penicillium notatum IgG4 Ab [Mass/volume] in Serum
Perennial rye grass IgG4 Ab [Mass/volume] in Serum
Cyanide [Mass/volume] in Serum or Plasma
Pineapple IgG4 Ab [Mass/volume] in Serum
Pinto Bean IgG4 Ab [Mass/volume] in Serum
Pistachio IgG4 Ab [Mass/volume] in Serum
Poppy Seed IgG4 Ab [Mass/volume] in Serum
Insulin porcine IgG4 Ab [Mass/volume] in Serum
Povertyweed IgG4 Ab [Mass/volume] in Serum
Queen Palm IgG4 Ab [Mass/volume] in Serum
Rabbit epithelium IgG4 Ab [Mass/volume] in Serum
False ragweed IgG4 Ab [Mass/volume] in Serum
Clostridioides difficile [Presence] in Specimen by Organism specific culture
Giant Ragweed IgG4 Ab [Mass/volume] in Serum
Common Ragweed IgG4 Ab [Mass/volume] in Serum
Western Ragweed IgG4 Ab [Mass/volume] in Serum
Raspberry IgG4 Ab [Mass/volume] in Serum
Rat epithelium IgG4 Ab [Mass/volume] in Serum
Red Snapper IgG4 Ab [Mass/volume] in Serum
Red top grass IgG4 Ab [Mass/volume] in Serum
Cultivated Rye IgG4 Ab [Mass/volume] in Serum
Safflower IgG4 Ab [Mass/volume] in Serum
Sardine (pilchard) IgG4 Ab [Mass/volume] in Serum
Sesame Seed IgG4 Ab [Mass/volume] in Serum
Sheep Sorrel IgG4 Ab [Mass/volume] in Serum
Spiny Pigweed IgG4 Ab [Mass/volume] in Serum
Strawberry IgG4 Ab [Mass/volume] in Serum
Sugar Cane IgG4 Ab [Mass/volume] in Serum
Sunflower Seed IgG4 Ab [Mass/volume] in Serum
Sweet potato IgG4 Ab [Mass/volume] in Serum
Sweet Vernal grass IgG4 Ab [Mass/volume] in Serum
Swiss Cheese IgG4 Ab [Mass/volume] in Serum
Trichoderma viride IgG4 Ab [Mass/volume] in Serum
Velvet grass IgG4 Ab [Mass/volume] in Serum
Virginia Live Oak IgG4 Ab [Mass/volume] in Serum
Watermelon IgG4 Ab [Mass/volume] in Serum
Western Water Hemp IgG4 Ab [Mass/volume] in Serum
Cultivated Wheat IgG4 Ab [Mass/volume] in Serum
White Ash IgG4 Ab [Mass/volume] in Serum
White Bean IgG4 Ab [Mass/volume] in Serum
White Birch IgG4 Ab [Mass/volume] in Serum
White Hickory IgG4 Ab [Mass/volume] in Serum
Whitefaced Hornet IgG4 Ab [Mass/volume] in Serum
White mulberry IgG4 Ab [Mass/volume] in Serum
White Oak IgG4 Ab [Mass/volume] in Serum
Eastern White Pine IgG4 Ab [Mass/volume] in Serum
White Poplar IgG4 Ab [Mass/volume] in Serum
Whitefish IgG4 Ab [Mass/volume] in Serum
Wine vinegar IgG4 Ab [Mass/volume] in Serum
Ethanol [Mass/volume] in Serum or Plasma
Yellow Hornet IgG4 Ab [Mass/volume] in Serum
Yellow Jacket IgG4 Ab [Mass/volume] in Serum
Chicken feather IgG4 Ab [Mass/volume] in Serum
Chub Mackerel IgG4 Ab [Mass/volume] in Serum
Chloride [Moles/volume] in Sweat by Screen method
Baker's yeast IgG4 Ab [Mass/volume] in Serum
Colony count [#] in Specimen by Visual count
Black Pepper IgG4 Ab [Mass/volume] in Serum
Chymopapain IgG4 Ab [Mass/volume] in Serum
Cottonseed IgG4 Ab [Mass/volume] in Serum
Cow dander IgG4 Ab [Mass/volume] in Serum
Horse dander IgG4 Ab [Mass/volume] in Serum
Pepper tree IgG4 Ab [Mass/volume] in Serum
Red Alder IgG4 Ab [Mass/volume] in Serum
Red Pepper IgG4 Ab [Mass/volume] in Serum
Rough Pigweed IgG4 Ab [Mass/volume] in Serum
Ethylene glycol [Mass/volume] in Serum, Plasma or Blood
Salt grass IgG4 Ab [Mass/volume] in Serum
Swordfish IgG4 Ab [Mass/volume] in Serum
Horse Fly IgG4 Ab [Mass/volume] in Serum
Cardiac heart disease risk [Ratio] in Serum or Plasma
Blasts [#] in Cerebral spinal fluid by Manual count
Direct antiglobulin test.complement C3c specific reagent [Presence] on Red Blood Cells
Nucleated erythrocytes [#] in Specimen by Manual count
Metamyelocytes [#] in Cerebral spinal fluid by Manual count
Salmonella sp antigenic formula [Identifier] in Isolate by Agglutination
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Immunoassay
Ethanol [Mass/volume] in Blood by Gas chromatography
Superoxide dismutase [Enzymatic activity/mass] in Red Blood Cells
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoassay
Lambda light chains.free [Presence] in Urine by Immunofixation
Insulin [Units/volume] in Serum or Plasma --baseline
Taenia solium IgG Ab [Presence] in Serum by Immunoassay
Taenia solium IgG Ab [Units/volume] in Serum by Immunoassay
Androsterone [Mass/volume] in 24 hour Urine
Etiocholanolone [Mass/volume] in 24 hour Urine
Acidity.titratable [Moles/time] in 24 hour Urine
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --2nd specimen
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --3rd specimen
Insulin [Units/volume] in Serum or Plasma --6 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
Lutropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge
Prolactin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
Choriogonadotropin.beta subunit [Units] in 24 hour Urine
Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Fluoride [Mass/volume] in Serum or Plasma
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --6 hours post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --7 hours post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --8 hours post XXX challenge
Corticotropin [Mass/volume] in Plasma --15 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma --45 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma --2 hours post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge
Hepatitis E virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence
Plasmodium falciparum IgG Ab [Presence] in Serum by Immunofluorescence
C peptide [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Colony count [#] in Specimen Qualitative by Visual count
11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
5-Hydroxytryptophan [Mass/volume] in Urine
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post exercise
Vasopressin [Mass/volume] in Plasma --1 hour post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Ma+Ta Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
CV2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Amphiphysin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Asialoglycoprotein receptor Ab [Units/volume] in Serum by Immunoassay
Calcitonin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
8-Dehydrocholesterol [Moles/volume] in Serum or Plasma
Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay
Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay
Intrinsic factor Ab [Units/volume] in Serum by Immunoassay
Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay
Insulin Ab [Units/volume] in Serum by Immunoassay
Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay
PCA-Tr Ab [Titer] in Serum by Immunofluorescence
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --baseline
Microalbumin [Mass/time] in 8 hour Urine
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --baseline
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --10 minutes post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --post exercise
Gold [Mass/volume] in Cerebral spinal fluid
Somatotropin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --30 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --1 hour post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --20 minutes post XXX challenge
Insulin [Units/volume] in Serum or Plasma --12 minutes post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge
Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum
Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Cryptosporidium sp Ag [Presence] in Specimen by Immunofluorescence
European Hornet IgG Ab [Mass/volume] in Serum
Hyaluronate [Mass/volume] in Peritoneal fluid
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --pre XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Elastase Ab [Units/volume] in Serum by Immunoassay
Coxsackievirus A9 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Heavy metals [Presence] in Urine by Reinsch
Echovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Echovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Methylene chloride [Moles/volume] in Blood
Tetrachloroethylene [Moles/volume] in Blood
Procollagen type III [Mass/volume] in Serum
Amikacin [Moles/volume] in Serum or Plasma
Myelin Ab [Titer] in Serum by Immunofluorescence
Heavy metals positive [Identifier] in Urine by Screen method
Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay
Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay
Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence
Myocardium IgG Ab [Titer] in Serum by Immunofluorescence
Nuclear IgG Ab [Titer] in Serum by Immunofluorescence
Thyroglobulin IgG Ab [Units/volume] in Serum
Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence
Mi-2 Ab [Units/volume] in Serum by Immunoassay
Methyl ethyl ketone [Moles/volume] in Urine
Aspartate/Creatinine [Ratio] in 24 hour Urine
Threonine/Creatinine [Ratio] in 24 hour Urine
Serine/Creatinine [Ratio] in 24 hour Urine
Asparagine/Creatinine [Ratio] in 24 hour Urine
Glutamate/Creatinine [Ratio] in 24 hour Urine
Vanillylmandelate/Creatine [Ratio] in 24 hour Urine
Trichloroacetate/Creatinine [Ratio] in Urine
Phenol/Creatinine [Ratio] in 24 hour Urine
Heavy metals negative [Identifier] in Urine by Screen method
Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine
Hippurate/Creatinine [Ratio] in 24 hour Urine
Tetrahydrocortisone [Moles/time] in 24 hour Urine
Delta aminolevulinate/Creatinine [Ratio] in Urine
Para aminophenol/Creatinine [Ratio] in Urine
Methyl formamide/Creatinine [Ratio] in Urine
Myelin basic protein [Mass/volume] in Serum
Beta-2-Microglobulin [Moles/time] in 24 hour Urine
5-Hydroxytryptophan [Moles/time] in 24 hour Urine
Methylmalonate/Creatinine [Ratio] in Urine
Taenia solium IgG Ab [Titer] in Serum by Immunofluorescence
1-Methylhistidine/Creatinine [Ratio] in 24 hour Urine
3-Methylhistidine/Creatinine [Ratio] in 24 hour Urine
Alpha aminoadipate/Creatinine [Ratio] in 24 hour Urine
Adrenal cortex IgG Ab [Units/volume] in Serum
Alanine/Creatinine [Ratio] in 24 hour Urine
Arginine/Creatinine [Ratio] in 24 hour Urine
Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine
Beta alanine/Creatinine [Ratio] in 24 hour Urine
Carnosine/Creatinine [Ratio] in 24 hour Urine
Citrulline/Creatinine [Ratio] in 24 hour Urine
Cystine/Creatinine [Ratio] in 24 hour Urine
Ethanolamine/Creatinine [Ratio] in 24 hour Urine
Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine
Glutamine/Creatinine [Ratio] in 24 hour Urine
Glycine/Creatinine [Ratio] in 24 hour Urine
Homocystine/Creatinine [Ratio] in 24 hour Urine
Histidine/Creatinine [Ratio] in 24 hour Urine
Hydroxylysine/Creatinine [Ratio] in 24 hour Urine
Hydroxyproline Free [Moles/volume] in Serum or Plasma
Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine
Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence
Isopropanol [Presence] in Serum or Plasma
Isoleucine/Creatinine [Ratio] in 24 hour Urine
Insulin [Mass/volume] in Serum or Plasma --16 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge
Insulin [Mass/volume] in Serum or Plasma --1 day post XXX challenge
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
Chicken droppings Ab [Presence] in Serum by Immune diffusion (ID)
Cephalexin IgE Ab [Units/volume] in Serum
Cloxacillin IgE Ab [Units/volume] in Serum
Isopropanol [Mass/volume] in Serum or Plasma
Thiopental IgE Ab [Units/volume] in Serum
Bupivacaine IgE Ab [Units/volume] in Serum
Diclofenac IgE Ab [Units/volume] in Serum
Ciprofloxacin IgE Ab [Units/volume] in Serum
Piroxicam IgE Ab [Units/volume] in Serum
Droperidol IgE Ab [Units/volume] in Serum
Tobramycin IgE Ab [Units/volume] in Serum
Doxycycline IgE Ab [Units/volume] in Serum
Spiramycin IgE Ab [Units/volume] in Serum
metroNIDAZOLE IgE Ab [Units/volume] in Serum
Tartrazine IgE Ab [Units/volume] in Serum
Clarithromycin IgE Ab [Units/volume] in Serum
Sodium benzoate IgE Ab [Units/volume] in Serum
Dexamethasone IgE Ab [Units/volume] in Serum
Dog dander+Dog epithelium IgE Ab [Units/volume] in Serum
Bacteria identified in Contact lens by Culture
Bacteria identified in Pericardial fluid by Culture
Nuclear pore protein gp210 Ab [Presence] in Serum by Immunoblot
Histone Ab [Presence] in Serum by Immunoblot
Islet cell 512 Ab [Units/volume] in Serum by Immunoassay
Liver cytosol Ab [Presence] in Serum by Immunoblot
Ma+Ta Ab [Presence] in Serum by Immunoblot
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot
Soluble liver Ab [Presence] in Serum by Immunoblot
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
Perennial rye grass recombinant profilin IgE Ab [Units/volume] in Serum
Olive recombinant (rOle e) 2 IgE Ab [Units/volume] in Serum
Thermoactinomyces vulgaris IgE Ab [Units/volume] in Serum
Cladosporium cladosporioides IgE Ab [Units/volume] in Serum
Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot
Ribosomal P Ab [Presence] in Serum by Immunoblot
PCNA extractable nuclear Ab [Presence] in Serum by Immunoblot
Centromere protein B Ab [Presence] in Serum by Immunoblot
Mitochondria M2 Ab [Presence] in Serum by Immunoblot
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoblot
Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoblot
Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoblot
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoblot
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoblot
Mi-2 Ab [Presence] in Serum by Immunoblot
PL-7 Ab [Presence] in Serum by Immunoblot
PL-12 Ab [Presence] in Serum by Immunoblot
Azithromycin IgE Ab [Units/volume] in Serum
Norovirus RNA [Presence] in Specimen by NAA with probe detection
Estradiol (E2) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Glucose [Mass/volume] in Serum or Plasma --2.17 hours post XXX challenge
APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PML Ab [Presence] in Serum by Immunoblot
sp100 Ab [Presence] in Serum by Immunoblot
Aldosterone [Mass/volume] in Serum or Plasma --100 minutes post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --100 minutes post XXX challenge
Renin [Enzymatic activity/volume] in Plasma --70 minutes post XXX challenge
Liver kidney microsomal Ab [Presence] in Serum by Immunoblot
Baker's yeast Ab [Titer] in Serum by Immunofluorescence
Oligoclonal Bands IgG [Presence] in Serum or Plasma
Oligoclonal Bands IgM [Interpretation] in Serum or Plasma
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
Oligoclonal Bands IgM [Presence] in Cerebral spinal fluid by Isoelectric focusing
Protein.monoclonal band 1/Protein.total in Serum or Plasma by Electrophoresis
Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis
Protein.monoclonal.beta/Protein.total in Urine by Electrophoresis
Lymphocytes/100 leukocytes in Bronchial specimen by Flow cytometry (FC)
Neutrophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC)
Eosinophils/100 leukocytes in Bronchial specimen by Flow cytometry (FC)
Macrophages/100 leukocytes in Bronchial specimen by Flow cytometry (FC)
CD1a cells/100 cells in Bronchial specimen
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Tissue
Amylase S3+S4/Amylase.total in Serum or Plasma
Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma
Articaine IgE Ab [Units/volume] in Serum
Diphtheria identified in Specimen by Organism specific culture
CYP21A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Epidermal Allergen Mix C (Canary feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk
Amylase S4/Amylase.total in Serum or Plasma
Fibrinogen fragments [Mass/volume] in Urine
Baker's yeast Ab [Units/volume] in Serum
Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum
Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)
Insulin [Units/volume] in Serum or Plasma --28 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --32 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --36 hours post XXX challenge
Entecavir [Susceptibility] by Genotype method
Telbivudine [Susceptibility] by Genotype method
Lysergate diethylamide [Mass/volume] in Urine
Malathion [Mass/volume] in Serum or Plasma
Manganese [Mass/volume] in Red Blood Cells
Manganese [Mass/volume] in Serum or Plasma
Fungus identified in Aspirate by Culture
Mepivacaine IgE Ab [Units/volume] in Serum
Phenylbutazone IgE Ab [Units/volume] in Serum
Mercury [Mass/volume] in Serum or Plasma
TCRB gene+TCRD gene+TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
Rickettsia typhi IgG Ab [Presence] in Serum by Immunofluorescence
Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Units/volume] in Serum
BCHE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Somatotropin [Mass/volume] in Serum or Plasma --160 minutes post exercise
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post exercise
Indirect antiglobulin test.unspecified reagent [Titer] in Serum or Plasma
Mercury [Presence] in Urine by Visual.Reinsch
Myoglobin [Moles/volume] in Serum or Plasma
HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
CD13+HLA-DR+ cells/100 cells in Aspirate
CD13+HLA-DR+ cells/100 cells in Specimen
CD13+HLA-DR+ cells/100 cells in Body fluid
CD13+HLA-DR+ cells/100 cells in Cerebral spinal fluid
CD13+HLA-DR+ cells/100 cells in Bone marrow
CD33+CD34+ cells/100 cells in Bone marrow
CD3-CD56+ cells/100 cells in Cerebral spinal fluid
CD5+FMC7+ cells/100 cells in Bone marrow
Terminal deoxyribonucleotidyl transferase cells/100 cells in Cerebral spinal fluid by Flow cytometry (FC)
Amino acid pattern [Interpretation] in Body fluid
Amylase/Creatinine [Ratio] in 24 hour Urine
Anserine/Creatinine [Ratio] in 24 hour Urine
Bilirubin.direct [Mass/volume] in Pleural fluid
Bilirubin.direct [Mass/volume] in Peritoneal fluid
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Cholesterol [Mass/volume] in Pericardial fluid
Corticotropin [Mass/volume] in Plasma --morning specimen
Corticotropin [Mass/volume] in Plasma --evening specimen
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence
Coxiella burnetii IgM Ab [Units/volume] in Serum by Immunofluorescence --2nd specimen
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen
Entamoeba histolytica Ab [Presence] in Serum by Immunofluorescence
Entamoeba histolytica IgG Ab [Presence] in Serum by Immunoassay
Fasciola hepatica Ab [Presence] in Serum by Immunoassay
Fasciola hepatica Ab [Titer] in Serum by Hemagglutination
Fractional excretion of phosphate [Ratio] in 24 hour Urine and Serum or Plasma
Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose lactulose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose lactulose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hour post dose lactulose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hour post dose lactulose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hour post dose lactose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hour post dose lactulose
Methanol [Mass/volume] in Serum or Plasma
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose glucose
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose lactulose
Hydroxyproline/Creatinine [Ratio] in 24 hour Urine
Fungus identified in Cerebral spinal fluid by Culture
Inhibin B [Mass/volume] in Serum or Plasma by Immunoassay
Insulin [Units/volume] in Serum or Plasma --8 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --64 hour post XXX challenge
Insulin [Units/volume] in Serum or Plasma --68 hour post XXX challenge
Insulin [Units/volume] in Serum or Plasma --3 days post XXX challenge
Insulin [Units/volume] in Serum or Plasma --56 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --2 days post XXX challenge
Insulin [Units/volume] in Serum or Plasma --60 hour post XXX challenge
Insulin [Units/volume] in Serum or Plasma --44 hour post XXX challenge
Insulin [Units/volume] in Serum or Plasma --40 hours post XXX challenge
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Leishmania sp IgG Ab [Presence] in Serum by Immunofluorescence
Leptospira interrogans Ab [Titer] in Serum by Agglutination
Leptospira interrogans IgM Ab [Presence] in Serum by Immunoassay
Leucine/Creatinine [Ratio] in 24 hour Urine
Lysine/Creatinine [Ratio] in 24 hour Urine
Methionine/Creatinine [Ratio] in 24 hour Urine
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Segmented neutrophils/100 leukocytes in Bone marrow by Manual count
Nicotinamide [Mass/volume] in Serum or Plasma
Ovary IgG Ab [Presence] in Serum by Immunofluorescence
Phosphate/Creatinine [Ratio] in 24 hour Urine
Phosphoethanolamine/Creatinine [Ratio] in 24 hour Urine
Plasmodium falciparum Ab [Presence] in Serum by Immunoassay
Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
Paper wasp IgG4 Ab [Units/volume] in Serum
Porphyrins [Mass/volume] in 24 hour Urine
Potassium/Creatinine [Ratio] in 24 hour Urine
Prolactin [Mass/volume] in Serum or Plasma --post precipitation
Proline/Creatinine [Ratio] in 24 hour Urine
Oligoclonal bands [Interpretation] in Serum or Plasma by Isoelectric focusing
Renin [Mass/volume] in Plasma --upright+30 minutes post XXX challenge
Renin [Mass/volume] in Plasma --upright+1 hour post XXX challenge
Rheumatoid arthritis nuclear Ab [Titer] in Serum by Immunofluorescence
Serotonin [Mass/volume] in 24 hour Urine
Sodium [Moles/volume] in Saliva (oral fluid)
Sodium/Creatinine [Ratio] in 24 hour Urine
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post resting
Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post resting
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post resting
Taenia solium larva Ab [Presence] in Serum by Immunoassay
Taurine/Creatinine [Ratio] in 24 hour Urine
Molybdenum [Mass/volume] in Serum or Plasma
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
Trichinella sp IgG Ab [Presence] in Serum by Immunofluorescence
Tryptophan/Creatinine [Ratio] in 24 hour Urine
Tyrosine/Creatinine [Ratio] in 24 hour Urine
Urea/Creatinine [Mass Ratio] in 24 hour Urine
Urea/Creatinine [Mass Ratio] in Serum or Plasma
Valine/Creatinine [Ratio] in 24 hour Urine
European Hornet IgG4 Ab [Units/volume] in Serum
Capreomycin [Susceptibility] by Disk diffusion (KB)
Yellow Jacket IgG4 Ab [Units/volume] in Serum
Yersinia sp IgA Ab [Units/volume] in Serum by Immunoassay
11-Deoxycortisol [Mass/volume] in Serum or Plasma --4 days post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
Glucose/Creatinine [Mass Ratio] in 24 hour Urine
Glutathione [Moles/volume] in Serum or Plasma
Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay
Insulin [Units/volume] in Serum or Plasma --52 hours post XXX challenge
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Nuclear Ab [Presence] in Pleural fluid by Immunoassay
Ornithine/Creatinine [Ratio] in 24 hour Urine
Osteoblasts/100 cells in Bone marrow by Manual
Phosphoserine/Creatinine [Ratio] in 24 hour Urine
Iron/Creatinine [Mass Ratio] in 24 hour Urine
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose lactulose
Urinalysis dipstick W Reflex Culture panel - Urine
Fungus identified in Body fluid by Culture
Urinalysis dipstick W Reflex Microscopic panel - Urine
CBC W Reflex Manual Differential panel - Blood
Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal
Chromosome 13+18+21+X+Y aneuploidy in Blood by Molecular genetics method Nominal
Herpesviruses 6 DNA panel - Specimen by NAA with probe detection
Treponema pallidum Ab [Presence] in Serum by Immunoblot
Alternaria alternata Ab [Presence] in Serum by Immune diffusion (ID)
Penicillium sp Ab [Presence] in Serum by Immune diffusion (ID)
Cow milk Ab [Presence] in Serum by Immune diffusion (ID)
Phadiatop inhalant allergen IgE Ab [Units/volume] in Serum
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by Molecular genetics method Nominal
Chromosome 12 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal
Fatty acid oxidation newborn screen panel
Congenital adrenal hyperplasia newborn screening panel
Eosinophil cationic protein (ECP) [Mass/volume] in Nasal fluid
Paraquat [Mass/volume] in Serum or Plasma
Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Phenol [Mass/volume] adjusted to specific gravity 1.024 in Urine
Follitropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone
Follitropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose gonadotropin releasing hormone
Lutropin [Units/volume] in Serum or Plasma --10 minutes pre dose gonadotropin releasing hormone
Pentachlorophenol [Mass/volume] in Serum or Plasma
Pentachlorophenol [Mass/volume] in Urine
Full newborn screening summary report for display or printing
Newborn screening report - overall interpretation
Newborn conditions with positive markers [Identifier] in DBS
CYP2C19 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Platinum [Mass/volume] in Serum or Plasma
Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma
Polychlorinated biphenyl (PCB) [Mass/volume] in Urine
Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection
HIV 1 RNA tropism [Identifier] in Plasma Narrative
Rubidium [Mass/volume] in Serum or Plasma
Selenium [Mass/volume] in Red Blood Cells
Selenium [Mass/volume] in Serum or Plasma
Fungus identified in Bone marrow by Culture
Chlamydia trachomatis rRNA [Presence] in Anal by NAA with probe detection
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection
Silicate [Mass/volume] in Serum or Plasma
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid)
Benzoylecgonine [Mass/volume] in Saliva (oral fluid)
Temazepam [Mass/volume] in Saliva (oral fluid)
7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid)
Codeine [Mass/volume] in Saliva (oral fluid)
Tropomyosin IgE Ab [Mass/volume] in Serum
CYP11B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PRNP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SRY gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYP11B1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
PRNP gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
SRY gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Sulphonamide IgE Ab [Units/volume] in Serum
Tropomyosin IgE Ab [Units/volume] in Serum
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal
Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal
Trypanosoma cruzi Ab [Presence] in Serum or Plasma by Immunoassay
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Corticotropin [Mass/volume] in Plasma --40 minutes post XXX challenge
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Serum or Plasma by Ion-selective membrane electrode (ISE)
Beta hydroxybutyrate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Chloride [Moles/volume] in 12 hour Urine
Creatinine [Mass/volume] in 2 hour Urine
Creatinine [Mass/volume] in Peritoneal dialysis fluid --overnight
Creatinine [Mass/volume] in 12 hour Urine
Phosphate [Mass/volume] in 12 hour Urine
Glucose [Mass/volume] in Serum or Plasma --1 minute post XXX challenge
Insulin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge
Potassium [Moles/volume] in 12 hour Urine
Lactate [Mass/volume] in Serum or Plasma --1 minute post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --3 minutes post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge
Strontium [Mass/volume] in Serum or Plasma
Lactate [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Lactate [Mass/volume] in Serum or Plasma --pre XXX challenge
Magnesium [Mass/volume] in 12 hour Urine
Microalbumin [Mass/volume] in 12 hour Urine
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay
Strychnine [Presence] in Serum or Plasma
C peptide [Mass/volume] in Serum or Plasma --baseline
Pyruvate [Mass/volume] in Blood --5 minutes post XXX challenge
Porphyrins/Creatinine [Molar ratio] in Urine
Potassium [Moles/volume] in 2 hour Urine
Strychnine [Mass/volume] in Serum or Plasma
Urea [Mass/volume] in 24 hour Peritoneal dialysis fluid
Eosinophils/100 leukocytes in Synovial fluid by Manual count
CD19+CD34+ cells/100 cells in Body fluid
CD19+CD38+ cells/100 cells in Body fluid
CD19+CD56+ cells/100 cells in Body fluid
CD19+CD20+ cells/100 cells in Body fluid
CD22+CD19+ cells/100 cells in Body fluid
CD19+CD23+ cells/100 cells in Body fluid
CD8+CD45RA+ cells/100 cells in Body fluid
CD8+CD45RO+ cells/100 cells in Body fluid
CD3+TCR alpha beta+ cells/100 cells in Body fluid
Actin.filamentous Ab [Units/volume] in Serum or Plasma by Immunoassay
Desmoglein 1 Ab [Units/volume] in Serum by Immunoassay
Desmoglein 3 Ab [Units/volume] in Serum by Immunoassay
Mitochondria Ab [Presence] in Serum by Immunoblot
Reticulin Ab [Presence] in Serum by Immunofluorescence
Baker's yeast IgA Ab [Presence] in Serum by Immunoassay
Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay
CD10+FMC7+ cells/100 cells in Body fluid
CD3+TCR gamma delta+ cells/100 cells in Body fluid
Extractable nuclear Ab [Presence] in Serum by Immunoblot
CD19+Kappa+ cells/100 cells in Body fluid
CD19+Lambda+ cells/100 cells in Body fluid
Liver kidney microsomal 1 Ab [Titer] in Serum by Immunofluorescence
Myeloperoxidase cells [Presence] in Body fluid
Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay
CD56+CD138+ cells/100 cells in Body fluid
CD56-CD138+ cells/100 cells in Body fluid
Terminal deoxyribonucleotidyl transferase cells [Presence] in Body fluid
Fungus identified in Peritoneal fluid by Culture
Platelet Ab [Presence] in Serum by Immunofluorescence
Toxoplasma gondii DNA [Presence] in Body fluid by NAA with probe detection
Spermatozoa Progressive Grade 3/100 spermatozoa in Semen --post concentration
Spermatozoa Progressive Grade 2/100 spermatozoa in Semen --post concentration
Spermatozoa Progressive Grade 1/100 spermatozoa in Semen --post concentration
Spermatozoa Immotile/100 spermatozoa in Semen --post concentration
Thallium [Mass/volume] in Serum or Plasma
Nuclear Ab pattern [Interpretation] in Synovial fluid by Immunofluorescence
Tubular basement membrane Ab [Units/volume] in Serum
CV2 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunoblot
Chromosome 18 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal
Chromosome 13 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal
Taenia solium IgG Ab [Units/volume] in Serum
Spermatozoa Progressive [#/volume] in Semen --post concentration
Neisseria gonorrhoeae rRNA [Presence] in Anal by NAA with probe detection
Activated T cells lymphocytes/100 lymphocytes.small in Bronchoalveolar lavage
Activated T cells lymphocytes/100 lymphocytes.small in Bronchial specimen
Normetanephrine Free [Mass/volume] in Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --12th specimen
Cortisol [Mass/volume] in Serum or Plasma --11th specimen
Cortisol [Mass/volume] in Serum or Plasma --10th specimen
Cortisol [Mass/volume] in Serum or Plasma --9th specimen
Calcitriol [Mass/volume] in Serum or Plasma --pre dose calcium
Calcitriol [Moles/volume] in Serum or Plasma --pre dose calcium
Calcitriol [Moles/volume] in Serum or Plasma --2 hours post dose calcium
Calcitriol [Mass/volume] in Serum or Plasma --2 hours post dose calcium
Calcitriol [Moles/volume] in Serum or Plasma --3 hours post dose calcium
Calcitriol [Mass/volume] in Serum or Plasma --3 hours post dose calcium
Calcitriol [Moles/volume] in Serum or Plasma --1 hour post dose calcium
Calcitriol [Mass/volume] in Serum or Plasma --1 hour post dose calcium
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
11-Ketoandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone
11-Ketoandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
11-Ketoandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose dexamethasone
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone
11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone
11-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose metyraPONE
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre dose metyraPONE
11-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose metyraPONE
11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 day post dose metyraPONE
11-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose metyraPONE
Toluene [Mass/volume] in Serum or Plasma
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post dose metyraPONE
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin
11-Deoxycortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone
11-Hydroxyandrosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --pre dose dexamethasone
11-Hydroxyetiocholanolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
17-Ketogenic steroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone
17-Ketogenic steroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --pre dose dexamethasone
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --pre dose dexamethasone
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1st specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --6th specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --7th specimen post dose gonadotropin releasing hormone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --pre dose dexamethasone
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre dose dexamethasone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 day post dose dexamethasone
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2 days post dose dexamethasone
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Vanadium [Mass/volume] in Red Blood Cells
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
18-Hydroxycortisol [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --pre dose corticotropin
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
Vanadium [Mass/volume] in Serum or Plasma
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone
21-Deoxycortisol [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone
21-Deoxycortisol [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone
25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --pre dose calcium
25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --2 hours post dose calcium
25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --3 hours post dose calcium
25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma --1 hour post dose calcium
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose dexamethasone
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 day post dose dexamethasone
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --2 days post dose dexamethasone
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --pre dose corticotropin
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Androstanolone [Moles/volume] in Serum or Plasma --pre dose corticotropin
Androstanolone [Moles/volume] in Serum or Plasma --30 minutes post dose corticotropin
Androstanolone [Moles/volume] in Serum or Plasma --1 hour post dose corticotropin
Aldosterone [Mass/volume] in Serum or Plasma --post 25 mg captopril PO
Aldosterone [Mass/volume] in Serum or Plasma --post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --pre XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --pre 25 mg captopril PO
Aldosterone [Moles/volume] in Serum or Plasma --2 hours post 25 mg captopril PO
Aldosterone [Moles/volume] in Serum or Plasma --3 hours post 25 mg captopril PO
Aldosterone [Mass/volume] in Serum or Plasma --3 hours post 25 mg captopril PO
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post 25 mg captopril PO
Aldosterone [Moles/volume] in Serum or Plasma --2 hours post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --3 hours post XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --30 minutes pre XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --1 hour post XXX challenge
Dimethylbenzene [Mass/volume] in Serum or Plasma
Aldosterone [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
6-Alpha hydroxytetrahydro-11-Deoxycortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --pre dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre high dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --pre dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --pre dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
Alpha cortol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
Alpha cortol [Mass/time] in 24 hour Urine --pre high dose dexamethasone
Alpha cortol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
Alpha cortol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
Alpha cortol [Mass/volume] in 24 hour Urine --pre dose dexamethasone
Alpha cortol [Mass/time] in 24 hour Urine --pre dose dexamethasone
Alpha cortol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
Alpha cortol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
Alpha cortolone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
Alpha cortolone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
Alpha cortolone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
Alpha cortolone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
Alpha cortolone [Mass/time] in 24 hour Urine --pre dose dexamethasone
Alpha cortolone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
Alpha cortolone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
Androsterone [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
Androsterone [Mass/time] in 24 hour Urine --pre high dose dexamethasone
Androsterone [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
Androsterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
Androsterone [Mass/volume] in 24 hour Urine --pre dose dexamethasone
Androsterone [Mass/time] in 24 hour Urine --pre dose dexamethasone
Androsterone [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
Androsterone [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
C peptide [Moles/volume] in Serum or Plasma --10 minutes pre XXX challenge
C peptide [Moles/volume] in Serum or Plasma --190 minutes post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --3.3 hours post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --5 minutes pre XXX challenge
C peptide [Moles/volume] in Serum or Plasma --1 hour pre XXX challenge
C peptide [Moles/volume] in Serum or Plasma --70 minutes pre XXX challenge
C peptide [Moles/volume] in Serum or Plasma --1.3 hours post XXX challenge
Ganglioside GQ1b IgG Ab [Units/volume] in Serum by Immunoassay
Ammonium urate crystals [Presence] in Urine sediment by Light microscopy
Tubular basement membrane Ab [Titer] in Serum by Immunofluorescence
U1 small nuclear ribonucleoprotein Ab [Units/volume] in Serum by Immunoassay
Norepinephrine [Mass/volume] in Plasma --post XXX challenge
Lactate dehydrogenase [Enzymatic activity/volume] in Semen
Oligoclonal Bands IgG [Presence] in Serum or Plasma by Isoelectric focusing
Oligoclonal Bands IgM [Presence] in Serum or Plasma by Isoelectric focusing
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Brucella melitensis IgG Ab [Units/volume] in Serum by Immunoassay
Brucella melitensis IgM Ab [Units/volume] in Serum by Immunoassay
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2 days post XXX challenge
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --1st specimen
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --2nd specimen
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --1st specimen
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --2nd specimen
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --1st specimen
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --2nd specimen
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen
Plasmodium falciparum IgM Ab [Presence] in Serum by Immunoassay
Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen
Ascorbate [Mass/volume] in Urine by Test strip
Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen
Fungus identified in Synovial fluid by Culture
Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen
Bacteria [#/area] in Urine sediment by Microscopy high power field
Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen
Protein Z Ag [Mass/volume] in Plasma by Immunoassay
Lipid panel with direct LDL - Serum or Plasma
Biotinidase deficiency newborn screening comment-discussion
Hearing loss newborn screening comment/discussion
Infectious diseases newborn screening comment-discussion
Infectious diseases newborn screen interpretation
Bilirubin.total [Presence] in Urine by Test strip
Hemoglobin disorders newborn screening comment-discussion
Galactosemias newborn screening comment-discussion
Congenital hypothyroidism newborn screening comment-discussion
Congenital adrenal hyperplasia newborn screening comment-discussion
Cystic fibrosis newborn screening comment-discussion
Organic acidemias defects newborn screening comment-discussion
Fatty acid oxidation defects newborn screening comment-discussion
Amino acidemias newborn screening comment-discussion
Bilirubin crystals [Presence] in Urine sediment by Light microscopy
Unique bar code number of Initial sample
State printed on filter paper card [Identifier] in NBS card
Conditions tested for in this newborn screening study [Identifier] in DBS
Newborn conditions with equivocal markers [Identifier] in DBS
Unique bar code number of Current sample
Newborn screening short narrative summary
Corticotropin [Mass/volume] in Plasma --20 minutes post XXX challenge
Creatinine [Mass/volume] in 24 hour Peritoneal dialysis fluid
Norolanzapine [Mass/volume] in Serum or Plasma
Lactate [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Calcium carbonate crystals [Presence] in Synovial fluid by Light microscopy
Lactate [Mass/volume] in Serum or Plasma --6 minutes post XXX challenge
Beta-trace protein [Mass/volume] in Body fluid
Ketones [Presence] in Urine by Automated test strip
Protein [Presence] in Urine by Automated test strip
Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy
Basement membrane Ab [Titer] in Serum by Immunofluorescence
Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
Centromere Ab [Presence] in Serum by Immunoblot
CD3+HLA-DR+ cells/100 cells in Body fluid
Lymphocyte proliferation stimulated by OKT3 in Blood
Phadiatop infant IgE Ab [Units/volume] in Serum
ABO group [Type] in Blood by Confirmatory method
Striated muscle Ab [Presence] in Serum by Immunofluorescence
Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy
Adrenal Ab [Presence] in Serum by Immunofluorescence
Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method
Erythrocytes [#/volume] in Urine by Automated test strip
Liver cytosol Ab [Presence] in Serum by Immunoassay
Amphiphysin Ab [Presence] in Serum by Immunoblot
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoblot
Hemoglobin [Presence] in Urine by Automated test strip
Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy
Urea [Mass/volume] in Peritoneal dialysis fluid --overnight
IKBKG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TNFRSF13B gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
WAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Procollagen type III.N-terminal propeptide [Units/volume] in Serum
IKBKG gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
TNFRSF13B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
WAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Calcium sulfate crystals [Presence] in Urine sediment by Light microscopy
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
CD55+CD59 cells [Presence] in Blood by Agglutination
Activated partial thromboplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma/pre addition of normal plasma
Microscopic exam [Interpretation] of Bone marrow by Cytology
Disaccharidases panel - Small intestine Tissue
Histoplasma capsulatum Ag [Mass/volume] in Body fluid
Trimipramine and Nortrimipramine panel - Serum or Plasma
Campylobacter jejuni+Campylobacter coli Ag [Presence] in Stool
Salmonella typhi O Vi Ab [Presence] in Serum
Toxoplasma gondii IgG and IgM panel - Serum
Paraneoplastic Ab [Interpretation] in Serum Narrative
Metanephrine.free and Normetanephrine.free panel [Moles/volume] - Serum or Plasma
Colorado tick fever virus IgG and IgM [Interpretation] in Serum Narrative
Colorado tick fever virus IgG and IgM panel [Titer] - Serum
Valproate.free and Valproate panel - Serum or Plasma
Gliadin peptide IgA and IgG panel - Serum
Myeloperoxidase Ab and Proteinase 3 panel - Serum
Cholesterol crystals [Presence] in Urine sediment by Light microscopy
Immunoglobulin light chains.free panel - Serum
Disaccharidases [Interpretation] in Small intestine Tissue Narrative
Thyroglobulin and Thyroglobulin Ab panel - Serum or Plasma
Chromosome breakage [Identifier] in Blood by Diepoxybutane Narrative
CBC W Ordered Manual Differential panel - Blood
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre high dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --pre dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --pre dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
Organic acidemia conditions suspected [Identifier] in DBS
Fatty acid oxidation conditions suspected [Identifier] in DBS
Amino acidemia disorder suspected [Identifier] in DBS
Crystals [type] in Bile fluid by Light microscopy
Newborn screening test results panel - DBS
Reducing substances [Presence] in Stool by Post hydrolysis
Glucose [Mass/volume] in Stool by Post hydrolysis
Progesterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
Crystals [type] in Duodenal fluid by Light microscopy
Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative
Occult blood panel - Stool by Immunoassay
Number of occult blood specimens recommended by testing kit protocol [#] in Stool
Crystals [type] in Synovial fluid by Light microscopy
Cortisol Free [Mass/volume] in Serum or Plasma --AM peak specimen
Cortisol Free [Mass/volume] in Serum or Plasma --PM trough specimen
Crystals [type] in Urine sediment by Light microscopy
Unidentified crystals [Presence] in Urine sediment by Light microscopy
Basophils/100 leukocytes in Synovial fluid by Manual count
Beta-1 transferrin [Presence] in Body fluid
dRVVT W excess phospholipid (LA confirm)
Activated clotting time.kaolin induced of Platelet poor plasma from Control
Eosinophils/100 leukocytes in Dialysis fluid by Manual count
Erythrocytes [#/volume] in Dialysis fluid by Automated count
Erythrocytes [#/volume] in Pericardial fluid by Automated count
Erythrocytes [#/volume] in Peritoneal fluid by Automated count
Cystine crystals [Presence] in Urine sediment by Light microscopy
Imatinib mesylate [Mass/volume] in Serum or Plasma
Leukocytes [#/volume] in Body fluid by Automated count
Leukocytes [#/volume] in Pericardial fluid by Automated count
Leukocytes [#/volume] in Dialysis fluid by Manual count
Mesothelial cells/100 leukocytes in Synovial fluid by Manual count
Eosinophils [#/area] in Urine sediment by Microscopy high power field
Microscopic observation [Identifier] in Urethra by Wet preparation
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunoassay
Thyrotropin [Units/volume] in Serum or Plasma --5 minutes post XXX challenge
Chlorpheniramine [Moles/volume] in Specimen
Normaprotiline [Moles/volume] in Specimen
Dextromethorphan [Moles/volume] in Specimen
Hydrocortisone [Moles/volume] in Specimen
HYDROmorphone [Moles/volume] in Specimen
PENTobarbital [Moles/volume] in Specimen
Epithelial casts [#/area] in Urine sediment by Microscopy low power field
Phencyclidine [Moles/volume] in Specimen
Phenylpropanolamine [Moles/volume] in Specimen
Cantaloupe triggered histamine release [Units/volume] in Blood
Cantaloupe IgG4 Ab [Mass/volume] in Serum
Honeydew melon IgG4 Ab [Mass/volume] in Serum
Epithelial cells [#/area] in Urine sediment by Microscopy high power field
Cantaloupe IgG Ab [Units/volume] in Serum
Honeydew melon IgG Ab [Units/volume] in Serum
Cantaloupe IgE Ab [Units/volume] in Serum
Honeydew melon IgE Ab [Units/volume] in Serum
Oval fat bodies (globules) [#/area] in Urine sediment by Microscopy high power field
Honeydew melon triggered histamine release [Units/volume] in Blood
Pregnanediol [Mass/volume] in 24 hour Urine --pre high dose dexamethasone
Pregnanediol [Mass/time] in 24 hour Urine --pre high dose dexamethasone
Pregnanediol [Mass/volume] in 24 hour Urine --2 days post high dose dexamethasone
Pregnanediol [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
Pregnanediol [Mass/volume] in 24 hour Urine --pre dose dexamethasone
Pregnanediol [Mass/time] in 24 hour Urine --pre dose dexamethasone
Pregnanediol [Mass/volume] in 24 hour Urine --2 days post dose dexamethasone
Fatty casts [#/area] in Urine sediment by Microscopy low power field
Pregnanediol [Mass/time] in 24 hour Urine --2 days post dose dexamethasone
C peptide [Moles/volume] in Serum or Plasma --100 minutes post XXX challenge
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method
Triiodothyronine (T3)/Triiodothyronine (T3).reverse [Ratio] in Serum or Plasma
Fungi.filamentous [#/area] in Urine sediment by Microscopy high power field
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool
Bg sup(a) Ab [Presence] in Serum or Plasma
Bg sup(a) Ag [Presence] on Red Blood Cells
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen
9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal
Atazanavir+Ritonavir [Susceptibility] by Phenotype method
AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Bartonella quintana DNA [Presence] in Specimen by NAA with probe detection
Basement membrane zone BP230 Ab [Units/volume] in Serum or Plasma
Beta lactoglobulin IgE Ab/IgE total in Serum
Borrelia burgdorferi C6 Ab [Presence] in Serum
Budgerigar droppings IgG Ab [Units/volume] in Serum
CACNA1S+SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field
Calcium [Mass/volume] in Nonbiological fluid
Carbon dioxide, total [Moles/volume] in Mixed venous blood by calculation
Carbon dioxide, total [Moles/volume] in Arterial cord blood by calculation
Carbon dioxide, total [Moles/volume] in Serum or Plasma by calculation
Carbon dioxide, total [Moles/volume] in Venous cord blood by calculation
Carboxy tetrahydrocannabinol [Presence] in Meconium
Glucose [Mass/volume] in Urine by Test strip
CDKN2A+CDK4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CFTR gene p.Asp1152His [Presence] in Blood or Tissue by Molecular genetics method
CFTR+PRSS1+SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cheese cheddar type IgE Ab/IgE total in Serum
Cheese mold type IgE Ab/IgE total in Serum
Chikungunya virus IgM Ab [Presence] in Serum or Plasma
Granular casts [#/area] in Urine sediment by Microscopy low power field
Cholesterol in HDL 2a [Mass/volume] in Serum or Plasma
Cholesterol in HDL 3a [Mass/volume] in Serum or Plasma
Chromium [Mass/volume] in Cerebral spinal fluid
Cladosporium sp IgG4 Ab [Mass/volume] in Serum
Hemoglobin [Presence] in Urine by Test strip
Cobalt [Mass/volume] in Cerebral spinal fluid
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Complement fixation
Collagen crosslinked C-telopeptide [Mass/volume] in 24 hour Urine
Complement C4c [Mass/volume] in Serum or Plasma
Hippurate crystals [Presence] in Urine sediment by Light microscopy
CPVT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Honeydew melon IgE Ab/IgE total in Serum
Darunavir [Mass/volume] in Serum or Plasma
Darunavir+Ritonavir [Susceptibility] by Phenotype method
Desoxymethyltestosterone [Presence] in Urine
Difenacoum [Mass/volume] in Serum or Plasma
DPYD2A gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
Erythrocytes [Morphology] in Body fluid by Light microscopy
Etravirine [Mass/volume] in Serum or Plasma
FECH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FLCN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Formebolone metabolite [Presence] in Urine
Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method
Furazabol metabolite [Presence] in Urine
Hyaline casts [#/area] in Urine sediment by Microscopy low power field
Ganglioside GD1a IgG Ab [Presence] in Serum
Ganglioside GD1a IgM Ab [Presence] in Serum
Glucose [Mass/volume] in Urine --3 hours post 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --4th specimen post lactose
Glucose [Mass/volume] in Serum or Plasma --5th specimen post lactose
Histoplasma capsulatum IgM Ab [Presence] in Cerebral spinal fluid
HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Ketones [Mass/volume] in Urine by Test strip
HIV 2 gp140 Ab [Presence] in Serum by Immunoblot
HIV 2 p16 Ab [Presence] in Serum by Immunoblot
HIV 2 p34 Ab [Presence] in Serum by Immunoblot
IDUA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Leucine crystals [Presence] in Urine sediment by Light microscopy
Indinavir+Ritonavir [Susceptibility] by Phenotype method
Influenza virus A H2 RNA [Presence] in Specimen by NAA with probe detection
Insulin-like growth factor [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Iron [Mass/volume] in Cerebral spinal fluid
KRIT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Leukocyte esterase [Presence] in Urine by Test strip
Legionella pneumophila 1+3+4+5+6+8 Ab [Presence] in Serum
Lepidoglyphus destructor IgE Ab/IgE total in Serum
Leucine/Phenylalanine [Mass Ratio] in DBS
Lopinavir+Ritonavir [Susceptibility] by Phenotype method
Magnesium [Mass/volume] in Nonbiological fluid
Manganese [Mass/volume] in Cerebral spinal fluid
Matrix metallopeptidase 9 [Mass/volume] in Blood
Mestanolone metabolite [Presence] in Urine
Methylandrostenediol [Presence] in Urine
Methylnortestosterone [Presence] in Urine
Lipids [#/area] in Urine sediment by Microscopy high power field
MPL gene p.Trp515 [Presence] in Blood or Tissue by Molecular genetics method
Fungus identified in Specimen by Culture
MSH2 gene+MLH1 gene+MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Myelin IgG Ab [Presence] in Serum by Immunofluorescence
Octreotide [Mass/volume] in Serum or Plasma
Phosphate [Mass/volume] in Nonbiological fluid
PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Rabies virus IgG Ab [Units/volume] in Serum
Nitrite [Presence] in Urine by Test strip
Saquinavir+Ritonavir [Susceptibility] by Phenotype method
Cultivated Rye IgE Ab/IgE total in Serum
Selenium [Mass/volume] in Nonbiological fluid
Tetrahydrogestrinone [Presence] in Urine
Tipranavir+Ritonavir [Susceptibility] by Phenotype method
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid
Bermuda grass smut IgE Ab/IgE total in Serum
Zinc [Mass/volume] in Cerebral spinal fluid
HLA-B SBT [Type] in Bone marrow by High resolution
Protein [Mass/volume] in Urine by Test strip
Phencyclidine [Presence] in Blood by Confirmatory method
American Sycamore IgE Ab/IgE total in Serum
RYR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Strongyloides stercoralis Ab [Titer] in Serum
Tetrahydrocannabinol [Presence] in Blood by Confirmatory method
Ch sup(a) Ag [Presence] on Red Blood Cells
Ch sup(a) Ab [Presence] in Serum or Plasma
Co sup(a) Ag [Presence] on Red Blood Cells
Co sup(b) Ag [Presence] on Red Blood Cells
Pyrophosphate crystals [Presence] in Synovial fluid by Light microscopy
Cs sup(a) Ab [Presence] in Serum or Plasma
Cs sup(a) Ag [Presence] in Serum or Plasma
Do sup(b) Ab [Presence] in Serum or Plasma
Do sup(b) Ag [Presence] on Red Blood Cells
Go sup(a) Ab [Presence] in Serum or Plasma
In sup (b) Ag [Presence] on Red Blood Cells
In sup (b) Ab [Presence] in Serum or Plasma
Jr sup(a) Ag [Presence] on Red Blood Cells
Pyrophosphate crystals [Presence] in Urine sediment by Light microscopy
Jr sup(a) Ab [Presence] in Serum or Plasma
Kn sup(a) Ag [Presence] on Red Blood Cells
Kn sup(a) Ab [Presence] in Serum or Plasma
Kn sup (b) Ab [Presence] in Serum or Plasma
Kn sup (b) Ag [Presence] on Red Blood Cells
McC sup(a) Ab [Presence] in Serum or Plasma
Rg sup(a) Ag [Presence] on Red Blood Cells
Rg sup(a) Ab [Presence] in Serum or Plasma
RBC casts [#/area] in Urine sediment by Microscopy low power field
Wr sup(a) Ag [Presence] on Red Blood Cells
Wr sup(a) Ab [Presence] in Serum or Plasma
Yk sup(a) Ag [Presence] on Red Blood Cells
Yk sup(a) Ab [Presence] in Serum or Plasma
Urinalysis complete W Reflex Culture panel - Urine
Penicillin Parenteral [Susceptibility] for meningitis
Erythrocytes [#/volume] in Urine sediment by Microscopy high power field
Acylcarnitine newborn screen interpretation
Glucose-6-Phosphate dehydrogenase newborn screen interpretation
Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion
Glucose-6-Phosphate dehydrogenase newborn screen panel
Acylcarnitine newborn screening comment-discussion
Specific gravity of Urine by Refractometry
Sulfonamide crystals [Presence] in Urine sediment by Light microscopy
Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy
Triple phosphate crystals [Presence] in Urine sediment by Light microscopy
Tyrosine crystals [Presence] in Urine sediment by Light microscopy
Urate crystals [Presence] in Synovial fluid by Light microscopy
Urate crystals [Presence] in Urine sediment by Light microscopy
Urobilinogen [Presence] in Urine by Test strip
Streptococcus agalactiae [Presence] in Cervix by Organism specific culture
Waxy casts [#/area] in Urine sediment by Microscopy low power field
WBC casts [#/area] in Urine sediment by Microscopy low power field
Leukocytes [#/area] in Urine sediment by Microscopy high power field
Yeast [#/area] in Urine sediment by Microscopy high power field
Adenovirus Ag [Presence] in Conjunctival specimen by Immunoassay
Maple syrup urine disease newborn screening comment-discussion
Phenylketonuria and variants/Biopterin defects newborn screening comment-discussion
Adenovirus Ag [Presence] in Conjunctival specimen by Immunofluorescence
Adenovirus Ag [Presence] in Stool by Immunoassay
Adenovirus Ag [Presence] in Stool by Immunofluorescence
Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture
Adenovirus Ag [Presence] in Throat by Immunoassay
Adenovirus Ag [Presence] in Throat by Immunofluorescence
Adenovirus Ag [Presence] in Tissue by Immunoassay
Adenovirus Ag [Presence] in Tissue by Immunofluorescence
Adenovirus Ag [Presence] in Urine by Immunoassay
Adenovirus Ag [Presence] in Urine by Immunofluorescence
Adenovirus Ag [Presence] in Specimen by Immunoassay
Adenovirus Ag [Presence] in Specimen by Immunofluorescence
MethylePHEDrine [Mass/volume] in Serum or Plasma by Confirmatory method
Streptococcus agalactiae [Presence] in Genital lochia by Organism specific culture
Plasma cells immature/100 cells in Blood
Connective tissue growth factor [Mass/volume] in Urine
Connective tissue growth factor [Moles/volume] in Urine
Human antihuman Ab [Mass/volume] in Plasma
Cytomegalovirus [Presence] in Blood by Organism specific culture
Human antihuman Ab [Moles/volume] in Plasma
Plasma cells immature [#/volume] in Blood
Ethanol/Creatinine [Mass Ratio] in Urine
Amphetamine/Creatinine [Mass Ratio] in Urine
Methamphetamine/Creatinine [Mass Ratio] in Urine
Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method
Buprenorphine/Creatinine [Mass Ratio] in Urine
Norbuprenorphine/Creatinine [Mass Ratio] in Urine
Cytomegalovirus [Presence] in Tissue by Organism specific culture
Norbuprenorphine [Presence] in Urine by Confirmatory method
Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine
7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine
7-Aminoclonazepam [Presence] in Urine by Confirmatory method
LORazepam/Creatinine [Mass Ratio] in Urine
Nordiazepam/Creatinine [Mass Ratio] in Urine
Oxazepam/Creatinine [Mass Ratio] in Urine
Temazepam/Creatinine [Mass Ratio] in Urine
Cytomegalovirus [Presence] in Urine by Organism specific culture
Carisoprodol+Meprobamate [Presence] in Urine by Screen method
Carisoprodol/Creatinine [Mass Ratio] in Urine
Meprobamate/Creatinine [Mass Ratio] in Urine
Meprobamate [Presence] in Urine by Confirmatory method
Meprobamate [Mass/volume] in Urine by Confirmatory method
Ethyl glucuronide [Presence] in Urine by Screen method
Ethyl glucuronide/Creatinine [Mass Ratio] in Urine
Ethyl glucuronide [Presence] in Urine by Confirmatory method
Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method
fentaNYL+Norfentanyl [Presence] in Urine by Screen method
fentaNYL/Creatinine [Mass Ratio] in Urine
fentaNYL [Mass/volume] in Urine by Confirmatory method
Norfentanyl/Creatinine [Mass Ratio] in Urine
Norfentanyl [Mass/volume] in Urine by Confirmatory method
6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine
Meperidine+Normeperidine [Presence] in Urine by Screen method
Meperidine/Creatinine [Mass Ratio] in Urine
Normeperidine/Creatinine [Mass Ratio] in Urine
Cytomegalovirus [Presence] in Specimen by Organism specific culture
Normeperidine [Presence] in Urine by Confirmatory method
Normeperidine [Mass/volume] in Urine by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine
Codeine/Creatinine [Mass Ratio] in Urine
Morphine/Creatinine [Mass Ratio] in Urine
HYDROcodone/Creatinine [Mass Ratio] in Urine
HYDROmorphone/Creatinine [Mass Ratio] in Urine
oxyCODONE/Creatinine [Mass Ratio] in Urine
Enterovirus identified in Cerebral spinal fluid by Organism specific culture
oxyMORphone/Creatinine [Mass Ratio] in Urine
Phencyclidine/Creatinine [Mass Ratio] in Urine
Propoxyphene/Creatinine [Mass Ratio] in Urine
Norpropoxyphene/Creatinine [Mass Ratio] in Urine
Tapentadol [Presence] in Urine by Confirmatory method
Tapentadol [Mass/volume] in Urine by Confirmatory method
Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine
Enterovirus identified in Isolate by Immunofluorescence
traMADol/Creatinine [Mass Ratio] in Urine
Hepatitis B virus surface Ab Signal/Cutoff in Serum
Other cells/100 leukocytes in Blood by Automated count
Clinical research drug XXX [Mass/volume] in Plasma
Enterovirus identified in Isolate by Neutralization test
Cefepime [Susceptibility] for meningitis by Disk diffusion (KB)
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Automated count
Herpes simplex virus 1+2 DNA [Presence] in Amniotic fluid by NAA with probe detection
BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method
Micafungin [Mass/volume] in Serum or Plasma
Caspofungin [Mass/volume] in Serum or Plasma
Enterovirus identified in Stool by Organism specific culture
Anidulafungin [Mass/volume] in Serum or Plasma
Ethyl sulfate/Creatinine [Mass Ratio] in Urine
Ethyl sulfate [Presence] in Urine by Screen method
Ethyl sulfate [Mass/volume] in Urine by Confirmatory method
Carisoprodol [Presence] in Urine by Confirmatory method
Carisoprodol [Mass/volume] in Urine by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
oxyCODONE+oxyMORphone [Presence] in Urine by Screen method
Casts [Type] in Urine sediment by Light microscopy
Microorganisms seen [Type] in Urine sediment by Light microscopy
Enterovirus identified in Specimen by Organism specific culture
Cells [Type] in Urine sediment by Light microscopy
Clinical research drug XXX [Mass/volume] in Urine
Classical swine fever virus E2 Ab [Units/volume] in Serum by Immunoassay
Other elements [Identifier] in Urine sediment by Light microscopy
Other cells [#/volume] in Blood by Automated count
Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
Manual differential comment [Interpretation] in Blood Narrative
Herpes simplex virus 1 Ag [Presence] in Genital specimen by Immunofluorescence
Creatinine 24H renal clearance adjusted for body surface area panel
Microalbumin/Creatinine panel in 24H Urine
Microalbumin ug/min [Mass/time] in 24 hour Urine
Erythrocyte clumps [#/area] in Urine sediment by Microscopy high power field
Bilirubin [Presence] in Urine by Confirmatory method
Glutamate decarboxylase 65 Ab [Mass/volume] in Serum
Hepatitis B virus surface Ag [Units/volume] in Serum
Herpes simplex virus 1 Ag [Presence] in Skin by Immunofluorescence
Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay
Subtelomere analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Taenia solium Ab [Presence] in Cerebral spinal fluid by Immunoassay
Bladder cells [Presence] in Urine sediment by Light microscopy
Sulfites [Presence] in Urine by Test strip
Mitochondria Ab pattern [Interpretation] in Serum by Immunofluorescence
Ganglioside GT1b Ab [Presence] in Serum by Immunofluorescence
Endothelial cell Ab [Titer] in Serum or Plasma
Herpes simplex virus 1 Ag [Presence] in Specimen by Immunofluorescence
Intestinal goblet cell Ab [Titer] in Serum
Complement functional activity [Units/volume] in Serum or Plasma by Immunoassay
Tau protein/Protein.total in Cerebral spinal fluid
Campesterol [Moles/volume] in Serum or Plasma
DNA double strand IgG Ab [Presence] in Serum by Immunoassay
DNA double strand IgG Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae
Horse Bot Fly IgG4 Ab [Mass/volume] in Serum
Nucleated cells [#/volume] in Cerebral spinal fluid
Erythrocytes.pitted/Erythrocytes.total in Red Blood Cells
Other cells [#] in Body fluid by Manual count
Haemophilus influenzae serotype DNA [Identifier] in Specimen by NAA with probe detection
Herpes simplex virus 2 Ag [Presence] in Genital specimen by Immunofluorescence
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --7th specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --6th specimen fasting
Protein C Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay
Protein S Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by Immunoassay
BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --8th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --baseline
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --7th specimen post XXX challenge
Herpes simplex virus 2 Ag [Presence] in Skin by Immunofluorescence
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --6th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --5th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --4th specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --3rd specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --2nd specimen post XXX challenge
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method --1st specimen post XXX challenge
Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post dose glucose
Herpes simplex virus 2 Ag [Presence] in Specimen by Immunofluorescence
C peptide [Moles/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV
C peptide [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV
Streptococcus agalactiae [Presence] in Throat by Organism specific culture
C peptide [Mass/volume] in Serum or Plasma --15 minutes post dose glucose
C peptide [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge
C peptide [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge
Herpes simplex virus Ag [Presence] in Genital specimen by Immunoassay
C peptide [Mass/volume] in Serum or Plasma --1 hour post dose glucose
C peptide [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --2.5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --2 minutes post 1 mg glucagon IV
C peptide [Mass/volume] in Serum or Plasma --3.5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --3.5 hours post dose glucose
C peptide [Mass/volume] in Serum or Plasma --30 minutes post dose glucose
Herpes simplex virus Ag [Presence] in Genital specimen by Immunofluorescence
C peptide [Mass/volume] in Serum or Plasma --3 hours post dose glucose
C peptide [Mass/volume] in Serum or Plasma --4.5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --4.5 hours post dose glucose
C peptide [Mass/volume] in Serum or Plasma --45 minutes post dose glucose
C peptide [Moles/volume] in Serum or Plasma --45 minutes post dose glucose
C peptide [Mass/volume] in Serum or Plasma --4 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --4 hours post dose glucose
C peptide [Mass/volume] in Serum or Plasma --5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --5 hours post dose glucose
C peptide [Moles/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV
C peptide [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
C peptide [Mass/volume] in Serum or Plasma --pre dose glucose
Corticosterone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin
Corticosterone [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin
Corticosterone [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucagon
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucagon
Corticotropin [Mass/volume] in Plasma --1.5 hours post dose glucose
Herpes simplex virus Ag [Presence] in Skin by Immunoassay
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose glucose
Corticotropin [Moles/volume] in Plasma --1.5 hours post 1 ug/kg CRH IV
Corticotropin [Moles/volume] in Plasma --1.5 hours post dose insulin IV
Corticotropin [Mass/volume] in Plasma --10 AM specimen
Corticotropin [Moles/volume] in Plasma --10 AM specimen
Corticotropin [Mass/volume] in Plasma --10 PM specimen
Corticotropin [Moles/volume] in Plasma --10 PM specimen
Corticotropin [Mass/volume] in Plasma --105 minutes post dose insulin IV
Herpes simplex virus Ag [Presence] in Skin by Immunofluorescence
Corticotropin [Moles/volume] in Plasma --105 minutes post dose insulin IV
Corticotropin [Mass/volume] in Plasma --10th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --10th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --11th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --11th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --12 AM specimen
Corticotropin [Moles/volume] in Plasma --12 PM specimen
Corticotropin [Mass/volume] in Plasma --12th specimen post XXX challenge
Herpes simplex virus Ag [Presence] in Specimen by Immunoassay
Corticotropin [Moles/volume] in Plasma --12th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --15 minutes post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --15 minutes post dose insulin IV
Corticotropin [Moles/volume] in Plasma --15 minutes post dose insulin IV
Corticotropin [Moles/volume] in Plasma --15 minutes post XXX challenge
Corticotropin [Moles/volume] in Plasma --15 minutes pre 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --15 minutes pre dose insulin IV
Herpes simplex virus Ag [Presence] in Specimen by Immunofluorescence
Corticotropin [Moles/volume] in Plasma --15 minutes pre dose insulin IV
Corticotropin [Moles/volume] in Plasma --1 hour post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --1 hour post dose glucagon
Corticotropin [Moles/volume] in Plasma --1 hour post dose glucagon
Corticotropin [Mass/volume] in Plasma --1 hour post dose glucose
Corticotropin [Moles/volume] in Plasma --1 hour post dose glucose
Corticotropin [Moles/volume] in Plasma --1 hour post dose insulin IV
Corticotropin [Moles/volume] in Plasma --1 hour post XXX challenge
Herpes simplex virus identified in Genital specimen by Organism specific culture
Corticotropin [Moles/volume] in Plasma --1st specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --2 PM specimen
Corticotropin [Moles/volume] in Plasma --2 PM specimen
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucagon
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucagon
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose insulin IV
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose insulin IV
Corticotropin [Mass/volume] in Plasma --2.5 hours post dose glucose
Corticotropin [Moles/volume] in Plasma --2.5 hours post dose glucose
Corticotropin [Mass/volume] in Plasma --1 day post dose metyraPONE
Corticotropin [Moles/volume] in Plasma --1 day post dose metyraPONE
Corticotropin [Moles/volume] in Plasma --2 hours post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --2 hours post dose glucagon
Corticotropin [Moles/volume] in Plasma --2 hours post dose glucagon
Corticotropin [Mass/volume] in Plasma --2 hours post dose glucose
Corticotropin [Moles/volume] in Plasma --2 hours post dose glucose
Corticotropin [Mass/volume] in Plasma --2 hours post dose insulin IV
Corticotropin [Moles/volume] in Plasma --2 hours post dose insulin IV
Herpes simplex virus identified in Isolate by Immunofluorescence
Corticotropin [Moles/volume] in Plasma --2 hours post XXX challenge
Corticotropin [Moles/volume] in Plasma --2nd specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --30 minutes post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucagon
Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucagon
Corticotropin [Mass/volume] in Plasma --30 minutes post dose glucose
Corticotropin [Moles/volume] in Plasma --30 minutes post dose glucose
Corticotropin [Moles/volume] in Plasma --30 minutes post dose insulin IV
Herpes simplex virus identified in Skin by Organism specific culture
Corticotropin [Moles/volume] in Plasma --30 minutes post XXX challenge
Corticotropin [Mass/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV
Corticotropin [Moles/volume] in Plasma --30 minutes pre 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --30 minutes pre dose glucagon
Corticotropin [Moles/volume] in Plasma --30 minutes pre dose glucagon
Corticotropin [Moles/volume] in Plasma --30 minutes pre dose insulin IV
Corticotropin [Mass/volume] in Plasma --30 minutes pre XXX challenge
Corticotropin [Moles/volume] in Plasma --30 minutes pre XXX challenge
Herpes simplex virus identified in Specimen by Organism specific culture
Corticotropin [Mass/volume] in Plasma --3 hours post dose glucagon
Corticotropin [Moles/volume] in Plasma --3 hours post dose glucagon
Corticotropin [Mass/volume] in Plasma --3 hours post dose glucose
Corticotropin [Moles/volume] in Plasma --3 hours post dose glucose
Corticotropin [Mass/volume] in Plasma --3 hours post dose insulin IV
Corticotropin [Moles/volume] in Plasma --3 hours post dose insulin IV
Corticotropin [Mass/volume] in Plasma --3 hours post XXX challenge
Corticotropin [Moles/volume] in Plasma --3 hours post XXX challenge
Influenza virus A Ag [Presence] in Throat by Immunoassay
Corticotropin [Moles/volume] in Plasma --3rd specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --4 AM specimen
Corticotropin [Moles/volume] in Plasma --4 PM specimen
Corticotropin [Moles/volume] in Plasma --45 minutes post 1 ug/kg CRH IV
Corticotropin [Moles/volume] in Plasma --45 minutes post dose insulin IV
Corticotropin [Moles/volume] in Plasma --2 days post dose metyraPONE
Corticotropin [Moles/volume] in Plasma --4th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --5th specimen post XXX challenge
Influenza virus A Ag [Presence] in Throat by Immunofluorescence
Corticotropin [Moles/volume] in Plasma --6 PM specimen
Corticotropin [Moles/volume] in Plasma --6th specimen post XXX challenge
Corticotropin [Mass/volume] in Plasma --75 minutes post dose insulin IV
Corticotropin [Moles/volume] in Plasma --75 minutes post dose insulin IV
Corticotropin [Moles/volume] in Plasma --7th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --8 AM specimen
Corticotropin [Moles/volume] in Plasma --8 PM specimen
Corticotropin [Moles/volume] in Plasma --8th specimen post XXX challenge
Corticotropin [Moles/volume] in Plasma --post dose dexamethasone
Corticotropin [Moles/volume] in Plasma --pre 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --pre dose dexamethasone
Corticotropin [Moles/volume] in Plasma --pre dose dexamethasone
Corticotropin [Mass/volume] in Plasma --pre dose glucagon
Corticotropin [Moles/volume] in Plasma --pre dose glucagon
Corticotropin [Mass/volume] in Plasma --pre dose glucose
Corticotropin [Moles/volume] in Plasma --pre dose glucose
Corticotropin [Moles/volume] in Plasma --pre dose insulin IV
Corticotropin [Mass/volume] in Plasma --pre dose metyraPONE
Influenza virus A Ag [Presence] in Specimen by Immunoassay
Corticotropin [Moles/volume] in Plasma --pre dose metyraPONE
Corticotropin [Mass/volume] in Plasma --pre XXX challenge
Corticotropin [Moles/volume] in Plasma --pre XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --1.5 hours post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --10 AM specimen
Cortisol [Moles/volume] in Serum or Plasma --10 AM specimen
Cortisol [Mass/volume] in Serum or Plasma --10 PM specimen
Influenza virus A Ag [Presence] in Specimen by Immunofluorescence
Cortisol [Moles/volume] in Serum or Plasma --10 PM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --10th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --10th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --11th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --11th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --12 AM specimen
Cortisol [Moles/volume] in Saliva (oral fluid) --12 AM specimen
Influenza virus B Ag [Presence] in Throat by Immunoassay
Cortisol [Mass/volume] in Saliva (oral fluid) --12 PM specimen
Cortisol [Moles/volume] in Saliva (oral fluid) --12 PM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --12th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --12th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV
Influenza virus B Ag [Presence] in Throat by Immunofluorescence
Cortisol [Moles/volume] in Saliva (oral fluid) --15 minutes pre 1 ug/kg CRH IV
Cortisol [Mass/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --1 hour post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --1st specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --2 PM specimen
Cortisol [Moles/volume] in Serum or Plasma --2 PM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --2 hours post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --2 hours post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --30 minutes pre 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --30 minutes pre 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --4 AM specimen
Cortisol [Moles/volume] in Saliva (oral fluid) --4 AM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --4 PM specimen
Influenza virus B Ag [Presence] in Specimen by Immunoassay
Cortisol [Moles/volume] in Saliva (oral fluid) --4 PM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --45 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --4th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --8 AM specimen
Cortisol [Moles/volume] in Saliva (oral fluid) --8 AM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --8 PM specimen
Influenza virus B Ag [Presence] in Specimen by Immunofluorescence
Cortisol [Moles/volume] in Saliva (oral fluid) --8 PM specimen
Cortisol [Mass/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV
Cortisol [Moles/volume] in Saliva (oral fluid) --pre 1 ug/kg CRH IV
Streptococcus agalactiae [Presence] in Specimen by Organism specific culture
Cortisol [Moles/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h
Complement C5 [Presence] in Serum or Plasma
Uroporphyrin 1 isomer/Creatinine [Molar ratio] in Urine
Parainfluenza virus 1 Ag [Presence] in Throat by Immunofluorescence
Beta hydroxybutyrate [Moles/volume] in Vitreous fluid
C peptide [Mass/volume] in Serum or Plasma --2 hours post dose glucose
Corticotropin [Moles/volume] in Plasma --9th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge
Cortisol [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --5th specimen post XXX challenge
Parainfluenza virus 1 Ag [Presence] in Specimen by Immunofluorescence
Cortisol [Moles/volume] in Saliva (oral fluid) --6th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --7th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --8th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --8th specimen post XXX challenge
Cortisol [Mass/volume] in Saliva (oral fluid) --9th specimen post XXX challenge
Cortisol [Moles/volume] in Saliva (oral fluid) --9th specimen post XXX challenge
Parainfluenza virus 2 Ag [Presence] in Throat by Immunofluorescence
cefTAZidime [Susceptibility] by Method for Slow-growing mycobacteria
OmpC IgA Ab [Presence] in Serum by Immunoassay
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine by Confirmatory method
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence
Gliadin peptide IgA Ab [Units/volume] in Serum
Gliadin peptide IgG Ab [Units/volume] in Serum
Doripenem [Susceptibility] by Gradient strip
Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria
Streptococcal DNAse B and ASO antibodies panel - Serum
Testosterone.free+weakly bound and total panel - Serum or Plasma
Lymphocyte proliferation stimulated by concanavalin A [Interpretation] in Blood
Lymphocyte proliferation stimulated by 10 ug concanavalin A actual/normal in Blood
Parainfluenza virus 2 Ag [Presence] in Specimen by Immunofluorescence
Lymphocyte proliferation stimulated by 5 ug concanavalin A actual/normal in Blood
Lymphocyte proliferation stimulated by 2.0 ug concanavalin A actual/normal in Blood
Lymphocyte proliferation stimulated by 0.5 ug concanavalin A actual/normal in Blood
Lymphocyte proliferation stimulated by pokeweed mitogen [Interpretation] in Blood
Lymphocyte proliferation stimulated by 10 ug pokeweed mitogen actual/normal in Blood
Lymphocyte proliferation stimulated by 5 ug pokeweed mitogen actual/normal in Blood
Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen actual/normal in Blood
Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen actual/normal in Blood
Parainfluenza virus 3 Ag [Presence] in Throat by Immunofluorescence
Lymphocyte proliferation stimulated by phytohemagglutinin [Interpretation] in Blood Narrative
Lymphocyte proliferation stimulated by 5 ug phytohemagglutin actual/normal in Blood
Lymphocyte proliferation stimulated by 2.5 ug phytohemagglutin actual/normal in Blood
Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin actual/normal in Blood
Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin actual/normal in Blood
Porphyrin fractions panel [Mass/volume] - Serum or Plasma
Mycoplasma pneumoniae IgG and IgM panel - Serum
Parainfluenza virus 3 Ag [Presence] in Specimen by Immunofluorescence
Alpha-1-Fetoprotein panel - Amniotic fluid
Parvovirus B19 IgG and IgM [Interpretation] in Serum
Drugs of abuse [Interpretation] in Meconium
Haemophilus influenzae serotype [Identifier] in Isolate by Agglutination
Respiratory syncytial virus Ag [Presence] in Throat by Immunoassay
Respiratory syncytial virus Ag [Presence] in Throat by Immunofluorescence
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Wheat recombinant (rTri a) 19 IgE Ab [Units/volume] in Serum
Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
Olive pollen native (nOle e) 1 IgE Ab [Units/volume] in Serum
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Echovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Helicobacter pylori [Presence] in Specimen by Organism specific culture
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Coxiella burnetii phase 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Histone Ab [Presence] in Serum by Immunoassay
Epithelial cells [#/area] in Semen by Microscopy high power field
Erythrocytes [#/area] in Semen by Microscopy high power field
Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay
Gamma glutamyl transferase [Enzymatic activity/time] in 24 hour Urine
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence
Bactericidal permeability increasing protein Ab [Units/volume] in Serum
Dog recombinant (rCan f) 2 IgE Ab [Units/volume] in Serum
Dog recombinant (rCan f) 1 IgE Ab [Units/volume] in Serum
Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Units/volume] in Serum
Peach recombinant (rPru p) 4 IgE Ab [Units/volume] in Serum
Respiratory syncytial virus Ag [Presence] in Specimen by Immunofluorescence
Peach recombinant (rPru p) 1 IgE Ab [Units/volume] in Serum
Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
Coxsackievirus B IgG Ab [Titer] in Serum
Calcium [Mass/volume] in Peritoneal dialysis fluid
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Rickettsia sp identified in Blood by Organism specific culture
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay
Campylobacter jejuni IgM Ab [Titer] in Serum by Immunofluorescence
Campylobacter jejuni IgG Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus B IgM Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus A9 IgM Ab [Titer] in Serum by Immunofluorescence
Rotavirus Ag [Presence] in Stool by Agglutination
Coxsackievirus A9 IgG Ab [Titer] in Serum by Immunofluorescence
Phytonadione [Moles/volume] in Serum or Plasma
5-Hydroxytryptophan [Mass/volume] in 24 hour Urine
Glomerular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunofluorescence
Yersinia enterocolitica Ab [Titer] in Serum by Complement fixation
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum by Immunoassay
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum by Immunoassay
Capreomycin [Susceptibility] by Serum bactericidal titer
Rotavirus Ag [Presence] in Stool by Immunoassay
Oligoclonal bands [Interpretation] in 24 hour Urine by Isoelectric focusing
Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
Mononuclear cells/100 leukocytes in Peritoneal dialysis fluid
Acetone/Creatinine [Mass Ratio] in Urine
European paper wasp IgE Ab [Units/volume] in Serum
Leukocytes [#/volume] in Urine by Automated test strip
Brucella sp Ab [Titer] in Cerebral spinal fluid by Agglutination
Conalbumin native (nGal d) 3 IgE Ab [Units/volume] in Serum
Aspergillus sp Ab [Titer] in Serum by Hemagglutination
Rickettsia conorii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Testosterone [Mass/volume] in Serum or Plasma --2nd specimen
Renin [Mass/volume] in Plasma --post XXX challenge
Renin [Mass/volume] in Plasma --3rd specimen
Renin [Mass/volume] in Plasma --2nd specimen
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen
C peptide [Mass/volume] in Serum or Plasma --2nd specimen
Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen
Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence
Estrogen [Mass/volume] in Serum or Plasma --2nd specimen
Cortisol [Mass/volume] in Serum or Plasma --21st specimen
Cortisol [Mass/volume] in Serum or Plasma --24th specimen
Cortisol [Mass/volume] in Serum or Plasma --23rd specimen
Cortisol [Mass/volume] in Serum or Plasma --22nd specimen
Cortisol [Mass/volume] in Serum or Plasma --20th specimen
Cortisol [Mass/volume] in Serum or Plasma --19th specimen
Cortisol [Mass/volume] in Serum or Plasma --18th specimen
Varicella zoster virus Ag [Presence] in Specimen by Immunofluorescence
Cortisol [Mass/volume] in Serum or Plasma --17th specimen
Cortisol [Mass/volume] in Serum or Plasma --16th specimen
Cortisol [Mass/volume] in Serum or Plasma --14th specimen
Cortisol [Mass/volume] in Serum or Plasma --15th specimen
Cortisol [Mass/volume] in Serum or Plasma --13th specimen
Urea [Moles/volume] in Cerebral spinal fluid
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --baseline
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Thyroxine (T4) free [Mass/volume] in Serum or Plasma --baseline
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Legionella pneumophila Ag [Presence] in Specimen by Immunofluorescence
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma --baseline
C peptide [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge
Virus identified in Cerebral spinal fluid by Culture
Somatotropin [Mass/volume] in Serum or Plasma --25th specimen
Somatotropin [Mass/volume] in Serum or Plasma --24th specimen
Somatotropin [Mass/volume] in Serum or Plasma --20th specimen
Somatotropin [Mass/volume] in Serum or Plasma --19th specimen
Somatotropin [Mass/volume] in Serum or Plasma --18th specimen
Somatotropin [Mass/volume] in Serum or Plasma --17th specimen
Somatotropin [Mass/volume] in Serum or Plasma --16th specimen
Somatotropin [Mass/volume] in Serum or Plasma --15th specimen
Somatotropin [Mass/volume] in Serum or Plasma --14th specimen
Testosterone [Mass/volume] in Serum or Plasma --3 days post XXX challenge
Osmolality of Urine--1.5 hours post fluid fast
Osmolality of Urine--30 minutes post fluid fast
Estradiol (E2) [Mass/volume] in Serum or Plasma --4 days post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --13th specimen
Somatotropin [Mass/volume] in Serum or Plasma --10th specimen
Somatotropin [Mass/volume] in Serum or Plasma --9th specimen
Parathyrin.intact [Mass/volume] in Serum or Plasma --post XXX challenge
Homocyst(e)ine [Moles/volume] in Serum or Plasma --post XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --48th specimen
Somatotropin [Mass/volume] in Serum or Plasma --47th specimen
Somatotropin [Mass/volume] in Serum or Plasma --46th specimen
Somatotropin [Mass/volume] in Serum or Plasma --45th specimen
Somatotropin [Mass/volume] in Serum or Plasma --44th specimen
Somatotropin [Mass/volume] in Serum or Plasma --43rd specimen
Somatotropin [Mass/volume] in Serum or Plasma --42nd specimen
Somatotropin [Mass/volume] in Serum or Plasma --41st specimen
Somatotropin [Mass/volume] in Serum or Plasma --40th specimen
Somatotropin [Mass/volume] in Serum or Plasma --39th specimen
Somatotropin [Mass/volume] in Serum or Plasma --38th specimen
Somatotropin [Mass/volume] in Serum or Plasma --37th specimen
Somatotropin [Mass/volume] in Serum or Plasma --36th specimen
Somatotropin [Mass/volume] in Serum or Plasma --35th specimen
Somatotropin [Mass/volume] in Serum or Plasma --33rd specimen
Somatotropin [Mass/volume] in Serum or Plasma --32nd specimen
Somatotropin [Mass/volume] in Serum or Plasma --31st specimen
Somatotropin [Mass/volume] in Serum or Plasma --30th specimen
Somatotropin [Mass/volume] in Serum or Plasma --29th specimen
Somatotropin [Mass/volume] in Serum or Plasma --28th specimen
Somatotropin [Mass/volume] in Serum or Plasma --27th specimen
Somatotropin [Mass/volume] in Serum or Plasma --26th specimen
Somatotropin [Mass/volume] in Serum or Plasma --23rd specimen
Somatotropin [Mass/volume] in Serum or Plasma --22nd specimen
Somatotropin [Mass/volume] in Serum or Plasma --21st specimen
Urea [Mass/volume] in Peritoneal dialysis fluid
Pyruvate [Mass/volume] in Blood --30 minutes post XXX challenge
Pyruvate [Mass/volume] in Blood --15 minutes post XXX challenge
Pyruvate [Mass/volume] in Blood --10 minutes post XXX challenge
Pyruvate [Mass/volume] in Blood --3 minutes post XXX challenge
Pyruvate [Mass/volume] in Blood --1 minute post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --1 minute post XXX challenge
Calcitonin [Mass/volume] in Serum or Plasma --baseline
Vasopressin [Mass/volume] in Plasma --1.5 hours post XXX challenge
Vasopressin [Mass/volume] in Plasma --baseline
Pyruvate [Mass/volume] in Blood --post exercise
C peptide [Mass/volume] in Serum or Plasma --post XXX challenge
Methyl ethyl ketone/Creatinine [Mass Ratio] in Urine
Renin [Enzymatic activity/volume] in Plasma --4 hours post XXX challenge
Aldosterone [Mass/volume] in Serum or Plasma --4 hours post XXX challenge
HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay
Spermatozoa Progressive [#/volume] in Semen
F12 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Nucleated cells [#/volume] in Pleural fluid by Manual count
Nucleated cells [#/volume] in Pericardial fluid by Manual count
Nucleated cells [#/volume] in Cerebral spinal fluid by Manual count
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunofluorescence
11-Deoxycortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge
Protein S+Acarboxy Free Ag [Units/volume] in Platelet poor plasma by Immunoassay
11-Deoxycortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge
11-Deoxycortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Chicken droppings IgG Ab [Mass/volume] in Serum
Pigeon feather IgG Ab [Mass/volume] in Serum
Parrot feather IgG Ab [Mass/volume] in Serum
Aspergillus niger IgG Ab [Mass/volume] in Serum
Parakeet feather IgG Ab [Mass/volume] in Serum
Canary feather IgG Ab [Mass/volume] in Serum
Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay
Androstanolone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge
Androstenedione [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Legionella sp identified in Bronchial specimen by Organism specific culture
CD4+CD45RO+ cells/CD3+CD4+ (T4 helper) cells [# Ratio] in Blood
Glutamine+Histidine [Moles/volume] in Cerebral spinal fluid
Vasopressin [Mass/volume] in Plasma --2 hours post XXX challenge
Perennial rye grass IgG Ab [Mass/volume] in Serum
LCT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Protein S [Units/volume] in Platelet poor plasma by Coagulation assay
Dextromethamphetamine [Presence] in Urine
Glutamine+Histidine/Creatinine [Ratio] in Urine
Glutamine+Histidine [Moles/volume] in Serum or Plasma
Mycobacterium tuberculosis DNA [Presence] in Body fluid by NAA with probe detection
Protein S [Units/volume] in Platelet poor plasma by Chromogenic method
Endothelial cell Ab [Presence] in Serum or Plasma by Immunofluorescence
Yersinia pseudotuberculosis Ab [Presence] in Serum by Agglutination
Hepatitis E virus Ab [Presence] in Serum by Immunoassay
F12 gene mutations found [Type] in Blood or Tissue by Molecular genetics method
LCT gene mutations found [Type] in Blood or Tissue by Molecular genetics method
Bacteria identified in Total parental nutrition by Culture
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Ziehl-Neelsen
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain.Ziehl-Neelsen
Microscopic observation [Identifier] in Body fluid by Acid fast stain.Ziehl-Neelsen
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain.Ziehl-Neelsen
Lutropin [Units/volume] in Serum or Plasma --pre XXX challenge
Follitropin [Units/volume] in Serum or Plasma --pre XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --pre XXX challenge
Somatotropin [Mass/volume] in Serum or Plasma --12th specimen
Somatotropin [Mass/volume] in Serum or Plasma --11th specimen
Creatinine [Mass/volume] in Urine --2nd specimen
Testosterone free and total panel [Mass/volume] - Serum or Plasma
Meperidine and Normeperidine panel - Urine
Deoxypyridinoline/Pyridinoline [Molar ratio] in Urine
Pyridinoline and Deoxypyridinoline [Interpretation] in Urine
Direct antiglobulin test.complement C3b+C4d specific reagent [Presence] on Red Blood Cells
Fusarium oxysporum IgG Ab [Mass/volume] in Serum
Ganglioside GT1b IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GT1b IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GT1a IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GT1a IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM4 IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM4 IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM3 IgM Ab [Units/volume] in Serum by Immunoassay
Asialoganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GQ1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD1b IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD3 IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD3 IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD2 IgM Ab [Units/volume] in Serum by Immunoassay
Timothy recombinant (rPhl p) 5b IgE Ab [Units/volume] in Serum
Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum
Bromelin MUXF3 IgE Ab [Units/volume] in Serum
11-Deoxycortisol [Mass/volume] in Serum or Plasma --pre XXX challenge
Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Units/volume] in Serum
ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FGB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
aPTT normal/actual in Platelet poor plasma by Coagulation assay
Almecillin [Susceptibility] by Serum bactericidal titer
Legionella sp identified in Sputum by Organism specific culture
Amylase [Enzymatic activity/time] in 18 hour Urine
Lactoferrin Ab [Units/volume] in Serum by Immunoassay
Lactate [Moles/volume] in Serum or Plasma --baseline
Lactate [Moles/volume] in Serum or Plasma --1 minute post XXX challenge
Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma
Lactate [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge
Lactate [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge
Fractional excretion of urea [Ratio] in Urine and Serum or Plasma collected for unspecified duration
Fractional excretion of potassium [Ratio] in Urine and Serum or Plasma collected for unspecified duration
Lactate [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Lactate [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Lactate [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Prothrombin time (PT) in Control Platelet poor plasma by Coagulation assay
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoblot
Carbohydrates [Mass/mass] in Stool by Infrared spectroscopy
Water [Mass/mass] in Stool by Infrared spectroscopy
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal dialysis fluid
Renin [Enzymatic activity/volume] in Plasma --supine+30 minutes post XXX challenge
Neutrophil Ab [Units/volume] in Serum by Flow cytometry (FC)
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
Asialoganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Russell viper venom time in Control Platelet poor plasma by Coagulation assay
Ganglioside GM3 IgG Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD2 IgG Ab [Units/volume] in Serum by Immunoassay
Triglyceride [Mass/volume] in Peritoneal dialysis fluid
Phosphate [Mass/volume] in Peritoneal dialysis fluid
Cholesterol [Mass/volume] in Peritoneal dialysis fluid
Amylase [Enzymatic activity/volume] in Peritoneal dialysis fluid
Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid
BRCA1+BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
TCR gamma delta cells/100 cells in Tissue
Somatotropin [Mass/volume] in Serum or Plasma --34th specimen
ACE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ITGB3 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
FGB gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
F5 gene p.His1299Arg [Presence] in Blood or Tissue by Molecular genetics method
Russell viper venom time in Platelet poor plasma by Coagulation assay
Coccidioides sp IgG and IgM panel - Specimen
Chromosome analysis.interphase [Interpretation] in Specimen by FISH Narrative
Bacteria # 4 identified in Tissue by Anaerobe culture
HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
Glucagon [Mass/volume] in Serum or Plasma --5th specimen fasting
Glucagon [Mass/volume] in Serum or Plasma --4th specimen fasting
Monocytes/100 leukocytes in Blood by Automated count
Glucagon [Mass/volume] in Serum or Plasma --3rd specimen fasting
Glucagon [Mass/volume] in Serum or Plasma --2nd specimen fasting
Glucagon [Mass/volume] in Serum or Plasma --1st specimen fasting
Inflammatory bowel disease Ab 7 panel - Serum
Inflammatory bowel disease Ab 7 [Interpretation] in Serum
Neutrophils [#/volume] in Synovial fluid by Automated count
PAX6 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
Chlamydophila psittaci [Presence] in Bronchial brush by Organism specific culture
sp100 Ab [Presence] in Serum by Immunoassay
ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
RPS19 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method
Nuclear Ab [Presence] in Serum by Hep2 substrate
Tropheryma whipplei Ab [Presence] in Serum
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunoblot
Giant platelets [Presence] in Blood by Light microscopy
Blood smear finding [Identifier] in Blood by Light microscopy
Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
Lipoprotein fractions [Interpretation] in Serum or Plasma
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma
ePHEDrine [Mass/volume] in Urine by Confirmatory method
Benzylpiperazine [Mass/volume] in Urine by Confirmatory method
CD11c+CD103+ cells/100 cells in Bone marrow
CD5+CD23+ cells/100 cells in Bone marrow
CD7+CD34+ cells/100 cells in Bone marrow
Hemoglobin F/Hemoglobin.total in Amniotic fluid
CD19+CD34+ cells/100 cells in Bone marrow
CD13+CD34+ cells/100 cells in Bone marrow
Calcium [Moles/volume] in Serum or Plasma --post dialysis
Creatine kinase.macromolecular [Presence] in Serum or Plasma
Vancomycin resistant enterococcus [Presence] in Anal by Organism specific culture
Vancomycin resistant enterococcus [Presence] in Urine by Organism specific culture
Cortisol [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge
Glucose [Moles/volume] in Urine by Automated test strip
Glucose [Moles/volume] in Serum or Plasma --pre dose lactose PO
Ketones [Moles/volume] in Urine by Automated test strip
Microalbumin/Creatinine [Ratio] in 24 hour Urine
Potassium [Moles/volume] in 24 hour Stool
Alkaline phosphatase [Enzymatic activity/volume] in Dialysis fluid
Carbon dioxide [Partial pressure] in Dialysis fluid
Bilirubin.total [Moles/time] in 24 hour Stool
Methotrimeprazine metabolite [Presence] in Urine
QUEtiapine metabolite [Presence] in Urine
Beta-2-Microglobulin/Creatinine [Ratio] in Urine
Chloride [Moles/volume] in Gastric fluid
Insulin [Moles/volume] in Serum or Plasma --fasting
Monoethylglycinexylidide [Presence] in Urine
C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method
Epstein Barr virus early diffuse IgG Ab [Presence] in Serum
Hemoglobin H inclusion bodies [Presence] in Blood
Urea renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma
Urea nitrogen [Mass/volume] in Dialysis fluid
Alkaline phosphatase.placental [Enzymatic activity/volume] in Cerebral spinal fluid
Methyl ethyl ketone/Creatinine [Molar ratio] in Urine
2-Hydroxycaproate/Creatinine [Molar ratio] in Urine
2-Ketobutyrate/Creatinine [Molar ratio] in Urine
3-Methyl crotonate/Creatinine [Molar ratio] in Urine
Deoxyuridine/Creatinine [Molar ratio] in Urine
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Serum or Plasma
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Serum or Plasma
Creatinine [Mass/volume] in Dialysis fluid
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Deoxyadenosine/Creatinine [Molar ratio] in Urine
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Deoxyguanosine/Creatinine [Molar ratio] in Urine
Deoxyinosine/Creatinine [Molar ratio] in Urine
Adenine/Creatinine [Molar ratio] in Urine
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Gamma tocopherol [Moles/volume] in Serum or Plasma
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Serum or Plasma
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Serum or Plasma
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Serum or Plasma
Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma
Inosine/Creatinine [Molar ratio] in Urine
Transcobalamin I+Transcobalamin III [Moles/volume] in Serum
Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid
Alloisoleucine [Moles/time] in Urine collected for unspecified duration
Succinyladenosine/Creatinine [Molar ratio] in Urine
Thymidine/Creatinine [Molar ratio] in Urine
Uridine/Creatinine [Molar ratio] in Urine
Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid
Beta-2-Microglobulin [Mass/volume] in Pleural fluid
Testosterone [Moles/volume] in Pleural fluid
Gastric acid [Moles/volume] in Gastric fluid
Chromogranin A [Units/volume] in Pleural fluid
Prostate specific Ag [Mass/volume] in Pleural fluid
Squamous cell carcinoma Ag [Mass/volume] in Pleural fluid
Prostate specific Ag [Mass/volume] in Peritoneal fluid
Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid
Squamous cell carcinoma Ag [Mass/volume] in Peritoneal fluid
Chromogranin A [Units/volume] in Peritoneal fluid
Chromogranin A [Units/volume] in Cerebral spinal fluid
Squamous cell carcinoma Ag [Mass/volume] in Cerebral spinal fluid
Testosterone [Moles/volume] in Peritoneal fluid
Prostate specific Ag [Mass/volume] in Cerebral spinal fluid
Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid
Prostate Specific Ag Free [Mass/volume] in Pleural fluid
Testosterone [Moles/volume] in Cerebral spinal fluid
Reducing substances [Moles/volume] in Urine
Prostate Specific Ag Free/Prostate specific Ag.total in Cerebral spinal fluid
Prostate Specific Ag Free/Prostate specific Ag.total in Peritoneal fluid
Prostate Specific Ag Free/Prostate specific Ag.total in Pleural fluid
Gastric acid free [Moles/volume] in Gastric fluid
Prostate Specific Ag Free/Prostate specific Ag.total in Body fluid
Prostate Specific Ag Free [Mass/volume] in Body fluid
Testosterone [Moles/volume] in Body fluid
Chromogranin A [Units/volume] in Body fluid
Reducing substances [Moles/volume] in Stool
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in DBS
Arylsulfatase C [Enzymatic activity/mass] in Leukocytes
Alanine glyoxylate aminotransferase [Enzymatic activity/mass] in Tissue
Palmitoyl protein thioesterase [Enzymatic activity/volume] in DBS
Tetrahydrobiopterin [Moles/volume] in Cerebral spinal fluid
Cholesterol esterase [Enzymatic activity/mass] in Tissue
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in DBS
Tocopherols/Cholesterol [Molar ratio] in Serum or Plasma
N-carbamoyl beta alanine/Creatinine [Molar ratio] in Urine
Homocysteine cysteine disulfide [Moles/volume] in Cerebral spinal fluid
Homocysteine cysteine disulfide [Moles/volume] in Urine
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in Serum or Plasma
Cytologist who read Cyto stain of Specimen
Cell count and Differential panel - Pericardial fluid
Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol
Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip
Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification
Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification
8-Hydroxydeoxyguanosine/Creatinine [Mass Ratio] in Urine
Maternal cell contamination [Identifier] in Specimen Nominal
Karyotype [Identifier] in Blood or Tissue by FISH Narrative
Cortisol [Mass/volume] in Serum or Plasma --post 6 mg dexamethasone PO overnight
Oxygen content in Arterial blood by calculation
Oxygen capacity [Volume Fraction] in Arterial blood
Calcium hydrogen phosphate dihydrate crystals [Presence] in Stone by X-ray diffraction
Cystine crystals [Presence] in Stone by X-ray diffraction
Calcium oxalate dihydrate crystals [Presence] in Stone by X-ray diffraction
Urate crystals [Presence] in Stone by X-ray diffraction
Urate dihydrate crystals [Presence] in Stone by X-ray diffraction
Benzylpiperazine [Mass/volume] in Serum or Plasma
Iloperidone [Mass/volume] in Serum or Plasma
Levamisole [Mass/volume] in Serum or Plasma
Candida albicans reaction wheal [Diameter] --3 days post 50 ug Candida albicans intradermal
Lacosamide [Mass/volume] in Serum or Plasma
Desloratadine [Mass/volume] in Serum or Plasma
Mumps reaction wheal [Diameter] --3 days post 0.1 mL mumps intradermal
Memantine [Mass/volume] in Serum or Plasma
Metaxalone [Mass/volume] in Serum or Plasma
Trichophyton reaction wheal [Diameter] --3 days post 50 ug trichophyton intradermal
Milnacipran [Mass/volume] in Serum or Plasma
Ramelteon M-II [Mass/volume] in Body fluid
Ramelteon M-II [Mass/volume] in Serum or Plasma
Ramelteon [Mass/volume] in Serum or Plasma
Rufinamide [Mass/volume] in Serum or Plasma
Salvinorin A [Mass/volume] in Serum or Plasma
Salvinorin B [Mass/volume] in Serum or Plasma
Cholesterol [Presence] in Blood by Test strip
Norsibutramine [Mass/volume] in Serum or Plasma
Dinorsibutramine [Mass/volume] in Serum or Plasma
Sibutramine [Mass/volume] in Serum or Plasma
Legionella sp identified in Specimen by Organism specific culture
Stiripentol [Mass/volume] in Serum or Plasma
Tadalafil [Mass/volume] in Serum or Plasma
4-Hydroxy-Tamoxifen [Mass/volume] in Blood
Endoxifen [Mass/volume] in Serum or Plasma
4-Hydroxy-Tamoxifen [Mass/volume] in Serum or Plasma
Nortamoxifen [Mass/volume] in Serum or Plasma
Tapentadol [Mass/volume] in Serum or Plasma
Desethylvardenafil [Mass/volume] in Blood
Desethylvardenafil [Mass/volume] in Serum or Plasma
Vardenafil [Mass/volume] in Serum or Plasma
Desethylvardenafil [Mass/volume] in Urine
Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination
3-Keto, 2-Methylvalerate/Creatinine [Molar ratio] in Urine
2-Methylacetoacetate/Creatinine [Molar ratio] in Urine
Amikacin [Mass/volume] in Serum or Plasma --post dialysis
Gentamicin [Mass/volume] in Serum or Plasma --post dialysis
Tobramycin [Mass/volume] in Serum or Plasma --post dialysis
Vancomycin [Mass/volume] in Serum or Plasma --post dialysis
Aspergillus versicolor IgG Ab [Mass/volume] in Serum
Hydroxyproline/Creatinine [Mass Ratio] in 2 hour Urine
Acetaminophen [Presence] in Urine by Screen method
Nitrogen [Mass/mass] in Stool by Infrared spectroscopy
Starch [Mass/mass] in Stool by Infrared spectroscopy
Trypanosoma cruzi IgG Ab [Units/volume] in Serum by Immunoassay
Taenia solium larva DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Androstanolone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
Neuronal nuclear Ab [Titer] in Serum by Immunofluorescence
Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
Hydroxyproline [Mass/volume] in 24 hour Urine
Trypanosoma cruzi IgG Ab [Titer] in Serum by Immunofluorescence
Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
Latex recombinant (rHev b) 9 IgE Ab [Units/volume] in Serum
Echovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Echovirus IgG Ab [Units/volume] in Cerebral spinal fluid
PM-1 Ab [Titer] in Serum by Immunofluorescence
RNA Ab [Units/volume] in Serum by Immunoassay
Echovirus IgG Ab [Units/volume] in Serum by Immunoassay
Mi-1+Mi-2 Ab [Titer] in Serum by Immunofluorescence
Ku Ab [Titer] in Serum by Immunofluorescence
Oxygen capacity [Moles/volume] in Arterial blood
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe with signal amplification
Leptospira sp identified in Specimen by Organism specific culture
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification
Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination
Influenza virus A hemagglutinin type RNA [Identifier] in Specimen by NAA with probe detection
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection
Reptilase time in Control Platelet poor plasma by Coagulation assay
Lymphocytes/100 leukocytes in Dialysis fluid
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
Calcium.ionized [Mass/volume] in Arterial blood
Calcium.ionized [Mass/volume] in Venous blood
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE)
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE)
Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma
aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma
Thrombin time in Control Platelet poor plasma by Coagulation assay
Propofol glucuronide [Mass/volume] in Urine
Protein.monoclonal band 4 [Mass/volume] in Urine by Electrophoresis
Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid
Netilmicin [Moles/volume] in Serum or Plasma --trough
Netilmicin [Moles/volume] in Serum or Plasma
Netilmicin [Moles/volume] in Serum or Plasma --peak
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
Calcitonin [Moles/volume] in Serum or Plasma --post XXX challenge
Triglyceride [Moles/time] in 24 hour Urine
Cannabinoids [Presence] in Gastric fluid
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma
Glucagon [Mass/volume] in Serum or Plasma --7th specimen fasting
Glucagon [Mass/volume] in Serum or Plasma --6th specimen fasting
Coxsackievirus A24 IgM Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus A16 IgM Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence
Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence
Prothrombin time (PT) factor substitution in Control Platelet poor plasma by Coagulation assay --20M post incubation with normal plasma
Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence
GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method
HLA IgG Ab [Presence] in Serum by Immunofluorescence
Homovanillate [Mass/volume] in Urine collected for unspecified duration
1-Hydroxymidazolam [Mass/mass] in Meconium
1-Hydroxymidazolam [Mass/volume] in Urine
Bacteria identified in Abscess by Aerobe culture
1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method
7-Aminoclonazepam [Mass/volume] in Blood
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma
7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method
7-Aminoclonazepam [Mass/volume] in Body fluid
7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method
7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method
7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method
Alpha hydroxyalprazolam [Mass/volume] in Blood
Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC)
Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method
Alpha hydroxyalprazolam [Mass/volume] in Body fluid
Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method
Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method
Alpha hydroxyalprazolam [Mass/mass] in Tissue
Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method
ALPRAZolam [Mass/volume] in Blood by Confirmatory method
ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method
ALPRAZolam [Mass/mass] in Meconium by Confirmatory method
ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method
ALPRAZolam [Mass/mass] in Stool by Confirmatory method
ALPRAZolam [Mass/mass] in Tissue by Confirmatory method
ALPRAZolam [Mass/volume] in Urine by Confirmatory method
Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method
chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method
chlordiazePOXIDE [Mass/volume] in Body fluid
chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method
chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method
chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method
chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method
cloBAZam [Mass/volume] in Blood by Confirmatory method
cloBAZam [Mass/volume] in Body fluid by Confirmatory method
cloBAZam [Mass/mass] in Meconium by Confirmatory method
cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method
cloBAZam [Mass/mass] in Tissue by Confirmatory method
cloBAZam [Mass/volume] in Urine by Confirmatory method
clonazePAM [Mass/volume] in Blood by Confirmatory method
clonazePAM [Mass/volume] in Body fluid by Confirmatory method
clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method
Prothrombin time (PT) in Blood by Coagulation assay
clonazePAM [Mass/mass] in Tissue by Confirmatory method
Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method
Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method
Cotinine [Presence] in Serum or Plasma by Screen method
Cotinine [Presence] in Urine by Screen method
N-desalkylflurazepam [Mass/volume] in Blood
N-desalkylflurazepam [Mass/volume] in Body fluid
N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method
N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method
N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method
N-desalkylflurazepam [Mass/mass] in Tissue
N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method
diazePAM [Mass/volume] in Blood by Confirmatory method
diazePAM [Mass/volume] in Body fluid by Confirmatory method
diazePAM [Mass/mass] in Meconium by Confirmatory method
Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
diazePAM [Mass/mass] in Stool by Confirmatory method
diazePAM [Mass/mass] in Tissue by Confirmatory method
Estazolam [Mass/volume] in Blood by Confirmatory method
Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Estazolam [Mass/volume] in Body fluid by Confirmatory method
Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method
Estazolam [Mass/mass] in Stool by Confirmatory method
Bacteria identified in Amniotic fluid by Culture
Estazolam [Mass/mass] in Tissue by Confirmatory method
Estazolam [Mass/volume] in Urine by Confirmatory method
fentaNYL [Presence] in Urine by Screen method
Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay
Flurazepam [Mass/volume] in Blood by Confirmatory method
Flurazepam [Mass/volume] in Body fluid by Confirmatory method
Flurazepam [Mass/mass] in Tissue by Confirmatory method
Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method
Hydroxyethylflurazepam [Mass/volume] in Blood
Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method
Hydroxyethylflurazepam [Mass/volume] in Body fluid
Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method
Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method
Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method
Hydroxyethylflurazepam [Mass/mass] in Tissue
Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method
Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay
Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method
Hydroxytriazolam [Mass/volume] in Body fluid
Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method
Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method
Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method
LORazepam [Mass/volume] in Blood by Confirmatory method
LORazepam [Mass/volume] in Body fluid by Confirmatory method
LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Methadone [Presence] in Serum or Plasma by Screen method
MethylePHEDrine [Mass/volume] in Serum or Plasma
Midazolam [Mass/volume] in Blood by Confirmatory method
Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method
Midazolam [Mass/volume] in Body fluid by Confirmatory method
Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method
Midazolam [Mass/mass] in Tissue by Confirmatory method
Nitrous oxide [Mass/volume] in Serum or Plasma
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Nordiazepam [Mass/volume] in Blood by Confirmatory method
Nordiazepam [Mass/volume] in Body fluid by Confirmatory method
Nordiazepam [Mass/mass] in Meconium by Confirmatory method
Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Nordiazepam [Mass/mass] in Stool by Confirmatory method
Cathine [Mass/volume] in Serum or Plasma
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis
Oxazepam [Mass/volume] in Blood by Confirmatory method
Oxazepam [Mass/volume] in Body fluid by Confirmatory method
Oxazepam [Mass/mass] in Meconium by Confirmatory method
Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Oxazepam [Mass/mass] in Stool by Confirmatory method
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis
Propoxyphene [Presence] in Serum or Plasma by Screen method
Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic method
Temazepam [Mass/volume] in Blood by Confirmatory method
Temazepam [Mass/volume] in Body fluid by Confirmatory method
Temazepam [Mass/mass] in Meconium by Confirmatory method
Bacteria identified in Aspirate by Aerobe culture
Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method
Temazepam [Mass/mass] in Stool by Confirmatory method
Titanium [Mass/volume] in Red Blood Cells
Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunoassay
Triazolam [Mass/volume] in Blood by Confirmatory method
Triazolam [Mass/volume] in Body fluid by Confirmatory method
Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method
Triazolam [Mass/mass] in Tissue by Confirmatory method
Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic method
Tungsten [Mass/volume] in Red Blood Cells
Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic method
Hexacarboxylporphyrin [Moles/volume] in Serum or Plasma
Glucose [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --1.5 hours post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --2 hours post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --3 hours post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --4 hours post XXX challenge
Glucose [Molar concentration difference] in Serum or Plasma --5 hours post XXX challenge
Ganciclovir [Mass/volume] in Plasma --peak
Ganciclovir [Mass/volume] in Plasma --trough
Protein.monoclonal band 2/Protein.total in Urine by Electrophoresis
Protein.monoclonal band 3/Protein.total in Urine by Electrophoresis
Protein.monoclonal band 4/Protein.total in Urine by Electrophoresis
Cortisol [Molar concentration difference] in Serum or Plasma --30 minutes post XXX challenge
Cortisol [Molar concentration difference] in Serum or Plasma --1 hour post XXX challenge
Epstein Barr virus DNA [Presence] in Body fluid by NAA with probe detection
Phosphatidylglycerol [Moles/volume] in Amniotic fluid
Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Large granular lymphocytes [Presence] in Blood
Caffeine [Moles/volume] in Serum --trough
Glucose [Moles/volume] in Serum or Plasma --11 AM specimen
Glucose [Moles/volume] in Capillary blood by Glucometer --7 AM specimen
Glucose [Moles/volume] in Serum or Plasma --7 AM specimen
Glucose [Moles/volume] in Serum or Plasma --3 PM specimen
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay
Neutrophils.immature/100 leukocytes in Body fluid
Uroporphyrin 1 isomer/Creatinine [Molar ratio] in 24 hour Urine
Uroporphyrin 3 isomer/Creatinine [Molar ratio] in 24 hour Urine
Pentacarboxylporphyrins/Creatinine [Molar ratio] in 24 hour Urine
Coproporphyrin 1/Creatinine [Molar ratio] in 24 hour Urine
Coproporphyrin 3/Creatinine [Molar ratio] in 24 hour Urine
Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post dose
Tacrolimus [Mass/volume] in Serum or Plasma --2 hours post dose
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis
Bilirubin.total [Mass/volume] in Arterial blood
Bilirubin.total [Mass/volume] in Venous blood
Leukocytes in 3 hour Urine sediment by Light microscopy
Bacteria identified in Aspirate by Anaerobe culture
Erythrocytes in 3 hour Urine sediment by Light microscopy
Gastrin [Mass/volume] in Serum or Plasma --baseline
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis
Gastrin [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC)
Creatinine reduction ratio in Serum or Plasma
Parathyrin.intact [Mass/volume] in Body fluid
Mycoplasma sp+Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma
Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination
Urate crystals [Presence] in Tissue by Light microscopy
Plasminogen activator urokinase type [Units/volume] in Urine
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Methylenedioxyethylamphetamine [Presence] in Urine by Screen method
Salmonella sp identified [Type] in Isolate
Lactate [Moles/volume] in Serum or Plasma --post exercise
Wuchereria bancrofti Ag [Units/volume] in Serum by Immunoassay
Plasminogen activator urokinase type [Units/volume] in Platelet poor plasma
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method
Amobarbital [Moles/volume] in Gastric fluid
Amoxapine [Moles/volume] in Gastric fluid
Benztropine [Moles/volume] in Serum or Plasma
Benztropine [Moles/volume] in Gastric fluid
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method
Bromazepam [Moles/volume] in Gastric fluid
Brompheniramine [Moles/volume] in Gastric fluid
carBAMazepine [Presence] in Gastric fluid
Chloral hydrate [Moles/volume] in Gastric fluid
chlordiazePOXIDE [Moles/volume] in Urine
chlordiazePOXIDE [Moles/volume] in Gastric fluid
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis
Chlorpheniramine [Moles/volume] in Serum or Plasma
Chlorpheniramine [Moles/volume] in Urine
Chlorpheniramine [Moles/volume] in Gastric fluid
chlorproMAZINE [Moles/volume] in Gastric fluid
Citalopram [Moles/volume] in Gastric fluid
clomiPRAMINE [Moles/volume] in Gastric fluid
cloZAPine [Moles/volume] in Gastric fluid
Cotinine [Moles/volume] in Serum or Plasma
Cotinine [Moles/volume] in Gastric fluid
Desipramine [Moles/volume] in Gastric fluid
Dextromethorphan [Moles/volume] in Serum or Plasma
Dextromethorphan [Moles/volume] in Urine
Dextromethorphan [Moles/volume] in Gastric fluid
Disopyramide [Moles/volume] in Gastric fluid
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis
Ethylene glycol [Moles/volume] in Gastric fluid
Fenoprofen [Moles/volume] in Gastric fluid
FLUoxetine [Moles/volume] in Gastric fluid
fluPHENAZine [Moles/volume] in Gastric fluid
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis
fluvoxaMINE [Moles/volume] in Gastric fluid
hydrOXYzine [Moles/volume] in Gastric fluid
Bacteria identified in Blood product unit by Aerobe culture
Ibuprofen [Moles/volume] in Gastric fluid
Imipramine [Moles/volume] in Gastric fluid
Plasminogen Ag [Units/volume] in Platelet poor plasma by Immunoassay
Indomethacin [Moles/volume] in Gastric fluid
Isopropanol [Moles/volume] in Gastric fluid
Ketoprofen [Moles/volume] in Gastric fluid
lamoTRIgine [Moles/volume] in Gastric fluid
Mefenamate [Moles/volume] in Serum or Plasma
Platelet aggregation ADP induced in Platelet rich plasma
Mefenamate [Moles/volume] in Gastric fluid
Meperidine [Moles/volume] in Serum or Plasma
Mesoridazine [Moles/volume] in Gastric fluid
Methanol [Moles/volume] in Gastric fluid
Methaqualone [Moles/volume] in Gastric fluid
Methotrimeprazine [Moles/volume] in Urine
Platelet aggregation arachidonate induced in Platelet rich plasma
Methotrimeprazine [Moles/volume] in Gastric fluid
Mexiletine [Moles/volume] in Gastric fluid
Naproxen [Moles/volume] in Gastric fluid
Nicotine [Moles/volume] in Gastric fluid
Norclobazam [Moles/volume] in Gastric fluid
Norclomipramine [Moles/volume] in Gastric fluid
Nordoxepin [Moles/volume] in Gastric fluid
Normeperidine [Moles/volume] in Serum or Plasma
Nortriptyline [Moles/volume] in Gastric fluid
OLANZapine [Moles/volume] in Gastric fluid
OXcarbazepine [Moles/volume] in Gastric fluid
Platelet aggregation calcium ionophore induced in Platelet rich plasma
PARoxetine [Moles/volume] in Gastric fluid
Pentazocine [Moles/volume] in Gastric fluid
Perphenazine [Moles/volume] in Serum or Plasma
Perphenazine [Moles/volume] in Gastric fluid
Platelet aggregation collagen induced in Platelet rich plasma
Phencyclidine [Moles/volume] in Serum or Plasma
Promazine [Moles/volume] in Serum or Plasma
Promazine [Moles/volume] in Gastric fluid
Propoxyphene [Moles/volume] in Gastric fluid
Propranolol [Moles/volume] in Gastric fluid
Platelet aggregation EPINEPHrine induced in Platelet rich plasma
QUEtiapine [Moles/volume] in Gastric fluid
quiNINE [Moles/volume] in Serum or Plasma
Strychnine [Moles/volume] in Serum or Plasma
Strychnine [Moles/volume] in Gastric fluid
Sulfamethoxazole [Moles/volume] in Urine
Platelet aggregation norepinephrine induced in Platelet rich plasma
Sulfamethoxazole [Moles/volume] in Gastric fluid
Thiocyanate [Moles/volume] in Gastric fluid
traZODone [Moles/volume] in Gastric fluid
Venlafaxine [Moles/volume] in Gastric fluid
Platelet aggregation ristocetin induced in Platelet rich plasma
Warfarin [Moles/volume] in Gastric fluid
Zopiclone [Moles/volume] in Gastric fluid
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Testosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Platelet aggregation serotonin induced in Platelet rich plasma
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --baseline
Platelet aggregation thrombin induced [Units threshold] in Platelet rich plasma
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Platelet factor 3 [Units/volume] in Platelet poor plasma
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge
Corticotropin [Moles/volume] in Plasma --baseline
Corticotropin [Moles/volume] in Plasma --5 minutes post XXX challenge
Corticotropin [Moles/volume] in Plasma --1.5 hours post XXX challenge
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction
Platelet factor 4 [Units/volume] in Platelet poor plasma
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction
Urobilinogen [Moles/volume] in Urine by Automated test strip
Leukocyte esterase [Presence] in Urine by Automated test strip
West Nile virus IgG Ab avidity [Presence] in Serum by Immunoassay
West Nile virus IgG Ab avidity [Presence] in Serum by Immunofluorescence
West Nile virus IgG Ab [Presence] in Serum by Immunofluorescence
Bacteria identified in Peritoneal dialysis fluid by Culture
PIK3CA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PIK3CA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
10-Hydroxycarbazepine [Mass/volume] in Blood
Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by Immunoassay
Acebutolol [Mass/volume] in Serum or Plasma
N-acetylprocainamide [Mass/volume] in Blood
Acetaldehyde [Mass/volume] in Body fluid
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic method
Acetaldehyde [Mass/volume] in Red Blood Cells
Acetaminophen [Mass/volume] in Body fluid
Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasma
Bismuth [Mass/volume] in Red Blood Cells
Protein C [Units/volume] in Platelet poor plasma by Chromogenic method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma
Fexofenadine [Mass/volume] in Serum or Plasma
Finasteride [Mass/volume] in Serum or Plasma
Gallium [Mass/volume] in Red Blood Cells
Protein C [Units/volume] in Platelet poor plasma by Coagulation assay
Germanium [Mass/volume] in Red Blood Cells
Germanium [Mass/volume] in Serum or Plasma
Hydroxybupropion [Mass/volume] in Body fluid
Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay
Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay
O-desmethylvenlafaxine [Mass/volume] in Blood
Protein C inhibitor [Mass/volume] in Platelet poor plasma by Immunoassay
O-desmethylvenlafaxine [Mass/volume] in Body fluid
O-desmethylvenlafaxine [Mass/mass] in Tissue
Oxychlordane [Mass/volume] in Body fluid
Protein C cofactor [Units/volume] in Platelet poor plasma
PACLitaxel [Mass/volume] in Serum or Plasma
9-Hydroxyrisperidone [Mass/volume] in Blood
9-Hydroxyrisperidone [Mass/volume] in Urine
Palladium [Mass/volume] in Red Blood Cells
Palladium [Mass/volume] in Serum or Plasma
Pancuronium [Mass/volume] in Serum or Plasma
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay
Pargyline [Mass/volume] in Serum or Plasma
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
Penciclovir [Mass/volume] in Serum or Plasma
Pendimethalin [Mass/volume] in Serum or Plasma
von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation
Pentane [Mass/volume] in Serum or Plasma
PENTobarbital [Mass/volume] in Body fluid
Perfluorooctanoate [Mass/volume] in Blood
Perfluorooctanoate [Mass/volume] in Serum or Plasma
Corticotropin IgE Ab [Units/volume] in Serum
Phenolphthalein [Mass/volume] in Serum or Plasma
Platinum [Mass/volume] in Red Blood Cells
Rubidium [Mass/volume] in Red Blood Cells
Silicon [Mass/volume] in Red Blood Cells
Strontium [Mass/volume] in Red Blood Cells
Sulfamethizole [Mass/volume] in Serum or Plasma
Tellurium [Mass/volume] in Red Blood Cells
Terazosin [Mass/volume] in Serum or Plasma
Thallium [Mass/volume] in Red Blood Cells
House dust Allergopharma IgE Ab [Units/volume] in Serum
Thiethylperazine [Mass/volume] in Serum or Plasma
Trichlormethiazide [Mass/volume] in Blood
Trichlormethiazide [Mass/volume] in Serum or Plasma
Triclopyr [Mass/volume] in Serum or Plasma
Trifluralin [Mass/volume] in Serum or Plasma
Alternaria alternata IgE Ab [Units/volume] in Serum
Zolazepam [Mass/volume] in Serum or Plasma
Chloride [Moles/volume] in Mother's milk
Potassium [Moles/volume] in Mother's milk
Coenzyme Q10/Protein [Molar ratio] in Tissue
Intrinsic factor IgG Ab [Units/volume] in Serum
Beta-trace protein [Mass/volume] in Nasal fluid
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose fructose PO
Ascaris sp IgE Ab [Units/volume] in Serum
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose fructose PO
Bacteria identified in Bone by Aerobe culture
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.75 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.25 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.75 hours post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.25 hours post dose lactose PO
Aspergillus amstelodami IgE Ab [Units/volume] in Serum
European Ash IgE Ab [Units/volume] in Serum
Common wasp recombinant (rVes v) 5 IgE Ab [Units/volume] in Serum
Ecarin clotting time (ECT) in Platelet poor plasma by Coagulation assay
Matrix metallopeptidase 9 [Mass/volume] in Serum
Aspergillus flavus IgE Ab [Units/volume] in Serum
Androstanolone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Androstanolone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Aspergillus fumigatus IgE Ab [Units/volume] in Serum
Androstanolone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
MGMT gene methylation [Presence] in Tissue by Molecular genetics method
DNA index 4 in Specimen by Flow cytometry (FC)
Parainfluenza virus 1+2+3 RNA [Presence] in Specimen by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Throat by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection
Bacteria identified in Cornea by Culture
Bacteria identified in Bone marrow by Culture
Adenovirus DNA [Presence] in Isolate by NAA with probe detection
Chikungunya virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Coxiella burnetii DNA [Presence] in Serum or Plasma by NAA with probe detection
Dengue virus 1 RNA [Presence] in Serum by NAA with probe detection
Enterovirus RNA [Presence] in Isolate by NAA with probe detection
Human coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection
Human metapneumovirus RNA [Presence] in Isolate by NAA with probe detection
Influenza virus C RNA [Presence] in Isolate by NAA with probe detection
Orientia tsutsugamushi DNA [Presence] in Serum or Plasma by NAA with probe detection
Aspergillus terreus IgE Ab [Units/volume] in Serum
Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection
Rabies virus RNA [Presence] in Isolate by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Isolate by NAA with probe detection
Rickettsia typhus group DNA [Presence] in Serum or Plasma by NAA with probe detection
Rotavirus RNA [Presence] in Isolate by NAA with probe detection
Rubella virus RNA [Presence] in Serum or Plasma by NAA with probe detection
SARS coronavirus RNA [Presence] in Isolate by NAA with probe detection
oxyCODONE+oxyMORphone cutoff [Mass/volume] in Urine for Screen method
Aspergillus versicolor IgE Ab [Units/volume] in Serum
Complement C3 Ag [Presence] in Tissue by Immunofluorescence
Fibrinogen Ag [Presence] in Tissue by Immunofluorescence
IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method
Amitriptyline [Moles/volume] in Specimen
Brompheniramine [Moles/volume] in Specimen
Chloral hydrate [Moles/volume] in Specimen
Aureobasidium pullulans IgE Ab [Units/volume] in Serum
chlordiazePOXIDE [Moles/volume] in Specimen
chlorproMAZINE [Moles/volume] in Specimen
Budgerigar feather IgE Ab [Units/volume] in Serum
Methotrimeprazine [Moles/volume] in Specimen
Budgerigar serum proteins IgE Ab [Units/volume] in Serum
Norclomipramine [Moles/volume] in Specimen
Nortriptyline [Moles/volume] in Specimen
OXcarbazepine [Moles/volume] in Specimen
Australian pine IgE Ab [Units/volume] in Serum
Sulfamethoxazole [Moles/volume] in Specimen
Crystals.amorphous [Presence] in Urine sediment by Light microscopy
Borrelia burgdorferi IgG bands panel - Serum by Immunoblot
Bahia grass IgE Ab [Units/volume] in Serum
Borrelia burgdorferi IgM bands panel - Serum by Immunoblot
Lipoprotein a/total Lipoprotein in Serum or Plasma
Viable CD34 cells/100 cells in Body fluid
Viable CD34 cells/100 CD34 cells in Body fluid
Viable CD34 cells [#/volume] in Body fluid
Green Bean IgG Ab [Mass/volume] in Serum
Red Kidney Bean IgG Ab [Mass/volume] in Serum
Pinto Bean IgG Ab [Mass/volume] in Serum
Brussel Sprouts IgG Ab [Mass/volume] in Serum
Cantaloupe IgG Ab [Mass/volume] in Serum
Cauliflower IgG Ab [Mass/volume] in Serum
Cheese mold type IgG Ab [Mass/volume] in Serum
Chili Pepper IgG Ab [Mass/volume] in Serum
Grapefruit IgG Ab [Mass/volume] in Serum
American Beech IgE Ab [Units/volume] in Serum
Black Pepper IgG Ab [Mass/volume] in Serum
Green Pepper IgG Ab [Mass/volume] in Serum
Sweet potato IgG Ab [Mass/volume] in Serum
Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
House dust Bencard IgE Ab [Units/volume] in Serum
Sesame Seed IgG Ab [Mass/volume] in Serum
Red Snapper IgG Ab [Mass/volume] in Serum
Sunflower Seed IgG Ab [Mass/volume] in Serum
Brewer's yeast IgG Ab [Mass/volume] in Serum
Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Isolate by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Isolate by NAA with probe detection
Bermuda grass IgE Ab [Units/volume] in Serum
Dengue virus 4 RNA [Presence] in Serum by NAA with probe detection
Dengue virus 3 RNA [Presence] in Serum by NAA with probe detection
Dengue virus 2 RNA [Presence] in Serum by NAA with probe detection
Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
Measles virus genotype [Identifier] in Specimen by NAA with probe detection
Parainfluenza virus 4 Ag [Presence] in Specimen
Human metapneumovirus Ag [Presence] in Specimen
Beta lactoglobulin MF77 IgE Ab [Units/volume] in Serum
Norovirus RNA [Presence] in Isolate by NAA with probe detection
Toxoplasma gondii IgA Ab [Titer] in Serum
Enterovirus 71 RNA [Presence] in Isolate by NAA with probe detection
Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection
Leukocytes by Light microscopy in Urine sediment collected for unspecified duration
Diamine oxidase [Units/volume] in Serum or Plasma
Large granular lymphocytes/100 leukocytes in Blood by Flow cytometry (FC)
Oseltamivir [Susceptibility] by Genotype method
Oseltamivir+Zanamivir [Susceptibility] by Genotype method
Black Ant IgE Ab [Units/volume] in Serum
Bizarre platelets [Presence] in Blood by Light microscopy
Black Pepper IgE Ab [Units/volume] in Serum
Complement C6.functional [Units/volume] in Serum or Plasma
Herpes simplex virus 1 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Neisseria meningitidis serogroup w135 IgG Ab [Mass/volume] in Serum by Immunoassay
Neisseria meningitidis serogroup Y IgG Ab [Mass/volume] in Serum by Immunoassay
Black Walnut Pollen IgE Ab [Units/volume] in Serum
oxyMORphone [Mass/volume] in Serum or Plasma
PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method
Toxocara canis Ab [Units/volume] in Body fluid
Complement C5.functional [Units/volume] in Serum or Plasma
Lymphocytes.vacuolated [Presence] in Blood by Light microscopy
Reticulocytes [#/volume] in Blood by Automated count
Bloodworm IgE Ab [Units/volume] in Serum
Blue mussel IgE Ab [Units/volume] in Serum
Interferon gamma [Mass/volume] in Body fluid
MED12 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NPHP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NPHS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection
Bacteria identified in Bronchial specimen by Aerobe culture
UMOD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Botrytis cinerea IgE Ab [Units/volume] in Serum
LCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Calcidiol+Calciferol [Moles/volume] in Serum or Plasma
Influenza virus A H1 2009 pandemic and Influenza virus A swine origin RNA [Interpretation] in Specimen Qualitative by NAA with probe detection
MAP2K1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MAP2K2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SLC22A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Brazil Nut IgE Ab [Units/volume] in Serum
6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method
Brewer's yeast IgE Ab [Units/volume] in Serum
Iron/Transferrin [Ratio] in Serum or Plasma
Creatinine [Moles/time] in 24 hour Stool
Fatty acids.ethyl esters [Moles/mass] in Meconium
Eosinophils [Presence] in Body fluid by Light microscopy
Babesia microti IgG+IgM Ab [Presence] in Serum
Borrelia hermsii IgG+IgM Ab [Presence] in Serum
Carbromal [Mass/volume] in Serum or Plasma
Helicobacter pylori IgG Ab [Presence] in Serum by Immunoblot
Parechovirus RNA [Presence] in Specimen by NAA with probe detection
Pseudo Pelger Huet cells [Presence] in Blood by Light microscopy
Enterovirus subtype in Specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic Ab [Titer] in Serum
Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection
Japanese encephalitis virus IgM Ab [Titer] in Serum
Japanese encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid
Mycoplasma pneumoniae Ab [Titer] in Serum by Latex agglutination
SARS coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection
CLCN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Influenza virus A H1+H3+B RNA [Presence] in Specimen by NAA with probe detection
Tryptase.beta [Mass/volume] in Serum or Plasma
HBA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Buckwheat IgE Ab [Units/volume] in Serum
Cytomegalovirus early Ag [Presence] in Specimen
Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB)
Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB)
Giardia lamblia DNA [Presence] in Specimen by NAA with probe detection
Cryptosporidium sp DNA [Presence] in Specimen by NAA with probe detection
Polio virus identified [Type] in Isolate by Organism specific culture
11-Oxo-Androsterone/Creatinine [Mass Ratio] in Urine
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in Urine
Fascin [Presence] in Tissue by Immune stain
Interferon.beta 1a Ab [Titer] in Serum or Plasma
Interferon.beta 1b Ab [Titer] in Serum or Plasma
Trypanosoma cruzi Ab [Presence] in Serum from Donor
CD59 deficient monocytes/100 cells in Blood
Bacteria identified in Cannula specimen by Aerobe culture
Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Bumble Bee IgE Ab [Units/volume] in Serum
Respiratory pathogens DNA and RNA 12b panel - Specimen by NAA with probe detection
Pathology Report addendum.synoptic Document
Chamomile IgE Ab [Units/volume] in Serum
HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method
SERPINE1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method
TCRG gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method
TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
TCRB gene rearrangements [Presence] in Body fluid by Molecular genetics method
Canary grass IgE Ab [Units/volume] in Serum
TCRB gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method
TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method
Cell count and Differential panel - Peritoneal dialysis fluid
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Candida albicans IgE Ab [Units/volume] in Serum
Careless Weed IgE Ab [Units/volume] in Serum
Castor Bean IgE Ab [Units/volume] in Serum
Bacteria identified in Cerebral spinal fluid by Culture
Acremonium sp IgE Ab [Units/volume] in Serum
Cheese cheddar type IgE Ab [Units/volume] in Serum
Alpha hydroxytriazolam [Mass/volume] in Urine
Protein/Creatinine [Mass Ratio] in 12 hour Urine
Cortisol Free [Mass/volume] in Serum or Plasma --30 minutes post dose corticotropin
Cheese mold type IgE Ab [Units/volume] in Serum
Cortisol Free [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin
Chestnut Pollen IgE Ab [Units/volume] in Serum
Chicken feather IgE Ab [Units/volume] in Serum
Chicken meat IgE Ab [Units/volume] in Serum
Bacteria identified in Drain by Aerobe culture
Chloramin T IgE Ab [Units/volume] in Serum
Chocolate IgE Ab [Units/volume] in Serum
Chymopapain IgE Ab [Units/volume] in Serum
Cladosporium herbarum IgE Ab [Units/volume] in Serum
Cocklebur IgE Ab [Units/volume] in Serum
Cockroach IgE Ab [Units/volume] in Serum
Bacteria identified in Ear by Aerobe culture
Base excess in Extracellular fluid by calculation
Oxygen content in Venous blood by calculation
Common Ragweed IgE Ab [Units/volume] in Serum
Cultivated Cotton IgE Ab [Units/volume] in Serum
Cottonseed IgE Ab [Units/volume] in Serum
Cottonwood IgE Ab [Units/volume] in Serum
Cow dander IgE Ab [Units/volume] in Serum
Oat pollen IgE Ab [Units/volume] in Serum
Curvularia lunata IgE Ab [Units/volume] in Serum
American house dust mite IgE Ab [Units/volume] in Serum
European house dust mite IgE Ab [Units/volume] in Serum
Dandelion IgE Ab [Units/volume] in Serum
Bacteria identified in Eye by Aerobe culture
Dog dander IgE Ab [Units/volume] in Serum
Dog epithelium IgE Ab [Units/volume] in Serum
Duck feather IgE Ab [Units/volume] in Serum
Duck meat IgE Ab [Units/volume] in Serum
7-Aminoclonazepam [Presence] in Serum or Plasma
7-Aminoclonazepam [Presence] in Specimen
7-Aminoflunitrazepam [Presence] in Serum or Plasma
7-Aminoflunitrazepam [Presence] in Urine
7-Aminoflunitrazepam [Presence] in Specimen
Alpha hydroxyalprazolam [Presence] in Serum or Plasma
Echinococcus sp IgE Ab [Units/volume] in Serum
Alpha hydroxyalprazolam [Presence] in Urine
Alpha hydroxyalprazolam [Presence] in Specimen
N-desalkylflurazepam [Presence] in Urine
N-desalkylflurazepam [Presence] in Specimen
Methylenedioxyamphetamine [Presence] in Serum or Plasma
Methylenedioxyamphetamine [Presence] in Specimen
Methylenedioxyethylamphetamine [Presence] in Serum or Plasma
Methylenedioxyethylamphetamine [Presence] in Urine
Methylenedioxyethylamphetamine [Presence] in Specimen
Norfentanyl [Presence] in Serum or Plasma
Pseudoephedrine [Presence] in Serum or Plasma
Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine
Alpha-Phenyl-2-Piperidine acetate [Presence] in Specimen
Bacteria identified in Body fluid by Aerobe culture
Carboxy tetrahydrocannabinol [Presence] in Gastric fluid
Carboxy tetrahydrocannabinol [Presence] in Specimen
Lysergate diethylamide [Presence] in Specimen
Ethanol [Presence] in Specimen by Screen method
Barbiturates [Presence] in Specimen by Screen method
Egg white IgE Ab [Units/volume] in Serum
7-Aminoclonazepam [Presence] in Gastric fluid
7-Aminoflunitrazepam [Presence] in Gastric fluid
Alpha hydroxyalprazolam [Presence] in Gastric fluid
diphenhydrAMINE [Presence] in Gastric fluid
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid
Flunitrazepam [Presence] in Gastric fluid
Methylenedioxyethylamphetamine [Presence] in Gastric fluid
Methylenedioxymethamphetamine [Presence] in Gastric fluid
Methylphenidate [Presence] in Gastric fluid
Normeperidine [Presence] in Gastric fluid
Pseudoephedrine [Presence] in Gastric fluid
Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid
White Elm IgE Ab [Units/volume] in Serum
Lysergate diethylamide [Presence] in Gastric fluid
Ethanol [Presence] in Gastric fluid by Screen method
Barbiturates [Presence] in Gastric fluid by Screen method
N-desalkylflurazepam [Presence] in Gastric fluid
English plantain IgE Ab [Units/volume] in Serum
Influenza virus A neuraminidase RNA [Type] in Specimen by Sequencing
Influenza virus A and B Ag [Identifier] in Specimen by Immunofluorescence
Prochlorperazine [Moles/volume] in Urine
Prochlorperazine [Moles/volume] in Specimen
Prochlorperazine [Moles/volume] in Gastric fluid
16p11.2 chromosome region deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SLC25A13 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitochondria DNA complex I targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitochondria DNA complex V targeted mutation analysis in Blood or Tissue by Molecular genetics method
ACSL4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitochondria tRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method
Immunoglobulin gene rearrangements in Blood or Tissue by Molecular genetics method Narrative
Mitochondria DNA complex III targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitochondria DNA complex IV targeted mutation analysis in Blood or Tissue by Molecular genetics method
Mitochondria rRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immune stain
Lymphocytes.cytoplasmic IgG/100 lymphocytes in Body fluid
Epicoccum purpurascens IgE Ab [Units/volume] in Serum
Lymphocytes.cytoplasmic IgM/100 lymphocytes in Body fluid
PM-SCL-100 IgG Ab [Units/volume] in Serum
Lymphocytes/100 leukocytes in Specimen by Flow cytometry (FC)
Granulocytes/100 leukocytes in Specimen by Flow cytometry (FC)
Monocytes/100 leukocytes in Specimen by Flow cytometry (FC)
Blasts/100 cells in Specimen by Flow cytometry (FC)
Ethylene oxide IgE Ab [Units/volume] in Serum
Isocyanate TDI IgG Ab [Mass/volume] in Serum
Bacteria identified in Body fluid by Culture
Isocyanate MDI IgG Ab [Mass/volume] in Serum
Isocyanate HDI IgG Ab [Mass/volume] in Serum
Trimellitic anhydride (TMA) IgG Ab [Mass/volume] in Serum
Euroglyphus maynei IgE Ab [Units/volume] in Serum
False ragweed IgE Ab [Units/volume] in Serum
Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method
Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method
Glucose [Mass/volume] in Peritoneal dialysis fluid --baseline
Hepatitis B virus codon L180M [Presence] by Genotype method
Hepatitis B virus codon L80V [Presence] by Genotype method
Hepatitis B virus codon V173L [Presence] by Genotype method
Hepatitis B virus codon M204V [Presence] by Genotype method
Hepatitis B virus codon M204I [Presence] by Genotype method
Hepatitis B virus codon M204S [Presence] by Genotype method
Hepatitis B virus codon A181V [Presence] by Genotype method
Hepatitis B virus codon A181T [Presence] by Genotype method
Hepatitis B virus codon N236T [Presence] by Genotype method
Hepatitis B virus codon A194T [Presence] by Genotype method
Hepatitis B virus codon T184S [Presence] by Genotype method
Hepatitis B virus codon T184I [Presence] by Genotype method
Hepatitis B virus codon S202G [Presence] by Genotype method
Hepatitis B virus codon S202C [Presence] by Genotype method
Hepatitis B virus codon S202I [Presence] by Genotype method
Hepatitis B virus codon I233V [Presence] by Genotype method
Hepatitis B virus codon M250V [Presence] by Genotype method
Hepatitis B virus codon M250I [Presence] by Genotype method
Hepatitis B virus codon M250L [Presence] by Genotype method
Hepatitis B virus codon L80I [Presence] by Genotype method
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20 minutes pre XXX challenge
Polychlorinated biphenyl.Aroclor 1242 [Mass/volume] in Serum or Plasma
Red Imported Fire Ant IgE Ab [Units/volume] in Serum
Polychlorinated biphenyl.Aroclor 1248 [Mass/volume] in Serum or Plasma
Paraneoplastic Ab [Presence] in Serum by Immunofluorescence
Leukocyte morphology finding [Identifier] in Blood from Fetus
Hemoglobin [Mass/volume] in Blood from Fetus
Cells Counted Total [#] in Blood from Fetus
Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood from Fetus
Myeloperoxidase cells/100 cells in Blood
Spermatozoa broken tail/100 spermatozoa in Semen
Spermatozoa thick midpiece/100 spermatozoa in Semen
Spermatozoa thin midpiece/100 spermatozoa in Semen
Spermatozoa bent midpiece/100 spermatozoa in Semen
INR in Platelet poor plasma from Fetus by Coagulation assay
Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assay
aPTT in Platelet poor plasma from Fetus by Coagulation assay
Formaldehyde IgE Ab [Units/volume] in Serum
Cells Counted Total [#] in Pleural fluid from Fetus
Albumin [Mass/volume] in Serum or Plasma from Fetus
Albumin [Mass/volume] in Urine from Fetus
oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method
Raltegravir [Susceptibility] by Phenotype method
HIV 1 integrase gene mutations detected [Identifier]
Carbenicillin [Susceptibility] by Disk diffusion (KB)
Fusarium culmorum IgE Ab [Units/volume] in Serum
Colorado tick fever virus IgG Ab [Titer] in Serum by Immunofluorescence
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab/IgE total in Serum by Multidisk
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab/IgE total in Serum by Multidisk
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab/IgE total in Serum by Multidisk
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab/IgE total in Serum by Multidisk
Aedes mosquito IgE Ab/IgE total in Serum
Lactalbumin alpha IgE Ab/IgE total in Serum
Common Ragweed IgE Ab/IgE total in Serum
Sweet Vernal grass IgE Ab/IgE total in Serum
Fusarium moniliforme IgE Ab [Units/volume] in Serum
Bacterial strain [Type] in Isolate by Bacteria subtyping
Aspergillus niger IgE Ab/IgE total in Serum
Aspergillus sp IgE Ab/IgE total in Serum
Aureobasidium pullulans IgE Ab/IgE total in Serum
Silver Birch recombinant (rBet v) 1 IgE Ab/IgE total in Serum
Botrytis cinerea IgE Ab/IgE total in Serum
Budgerigar droppings IgE Ab/IgE total in Serum
Budgerigar feather IgE Ab/IgE total in Serum
Candida albicans IgE Ab/IgE total in Serum
Pecan or Hickory Tree IgE Ab/IgE total in Serum
Giant Ragweed IgE Ab [Units/volume] in Serum
Chaetomium globosum IgE Ab/IgE total in Serum
Cladosporium herbarum IgE Ab/IgE total in Serum
Japanese Cedar IgE Ab/IgE total in Serum
Arizona Cypress IgE Ab/IgE total in Serum
Italian Cypress IgE Ab/IgE total in Serum
Dermatophagoides microceras IgE Ab/IgE total in Serum
European house dust mite IgE Ab/IgE total in Serum
Whitefaced Hornet IgE Ab/IgE total in Serum
American Beech IgE Ab/IgE total in Serum
Glycyphagus domesticus IgE Ab [Units/volume] in Serum
Sunflower Seed IgE Ab/IgE total in Serum
House dust Greer IgE Ab/IgE total in Serum
Goat epithelium IgE Ab [Units/volume] in Serum
Insulin porcine IgE Ab/IgE total in Serum
Isocyanate HDI IgE Ab/IgE total in Serum
Isocyanate TDI IgE Ab/IgE total in Serum
English Walnut IgE Ab/IgE total in Serum
Perennial rye grass IgE Ab/IgE total in Serum
Goldenrod IgE Ab [Units/volume] in Serum
White mulberry IgE Ab/IgE total in Serum
Goose feather IgE Ab [Units/volume] in Serum
Phthalic anhydride IgE Ab/IgE total in Serum
Eastern White Pine IgE Ab/IgE total in Serum
Fungal strain [Type] in Isolate by Fungus subtyping
English plantain IgE Ab/IgE total in Serum
Kentucky blue grass IgE Ab/IgE total in Serum
Rhizopus nigricans IgE Ab/IgE total in Serum
Goose meat IgE Ab [Units/volume] in Serum
Red Imported Fire Ant IgE Ab/IgE total in Serum
Grapefruit IgE Ab [Units/volume] in Serum
Trimellitic anhydride (TMA) IgE Ab/IgE total in Serum
Green Coffee Bean IgE Ab [Units/volume] in Serum
European Hornet IgE Ab/IgE total in Serum
Green Nimitti IgE Ab [Units/volume] in Serum
Dog epithelium IgE Ab/IgE total in Serum
Cochineal extract IgE Ab/IgE total in Serum
Chicken feather IgE Ab/IgE total in Serum
Guinea pig epithelium IgE Ab [Units/volume] in Serum
Gerbil epithelium IgE Ab/IgE total in Serum
Mouse urine proteins IgE Ab/IgE total in Serum
Ferret epithelium IgE Ab/IgE total in Serum
Sheep epithelium IgE Ab/IgE total in Serum
Rat urine proteins IgE Ab/IgE total in Serum
Cockatiel droppings IgE Ab/IgE total in Serum
Cockatiel feather IgE Ab/IgE total in Serum
Lymphocyte proliferation stimulated by 2.5 ug concanavalin A in Blood
Lymphocyte proliferation stimulated by 0.6 ug pokeweed mitogen in Blood
Lymphocyte proliferation stimulated by 2.5 ug pokeweed mitogen in Blood
Lymphocyte proliferation stimulated by 10 ug phytohemagglutinin in Blood
Lymphocyte proliferation stimulated by 40 ug phytohemagglutinin in Blood
Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Hamster epithelium IgE Ab [Units/volume] in Serum
Acinetobacter baumannii DNA [Presence] in Specimen by NAA with probe detection
Klebsiella aerogenes DNA [Presence] in Specimen by NAA with probe detection
Enterococcus faecalis DNA [Presence] in Specimen by NAA with probe detection
Adenovirus 3+4+7+21 DNA [Presence] in Specimen by NAA with probe detection
Echovirus+Coxsackievirus RNA [Presence] in Specimen by NAA with probe detection
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
Clostridioides difficile DNA [Presence] in Specimen by NAA with probe detection
Campylobacter jejuni DNA [Presence] in Specimen by NAA with probe detection
Listeria monocytogenes DNA [Presence] in Specimen by NAA with probe detection
Salmonella enterica DNA [Presence] in Specimen by NAA with probe detection
Vibrio cholerae DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 16 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Specimen by NAA with probe detection
Hazelnut Pollen IgE Ab [Units/volume] in Serum
Human papilloma virus 26 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 31 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 33 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 35 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 39 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 44 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 45 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 51 DNA [Presence] in Specimen by NAA with probe detection
Setomelanomma rostrata IgE Ab [Units/volume] in Serum
Human papilloma virus 52 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 53 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 58 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 59 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 66 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 67 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 68 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 69 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 70 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 73 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 82 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 6 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 11 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 42 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 56 DNA [Presence] in Specimen by NAA with probe detection
Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection
Escherichia coli DNA [Presence] in Specimen by NAA with probe detection
Klebsiella pneumoniae DNA [Presence] in Specimen by NAA with probe detection
Proteus mirabilis DNA [Presence] in Specimen by NAA with probe detection
Pseudomonas aeruginosa DNA [Presence] in Specimen by NAA with probe detection
Serratia marcescens DNA [Presence] in Specimen by NAA with probe detection
Stenotrophomonas maltophilia DNA [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection
Staphylococcus epidermidis DNA [Presence] in Specimen by NAA with probe detection
XXX blood group Ab [Titer] in Serum or Plasma
Amitriptyline/Creatinine [Mass Ratio] in Urine
Cyclobenzaprine/Creatinine [Mass Ratio] in Urine
Cyclobenzaprine [Presence] in Urine by Confirmatory method
Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method
Desipramine/Creatinine [Mass Ratio] in Urine
Desipramine [Presence] in Urine by Confirmatory method
Desipramine [Mass/volume] in Urine by Confirmatory method
Doxepin/Creatinine [Mass Ratio] in Urine
Doxepin [Presence] in Urine by Confirmatory method
Doxepin [Mass/volume] in Urine by Confirmatory method
Imipramine/Creatinine [Mass Ratio] in Urine
Imipramine [Presence] in Urine by Confirmatory method
Imipramine [Mass/volume] in Urine by Confirmatory method
Norhydrocodone/Creatinine [Mass Ratio] in Urine
Norhydrocodone [Presence] in Urine by Confirmatory method
Norhydrocodone [Mass/volume] in Urine by Confirmatory method
Noroxycodone/Creatinine [Mass Ratio] in Urine
Hornet venom IgE Ab [Units/volume] in Serum
Noroxycodone [Presence] in Urine by Confirmatory method
Noroxycodone [Mass/volume] in Urine by Confirmatory method
Nortriptyline/Creatinine [Mass Ratio] in Urine
Nortriptyline [Presence] in Urine by Confirmatory method
Nortriptyline [Mass/volume] in Urine by Confirmatory method
Tapentadol/Creatinine [Mass Ratio] in Urine
Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay
Horse dander IgE Ab [Units/volume] in Serum
Horse Fly IgE Ab [Units/volume] in Serum
House dust IgE Ab [Units/volume] in Serum
Insulin bovine IgE Ab [Units/volume] in Serum
Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping
Insulin human IgE Ab [Units/volume] in Serum
Insulin porcine IgE Ab [Units/volume] in Serum
Ispaghula laxative IgE Ab [Units/volume] in Serum
Italian Cypress IgE Ab [Units/volume] in Serum
Johnson grass IgE Ab [Units/volume] in Serum
Kentucky blue grass IgE Ab [Units/volume] in Serum
Kiwifruit IgE Ab [Units/volume] in Serum
Viral strain [Type] in Isolate by Viral subtyping
Goosefoot IgE Ab [Units/volume] in Serum
Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
Bacteria identified in Line specimen by IV Line culture
Lime Tree (Citrus aurantifolia tree) IgE Ab [Units/volume] in Serum
Virginia Live Oak IgE Ab [Units/volume] in Serum
Meadow Fescue IgE Ab [Units/volume] in Serum
Meadow Foxtail IgE Ab [Units/volume] in Serum
Bacteria identified in Placenta by Aerobe culture
Cajeput tree IgE Ab [Units/volume] in Serum
Common Millet IgE Ab [Units/volume] in Serum
Aedes mosquito IgE Ab [Units/volume] in Serum
Mountain Juniper IgE Ab [Units/volume] in Serum
Mouse epithelium IgE Ab [Units/volume] in Serum
Mouse serum proteins IgE Ab [Units/volume] in Serum
Mouse urine proteins IgE Ab [Units/volume] in Serum
Mucor racemosus IgE Ab [Units/volume] in Serum
Neurospora sitophila IgE Ab [Units/volume] in Serum
Bacteria identified in Pleural fluid by Culture
White Oak IgE Ab [Units/volume] in Serum
Olive Pollen IgE Ab [Units/volume] in Serum
Cocksfoot IgE Ab [Units/volume] in Serum
Ox-eye daisy IgE Ab [Units/volume] in Serum
Bacteria identified in Peritoneal fluid by Culture
Paecilomyces sp IgE Ab [Units/volume] in Serum
Paper wasp IgE Ab [Units/volume] in Serum
Pellitory (Parietaria judaica) IgE Ab [Units/volume] in Serum
Carbenicillin [Susceptibility] by Serum bactericidal titer
Pellitory (Parietaria officinalis) IgE Ab [Units/volume] in Serum
Parrot droppings IgE Ab [Units/volume] in Serum
Parrot feather IgE Ab [Units/volume] in Serum
Bacteria identified in Skin by Aerobe culture
Pecan or Hickory Nut IgE Ab [Units/volume] in Serum
Pecan or Hickory Tree IgE Ab [Units/volume] in Serum
Penicillin V IgE Ab [Units/volume] in Serum
Penicillium brevicompactum IgE Ab [Units/volume] in Serum
Penicillium notatum IgE Ab [Units/volume] in Serum
Bacteria identified in Synovial fluid by Culture
Pepper tree IgE Ab [Units/volume] in Serum
Phoma betae IgE Ab [Units/volume] in Serum
Pigeon droppings IgE Ab [Units/volume] in Serum
Pineapple IgE Ab [Units/volume] in Serum
XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection
XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection
t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Bacteria identified in Sputum by Aerobe culture
Queen Palm IgE Ab [Units/volume] in Serum
Rabbit epithelium IgE Ab [Units/volume] in Serum
Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method
Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method
Pyridoxal phosphate [Moles/volume] in Serum or Plasma
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
Leukocytes [#/volume] in Blood from Fetus by Automated count
Rat epithelium IgE Ab [Units/volume] in Serum
Erythrocytes [#/volume] in Blood from Fetus by Automated count
Hematocrit [Volume Fraction] of Blood from Fetus by Automated count
MCV [Entitic volume] in Blood from Fetus by Automated count
MCH [Entitic mass] in Blood from Fetus by Automated count
Platelets [#/volume] in Blood from Fetus by Automated count
Nucleated erythrocytes/100 leukocytes [Ratio] in Blood from Fetus by Automated count
MCHC [Mass/volume] in Blood from Fetus by Automated count
Erythrocyte distribution width [Ratio] in Blood from Fetus by Automated count
Nucleated erythrocytes [#/volume] in Blood from Fetus by Automated count
Reticulocytes [#/volume] in Blood from Fetus by Automated count
Immature reticulocytes/Reticulocytes.total in Blood from Fetus by Automated count
Leukocytes [#/volume] in Pleural fluid from Fetus by Automated count
Lipoprotein.alpha [Entitic length] in Serum or Plasma
Lipoprotein.pre-beta [Entitic length] in Serum or Plasma
Lipoprotein insulin resistance score in Serum or Plasma
Aminoglycoside resistance aacA gene [Presence] by Molecular method
Rat serum proteins IgE Ab [Units/volume] in Serum
Erythromyin+clindamycin resistance ermA + ermC genes [Presence] by Molecular method
Tetracycline resistance tetK + tetM genes [Presence] by Molecular method
Vancomycin resistance vanA + vanB genes [Presence] by Molecular method
Rat urine proteins IgE Ab [Units/volume] in Serum
Red Pepper IgE Ab [Units/volume] in Serum
Red top grass IgE Ab [Units/volume] in Serum
1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma
1,25-Dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma
Rhizopus nigricans IgE Ab [Units/volume] in Serum
Lysosomal storage disorders newborn screening panel
Lysosomal storage disorders newborn screen interpretation
Lysosomal storage disorders suspected [Identifier] in DBS
Lysosomal storage disorders newborn screening comment-discussion
Fabry disease newborn screen interpretation
Fabry disease newborn screening comment-discussion
Krabbe disease newborn screen interpretation
Krabbe disease newborn screening comment-discussion
Galactosylceramidase [Enzymatic activity/volume] in DBS
Gaucher disease newborn screen interpretation
Gaucher disease newborn screening comment-discussion
Niemann Pick disease A/B newborn screening panel
Acid sphingomyelinase [Enzymatic activity/volume] in DBS
Niemann Pick disease A/B newborn screen interpretation
Niemann Pick disease A/B newborn screening comment-discussion
T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection
Severe combined immunodeficiency newborn screen interpretation
Severe combined immunodeficiency newborn screening comment-discussion
Rough Marsh Elder IgE Ab [Units/volume] in Serum
Post-discharge provider name in Provider
Post-discharge provider practice address
Rough Pigweed IgE Ab [Units/volume] in Serum
Severe combined immunodeficiency (SCID) newborn screening panel
Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum
Borrelia burgdorferi IgG and IgM [Interpretation] in Serum by Immunoblot
Chromosome analysis copy number change panel by Microarray
Chromosome analysis.metaphase panel - Blood by FISH
Chromosome analysis.interphase panel - Blood by FISH
Chromosome analysis.interphase panel - Amniotic fluid by FISH
Chromosome analysis.prenatal panel by FISH
Chromosome analysis panel - Blood by G-banded
Chromosome analysis panel - Blood from Fetus by G-banded
Chromosome analysis panel - Chorionic villus sample by G-banded
Chromosome analysis panel - Amniotic fluid by G-banded
Chromosome analysis panel - Products of Conception by G-banded
Chromosome analysis panel - Skin by G-banded
Chromosome analysis.metaphase panel - Amniotic fluid by FISH
Chromosome analysis result in ISCN expression
Chromosome analysis overall interpretation Qualitative
Cultivated Rye IgE Ab [Units/volume] in Serum
Test performance information in Specimen Narrative
Diagnostic impression [Interpretation] in Specimen Narrative
FISH probe name panel - Laboratory device
FISH probe gene name [Identifier] in Laboratory device
FISH probe locus [Identifier] in Laboratory device
FISH probe vendor [Identifier] in Laboratory device
Human reference assembly release, UCSC version [Identifier]
Human reference sequence assembly version
Microarray platform [Identifier] Narrative
Microarray platform version number Narrative
Salt grass IgE Ab [Units/volume] in Serum
Recommendation [Interpretation] Document
Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol
Bacteria identified in Sputum by Cystic fibrosis respiratory culture
Seminal fluid IgE Ab [Units/volume] in Serum
Dry-rot Fungus IgE Ab [Units/volume] in Serum
Glucose/Insulin [Ratio] in Serum or Plasma
Galectin 3 [Mass/volume] in Serum or Plasma
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --8th specimen fasting
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --9th specimen fasting
Sesame Seed IgE Ab [Units/volume] in Serum
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma --10th specimen fasting
Human coronavirus HKU1 RNA [Presence] in Specimen by NAA with probe detection
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
Creatinine [Moles/volume] in Serum or Plasma --post XXX challenge
Bordetella sp DNA panel - Specimen by NAA with probe detection
Bordetella holmesii DNA [Presence] in Specimen by NAA with probe detection
Bordetella sp DNA [Identifier] in Specimen by NAA with probe detection
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence
Sheep epithelium IgE Ab [Units/volume] in Serum
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay
Eastern equine encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay
La Crosse virus IgM Ab [Presence] in Body fluid by Immunoassay
La Crosse virus IgG Ab [Presence] in Body fluid by Immunoassay
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence
Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay
West Nile virus IgM Ab [Presence] in Body fluid by Immunoassay
Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Automated count
Nucleated erythrocytes [#/volume] in Synovial fluid by Automated count
Nucleated erythrocytes [#/volume] in Body fluid by Automated count
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid by Automated count
Nucleated erythrocytes/100 leukocytes [Ratio] in Cerebral spinal fluid by Automated count
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid by Automated count
Sheep Sorrel IgE Ab [Units/volume] in Serum
Fatty acids.ethyl esters [Moles/mass] in Hair
Herpes simplex virus and Varicella zoster virus identified in Specimen by Organism specific culture
Sheep wool IgE Ab [Units/volume] in Serum
Coccidioides sp F Ab [Presence] in Serum by Immune diffusion (ID)
HIV 2 p15 Ab [Presence] in Serum by Immunoblot
Coccidioides sp TP Ab [Presence] in Serum by Immune diffusion (ID)
Coccidioides immitis IgM Ab [Presence] in Serum by Immune diffusion (ID)
Coccidioides immitis IgG Ab [Presence] in Serum by Immune diffusion (ID)
Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by NAA with probe detection
Influenza virus A+B RNA [Presence] in Specimen by NAA with probe detection
Enterovirus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Enterovirus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Toxoplasma gondii DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection
BK virus IgG Ab [Presence] in Serum or Plasma
Galactomannan Ag [Units/volume] in Specimen by Immunoassay
1,3 beta glucan [Mass/volume] in Specimen
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Bacteria identified in Sputum by Respiratory culture
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection
Aspergillus fumigatus DNA [Presence] in Specimen by NAA with probe detection
Aspergillus terreus DNA [Presence] in Specimen by NAA with probe detection
Adenovirus DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Herpes virus 6A DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Herpes virus 6B DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Herpes virus 6A DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes virus 6B DNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes virus 6A DNA [Presence] in Specimen by NAA with probe detection
Herpes virus 6B DNA [Presence] in Specimen by NAA with probe detection
Urobilinogen [Presence] in Urine by Automated test strip
Sulfate.inorganic [Moles/time] in 24 hour Urine
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Streptococcus agalactiae DNA [Identifier] in Unspecified specimen by NAA with probe detection
Spiny lobster IgE Ab [Units/volume] in Serum
Spiny Pigweed IgE Ab [Units/volume] in Serum
Sporobolomyces roseus IgE Ab [Units/volume] in Serum
Stemphylium botryosum IgE Ab [Units/volume] in Serum
Midge stinging IgE Ab [Units/volume] in Serum
Acarus siro IgE Ab [Units/volume] in Serum
Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
Strawberry IgE Ab [Units/volume] in Serum
Sunflower Seed IgE Ab [Units/volume] in Serum
Sweet gum IgE Ab [Units/volume] in Serum
Sweet Vernal grass IgE Ab [Units/volume] in Serum
Bacteria identified in Throat by Culture
Swine epithelium IgE Ab [Units/volume] in Serum
American Sycamore IgE Ab [Units/volume] in Serum
Trichoderma viride IgE Ab [Units/volume] in Serum
Bacteria identified in Tissue by Aerobe culture
Turkey meat IgE Ab [Units/volume] in Serum
Velvet grass IgE Ab [Units/volume] in Serum
California Walnut IgE Ab [Units/volume] in Serum
Western Ragweed IgE Ab [Units/volume] in Serum
Cultivated Wheat IgE Ab [Units/volume] in Serum
White Ash IgE Ab [Units/volume] in Serum
White Bean IgE Ab [Units/volume] in Serum
Whitefaced Hornet IgE Ab [Units/volume] in Serum
White mulberry IgE Ab [Units/volume] in Serum
Eastern White Pine IgE Ab [Units/volume] in Serum
Wild Silk IgE Ab [Units/volume] in Serum
Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma
Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma
Micromegakaryocytes [#/volume] in Blood by Manual count
Micromegakaryocytes/100 leukocytes in Blood by Manual count
Rotavirus RNA [Presence] in Specimen by NAA with probe detection
Influenza virus C RNA [Presence] in Specimen by NAA with probe detection
Enterovirus 71 RNA [Presence] in Specimen by NAA with probe detection
Microsatellite instability [Presence] in Tissue by Immune stain
Baker's yeast IgE Ab [Units/volume] in Serum
Bacteria identified in Tissue by Anaerobe culture
Yellow Hornet IgE Ab [Units/volume] in Serum
Lysozyme [Moles/volume] in Serum or Plasma
Complement membrane C3b-C4b cofactor protein [Presence] in Leukocytes
Complement iC3b receptors [Presence] in Leukocytes
Complement decay accelerating factor [Presence] in Red Blood Cells
Complement C4d [Presence] in Red Blood Cells
Jamestown canyon virus IgM Ab [Titer] in Body fluid by Immunofluorescence
MPL gene p.Trp515Leu+Trp515Lys+Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method
MPL gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Complement C3d [Presence] in Red Blood Cells
Complement C3b-C4b receptor [Presence] in Red Blood Cells
Complement C1q Ag [Units/volume] in Serum
INR in Platelet poor plasma by Coagulation assay
Prothrombin index in Platelet poor plasma by Coagulation assay
Budgerigar droppings IgE Ab [Units/volume] in Serum
17-Hydroxyprogesterone/Creatinine [Mass Ratio] in Urine
Cotinine [Presence] in Saliva (oral fluid) by Screen method
Plasmodium malariae Ab [Units/volume] in Serum
Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay
TOP2A gene copy number/Chromosome 17 copy number in Tissue by FISH
TOP2A gene [Interpretation] in Tissue Narrative
TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH
Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular method
Adenovirus rRNA [Presence] in Tissue by Probe
American house dust mite IgG Ab [Mass/volume] in Serum
Cat dander IgG Ab [Mass/volume] in Serum
Dog dander IgG Ab [Mass/volume] in Serum
White Bean IgG Ab [Mass/volume] in Serum
Adenovirus rRNA [Presence] in Specimen by Probe
Brazil Nut IgG Ab [Mass/volume] in Serum
Blue mussel IgG Ab [Mass/volume] in Serum
Chub Mackerel IgG Ab [Mass/volume] in Serum
Common Millet IgG Ab [Mass/volume] in Serum
Parmesan Cheese IgG Ab [Mass/volume] in Serum
Beta lactoglobulin IgG Ab [Mass/volume] in Serum
Cheese cheddar type IgG Ab [Mass/volume] in Serum
Honeydew melon IgG Ab [Mass/volume] in Serum
Cottonseed IgG Ab [Mass/volume] in Serum
Arbovirus identified in Blood by Organism specific culture
American Cheese IgG Ab [Mass/volume] in Serum
Black-eye pea IgG Ab [Mass/volume] in Serum
Swiss Cheese IgG Ab [Mass/volume] in Serum
Arbovirus identified in Specimen by Organism specific culture
Pecan or Hickory Nut IgG Ab [Mass/volume] in Serum
Cashew nut IgG Ab [Mass/volume] in Serum
Blackberry IgG Ab [Mass/volume] in Serum
Babesia microti Ab [Units/volume] in Serum by Immunoassay
Poppy Seed IgG Ab [Mass/volume] in Serum
Bacteria identified in Unknown substance by Aerobe culture
Bartonella henselae IgM Ab [Units/volume] in Serum by Immunoassay
Fennel Fresh IgG Ab [Mass/volume] in Serum
Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay
Papaya (Carica papaya) IgG Ab [Mass/volume] in Serum
Sardine (pilchard) IgG Ab [Mass/volume] in Serum
Wine vinegar IgG Ab [Mass/volume] in Serum
Bass, Black IgG Ab [Mass/volume] in Serum
Gum arabic IgG Ab [Mass/volume] in Serum
Karaya gum IgG Ab [Mass/volume] in Serum
Horseradish IgG Ab [Mass/volume] in Serum
Maple syrup IgG Ab [Mass/volume] in Serum
Bordetella pertussis Ab [Titer] in Specimen by Immunofluorescence
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum by Multidisk
Bermuda grass IgG Ab [Mass/volume] in Serum
Johnson grass IgG Ab [Mass/volume] in Serum
Cultivated Rye IgG Ab [Mass/volume] in Serum
Cultivated Wheat IgG Ab [Mass/volume] in Serum
Bordetella pertussis Ab [Titer] in Serum by Agglutination
Bahia grass IgG Ab [Mass/volume] in Serum
House dust Greer IgG Ab [Mass/volume] in Serum
House dust Hollister Stier IgG Ab [Mass/volume] in Serum
Castor Bean IgG Ab [Mass/volume] in Serum
Curvularia lunata IgG Ab [Mass/volume] in Serum
Paecilomyces sp IgG Ab [Mass/volume] in Serum
Bordetella pertussis Ab [Titer] in Serum by Complement fixation
Penicillium brevicompactum IgG Ab [Mass/volume] in Serum
Dry-rot Fungus IgG Ab [Mass/volume] in Serum
Aspergillus terreus IgG Ab [Mass/volume] in Serum
Trichophyton mentagrophytes IgG Ab [Mass/volume] in Serum
Aspergillus amstelodami IgG Ab [Mass/volume] in Serum
Aspergillus nidulans IgG Ab [Mass/volume] in Serum
Helminthosporium interseminatum IgG Ab [Mass/volume] in Serum
Neurospora sitophila IgG Ab [Mass/volume] in Serum
Bordetella sp identified in Specimen by Organism specific culture
Mucor plumbeus IgG Ab [Mass/volume] in Serum
Mycogone perniciosa IgG Ab [Mass/volume] in Serum
Spondylocladium sp IgG Ab [Mass/volume] in Serum
Epidermophyton floccosum IgG Ab [Mass/volume] in Serum
Acremonium sp IgG Ab [Mass/volume] in Serum
Chaetomium globosum IgG Ab [Mass/volume] in Serum
Johnson grass smut IgG Ab [Mass/volume] in Serum
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Mountain Juniper IgG Ab [Mass/volume] in Serum
Cottonwood IgG Ab [Mass/volume] in Serum
Rough Pigweed IgG Ab [Mass/volume] in Serum
Rough Marsh Elder IgG Ab [Mass/volume] in Serum
Yellow Dock IgG Ab [Mass/volume] in Serum
Common Sagebrush IgG Ab [Mass/volume] in Serum
Sunflower Pollen IgG Ab [Mass/volume] in Serum
Alternaria alternata+American house dust mite IgG Ab [Mass/volume] in Serum by Multidisk
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk
Borrelia burgdorferi Ab [Units/volume] in Body fluid by Immunoassay
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk
Bacteria identified in Wound by Aerobe culture
White mulberry IgG Ab [Mass/volume] in Serum
Smooth Alder IgG Ab [Mass/volume] in Serum
Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot
Common Ragweed IgG Ab [Mass/volume] in Serum
False ragweed IgG Ab [Mass/volume] in Serum
English plantain IgG Ab [Mass/volume] in Serum
Actin smooth muscle Ab [Presence] in Serum by Immunoassay
Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence
Asialoganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay
Bactericidal permeability increasing protein Ab [Units/volume] in Serum by Immunoassay
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot
Bactericidal permeability increasing protein Ab [Presence] in Body fluid by Immunoassay
Cathepsin G Ab [Units/volume] in Serum by Immunoassay
CV2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Cyclic citrullinated peptide IgG Ab [Units/volume] in Body fluid by Immunoassay
Desmoglein 1 Ab [Presence] in Serum by Immunoassay
Desmoglein 3 Ab [Presence] in Serum by Immunoassay
DNA double strand Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
DNA double strand Ab [Presence] in Pleural fluid by Immunofluorescence
Borrelia burgdorferi Ag [Units/volume] in Serum
DNA double strand Ab [Units/volume] in Pleural fluid by Immunoassay
DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
DNA double strand IgG Ab [Presence] in Body fluid by Immunoassay
DNA double strand IgG Ab [Presence] in Body fluid by Immunofluorescence
DNA double strand IgG Ab [Units/volume] in Body fluid by Immunoassay
DNA double strand IgG Ab [Titer] in Body fluid by Immunofluorescence
DNA double strand IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Borrelia sp identified in Specimen by Organism specific culture
DNA double strand IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Immunoassay
DNA double strand IgM Ab [Presence] in Body fluid by Immunofluorescence
DNA double strand IgM Ab [Units/volume] in Body fluid by Immunoassay
DNA double strand IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
DNA double strand IgM Ab [Units/volume] in Pleural fluid by Immunoassay
DNA double strand IgM Ab [Presence] in Serum by Immunofluorescence
DNA double strand IgM Ab [Units/volume] in Serum by Immunoassay
Extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GM1 IgG Ab [Presence] in Body fluid by Immunoassay
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Ganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GM1 IgM Ab [Presence] in Body fluid by Immunoassay
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Ganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay
Brucella abortus Ab [Titer] in Serum by Agglutination
Ganglioside GM2 IgG Ab [Presence] in Serum by Immunoassay
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GM2 IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GM3 IgG Ab [Presence] in Serum by Immunoassay
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GM3 IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoassay
Brucella abortus Ab [Titer] in Serum by Complement fixation
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GT1b IgG Ab [Presence] in Serum by Immunoassay
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Immunoassay
Ganglioside GT1b IgM Ab [Presence] in Serum by Immunoassay
Gliadin IgA Ab [Titer] in Cerebral spinal fluid by Immunoassay
Gliadin IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay
Glomerular basement membrane Ab [Presence] in Serum by Immunoassay
Brucella abortus IgM Ab [Units/volume] in Serum by Immunoassay
Histone Ab [Presence] in Body fluid by Immunoassay
Histone Ab [Presence] in Cerebral spinal fluid by Immunoassay
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Keratin Ab [Presence] in Serum by Immunofluorescence
Ku Ab [Presence] in Body fluid by Immunoassay
Liver kidney microsomal 1 Ab [Presence] in Body fluid by Immunofluorescence
Brucella canis Ab [Units/volume] in Serum by Immunoassay
Liver kidney microsomal 1 Ab [Titer] in Body fluid by Immunofluorescence
Liver kidney microsomal 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Liver kidney microsomal 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Liver kidney microsomal 2 Ab [Presence] in Serum by Immunofluorescence
Liver kidney microsomal 2 Ab [Titer] in Serum by Immunofluorescence
Mi-2 Ab [Presence] in Body fluid by Immunoassay
Mitochondria Ab [Presence] in Body fluid by Immunofluorescence
Mitochondria Ab [Titer] in Body fluid by Immunofluorescence
Mitochondria Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Mitochondria Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Mitochondria M2 Ab [Presence] in Body fluid by Immunoassay
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Immunoassay
Mitochondria M2 Ab [Presence] in Serum by Immunoassay
Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence
Mitochondria M5 Ab [Titer] in Serum by Immunofluorescence
Myelin Ab [Presence] in Body fluid by Immunofluorescence
Myelin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoassay
Brucella sp Ab [Titer] in Serum by Immunofluorescence
Myelin associated glycoprotein Ab [Units/volume] in Body fluid by Immunoassay
Myelin associated glycoprotein Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoassay
Neutrophil cytoplasmic Ab [Titer] in Body fluid by Immunofluorescence
Neutrophil cytoplasmic Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Nuclear Ab [Presence] in Cerebral spinal fluid by Hep2 substrate
Nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Campylobacter coli rRNA [Presence] in Specimen by Probe
Nuclear Ab [Titer] in Cerebral spinal fluid by Hep2 substrate
Nucleosome Ab [Presence] in Body fluid by Immunoassay
Nucleosome Ab [Presence] in Cerebral spinal fluid by Immunoassay
Nucleosome Ab [Presence] in Serum by Immunoassay
Parathyrin Ab [Presence] in Serum by Immunofluorescence
Parathyrin Ab [Titer] in Serum by Immunofluorescence
Parietal cell Ab [Presence] in Gastric fluid by Immunofluorescence
Parietal cell Ab [Titer] in Gastric fluid by Immunofluorescence
Campylobacter sp identified in Blood by Organism specific culture
PCNA extractable nuclear Ab [Presence] in Body fluid by Immunoassay
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
PM-SCL extractable nuclear Ab [Presence] in Body fluid by Immunoassay
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Proteinase 3 Ab [Presence] in Body fluid by Immunoassay
Proteinase 3 Ab [Presence] in Serum by Immunoassay
Proteinase 3 Ab [Presence] in Serum by Immunofluorescence
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay
Campylobacter sp identified in Stool by Organism specific culture
Rheumatoid factor [Units/volume] in Body fluid by Sheep Cell Agglutination
Rheumatoid factor IgA [Units/volume] in Body fluid by Immunoassay
Rheumatoid factor IgM [Units/volume] in Body fluid by Immunoassay
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Ribosomal Ab [Presence] in Body fluid by Immunofluorescence
Campylobacter sp identified in Specimen by Organism specific culture
Ribosomal Ab [Titer] in Body fluid by Immunofluorescence
Ribosomal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Ribosomal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Ribosomal IgG Ab [Presence] in Serum by Immunoassay
Ribosomal IgG Ab [Titer] in Serum by Immunoassay
Ribosomal P Ab [Presence] in Body fluid by Immunoassay
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoassay
RNA polymerase III Ab [Presence] in Serum by Immunoassay
RNA polymerase III Ab [Units/volume] in Serum by Immunoassay
Baker's yeast IgA Ab [Units/volume] in Body fluid by Immunoassay
Baker's yeast IgA Ab [Presence] in Serum by Immunofluorescence
Baker's yeast IgG Ab [Units/volume] in Body fluid by Immunoassay
Baker's yeast IgG Ab [Presence] in Serum by Immunofluorescence
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immunoassay
SCL-70 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
SCL-70 extractable nuclear Ab [Titer] in Serum by Immunoassay
Campylobacter jejuni rRNA [Presence] in Specimen by Probe
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD Ab [Titer] in Body fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoassay
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear 60kD Ab [Titer] in Body fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Flow cytometry (FC)
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
Campylobacter lari rRNA [Presence] in Specimen by Probe
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Smith extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)
Smith extractable nuclear Ab [Presence] in Body fluid by Immunoassay
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Smooth muscle Ab [Presence] in Body fluid by Immunofluorescence
Smooth muscle Ab [Titer] in Body fluid by Immunofluorescence
Smooth muscle Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Smooth muscle Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Thyroglobulin Ab [Units/volume] in Body fluid by Immunoassay
Thyroglobulin Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Thyroperoxidase Ab [Units/volume] in Body fluid by Immunoassay
Thyroperoxidase Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Thyrotropin receptor Ab [Units/volume] in Blood from Fetus
Thyrotropin receptor Ab [Units/volume] in Cord blood
Thyrotropin receptor Ab [Units/volume] in Body fluid
Thyrotropin receptor Ab [Units/volume] in Cerebral spinal fluid
U1 small nuclear ribonucleoprotein Ab [Titer] in Serum by Immunoassay
Carbapenem resistance genes [Identifier] by NAA with probe detection
Candida albicans Ag [Presence] in Serum by Immune diffusion (ID)
Gamma tocopherol [Mass/volume] in Serum or Plasma
Ketones [Presence] in Urine by Test strip --1 hour post dose glucose
Ketones [Presence] in Urine by Test strip --3 hours post dose glucose
Ketones [Presence] in Urine by Test strip --4 hours post dose glucose
Fusarium roseum IgE Ab [Units/volume] in Serum
Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum
Erythrocyte clumps [Presence] in Urine sediment by Light microscopy
DNA double strand IgG Ab [Presence] in Serum
Bacteria identified in Wound by Anaerobe culture
DNA double strand IgG Ab [Titer] in Serum
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoassay
Asialoganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay
DNA double strand IgG Ab [Units/volume] in Body fluid by Flow cytometry (FC)
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Flow cytometry (FC)
Elastase Ab [Presence] in Body fluid by Immunoassay
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunoassay
Extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Extractable nuclear Ab [Presence] in Serum by Immunoassay
Herpes gestationis Ab [Titer] in Serum by Immunofluorescence
Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Jo-1 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Liver cytosol Ab [Titer] in Serum by Immunofluorescence
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunofluorescence
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoblot
Myeloperoxidase Ab [Presence] in Body fluid by Immunoassay
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
SCL-70 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Chlamydophila psittaci Ag [Presence] in Specimen by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Smith extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay
Smith extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Thyroid colloidal Ab [Presence] in Serum by Immunofluorescence
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunoassay
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
DNA double strand Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoassay
Chlamydophila psittaci Ag [Presence] in Specimen by Immunofluorescence
Thyroid colloidal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Thyroid colloidal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Pompe disease newborn screen interpretation
Pompe disease newborn screening comment-discussion
Lactalbumin alpha IgG Ab [Mass/volume] in Serum
PIK3CA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Gliadin peptide+tissue transglutaminase IgA+IgG Ab [Presence] in Serum by Immunoassay
JAK2 gene exon 12 mutations tested for in Blood or Tissue by Molecular genetics method Nominal
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Escherichia coli eaeA gene [Presence] in Specimen by NAA with probe detection
Bacterial enterohemolysin ehlyA gene [Presence] in Specimen by NAA with probe detection
Bacterial heat-labile enterotoxin LT gene [Presence] in Specimen by NAA with probe detection
Bacterial heat-stable enterotoxin ST gene [Presence] in Specimen by NAA with probe detection
Escherichia coli Stx1 toxin stx1 gene [Presence] in Specimen by NAA with probe detection
Escherichia coli Stx2 toxin stx2 gene [Presence] in Specimen by NAA with probe detection
Bacterial beta-glucuronidase uidA gene [Presence] in Specimen by NAA with probe detection
Human coronavirus RNA panel - Specimen by NAA with probe detection
Bordetella sp DNA [Presence] in Specimen by NAA with probe detection
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid
Microscopic observation [Identifier] in Synovial fluid by Acid fast stain.Ziehl-Neelsen
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid by Complement fixation
Brucella abortus Ab [Titer] in Cerebral spinal fluid by Antihuman globulin
Paper wasp recombinant (rPol d) 5 IgE Ab [Units/volume] in Serum
Brucella abortus Ab [Titer] in Serum by Antihuman globulin
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunoassay
MAPT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
PCA-Tr Ab [Presence] in Serum by Immunoblot
Tissue polypeptide Ag [Units/volume] in Serum or Plasma
Fasciola hepatica Ab [Presence] in Serum by Hemagglutination
Somatotropin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoblot
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunofluorescence
CD3+CD5- cells/100 cells in Cerebral spinal fluid
CD3+CD5- cells [#/volume] in Cerebral spinal fluid
CD3+CD5+ cells/100 cells in Cerebral spinal fluid
CD3 cells [#/volume] in Cerebral spinal fluid
CD3+CD4+ (T4 helper) cells [#/volume] in Cerebral spinal fluid
CD3+CD8+ (T8 suppressor) cells [#/volume] in Cerebral spinal fluid
Chlamydia sp Ag [Presence] in Genital specimen by Immunoassay
Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
TPMT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum by Immunofluorescence
European house dust mite native (nDer p) 1 IgE Ab [Units/volume] in Serum
European house dust mite recombinant (rDer p) 2 IgE Ab [Units/volume] in Serum
Mugwort native (nArt v) 1 IgE Ab [Units/volume] in Serum
Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
Bacteria identified in Specimen by Aerobe culture
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Chlamydia sp Ag [Presence] in Genital specimen by Immunofluorescence
Rubella virus IgG Ab [Presence] in Serum by Latex agglutination
European house dust mite recombinant (rDer p) 10 IgE Ab [Units/volume] in Serum
Treponema pallidum Ab [Units/volume] in Serum by Immunoassay
Brucella sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Ganglioside GM3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM3 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GT1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GT1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GM4 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Ganglioside GD3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Codfish recombinant (rGad c) 1 IgE Ab [Units/volume] in Serum
Microalbumin [Mass/time] in 18 hour Urine
Soybean recombinant (rGly m) 4 IgE Ab [Units/volume] in Serum
Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
Platelet glycoprotein Ib/Ix Ab [Presence] in Blood by Immunoassay
Chlamydia sp Ag [Presence] in Specimen by Immunoassay
Platelet glycoprotein Ia/IIa Ab [Presence] in Blood by Immunoassay
Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Specimen by Organism specific culture
Methotrimeprazine [Mass/volume] in Serum or Plasma
Penicillium notatum Ab [Presence] in Serum by Immune diffusion (ID)
Actin.filamentous Ab [Presence] in Serum or Plasma by Immunofluorescence
Chlamydia sp identified in Sputum by Organism specific culture
Epithelial cells.squamous [Presence] in Bronchoalveolar lavage
Epithelial cells.ciliated [Presence] in Bronchoalveolar lavage
Chlamydia trachomatis [Presence] in Specimen by Organism specific culture
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunoassay
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence
Carboxyhemoglobin/Hemoglobin.total in Arterial cord blood
Carboxyhemoglobin/Hemoglobin.total in Venous cord blood
Centromere Ab [Presence] in Body fluid by Immunoassay
Centromere Ab [Presence] in Body fluid by Immunofluorescence
Chlamydia trachomatis Ag [Presence] in Stool by Immunofluorescence
Centromere Ab [Titer] in Body fluid by Immunofluorescence
Bacteria identified in Specimen by Anaerobe culture
Centromere Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Centromere Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Centromere protein B Ab [Presence] in Body fluid by Immunoassay
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Immunoassay
DNA double strand IgG Ab [Units/volume] in Body fluid
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid
Jo-1 extractable nuclear Ab [Presence] in Body fluid
Chlamydia trachomatis Ag [Presence] in Tissue by Immunofluorescence
Muscle specific receptor tyrosine kinase IgG Ab [Mass/volume] in Serum by Immunoassay
Myeloperoxidase Ab [Units/volume] in Body fluid
Proteinase 3 Ab [Units/volume] in Body fluid
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid
SCL-70 extractable nuclear Ab [Presence] in Body fluid
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid
Chlamydia trachomatis Ag [Presence] in Specimen by Immunoassay
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid
Smith extractable nuclear Ab [Presence] in Body fluid
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid
Smith extractable nuclear B Ab [Units/volume] in Serum by Immunoassay
Albumin in serum - albumin in peritoneal fluid [Mass concentration difference]
Calcium magnesium phosphate/Total in Stone
Pituitary Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis Ag [Presence] in Specimen by Immunofluorescence
Macrophages/100 cells in Bone marrow by Manual count
Succinylaminoimidazole carboxamide riboside [Presence] in Urine
Leukocytes in 24 hour Urine sediment by Microscopy
Leukocytes [#/volume] by Microscopy high power field in Urine sediment collected for unspecified duration
Hepatitis B virus surface Ag [Units/volume] in Serum or Plasma by Immunoassay
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunoblot
Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection
Somatotropin [Mass/volume] in Serum or Plasma --8.5 hours post XXX challenge
aPTT actual/normal in Platelet poor plasma by Coagulation assay
Japanese encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
Japanese encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Giardia lamblia Ag and Cryptosporidium parvum Ag and Entamoeba histolytica/dispar Ag [Identifier] in Stool
Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria
Basement membrane Ab pattern [Interpretation] in Serum by Immunofluorescence
Neutrophil cytoplasmic Ab pattern [Interpretation] in Body fluid by Immunofluorescence
Neutrophil cytoplasmic Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence
Nuclear Ab pattern [Interpretation] in Cerebral spinal fluid by Immunofluorescence
Nuclear Ab pattern [Interpretation] in Pleural fluid by Immunofluorescence
Pancreatic islet cell Ab pattern [Interpretation] in Serum by Immunofluorescence
Staphylococcus sp.coagulase negative DNA [Presence] in Isolate by NAA with probe detection
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
Clostridioides difficile toxin A [Units/volume] in Stool by Immunoassay
Clostridioides difficile toxin A [Units/volume] in Specimen by Immunoassay
Bacteria identified in Specimen by Sterile body fluid culture
Clostridioides difficile toxin A+B [Units/volume] in Serum by Immunoassay
Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay
Clostridioides difficile toxin A+B [Units/volume] in Stool by Immunoassay
Clostridioides difficile toxin A+B [Units/volume] in Specimen by Immunoassay
Clostridioides difficile toxin B [Units/volume] in Stool by Immunoassay
Clostridioides difficile toxin B [Units/volume] in Specimen by Immunoassay
Coccidioides immitis Ab [Titer] in Serum by Latex agglutination
Cryptococcus neoformans Ab [Titer] in Serum by Agglutination
Cryptococcus sp Ab [Presence] in Serum by Immunofluorescence
Cryptosporidium sp Ag [Presence] in Stool by Immunoassay
Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Taenia solium larva IgG Ab [Presence] in Serum by Immunoblot
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunoassay
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunofluorescence
Plasmodium sp identified in Blood by Thick film
Cytomegalovirus Ag [Presence] in Specimen by Immunoassay
Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC)
Cytomegalovirus Ag [Presence] in Specimen by Immunofluorescence
Dengue virus Ag [Presence] in Serum by Immunofluorescence
Dengue virus Ag [Presence] in Specimen by Immunofluorescence
Dengue virus DNA [Presence] in Serum by Probe
Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep
Dengue virus DNA [Presence] in Specimen by Probe
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunoassay
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence
Echinococcus sp Ab [Units/volume] in Serum by Complement fixation
Echinococcus sp Ab [Units/volume] in Serum by Immunoassay
Echovirus 30 Ab [Titer] in Serum by Complement fixation
Echovirus 30 neutralizing antibody [Units/volume] in Serum by Neutralization test
Echovirus 40 Ab [Titer] in Serum by Complement fixation
Echovirus 40 neutralizing antibody [Units/volume] in Serum by Neutralization test
Entamoeba histolytica DNA [Presence] in Specimen by NAA with probe detection
Entamoeba histolytica Ag [Units/volume] in Serum by Immunoassay
Entamoeba histolytica Ag [Units/volume] in Stool by Immunoassay
Entamoeba histolytica Ag [Units/volume] in Specimen by Immunoassay
Ehrlichia canis Ab [Presence] in Serum by Immunoassay
CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay
Ehrlichia chaffeensis IgG Ab [Presence] in Serum by Immunoassay
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Specimen by NAA with probe detection
Ehrlichia chaffeensis IgM Ab [Presence] in Serum by Immunoassay
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun
Anaplasma phagocytophilum Ab [Presence] in Serum by Immunoassay
Adenovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Ehrlichia sp Ab [Presence] in Serum by Immunoassay
Flavivirus identified in Specimen by Organism specific culture
Francisella tularensis IgM Ab [Presence] in Serum by Latex agglutination
FMRP cells/100 lymphocytes in Blood by Immune stain
Bilirubin.indirect [Mass/volume] in Cord blood
MGMT gene methylation score in Tissue by Molecular genetics method
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
Cells karyotyped.total [#] in Chorionic villus sample
Cells analyzed [#] in Chorionic villus sample by Molecular genetics method
ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method
Karyotype [Identifier] in Chorionic villus sample Narrative
Francisella tularensis Ag [Presence] in Specimen by Immunofluorescence
Cells counted [#] in Chorionic villus sample by Molecular genetics method
Chromosome analysis overall interpretation in Specimen Qualitative by Molecular genetics method
Cells karyotyped.total [#] in Amniotic fluid
Cells analyzed [#] in Amniotic fluid by Molecular genetics method
ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method
Karyotype [Identifier] in Amniotic fluid Narrative
Cells counted [#] in Amniotic fluid by Molecular genetics method
Colonies counted [#] in Amniotic fluid by Molecular genetics method
Fungus identified in Sputum tracheal aspirate by Culture
Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun modified
Giardia lamblia IgG Ab [Titer] in Serum by Immunofluorescence
Hemoglobin observations newborn screening panel
Second most predominant hemoglobin in DBS
Third most predominant hemoglobin in DBS
Fourth most predominant hemoglobin in DBS
Giardia lamblia Ag [Presence] in Stool by Immunoassay
Fifth most predominant hemoglobin in DBS
Hemoglobins that can be presumptively identified based on available controls in DBS
Pregabalin [Mass/volume] in Urine by Confirmatory method
Drugs identified in Meconium by Confirmatory method
Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine
Amobarbital/Creatinine [Mass Ratio] in Urine
N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine
diazePAM/Creatinine [Mass Ratio] in Urine
Dihydrocodeine/Creatinine [Mass Ratio] in Urine
PENTobarbital/Creatinine [Mass Ratio] in Urine
PHENobarbital/Creatinine [Mass Ratio] in Urine
Phentermine/Creatinine [Mass Ratio] in Urine
Secobarbital/Creatinine [Mass Ratio] of Urine
Pregabalin/Creatinine [Mass Ratio] in Urine
Pregabalin [Presence] in Urine by Screen method
Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine
Giardia lamblia Ag [Presence] in Specimen by Immunoassay
Butalbital/Creatinine [Mass Ratio] in Urine
Haemophilus influenzae A Ag [Presence] in Specimen by Immunofluorescence
Haemophilus influenzae D Ag [Presence] in Specimen by Immunofluorescence
Haemophilus influenzae E Ag [Presence] in Specimen by Immunofluorescence
Haemophilus influenzae F Ag [Presence] in Specimen by Immunofluorescence
Helicobacter pylori Ab [Presence] in Serum by Immunofluorescence
Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay
Hepatitis B virus rRNA [Presence] in Specimen by Probe
Benzylpiperazine [Presence] in Urine by Confirmatory method
Heterophile Ab [Titer] in Serum by Agglutination
Heterophile Ab [Presence] in Serum or Plasma by Immunoassay
Histoplasma capsulatum Ab [Units/volume] in Serum by Immunoassay
Histoplasma capsulatum Ab [Presence] in Serum by Latex agglutination
Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Ziehl-Neelsen
HIV identified in Blood by Organism specific culture
HIV identified in Semen by Organism specific culture
HIV identified in Specimen by Organism specific culture
HTLV I Ab [Presence] in Serum by Immunoblot
HTLV I IgG Ab [Presence] in Serum by Immunoassay
Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence
Influenza virus A+B Ag [Presence] in Throat by Immunoassay
Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence
Microscopic observation [Identifier] in Pus by Gram stain
Influenza virus A+B Ag [Presence] in Specimen by Immunoassay
Influenza virus A+B Ag [Presence] in Specimen by Immunofluorescence
Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay
Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence
Influenza virus A+B+C Ag [Presence] in Specimen by Immunoassay
Mycobacterium sp [Presence] in Blood by Organism specific culture
KIR gene allele 2DL1 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DL2 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DL3 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DL4 [Presence] in Blood or Tissue by Molecular genetics method
Fragile X protein (FMRP) [Interpretation] in Blood
KIR gene allele 2DL5 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DS1 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DS2 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DS3 [Presence] in Blood or Tissue by Molecular genetics method
KIR2DS4 gene full variant [Presence] in Blood or Tissue by Molecular genetics method
KIR2DS4 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DS5 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 3DL1 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 3DL2 [Presence] in Blood or Tissue by Molecular genetics method
Influenza virus A+B+C Ag [Presence] in Specimen by Immunofluorescence
KIR gene allele 3DL3 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 3DS1 [Presence] in Blood or Tissue by Molecular genetics method
KIR gene allele 2DP1 [Presence] in Blood or Tissue by Molecular genetics method
KIR3DP1 gene full variant [Presence] in Blood or Tissue by Molecular genetics method
KIR3DP1 gene deletion variant [Presence] in Blood or Tissue by Molecular genetics method
Lactoferrin [Presence] in Stool by Latex agglutination
Lactoferrin [Presence] in Specimen by Latex agglutination
Microscopic observation [Identifier] in Skin by KOH preparation
Legionella pneumophila Ag [Presence] in Sputum by Immunofluorescence
Legionella pneumophila Ag [Presence] in Sputum by Latex agglutination
Legionella pneumophila Ag [Presence] in Urine by Immunoassay
Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA)
Legionella pneumophila Ag [Presence] in Specimen by Latex agglutination
Legionella sp Ab [Titer] in Serum by Immunofluorescence
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun
Leptospira interrogans Ag [Presence] in Specimen by Immunofluorescence
Leptospira sp identified in Blood by Organism specific culture
Leptospira sp identified in Cerebral spinal fluid by Organism specific culture
Leptospira sp identified in Urine by Organism specific culture
Listeria monocytogenes Ab [Titer] in Serum by Complement fixation
DNA double strand Ab [Presence] in Serum by Immunofluorescence (IF) Crithidia luciliae
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Immunofluorescence
Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun modified
Bacteria identified in Sputum by Culture
Bacteria identified in Stool by Anaerobe culture
Bacteria identified in Specimen by Culture
Microscopic observation [Identifier] in Cervix by Gram stain
Microscopic observation [Identifier] in Duodenal fluid by Trichrome stain
Microscopic observation [Identifier] in Duodenal fluid by Wet preparation
Microscopic observation [Identifier] in Genital fluid by Gram stain
Microscopic observation [Identifier] in Sputum by Calcofluor white
Microscopic observation [Identifier] in Stool by Trichrome stain
Microscopic observation [Identifier] in Stool by Wet preparation
Microscopic observation [Identifier] in Tissue by Other stain
Microscopic observation [Identifier] in Tissue by Calcofluor white
Microscopic observation [Identifier] in Tissue by Trichrome stain
Microscopic observation [Identifier] in Urethra by Gram stain
Mobiluncus sp rRNA [Presence] in Specimen by Probe
Mumps virus IgG Ab [Presence] in Serum by Immunoassay
Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen
Mumps virus IgM Ab [Presence] in Serum by Immunoassay
Mumps virus IgM Ab [Titer] in Serum by Immunofluorescence
Oxygen content in Venous cord blood by calculation
Oxygen content in Mixed venous blood by calculation
Oxygen content in Capillary blood by calculation
Oxygen content in Arterial cord blood by calculation
Mumps virus Ag [Presence] in Serum by Immunofluorescence
Mycoplasma pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence
Mycoplasma pneumoniae rRNA [Presence] in Sputum by Probe
Mycoplasma pneumoniae rRNA [Presence] in Specimen by Probe
Microscopic observation [Identifier] in Sputum by Gram stain
Mycoplasma sp identified in Specimen by Organism specific culture
Neisseria meningitidis Ag [Presence] in Specimen by Immunofluorescence
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunoassay
Microscopic observation [Identifier] in Stool by Gram stain
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Immunofluorescence
Kiwi recombinant (rAct d) 8 IgE Ab [Units/volume] in Serum
Celery recombinant (rApi g) 1 IgE Ab [Units/volume] in Serum
Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum
Cashew nut recombinant (rAna o) 2 IgE Ab [Units/volume] in Serum
Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunoassay
Hazelnut recombinant (rCor a) 1.0401 IgE Ab [Units/volume] in Serum
Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
Wheat recombinant (rTri a) 14 IgE Ab [Units/volume] in Serum
Black Alder recombinant (rAln g) 1 IgE Ab [Units/volume] in Serum
Hazelnut recombinant (rCor a) 1.0101 IgE Ab [Units/volume] in Serum
London Plane recombinant (rPla a) 1 IgE Ab [Units/volume] in Serum
London Plane recombinant (rPla a) 3 IgE Ab [Units/volume] in Serum
Goosefoot recombinant (rChe a) 1 IgE Ab [Units/volume] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
English plantain recombinant (rPla l) 1 IgE Ab [Units/volume] in Serum
Dog recombinant 5 IgE Ab [Units/volume] in Serum
Horse recombinant (rEqu c) 1 IgE Ab [Units/volume] in Serum
Cat recombinant (rFel d) 1 IgE Ab [Units/volume] in Serum
Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum
Alternaria alternata recombinant (rAlt a) 6 IgE Ab [Units/volume] in Serum
Cladosporium herbarum recombinant (rCla h) 8 IgE Ab [Units/volume] in Serum
Blomia tropicalis recombinant (rBlo t) 5 IgE Ab [Units/volume] in Serum
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Latex agglutination
American house dust mite recombinant (rDer f) 2 IgE Ab [Units/volume] in Serum
Lepidoglyphus destructor recombinant (rLep d) 2 IgE Ab [Units/volume] in Serum
Cockroach recombinant (rBla g) 1 IgE Ab [Units/volume] in Serum
Cockroach recombinant (rBla g) 2 IgE Ab [Units/volume] in Serum
Cockroach recombinant (rBla g) 5 IgE Ab [Units/volume] in Serum
Anisakis recombinant (rAni s) 1 IgE Ab [Units/volume] in Serum
Anisakis recombinant (rAni s) 3 IgE Ab [Units/volume] in Serum
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunoassay
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Immunofluorescence
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun
Neisseria meningitidis serogroup Y Ab [Titer] in Specimen by Immunofluorescence
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunoassay
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination
Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid
Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by Probe
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun modified
Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay
Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot
Human papilloma virus Ab [Presence] in Tissue by Immunoassay
Human papilloma virus Ab [Presence] in Tissue by Immunoblot
Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection
Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus rRNA [Presence] in Specimen by NAA with probe detection
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoblot
Pneumocystis jiroveci Ag [Presence] in Serum by Immunofluorescence
Pneumocystis jiroveci Ag [Presence] in Sputum by Immunofluorescence
Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
Rabies virus Ab [Units/volume] in Cerebral spinal fluid
Rabies virus neutralizing antibody [Units/volume] in Cerebral spinal fluid by Neutralization test
Rabies virus neutralizing antibody [Units/volume] in Serum by Neutralization test
Rabies virus neutralizing antibody [Units/volume] in Tissue by Neutralization test
Rabies virus Ab [Units/volume] in Specimen
Rabies virus neutralizing antibody [Units/volume] in Specimen by Neutralization test
Microscopic observation [Identifier] in Urine by Acid fast stain.Ziehl-Neelsen
Rabies virus Ag [Presence] in Tissue by Immunofluorescence
Cefadroxil [Susceptibility] by Disk diffusion (KB)
At sup(a) Ab [Presence] in Serum or Plasma
Gy sup(a) Ab [Presence] in Serum or Plasma
Rabies virus Ag [Presence] in Specimen by Immunofluorescence
LW sup(a) Ab [Presence] in Serum or Plasma
McC sup(c) Ab [Presence] in Serum or Plasma
little cE Ab [Presence] in Serum or Plasma
Sw sup(a) Ab [Presence] in Serum or Plasma
Tr sup(a) Ab [Presence] in Serum or Plasma
WES sup(b) Ab [Presence] in Serum or Plasma
Wr sup(b) Ab [Presence] in Serum or Plasma
Oxygen [Partial pressure] saturation adjusted to 0.5 in Blood
Glucagon [Mass/volume] in Serum or Plasma --pre XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge
Glucagon [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge
Follitropin [Units/volume] in Serum or Plasma --pre or post XXX challenge
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge
Proinsulin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge
Sex hormone binding globulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge
Microscopic observation [Identifier] in Urine by Gram stain
Thyrotropin [Units/volume] in Serum or Plasma --pre or post XXX challenge
Phenytoin [Moles/volume] corrected for albumin in Serum or Plasma
Magnesium [Moles/volume] corrected for albumin in Serum or Plasma
Cortisol Free/Cortisol.total in Serum or Plasma
Rabies virus identified in Tissue by Organism specific culture
Rabies virus identified in Specimen by Organism specific culture
Rickettsia prowazekii Ab [Units/volume] in Serum by Complement fixation
Rickettsia rickettsii Ag [Identifier] in Tissue by Immunofluorescence
Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun
Rickettsia sp identified in Genital specimen by Organism specific culture
Rickettsia sp identified in Sputum by Organism specific culture
Rickettsia sp identified in Specimen by Organism specific culture
Rotavirus identified in Specimen by Organism specific culture
Rubella virus identified in Serum by Organism specific culture
Saint Louis encephalitis virus Ag [Units/volume] in Serum
Staphylococcus aureus Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun modified
Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence
Streptococcus pneumoniae Ab [Presence] in Serum by Immunoassay
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Streptococcus pneumoniae Ag [Presence] in Sputum by Immunofluorescence
Streptococcus pneumoniae Ag [Presence] in Specimen by Immunofluorescence
Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence
Streptococcus pyogenes Ag [Presence] in Specimen by Immunoassay
Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence
Plasmodium ovale Ab [Units/volume] in Serum
Treponema pallidum IgG Ab [Presence] in Serum
Treponema pallidum IgM Ab [Presence] in Serum
Trichinella spiralis IgG Ab [Presence] in Serum by Immunoassay
cloZAPine and Norclozapine panel - Serum or Plasma
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Confirmatory method
Trichomonas vaginalis [Presence] in Genital specimen by Complement fixation
Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunoassay
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunofluorescence
Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe
Microscopic observation [Identifier] in Specimen by Acid fast stain.Ziehl-Neelsen
Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence
Varicella zoster virus IgM Ab [Titer] in Serum by Immunofluorescence
Venezuelan equine encephalitis virus Ab [Units/volume] in Serum
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunoassay
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence
Escherichia coli verotoxin 1 [Presence] in Stool
Drugs of abuse 5 panel - Urine by Screen method
Escherichia coli verotoxin 1 neutralizing antibody [Titer] in Stool by Neutralization test
T-cell helper (CD4) subset panel - Blood
T-cell subsets CD4 and CD8 panel - Blood
Lymphocyte subset interpretation in Blood by Flow cytometry (FC)
Hantavirus Ag [Presence] in Tissue by Immune stain
Escherichia coli verotoxin 2 [Presence] in Stool
Neisseria meningitidis Ag [Presence] in Tissue by Immune stain
Kiwi native (nAct d) 5 IgE Ab [Units/volume] in Serum
Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
English Walnut native (nJug r) 1 IgE Ab [Units/volume] in Serum
English Walnut native (nJug r) 2 IgE Ab [Units/volume] in Serum
English Walnut native (nJug r) 3 IgE Ab [Units/volume] in Serum
Peanut native (nAra h) 1 IgE Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Specimen by Acridine orange stain
Peanut native (nAra h) 2 IgE Ab [Units/volume] in Serum
Escherichia coli verotoxin 2 neutralizing antibody [Titer] in Stool by Neutralization test
Peanut native (nAra h) 3 IgE Ab [Units/volume] in Serum
Soybean native (nGly m) 6 IgE Ab [Units/volume] in Serum
Buckwheat native (nFag e) 2 IgE Ab [Units/volume] in Serum
Wheat native (nTri a) aA/TI IgE Ab [Units/volume] in Serum
Bermuda grass native (nCyn d) 1 IgE Ab [Units/volume] in Serum
Silver birch native (nBet v) 1 IgE Ab [Units/volume] in Serum
Japanese Cedar native (nCry j) 1 IgE Ab [Units/volume] in Serum
Arizona Cypress native (nCup a) 1 IgE Ab [Units/volume] in Serum
Olive pollen native (nOle e) 7 IgE Ab [Units/volume] in Serum
Olive pollen recombinant (rOle e) 9 IgE Ab [Units/volume] in Serum
London Plane native (nPla a) 2 IgE Ab [Units/volume] in Serum
Common ragweed native (nAmb a) 1 IgE Ab [Units/volume] in Serum
Mugwort native (nArt v) 3 IgE Ab [Units/volume] in Serum
Saltwort native (nSal k) 1 IgE Ab [Units/volume] in Serum
Chicken CSA serum albumin native (nGal d) 5 IgE Ab [Units/volume] in Serum
Shrimp native (nPen m) 2 IgE Ab [Units/volume] in Serum
Shrimp native (nPen m) 4 IgE Ab [Units/volume] in Serum
Horse serum albumin native (nEqu c) 3 IgE Ab [Units/volume] in Serum
Vibrio sp identified in Blood by Organism specific culture
Mouse lipocain native (nMus m) 1 IgE Ab [Units/volume] in Serum
American house dust mite native (nDer f) 1 IgE Ab [Units/volume] in Serum
Honey bee native (nApi m) 4 IgE Ab [Units/volume] in Serum
Horseradish native (nArm r) HRP IgE Ab [Units/volume] in Serum
Cockroach native (nBla g) 7 IgE Ab [Units/volume] in Serum
Shrimp native (nPen m) 1 IgE Ab [Units/volume] in Serum
Kiwi native (nAct d) 1 IgE Ab [Units/volume] in Serum
Kiwi native (nAct d) 2 IgE Ab [Units/volume] in Serum
Vibrio sp identified in Stool by Organism specific culture
Vibrio sp identified in Water by Organism specific culture
Kingella kingae DNA [Presence] in Specimen by NAA with probe detection
SEPT9 gene methylation [Presence] in Plasma by Molecular genetics method
Vibrio sp identified in Specimen by Organism specific culture
Microscopic observation [Identifier] in Specimen by Calcofluor white
Western equine encephalitis virus Ag [Presence] in Serum by Immunoassay
Western equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence
Yellow fever virus Ab [Titer] in Serum by Immunofluorescence
Yellow fever virus neutralizing antibody [Units/volume] in Serum by Neutralization test
Yellow fever virus IgG Ab [Units/volume] in Serum by Immunoassay
Microscopic observation [Identifier] in Specimen by Carbol-fuchsin stain
Yellow fever virus IgM Ab [Units/volume] in Serum by Immunoassay
Amoeba identified in Specimen by Organism specific culture
Klebsiella granulomatis [Presence] in Isolate by Organism specific culture
Diphtheria identified in Isolate by Organism specific culture
Troponin T.cardiac [Mass/volume] in Venous blood
Troponin T.cardiac [Mass/volume] in Serum or Plasma
Haemophilus influenzae B Ag [Presence] in Specimen by Immunofluorescence
Haemophilus sp identified in Specimen by Organism specific culture
Microscopic observation [Identifier] in Specimen by Dark field examination
Influenza virus identified in Sputum by Organism specific culture
Influenza virus identified in Sputum tracheal aspirate by Organism specific culture
Influenza virus identified in Throat by Organism specific culture
Influenza virus identified in Specimen by Organism specific culture
Leptospira interrogans Ag [Presence] in Tissue by Immunofluorescence
Brugia malayi Ab [Presence] in Serum by Immunoassay
Microscopic observation [Identifier] in Tissue by Dark field examination
Listeria sp identified in Specimen by Organism specific culture
Cefadroxil [Susceptibility] by Serum bactericidal titer
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Bone marrow Pathology biopsy report Narrative
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation
Amphetamine [Presence] in Serum or Plasma by Confirmatory method
chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine
fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method
fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method
Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method
Mononuclear+Mesothelial cells/100 leukocytes in Body fluid by Manual count
Mononuclear cells atypical/100 leukocytes in Body fluid by Manual count
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Blasts [#/volume] in Blood from Fetus by Manual count
Promyelocytes [#/volume] in Blood from Fetus by Manual count
Myelocytes [#/volume] in Blood from Fetus by Manual count
Metamyelocytes [#/volume] in Blood from Fetus by Manual count
Band form neutrophils [#/volume] in Blood from Fetus by Manual count
Neutrophils [#/volume] in Blood from Fetus by Manual count
Lymphocytes [#/volume] in Blood from Fetus by Manual count
Eosinophils [#/volume] in Blood from Fetus by Manual count
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Basophils [#/volume] in Blood from Fetus by Manual count
Monocytes [#/volume] in Blood from Fetus by Manual count
Variant lymphocytes [#/volume] in Blood from Fetus by Manual count
Leukocytes other [#/volume] in Blood from Fetus by Manual count
Reticulocytes [#/volume] in Blood from Fetus by Manual count
Polymorphonuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count
Mononuclear cells/100 leukocytes in Pleural fluid from Fetus by Manual count
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Acanthamoeba sp Ab [Presence] in Cornea by Immunofluorescence
Microscopic observation [Identifier] in Specimen by Dry mount
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunoassay
Leishmania sp Ab [Presence] in Serum by Immunofluorescence
Leishmania sp Ab [Presence] in Serum by Hemagglutination
Leishmania sp Ab [Presence] in Serum by Complement fixation
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay
Schistosoma japonicum Ab [Titer] in Serum by Complement fixation
Microscopic observation [Identifier] in Specimen by Giemsa stain
Schistosoma mansoni Ab [Presence] in Serum by Immunoassay
Schistosoma sp Ab [Presence] in Serum by Immunofluorescence
Schistosoma sp Ab [Presence] in Serum by Immunoassay
Schistosoma sp Ab [Presence] in Serum by Hemagglutination
Schistosoma sp Ab [Presence] in Serum by Complement fixation
Strongyloides stercoralis IgG Ab [Presence] in Serum by Immunoassay
Wuchereria bancrofti Ab [Presence] in Serum by Immunoassay
Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition
Microscopic observation [Identifier] in Specimen by Gimenez stain
Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition
Microscopic observation [Identifier] in Specimen by Gram stain
Cefepime [Susceptibility] by Minimum lethal concentration (MLC)
Beta hydroxybutyrate [Moles/volume] in Blood by Test strip
Cockroach recombinant (rBla g) 4 IgE Ab [Units/volume] in Serum
Cyprinus carpio recombinant (rCyp c) 1 IgE Ab [Units/volume] in Serum
Carrot recombinant (rDau c) 1 IgE Ab [Units/volume] in Serum
Euroglyphus maynei recombinant (rEur m) 2 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 6 IgE Ab [Units/volume] in Serum
Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)
Annual mercury recombinant (rMer a) 1 IgE Ab [Units/volume] in Serum
Olive native (nOle e) 2 IgE Ab [Units/volume] in Serum
Shrimp native (nPen i) 11 IgE Ab [Units/volume] in Serum
Wheat native (nTri a) 18 IgE Ab [Units/volume] in Serum
McD sup(d) Ab [Presence] in Serum or Plasma
Protein.monoclonal band 2 [Mass/time] in Urine collected for unspecified duration
OmpC IgA Ab [Units/volume] in Serum by Immunoassay
Heparin unfractionated [Units/volume] in Platelet poor plasma
DNA single strand Ab [Units/volume] in Serum by Immunoassay
Brucella sp IgG and IgM [Interpretation] in Serum
Serotonin release.heparin.unfractionated in Serum Narrative
CYP2C19 gene targeted mutation analysis in Blood by Molecular genetics method
Urease [Presence] in Tissue --2nd specimen
Urease [Presence] in Tissue --3rd specimen
Epstein Barr virus nuclear 1 IgG Ab [Units/volume] in Serum
Spermatozoa Acrosome defects/100 spermatozoa in Semen
Spermatozoa Abnormal head shape/100 spermatozoa in Semen
Spermatozoa Abnormal head size/100 spermatozoa in Semen
Spermatozoa Double forms/100 spermatozoa in Semen
Spermatozoa Multiple defects/100 spermatozoa in Semen
Cholesterol in VLDL.beta [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Specimen by Hematoxylin and eosin stain
HBA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Cefpirome [Susceptibility] by Serum bactericidal titer
Meropenem [Susceptibility] by Minimum lethal concentration (MLC)
Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Meropenem [Susceptibility] by Disk diffusion (KB)
Meropenem [Susceptibility] by Serum bactericidal titer
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun modified
Microscopic observation [Identifier] in Tissue by Acid fast stain.Ziehl-Neelsen
Microscopic observation [Identifier] in Tissue by Acridine orange stain
Microscopic observation [Identifier] in Tissue by Carbol-fuchsin stain
Microscopic observation [Identifier] in Tissue by Dry mount
Microscopic observation [Identifier] in Tissue by Giemsa stain
Microscopic observation [Identifier] in Tissue by Gimenez stain
Microscopic observation [Identifier] in Tissue by Gram stain
Microscopic observation [Identifier] in Tissue by Hematoxylin and eosin stain
Microscopic observation [Identifier] in Tissue by India ink prep
Microscopic observation [Identifier] in Tissue by KOH preparation
Microscopic observation [Identifier] in Specimen by India ink prep
Microscopic observation [Identifier] in Tissue by M'Fadyean stain
Microscopic observation [Identifier] in Tissue by Macchiavello stain
Microscopic observation [Identifier] in Tissue by Malaria smear
Microscopic observation [Identifier] in Tissue by Methenamine silver nitrate stain
Common wasp recombinant (rVes v) 1 IgE Ab [Units/volume] in Serum
Chlorhexidine IgE Ab [Units/volume] in Serum
Rickettsia typhi and Rickettsia spotted fever group IgG and IgM [Interpretation] in Specimen
Adenovirus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
Microscopic observation [Identifier] in Tissue by Methylene blue stain.Loeffler
Adenovirus DNA [Log #/volume] (viral load) in Body fluid by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Body fluid by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Stool by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Genital specimen by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Genital specimen by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Skin by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Skin by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Adenovirus DNA [Log #/volume] (viral load) in Sputum or Bronchial by NAA with probe detection
Normalized silica clotting time of Platelet poor plasma
CYP2C19 gene c.1A>G(*4) [Presence] in Blood or Tissue by Molecular genetics method
Microscopic observation [Identifier] in Tissue by Neisser stain
CYP2C19 gene c.358T>C(*8) [Presence] in Blood or Tissue by Molecular genetics method
CYP2C19 gene c.395G>A(*6) [Presence] in Blood or Tissue by Molecular genetics method
CYP2C19 gene c.636G>A(*3) [Presence] in Blood or Tissue by Molecular genetics method
CYP2C19 gene c.681G>A(*2) [Presence] in Blood or Tissue by Molecular genetics method
CYP2C19 gene c.806C>T(*17) [Presence] in Blood or Tissue by Molecular genetics method
CYP2C19 gene c.IVS5+2T>A(*7) [Presence] in Blood or Tissue by Molecular genetics method
Heparin/Body weight [Mass/mass] in Blood
Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitude
Ova and parasites identified in Tissue by Light microscopy
Clotting time of Blood by Heparin protamine titration
Clot angle in Blood by Thromboelastography
Clot angle in Blood by Thromboelastography --after addition of heparinase
Clot strength in Blood by Thromboelastography
Clot strength in Blood by Thromboelastography --after addition of heparinase
Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain
Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase
Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinase
Clot initiation [Time] in Blood by Thromboelastography --after addition of heparinase
Clot lysis estimate [Percentile] by Thromboelastography
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60M post maximum clot amplitude
Heparin neutralization [Presence] in Blood by Thromboelastography
Microscopic observation [Identifier] in Specimen by KOH preparation
Coagulation index in Blood by Thromboelastography
Enterobius vermicularis [Presence] in Anal by Pinworm exam
Lymphocytes/100 leukocytes in Dialysis fluid by Manual count
Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid
Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid
Nucleated erythrocytes/100 leukocytes [Ratio] in Cord blood
Albumin in pericardial fld/Albumin in Serum or Plasma
Albumin in peritoneal fluid/Albumin in Serum or Plasma
Vanillylmandelate/Body weight [Moles/kg/time] in 24 hour Urine
Leukocytes [#/volume] corrected for nucleated erythrocytes in Cord blood
Triglyceride [Moles/volume] in Peritoneal fluid
Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain
Microscopic observation [Identifier] in Tissue by Toluidine blue O stain
Microscopic observation [Identifier] in Tissue by Warthin-Starry stain
Microscopic observation [Identifier] in Tissue by Wet preparation
Microscopic observation [Identifier] in Tissue by Wright stain
Microscopic observation [Identifier] in Tissue by Wright Giemsa stain
Microscopic observation [Identifier] in Specimen by M'Fadyean stain
Myeloperoxidase [Moles/volume] in Plasma
FMR1 gene activation in Blood by Molecular genetics method
FMR1 gene methylation/methylated+unmethylated in Blood by Molecular genetics method
FMR1 gene premutation/premutation+full mutation in Blood by Molecular genetics method
Skin Ab pattern [Interpretation] in Serum
Skin IgG Ab [Titer] in Serum by Guinea pig esophagus substrate
Skin Ab.IgG pattern [Interpretation] in Serum by Monkey esophagus substrate
Skin IgG Ab [Presence] in Serum by Monkey esophagus substrate
Skin IgG Ab [Presence] in Serum by Guinea pig esophagus substrate
Skin IgG Ab [Titer] in Serum by Monkey esophagus substrate
Skin Ab.IgG pattern [Interpretation] in Serum by Guinea pig esophagus substrate
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation
Glucose [Mass/volume] in Blood --2 hours post meal
Leukocytes [#/volume] in Blood by Automated count
Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Specimen by Macchiavello stain
quiNIDine [Mass/volume] in Serum or Plasma
MALT1 18q21 gene rearrangements in Blood or Tissue by FISH
Complement C1.functional [Units/volume] in Serum
Thiothixene [Mass/volume] in Serum or Plasma
Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine
Microscopic observation [Identifier] in Specimen by Methenamine silver nitrate stain
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine
11-Ketoandrosterone [Mass/time] in 24 hour Urine
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine
11-Ketopregnanetriol [Mass/time] in 24 hour Urine
Androsterone [Mass/time] in 24 hour Urine
buPROPion [Mass/volume] in Serum or Plasma
Echovirus 11 Ab [Titer] in Serum by Complement fixation
Acetaminophen IgE Ab [Units/volume] in Serum
Ampicillin IgE Ab [Units/volume] in Serum
Cannabinoids synthetic [Presence] in Urine by Confirmatory method
Cellularity assessment [Interpretation] in Specimen by Flow cytometry (FC) Narrative
Abnormal leukocytes/100 leukocytes in Specimen by Flow cytometry (FC)
Baker's yeast IgG Ab [Units/volume] in Serum
Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
Brewer's yeast IgG Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Specimen by Methylene blue stain.Loeffler
Cashew nut IgE Ab [Units/volume] in Serum
Chocolate IgG Ab [Units/volume] in Serum
Egg white IgG Ab [Units/volume] in Serum
Microscopic observation [Identifier] in Specimen by Neisser stain
False oat grass IgE Ab [Units/volume] in Serum
Honey bee IgG Ab [Units/volume] in Serum
Latex glove extract IgE Ab [Units/volume] in Serum
Paper wasp IgG Ab [Units/volume] in Serum
Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID)
Ova and parasites identified in Specimen by Light microscopy
Yellow Dock IgE Ab [Units/volume] in Serum
Yellow Hornet IgG Ab [Units/volume] in Serum
Yellow Jacket IgE Ab [Units/volume] in Serum
Erythrocytes [#/volume] in Body fluid by Manual count
Microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain
Erythrocyte morphology finding [Identifier] in Blood
Leukocytes [#/volume] in Body fluid by Manual count
Lymphocytes [#/volume] in Body fluid by Manual count
Segmented neutrophils [#/volume] in Body fluid by Manual count
Prolymphocytes/100 leukocytes in Blood by Manual count
Glucose [Presence] in Urine by Test strip --1 hour post 50 g lactose PO
Glucose [Presence] in Urine by Test strip --1 hour post 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --2 hours post 50 g lactose PO
Glucose [Presence] in Urine by Test strip --2 hours post 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --30 minutes post 50 g lactose PO
Glucose [Presence] in Urine by Test strip --30 minutes post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --3 hours post 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO
Corynebacterium diphtheriae DNA [Presence] in Specimen by NAA with probe detection
Achromobacter sp DNA [Presence] in Specimen by NAA with probe detection
Legionella micdadei DNA [Presence] in Specimen by NAA with probe detection
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --with normal plasma 2H post incubation separate tubes
Circulating tumor cells.breast [#/volume] in Blood
Streptococcus pyogenes M protein emm gene [Type] in Isolate by Sequencing
Glucose [Presence] in Urine by Test strip --4 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --5 hours post 75 g glucose PO
Enterobius vermicularis [Presence] in Specimen by Pinworm exam
Glucose [Presence] in Urine by Test strip --6 hours post 75 g glucose PO
Glucose [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO
Glucose [Presence] in Urine by Test strip --1.5 hours post 50 g lactose PO
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO
Glucose [Presence] in Urine by Test strip --1.5 hours post 75 g glucose PO
Fasting glucose [Presence] in Urine by Test strip
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma
17-Ketosteroids [Mass/time] in 24 hour Urine
Microscopic observation [Identifier] in Specimen by Rhodamine-auramine fluorochrome stain
18-Hydroxycorticosteroids [Mass/volume] in Serum
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Alpha 1 antitrypsin phenotype [Identifier] in Serum or Plasma by Immunofixation
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS
Mycobacterium sp identified in Isolate by HPLC
Rickettsia sp DNA [Identifier] in Specimen by NAA with probe detection
Desethylamiodarone [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Specimen by Toluidine blue O stain
Estrone (E1) [Mass/time] in 24 hour Urine
IgA [Mass/volume] in Urine by Electrophoresis
IgA [Mass/volume] in Urine by Immunoassay
IgG [Mass/volume] in Urine by Electrophoresis
Cytomegalovirus Ag [Presence] in Isolate by Immunofluorescence
Measles virus Ag [Presence] in Isolate by Immunofluorescence
Mumps virus Ag [Presence] in Isolate by Immunofluorescence
Parainfluenza virus 1 Ag [Presence] in Isolate by Immunofluorescence
Parainfluenza virus 2 Ag [Presence] in Isolate by Immunofluorescence
Parainfluenza virus 3 Ag [Presence] in Isolate by Immunofluorescence
Parainfluenza virus 4 Ag [Presence] in Isolate by Immunofluorescence
Varicella zoster virus Ag [Presence] in Isolate by Immunofluorescence
Fatty casts [#/area] in Urine sediment by Microscopy high power field
Granulocytic cells/100 cells in Bone marrow by Manual count
HTLV I Ab [Units/volume] in Serum by Immunoassay
Trisomy 18 + Trisomy 13 risk [Likelihood] in Fetus
Parainfluenza virus 4a RNA [Presence] in Specimen by NAA with probe detection
IgG [Mass/volume] in Urine by Immunoassay
Parainfluenza virus 4b RNA [Presence] in Specimen by NAA with probe detection
Human metapneumovirus A RNA [Presence] in Specimen by NAA with probe detection
Human metapneumovirus B RNA [Presence] in Specimen by NAA with probe detection
Borrelia burgdorferi IgG bands [#] in Cerebral spinal fluid by Immunoblot
Borrelia burgdorferi IgM bands [#] in Cerebral spinal fluid by Immunoblot
Neutrophils [#/volume] in Pericardial fluid
Lymphocytes [#/volume] in Pericardial fluid
Macrophages [#/volume] in Pericardial fluid
Eosinophils [#/volume] in Pericardial fluid
Microscopic observation [Identifier] in Specimen by Trichrome stain
Leukocytes other [#/volume] in Pericardial fluid
Erythrocytes [#/volume] in Pleural fluid from Fetus
Neutrophils [#/volume] in Pleural fluid from Fetus
Lymphocytes [#/volume] in Pleural fluid from Fetus
Macrophages [#/volume] in Pleural fluid from Fetus
IgM [Mass/volume] in Urine by Electrophoresis
Eosinophils [#/volume] in Pleural fluid from Fetus
Leukocytes other [#/volume] in Pleural fluid from Fetus
Cells Counted Total [#] in Bronchial specimen
Mephedrone [Presence] in Urine by Confirmatory method
IgM [Mass/volume] in Urine by Immunoassay
Leukocyte clumps [Presence] in Urine sediment by Light microscopy
Kappa light chains [Presence] in Serum by Electrophoresis
Kappa light chains [Presence] in Urine by Electrophoresis
Kappa light chains [Presence] in Serum by Immunoassay
Kappa light chains/Lambda light chains [Mass Ratio] in Serum by Immunoassay
Lambda light chains [Presence] in Serum by Electrophoresis
Cefamandole [Susceptibility] by Minimum lethal concentration (MLC)
Lambda light chains [Presence] in Urine by Electrophoresis
Microscopic observation [Identifier] in Specimen by Warthin-Starry stain
Lambda light chains [Presence] in Serum by Immunoassay
Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay
Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
Alpha 2 globulin [Mass/time] in 24 hour Urine by Electrophoresis
Cyclobenzaprine [Mass/volume] in Serum or Plasma
Tricyclic antidepressants [Presence] in Urine by Immunoassay
Spermatozoa Motile/100 spermatozoa in Semen
Complement C3 [Mass/volume] in Body fluid
Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID)
Microscopic observation [Identifier] in Specimen by Wet preparation
Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID)
Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID)
Circulating tumor cells.prostate [#/volume] in Blood
Circulating tumor cells.colon [#/volume] in Blood
Echovirus 16 Ab [Titer] in Serum by Complement fixation
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum
Microscopic observation [Identifier] in Specimen by Wright stain
Histoplasma capsulatum yeast phase Ab [Presence] in Serum
Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID)
Thermoactinomyces vulgaris Ab [Presence] in Serum by Immune diffusion (ID)
Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence
Rheumatoid factor [Presence] in Synovial fluid by Latex agglutination
Microscopic observation [Identifier] in Specimen by Wright Giemsa stain
Crystals [type] in Body fluid by Light microscopy
Crystals [type] in Pleural fluid by Light microscopy
Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)
Amoxicillin IgE Ab [Units/volume] in Serum
Aspergillus niger IgE Ab [Units/volume] in Serum
Green Bean IgE Ab [Units/volume] in Serum
Meperidine and Normeperidine panel - Serum or Plasma
Transcortin and Cortisol.free panel - Serum or Plasma
Metanephrine, Normetanephrine and Creatinine panel - Urine
Oregon Ash IgE Ab [Units/volume] in Serum
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
Genital Mycoplasma identified in Genital specimen by Organism specific culture
Cat dander IgE Ab [Units/volume] in Serum
Cauliflower IgE Ab [Units/volume] in Serum
Chicken serum proteins IgE Ab [Units/volume] in Serum
Pincer cells [Presence] in Blood by Light microscopy
Bacteria identified in Blood product unit by Culture
Bilirubin.total [Moles/volume] in Urine by Automated test strip
Leukocytes [#/volume] in Dialysis fluid by Automated count
Nuclear Ab [Presence] in Pericardial fluid by Immunofluorescence
Nuclear Ab [Presence] in Pleural fluid by Immunofluorescence
Nuclear Ab [Presence] in Peritoneal fluid by Immunofluorescence
Nuclear Ab [Presence] in Synovial fluid by Immunofluorescence
Nuclear Ab [Titer] in Pericardial fluid by Immunofluorescence
Nuclear Ab [Titer] in Pleural fluid by Immunofluorescence
Nuclear Ab [Titer] in Peritoneal fluid by Immunofluorescence
Nuclear Ab [Titer] in Body fluid by Immunofluorescence
Ribonucleoprotein extractable nuclear 63kD Ab [Presence] in Serum or Plasma
Leukocytes.disintegrated/100 leukocytes in Blood
Chromatin Ab [Presence] in Serum or Plasma
Microscopic observation [Identifier] in Body fluid by KOH preparation
Specific gravity of Pericardial fluid by Refractometry
Glomerular basement membrane Ab [Presence] in Serum
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunoassay
Cockatiel droppings IgE Ab [Units/volume] in Serum
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction
DNA double strand IgG Ab [Units/volume] in Peritoneal fluid by Immunoassay
DNA double strand IgG Ab [Units/volume] in Synovial fluid by Immunoassay
Basophils [#/volume] in Peritoneal fluid by Manual count
Basophils [#/volume] in Pericardial fluid by Manual count
Basophils [#/volume] in Pleural fluid by Manual count
Cryptostroma corticale IgE Ab [Units/volume] in Serum
Basophils [#/volume] in Synovial fluid by Manual count
Basophils/100 leukocytes in Vitreous fluid by Manual count
Basophils [#/volume] in Vitreous fluid by Manual count
Eosinophils [#/volume] in Pericardial fluid by Manual count
Eosinophils [#/volume] in Peritoneal fluid by Manual count
Eosinophils [#/volume] in Pleural fluid by Manual count
Eosinophils [#/volume] in Synovial fluid by Manual count
Eosinophils [#/volume] in Vitreous fluid by Manual count
Eosinophils/100 leukocytes in Vitreous fluid by Manual count
Lymphocytes [#/volume] in Pericardial fluid by Manual count
Lymphocytes [#/volume] in Pleural fluid by Manual count
Abnormal lymphocytes/100 leukocytes in Vitreous fluid by Manual count
Lymphocytes [#/volume] in Vitreous fluid by Manual count
Macrophages [#/volume] in Pericardial fluid by Manual count
Macrophages [#/volume] in Peritoneal fluid by Manual count
Respiratory Mycoplasma identified in Sputum by Organism specific culture
Macrophages [#/volume] in Pleural fluid by Manual count
Macrophages [#/volume] in Synovial fluid by Manual count
Macrophages/100 leukocytes in Vitreous fluid by Manual count
Macrophages [#/volume] in Vitreous fluid by Manual count
Mesothelial cells [#/volume] in Pericardial fluid by Manual count
Mesothelial cells [#/volume] in Peritoneal fluid by Manual count
Mesothelial cells [#/volume] in Pleural fluid by Manual count
Mesothelial cells [#/volume] in Synovial fluid by Manual count
Mesothelial cells/100 leukocytes in Vitreous fluid by Manual count
Mesothelial cells [#/volume] in Vitreous fluid by Manual count
Monocytes [#/volume] in Pericardial fluid by Manual count
Monocytes [#/volume] in Peritoneal fluid by Manual count
Monocytes [#/volume] in Pleural fluid by Manual count
Monocytes/100 leukocytes in Vitreous fluid by Manual count
Monocytes [#/volume] in Vitreous fluid by Manual count
Neutrophils [#/volume] in Pericardial fluid by Manual count
Neutrophils/100 leukocytes in Vitreous fluid by Manual count
Neutrophils [#/volume] in Vitreous fluid by Manual count
Leukocytes other [#/volume] in Pericardial fluid by Manual count
Leukocytes other [#/volume] in Peritoneal fluid by Manual count
Leukocytes other [#/volume] in Pleural fluid by Manual count
Leukocytes other [#/volume] in Synovial fluid by Manual count
Leukocytes other/100 leukocytes in Vitreous fluid by Manual count
Leukocytes other [#/volume] in Vitreous fluid by Manual count
Leukocytes [#/volume] in Vitreous fluid by Automated count
Erythrocytes [#/volume] in Vitreous fluid by Automated count
Smudge cells [#/volume] in Blood by Manual count
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
Gamma hydroxybutyrate [Moles/volume] in Urine
Gamma hydroxybutyrate [Moles/volume] in Gastric fluid
Honey bee IgE Ab [Units/volume] in Serum
Latex glove extract ammoniated IgE Ab [Units/volume] in Serum
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction
Phenylbutazone [Moles/volume] in Gastric fluid
Enterovirus and Parechovirus A RNA [Identifier] in Specimen by NAA with probe detection
Trichomonas sp identified in Specimen by Organism specific culture
Latex glove extract buffered IgE Ab [Units/volume] in Serum
Picornavirus Ag [Presence] in Isolate by Immunofluorescence
Rilpivirine [Susceptibility] by Genotype method
Insulin [Units/volume] in Serum or Plasma --1.25 hours post XXX challenge
Insulin [Units/volume] in Serum or Plasma --1.75 hours post XXX challenge
Epstein-Barr virus-encoded RNA 1 [Presence] in Tissue by Probe
APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Mexican tea IgE Ab [Units/volume] in Serum
Serotonin release.heparin.unfractionated and low molecular weight panel - Serum
Papaya (Carica papaya) IgE Ab [Units/volume] in Serum
Treponema pallidum IgG and IgM panel - Serum Qualitative by Immunofluorescence
Penicillin G IgE Ab [Units/volume] in Serum
Green Pepper IgE Ab [Units/volume] in Serum
HYDROmorphone [Mass/mass] in Meconium by Confirmatory method
Codeine [Mass/mass] in Meconium by Confirmatory method
oxyCODONE [Mass/mass] in Meconium by Confirmatory method
HYDROcodone [Mass/mass] in Meconium by Confirmatory method
Nucleated erythrocytes/100 leukocytes [Ratio] in Synovial fluid
Mycoplasma hominis DNA [Presence] in Specimen by NAA with probe detection
Ureaplasma sp DNA [Presence] in Specimen by NAA with probe detection
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
U2 small nuclear ribonucleoprotein Ab [Presence] in Serum
Common Reed IgE Ab [Units/volume] in Serum
Respiratory Mycoplasma identified in Throat by Organism specific culture
Trichophyton rubrum IgE Ab [Units/volume] in Serum
Black Willow IgE Ab [Units/volume] in Serum
Prolymphocytes [#/volume] in Blood by Manual count
Hemoglobin S [Presence] in Blood by Solubility test
1-Methylhistidine [Mass/time] in 24 hour Urine
Respiratory Mycoplasma identified in Specimen by Organism specific culture
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine
3-Methylhistidine [Mass/time] in 24 hour Urine
Adenosine monophosphate.cyclic [Mass/volume] in Urine
Allo-tetrahydrocortisol [Mass/time] in 24 hour Urine
Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)
Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
Mycoplasma sp and Ureaplasma sp [Identifier] in Specimen by Organism specific culture
Cancer Ag 15-3 [Units/volume] in Serum or Plasma
Coproporphyrin 1 [Mass/time] in 24 hour Urine
Coproporphyrin 3 [Mass/time] in 24 hour Urine
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA)
Ethanolamine [Mass/time] in 24 hour Urine
Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture
Glucose.protein bound [Mass/volume] in Serum or Plasma
Homocystine [Mass/time] in 24 hour Urine
Beta globulin [Mass/volume] in 24 hour Urine
Erythrocytes [Presence] in Dialysis fluid
Erythrocytes [#/volume] by Light microscopy in Urine sediment collected for unspecified duration
Erythrocytes by Light microscopy in Urine sediment collected for unspecified duration
Gamma globulin [Mass/volume] in 24 hour Urine
Lactate [Mass/volume] in Serum or Plasma --post exercise
Erythrocytes in 24 hour Urine sediment by Light microscopy
Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid
Spermatozoa Progressive/100 spermatozoa in Semen --post concentration
Testosterone.free+weakly bound/Testosterone.total in Serum or Plasma
dRVVT W excess phospholipid actual/normal (normalized LA confirm)
Parathyrin.intact [Mass/volume] in Serum or Plasma --20 minutes post excision
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post exercise
Cancer Ag 125 [Units/volume] in Pericardial fluid
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis
Cancer Ag 72-4 [Units/volume] in Peritoneal fluid
Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid
Cancer Ag 72-4 [Units/volume] in Pericardial fluid
Cytokeratin 19 [Mass/volume] in Peritoneal fluid
Cytokeratin 19 [Mass/volume] in Cerebral spinal fluid
Cytokeratin 19 [Mass/volume] in Pericardial fluid
Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid by Electrophoresis
Catecholamines Free [Mass/volume] in 24 hour Urine
Urobilinogen [Mass/time] in 24 hour Stool
Heat shock protein 60 Ab [Units/volume] in Serum or Plasma by Immunoassay
LDL.oxidized Ab [Units/volume] in Serum by Immunoassay
Baker's yeast Ab [Units/volume] in Serum by Immunoassay
Acetylcholine receptor Ab [Moles/volume] in Serum by Immunoassay
Cytokeratin 19 [Mass/volume] in Pleural fluid
Enolase.neuron specific [Mass/volume] in Pleural fluid
Zidovudine [Mass/volume] in Serum or Plasma
Somatotropin [Mass/volume] in Serum or Plasma --90 minutes post exercise
Somatotropin [Mass/volume] in Serum or Plasma --110 minutes post exercise
Somatotropin [Mass/volume] in Serum or Plasma --130 minutes post exercise
Voltage-gated potassium channel Ab [Units/volume] in Serum
Listeria monocytogenes IgG Ab [Titer] in Serum by Agglutination
CD3+CD5+ cells [#/volume] in Cerebral spinal fluid
SERPINA10 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
ATP1A2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Candida albicans Ab [Titer] in Serum by Immunofluorescence
Ehrlichia chaffeensis Ab [Titer] in Serum by Immunofluorescence
Herpes virus 8 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Pyruvate [Mass/volume] in Blood --20 minutes post XXX challenge
Enolase.neuron specific [Mass/volume] in Pericardial fluid
Streptococcus pyogenes rRNA [Presence] in Throat by Probe
DNA double strand IgG Ab [Units/volume] in Pericardial fluid by Immunoassay
Butalbital [Mass/volume] in Serum or Plasma
Microscopic observation [Identifier] in Urine by KOH preparation
Specimen condition [Interpretation] of Urine Narrative
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Phenylbutazone [Moles/volume] in Specimen
cloZAPine [Mass/volume] in Serum or Plasma
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay
Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method
Gamma hydroxybutyrate [Moles/volume] in Specimen
Norsertraline [Mass/volume] in Serum or Plasma
IgA.intrathecally synthesized/IgA.total in Cerebral spinal fluid
IgG.intrathecally synthesized/IgG.total in Cerebral spinal fluid
IgM.intrathecally synthesized/IgM.total in Cerebral spinal fluid
Pseudomonas aeruginosa alkaline protease Ab [Titer] in Serum by Immunoassay
Pseudomonas aeruginosa elastase Ab [Titer] in Serum by Immunoassay
Pseudomonas aeruginosa exotoxin A Ab [Titer] in Serum by Immunoassay
Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic method
Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic method
dilTIAZem [Mass/volume] in Serum or Plasma
Argatroban [Units/volume] in Platelet poor plasma by Chromogenic method
National (USA) PFGE pattern [Identifier] in Isolate
Bacteria antigenic formula [Identifier] in Isolate
Influenza virus A H5a RNA [Presence] in Specimen by NAA with probe detection
Influenza virus A H5b RNA [Presence] in Specimen by NAA with probe detection
Local PFGE pattern [Identifier] in Isolate
Performing laboratory medical director [Identifier]
Epidemiologically important information for public health reporting panel
Human RNase P RNA [Presence] in Specimen by NAA with probe detection
Felbamate [Mass/volume] in Serum or Plasma
Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
Mononuclear cells atypical/100 leukocytes in Blood by Manual count
Immature granulocytes/100 leukocytes in Body fluid
Immature granulocytes/100 leukocytes in Cerebral spinal fluid
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method
Cocaine panel - Meconium by Confirmatory method
Cocaine [Mass/mass] in Meconium by Confirmatory method
Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method
Cocaethylene [Mass/mass] in Meconium by Confirmatory method
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method
Insulin Free [Units/volume] in Serum or Plasma
Lymphocyte proliferation.phytohemagglutinin.maximum/CD3 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.Candida albicans.maximum/CD45 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.Candida albicans.maximum/CD3 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.tetanus toxoid.maximum/CD45 in Blood by Flow cytometry (FC)
Immature granulocytes/100 leukocytes in Synovial fluid
Lymphocyte proliferation mitogen panel - Blood by Flow cytometry (FC)
Lymphocyte proliferation stimulated by pokeweed mitogen/CD45 in Blood by Flow cytometry (FC)
Lymphocyte proliferation stimulated by pokeweed mitogen/CD3 in Blood by Flow cytometry (FC)
Amphetamines panel - Meconium by Confirmatory method
Methamphetamine [Mass/mass] in Meconium by Confirmatory method
Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method
Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method
Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method
Opiates panel - Meconium by Confirmatory method
Morphine [Mass/mass] in Meconium by Confirmatory method
oxyMORphone [Mass/mass] in Meconium by Confirmatory method
Lymphocyte proliferation.tetanus toxoid.maximum/CD3 in Blood by Flow cytometry (FC)
Buprenorphine and Norbuprenorphine panel - Urine
Eastern equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence
Eastern equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence
Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence
Lymphocyte proliferation.pokeweed mitogen.maximum/CD19 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.phytohemagglutinin.maximum/CD45 in Blood by Flow cytometry (FC)
Norverapamil [Mass/volume] in Serum or Plasma
Chronic urticaria index panel - Serum or Plasma
Western equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence
Lymphocyte proliferation antigen panel - Blood by Flow cytometry (FC)
Coagulation specialist review of results
Flow cytometry specialist review of results
Propafenone [Mass/volume] in Serum or Plasma
Sertraline [Mass/volume] in Serum or Plasma
sulfADIAZINE [Mass/volume] in Serum or Plasma
Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture
Complement C4 [Mass/volume] in Body fluid
Mucin clot [Appearance] in Synovial fluid Qualitative
Brucella abortus IgA Ab [Units/volume] in Serum
Brucella abortus IgG Ab [Units/volume] in Serum
Chlamydophila pneumoniae IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydophila pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence
Chlamydophila psittaci IgA Ab [Titer] in Serum by Immunofluorescence
Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture
Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydophila psittaci IgM Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis IgA Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Echovirus 7 Ab [Titer] in Serum by Complement fixation
Adrenal cortex Ab [Units/volume] in Serum by Immunofluorescence
Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture
Platelet IgG Ab [Presence] in Serum by Flow cytometry (FC)
Rheumatoid factor [Units/volume] in Serum by Immunoassay
Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture
Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection
HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Parvovirus B19 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
oxyCODONE [Presence] in Saliva (oral fluid) by Screen method
Amylase [Enzymatic activity/volume] in Serum or Plasma --fasting
HPV E6+E7 mRNA cells/cells [Presence] in Cervix by Flow cytometry (FC)
Amylase [Enzymatic activity/volume] in Serum or Plasma --2nd specimen post XXX challenge
Amylase [Enzymatic activity/volume] in Serum or Plasma --1st specimen post XXX challenge
PCA3 score in Urine by Molecular genetics method
PCA3 score in Urine Qualitative by Molecular genetics method
SERPINA10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ATP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoblot
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoblot
Bordetella pertussis IgM Ab [Presence] in Serum by Immunoblot
Blood group antibody screen [Presence] in Cord blood
Passive D Ab [Presence] in Serum or Plasma
Vancomycin resistance vanA and vanB and vanC1 and vanC2 genes [Identifier] by Molecular method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method
AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
IgA [Mass/volume] in Saliva (oral fluid)
Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture
Potassium [Moles/time] in unspecified time Stool
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
Haemophilus influenzae [Identifier] in Specimen by Organism specific culture
Albumin [Mass/time] in 24 hour Urine by Electrophoresis
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay
Heterophile Ab [Presence] in Blood by Immunoassay
Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
Carnitine free (C0) [Moles/volume] in Semen
Rosner index in Platelet poor plasma by Coagulation assay
Albumin [Mass/volume] in Urine by Electrophoresis
ISOtretinoin [Mass/volume] in Serum or Plasma
AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
BTK gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
CFTR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
ACVRL1 gene+ENG gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
ENG gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
F9 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
lamoTRIgine [Mass/volume] in Serum or Plasma
FBN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
LDLR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
LDLR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
TNFRSF13B gene full mutation analysis in Blood or Tissue by Sequencing
TNFRSF13B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
VHL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Metaproterenol [Mass/volume] in Serum or Plasma
Cefamandole [Susceptibility] by Disk diffusion (KB)
raNITIdine [Mass/volume] in Serum or Plasma
Zolpidem [Mass/volume] in Serum or Plasma
Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence
DNA region of interest start [Identifier]
DNA region of interest stop [Identifier]
Genetic knowledge reference [Identifier]
Thromboelastography after addtion of heparinase panel - Blood
Lactose tolerance [Interpretation] in Serum or Plasma Narrative
Lactose tolerance panel [Moles/volume] in Serum or Plasma
Lactose tolerance panel [Mass/volume] in Serum or Plasma
Ma1 Ab [Presence] in Serum by Immunoblot
Bartonella henselae IgM Ab [Titer] in Serum by Immunofluorescence
Ma1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
Enolase.neuron specific [Mass/volume] in Peritoneal fluid
Thyrotropin [Units/volume] in Cord blood
Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection
Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection
Bacterial vaginosis score in Vaginal fluid Qualitative by NAA with probe detection
Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection
Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection
Coxsackievirus A21 Ab [Titer] in Serum by Complement fixation
Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection
Bacterial vaginosis [Interpretation] in Vaginal fluid Qualitative
Risk of ovarian malignancy algorithm score in Serum or Plasma --premenopausal
Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture
Risk of ovarian malignancy algorithm score in Serum or Plasma --postmenopausal
Bacterial vaginosis DNA and score panel - Vaginal fluid by NAA with probe detection
ERCC1 Ag [Presence] in Tissue by Immune stain
Tiglylcarnitine+methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma
Western equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence
Campylobacter jejuni Ab [Presence] in Serum by Complement fixation
Campylobacter fetus Ab [Presence] in Serum
Hepatitis E virus RNA [Presence] in Blood by NAA with probe detection
Local assigning authority [Identifier] in Isolate
National (USA) PFGE cluster code or CDC cluster [Identifier] in Isolate
PFGE restriction enzyme [Identifier] in Isolate
Western equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence
Yersinia enterocolitica O:3 Ab [Titer] in Serum
Yersinia enterocolitica O:5 Ab [Titer] in Serum
Yersinia enterocolitica O:8 Ab [Titer] in Serum
Yersinia enterocolitica O:9 Ab [Titer] in Serum
Yersinia enterocolitica Ab [Titer] in Serum
Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay
Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture
Yersinia enterocolitica IgG Ab [Units/volume] in Serum by Immunoassay
Yersinia enterocolitica IgM Ab [Units/volume] in Serum by Immunoassay
HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay
Yersinia pseudotuberculosis Ab [Titer] in Serum
Myeloperoxidase Ab [Units/volume] in Serum
2,4 toluenediamine [Mass/volume] in Urine
2,6 toluenediamine [Mass/volume] in Urine
Tissue transglutaminase IgA + Gliadin peptides IgA and IgG panel - Serum
Tissue transglutaminase IgA + Gliadin peptides IgA and IgG [Interpretation] in Serum Narrative
Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture
Differential panel, method unspecified - Blood
Drugs of abuse panel - Urine by Screen method
CBC W Differential panel, method unspecified - Blood
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgA Ab [Presence] in Serum by Line blot
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgG Ab [Presence] in Serum by Line blot
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Line blot
Bordetella sp filamentous hemagglutinin and pertussis toxin Ab.IgA and IgG panel - Serum by Line blot
Amikacin [Susceptibility] by Gradient strip
Amoxicillin [Susceptibility] by Gradient strip
Rubella virus IgM Ab [Presence] in Body fluid by Immunoassay
Mumps virus IgM Ab [Presence] in Body fluid by Immunoassay
La Crosse virus RNA [Presence] in Specimen by NAA with probe detection
2-Oxoadipate [Moles/volume] in Serum or Plasma
Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine [Molar ratio] in Urine
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Cerebral spinal fluid
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Amniotic fluid
Orotate [Moles/volume] in Serum or Plasma
Amoxicillin+Clavulanate [Susceptibility] by Gradient strip
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Urine
Propionylcarnitine (C3) [Moles/volume] in Urine
Stearoylcarnitine (C18) [Moles/volume] in Urine
Suberylcarnitine (C8-DC)/Creatinine [Molar ratio] in Urine
Suberylcarnitine (C8-DC) [Moles/volume] in Cerebral spinal fluid
Suberylcarnitine (C8-DC) [Moles/volume] in Amniotic fluid
Suberylcarnitine (C8-DC) [Moles/volume] in Urine
2-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid
Amphotericin B [Susceptibility] by Gradient strip
2-Hydroxyisovalerate [Moles/volume] in Serum or Plasma
2-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid
2-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma
2-Hydroxysebacate [Moles/volume] in Cerebral spinal fluid
2-Hydroxysebacate [Moles/volume] in Serum or Plasma
2-Methylacetoacetate [Moles/volume] in Cerebral spinal fluid
2-Methylacetoacetate [Moles/volume] in Serum or Plasma
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Cerebral spinal fluid
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Serum or Plasma
2-Methylbutyrylglycine [Moles/volume] in Serum or Plasma
Tetradecadienoylcarnitine (C14:2)/Creatinine [Molar ratio] in Urine
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Cerebral spinal fluid
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Amniotic fluid
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Urine
Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine [Molar ratio] in Urine
17-Hydroxyprogesterone [Moles/volume] in Amniotic fluid
1-Hydroxymidazolam [Mass/volume] in Serum or Plasma
2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine
Ampicillin [Susceptibility] by Gradient strip
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma
Methyl ethyl ketone [Mass/volume] in Body fluid
2-Oxoadipate [Moles/volume] in Cerebral spinal fluid
Alpha ketoglutarate [Moles/volume] in Cerebral spinal fluid
Alpha ketoglutarate [Moles/volume] in Serum or Plasma
2-Oxoisocaproate [Moles/volume] in Cerebral spinal fluid
2-Dechloroethylifosfamide [Mass/volume] in Blood --12 hours post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --post dose ifosfamide
Ampicillin+Sulbactam [Susceptibility] by Gradient strip
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --pre dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --pre dose ifosfamide
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --1 day post dose ifosfamide
Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --1 day post dose ifosfamide
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --2 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --2 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --3 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --3 days post dose ifosfamide
Azithromycin [Susceptibility] by Gradient strip
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --4 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --4 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --5 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --6 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --6 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in Blood --7 days post dose ifosfamide
Aztreonam [Susceptibility] by Gradient strip
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --7 days post dose ifosfamide
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --7 days post dose ifosfamide
2-Ethylhydracrylate [Moles/volume] in Cerebral spinal fluid
2-Ethylhydracrylate [Moles/volume] in Serum or Plasma
2-Methylglutarate [Moles/volume] in Serum or Plasma
Methylsuccinate [Moles/volume] in Amniotic fluid
Methylsuccinate [Moles/volume] in Serum or Plasma
3,4-Dihydroxyphenylacetate [Moles/volume] in 24 hour Urine
Bacitracin [Susceptibility] by Gradient strip
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in Urine
3-Hydroxy,3-Methylglutarate [Moles/volume] in Cerebral spinal fluid
3-Hydroxy,3-Methylglutarate [Moles/volume] in Amniotic fluid
3-Hydroxy,3-Methylglutarate [Moles/volume] in Serum or Plasma
3-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid
3-Hydroxyadipate [Moles/volume] in Serum or Plasma
3-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid
2-Hydroxy-3-Methylvalerate [Moles/volume] in Cerebral spinal fluid
2-Hydroxy-3-Methylvalerate [Moles/volume] in Serum or Plasma
2-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid
2-Hydroxyadipate [Moles/volume] in Serum or Plasma
Alpha hydroxybutyrate [Moles/volume] in Cerebral spinal fluid
Alpha hydroxybutyrate [Moles/volume] in Serum or Plasma
2-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid
2-Hydroxyglutarate [Moles/volume] in Serum or Plasma
2-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid
2-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma
2-Hydroxyisocaproate [Moles/volume] in Cerebral spinal fluid
Beta lactamase.extended spectrum [Susceptibility]
2-Hydroxyisocaproate [Moles/volume] in Serum or Plasma
3-Hydroxyglutarate [Moles/volume] in Amniotic fluid
3-Hydroxyglutarate [Moles/volume] in Serum or Plasma
3-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid
3-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma
Cefaclor [Susceptibility] by Gradient strip
Cefepime [Susceptibility] by Gradient strip
Cefodizime [Susceptibility] by Gradient strip
Cefotaxime [Susceptibility] by Gradient strip
cefoTEtan [Susceptibility] by Gradient strip
Basophils+Mast cells/100 leukocytes in Body fluid
Basophils+Mast cells/100 leukocytes in Cerebral spinal fluid
cefOXitin [Susceptibility] by Gradient strip
Basophils+Mast cells/100 leukocytes in Synovial fluid
Thrombin time.high dose in Platelet poor plasma by Coagulation assay
Adenovirus IgA Ab [Presence] in Serum by Immunoassay
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Cefpirome [Susceptibility] by Gradient strip
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Units/volume] in Serum by Multidisk
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
European tick borne encephalitis virus IgM Ab index [Units/volume] in Serum and CSF by Immunoassay
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
European tick borne encephalitis virus IgG Ab index [Units/volume] in Serum and CSF by Immunoassay
Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay
Cefpodoxime [Susceptibility] by Gradient strip
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Units/volume] in Serum by Multidisk
Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection
Ureaplasma urealyticum+Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Specimen by NAA with probe detection
Gardnerella vaginalis DNA [Presence] in Specimen by NAA with probe detection
Trichomonas vaginalis DNA [Presence] in Specimen by NAA with probe detection
Astrovirus RNA [Presence] in Specimen by NAA with probe detection
Trichophyton rubrum DNA [Presence] in Nail by NAA with probe detection
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --20 minutes post 50 g lactose PO
Glucose [Moles/volume] in Serum or Plasma --40 minutes post 50 g lactose PO
Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid
Treponema pallidum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Triglyceride [Moles/volume] in Pericardial fluid
Cefprozil [Susceptibility] by Gradient strip
Bordetella parapertussis IgG Ab [Presence] in Serum by Immunoassay
Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay
Hemoglobin [Mass/volume] in Pericardial fluid
Amylase.pancreatic/Creatinine [Ratio] in Urine
Liver kidney microsomal 1 IgG Ab [Presence] in Serum by Immunoassay
PCA-1 IgG Ab [Presence] in Serum by Immunoassay
Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Immunoassay
cefTAZidime [Susceptibility] by Gradient strip
Intestinal goblet cell Ab [Presence] in Serum by Immunoassay
Human upstream binding factor IgG Ab [Presence] in Serum by Immunoassay
Proteinase 3 IgG Ab [Presence] in Serum by Immunoassay
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Units/volume] in Serum by Multidisk
Hepatitis E virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Respiratory syncytial virus IgM Ab [Presence] in Serum by Immunoassay
Ceftibuten [Susceptibility] by Gradient strip
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Bicarbonate [Moles/volume] standard in Plasma
Clinical cytogeneticist review of results
Newborn screening report overall laboratory comment
Ceftizoxime [Susceptibility] by Gradient strip
cefTRIAXone [Susceptibility] by Gradient strip
Organism count [#/volume] in Specimen by Microscopic count
Cefuroxime Parenteral [Susceptibility] by Gradient strip
Cephalothin [Susceptibility] by Gradient strip
Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Enterovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Chloramphenicol [Susceptibility] by Gradient strip
Enterovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Coxsackievirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Coxsackievirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Parainfluenza virus 1+2+3+4 IgA Ab [Presence] in Serum by Immunoassay
Streptococcus sp DNA [Presence] in Blood by NAA with probe detection
Staphylococcus sp.coagulase negative DNA [Presence] in Blood by NAA with probe detection
Parainfluenza virus 1+2+3+4 IgM Ab [Presence] in Serum by Immunoassay
Staphylococcus haemolyticus DNA [Presence] in Blood by NAA with probe detection
Klebsiella oxytoca DNA [Presence] in Blood by NAA with probe detection
Bacteroides fragilis DNA [Presence] in Blood by NAA with probe detection
Salmonella typhi DNA [Presence] in Blood by NAA with probe detection
Candida albicans DNA [Presence] in Blood by NAA with probe detection
Candida tropicalis DNA [Presence] in Blood by NAA with probe detection
Candida parapsilosis DNA [Presence] in Blood by NAA with probe detection
Candida krusei DNA [Presence] in Blood by NAA with probe detection
Candida glabrata DNA [Presence] in Blood by NAA with probe detection
Dermatophytes chitin synthase 1 chs1 gene [Presence] in Nail by NAA with probe detection
Megakaryocytic nuclei/100 leukocytes in Blood by Manual count
Ciprofloxacin [Susceptibility] by Gradient strip
Ragocytes/100 leukocytes in Synovial fluid by Manual count
Lipophages/100 leukocytes in Cerebral spinal fluid by Manual count
Siderophages/100 leukocytes in Cerebral spinal fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Automated count
Clarithromycin [Susceptibility] by Gradient strip
Mononuclear cells/100 leukocytes in Pericardial fluid by Automated count
Mononuclear cells/100 leukocytes in Peritoneal fluid by Automated count
Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Automated count
Polymorphonuclear cells/100 leukocytes in Synovial fluid by Automated count
FSHB gene c.-211G>T [Presence] in Blood or Tissue by Molecular genetics method
Mononuclear cells/100 leukocytes in Synovial fluid by Automated count
Mononuclear cells [#/volume] in Pleural fluid by Automated count
Polymorphonuclear cells [#/volume] in Pleural fluid by Automated count
Clinafloxacin [Susceptibility] by Gradient strip
Polymorphonuclear cells [#/volume] in Pericardial fluid by Automated count
Mononuclear cells [#/volume] in Pericardial fluid by Automated count
Mononuclear cells [#/volume] in Peritoneal fluid by Automated count
Polymorphonuclear cells [#/volume] in Peritoneal fluid by Automated count
Polymorphonuclear cells [#/volume] in Synovial fluid by Automated count
Pneumocystis jiroveci Ag [Presence] in Specimen by Immunofluorescence
Mononuclear cells [#/volume] in Synovial fluid by Automated count
Multiple inhalant allergen IgE Ab [Presence] in Serum by Immunoassay
Clindamycin [Susceptibility] by Gradient strip
Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus dobrova IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus dobrova IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus saaremaa IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus saaremaa IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Demeclocycline [Susceptibility] by Gradient strip
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Human papilloma virus 16 and 18 DNA [Presence] in Specimen by NAA with probe detection
Enterovirus Ag [Presence] in Stool by Immunoassay
Mononuclear cells/100 leukocytes in Pleural fluid by Automated count
Polymorphonuclear cells/100 leukocytes in Pleural fluid by Automated count
Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Specimen by NAA with probe detection
Streptococcus intermedius DNA [Presence] in Specimen by NAA with probe detection
Streptococcus anginosus DNA [Presence] in Specimen by NAA with probe detection
Streptococcus constellatus DNA [Presence] in Specimen by NAA with probe detection
Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
Amyloid beta 40 peptide [Mass/volume] in Plasma
Angiotensin II [Mass/volume] in Plasma --supine
Interleukin 1 alpha [Mass/volume] in Cerebral spinal fluid
Interleukin 1 alpha [Mass/volume] in Body fluid
Interleukin 2 [Mass/volume] in Cerebral spinal fluid
Dirithromycin [Susceptibility] by Gradient strip
Interleukin 2 [Mass/volume] in Body fluid
Interleukin 3 [Mass/volume] in Serum or Plasma
Interleukin 3 [Mass/volume] in Cerebral spinal fluid
Interleukin 3 [Mass/volume] in Body fluid
Interleukin 4 [Mass/volume] in Body fluid
Interleukin 4 [Mass/volume] in Cerebral spinal fluid
Interleukin 5 [Mass/volume] in Cerebral spinal fluid
Interleukin 5 [Mass/volume] in Body fluid
Doxycycline [Susceptibility] by Gradient strip
Interleukin 7 [Mass/volume] in Serum or Plasma
Interleukin 7 [Mass/volume] in Cerebral spinal fluid
Interleukin 7 [Mass/volume] in Body fluid
Interleukin 13 [Mass/volume] in Cerebral spinal fluid
Interleukin 13 [Mass/volume] in Body fluid
Prostaglandin E2 [Mass/volume] in Cerebral spinal fluid
Prostaglandin E1 [Mass/volume] in Body fluid
Prostaglandin E1 [Mass/volume] in Cerebral spinal fluid
Erythromycin [Susceptibility] by Gradient strip
Prostaglandin F2 alpha [Mass/volume] in Cerebral spinal fluid
Prostaglandin F2 alpha [Mass/volume] in Body fluid
Thyrotropin releasing hormone [Mass/volume] in Urine
Methotrexate [Moles/volume] in Serum or Plasma --10th specimen
Methotrexate [Moles/volume] in Serum or Plasma --2nd specimen
Methotrexate [Moles/volume] in Serum or Plasma --3rd specimen
Methotrexate [Moles/volume] in Serum or Plasma --4th specimen
Ethambutol [Susceptibility] by Gradient strip
Methotrexate [Moles/volume] in Serum or Plasma --5th specimen
Methotrexate [Moles/volume] in Serum or Plasma --6th specimen
Methotrexate [Moles/volume] in Serum or Plasma --7th specimen
Methotrexate [Moles/volume] in Serum or Plasma --8th specimen
Methotrexate [Moles/volume] in Serum or Plasma --9th specimen
SERPINC1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Glutathione S-transferase T1 Ab [Titer] in Serum or Plasma by Immunofluorescence
Number of chromosome 13 present [#] in Amniotic fluid by NAA with probe detection
Ethionamide [Susceptibility] by Gradient strip
Number of chromosome 18 present [#] in Amniotic fluid by NAA with probe detection
Number of chromosome 21 present [#] in Amniotic fluid by NAA with probe detection
Francisella tularensis IgG Ab [Units/volume] in Serum or Plasma
Epithelial cells.squamous [Presence] in Body fluid
Epithelial cells.ciliated [Presence] in Body fluid
Erythrocytes [Presence] in Specimen by Wet preparation
Yeast.hyphae [Presence] in Specimen by KOH preparation
Leukocytes [#/volume] corrected for nucleated erythrocytes in Pleural fluid
Fleroxacin [Susceptibility] by Gradient strip
Yersinia sp identified in Specimen by Organism specific culture
Rickettsia typhus group and Rickettsia spotted fever group acute and convalescent IgG and IgM panel - Serum by Immunofluorescence
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen
Fluconazole [Susceptibility] by Gradient strip
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen
Sample icteric [Presence] of Cerebral spinal fluid Qualitative by Spectrophotometry
Amphetamines [Mass/volume] in Urine by Screen method
Barbiturates [Presence] in Urine by Screen method >300 ng/mL
Benzodiazepines [Mass/volume] in Urine by Screen method
Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL
Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL
Cannabinoids [Mass/volume] in Urine by Screen method
5-Fluorocytosine [Susceptibility] by Gradient strip
Cannabinoids [Presence] in Urine by Screen method >20 ng/mL
Cannabinoids [Presence] in Urine by Screen method >50 ng/mL
Benzoylecgonine [Mass/volume] in Urine by Screen method
Methadone [Mass/volume] in Urine by Screen method
Methadone [Presence] in Urine by Screen method >150 ng/mL
Methadone [Presence] in Urine by Screen method >300 ng/mL
Opiates [Mass/volume] in Urine by Screen method
Fusidate [Susceptibility] by Gradient strip
Opiates [Presence] in Urine by Screen method >300 ng/mL
Triiodothyronine (T3)/Thyroxine (T4) [Mass Ratio] in Serum or Plasma
Sample hemolyzed [Presence] of Cerebral spinal fluid Qualitative
Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method
Barbiturates [Presence] in Urine by Screen method >200 ng/mL
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue
Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urine by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urethra by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by NAA with probe detection
Trichomonas vaginalis rRNA [Presence] in Vaginal fluid by NAA with probe detection
Trichomonas vaginalis rRNA [Presence] in Cervix by NAA with probe detection
Trichomonas vaginalis rRNA [Presence] in Urine by NAA with probe detection
Hematocrit [Volume Fraction] of Synovial fluid
Gentamicin [Susceptibility] by Gradient strip
Hematocrit [Volume Fraction] of Pleural fluid
Nucleated erythrocytes/100 cells in Pleural fluid
Nucleated erythrocytes/100 cells in Peritoneal fluid
Neisseria meningitidis serogroup [Identifier] in Specimen
JC virus Ab [Presence] in Serum or Plasma by Immunoassay
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Cerebral spinal fluid
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Amniotic fluid
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Serum or Plasma
Gentamicin.high potency [Susceptibility] by Disk diffusion (KB)
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Urine
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood
1-Methylhistidine [Moles/volume] in Serum or Plasma from Fetus
Alpha aminoadipate [Moles/volume] in Serum or Plasma from Fetus
Alpha aminobutyrate [Moles/volume] in Serum or Plasma from Fetus
Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
Imipenem [Susceptibility] by Gradient strip
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method
Acetaminophen [Moles/volume] in Serum or Plasma by Screen method
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
Isoniazid [Susceptibility] by Gradient strip
Cholesterol in IDL [Moles/volume] in Serum or Plasma
Cholesterol in IDL+Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma
Cholesterol in VLDL 3 [Moles/volume] in Serum or Plasma
Cholesterol non HDL [Moles/volume] in Serum or Plasma
clonazePAM [Moles/volume] in Serum or Plasma by Screen method
Codeine [Moles/volume] in Urine by Confirmatory method
Estrogen [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO
Haptoglobin [Moles/volume] in Serum or Plasma
Anisocytosis [Presence] in Blood by Light microscopy
Morphine [Moles/volume] in Urine by Confirmatory method
Mycophenolate [Moles/volume] in Serum or Plasma
Nordiazepam [Moles/volume] in Serum or Plasma by Screen method
Nordiazepam [Moles/volume] in Urine by Confirmatory method
Oxazepam [Moles/volume] in Urine by Confirmatory method
oxyCODONE [Moles/volume] in Urine by Confirmatory method
Salicylates [Moles/volume] in Serum or Plasma by Screen method
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
Itraconazole [Susceptibility] by Gradient strip
Basic metabolic 2008 panel with ionized calcium - Serum or Plasma
Kanamycin [Susceptibility] by Gradient strip
Kanamycin.high potency [Susceptibility] by Disk diffusion (KB)
Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L
Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe and target amplification method detection limit = 20 copies/mL
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
CLN3 gene exon 7+8 deletion [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene c.394delTT [Presence] in Blood or Tissue by Molecular genetics method
PAH gene.p.Arg408Trp [Presence] in Blood or Tissue by Molecular genetics method
CCR2 gene p.Val64Ile [Presence] in Blood or Tissue by Molecular genetics method
CCR5 gene c.794_825del [Presence] in Blood or Tissue by Molecular genetics method
GALT gene p.Gln188Arg [Presence] in Blood or Tissue by Molecular genetics method
Ketoconazole [Susceptibility] by Gradient strip
Pyruvate dehydrogenase IgG Ab [Units/volume] in Serum by Immunoassay
Islet cell 512 IgG Ab [Presence] in Serum or Plasma by Immunoassay
Islet cell 512 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Follitropin IgG Ab [Units/volume] in Serum by Immunoassay
Follitropin IgA Ab [Units/volume] in Serum by Immunoassay
Nuclear IgG Ab [Ratio] in Serum by Immunoassay
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Units/volume] in Serum by Immunoassay
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal fluid
Triglyceride in pericardial fluid/Triglyceride in serum
Triglyceride in peritoneal fluid/Triglyceride in serum
Cholesterol in peritoneal fluid/Cholesterol in serum
Amylase in peritoneal fluid/Amylase in serum
Cholesterol in pericardial fluid/Cholesterol in serum
Creatinine in pleural fluid/Creatinine in serum
Protein in pericardial fluid/Protein in serum
Creatinine in peritoneal fluid/Creatinine in serum
Protein in peritoneal fluid/Protein in serum
levoFLOXacin [Susceptibility] by Gradient strip
Cholesterol in pleural fluid/Cholesterol in serum
Triglyceride in pleural fluid/Triglyceride in serum
Amylase.pancreatic [Enzymatic activity/volume] in Pleural fluid
t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Loracarbef [Susceptibility] by Gradient strip
t(1;11)(p32;q23)(EPS15,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;9)(q34;q34)(NUP214,SET) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Amdinocillin [Susceptibility] by Gradient strip
t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Del(1)(p32p32)(STIL,TAL1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
Meropenem [Susceptibility] by Gradient strip
Blastocystis hominis DNA [Presence] in Stool by NAA with probe detection
Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA [Presence] in Specimen by NAA with probe detection
Entamoeba sp DNA [Identifier] in Specimen by Sequencing
Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with probe detection
Cefamandole [Susceptibility] by Serum bactericidal titer
Methicillin [Susceptibility] by Gradient strip
metroNIDAZOLE [Susceptibility] by Gradient strip
Minocycline [Susceptibility] by Gradient strip
Mupirocin [Susceptibility] by Gradient strip
Nalidixate [Susceptibility] by Gradient strip
Netilmicin [Susceptibility] by Gradient strip
Nitrofurantoin [Susceptibility] by Gradient strip
Norfloxacin [Susceptibility] by Gradient strip
Ofloxacin [Susceptibility] by Gradient strip
Basophilic stippling [Presence] in Blood by Light microscopy
Oxacillin [Susceptibility] by Gradient strip
Pefloxacin [Susceptibility] by Gradient strip
Penicillin G [Susceptibility] by Gradient strip
Penicillin V [Susceptibility] by Gradient strip
Piperacillin [Susceptibility] by Gradient strip
Piperacillin+Tazobactam [Susceptibility] by Gradient strip
rifAMPin [Susceptibility] by Gradient strip
Roxithromycin [Susceptibility] by Gradient strip
Basophils [#/volume] in Blood by Automated count
Sparfloxacin [Susceptibility] by Gradient strip
Streptomycin [Susceptibility] by Gradient strip
Streptomycin.high potency [Susceptibility] by Disk diffusion (KB)
sulfADIAZINE [Susceptibility] by Gradient strip
Teicoplanin [Susceptibility] by Gradient strip
Tetracycline [Susceptibility] by Gradient strip
Ticarcillin [Susceptibility] by Gradient strip
Basophils [#/volume] in Blood by Manual count
Ticarcillin+Clavulanate [Susceptibility] by Gradient strip
Tobramycin [Susceptibility] by Gradient strip
Trimethoprim [Susceptibility] by Gradient strip
Plasmodium knowlesi DNA [Presence] in Blood by NAA with probe detection
Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay
Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip
Trovafloxacin [Susceptibility] by Gradient strip
Vancomycin [Susceptibility] by Gradient strip
Basophils/100 leukocytes in Blood by Automated count
Red Alder IgE Ab [Units/volume] in Serum
Smooth Alder IgE Ab [Units/volume] in Serum
White Alder IgE Ab [Units/volume] in Serum
Parathyrin.intact intraoperative percent change in Serum or Plasma
Cold agglutinin [Presence] in Serum by 18 degree C incubation
Cold agglutinin [Presence] in Serum by 22 degree C incubation
Cold agglutinin [Presence] in Serum by 28 degree C incubation
Mycobacterium avium ss paratuberculosis Ab [Presence] in Milk by Immunoassay
Alfalfa Pollen IgE Ab [Units/volume] in Serum
Basophils/100 leukocytes in Blood by Manual count
Almond triggered histamine release [Units/volume] in Blood
Almond Tree IgE Ab [Units/volume] in Serum
Alternaria sp IgE Ab [Units/volume] in Serum
Alternaria sp IgG Ab [Units/volume] in Serum
Alternaria alternata IgG Ab [Units/volume] in Serum
Alternaria alternata triggered histamine release [Units/volume] in Blood
Ampicillin IgM Ab [Units/volume] in Serum
Black Ant IgG Ab [Units/volume] in Serum
Black Ant triggered histamine release [Units/volume] in Blood
Burkholderia mallei [Presence] in Specimen by Organism specific culture
Burkholderia pseudomallei [Presence] in Specimen by Organism specific culture
Burkholderia pseudomallei DNA [Presence] in Specimen by NAA with probe detection
Burkholderia mallei DNA [Presence] in Specimen by NAA with probe detection
Burkholderia mallei Ag [Presence] in Specimen by Immunofluorescence
Burkholderia pseudomallei Ag [Presence] in Specimen by Immunofluorescence
Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Rabies virus Ab [Presence] in Cerebral spinal fluid by Immunoassay
Rabies virus neutralizing antibody [Presence] in Serum by Neutralization test
Rabies virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test
Rabies virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence
Rabies virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Black Imported Fire Ant IgE Ab [Units/volume] in Serum
Rabies virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Rabies virus IgM Ab [Presence] in Serum by Immunofluorescence
Rabies virus IgM Ab [Titer] in Serum by Immunofluorescence
Rabies virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rabies virus strain identified in Specimen by Immunofluorescence
Rabies virus strain identified in Specimen by Sequencing
Blasts [#/volume] in Blood by Manual count
Apple triggered histamine release [Units/volume] in Serum
Apple Tree IgE Ab [Units/volume] in Serum
Cryptococcus sp rRNA gene [Identifier] in Specimen by Sequencing
Cryptococcus sp Ag [Presence] in Tissue by Immunofluorescence
Cryptococcus sp Ag [Presence] in Tissue by Immune stain
Cryptococcus sp Ag [Presence] in Serum by Rapid immunoassay
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay
Arrowroot IgE Ab [Units/volume] in Serum
Artichoke IgE Ab [Units/volume] in Serum
Arizona Ash IgE Ab [Units/volume] in Serum
Blasts/100 leukocytes in Blood by Manual count
Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
Cryoglobulin [Presence] in Serum by Hypotonic dilution
White Ash triggered histamine release [Units/volume] in Blood
Asparagus IgE Ab [Units/volume] in Serum
Asparagus IgG Ab [Units/volume] in Serum
Aspergillus fumigatus IgG Ab [Units/volume] in Serum
Blood smear finding positive [Identifier] in Blood by Light microscopy
Aspergillus fumigatus triggered histamine release [Units/volume] in Blood
Aspergillus nidulans IgE Ab [Units/volume] in Serum
Aspergillus sp IgE Ab [Units/volume] in Serum
Aspergillus sp IgG Ab [Units/volume] in Serum
Acetylsalicylate IgE Ab [Units/volume] in Serum
Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC)
Groundsel Tree IgE Ab [Units/volume] in Serum
Bahia grass triggered histamine release [Units/volume] in Blood
Eosinophils [#/volume] in Blood by Automated count
Banana triggered histamine release [Units/volume] in Blood
Barley triggered histamine release [Units/volume] in Blood
Barley Pollen IgE Ab [Units/volume] in Serum
Oat+Barley IgE Ab [Units/volume] in Serum
Eosinophils [#/volume] in Blood by Manual count
Bass, Black IgE Ab [Units/volume] in Serum
Bayberry Pollen IgE Ab [Units/volume] in Serum
Green Bean IgG Ab [Units/volume] in Serum
Green Bean triggered histamine release [Units/volume] in Blood
Red Kidney Bean IgE Ab [Units/volume] in Serum
Red Kidney Bean IgG Ab [Units/volume] in Serum
Lima Bean IgE Ab [Units/volume] in Serum
Lima Bean IgG Ab [Units/volume] in Serum
Mung Bean IgE Ab [Units/volume] in Serum
Mung Bean IgG Ab [Units/volume] in Serum
SLC26A5 gene c.-53-2A>G [Presence] in Blood or Tissue by Molecular genetics method
TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
Pinto Bean IgE Ab [Units/volume] in Serum
PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing
GJB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Y chromosome AZFa region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative
Y chromosome AZFb region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative
Y chromosome AZFc region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative
Alkaline phosphatase.placental 2/Alkaline phosphatase.total in Serum or Plasma
Pinto Bean IgG Ab [Units/volume] in Serum
Alkaline phosphatase.intestinal 2 [Enzymatic activity/volume] in Serum or Plasma
Alkaline phosphatase.intestinal 3 [Enzymatic activity/volume] in Serum or Plasma
Alkaline phosphatase.placental 2 [Enzymatic activity/volume] in Serum or Plasma
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
Neutrophils.dysplastic [Presence] in Blood by Light microscopy
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Units/volume] in Serum by Multidisk
Soybean triggered histamine release [Units/volume] in Blood
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 51 (Carrot+Tomato+Mustard+Potato+Garlic) IgE Ab [Units/volume] in Serum by Multidisk
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Units/volume] in Serum by Multidisk
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum by Multidisk
Legionella sp [Identifier] in Isolate by Agglutination
Leptospira sp [Identifier] in Isolate by Agglutination
Eosinophils/100 leukocytes in Blood by Automated count
Soybean dust IgE Ab [Units/volume] in Serum
Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
Spermatozoa Motile [#] in Semen --post ejaculate
Bean string IgG Ab [Units/volume] in Serum
White Bean IgG Ab [Units/volume] in Serum
Yellow Bean IgG Ab [Units/volume] in Serum
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay
C reactive protein [Mass/volume] in Blood by High sensitivity method
Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay
Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method
Beef triggered histamine release [Units/volume] in Blood
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
Liver beef triggered histamine release [Units/volume] in Blood
Eosinophils/100 leukocytes in Blood by Manual count
Sugar Beet IgE Ab [Units/volume] in Serum
Bipolanis curvularia IgE Ab [Units/volume] in Serum
Blackberry IgE Ab [Units/volume] in Serum
Blueberry IgE Ab [Units/volume] in Serum
Blueberry IgG Ab [Units/volume] in Serum
Blueberry triggered histamine release [Units/volume] in Blood
Brazil Nut IgG Ab [Units/volume] in Serum
Brazil Nut triggered histamine release [Units/volume] in Blood
Hemoglobinopathies conditions suspected [Identifier] in DBS
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/substance] in Red Blood Cells
Macrophages/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count
Basophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Bronchial specimen by Manual count
Mesothelial cells/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Leukocytes other/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Basophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Brussel Sprouts IgE Ab [Units/volume] in Serum
Lymphocytes/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Pericardial fluid by Manual count
Mesothelial cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Heinz bodies [Presence] in Blood by Light microscopy
Mononuclear cells/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Leukocytes other/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Basophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Brussel Sprouts IgG Ab [Units/volume] in Serum
Eosinophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Pleural fluid by Manual count
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Mononuclear cells/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Leukocytes other/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Buckwheat IgG Ab [Units/volume] in Serum
Basophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Synovial fluid by Manual count
Mesothelial cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Polymorphonuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Mononuclear cells/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Leukocytes other/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Basophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Peritoneal fluid by Manual count
Plasma cells/Leukocytes [Pure number fraction] in Body fluid by Manual count
Unspecified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count
Unidentified cells/Leukocytes [Pure number fraction] in Body fluid by Manual count
Monocytes+Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count
Mesothelial cells/Leukocytes [Pure number fraction] in Body fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Body fluid by Manual count
Promyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count
Metamyelocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count
Blasts/Leukocytes [Pure number fraction] in Body fluid by Manual count
Band form neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Body fluid by Manual count
Burrobrush IgE Ab [Units/volume] in Serum
Basophils/Leukocytes [Pure number fraction] in Body fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Body fluid by Manual count
Segmented neutrophils/Leukocytes [Pure number fraction] in Body fluid by Manual count
Macrophages/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Plasma cells/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Promyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Myelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Metamyelocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Blasts/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Band form neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Monocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Basophils/Leukocytes [Pure number fraction] in Cerebral spinal fluid by Manual count
Plasma cells/Leukocytes [Pure number fraction] in Blood
Smudge cells/Leukocytes [Pure number fraction] in Blood by Manual count
Variant lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Promyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Myelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Blasts/Leukocytes [Pure number fraction] in Blood by Manual count
Butterfly IgE Ab [Units/volume] in Serum
Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Blood by Manual count
Monocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Lymphocytes/Leukocytes [Pure number fraction] in Blood by Manual count
Eosinophils/Leukocytes [Pure number fraction] in Blood by Manual count
Basophils/Leukocytes [Pure number fraction] in Blood by Manual count
Neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count
Monocytes/Leukocytes [Pure number fraction] in Blood by Automated count
Lymphocytes/Leukocytes [Pure number fraction] in Blood by Automated count
Eosinophils/Leukocytes [Pure number fraction] in Blood by Automated count
Basophils/Leukocytes [Pure number fraction] in Blood by Automated count
Buttermilk triggered histamine release [Units/volume] in Blood
Mononuclear cells [#/volume] in Body fluid by Automated count
Nucleated cells [#/volume] in Body fluid by Automated count
Hematopoietic progenitor cells [#/volume] in Blood by Automated count
Platelets reticulated [#/volume] in Blood by Automated count
Platelets reticulated/100 platelets in Blood by Automated count
Hemoglobin [Entitic mass] in Reticulocytes by Automated count
Immature granulocytes/100 leukocytes in Blood by Automated count
Polymorphonuclear cells/100 leukocytes in Body fluid by Automated count
Mononuclear cells/100 leukocytes in Body fluid by Automated count
Polymorphonuclear cells [#/volume] in Body fluid by Automated count
Flavivirus Ag [Presence] in Specimen by Immune stain
Rotavirus RNA [Identifier] in Stool by NAA with probe detection
Rotavirus dsRNA [Identifier] in Stool by Polyacrylamide gel electrophoresis (PAGE)
Rotavirus dsRNA [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE)
Rotavirus IgG Ab [Titer] in Serum by Immunoassay
Rotavirus IgA Ab [Units/volume] in Serum by Immunoassay
Rotavirus Ab [Units/volume] in Serum by Immunoassay
Marburg virus IgM Ab [Titer] in Serum by Immunoassay
Marburg virus IgG Ab [Titer] in Serum by Immunoassay
Marburg virus Ag [Presence] in Specimen by Immunoassay
Lassa virus IgM Ab [Titer] in Serum by Immunoassay
Lassa virus IgG Ab [Titer] in Serum by Immunoassay
Ebola virus IgM Ab [Titer] in Serum by Immunoassay
Canary feather IgE Ab [Units/volume] in Serum
Ebola virus IgM Ab [Presence] in Serum by Immunoassay
Pyruvate kinase [Enzymatic activity/substance] in Red Blood Cells
Brucella abortus Ab [Presence] in Milk by Heat-inactivation ring test
Brucella abortus IgG1 and IgG2 Ab [Presence] in Serum by Immunoassay
Brucella suis Ab [Titer] in Serum by Tube agglutination
Brucella suis Ab [Titer] in Serum by Plate agglutination
Enterococcus sp DNA [Presence] in Specimen by NAA with probe detection
Mycobacterium avium complex DNA [Presence] in Specimen by NAA with probe detection
Candida albicans IgG Ab [Units/volume] in Serum
Candida albicans triggered histamine release [Units/volume] in Blood
Candida sp IgG Ab [Units/volume] in Serum
Rotavirus RNA [Identifier] in Isolate by NAA with probe detection
Rotavirus identified in Stool by Sequencing
Rotavirus identified in Isolate by Sequencing
Rotavirus IgA Ab [Presence] in Serum by Immunoassay
Rotavirus IgA Ab [Titer] in Serum by Immunoassay
Rotavirus Ab [Titer] in Serum by Immunoassay
Rotavirus Ab [Presence] in Serum by Immunoassay
Ebola virus IgG Ab [Titer] in Serum by Immunoassay
Ebola virus Ag [Presence] in Specimen by Immunoassay
Marburg virus IgG Ab [Presence] in Serum by Immunoassay
Ebola virus IgG Ab [Presence] in Serum by Immunoassay
Marburg virus IgM Ab [Presence] in Serum by Immunoassay
Mitogen stimulated gamma interferon [Units/volume] in Blood
Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative
Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood
Mycobacterium tuberculosis stimulated gamma interferon panel - Blood
Gamma interferon background [Units/volume] in Blood by Immunoassay
Rift valley fever virus Ag [Presence] in Serum by Immunoassay
Rift valley fever virus IgM Ab [Titer] in Serum by Immunoassay
Rift valley fever virus IgG Ab [Presence] in Serum by Immunoassay
Rift valley fever virus IgM Ab [Presence] in Serum by Immunoassay
Yellow fever virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Yellow fever virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Rift valley fever virus IgG Ab [Titer] in Serum by Immunoassay
Staphylococcus aureus exfoliative toxin A eta gene [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus exfoliative toxin B etb gene [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis DNA [Identifier] in Specimen by NAA with probe detection
Calcium [Moles/volume] in Urine collected for unspecified duration
Metanephrines [Moles/volume] in 24 hour Urine
Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination
Promyelocytic leukemia protein distribution pattern [Interpretation] in Blood or Tissue Qualitative by Immunofluorescence
Protoporphyrin.zinc [Moles/volume] in Red Blood Cells
Serotonin [Entitic substance] in Platelets
Cortisol Free/Cortisone free [Molar ratio] in Urine
Carrot triggered histamine release [Units/volume] in Blood
Hematocrit [Pure volume fraction] of Body fluid
Hematocrit [Pure volume fraction] of Venous blood
Hematocrit [Pure volume fraction] of Mixed venous blood
Hematocrit [Pure volume fraction] of Capillary blood
Hematocrit [Pure volume fraction] of Arterial blood
Hematocrit [Pure volume fraction] of Blood by Automated count
Cryoglobulin/Serum.total [Pure volume fraction] in Serum by Spun Westergren
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood
Cashew nut IgG Ab [Units/volume] in Serum
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Venous blood
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Capillary blood
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Arterial blood
Oxygen saturation [Pure mass fraction] Calculated from oxygen partial pressure in Blood
Cat dander IgG Ab [Units/volume] in Serum
Oxygen saturation [Pure mass fraction] in Venous blood
Oxygen saturation [Pure mass fraction] in Mixed venous blood
Oxygen saturation [Pure mass fraction] in Venous cord blood
Oxygen saturation [Pure mass fraction] in Arterial cord blood
Oxygen saturation [Pure mass fraction] in Cord blood
Oxygen saturation [Pure mass fraction] in Capillary blood
Cat dander triggered histamine release [Units/volume] in Blood
Oxygen saturation [Pure mass fraction] in Arterial blood
Oxygen saturation [Pure mass fraction] in Blood
Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood
Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Hemoglobin.other/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin S/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Hemoglobin M/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin Lepore/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin H/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Kleihauer-Betke method
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin F/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Hemoglobin E/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin D/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin C/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin Barts/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin A2/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by HPLC
Hemoglobin A/Hemoglobin.total [Pure mass fraction] in Blood by Electrophoresis
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood
Methemoglobin/Hemoglobin.total [Pure mass fraction] in Blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Mixed venous blood
Catfish triggered histamine release [Units/volume] in Blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Venous cord blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial cord blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood
Carboxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Blood
Cortisone [Moles/volume] in Saliva (oral fluid) --AM peak specimen
Cortisone [Moles/volume] in Saliva (oral fluid) --PM trough specimen
Cortisone free [Moles/time] in 24 hour Urine
Cauliflower IgG Ab [Units/volume] in Serum
Cauliflower triggered histamine release [Units/volume] in Blood
Cedar dust IgE Ab [Units/volume] in Serum
Mountain Juniper IgG Ab [Units/volume] in Serum
Mountain Juniper triggered histamine release [Units/volume] in Blood
Hemoglobin [Mass/volume] in Cerebral spinal fluid
Red Cedar IgE Ab [Units/volume] in Serum
Saltcedar IgE Ab [Units/volume] in Serum
Celery triggered histamine release [Units/volume] in Blood
Cephalosporine mold IgE Ab [Units/volume] in Serum
Chaetomium globosum IgE Ab [Units/volume] in Serum
American Cheese IgE Ab [Units/volume] in Serum
American Cheese IgG Ab [Units/volume] in Serum
Blue Cheese IgE Ab [Units/volume] in Serum
Cheese cheddar type IgG Ab [Units/volume] in Serum
Cheese cheddar type triggered histamine release [Units/volume] in Blood
Cottage Cheese IgE Ab [Units/volume] in Serum
Cottage Cheese IgG Ab [Units/volume] in Serum
Cream Cheese triggered histamine release [Units/volume] in Blood
Mozzarella Cheese IgE Ab [Units/volume] in Serum
Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
Acute and chronic leukemia fusion transcript per control transcript panel - Blood or Tissue by Molecular genetics method
Mozzarella Cheese IgG Ab [Units/volume] in Serum
Sapovirus RNA [Presence] in Specimen by NAA with probe detection
Mozzarella Cheese triggered histamine release [Units/volume] in Blood
Parmesan Cheese IgE Ab [Units/volume] in Serum
Parmesan Cheese triggered histamine release [Units/volume] in Blood
Roquefort Cheese IgE Ab [Units/volume] in Serum
Swiss Cheese IgE Ab [Units/volume] in Serum
Apo-transcobalamin II [Moles/volume] in Serum
Apo-transcobalamin I [Moles/volume] in Serum
Inulin renal clearance/1.73 sq M in Urine and Serum or Plasma
Holo-transcobalamin II [Moles/volume] in Serum
Epithelial cells [Presence] in Specimen by Gram stain
Erythrocytes [Presence] in Specimen by Gram stain
Leukocytes [Presence] in Specimen by Gram stain
Swiss Cheese IgG Ab [Units/volume] in Serum
Ofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Glucose tolerance 2 hours panel - Serum or Plasma
Rotavirus Ag [Presence] in Stool by Rapid immunoassay
Cherry triggered histamine release [Units/volume] in Blood
Influenza virus A neuraminidase segment sequence identifier
Influenza virus A matrix protein segment sequence identifier
Parathyrin.intact intraoperative panel - Serum or Plasma
Epstein Barr virus nuclear 1 IgG and IgM [Color Ratio] in Serum or Plasma by Rapid immunoassay
Horse Chestnut IgE Ab [Units/volume] in Serum
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Chewing gum IgE Ab [Units/volume] in Serum
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Lymphocytes [#/area] in Urine sediment by Microscopy high power field
Macrophages [#/area] in Urine sediment by Microscopy high power field
Pathologic casts [Presence] in Urine by Automated
Chicken triggered histamine release [Units/volume] in Blood
Chicken feather IgG Ab [Units/volume] in Serum
Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
Malondialdehyde [Entitic substance] in Platelets
Adefovir [Mass/volume] in Serum or Plasma by LC/MS/MS
Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
Bilirubin excess [Moles/volume] in Serum and CSF
Methemoglobin [Moles/volume] in Cerebral spinal fluid
Oxyhemoglobin [Moles/volume] in Cerebral spinal fluid
Chinese Tallow Tree IgE Ab [Units/volume] in Serum
Bilirubin excess and oxyhemoglobin and methemoglobin and xanthochromia and albumin quotient panel - Serum and CSF
Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay
Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay
Streptococcus pyogenes exotoxin B speB gene [Presence] in Specimen by NAA with probe detection
Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast
Creatinine [Mass/volume] in Serum or Plasma --pre contrast
Chocolate triggered histamine release [Units/volume] in Blood
Amylase and triacylglycerol lipase panel - Serum or Plasma
Blood product ordered [Volume] in Blood product unit
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method
Trichomonas vaginalis [Presence] in Prostatic fluid by Light microscopy
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Units/volume] in Serum by Multidisk
Rh immune globulin expiration [Date and time]
Days in therapeutic INR range/Days INR result determined [Ratio]
Hemoglobin [Mass/volume] in Pleural fluid
Cladosporium herbarum IgG Ab [Units/volume] in Serum
Nicotinurate [Mass/volume] in Serum or Plasma
Brucella sp IgG Ab [Titer] in Serum --2nd specimen
Brucella sp IgG Ab [Titer] in Serum --1st specimen
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Cladosporium herbarum triggered histamine release [Units/volume] in Blood
Th-To IgG Ab [Presence] in Serum or Plasma by Immunoassay
Platelet-derived growth factor receptor IgG Ab [Presence] in Serum or Plasma by Immunoassay
RNA polymerase III RP155 IgG Ab [Presence] in Serum or Plasma by Immunoassay
RNA polymerase III RP11 IgG Ab [Presence] in Serum or Plasma by Immunoassay
Centromere protein A IgG Ab [Presence] in Serum or Plasma by Immunoassay
Mitochondria M2-3E IgG Ab [Presence] in Serum by Immunoassay
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Immunoassay
HLA-A+B+C (class I) IgG Ab [Presence] in Serum or Plasma by Immunoassay
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Flow cytometry (FC)
Amphiphysin IgG Ab [Presence] in Serum by Immunoassay
HLA-A+B+C (class I) IgG Ab [Presence] in Serum by Flow cytometry (FC)
Anucleated bodies/100 round cells in Semen by Manual count
Clam triggered histamine release [Units/volume] in Blood
Nucleated cells/100 round cells in Semen by Manual count
Anucleated bodies/100 round cells in Prostatic fluid by Manual count
Nucleated cells/100 round cells in Prostatic fluid by Manual count
JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Protein S Ag [Units/volume] in Platelet poor plasma by Immunoassay
Erythrocytes [Presence] in Prostatic fluid by Light microscopy
Lecithin [Presence] in Prostatic fluid by Light microscopy
Bacteria [Presence] in Prostatic fluid by Light microscopy
Amyloid bodies [Presence] in Prostatic fluid by Light microscopy
Neutrophils/100 round cells in Semen by Manual count
Monocytes/100 round cells in Semen by Manual count
Monocytes/100 round cells in Prostatic fluid by Manual count
Neutrophils/100 round cells in Prostatic fluid by Manual count
Round cells [#/volume] in Prostatic fluid by Manual count
Neutrophils [#/volume] in Prostatic fluid by Manual count
Leukocytes [#/volume] in Prostatic fluid by Manual count
Influenza virus A and B Ag [Identifier] in Specimen by Rapid immunoassay
Microscopic observation [Presence] in Specimen by Acid fast stain
Methemoglobin/Hemoglobin.total in Venous cord blood
Methemoglobin/Hemoglobin.total in Arterial cord blood
Starch granules [#/area] in Urine sediment by Microscopy low power field
Lymphocytes/100 leukocytes in Vitreous fluid by Manual count
Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence
Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay
Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Hemoglobin [Mass/volume] in Peritoneal fluid
Virus identified in Nasopharynx by Culture
Virus identified in Lung tissue by Culture
Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Nordiazepam [Mass/volume] in Saliva (oral fluid)
Oxazepam [Mass/volume] in Saliva (oral fluid)
Cannabinoids synthetic [Presence] in Specimen by Screen method
LORazepam [Mass/volume] in Saliva (oral fluid)
ALPRAZolam [Mass/volume] in Saliva (oral fluid)
HER2 [Units/volume] in Tissue by Immunoassay
HER2 [Presence] in Tissue by Immunoassay
Meperidine+Normeperidine [Presence] in Urine by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method
Methadone [Presence] in Saliva (oral fluid) by Confirmatory method
Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Cocklebur IgG Ab [Units/volume] in Serum
Candida krusei DNA [Presence] in Vaginal fluid by NAA with probe detection
Candida lusitaniae DNA [Presence] in Vaginal fluid by NAA with probe detection
Candida tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection
Cortisol/Cortisone [Mass Ratio] in Serum or Plasma
Cell count and Differential panel - Vitreous fluid by Manual count
Cell count panel - Vitreous fluid by Manual count
PHENobarbital [Mass/volume] in Blood by Confirmatory method
Cocklebur triggered histamine release [Units/volume] in Blood
Secobarbital [Mass/volume] in Blood by Confirmatory method
Butalbital [Mass/volume] in Blood by Confirmatory method
Amobarbital [Mass/volume] in Blood by Confirmatory method
Methadone [Presence] in Blood by Screen method
Propoxyphene [Presence] in Blood by Screen method
oxyCODONE [Presence] in Blood by Screen method
3-epi-25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma
3-epi-25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma
Cocaine [Mass/volume] in Blood by Confirmatory method
Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method
Benzoylecgonine [Presence] in Blood by Screen method
Microscopic observation [Identifier] in Anal by Gram stain
Testosterone [Moles/volume] in Serum or Plasma --post dose HCG
Testosterone [Moles/volume] in Serum or Plasma --pre dose HCG
Monocytes+Macrophages [#] in Cerebral spinal fluid by Manual count
BK virus subtype in Urine by NAA with probe detection
Coconut triggered histamine release [Units/volume] in Blood
BK virus subtype in Specimen by NAA with probe detection
Acetoacetate [Moles/volume] in Blood --pre-meal
Acetoacetate [Moles/volume] in Blood --post meal
Beta hydroxybutyrate [Moles/volume] in Blood --post meal
Beta hydroxybutyrate [Moles/volume] in Blood --pre-meal
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --pre-meal
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --post meal
Gamma aminobutyrate.free [Moles/volume] in Cerebral spinal fluid
Codfish triggered histamine release [Units/volume] in Blood
Vancomycin resistance vanB gene [Presence] by Molecular method
Gamma aminobutyrate [Moles/volume] in Blood from Fetus
3-Methylhistidine [Moles/volume] in Blood from Fetus
3-Methylhistidine/Amino acids.total in Serum or Plasma
7-Hydroxyoctanoate [Moles/volume] in Serum or Plasma
5-Hydroxyhexanoate [Moles/volume] in Serum or Plasma
4-Hydroxyphenylpyruvate [Moles/volume] in Cerebral spinal fluid
4-Hydroxyphenylpyruvate [Moles/volume] in Serum or Plasma
4-Hydroxyphenyllactate [Moles/volume] in Cerebral spinal fluid
4-Hydroxyphenyllactate [Moles/volume] in Serum or Plasma
4-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid
4-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma
Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid
4,5-Dihydroxyhexanolactone [Moles/volume] in Serum or Plasma
4,5-Dihydroxyhexanoate [Moles/volume] in Serum or Plasma
Phenylpyruvate [Moles/volume] in Serum or Plasma
Phenyllactate [Moles/volume] in Serum or Plasma
3-Methylglutarate [Moles/volume] in Cerebral spinal fluid
Coffee bean IgE Ab [Units/volume] in Serum
3-Methylglutarate [Moles/volume] in Serum or Plasma
3-Methylglutaconate [Moles/volume] in Cerebral spinal fluid
3-Methylcrotonylglycine [Moles/volume] in Amniotic fluid
3-Methylcrotonylglycine [Moles/volume] in Cerebral spinal fluid
3-Methyladipate [Moles/volume] in Serum or Plasma
3-Hydroxytetradecanedioate [Moles/volume] in Serum or Plasma
3-Hydroxysuberate [Moles/volume] in Cerebral spinal fluid
3-Hydroxysuberate [Moles/volume] in Serum or Plasma
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Cerebral spinal fluid
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Serum or Plasma
3-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid
Hemoglobin [Mass/volume] in Synovial fluid
3-Hydroxyisovalerate [Moles/volume] in Serum or Plasma
Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method
Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method
Desmin Ab [Presence] in Serum or Plasma by Immunoblot
Myosin Ab [Presence] in Serum or Plasma by Immunoblot
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Cola nut triggered histamine release [Units/volume] in Blood
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Corn triggered histamine release [Units/volume] in Blood
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method
Methadone panel - Saliva (oral fluid) by Confirmatory method
Synthetic cannabinoids panel - Urine by Confirmatory method
Drugs of abuse panel - Blood by Screen method
Barbiturates panel - Blood by Confirmatory method
Candida sp 6 panel - Vaginal fluid by NAA with probe detection
BK virus subtype in Tissue by NAA with probe detection
BK virus subtype in Serum or Plasma by NAA with probe detection
BK virus subtype in Blood by NAA with probe detection
Tapentadol [Presence] in Urine by Screen method
TF gene full mutation analysis in Blood or Tissue by Sequencing
Cultivated Corn IgE Ab [Units/volume] in Serum
Beta 2 glycoprotein 1 IgG and IgM panel - Serum
Androstenedione [Moles/volume] in Saliva (oral fluid)
17-Hydroxyprogesterone [Moles/volume] in Saliva (oral fluid)
Paraoxonase-arylesterase 1 (PON1) [Enzymatic activity/volume] in Serum
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Cytomegalovirus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Candida parapsilosis DNA [Presence] in Vaginal fluid by NAA with probe detection
Cornish hen triggered histamine release [Units/volume] in Blood
DNA double strand [Mass/volume] in Specimen
Dihydropteridine reductase [Enzymatic activity/mass] in DBS
Tripeptidyl peptidase I [Enzymatic activity/volume] in DBS
Oval fat bodies (globules) [#/area] in Stool by Microscopy low power field
Homocyst(e)ine [Moles/volume] in Serum or Plasma --fasting
Homocyst(e)ine [Moles/volume] in Serum or Plasma --6 hours post dose methionine
Homocyst(e)ine [Molar concentration difference] in Serum or Plasma --6 hours post dose methionine - post CFst
WT1 gene exon 1+2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
Cotton gin dust IgE Ab [Units/volume] in Serum
CV2 Ab [Presence] in Serum or Plasma by Immunofluorescence
Exserohilum rostratum DNA [Presence] in Specimen by NAA with probe detection
ABCB1 gene c.3435C>T [Presence] in Blood or Tissue by Molecular genetics method
VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method
UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method
CYP2B6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Cotton linters IgE Ab [Units/volume] in Serum
VKORC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Glucose [Moles/volume] in Blood by Automated test strip
Spermatozoa [#] in Semen --post ejaculate
CHEK2 gene c.470C>T and 1100delC [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Cotton linters triggered histamine release [Units/volume] in Blood
FLT3 gene.p.Asp835+Ile836 mutations [Presence] in Blood or Tissue by Molecular genetics method
p-ANCA formalin sensitive IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
p-ANCA formalin resistant IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence
Myelin Ab [Presence] in Serum or Plasma by Immunofluorescence
Raltegravir [Susceptibility] by Genotype method
Elvitegravir [Susceptibility] by Genotype method
Cottonseed IgG Ab [Units/volume] in Serum
Black Cottonwood IgE Ab [Units/volume] in Serum
Western Cottonwood IgE Ab [Units/volume] in Serum
Rilpivirine [Susceptibility] by Phenotype method
Etravirine [Susceptibility] by Phenotype method
HIV integrase inhibitor susceptibility panel by Phenotype method
HIV integrase inhibitor susceptibility panel by Genotype method
Creatine Kinase aberrant band/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis
Creatine kinase.MM/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis
Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis
Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by calculation
Creatine kinase.BB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis
Cholinesterase.scoline inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma
Cholinesterase.RO 020683 inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma
Cholinesterase.fluoride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma
Cholinesterase [Pure catalytic fraction] in Serum or Plasma --dibucaine/Cholinesterase
Cholinesterase.chloride inhibited/Cholinesterase [Pure catalytic fraction] in Serum or Plasma
Amylase.pancreatic/Amylase.total [Pure catalytic fraction] in Serum or Plasma
Amylase.salivary/Amylase.total [Pure catalytic fraction] in Serum or Plasma
Uroporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine
Coproporphyrin/Porphyrins.total [Pure substance fraction] in 24 hour Urine
Macroprolactin/Prolactin [Pure mass fraction] in Serum or Plasma
Prostate Specific Ag Free/Prostate specific Ag.total [Pure mass fraction] in Serum or Plasma
Protein.monoclonal/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Prealbumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Cow epithelium IgE Ab [Units/volume] in Serum
Prealbumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Gamma globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Gamma globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Gamma globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis
Gamma globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Beta globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Beta globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Beta globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis
Beta globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Alpha 2 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Alpha 2 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Alpha 2 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis
Alpha 2 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Alpha 1 globulin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Alpha 1 globulin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Alpha 1 globulin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis
Cow milk triggered histamine release [Units/volume] in Blood
Alpha 1 globulin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Albumin/Protein.total [Pure mass fraction] in 24 hour Urine by Electrophoresis
Albumin/Protein.total [Pure mass fraction] in Urine by Electrophoresis
Albumin/Protein.total [Pure mass fraction] in Serum or Plasma by Electrophoresis
Albumin/Protein.total [Pure mass fraction] in Cerebral spinal fluid by Electrophoresis
Albumin/Protein.total [Pure mass fraction] in Body fluid by Electrophoresis
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --pre-meal
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood --post meal
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood
Insulin [Units/volume] in Serum or Plasma --4.5 hours post 75 g glucose PO
Cytomegalovirus glycoprotein genotype in Specimen by NAA with probe detection
Hepatitis D virus genotype [Identifier] in Specimen by NAA with probe detection
Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture
Apixaban [Mass/volume] in Serum or Plasma
Nonsteroidal antiinflammatory drugs [Presence] in Serum or Plasma by Screen method
diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Crab triggered histamine release [Units/volume] in Blood
diazePAM [Presence] in Saliva (oral fluid)
ALPRAZolam [Presence] in Saliva (oral fluid)
Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Oxazepam [Presence] in Saliva (oral fluid)
Nordiazepam [Presence] in Saliva (oral fluid)
Benzodiazepines [Presence] in Saliva (oral fluid)
Propoxyphene [Presence] in Saliva (oral fluid) by Screen method
Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid)
Norpropoxyphene [Mass/volume] in Saliva (oral fluid)
Norpropoxyphene [Presence] in Saliva (oral fluid)
Propoxyphene [Mass/volume] in Saliva (oral fluid)
Propoxyphene [Presence] in Saliva (oral fluid)
inFLIXimab Ab [Mass/volume] in Serum or Plasma
Rivaroxaban [Mass/volume] in Serum or Plasma
Dabigatran [Mass/volume] in Serum or Plasma
Methadone [Presence] in Saliva (oral fluid) by Screen method
Barbiturates [Presence] in Saliva (oral fluid) by Screen method
PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
Cranberry IgE Ab [Units/volume] in Serum
Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method
Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method
Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method
Temazepam [Presence] in Saliva (oral fluid)
PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Cranberry IgG Ab [Units/volume] in Serum
Cranberry triggered histamine release [Units/volume] in Blood
Albumin in serum - albumin in pericardial fluid [Mass concentration difference]
Albumin in serum - albumin in pleural fluid [Mass concentration difference]
Glucose in serum - glucose in synovial fluid [Molar concentration difference]
Glucose in serum - glucose in peritoneal fluid [Molar concentration difference]
Glucose in serum - glucose in pericard fld [Molar concentration difference]
Glucose in serum - glucose in pleural fluid [Molar concentration difference]
Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative
Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative
SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal
Aldolase [Enzymatic activity/mass] in Red Blood Cells
risperiDONE [Mass/volume] in Serum or Plasma --trough
Procainamide [Mass/volume] in Serum or Plasma --trough
PARoxetine [Mass/volume] in Serum or Plasma --trough
OXcarbazepine [Mass/volume] in Serum or Plasma --trough
Beta-trace protein [Mass/volume] in Ear fluid
Intrinsic coagulation factor activity 4 panel - Platelet poor plasma by Coagulation assay
Extrinsic coagulation factor activity 4 panel - Platelet poor plasma
Bisphosphoglycerate mutase [Enzymatic activity/mass] in Red Blood Cells
Phosphofructokinase [Enzymatic activity/mass] in Red Blood Cells
Trans,trans-muconic acid [Mass/volume] in Urine
Nitrazepam [Mass/volume] in Serum or Plasma --trough
Mycophenolate [Mass/volume] in Serum or Plasma --trough
Mirtazapine [Mass/volume] in Serum or Plasma --trough
Mianserin [Mass/volume] in Serum or Plasma --trough
Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - Urine
Everolimus [Mass/volume] in Plasma --trough
traZODone [Mass/volume] in Serum or Plasma --trough
Theophylline [Mass/volume] in Serum or Plasma --trough
Sulfamethoxazole [Mass/volume] in Serum or Plasma --trough
Sotalol [Mass/volume] in Serum or Plasma --trough
Sirolimus [Mass/volume] in Plasma --trough
Salicylates [Mass/volume] in Serum or Plasma --trough
Cryptococcus terreus IgE Ab [Units/volume] in Serum
Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma --trough
Macroprolactin [Presence] in Serum or Plasma
Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma
Cucumber triggered histamine release [Units/volume] in Blood
Cholinesterase activity panel - Serum or Plasma
Erythrocyte enzyme panel - Red Blood Cells
SLC40A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYP3A5 gene c.6986A>G(*3) [Presence] in Blood or Tissue by Molecular genetics method
Curvularia sp IgE Ab [Units/volume] in Serum
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
Base excess.100% oxygenated [Moles/volume] standard in Arterial blood by calculation
Base excess.100% oxygenated [Moles/volume] standard in Mixed venous blood by calculation
Base excess.100% oxygenated [Moles/volume] standard in Venous blood by calculation
PM-SCL-75 IgG Ab [Presence] in Serum or Plasma by Immunoassay
t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal
t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal
Del(13)(q14) and del(17)(p13) in Blood or Tissue
Bald Cypress IgE Ab [Units/volume] in Serum
Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal
7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine
Mitragynine/Creatinine [Mass Ratio] in Urine
7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method
Mitragynine [Mass/volume] in Urine by Confirmatory method
HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Methadone [Mass/volume] in Saliva (oral fluid) by Screen method
Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Date Palm Pollen IgE Ab [Units/volume] in Serum
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method
Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method
ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method
Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Influenza virus A hemagglutinin segment sequence identifier
Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method
American house dust mite IgG Ab [Units/volume] in Serum
Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine
Zolpidem [Mass/volume] in Urine by Confirmatory method
Zolpidem/Creatinine [Mass Ratio] in Urine
O-desmethylvenlafaxine [Mass/volume] in Urine by Confirmatory method
O-desmethylvenlafaxine/Creatinine [Mass Ratio] in Urine
Venlafaxine [Mass/volume] in Urine by Confirmatory method
Venlafaxine/Creatinine [Mass Ratio] in Urine
American house dust mite triggered histamine release [Units/volume] in Blood
JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
PARoxetine [Mass/volume] in Urine by Confirmatory method
European house dust mite IgG Ab [Units/volume] in Serum
PARoxetine/Creatinine [Mass Ratio] in Urine
Cotinine [Mass/volume] in Urine by Screen method
Naltrexone/Creatinine [Mass Ratio] in Urine
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method
Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine
Methylphenidate/Creatinine [Mass Ratio] in Urine
European house dust mite triggered histamine release [Units/volume] in Blood
Methylone [Mass/volume] in Urine by Confirmatory method
Methylone/Creatinine [Mass Ratio] in Urine
Mephedrone [Mass/volume] in Urine by Confirmatory method
Mephedrone/Creatinine [Mass Ratio] in Urine
Methylenedioxypyrovalerone [Mass/volume] in Urine by Confirmatory method
Methylenedioxypyrovalerone/Creatinine [Mass Ratio] in Urine
Norketamine [Mass/volume] in Urine by Confirmatory method
Norketamine/Creatinine [Mass Ratio] in Urine
Ketamine/Creatinine [Mass Ratio] in Urine
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
Gabapentin [Mass/volume] in Urine by Confirmatory method
Gabapentin/Creatinine [Mass Ratio] in Urine
Norfluoxetine/Creatinine [Mass Ratio] in Urine
FLUoxetine/Creatinine [Mass Ratio] in Urine
DULoxetine [Mass/volume] in Urine by Confirmatory method
DULoxetine/Creatinine [Mass Ratio] in Urine
DOPamine [Mass/volume] in Urine by Confirmatory method
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
Acetaminophen/Creatinine [Mass Ratio] in Urine
5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method
Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration
Staphylococcus aureus enterotoxin D sed gene [Presence] in Specimen by NAA with probe detection
Staphylococcus aureus enterotoxin C sec gene [Presence] in Specimen by NAA with probe detection
Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal
Phencyclidine [Mass/volume] in Urine by Screen method
dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal
Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Specimen
Cytomegalovirus UL97 gene mutations detected [Identifier]
Foscarnet [Susceptibility] by Phenotype method
Yellow Dock triggered histamine release [Units/volume] in Blood
Raltegravir [Mass/volume] in Serum or Plasma
Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular method
Vancomycin resistance vanC1 gene [Presence] by Molecular method
Herpes simplex virus DNA [Identifier] in Specimen by NAA with probe detection
Famciclovir [Susceptibility] by Genotype method
Hepatitis B virus codon 250 [Identifier] by Genotype method
Hepatitis B virus codon 237 [Identifier] by Genotype method
Hepatitis B virus codon 233 [Identifier] by Genotype method
Dog dander IgG Ab [Units/volume] in Serum
Hepatitis B virus codon 215 [Identifier] by Genotype method
Hepatitis B virus codon 214 [Identifier] by Genotype method
Hepatitis B virus codon 202 [Identifier] by Genotype method
Hepatitis B virus codon 194 [Identifier] by Genotype method
Hepatitis B virus codon 191 [Identifier] by Genotype method
Hepatitis B virus codon 184 [Identifier] by Genotype method
Hepatitis B virus codon 169 [Identifier] by Genotype method
Dog epithelium IgG Ab [Units/volume] in Serum
Hepatitis B virus codon 85 [Identifier] by Genotype method
Hepatitis B virus codon 84 [Identifier] by Genotype method
Cytomegalovirus resistance panel by Genotype method
Maribavir [Susceptibility] by Genotype method
Ganciclovir [Susceptibility] by Genotype method
Cidofovir [Susceptibility] by Phenotype method
Cidofovir [Susceptibility] by Genotype method
Dolutegravir [Susceptibility] by Genotype method
Enfuvirtide [Susceptibility] by Genotype method
Boceprevir [Susceptibility] by Genotype method
Hypochromia [Presence] in Blood by Light microscopy
Telaprevir [Susceptibility] by Genotype method
Ganciclovir [Susceptibility] by Phenotype method
Hepatitis C virus resistance panel by Genotype method
Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method
Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular method
Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular method
Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular method
Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method
Dog epithelium triggered histamine release [Units/volume] in Blood
Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular method
Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method
Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular method
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
Dog Fennel IgE Ab [Units/volume] in Serum
UGT2B15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
UGT2B15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYP2B6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
CYP2E1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Dogwood pollen IgE Ab [Units/volume] in Serum
CYP1A2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay
CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method
Staphylococcus aureus methicillin resistance SCCmec [Presence] in Nose by NAA with probe detection
3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total in Serum or Plasma
Progesterone Free [Mass/volume] in Serum or Plasma
Progesterone Free/Progesterone.total in Serum or Plasma
Staphylococcus protein A spa gene [Presence] in Isolate or Specimen by NAA with probe detection
Duck feather IgG Ab [Units/volume] in Serum
MRSA SCCmec and mecA genes panel - Nose by NAA with probe detection
Doripenem [Susceptibility] by Disk diffusion (KB)
Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose lactose PO
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO
Isoleucine+Leucine [Moles/volume] in Serum or Plasma
Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)
Egg white triggered histamine release [Units/volume] in Blood
Insulin [Moles/volume] in Serum or Plasma --3 hours post 75 g glucose PO
Insulin [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO
Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO
Neutrophil Ab and HLA Ab screen panel - Serum or Plasma
Drug induced platelet Ab panel - Serum or Plasma
Drug induced neutrophil Ab panel - Serum or Plasma
HNA 4a/4b Ab [Presence] in Serum by Immunoassay
HNA 4b/4b Ab [Presence] in Serum by Immunoassay
HNA 4a/4a Ab [Presence] in Serum by Immunoassay
HNA 2 Ab [Presence] in Serum by Immunoassay
HNA 1c Ab [Presence] in Serum by Immunoassay
HNA 1a/1b Ab [Presence] in Serum by Immunoassay
HNA 1b/1b Ab [Presence] in Serum by Immunoassay
Whole Egg IgE Ab [Units/volume] in Serum
HNA 1a/1a Ab [Presence] in Serum by Immunoassay
Specimen source [Identifier] of Synovial fluid
Bilirubin.total [Moles/volume] in Amniotic fluid
Whole Egg IgG Ab [Units/volume] in Serum
Warfarin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Warfarin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Vancomycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Whole Egg triggered histamine release [Units/volume] in Blood
Vancomycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valproate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valproate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Trimethoprim induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Trimethoprim induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Topiramate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Leukocytes other [#/volume] in Blood by Manual count
Topiramate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Terazosin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Terazosin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tazobactam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tazobactam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tacrolimus induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tacrolimus induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulfamethoxazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulfamethoxazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Spironolactone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Spironolactone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sildenafil citrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sildenafil citrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Egg yolk triggered histamine release [Units/volume] in Blood
raNITIdine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
raNITIdine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ramipril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ramipril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNINE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNINE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Phenytoin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Phenytoin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Penicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Penicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pantoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pantoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Omeprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Omeprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mycophenolate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mycophenolate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Montelukast induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Montelukast induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoprolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoprolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoclopramide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoclopramide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
metFORMIN induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
metFORMIN induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Losartan induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Losartan induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loratadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loratadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lisinopril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lisinopril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levoFLOXacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levoFLOXacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levETIRAcetam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levETIRAcetam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lansoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lansoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gentamicin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
White Elm triggered histamine release [Units/volume] in Blood
Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Furosemide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Furosemide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fluconazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Leukocytes other/100 leukocytes in Blood by Manual count
Fluconazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fexofenadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fexofenadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Chinese Elm IgE Ab [Units/volume] in Serum
Fenofibrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fenofibrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Enalapril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Enalapril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clopidogrel induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clopidogrel induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cloNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cloNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clindamycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clindamycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ciprofloxacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Celecoxib induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Celecoxib induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTRIAXone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTRIAXone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTAZidime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTAZidime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefepime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefepime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ceFAZolin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ceFAZolin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
buPROPion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
buPROPion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atorvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atorvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atenolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atenolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetylsalicylate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetylsalicylate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ampicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ampicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amiodarone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amiodarone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Allopurinol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Allopurinol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Alendronate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Epidermophyton floccosum IgE Ab [Units/volume] in Serum
Alendronate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetaminophen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetaminophen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Drug induced neutrophil Ab [Interpretation] in Serum or Plasma by Flow cytometry (FC) Narrative
Neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Warfarin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Warfarin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Voriconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Voriconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Verapamil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Verapamil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Vancomycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Vancomycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valsartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valsartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valproate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valproate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
valGANciclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
valGANciclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valdecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Valdecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
valACYclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
valACYclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Weeping Fig IgE Ab [Units/volume] in Serum
Ursodeoxycholate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ursodeoxycholate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lymphocytes [#/volume] in Blood by Automated count
Trimethoprim induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Trimethoprim induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Triamterene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Triamterene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Douglas Fir IgE Ab [Units/volume] in Serum
Triamcinolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Triamcinolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Topiramate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Topiramate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tolterodine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tolterodine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tobramycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tobramycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tirofiban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tirofiban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Timolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Timolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tetracycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tetracycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Terazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Terazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Telmisartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tamsulosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tamsulosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tamoxifen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tamoxifen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tacrolimus induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Tacrolimus induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulindac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulindac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
sulfiSOXAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
sulfiSOXAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
sulfaSALAzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
sulfaSALAzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulfamethoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sulfamethoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sucralfate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sucralfate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Spironolactone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Spironolactone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sotalol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sotalol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simethicone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Simethicone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sildenafil citrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sildenafil citrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Flea triggered histamine release [Units/volume] in Blood
Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rosuvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rosuvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rosiglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rosiglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rofecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Rofecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Risedronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Risedronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
rifAMPin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
rifAMPin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
raNITIdine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
raNITIdine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ramipril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ramipril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Raloxifene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Raloxifene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
RABEprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
RABEprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
quiNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Quinapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Quinapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Propranolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Propranolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Flounder triggered histamine release [Units/volume] in Blood
Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Procainamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Procainamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Primidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Primidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
predniSONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
predniSONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pravastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pravastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin+Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin+Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Piperacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pioglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Horse Fly IgG Ab [Units/volume] in Serum
Pioglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Phenytoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Phenytoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Penicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Housefly triggered histamine release [Units/volume] in Blood
Penicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Papaverine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Papaverine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pantoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Pantoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Formaldehyde triggered histamine release [Units/volume] in Blood
oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Oxaliplatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Oxacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Oxacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ondansetron induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ondansetron induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Omeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Omeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nystatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nystatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nizatidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nizatidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nitroglycerin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nitroglycerin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nitrofurantoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nitrofurantoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
NIFEdipine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
NIFEdipine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Niacin+Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fusarium culmorum IgG Ab [Units/volume] in Serum
Niacin+Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Naproxen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Naproxen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mycophenolate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mycophenolate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fusarium moniliforme IgG Ab [Units/volume] in Serum
Moxifloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Moxifloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Montelukast induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Montelukast induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fusarium oxysporum IgE Ab [Units/volume] in Serum
Minoxidil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Minoxidil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Minocycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Minocycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Milrinone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Milrinone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fusarium solani IgE Ab [Units/volume] in Serum
metroNIDAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
metroNIDAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoprolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoprolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoclopramide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Metoclopramide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylprednisolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylprednisolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lymphocytes [#/volume] in Blood by Manual count
Methyldopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methyldopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
metFORMIN induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
metFORMIN induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fusarium solani IgG Ab [Units/volume] in Serum
Meropenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Meropenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loratadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loratadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loperamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Loperamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lisinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lisinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lidocaine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lidocaine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levoFLOXacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levoFLOXacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Levodopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Levodopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levETIRAcetam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
levETIRAcetam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Garlic triggered histamine release [Units/volume] in Blood
Levalbuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Levalbuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Leuprolide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Leuprolide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lepirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lepirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lansoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Lansoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ketorolac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ketorolac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Isosorbide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Isosorbide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Irbesartan+hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Irbesartan+hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Irbesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Irbesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Imipenem+Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Imipenem+Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Imipenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Imipenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Geotrichum candidum IgE Ab [Units/volume] in Serum
hydrOXYzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydrOXYzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Hydrocortisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Hydrocortisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gerbil epithelium IgE Ab [Units/volume] in Serum
HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide+Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydrALAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
hydrALAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
glyBURIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
glyBURIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Variant lymphocytes [Presence] in Blood by Light microscopy
glipiZIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
glipiZIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Glimepride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Glimepride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gentamicin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gentamicin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Furosemide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Furosemide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fosinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fosinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fluvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fluvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fluconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fluconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Finasteride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gladiolus IgE Ab [Units/volume] in Serum
Finasteride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fexofenadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fexofenadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fenofibrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Fenofibrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Famotidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Famotidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ezetimibe induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ezetimibe induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Esomeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Esomeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Erythromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Gnat whole body IgE Ab [Units/volume] in Serum
Erythromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Eptifibatide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Eptifibatide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Erythropoietin (EPO) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Erythropoietin (EPO) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Enalapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Enalapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Doxycycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Goat milk IgE Ab [Units/volume] in Serum
Doxycycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Doxazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Doxazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Donepezil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Donepezil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Docusate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Docusate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Dipyridamole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Goat milk IgG Ab [Units/volume] in Serum
Dipyridamole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
diphenhydrAMINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
diphenhydrAMINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
dilTIAZem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
dilTIAZem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Digoxin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Digoxin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Dicyclomine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Dicyclomine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cycloSPORINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cycloSPORINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Colchicine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Goldenrod IgG Ab [Units/volume] in Serum
Colchicine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clopidogrel induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clopidogrel induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cloNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clindamycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Goldenrod triggered histamine release [Units/volume] in Blood
Clindamycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Variant lymphocytes [#/volume] in Blood by Manual count
Clarithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Clarithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ciprofloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Goose feather IgG Ab [Units/volume] in Serum
Ciprofloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cimetidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cimetidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Chlorthalidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Chlorthalidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlorproPAMIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlorproPAMIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cephalexin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cephalexin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Grain dust IgE Ab [Units/volume] in Serum
Celecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Celecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefuroxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefuroxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTRIAXone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTRIAXone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ceftizoxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ceftizoxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTAZidime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
cefTAZidime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefepime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefepime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ceFAZolin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ceFAZolin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefadroxil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Cefadroxil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Caspofungin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Grain mill dust IgE Ab [Units/volume] in Serum
Casanthranol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Casanthranol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carvedilol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carvedilol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carbidopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Carbidopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Captopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Captopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Candesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Candesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Grape raisin triggered histamine release [Units/volume] in Blood
busPIRone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
busPIRone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
buPROPion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
buPROPion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Bumetanide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Bumetanide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Budesonide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Budesonide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Grapefruit IgG Ab [Units/volume] in Serum
Bivalirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Bivalirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Benztropine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Benztropine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Aztreonam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Aztreonam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Variant lymphocytes/100 leukocytes in Blood by Manual count
Grapefruit triggered histamine release [Units/volume] in Blood
Azithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Azithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atorvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atorvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atenolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Argatroban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Argatroban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ampicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Ampicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin+Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin+Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amoxicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine+Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine+Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
amLODIPine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amiodarone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Amiodarone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Bermuda grass IgG Ab [Units/volume] in Serum
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Allopurinol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Allopurinol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Alendronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Alendronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Albuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Albuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Bermuda grass triggered histamine release [Units/volume] in Blood
Acyclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acyclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acebutolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acebutolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Acarbose induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Annual blue grass IgE Ab [Units/volume] in Serum
Acarbose induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative
Abciximab induced platelet Ab [Interpretation] in Serum or Plasma
Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Abciximab induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Thyroxine (T4) free [Mass/volume] in Cord blood
Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture
Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence
Mumps virus IgG and IgM [Interpretation] in Serum
Insulin-like growth factor-I [Z-score] in Serum or Plasma
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method
7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method
Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method
Propoxyphene [Presence] in Meconium by Screen method
Canadian blue grass IgE Ab [Units/volume] in Serum
Testosterone/Epitestosterone [Interpretation] in Urine Qualitative
Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE)
Magnesium Ionized [Moles/volume] adjusted to pH 7.4 in Blood by Ion-selective membrane electrode (ISE)
Acyclovir [Susceptibility] by Genotype method
Molybdenum/Creatinine [Mass Ratio] in Urine
Kentucky blue grass triggered histamine release [Units/volume] in Blood
Meadow Fescue triggered histamine release [Units/volume] in Blood
Ormetroprim+Sulfamethoxazole [Susceptibility]
Gramma grass (Bouteloua gracilis) IgE Ab [Units/volume] in Serum
Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)
Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC)
Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
rifAXIMin [Susceptibility] by Minimum inhibitory concentration (MIC)
Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)
Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Johnson grass triggered histamine release [Units/volume] in Blood
Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC)
Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC)
Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
cefTAZidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Koehlers grass IgE Ab [Units/volume] in Serum
Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC)
Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tizoxanide [Susceptibility] by Disk diffusion (KB)
Telavancin [Susceptibility] by Disk diffusion (KB)
Tedizolid [Susceptibility] by Disk diffusion (KB)
Solithromycin [Susceptibility] by Disk diffusion (KB)
Sarafloxacin [Susceptibility] by Disk diffusion (KB)
rifAXIMin [Susceptibility] by Disk diffusion (KB)
Razupenem [Susceptibility] by Disk diffusion (KB)
Premafloxacin [Susceptibility] by Disk diffusion (KB)
Plazomicin [Susceptibility] by Disk diffusion (KB)
Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
Omadacycline [Susceptibility] by Disk diffusion (KB)
Nitazoxanide [Susceptibility] by Disk diffusion (KB)
Marbofloxacin [Susceptibility] by Disk diffusion (KB)
Iclaprim [Susceptibility] by Disk diffusion (KB)
Meadow Fescue IgG Ab [Units/volume] in Serum
Finafloxacin [Susceptibility] by Disk diffusion (KB)
Fidaxomicin [Susceptibility] by Disk diffusion (KB)
Faropenem [Susceptibility] by Disk diffusion (KB)
Danofloxacin [Susceptibility] by Disk diffusion (KB)
Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB)
cefTAZidime+Avibactam [Susceptibility] by Disk diffusion (KB)
Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB)
Cocksfoot IgG Ab [Units/volume] in Serum
Ceftaroline [Susceptibility] by Disk diffusion (KB)
Besifloxacin [Susceptibility] by Disk diffusion (KB)
Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Apramycin [Susceptibility] by Disk diffusion (KB)
Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method
Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method
Varicella zoster virus ORF28 genotype [Identifier]
Varicella zoster virus ORF36 genotype [Identifier]
HIV 1 subtype in Specimen by NAA with probe detection
HIV 2 subtype in Specimen by NAA with probe detection
Propoxyphene panel - Saliva (oral fluid)
Methadone panel - Saliva (oral fluid) by Screen method
Benzodiazepines panel - Saliva (oral fluid) by Screen method
Barbiturates panel - Saliva (oral fluid) by Confirmatory method
Yersinia adhesion protein YadA [Presence] in Isolate
Optochin [Susceptibility] by Disk diffusion (KB)
Streptococcus.beta-hemolytic [Type] in Isolate by Latex agglutination
Bacteria producing hippuricase [Presence] in Isolate
Cocksfoot triggered histamine release [Units/volume] in Blood
Bacteria soluble by bile [Presence] in Isolate
Bacteria producing DNAse [Presence] in Isolate
Bacteria producing coagulase and protein A [Presence] in Isolate by Latex agglutination
Legionella pneumophila serogroup [Type] in Isolate by Agglutination
Yersinia enterocolitica serotype [Type] in Isolate by Agglutination
Streptococcus pneumoniae serotype [Type] in Isolate by Agglutination
Adenosine triphosphate/Adenosine diphosphate [Entitic molar ratio] in Platelets
Quack grass IgE Ab [Units/volume] in Serum
Voriconazole [Mass/volume] in Serum or Plasma --trough
Valproate [Mass/volume] in Serum or Plasma --peak
Topotecan [Mass/volume] in Serum or Plasma --trough
SORAfenib [Mass/volume] in Serum or Plasma
Mycophenolate [Mass/volume] in Serum or Plasma --peak
CYP2D6 gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CYP2D6 gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Busulfan [Mass/volume] in Serum or Plasma --trough
Red top grass triggered histamine release [Units/volume] in Blood
Atovaquone [Mass/volume] in Serum or Plasma
Streptococcus pneumoniae Ag [Presence] in Isolate by Latex agglutination
Methylone [Presence] in Urine by Screen method
Methylenedioxypyrovalerone [Presence] in Urine by Screen method
Danazol [Presence] in Urine by Screen method
Lymphocytes/100 leukocytes in Blood by Automated count
Perennial rye grass IgE Ab [Units/volume] in Serum
African swine fever virus DNA [Cycle Threshold #] in Tissue by NAA with probe detection
Microscopic observation [Identifier] in Blood by KOH preparation
CCHD newborn screening protocol used [Type]
Number of prior CCHD screens [#] Qualitative
Cefatrizine [Susceptibility] by Disk diffusion (KB)
Perennial rye grass IgG Ab [Units/volume] in Serum
Multiple carboxylase deficiency (MCD) newborn screen interpretation
Neisseria meningitidis serosubtype [Type] in Isolate by Immunoassay
Pathology report preliminary diagnosis [Interpretation] in Specimen
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Units/volume] in Serum by Multidisk
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk
Soybean native (nGly m) 5 IgE Ab [Units/volume] in Serum
Pholcodine IgE Ab [Units/volume] in Serum
Rocuronium IgE Ab [Units/volume] in Serum
Bile acid dihydroxy and trihydroxy panel - Serum or Plasma
Lysergate diethylamide [Presence] in Hair
Lysergate diethylamide [Presence] in Meconium
Transaldolase [Enzymatic activity/mass] in Lymphoblasts
Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection
ACADVL gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
ACADVL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Phospholipase A2 receptor IgG Ab [Units/volume] in Serum by Immunoassay
Perennial rye grass triggered histamine release [Units/volume] in Blood
Keyhole limpet hemocyanin IgA Ab [Mass/volume] in Serum
Keyhole limpet hemocyanin IgG Ab [Mass/volume] in Serum
Keyhole limpet hemocyanin IgM Ab [Mass/volume] in Serum
APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal
4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal
RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal
5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal
Reagin and Treponema pallidum IgG and IgM [Interpretation] in Serum or Plasma
Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection
Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection
Sorghum grass IgE Ab [Units/volume] in Serum
Sudan grass IgE Ab [Units/volume] in Serum
Lymphocytes/100 leukocytes in Blood by Manual count
Sweet Vernal grass triggered histamine release [Units/volume] in Blood
Wheat grass IgG Ab [Units/volume] in Serum
Infant activity during postductal oxygen saturation measurement
Infant activity during preductal oxygen saturation measurement
B cell+T cell crossmatch.autologous [Interpretation] Qualitative by Complement dependent cytotoxicity
B cell+T cell crossmatch [Interpretation] Qualitative by Flow cytometry (FC)
B cell+T cell crossmatch [Interpretation] Qualitative by Complement dependent cytotoxicity
CD3-CD16+CD56+HLA-DR+ (activated Natural Killer) cells/100 cells.CD3-CD16+CD56+ (Natural killer) cells in Blood by Flow cytometry (FC)
Heparin induced platelet IgG Ab [Interpretation] in Serum Narrative
Greasewood IgE Ab [Units/volume] in Serum
Percent heparin inhibition [Ratio] in Serum
Heparin induced platelet IgG Ab in Serum or Plasma by Immunoassay
Heparin induced platelet IgG Ab [Presence] in Serum or Plasma by Immunoassay
Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal
Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Gum arabic IgE Ab [Units/volume] in Serum
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood
Flunitrazepam [Mass/volume] in Serum, Plasma or Blood
7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood
Hackberry tree IgE Ab [Units/volume] in Serum
Legionella sp Ab [Presence] in Specimen by Immunofluorescence
Bacteria.carbapenem resistant identified in Anal by Organism specific culture
Bacteria.extended spectrum beta lactamase resistance [Identifier] in Anal by Organism specific culture
Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture
Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
11-Dehydrotetrahydrocorticosterone [Moles/volume] in Urine
11-Dehydrotetrahydrocorticosterone [Moles/volume] in 24 hour Urine
11-Dehydrotetrahydrocorticosterone [Moles/time] in 24 hour Urine
Tetrahydrodeoxycortisol [Moles/volume] in Urine
Tetrahydrodeoxycortisol [Moles/volume] in 24 hour Urine
Tetrahydrodeoxycortisol [Moles/time] in 24 hour Urine
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in Urine
16-Alpha hydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine
16-Ketoandrostenediol [Moles/volume] in 24 hour Urine
16-Ketoandrostenediol [Moles/time] in 24 hour Urine
16-Ketoandrostenediol [Moles/volume] in Urine
Macrocytes [Presence] in Blood by Light microscopy
18-Beta glycyrrhetinate [Mass/volume] in Urine
18-Beta glycyrrhetinate [Mass/volume] in 24 hour Urine
7-Dehydrocholesterol and 8-Dehydrocholesterol panel - Serum or Plasma
Aldosterone-18-glucuronide [Moles/volume] in 24 hour Urine
Aldosterone-18-glucuronide [Moles/time] in 24 hour Urine
Aldosterone-18-glucuronide [Moles/volume] in Urine
Allo-pregnanediol [Moles/volume] in Urine
Allo-pregnanediol [Moles/time] in 24 hour Urine
Allo-pregnanediol [Moles/volume] in 24 hour Urine
Allo-tetrahydrocorticosterone [Moles/volume] in Urine
Allo-tetrahydrocorticosterone [Moles/volume] in 24 hour Urine
Allo-tetrahydrocorticosterone [Moles/time] in 24 hour Urine
Allo-tetrahydrocortisol [Moles/time] in 24 hour Urine
Allo-tetrahydrocortisol [Moles/volume] in Urine
Allo-tetrahydrocortisol [Moles/volume] in 24 hour Urine
Catecholamines 3 panel [Moles/volume] - Plasma
Catecholamines 3 and creatinine panel [Molar ratio] - Urine
Alpha cortol [Moles/time] in 24 hour Urine
Alpha cortol [Moles/volume] in 24 hour Urine
Alpha cortolone [Moles/time] in 24 hour Urine
Alpha cortolone [Moles/volume] in 24 hour Urine
Androstenetriol [Moles/volume] in 24 hour Urine
Halibut triggered histamine release [Units/volume] in Blood
Androstenetriol [Moles/time] in 24 hour Urine
Beta cortolone [Moles/time] in 24 hour Urine
Beta cortolone [Moles/volume] in 24 hour Urine
Catecholamine metabolites and creatinine panel - Urine
Cortisone free [Moles/volume] in 24 hour Urine
Ham triggered histamine release [Units/volume] in Blood
Glycolate [Moles/volume] in 24 hour Urine
Steroid fractions interpretation in 24 hour Urine Narrative
Tetrahydrocorticosterone [Moles/volume] in 24 hour Urine
Tetrahydrocorticosterone [Moles/time] in 24 hour Urine
Tetrahydrocorticosterone [Moles/volume] in Urine
Tetrahydrocortisol [Moles/volume] in Urine
Tetrahydrocortisol [Moles/volume] in 24 hour Urine
Tetrahydrocortisol [Moles/time] in 24 hour Urine
Tetrahydrocortisone [Moles/volume] in 24 hour Urine
Tetrahydrocortisone [Moles/volume] in Urine
Hemoglobin [Entitic substance] in Reticulocytes by Automated count
Chronic lyme disease panel - Blood by Flow cytometry (FC)
CD8-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC)
CD3- CD8- CD57+ Cells [#/volume] in Blood by Flow cytometry (FC)
CD3- CD8- CD57+ Cells/100 leukocytes in Blood by Flow cytometry (FC)
CD3- CD8- CD57+ Cells/100 lymphocytes in Blood by Flow cytometry (FC)
CD3-CD57+ cells [#/volume] in Blood by Flow cytometry (FC)
CD3-CD57+ cells/100 leukocytes in Blood by Flow cytometry (FC)
CD3-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC)
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay
HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay
Polio virus identified in Specimen by Organism specific culture
Alloisoleucine/Creatinine [Ratio] in Urine
D2-40 Ag [Presence] in Tissue by Immune stain
PAX8 Ag [Presence] in Tissue by Immune stain
SOX10 Ag [Presence] in Tissue by Immune stain
DOG1 Ag [Presence] in Tissue by Immune stain
JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method
1,3-Dimethylamylamine [Presence] in Urine by Screen method
1,3-Dimethylamylamine [Mass/volume] in Urine by Confirmatory method
JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
Hazelnut triggered histamine release [Units/volume] in Blood
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
Metamyelocytes [#/volume] in Blood by Manual count
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
Helminthosporium interseminatum IgE Ab [Units/volume] in Serum
Normeperidine [Mass/volume] in Serum, Plasma or Blood
Meperidine [Mass/volume] in Serum, Plasma or Blood
Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
fentaNYL [Presence] in Blood by Screen method
Norfentanyl [Mass/volume] in Blood by Confirmatory method
fentaNYL [Mass/volume] in Blood by Confirmatory method
Helminthosporium maydis IgE Ab [Units/volume] in Serum
HYDROmorphone Free [Mass/volume] in Blood
6-monoacetylmorphine free [Mass/volume] in Blood
Buprenorphine [Presence] in Saliva (oral fluid) by Screen method
Cannabinoids synthetic [Presence] in Blood
MAM-2201 (synthetic cannabinoid) [Presence] in Blood
UR-144 (synthetic cannabinoid) [Presence] in Blood
JWH-200 (synthetic cannabinoid) [Presence] in Blood
JWH-398 (synthetic cannabinoid) [Presence] in Blood
JWH-122 (synthetic cannabinoid) [Presence] in Blood
JWH-018 (synthetic cannabinoid) [Presence] in Blood
JWH-250 (synthetic cannabinoid) [Presence] in Blood
RCS-4 (synthetic cannabinoid) [Presence] in Blood
AM-2201 (synthetic cannabinoid) [Presence] in Blood
JWH-073 (synthetic cannabinoid) [Presence] in Blood
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
Helminthosporium sp IgE Ab [Units/volume] in Serum
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood
Cholesterol esterase [Enzymatic activity/volume] in DBS
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe
Escherichia coli and Klebsiella pneumoniae and Pseudomonas aeruginosa rRNA [Identifier] by FISH in Positive blood culture
Candida sp rRNA [Identifier] by FISH in Positive blood culture
Enterococcus faecalis and other enterococcus sp rRNA [Identifier] by FISH in Positive blood culture
Helminthosporium sp IgG Ab [Units/volume] in Serum
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative
Eastern Hemlock IgE Ab [Units/volume] in Serum
Cancer related multigene analysis in Blood or Tissue by Molecular genetics method
von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by Immunoassay
Keyhole limpet hemocyanin Ab panel - Serum or Plasma
Carbapenem resistance blaNDM gene [Presence] by Molecular method
2,2',3,4,4',5-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,2',4,5,5'-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,3',4,4',5-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,3',4',5-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,2',5,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,2',5-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Confirmatory method
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Screen method
Mitragynine [Presence] in Urine by Confirmatory method
oxyCODONE [Presence] in Meconium by Screen method
25H-NBOMe [Presence] in Urine by Confirmatory method
Hemp fiber IgE Ab [Units/volume] in Serum
2C-C-NBOMe [Presence] in Urine by Confirmatory method
25I-NBOMe [Presence] in Urine by Confirmatory method
NBOMe [Presence] in Urine by Screen method
Tungsten/Creatinine [Mass Ratio] in 24 hour Urine
CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method
ABCB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Water Hemp IgE Ab [Units/volume] in Serum
Serotonin release 0.5 IU/mL heparin.unfractionated [Units/volume] in Serum
CYP3A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Metamyelocytes/100 leukocytes in Blood by Manual count
Pecan or Hickory Nut triggered histamine release [Units/volume] in Blood
Arbovirus identified in Serum by Immunofluorescence
Arbovirus IgM Ab [Presence] in Serum by Immunofluorescence
MAML2 11q21 gene rearrangements in Tissue by FISH
Abnormal Prion Protein [Identifier] in Tissue by Immune stain
Abnormal Prion Protein [Identifier] in Tissue by Immunoblot
Transmissible spongiform encephalopathy [Identifier] in Brain by Light microscopy
Influenza virus A H1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus A H3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus A N2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment
Shagbark Hickory IgE Ab [Units/volume] in Serum
Shellbark Hickory IgE Ab [Units/volume] in Serum
White Hickory IgE Ab [Units/volume] in Serum
Norolanzapine [Moles/volume] in Serum or Plasma
Glucose [Moles/volume] in Serum or Plasma --15 minutes post 50 g lactose PO
Pentacarboxylporphyrin III [Moles/mass] in Stool
Hexacarboxylporphyrin III [Moles/mass] in Stool
Histamine extract triggered histamine release [Units/volume] in Blood
Heptacarboxylporphyrin III [Moles/mass] in Stool
Pentacarboxylporphyrin III/Creatinine [Molar ratio] in Urine
Hexacarboxylporphyrin III/Creatinine [Molar ratio] in Urine
Heptacarboxylporphyrin III/Creatinine [Molar ratio] in Urine
Acidity.titratable [Moles/volume] in Urine
Gliquidone [Mass/volume] in Serum or Plasma
Gliclazide [Mass/volume] in Serum or Plasma
Didesmethylcitalopram [Mass/volume] in Serum or Plasma
Swine triggered histamine release [Units/volume] in Blood
Tacrolimus [Mass/volume] in Blood by Immunoassay
Tacrolimus [Mass/volume] in Blood by LC/MS/MS
Endothelin [Moles/volume] in Serum or Plasma
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Urine by Rapid immunoassay
Nitrate+Nitrite [Moles/volume] in Serum or Plasma
Tissue inhibitor of metalloproteinases 1 [Mass/volume] in Serum or Plasma by Immunoassay
Matrix metallopeptidase 2 [Mass/volume] in Serum
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Serum or Plasma by Rapid immunoassay
Swine epithelium IgG Ab [Units/volume] in Serum
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Urine by Immunoassay
Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood
Proteinase 3 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Warfarin [Presence] in Specimen by Screen method
Meperidine [Presence] in Saliva (oral fluid) by Screen method
4-hydroxycoumarins [Presence] in Specimen by Screen method
traMADol [Presence] in Saliva (oral fluid) by Screen method
Brodifacoum [Presence] in Specimen by Screen method
Bromadiolone [Presence] in Specimen by Screen method
Coumafuryl [Presence] in Specimen by Screen method
Coumatetralyl [Presence] in Specimen by Screen method
Difenacoum [Presence] in Specimen by Screen method
Adalimumab Ab [Mass/volume] in Serum or Plasma
Adalimumab [Mass/volume] in Serum or Plasma
P27 Ag [Presence] in Tissue by Immune stain
P504S Ag [Presence] in Tissue by Immune stain
PDGFR-alpha Ag [Presence] in Tissue by Immune stain
Perforin Ag [Presence] in Tissue by Immune stain
Ubiquitin Ag [Presence] in Tissue by Immune stain
Phospho-S6 ribosomal protein Ag [Presence] in Tissue by Immune stain
Blood group 8 (BG8) Ag [Presence] in Tissue by Immune stain
Mesothelin Ag [Presence] in Tissue by Immune stain
Mucin-4 (MUC-4) Ag [Presence] in Tissue by Immune stain
Akt1 phosphate Ag [Presence] in Tissue by Immune stain
Neuroblastoma 84 Ag [Presence] in Tissue by Immune stain
Transforming growth factor alpha Ag [Presence] in Tissue by Immune stain
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood
Morphine [Mass/volume] in Serum, Plasma or Blood
N-acetyl ezogabine [Mass/volume] in Plasma
fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Honeysuckle IgE Ab [Units/volume] in Serum
Mononuclear cells [#/volume] in Peritoneal dialysis fluid
Granulocytes [#/volume] in Peritoneal dialysis fluid
Granulocytes/100 leukocytes in Peritoneal dialysis fluid
Granulocytes/100 leukocytes in Body fluid
Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum
Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method
Horn beam IgE Ab [Units/volume] in Serum
Opiates [Mass/volume] in Saliva (oral fluid) by Screen method
Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method
Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method
Ceftaroline [Susceptibility] by Gradient strip
Whitefaced Hornet IgG Ab [Units/volume] in Serum
Horse dander triggered histamine release [Units/volume] in Blood
Microcytes [Presence] in Blood by Light microscopy
Horse epithelium IgE Ab [Units/volume] in Serum
Horseradish IgE Ab [Units/volume] in Serum
House dust AP IgE Ab [Units/volume] in Serum
Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic method
Rivaroxaban [Mass/volume] in Serum or Plasma by LC/MS/MS
Fondaparinux [Mass/volume] in Serum or Plasma by LC/MS/MS
Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic method
Apixaban [Mass/volume] in Serum or Plasma by LC/MS/MS
Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assay
Reviewed material and summary of stains in Bone marrow Narrative
Immunohistochemical stains in Bone marrow Narrative
Disease category [Interpretation] in Bone marrow
Cytochemical stains in Bone marrow Narrative
Plasma cells assessment in Bone marrow Narrative
Other observations in Bone marrow Narrative
Myelopoiesis assessment in Bone marrow Narrative
House dust AP IgG Ab [Units/volume] in Serum
Megakaryopoiesis assessment in Bone marrow Narrative
Lymphocytes assessment in Bone marrow Narrative
Erythropoiesis assessment in Bone marrow Narrative
Cellularity assessment in Bone marrow Narrative
Blasts assessment in Bone marrow Narrative
Unidentified cells/100 leukocytes in Pericardial fluid by Manual count
House dust triggered histamine release [Units/volume] in Blood
House dust Greer IgG Ab [Units/volume] in Serum
House dust Hollister Stier IgE Ab [Units/volume] in Serum
House dust Hollister Stier IgG Ab [Units/volume] in Serum
Dabigatran [Mass/volume] in Serum or Plasma by LC/MS/MS
Monocytes [#/volume] in Blood by Automated count
Mycobacterium tuberculosis stimulated gamma interferon CFP10 Ag spot count [#] in Blood
Mycobacterium tuberculosis stimulated gamma interferon ESAT-6 Ag spot count [#] in Blood
Gamma interferon negative control spot count [#] in Blood
Mitogen stimulated gamma interferon positive control spot count [#] in Blood
Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood
Iodinebush IgE Ab [Units/volume] in Serum
Isocyanate HDI IgE Ab [Units/volume] in Serum
Isovaleric acidemia newborn screen interpretation
Hydroxymethylglutaryl CoA lyase deficiency newborn screen interpretation
3-Methylcrotonyl-CoA carboxylase deficiency newborn screen interpretation
Isobutyryl-CoA dehydrogenase deficiency newborn screen interpretation
Short-chain acyl-CoA dehydrogenase deficiency newborn screen interpretation
Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet
Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet
Succinylacetone [Moles/volume] in DBS --post therapeutic diet
Isocyanate MDI IgE Ab [Units/volume] in Serum
Tyrosine [Moles/volume] in DBS --post therapeutic diet
Phenylalanine [Moles/volume] in DBS --post therapeutic diet
PRRSV neutralizing antibody [Titer] in Serum by Neutralization test
PRRSV Ag [Presence] in Specimen by Immunofluorescence
PRRSV ORF5 gene sequence homology to Fostera in Isolate by Sequencing
PRRSV ORF5 gene sequence homology to Lelystad in Isolate by Sequencing
PRRSV ORF5 gene sequence homology to Ingelvac ATP in Isolate by Sequencing
PRRSV ORF5 gene sequence homology to Ingelvac MLV in Isolate by Sequencing
Isocyanate TDI IgE Ab [Units/volume] in Serum
PRRSV strain identified in Isolate by Sequencing
PRRSV ORF5 gene sequence [Nucleotide sequence] in Isolate by Sequencing
PRRSV [Presence] in Specimen by Organism specific culture
PRRSV Ab/Positive control in Specimen by Immunoassay
PRRSV ORF5 gene RNA pattern [Identifier] in Isolate by RFLP
PRRSV RNA [#/volume] (viral load) in Specimen by NAA with probe detection
PRRSV ORF5 gene RNA [Presence] in Specimen by NAA with probe detection
PRRSV European strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection
PRRSV North American strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Juniper triggered histamine release [Units/volume] in Blood
Pinchot Juniper IgE Ab [Units/volume] in Serum
Leukocyte aggregates [Presence] in Blood by Light microscopy
Bacteria identified in Bone from Donor by Aerobe culture
Lactose [Moles/volume] in Serum or Plasma --fasting
Monocytes [#/volume] in Blood by Manual count
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20M post dose corticotropin
Western Juniper IgE Ab [Units/volume] in Serum
Glucose [Moles/volume] in Urine collected for unspecified duration
Cryoglobulin and cryofibrinogen panel - Serum and Plasma
Sodium and Potassium panel [Moles/volume] - Blood
Epithelial cells/100 leukocytes in Sputum
Bacteria identified in Bartholin cyst by Aerobe culture
Bacteria identified in Ventriculoperitoneal (VP) shunt by Culture
Lymphocytes Immunoblastic [Presence] in Blood by Light microscopy
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Serum or Plasma
Cholesterol ester transfer protein actual/normal in Serum or Plasma
Cortisone [Moles/volume] in Saliva (oral fluid)
Dehydroepiandrosterone (DHEA) [Moles/volume] in Saliva (oral fluid)
Lecithin cholesterol acyltransferase actual/normal in Serum or Plasma
N,N-dimethylarginine [Moles/volume] in Serum or Plasma
Oxytocin [Mass/volume] in Saliva (oral fluid)
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Fibroblast
Clorazepate [Mass/volume] in Serum or Plasma --trough
Nitric oxide [Moles/volume] in Exhaled gas
Cotinine [Presence] in Saliva (oral fluid) by Confirmatory method
Cotinine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
cloNIDine [Mass/volume] in Unknown substance
2,4,4'-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,2',3,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method
Baclofen [Mass/volume] in Unknown substance
Meperidine [Mass/volume] in Unknown substance
Morphine [Mass/volume] in Unknown substance
HYDROmorphone [Mass/volume] in Unknown substance
Midazolam [Mass/volume] in Unknown substance
Bupivacaine [Mass/volume] in Unknown substance
fentaNYL [Mass/volume] in Unknown substance
Kapok triggered histamine release [Units/volume] in Blood
Normirtazapine [Mass/volume] in Body fluid
Karaya gum IgE Ab [Units/volume] in Serum
Immature reticulocytes/100 erythrocytes in Cord blood by Automated count
Large unstained cells/100 leukocytes in Cord blood by Automated count
Reticulocytes/100 erythrocytes in Cord blood by Automated count
Kiwifruit IgG Ab [Units/volume] in Serum
Lymphocytes/100 leukocytes in Cord blood
Normoblasts/100 leukocytes in Cord blood
Eosinophils/100 leukocytes in Cord blood
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA panel - Specimen
Polychlorinated biphenyl (PCB) panel - Serum or Plasma by Confirmatory method
Varicella zoster virus IgM Ab [Units/volume] in Body fluid by Immunoassay
Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay
Measles virus IgM Ab [Units/volume] in Body fluid by Immunoassay
Measles virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Measles virus IgG Ab [Units/volume] in Body fluid by Immunoassay
Kiwifruit triggered histamine release [Units/volume] in Blood
Parvovirus B19 DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Parvovirus B19 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
Mumps virus IgM Ab [Units/volume] in Body fluid by Immunoassay
Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay
Enterovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Enterovirus RNA [Cycle Threshold #] in Stool by NAA with probe detection
Myelocytes.neutrophilic/100 leukocytes in Blood by Manual count
Myelocytes.neutrophilic/100 cells in Bone marrow by Manual count
Myelocytes.eosinophilic/100 leukocytes in Blood by Manual count
Metamyelocytes.neutrophilic/100 leukocytes in Blood by Manual count
Metamyelocytes.eosinophilic/100 cells in Bone marrow by Manual count
Monocytes/100 leukocytes in Blood by Manual count
3-Hydroxykynurenin [Moles/volume] in Serum or Plasma
Cholestanol [Moles/volume] in Serum or Plasma
Cholestanol/Cholesterol in Serum or Plasma
Bilirubin.total/Total in Stone by Infrared spectroscopy
Cholesterol.non-esterified/Cholesterol.total in Serum or Plasma by Gas chromatography
Galactokinase [Enzymatic activity/mass] in Leukocytes
Lactose/Creatinine [Molar ratio] in Urine
GABA free and total panel - Cerebral spinal fluid
Porphobilinogen/Creatinine [Molar ratio] in 24 hour Urine
Pyridoxal phosphate [Moles/volume] in Blood
Lactalbumin IgG Ab [Units/volume] in Serum
Sucrose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO
Thiamine pyrophosphate [Moles/volume] in Blood
Porphyrin fractions panel [Moles/mass] - Stool
Sugars and polyols panel [Molar ratio] - Urine
Sugars and polyols pattern [Interpretation] in Urine
Lactalbumin alpha IgE Ab [Units/volume] in Serum
Other cells/100 leukocytes in Blood from Fetus
Platelet distribution width [Entitic volume] in Cord blood by Automated count
Normoblasts [#/volume] in Blood from Fetus
Plasma cells/100 leukocytes in Cord blood
Neutrophils/100 leukocytes in Cord blood
Large unstained cells/100 leukocytes in Blood from Fetus by Automated count
Immature granulocytes/100 leukocytes in Blood from Fetus
Blasts/100 leukocytes in Blood from Fetus
Lymphocytes/100 leukocytes in Blood from Fetus
Basophils/100 leukocytes in Blood from Fetus
Normoblasts/100 leukocytes in Blood from Fetus
Platelets [#/volume] in Capillary blood by Manual count
Lactalbumin triggered histamine release [Units/volume] in Blood
Glucose-6-Phosphate dehydrogenase/Pyruvate kinase [Ratio] in Blood
Middle East respiratory syndrome coronavirus (MERS-CoV) N3 gene RNA [Presence] in Specimen by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) N2 gene RNA [Presence] in Specimen by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) upE gene RNA [Presence] in Specimen by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Interpretation] in Specimen Qualitative by NAA with probe detection
Lactoglobulin IgG Ab [Units/volume] in Serum
Tyrosine/Phenylalanine [Molar ratio] in DBS
Reason for unsatisfactory specimen not related to sample quality of dried blood spot
Argininosuccinate [Moles/volume] in Urine
CD3 and CD20 Ag [Identifier] in Tissue by Immune stain
Cytokeratin 5 and p63 and Cytokeratin AE1 Ag [Identifier] in Tissue by Immune stain
P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain
p63 and Smooth muscle myosin heavy chain and Cytokeratin 8 Ag [Identifier] in Tissue by Immune stain
Melan-A and Ki67 Ag [Identifier] in Tissue by Immune stain
PAX5 and BCL2 Ag [Identifier] in Tissue by Immune stain
Cytokeratin 7 and Thyroid transcription factor 1 Ag [Identifier] in Tissue by Immune stain
Lamb triggered histamine release [Units/volume] in Blood
PAX5 and CD43 Ag [Identifier] in Tissue by Immune stain
PAX5 and CD5 Ag [Identifier] in Tissue by Immune stain
CD34 and Coagulation factor XIII Ag [Identifier] in Tissue by Immune stain
Cefatrizine [Susceptibility] by Serum bactericidal titer
Goosefoot triggered histamine release [Units/volume] in Blood
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in Urine
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine
16-Alpha hydroxypregnenolone [Moles/time] in 24 hour Urine
16-Alpha hydroxypregnenolone [Moles/volume] in Urine
16-Alpha hydroxypregnenolone [Moles/volume] in 24 hour Urine
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma
3-Hydroxyeicosanoylcarnitine (C20-OH) [Moles/volume] in Serum or Plasma
COMT gene c.1947G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Chemokine (C-C motif) ligand 18 [Mass/volume] in Serum
Alpha tocopherol [Entitic substance] in Red Blood Cells
Amino acids panel [Moles/volume] - Urine
Calcium [Moles/volume] in Saliva (oral fluid)
Cholesterol sulfate [Moles/volume] in Serum or Plasma
Latex ALK triggered histamine release [Units/volume] in Blood
Clara cell protein 16 [Mass/volume] in Serum
Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
Complement total hemolytic CH50 actual/normal in Serum by Immunoassay
Complement lectin pathway actual/normal in Serum by Immunoassay
Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma
Decatrienoylcarnitine (C10:3) [Moles/volume] in Serum or Plasma
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in Serum or Plasma
Latex Bencard triggered histamine release [Units/volume] in Blood
Delta aminolevulinate, porphobilinogen and creatinine panel - 24 hour Urine
Delta aminolevulinate, porphobilinogen and creatinine panel - Urine
Dicarboxyeicosanoylcarnitine (C20-DC) [Moles/volume] in Serum or Plasma
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in Serum or Plasma
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in Serum or Plasma
Energy content [Energy/mass] of 24 hour Stool.wet
Latex Greer triggered histamine release [Units/volume] in Blood
Neisseria meningitidis serogroup Y DNA [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup X DNA [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup w135 DNA [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup C DNA [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup B DNA [Presence] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup A DNA [Presence] in Specimen by NAA with probe detection
Hexenoylcarnitine (C6:1) [Moles/volume] in Serum or Plasma
Surfactant pulmonary-associated protein D [Mass/volume] in Serum
Latex Stallerg triggered histamine release [Units/volume] in Blood
Pyruvate kinase/Glucose-6-Phosphate dehydrogenase [Enzymatic activity ratio] in Red Blood Cells
Tocopherols [Entitic substance] in Red Blood Cells
Tryptophan-related indole profiling panel - Platelet rich plasma
Lemon triggered histamine release [Units/volume] in Blood
Macroscopic observation [Interpretation] in Specimen Narrative
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Tissue
Tripeptidyl peptidase I [Enzymatic activity/mass] in Fibroblast
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Fibroblast
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Tissue
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Fibroblast
Fumarase [Enzymatic activity/mass] in Tissue
Fumarase [Enzymatic activity/mass] in Fibroblast
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast
Cytochrome C oxidase/Citrate synthase [Enzymatic activity ratio] in Tissue
Coenzyme Q cytochrome C reductase (Complex III)/Citrate synthase [Enzymatic activity ratio] in Tissue
Coenzyme Q cytochrome C reductase (Complex III) [Enzymatic activity/mass] in Tissue
Succinate cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue
Succinate cytochrome C reductase [Enzymatic activity/mass] in Fibroblast
Succinate dehydrogenase/Citrate synthase [Enzymatic activity ratio] in Tissue
NADH cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/mass] in Fibroblast
Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/mass] in Fibroblast
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/mass] in Fibroblast
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Fibroblast
Lettuce triggered histamine release [Units/volume] in Blood
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Molar ratio] in Red Blood Cells
1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/mass] in Fibroblast
1,1-Dimethoxyoctadecane (DMA 18:0) [Moles/mass] in Red Blood Cells
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Molar ratio] in Red Blood Cells
1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast
1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells
Adipoylcarnitine (C6-DC) [Moles/volume] in DBS
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma
Glycosaminoglycans/Creatinine [Ratio] in 24 hour Urine
Glycosaminoglycans [Presence] in 24 hour Urine
Easter lily IgE Ab [Units/volume] in Serum
Dimethylacetal (DMA) panel - Red Blood Cells
Bacterial vaginosis DNA panel - Vaginal fluid by NAA with probe detection
Protein.monoclonal band 3 [Mass/time] in 24 hour Urine by Electrophoresis
Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis
Monoclonal band 3 observed [Identifier] in Urine by Immunofixation
Monoclonal band 2 observed [Identifier] in Urine by Immunofixation
Monoclonal band 3 observed [Identifier] in Serum or Plasma by Immunofixation
Monoclonal band 2 observed [Identifier] in Serum or Plasma by Immunofixation
1,3-Dichlorobenzene [Mass/volume] in Serum or Plasma
HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method
HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method
Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood
Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
Morphine [Presence] in Saliva (oral fluid) by Confirmatory method
Opiates [Presence] in Saliva (oral fluid) by Confirmatory method
oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method
oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method
Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method
Phosphatidylethanol [Mass/volume] in Blood
Monoclonal band observed [Identifier] in Serum or Plasma by Immunofixation
Monoclonal band observed [Identifier] in Urine by Immunofixation
Atopobium vaginae DNA [Log #/volume] in Vaginal fluid by NAA with probe detection
Gardnerella vaginalis DNA [Log #/volume] in Vaginal fluid by NAA with probe detection
Lactobacillus sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection
Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method
Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method
Carisoprodol+Meprobamate [Mass/volume] in Urine
Ethanol [Presence] in Saliva (oral fluid) by Confirmatory method
Chlorinated solvents [Presence] in Urine
Codeine [Presence] in Saliva (oral fluid) by Confirmatory method
Carbapenemase [Type] in Isolate by Carba NP
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method
Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method
Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method
Myeloblasts [#/volume] in Blood by Manual count
Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method
Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method
Trichloroethanol.free [Mass/volume] in Blood
Ethyl sulfate [Presence] in Urine by Confirmatory method
Carbon dioxide, total [Moles/volume] in Serum or Plasma --post dialysis
Sodium [Moles/volume] in Serum or Plasma --post dialysis
Nucleated cells [#/volume] in Body fluid by Manual count
Liver calf IgE Ab [Units/volume] in Serum
Weak D Ag [Presence] in Cord red blood cells
Round cells [#/area] in Semen by Microscopy high power field
MT-ND6 gene m.14459G>A [Presence] in Blood or Tissue by Molecular genetics method
Magnesium [Moles/volume] in 12 hour Urine
Acamprosate [Mass/volume] in Serum or Plasma
Cefuroxime [Susceptibility] by Disk diffusion (KB)
Llama fur IgE Ab [Units/volume] in Serum
Locust tree IgE Ab [Units/volume] in Serum
Adrenoleukodystrophy protein (ALDP) [Presence] in Fibroblast by Immune stain
Oligosaccharides pattern [Interpretation] in 24 hour Urine Narrative
Black Locust IgE Ab [Units/volume] in Serum
Lymphocytes clefted [Presence] in Blood or Tissue by Light microscopy
Porcine epidemic diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Blood group antigens present [Identifier] in Blood by IAT
Blood group antigens present [Identifier] in Blood by Immediate spin
Placental growth factor [Mass/volume] in Serum
Soluble fms-like tyrosine kinase-1 [Mass/volume] in Serum
Mackerel triggered histamine release [Units/volume] in Blood
Soluble fms-like tyrosine kinase-1/placental growth factor [Ratio] in Serum
Ethyl sulfate+Ethyl glucuronide [Presence] in Urine by Confirmatory method
Yeast [Presence] in Specimen by Gram stain
Myeloblasts/100 leukocytes in Blood by Manual count
HYDROcodone and metabolites panel - Urine by Confirmatory method
Megasphaera sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection
Human papilloma virus E6+E7 mRNA [Presence] in Anal by NAA with probe detection
Soluble fms-like tyrosine kinase-1 and placental growth factor panel - Serum or Plasma
Bordetella pertussis.pertussis toxin IgA Ab [Presence] in Serum by Line blot
Bordetella pertussis.pertussis toxin 100 IgG Ab [Presence] in Serum by Line blot
Tryptophan [Moles/volume] in Platelet rich plasma
5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma
5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma
Mango Pollen IgE Ab [Units/volume] in Serum
Immunoglobulin light chains and heavy chains panel - Serum or Plasma
Glucose [Mass/volume] in Serum, Plasma or Blood
Platelets [#/volume] in Platelet rich plasma by Automated count
Human papilloma virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Human papilloma virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Human papilloma virus 11 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Human papilloma virus 11 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method
Coastal Maple IgE Ab [Units/volume] in Serum
Malignant cells [Presence] in Body fluid by Light microscopy
Influenza virus B lineage RNA [Identifier] in Specimen by NAA with probe detection
Influenza virus B Victoria lineage RNA [Presence] in Specimen by NAA with probe detection
Influenza virus B Yamagata lineage RNA [Presence] in Specimen by NAA with probe detection
Influenza virus B Victoria and Yamagata lineage RNA panel - Specimen
Lactulose challenge (hydrogen breath test) panel - Exhaled gas
Fructose challenge (hydrogen breath test) panel - Exhaled gas
Glucose challenge (hydrogen breath test) panel - Exhaled gas
Lactulose challenge (hydrogen breath test) [Interpretation] in Exhaled gas
Thyroid hormone uptake (T-uptake) in Serum or Plasma
Thyroid hormone binding ratio (THBR) in Serum or Plasma
Total thyroxine binding capacity in Serum or Plasma
Red Maple IgE Ab [Units/volume] in Serum
Glucose challenge (hydrogen breath test) [Interpretation] in Exhaled gas
Lactose challenge (hydrogen breath test) [Interpretation] in Exhaled gas
Fructose challenge (hydrogen breath test) [Interpretation] in Exhaled gas
Penicillium sp IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
Lithium [Moles/volume] in Serum or Plasma --trough
Red Maple triggered histamine release [Units/volume] in Blood
Transferrin receptor.soluble/log Ferritin index [Mass Ratio] in Serum or Plasma
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasma
von Willebrand factor (vWf).activity actual/normal in Control Platelet poor plasma by Immunoassay
Acetyl fentanyl [Presence] in Urine by Confirmatory method
Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Nucleated cells [#/volume] in Dialysis fluid by Manual count
Plasma cells.centroblasts/100 leukocytes in Blood by Manual count
Red+Silver Maple IgE Ab [Units/volume] in Serum
Ascaris sp IgG Ab [Presence] in Serum by Immunoassay
Bacteria identified in Eye by Anaerobe+Aerobe culture
Desomorphine [Mass/volume] in Urine by Confirmatory method
Desomorphine [Presence] in Urine by Screen method
Promazine [Presence] in Urine by Screen method
Plasma cells.centrocytes/100 leukocytes in Blood by Manual count
Chikungunya virus Ab [Presence] in Serum by Hemagglutination inhibition
Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection
Maple sugar IgE Ab [Units/volume] in Serum
Jamestown canyon virus Ab [Presence] in Serum by Immunoassay
Powassan virus Ab [Presence] in Serum by Hemagglutination inhibition
Saint Louis encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition
Semliki Forest virus Ab [Presence] in Serum by Hemagglutination inhibition
Snowshoe hare virus Ab [Presence] in Serum by Hemagglutination inhibition
Snowshoe hare virus neutralizing antibody [Presence] in Serum by Neutralization test
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunofluorescence
Toxoplasma gondii IgA Ab [Presence] in Serum by Immunoassay
Maple syrup IgE Ab [Units/volume] in Serum
ACAT1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
MARS2 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
Myelocytes [#/volume] in Blood by Manual count
Baylisascaris sp IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay
Sindbis virus Ab [Presence] in Serum by Hemagglutination inhibition
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunofluorescence
Toxoplasma gondii IgE Ab [Presence] in Serum by Immunoassay
Lymphocytes/100 cells in Lymph node by Manual count
Burweed marshelder IgE Ab [Units/volume] in Serum
Plasma cells/100 cells in Lymph node by Manual count
Lymphoblasts/100 cells in Lymph node by Manual count
Blasts/100 cells in Lymph node by Manual count
Mesothelial cells/100 cells in Lymph node by Manual count
HIV 1 proviral DNA [Presence] in Specimen by NAA with probe detection
HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection
HIV 1 proviral DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Burweed marshelder IgG Ab [Units/volume] in Serum
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection
West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection
Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection
Ethanol [Mass/volume] in Blood Estimated from serum or plasma level
ERBB2 gene copy number/nucleus in Tissue by FISH
Chromosome 17 copy number/nucleus in Tissue by FISH
IgG.kappa [Mass/volume] in Serum or Plasma
IgG.lambda [Mass/volume] in Serum or Plasma
Mattress dust IgE Ab [Units/volume] in Serum
IgA.kappa [Mass/volume] in Serum or Plasma
IgA.lambda [Mass/volume] in Serum or Plasma
IgM.kappa [Mass/volume] in Serum or Plasma
IgM.lambda [Mass/volume] in Serum or Plasma
IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma
IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma
IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma
Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method
21-Deoxycortisol [Mass/volume] in Serum or Plasma
Metabolic disorder being monitored [Identifier] in DBS
Metabolic disorder therapy monitoring panel - DBS
Alloisoleucine [Moles/volume] in DBS --post therapeutic diet
Arginine [Moles/volume] in DBS --post therapeutic diet
Argininosuccinate [Moles/volume] in DBS --post therapeutic diet
Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet
Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet
Mayfly triggered histamine release [Units/volume] in Blood
Hydroxyproline [Moles/volume] in DBS --post therapeutic diet
Isoleucine [Moles/volume] in DBS --post therapeutic diet
Leucine [Moles/volume] in DBS --post therapeutic diet
Ornithine [Moles/volume] in DBS --post therapeutic diet
Valine [Moles/volume] in DBS --post therapeutic diet
ERBB2 gene (HER2) duplication associated observations panel - Tissue by FISH
Stigmasterol [Moles/volume] in Serum or Plasma
Stigmastanol [Moles/volume] in Serum or Plasma
Sterols panel [Moles/volume] - Serum or Plasma
Phosphate [Moles/volume] in Saliva (oral fluid)
Inositol Free/Creatinine [Molar ratio] in Urine
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast
Mannose/Creatinine [Molar ratio] in Urine
Mannitol [Moles/time] in 5 hour Urine --post XXX g sugar solution PO
Maltose/Creatinine [Molar ratio] in Urine
Lithocholate [Moles/volume] in Serum or Plasma
Cajeput tree triggered histamine release [Units/volume] in Blood
Lanosterol [Moles/volume] in Serum or Plasma
Lactulose/Mannitol [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO
Lactulose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO
Gamma tocopherol [Entitic substance] in Red Blood Cells
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Leukocytes
Fatty acids [Mass/time] in 24 hour Stool
DOPamine [Moles/volume] in Cerebral spinal fluid
Desmosterol [Moles/volume] in Serum or Plasma
Bilirubin.total [Moles/volume] in Cerebral spinal fluid
Beta sitosterol [Moles/volume] in Serum or Plasma
3-ketoacyl-CoA thiolase [Enzymatic activity/mass] in Fibroblast
Calcium oxalate dihydrate/Total in Stone
Porphyrin fractions and creatinine panel [Molar ratio] - 24 hour Urine
Sertraline [Mass/volume] in Serum or Plasma --trough
Primidone [Mass/volume] in Serum or Plasma --trough
Mexican Firebush IgE Ab [Units/volume] in Serum
Acylglycines panel [Molar ratio] - Urine
Sulpiride [Mass/volume] in Serum or Plasma --trough
Metoprolol [Mass/volume] in Serum or Plasma --trough
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
Fatty acids [Mass/mass] in 24 hour Stool
Caffeine [Mass/volume] in Serum or Plasma --trough
Myelocytes/100 leukocytes in Blood by Manual count
Gamma hydroxybutyrate [Moles/volume] in Blood
Multiple inhalant allergen IgE Ab [Units/volume] in Serum
N-acetyl-L-aspartate [Moles/volume] in Cerebral spinal fluid
Nortriptyline [Mass/volume] in Serum or Plasma --trough
PHENobarbital [Mass/volume] in Serum or Plasma --trough
Allopurinol [Mass/volume] in Serum or Plasma --trough
Milk evaporated IgE Ab [Units/volume] in Serum
3-Hydroxykynurenin [Moles/volume] in Cerebral spinal fluid
ARIPiprazole [Mass/volume] in Serum or Plasma --trough
fluPHENAZine [Mass/volume] in Serum or Plasma --trough
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Leukocytes
QUEtiapine [Mass/volume] in Serum or Plasma --trough
Vigabatrin [Mass/volume] in Serum or Plasma --trough
Moclobemide [Mass/volume] in Serum or Plasma --trough
Moclobemide [Mass/volume] in Serum or Plasma
Kynurenin [Moles/volume] in Cerebral spinal fluid
busPIRone [Mass/volume] in Serum or Plasma --trough
lamoTRIgine [Mass/volume] in Serum or Plasma --trough
clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma --trough
Common Millet IgG Ab [Units/volume] in Serum
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough
Perphenazine [Mass/volume] in Serum or Plasma --trough
Lymphocyte proliferation [Interpretation] in Blood Narrative
Macroprolactin [Units/volume] in Serum or Plasma
Isomaltase [Enzymatic activity/mass] in Small intestine Tissue
Mite dust IgE Ab [Units/volume] in Serum
Succinylacetone [Moles/volume] in Plasma
clomiPRAMINE [Mass/volume] in Serum or Plasma --trough
valGANciclovir [Mass/volume] in Plasma --trough
Maprotiline [Mass/volume] in Serum or Plasma --trough
Cheese mold type IgG Ab [Units/volume] in Serum
Gabapentin [Mass/volume] in Serum or Plasma --trough
Haloperidol [Mass/volume] in Serum or Plasma --trough
Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence
Acetylsalicylate [Mass/volume] in Serum or Plasma --trough
Cheese mold type triggered histamine release [Units/volume] in Blood
carBAMazepine [Mass/volume] in Serum or Plasma --trough
carBAMazepine free [Mass/volume] in Serum or Plasma --trough
Nordiazepam [Mass/volume] in Serum or Plasma --trough
Phenytoin [Mass/volume] in Serum or Plasma --trough
Transferrin [Mass/time] in 24 hour Urine
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes
Urate [Moles/volume] in Bronchoalveolar lavage
LORazepam [Mass/volume] in Serum or Plasma --trough
Pimozide [Mass/volume] in Serum or Plasma --trough
FLUoxetine [Mass/volume] in Serum or Plasma --trough
Phenytoin Free [Mass/volume] in Serum or Plasma --trough
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Lymphoblasts
ALPRAZolam [Mass/volume] in Serum or Plasma --trough
Hydroxychloroquine [Mass/volume] in Serum or Plasma --trough
Hexacarboxylporphyrin [Moles/volume] in Red Blood Cells
Chrysonilia sitophila IgE Ab [Units/volume] in Serum
Pentacarboxylporphyrins [Moles/volume] in Serum or Plasma
Alpha 1 antitrypsin [Mass/time] in 24 hour Stool
Amylase [Enzymatic activity/volume] in Saliva (oral fluid)
Chloride and sodium panel [Moles/volume] - Sweat
Collagen crosslinked C-telopeptide [Z-score] in Serum or Plasma
Osteocalcin [Z-score] in Serum or Plasma
Alkaline phosphatase.bone [Z-score] in Serum or Plasma
Monkey epithelium IgE Ab [Units/volume] in Serum
Alpha 1 antitrypsin [Mass/mass] in Stool.dried
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Fibroblast
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Leukocytes
Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC)
Coproporphyrin 3/Coproporphyrin.total in 24 hour Urine
Coproporphyrin 3/Coproporphyrin.total in Stool
Aedes mosquito triggered histamine release [Units/volume] in Blood
Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 7A (Peanut+Cow milk+Egg white+Soybean+Wheat+Rice) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix fp73 (Beef+Chicken+Pork+Lamb) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Units/volume] in Serum by Multidisk
Aspergillus restrictus native (nAsp r) 1 IgE Ab [Units/volume] in Serum
Dog native (nCan f) 1 IgE Ab [Units/volume] in Serum
CEBPA gene full mutation analysis in Blood or Tissue by Sequencing
Spanish Moss IgE Ab [Units/volume] in Serum
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method
Fat.microscopic observation [Presence] in Urine sediment by Oil red O stain
CD63 (Activated) Basophils/100 basophils in Blood by Flow cytometry (FC)
Coproporphyrin 1/Porphyrins.total in Stool
Coproporphyrin 3/Porphyrins.total in Stool
Deuteroporphyrin/Porphyrins.total in Stool
Protoporphyrin/Porphyrins.total in Stool
Zanamivir [Susceptibility] by Genotype method
CEBPA gene full mutation analysis in Bone marrow by Sequencing
MPL gene mutations tested for in Bone marrow by Molecular genetics method Nominal
NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal
Oxytocin [Moles/volume] in Saliva (oral fluid)
Moth triggered histamine release [Units/volume] in Blood
2-Hydroxyglutarate [Moles/volume] in Amniotic fluid
2-Hydroxyglutarate [Moles/volume] in DBS
Bile acid pattern [Interpretation] in Serum or Plasma Narrative
Biopterin [Moles/volume] in Serum or Plasma
D-Lactate [Moles/volume] in Cerebral spinal fluid
Pyridoxal [Moles/volume] in Serum or Plasma
Pyridoxal [Moles/volume] in Cerebral spinal fluid
Pyridoxine [Moles/volume] in Cerebral spinal fluid
Mouse hair IgE Ab [Units/volume] in Serum
Sepiapterin/Creatinine [Molar ratio] in Urine
Sialate [Moles/volume] in Amniotic fluid
Sialate [Moles/volume] in Cerebral spinal fluid
Sialate [Moles/volume] in Serum or Plasma
Tetrahydrofolate [Moles/volume] in Cerebral spinal fluid
Coenzyme Q10 [Moles/volume] in Serum or Plasma
Mouse multi IgE Ab [Units/volume] in Serum
Xylose/Creatinine [Molar ratio] in Urine
Adenosine deaminase [Enzymatic activity/volume] in DBS
Alpha-L-iduronidase [Enzymatic activity/volume] in Serum or Plasma
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast
Pyridoxal phosphate [Moles/volume] in Cerebral spinal fluid
Sialidase [Enzymatic activity/mass] in Leukocytes
Thymidine phosphorylase [Enzymatic activity/volume] in DBS
Transaldolase [Enzymatic activity/mass] in Fibroblast
Pantothenate/Creatinine [Molar ratio] in Urine
Malonate [Moles/volume] in Serum or Plasma
Phenylacetate [Moles/volume] in Serum or Plasma
Glycerate [Moles/volume] in Serum or Plasma
Vanillylmandelate [Moles/volume] in Serum or Plasma
Benzoate [Moles/volume] in Serum or Plasma
Pantothenate [Moles/volume] in Serum or Plasma
Indole-3-Acetate [Moles/volume] in Serum or Plasma
Malate [Moles/volume] in Serum or Plasma
Mucor plumbeus IgE Ab [Units/volume] in Serum
Hippurate [Moles/volume] in Serum or Plasma
Catechol [Moles/volume] in Serum or Plasma
Acetaminophen/Creatinine [Molar ratio] in Urine
Mandelate [Moles/volume] in Serum or Plasma
Suberate [Moles/volume] in Serum or Plasma
4-Hydroxybenzoate [Moles/volume] in Serum or Plasma
Vanillate [Moles/volume] in Serum or Plasma
Mucor racemosus IgG Ab [Units/volume] in Serum
Quinolinate [Moles/volume] in Serum or Plasma
3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Molar ratio] in Urine
Succinylacetone [Moles/volume] in Serum or Plasma
N-acetyl-L-aspartate [Moles/volume] in Serum or Plasma
Fumarate [Moles/volume] in Serum or Plasma
Aconitate [Moles/volume] in Serum or Plasma
Sebacate (C8) [Moles/volume] in Serum or Plasma
Mucor racemosus triggered histamine release [Units/volume] in Blood
Homogentisate/Creatinine [Molar ratio] in 24 hour Urine
Catecholamine metabolites pattern [Interpretation] in Urine Narrative
Adipate [Moles/volume] in Serum or Plasma
3-Indolelactate [Moles/volume] in Serum or Plasma
5-Oxoproline [Moles/volume] in Serum or Plasma
Isocitrate [Moles/volume] in Serum or Plasma
Catechol/Creatinine [Molar ratio] in Urine
Galactose [Mass/volume] in DBS --post therapeutic diet
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS --post therapeutic diet
Docosahexaenoate (C22:6w3) [Entitic substance] in Red Blood Cells
Fatty acids.very long chain C26:0 (Hexacosanoate) [Entitic substance] in Red Blood Cells
Eicosapentaenoate (C20:5w3) [Entitic substance] in Red Blood Cells
Nervonate (C24:1) [Entitic substance] in Red Blood Cells
Laurate (C12:0) [Entitic substance] in Red Blood Cells
Fatty acids [Entitic substance] in Red Blood Cells
Mugwort triggered histamine release [Units/volume] in Blood
Fatty acids.very long chain C22:0 (Docosanoate) [Entitic substance] in Red Blood Cells
Oleate (C18:1w9) [Entitic substance] in Red Blood Cells
Myristate (C14:0) [Entitic substance] in Red Blood Cells
Fatty acids.very long chain C24:0 (Tetracosanoate) [Entitic substance] in Red Blood Cells
Fatty acids.very long chain C26:1 (Hexacosenoate) [Entitic substance] in Red Blood Cells
Mead acid (C20:3w9) [Entitic substance] in Red Blood Cells
Pentadecanoate [Entitic substance] in Red Blood Cells
Arachidate (C20:0) [Entitic substance] in Red Blood Cells
Fatty acids.very long chain.C22:1n9 (Erucate) [Entitic substance] in Red Blood Cells
Arachidonate (C20:4w6) [Entitic substance] in Red Blood Cells
Palmitoleate (C16:1w7) [Entitic substance] in Red Blood Cells
Docosatetraenoate (C22:4w6) [Entitic substance] in Red Blood Cells
Alpha linolenate (C18:3w3) [Entitic substance] in Red Blood Cells
Fatty acids pattern [Interpretation] in Red Blood Cells Narrative
Palmitate (C16:0) [Entitic substance] in Red Blood Cells
Decanoate (C10:0) [Entitic substance] in Red Blood Cells
Linoleate (C18:2w6) [Entitic substance] in Red Blood Cells
Octadecanoate (C18:0) [Entitic substance] in Red Blood Cells
California Mugwort IgE Ab [Units/volume] in Serum
Gamma Linolenate (C18:3w6) [Entitic substance] in Red Blood Cells
Octanoate (C8:0) [Entitic substance] in Red Blood Cells
Thymine [Moles/volume] in Serum or Plasma
Deoxyadenosine [Moles/volume] in Serum or Plasma
Hypoxanthine [Moles/volume] in Cerebral spinal fluid
Deoxyadenosine [Moles/volume] in Cerebral spinal fluid
Orotidine [Moles/volume] in Serum or Plasma
Orotate [Moles/volume] in Cerebral spinal fluid
Deoxyinosine [Moles/volume] in Serum or Plasma
Uracil [Moles/volume] in Cerebral spinal fluid
Xanthine [Moles/volume] in Cerebral spinal fluid
Uridine [Moles/volume] in Cerebral spinal fluid
Adenine [Moles/volume] in Serum or Plasma
Oxipurinol/Creatinine [Molar ratio] in Urine
Adenine [Moles/volume] in Cerebral spinal fluid
Deoxyguanosine [Moles/volume] in Serum or Plasma
White mulberry IgG Ab [Units/volume] in Serum
Hypoxanthine [Moles/volume] in Serum or Plasma
Adenosine [Moles/volume] in Cerebral spinal fluid
Acadesine [Moles/volume] in Serum or Plasma
Succinylaminoimidazole carboxamide riboside/Creatinine [Molar ratio] in Urine
Urate [Moles/volume] in Cerebral spinal fluid
Allantoine [Moles/volume] in Cerebral spinal fluid
Acadesine [Moles/volume] in Cerebral spinal fluid
Adenosine [Moles/volume] in Serum or Plasma
Red mulberry IgE Ab [Units/volume] in Serum
Deoxyuridine [Moles/volume] in Cerebral spinal fluid
Xanthine [Moles/volume] in Serum or Plasma
Succinyladenosine [Moles/volume] in Serum or Plasma
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Serum or Plasma
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Cerebral spinal fluid
Orotidine [Moles/volume] in Cerebral spinal fluid
Deoxyguanosine [Moles/volume] in Cerebral spinal fluid
Inosine [Moles/volume] in Serum or Plasma
Acadesine/Creatinine [Molar ratio] in Urine
Uracil [Moles/volume] in Serum or Plasma
Thymine [Moles/volume] in Cerebral spinal fluid
Inosine [Moles/volume] in Cerebral spinal fluid
Allantoine/Creatinine [Molar ratio] in Urine
Thymidine [Moles/volume] in Cerebral spinal fluid
Deoxyinosine [Moles/volume] in Cerebral spinal fluid
Allantoine [Moles/volume] in Serum or Plasma
Uridine [Moles/volume] in Serum or Plasma
Adenosine/Creatinine [Molar ratio] in Urine
Mushroom triggered histamine release [Units/volume] in Blood
Oyster Mushroom IgE Ab [Units/volume] in Serum
Neutrophils [#/volume] in Blood by Automated count
Blue mussel IgG Ab [Units/volume] in Serum
ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC)
Blue mussel triggered histamine release [Units/volume] in Blood
Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS
Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS
Ornithine/Citrulline [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS
Biotinidase [Enzymatic activity/volume] in DBS
Microscopic observation [Identifier] in Throat by Alberts stain
Dengue virus IgG and IgM [Identifier] in Serum, Plasma or Blood by Rapid immunoassay
Chediak-Higashi cells [Presence] in Blood
Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS
Mycogone sp IgE Ab [Units/volume] in Serum
Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method
M-chlorophenylpiperazine [Presence] in Urine
Nectarine IgE Ab [Units/volume] in Serum
O-desmethylvenlafaxine [Presence] in Urine
Crystals [#/area] in Body fluid by Light microscopy
Erythrocytes [#/area] in Synovial fluid by Microscopy high power field
Albumin.ischemia modified [Units/volume] in Serum
Meat fibers [#/area] in Stool by Microscopy low power field
Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay
Nectarine IgG Ab [Units/volume] in Serum
Antipsychotics [Presence] in Urine by Screen method
Nigrospora oryzae IgE Ab [Units/volume] in Serum
Blood group antibody screen [Presence] in Serum or Plasma by GEL
Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS)
Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method
Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS
Nigrospora sphaerica IgE Ab [Units/volume] in Serum
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS
Leucine/Phenylalanine [Molar ratio] in DBS
Bacteria identified in Genital specimen by Anaerobe+Aerobe culture
Promethazine [Presence] in Serum or Plasma or Urine by Screen method
Other cells/100 cells in Lymph node by Manual count
Black Oak IgE Ab [Units/volume] in Serum
California Black Oak IgE Ab [Units/volume] in Serum
Fetal blood [Volume] in Blood by Flow cytometry (FC)
Gamble Oak IgE Ab [Units/volume] in Serum
Jerusalem oak IgE Ab [Units/volume] in Serum
California Live Oak IgE Ab [Units/volume] in Serum
Interior Live Oak IgE Ab [Units/volume] in Serum
Neutrophils [#/volume] in Blood by Manual count
Promethazine [Mass/volume] in Blood by Confirmatory method
Tapentadol [Mass/volume] in Serum, Plasma or Blood
Other cells [#/volume] in Peritoneal fluid by Manual count
Other cells/100 leukocytes in Peritoneal fluid by Manual count
Other cells [#/volume] in Synovial fluid by Manual count
Other cells/100 leukocytes in Pericardial fluid by Manual count
Other cells/100 leukocytes in Body fluid by Manual count
Other cells [#/volume] in Pleural fluid by Manual count
Other cells/100 leukocytes in Synovial fluid by Manual count
Other cells/100 leukocytes in Pleural fluid by Manual count
Bacteria identified in Abscess by Anaerobe+Aerobe culture
Valley Oak IgE Ab [Units/volume] in Serum
Bacteria identified in Bone by Anaerobe+Aerobe culture
Bacteria identified in Bone marrow by Anaerobe+Aerobe culture
Tapentadol glucuronide [Mass/volume] in Urine by Screen method
Creatinine [Moles/volume] in Vitreous fluid
First and Second trimester integrated maternal screen [Interpretation] Narrative
White Oak IgG Ab [Units/volume] in Serum
Lactate [Moles/volume] in Capillary blood from Fetus by Test strip
Buprenorphine [Mass/mass] in Meconium by Confirmatory method
Buprenorphine [Mass/volume] in Serum, Plasma or Blood
Diuretics [Interpretation] in Urine Qualitative by Screen method
Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood
Bartlett score of Sputum Qualitative by Light microscopy
Hexane [Mass/volume] in Serum or Plasma by Screen method
Erythrocytes.fetal/2000 erythrocytes in Blood by Kleihauer-Betke method
White Oak triggered histamine release [Units/volume] in Blood
Other cells/100 leukocytes in Cerebral spinal fluid by Manual count
Other cells/100 leukocytes in Sputum by Manual count
Siderocytes per HPF [Presence] in Blood by Light microscopy
Dengue virus NS1 Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Hepatitis B virus core Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method
SERPING1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
TTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
ATP7B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
DMD gene deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by MLPA
PMP22 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
MEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
INS gene full mutation analysis in Blood or Tissue by Sequencing
CDKN1B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
CDKN1B gene full mutation analysis in Blood or Tissue by Sequencing
Oat triggered histamine release [Units/volume] in Blood
APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
FGFR3 gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
FXN gene GAA repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method
HTT gene CAG repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method
Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method Narrative
AIP gene full mutation analysis in Blood or Tissue by Sequencing
AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
HNF1A gene full mutation analysis in Blood or Tissue by Sequencing
HNF1B gene full mutation analysis in Blood or Tissue by Sequencing
HNF4A gene full mutation analysis in Blood or Tissue by Sequencing
KCNJ11 gene full mutation analysis in Blood or Tissue by Sequencing
GCDH gene full mutation analysis in Blood or Tissue by Sequencing
GCDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PDHA1 gene full mutation analysis in Blood or Tissue by Sequencing
West Nile virus Ab [Presence] in Serum by Hemagglutination inhibition
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose triple bolus
Hepatitis B virus e Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Hepatitis B virus e Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection
Neutrophils [#/volume] in Cerebral spinal fluid by Automated count
Wild Oats IgE Ab [Units/volume] in Serum
Oidiodendrum spp IgE Ab [Units/volume] in Serum
Onion triggered histamine release [Units/volume] in Blood
aPTT.lupus sensitive W excess phospholipid (LA confirm)
Orange triggered histamine release [Units/volume] in Blood
aPTT.lupus sensitive W excess phospholipid percent correction
aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm)
aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix)
aPTT.lupus sensitive with 1:1 PNP (LA mix)
dRVVT W excess phospholipid percent correction
dRVVT with 1:1 PNP actual/normal (normalized LA mix)
Lupus anticoagulant two screening tests W Reflex [interpretation]
Orange Tree IgE Ab [Units/volume] in Serum
Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
Cortisol Free [Moles/volume] in 24 hour Urine
Protein.monoclonal band 4 [Mass/time] in 24 hour Urine by Electrophoresis
Bacteria identified in Cerebral spinal fluid by Latex agglutination
Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection
Parvovirus B19 DNA [log units/volume] (viral load) in Plasma from Donor by NAA with probe detection
Hepatitis A virus RNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection
Parvovirus B19 DNA [Presence] in Plasma from Donor by NAA with probe detection
Noninvasive prenatal testing overall interpretation Qualitative
Noninvasive prenatal testing comment [Text]
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Oregano triggered histamine release [Units/volume] in Blood
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Orris root IgE Ab [Units/volume] in Serum
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Ovalbumin IgE Ab [Units/volume] in Serum
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Monosomy X prior risk [Likelihood] Based on maternal age
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Ovomucoid IgE Ab [Units/volume] in Serum
Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Neutrophils [#/volume] in Cerebral spinal fluid by Manual count
Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 5p deletion prior risk [Likelihood] based on general population risk
Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative
Comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Oyster triggered histamine release [Units/volume] in Blood
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative
Citation [Bibliographic Citation] in Referral lab test Narrative
Vascular adhesion protein 1 [Mass/volume] in Serum or Plasma
Vascular endothelial growth factor A [Mass/volume] in Serum or Plasma
Tumor necrosis factor receptor superfamily member 1A [Mass/volume] in Serum or Plasma
Interstitial collagenase [Mass/volume] in Serum or Plasma
Stromelysin-1 [Mass/volume] in Serum or Plasma
Resistin [Mass/volume] in Serum or Plasma
Rheumatoid arthritis disease activity score Calculated by VectraDA
Rheumatoid arthritis disease activity score level Qualitative by VectraDA
Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA
Glucose [Moles/volume] in Serum or Plasma --45 minutes post 50 g lactose PO
Homocarnosine [Moles/volume] in Cerebral spinal fluid
Lactate dehydrogenase in body fluid/Lactate dehydrogenase in serum
Lysozyme [Moles/volume] in 24 hour Urine
Electrolytes 3 panel - Cerebral spinal fluid
Urate/Creatinine [Molar ratio] in 24 hour Urine
7-Hydroxymitragynine [Presence] in Urine by Confirmatory method
Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method
Butabarbital [Mass/volume] in Blood by Confirmatory method
Ethylene glycol [Presence] in Gastric fluid
Parakeet droppings IgE Ab [Units/volume] in Serum
Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood
Mitragynine+7-Hydroxymitragynine [Presence] in Urine by Confirmatory method
Sulfonamide [Moles/volume] in Serum or Plasma
Tetrahydrocannabivarin [Mass/volume] in Urine
Immature lymphocytes [Presence] in Blood
Manual differential comment [Interpretation] in Body fluid Narrative
Manual differential comment [Interpretation] in Cerebral spinal fluid Narrative
Parakeet feather IgE Ab [Units/volume] in Serum
Mononuclear cells [#] in Cerebral spinal fluid by Manual count
Mononuclear cells [#] in Pericardial fluid by Manual count
Mononuclear cells [#] in Pleural fluid by Manual count
Plasma cells/100 leukocytes in Bronchial specimen
Polymorphonuclear cells [#] in Pericardial fluid by Manual count
Polymorphonuclear cells [#] in Peritoneal fluid by Manual count
Polymorphonuclear cells [#] in Pleural fluid by Manual count
Polymorphonuclear cells [#] in Synovial fluid by Manual count
Parakeet serum IgE Ab [Units/volume] in Serum
Human papilloma virus 16 DNA [Presence] in Anorectal specimen by Probe and signal amplification method
Ova and parasites identified in Urine by Trichrome stain
HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay
Fetal sex [Likelihood] in Plasma cell-free DNA by Dosage of chromosome specifi cell free (cf) DNA
Neutrophils [#/volume] in Pleural fluid by Automated count
Parrot serum IgE Ab [Units/volume] in Serum
Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA
Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Anorectal specimen by Probe and signal amplification method
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal specimen by Probe and signal amplification method
Bilirubin fractions panel [Moles/volume] - Serum or Plasma
Bruton tyrosine kinase [Interpretation] in B cells+monocytes by Flow cytometry (FC) Narrative
Calcitonin [Mass/volume] in Lymph node fine needle aspirate
Coccidioides immitis+posadasii IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Microscopic description [Description] in Endomyocardium Narrative
Black-eye pea IgE Ab [Units/volume] in Serum
CYP1A2 gene c.125C>G [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.-2467delT [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.2473G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.2499A>T [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.3497G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.3533G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.-3860G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.5090C>T [Presence] in Blood or Tissue by Molecular genetics method
Black-eye pea IgG Ab [Units/volume] in Serum
CYP1A2 gene c.5166G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.-163C>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.2385G>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.558C>A [Presence] in Blood or Tissue by Molecular genetics method
CYP1A2 gene c.-729C>T [Presence] in Blood or Tissue by Molecular genetics method
HTR2A gene c.-1438G>A [Presence] in Blood or Tissue by Molecular genetics method
HTR2A gene c.IVS2+54538A>G [Presence] in Blood or Tissue by Molecular genetics method
HTR2A gene c.74C>A [Presence] in Blood or Tissue by Molecular genetics method
HTR2A gene c.1354C>T [Presence] in Blood or Tissue by Molecular genetics method
HTR2C gene c.796G>C [Presence] in Blood or Tissue by Molecular genetics method
HTR2A gene c.102T>C [Presence] in Blood or Tissue by Molecular genetics method
HTR2C gene c.-759C>T [Presence] in Blood or Tissue by Molecular genetics method
AXIN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
AXIN2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
BMPR1A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Lysophosphatidylcholine(16:0) [Moles/volume] in Plasma
Lysophosphatidylcholine(18:0) [Moles/volume] in Plasma
Campesterol [Mass/volume] in Serum or Plasma
Chick Pea IgE Ab [Units/volume] in Serum
Desmosterol [Mass/volume] in Serum or Plasma
Lathosterol [Mass/volume] in Serum or Plasma
Beta sitosterol [Mass/volume] in Serum or Plasma
Pea triggered histamine release [Units/volume] in Blood
Neutrophils [#/volume] in Pleural fluid by Manual count
Vancomycin resistance vanD gene [Presence] by Molecular method
Streptobacillus moniliformis DNA [Presence] in Specimen by NAA with probe detection
Methicillin susceptible Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection
Bacteria identified in Isolate by MS.MALDI-TOF
Chlamydia sp Ab [Presence] in Serum by Complement fixation
Brompheniramine [Presence] in Serum or Plasma or Urine by Screen method
Chlorpheniramine [Presence] in Serum or Plasma or Urine by Screen method
Haloperidol [Presence] in Blood or Urine by Screen method
Doxylamine [Presence] in Serum or Plasma or Urine by Screen method
Peach triggered histamine release [Units/volume] in Blood
Methapyrilene [Presence] in Serum or Plasma or Urine by Screen method
Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method
Tripelennamine [Presence] in Serum or Plasma or Urine by Screen method
Triprolidine [Presence] in Serum or Plasma or Urine by Screen method
fluPHENAZine [Presence] in Blood or Urine by Screen method
Mesoridazine [Presence] in Blood or Urine by Screen method
Prochlorperazine [Presence] in Blood or Urine by Screen method
Promazine [Presence] in Blood or Urine by Screen method
Peanut triggered histamine release [Units/volume] in Blood
Thioridazine [Presence] in Blood or Urine by Screen method
Trifluoperazine [Presence] in Blood or Urine by Screen method
Pear Pollen IgE Ab [Units/volume] in Serum
Pecan or Hickory Nut IgG Ab [Units/volume] in Serum
Antipsychotics [Interpretation] in Blood or Urine Qualitative by Screen method
Antihistamines [Interpretation] in Serum or Plasma or Urine Qualitative by Screen method
Promethazine [Presence] in Blood or Urine by Screen method
Antihistamines panel - Serum or Plasma or Urine by Screen method
Antipsychotics drug panel - Blood or Urine by Screen method
Erythrocyte chromasia [Identifier] in Blood by Light microscopy
Neutrophils [#/volume] in Peritoneal fluid by Automated count
Penicillium sp IgG Ab [Units/volume] in Serum
Penicillium notatum IgG Ab [Units/volume] in Serum
Penicillium notatum triggered histamine release [Units/volume] in Blood
Sterols panel [Mass/volume] - Serum or Plasma
Hepatitis A virus RNA and Parvovirus B19 DNA panel - Plasma from Donor by NAA with probe detection
Bell Pepper IgE Ab [Units/volume] in Serum
Bell Pepper IgG Ab [Units/volume] in Serum
14-3-3 eta Ag [Mass/volume] in Serum by Immunoassay
Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex
Lupus anticoagulant three screening tests W Reflex [interpretation]
dRVVT W excess hexagonal phospholipid (STA-StaClot confirm)
aPTT.lupus sensitive/aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio)
HCV antibody screening - Meaningful Use set
Black Pepper IgG Ab [Units/volume] in Serum
HCV antibody RIBA tests - Meaningful Use set by Immunoblot
HCV RNA screening tests - Meaningful Use set
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Black Pepper triggered histamine release [Units/volume] in Blood
Neutrophils [#/volume] in Peritoneal fluid by Manual count
Chili Pepper IgE Ab [Units/volume] in Serum
dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm)
aPTT W hexagonal phospholipid/Normal (StaClot LA confirm)
Hemoglobin [Moles/volume] in Arterial blood
Chili Pepper IgG Ab [Units/volume] in Serum
Chili Pepper triggered histamine release [Units/volume] in Blood
Green Pepper IgG Ab [Units/volume] in Serum
Red Pepper triggered histamine release [Units/volume] in Blood
White Pepper IgE Ab [Units/volume] in Serum
KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Chromosome 21 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Fetal Chromosome X and Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
White Pepper IgG Ab [Units/volume] in Serum
Fetal Chromosome 18 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Fetal Chromosome 13 trisomy [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
Phadiatop IgE Ab [Units/volume] in Serum
ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC)
Phospholipase IgE Ab [Units/volume] in Serum
Phthalic anhydride IgE Ab [Units/volume] in Serum
Delta dRVVT [Time] in Platelet poor plasma by Coagulation assay
Delta aPTT [Time] in Platelet poor plasma by Coagulation assay
8(9)-Cholestenol [Moles/volume] in Serum or Plasma
N-acetyl-L-aspartate/Creatinine [Molar ratio] in Urine
Sialate/Creatinine [Molar ratio] in Urine
Arylsulfatase C [Enzymatic activity/mass] in Fibroblast
Pickleweed IgE Ab [Units/volume] in Serum
Phosphomannomutase 2 [Enzymatic activity/mass] in Fibroblast
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Fibroblast
IDUA gene full mutation analysis in Blood or Tissue by Sequencing
HEXB gene full mutation analysis in Blood or Tissue by Sequencing
IDS gene full mutation analysis in Blood or Tissue by Sequencing
NPC1 gene full mutation analysis in Blood or Tissue by Sequencing
SGSH gene full mutation analysis in Blood or Tissue by Sequencing
HEXA gene full mutation analysis in Blood or Tissue by Sequencing
Pigeon droppings IgG Ab [Units/volume] in Serum
GAA gene full mutation analysis in Blood or Tissue by Sequencing
ARSA gene full mutation analysis in Blood or Tissue by Sequencing
GLA gene full mutation analysis in Blood or Tissue by Sequencing
GALT gene full mutation analysis in Blood or Tissue by Sequencing
Tripeptidyl peptidase I [Enzymatic activity/mass] in Leukocytes
Interleukin 2 Receptor Soluble [Mass/volume] in Serum or Plasma
levoFLOXacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
levoFLOXacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Common Pigweed IgE Ab [Units/volume] in Serum
levoFLOXacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Rheumatoid arthritis disease activity score confidence interval by VectraDA
6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH
Pigweed triggered histamine release [Units/volume] in Blood
MBL2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Erythrocytes.hypochromic/100 erythrocytes in Blood by Automated count
Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection
Aspergillus sp DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Enterovirus D68 RNA [Presence] in Specimen by NAA with probe detection
Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection
Galactomannan Ag [Units/volume] in Bronchoalveolar lavage
Haemophilus ducreyi DNA [Presence] in Genital specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
Microscopic observation [Identifier] in Bronchoalveolar lavage by Methenamine silver nitrate stain
Loblolly Pine IgE Ab [Units/volume] in Serum
Microscopic observation [Presence] in Bronchoalveolar lavage by Acid fast stain.Ziehl-Neelsen
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection
Neutrophils [#/volume] in Synovial fluid by Manual count
Erythrocytes.hyperchromic/100 erythrocytes in Blood by Automated count
Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detection
Pondorosa Pine IgE Ab [Units/volume] in Serum
Western White Pine IgE Ab [Units/volume] in Serum
Pineapple IgG Ab [Units/volume] in Serum
Sucrose/Creatinine [Molar ratio] in Urine
Pistachio IgE Ab [Units/volume] in Serum
Sugar absorption test panel [Molar ratio] - 5 hour Urine
Sucrose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO
Inositol Free/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO
Lactulose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO
Platelet component distribution width [Mass/volume] in Blood by calculation
Reticulocyte distribution width [Ratio] in Blood by calculation
Reticulocyte hemoglobin distribution width [Mass/volume] in Blood by calculation
Reticulocytes.hypochromic/100 erythrocytes in Blood by Automated count
Pitosporium triggered histamine release [Units/volume] in Blood
Reticulocyte corpuscular hemoglobin concentration mean [Mass/volume] in Blood
Immature lymphocytes [Presence] in Blood by Manual count
Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC)
Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC)
Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC)
English plantain triggered histamine release [Units/volume] in Blood
Neutrophils [#/volume] in Urine by Automated count
Plum Pollen IgE Ab [Units/volume] in Serum
Poison ivy IgE Ab [Units/volume] in Serum
White Poplar triggered histamine release [Units/volume] in Blood
Poppy Seed IgE Ab [Units/volume] in Serum
Pork triggered histamine release [Units/volume] in Blood
Neutrophils [#/volume] in Urine by Manual count
Potato triggered histamine release [Units/volume] in Blood
Sweet potato IgE Ab [Units/volume] in Serum
Sweet potato IgG Ab [Units/volume] in Serum
Sweet potato triggered histamine release [Units/volume] in Blood
Povertyweed IgE Ab [Units/volume] in Serum
Band form neutrophils [#/volume] in Blood by Manual count
Porcine epidemic diarrhea virus RNA [Presence] in Specimen by NAA with probe detection
Porcine deltacoronavirus RNA [Presence] in Specimen by NAA with probe detection
Porcine deltacoronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Microorganism identified in Isolate by MS.MALDI-TOF
Dehydroepiandrosterone sulfate (DHEA-S)/Cortisol [Molar ratio] in Serum or Plasma
Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
clonazePAM [Mass/mass] in Meconium by Confirmatory method
Other cells/100 leukocytes in Body fluid
Methotrexate polyglutamates [Moles/volume] in Red Blood Cells
Testosterone/Cortisol [Molar ratio] in Serum or Plasma
Psyllium seed IgE Ab [Units/volume] in Serum
Pullularia sp IgE Ab [Units/volume] in Serum
Pullularia sp IgG Ab [Units/volume] in Serum
Pyrethrum IgE Ab [Units/volume] in Serum
Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Albumin/Creatinine [Ratio] in 24 hour Urine
Myelocytes [#] in Body fluid by Manual count
Blasts [#] in Body fluid by Manual count
Promyelocytes [#] in Body fluid by Manual count
Metamyelocytes [#] in Body fluid by Manual count
Pyrethrum triggered histamine release [Units/volume] in Blood
Basophils [#] in Body fluid by Manual count
Eosinophils [#] in Body fluid by Manual count
Monocytes+Macrophages [#] in Body fluid by Manual count
Lymphocytes [#] in Body fluid by Manual count
Band form neutrophils/100 leukocytes in Blood by Manual count
Band form neutrophils [#] in Body fluid by Manual count
Neutrophils [#] in Body fluid by Manual count
Sheep prion protein codon 141 [Type] in Blood by Genotype method
Sheep prion protein codon 112 [Type] in Blood by Genotype method
Rabbit Bush IgE Ab [Units/volume] in Serum
Sheep prion protein codon 136 [Type] in Blood by Genotype method
Sheep prion protein codon 154 [Type] in Blood by Genotype method
Sheep prion protein codon 171 [Type] in Blood by Genotype method
Rabbit meat IgE Ab [Units/volume] in Serum
Canyon Ragweed IgE Ab [Units/volume] in Serum
Common Ragweed IgG Ab [Units/volume] in Serum
Desert Ragweed IgE Ab [Units/volume] in Serum
Ghrelin [Mass/volume] in Serum or Plasma
Cortisone free [Moles/volume] in Serum or Plasma
Acetylcholinesterase panel - Amniotic fluid
Acetylcholinesterase [Interpretation] in Amniotic fluid Narrative
Albumin [Moles/volume] in Cerebral spinal fluid
Alpha 1 antitrypsin [Moles/volume] in Serum or Plasma
Apolipoprotein B [Moles/volume] in Serum or Plasma
Apolipoprotein A-I [Moles/volume] in Serum or Plasma
Beta-2-Microglobulin [Moles/volume] in Serum or Plasma
C reactive protein [Moles/volume] in Serum or Plasma
C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method
IgE [Mass/volume] in Serum or Plasma by Immunoassay
False ragweed triggered histamine release [Units/volume] in Blood
IgG [Moles/volume] in Cerebral spinal fluid
Amphetamine+Methamphetamine [Presence] in Urine by Screen method
Nitrazepam [Moles/volume] in Gastric fluid
Tacrolimus [Moles/volume] in Blood by Immunoassay
Complement C4 [Moles/volume] in Serum or Plasma
Giant Ragweed triggered histamine release [Units/volume] in Blood
Polymorphonuclear cells [#] in Cerebral spinal fluid by Manual count
Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells by Flow cytometry (FC)
Common Ragweed triggered histamine release [Units/volume] in Blood
Short+Giant Ragweed IgG Ab [Units/volume] in Serum
Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna
Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna
Breast cancer 10-year risk of distant recurrence panel by Prosigna
Slender Ragweed IgE Ab [Units/volume] in Serum
Southern Ragweed IgE Ab [Units/volume] in Serum
Raspberry IgE Ab [Units/volume] in Serum
Raspberry IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae nanA gene [Presence] in Swab specimen by NAA with probe detection
Moraxella catarrhalis g1b gene [Presence] in Swab specimen by NAA with probe detection
Haemophilus influenzae lex2 gene [Presence] in Swab specimen by NAA with probe detection
Bacterial 16S rRNA [Presence] in Specimen by NAA with probe detection
Serratia marcescens gyrB gene [Presence] in Swab specimen by NAA with probe detection
Staphylococcus aureus sau3AI gene [Presence] in Swab specimen by NAA with probe detection
Pseudomonas aeruginosa regA gene [Presence] in Swab specimen by NAA with probe detection
Enterococcus faecium sodA gene [Presence] in Swab specimen by NAA with probe detection
Neutrophils.hypersegmented [Presence] in Blood by Light microscopy
Candida albicans its gene [Presence] in Swab specimen by NAA with probe detection
Streptococcus pyogenes csrS gene [Presence] in Swab specimen by NAA with probe detection
Streptococcus agalactiae cfb gene [Presence] in Swab specimen by NAA with probe detection
Klebsiella pneumoniae phoE gene [Presence] in Swab specimen by NAA with probe detection
Enterococcus faecalis cpn60 gene [Presence] in Swab specimen by NAA with probe detection
Wound microorganism gene identification panel by NAA with probe detection
ENT microorganism gene identification panel by NAA with probe detection
Streptococcus pneumoniae nanA gene [#/mass] in XXX.tissue by NAA with probe detection
Raspberry triggered histamine release [Units/volume] in Blood
Moraxella catarrhalis g1b gene [#/mass] in XXX.tissue by NAA with probe detection
Haemophilus influenzae lex2 gene [#/mass] in XXX.tissue by NAA with probe detection
Bacterial 16S rRNA [#/mass] in XXX.tissue by NAA with probe detection
Serratia marcescens gyrB gene [#/mass] in XXX.tissue by NAA with probe detection
Staphylococcus aureus sau3AI gene [#/mass] in XXX.tissue by NAA with probe detection
Pseudomonas aeruginosa regA gene [#/mass] in XXX.tissue by NAA with probe detection
Enterococcus faecium sodA gene [#/mass] in XXX.tissue by NAA with probe detection
Candida albicans its gene [#/mass] in XXX.tissue by NAA with probe detection
Streptococcus pyogenes csrS gene [#/mass] in XXX.tissue by NAA with probe detection
Streptococcus agalactiae cfb gene [#/mass] in XXX.tissue by NAA with probe detection
Klebsiella pneumoniae phoE gene [#/mass] in XXX.tissue by NAA with probe detection
Enterococcus faecalis cpn60 gene [#/mass] in XXX.tissue by NAA with probe detection
Streptococcus pneumoniae nanA gene [#/volume] in XXX.body fluid by NAA with probe detection
Moraxella catarrhalis g1b gene [#/volume] in XXX.body fluid by NAA with probe detection
Haemophilus influenzae lex2 gene [#/volume] in XXX.body fluid by NAA with probe detection
Bacterial 16S rRNA [#/volume] in XXX.body fluid by NAA with probe detection
Rat muliialgro IgE Ab [Units/volume] in Serum
Serratia marcescens gyrB gene [#/volume] in XXX.body fluid by NAA with probe detection
Staphylococcus aureus sau3AI gene [#/volume] in XXX.body fluid by NAA with probe detection
Pseudomonas aeruginosa regA gene [#/volume] in XXX.body fluid by NAA with probe detection
Enterococcus faecium sodA gene [#/volume] in XXX.body fluid by NAA with probe detection
Candida albicans its gene [#/volume] in XXX.body fluid by NAA with probe detection
Streptococcus pyogenes csrS gene [#/volume] in XXX.body fluid by NAA with probe detection
Streptococcus agalactiae cfb gene [#/volume] in XXX.body fluid by NAA with probe detection
Klebsiella pneumoniae phoE gene [#/volume] in XXX.body fluid by NAA with probe detection
Red Snapper IgE Ab [Units/volume] in Serum
Enterococcus faecalis cpn60 gene [#/volume] in XXX.body fluid by NAA with probe detection
Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total in Serum or Plasma
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-pyruvate substrate
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2-14C-pyruvate substrate
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-glutamate substrate
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2,3-14C-succinate substrate
Red Snapper IgG Ab [Units/volume] in Serum
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-leucine substrate
Lysosomal acid lipase panel - Fibroblast
Lysosomal acid lipase [Interpretation] in Fibroblast Narrative
Mitochondrial respiratory chain enzyme analysis panel - Fibroblast
Mitochondrial respiratory chain enzyme analysis [Interpretation] in Fibroblast Narrative
Alanine aminotransferase [Enzymatic activity/volume] in Blood
Measles virus [Presence] in Specimen by Organism specific culture
Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria
Norovirus genogroup I and II RNA [Identifier] in Stool by NAA with probe detection
Amylase [Enzymatic activity/volume] in Blood
Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method
Enterovirus sp [Presence] in Isolate by Immunofluorescence
Redwood Dust IgE Ab [Units/volume] in Serum
Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay
Rhodotorula spp IgE Ab [Units/volume] in Serum
Antipsychotics drug panel - Urine by Screen method
Neutrophils.hypersegmented [#/volume] in Blood by Manual count
Phosphatidylethanol [Presence] in Blood by Screen method
Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma
Protein [Mass/volume] in Cerebral spinal fluid --1st tube
Protein [Mass/volume] in Cerebral spinal fluid --2nd tube
Protein [Mass/volume] in Cerebral spinal fluid --3rd tube
Protein [Mass/volume] in Cerebral spinal fluid --4th tube
Glucose [Moles/volume] in Cerebral spinal fluid --1st tube
Glucose [Moles/volume] in Cerebral spinal fluid --2nd tube
Glucose [Moles/volume] in Cerebral spinal fluid --3rd tube
Glucose [Moles/volume] in Cerebral spinal fluid --4th tube
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --1st tube
Leukocytes [#/volume] in Cerebral spinal fluid --1st tube
Appearance of Cerebral spinal fluid--1st tube
Appearance of Cerebral spinal fluid--2nd tube
Appearance of Cerebral spinal fluid--3rd tube
Appearance of Cerebral spinal fluid--4th tube
Color of Cerebral spinal fluid--1st tube
Color of Cerebral spinal fluid--2nd tube
Color of Cerebral spinal fluid--3rd tube
Color of Cerebral spinal fluid--4th tube
Mean platelet component [Mass/volume] in Blood by calculation
Mean platelet dry mass [Entitic mass] in Blood by calculation
Platelet dry mass distribution width [Entitic mass] in Blood by calculation
Reticulocyte cellular hemoglobin distribution width [Entitic mass] in Blood by calculation
Mycobacterium sp identified in Bronchoalveolar lavage by Organism specific culture
Alpha-1-acid glycoprotein/Creatinine [Mass Ratio] in Urine
Fungus identified [#/volume] in Mouth by Culture
Bacteria identified in Blood product unit.autologous by Culture
Rice triggered histamine release [Units/volume] in Blood
Filaria identified in Skin by Light microscopy
Brazilian Rubber Tree IgE Ab [Units/volume] in Serum
Trichomonas vaginalis [Presence] in Specimen by Gram stain
Wheat Stem Rust IgE Ab [Units/volume] in Serum
Rye triggered histamine release [Units/volume] in Blood
Neutrophils.hypersegmented/100 leukocytes in Blood by Manual count
Safflower IgE Ab [Units/volume] in Serum
Phosphatidylcholine.saturated [Moles/volume] in Amniotic fluid
Treponema pallidum polA gene [Presence] in Genital specimen by NAA with probe detection
Schistosoma sp identified in Semen by Light microscopy
Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry
Hemoglobin [Mass/volume] in Venous blood by Oximetry
Respiratory pathogens RNA 8 panel - Specimen by NAA with probe detection
Plasmodium falciparum Ag [Presence] in Blood by Rapid immunoassay
Heptacarboxylporphyrin [Moles/volume] in Serum or Plasma
Safflower IgG Ab [Units/volume] in Serum
Common Sagebrush IgE Ab [Units/volume] in Serum
Segmented neutrophils [#/volume] in Blood by Manual count
Common Sagebrush IgG Ab [Units/volume] in Serum
California Sagebrush IgE Ab [Units/volume] in Serum
Annual Saltbush IgE Ab [Units/volume] in Serum
Segmented neutrophils/100 leukocytes in Blood by Manual count
Schistosoma sp IgE Ab [Units/volume] in Serum
Scotch broom IgE Ab [Units/volume] in Serum
Sesame Seed IgG Ab [Units/volume] in Serum
Sesame Seed triggered histamine release [Units/volume] in Blood
Sheep epithelium triggered histamine release [Units/volume] in Blood
Sheep Sorrel triggered histamine release [Units/volume] in Blood
Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection
Porphyrin fractions panel [Moles/volume] - Serum or Plasma
Urea [Molar ratio] in Serum or Plasma --post dialysis/pre dialysis
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Fetal Chromosome 13 trisomy [Presence] based on Plasma cell-free DNA by Sequencing
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Shrimp triggered histamine release [Units/volume] in Blood
Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF
CFTR gene mutation analysis [interpretation] in Blood or Tissue Qualitative by MS.MALDI
Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
Fetal Y chromosome [Interpretation] based on Plasma cell-free DNA by Sequencing
Fetal Y chromosome [Presence] based on Plasma cell-free DNA by Sequencing
Respiratory syncytial virus A RNA [Presence] in Nasopharynx by NAA with probe detection
Respiratory syncytial virus B RNA [Presence] in Nasopharynx by NAA with probe detection
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with probe detection
Rhinovirus RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection
Respiratory pathogens DNA and RNA 14 panel - Nasopharynx by NAA with probe detection
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH
Corn smut IgE Ab [Units/volume] in Serum
t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH
t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH
t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH
Bermuda grass smut IgE Ab [Units/volume] in Serum
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH
inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH
t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH
ACAD8 gene full mutation analysis in Blood or Tissue by Sequencing
ACAD8 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
ACADSB gene full mutation analysis in Blood or Tissue by Sequencing
ACADSB gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
ACSF3 gene full mutation analysis in Blood or Tissue by Sequencing
ACSF3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
SUGCT gene full mutation analysis in Blood or Tissue by Sequencing
SUGCT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
IFITM5 gene full mutation analysis in Blood or Tissue by Sequencing
IFITM5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MTR gene full mutation analysis in Blood or Tissue by Sequencing
MTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
CYP11B1 gene full mutation analysis in Blood or Tissue by Sequencing
CYP11B1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Johnson grass smut IgE Ab [Units/volume] in Serum
CYP17A1 gene full mutation analysis in Blood or Tissue by Sequencing
CYP17A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
GNMT gene full mutation analysis in Blood or Tissue by Sequencing
GNMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
HPD gene full mutation analysis in Blood or Tissue by Sequencing
HPD gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
TAT gene full mutation analysis in Blood or Tissue by Sequencing
TAT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Johnson grass smut IgG Ab [Units/volume] in Serum
AHCY gene full mutation analysis in Blood or Tissue by Sequencing
AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
AGA gene full mutation analysis in Blood or Tissue by Sequencing
AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PLOD2 gene full mutation analysis in Blood or Tissue by Sequencing
PLOD2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
ATP5A1 gene full mutation analysis in Blood or Tissue by Sequencing
ATP5A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
C12orf65 gene full mutation analysis in Blood or Tissue by Sequencing
C12orf65 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRPL40 gene full mutation analysis in Blood or Tissue by Sequencing
MRPL40 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MTFMT gene full mutation analysis in Blood or Tissue by Sequencing
MTFMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Neutrophils/100 leukocytes in Blood by Automated count
SERPINF1 gene full mutation analysis in Blood or Tissue by Sequencing
Wheat smut IgE Ab [Units/volume] in Serum
SERPINF1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
FARS2 gene full mutation analysis in Blood or Tissue by Sequencing
FARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
ALPL gene full mutation analysis in Blood or Tissue by Sequencing
ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
TYROBP gene full mutation analysis in Blood or Tissue by Sequencing
TYROBP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
GFM1 gene full mutation analysis in Blood or Tissue by Sequencing
GFM1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
TFB1M gene full mutation analysis in Blood or Tissue by Sequencing
TFB1M gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRRF gene full mutation analysis in Blood or Tissue by Sequencing
MRRF gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRPS2 gene full mutation analysis in Blood or Tissue by Sequencing
MRPS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRPS22 gene full mutation analysis in Blood or Tissue by Sequencing
MRPS22 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRPL44 gene full mutation analysis in Blood or Tissue by Sequencing
MRPL44 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing
MRPL18A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
NARS2 gene full mutation analysis in Blood or Tissue by Sequencing
NARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
HARS2 gene full mutation analysis in Blood or Tissue by Sequencing
HARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
SARS2 gene full mutation analysis in Blood or Tissue by Sequencing
SARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
AARS2 gene full mutation analysis in Blood or Tissue by Sequencing
AARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
KARS gene full mutation analysis in Blood or Tissue by Sequencing
KARS gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PLOD3 gene full mutation analysis in Blood or Tissue by Sequencing
PLOD3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
FBN1 gene full mutation analysis in Blood or Tissue by Sequencing
FKBP10 gene full mutation analysis in Blood or Tissue by Sequencing
FKBP10 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
RPGRIP1 gene full mutation analysis in Blood or Tissue by Sequencing
RPGRIP1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
RPGR gene full mutation analysis in Blood or Tissue by Sequencing
RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
DFNB31 gene full mutation analysis in Blood or Tissue by Sequencing
DFNB31 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Spondylocladium atrovirens IgE Ab [Units/volume] in Serum
GPR98 gene full mutation analysis in Blood or Tissue by Sequencing
GPR98 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PCDH15 gene full mutation analysis in Blood or Tissue by Sequencing
PCDH15 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
USH1C gene full mutation analysis in Blood or Tissue by Sequencing
USH1C gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
CERKL gene full mutation analysis in Blood or Tissue by Sequencing
CERKL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
CDHR1 gene full mutation analysis in Blood or Tissue by Sequencing
CDHR1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
LCA5 gene full mutation analysis in Blood or Tissue by Sequencing
LCA5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Glucose [Moles/volume] in Serum, Plasma or Blood
Urea [Moles/volume] in Serum, Plasma or Blood
Bilirubin.total [Moles/volume] in Serum, Plasma or Blood
Chloride [Moles/volume] in Serum, Plasma or Blood
Sodium [Moles/volume] in Serum, Plasma or Blood
Creatinine [Moles/volume] in Serum, Plasma or Blood
Alkaline phosphatase [Enzymatic activity/volume] in Serum, Plasma or Blood
Potassium [Moles/volume] in Serum, Plasma or Blood
Carbon dioxide, total [Moles/volume] in Serum, Plasma or Blood
Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood
Fasting glucose [Moles/volume] in Serum, Plasma or Blood
Amylase [Enzymatic activity/volume] in Serum, Plasma or Blood
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method
Summer Squash IgE Ab [Units/volume] in Serum
Energy content [Energy/mass] in 24 hour Stool.dried
Summer Squash IgG Ab [Units/volume] in Serum
Microalbumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L
Erythrocytes.ghost cells [Presence] in Blood by Light microscopy
Nucleated erythrocytes [#/volume] in Blood by Automated count
Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma
Anidulafungin [Susceptibility] by Gradient strip
Alpha-1-Microglobulin [Moles/volume] in Urine
Yellow Squash IgE Ab [Units/volume] in Serum
Karyotype [Identifier] in Products of Conception Nominal
Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG panel [Titer] - Serum
Chlamydia sp IgG and IgM panel [Titer] - Serum by Immunofluorescence
cycloSPORINE [Mass/volume] in Blood --3 hours post dose
cycloSPORINE [Mass/volume] in Blood --4 hours post dose
cycloSPORINE [Mass/volume] in Blood --1 hour post dose
PDGFRA gene p.Asp842Val [Presence] in Blood or Tissue by Molecular genetics method
KIT gene exon 11 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Yellow Squash IgG Ab [Units/volume] in Serum
KIT gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain
CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Coxiella burnetii phase 1 and 2 IgG and IgM panel - Serum
Hepatitis B virus little e Ag and Ab panel - Serum
Niobium/Creatinine [Molar ratio] in Urine
Zirconium/Creatinine [Molar ratio] in Urine
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
Prealbumin [Moles/volume] in Serum or Plasma
Bacteria identified in Uterus by Culture
Staphylococcus aureus IgE Ab [Units/volume] in Serum
SI gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
Laboratory comment [Text] in Report Narrative
Smut fungi (Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici) IgE Ab [Units/volume] in Serum
Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
Buprenorphine [Presence] in Meconium by Screen method
Stemphylium solani IgE Ab [Units/volume] in Serum
Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
Naloxone [Mass/volume] in Urine by Confirmatory method
Salivary gland protein 1 IgA Ab [Units/volume] in Serum by Immunoassay
Salivary gland protein 1 IgM Ab [Units/volume] in Serum by Immunoassay
Salivary gland protein 1 IgG Ab [Units/volume] in Serum by Immunoassay
Carbonic anhydrase 6 IgA Ab [Units/volume] in Serum by Immunoassay
Carbonic anhydrase 6 IgG Ab [Units/volume] in Serum by Immunoassay
Carbonic anhydrase 6 IgM Ab [Units/volume] in Serum by Immunoassay
Strawberry IgG Ab [Units/volume] in Serum
Parotid secretory protein IgA Ab [Units/volume] in Serum by Immunoassay
Parotid secretory protein IgG Ab [Units/volume] in Serum by Immunoassay
Parotid secretory protein IgM Ab [Units/volume] in Serum by Immunoassay
Salivary gland protein 1 and Carbonic anhydrase 6 and Parotid secretory protein IgA and IgG and IgM panel - Serum by Immunoassay
Strawberry triggered histamine release [Units/volume] in Blood
Sugar Cane IgE Ab [Units/volume] in Serum
Nucleated erythrocytes [#/volume] in Blood by Manual count
Sugar Cane IgG Ab [Units/volume] in Serum
Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L
Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L
Sunflower Pollen IgE Ab [Units/volume] in Serum
Sunflower Seed triggered histamine release [Units/volume] in Blood
Swordfish IgE Ab [Units/volume] in Serum
Swordfish IgG Ab [Units/volume] in Serum
Acylcarnitine pattern [Interpretation] in Serum or Plasma Narrative
Measles virus IgG associated observations panel - Serum
Benzoylecgonine [Moles/volume] in Specimen
Amitriptyline+Nortriptyline [Moles/volume] in Specimen
N-desalkylflurazepam [Moles/volume] in Specimen
Protriptyline [Moles/volume] in Specimen
Nortrimipramine [Moles/volume] in Specimen
Imipramine+Desipramine [Moles/volume] in Specimen
Norpropoxyphene [Moles/volume] in Specimen
Propoxyphene + Norpropoxyphene [Moles/volume] in Specimen
Trimipramine+Nortrimipramine [Moles/volume] in Specimen
Indocyanine green [Mass/volume] in Plasma --1 minute post dose indocyanine green
Indocyanine green [Mass/volume] in Plasma --15 minutes post dose indocyanine green
Alpha 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
Beta 1 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
Gamma globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
Colony count [#/volume] in Implanted device by Culture
Enterobius vermicularis [Presence] in Anal by Pinworm exam --2nd specimen
Enterobius vermicularis [Presence] in Anal by Pinworm exam --3rd specimen
Beta-2 transferrin panel - Serum or Plasma and CSF
Tacrolimus [Mass/volume] in Blood --trough
Everolimus [Mass/volume] in Blood by LC/MS/MS --trough
Erythropoietin (EPO) Ab [Presence] in Serum
Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative
Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool
Non-hematopoietic stem cells/100 leukocytes in Body fluid by Manual count
Non-hematopoietic stem cells/100 leukocytes in Cerebral spinal fluid by Manual count
Protein [Mass/volume] in Saliva (oral fluid)
Triglyceride [Mass/mass] in 24 hour Stool
Triglyceride [Mass/time] in 24 hour Stool
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in 24 hour Urine
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in Urine
Tryptophan, kynurenin and 3-hydroxykynurenin panel - Serum or Plasma
Metanephrine.free and Normetanephrine.free and 3-Methoxytyramine.free panel - Serum or Plasma
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma by calculation --Dibucaine
HIV 1 proviral DNA [Presence] in Semen by NAA with probe detection
HIV 1 RNA [Presence] in Semen by NAA with probe detection
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum or Plasma by Immunoassay
Brassicasterol [Moles/volume] in Serum or Plasma
3-Methoxytyramine.free [Moles/volume] in Serum or Plasma
Lathosterol [Moles/volume] in Serum or Plasma
clomiPRAMINE trough, clomiPRAMINE+Norclomipramine trough and Norclomipramine panel - Serum or Plasma
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Specimen by NAA with probe detection
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Specimen
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Anorectal
Protein electrophoresis panel in Urine collected for unspecified duration
Adenovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Parainfluenza virus 2 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Parainfluenza virus 3 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Timothy triggered histamine release [Units/volume] in Blood
Cytomegalovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Respiratory syncytial virus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence
Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence
Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Anorectal by NAA with probe detection
Human papilloma virus 16 DNA [Presence] in Anorectal by NAA with probe detection
ABO and Rh group [Type] in Blood by Confirmatory method
Mumps virus IgG and IgM index panel - Serum
Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection
Ovalocytes [Presence] in Blood by Light microscopy
Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection
Tobacco triggered histamine release [Units/volume] in Blood
Tomato triggered histamine release [Units/volume] in Blood
Tragacanth IgE Ab [Units/volume] in Serum
Tree of Heaven IgE Ab [Units/volume] in Serum
Bilirubin [Presence] in Peritoneal fluid
Trichophyton sp IgE Ab [Units/volume] in Serum
Trimellitic anhydride (TMA) IgE Ab [Units/volume] in Serum
Bacillus cereus [Presence] in Specimen by Organism specific culture
Clostridium perfringens [Presence] in Specimen by Organism specific culture
Tuna triggered histamine release [Units/volume] in Blood
Turkey triggered histamine release [Units/volume] in Blood
Turkey feather IgE Ab [Units/volume] in Serum
Upholstery dust IgE Ab [Units/volume] in Serum
Leukocyte esterase [Presence] in Body fluid by Automated test strip
Platelet mean diameter [Entitic length] in Blood by Rees-Ecker
Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Urethra by NAA with probe detection
Alpha 2 globulin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
Veal triggered histamine release [Units/volume] in Blood
Wall pellitory IgE Ab [Units/volume] in Serum
Influenza virus A H5 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Cortisol [Moles/volume] in Serum or Plasma --1 minute post XXX challenge
Androstenedione [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Aldosterone [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Walleye Pike IgE Ab [Units/volume] in Serum
C peptide [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge
Calcitonin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge
Calcitonin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Liver fibrosis score in Serum or Plasma Calculated by FibroMeter
Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma
Arginase-1 [Mass/volume] in Serum by Immunoassay
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Peritoneal dialysis fluid by Immunoassay
Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge
SMAD4 gene full mutation analysis in Blood or Tissue by Sequencing
ENG gene full mutation analysis in Blood or Tissue by Sequencing
Pyruvate kinase [Entitic Catalytic Activity] in Red Blood Cells
HBB gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
Walnut triggered histamine release [Units/volume] in Blood
PSEN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PARK7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
VAPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TARDBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
FUS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
C9orf72 gene GGGGCC repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Black Walnut IgE Ab [Units/volume] in Serum
HLA-A and B and C (class I) IgG panel [Identifier] - Serum or Plasma by Immunoassay
HLA-DP and DQ and DR (class II) IgG panel [Identifier] - Serum or Plasma by Immunoassay
HLA class I and II IgG panel - Serum or Plasma by Immunoassay
HLA class I and II IgG Ab in Serum or Plasma by Immunoassay [interpretation] Narrative
HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay
HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay
HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay
Black Western Walnut IgE Ab [Units/volume] in Serum
HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay
HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay
HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Platelet mean volume [Entitic volume] in Blood by Rees-Ecker
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
English Walnut IgE Ab [Units/volume] in Serum
C peptide [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge
C peptide [Moles/volume] in Serum or Plasma --5 hours post XXX challenge
Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep
Diploid cells in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC)
Diploid cells/100 cells in Cells.XXX by Flow cytometry (FC)
Diploid cells in S phase/100 cells in Cells.XXX by Flow cytometry (FC)
Diploid cells in G1 phase/100 cells in Cells.XXX by Flow cytometry (FC)
Aneuploid cell population in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC)
Aneuploid cell population in S phase/100 cells in Cells.XXX by Flow cytometry (FC)
Aneuploid cell population 2 in G2 phase/100 cells in Cells.XXX by Flow cytometry (FC)
Aneuploid cell population 2 in S phase/100 cells in Cells.XXX by Flow cytometry (FC)
Diploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC)
Aneuploid G1 phase cell population peak channel [#] in Cells.XXX by Flow cytometry (FC)
Aneuploid G1 phase cell population 2 peak channel [#] in Cells.XXX by Flow cytometry (FC)
Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood culture
Calcitonin [Moles/volume] in Serum or Plasma --2 minutes post XXX challenge
Calcitonin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
English Walnut Pollen IgE Ab [Units/volume] in Serum
Calcitonin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --pre XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --1 minute post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge
Gastrin [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge
Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
Renin [Mass/volume] in Plasma --4 hours post XXX challenge
Glucose [Moles/volume] in Serum or Plasma --11 hour post XXX challenge
Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detection
Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
Legionella pneumophila 1 Ag [Presence] in Urine by Rapid immunoassay
Yellow Jacket IgG Ab [Units/volume] in Serum
HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot
Water Chestnut IgE Ab [Units/volume] in Serum
Watermelon IgE Ab [Units/volume] in Serum
Watermelon IgG Ab [Units/volume] in Serum
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by FVIII dosing
Wheat triggered histamine release [Units/volume] in Blood
XXX allergen triggered histamine release [Units/volume] in Blood
Serotonin release 0.2 IU/mL heparin.unfractionated [Units/volume] in Serum
oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Platelets [#/volume] in Blood by Automated count
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method
oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method
Gamma hydroxybutyrate [Presence] in Specimen by Screen method
Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular method
Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular method
Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular method
Mycobacterium abscessus complex clarithromycin resistance erm(41) gene panel by Molecular genetics method
Mother's Hepatitis B virus surface Ag status
Streptavidin [Presence] in Serum or Plasma by Immunoblot
HTLV I and II panel - Serum or Plasma by Immunoblot
Toxocara sp Ab [Presence] in Ocular fluid by Immunoassay
HTLV I and II Ab band pattern [Interpretation] in Serum or Plasma
HTLV I p19-I Ab [Presence] in Serum or Plasma by Immunoblot
HTLV I gp46-I Ab [Presence] in Serum or Plasma by Immunoblot
HTLV II gp46-II Ab [Presence] in Serum or Plasma by Immunoblot
PCDH15 gene c.733C>T [Presence] in Blood or Tissue by Molecular genetics method
CLRN1 gene c.144T>G [Presence] in Blood or Tissue by Molecular genetics method
Whitefish IgE Ab [Units/volume] in Serum
DLD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TMEM216 gene c.218G>T [Presence] in Blood or Tissue by Molecular genetics method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Screen method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method
6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
7-Aminoclonazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method
7-Hydroxyquetiapine cutoff [Mass/volume] in Urine for Confirmatory method
9-Hydroxyrisperidone cutoff [Mass/volume] in Urine for Confirmatory method
ARIPiprazole cutoff [Mass/volume] in Urine for Confirmatory method
ARIPiprazole [Mass/volume] in Urine by Confirmatory method
Alpha hydroxyalprazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Buprenorphine cutoff [Mass/volume] in Urine for Confirmatory method
Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method
clonazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Codeine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Whitefish IgG Ab [Units/volume] in Serum
Ethanol cutoff [Mass/volume] in Urine for Confirmatory method
Ethyl glucuronide cutoff [Mass/volume] in Urine for Confirmatory method
HYDROmorphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
Methylenedioxyethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method
Morphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Norbuprenorphine cutoff [Mass/volume] in Urine for Confirmatory method
Norfentanyl cutoff [Mass/volume] in Urine for Confirmatory method
Wild Rice IgE Ab [Units/volume] in Serum
Norhydrocodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Normeperidine cutoff [Mass/volume] in Urine for Confirmatory method
Noroxycodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Noroxycodone cutoff [Mass/volume] in Urine for Confirmatory method
oxyMORphone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Pregabalin cutoff [Mass/volume] in Urine for Confirmatory method
Pussy Willow IgE Ab [Units/volume] in Serum
Buprenorphine cutoff [Mass/volume] in Urine for Screen method
cloZAPine cutoff [Mass/volume] in Urine for Confirmatory method
Cocaine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Benzoylecgonine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Wingscale IgE Ab [Units/volume] in Serum
ceFAZolin [Susceptibility] by Disk diffusion (KB)
Winterfat IgE Ab [Units/volume] in Serum
Platelets [#/volume] in Blood by Manual count
Baker's yeast triggered histamine release [Units/volume] in Blood
Brewer's yeast triggered histamine release [Units/volume] in Blood
Phencyclidine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Ziprasidone [Mass/volume] in Urine by Confirmatory method
Ziprasidone cutoff [Mass/volume] in Urine for Confirmatory method
Tapentadol cutoff [Mass/volume] in Urine for Confirmatory method
risperiDONE [Mass/volume] in Urine by Confirmatory method
risperiDONE cutoff [Mass/volume] in Urine for Confirmatory method
Dehydroaripiprazole cutoff [Mass/volume] in Urine for Confirmatory method
QUEtiapine cutoff [Mass/volume] in Urine for Confirmatory method
Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method
Ethyl sulfate cutoff [Mass/volume] in Urine for Confirmatory method
Nortriptyline cutoff [Mass/volume] in Urine for Confirmatory method
OLANZapine cutoff [Mass/volume] in Urine for Confirmatory method
OLANZapine [Mass/volume] in Urine by Confirmatory method
Acanthocytes [Presence] in Blood by Light microscopy
Burr cells [Presence] in Blood by Light microscopy
Dacrocytes [Presence] in Blood by Light microscopy
Enterobacteriaceae.carbapenem resistant [Presence] in Anorectal or stool specimen by Organism specific culture
Dohle body [Presence] in Blood by Light microscopy
Cortisol [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --3 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --3.5 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --4 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --6 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --8 hours post XXX challenge
Howell-Jolly bodies [Presence] in Blood by Light microscopy
Cortisol [Moles/volume] in Serum or Plasma --9 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --9.5 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --10 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --10.5 hours post XXX challenge
Cortisol [Moles/volume] in Serum or Plasma --12 hours post XXX challenge
Corticotropin [Moles/volume] in Plasma --45 minutes post XXX challenge
Albumin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
Normocytic/Normochromic polychromasia [Presence] in Blood by Light microscopy
Schistosoma mansoni+haematobium+intercalatum [Titer] in Serum by Hemagglutination
Streptococcus pneumoniae Ag [Presence] in Urine by Rapid immunoassay
Toscana virus IgM Ab [Presence] in Serum by Immunoassay
Toscana virus IgG Ab [Presence] in Serum by Immunoassay
Trypanosoma cruzi Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Yellow fever virus IgG Ab [Presence] in Serum by Immunofluorescence
Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence
Yersinia enterocolitica O:3 IgG Ab [Presence] in Serum by Agglutination
Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
Pappenheimer bodies [Presence] in Blood by Light microscopy
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Cerebral spinal fluid by NAA with probe detection
Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Penicillin Parenteral [Susceptibility] by Disk diffusion (KB)
cloZAPine [Mass/volume] in Urine by Confirmatory method
Cholesterol crystals [#/area] in Urine sediment by Microscopy low power field
Platelet clump [Presence] in Blood by Light microscopy
Rouleaux [Presence] in Blood by Light microscopy
Smudge cells [Presence] in Blood by Light microscopy
Poikilocytosis [Presence] in Blood by Light microscopy
Cytomegalovirus pp65 Ag/100000 PMN cells in Blood by Immunofluorescence
CD34 dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass
Nucleated cell dose in hematopoietic progenitor cell transfusion [#/mass] per recipient body mass
Staphylococcus aureus.vancomycin resistance [Susceptibility] Qualitative
Isotopic Glomerular filtration rate/1.73 sq M [Volume Rate/Area] in Urine and Serum or Plasma
HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection
HIV 1 proviral DNA [Entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection
HIV 1 proviral DNA [Entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection
HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection
Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay
HLA-A and B and DRB and DQB1 panel [Type] - Blood or Tissue by Low resolution
Phospholipid IgG Ab [Units/volume] in Serum
Toscana virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Toscana virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Phospholipid IgM Ab [Units/volume] in Serum
Cortisol [Moles/volume] in Serum or Plasma --24 hour post XXX challenge
Actinomyces sp Ab [Units/volume] in Serum
Ascaris lumbricoides Ab [Units/volume] in Serum
Aspergillus sp Ab [Units/volume] in Serum
Astrovirus [Presence] in Stool by Electron microscopy
Astrovirus Ag [Presence] in Stool by Immunoassay
Astrovirus RNA [Presence] in Serum by NAA with probe detection
Babesia microti Ab [Units/volume] in Serum
Bacillus anthracis Ab [Units/volume] in Serum
Promyelocytes [#/volume] in Blood by Manual count
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunoassay
Blastomyces dermatitidis Ab [Presence] in Serum
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal
9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH
BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH
CCND1 gene duplication [Presence] in Blood or Tissue by FISH
ALK gene rearrangements [Presence] in Blood or Tissue by FISH
4q12 chromosome region rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
9q34 chromosome region deletion [Interpretation] in Blood or Tissue by FISH Narrative
BCL6 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
CCND1 gene duplication [Interpretation] in Blood or Tissue by FISH Narrative
ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
Cells.4q12 chromosome region rearrangements/Cells counted in Blood or Tissue by FISH
Chlamydophila pneumoniae rRNA [Presence] in Serum by NAA with probe detection
Cells.9q34 chromosome region deletion/Cells counted in Blood or Tissue by FISH
Cells.BCL6 gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.CCND1 gene duplication/Cells counted in Blood or Tissue by FISH
MYC gene rearrangements [Presence] in Blood or Tissue by FISH
TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH
RARA gene rearrangements [Presence] in Blood or Tissue by FISH
BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH
MLL gene rearrangements [Presence] in Blood or Tissue by FISH
Chlamydophila psittaci Ab [Units/volume] in Serum
PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH
IGH gene rearrangements [Presence] in Blood or Tissue by FISH
MYC gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
TRA+TRD gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
RARA gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
BCL2 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
PDGFRB gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
IGH gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
Cells.MYC gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.RARA gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.TRA+TRD gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.BCL2 gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.ALK gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.MLL gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.PDGFRB gene rearrangements/Cells counted in Blood or Tissue by FISH
Cells.IGH gene rearrangements/Cells counted in Blood or Tissue by FISH
Chromosome 8 copy number/nucleus in Blood or Tissue by FISH
Chromosome 3 copy number/nucleus in Blood or Tissue by FISH
MYB gene deletion [Presence] in Blood or Tissue by FISH
Chlamydia trachomatis Ab [Units/volume] in Serum
Coccidioides immitis IgG Ab [Units/volume] in Serum
Coccidioides immitis IgM Ab [Units/volume] in Serum
Coxiella burnetii Ab [Units/volume] in Serum
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum
Promyelocytes/100 leukocytes in Blood by Manual count
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum
Coxsackievirus A16 Ab [Units/volume] in Serum
MYB gene deletion [Interpretation] in Blood or Tissue by FISH Narrative
Cells.MYB gene deletion/Cells counted in Blood or Tissue by FISH
Fatty acid comprehensive (C8-C26) panel - Red Blood Cells
Coxsackievirus A7 Ab [Units/volume] in Serum
Docosenoate (C22:1) [Entitic substance] in Red Blood Cells
Hexadecenoate (C16:1w9) [Entitic substance] in Red Blood Cells
Docosapentaenate (C22:5w3) [Entitic substance] in Red Blood Cells
Docosapentaenate (C22:5w6) [Entitic substance] in Red Blood Cells
Lauroleate (C12:1) [Entitic substance] in Red Blood Cells
Decenoate (C10:1) [Entitic substance] in Red Blood Cells
Tetradecadienoate (C14:2) [Entitic substance] in Red Blood Cells
Coxsackievirus A9 Ab [Units/volume] in Serum
Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells
Hexadecadienoate (C16:2) [Entitic substance] in Red Blood Cells
Abnormal lymphocytes [Presence] in Blood by Manual count
Bacteria identified in Implanted device by Culture
Mycobacterium tuberculosis DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] palmitate substrate
Acyl CoA dehydrogenases.palmitate substrate/Acyl CoA dehydrogenases.myristate substrate [Enzymatic activity ratio] in Fibroblast
Coxsackievirus B1 Ab [Units/volume] in Serum
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] myristate substrate
Fatty acid and triglyceride panel - 24 hour Stool
Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough
Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method
Amphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Imipramine trough, Imipramine+desimipramine trough and Desipramine panell - Serum or Plasma
Goose feather IgG Ab [Mass/volume] in Serum
Pigeon serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum
Parrot serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum
American house dust mite native (nDer f) 2 IgE Ab [Units/volume] in Serum
Epipregnanolone [Moles/time] in 24 hour Urine
Epipregnanolone [Moles/volume] in 24 hour Urine
Coxsackievirus B2 Ab [Units/volume] in Serum
PON1 gene c.575A>G [Presence] in Blood or Tissue by Molecular genetics method
CFTR gene mutations found [Identifier] in Blood or Tissue by MS.MALDI-TOF Nominal
Cat dander native (nFel d) 1 IgE Ab [Units/volume] in Serum
Budgerigar serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum
Coxsackievirus B3 Ab [Units/volume] in Serum
Coxsackievirus B4 Ab [Units/volume] in Serum
Coxsackievirus B5 Ab [Units/volume] in Serum
Coxsackievirus B6 Ab [Units/volume] in Serum
Cryptococcus neoformans Ab [Units/volume] in Serum
Soluble liver IgG Ab [Presence] in Serum by Line blot
carBAMazepine free and total trough and 10,11-Epoxide panel - Serum or Plasma
Mirtazapine trough and Normirtazapine panel - Serum or Plasma
Primidone and PHENobarbital trough panel - Serum or Plasma
FLUoxetine trough, FLUoxetine+norfluoxetine trough and Norfluoxetine panel - Serum or Plasma
Sertraline trough and Norsertraline panel - Serum or Plasma
Phenytoin free and total trough panel - Serum or Plasma
risperiDONE trough and 9-Hydroxyrisperidone panel - Serum or Plasma
Bilirubin.conjugated [Moles/volume] in Peritoneal fluid
Bilirubin.indirect [Moles/volume] in Peritoneal fluid
Taenia solium larva IgA Ab [Presence] in Cerebral spinal fluid
Hepatitis A virus IgG+IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
Taenia solium larva IgA Ab [Presence] in Serum
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid
Taenia solium larva IgG Ab [Presence] in Serum
Taenia solium larva IgM Ab [Presence] in Cerebral spinal fluid
Erythrocyte mean corpuscular diameter [Length] by Automated count
Taenia solium larva IgM Ab [Presence] in Serum
Taenia solium larva Ab [Units/volume] in Serum
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination
Lactose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO
Lactose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO
Renin [Mass/volume] in Plasma --2 hours post XXX challenge
Cholesterol [Moles/volume] in Pericardial fluid
Cytomegalovirus Ab [Units/volume] in Serum or Plasma
Platelet aggregation ADP induced in Platelet rich plasma --2 umol/L
Platelet aggregation ADP induced in Platelet rich plasma --2.5 umol/L
Platelet aggregation ADP induced in Platelet rich plasma --4 umol/L
Platelet aggregation ADP induced in Platelet rich plasma --5 umol/L
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --100 umol/L
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --6 umol/L
Platelet aggregation arachidonate induced in Platelet rich plasma --1.6 mmol/L
Platelet aggregation collagen induced in Platelet rich plasma --1.25 ug/ml
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
Platelet aggregation collagen induced in Platelet rich plasma --5 ug/mL
Platelet aggregation ristocetin induced in Platelet rich plasma --1.25 mg/ml
Adenovirus Ag [Presence] in Stool by Rapid immunoassay
Vesicular stomatitis New Jersey virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Vesicular stomatitis Indiana virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Creatinine [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
Creatinine [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Glucose [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
Glucose [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --4 hour dwell specimen
Dengue virus 1 Ab [Presence] in Serum by Immunoassay
Dengue virus 1+2+3+4 RNA [Presence] in Serum by NAA with probe detection
Dengue virus 2 Ab [Presence] in Serum by Immunoassay
Dengue virus 3 Ab [Presence] in Serum by Immunoassay
Dengue virus 4 Ab [Presence] in Serum by Immunoassay
ceFAZolin [Susceptibility] by Serum bactericidal titer
Eastern equine encephalitis virus IgG Ab [Units/volume] in Serum
Eastern equine encephalitis virus IgM Ab [Units/volume] in Serum
Ebola virus Ab [Titer] in Serum by Immunofluorescence
Echinococcus sp Ab [Units/volume] in Serum
Platelet aggregation collagen induced [Units/volume] in Blood
Platelet aggregation ristocetin induced [Units/volume] in Blood --High dose
Platelet aggregation thrombin receptor activating peptide-6 induced [Units/volume] in Blood
Platelet aggregation adenosine diphosphate+prostaglandin E1 induced [Units/volume] in Blood
Adenylosuccinate/Creatinine [Molar ratio] in Urine
5-Hydroxymethyluracil/Creatinine [Molar ratio] in Urine
Guanosine/Creatinine [Molar ratio] in Urine
Pseudouridine/Creatinine [Molar ratio] in Urine
Dihydrothymine/Creatinine [Molar ratio] in Urine
Dihydroorotate/Creatinine [Molar ratio] in Urine
Guanine/Creatinine [Molar ratio] in Urine
Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore
Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter
Cedar elm IgE Ab [Units/volume] in Serum
Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture
Platelet aggregation ristocetin induced [Units/volume] in Blood --Low dose
Pathologic casts [#/area] in Urine by Automated count
Pathologic casts [#/volume] in Urine by Automated count
Yeast [#/area] in Urine by Automated count
Steroid fractions interpretation in Urine Narrative
Peritoneal equilibration test panel - Peritoneal dialysis fluid
Hemoglobin pattern [Interpretation] in Blood by Capillary electrophoresis (CE)
Glycolate [Mass/volume] in Serum or Plasma by Gas chromatography
Hepatitis E virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method
1-Hydroxymidazolam [Mass/volume] in Blood
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum by Immunoassay
4-Hydroxymidazolam [Mass/volume] in Urine
6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method
6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method
7-Aminoflunitrazepam [Mass/mass] in Hair
OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
7-Hydroxyquetiapine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
oxyMORphone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
Ehrlichia chaffeensis IgM Ab [Presence] in Serum
fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
oxyCODONE [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
Morphine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
HYDROcodone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
9-Hydroxyrisperidone [Mass/mass] in Hair
Abacavir [Mass/volume] in Amniotic fluid
Abacavir [Mass/volume] in Serum or Plasma
Anaplasma phagocytophilum Ab [Presence] in Serum
Alfentanil [Presence] in Blood by Screen method
ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
Amphetamine [Presence] in Body fluid by Screen method
Anakinra [Mass/volume] in Serum or Plasma
Atazanavir [Mass/volume] in Amniotic fluid
Atazanavir [Mass/volume] in Serum or Plasma --trough
Erythrocyte distribution width [Ratio] by Automated count
Alminoprofen [Mass/volume] in Body fluid
Barium [Moles/volume] in Serum or Plasma
Entamoeba histolytica Ab [Units/volume] in Serum
Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL
Buprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
buPROPion cutoff [Mass/volume] in Urine for Confirmatory method
Cannabicyclohexanol [Mass/volume] in Urine by Confirmatory method
Cannabicyclohexanol cutoff [Mass/volume] in Urine for Confirmatory method
Carisoprodol [Mass/volume] in Blood by Confirmatory method
Enterovirus RNA [Presence] in Nose by NAA with probe detection
Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method
Cathinone [Mass/volume] in Urine by Confirmatory method
Citalopram cutoff [Mass/volume] in Urine for Confirmatory method
clomiPRAMINE cutoff [Mass/volume] in Urine for Confirmatory method
Cyclobenzaprine cutoff [Mass/volume] in Urine for Confirmatory method
Desipramine cutoff [Mass/volume] in Urine for Confirmatory method
Doxepin cutoff [Mass/volume] in Urine for Confirmatory method
DULoxetine [Presence] in Urine by Confirmatory method
Epstein Barr virus early Ab [Presence] in Serum
DULoxetine cutoff [Mass/volume] in Urine for Confirmatory method
Ecgonine methyl ester [Mass/mass] in Hair
fentaNYL cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Gamma hydroxybutyrate [Mass/mass] in Hair
Hydroxybupropion [Presence] in Urine by Confirmatory method
Epstein Barr virus nuclear IgG Ab [Presence] in Serum
Hydroxybupropion cutoff [Mass/volume] in Urine for Confirmatory method
Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method
Hydroxylurasidone cutoff [Mass/volume] in Urine for Confirmatory method
Imipramine cutoff [Mass/volume] in Urine for Confirmatory method
JWH-018 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-018 pentanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-073 butanoate (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
Epstein Barr virus nuclear IgM Ab [Presence] in Serum
JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
M-chlorophenylpiperazine [Mass/mass] in Hair
M-chlorophenylpiperazine [Mass/volume] in Blood
M-chlorophenylpiperazine [Mass/volume] in Body fluid
M-chlorophenylpiperazine [Mass/volume] in Serum or Plasma
M-chlorophenylpiperazine [Mass/volume] in Urine
Meprobamate [Mass/volume] in Blood by Confirmatory method
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum
Methcathinone [Mass/volume] in Urine by Confirmatory method
Mirtazapine [Presence] in Urine by Confirmatory method
Mirtazapine cutoff [Mass/volume] in Urine for Confirmatory method
Naloxol [Mass/volume] in Urine by Confirmatory method
Naloxol cutoff [Mass/volume] in Urine for Confirmatory method
Naloxone cutoff [Mass/volume] in Urine for Confirmatory method
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum
Naltrexol cutoff [Mass/volume] in Urine for Confirmatory method
Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Norhydrocodone cutoff [Mass/volume] in Urine for Confirmatory method
O-desmethylvenlafaxine cutoff [Mass/volume] in Urine for Confirmatory method
OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method
OPC3373 (Metabolite of Ariprazole) cutoff [Mass/volume] in Urine for Confirmatory method
OPC3373 (Metabolite of Ariprazole) [Z-score] in Urine
PARoxetine cutoff [Mass/volume] in Urine for Confirmatory method
QUEtiapine [Mass/volume] in Urine by Confirmatory method
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
Francisella tularensis Ab [Presence] in Serum
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
Sertraline cutoff [Mass/volume] in Urine for Confirmatory method
Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Lurasidone [Mass/volume] in Urine by Confirmatory method
traZODone cutoff [Mass/volume] in Urine for Confirmatory method
Venlafaxine cutoff [Mass/volume] in Urine for Confirmatory method
Trans-3-Hydroxycotinine [Mass/volume] in Saliva (oral fluid)
Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL
Tricyclic antidepressants [Presence] in Hair
Tricyclic antidepressants [Presence] in Gastric fluid
Liver fibrosis score in Serum or Plasma Calculated by HepaScore
Francisella tularensis IgG Ab [Presence] in Serum
Francisella tularensis IgM Ab [Presence] in Serum
Giardia lamblia IgG Ab [Units/volume] in Serum
FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH
FGFR1 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
Cells.FGFR1 gene rearrangements/Cells counted in Blood or Tissue by FISH
cycloSPORINE [Moles/volume] in Blood by Immunoassay
Bordetella pertussis and Bordetella parapertussis DNA and culture panel - Nasopharynx
Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with probe detection
Giardia lamblia IgM Ab [Units/volume] in Serum
Haemophilus influenzae Ab [Units/volume] in Serum
Hantavirus hantaan IgG Ab [Units/volume] in Serum
Cathepsin A [Enzymatic activity/mass] in Leukocytes
Hyocholate [Moles/volume] in Serum or Plasma
Aldosterone and renin concentration panel - Plasma
IgG clearance/Albumin clearance [Ratio] in Urine and Serum or Plasma
IgG clearance/Transferrin clearance [Ratio] in Urine and Serum or Plasma
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Leukocytes
Hantavirus hantaan IgM Ab [Units/volume] in Serum
N-acetylaspartylglutamate [Moles/volume] in Cerebral spinal fluid
Neurofilament medium chain Ab [Mass/volume] in Cerebral spinal fluid
S-adenosylmethionine [Moles/volume] in Serum or Plasma
Sedoheptulose/Creatinine [Molar ratio] in Urine
Benperidol [Mass/volume] in Serum or Plasma
Neurofilament heavy chain Ab [Mass/volume] in Cerebral spinal fluid
Phosphomannomutase 1 [Enzymatic activity/mass] in Leukocytes
Phosphomannomutase 1 [Enzymatic activity/mass] in Fibroblast
Hantavirus puumala IgG Ab [Units/volume] in Serum
CYP2C8 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Erythrocytes [#/volume] in Blood by Automated count
Hantavirus puumala IgM Ab [Units/volume] in Serum
D-3-phosphoglycerate dehydrogenase [Enzymatic activity/mass] in Fibroblast
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Cerebral spinal fluid
Macroprolactin/Prolactin in Serum or Plasma
Prolactin.dimeric [Units/volume] in Serum or Plasma
Prolactin.dimeric/Prolactin in Serum or Plasma
Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
Flavin adenine dinucleotide [Moles/volume] in Serum or Plasma
Flavin adenine dinucleotide [Moles/volume] in Blood
Melatonin [Mass/volume] in Saliva (oral fluid)
Prolactin isoforms panel - Serum or Plasma
Prolactin monomeric [Units/volume] in Serum or Plasma
Prolactin monomeric/Prolactin in Serum or Plasma
Hantavirus RNA [Presence] in Serum by NAA with probe detection
Helicobacter pylori Ab [Units/volume] in Serum
Helicobacter pylori IgA Ab [Units/volume] in Serum
Helicobacter pylori IgG Ab [Units/volume] in Serum
Helicobacter pylori IgM Ab [Units/volume] in Serum
Hepatitis A virus RNA [Presence] in Serum by NAA with probe detection
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test
Erythrocytes [#/volume] in Blood by Manual count
Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection
Herpes simplex virus Ab [Units/volume] in Serum
Herpes simplex virus 1 Ab [Units/volume] in Serum
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum
Heart transplant acute cellular rejection risk [Score] in Mononuclear cells Calculated by AlloMap
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum
Herpes simplex virus 2 Ab [Units/volume] in Serum
Hawkinsin [Moles/volume] in Serum or Plasma
Uroporphyrin 1 isomer [Mass/time] in 24 hour Urine
Uroporphyrin 1 isomer/Creatinine [Mass Ratio] in Urine
Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum
Uroporphyrin 3 isomer/Creatinine [Mass Ratio] in Urine
Platelet aggregation ristocetin induced in Platelet rich plasma --500 ug/mL
1-Hydroxymidazolam [Mass/volume] in Body fluid
4-Hydroxymidazolam [Mass/volume] in Body fluid
9-Hydroxyrisperidone [Mass/volume] in Body fluid
Abacavir [Mass/volume] in Cerebral spinal fluid
Acepromazine [Mass/volume] in Body fluid
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum
Benzylpiperazine [Mass/volume] in Body fluid
Buprenorphine [Presence] in Blood by Confirmatory method
Buprenorphine [Presence] in Blood by Screen method
Erythrocytes [#/volume] in Cerebral spinal fluid by Automated count
Carisoprodol+Meprobamate [Presence] in Blood by Screen method
Cathinone [Presence] in Urine by Screen method
Gamma hydroxybutyrate [Mass/volume] in Body fluid
Methcathinone [Presence] in Urine by Screen method
Heterophile Ab after beef cell absorption [Titer] in Serum
Tapentadol [Presence] in Blood by Confirmatory method
Tapentadol [Presence] in Blood by Screen method
traMADol [Presence] in Blood by Confirmatory method
traMADol [Presence] in Blood by Screen method
Trimeprazine [Mass/volume] in Body fluid
Heterophile Ab after guinea pig cell absorption [Titer] in Serum
Acenocoumarol [Mass/volume] in Body fluid
Cold agglutinin [Titer] in Serum by 37 degree C incubation --1 hour post incubation
Cold agglutinin [Titer] in Serum by 22 degree C incubation --1 hour post incubation
Cold agglutinin [Titer] in Serum by 4 deg C incubation --1 hour post incubation
Cold agglutinin [Titer] in Serum by 4 deg C incubation --24 hour post incubation
Histoplasma capsulatum Ab [Units/volume] in Serum
Nortriptyline and E-10-hydroxynortriptyline and Z-10-hydroxynortriptyline panel - Serum or Plasma
chlordiazePOXIDE and Norchlordiazepoxide panel - Serum or Plasma
Z-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma
CES1 gene c.428G>A [Presence] in Blood or Tissue by Molecular genetics method
OXcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma
Peach natural (nPru p) 3 IgE Ab [Units/volume] in Serum
Honey bee recombinant (rApi m) 2 IgE Ab [Units/volume] in Serum
Cherry recombinant (rPru av) 4 IgE Ab [Units/volume] in Serum
Cherry recombinant (rPru av) 3 IgE Ab [Units/volume] in Serum
Cherry recombinant (rPru av) 1 IgE Ab [Units/volume] in Serum
Apple recombinant (rMal d) 4 IgE Ab [Units/volume] in Serum
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge
Clostridioides difficile glutamate dehydrogenase and toxins A+B [Presence] in Stool by Rapid immunoassay
4-Hydroxycyclohexylacetate/Creatinine [Molar ratio] in Urine
Somatotropin [Units/volume] in Serum or Plasma --75 minutes post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge
RNA polymerase III IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
First name of Guardian or legally authorized representative
Last name of Guardian or legally authorized representative
Cells.CD3+CD4+CD8+ (Double positive)/100 cells in Blood
Cells.CD3+CD4+CD8+ (Double positive) [#/volume] in Blood
Platelet aggregation ADP induced in Platelet rich plasma --10 umol/L
Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay
Zika virus RNA [Presence] in Specimen by NAA with probe detection
Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin
Influenza virus A Ab [Units/volume] in Serum
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH
BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method
Influenza virus A Bangkok Ab [Units/volume] in Serum
FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method
Fetal Chromosome X and Y aneuploidy risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing
Fetal Microdeletions risk [interpretation] in Plasma cell-free DNA Qualitative by Sequencing
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count
Steroid fractions interpretation in Serum or Plasma Narrative
Steroid fractions panel - Serum or Plasma
Benzodiazepines [Presence] in Body fluid by Screen method
ARIPiprazole [Mass/volume] in Body fluid
Influenza virus A England Ab [Units/volume] in Serum
Amitriptyline [Mass/volume] in Body fluid
Naphyrone [Mass/volume] in Urine by Confirmatory method
Naphyrone cutoff [Mass/volume] in Urine for Confirmatory method
Butylone [Mass/volume] in Urine by Confirmatory method
Butylone cutoff [Mass/volume] in Urine for Confirmatory method
Influenza virus A Hong Kong Ab [Units/volume] in Serum
Methcathinone cutoff [Mass/volume] in Urine for Confirmatory method
Mephedrone cutoff [Mass/volume] in Urine for Confirmatory method
Methylenedioxypyrovalerone cutoff [Mass/volume] in Urine for Confirmatory method
Ethyl glucuronide cutoff [Mass/volume] in Urine for Screen method
Tapentadol cutoff [Mass/volume] in Urine for Screen method
Methedrone cutoff [Mass/volume] in Urine for Confirmatory method
Methylone cutoff [Mass/volume] in Urine for Confirmatory method
Ethylone [Mass/volume] in Urine by Confirmatory method
Influenza virus A Leningrad Ab [Units/volume] in Serum
Ethylone cutoff [Mass/volume] in Urine for Confirmatory method
Triazolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Methedrone [Mass/volume] in Urine by Confirmatory method
Methylenedioxymethamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Methylenedioxyethylamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Methadone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Influenza virus A Mississippi Ab [Units/volume] in Serum
diazePAM cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Nordiazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Oxazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
LORazepam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
oxyCODONE cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Carisoprodol+Meprobamate cutoff [Mass/volume] in Urine for Screen method
Methylenedioxyamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Meprobamate cutoff [Mass/volume] in Urine for Confirmatory method
fentaNYL cutoff [Mass/volume] in Urine for Confirmatory method
fentaNYL cutoff [Mass/volume] in Urine for Screen method
HYDROcodone cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Methamphetamine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Creatinine [Moles/volume] in Peritoneal dialysis fluid --overnight dwell
Glucose [Moles/volume] in Peritoneal dialysis fluid --overnight dwell
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --overnight dwell
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Serum or Plasma
Influenza virus A Phillipines Ab [Units/volume] in Serum
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Cerebral spinal fluid
3-Hydroxytrimethyl-L-lysine [Moles/volume] in DBS
3-Hydroxytrimethyl-L-lysine/Creatinine [Molar ratio] in Urine
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in DBS
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Serum or Plasma
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Urine
7,8-Dihydrobiopterin [Moles/volume] in Cerebral spinal fluid
Influenza virus A Port Chalmers Ab [Units/volume] in Serum
7-lathosterol [Moles/volume] in Serum or Plasma
8-lathosterol [Moles/volume] in Serum or Plasma
Alpha-aminoadipic semialdehyde [Moles/volume] in Serum or Plasma
Alpha-aminoadipic semialdehyde [Moles/volume] in Cerebral spinal fluid
Arabinose/Creatinine [Molar ratio] in Urine
Biopterin/Biopterin+Neopterin [Molar ratio] in Urine
C29 dicarboxylate [Moles/volume] in Serum or Plasma
Carnitine biosynthesis intermediates panel - DBS
Influenza virus A Texas Ab [Units/volume] in Serum
Carnitine biosynthesis intermediates panel - Serum or Plasma
Carnitine biosynthesis intermediates panel - Cerebral spinal fluid
Carnitine biosynthesis intermediates panel - Urine
Creatine and guanidinoacetate panel - Cerebral spinal fluid
Creatine and guanidinoacetate panel - Serum or Plasma
Creatine, guanidinoacetate and creatinine panel - Urine
Creatine and guanidinoacetate pattern [Interpretation] in Serum or Plasma Narrative
Creatine, guanidinoacetate and creatinine pattern [Interpretation] in Urine Narrative
Influenza virus A Victoria Ab [Units/volume] in Serum
Creatine and guanidinoacetate pattern [Interpretation] in Cerebral spinal fluid Narrative
D- and L-2-hydroxyglutarate panel - Cerebral spinal fluid
D- and L-2-hydroxyglutarate panel - Serum or Plasma
D- and L-2-hydroxyglutarate panel - Amniotic fluid
D- and L-2-hydroxyglutarate panel - Urine
D- and L-2-hydroxyglutarate pattern [Interpretation] in Cerebral spinal fluid Narrative
Erythrocytes [#/volume] in Pleural fluid by Manual count
D- and L-2-hydroxyglutarate pattern [Interpretation] in Serum or Plasma Narrative
Influenza virus A+B Ab [Units/volume] in Serum
D- and L-2-hydroxyglutarate pattern newborn screen interpretation
D- and L-2-hydroxyglutarate pattern [Interpretation] in Amniotic fluid Narrative
D- and L-2-hydroxyglutarate pattern [Interpretation] in Urine Narrative
D-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid
D-2-hydroxyglutarate [Moles/volume] in Serum or Plasma
D-2-hydroxyglutarate [Moles/volume] in DBS
D-2-hydroxyglutarate [Moles/volume] in Amniotic fluid
Gamma butyrobetaine [Moles/volume] in Serum or Plasma
Gamma butyrobetaine [Moles/volume] in Cerebral spinal fluid
Gamma butyrobetaine [Moles/volume] in DBS
Gamma butyrobetaine/Creatinine [Molar ratio] in Urine
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Serum or Plasma
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Urine
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in DBS
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid
Isoxanthopterin [Moles/volume] in Serum or Plasma
L-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid
L-2-hydroxyglutarate [Moles/volume] in Serum or Plasma
Influenza virus B Ab [Units/volume] in Serum
L-2-hydroxyglutarate [Moles/volume] in Amniotic fluid
Lysophosphatidylcholine(26:0) [Moles/volume] in Cerebral spinal fluid
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS
Lysophosphatidylcholine(26:0) [Moles/volume] in Serum or Plasma
7-Isobiopterin/Creatinine [Molar ratio] in Urine
Pyridoxal phosphate and pyridoxal and pyridoxine panel - Cerebral spinal fluid
Pyridoxal phosphate and pyridoxal and pyridoxine panel - Serum or Plasma
Squalene [Moles/volume] in Serum or Plasma
Influenza virus C Ab [Units/volume] in Serum
Sterols pattern [Interpretation] in Serum or Plasma Narrative
Trimethyllysine [Moles/volume] in Serum or Plasma
Trimethyllysine [Moles/volume] in Cerebral spinal fluid
Trimethyllysine/Creatinine [Molar ratio] in Urine
L-2-hydroxyglutarate [Moles/volume] in DBS
Hypoglycemics.oral [Presence] in Hair by Screen method
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay
Hypoglycemics.oral [Presence] in Blood by Screen method
Hypoglycemics.oral [Presence] in Serum or Plasma by Screen method
Hypoglycemics.oral [Presence] in Body fluid by Screen method
Hypoglycemics.oral [Presence] in Urine by Screen method
Carnitine biosynthesis intermediates pattern newborn screen interpretation
Carnitine biosynthesis intermediates pattern [Interpretation] in Cerebral spinal fluid Narrative
Carnitine biosynthesis intermediates pattern [Interpretation] in Serum or Plasma Narrative
Carnitine biosynthesis intermediates pattern [Interpretation] in Urine Narrative
Japanese encephalitis virus Ab [Presence] in Serum by Immunoassay
Dimethylacetals pattern [Interpretation] in Red Blood Cells Narrative
Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Serum or Plasma Narrative
Pyridoxal phosphate and pyridoxal and pyridoxine pattern [Interpretation] in Cerebral spinal fluid Narrative
Alpha-aminoadipic semialdehyde/Creatinine [Molar ratio] in Urine
Sulfate.total/Creatinine [Molar ratio] in Urine
Japanese encephalitis virus Ab [Units/volume] in Serum by Hemagglutination inhibition
Japanese encephalitis virus RNA [Presence] in Serum by NAA with probe detection
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--2nd specimen
Junin virus Ab [Presence] in Serum by Immunoassay
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--3rd specimen
Naltrexol [Mass/volume] in Urine by Confirmatory method
HIV 1 RNA+proviral DNA [Presence] in Plasma by NAA with probe detection
HIV 1 RNA+proviral DNA [Presence] in Blood by NAA with probe detection
Gastrointestinal pathogens panel - Stool by NAA with probe detection
Campylobacter coli+jejuni+lari fusA gene [Presence] in Stool by NAA with probe detection
Salmonella sp rpoD gene [Presence] in Stool by NAA with probe detection
Vibrio cholerae+parahaemolyticus rfbL+trkH+tnaA genes [Presence] in Stool by NAA with probe detection
Yersinia enterocolitica recN gene [Presence] in Stool by NAA with probe detection
Escherichia coli Stx1 toxin stx1 gene [Presence] in Stool by NAA with probe detection
Escherichia coli Stx2 toxin stx2 gene [Presence] in Stool by NAA with probe detection
Norovirus genogroup I+II orf1-orf2 junction region [Presence] in Stool by NAA with probe detection
Rotavirus A nsp5 gene [Presence] in Stool by NAA with probe detection
Gastrointestinal pathogens identified in Stool by NAA with probe detection
Catecholamine metabolites panel - Cerebral spinal fluid
Catecholamine metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative
Flavin mononucleotide [Moles/volume] in Serum or Plasma
Hepatocyte growth factor [Mass/volume] in Serum or Plasma
NADH:ubiquinone reductase [Enzymatic activity/mass] in Fibroblast
NADH:ubiquinone reductase [Enzymatic activity/mass] in Tissue
Mastic tree (Pistacia lentiscus) IgE Ab [Units/volume] in Serum
Prolactin isoforms pattern [Interpretation] in Serum or Plasma Narrative
Synovial fluid analysis panel - Synovial fluid
Cefixime [Susceptibility] by Minimum lethal concentration (MLC)
La Crosse virus IgG Ab [Units/volume] in Serum
Vanillylmandelate [Moles/volume] in Cerebral spinal fluid
HBB gene full mutation analysis [Identifier] in Blood or Tissue by Sequencing
Adenosine deaminase [Enzymatic activity/substance] in Red Blood Cells
1,4-Alpha glucan branching enzyme [Enzymatic activity/mass] in Fibroblast
IgM clearance/Albumin clearance [Ratio] in Serum and CSF
Catecholamine metabolites pattern [Interpretation] in Serum or Plasma Narrative
cloBAZam and norclobazam panel - Serum or Plasma
Dothiepin+nordothiepin trough and dothiepin sulfoxide panel - Serum or Plasma
Penfluridol [Mass/volume] in Serum or Plasma --trough
Creatine transport protein [Enzymatic activity/mass] in Fibroblast by Creatine uptake assay
Mianserin trough and Normianserin panel - Serum or Plasma
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma --trough
MSH6 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
MSH2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
MLH1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
PMS2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
La Crosse virus IgM Ab [Units/volume] in Serum
EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by MLPA
PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Miscellaneous allergen IgE Ab [Units/volume] in Serum
Serial sputum smears for diagnosing pulmonary tuberculosis panel - by Acid fast stain
Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture
Lassa virus IgG Ab [Presence] in Serum by Immunoassay
Plasma cells/100 leukocytes in Blood by Manual count
Platelets [#/area] in Blood by Microscopy high power field
Lassa virus IgG Ab [Titer] in Serum by Immunofluorescence
Lassa virus IgM Ab [Presence] in Serum by Immunoassay
Fluspirilene [Mass/volume] in Serum or Plasma
Pericyazine [Mass/volume] in Serum or Plasma
Staphylococcus aureus capsular polysaccharide enzyme cpe gene [Presence] in Nose by NAA with probe detection
Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus panel - Nose by NAA with probe detection
Adenine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells
Adenosine deaminase [Enzymatic activity/mass] in Leukocytes
Adenylosuccinate lyase [Enzymatic activity/substance] in Red Blood Cells
Alcohol dehydrogenase [Enzymatic activity/mass] in Liver
Alpha fucosidase [Enzymatic activity/volume] in DBS
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in DBS
Arginase [Enzymatic activity/mass] in Red Blood Cells
Beta glucuronidase [Enzymatic activity/volume] in DBS
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in DBS
Lassa virus IgM Ab [Titer] in Serum by Immunofluorescence
Dihydropteridine reductase [Enzymatic activity/mass] in Red Blood Cells
Galactose 1 phosphate uridyl transferase [Enzymatic activity/substance] in Red Blood Cells
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells
Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in DBS
Phosphorylase [Enzymatic activity/mass] in Red Blood Cells
Porphobilinogen synthase [Enzymatic activity/mass] in Red Blood Cells
Purine nucleoside phosphorylase [Enzymatic activity/substance] in Red Blood Cells
Lassa virus Ag [Presence] in Serum by Immunoassay
Purine nucleoside phosphorylase [Enzymatic activity/volume] in DBS
Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/mass] in Red Blood Cells
Uridine monophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells
1,4-Cyclohexanediol/Creatinine [Molar ratio] in Urine
Phenylpropionylglycine [Moles/volume] in Serum or Plasma
Hexanoylglycine [Moles/volume] in Serum or Plasma
3,4-Dihydroxybutyrate/Creatinine [Molar ratio] in Urine
Legionella pneumophila Ab [Presence] in Serum
2,5-Furandicarboxylate [Moles/volume] in Serum or Plasma
Ethylmalonate [Moles/volume] in Serum or Plasma
5-Hydroxymethyl-2-Furoate/Creatinine [Molar ratio] in Urine
Salicylurate/Creatinine [Molar ratio] in Urine
3-Hydroxyadipate 3,6-lactone [Moles/volume] in Serum or Plasma
Erythrocytes [#/volume] in Pleural fluid by Automated count
3,4-Dihydroxyhydrocinnamate [Moles/volume] in Serum or Plasma
Hydantoin-5-propionate/Creatinine [Molar ratio] in Urine
3-(3-Hydroxyphenyl)propanoate/Creatinine [Molar ratio] in Urine
Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence
Vanilloylglycine/Creatinine [Molar ratio] in Urine
Levulinate [Moles/volume] in Serum or Plasma
4-Hydroxyvalerate/Creatinine [Molar ratio] in Urine
3,5-Dihydroxybenzoate/Creatinine [Molar ratio] in Urine
Lactyl lactate/Creatinine [Molar ratio] in Urine
3,4-Dihydroxybutyrate [Moles/volume] in Serum or Plasma
Salicylurate [Moles/volume] in Serum or Plasma
3,4-Dihydroxyhydrocinnamate/Creatinine [Molar ratio] in Urine
Legionella pneumophila 2 Ab [Titer] in Serum by Immunofluorescence
3-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma
Furoylglycine [Moles/volume] in Serum or Plasma
3-Hydroxysuberate.unsaturated [Moles/volume] in Serum or Plasma
Pimelate/Creatinine [Molar ratio] in Urine
Azelate [Moles/volume] in Serum or Plasma
Hydantoin-5-propionate [Moles/volume] in Serum or Plasma
3-Hydroxybenzoate [Moles/volume] in Serum or Plasma
4-Hydroxyhippurate/Creatinine [Molar ratio] in Urine
Catecholamine metabolites panel - Serum or Plasma
Furoylglycine/Creatinine [Molar ratio] in Urine
3-Hydroxyhippurate/Creatinine [Molar ratio] in Urine
4-Hydroxyvalerate [Moles/volume] in Serum or Plasma
4-Hydroxyhippurate [Moles/volume] in Serum or Plasma
Levulinate/Creatinine [Molar ratio] in Urine
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Serum or Plasma
Desaminotyrosine [Moles/volume] in Serum or Plasma
P-cresol/Creatinine [Molar ratio] in Urine
4-Hydroxymandelate [Moles/volume] in Serum or Plasma
Legionella pneumophila 3 Ab [Titer] in Serum by Immunofluorescence
Decenedioate [Moles/volume] in Serum or Plasma
3-Hydroxyhippurate [Moles/volume] in Serum or Plasma
Suberylglycine [Moles/volume] in Serum or Plasma
Vanilloylglycine [Moles/volume] in Serum or Plasma
1,4-Cyclohexanediol [Moles/volume] in Serum or Plasma
N-acetyltyrosine [Moles/volume] in Serum or Plasma
Gentisate [Moles/volume] in Serum or Plasma
Octenedioate (C8:1) [Moles/volume] in Serum or Plasma
Legionella pneumophila 4 Ab [Titer] in Serum by Immunofluorescence
Desaminotyrosine/Creatinine [Molar ratio] in Urine
3-Hydroxybenzoate/Creatinine [Molar ratio] in Urine
Pimelate [Moles/volume] in Serum or Plasma
4-Deoxythreonate [Moles/volume] in Serum or Plasma
Lactyl lactate [Moles/volume] in Serum or Plasma
2,5-Furandicarboxylate/Creatinine [Molar ratio] in Urine
3-(3-Hydroxyphenyl)propanoate [Moles/volume] in Serum or Plasma
P-cresol [Moles/volume] in Serum or Plasma
Legionella pneumophila 5 Ab [Titer] in Serum by Immunofluorescence
3-Hydroxysebacate (3-OH-C8) unsaturated [Moles/volume] in Serum or Plasma
3,5-Dihydroxybenzoate [Moles/volume] in Serum or Plasma
4-Deoxythreonate/Creatinine [Molar ratio] in Urine
5-Hydroxymethyl-2-Furoate [Moles/volume] in Serum or Plasma
Legionella pneumophila 6 Ab [Titer] in Serum by Immunofluorescence
Formate [Moles/volume] in Serum or Plasma by Confirmatory method
Legionella pneumophila 7 Ab [Titer] in Serum by Immunofluorescence
Erythrocytes [#/volume] in Peritoneal fluid by Manual count
Legionella pneumophila 8 Ab [Titer] in Serum by Immunofluorescence
Mucopolysaccharidosis type I newborn screening panel
Mucopolysaccharidosis type I newborn screen interpretation
Mucopolysaccharidosis type I newborn screening comment-discussion
Legionella pneumophila 9 Ab [Titer] in Serum by Immunofluorescence
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS by LC/MS/MS
ABCD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MLH1+MSH2+MSH6+PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
BCHE gene full mutation analysis in Blood or Tissue by Sequencing
Folate and tryptophan and metabolites panel - Cerebral spinal fluid
Riboflavin and flavin mononucleotide and flavin adenine dinucleotide panel - Serum or Plasma
Legionella sp Ab [Units/volume] in Serum
Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative
Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - 24 hour Urine
Allocystathionine [Moles/volume] in Serum or Plasma
Levodopa/Creatinine [Molar ratio] in Urine
N6-Acetyl-L-lysine [Moles/volume] in Serum or Plasma
Alanylproline/Creatinine [Molar ratio] in Urine
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Urine Narrative
Alanylproline [Moles/volume] in Serum or Plasma
Beta-ureidoisobutyrate [Moles/volume] in Serum or Plasma
R- and S-beta aminoisobutyrate and D- and L-serine panel - Serum or Plasma
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Urine
Aspartylglycine [Moles/volume] in Serum or Plasma
R- and S-beta aminoisobutyrate and D- and L-serine panel - Cerebral spinal fluid
L-homoarginine/Creatinine [Molar ratio] in Urine
Prolylhydroxyproline [Moles/volume] in Serum or Plasma
Aspartylglycosamine [Moles/volume] in Serum or Plasma
Alpha aminoisobutyrate [Moles/volume] in Serum or Plasma
N-alpha acetyllysine [Moles/volume] in Serum or Plasma
Homocitrulline/Creatinine [Molar ratio] in Urine
Allocystathionine/Creatinine [Molar ratio] in Urine
Glycylproline/Creatinine [Molar ratio] in Urine
N,N'-dimethylarginine [Moles/volume] in Serum or Plasma
D-serine/Creatinine [Molar ratio] in Urine
N-monomethylarginine/Creatinine [Molar ratio] in Urine
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Urine Narrative
Cysteate/Creatinine [Molar ratio] in Urine
Glutathione.reduced [Moles/volume] in Serum or Plasma
L-serine [Moles/volume] in Cerebral spinal fluid
Homocarnosine [Moles/volume] in Serum or Plasma
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Cerebral spinal fluid
S-beta aminoisobutyrate [Moles/volume] in Serum or Plasma
R- and S-beta aminoisobutyrate and D- and L-serine panel - Urine
Cysteate [Moles/volume] in Serum or Plasma
Saccharopine [Moles/volume] in Serum or Plasma
Leptospira interrogans Ab [Units/volume] in Serum by Hemagglutination
2-Methyltyrosine [Moles/volume] in Serum or Plasma
Glutathione.oxidized [Moles/volume] in Serum or Plasma
D-serine [Moles/volume] in Serum or Plasma
Prolylhydroxyproline/Creatinine [Molar ratio] in Urine
L-homoarginine [Moles/volume] in Serum or Plasma
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Cerebral spinal fluid Narrative
N-monomethylarginine [Moles/volume] in Serum or Plasma
R-beta aminoisobutyrate [Moles/volume] in Serum or Plasma
Measles virus Ab [Units/volume] in Serum
S-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid
Glycylproline [Moles/volume] in Serum or Plasma
L-serine [Moles/volume] in Serum or Plasma
S-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine
Formiminoglutamate/Creatinine [Molar ratio] in Urine
R-beta aminoisobutyrate/Creatinine [Molar ratio] in Urine
Alpha aminoisobutyrate/Creatinine [Molar ratio] in Urine
Measles virus IgG Ab [Units/volume] in Serum
5-S-cysteinyldopa [Moles/volume] in Serum or Plasma
Aspartylglycine/Creatinine [Molar ratio] in Urine
L-leucyl-L-proline/Creatinine [Molar ratio] in Urine
N-alpha acetyllysine/Creatinine [Molar ratio] in Urine
Formiminoglutamate [Moles/volume] in Serum or Plasma
R-beta aminoisobutyrate [Moles/volume] in Cerebral spinal fluid
Erythrocytes [#/volume] in Synovial fluid by Automated count
R- and S-beta aminoisobutyrate and D- and L-serine pattern [Interpretation] in Serum or Plasma Narrative
L-homoserine [Moles/volume] in Serum or Plasma
Measles virus IgM Ab [Units/volume] in Serum
Homocarnosine/Creatinine [Molar ratio] in Urine
L-leucyl-L-proline [Moles/volume] in Serum or Plasma
N6-Acetyl-L-lysine/Creatinine [Molar ratio] in Urine
N,N-dimethylarginine/Creatinine [Molar ratio] in Urine
Aspartylglycosamine/Creatinine [Molar ratio] in Urine
Glutathione.oxidized/Creatinine [Molar ratio] in Urine
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Serum or Plasma Narrative
N,N'-dimethylarginine/Creatinine [Molar ratio] in Urine
Measles virus RNA [Presence] in Nose by NAA with probe detection
Saccharopine/Creatinine [Molar ratio] in Urine
Glutathione.reduced/Creatinine [Molar ratio] in Urine
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate pattern [Interpretation] in Cerebral spinal fluid Narrative
5-S-cysteinyldopa/Creatinine [Molar ratio] in Urine
L-homoserine/Creatinine [Molar ratio] in Urine
L-serine/Creatinine [Molar ratio] in Urine
Delta aminolevulinate [Moles/volume] in Serum or Plasma
Beta-ureidoisobutyrate/Creatinine [Molar ratio] in Urine
D-serine [Moles/volume] in Cerebral spinal fluid
Homocysteine cysteine disulfide/Creatinine [Molar ratio] in Urine
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Serum or Plasma
Dihydrothymine [Moles/volume] in Cerebral spinal fluid
5-Aminoimidazole-4-carboxamide [Moles/volume] in Cerebral spinal fluid
Dihydroorotate [Moles/volume] in Serum or Plasma
Cytosine [Moles/volume] in Serum or Plasma
N-carbamoyl beta alanine [Moles/volume] in Serum or Plasma
Pseudouridine [Moles/volume] in Serum or Plasma
Cytosine/Creatinine [Molar ratio] in Urine
Purine and Pyrimidine pattern [Interpretation] in Serum or Plasma Narrative
Guanosine [Moles/volume] in Cerebral spinal fluid
Dihydroorotate [Moles/volume] in Cerebral spinal fluid
Allopurinol [Moles/volume] in Serum or Plasma
Guanine [Moles/volume] in Cerebral spinal fluid
N-carbamoyl beta alanine [Moles/volume] in Cerebral spinal fluid
Mumps virus IgG Ab [Units/volume] in Serum
Purine and Pyrimidine panel - Serum or Plasma
Purine and Pyrimidine pattern [Interpretation] in Cerebral spinal fluid Narrative
5,6-Dihydrouridine [Moles/volume] in Serum or Plasma
Purine and Pyrimidine panel - Cerebral spinal fluid
Dihydrothymine [Moles/volume] in Serum or Plasma
Guanosine [Moles/volume] in Serum or Plasma
Cytidine [Moles/volume] in Cerebral spinal fluid
5-Aminoimidazole-4-carboxamide/Creatinine [Molar ratio] in Urine
Mumps virus IgM Ab [Units/volume] in Serum
Pseudouridine [Moles/volume] in Cerebral spinal fluid
Cytidine [Moles/volume] in Serum or Plasma
5,6-Dihydrouridine [Moles/volume] in Cerebral spinal fluid
Purine and Pyrimidine pattern [Interpretation] in Urine Narrative
5,6-Dihydrouridine/Creatinine [Molar ratio] in Urine
5-Aminoimidazole-4-carboxamide [Moles/volume] in Serum or Plasma
2,8-dihydroxyadenine [Moles/volume] in Cerebral spinal fluid
Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Allopurinol/Creatinine [Molar ratio] in Urine
5,6-Dihydrouracil [Moles/volume] in Serum or Plasma
Cytosine [Moles/volume] in Cerebral spinal fluid
Cytidine/Creatinine [Molar ratio] in Urine
5,6-Dihydrouracil/Creatinine [Molar ratio] in Urine
5-Hydroxymethyluracil [Moles/volume] in Cerebral spinal fluid
2,8-dihydroxyadenine/Creatinine [Molar ratio] in Urine
5-Hydroxymethyluracil [Moles/volume] in Serum or Plasma
Allopurinol [Moles/volume] in Cerebral spinal fluid
Guanine [Moles/volume] in Serum or Plasma
Oxipurinol [Moles/volume] in Cerebral spinal fluid
2,8-dihydroxyadenine [Moles/volume] in Serum or Plasma
5,6-Dihydrouracil [Moles/volume] in Cerebral spinal fluid
Eicosadienoate (C20:2w6) [Moles/volume] in Serum or Plasma
Octadecatetraenoate (C18:4w3) [Moles/volume] in Serum or Plasma
cis-11-Eicosenoate (cis 11 C20:1w9) [Entitic substance] in Red Blood Cells
Docosadienoate (C22:2w6) [Entitic substance] in Red Blood Cells
Docosadienoate (C22:2w6) [Moles/volume] in Serum or Plasma
Mycoplasma pneumoniae Ab [Units/volume] in Serum
cis-11-Eicosenoate (cis 11 C20:1w9) [Moles/volume] in Serum or Plasma
cis-11,14-Eicosadienoate (cis 11,14 C20:2w6) [Moles/volume] in Serum or Plasma
Fatty acids.very long chain.C22:1n9 (Erucate) [Moles/volume] in Serum or Plasma
cis-13-Eicosenoate (cis 13 C20:1w7) [Entitic substance] in Red Blood Cells
cis-13-Eicosenoate (cis 13 C20:1w7) [Moles/volume] in Serum or Plasma
Homo-gamma Linolenate (C20:3w6) [Entitic substance] in Red Blood Cells
Eicosadienoate (C20:2w6) [Entitic substance] in Red Blood Cells
Octadecatetraenoate (C18:4w3) [Entitic substance] in Red Blood Cells
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
Fatty acids.very long chain C26:1 (Hexacosenoate)/C22:0 (Docosanoate) [Molar ratio] in Serum or Plasma
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Erythrocytes [#/volume] in Synovial fluid by Manual count
HLA-B*58:01 [Presence] in Blood or Tissue
HLA-A*31:01 [Presence] in Blood or Tissue
TPMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid
CYP2D6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP3A5 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
UGT1A1 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP2B6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP4F2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
SLCO1B1 gene product functional interpretation in Blood or Tissue Qualitative by Molecular genetics method
Neisseria meningitidis serogroup Y Ab [Presence] in Specimen
Norovirus [Presence] in Stool by Electron microscopy
Norovirus RNA [Presence] in Stool by NAA with probe detection
Human papilloma virus Ab [Presence] in Genital specimen
Paracoccidioides brasiliensis Ab [Units/volume] in Serum
Platelet dense bodies [Presence] in Blood by Electron microscopy
Paragonimus sp Ab [Units/volume] in Serum
Parainfluenza virus 1 Ab [Units/volume] in Serum
Parainfluenza virus 2 Ab [Units/volume] in Serum
Parainfluenza virus 3 Ab [Units/volume] in Serum
Parvovirus B19 IgM Ab [Presence] in Serum
Parvovirus B19 Ab [Units/volume] in Serum
Parvovirus B19 IgG Ab [Units/volume] in Serum
Parvovirus B19 IgM Ab [Units/volume] in Serum
Polio virus 1 Ab [Units/volume] in Serum
Polio virus 2 Ab [Units/volume] in Serum
Polio virus 3 Ab [Units/volume] in Serum
Burkholderia pseudomallei IgG Ab [Units/volume] in Serum
Erythrocytes [#/volume] in Urine by Automated count
Burkholderia pseudomallei IgM Ab [Units/volume] in Serum
Respiratory syncytial virus Ab [Units/volume] in Serum
Respiratory syncytial virus IgG Ab [Units/volume] in Serum
Respiratory syncytial virus IgM Ab [Units/volume] in Serum
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
Rickettsia sp Ab [Units/volume] in Serum
Rickettsia prowazekii Ab [Units/volume] in Serum
Rickettsia prowazekii RNA [Presence] in Serum by NAA with probe detection
Erythrocytes [#/volume] in Urine by Manual count
Rickettsia spotted fever group Ab [Units/volume] in Serum
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum
Rickettsia typhus group Ab [Units/volume] in Serum
Rickettsia typhus group IgG Ab [Units/volume] in Serum
Rickettsia typhus group IgM Ab [Units/volume] in Serum
Schistocytes [Presence] in Blood by Light microscopy
Rickettsia rickettsii IgG Ab [Units/volume] in Serum
Rickettsia rickettsii IgM Ab [Units/volume] in Serum
Rickettsia rickettsii RNA [Presence] in Serum by NAA with probe detection
Orientia tsutsugamushi Ab [Units/volume] in Serum
Rickettsia typhi IgG Ab [Units/volume] in Serum
Rickettsia typhi IgM Ab [Units/volume] in Serum
Glycyl-4-hydroxyproline/Creatinine [Molar ratio] in Urine
Bartonella quintana IgG Ab [Units/volume] in Serum
Glucosamine [Moles/volume] in Serum or Plasma
Glutamylphenylalanine/Creatinine [Molar ratio] in Urine
Galactosamine/Creatinine [Molar ratio] in Urine
Glutamylphenylalanine [Moles/volume] in Serum or Plasma
Glycyl-4-hydroxyproline [Moles/volume] in Serum or Plasma
Glucosamine/Creatinine [Molar ratio] in Urine
L-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine
D-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine
Bartonella quintana IgM Ab [Units/volume] in Serum
Sickle cells [Presence] in Blood by Light microscopy
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method
7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method
Rotavirus [Presence] in Stool by Electron microscopy
Acebutolol [Mass/mass] in Hair by Confirmatory method
Acyclovir [Mass/volume] in Cerebral spinal fluid
Alfentanil [Mass/volume] in Blood by Confirmatory method
Rotavirus dsRNA [Presence] in Stool by NAA with probe detection
Aluminum [Moles/volume] in Cerebral spinal fluid
Amoxicillin [Mass/volume] in Cerebral spinal fluid
Amphetamine [Mass/mass] in Hair by Confirmatory method
Rubella virus Ab [Units/volume] in Serum
Amphetamine [Mass/volume] in Body fluid by Confirmatory method
Antihistamines [Presence] in Blood by Screen method
Antihistamines [Presence] in Body fluid by Screen method
Atazanavir [Mass/volume] in Cerebral spinal fluid by Confirmatory method
Rubella virus IgG Ab [Units/volume] in Serum
Ecgonine methyl ester [Presence] in Urine by Screen method
Tricyclic antidepressants [Presence] in Blood by Screen method
Tricyclic antidepressants [Presence] in Body fluid by Screen method
Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method
Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL
Rubella virus IgM Ab [Units/volume] in Serum
Brucella abortus IgG Ab [Titer] in Serum by Agglutination
N-methylhistamine/Creatinine [Molar ratio] in 24 hour Urine
Soluble CD27 [Units/volume] in Cerebral spinal fluid
Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS
Soluble CD27 [Units/volume] in Serum or Plasma
3-Methoxytyramine/Creatinine [Molar ratio] in Urine
Etiocholanolone [Moles/volume] in Serum or Plasma
Galactosylhydroxylysine/Creatinine [Molar ratio] in Urine
27-Norcholestanehexol/Creatinine [Ratio] in Urine
5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine [Ratio] in Urine
5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine [Ratio] in Urine
Bile alcohols [Interpretation] in Urine Qualitative
Bile alcohols pattern [Interpretation] in Urine Narrative
2-Amino-4-hydroxypteridine [Moles/volume] in Cerebral spinal fluid
2-Amino-4-hydroxypteridine [Moles/volume] in Serum or Plasma
2-Amino-4-hydroxypteridine/Creatinine [Molar ratio] in Serum or Plasma
Saint Louis encephalitis virus IgG Ab [Units/volume] in Serum
Pterins pattern [Interpretation] in Urine Narrative
Pterins pattern [Interpretation] in Serum or Plasma Narrative
Pterins pattern [Interpretation] in Cerebral spinal fluid Narrative
S-adenosylhomocysteine [Moles/volume] in Cerebral spinal fluid
S-adenosylhomocysteine [Moles/volume] in Serum or Plasma
Saint Louis encephalitis virus IgM Ab [Units/volume] in Serum
S-adenosylhomocysteine/Creatinine [Molar ratio] in Urine
S-adenosylmethionine [Moles/volume] in Cerebral spinal fluid
S-adenosylmethionine and S-adenosylhomocystine panel - Serum or Plasma
S-adenosylmethionine and S-adenosylhomocystine panel - Cerebral spinal fluid
S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Cerebral spinal fluid Narrative
S-adenosylmethionine and S-adenosylhomocystine pattern [Interpretation] in Serum or Plasma Narrative
S-adenosylmethionine/Creatinine [Molar ratio] in Urine
Xanthopterin [Moles/volume] in Serum or Plasma
Schistosoma japonicum Ab [Units/volume] in Serum
Xanthopterin [Moles/volume] in Cerebral spinal fluid
Xanthopterin/Creatinine [Molar ratio] in Urine
JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
Galactosamine [Moles/volume] in Serum or Plasma
Schistosoma mansoni Ab [Units/volume] in Serum
Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method
Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method
Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method
Ecgonine methyl ester [Presence] in Blood by Screen method
Antihistamines [Presence] in Serum or Plasma by Screen method
Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method
Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method
Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)
Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method
Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activated
HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay
Influenza virus A and B identified in Nasopharynx by Shell vial culture
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence
Leishmania infantum+donovani IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Beta blockers [Presence] in Hair by Screen method
Beta blockers [Presence] in Blood by Screen method
Beta blockers [Presence] in Serum or Plasma by Screen method
Beta blockers [Presence] in Body fluid by Screen method
Mycoplasma hyopneumoniae Ag [Presence] in Fixed tissue by Immune stain
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay
Mycoplasma hyopneumoniae Ab sample/Buffer control in Serum by Immunoassay
Mycoplasma hyopneumoniae Ab sample/Positive control in Serum by Immunoassay
NMDAR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
NMDAR IgG Ab [Titer] in Serum by Immunofluorescence
Saint Louis encephalitis virus Ab [Units/volume] in Serum by Complement fixation
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunoassay
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunofluorescence
Mycoplasma hyopneumoniae DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Saint Louis encephalitis virus RNA [Presence] in Serum by NAA with probe detection
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum by Immunoassay
Spherocytes [Presence] in Blood by Light microscopy
Streptococcus pneumoniae Ab [Presence] in Serum
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae IgM Ab [Units/volume] in Serum
Strongyloides sp Ab [Units/volume] in Serum
Escherichia coli enteropathogenic eae gene [Presence] in Stool by NAA with non-probe detection
Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes [Presence] in Stool by NAA with non-probe detection
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with non-probe detection
Escherichia coli enterotoxigenic ltA+st1a+st1b genes [Presence] in Stool by NAA with non-probe detection
Environment temperature during transport
Herpes simplex virus 1 genome DNA polymerase region B+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Anogenital specimen by Probe and target amplification method
Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection
Strongyloides stercoralis IgG Ab [Presence] in Serum
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection
Chlamydia trachomatis DNA [Presence] in Anorectal by NAA with probe detection
Chlamydia trachomatis rRNA [Presence] in Anorectal by NAA with probe detection
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection
Taenia saginata Ab [Units/volume] in Serum
Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection
Chlamydia trachomatis [Presence] in Anorectal by Organism specific culture
Neisseria gonorrhoeae [Presence] in Anorectal by Organism specific culture
Neisseria sp identified in Anorectal by Organism specific culture
Toxic granules [Presence] in Blood by Light microscopy
Biotinidase [Enzymatic activity/mass] in Serum or Plasma
Chitotriosidase [Enzymatic activity/mass] in Serum or Plasma
Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay
Helicobacter pylori Ag [Presence] in Stool by Rapid immunoassay
Taenia solium adult Ab [Units/volume] in Serum
Adenovirus and Norovirus and Rotavirus Ag panel - Stool by Rapid immunoassay
Norovirus Ag [Presence] in Stool by Rapid immunoassay
Rotavirus and Adenovirus Ag panel - Stool by Rapid immunoassay
Influenza virus A and B Ag panel - Upper respiratory specimen by Rapid immunoassay
Toxocara canis Ab [Units/volume] in Serum
Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay
Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay
Bladder tumor Ag [Presence] in Urine by Rapid immunoassay
HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Toxoplasma gondii IgG Ab [Units/volume] in Serum
Toxoplasma gondii IgM Ab [Units/volume] in Serum
Treponema pallidum Ab [Presence] in Serum by Hemagglutination
Trichinella spiralis Ab [Units/volume] in Serum
Inosine triphosphate pyrophosphatase [Enzymatic activity/substance] in Red Blood Cells
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in DBS
Hepatitis D virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Trichinella spiralis IgG Ab [Presence] in Serum
Leukocytes [#/volume] in Blood by Manual count
Trypanosoma cruzi Ab [Units/volume] in Serum
Varicella zoster virus Ab [Units/volume] in Serum
Varicella zoster virus IgG Ab [Units/volume] in Serum
Varicella zoster virus IgM Ab [Units/volume] in Serum
Varicella zoster virus DNA [Presence] in Serum by NAA with probe detection
Venezuelan equine encephalitis virus IgG Ab [Units/volume] in Serum
Venezuelan equine encephalitis virus IgM Ab [Units/volume] in Serum
Kappa light chains.free [Mass/volume] in Serum by Nephelometry
Lambda light chains.free [Mass/volume] in Serum by Nephelometry
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry
Clostridium baratii toxin F bont gene [Presence] in Specimen by NAA with probe detection
Leukocytes [#/volume] in Cerebral spinal fluid by Automated count
Western equine encephalitis virus IgG Ab [Units/volume] in Serum
Western equine encephalitis virus IgM Ab [Units/volume] in Serum
Methylenedioxyamphetamine [Mass/mass] in Hair
Methylenedioxyethylamphetamine [Mass/mass] in Hair
Methylenedioxyethylamphetamine [Mass/volume] in Blood
Methylenedioxymethamphetamine [Mass/mass] in Hair
Rilpivirine [Mass/volume] in Serum or Plasma
Yellow fever virus Ab [Units/volume] in Serum
Tetrahydrocannabinol [Mass/mass] in Hair
Zopiclone [Mass/volume] in Serum or Plasma
Yellow fever virus IgG Ab [Units/volume] in Serum
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair
Yellow fever virus IgM Ab [Units/volume] in Serum
Yellow fever virus RNA [Presence] in Serum by NAA with probe detection
Acetylcholine receptor Ab [Units/volume] in Serum
Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection
Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H3 HA gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 1 F gene [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 2 L gene [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 3 NP gene [Presence] in Nasopharynx by NAA with probe detection
Parainfluenza virus 4 P gene [Presence] in Nasopharynx by NAA with probe detection
Rhinovirus 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection
Respiratory syncytial virus A 5' UTR RNA [Presence] in Nasopharynx by NAA with probe detection
Respiratory syncytial virus B F gene [Presence] in Nasopharynx by NAA with probe detection
Bordetella holmesii fumC gene [Presence] in Nasopharynx by NAA with probe detection
Leukocytes [#/volume] in Cerebral spinal fluid by Manual count
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with probe detection
Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Nasopharynx by NAA with probe detection
Respiratory pathogens identified [Type] in Nasopharynx by NAA with probe detection
Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Desacetylrifampicin [Mass/volume] in Serum or Plasma
Desacetylrifampicin [Mass/volume] in DBS
Adrenal cortex Ab [Units/volume] in Serum
14-Hydroxyclarithromycin [Mass/volume] in Serum or Plasma
14-Hydroxyclarithromycin [Mass/volume] in DBS
Cefuroxime [Mass/volume] in Serum or Plasma
Phosphate [Moles/volume] in Urine collected for unspecified duration
Bicarbonate [Moles/volume] in Urine collected for unspecified duration
Cefuroxime free [Mass/volume] in Serum or Plasma
Zika virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Zika virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --1st specimen
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --2nd specimen
Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma
1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Blood
Cardiolipin IgA Ab [Units/volume] in Serum or Plasma
1,2-Dichloroethane [Mass/volume] in Blood
1,3-Dimethylbenzene+1,4-Dimethylbenzene [Mass/volume] in Blood
2-Methylpropyl methylphosphonate [Mass/volume] in Blood
Aldicarb sulfoxide [Mass/volume] in Urine
Bedaquiline [Mass/volume] in Serum or Plasma
Disopyramide+Nordisopyramide [Mass/volume] in Serum or Plasma
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma
Floxacillin Free [Mass/volume] in Serum or Plasma
Isopropyl methylphosphonate [Mass/volume] in Blood
Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma
Monocyclohexyl methylphosphonate [Mass/volume] in Blood
Monoethyl methylphosphonate [Mass/volume] in Blood
N-monodesmethyl bedaquiline [Mass/volume] in Serum or Plasma
Tetramethylenedisulfotetramine [Mass/volume] in Urine
Voriconazole N-oxide [Mass/volume] in Serum or Plasma
Spermatozoa Normal chromatin/100 spermatozoa in Semen by Romanowsky stain
Spermatozoa Progressive Grade 1+2/100 spermatozoa in Semen
Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
Hemoglobin G - Philadelphia/Hemoglobin.total in Blood
Hemoglobin Hope/Hemoglobin.total in Blood
Activated clotting time (ACT) of Blood induced by Diatomaceous earth
Activated clotting time (ACT) of Blood induced by Kaolin
Strongyloides sp IgG Ab [Presence] in Serum by Immunoassay
4-Hydroxy 3-Nitrophenylacetate (HNPAA) [Mass/volume] in Urine
Cardiolipin IgM Ab [Units/volume] in Serum or Plasma
Adenovirus 40+41 fiber protein gene [Presence] in Stool by NAA with probe detection
Rotavirus A VP6 gene [Presence] in Stool by NAA with probe detection
Escherichia coli O157 rfbE gene [Presence] in Stool by NAA with probe detection
Escherichia coli enterotoxigenic eltA+estB genes [Presence] in Stool by NAA with probe detection
Salmonella sp invA+fliC genes [Presence] in Stool by NAA with probe detection
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection
Vibrio cholerae toxin ctxA gene [Presence] in Stool by NAA with probe detection
Cryptosporidium parvum+hominis oocyst wall protein COWP gene [Presence] in Stool by NAA with probe detection
Entamoeba histolytica 18S rRNA [Presence] in Stool by NAA with probe detection
Giardia lamblia 18S rRNA [Presence] in Stool by NAA with probe detection
Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection
CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CYP1A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HIV 1 RNA tropism [Identifier] in Plasma
HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by Sequencing
HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cells
HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing
HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing
HIV 1 proviral DNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing
HIV 1 proviral DNA genotype [Interpretation] in Mononuclear cells from whole blood Narrative
HIV 1 proviral DNA genotype in Mononuclear cells from whole blood
2-Chlorovinyl arsonous acid [Mass/volume] in Urine
Mycophenolate acyl-glucuronide [Mass/volume] in Serum or Plasma
Viable CD34 cells/100 CD34 cells in Hematopoietic progenitor cells from Blood product unit
CD4-CD8-/100 CD3+TCR alpha beta+ cells in Blood
CD25+CD127- (regulatory T) cells/100 CD3+CD4+ cells in Blood
CD27+CD45RA- cells/100 CD3+CD4+ cells in Blood
CD27+CD45RA- cells/100 CD3+CD8+ cells in Blood
CD27+CD45RA+ cells/100 CD3+CD4+ cells in Blood
CD27+CD45RA+ cells/100 CD3+CD8+ cells in Blood
CD27+IgD- cells/100 CD19+CD20+ cells in Blood
CD27+IgD+ cells/100 CD19+CD20+ cells in Blood
CD27-CD45RA- cells/100 CD3+CD4+ cells in Blood
CD27-CD45RA+ cells/100 CD3+CD4+ cells in Blood
CD27-IgD+ cells/100 CD19+CD20+ cells in Blood
CD38+HLA-DR+ cells/100 CD3+CD4+ cells in Blood
CD38+HLA-DR+ cells/100 CD3+CD8+ cells in Blood
TCR alpha beta cells/100 CD3 cells in Blood
TCR gamma delta cells/100 CD3 cells in Blood
FSHR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
T-cell activated (CD38+HLA-DR+) subsets panel - Blood
B-cell CD27 and IgD subsets panel - Blood
Lymphocyte TCR gamma delta and alpha beta subsets panel - Blood
T-cell naive and memory and effector (CD27 and CD45RA) subsets [Interpretation] in Blood Narrative
T-cell naive and memory and effector (CD27 and CD45RA) subsets panel - Blood
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
Lymphocyte T-cell and B-cell and Natural killer subsets [Interpretation] in Blood Narrative
B-cell CD27 and IgD subsets [Interpretation] in Blood Narrative
Estimated Non-liquefied volume [Volume Fraction] in Semen
Trichomonas sp [Presence] in Semen by Light microscopy
Calculated panel reactive antibody - Serum
TPMT gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
Insulin bovine Ab [Units/volume] in Serum
Insulin human Ab [Units/volume] in Serum
Insulin porcine Ab [Units/volume] in Serum
Jo-1 extractable nuclear Ab [Presence] in Serum
Leukocytes [#/volume] in Pleural fluid by Automated count
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum
Myelin basic protein Ab [Titer] in Serum
Zika virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test
Zika virus neutralizing antibody [Presence] in Serum by Neutralization test
Zika virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Zika virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Zika virus envelope E gene [Presence] in Serum by NAA with probe detection
Zika virus envelope E gene [Presence] in Cerebral spinal fluid by NAA with probe detection
Clostridium botulinum and Clostridium baratii toxins gene panel - Specimen by NAA with probe detection
Pepsin A+Pepsinogen A [Mass/volume] in Lower respiratory specimen by Immunoassay
Pepsin A+Pepsinogen A [Interpretation] in Lower respiratory specimen Narrative
Pepsin A Panel - Lower respiratory specimen
Protein [Mass/volume] in Lower respiratory specimen
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum
Leukocytes [#/volume] in Pleural fluid by Manual count
Pancreatic islet cell Ab [Units/volume] in Serum
Parietal cell Ab [Units/volume] in Serum
PCNA extractable nuclear Ab [Presence] in Serum
Heparin unfractionated [Units/volume] in Blood by Heparin protamine titration
Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculation
2-Methyltyrosine/Creatinine [Molar ratio] in Urine
Platelet associated IgG Ab [Units/volume] in Blood
Platelet associated IgM Ab [Units/volume] in Blood
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum
Gadolinium [Mass/volume] in Serum or Plasma
SCL-70 extractable nuclear Ab [Presence] in Serum
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum
Leukocytes [#/volume] in Peritoneal fluid by Automated count
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum
cefTRIAXone free [Mass/volume] in Serum or Plasma
Fractional excretion of magnesium [Ratio] in Urine and Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post meal
Somatotropin Ab [Units/volume] in Serum or Plasma
cefTAZidime free [Mass/volume] in Serum or Plasma
Cefotaxime free [Mass/volume] in Serum or Plasma
ceFAZolin free [Mass/volume] in Serum or Plasma
Salicylates free [Mass/volume] in Serum or Plasma
Acetaminophen free [Mass/volume] in Serum or Plasma
Topiramate free [Mass/volume] in Serum or Plasma
Tobramycin free [Mass/volume] in Serum or Plasma
Theophylline free [Mass/volume] in Serum or Plasma
Teicoplanin free [Mass/volume] in Serum or Plasma
Methotrexate free [Mass/volume] in Serum or Plasma
Lithium free [Moles/volume] in Serum or Plasma
Gentamicin free [Mass/volume] in Serum or Plasma
Amikacin free [Mass/volume] in Serum or Plasma
Trimethoprim free [Mass/volume] in Serum or Plasma
Sulfamethoxazole free [Mass/volume] in Serum or Plasma
N,N-dimethylarginine [Mass/volume] in Serum or Plasma
Phytanoyl CoA hydroxlase [Enzymatic activity/mass] in Fibroblast
Thyroglobulin Ab [Units/volume] in Serum or Plasma
Thyroperoxidase Ab [Units/volume] in Serum or Plasma
Cefixime [Susceptibility] by Disk diffusion (KB)
CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
Leukocytes [#/volume] in Peritoneal fluid by Manual count
West Nile virus Kunjin strain IgM Ab [Presence] in Serum
West Nile virus Kunjin strain Ab [Presence] in Serum
Leptospira borgpetersenii sv Arborea Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Bulgarica Ab [Titer] in Serum by Agglutination
Leukocytes [#/volume] in Semen by Automated count
Leptospira interrogans sv Celledoni Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Copenhageni Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Cynopteri Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Kremastos Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Medanensis Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Panama Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Robinsoni Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Shermani Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Szwajizak Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Zanoni Ab [Titer] in Serum by Agglutination
Leptospira weilii serovar Topaz Ab [Titer] in Serum by Agglutination
Murray Valley encephalitis virus IgG Ab [Presence] in Serum
Murray Valley encephalitis virus IgG Ab [Titer] in Serum
Murray Valley encephalitis virus IgM Ab [Presence] in Serum
Murray Valley encephalitis virus IgM Ab [Titer] in Serum
Murray Valley encephalitis virus Ab [Titer] in Serum
Hepatitis C virus core Ab+Ag [Presence] in Serum
Ross River virus RNA [Presence] in Serum by NAA with probe detection
Legionella sp IgM Ab [Presence] in Serum
Epstein Barr virus capsid IgG Ab avidity [Ratio] in Serum by Immunoassay
Murray Valley encephalitis virus Ab [Presence] in Serum
HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing
Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assay
CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
Platelet aggregation.ristocetin inhibitor [Presence] in Platelet poor plasma
Spermatozoa Aggregated [Presence] in Semen
CYP3A4 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
CYP3A5 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Spermatozoa motility [Score] in Semen by Automated
PTPN22 gene.c.1858C>T [Presence] in Blood or Tissue by Molecular genetics method
Galactokinase [Enzymatic activity/mass] in Red Blood Cells
CYP3A4 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Specimen source patient identification [Interpretation] Narrative
Zika virus envelope E gene [Presence] in Urine by NAA with probe detection
Zika virus envelope E gene [Presence] in Amniotic fluid by NAA with probe detection
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Serum by NAA with probe detection
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Serum by NAA with probe detection
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Dengue and Chikungunya and Zika virus panel by NAA with probe detection
Islet cell 512 Ab [Moles/volume] in Serum
Coenzyme Q10.reduced/Coenzyme Q10 in Serum or Plasma
Coenzyme Q10.reduced [Mass/volume] in Serum or Plasma
Greater curvature of stomach [Length] in Specimen
Lesser curvature of stomach [Length] in Specimen
Tumor type in Stomach cancer by Macroscopy
Distance of tumor from closest margin [Length] in Specimen by Macroscopy
Distance of tumor from circumferential resection margin [Length] in Specimen by Macroscopy
Serosal classification [Appearance] in Stomach cancer
Tissue block description and site Narrative
Histologic type of Stomach cancer by Lauren classification
Serosal surface involvement [Presence] in Tumor by Light microscopy
Distance of tumor from closest proximal margin [Length] in Specimen by Light microscopy
Distance of tumor from closest distal margin [Length] in Specimen by Light microscopy
Distance of tumor from circumferential resection margin [Length] by Microscopy
Non-regional lymph nodes positive [#] in Specimen
Non-regional lymph nodes examined [#] in Specimen
Tumor regression [Type] in Tumor --post preoperative therapy
Histologic type of Stomach cancer by WHO Classification
Beta-ureidopropionase [Enzymatic activity/mass] in Liver
Phospholipase A2 receptor IgG Ab [Titer] in Serum by Immunofluorescence
Cryoglobulin IgA and IgG and IgM and C3 panel - Serum
Amitriptyline and Nortriptyline panel - Gastric fluid
Amitriptyline and Nortriptyline panel - Urine
clomiPRAMINE and Norclomipramine panel - Urine
clomiPRAMINE and Norclomipramine panel - Gastric fluid
Amitriptyline and Nortriptyline panel - Specimen
clomiPRAMINE and Norclomipramine panel - Specimen
Protein electrophoresis panel - 24 hour Urine
CD3+CD4+ (T4 helper) cells/100 cells in Blood
Influenza virus types A and B and subtypes RNA panel - Respiratory system specimen by NAA with probe detection
Varicella zoster virus IgG and IgM panel - Serum or Plasma Qualitative
HIV 2 RNA panel - Serum or Plasma by NAA with probe detection
Cell count and Differential panel - Dialysis fluid
fentaNYL and Norfentanyl panel - Specimen
Doxepin and Nordoxepin panel - Gastric fluid
fentaNYL and Norfentanyl panel - Serum or Plasma
fentaNYL and Norfentanyl panel - Gastric fluid
Meperidine and Normeperidine panel - Gastric fluid
Meperidine and Normeperidine panel - Specimen
Leukocytes [#/volume] in Semen by Manual count
Spermatozoa Motile [#] in Semen by Automated count
Spermatozoa Nonprogressive [#] in Semen by Microscopy
Malignant cells/100 cells in Bronchoalveolar lavage by Manual count
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes [Identifier] in Stool by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Influenza virus A RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Influenza virus B RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Carbonic anhydrase 2 Ab [Presence] in Serum by Immunoassay
Cryoglobulin.complement C3 [Presence] in Serum
Palatinase [Enzymatic activity/mass] in Small intestine Tissue
Lactase [Enzymatic activity/mass] in Small intestine Tissue
Trichomonas vaginalis [Presence] in Urine sediment by Organism specific culture
Additional pathological findings [Identifier] in Specimen
Spermatozoa.normal morphology [#] in Semen by Automated count
Spermatozoa Progressive [#] in Semen by Automated count
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5a
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5b
Glucan 1,4 alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue
Urine collection associated observations panel - 24 hour Urine
Glucose tolerance 2 hours gestational panel - Serum or Plasma
Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Human RNase P RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
Cytomegalovirus [Presence] in Lower respiratory specimen by Shell vial culture
Leukocytes [#/volume] in Synovial fluid by Automated count
Amphetamines [Mass/volume] in Gastric fluid
Amphetamines [Presence] in Gastric fluid
Amphetamines [Presence] in Gastric fluid by Confirmatory method
KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Baker's yeast IgG Ab [Presence] in Serum by Immunoassay
Amphetamines [Presence] in Gastric fluid by Screen method
GATA1 gene exon 2 targeted mutation analysis in Blood or Tissue by Sequencing
Microscopic observation [Identifier] in Bone marrow by Acetate esterase stain
Microscopic observation [Identifier] in Bone marrow by Toluidine blue O stain
Microscopic observation [Identifier] in Bone marrow by Oil red O stain
Microscopic observation [Identifier] in Venous blood by Acetate esterase stain
Microscopic observation [Identifier] in Venous blood by Oil red O stain
Influenza virus A H7 Eurasia RNA [Presence] in Respiratory system specimen by NAA with probe detection
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal dialysis fluid by Lactate to pyruvate reaction
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe
Leukocytes [#/volume] in Synovial fluid by Manual count
Amphetamines [Presence] in Meconium by Confirmatory method
Amphetamines [Presence] in Meconium by Screen method
Amphetamines [Mass/volume] in Serum or Plasma
Amphetamines [Presence] in Serum or Plasma by Confirmatory method
Amphetamines [Presence] in Serum or Plasma by Screen method
A Ab [Presence] in Serum or Plasma from Blood product unit
Amphetamines [Presence] in Urine by SAMHSA confirm method
Amphetamines [Presence] in Urine by SAMHSA screen method
Amphetamines [Mass/volume] in Unknown substance
Amphetamines [Presence] in Unknown substance
Amphetamines [Presence] in Unknown substance by Confirmatory method
Amphetamines [Presence] in Unknown substance by Screen method
Beryllium [Mass/volume] in Saliva (oral fluid)
Tetrahydrocannabinol [Mass/volume] in Gastric fluid
Herpes simplex virus 1 and 2 IgG panel - Serum or Plasma
Hydroxyapatite [Energy Difference] in 24 hour Urine
Calcium oxalate [Energy Difference] in 24 hour Urine
Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells
Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells
Methotrexate triglutamate [Moles/volume] in Red Blood Cells
Methotrexate diglutamate [Moles/volume] in Red Blood Cells
Methotrexate monoglutamate [Moles/volume] in Red Blood Cells
Gamma hydroxybutyrate [Presence] in Specimen by Confirmatory method
Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells
Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative
Immunoglobulin light chains.free panel - Serum by Nephelometry
Glucose meter to reference method correlation [Ratio] in Serum, Plasma or Blood by calculation
Tetrahydrocannabinol [Presence] in Gastric fluid
Clotting time of Capillary blood by Sukharev method
Heparin dose response slope in Blood by Coagulation assay
Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
CYP3A4 and CYP3A5 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method
von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma
Clostridium botulinum toxin C botC gene [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin D botD gene [Presence] in Specimen by NAA with probe detection
Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method
Clostridium botulinum toxin E botE gene [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin F botF gene [Presence] in Specimen by NAA with probe detection
Clostridium botulinum toxin G botG gene [Presence] in Specimen by NAA with probe detection
Cryptococcus sp rRNA gene [Presence] in Specimen by NAA with probe detection
West Nile virus Kunjin strain RNA [Presence] in Specimen by NAA with probe detection
Murray Valley encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
HIV 2 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method
Blastomyces dermatitidis drk1 and Histoplasma capsulatum gapdh genes [Identifier] in Specimen by NAA with probe detection
Respiratory pathogens DNA and RNA identified in Respiratory system specimen by NAA with probe detection
Campylobacter coli+jejuni tuf gene [Presence] in Stool by NAA with probe detection
Salmonella sp spaO gene [Presence] in Stool by NAA with probe detection
Suspected organism [Identifier] in Specimen
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes panel - Stool by NAA with probe detection
Tetrahydrocannabinol [Presence] in Meconium
Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method
Barmah forest virus RNA [Presence] in Blood by NAA with probe detection
Hendra virus RNA [Presence] in Specimen by NAA with probe detection
A Ab [Presence] in Serum or Plasma from Donor
Legionella longbeachae 1 and 2 DNA [Identifier] in Specimen by NAA with probe detection
DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain
DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain
DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain
Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain
Tetrahydrocannabinol [Presence] in Meconium by Screen method
Microsatellite instability [Interpretation] in Cancer specimen Qualitative
Microsatellite instability markers assessed [#] in Cancer specimen
Microsatellite instability marker BAT25 in Cancer specimen Qualitative
Microsatellite instability marker BAT26 in Cancer specimen Qualitative
Microsatellite instability marker NR21 in Cancer specimen Qualitative
Microsatellite instability marker NR24 in Cancer specimen Qualitative
Microsatellite instability marker MONO27 in Cancer specimen Qualitative
Microsatellite instability marker D2S123 in Cancer specimen Qualitative
Cannabinoids [Mass/volume] in Serum or Plasma
Microsatellite instability marker D5S346 in Cancer specimen Qualitative
Microsatellite instability marker D17S250 in Cancer specimen Qualitative
BRAF protein [Presence] in Cancer specimen by Immune stain
Phosphatase and tensin homolog (PTEN) protein [Presence] in Cancer specimen by Immune stain
Microsatellite markers exhibiting instability/Microsatellite instability markers assessed in Cancer specimen
Microsatellite markers exhibiting instability [#] in Cancer specimen
PTEN gene [Presence] in Cancer specimen by FISH
Cannabinoids [Presence] in Serum or Plasma by Confirmatory method
Microsatellite instability marker panel - Cancer specimen
Actin.filamentous Ab [Presence] in Serum by Line blot
Centromere protein A Ab [Presence] in Serum by Line blot
DNA double strand Ab [Presence] in Serum by Line blot
Glutamate decarboxylase 65 Ab [Presence] in Serum by Line blot
Mitochondria M2-3E Ab [Presence] in Serum by Line blot
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Cannabinoids [Presence] in Serum or Plasma by Screen method
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot
PM-SCL-100 Ab [Presence] in Serum by Line blot
PM-SCL-75 Ab [Presence] in Serum by Line blot
RNA polymerase III RP11 Ab [Presence] in Serum by Line blot
RNA polymerase III RP155 Ab [Presence] in Serum by Line blot
Th-To Ab [Units/volume] in Serum by Line blot
Th-To Ab [Presence] in Serum by Line blot
Submitter's laboratory test method [Type] in Specimen
Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method
Chromosome region 17p13.1 deletion in Blood or Tissue by FISH
Chromosome region 6q22 rearrangements in Tissue by FISH
Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH
Chromosome region 13q14 deletion in Bone marrow by FISH
Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH
Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method
Chromosome region 1q21 duplication in Bone marrow by FISH
Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin
Nortapentadol [Mass/volume] in Urine by Confirmatory method
Lymphocyte proliferation.Interleukin 2.maximum/CD45 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.anti-CD3.maximum/CD3 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.Interleukin 2.maximum/CD3 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.anti-CD28.maximum/CD3 in Blood by Flow cytometry (FC)
Lymphocyte proliferation.anti-CD28.maximum/CD45 in Blood by Flow cytometry (FC)
Cannabinoids [Mass/volume] in Unknown substance
Lymphocyte proliferation.anti-CD3.maximum/CD45 in Blood by Flow cytometry (FC)
F8 gene intron 1 and 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method
F8 gene intron 1 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method
Phytanate and pristanate panel - Serum or Plasma
Docosatrienoate (C22:3w9) [Moles/volume] in Serum or Plasma
Docosatrienoate (C22:3w9) [Entitic substance] in Red Blood Cells
Eicosatrienoate (C20:3w3) [Entitic substance] in Serum or Plasma
Eicosatrienoate (C20:3w3) [Moles/volume] in Serum or Plasma
U1 small nuclear ribonucleoprotein 70kD IgG Ab [Units/volume] in Serum by Immunoassay
Adipoylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine
Tiglylcarnitine (C5:1)/Creatinine [Molar ratio] in Urine
Myeloperoxidase IgG Ab [Presence] in Serum by Immunoblot
European house dust mite IgG Ab [Mass/volume] in Serum
Actin smooth muscle IgG Ab [Presence] in Serum
Epipregnanolone/Creatinine [Molar ratio] in Urine
Ureidopropionate/Creatinine [Molar ratio] in Urine
Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine
Cannabinoids [Presence] in Unknown substance
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine
Tetradecenoylcarnitine (C14:1)/Creatinine [Molar ratio] in Urine
Saccharopine [Moles/volume] in Cerebral spinal fluid
Chicken feather IgG Ab [Mass/volume] in Serum
Canary droppings IgG Ab [Mass/volume] in Serum
Duck feather IgG Ab [Mass/volume] in Serum
Cannabinoids [Presence] in Unknown substance by Confirmatory method
Chemokine (C-C motif) ligand 17 [Mass/volume] in Serum by Immunoassay
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunoassay
Hazelnut recombinant (rCor a) 14 IgE Ab [Units/volume] in Serum
English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
English walnut recombinant (rJug r) 1 IgE Ab [Units/volume] in Serum
Apple recombinant (rMal d) 3 IgE Ab [Units/volume] in Serum
Dermatophagoides pteronyssinus native (nDer p) 2 IgE Ab [Units/volume] in Serum
Tetrahydrodeoxycortisol/Creatinine [Molar ratio] in 24 hour Urine
Cannabinoids [Presence] in Unknown substance by Screen method
Tetrahydrocortisol/Creatinine [Molar ratio] in Urine
Tetrahydrocortisone/Creatinine [Molar ratio] in Urine
Tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine
11-Dehydrotetrahydrocorticosterone/Creatinine [Molar ratio] in Urine
Pregnanediolone/Creatinine [Molar ratio] in Urine
16-Alpha hydroxypregnenolone/Creatinine [Molar ratio] in Urine
16-Ketoandrostenediol/Creatinine [Molar ratio] in Urine
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine
16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine
Beta cortolone/Creatinine [Molar ratio] in Urine
Allo-tetrahydrocortisol/Creatinine [Molar ratio] in Urine
Allo-tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine
Alpha cortolone/Creatinine [Molar ratio] in Urine
Alpha cortol/Creatinine [Molar ratio] in Urine
Androstenetriol/Creatinine [Molar ratio] in Urine
3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine [Molar ratio] in Urine
Chromium [Mass/volume] in Saliva (oral fluid)
3-Hydroxydecanoylcarnitine (C10-OH)/Creatinine [Molar ratio] in Urine
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS
TPP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
F11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HSD17B4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CTNS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MPI gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PMM2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CLN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ASS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
RMRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BBS10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SACS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SLC12A6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
MAN2B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
HGD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CNGB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Benzoylecgonine [Mass/volume] in Gastric fluid
SLC37A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SDHA gene full mutation analysis in Blood or Tissue by Sequencing
AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
LAMB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
SLC26A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing
SLC17A5 gene full mutation analysis in Blood or Tissue by Sequencing
PEX7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Benzoylecgonine [Presence] in Gastric fluid
CTSK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GRHPR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PEX1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CLN8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
POMGNT1 gene full mutation analysis in Blood or Tissue by Sequencing
MLC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
BCKDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GALC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method
IVD gene full mutation analysis in Blood or Tissue by Sequencing
PALB2 gene full mutation analysis in Blood or Tissue by Sequencing
C9orf72 gene GGGGCC repeat analysis in Blood or Tissue by Molecular genetics method
C9orf72 gene GGGGCC repeat analysis in Amniotic fluid by Molecular genetics method
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Blood or Tissue by Molecular genetics method
A Ag [Presence] on Red Blood Cells from Blood product unit
Chromosome region 11p15 methylation and deletion+duplication in Amniotic fluid by Molecular genetics method
Benzoylecgonine [Presence] in Gastric fluid by Screen method
Chromosome region 11p15 methylation and deletion+duplication in Blood or Tissue by Molecular genetics method
Chromosome region 7q11.23 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method
Chromosome 15 and 16 and 22 aneuploidy in Blood or Tissue by Molecular genetics method
CYP21A2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
DMPK gene CTG repeat analysis in Blood or Tissue by Molecular genetics method
FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
GDAP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GJB1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
GRN gene full mutation analysis in Blood or Tissue by Sequencing
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Sequencing
Karyotype in Blood or Tissue --post mitogen stimulation
KCNH2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
KCNQ1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MYBPC3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
MYH7 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
NOTCH3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PRNP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
PRNP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PSEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
PSEN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
SCN5A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by MLPA
SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing
SPAST gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
SPG11 gene deletion+duplication and mutation analysis in Blood or Tissue by Molecular genetics method
SPG3A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Subtelomere analysis in Blood or Tissue by Molecular genetics method
t(11;22)(q24;q12.2)(FLI1,EWSR1) and t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript in Blood or Tissue by Molecular genetics method
TNNT2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
TNNT3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
TSC2 and PKD1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
CNBP gene CCTG repeat analysis in Blood or Tissue by Molecular genetics method
NIPA1 and REEP1 gene full mutation analysis in Blood or Tissue by Sequencing
Benzoylecgonine [Presence] in Meconium by Confirmatory method
Benzoylecgonine [Presence] in Meconium by Screen method
Patient satisfaction with healthcare delivery [Score]
Cocaine [Presence] in Serum or Plasma by Confirmatory method
Cocaine [Presence] in Serum or Plasma by Screen method
Benzoylecgonine [Presence] in Urine by SAMHSA confirm method
A Ag [Presence] on Red Blood Cells from Donor
Benzoylecgonine [Presence] in Urine by SAMHSA screen method
Cocaine [Mass/volume] in Unknown substance
Public health laboratory ask at order entry panel
Cocaine [Presence] in Unknown substance by Confirmatory method
Cocaine [Presence] in Unknown substance by Screen method
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Units/volume] in Serum by Multidisk
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab RAST class [Presence] in Serum by Multidisk
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Units/volume] in Serum by Multidisk
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab RAST class [Presence] in Serum by Multidisk
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab RAST class [Presence] in Serum by Multidisk
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab RAST class [Presence] in Serum by Multidisk
Nickel [Mass/volume] in Saliva (oral fluid)
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Units/volume] in Serum by Multidisk
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab RAST class [Presence] in Serum by Multidisk
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab RAST class [Presence] in Serum by Multidisk
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab RAST class [Presence] in Serum by Multidisk
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab RAST class [Presence] in Serum by Multidisk
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab RAST class [Presence] in Serum by Multidisk
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Units/volume] in Serum by Multidisk
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab RAST class [Presence] in Serum by Multidisk
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab RAST class [Presence] in Serum by Multidisk
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Units/volume] in Serum by Multidisk
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab RAST class [Presence] in Serum by Multidisk
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Units/volume] in Serum by Multidisk
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab RAST class [Presence] in Serum by Multidisk
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum
Opiates [Presence] in Gastric fluid by Confirmatory method
Opiates [Presence] in Gastric fluid by Screen method
Respiratory pathogens DNA and RNA tested for in Pleural fluid by NAA with probe detection
Respiratory pathogens DNA and RNA identified in Pleural fluid by NAA with probe detection
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method
LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method
MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method
Opiates [Presence] in Meconium by Confirmatory method
Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection
Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection
Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection
Opiates [Presence] in Meconium by Screen method
Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Opiates [Mass/volume] in Serum or Plasma
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection
Opiates [Presence] in Serum or Plasma by Confirmatory method
Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with non-probe detection
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Au sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Gastrointestinal pathogens DNA and RNA panel - Stool by NAA with non-probe detection
Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection
Opiates [Presence] in Serum or Plasma by Screen method
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection
Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection
Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection
Escherichia coli O157 DNA [Presence] in Stool by NAA with non-probe detection
Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection
Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection
Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection
Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection
Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection
Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection
Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection
Opiates [Presence] in Urine by SAMHSA confirm method
3-Hydroxyisobutyrate dehydrogenase [Enzymatic activity/mass] in Fibroblast
3-Hydroxyisobutyryl-CoA hydrolase [Enzymatic activity/mass] in Fibroblast
3-Methylcrotonyl-CoA carboxylase [Enzymatic activity/mass] in Fibroblast
3-Methylglutaconyl-CoA hydratase [Enzymatic activity/mass] in Fibroblast
Alkyl-dihydroxyacetonephosphate synthase [Enzymatic activity/mass] in Fibroblast
Alpha-methylacyl CoA racemase [Enzymatic activity/mass] in Fibroblast
Opiates [Presence] in Urine by SAMHSA screen method
Amylo-alpha-1,6-glucosidase [Enzymatic activity/mass] in Leukocytes
Cystathionine beta synthase [Enzymatic activity/mass] in Fibroblast
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Lymphoblasts
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Fibroblast
Opiates [Mass/volume] in Unknown substance
Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 16p13.3 deletion in Blood or Tissue by FISH
Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 17p13.3 deletion in Blood or Tissue by FISH
Chromosome region 1p36 deletion in Blood or Tissue by FISH
Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH
Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH
Chromosome region 7q11.23 deletion in Blood or Tissue by FISH
Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH
Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH
Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH
Constitutive heterochromatin analysis in Blood or Tissue by Banding
JAG1 gene deletion in Blood or Tissue by FISH
Marker and derivative chromosome analysis in Amniotic fluid or Chorionic villus sample Document by Cytogenetics
Opiates [Presence] in Unknown substance by Confirmatory method
Marker and derivative chromosome analysis in Blood or Tissue Document by Cytogenetics
Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
SRY gene deletion in Blood or Tissue by FISH
Subtelomere analysis in Bone marrow by FISH
Opiates [Presence] in Unknown substance by Screen method
Au sup(a) Ab [Presence] in Serum or Plasma from Donor
Phencyclidine [Mass/volume] in Gastric fluid
Phencyclidine [Presence] in Gastric fluid
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH
Phencyclidine [Presence] in Gastric fluid by Confirmatory method
Chikungunya virus structural proteins (E1+E2) IgG Ab [Presence] in Serum by Immunoassay
Yersinia enterocolitica [Presence] in Specimen by Culture
Escherichia coli shiga-like toxin 1+2 [Presence] in Stool by Immunoassay
Shigella sp [Presence] in Stool by Culture
Salmonella sp [Presence] in Stool by Culture
Campylobacter sp [Presence] in Stool by Culture
Escherichia coli O157 [Presence] in Stool by Culture
Plesiomonas shigelloides [Presence] in Stool by Culture
Phencyclidine [Presence] in Gastric fluid by Screen method
Gastrointestinal pathogens panel - Stool by Culture
Chlamydia trachomatis rRNA [Presence] in Throat by NAA with probe detection
Interleukin 17A [Mass/volume] in Serum or Plasma
Phencyclidine [Presence] in Meconium by Confirmatory method
F8 gene intron 1 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
F8 gene intron 1 and 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
Phencyclidine [Presence] in Meconium by Screen method
Au sup(a) Ab [Presence] in Serum or Plasma
Phencyclidine [Presence] in Serum or Plasma by Confirmatory method
Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection
Phencyclidine [Presence] in Serum or Plasma by Screen method
Peripheral deiodinase activity [Moles/time] in Serum or Plasma by Calculated.SPINA
Thyroid secretory capacity [Moles/time] in Serum or Plasma by Calculated.SPINA
Buprenorphine [Presence] in Serum or Plasma by Screen method
Phencyclidine [Presence] in Urine by SAMHSA confirm method
Norbuprenorphine [Presence] in Gastric fluid by Screen method
Norbuprenorphine [Presence] in Urine by Screen method
Buprenorphine [Presence] in Gastric fluid by Screen method
Buprenorphine [Presence] in Specimen by Screen method
Norbuprenorphine [Presence] in Serum or Plasma by Screen method
Norbuprenorphine [Presence] in Specimen by Screen method
Elbasvir [Susceptibility] by Genotype method
Ledipasvir [Susceptibility] by Genotype method
Ombitasvir [Susceptibility] by Genotype method
Daclatasvir [Susceptibility] by Genotype method
Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier]
Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier]
Sofosbuvir [Susceptibility] by Genotype method
Dengue virus 2+4 RNA [Presence] in Serum by NAA with probe detection
Dengue virus 1+3 RNA [Presence] in Serum by NAA with probe detection
Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood
Phencyclidine [Presence] in Urine by SAMHSA screen method
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum by Line blot
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Presence] in Serum by Line blot
Centromere protein A Ab [Units/volume] in Serum by Line blot
Centromere protein B Ab [Units/volume] in Serum by Line blot
Fibrillarin Ab [Units/volume] in Serum by Line blot
Fibrillarin Ab [Presence] in Serum by Line blot
Ganglioside GD1a IgG Ab [Presence] in Serum by Line blot
Phencyclidine [Mass/volume] in Unknown substance
Ganglioside GD1a IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GD1a IgM Ab [Presence] in Serum by Line blot
Ganglioside GD1b IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GD2 IgG Ab [Presence] in Serum by Line blot
Ganglioside GD2 IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GD2 IgM Ab [Presence] in Serum by Line blot
Ganglioside GD3 IgG Ab [Presence] in Serum by Line blot
Phencyclidine [Presence] in Unknown substance
Ganglioside GD3 IgM Ab [Presence] in Serum by Line blot
Ganglioside GM4 IgG Ab [Presence] in Serum by Line blot
Ganglioside GM4 IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GM4 IgM Ab [Presence] in Serum by Line blot
Ganglioside GQ1b IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GT1a IgG Ab [Presence] in Serum by Line blot
Phencyclidine [Presence] in Unknown substance by Confirmatory method
Ganglioside GT1a IgM Ab [Presence] in Serum by Line blot
Ha Ab [Units/volume] in Serum by Line blot
Human upstream binding factor Ab [Units/volume] in Serum by Line blot
Human upstream binding factor Ab [Presence] in Serum by Line blot
Phencyclidine [Presence] in Unknown substance by Screen method
Ks Ab [Units/volume] in Serum by Line blot
Ma+Ta Ab [Presence] in Serum by Line blot
MDA5 Ab [Presence] in Serum by Line blot
Mj Ab [Units/volume] in Serum by Line blot
Au sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
OJ Ab [Units/volume] in Serum by Line blot
Platelet-derived growth factor receptor Ab [Units/volume] in Serum by Line blot
Platelet-derived growth factor receptor Ab [Presence] in Serum by Line blot
SUMO-activating enzyme subunit 1 Ab [Units/volume] in Serum by Line blot
SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
SUMO-activating enzyme subunit 2 Ab [Units/volume] in Serum by Line blot
SUMO-activating enzyme subunit 2 Ab [Presence] in Serum by Line blot
Glial nuclear type 1 Ab [Presence] in Serum by Line blot
Sulfatide Ab [Presence] in Serum by Line blot
Titanium [Mass/volume] in Serum or Plasma
Sulfatide IgM Ab [Presence] in Serum by Line blot
TIF1-gamma Ab [Presence] in Serum by Line blot
Titin Ab [Presence] in Serum by Line blot
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot
Ganglioside Ab panel - Serum by Immunoblot
Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 16 and 18+45 E6+E7 mRNA panel - Cervix by NAA with probe detection
Alaska pollock roe IgE Ab [Units/volume] in Serum
Amorphous sediment [Presence] in Urine sediment by Light microscopy
Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection
Mosquito count [#] in Environmental specimen
Mosquito identified [Type] in Environmental specimen
riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay
riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay
Edoxaban [Mass/volume] in Serum or Plasma by LC/MS/MS
Etanercept Ab [Mass/volume] in Serum or Plasma by Immunoassay
Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
Borrelia garinii+afzelii oppA1 gene [Presence] in Blood by NAA with non-probe detection
Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection
Borrelia mayonii oppA1 gene [Presence] in Blood by NAA with non-probe detection
Borrelia mayonii oppA1 gene [Presence] in Specimen by NAA with non-probe detection
Borrelia miyamotoi glpQ gene [Presence] in Blood by NAA with non-probe detection
Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection
Erythrocyte sedimentation rate by Photometric method
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Serum or Plasma
Mucus [Presence] in Urine sediment by Light microscopy
TRBV30 gene segment/TRBV gene segments.total in Blood
TRBV29 gene segments/TRBV gene segments.total in Blood
TRBV28 gene segment/TRBV gene segments.total in Blood
TRBV27 gene segment/TRBV gene segments.total in Blood
TRBV25 gene segments/TRBV gene segments.total in Blood
TRBV24-1 gene segment/TRBV gene segments.total in Blood
TRBV20-1 gene segment/TRBV gene segments.total in Blood
TRBV19 gene segments/TRBV gene segments.total in Blood
Spermatozoa [Presence] in Urine sediment by Light microscopy
TRBV18 gene segments/TRBV gene segments.total in Blood
TRBV16 gene segments/TRBV gene segments.total in Blood
TRBV15 gene segments/TRBV gene segments.total in Blood
TRBV14 gene segments/TRBV gene segments.total in Blood
TRBV13 gene segments/TRBV gene segments.total in Blood
TRBV12 gene segments/TRBV gene segments.total in Blood
TRBV11 gene segments/TRBV gene segments.total in Blood
TRBV10 gene segments/TRBV gene segments.total in Blood
Transitional cells [Presence] in Urine sediment by Light microscopy
TRBV9 gene segments/TRBV gene segments.total in Blood
TRBV7 gene segments/TRBV gene segments.total in Blood
TRBV6 gene segments/TRBV gene segments.total in Blood
TRBV5 gene segments/TRBV gene segments.total in Blood
TRBV4 gene segments/TRBV gene segments.total in Blood
Au sup(a) Ag [Presence] on Red Blood Cells from Donor
TRBV3-1 gene segment/TRBV gene segments.total in Blood
TRBV2 gene segments/TRBV gene segments.total in Blood
Microscopic observation [Identifier] in Stool by Electron microscopy
3-Hydroxyglutarate [Moles/volume] in DBS
Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative
Oligosaccharides pattern [Interpretation] in Leukocytes by Screen method Narrative
Ethyl sulfate [Mass/volume] in Saliva (oral fluid)
Gamma interferon.negative control [Units/volume] in Blood
Mycobacterium bovis tuberculin stimulated gamma interferon [Interpretation] in Blood Qualitative
Mycobacterium bovis tuberculin stimulated gamma interferon [Units/volume] in Blood
Hepatitis C virus genotype 1 [Type] in Serum or Plasma by NAA with probe detection
Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection
Hepatitis C virus genotype 3 NS5a gene mutations detected [Identifier]
NBN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
LAMC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
LAMA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Dengue virus 1+3 and 2+4 panel - Serum by NAA with probe detection
Velpatasvir [Susceptibility] by Genotype method
Paritaprevir [Susceptibility] by Genotype method
Simeprevir [Susceptibility] by Genotype method
Grazoprevir [Susceptibility] by Genotype method
6-Beta naltrexol [Mass/volume] in Urine by Confirmatory method
Hepatitis C virus genotype and drug resistance panel
6-Beta naltrexol [Mass/volume] in Serum or Plasma
6-Beta naltrexol/Creatinine [Mass Ratio] in Urine
VHL gene full mutation analysis in Blood or Tissue by Sequencing
SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
SDHB gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
SDHC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
SDHB and SDHC and SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
CASR gene full mutation analysis in Blood or Tissue by Sequencing
KRAS gene full mutation analysis in Blood or Tissue by Sequencing
SOS1 gene full mutation analysis in Blood or Tissue by Sequencing
RAF1 gene full mutation analysis in Blood or Tissue by Sequencing
CALR gene exon 9 full mutation analysis in Blood or Tissue by Molecular genetics method
Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
Cetuximab IgE Ab [Units/volume] in Serum
Dog recombinant (rCan f) 4 IgE Ab [Units/volume] in Serum
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Units/volume] in Serum
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Presence] in Serum by Multidisk
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab RAST class [Presence] in Serum by Multidisk
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Units/volume] in Serum by Multidisk
Mahi mahi IgE Ab [Units/volume] in Serum
Silver Birch recombinant (rBet v) 6 IgE Ab [Units/volume] in Serum
Staphylococcus aureus enterotoxin E IgE Ab [Units/volume] in Serum
Cyclic citrullinated peptide IgA Ab [Units/volume] in Serum or Plasma
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Units/volume] in Serum by Multidisk
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Presence] in Serum by Multidisk
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab RAST class [Presence] in Serum by Multidisk
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Units/volume] in Serum by Multidisk
Wheat native (nTri a) 19+20+21 IgE Ab [Units/volume] in Serum
Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine [Molar ratio] in Urine
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in DBS
Nucleated cells [#] in Bone marrow by Automated count
Leukocytes [#/volume] in Bone marrow by Automated count
Erythrocytes [#/volume] in Bone marrow by Automated count
Reticulocytes.low light scatter/Reticulocytes.total in Blood by Automated count
Reticulocytes.mid light scatter/Reticulocytes.total in Blood by Automated count
Chromosome painting analysis in Blood or Tissue by FISH
Chum salmon roe IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 10 IgE Ab [Units/volume] in Serum
Latex recombinant (rHev b) 2 IgE Ab [Units/volume] in Serum
Grass Allergen Mix 7 (Bermuda grass+Meadow fescue+Rye grass+Timothy grass+Cultivated rye) IgE Ab [Units/volume] in Serum by Multidisk
Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
Glutamate decarboxylase Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Thyrotropin receptor Ab [Presence] in Serum
Glutamate decarboxylase Ab [Presence] in Serum or Plasma by Immunofluorescence
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
Au sup(a) Ag [Presence] on Red Blood Cells
Haemophilus influenzae C Ag [Presence] in Specimen by Immunofluorescence
Enfuvirtide [Susceptibility] by Phenotype method
Natural killer cell cytotoxicity panel - Blood mononuclear cells
Intravenous lipid emulsion [Mass/volume] in Serum by Nephelometry
Potassium [Mass/volume] in Red Blood Cells
Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method
Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Cefepime [Susceptibility] by Disk diffusion (KB)
Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.100:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Zika virus IgM Ab [Presence] in Serum by Immunofluorescence
AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Cefepime [Susceptibility] by Serum bactericidal titer
AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Calcium-calmodulin-dependent protein kinase II activity actual/normal in Serum
Beta tubulin IgG Ab [Titer] in Serum by Immunoassay
Dopamine receptor D2 IgG Ab [Titer] in Serum by Immunoassay
Dopamine receptor D1 IgG Ab [Titer] in Serum by Immunoassay
Lysoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay
Pediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS) panel - Serum
Cefpirome [Susceptibility] by Minimum lethal concentration (MLC)
CD8+CD45RA+ cells/100 CD8 cells in Blood
Varicella zoster virus strain [Type] in Isolate
Babesia microti IgG Ab [Presence] in Serum by Immunoblot
Erythrocytes.Babesia sp infected/100 erythrocytes in Blood
Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)
Am Ag [Presence] on Red Blood Cells from Blood product unit
Cefpirome [Susceptibility] by Disk diffusion (KB)
Borrelia miyamotoi flaB gene [Presence] in Tick by NAA with probe detection
Borrelia miyamotoi flaB gene [Presence] in Specimen by NAA with probe detection
Clot size [Length] in Platelet poor plasma --30 minutes post incubation
Spontaneous clot formation [Time] in Platelet poor plasma
Clot growth mean [Velocity] Platelet poor plasma
Stationary clot growth mean [Velocity] Platelet poor plasma
Initial clot growth [Velocity] in Platelet poor plasma
Clot formation lag time in Platelet poor plasma
Spatial clot growth analysis panel - Platelet poor plasma
Cefixime [Susceptibility] by Serum bactericidal titer
Am Ag [Presence] on Red Blood Cells from Donor
Mitochondria IgG Ab [Presence] in Serum by Immunofluorescence
PCNA extractable nuclear IgG Ab [Titer] in Serum by Immunofluorescence
Liver kidney microsomal IgG Ab [Presence] in Serum by Immunofluorescence
Campylobacter jejuni IgA and IgG and IgM panel - Serum
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in Urine
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in Urine
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in Urine
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in 24 hour Urine
11-Deoxytetrahydrocorticosterone [Moles/volume] in Urine
11-Deoxytetrahydrocorticosterone [Moles/time] in 24 hour Urine
11-Deoxytetrahydrocorticosterone [Moles/volume] in 24 hour Urine
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in Urine
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/time] in 24 hour Urine
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in 24 hour Urine
Allo-pregnanediolone [Moles/time] in 24 hour Urine
Allo-pregnanediolone [Moles/volume] in 24 hour Urine
Allo-pregnanediolone [Moles/volume] in Urine
6-Thioguanine and 6-methylmercaptopurine panel - Red Blood Cells
Au sup(b) Ab [Presence] in Serum or Plasma
Adenosine diphosphate [Entitic substance] in Platelets
Brallobarbital [Mass/volume] in Serum or Plasma
Campylobacter jejuni IgA Ab [Titer] in Serum
Complement C1 esterase inhibitor [Units/volume] in Serum or Plasma by Chromogenic method
Cytochrome C oxidase [Enzymatic activity/mass] in Leukocytes
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma
Etiocholanolone/Androsterone [Molar ratio] in Urine
Etiocholanolone/Androsterone [Molar ratio] in 24 hour Urine
Lysosomal acid lipase [Enzymatic activity/mass] in Leukocytes by 4-MU-palmitate substrate
MAOA gene upstream VNTR repeats [Entitic number] in Blood or Tissue by Molecular genetics method
Meta methylhippurate [Moles/volume] in Urine
Meta methylhippurate/Creatinine [Molar ratio] in Urine
Ortho methylhippurate [Moles/volume] in Urine
Ortho methylhippurate/Creatinine [Molar ratio] in Urine
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine
Para methylhippurate [Moles/volume] in Urine
Para methylhippurate/Creatinine [Molar ratio] in Urine
Penfluridol [Mass/volume] in Serum or Plasma
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in Urine
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in 24 hour Urine
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in Urine
Thromboxane beta 2 [Moles/volume] in Serum or Plasma
Vascular endothelial growth factor D [Mass/volume] in Serum or Plasma
Centromere protein B IgG Ab [Presence] in Serum by Line blot
Dothiepin [Mass/volume] in Serum or Plasma --trough
Fibrillarin IgG Ab [Presence] in Serum by Line blot
Flurazepam [Mass/volume] in Serum or Plasma --trough
Bromperidol [Mass/volume] in Serum or Plasma --trough
Jo-1 extractable nuclear IgG Ab [Presence] in Serum by Line blot
Ku IgG Ab [Presence] in Serum by Line blot
Legionella pneumophila IgA Ab [Units/volume] in Serum by Immunoassay
Liver cytosol IgG Ab [Presence] in Serum by Line blot
PML IgG Ab [Presence] in Serum by Line blot
PL-7 IgG Ab [Presence] in Serum by Immunoassay
PM-SCL-100 IgG Ab [Presence] in Serum by Line blot
Phospholipase A2 receptor IgG Ab [Presence] in Serum by Line blot
Mitochondria M2 IgG Ab [Presence] in Serum by Line blot
Nuclear pore protein gp210 IgG Ab [Presence] in Serum by Line blot
sp100 IgG Ab [Presence] in Serum by Line blot
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Presence] in Serum by Line blot
clonazePAM [Mass/volume] in Serum or Plasma --trough
Oxazepam [Mass/volume] in Serum or Plasma --trough
Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum by Line blot
SAP and XIAP [Interpretation] in Leukocytes by Flow cytometry (FC)
Smith extractable nuclear D IgG Ab [Units/volume] in Serum
Genetic variant details in Blood or Tissue by Molecular genetics method Narrative
Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Desmosome IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
GABABR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Contactin-associated protein 2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
NMDAR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Exocrine pancreas IgA+IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Ma+Ta IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
NMDAR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Presence] in Serum or Plasma by Line blot
Phospholipase A2 receptor IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
SUMO-activating enzyme subunit 1 IgG Ab [Presence] in Serum by Line blot
Mj IgG Ab [Presence] in Serum by Line blot
MDA5 IgG Ab [Presence] in Serum by Line blot
TIF1-gamma IgG Ab [Presence] in Serum by Line blot
Mi-2 beta IgG Ab [Presence] in Serum by Line blot
Mi-2 alpha IgG Ab [Presence] in Serum by Line blot
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Line blot
PCA-Tr IgG Ab [Presence] in Serum or Plasma by Line blot
Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
Titin IgG Ab [Presence] in Serum or Plasma by Line blot
Glial nuclear type 1 IgG Ab [Presence] in Serum or Plasma by Line blot
Zinc finger protein of the cerebellum 4 IgG Ab [Presence] in Serum or Plasma by Line blot
Recoverin IgG Ab [Presence] in Serum or Plasma by Line blot
Glutamate decarboxylase 65 IgG Ab [Presence] in Serum or Plasma by Line blot
PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain
Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain
PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative
PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain
PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative
PD-L1 by clone SP142 [Presence] in Tissue by Immune stain
Nucleoprotein expression [Presence] in Control Tissue by Immune stain
KRAS gene [VCF] in Cancer specimen by Sequencing
NRAS gene [VCF] in Cancer specimen by Sequencing
BRAF gene [VCF] in Cancer specimen by Sequencing
PIK3CA gene [VCF] in Cancer specimen by Sequencing
PTEN gene [VCF] in Cancer specimen by Sequencing
Calcium.ionized [Moles/volume] in Blood drawn from CRRT circuit
Cytomegalovirus DNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Mycobacterium tuberculosis complex immunogenic protein MPB64 [Presence] in Isolate by Immunoassay
Chikungunya virus structural proteins (E1+E2) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Chikungunya virus structural proteins (E1+E2) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Zika virus non-structural protein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma by Immunoassay
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay
Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay
Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay
Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoassay
Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay
Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay
Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool by Immunoassay
Cortisol [Mass/volume] in Serum or Plasma by Immunoassay
Cortisol [Mass/volume] in 24 hour Urine by Immunoassay
Cortisol [Moles/volume] in Serum or Plasma by Immunoassay
Cortisol [Moles/volume] in 24 hour Urine by Immunoassay
Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay
Digoxin [Mass/volume] in Serum or Plasma by Immunoassay
Digoxin [Moles/volume] in Serum or Plasma by Immunoassay
Epstein Barr virus capsid+early IgG Ab [Presence] in Serum by Immunoassay
Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay
Estradiol (E2) [Moles/volume] in Serum or Plasma by Immunoassay
Follitropin [Units/volume] in Serum or Plasma by Immunoassay
Galectin 3 [Mass/volume] in Serum or Plasma by Immunoassay
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
HIV 1+2 Ab and HIV1 p24 Ag panel - Serum or Plasma by Immunoassay
IgE [Units/volume] in Serum or Plasma by Immunoassay
Lutropin [Units/volume] in Serum or Plasma by Immunoassay
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma by Immunoassay
Myoglobin [Mass/volume] in Serum or Plasma by Immunoassay
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay
Progesterone [Mass/volume] in Serum or Plasma by Immunoassay
Progesterone [Moles/volume] in Serum or Plasma by Immunoassay
Prolactin [Units/volume] in Serum or Plasma by Immunoassay
Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay
S100 calcium binding protein B [Mass/volume] in Serum by Immunoassay
Testosterone [Moles/volume] in Serum or Plasma by Immunoassay
Testosterone [Mass/volume] in Serum or Plasma by Immunoassay
Thyroglobulin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Thyroxine (T4) [Mass/volume] in Serum or Plasma by Immunoassay
Thyroxine (T4) [Moles/volume] in Serum or Plasma by Immunoassay
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma by Immunoassay
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Immunoassay
Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
11-Deoxytetrahydrocorticosterone/Creatinine [Molar ratio] in Urine
Pregnanolone [Moles/time] in 24 hour Urine
Pregnanolone/Creatinine [Molar ratio] in Urine
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone/Creatinine [Molar ratio] in Urine
Allo-pregnanediolone/Creatinine [Molar ratio] in Urine
Allo-pregnanediol/Creatinine [Molar ratio] in Urine
OJ IgG Ab [Presence] in Serum by Line blot
17-Hydroxypregnenetriol [Moles/time] in 24 hour Urine
17-Hydroxypregnenetriol/Creatinine [Molar ratio] in Urine
17-Hydroxypregnenetriol [Moles/volume] in Urine
Pathology report intraoperative observation in Specimen Document
HIV 1 RNA genotype and phenotype in Isolate
Cefaclor [Susceptibility] by Minimum lethal concentration (MLC)
Ax Ag [Presence] on Red Blood Cells from Blood product unit
Ax Ag [Presence] on Red Blood Cells from Donor
A1 Ab [Presence] in Serum or Plasma from Blood product unit
A1 Ab [Presence] in Serum or Plasma from Donor
A1 Ag [Presence] on Red Blood Cells from Blood product unit
A1 Ag [Presence] on Red Blood Cells from Donor
Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)
A1 B Ag [Presence] on Red Blood Cells from Blood product unit
Epstein Barr virus capsid p18 IgG Ab [Presence] in Serum by Rapid immunoassay
Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassay
Myelin oligodendrocyte glycoprotein IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Tumor perforation [Presence] by Macroscopy
Position of rectal tumor in relation to anterior peritoneal reflection [Anatomy] in Tumor
Histologic type in Colorectal cancer specimen by WHO classification
Deepest extent of tumor invasion [Type] in Colorectal cancer specimen
Distal AndOr proximal margin involvement [Presence] in Colorectal cancer specimen
Surgical margin tumor involvement.circumferential [Presence] in Colorectal cancer specimen
Satellite nodules [Presence] in Colorectal cancer specimen
Apical lymph node involvement of Colorectal cancer
Intramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy
Extramural vein invasion [Presence] in Colorectal cancer specimen by Light microscopy
Distant metastases confirmed by histology [Presence] in Cancer specimen
Residual tumor classification [Type] in Cancer specimen
Dominant nodule quadrant [Anatomy] in Prostate tumor
Dominant nodule plane [Anatomy] in Prostate tumor
Other nodules greater than 10mm in diameter [Presence] in Prostate tumor
A1 B Ag [Presence] on Red Blood Cells from Donor
Other nodule quadrant [Anatomy] in Prostate tumor
Other nodule plane [Anatomy] in Prostate tumor
Extraprostatic extension site [Anatomy] of Prostate tumor
Extraprostatic extension extent [Type] of Prostate tumor
Gleason score at positive margin in Prostate tumor Qualitative
Margin involvement [Type] in Prostate tumor
Bladder neck involvement of Prostate tumor
Cancer pathology panel - Colorectal cancer specimen
Cancer pathology panel - Prostate cancer
Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH
Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH
Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH
Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH
Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH
Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH
Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH
Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH
Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH
Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH
Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH
PCA-1 Ab [Units/volume] in Serum by Immunoblot
PCA-1 Ab [Presence] in Serum by Immunofluorescence
PCA-2 Ab [Presence] in Serum by Immunofluorescence
PCA-Tr Ab [Presence] in Serum by Immunofluorescence
Glial nuclear type 1 Ab [Presence] in Serum by Immunofluorescence
NMDAR subunit 1 Ab [Presence] in Serum by Immunofluorescence
AMPAR1 Ab [Presence] in Serum by Immunofluorescence
AMPAR2 Ab [Presence] in Serum by Immunofluorescence
GABABR Ab [Presence] in Serum by Immunofluorescence
HIV 1 and 2 Ab and HIV 1 p24 Ag panel - Serum or Plasma by Immunoassay
JAK2 gene.p.Val617Phe mutant/Normal in Bone marrow by Molecular genetics method
Staphylococcus aureus glycopeptide resistant identified [Type] in Isolate
ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient strip
Staphylococcus aureus glycopeptide resistance panel
Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient strip
AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient strip
MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient strip
Micafungin [Susceptibility] by Gradient strip
ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip
ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Presence] by ARD gradient strip
Telavancin [Susceptibility] by Gradient strip
Ceftobiprole [Susceptibility] by Gradient strip
MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient strip
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose follitropin
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose lutropin
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose gonadotropin releasing hormone
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose dexamethasone
Other nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Nucleolar nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Multiple nuclear dots nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Nuclear membrane pores nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Homogeneous nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Coarse speckled nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Centrosomal nuclear IgG pattern [Titer] in Serum by Immunofluorescence
Elastase IgG Ab [Presence] in Serum by Immunoassay
Hexanoate (C6:0) [Moles/volume] in Serum or Plasma
Maprotiline and normaprotiline panel - Serum or Plasma
Dothiepin and nordothiepin and dothiepin sulfoxide panel - Serum or Plasma
Citalopram and norcitalopram and didesmethylcitalopram panel - Serum or Plasma
HBA2 gene alpha 3.7kb triplication [Presence] in Blood by Molecular genetics method
Liver diseases autoimmune IgG panel - Serum or Plasma by Line blot
Crystal casts [Presence] in Urine sediment by Light microscopy
Escitalopram and norescitalopram panel - Serum or Plasma
D-3-phosphoglycerate dehydrogenase IgG Ab [Presence] in Serum by Line blot
Myoglobin casts [Presence] in Urine sediment by Light microscopy
Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel - Urine
Nitisinone [Moles/volume] in DBS by LC/MS/MS
Norescitalopram [Mass/volume] in Serum or Plasma
Cefaclor [Susceptibility] by Disk diffusion (KB)
FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method
BRAF gene p.Val600Glu [Presence] in Bone marrow by Molecular genetics method
PD-L1 by clone 22C3 in Tissue by Immune stain Report
PD-L1 by clone 28-8 in Tissue by Immune stain Report
PD-L1 by clone SP142 in Tissue by Immune stain Report
X-linked adrenoleukodystrophy (X-ALD) newborn screening panel
X-linked adrenoleukodystrophy newborn screening comment-discussion
X-linked adrenoleukodystrophy newborn screen interpretation
Adjacent structure invaded by tumor [Anatomy] in Colorectal cancer specimen by Light microscopy
Closest surgical margin when all margins are uninvolved [Type] in Colorectal cancer specimen by Light microscopy
Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved [Length] in Colorectal cancer specimen by Light microscopy
Distance of carcinoma from closest surgical margin when all margins are uninvolved [Length] in Cancer specimen by Light microscopy
Excised length [Length] of Colon by Macroscopy
Intratumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy
Mucinous fraction [Area Fraction] in Colorectal cancer specimen by Light microscopy
Organ tumor is adherent to [Anatomy] in Colorectal cancer specimen by Light microscopy
Peritumoral lymphocytic response in Cancer specimen Qualitative by Light microscopy
Polyp in which invasive carcinoma arose [Type] in Colorectal cancer specimen by Light microscopy
Promoter methylation testing method [Type] in Cancer specimen
Radial position of closest mucosal margin involved by invasive carcinoma [Angle] in Colorectal cancer specimen by Light microscopy
Radial position of closest uninvolved mucosal margin [Angle] in Colorectal cancer specimen by Light microscopy
Signet ring cells/100 cells in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement [Presence] in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement.distant [Presence] in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement.mesenteric [Presence] in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement.mucosal [Identifier] in Colorectal cancer specimen by Light microscopy
Surgical margin tumor involvement.proximal [Presence] in Colorectal cancer specimen by Light microscopy
Tumor budding [Presence] in Cancer specimen by Light microscopy
Tumor buds [#/area] in Cancer specimen by Light microscopy
Body structure included in specimen [Anatomy] in Specimen
BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain
Mitotic rate [Score] in Breast cancer specimen by Nottingham
Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Macroscopy
Growth pattern of DCIS [Type] in Breast cancer specimen by Light microscopy
Body structure of origin [Anatomy] in Breast cancer specimen
Distance of carcinoma from anterior margin [Length] in Breast cancer specimen by Light microscopy
Distance of carcinoma from inferior margin [Length] in Breast cancer specimen by Light microscopy
Distance of carcinoma from lateral margin [Length] in Breast cancer specimen by Light microscopy
Distance of carcinoma from medial margin [Length] in Breast cancer specimen by Light microscopy
Distance of carcinoma from posterior margin [Length] in Breast cancer specimen by Light microscopy
Distance of carcinoma from superior margin [Length] in Breast cancer specimen by Light microscopy
Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain
Extent of anterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
Extent of inferior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
Extent of lateral margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
Extent of medial margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
Extent of posterior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
Extent of superior margin carcinoma involvement in Breast cancer specimen Qualitative by Light microscopy
DCIS.max dimension [Length] in Breast cancer specimen by Light microscopy
ERBB2 gene duplication [Presence] in Breast cancer specimen by FISH
HER2 [Presence] in Breast cancer specimen by Immune stain
Foci [Type] in Breast cancer specimen by Light microscopy
Glandular differentiation [Score] in Breast cancer specimen by Nottingham
Adjacent structure invaded by tumor [Anatomy] in Breast cancer specimen by Light microscopy
Response to neoadjuvant therapy in Breast cancer specimen Qualitative
Cells.progesterone receptor/100 cells in Breast cancer specimen by Immune stain
Tissue blocks positive for DCIS [#] in Breast cancer specimen by Light microscopy
Foci [#] in Breast cancer specimen by Light microscopy
Cells.HER2 uniform intense membrane staining/100 cells in Breast cancer specimen by Immune stain
Cells.estrogen receptor/100 cells in Breast cancer specimen by Immune stain
Cells.Ki-67 nuclear Ag/100 cells in Breast cancer specimen by Immune stain
Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain
Radial position in breast [Angle] in Breast cancer specimen
DCIS.additional dimension 1 [Length] in Breast cancer specimen by Light microscopy
Surgical margin DCIS involvement [Presence] in Breast cancer specimen by Light microscopy
DCIS.additional dimension 2 [Length] in Breast cancer specimen by Light microscopy
DCIS intraductal extension in Breast cancer specimen Qualitative by Light microscopy
Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain
LCIS [Presence] in Breast cancer specimen by Light microscopy
Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain
DCIS necrosis [Type] in Breast cancer specimen by Light microscopy
Pathology report reviewed [Identifier] in Specimen
Lymph node site of origin [Anatomy] in Cancer specimen
Lymph nodes with macrometastases [#] in Cancer specimen by Light microscopy
Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy
Dermal lymph-vascular invasion in Cancer specimen Qualitative by Light microscopy
Sentinel lymph nodes examined [#] in Cancer specimen by Light microscopy
Procedure used to obtain tumor specimen [Type] in Specimen
Lymph node response to neoadjuvant therapy in Cancer specimen by CAP cancer protocols
Extranodal extension of carcinoma [Presence] in Cancer specimen by Light microscopy
Lymph node metastatic deposit.max dimension [Length] in Cancer specimen by Light microscopy
Lymph nodes with isolated tumor cells [#] in Cancer specimen by Light microscopy
PEDV S INDEL strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection
PEDV prototype strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection
PEDV prototype and S INDEL strain S gene panel - Specimen by NAA with probe detection
Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection
HIV 1+2 RNA [Presence] in Blood by NAA with probe detection
Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection
Muscarinic acetylcholine receptor M3 Ab [Presence] in Serum
Neutrophil membrane Ab [Presence] in Serum by Immunofluorescence
Neutrophil membrane IgM Ab [Presence] in Serum by Immunofluorescence
Neutrophil membrane IgG Ab [Presence] in Serum by Immunofluorescence
HIV 1+2 RNA [Presence] in Serum or Plasma by NAA with probe detection
Neutrophils [#/volume] in Control Blood by Flow cytometry (FC)
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Blood by Flow cytometry (FC)
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Control Blood by Flow cytometry (FC)
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Control Blood by Flow cytometry (FC)
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Blood by Flow cytometry (FC)
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Blood by Flow cytometry (FC)
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Control Blood by Flow cytometry (FC)
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Blood by Flow cytometry (FC)
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Control Blood by Flow cytometry (FC)
Erythrocytes.EMA mean fluorescence intensity actual/normal in Blood by Flow cytometry (FC)
Purine/Pyrimidine [Ratio] in Red Blood Cells by Spectrophotometry
HIV immunoassay testing algorithm interpretation in Serum, Plasma or Blood
Isavuconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
EGFR gene c.2369C>T actual/normal in Plasma cell-free DNA by Molecular genetics method
Amisulpride [Mass/volume] in Serum or Plasma
A2 Ag [Presence] on Red Blood Cells from Blood product unit
Bacterial identification and susceptibility panel - Isolate
ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC)
Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC)
Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC)
Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC)
Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Bg sup(b) Ag [Presence] on Red Blood Cells
Bg sup(c) Ag [Presence] on Red Blood Cells
Streptococcus pneumoniae serotype [Identifier] in Specimen by NAA with probe detection
clozapine N-oxide [Mass/volume] in Serum or Plasma
Carbapenem resistance blaIMP gene [Presence] by Molecular method
Carbapenem resistance blaVIM gene [Presence] by Molecular method
Carbapenemase resistance genes panel by Molecular genetics method
Carbapenem resistance blaOXA-48 gene [Presence] by Molecular method
Presumptive ABO group [Type] in Saliva (oral fluid) by Molecular genetics method
Presumptive Rh [Type] in Saliva (oral fluid) by Molecular genetics method
PTEN gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
PIK3CA gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
Satellite nodules [#] in Colorectal cancer specimen by Light microscopy
KRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
NRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
BRAF gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal
Hepatitis D virus RNA [Units/volume] (viral load) in Serum by NAA with probe detection
Hepatitis D virus RNA [log units/volume] (viral load) in Serum by NAA with probe detection
PRRSV North American strain IgG Ab [Titer] in Serum by Immunofluorescence
Influenza virus D PB2 gene [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis in Specimen Document
PRRSV European strain IgG Ab [Titer] in Serum by Immunofluorescence
PRRSV North American strain IgG Ab [Presence] in Serum by Immunofluorescence
PRRSV European strain IgG Ab [Presence] in Serum by Immunofluorescence
PRRSV whole genome [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A whole genome [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A porcine origin nucleoprotein IgG Ab/Positive control in Specimen by Immunoassay
Influenza virus A avian origin nucleoprotein Ab/Negative control in Serum by Immunoassay
Influenza virus A RNA TCID50 [#/volume] in Specimen
Mycoplasma hyopneumoniae DNA [#/volume] in Specimen by NAA with probe detection
Mycoplasma hyosynoviae 16S rRNA gene [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma hyorhinis 16S rRNA gene [Cycle Threshold #] in Specimen by NAA with probe detection
PRRSV North American strain RNA [#/volume] (viral load) in Specimen by NAA with probe detection
PRRSV European strain RNA [#/volume] (viral load) in Specimen by NAA with probe detection
PRRSV Ingelvac MLV strain ORF5 gene [Cycle Threshold #] in Specimen by NAA with probe detection
PRRSV Ingelvac ATP strain ORF5 gene [Cycle Threshold #] in Specimen by NAA with probe detection
PRRSV IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay
PRRSV Ab/Positive control in Serum or Plasma by Immunoassay
PRRSV North American strain RNA [Presence] in Specimen by NAA with probe detection
PRRSV European strain RNA [Presence] in Specimen by NAA with probe detection
PRRSV North American strain neutralizing antibody [Titer] in Serum by Neutralization test
PRRSV European strain neutralizing antibody [Titer] in Serum by Neutralization test
PRRSV European strain neutralizing antibody [Presence] in Serum by Neutralization test
PRRSV North American strain neutralizing antibody [Presence] in Serum by Neutralization test
PRRSV European and North American strains neutralizing antibody panel - Serum by Neutralization test
Influenza virus A porcine origin nucleoprotein IgA Ab/Positive control in Specimen by Immunoassay
Mycoplasma flocculare 16S rRNA gene [Presence] in Specimen by NAA with probe detection
A2 Ag [Presence] on Red Blood Cells from Donor
PRRSV European strain ORF5 gene [Presence] in Specimen by NAA with probe detection
Mycobacterium avium and Mycobacterium intracellulare DNA [Identifier] in Sputum or Bronchial by NAA with probe detection
Chikungunya virus RNA+Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection
Chikungunya virus RNA [Presence] in Plasma from Donor by NAA with probe detection
Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection
PRRSV European and North American strains IgG panel - Serum by Immunofluorescence
Zika virus RNA [Presence] in Amniotic fluid by NAA with probe detection
Zika virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Zika virus RNA [Presence] in Urine by NAA with probe detection
Kidney failure 2-year risk [Likelihood] by KFRE
Kidney failure 5-year risk [Likelihood] by KFRE
Kidney failure 2-year and 5-year risk panel by KFRE
Haemophilus influenzae hpd gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis sodC gene [Presence] in Specimen by NAA with probe detection
Haemophilus influenzae acs gene [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus influenzae bex gene [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus influenzae ecs gene [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus influenzae dcs gene [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus influenzae ccs gene [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus influenzae bcs gene [Cycle Threshold #] in Specimen by NAA with probe detection
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Immunoassay
Mycoplasma hyopneumoniae P146 gene [Nucleotide sequence] in Specimen by Sequencing
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence
Streptococcus pneumoniae lytA gene [Cycle Threshold #] in Specimen by NAA with probe detection
Bombay phenotype [Presence] on Red Blood Cells
Bombay phenotype [Presence] on Red Blood Cells from Blood product unit
Bombay phenotype [Presence] on Red Blood Cells from Donor
Streptococcus pneumoniae Danish serotype 5 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 4 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 23F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 19F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 14 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 7A+7F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 22A+22F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 23A DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 16F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 9A+9V DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 15A+15F DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotypes 11A+11D DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus pneumoniae Danish serotype 19A DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Klebsiella pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Blood pathogens panel by NAA with non-probe detection in Positive blood culture
Listeria monocytogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture
Staphylococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
Staphylococcus aureus DNA [Presence] by NAA with non-probe detection in Positive blood culture
Streptococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
Streptococcus agalactiae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Streptococcus pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Streptococcus pyogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture
Acinetobacter baumannii DNA [Presence] by NAA with non-probe detection in Positive blood culture
Enterobacteriaceae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Enterobacter cloacae complex DNA [Presence] by NAA with non-probe detection in Positive blood culture
Escherichia coli DNA [Presence] by NAA with non-probe detection in Positive blood culture
Klebsiella oxytoca DNA [Presence] by NAA with non-probe detection in Positive blood culture
Enterococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
Serratia marcescens DNA [Presence] by NAA with non-probe detection in Positive blood culture
Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Neisseria meningitidis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Pseudomonas aeruginosa DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida albicans DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida glabrata DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida krusei DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida parapsilosis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida tropicalis DNA [Presence] by NAA with non-probe detection in Positive blood culture
CD3+CD8+CD45RO+ cells/100 CD3 cells in Blood
CD3+CD8+CD45RO+ cells [#/volume] in Blood
CD3+CD4+CD45RO+ cells/100 CD3 cells in Blood
CD3+CD4+CD45RO+ cells [#/volume] in Blood
Rubella virus E1 gene and genotype panel - Specimen
Rubella virus E1 gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup DNA panel - Specimen by NAA with probe detection
Measles virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mumps virus SH gene [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition
Measles virus RNA and N gene panel - Specimen by NAA with probe detection
Mumps virus RNA and SH gene panel - Specimen by NAA with probe detection
Bordetella pertussis and parapertussis and holmesii DNA panel - Specimen by NAA with probe detection
Adenovirus serotype DNA panel - Specimen by NAA with probe detection
Clot formation+Clotting time of Blood by Thromboelastography
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase
Influenza virus B Victoria lineage Ag [Presence] in Isolate by Hemagglutination inhibition
Beta-lactam resistance AmpC blaCMY+blaMOX genes [Presence] by Molecular method
Carbapenem resistance blaGES gene [Presence] by Molecular method
Carbapenem resistance blaOXA-23-like gene [Presence] by Molecular method
Carbapenem resistance blaOXA-24-like gene [Presence] by Molecular method
Carbapenem resistance bla OXA-48-like gene [Presence] by Molecular method
Carbapenem resistance blaOXA-58-like gene [Presence] by Molecular method
Carbapenem resistance blaSPM gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaBEL gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaCTX-M-1 Group gene [Presence] by Molecular method
Carbapenem resistance blaGIM gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaCTX-M-9 Group gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 Group genes [Presence] by Molecular method
Beta-lactam resistance ESBL blaGES gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaPER gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaSHV gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaTEM gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaVEB gene [Presence] by Molecular method
Beta-lactam resistance AmpC blaACC gene [Presence] by Molecular method
Beta-lactam resistance AmpC blaACT+blaMIR genes [Presence] by Molecular method
Beta-lactam resistance AmpC blaFOX gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaCTX-M-2 Group gene [Presence] by Molecular method
Cancer pathology panel - Breast cancer specimen by CAP cancer protocols
Cancer pathology panel - Colorectal cancer specimen by CAP cancer protocols
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 12F Ab [Presence] in Serum
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 12F Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 18F Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --2nd specimen
A2 B Ag [Presence] on Red Blood Cells from Blood product unit
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 3 Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 6A Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 6A Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum
A2 B Ag [Presence] on Red Blood Cells from Donor
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --1st specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum --1st specimen/2nd specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --2nd specimen
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --2nd specimen
Zika virus RNA [Presence] in Plasma from Donor by NAA with probe detection
Eutylone [Mass/volume] in Urine by Confirmatory method
4-Methylethcathinone [Mass/volume] in Urine by Confirmatory method
Pentedrone [Mass/volume] in Urine by Confirmatory method
3,4-Dimethylmethcathinone [Mass/volume] in Urine by Confirmatory method
4-Ethylmethcathinone [Mass/volume] in Urine by Confirmatory method
Alpha pyrrolidinovalerophenone [Mass/volume] in Urine by Confirmatory method
Pentylone [Mass/volume] in Urine by Confirmatory method
Neisseria meningitidis serogroup Y synF gene [Cycle Threshold #] in Specimen by NAA with probe detection
Rotavirus A Ag [Presence] in Tissue by Immune stain
Porcine epidemic diarrhea virus [Presence] in Specimen by Organism specific culture
Porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in Specimen Document
Porcine epidemic diarrhea virus [Presence] in Tissue by Immune stain
Lawsonia intracellularis Ag [Presence] in Tissue by Immune stain
Porcine deltacoronavirus [Presence] in Specimen by Organism specific culture
Whole exome sequence analysis in Blood or Tissue by Molecular genetics method
Whole genome sequence analysis in Blood or Tissue by Molecular genetics method
Porcine epidemic diarrhea virus IgG Ab [Presence] in Serum by Immunofluorescence
Porcine epidemic diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test
Rotavirus A VP6 capsid protein [Presence] in Specimen by Immunoassay
Transmissible gastroenteritis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine epidemic diarrhea virus IgG Ab [Titer] in Serum by Immunofluorescence
Colistin resistance mcr-1 gene [Presence] by Molecular method
Lipoprotein.alpha 3 [Moles/volume] in Serum
Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method
Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Ethyl sulfate [Presence] in Saliva (oral fluid)
HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot
Neisseria meningitidis serogroup A sacB gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup B synD gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup C synE gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup w135 synG gene [Cycle Threshold #] in Specimen by NAA with probe detection
Neisseria meningitidis serogroup X xcbB gene [Cycle Threshold #] in Specimen by NAA with probe detection
Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Flow cytometry (FC)
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Flow cytometry (FC)
Transferrin.gastrointestinal [Mass/volume] in Stool by Immunoassay
Erythrocyte deformability [Interpretation] in Red Blood Cells Narrative
Human RNase P RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus B Yamagata lineage Ag [Presence] in Isolate by Hemagglutination inhibition
Staphylococcus aureus [Presence] in Food by Culture
Zika virus neutralizing antibody [Presence] in Specimen by Neutralization test
Zika virus neutralizing antibody [Titer] in Specimen by Neutralization test
Enterovirus [Presence] in Specimen by Organism specific culture
Enterovirus Ag [Presence] in Specimen by Immunofluorescence
Coliform bacteria [#/mass] in Food by Viability count
Bordetella pertussis+parapertussis ptxS1 gene [Cycle Threshold #] in Specimen by NAA with probe detection
Bordetella holmesii hIS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bordetella parapertussis IS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Adenovirus B(21) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus B(16) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus B(11) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus B(14) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus B(7) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus E(4) DNA [Presence] in Specimen by NAA with probe detection
Adenovirus B(3) DNA [Presence] in Specimen by NAA with probe detection
Virus identified in Isolate by Shell vial culture
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum by Immunoassay
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum --1st specimen
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum --1st specimen
Brucella sp Ab [Presence] in Serum by Acidified buffered plate agglutination
Brucella sp Ab [Presence] in Serum by Card agglutination
Brucella sp Ab [Presence] in Serum by Fluorescent polarization assay
Brucella sp Ab [Titer] in Serum by Rivanol agglutination
Brucella sp Ab [Titer] in Serum by Plate agglutination
AST to platelet ratio index in Serum and Blood by calculation
Varicella zoster virus strain DNA [Type] in Specimen by NAA with probe detection
Varicella zoster virus clade [Type] in Specimen by Molecular genetics method
Adenovirus DNA [Presence] in Tissue by NAA with probe detection
Adenovirus DNA [Presence] in Blood by NAA with probe detection
Adenovirus DNA [Presence] in Urine by NAA with probe detection
Adenovirus IgM Ab [Presence] in Serum by Immunoassay
Chikungunya virus RNA [Presence] in Amniotic fluid by NAA with probe detection
Chikungunya virus RNA [Presence] in Urine by NAA with probe detection
Coxsackievirus A Ab [Titer] in Serum by Complement fixation
Cytomegalovirus Ag [Presence] in Tissue by Immunofluorescence
Ebola virus RNA [Presence] in Blood by NAA with probe detection
European tick borne encephalitis virus RNA [Presence] in Serum by NAA with probe detection
Hantavirus RNA [Presence] in Blood by NAA with probe detection
Hantavirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Hantavirus RNA [Presence] in Tissue by NAA with probe detection
Hantavirus RNA [Presence] in Urine by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Tissue by NAA with probe detection
Herpes simplex virus 2 Ag [Presence] in Tissue by Immunofluorescence
Herpes simplex virus 2 DNA [Presence] in Tissue by NAA with probe detection
Herpes simplex virus DNA [Presence] in Tissue by NAA with probe detection
Herpes virus 6 DNA [Presence] in Bone marrow by NAA with probe detection
Herpes virus 7 DNA [Presence] in Blood by NAA with probe detection
Herpes virus 8 DNA [Presence] in Blood by NAA with probe detection
Herpes virus 8 DNA [Presence] in Tissue by NAA with probe detection
HIV 2 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
HIV 2 RNA [#/volume] (viral load) in Plasma by NAA with probe detection
HIV 2 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
HTLV I+II RNA [Presence] in Blood by NAA with probe detection
Human bocavirus DNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection
Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection
Influenza virus A Ag [Presence] in Tissue by Immunofluorescence
Influenza virus A IgG Ab [Presence] in Serum by Immunoassay
Influenza virus A IgM Ab [Presence] in Serum by Immunoassay
Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Influenza virus A RNA [Presence] in Tissue by NAA with probe detection
Influenza virus B IgM Ab [Presence] in Serum by Immunoassay
Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Influenza virus B RNA [Presence] in Tissue by NAA with probe detection
JC virus DNA [Presence] in Blood by NAA with probe detection
Marburg virus RNA [Presence] in Blood by NAA with probe detection
Measles virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Measles virus RNA [Presence] in Serum by NAA with probe detection
Measles virus RNA [Presence] in Urine by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Blood by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Urine by NAA with probe detection
Mumps virus RNA [Presence] in Urine by NAA with probe detection
Neisseria meningitidis [Presence] in Cerebral spinal fluid by Organism specific culture
Parechovirus A RNA [Presence] in Blood by NAA with probe detection
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Rabies virus IgG Ab [Presence] in Serum by Immunoassay
Rabies virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Rubella virus RNA [Presence] in Urine by NAA with probe detection
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay
Toscana virus RNA [Presence] in Serum by NAA with probe detection
Varicella zoster virus Ag [Presence] in Tissue by Immunofluorescence
Varicella zoster virus DNA [Presence] in Amniotic fluid by NAA with probe detection
Zika virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method
Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method
Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method
SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method
Chromosome analysis in Amniotic fluid or Chorionic villus sample by Microarray
Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detection
Methicillin resistance mecC gene [Presence] by Molecular method
MRSA SCCmec and mecA+mecC genes panel - Nose
A3 Ag [Presence] on Red Blood Cells from Blood product unit
Location within lymph node [Anatomy] in Skin melanoma by Light microscopy
Level of tumor invasion in Skin melanoma Qualitative by Clark
Depth of deep margin involved by invasive melanoma [Length] in Skin melanoma by Light microscopy
Mitotic figures [#/area] in Cancer specimen by Light microscopy
Rotavirus C [Presence] in Specimen by Organism specific culture
Rotavirus A [Presence] in Specimen by Organism specific culture
Rotavirus C RNA [Presence] in Specimen by NAA with probe detection
Rotavirus B RNA [Presence] in Specimen by NAA with probe detection
Rotavirus A RNA [Presence] in Specimen by NAA with probe detection
Porcine epidemic diarrhea virus IgA Ab/Positive control in Specimen by Immunoassay
Porcine epidemic diarrhea virus IgG Ab/Positive control in Specimen by Immunoassay
Porcine epidemic diarrhea virus Ab/Positive control in Serum by Immunoassay
Rotavirus B RNA [Nucleotide sequence] in Isolate by Sequencing
Rotavirus A RNA [Nucleotide sequence] in Isolate by Sequencing
Porcine epidemic diarrhea virus RNA [Nucleotide sequence] in Isolate by Sequencing
Rotavirus C RNA [Nucleotide sequence] in Isolate by Sequencing
Rotavirus C RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Rotavirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Rotavirus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine respiratory coronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Lawsonia intracellularis RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Lawsonia intracellularis Ab [Titer] in Serum by Immunoassay
Lawsonia intracellularis RNA [#/volume] in Specimen by NAA with probe detection
Porcine epidemic diarrhea virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Porcine deltacoronavirus Ag [Presence] in Tissue by Immune stain
Carbapenem resistance blaOXA gene [Presence] by Molecular method
Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular method
Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular method
Actinobacillus pleuropneumoniae Ab [Titer] in Serum by Complement fixation
Actinobacillus pleuropneumoniae DNA [Cycle Threshold #] in Isolate by NAA with probe detection
Actinobacillus pleuropneumoniae serotype 1 Ab [Titer] in Serum by Complement fixation
Actinobacillus pleuropneumoniae serotype 3 Ab [Titer] in Serum by Complement fixation
Actinobacillus pleuropneumoniae serotype 5 Ab [Titer] in Serum by Complement fixation
A3 Ag [Presence] on Red Blood Cells from Donor
Actinobacillus pleuropneumoniae serotype 7 Ab [Titer] in Serum by Complement fixation
Actinobacillus pleuropneumoniae serotype identified in Isolate by NAA with probe detection
Actinobacillus suis DNA [Presence] in Specimen by NAA with probe detection
Actinobacillus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Erysipelothrix rhusiopathiae [Presence] in Specimen by Organism specific culture
Erysipelothrix rhusiopathiae Ag [Presence] in Tissue by Immune stain
Erysipelothrix rhusiopathiae DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Erysipelothrix sp strain 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Erysipelothrix tonsillarum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus parasuis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Leptospira borgpetersenii sv Hardjo-bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Leptospira sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Leptospira sp identified [Type] in Isolate by Sequencing
Porcine parvovirus [Presence] in Specimen by Organism specific culture
Porcine parvovirus Ab [Titer] in Serum by Hemagglutination inhibition
Porcine parvovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine parvovirus type 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Toxoplasma gondii Ag [Presence] in Tissue by Immune stain
Toxoplasma gondii IgG Ab [Presence] in Specimen by Immunoassay
Streptococcus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Streptococcus suis Ag [Presence] in Specimen by Immune stain
Porcine parvovirus type 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Growth phase [Type] in Skin melanoma by Light microscopy
Surgical margin tumor involvement.deep [Presence] in Skin melanoma by Light microscopy
Flavivirus neutralizing antibody [Presence] in Specimen by Neutralization test
Dengue virus 2 neutralizing antibody [Titer] in Specimen by Neutralization test
Dengue virus 3 neutralizing antibody [Titer] in Specimen by Neutralization test
Dengue virus 1 neutralizing antibody [Titer] in Specimen by Neutralization test
Dengue virus 4 neutralizing antibody [Titer] in Specimen by Neutralization test
Dengue virus 4 neutralizing antibody [Presence] in Specimen by Neutralization test
Dengue virus 3 neutralizing antibody [Presence] in Specimen by Neutralization test
Dengue virus 2 neutralizing antibody [Presence] in Specimen by Neutralization test
Dengue virus 1 neutralizing antibody [Presence] in Specimen by Neutralization test
Adalimumab [Mass/volume] in Serum or Plasma by Immunoassay
Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
inFLIXimab [Mass/volume] in Serum or Plasma by Immunoassay
inFLIXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Cefaclor [Susceptibility] by Serum bactericidal titer
Plasma cells monotypic population [Identifier] in Blood by Flow cytometry (FC)
Lawsonia intracellularis Ab [Presence] in Serum by Immunoassay
Transmissible gastroenteritis virus Ab/Negative control in Serum by Immunoassay
Porcine respiratory coronavirus Ab/Negative control in Serum by Immunoassay
Porcine epidemic diarrhea virus whole genome [Nucleotide sequence] in Isolate by Sequencing
Lawsonia intracellularis Ab/Negative control in Serum by Immunoassay
Metanephrine, Normetanephrine and Creatinine panel - 24 hour Urine
Trichomonas vaginalis and Mycoplasma genitalium DNA panel - Specimen
Thymus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Lipoprotein associated phospholipase A2 [Enzymatic activity/volume] in Serum or Plasma
A3 B Ag [Presence] on Red Blood Cells from Blood product unit
Bacillus atrophaeus [Presence] in Laboratory device by Culture
Geobacillus stearothermophilus [Presence] in Laboratory device by Culture
Microscopic observation [Presence] in Specimen by Auramine fluorochrome stain
Borrelia afzelii+burgdorferi+garinii IgG and IgM panel - Serum by Line blot
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Line blot
Borrelia afzelii+burgdorferi+garinii IgG band pattern [Interpretation] in Serum by Line blot
Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Line blot
Borrelia afzelii+burgdorferi+garinii IgM band pattern [Interpretation] in Serum by Line blot
Brachyspira hyodysenteriae DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Brachyspira hampsonii DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Brachyspira hyodysenteriae DNA [Presence] in Isolate by NAA with probe detection
Brachyspira pilosicoli DNA [Presence] in Specimen by NAA with probe detection
A3 B Ag [Presence] on Red Blood Cells from Donor
Clostridium perfringens cpa gene [Presence] in Isolate by NAA with probe detection
Clostridium perfringens cpb2 gene [Presence] in Isolate by NAA with probe detection
Clostridium perfringens cpe gene [Presence] in Isolate by NAA with probe detection
Clostridium perfringens etx gene [Presence] in Isolate by NAA with probe detection
Clostridium perfringens iota toxin DNA [Presence] in Isolate by NAA with probe detection
Encephalomyocarditis virus [Presence] in Tissue by Organism specific culture
Encephalomyocarditis virus RNA [Presence] in Tissue by NAA with probe detection
Enterovirus G RNA [Presence] in Specimen by NAA with probe detection
Escherichia coli [#/volume] in Water by Viability count
Escherichia coli eaeA gene [Presence] in Isolate by NAA with probe detection
Escherichia coli enteroaggregative astA gene [Presence] in Isolate by NAA with probe detection
Escherichia coli enterotoxigenic heat-labile toxin DNA [Presence] in Isolate by NAA with probe detection
Escherichia coli enterotoxigenic sta gene [Presence] in Isolate by NAA with probe detection
Escherichia coli enterotoxigenic stb gene [Presence] in Isolate by NAA with probe detection
Porcine circovirus type 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 2 [Presence] in Specimen by Organism specific culture
Porcine circovirus type 2 Ab [Titer] in Serum by Immunoassay
Porcine circovirus type 2 IgG Ab [Titer] in Serum by Immunoassay
Porcine circovirus type 2 IgG+IgM Ab [Titer] in Serum by Immunofluorescence
Porcine circovirus type 2 IgG+IgM Ab [Presence] in Serum by Immunofluorescence
Porcine circovirus type 2 IgG Ab/Positive control in Serum by Immunoassay
Porcine circovirus type 2 neutralizing antibody [Titer] in Serum by Neutralization test
Porcine circovirus type 2 Ab/Negative control in Serum by Immunoassay
Porcine circovirus type 2 Ag [Presence] in Tissue by Immune stain
Porcine circovirus type 2 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing
Porcine circovirus type 2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Porcine circovirus type 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 2 DNA [Presence] in Specimen by NAA with probe detection
Porcine circovirus type 2 RFLP pattern [Type] in Isolate by RFLP
Porcine circovirus type 2 strain identified [Type] in Isolate by Sequencing
Porcine circovirus type 2a DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 2b DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Pseudorabies virus [Presence] in Specimen by Organism specific culture
Pseudorabies virus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Pseudorabies virus glycoprotein 1 Ab/Negative control in Serum by Immunoassay
Pseudorabies virus glycoprotein B Ab/Negative control in Serum by Immunoassay
Senecavirus A [Presence] in Specimen by Organism specific culture
Senecavirus A Ab [Titer] in Serum by Immunofluorescence
Senecavirus A IgG Ab/Positive control in Serum by Immunoassay
Senecavirus A RNA [Presence] in Specimen by NAA with probe detection
Senecavirus A VP1 gene [Nucleotide sequence] in Isolate by Sequencing
Senecavirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Senecavirus A RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Senecavirus A whole genome [Nucleotide sequence] in Isolate by Sequencing
Actinobacillus pleuropneumoniae Ab/Positive control in Serum or Plasma by Immunoassay
Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control in Serum by Immunoassay
Toxoplasma gondii Ab/Negative control in Serum or Plasma by Immunoassay
Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay
Haemophilus parasuis Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control in Serum by Immunoassay
Erysipelothrix rhusiopathiae Ab/Positive control in Serum by Immunoassay
Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control in Serum by Immunoassay
Lawsonia intracellularis VNTR pattern [Type] in Specimen by Molecular genetics method
Escherichia coli fasA gene [Presence] in Isolate by NAA with probe detection
Escherichia coli fedF gene [Presence] in Isolate by NAA with probe detection
Escherichia coli FimF41a gene [Presence] in Isolate by NAA with probe detection
Escherichia coli K88 DNA [Presence] in Isolate by NAA with probe detection
Escherichia coli K99 DNA [Presence] in Isolate by NAA with probe detection
Escherichia coli paa gene [Presence] in Isolate by NAA with probe detection
Escherichia coli Stx1 toxin stx1 gene [Presence] in Isolate by NAA with probe detection
Escherichia coli Stx2 toxin stx2 gene [Presence] in Isolate by NAA with probe detection
Isotopic Tubular extraction rate/1.73 sq M [Volume Rate/Area] in Serum or Blood
Cannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Escherichia coli Stx2e toxin stx2e gene [Presence] in Isolate by NAA with probe detection
Porcine adenovirus Ab [Titer] in Serum by Immunoassay
Porcine cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
Porcine hemagglutinating encephalomyelitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine parainfluenza virus 1 HN gene [Nucleotide sequence] in Isolate by Sequencing
Porcine parainfluenza virus 1 F gene [Nucleotide sequence] in Isolate by Sequencing
Porcine parainfluenza virus 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
Porcine sapelovirus [Presence] in Specimen by Organism specific culture
Porcine sapelovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine sapelovirus RNA [Presence] in Specimen by NAA with probe detection
Porcine teschovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine teschovirus RNA [Presence] in Specimen by NAA with probe detection
Salmonella sp Ab/Positive control in Serum by Immunoassay
Salmonella sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection
West Nile virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Clostridium perfringens cpb gene [Presence] in Isolate by NAA with probe detection
Brachyspira sp DNA [Presence] in Isolate by NAA with probe detection
Porcine teschovirus [Presence] in Specimen by Organism specific culture
Brachyspira sp Ag [Presence] in Tissue by Immune stain
Brachyspira pilosicoli DNA [Presence] in Isolate by NAA with probe detection
Escherichia coli aidA-I gene [Presence] in Isolate by NAA with probe detection
Platelet aggregation ristocetin induced in Platelet rich plasma --750 ug/mL
Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay
Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay
Thymidine synthase activity interpretation in Blood or Tissue Qualitative
Brachyspira hyodysenteriae DNA [Presence] in Specimen by NAA with probe detection
Brachyspira sp nox gene [Nucleotide sequence] in Isolate by Sequencing
Brachyspira sp [Type] in Isolate by Sequencing
Cytolethal distending toxin B and Vinculin Ab panel - Serum by Immunoassay
Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay
Cytolethal distending toxin B+Vinculin Ab [Interpretation] in Serum Qualitative by Immunoassay
Vinculin Ab [Units/volume] in Serum by Immunoassay
Glucose [Mass/volume] in Blood --post meal
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoblot
Cytomegalovirus IgG and IgM panel - Serum or Plasma Qualitative
Neutrophil cytoplasmic Ab panel - Serum by Immunofluorescence
Drugs of abuse screen W Reflex confirm panel - Urine
Cortisol AM and PM panel - Serum or Plasma
Cystatin C and Glomerular filtration rate by Cystatin C-based formula panel - Serum or Plasma
Herpes simplex virus 1 and 2 DNA panel - Specimen Qualitative by NAA with probe detection
Mycophenolate and mycophenolate glucuronide panel - Serum or Plasma
Free hemoglobin and oxyhemoglobin panel - Plasma
Coccidioides immitis IgG and IgM panel - Serum or Plasma
Chromosome X and Y aneuploidy in Blood or Tissue by FISH
Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen by Immunoassay
Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay
Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay
Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Specimen by Immunoassay
Hardness [Mass/volume] of Water by Calculation
Electrical conductivity [Fluid Conductance] of Water
Mean diameter [Length] of Feed particles
BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Gabapentin [Presence] in Serum, Plasma or Blood by Screen method
Meperidine [Presence] in Serum, Plasma or Blood by Screen method
3-Methoxytyramine.free/Creatinine [Molar ratio] in 24 hour Urine
3-Methoxytyramine.free [Molar ratio] in Urine
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase with reflex to HEXA gene panel [Enzymatic activity/mass] - Leukocytes
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel [Enzymatic activity/mass] - Leukocytes
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel - Serum or Plasma
Dengue virus IgG and IgM panel - Serum Qualitative
Borrelia burgdorferi Ab and Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum
Anaplasma phagocytophilum and Ehrlichia sp DNA panel - Blood Qualitative by NAA with non-probe detection
1,25-Dihydroxyvitamin D and 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 panel - Serum or Plasma
A,B Ab [Presence] in Serum or Plasma from Blood product unit
Haloperidol and reduced haloperidol panel - Serum or Plasma
Neutrophil cytoplasmic Ab.IgG and Saccharomyces cerevisiae IgA and IgG in Serum
IgA, IgA1 and IgA2 panel - Serum or Plasma
Aspergillus fumigatus and Saccharopolyspora rectivirgula and Thermoactinomyces vulgaris IgG panel - Serum
Sjogrens syndrome-A and B extractable nuclear IgG panel - Serum
Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma
Protein S Ag and protein S Ag.free panel - Platelet poor plasma by Immunoassay
Anaplasma phagocytophilum groEL gene [Presence] in Blood by NAA with non-probe detection
Ehrlichia chaffeensis groEL gene [Presence] in Blood by NAA with non-probe detection
Ehrlichia canis+ewingii groEL gene [Presence] in Blood by NAA with non-probe detection
Ehrlichia muris eauclairensis groEL gene [Presence] in Blood by NAA with non-probe detection
Chlortetracycline [Mass/mass] in Specimen
Candida auris ITS2 gene [Presence] in Specimen by NAA with probe detection
Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection
Zika virus IgM Ab [Presence] in Specimen by Immunoassay
A,B Ab [Presence] in Serum or Plasma from Donor
Aldicarb sulfone [Mass/mass] in Specimen
p,p'- Dichlorodiphenyldichloroethane [Mass/mass] in Specimen
Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen
Dichlorodiphenyldichloroethylene [Mass/mass] in Specimen
o,p'- Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen
Methyl parathion [Mass/mass] in Specimen
2,3,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen
Hexachlorobenzene [Mass/mass] in Specimen
Heptachlor epoxide [Mass/mass] in Specimen
Alpha benzene hexachloride [Mass/mass] in Specimen
Chlorinated hydrocarbon panel - Specimen
Cholecalciferol (Vit D3) [Mass/mass] in Specimen
Tocopherol+tocotrienol [Mass/mass] in Specimen
Retinal+retinol+retinoic acid [Mass/mass] in Specimen
Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC)
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis
Virus identified in Lower respiratory specimen by Culture
Rotavirus C VP7 gene [Nucleotide sequence] in Isolate by Sequencing
Rotavirus B VP7 gene [Nucleotide sequence] in Isolate by Sequencing
Rotavirus A VP7 gene [Nucleotide sequence] in Isolate by Sequencing
Rotavirus A VP4 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing
Complement C1q.functional [Units/volume] in Serum or Plasma
Complement C3.functional [Units/volume] in Serum or Plasma
Complement C7.functional [Units/volume] in Serum or Plasma
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma from Donor by Immunoassay
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay
Complement C9.functional [Units/volume] in Serum or Plasma
HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing
KIT gene exon 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method
KIT gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method
KIT gene exon 8 targeted mutation analysis in Blood or Tissue by Molecular genetics method
cefTAZidime+Avibactam [Susceptibility] by Gradient strip
Ceftolozane+Tazobactam [Susceptibility] by Gradient strip
3,4,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen
GALC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Adalimumab Ab [Units/volume] in Serum or Plasma
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/mass] in Specimen
Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection
BMPR1A and SMAD4 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Platelet glycoprotein IV Ab [Presence] in Serum or Plasma by Immunoassay
Naegleria fowleri DNA [Presence] in Specimen by NAA with probe detection
N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method
Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Methcathinone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Ezogabine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method
levETIRAcetam/Creatinine [Mass Ratio] in Urine by Confirmatory method
10-Hydroxycarbazepine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Primidone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Rufinamide/Creatinine [Mass Ratio] in Urine by Confirmatory method
tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Topiramate/Creatinine [Mass Ratio] in Urine by Confirmatory method
Zonisamide/Creatinine [Mass Ratio] in Urine by Confirmatory method
lamoTRIgine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method
tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method
8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method
Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method
ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method
Diclofenac/Creatinine [Mass Ratio] in Urine by Confirmatory method
Ketoprofen/Creatinine [Mass Ratio] in Urine by Confirmatory method
Naproxen/Creatinine [Mass Ratio] in Urine by Confirmatory method
Oxaprozin/Creatinine [Mass Ratio] in Urine by Confirmatory method
Bupivacaine/Creatinine [Mass Ratio] in Urine by Confirmatory method
guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method
Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method
Theophylline/Creatinine [Mass Ratio] in Urine by Confirmatory method
Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC)
Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC)
Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC)
Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC)
Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC)
Ormetoprim+Sulfadimethoxine [Susceptibility]
Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC)
Methylphenidate [Presence] in Saliva (oral fluid) by Screen method
Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method
Meprobamate [Presence] in Saliva (oral fluid) by Screen method
Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
fentaNYL [Presence] in Saliva (oral fluid) by Screen method
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method
Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Tapentadol [Presence] in Saliva (oral fluid) by Screen method
Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Zolpidem [Presence] in Saliva (oral fluid) by Screen method
Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Naltrexone [Presence] in Saliva (oral fluid) by Screen method
Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method
6-Beta naltrexol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by Molecular genetics method
Fibroblast growth factor 21.intact [Mass/volume] in Serum or Plasma
Protein.monoclonal band 3 [Mass/volume] in Urine by Immunofixation
Protein.monoclonal band 2 [Mass/volume] in Urine by Immunofixation
Protein.monoclonal [Mass/volume] in Urine by Immunofixation
A,B Ag [Presence] on Red Blood Cells from Blood product unit
Rickettsia conorii IgM Ab [Presence] in Serum by Immunoassay
Rickettsia conorii IgG Ab [Presence] in Serum by Immunoassay
Reagin Ab [Titer] in Cerebral spinal fluid by RPR
Epithelial cells [#/volume] in Urine by Automated
Bacterial susceptibility panel - Isolate by Minimum lethal concentration (MLC)
Macroscopic observation [Interpretation] in Stool Narrative
Bacteria identified in Amniotic fluid by Aerobe culture
Bacteria identified in Burn by Aerobe culture
Bacteria identified in Implanted device by Aerobe culture
Bacteria identified in Sinus by Aerobe culture
Bacteria identified in Amniotic fluid by Anaerobe culture
Bacteria identified in Bile fluid by Anaerobe culture
Bacteria identified in Blood product unit by Anaerobe culture
Bacteria identified in Burn by Anaerobe culture
Bacteria identified in Cerebral spinal fluid by Anaerobe culture
Bacteria identified in Implanted device by Anaerobe culture
Bacteria identified in Pericardial fluid by Anaerobe culture
Bacteria identified in Peritoneal fluid by Anaerobe culture
Bacteria identified in Placenta by Anaerobe culture
Bacteria identified in Pleural fluid by Anaerobe culture
Bacteria identified in Sinus by Anaerobe culture
Bacteria identified in Synovial fluid by Anaerobe culture
Borrelia sp identified in Cerebral spinal fluid by Organism specific culture
Borrelia sp identified in Tissue by Organism specific culture
Borrelia sp DNA identified in Tissue by NAA with probe detection
Clostridium botulinum [Presence] in Stool by Organism specific culture
Chlamydia trachomatis DNA [Presence] in Tissue by NAA with probe detection
Chlamydia trachomatis [Presence] in Tissue by Organism specific culture
Escherichia coli eaeA gene [Presence] in Stool by NAA with probe detection
Helicobacter pylori [Presence] in Stool by Organism specific culture
Helicobacter pylori [Presence] in Tissue by Organism specific culture
Bacteria identified in Cord blood by Aerobe culture
Bacteria identified in Cord blood by Anaerobe culture
Legionella sp identified in Tissue by Organism specific culture
Legionella sp identified in Water by Organism specific culture
Neisseria meningitidis [Presence] in Throat by Organism specific culture
Adenovirus Ag [Presence] in Cerebral spinal fluid by Immunoassay
Enterovirus RNA [Presence] in Body fluid by NAA with probe detection
Varicella zoster virus DNA [Presence] in Body fluid by NAA with probe detection
HIV 1 subtype identified in Cerebral spinal fluid by NAA with probe detection
HIV 1 RNA tropism [Identifier] in Cerebral spinal fluid
Respiratory pathogens panel - Bronchoalveolar lavage by Immunofluorescence
Microscopic observation [Identifier] in Cerebral spinal fluid by Giemsa stain
Microscopic observation [Identifier] in Bone marrow by Giemsa stain
Microscopic observation [Identifier] in Bone marrow by Gram stain
Microscopic observation [Identifier] in Body fluid by Giemsa stain
Microscopic observation [Identifier] in Blood by Gram stain
A,B Ag [Presence] on Red Blood Cells from Donor
Microscopic observation [Identifier] in Amniotic fluid by Giemsa stain
Microscopic observation [Identifier] in Amniotic fluid by Gram stain
Microscopic observation [Identifier] in Sinus by Gram stain
Microscopic observation [Identifier] in Semen by Gram stain
Microscopic observation [Identifier] in Burn by Gram stain
Microscopic observation [Identifier] in Isolate by Gram stain
Fungus identified in Implanted device by Culture
Fungus identified in Pericardial fluid by Culture
Fungus identified in Peritoneal dialysis fluid by Culture
Fungus identified in Pleural fluid by Culture
Toxoplasma gondii [Presence] in Bone marrow by Organism specific culture
Toxoplasma gondii DNA [Presence] in Placenta by NAA with probe detection
Toxoplasma gondii DNA [Presence] in Tissue by NAA with probe detection
Trichinella spiralis DNA [Presence] in Tissue by NAA with probe detection
Leishmania sp identified in Bone marrow by Organism specific culture
Leishmania sp identified in Blood by Organism specific culture
Acanthamoeba sp DNA [Presence] in Contact lens by NAA with probe detection
Toxoplasma gondii DNA [Presence] in Bone marrow by NAA with probe detection
Acanthamoeba sp identified in Cerebral spinal fluid by Organism specific culture
Acanthamoeba sp identified in Contact lens by Organism specific culture
Onchocerca sp IgG Ab [Presence] in Serum by Immunoassay
Toxoplasma gondii DNA [Presence] in Cord blood by NAA with probe detection
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunoassay
Strongyloides sp identified in Stool by Organism specific culture
Fasciola hepatica Ab [Titer] in Serum by Complement fixation
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunoassay
Amoeba identified in Stool by Wet preparation
Microscopic observation [Identifier] in Contact lens by Gram stain
Microscopic observation [Identifier] in Pleural fluid by Giemsa stain
Microscopic observation [Identifier] in Peritoneal dialysis fluid by Gram stain
Kanamycin 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency [Likelihood] in Fetus
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma
Sialate.lipid bound/Creatinine [Molar ratio] in Urine
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in DBS
5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in Serum or Plasma
little p phenotype [Presence] on Red Blood Cells
little p phenotype [Presence] on Red Blood Cells from Blood product unit
little p phenotype [Presence] on Red Blood Cells from Donor
P sup(k) Ab [Presence] in Serum or Plasma
P sup(k) Ab [Presence] in Serum or Plasma from Blood product unit
P sup(k) Ab [Presence] in Serum or Plasma from Donor
P sup(k) Ag [Presence] on Red Blood Cells
P sup(k) Ag [Presence] on Red Blood Cells from Blood product unit
P sup(k) Ag [Presence] on Red Blood Cells from Donor
P2 phenotype [Presence] on Red Blood Cells
P2 phenotype [Presence] on Red Blood Cells from Blood product unit
P2 phenotype [Presence] on Red Blood Cells from Donor
Cells.CD4-CD8-CD45R+TCR alpha beta+/100 CD3 cells in Blood by Flow cytometry (FC)
Cells.CD4-CD8-CD45R+TCR alpha beta+ [#/volume] in Blood by Flow cytometry (FC)
Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay
Liver fibrosis score in Serum or Plasma by Calculated by ELF
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Acetaminophen [Presence] in Blood by Screen method
Porcine epidemic diarrhea virus S1 gene [Nucleotide sequence] in Isolate by Sequencing
Parathyrin.intact [Mass/volume] in Tissue fine needle aspirate
OXcarbazepine [Moles/volume] in Serum or Plasma --trough
Gentamicin [Moles/volume] in Serum or Plasma --random post extended interval dosing
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P
Erythrocytes [Presence] in Cerebral spinal fluid by Gram stain
Leukocytes [Presence] in Cerebral spinal fluid by Gram stain
Round cells [Presence] in Semen by Light microscopy
Escherichia coli gene panel - Specimen by NAA with probe detection
Escherichia coli enterotoxigenic gene panel - Specimen by NAA with probe detection
Herpes simplex virus identified in Cornea or Conjunctiva by Organism specific culture
Herpes simplex virus 1 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Respiratory pathogens panel - Throat by Immunofluorescence
ABO and Rh group [Type] in Blood from Blood product unit
Cytomegalovirus DNA [#/volume] (viral load) in Ocular fluid by NAA with probe detection
Cytomegalovirus DNA [Presence] in Ocular fluid by NAA with probe detection
Varicella zoster virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Varicella zoster virus DNA [Presence] in Ocular fluid by NAA with probe detection
Varicella zoster virus [Presence] in Cornea or Conjunctiva by Organism specific culture
Varicella zoster virus [Presence] in Ocular fluid by Organism specific culture
Respiratory pathogens panel - Nasopharynx by Immunofluorescence
Herpes simplex virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Bacteria identified in Ocular fluid by Anaerobe culture
Tropheryma whipplei DNA [Presence] in Ocular fluid by NAA with probe detection
Bacteria identified in Ocular fluid by Aerobe culture
Bacteria identified in Cornea or Conjunctiva by Aerobe culture
Fungus identified in Cornea or Conjunctiva by Culture
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain
Microscopic observation [Identifier] in Pericardial fluid by Acid fast stain
Microscopic observation [Identifier] in Placenta by Gram stain
Microscopic observation [Identifier] in Pericardial fluid by Gram stain
Microscopic observation [Identifier] in Genital specimen by Acid fast stain
Microscopic observation [Identifier] in Nasopharynx by Gram stain
Microscopic observation [Identifier] in Ocular fluid by Giemsa stain
Microscopic observation [Identifier] in Wound by Acid fast stain
Microscopic observation [Identifier] in Cervix by Acid fast stain.Kinyoun
Microscopic observation [Identifier] in Bone marrow by Acid fast stain
Microscopic observation [Identifier] in Sinus by Acid fast stain
Microscopic observation [Identifier] in Ocular fluid by Acid fast stain
Microscopic observation [Identifier] in Amniotic fluid by Acid fast stain
Microscopic observation [Identifier] in Semen by Acid fast stain
Microscopic observation [Identifier] in Ocular fluid by Gram stain
Microscopic observation [Identifier] in Aspirate by Acid fast stain
Microsporidia DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Toxoplasma gondii [Presence] in Ocular fluid by Organism specific culture
Acanthamoeba sp identified in Cornea or Conjunctiva by Organism specific culture
Acanthamoeba sp DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Toxoplasma gondii DNA [Presence] in Ocular fluid by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Ocular fluid by NAA with probe detection
Mycobacterium sp identified in Cornea or Conjunctiva by Organism specific culture
Mycobacterium sp identified in Ocular fluid by Organism specific culture
Microscopic observation [Identifier] in Cornea or Conjunctiva by Gram stain
Microscopic observation [Presence] in Cornea or Conjunctiva by Acid fast stain
Microscopic observation [Presence] in Isolate by Acid fast stain
Microscopic observation [Presence] in Pleural fluid by Acid fast stain
Coxiella burnetii DNA [Presence] in Blood by NAA with probe detection
Coxiella burnetii DNA [Presence] in Tissue by NAA with probe detection
Wuchereria bancrofti+Brugia malayi IgG4 Ab [Presence] in Serum by Immunoassay
Wuchereria bancrofti+Brugia malayi IgG3 Ab [Presence] in Serum by Immunoassay
Wuchereria bancrofti+Brugia malayi IgG2 Ab [Presence] in Serum by Immunoassay
Wuchereria bancrofti+Brugia malayi IgG1 Ab [Presence] in Serum by Immunoassay
Mycobacterium sp identified in Isolate by Sequencing
IgG+IgM.porcine [Presence] in Pleural fluid from Fetus by Immune diffusion (ID)
IgG+IgM.porcine [Presence] in Serum from Fetus by Immune diffusion (ID)
Ebola and Marburg virus RNA Panel - Blood by NAA with probe detection
Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection
Dengue virus 1+2+3+4 RNA [Presence] in Urine by NAA with probe detection
Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with probe detection
Crimean-Congo hemorrhagic fever virus IgM Ab [Presence] in Serum by Immunoassay
Crimean-Congo hemorrhagic fever virus IgG Ab [Presence] in Serum by Immunoassay
Crimean-Congo hemorrhagic fever virus RNA [Presence] in Serum by NAA with probe detection
Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Influenza virus B Ag [Presence] in Tissue by Immunofluorescence
Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Stool by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Aspirate by NAA with probe detection
Influenza virus identified in Cornea or Conjunctiva by Organism specific culture
Herpes simplex virus 1 Ag [Presence] in Tissue by Immunofluorescence
Respiratory syncytial virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Serum or Blood by NAA with probe detection
Respiratory syncytial virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum by Immunoassay
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum by Immunoassay
Lymphocytic choriomeningitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Parainfluenza virus 1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Rabies virus Ag [Presence] in Cerebral spinal fluid by Immunoassay
HIV 1 proviral DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Rhinovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Rabies virus RNA [Presence] in Tissue by NAA with probe detection
Rabies virus RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Hantavirus puumala RNA [Presence] in Urine by NAA with probe detection
Parechovirus RNA [Presence] in Aspirate by NAA with probe detection
Parechovirus RNA [Presence] in Stool by NAA with probe detection
Parechovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Hantavirus puumala RNA [Presence] in Blood by NAA with probe detection
Chlamydia trachomatis DNA [Presence] in Throat by NAA with probe detection
Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence
Francisella sp DNA [Presence] in Aspirate by NAA with probe detection
Neisseria gonorrhoeae DNA [Presence] in Anorectal by NAA with probe detection
Neisseria gonorrhoeae DNA [Presence] in Throat by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Urine by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Cervix by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Vaginal fluid by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Anorectal by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Throat by NAA with probe detection
Microscopic observation [Identifier] in Bile fluid by Acid fast stain
Trypanosoma cruzi DNA [Presence] in Tissue by NAA with probe detection
Babesia sp DNA [Presence] in Blood by NAA with probe detection
Microscopic observation [Presence] in Synovial fluid by Acid fast stain
Microscopic observation [Identifier] in Synovial fluid by Giemsa stain
Bacteria identified in Cerebral spinal fluid by Aerobe culture
Acinetobacter sp rpsA gene [Presence] by Probe in Positive blood culture
Cephalosporin resistance blaCTX-M gene [Presence] by Molecular method
Citrobacter sp ompA+mrkC genes [Presence] by Probe in Positive blood culture
Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture
Enterococcus faecalis hsp60 gene [Presence] by Probe in Positive blood culture
Enterococcus faecium hsp60 gene [Presence] by Probe in Positive blood culture
Escherichia coli oppA gene [Presence] by Probe in Positive blood culture
Gram negative bacteria identified [Interpretation] by Probe in Positive blood culture
Gram negative blood culture panel by Probe in Positive blood culture
Gram positive bacteria identified [Interpretation] by Probe in Positive blood culture
Gram positive blood culture panel by Probe in Positive blood culture
Klebsiella oxytoca ompA gene [Presence] by Probe in Positive blood culture
Klebsiella pneumoniae yggE gene [Presence] by Probe in Positive blood culture
Listeria sp tuf gene [Presence] by Probe in Positive blood culture
Mycobacterium sp rRNA [Identifier] by Probe in Positive blood culture
Proteus sp atpD gene [Presence] by Probe in Positive blood culture
Pseudomonas aeruginosa sodA gene [Presence] by Probe in Positive blood culture
Staphylococcus aureus gyrB gene [Presence] by Probe in Positive blood culture
Staphylococcus epidermidis hsp60 gene [Presence] by Probe in Positive blood culture
Staphylococcus lugdunensis sodA gene [Presence] by Probe in Positive blood culture
Staphylococcus sp tuf gene [Presence] by Probe in Positive blood culture
Streptococcus agalactiae hsp60 gene [Presence] by Probe in Positive blood culture
Streptococcus anginosus group gyrB gene [Presence] by Probe in Positive blood culture
Streptococcus pneumoniae gryB gene [Presence] by Probe in Positive blood culture
Streptococcus pyogenes hsp60 gene [Presence] by Probe in Positive blood culture
Streptococcus sp tuf gene [Presence] by Probe in Positive blood culture
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
Kappa light chains.free [Presence] in 24 hour Urine by Immunofixation
Lambda light chains.free [Presence] in 24 hour Urine by Immunofixation
Lambda light chains [Presence] in 24 hour Urine by Immunofixation
Kappa light chains [Presence] in 24 hour Urine by Immunofixation
Predominant leukocyte identified [Type] in Ear by Light microscopy
Microscopic observation [Interpretation] of Ear specimen Narrative
Mite identified in Ear by Light microscopy
Coccal bacteria [Presence] in Ear by Light microscopy
Bacilliform bacteria [Presence] in Ear by Light microscopy
Mite [Presence] in Ear by Light microscopy
Malassezia sp [Presence] in Ear by Light microscopy
Leukocytes [Presence] in Ear by Light microscopy
Intracellular bacteria [Presence] in Ear by Light microscopy
Microscopic exam panel - Ear by Light microscopy
Actinobacillus pleuropneumoniae IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay
Glucose [Mass/volume] in Blood --pre-meal
Microscopic observation [Presence] in Vomitus by Acid fast stain
Tildipirosin [Susceptibility] by Disk diffusion (KB)
Gamithromycin [Susceptibility] by Disk diffusion (KB)
Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC)
Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20M post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40 minutes post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40M post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose fructose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose lactose PO
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20 minutes post dose lactose PO
Liver fibrosis interpretation in Serum Qualitative
Necroinflammatory activity interpretation in Serum Qualitative
Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic method
Babesia divergens+MO-1 strain 18S rRNA gene [Presence] in Blood by NAA with non-probe detection
Babesia duncani 18S rRNA gene [Presence] in Blood by NAA with non-probe detection
Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection
HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection
Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence
California encephalitis virus Ab.IgG and IgM panel - Serum by Immunofluorescence
California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Mumps virus Ab.IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence
Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum
Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum
Babesia microti and B. divergens+MO-1 and B. duncani 18S rRNA gene panel - Blood by NAA with non-probe detection
ABO and Rh group [Type] in Capillary blood
Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)
Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method
Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Gastrointestinal pathogens identified in Specimen by NAA with probe detection
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method
Respiratory syncytial virus [Presence] in Cornea or Conjunctiva by Organism specific culture
Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Parainfluenza virus identified in Cornea or Conjunctiva by Organism specific culture
Human metapneumovirus identified in Cornea or Conjunctiva by Organism specific culture
Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection
Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection
Enterovirus identified in Pericardial fluid by Organism specific culture
Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection
Adenovirus DNA [Presence] in Stool by NAA with probe detection
Am Ab [Presence] in Serum or Plasma from Blood product unit
Enterovirus RNA [Presence] in Aspirate by NAA with probe detection
Adenovirus DNA [Presence] in Aspirate by NAA with probe detection
HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing
HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing
HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing
Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection
Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Scedosporium apiospermum DNA [Presence] in Tissue by NAA with probe detection
Scedosporium apiospermum DNA [Presence] in Isolate by NAA with probe detection
Scedosporium apiospermum DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Scedosporium apiospermum DNA [Presence] in Aspirate by NAA with probe detection
Scedosporium prolificans DNA [Presence] in Specimen by NAA with probe detection
Scedosporium prolificans DNA [Presence] in Isolate by NAA with probe detection
Scedosporium prolificans DNA [Presence] in Tissue by NAA with probe detection
Galactomannan Ag [Presence] in Bronchoalveolar lavage
Scedosporium prolificans DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Scedosporium apiospermum DNA [Presence] in Specimen by NAA with probe detection
Cytomegalovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Cytomegalovirus [Presence] in Bone marrow by Organism specific culture
Varicella zoster virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Cytomegalovirus Ag [Presence] in Bone marrow by Immunofluorescence
Cytomegalovirus DNA [Presence] in Bone marrow by NAA with probe detection
Influenza virus identified in Lower respiratory specimen by Organism specific culture
Ocular pathogens panel - Cornea or Conjunctiva Qualitative by NAA with probe detection
Acanthamoeba sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
Onchocerca sp IgG2 Ab [Presence] in Serum by Immunoassay
Onchocerca sp IgG3 Ab [Presence] in Serum by Immunoassay
Onchocerca sp IgG4 Ab [Presence] in Serum by Immunoassay
Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection
Legionella pneumophila DNA [Presence] in Tissue by NAA with probe detection
Clostridium botulinum toxin [Identifier] in Stool by Mouse bioassay neutralization
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Burkholderia sp identified in Lower respiratory specimen by Organism specific culture
Borrelia sp DNA [Identifier] in Cerebral spinal fluid by NAA with probe detection
Bordetella sp identified in Nasopharynx by Organism specific culture
Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection
Corynebacterium diphtheriae [Presence] in Upper respiratory specimen by Organism specific culture
Legionella sp identified in Lower respiratory specimen by Organism specific culture
Shigella sp identified in Stool by Organism specific culture
Legionella sp DNA [Identifier] in Tissue by NAA with probe detection
Legionella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection
Clostridium botulinum toxin [Identifier] in Serum by Mouse bioassay neutralization
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Scedosporium prolificans DNA [Presence] in Aspirate by NAA with probe detection
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human bocavirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Respiratory syncytial virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection
Respiratory syncytial virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Toscana virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection
Influenza virus types A and B panel - Lower respiratory specimen by NAA with probe detection
Adenovirus Ag [Presence] in Nasopharynx by Immunoassay
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunoassay
Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Herpes simplex virus identified in Lower respiratory specimen by Organism specific culture
Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection
Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human coronavirus 229E RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus HKU1 RNA [Presence] in Aspirate by NAA with probe detection
Human coronavirus HKU1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus RNA [Presence] in Aspirate by NAA with probe detection
Human coronavirus NL63 RNA [Presence] in Aspirate by NAA with probe detection
Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human coronavirus NL63 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus OC43 RNA [Presence] in Aspirate by NAA with probe detection
Am Ab [Presence] in Serum or Plasma from Donor
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human coronavirus OC43 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Cytomegalovirus [Presence] in Ocular fluid by Shell vial culture
Cytomegalovirus [Presence] in Cerebral spinal fluid by Organism specific culture
Cytomegalovirus [Presence] in Amniotic fluid by Shell vial culture
Cytomegalovirus [Presence] in Ocular fluid by Organism specific culture
Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human coronavirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunoassay
Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Microscopic observation [Presence] in Lower respiratory specimen by Acid fast stain.Kinyoun
Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain
Microscopic observation [Identifier] in Lower respiratory specimen by Giemsa stain
Microscopic observation [Identifier] in Saliva (oral fluid) by Gram stain
Microscopic observation [Identifier] in Vomitus by Gram stain
Herpes simplex virus 1 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence
Herpes simplex virus 2 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence
Leishmania sp IgM Ab [Titer] in Serum by Immunofluorescence
Bacteria identified in Bronchoalveolar lavage by Anaerobe culture
Microscopic observation [Identifier] in Aspirate by Giemsa stain
Microscopic observation [Identifier] in Lower respiratory specimen by KOH preparation
Fungus identified in Bronchoalveolar lavage by Culture
Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection
Pneumocystis jiroveci [Presence] in Lower respiratory specimen by Calcofluor white
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Pneumocystis jiroveci Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Electrolytes and Osmolality panel - Stool
Protein electrophoresis panel - Body fluid
Procainamide and N-acetylprocainamide panel - Serum or Plasma
Babesia microti IgG and IgM [Interpretation] in Serum
Norovirus genogroups I and II RNA panel - Stool by NAA with probe detection
Systemic sclerosis panel - Serum by Immunoassay
Bedaquiline [Susceptibility] by Minimum inhibitory concentration (MIC)
Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria
Kanamycin 3.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgE Ab [Units/volume] in Serum
Albumin/Globulin [Mass Ratio] in Body fluid by Electrophoresis
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal dialysis fluid
Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid
Lipase [Enzymatic activity/volume] in Peritoneal dialysis fluid
Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method
Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method
Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection
Streptococcus pneumoniae serotype [Type] in Isolate
Asialoganglioside GM1 IgG+IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD1a IgG+IgM Ab [Units/volume] in Serum by Immunoassay
MDA5 Ab [Units/volume] in Serum by Line blot
Glial nuclear type 1 Ab [Units/volume] in Serum by Line blot
Recoverin Ab [Units/volume] in Serum by Line blot
Babesia microti IgG and IgM panel - Serum by Immunofluorescence
Ganglioside GQ1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GD1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay
Ganglioside GM2 IgG+IgM Ab [Units/volume] in Serum by Immunoassay
Mi-2 alpha Ab [Units/volume] in Serum by Line blot
Mi-2 beta Ab [Units/volume] in Serum by Line blot
PCA-Tr Ab [Units/volume] in Serum by Line blot
PM-SCL-100 Ab [Units/volume] in Serum by Line blot
PM-SCL-75 Ab [Units/volume] in Serum by Line blot
RNA polymerase III RP11 Ab [Units/volume] in Serum by Line blot
RNA polymerase III RP155 Ab [Units/volume] in Serum by Line blot
TIF1-gamma Ab [Units/volume] in Serum by Line blot
Titin Ab [Units/volume] in Serum by Line blot
U1 small nuclear ribonucleoprotein A Ab [Units/volume] in Serum by Line blot
U1 small nuclear ribonucleoprotein C Ab [Units/volume] in Serum by Line blot
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Serum by Line blot
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method
Coccidioides immitis IgG and IgM panel - Cerebral spinal fluid
Toxoplasma gondii IgG and IgM panel - Serum or Plasma by Immunoassay
Influenza virus A swine origin RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Microbiology CNAMTS panel - Synovial fluid
Microbiology CNAMTS panel - Cerebral spinal fluid
Metabolic panel.dialysis patient - Serum or Plasma
Microbiology CNAMTS panel - Bronchial specimen
Urinary cell count CNAMTS panel - 3 hour Urine
Microbiology CNAMTS panel - Vaginal fluid
Lung cancer antibody panel - Serum or Plasma by Immunoassay
Microbiology CNAMTS panel - Cornea or Conjunctiva
Other Chemical [Mass/volume] in Specimen
Veterinary toxicology quantitative panel - Unspecified specimen
Veterinary toxicology panel [Presence] - Specimen
Sympathomimetics [Presence] in Serum, Plasma or Blood by Confirmatory method
Measles virus genotype A vaccine strain N gene [Presence] in Specimen by NAA with probe detection
Measles virus genotype A vaccine strain N gene [Cycle Threshold #] in Specimen by NAA with probe detection
Blood group antibodies identified in Serum or Plasma
Monocyte distribution width [Entitic volume] in Blood by Automated
Smith extractable nuclear D Ab [Presence] in Serum by Line blot
Smith extractable nuclear B Ab [Presence] in Serum by Line blot
Connective tissue autoimmune Ab panel - Serum
Fatty acid omega-3 and omega-6 panel - Serum or Plasma
Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection
Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma
Brivaracetam [Mass/volume] in Serum or Plasma
Perampanel [Mass/volume] - Serum or Plasma
Reboxetine [Mass/volume] in Serum or Plasma
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture
Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture
Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture
Adenovirus [Presence] in Stool by Organism specific culture
Adenovirus [Presence] in Urine by Organism specific culture
Influenza virus B IgG Ab [Presence] in Serum by Immunoassay
Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Parainfluenza virus 3 Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Respiratory syncytial virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Taenia sp DNA [Presence] in Specimen by NAA with probe detection
Taenia solium larva DNA [Presence] in Tissue by NAA with probe detection
Taenia solium larva DNA [Presence] in Blood by NAA with probe detection
Strongyloides stercoralis DNA [Presence] in Stool by NAA with probe detection
Acanthamoeba sp DNA [Presence] in Tissue by NAA with probe detection
Filaria DNA [Presence] in Tissue by NAA with probe detection
Leishmania sp DNA [Identifier] in Tissue by NAA with probe detection
Leishmania sp DNA [Identifier] in Bone marrow by NAA with probe detection
Filaria DNA [Presence] in Blood by NAA with probe detection
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Taenia solium larva Ag [Presence] in Serum by Immunoassay
Echinococcus granulosus Ab [Titer] in Serum by Complement fixation
Actinomyces sp identified in Tissue by Organism specific culture
1,3 beta glucan [Mass/volume] in Lower respiratory specimen
Microsporidia DNA [Presence] in Tissue by NAA with probe detection
Microsporidia DNA [Presence] in Stool by NAA with probe detection
Histoplasma capsulatum DNA [Presence] in Tissue by NAA with probe detection
Cryptosporidium sp DNA [Presence] in Tissue by NAA with probe detection
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
Blood group antibodies identified in Blood product unit
Hyaline casts [#/area] in Urine sediment
Leucine crystals [#/area] in Urine sediment
Tyrosine crystals [#/area] in Urine sediment
Mixed cellular casts [#/area] in Urine sediment
Crystals.amorphous [#/area] in Urine sediment
Granular casts [#/area] in Urine sediment
Epithelial casts [#/area] in Urine sediment
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma
Elvitegravir [Mass/volume] in Serum or Plasma
Maraviroc [Mass/volume] in Serum or Plasma
Melperone [Mass/volume] in Serum or Plasma
Perazine [Mass/volume] in Serum or Plasma
Sertindole [Mass/volume] in Serum or Plasma
Zotepine [Mass/volume] in Serum or Plasma
Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Acute kidney injury risk [Likelihood] by Calculated by NephroCheck
Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma
Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma
Omega-3 (EPA+DHA) index in Serum or Plasma
Omega-3 (EPA+DHA) index risk in Serum or Plasma
Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method
CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay
GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay
HuD Ab [Units/volume] in Serum or Plasma by Immunoassay
MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay
p53 Ab [Units/volume] in Serum or Plasma by Immunoassay
SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay
CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method
Blood group antibody screen [Presence] in Serum or Plasma
Rubella virus Ab [Presence] in Serum by Immunofluorescence
Lung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay
Zopiclone-N-oxide [Mass/volume] in Urine
Basic metabolic and albumin panel - Serum or Plasma
Blood group antibody screen.cell I [Presence] in Serum or Plasma
Blood group antibody screen.cell III [Presence] in Serum or Plasma
Phenotypic lab test method used to determine resistance [Identifier] in Isolate
Molecular lab test method used to determine resistance [Identifier] in Isolate or Specimen
Oxygen saturation in Arterial blood by Pulse oximetry --W exercise
Oxygen saturation in Arterial blood by Pulse oximetry --during anesthesia
Cefmetazole [Susceptibility] by Disk diffusion (KB)
Tapentadol glucuronide [Presence] in Urine by Screen method
oxymorphone-3-glucuronide [Presence] in Urine by Screen method
Noroxymorphone [Presence] in Urine by Screen method
Noroxycodone [Presence] in Urine by Screen method
Norhydrocodone [Presence] in Urine by Screen method
Norbuprenorphine-3-glucuronide [Presence] in Urine by Screen method
Nortapentadol [Presence] in Urine by Screen method
Naloxone-3-glucuronide [Presence] in Urine by Screen method
Morphine-6-Glucuronide [Presence] in Urine by Screen method
Hydromorphone-3-glucuronide [Presence] in Urine by Screen method
Codeine-6-glucuronide [Presence] in Urine by Screen method
Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular method
CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood
CD4+CD25+CD45RO+CD127Low+ cells [#/volume] in Blood
CD4+CD25-CD127+ cells [#/volume] in Blood
CD25-CD127+ cells/100 CD4 cells in Blood
CD25+CD45RA+CD127Low+ cells/100 CD4 cells in Blood
CD25+CD45RO+CD127Low+ cells/100 CD4 cells in Blood
Buprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method
Norbuprenorphine-3-glucuronide [Mass/volume] in Serum or Plasma by Confirmatory method
APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Insulin intact [Units/volume] in Serum by LC/MS/MS
CD3+CD8+CD28+HLA DR+ cells [#/volume] in Blood
CD3+CD4+CD28+HLA DR+ cells [#/volume] in Blood
CD3+CD8+CD27-CD45RO+CD62L- cells [#/volume] in Blood
CD3+CD4+CD27-CD45RO+CD62L- cells [#/volume] in Blood
CD3+CD4+CD27+CD45RO+CD62L+ cells [#/volume] in Blood
CD3+CD8+CD27+CD62L+ cells [#/volume] in Blood
CD3+CD4+CD27+CD62L+ cells [#/volume] in Blood
CD28+HLA DR+ cells/100 CD3+CD8+ cells in Blood
CD28+HLA DR+ cells/100 CD3+CD4+ cells in Blood
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD8+ cells in Blood
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD8+ cells in Blood
CD45RO cells/100 CD3+CD8+ cells in Blood
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD4+ cells in Blood
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD4+ cells in Blood
CD27+CD62L+ cells/100 CD3+CD8+ cells in Blood
CD27+CD62L+ cells/100 CD3+CD4+ cells in Blood
Babesia sp 18S rRNA [Presence] in Blood by NAA with probe detection
CD19+CD38+IgM- cells [#/volume] in Blood
CD19+CD27+IgD-IgM+ cells [#/volume] in Blood
CD27+IgD-IgM+ cells/100 CD19 cells in Blood
CD19+CD27+IgD-IgM- cells [#/volume] in Blood
CD27+IgD-IgM- cells/100 CD19 cells in Blood
CD19+CD27+IgD+IgM+ cells [#/volume] in Blood
CD27+IgD+IgM+ cells/100 CD19 cells in Blood
CD19+CD38+IgM+ cells [#/volume] in Blood
Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Cholinesterase [Enzymatic activity/volume] in Body fluid
Free Hemoglobin [Mass/volume] in Body fluid
HIV 1 and 2 Ab panel - Serum, Plasma or Blood by Rapid immunoassay
von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
Zika virus non-structural protein 1 IgM panel - Serum or Plasma by Immunoassay
Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Zika virus non-structural protein 1 IgM Ab [Interpretation] in Serum by Immunoassay
MTB complex DNA and rpoB RIF resistance mutation panel [Presence]
Hepatitis A virus genotype in Specimen by NAA with probe detection
HIV 1 Ab [Presence] in Specimen by Immunoassay
Blood group antibody screen.autologous [Interpretation] in Serum or Plasma
Blood group antibody screen.cell II [Presence] in Serum or Plasma
Azithromycin [Susceptibility] by Genotype method
Gentamicin [Susceptibility] by Genotype method
Kanamycin [Susceptibility] by Genotype method
Capreomycin [Susceptibility] by Genotype method
Amikacin [Susceptibility] by Genotype method
Clarithromycin [Susceptibility] by Genotype method
Mycobacterial susceptibility panel Qualitative by Genotype method
Fluoroquinolone [Susceptibility] by Genotype method
Isoniazid [Susceptibility] by Genotype method
rifAMPin [Susceptibility] by Genotype method
Aminoglycoside [Susceptibility] by Genotype method
Ethambutol [Susceptibility] by Genotype method
Sulfatide IgG Ab [Presence] in Serum by Line blot
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Line blot
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Line blot
RNA polymerase III Ab [Units/volume] in Serum by Line blot
Ribosomal Ab [Presence] in Serum by Line blot
Proteinase 3 Ab [Presence] in Serum by Line blot
Nucleosome Ab [Presence] in Serum by Line blot
Myeloperoxidase Ab [Presence] in Serum by Line blot
Intrinsic factor Ab [Presence] in Serum by Line blot
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GM3 IgM Ab [Presence] in Serum by Line blot
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Line blot
RNA polymerase III Ab [Presence] in Serum by Line blot
Glomerular basement membrane Ab [Presence] in Serum by Line blot
Ganglioside GT1b IgM Ab [Presence] in Serum by Line blot
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Line blot
Ganglioside GM1 IgM Ab [Presence] in Serum by Line blot
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Line blot
Actin smooth muscle Ab [Presence] in Serum by Line blot
Ganglioside GM1 IgG Ab [Presence] in Serum by Line blot
Ganglioside GM3 IgG Ab [Presence] in Serum by Line blot
Ganglioside GT1b IgG Ab [Presence] in Serum by Line blot
Ganglioside GM2 IgM Ab [Presence] in Serum by Line blot
Ganglioside GM2 IgG Ab [Presence] in Serum by Line blot
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Nucleosome Ab [Presence] in Cerebral spinal fluid by Line blot
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma
Histone Ab [Presence] in Cerebral spinal fluid by Line blot
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Line blot
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Line blot
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Line blot
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Line blot
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Line blot
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Line blot
Troponin T.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method
Troponin T.cardiac panel - Serum or Plasma by High sensitivity method
Troponin I.cardiac panel - Serum or Plasma by High sensitivity method
Troponin I.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
Microscopic observation [Identifier] in Cervix by Acid fast stain
Cytomegalovirus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Herpes simplex virus 1 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Herpes simplex virus 2 DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Herpes simplex virus 2 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Varicella zoster virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence
Zika virus IgG Ab [Titer] in Serum by Immunofluorescence
Zika virus IgM Ab [Titer] in Serum by Immunofluorescence
Bartonella quintana DNA [Presence] in Tissue by NAA with probe detection
Bartonella sp DNA [Presence] in Tissue by NAA with probe detection
Legionella pneumophila Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Legionella pneumophila Ag [Presence] in Tissue by Immunofluorescence
Listeria monocytogenes DNA [Presence] in Blood by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Mycoplasma hominis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Organism specific culture
Blood group antibody screen [Presence] in Serum or Plasma by Cold absorption
Toxoplasma gondii [Presence] in Placenta by Organism specific culture
Actinomyces sp identified in Lower respiratory specimen by Organism specific culture
Actinomyces sp identified in Implanted device by Organism specific culture
Mycobacterium tuberculosis DNA [Presence] in Implanted device by NAA with probe detection
Mycobacterium sp identified in Lower respiratory specimen by Organism specific culture
Mycobacterium sp identified in Implanted device by Organism specific culture
Nocardia sp identified in Lower respiratory specimen by Organism specific culture
Nocardia sp identified in Implanted device by Organism specific culture
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay
Corynebacterium diphtheriae toxin IgG Ab [Presence] in Serum by Immunoassay
Bacteria identified in Lower respiratory specimen by Aerobe culture
Bacteria identified in Lower respiratory specimen by Anaerobe culture
Bartonella henselae DNA [Presence] in Implanted device by NAA with probe detection
Bartonella quintana DNA [Presence] in Implanted device by NAA with probe detection
Bartonella sp DNA [Presence] in Implanted device by NAA with probe detection
Chlamydia trachomatis [Presence] in Throat by Organism specific culture
Coxiella burnetii DNA [Presence] in Implanted device by NAA with probe detection
Tropheryma whipplei DNA [Presence] in Implanted device by NAA with probe detection
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human metapneumovirus identified in Lower respiratory specimen by Organism specific culture
Parainfluenza virus identified in Lower respiratory specimen by Organism specific culture
Parainfluenza virus identified in Upper respiratory specimen by Organism specific culture
Virus identified in Tissue by Shell vial culture
Fungus identified in Lower respiratory specimen by Culture
Microscopic observation [Identifier] in Lower respiratory specimen by Toluidine blue O stain
Microscopic observation [Identifier] in Lower respiratory specimen by Methenamine silver nitrate stain
Microscopic observation [Identifier] in Implanted device by Gram stain
Microscopic observation [Identifier] in Implanted device by Acid fast stain
Microscopic observation [Identifier] in Upper respiratory specimen by Acid fast stain
Microscopic observation [Identifier] in Lower respiratory specimen by Acid fast stain
Pseudocasts [#/area] in Urine by Computer assisted method
Blood group antibody screen [Presence] in Serum or Plasma by Elution
BRAF gene p.Val600Lys [Presence] in Tissue by Molecular genetics method
Blood group antibody screen.cell I [Presence] in Serum or Plasma by Prewarmed
Bilirubin.total [Moles/volume] in Venous blood
Bilirubin.total [Moles/volume] in Arterial blood
Unique identifier [Identifier] of Initial sample
MTB complex rifAMPin and isoniazid resistance panel by Molecular genetics method
Blood group antibody screen.cell II [Presence] in Serum or Plasma by Prewarmed
Ziprasidone [Presence] in Urine by Screen method
Trifluoperazine [Presence] in Urine by Screen method
Norquetiapine [Mass/volume] in Urine by Confirmatory method
Norquetiapine [Presence] in Urine by Screen method
Norolanzapine [Mass/volume] in Urine by Confirmatory method
Norolanzapine [Presence] in Urine by Screen method
Molindone [Presence] in Urine by Screen method
8-Hydroxyloxapine [Presence] in Urine by Screen method
Loxapine [Mass/volume] in Urine by Confirmatory method
7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method
7-Hydroxyfluphenazine [Presence] in Urine by Screen method
Norclozapine [Mass/volume] in Urine by Confirmatory method
7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method
7-Hydroxychlorpromazine [Presence] in Urine by Screen method
ARIPiprazole [Presence] in Urine by Screen method
Ziprasidone [Presence] in Serum or Plasma by Screen method
Thiothixene [Presence] in Serum or Plasma by Screen method
QUEtiapine [Presence] in Serum or Plasma by Screen method
9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method
OLANZapine [Presence] in Serum or Plasma by Screen method
Molindone [Presence] in Serum or Plasma by Screen method
ARIPiprazole [Presence] in Serum or Plasma by Screen method
Vortioxetine [Mass/volume] in Urine by Confirmatory method
Vortioxetine [Presence] in Urine by Screen method
Vilazodone [Mass/volume] in Urine by Confirmatory method
Vilazodone [Presence] in Urine by Screen method
fluvoxaMINE [Mass/volume] in Urine by Confirmatory method
Citalopram+Escitalopram [Presence] in Urine by Screen method
Hydroxybupropion [Presence] in Urine by Screen method
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Rapid immunoassay
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
SUMF1 gene full mutation analysis in Blood or Tissue by Sequencing
Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L
Microalbumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L
Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Nose by NAA with probe detection
Candida auris [Presence] in Specimen by Organism specific culture
Acinetobacter sp identified in Specimen by Organism specific culture
Blood group antibody screen.cell III [Presence] in Serum or Plasma by Prewarmed
ABO and Rh group [Type] in Blood--after transfusion reaction
Alpha globin gene cluster and HS-40 region deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method
Borrelia sp DNA [Presence] in Tick by NAA with probe detection
t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH
Epithelial cells.renal [Presence] in Urine sediment
Treatment history of specimen [Identifier] in Semen
Spermatozoa.abnormal principal pieces/100 spermatozoa in Semen
Spermatozoa.excess residual cytoplasm/100 spermatozoa in Semen
Somatotropin binding protein [Mass/volume] in Serum or Plasma by Immunoassay
Corynebacterium sp identified in Isolate by Organism specific culture
Enterobacteriaceae identified in Isolate by Organism specific culture
Gram negative bacilli identified in Isolate by Organism specific culture
Gram positive bacilli identified in Isolate by Organism specific culture
Gram positive catalase producing cocci identified in Isolate by Organism specific culture
Gram positive non-catalase producing cocci identified in Isolate by Organism specific culture
Haemophilus and Neisseria species identified in Isolate by Organism specific culture
Lactobacillales identified in Isolate by Organism specific culture
Non-Enterobacteriaceae identified in Isolate by Organism specific culture
Staphylococcus sp identified in Isolate by Organism specific culture
Urinary pathogens identified in Isolate by Organism specific culture
Yeast identified in Isolate by Organism specific culture
Bictegravir [Susceptibility] by Genotype method
Cefmetazole [Susceptibility] by Serum bactericidal titer
Listeria sp identified in Isolate by Organism specific culture
Blood group antibody screen.cells I+II+III [Presence] in Serum or Plasma by Prewarmed
Neutrophils.immature/Neutrophils.total [Pure number fraction] in Blood
Thyroxine and Thyroxine.free panel - Serum or Plasma
Coagulation factor VII activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Nicotine and Cotinine panel - Serum or Plasma
Histoplasma capsulatum H and M Ab panel - Serum
Extractable nuclear antigen Ab.IgG panel - Serum
Herpes simplex virus 1 and 2 Ab.IgG and IgM panel - Serum or Plasma
Myeloperoxidase Ab.IgG and Proteinase 3 Ab.IgG Panel - Serum
Thymoma and myasthenia gravis antibody panel - Serum
Histoplasma capsulatum Ab [Identifier] in Serum or Plasma by Immune diffusion (ID)
Globotriaosylsphingosine [Mass/volume] in Serum or Plasma
Phenylacetylcarnitine (PheC2) [Moles/volume] in Serum or Plasma
Salicylcarnitine [Moles/volume] in Serum or Plasma
ST2.soluble [Mass/volume] in Serum by Immunoassay
Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Bacterial whole genome [Nucleotide sequence] in Isolate by Sequencing
Trypanosoma cruzi IgG Ab [Presence] in Serum from Donor by Immunoassay
Myelin oligodendrocyte glycoprotein IgG1 Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells
Vanillylmandelate and Homovanillate panel - Urine
Bartonella henselae and Bartonella quintana IgG and IgM panel [Titer] - Serum
Measles virus IgG and IgM Ql panel - Serum
Measles virus IgG and IgM panel [Titer] - Cerebral spinal fluid
CFTR gene full mutation analysis in Blood or Tissue by Sequencing
LDLR gene full mutation analysis in Blood or Tissue by Sequencing
NAT2 gene full mutation analysis in Blood or Tissue by Sequencing
Rickettsia spotted fever group Ab.IgG and IgM panel [Titer] - Serum
Microscopic observation [Identifier] in Bile fluid by Giemsa stain
Microscopic observation [Identifier] in Bile fluid by Gram stain
Microscopic observation [Identifier] in Milk by Gram stain
Microscopic observation [Identifier] in Pericardial fluid by Giemsa stain
Microscopic observation [Identifier] in Peritoneal fluid by Giemsa stain
Microscopic observation [Identifier] in Milk by Acid fast stain
Blood group antibody screen.autologous [Presence] in Serum or Plasma by Prewarmed
Bacteria identified in Bile fluid by Aerobe culture
Bacteria identified in Pericardial fluid by Aerobe culture
Streptococcus agalactiae DNA [Presence] in Vaginal fluid by NAA with probe detection
Bacteria identified in Catheter tip by Anaerobe culture
Bacteria identified in Catheter tip by Aerobe culture
Gardnerella vaginalis [Presence] in Vaginal fluid by Organism specific culture
Bacteria identified in Semen by Anaerobe culture
Bacteria identified in Peritoneal dialysis fluid by Anaerobe culture
Bacteria identified in Synovial fluid by Aerobe culture
Bacteria identified in Semen by Aerobe culture
Bacteria identified in Peritoneal dialysis fluid by Aerobe culture
Bacteria identified in Peritoneal fluid by Aerobe culture
Microscopic observation [Identifier] in Catheter tip by Gram stain
Mycobacterium tuberculosis DNA [Presence] in Bile fluid by NAA with probe detection
Mycobacterium sp identified in Bile fluid by Organism specific culture
Trichomonas vaginalis [Presence] in Vaginal fluid by Organism specific culture
Trichomonas vaginalis [Presence] in Vaginal fluid by Light microscopy
Norovirus RNA [Presence] in Vomitus by NAA with probe detection
Norovirus genogroup I RNA [Presence] in Vomitus by NAA with probe detection
Norovirus genogroup II RNA [Presence] in Vomitus by NAA with probe detection
Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay
EpCAM Ab [Units/volume] in Serum or Plasma by Immunoassay
Liver cancer antibodies and AFP [Interpretation] in Serum or Plasma Qualitative
Liver cancer antibodies and AFP panel - Serum or Plasma by Immunoassay
MMP-9 Ab [Units/volume] in Serum or Plasma by Immunoassay
RalA Ab [Units/volume] in Serum or Plasma by Immunoassay
Microscopic observation [Identifier] in Skin by Gram stain
Entamoeba histolytica Ab [Presence] in Serum by Immunoassay
Entamoeba sp DNA [Identifier] in Stool by Sequencing
Giardia sp DNA [Presence] in Stool by NAA with probe detection
Helminth identified in Specimen by NAA with probe detection
Toxoplasma gondii [Presence] in Amniotic fluid by Organism specific culture
Trichomonas vaginalis DNA [Presence] in Cervix by NAA with probe detection
Trichomonas vaginalis [Presence] in Cervix by Light microscopy
t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript in Blood or Tissue by Molecular genetics method
Mycobacterium sp identified in Specimen by Sequencing
Aichivirus C RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Aichivirus C RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus parasuis serotype [Identifier] in Specimen by NAA with probe detection
Influenza virus A Ab/Positive control in Serum by Immunoassay
Mycoplasma hyopneumoniae DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 2d DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Porcine circovirus type 2d DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine deltacoronavirus IgG Ab/Positive control in Specimen by Immunoassay
Porcine parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection
PRRSV IgA+IgM/Positive control in Specimen by Immunoassay
PRRSV IgA Ab/Positive control in Specimen by Immunoassay
PRRSV IgM Ab/Positive control in Specimen by Immunoassay
Cryptococcus sp rRNA gene [Presence] in Cerebral spinal fluid by NAA with probe detection
Cryptococcus sp rRNA gene [Presence] in Blood by NAA with probe detection
Aspergillus sp DNA [Presence] in Tissue by NAA with probe detection
Aspergillus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Blood group antibody screen [Presence] in Serum or Plasma by RESt absorption
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Nasopharynx by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Anorectal by NAA with probe detection
Trimethylamine N-oxide [Moles/volume] in Serum or Plasma by LC/MS/MS
Chlamydia trachomatis L1 IgA Ab [Titer] in Serum by Immunoassay
Chlamydia trachomatis L1 IgG Ab [Titer] in Serum by Immunoassay
Chlamydia trachomatis L1 IgM Ab [Titer] in Serum by Immunoassay
Cholesterol.in LDL.small dense [Mass/volume] in Serum or Plasma
Chlamydia trachomatis L1 Ab.IgG+IgA+IgM Interpretation in Serum by Immunoassay
Sample collection timing related to drug dose
T-cell regulatory (Treg) subsets panel - Blood
B-cell TACI and BAFF-R subsets panel - Blood
Lymphocyte subset and B-cell phenotyping panel - Blood
Transferrin.carbohydrate deficient and Apolipoprotein C-III panel - Serum or Plasma
Apolipoprotein CIII-0/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma
Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma
Apolipoprotein CIII-1/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma
Microorganism preliminary growth detection panel - Blood by Culture
Microorganism preliminary growth detection panel - Body fluid by Culture
Microorganism preliminary growth detection panel - Platelets from Blood product unit by Culture
Microorganism preliminary growth [Presence] in Blood by Aerobic culture with antimicrobial neutralizer
Microorganism preliminary growth [Presence] in Blood by Anaerobic culture with antimicrobial neutralizer
Microorganism preliminary growth [Presence] in Body fluid by Aerobic culture with antimicrobial neutralizer
Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture
Blood group antibody screen [Presence] in Serum or Plasma by Warm absorption
Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture
Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture
Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture
Microorganism preliminary growth [Presence] in Blood by Aerobe culture
Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture
Microorganism preliminary growth [Presence] in Blood by Anaerobe culture
Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture
Atypical pneumonia pathogens panel - Respiratory system specimen by NAA with probe detection
BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
Bordetella pertussis and Bordetella parapertussis DNA panel - Nasopharynx
Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection
Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection
Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method
Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma
Norovirus genogroup I and II RNA [Identifier] in Specimen by NAA with probe detection
Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Aspirate by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Aspirate by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus types A and B panel - Cornea or Conjunctiva by NAA with probe detection
Influenza virus types A and B panel - Cerebral spinal fluid by NAA with probe detection
Influenza virus types A and B panel - Tissue by NAA with probe detection
Actinomyces sp identified in Aspirate by Organism specific culture
Yellow fever virus RNA [Presence] in Blood by NAA with probe detection
Hepatitis E virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoassay
Zika virus RNA [Presence] in Cord blood by NAA with probe detection
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunoassay
3-(4-fluorobenzoyl)propionate [Mass/volume] in Urine by Confirmatory method
3-(4-fluorobenzoyl)propionate [Presence] in Urine by Screen method
Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method
Hydroxyaripiprazole [Presence] in Urine by Screen method
Norfluvoxamine [Mass/volume] in Urine by Confirmatory method
Norfluvoxamine [Presence] in Urine by Screen method
9-Hydroxyrisperidone [Presence] in Urine by Screen method
Blood group antigens absent [Identifier] in Blood product unit
Blood group antigens present [Identifier] in Blood
PNH GPI-Linked WBC and RBC Ag Panel - Blood
CD14-FLAER- cells/100 cells.CD33 (Monocytes) in Blood
CD24-FLAER- cells/100 cells.CD15 (Neutrophils) in Blood
Erythrocytes.CD59 complete loss/100 erythrocytes in Blood
PHH GPI-Linked WBC and RBC Ag [Interpretation] in Blood Narrative
Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore
Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay
Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay
CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method
5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method
Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Blood group antigens present [Identifier] in Blood product unit
Adalimumab Ab [Units/volume] in Serum by Immunoassay
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
N,N'-dimethylarginine [Mass/volume] in Serum or Plasma
F2-Isoprostanes/Creatinine [Mass Ratio] in Urine
Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
Levothyroxine absorption panel - Serum or Plasma
Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine
Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine
Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine
Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine
Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine
Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine
Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation
Levothyroxine absorption in Serum or Plasma by calculation
Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough
Candida albicans DNA [Presence] in Serum by NAA with probe detection
Candida glabrata DNA [Presence] in Serum by NAA with probe detection
Candida krusei DNA [Presence] in Serum by NAA with probe detection
Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection
Candida tropicalis DNA [Presence] in Serum by NAA with probe detection
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot
Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot
Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot
Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot
NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Ax Ab [Presence] in Serum or Plasma from Blood product unit
NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot
PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
GJB2 gene full mutation analysis in Blood or Tissue by Sequencing
Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk
Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing
Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection
Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence
Benzodiazepines panel - Urine by Confirmatory method
Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge
Borrelia sp panel - Blood by NAA with non-probe detection
Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection
Noroxymorphone [Mass/volume] in Urine by Confirmatory method
HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing
HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing
HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing
HIV 1 RNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing
HIV 1 RNA reverse transcriptase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing
HIV 1 RNA integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing
HIV 1 RNA protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells --after transfusion reaction
Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 risk [Interpretation] in Blood Qualitative
Arachidonate (C20:4w6)/Eicosapentaenoate (C20:5w3) [Mass Ratio] in Blood
Omega 6 fatty acids (w6)/Omega 3 fatty acids (w3) [Mass Ratio] in Blood
Eicosapentaenoate (C20:5w3)+Docosapentaenate (C22:5w3)+Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C22 in Blood
Docosapentaenate (C22:5w3)/Fatty acids.C14-C22 in Blood
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 in Blood
Arachidonate (C20:4w6)+Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood
Arachidonate (C20:4w6)/Fatty acids.C14-C22 in Blood
Linoleate (C18:2w6)/Fatty acids.C14-C22 in Blood
Fatty acid omega-3 and omega-6 panel - Blood
Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by Immunoassay
Ax Ab [Presence] in Serum or Plasma from Donor
Lysophosphatidylcholine(20:0) [Mass/volume] in DBS
Lysophosphatidylcholine(22:0) [Mass/volume] in DBS
Lysophosphatidylcholine(24:0) [Mass/volume] in DBS
Lysophosphatidylcholine(26:0) [Mass/volume] in DBS
BK virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
HBB gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Sequencing
MET gene amplification in Blood or Tissue by FISH
RET gene rearrangements in Blood or Tissue by FISH
Clomethiazole [Mass/volume] in Serum or Plasma
Opipramol [Mass/volume] in Serum or Plasma
Tianeptine [Mass/volume] in Serum or Plasma
Vilazodone [Mass/volume] in Serum or Plasma
Vortioxetine [Mass/volume] in Serum or Plasma
Meropenem+Vaborbactam [Susceptibility] by Gradient strip
Protein.monoclonal isotype [Identifier] in Serum or Plasma by MS.MALDI-TOF
Protein electrophoresis and M protein isotype panel - Serum or Plasma
Monoclonal gammopathy panel - Serum or Plasma
Iothalamate clearance panel - Urine and Serum or Plasma
Iothalamate renal clearance/Body surface area
Amdinocillin [Susceptibility] by Disk diffusion (KB)
Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay
Buprenorphine-3-glucuronide [Presence] in Urine by Screen method
Barbiturates [Presence] in Body fluid by Screen method
Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method
Methadone+Metabolite [Presence] in Meconium by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method
oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method
Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method
Phencyclidine [Presence] in Tissue by Screen method
Benzodiazepines [Presence] in Tissue by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method
Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method
Methadone+Metabolite [Presence] in Body fluid by Screen method
Phencyclidine [Presence] in Body fluid by Screen method
Cannabinoids [Presence] in Body fluid by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method
Opiates [Presence] in Body fluid by Screen method
oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method
Methadone+Metabolite [Presence] in Hair by Screen method
Barbiturates [Presence] in Hair by Screen method
Cannabinoids [Presence] in Tissue by Screen method
Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method
Methadone+Metabolite [Presence] in Tissue by Screen method
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method
Opiates [Presence] in Tissue by Screen method
oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method
Tropheryma whipplei DNA [Presence] in Stool by NAA with probe detection
Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection
Kingella kingae DNA [Presence] in Blood by NAA with probe detection
Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection
Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection
Bacteria identified in Platelets from Blood product unit by Anaerobe culture
Bacteria identified in Platelets from Blood product unit by Aerobe culture
Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay
14-3-3 protein [Presence] in Tissue by NAA with probe detection
Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Enterovirus RNA [Presence] in Stool by NAA with probe detection
Enterovirus RNA [Presence] in Urine by NAA with probe detection
Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection
Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection
Influenza virus A subtype [Identifier] in Lower respiratory specimen by NAA with probe detection
Human papilloma virus genotype [Identifier] in Tissue by NAA with probe detection
Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay
Rabies virus Ag [Presence] in Tissue by Immunoassay
Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Zika virus RNA [Presence] in Blood by NAA with probe detection
Zika virus RNA [Presence] in Placenta by NAA with probe detection
Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
Candida sp DNA [Presence] in Specimen by NAA with probe detection
Fungal 18s rRNA gene [Presence] in Specimen by NAA with probe detection
Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection
Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection
Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection
Fungal BT2 gene [Presence] in Specimen by NAA with probe detection
Fungal BT2 gene [Presence] in Isolate by NAA with probe detection
Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection
Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection
Fungal ITS region [Presence] in Specimen by NAA with probe detection
Fungal ITS region [Presence] in Isolate by NAA with probe detection
Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection
aPTT.factor sensitive with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay
Cholesterol in LDL 1 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 2 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 3 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 4 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 5 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 6 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 7 [Mass/volume] in Serum or Plasma
Cholesterol in LDL 1 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 2 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 3 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 4 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 5 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 6 [Moles/volume] in Serum or Plasma
Cholesterol in LDL 7 [Moles/volume] in Serum or Plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma
Antithrombin in Platelet poor plasma by Chromo.no addition of heparin
Maltose binding protein IgE Ab [Units/volume] in Serum
Platelet function with adenosine diphosphate induction panel - Blood by Resonance TEG
Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG --after addition of heparinase
Maximum amplitude activator F induced [Length] in Blood by Resonance TEG
Maximum amplitude ADP induced [Length] in Blood by Resonance TEG
Clot strength ADP receptor inhibited [Length fraction] in Blood by calculation
Clot strength ADP induced [Length fraction] in Blood by calculation
Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Sexually transmitted pathogens panel - Specimen by NAA with probe detection
Acanthocytes [Presence] in Urine sediment by Light microscopy
Lipoprotein metabolism panel - Serum or Plasma
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method
ITPA gene g.9381A>C [Type] in Serum or Plasma by Molecular genetics method
Thiopurine methyltransferase activity panel - Red Blood Cells
Brucella sp IgG and IgM panel - Serum Qualitative
TPMT activity in RBC by production of 6-MMP
TPMT activity in RBC by production of 6-MMP riboside
TPMT activity in RBC by production of 6-MTG riboside
B Ab [Presence] in Serum or Plasma from Blood product unit
B Ab [Presence] in Serum or Plasma from Donor
B Ag [Presence] on Red Blood Cells from Blood product unit
Myelin oligodendrocyte glycoprotein Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Myelin oligodendrocyte glycoprotein Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
Myelin oligodendrocyte glycoprotein Ab [Presence] in Serum by Cell binding immunofluorescent assay
Other cells/100 leukocytes in Dialysis fluid by Manual count
Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay
Coding system [Identifier] in Referral lab test
B Ag [Presence] on Red Blood Cells from Donor
Mycobacterium preliminary growth [Presence] in Body fluid by Organism specific culture
clomiPRAMINE+Norclomipramine [Mass/volume] in Urine
Triangle bur ragweed (Ambrosia deltoidea) IgE Ab [Units/volume] in Serum
Ascorbate oxidase IgE Ab [Units/volume] in Serum
Aspergillus clavatus Ab [Units/volume] in Serum
Aspergillus oryzae Ab [Units/volume] in Serum
CYP3A7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Orexin-A [Mass/volume] in Cerebral spinal fluid
Transferrin.carbohydrate deficient.disialo/Transferrin.total standardized per IFCC-RMP for CDT in Serum or Plasma
ABCB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
CD3+CD16+CD56+ cells/100 cells in Bone marrow
CD3+CD16+CD56+ cells [#/volume] in Bone marrow
Giardia lamblia and Cryptosporidium parvum Ag panel - Stool by Rapid immunoassay
Giardia lamblia Ag [Presence] in Stool by Rapid immunoassay
Cryptosporidium parvum Ag [Presence] in Stool by Rapid immunoassay
Zika virus IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
F8 gene intron 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method
F8 gene intron 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method
F9 gene mutation analysis limited to known familial mutations in Amniotic fluid or Chorionic villus sample by Molecular genetics method
Histoplasma capsulatum Ab [Identifier] in Cerebral spinal fluid by Immune diffusion (ID)
Histoplasma capsulatum H and M and Blastomyces dermatitidis Ab panel - Cerebral spinal fluid
Histoplasma capsulatum H and M Ab panel - Cerebral spinal fluid
Corticotropin [Mass/volume] in Plasma --5 minutes pre 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --1 minute pre 1 ug/kg CRH IV
Corticotropin post CRH stimulation panel - Plasma
Corticotropin [Mass/volume] in Plasma --10 minutes post 1 ug/kg CRH IV
Corticotropin [Mass/volume] in Plasma --2 minutes post 1 ug/kg CRH IV
F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
B variant subtype Ab [Presence] in Serum or Plasma from Blood product unit
Giardia sp Ag [Presence] in Stool by Rapid immunoassay
Mycobacterium tuberculosis DNA [Presence] in Aspirate by NAA with probe detection
Nocardia sp identified in Aspirate by Organism specific culture
Entamoeba sp DNA [Identifier] in Aspirate by Sequencing
Entamoeba histolytica DNA [Presence] in Aspirate by NAA with probe detection
Giardia sp DNA [Presence] in Duodenal fluid by NAA with probe detection
Ova and parasites identified in Sputum by Light microscopy
Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Enterovirus identified in Upper respiratory specimen by Organism specific culture
Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection
Influenza virus identified in Upper respiratory specimen by Organism specific culture
Herpes simplex virus identified in Aspirate by Organism specific culture
Varicella zoster virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Bordetella sp identified in Lower respiratory specimen by Organism specific culture
Respiratory Mycoplasma identified in Lower respiratory specimen by Organism specific culture
Bordetella sp identified in Upper respiratory specimen by Organism specific culture
Human metapneumovirus identified in Upper respiratory specimen by Organism specific culture
Yeast identified in Upper respiratory specimen by Organism specific culture
Measles virus [Presence] in Lower respiratory specimen by Organism specific culture
Neisseria gonorrhoeae [Presence] in Aspirate by Organism specific culture
Respiratory syncytial virus [Presence] in Lower respiratory specimen by Organism specific culture
Cytomegalovirus [Presence] in Lower respiratory specimen by Organism specific culture
Varicella zoster virus [Presence] in Lower respiratory specimen by Organism specific culture
Respiratory syncytial virus [Presence] in Upper respiratory specimen by Organism specific culture
Measles virus [Presence] in Upper respiratory specimen by Organism specific culture
Mumps virus [Presence] in Upper respiratory specimen by Organism specific culture
Neisseria meningitidis [Presence] in Upper respiratory specimen by Organism specific culture
Haemophilus ducreyi [Presence] in Genital specimen by Organism specific culture
Trichomonas vaginalis [Presence] in Genital specimen by Organism specific culture
Varicella zoster virus DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Rubella virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Rhinovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parvovirus B19 DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parvovirus B19 DNA [#/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
Parainfluenza virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Neisseria meningitidis DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Mycoplasma pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Mycobacterium leprae DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Mumps virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Microscopic observation [Identifier] in Upper respiratory specimen by Gram stain
Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human metapneumovirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence
Human bocavirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence
Fungus identified in Upper respiratory specimen by Culture
Bordetella sp DNA [Identifier] in Upper respiratory specimen by NAA with probe detection
Bordetella sp Ag [Presence] in Upper respiratory specimen by Immunofluorescence
Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Bordetella parapertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Bordetella holmesii DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Bacteria identified in Upper respiratory specimen by Anaerobe culture
Bacteria identified in Upper respiratory specimen by Aerobe culture
Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Adenovirus Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
Adenovirus Ag [Presence] in Upper respiratory specimen by Immunoassay
Rubella virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Pneumocystis jiroveci Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Parechovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Ova and parasites identified in Lower respiratory specimen by Light microscopy
Mycoplasma hominis DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Mycobacterium tuberculosis DNA [Presence] in Lower respiratory specimen by NAA with probe detection
B variant subtype Ab [Presence] in Serum or Plasma from Donor
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human metapneumovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Human bocavirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Herpes simplex virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Herpes simplex virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Herpes simplex virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Giardia sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Francisella sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Bordetella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection
Bordetella sp Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Bordetella holmesii DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Adenovirus Ag [Presence] in Lower respiratory specimen by Rapid immunoassay
Ureaplasma urealyticum DNA [Presence] in Genital specimen by NAA with probe detection
Ureaplasma parvum DNA [Presence] in Genital specimen by NAA with probe detection
Trichomonas vaginalis DNA [Presence] in Genital specimen by NAA with probe detection
Trichomonas vaginalis [Presence] in Genital specimen by Light microscopy
Treponema pallidum DNA [Presence] in Genital specimen by NAA with probe detection
Streptococcus agalactiae DNA [Presence] in Genital specimen by NAA with probe detection
Mycoplasma hominis DNA [Presence] in Genital specimen by NAA with probe detection
Mycoplasma genitalium DNA [Presence] in Genital specimen by NAA with probe detection
Microscopic observation [Identifier] in Genital specimen by Giemsa stain
Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection
Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Genital specimen by NAA with probe detection
Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection
Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection
Herpes simplex virus DNA [Presence] in Genital specimen by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Genital specimen by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Genital specimen by NAA with probe detection
Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence
Chlamydia trachomatis Ag [Presence] in Aspirate by Immunofluorescence
Bartonella sp DNA [Presence] in Aspirate by NAA with probe detection
Bartonella quintana DNA [Presence] in Aspirate by NAA with probe detection
Bartonella henselae DNA [Presence] in Aspirate by NAA with probe detection
Bacteria identified in Genital specimen by Anaerobe culture
Bacteria identified in Mouth by Aerobe culture
Bordetella holmesii DNA [Presence] in Throat by NAA with probe detection
Bordetella parapertussis DNA [Presence] in Throat by NAA with probe detection
Bordetella pertussis DNA [Presence] in Throat by NAA with probe detection
Bordetella sp Ag [Presence] in Throat by Immunofluorescence
Bordetella sp DNA [Identifier] in Throat by NAA with probe detection
Bordetella sp identified in Throat by Organism specific culture
Chlamydia trachomatis Ag [Presence] in Throat by Immunofluorescence
Mycoplasma genitalium DNA [Presence] in Urethra by NAA with probe detection
Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection
Brucella sp Ab [Titer] in Serum by Immunocapture agglutination
Bacterial strain [Type] in Isolate by Sequencing
Mycoplasma pneumoniae Ab [Titer] in Serum by Agglutination
Doravirine [Susceptibility] by Genotype method
Epizootic hemorrhagic disease virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Anaplasma phagocytophilum and Ehrlichia chaffeensis DNA panel - Blood
Cefodizime [Susceptibility] by Minimum lethal concentration (MLC)
Parasite [Presence] in Blood by Light microscopy
B variant subtype Ab [Presence] in Serum or Plasma
SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection
Spinal muscular atrophy newborn screening comment-discussion
Spinal muscular atrophy newborn screen interpretation
Spinal muscular atrophy newborn screening panel
T-cell receptor excision circle [Cycle Threshold #] in DBS
T-cell receptor excision circle [Z-score] in DBS
T-cell receptor excision circle [Multiple of the median] in DBS
Plazomicin [Mass/volume] in Serum or Plasma --trough
Staphylococcus species methicillin resistant identified in Isolate or Specimen by Molecular genetics method
Streptococcus pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection
Mycoplasma pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection
Haemophilus influenzae DNA [Presence] in Respiratory system specimen by NAA with probe detection
Bordetella pertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection
Bordetella parapertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection
Rhinovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
Respiratory syncytial virus RNA [Presence] in Respiratory system specimen by NAA with probe detection
Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAA with probe detection
Chlamydophila pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection
Human metapneumovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human bocavirus 1+2+3 DNA [Presence] in Respiratory system specimen by NAA with probe detection
Adenovirus B+C+E DNA [Presence] in Respiratory system specimen by NAA with probe detection
Parainfluenza virus 4 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Parainfluenza virus 3 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Parainfluenza virus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Parainfluenza virus 1 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection
Respiratory pathogens DNA and RNA panel - Respiratory system specimen by NAA with probe detection
Moraxella catarrhalis DNA [Presence] in Respiratory system specimen by NAA with probe detection
Legionella pneumophila DNA [Presence] in Respiratory system specimen by NAA with probe detection
Human coronavirus 229E+NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Human coronavirus HKU1+OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection
Vancomycin [Susceptibility] by Genotype method
Pyrazinamide [Susceptibility] by Genotype method
Microorganism resistance mutation tested for by Molecular method
Microorganism resistance mutation nucleic acid change type by Molecular method
Microorganism resistance mutation nucleic acid change by Molecular method
Microorganism resistance mutation detected [Presence] by Molecular method
Microorganism resistance mutation amino acid change type by Molecular method
Microorganism resistance mutation amino acid change by Molecular method
Microorganism gene tested for [Identifier] by Molecular method
Microorganism gene target region [Type] by Molecular method
Microorganism gene detected [Presence] by Molecular method
Microorganism molecular resistance panel by Molecular genetics method
Microorganism identified in Isolate or Specimen by Molecular genetics method
Microorganism identification and resistance pattern determination panel by Molecular genetics method
Methicillin [Susceptibility] by Genotype method
VS Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
V Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
U Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Sc2 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Sc1 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
S Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
N Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
M Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
little s Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
little k Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
little e Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
little c Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
K Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Hy Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
E Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
C Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue by Molecular genetics method
VS Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
V Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
U Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Sc2 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Sc1 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
S Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
N Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
M Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
little s Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
little k Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
little e Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
little c Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
K Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Hy Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
E Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
C Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue from Donor by Molecular genetics method
Sodium [Molar amount] in 24 hour Dialysis fluid
Chlamydophila pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection
APOL1 inferred genotype [Identifier] in Plasma from Donor
traZODone [Mass/volume] in Urine by Confirmatory method
Sertraline [Mass/volume] in Urine by Confirmatory method
O-nortramadol [Mass/volume] in Urine by Confirmatory method
M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method
diphenhydrAMINE [Mass/volume] in Urine by Confirmatory method
Dextromethorphan [Mass/volume] in Urine by Confirmatory method
Cotinine [Mass/volume] in Urine by Confirmatory method
Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Citalopram [Presence] in Urine by Confirmatory method
Dextromethorphan [Presence] in Urine by Confirmatory method
diphenhydrAMINE [Presence] in Urine by Confirmatory method
Gabapentin [Presence] in Urine by Confirmatory method
Naloxone [Presence] in Urine by Confirmatory method
PARoxetine [Presence] in Urine by Confirmatory method
Pregabalin [Presence] in Urine by Confirmatory method
Sertraline [Presence] in Urine by Confirmatory method
traZODone [Presence] in Urine by Confirmatory method
9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method
Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay
Growth hormone and glucose post cloNIDine stimulation panel - Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine
Basement membrane zone BP180 and BP230 IgG panel - Serum or Plasma
Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - DBS
Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - Serum or Plasma
CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method
MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Genital specimen by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection
Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
Astrovirus RNA [Presence] in Stool by NAA with probe detection
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection
Rotavirus A RNA [Presence] in Stool by NAA with probe detection
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
Gastrointestinal viral pathogens panel - Stool by NAA with probe detection
Gastrointestinal parasitic pathogens panel - Stool by NAA with probe detection
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe
Candida sp DNA [Presence] in Vaginal fluid by Probe
Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe
Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection
Lactobacillus crispatus+jensenii + Gardnerella vaginalis + Atopobium vaginae + Bacterial Vaginosis Associated Bacteria-2 + Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection
Vaginal pathogens panel - Vaginal fluid by NAA with probe detection
Lipoprotein.alpha.subparticle.small [Moles/volume] in Serum
Lipoprotein.beta.subparticle.very small-d [Moles/volume] in Serum
Lipoprotein.beta.subparticle.very small-c [Moles/volume] in Serum
Lipoprotein.beta.subparticle.very small-b [Moles/volume] in Serum
Lipoprotein.beta.subparticle.very small-a [Moles/volume] in Serum
Lipoprotein.beta.subparticle.large-b [Moles/volume] in Serum
Lipoprotein.beta.subparticle.large-a [Moles/volume] in Serum
Lipoprotein.broad beta.subparticle.small [Moles/volume] in Serum
Lipoprotein.broad beta.subparticle.large [Moles/volume] in Serum
Lipoprotein.pre-beta.subparticle.small [Moles/volume] in Serum
Lipoprotein.pre-beta.subparticle.medium [Moles/volume] in Serum
Lipoprotein subparticle profile panel - Serum
Yersinia enterocolitica DNA [Presence] in Stool by NAA with probe detection
Candida sp and Gardnerella vaginalis and Trichomonas vaginalis DNA panel - Vaginal fluid by Probe
17-Hydroxyprogesterone [Mass/volume] in DBS by LC/MS/MS
Tacrolimus [Mass/volume] in Blood --4 hours post dose
Tacrolimus [Mass/volume] in Blood --2 hours post dose
Tacrolimus [Mass/volume] in Blood --1 hour post dose
Hepatitis C virus genotype in Serum or Plasma by Sequencing
Codon AndOr region with poor sequence quality [Identifier] in Isolate or Specimen by Sequencing Nominal
Glecaprevir [Susceptibility] by Genotype method
Voxilaprevir [Susceptibility] by Genotype method
Pibrentasvir [Susceptibility] by Genotype method
CD3+CD4+ (T4 helper) cells [#/volume] in Blood by Rapid immunoassay
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Blood
Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - Blood
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - DBS
Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - DBS
Iron.microscopic observation [Identifier] in Bronchoalveolar lavage by Potassium ferrocyanide stain
Hepatosplenomegaly due to lysosomal storage disorders screening panel - Serum or Plasma
Hepatosplenomegaly due to lysosomal storage disorders screening panel - Blood
Hepatosplenomegaly due to lysosomal storage disorders screening panel - DBS
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Serum or Plasma
Lyso-sphingomyelin [Moles/volume] in Serum or Plasma
Lyso-sphingomyelin [Moles/volume] in Blood
Lyso-sphingomyelin [Moles/volume] in DBS
Glucopsychosine [Moles/volume] in Serum or Plasma
Globotriaosylsphingosine [Moles/volume] in Blood
Globotriaosylsphingosine [Moles/volume] in DBS
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Serum or Plasma
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in Blood
Cholestane-3-beta, 5-alpha, 6-beta triol [Moles/volume] in DBS
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Serum or Plasma
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in Blood
7-Alpha,12-alpha dihydroxycholest-4-en-3-one [Moles/volume] in DBS
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Serum or Plasma
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in Blood
7-Alpha hydroxy-4-cholesten-3-one [Moles/volume] in DBS
7-Ketocholesterol [Moles/volume] in Serum or Plasma
Adalimumab neutralizing antibody [Titer] in Serum by Bioassay
Alpha-aminoadipic semialdehyde+Delta-1-piperideine-6-carboxylate [Moles/volume] in Serum or Plasma
Listeria sp DNA [Presence] by NAA with probe detection in Positive blood culture
Candida albicans+glabrata+krusei+parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture
Gram negative bacteria DNA [Presence] by NAA with probe detection in Positive blood culture
Streptococcus pyogenes DNA [Presence] by NAA with probe detection in Positive blood culture
Streptococcus pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture
Streptococcus anginosus group DNA [Presence] by NAA with probe detection in Positive blood culture
Streptococcus agalactiae DNA [Presence] by NAA with probe detection in Positive blood culture
Streptococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Staphylococcus lugdunensis DNA [Presence] by NAA with probe detection in Positive blood culture
Staphylococcus epidermidis DNA [Presence] by NAA with probe detection in Positive blood culture
Staphylococcus aureus DNA [Presence] by NAA with probe detection in Positive blood culture
Staphylococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Micrococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Listeria monocytogenes DNA [Presence] by NAA with probe detection in Positive blood culture
Lactobacillus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Enterococcus faecium DNA [Presence] by NAA with probe detection in Positive blood culture
Enterococcus faecalis DNA [Presence] by NAA with probe detection in Positive blood culture
Enterococcus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Cutibacterium acnes DNA [Presence] by NAA with probe detection in Positive blood culture
Corynebacterium sp DNA [Presence] by NAA with probe detection in Positive blood culture
Bacillus subtilis group DNA [Presence] by NAA with probe detection in Positive blood culture
Bacillus cereus group DNA [Presence] by NAA with probe detection in Positive blood culture
Gram positive blood culture panel by NAA with probe detection in Positive blood culture
Candida albicans DNA [Presence] by NAA with probe detection in Positive blood culture
Candida auris DNA [Presence] by NAA with probe detection in Positive blood culture
Candida dubliniensis DNA [Presence] by NAA with probe detection in Positive blood culture
Candida famata DNA [Presence] by NAA with probe detection in Positive blood culture
Candida glabrata DNA [Presence] by NAA with probe detection in Positive blood culture
Candida guilliermondii DNA [Presence] by NAA with probe detection in Positive blood culture
Candida kefyr DNA [Presence] by NAA with probe detection in Positive blood culture
Candida krusei DNA [Presence] by NAA with probe detection in Positive blood culture
Candida lusitaniae DNA [Presence] by NAA with probe detection in Positive blood culture
Candida parapsilosis DNA [Presence] by NAA with probe detection in Positive blood culture
Candida tropicalis DNA [Presence] by NAA with probe detection in Positive blood culture
Cryptococcus gattii DNA [Presence] by NAA with probe detection in Positive blood culture
Cryptococcus neoformans DNA [Presence] by NAA with probe detection in Positive blood culture
Fusarium sp DNA [Presence] by NAA with probe detection in Positive blood culture
Rhodotorula spp DNA [Presence] by NAA with probe detection in Positive blood culture
Blood Fungal Pathogens Panel by NAA with probe detection in Positive blood culture
Keratan sulfate/Creatinine [Ratio] in Urine
Rhinovirus+Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Serum by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgG Ab index [Units/volume] in Serum and CSF by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Immunoassay
Borrelia afzelii+burgdorferi+garinii IgG panel - Serum and CSF
Phencyclidine [Mass/mass] in Meconium by Confirmatory method
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucagon
Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucagon
Glucose post glucagon stimulation panel - Serum or Plasma
Source of population allelic frequency data
Renin [Units/volume] in Plasma --upright
Mycobacterium tuberculosis complex species identified in Specimen by Sequencing
Adenovirus B+E DNA [Presence] in Specimen by NAA with probe detection
Location of metastasis within sentinel lymph node [Anatomy] in Cancer specimen
Sentinel lymph node extranodal extension [Presence] in Cancer specimen
Lymph nodes with metastasis [#] in Cancer specimen
Sentinel lymph nodes with metastasis [#] in Cancer specimen
Lymph nodes examined [#] in Cancer specimen by Light microscopy
Tumor regression at peripheral margin [Presence] in Skin melanoma
Associated nevus [Presence] in Skin melanoma
Desmoplastic melanoma [Identifier] in Skin melanoma
Perineural invasion [Presence] in Cancer specimen
Satellite nodules [Presence] in Skin melanoma
Breslow thickness [Length] of Skin melanoma
FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method
FLT3 gene internal tandem duplication/Normal [Ratio] in Blood or Tissue by Molecular genetics method
Insulin resistance score in Serum by Calculated.CardioIQ
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Blood by NAA with probe detection
Varicella zoster virus DNA [#/volume] (viral load) in Blood by NAA with probe detection
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Cerebral spinal fluid by NAA with probe detection
Adenovirus and Bocavirus DNA panel - Lower respiratory specimen by NAA with probe detection
Adenovirus and Bocavirus DNA panel - Upper respiratory specimen by NAA with probe detection
Adenovirus DNA [#/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection
Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Bordetella parapertussis IS1001 DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Upper respiratory specimen by NAA with probe detection
Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Lower respiratory specimen by NAA with probe detection
Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Upper respiratory specimen by NAA with probe detection
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Skin by NAA with probe detection
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Serum or Plasma by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Skin by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Lower respiratory specimen by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Cerebral spinal fluid by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Serum or Plasma by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Upper respiratory specimen by NAA with probe detection
Herpes simplex virus 1 and 2 DNA panel - Bronchoalveolar lavage by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Skin by NAA with probe detection
Herpes simplex virus 1 DNA [Presence] in Anogenital by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Skin by NAA with probe detection
Herpes simplex virus 2 DNA [Presence] in Anogenital by NAA with probe detection
Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Lower respiratory specimen by NAA with probe detection
Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Upper respiratory specimen by NAA with probe detection
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Human metapneumovirus and Respiratory syncytial virus RNA panel - Lower respiratory specimen by NAA with probe detection
Human metapneumovirus and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection
Influenza virus types A and B panel - Upper respiratory specimen by NAA with probe detection
Parainfluenza virus 1+2+3+4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Parainfluenza virus 1+2+3+4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Torque teno virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
Torque teno virus DNA [#/volume] (viral load) in Blood by NAA with probe detection
Varicella zoster virus DNA [Presence] in Skin by NAA with probe detection
Chronic hepatitis differentiation between hepatitis B and C virus panel - Serum or Plasma
Hepatitis A and B and C virus immunity AndOr previous exposure panel - Serum or Plasma
INR goal in Platelet poor plasma by Coagulation assay
Aldosterone [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)
Aldosterone [Mass/volume] in Serum or Plasma by Immunoassay
Hepatitis B virus core Ab and surface and little e Ab and Ag panel - Serum or Plasma
Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Noninvasive prenatal fetal aneuploidy and microdeletion panel - Plasma cell-free DNA by Sequencing
Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing
Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing
N-nortramadol [Mass/volume] in Urine by Confirmatory method
Chromosome 7 copy number/nucleus in Blood or Tissue by FISH
MET gene copy number/nucleus in Blood or Tissue by FISH
MET gene copy number/Chromosome 7 copy number in Blood or Tissue by FISH
Measles, Mumps and Rubella virus IgG panel [Units/volume] - Serum or Plasma
LPA gene.c.3947+467T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
LPA gene.c.5673A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
KIF6 gene.c.2155T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9p21 g.22125503G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
4q25 g.111720761T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
4q25 g.111710169C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Eslicarbazepine [Mass/volume] in Serum or Plasma
Streptococcus pyogenes DNA [NCncRange] in Sputum by NAA with non-probe detection
Streptococcus pyogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Streptococcus pneumoniae DNA [NCncRange] in Sputum by NAA with non-probe detection
Streptococcus pneumoniae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Streptococcus agalactiae DNA [NCncRange] in Sputum by NAA with non-probe detection
Streptococcus agalactiae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Staphylococcus aureus DNA [NCncRange] in Sputum by NAA with non-probe detection
Staphylococcus aureus DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Serratia marcescens DNA [NCncRange] in Sputum by NAA with non-probe detection
Serratia marcescens DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with non-probe detection
Pseudomonas aeruginosa DNA [NCncRange] in Sputum by NAA with non-probe detection
Pseudomonas aeruginosa DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Proteus sp DNA [NCncRange] in Sputum by NAA with non-probe detection
Proteus sp DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Moraxella catarrhalis DNA [NCncRange] in Sputum by NAA with non-probe detection
Moraxella catarrhalis DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Methicillin resistance mecA+mecC genes [Presence] in Isolate or Specimen by Molecular genetics method
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection
Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection
Klebsiella oxytoca DNA [NCncRange] in Sputum by NAA with non-probe detection
Klebsiella oxytoca DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Klebsiella aerogenes DNA [NCncRange] in Sputum by NAA with non-probe detection
Klebsiella aerogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Haemophilus influenzae DNA [NCncRange] in Sputum by NAA with non-probe detection
Haemophilus influenzae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Escherichia coli DNA [NCncRange] in Sputum by NAA with non-probe detection
Escherichia coli DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Enterobacter cloacae complex DNA [NCncRange] in Sputum by NAA with non-probe detection
Enterobacter cloacae complex DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection
Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection
F10 gene full mutation analysis in Blood or Tissue by Sequencing
F13A1 and F13B gene full mutation analysis in Blood or Tissue by Sequencing
FGA, FGB, and FGG gene full mutation analysis in Blood or Tissue by Sequencing
PROCR gene full mutation analysis in Blood or Tissue by Sequencing
PROS1 gene full mutation analysis in Blood or Tissue by Sequencing
THBD gene full mutation analysis in Blood or Tissue by Sequencing
Plasma cells with abnormal marker pattern [#] in Bone marrow by Flow cytometry (FC)
Polyclonal plasma cells [#] in Bone marrow by Flow cytometry (FC)
Plasma cells [#] in Bone marrow by Flow cytometry (FC)
Polyclonal plasma cells/Total plasma cells in Bone marrow by Flow cytometry (FC)
Plasma cells with abnormal marker pattern/Cells counted in Bone marrow by Flow cytometry (FC)
Multiple myeloma minimal residual disease panel - Bone marrow by Flow cytometry (FC)
Mononuclear cells/100 leukocytes in Body fluid by Manual count
Polymorphonuclear cells/100 leukocytes in Body fluid by Manual count
Insulin [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO
Blood product reservation [Date and time]
Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay
2,4-Dinitrophenylhydrazine reacting substances [Presence] in Urine
Androstenedione [Mass/time] in 24 hour Urine
Albuterol [Mass/volume] in Serum or Plasma
Aminocaproate [Mass/volume] in Serum or Plasma
Gabapentin [Presence] in Tissue by Screen method
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Platelet adequacy [Presence] in Blood by Light microscopy
Albumin/Creatinine [Mass Ratio] in Urine
HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Warfarin response genotype panel - Blood or Tissue by Molecular genetics method
CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method
Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method
Calcium/Creatinine [Mass Ratio] in Urine
Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay
Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay
Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay
Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay
Cholesterol.total/Cholesterol in HDL [Percentile]
Imipenem+Relebactam [Susceptibility] by Gradient strip
Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence
dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization
aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization
aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization
Sarcosine [Moles/volume] in 24 hour Urine
aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization
dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization
dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization
dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization
11-Ketotestosterone [Mass/volume] in Serum or Plasma
11-Hydroxytestosterone [Mass/volume] in Serum or Plasma
Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay
Tryptophan [Moles/volume] in 24 hour Urine
Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay
Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay
Carbidopa [Mass/volume] in Serum or Plasma
Basement membrane Ab [Units/volume] in Serum by Immunoassay
Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative
Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC)
Platelet CD49b actual/normal in Blood by Flow cytometry (FC)
Platelet CD42b actual/normal in Blood by Flow cytometry (FC)
Platelet CD42a actual/normal in Blood by Flow cytometry (FC)
Platelet CD61 actual/normal in Blood by Flow cytometry (FC)
Platelet CD41 actual/normal in Blood by Flow cytometry (FC)
Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC)
PT mixing study panel - Platelet poor plasma by Coagulation assay
Tauroursodeoxycholate [Moles/volume] in Serum or Plasma
Taurolithocholate [Moles/volume] in Serum or Plasma
Taurohyodeoxycholate [Moles/volume] in Serum or Plasma
Taurodeoxycholate [Moles/volume] in Serum or Plasma
Taurocholate [Moles/volume] in Serum or Plasma
Carbon tetrachloride [Mass/volume] in Blood
Taurochenodeoxycholate [Moles/volume] in Serum or Plasma
Hyodeoxycholate [Moles/volume] in Serum or Plasma
Glycoursodeoxycholate [Moles/volume] in Serum or Plasma
Glycolithocholate [Moles/volume] in Serum or Plasma
Glycohyodeoxycholate [Moles/volume] in Serum or Plasma
Glycodeoxycholate [Moles/volume] in Serum or Plasma
Glycocholate [Moles/volume] in Serum or Plasma
Glycochenodeoxycholate [Moles/volume] in Serum or Plasma
Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool
THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal
Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal
Genetic variant effect on drug resistance in Blood or Tissue Narrative
Genetic variant effect on drug sensitivity in Blood or Tissue Narrative
Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal
Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal
Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal
Monocytes.HLA-DR/100 Monocytes in Blood by Flow cytometry (FC)
HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC)
Neutrophils.CD64/100 Neutrophils in Blood by Flow cytometry (FC)
CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC)
Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC)
Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method
Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method
Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC)
Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC)
Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC)
Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC)
Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC)
Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative
Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative
Gene studied with no variant found [Identifier] in Blood or Tissue Nominal
Variant of unknown significance [Identifier] in Blood or Tissue Nominal
Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative
Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay
Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum
von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method
Serratia sp DNA [Presence] by NAA with probe detection in Positive blood culture
Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay
Salmonella sp DNA [Presence] by NAA with probe detection in Positive blood culture
Pseudomonas aeruginosa DNA [Presence] by NAA with probe detection in Positive blood culture
Proteus mirabilis DNA [Presence] by NAA with probe detection in Positive blood culture
Neisseria meningitidis DNA [Presence] by NAA with probe detection in Positive blood culture
Gram positive bacteria DNA [Presence] by NAA with probe detection in Positive blood culture
Carbapenem resistance blaOXA-23-like+blaOXA-48-like genes [Presence] in Isolate or Specimen by Molecular method
Stenotrophomonas maltophilia DNA [Presence] by NAA with probe detection in Positive blood culture
Serratia marcescens DNA [Presence] by NAA with probe detection in Positive blood culture
Insulin [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO
Proteus sp DNA [Presence] by NAA with probe detection in Positive blood culture
Morganella morganii DNA [Presence] by NAA with probe detection in Positive blood culture
Klebsiella pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture
Fusobacterium nucleatum DNA [Presence] by NAA with probe detection in Positive blood culture
Haemophilus influenzae DNA [Presence] by NAA with probe detection in Positive blood culture
Klebsiella oxytoca DNA [Presence] by NAA with probe detection in Positive blood culture
Fusobacterium necrophorum DNA [Presence] by NAA with probe detection in Positive blood culture
Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA [Presence] by NAA with probe detection in Positive blood culture
Apolipoprotein B/Apolipoprotein A-I [Percentile]
Escherichia coli DNA [Presence] by NAA with probe detection in Positive blood culture
Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture
Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture
Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture
Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture
Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture
Gram negative blood culture panel by NAA with probe detection in Positive blood culture
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L
Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL
COMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method
Cerebroside sulfatase [Mass/time] in 24 hour Urine
Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool
APOA1 gene full mutation analysis in Blood or Tissue by Sequencing
Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Serum by Immunofluorescence
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay
Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay
Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay
Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay
Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion
Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion
Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion
Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion
Lurasidone [Mass/volume] in Serum or Plasma
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection
Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with non-probe detection
Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method
W-19 [Mass/volume] in Urine by Confirmatory method
W-15 [Mass/volume] in Urine by Confirmatory method
W-18 [Mass/volume] in Urine by Confirmatory method
IC-26 [Mass/volume] in Urine by Confirmatory method
MT-45 [Mass/volume] in Urine by Confirmatory method
AH-8529 [Mass/volume] in Urine by Confirmatory method
AH-8533 [Mass/volume] in Urine by Confirmatory method
U-47700 [Mass/volume] in Urine by Confirmatory method
AH-7921 [Mass/volume] in Urine by Confirmatory method
4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
Norcarfentanil [Mass/volume] in Urine by Confirmatory method
Ocfentanil [Mass/volume] in Urine by Confirmatory method
p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method
3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method
Valerylfentanyl [Mass/volume] in Urine by Confirmatory method
Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method
Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation
Acrylfentanyl [Mass/volume] in Urine by Confirmatory method
4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
Furanylfentanyl [Mass/volume] in Urine by Confirmatory method
Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method
4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method
Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method
Synthetic opioids panel - Urine by Confirmatory method
Busulfan clearance from plasma over study
Busulfan [Area under the curve] in Plasma
Busulfan area under the curve panel - Plasma
Cortisol post CRH stimulation panel - Serum or Plasma
Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV
Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay
Buprenorphine [Presence] in Urine by Screen method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method
Nortriptyline [Presence] in Urine by Screen method
Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence
Cefodizime [Susceptibility] by Disk diffusion (KB)
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Cholesterol crystals [Presence] in Stone by X-ray diffraction
Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine
Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine
Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine
Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine
Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine
Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine
Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum
Baclofen [Mass/volume] in Serum or Plasma
Bumetanide [Mass/volume] in Serum or Plasma
busPIRone [Mass/volume] in Serum or Plasma
Blood product unit expiration [Date and time]
Lithium [Mass/volume] in Saliva (oral fluid)
Tacrine [Mass/volume] in Serum or Plasma
Bartonella quintana IgG Ab [Titer] in Serum
Bartonella quintana IgM Ab [Titer] in Serum
Bordetella pertussis IgA Ab [Units/volume] in Serum
Bordetella pertussis IgG Ab [Units/volume] in Serum
Bordetella pertussis IgM Ab [Units/volume] in Serum
Clostridioides difficile Ab [Titer] in Serum
Ammonia [Moles/volume] in Arterial blood
Gas and Carbon monoxide and Electrolytes panel - Arterial blood
Psychosine [Moles/volume] in Cerebral spinal fluid
Psychosine [Moles/mass] in Red Blood Cells
THSD7A IgG Ab [Titer] in Serum or Plasma by Cell binding immunofluorescent assay
BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal
Nonalcoholic steatohepatitis and fibrosis panel - Serum or Plasma
Nonalcoholic steatohepatitis score in Serum or Plasma
Nonalcoholic steatohepatitis grade in Serum or Plasma Qualitative
Nonalcoholic steatohepatitis interpretation in Serum or Plasma Qualitative
Liver steatosis score in Serum or Plasma
Liver steatosis grade in Serum or Plasma Qualitative
Liver steatosis interpretation in Serum or Plasma Qualitative
Gram negative bacterial resistance panel by Molecular genetics method
Beta-lactam resistance AmpC blaCMY-2 gene [Presence] by Molecular method
Beta-lactam resistance AmpC blaDHA gene [Presence] by Molecular method
Colistin resistance mcr-2 gene [Presence] by Molecular method
Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL
Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Fibroblast
Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Leukocytes
Ethyl sulfate and Ethyl glucuronide panel - Urine
Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method
Heptacarboxylporphyrin I/Creatinine [Molar ratio] in Urine
Hexacarboxylporphyrin I/Creatinine [Molar ratio] in Urine
Pentacarboxylporphyrin I/Creatinine [Molar ratio] in Urine
Epstein Barr virus Ab panel - Serum from Donor
Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay
Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay
Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay
Francisella tularensis IgG and IgM panel - Serum
Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay
Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay
Francisella tularensis IgG and IgM [Interpretation] in Serum
traMADol [Presence] in Meconium by Screen method
traMADol [Mass/mass] in Meconium by Confirmatory method
O-nortramadol [Mass/mass] in Meconium by Confirmatory method
N-nortramadol [Mass/mass] in Meconium by Confirmatory method
Keratan sulfate [Mass/volume] in Serum or Plasma
Heparan sulfate [Mass/volume] in Serum or Plasma
Dermatan sulfate and heparan sulfate and keratan sulfate panel - Serum or Plasma
Insulin [Moles/volume] in Serum or Plasma --post meal
Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine
Testosterone [Moles/volume] in Amniotic fluid
Androstenedione [Moles/volume] in Amniotic fluid
Creatinine [Moles/volume] in 5 hour Urine
German turnip IgE Ab [Units/volume] in Serum
Cooked cauliflower IgE Ab [Units/volume] in Serum
Red cabbage IgE Ab [Units/volume] in Serum
HTLV I and II Ab band pattern [Interpretation] in Cerebral spinal fluid by Line blot
HTLV I and II IgG band [Type] in Cerebral spinal fluid by Line blot
HTLV I and II IgG panel - Cerebral spinal fluid
HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Protein catabolic rate based on 24 hour Urine [Calculated]
Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay
Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay
Mumps virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection
Mumps virus RNA and N gene panel - Specimen
Atypical porcine pestivirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Atypical porcine pestivirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Porcine cytomegalovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Encephalomyocarditis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Porcine circovirus type 3 DNA [Presence] in Specimen by NAA with probe detection
Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 100 g glucose PO
Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Specimen by Immunoassay
Erysipelothrix sp [Presence] in Tissue by Immune stain
Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing
Porcine astrovirus type 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post 100 g glucose PO
Trimethylamine N-oxide [Molar amount] in Serum
Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay
Eravacycline [Susceptibility] by Gradient strip
Acarboxyprothrombin [Units/volume] in Serum or Plasma
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
Ceramide trihexoside [Molar ratio] in Urine
Calprotectin [Mass/volume] in Synovial fluid
4-hydroxyglutamate/Creatinine [Molar ratio] in Urine
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post 100 g glucose PO
11-Deoxycortisol [Moles/volume] in Saliva (oral fluid)
Trans-cinnamoylglycine/Creatinine [Molar ratio] in Urine
2-Octenoate/Creatinine [Molar ratio] in Urine
Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence
Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe
Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe
Large B-cell lymphoma and cell of origin [Type] in Tissue
Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue
Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 100 g glucose PO
Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue
Diffuse large B-cell lymphoma cell of origin [Type] in Tissue
Diffuse large B-Cell lymphoma cell of origin subclassification panel - Tissue
Large B-cell lymphoma classification panel - Tissue
Varicella zoster virus Ab.IgM+total [Presence] in Cerebral spinal fluid
Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid
F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal
Time to microorganism growth detection in Specimen
Delafloxacin [Susceptibility] by Gradient strip
Glucose [Mass/volume] mean in Serum or Plasma
Insulin sensitivity index in Serum or Plasma by calculation
Insulin [Units/volume] mean in Serum or Plasma
Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma
NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method
MYCN gene amplification in Blood or Tissue by FISH
MYCN gene copy number/Chromosome 2 copy number in Tissue by FISH
MYCN gene copy number/nucleus in Tissue by FISH
Chromosome 2 copy number/nucleus in Tissue by FISH
1p/1q chromosome deletion [# Ratio] in Tissue by FISH
Chromosome 1 polysomy [Presence] in Tissue by FISH
19q/19p chromosome deletion [# Ratio] in Tissue by FISH
Chromosome 19 polysomy [Presence] in Tissue by FISH
Chromosome 12 copy number/nucleus in Tissue by FISH
MDM2 gene copy number/nucleus in Tissue by FISH
EWSR1 gene rearrangements in Tissue by FISH
Heptacarboxylporphyrin [Mass/time] in unspecified time Stool
FOXO1 gene rearrangements in Tissue by FISH
MDM2 gene amplification in Tissue by FISH
MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH
SS18 gene rearrangements in Tissue by FISH
F9 gene full mutation analysis in Blood or Tissue by Sequencing
NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method
SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing
PROC gene full mutation analysis in Blood or Tissue by Sequencing
Coproporphyrin [Mass/time] in unspecified time Stool
9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma
Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing
Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method
UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing
UGT1A1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Hemoglobin [Moles/volume] in Venous blood
Aspergillus oryzae IgE Ab [Units/volume] in Serum
Benztropine [Mass/volume] in Serum or Plasma
N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine
Gadolinium/Creatinine [Mass Ratio] in Urine
Levodopa [Mass/volume] in Serum or Plasma
Enterovirus RNA [Presence] in Specimen by NAA with non-probe detection
Toxoplasma gondii IgG panel - Serum from Donor
Toxoplasma gondii IgG Ab [Presence] in Serum from Donor by Immunoassay
Toxoplasma gondii IgG Ab [Units/volume] in Serum from Donor by Immunoassay
NIFEdipine [Mass/volume] in Serum or Plasma
C4 nephritic factor [Presence] in Serum or Plasma
GABABR Ab [Presence] in Serum by Cell binding immunofluorescent assay
AMPAR2 Ab [Presence] in Serum by Cell binding immunofluorescent assay
AMPAR1 Ab [Presence] in Serum by Cell binding immunofluorescent assay
NMDAR subunit 1 Ab [Presence] in Serum by Cell binding immunofluorescent assay
Borrelia miyamotoi IgG+IgM Ab [Interpretation] in Serum or Plasma
Procyclidine [Mass/volume] in Serum or Plasma
Tamoxifen metabolites pattern [Interpretation] in Serum or Plasma
Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Phosphohistone H3 [Presence] in Tissue by Immune stain
Ceramide risk score in Plasma by calculation
N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma
N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma
N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma
Propylthiouracil [Mass/volume] in Serum or Plasma
N-Nervonoylsphingosine [Moles/volume] in Plasma
N-Stearoylsphingosine [Moles/volume] in Plasma
N-Palmitoylsphingosine [Moles/volume] in Plasma
Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate
Methane/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate
Pseudoephedrine [Mass/volume] in Serum or Plasma
ABO group [Type] in Blood--during infancy
Pyridostigmine [Mass/volume] in Serum or Plasma
ABO and Rh group [Type] in Blood--during infancy
Au sup(b) Ag [Presence] on Red Blood Cells
little cE Ag [Presence] on Red Blood Cells
Quazepam [Mass/volume] in Serum or Plasma
Blood group antigens panel - Red Blood Cells
Rh antigens and K Ag panel - Blood from Blood product unit
ABO and Rh group panel - Blood from Blood product unit
K Ag [Presence] on Red Blood Cells --after transfusion reaction
little e Ag [Presence] on Red Blood Cells --after transfusion reaction
little c Ag [Presence] on Red Blood Cells --after transfusion reaction
E Ag [Presence] on Red Blood Cells --after transfusion reaction
C Ag [Presence] on Red Blood Cells --after transfusion reaction
Rh antigens and K Ag post transfusion reaction panel - Blood
ABO and Rh group post transfusion reaction panel - Blood
K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
Rh antigens and K Ag post hematopoietic stem cell transplant panel - Blood
risperiDONE [Mass/volume] in Serum or Plasma
D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant
ABO group [Type] in Blood--post hematopoietic stem cell transplant
ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant
ABO and Rh group post hematopoietic stem cell transplant panel - Blood
K Ag [Presence] on Red Blood Cells --during infancy
little e Ag [Presence] on Red Blood Cells --during infancy
little c Ag [Presence] on Red Blood Cells --during infancy
E Ag [Presence] on Red Blood Cells --during infancy
C Ag [Presence] on Red Blood Cells --during infancy
Rh antigens and K Ag during infancy panel - Blood
D Ag [Presence] on Red Blood Cells --during infancy
ABO and Rh group during infancy panel - Blood
little e Ag [Presence] in Cord red blood cells
little c Ag [Presence] in Cord red blood cells
risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma
D variant Ag [Presence] on Red Blood Cells
Metamyelocytes.neutrophilic/100 leukocytes in Bone marrow by Manual count
Villous lymphocytes [Presence] in Blood by Light microscopy
SUFentanil [Mass/volume] in Serum or Plasma
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma
Iohexol [Mass/volume] in Serum or Plasma
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour specimen
Chikungunya virus Ab.IgM and IgG panel - Serum or Plasma
Complement C2.functional [Units/volume] in Serum or Plasma
Complement C4.functional [Units/volume] in Serum or Plasma
Chikungunya virus IgG Ab [Presence] in Serum or Plasma
Iothalamate [Mass/volume] in Serum or Plasma
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate
Carbohydrate challenge panel - Exhaled gas
Osmolality of Serum or Plasma--1 hour post fluid fast
Osmolality of Serum or Plasma--2 hours post fluid fast
Osmolality of Serum or Plasma--3 hours post fluid fast
Osmolality of Serum or Plasma--4 hours post fluid fast
Osmolality of Serum or Plasma--5 hours post fluid fast
Osmolality of Serum or Plasma--6 hours post fluid fast
Osmolality of Serum or Plasma--7 hours post fluid fast
Ribonucleoprotein extractable nuclear Ab [Titer] in Serum
Sodium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin
Potassium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin
Creatinine [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin
Chloride [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin
Bicarbonate [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin
Anion gap 3 in Serum or Plasma --1 hour post dose vasopressin
Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin
Osmolality of Serum or Plasma--1 hour post dose vasopressin
Osmolality of Urine--1 hour post dose vasopressin
Sodium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin
Potassium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin
Creatinine [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin
Chloride [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin
Bicarbonate [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin
Anion gap 3 in Serum or Plasma --2 hours post dose vasopressin
Urea nitrogen [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin
Osmolality of Serum or Plasma--2 hours post dose vasopressin
Osmolality of Urine--2 hours post dose vasopressin
Adenovirus A+B+C+D+E DNA [Presence] in Respiratory system specimen by NAA with probe detection
Adenosine deaminase [Enzymatic activity/volume] in Body fluid
Mycobacterium tuberculosis complex resistance panel by Molecular genetics method
Bacterial katG gene drug resistance mutation [Identifier] by Molecular method
Bacterial inhA gene drug resistance mutation [Identifier] by Molecular method
Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular method
Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method
Bacterial embB gene drug resistance mutation [Identifier] by Molecular method
Bacterial pncA gene drug resistance mutation [Identifier] by Molecular method
Albumin/Globulin [Mass Ratio] in 24 hour Urine
Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular method
Bacterial gidB gene drug resistance mutation [Identifier] by Molecular method
Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method
Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method
Bacterial eis gene drug resistance mutation [Identifier] by Molecular method
Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method
Alpha 1 antitrypsin [Mass/volume] in Stool
PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal
Aminobenzoate [Mass/volume] in Serum or Plasma
Chromosome analysis in Blood or Tissue by Microarray
Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay
Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot
Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method
Zolpidem [Presence] in Urine by Screen method
Alpha hydroxytriazolam [Presence] in Urine by Screen method
Temazepam glucuronide [Presence] in Urine by Screen method
Oxazepam glucuronide [Presence] in Urine by Screen method
1-Hydroxymidazolam [Presence] in Urine by Screen method
LORazepam glucuronide [Presence] in Urine by Screen method
Hydrocorticosterone [Mass/time] in 24 hour Urine
2-Hydroxyethylflurazepam [Presence] in Urine by Screen method
7-Aminoflunitrazepam [Presence] in Urine by Screen method
7-Aminoclonazepam [Presence] in Urine by Screen method
Norclobazam [Presence] in Urine by Screen method
cloBAZam [Presence] in Urine by Screen method
Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method
ALPRAZolam [Presence] in Urine by Screen method
Benzodiazepines panel [Presence] - Urine by Screen method
Leucine [Moles/volume] in Cerebral spinal fluid
Vasopressin challenge post water deprivation panel - Urine and Serum or Plasma
Water deprivation challenge panel - Urine and Serum or Plasma
Phosphoserine [Moles/volume] in 24 hour Urine
Crotonylglycine/Creatinine [Molar ratio] in Urine
2-Decenedioate/Creatinine [Molar ratio] in Urine
Heterophile Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma
Bacteria.carbapenem resistant identified in Specimen by Organism specific culture
Acyclovir [Mass/volume] in Serum or Plasma
Heartland banyangvirus RNA [Presence] in Specimen by NAA with probe detection
Yellow fever virus RNA [Presence] in Specimen by NAA with probe detection
Hydroxybupropion [Mass/volume] in Serum or Plasma
Borrelia miyamotoi glpQ gene [Presence] in Specimen by NAA with probe detection
Origin of germline genetic variant [Type]
Platelet aggregation [Interpretation] in Platelet rich plasma
APC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
APOA2 gene full mutation analysis in Blood or Tissue by Sequencing
BPGM gene full mutation analysis in Blood or Tissue by Sequencing
BRCA1+BRCA2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
SLC25A20 gene full mutation analysis in Blood or Tissue by Sequencing
CDKN1C gene full mutation analysis in Blood or Tissue by Sequencing
CPOX gene full mutation analysis in Blood or Tissue by Sequencing
CPT2 gene full mutation analysis in Blood or Tissue by Sequencing
CTRC gene full mutation analysis in Blood or Tissue by Sequencing
CYP21A2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
DPYD gene full mutation analysis in Blood or Tissue by Sequencing
FGA gene full mutation analysis in Blood or Tissue by Sequencing
FTCD gene full mutation analysis in Blood or Tissue by Sequencing
Entamoeba histolytica Ab [Titer] in Serum by Complement fixation
GNPTAB gene full mutation analysis in Blood or Tissue by Sequencing
GRHPR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
GSN gene full mutation analysis in Blood or Tissue by Sequencing
HMBS gene full mutation analysis in Blood or Tissue by Sequencing
LYZ gene full mutation analysis in Blood or Tissue by Sequencing
MMACHC gene full mutation analysis in Blood or Tissue by Sequencing
MMADHC gene full mutation analysis in Blood or Tissue by Sequencing
MLYCD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
NAGLU gene full mutation analysis in Blood or Tissue by Sequencing
ARSB gene full mutation analysis in Blood or Tissue by Sequencing
NPC1 gene+NPC2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
PKLR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
PPOX gene full mutation analysis in Blood or Tissue by Sequencing
PRKAR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
PRSS1 gene full mutation analysis in Blood or Tissue by Sequencing
STK11 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
TP53 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
UBE3A gene full mutation analysis in Blood or Tissue by Sequencing
Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID)
VWF gene full mutation analysis in Blood or Tissue by Sequencing
SPINK1 gene full mutation analysis in Blood or Tissue by Sequencing
SMN1 gene full mutation analysis in Blood or Tissue by Sequencing
SERPINA1 gene full mutation analysis in Blood or Tissue by Sequencing
PTEN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
RET gene full mutation analysis in Blood or Tissue by Sequencing
TTR gene full mutation analysis in Blood or Tissue by Sequencing
PKHD1 gene full mutation analysis in Blood or Tissue by Sequencing
Herpes simplex virus IgG Ab [Units/volume] in Serum
AGXT gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
MUTYH gene full mutation analysis in Blood or Tissue by Sequencing
MECP2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
GBA gene full mutation analysis in Blood or Tissue by Sequencing
G6PD gene full mutation analysis in Blood or Tissue by Sequencing
FLCN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
FECH gene full mutation analysis in Blood or Tissue by Sequencing
F8 gene full mutation analysis in Blood or Tissue by Sequencing
Nuclear Ab [Units/volume] in Serum by Immunofluorescence
F7 gene full mutation analysis in Blood or Tissue by Sequencing
F5 gene full mutation analysis in Blood or Tissue by Sequencing
F2 gene full mutation analysis in Blood or Tissue by Sequencing
F12 gene full mutation analysis in Blood or Tissue by Sequencing
F11 gene full mutation analysis in Blood or Tissue by Sequencing
CDH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
BTK gene full mutation analysis in Blood or Tissue by Sequencing
BTD gene full mutation analysis in Blood or Tissue by Sequencing
Intercellular substance Ab [Titer] in Serum
Borrelia burgdorferi oppA2 gene [Presence] in Blood by NAA with non-probe detection
Borrelia mayonii oppA2 gene [Presence] in Blood by NAA with non-probe detection
Borrelia garinii+afzelii oppA2 gene [Presence] in Blood by NAA with non-probe detection
Borrelia burgdorferi oppA2 gene [Presence] in Specimen by NAA with non-probe detection
Borrelia mayonii oppA2 gene [Presence] in Specimen by NAA with non-probe detection
Borrelia garinii+afzelii oppA2 gene [Presence] in Specimen by NAA with non-probe detection
Borrelia sp panel - Specimen by NAA with non-probe detection
CYP1A2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Brucella sp Ab [Titer] in Cerebral spinal fluid by Immunocapture agglutination
CD11a, CD11b, and CD18 phenotyping panel - Blood Qualitative
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --50 umol/L
PCA-1 IgG Ab [Presence] in Serum by Line blot
PCA-1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Muscle specific receptor tyrosine kinase IgG Ab [Moles/volume] in Serum by Immunoassay
Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Units/volume] in Serum
Barbiturates [Mass/volume] in Gastric fluid
Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Units/volume] in Serum
Dog recombinant 6 IgE Ab [Units/volume] in Serum
Cat recombinant (rFel d) 7 IgE Ab [Units/volume] in Serum
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Contactin-associated protein 2 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
West Nile virus neutralizing antibody [Presence] in Specimen by Neutralization test
Saint Louis encephalitis virus neutralizing antibody [Presence] in Specimen by Neutralization test
Hydroxybupropion [Presence] in Serum or Plasma by Screen method
Citalopram+Escitalopram [Presence] in Serum or Plasma by Screen method
Citalopram+Escitalopram [Mass/volume] in Serum or Plasma by Confirmatory method
Norcitalopram [Presence] in Serum or Plasma by Screen method
DULoxetine [Presence] in Serum or Plasma by Screen method
Norfluvoxamine [Presence] in Serum or Plasma by Screen method
Norfluvoxamine [Mass/volume] in Serum or Plasma by Confirmatory method
O-desmethylvenlafaxine [Presence] in Serum or Plasma by Screen method
Vilazodone [Presence] in Serum or Plasma by Screen method
Cefodizime [Susceptibility] by Serum bactericidal titer
Vilazodone [Mass/volume] in Serum or Plasma by Confirmatory method
Vortioxetine [Presence] in Serum or Plasma by Screen method
Vortioxetine [Mass/volume] in Serum or Plasma by Confirmatory method
Pregnenolone and 17-Hydroxypregnenolone panel - Serum or Plasma
OxyCODONE and metabolites panel - Urine by Confirmatory method
OxyMORphone and Noroxymorphone panel - Urine by Confirmatory method
SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
C Ab [Presence] in Serum or Plasma from Blood product unit
SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1
SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2
SARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection
Isobutyl acetate [Mass/volume] in Specimen
Microsporidia sp 18S rRNA gene panel - Specimen by NAA with non-probe detection
Encephalitozoon sp 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection
Enterocytozoon bieneusi 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection
Desmoglein 1 and Desmoglein 3 IgG panel - Serum by Immunoassay
Desmoglein 1 IgG Ab [Units/volume] in Serum by Immunoassay
Desmoglein 3 IgG Ab [Units/volume] in Serum by Immunoassay
Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH
Amphiphysin IgG Ab [Titer] in Serum by Immunofluorescence
Glial nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence
Neuronal nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence
Neuronal nuclear type 2 IgG Ab [Titer] in Serum by Immunofluorescence
Neuronal nuclear type 3 IgG Ab [Titer] in Serum by Immunofluorescence
Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Immunofluorescence
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Immunofluorescence
Voltage-gated calcium channel N type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
Voltage-gated calcium channel P/Q type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
PCA-1 IgG Ab [Titer] in Serum by Immunofluorescence
PCA-2 IgG Ab [Titer] in Serum by Immunofluorescence
PCA-Tr IgG Ab [Titer] in Serum by Immunofluorescence
Myelopathy autoimmune Ab panel - Cerebral spinal fluid
Amphiphysin IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Glial nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Neuronal nuclear type 3 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
PCA-Tr IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
PCA-1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
PCA-2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Bordetella pertussis DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Streptococcus pyogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Streptococcus pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Streptococcus agalactiae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Staphylococcus aureus DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Serratia marcescens DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Pseudomonas aeruginosa DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Proteus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Moraxella catarrhalis DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Klebsiella pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Klebsiella oxytoca DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Klebsiella aerogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Haemophilus influenzae DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Escherichia coli DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Enterobacter cloacae complex DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Acinetobacter baumannii DNA [Presence] in Lower respiratory specimen by NAA with probe detection
2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in 24 hour Urine
Glial nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Amphiphysin IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Amphiphysin IgG Ab [Presence] in Serum by Line blot
PCA-Tr IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Line blot
Neuronal nuclear type 2 IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Neuronal nuclear type 1 IgG Ab [Presence] in Serum by Line blot
Neuronal nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot
Casts [#/area] in Urine sediment by Microscopy high power field
Respiratory viral pathogens DNA and RNA panel - Lower respiratory specimen by NAA with probe detection
Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Lower respiratory specimen by NAA with probe detection
Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Sulfocysteine, Hypoxanthine, Xanthine, Urate and Creatinine panel - Urine
Ethyl sulfate [Mass/mass] in Meconium by Confirmatory method
Ethyl glucuronide [Mass/mass] in Meconium by Confirmatory method
Protein.monoclonal [Presence] in Serum or Plasma
ADRA2A gene c.-1252G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
ANKK1 gene c.2137G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
CHRNA3 gene c.645C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
IgA lymphocytes/100 lymphocytes in Leukocytes
DRD2 gene c.-585A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
EPHX1 gene.c.416A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
GRIK4 gene c.83-10039T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
MTHFR gene c.677C>T and c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
OPRM1 gene c.118A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
SCN1A gene.c.603-91G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
IgD lymphocytes/100 lymphocytes in Leukocytes
SLC6A4 gene 5-HTTLPR variant [Genotype] in Blood or Tissue by Molecular genetics method Nominal
UGT2B15 gene c.253G>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Candida auris [Presence] in Isolate by MS.MALDI-TOF
Lactobacillus crispatus+gasseri+jensenii + Gardnerella vaginalis + Atopobium vaginae rRNA [Presence] in Vaginal fluid by NAA with probe detection
Candida glabrata RNA [Presence] in Vaginal fluid by NAA with probe detection
Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis RNA [Presence] in Vaginal fluid by NAA with probe detection
Lysosomal enzymes screen [Interpretation] in Urine Narrative
Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] by Molecular method
IgG lymphocytes/100 lymphocytes in Leukocytes
Human papilloma virus E6+E7 mRNA [Presence] in Specimen by NAA with probe detection
Dengue virus 1+2+3+4 3' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Dengue virus 1+2+3+4 3' UTR RNA [Presence] in Serum by NAA with probe detection
HLA class I and II IgG panel - Serum or Plasma by Flow cytometry (FC)
HLA-DP and DQ and DR (class II) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A and B and C (class I) IgG low risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
Dilution factor [Titer] in Serum or Plasma
HLA-DP and DQ and DR (class II) IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
IgM lymphocytes/100 lymphocytes in Leukocytes
HLA-DP and DQ and DR (class II) IgG with prozone effect [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DPB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DPA1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DQB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DQA1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DRB3 and HLA-DRB4 and HLA DRB5 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DRB1 IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DP and DQ and DR (class II) IgG panel - Serum or Plasma by Flow cytometry (FC)
House dust Hausstaub IgE Ab [Units/volume] in Serum
HLA-A and B and C (class I) IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A and B and C (class I) IgG with prozone effect [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-C IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-B IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A IgG Ab [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A and B and C (class I) IgG panel - Serum or Plasma by Flow cytometry (FC)
HLA-DP and DQ and DR (class II) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-DP and DQ and DR (class II) IgG intermediate risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A and B and C (class I) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
HLA-A and B and C (class I) IgG intermediate risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
11-Oxopregnanetriol [Mass/time] in 24 hour Urine
Monomethylarsonate [Mass/volume] in Urine
Heptacarboxylporphyrin [Mass/volume] in Red Blood Cells
F2 gene.c.20210G>A and c.1691G>A panel - Blood or Tissue by Molecular genetics method
VEGFA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
VEGFA gene c.-1154A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
VEGFA gene c.-1498C>G and c.-1498C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
VEGFA gene c.-2578A>C and c.-2578A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Heptacarboxylporphyrin [Mass/volume] in Serum or Plasma
VEGFA gene c.-634C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Borrelia burgdorferi IgA and IgG and IgM [Interpretation] in Cerebral spinal fluid
Borrelia burgdorferi G39/40 IgG bands [#] in Blood by Immunoblot
Borrelia burgdorferi 49736 IgG bands [#] in Blood by Immunoblot
Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Galactosylceramidase [Enzymatic activity/mass] in Leukocytes by Confirmatory method
Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes by Confirmatory method
Lysosomal storage disorders panel - Leukocytes
C Ab [Presence] in Serum or Plasma from Donor
Protoporphyrin fractions panel - Red Blood Cells
Protoporphyrin Free [Mass/volume] in Red Blood Cells
HLA-DQA1 and HLA-DQB1 typing panel - Blood or Tissue by Molecular genetics method
Celiac disease IgA and HLA typing and serology panel - Blood or Tissue
Packed erythrocytes [Volume] of Specimen
Respiratory viral pathogens DNA and RNA panel - Respiratory system specimen Qualitative by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory system specimen by NAA with probe detection
SARS-related coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay
SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Hexacarboxylporphyrin [Mass/volume] in Red Blood Cells
SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
SARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection
Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus identified in Isolate or Specimen by Molecular genetics method
Hexacarboxylporphyrin [Mass/volume] in Serum or Plasma
SARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection
Histidine [Moles/volume] in Cerebral spinal fluid
SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory system specimen by NAA with probe detection
Hemoglobin HPLC and electrophoresis panel - Blood
Hepatitis A virus IgM and total panel - Serum or Plasma Qualitative
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Mycobacterial stain and culture panel - Specimen
Mycobacterial identification panel - Specimen by Molecular genetics method
Microscopic observation [Identifier] in Skin by Acid fast stain
SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
Porphyrin fractions panel [Mass/time] - 24 hour Stool
Isoheptacarboxylporphyrin [Mass/time] in 24 hour Stool
Hexacarboxylporphyrin I [Mass/time] in 24 hour Stool
Hexacarboxylporphyrin III [Mass/time] in 24 hour Stool
Isohexacarboxylporphyrin [Mass/time] in 24 hour Stool
Isopentacarboxylporphyrin [Mass/time] in 24 hour Stool
Soluble CD14 subtype [Mass/volume] in Serum, Plasma or Blood by Immunoassay
dRVVT/dRVVT.excess phospholipid [Ratio] in Platelet poor plasma by Coagulation assay --post DOAC neutralization
dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post DOAC neutralization
dRVVT in Platelet poor plasma by Coagulation assay --post DOAC neutralization
SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay
SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
Maple syrup urine disease therapy monitoring panel - Serum or Plasma
Valine [Moles/volume] in Serum or Plasma --post therapeutic diet
Isoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet
Leucine [Moles/volume] in Serum or Plasma --post therapeutic diet
Alloisoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet
Tyrosinemia newborn screening follow-up and therapeutic monitoring panel - DBS
Mycobacterium tuberculosis complex species identified in Isolate by NAA with probe detection
Maximum amplitude arachidonate induced [Length] in Blood by Resonance TEG
Clot strength TXA2 receptor inhibited [Length fraction] in Blood by calculation
Clot strength arachidonate induced [Length fraction] in Blood by calculation
Herpes simplex virus 1 and 2 DNA panel - Specimen by NAA with non-probe detection
Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with non-probe detection
Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with non-probe detection
Herpes simplex virus 1 and 2 DNA panel - Cerebral spinal fluid by NAA with non-probe detection
Varicella zoster virus DNA [Presence] in Specimen by NAA with non-probe detection
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Specimen by NAA with non-probe detection
Dermatan sulfate and heparan sulfate and keratan sulfate panel - DBS
Germline disorder chromosome analysis in Amniotic fluid or Chorionic villus sample by Mate pair sequencing
Myeloid neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing
Hematologic neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing
Oncologic chromosome analysis in Tissue by Mate pair sequencing
Chromosome rearrangement [Identifier] in Blood or Tissue by Molecular genetics method Narrative
Chromosome rearrangement [Identifier] in Blood or Tissue by Mate pair sequencing Nominal
Multiplex allergen panel - Serum or Plasma
Equine infectious anemia virus Ab [Units/volume] in Serum by Immunoassay
Equine adenovirus 1 RNA [Presence] in Specimen by NAA with probe detection
Equine herpesvirus 2 RNA [Presence] in Specimen by NAA with probe detection
Equine herpesvirus 3 RNA [Presence] in Specimen by NAA with probe detection
Equine influenza virus [Presence] in Specimen by Organism specific culture
Listeria monocytogenes Ag [Presence] in Tissue by Immune stain
West Nile virus IgM Ab/Positive control in Serum by Immunoassay
Bacterial 16S rRNA gene [Nucleotide sequence] in Isolate by Sequencing
Equine arteritis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Equine herpesvirus 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Equine herpesvirus 4 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Equine rhinitis A virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Erbovirus A RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine leukemia virus Ab [Units/volume] in Serum by Immunoassay
Bovine diarrhea virus subtype [Identifier] in Specimen by NAA with probe detection
Pasteurella multocida toxin toxA gene [Presence] in Specimen by NAA with probe detection
Mycoplasma bovis Ag [Presence] in Tissue by Immune stain
Bovine respiratory syncytial virus Ag [Presence] in Tissue by Immune stain
Bovine parainfluenza virus 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine herpesvirus 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine coronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Anaplasma marginale DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine respiratory syncytial virus [Presence] in Specimen by Organism specific culture
Bovine herpesvirus 1 [Presence] in Specimen by Organism specific culture
Bovine diarrhea virus [Presence] in Specimen by Organism specific culture
Mycobacterium avium ss paratuberculosis Ab/Positive control in Specimen by Immunoassay
Bovine diarrhea virus Ag/Positive control in Specimen by Immunoassay
Ureaplasma diversum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Tritrichomonas foetus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Pasteurella multocida DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Ovine herpesvirus 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Neospora caninum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mannheimia haemolytica DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Haemophilus somnus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Escherichia coli K99 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Cryptosporidium parvum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Coxiella burnetii DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Bovine respiratory syncytial virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycobacterium avium ss paratuberculosis Ab [Titer] in Serum by Complement fixation
Bovine respiratory syncytial virus neutralizing antibody [Titer] in Serum by Neutralization test
SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
C Ag [Presence] on Red Blood Cells from Blood product unit
SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
Granulomatous prostatitis [Presence] in Specimen by Microscopy
High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
Delayed hypersensitivity anergy intradermal panel
Reaction wheal [Diameter] --1 day post dose control intradermal
Reaction wheal [Diameter] --2 day post dose control intradermal
Tetanus reaction wheal [Diameter] --1 day post tetanus toxoid intradermal
Tetanus reaction wheal [Diameter] --2 day post tetanus toxoid intradermal
24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass Ratio] in Serum or Plasma
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 ratio panel in Serum or Plasma
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Serum by Immunofluorescence
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI)
Chondroitin-6-sulfate/Creatinine [Ratio] in Urine
Dermatan sulfate, heparan sulfate, chondroitin-6-sulfate, keratan sulfate panel - Urine
Dermatan sulfate/Creatinine [Ratio] in Urine
Heparan sulfate/Creatinine [Ratio] in Urine
Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum by Immunoassay
Axonal autoimmune Ab panel - Serum or Plasma
Dementia autoimmune Ab panel - Serum or Plasma
Encephalopathy autoimmune Ab panel - Serum or Plasma
Epilepsy autoimmune Ab panel - Serum or Plasma
Glutamate decarboxylase 65 Ab [Moles/volume] in Serum by Immunoassay
Liver diseases autoimmune Ab panel - Serum or Plasma
Movement disorder autoimmune Ab panel - Serum or Plasma
PCA-1 Ab [Titer] in Serum by Immunofluorescence
PCA-2 Ab [Titer] in Serum by Immunofluorescence
Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum by Immunoassay
Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum by Immunoassay
CV2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Dementia autoimmune Ab panel - Cerebral spinal fluid
Encephalopathy autoimmune Ab panel - Cerebral spinal fluid
Epilepsy autoimmune Ab panel - Cerebral spinal fluid
Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay
Movement disorder autoimmune Ab panel - Cerebral spinal fluid
Aspartylglycosamine [Moles/volume] in Cerebral spinal fluid
Beta globulin [Mass/time] in 24 hour Urine by Electrophoresis
Gamma globulin [Mass/time] in 24 hour Urine by Electrophoresis
AGTR1 gene c.1166A>C [Genotype] in Blood by Molecular genetics method Nominal
SLC25A15 gene c.562_564delTTC [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Alpha defensins 1+2+3 [Presence] in Synovial fluid by Immunoassay
Plazomicin [Susceptibility] by Gradient strip
C Ag [Presence] on Red Blood Cells from Donor
SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Heptachlor [Mass/volume] in Serum or Plasma
Gabapentin [Mass/volume] in Saliva (oral fluid) by Confirmatory method
DULoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Cyclobenzaprine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Heptachlorepoxide [Mass/volume] in Serum or Plasma
Hypnotics [Presence] in Saliva (oral fluid) by Confirmatory method
Narcotics and opioids [Presence] in Saliva (oral fluid) by Confirmatory method
DULoxetine [Presence] in Saliva (oral fluid) by Confirmatory method
Anticonvulsants [Presence] in Saliva (oral fluid) by Confirmatory method
Prostate cancer grade group [Score] in Prostate tumor Qualitative
Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy
Tissue block identifier [Identifier] in Specimen
Intraductal carcinoma of prostate [Presence] in Specimen by Microscopy
Prostate cancer grade group basis [Type] in Prostate tumor
Gleason scoring basis [Type] in Prostate tumor
SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Hexachlorobenzene [Mass/volume] in Serum or Plasma
RHCE gene allele Ee [Genotype] in Blood or Tissue by Molecular genetics method Nominal
RHCE gene allele Cc [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Psychotropic medication pharmacogenomic analysis in Blood or Tissue by Molecular genetics method
CD21lowCD38- cells/100 CD19 cells in Blood
SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N1
SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by Nucleic acid amplification using CDC primer-probe set N2
SARS-related coronavirus E gene [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection
SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture
SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing
SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection
SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay
CV2 IgG Ab [Titer] in Serum by Immunofluorescence
Voltage-gated potassium channel Ab [Moles/volume] in Serum by Immunoassay
Striated muscle Ab [Titer] in Serum by Immunoassay
Paraneoplastic Ab panel - Cerebral spinal fluid by Immunofluorescence
SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection
Whole mRNA transcriptome sequence analysis in Blood or Tissue by Sequencing
SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing
Cytomegalovirus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Parvovirus B19 DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Parvovirus B19 DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Parvovirus B19 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Varicella zoster virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Varicella zoster virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection
Varicella zoster virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1+2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 1 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Herpes simplex virus 2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection
Dengue virus 1+2+3+4 RNA [Presence] in Amniotic fluid by NAA with probe detection
Enterovirus RNA [Presence] in Amniotic fluid by NAA with probe detection
Calcium [Mass/volume] in Urine from Fetus
Chloride [Moles/volume] in Urine from Fetus
Potassium [Moles/volume] in Urine from Fetus
Sodium [Moles/volume] in Urine from Fetus
Creatinine [Mass/volume] in Urine from Fetus
SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
West Nile virus IgG and IgM panel - Cerebral spinal fluid Qualitative
West Nile virus IgG and IgM panel - Serum Qualitative
carBAMazepine hypersensitivity genotype panel - Blood or Tissue
Microscopic observation [Presence] in Sputum by Acid fast stain --2nd specimen
Microscopic observation [Presence] in Sputum by Acid fast stain --3rd specimen
Glycerol [Moles/volume] in Serum by calculation
Glycerol and glycerol-corrected triglyceride panel - Serum or Plasma
Transthyretin - transthyretin peak 2 [Mass difference] in Blood
Transthyretin width at half peak height [Mass] in Blood
Transthyretin-associated familial amyloidosis panel - Blood
Triglyceride [Mass/volume] corrected for glycerol in Serum
7-Alpha hydroxy-4-cholesten-3-one [Mass/volume] in Serum or Plasma
Ganglioside GD1b IgG Ab [Titer] in Serum by Immunoassay
Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoassay
Ganglioside GD1b IgM Ab [Titer] in Serum by Immunoassay
Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoassay
Aldosterone and sodium panel - 24 hour Urine
Cholesterol and triglyceride panel - Body fluid
Cortisol.free post corticotropin stimulation panel - Serum or Plasma
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Nuclear IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Aspergillus flavus Ab [Presence] in Serum
Aspergillus sp IgA Ab [Units/volume] in Serum
Aspergillus sp IgM Ab [Units/volume] in Serum
Blastomyces dermatitidis IgG Ab [Units/volume] in Serum
Brucella canis IgG Ab [Units/volume] in Serum by Immunoassay
Brucella canis IgM Ab [Units/volume] in Serum by Immunoassay
C little e Ab [Presence] in Serum or Plasma from Blood product unit
Candida sp IgA Ab [Units/volume] in Serum
Cefonicid [Susceptibility] by Minimum lethal concentration (MLC)
Candida sp IgM Ab [Units/volume] in Serum
Carbophenothion [Mass/volume] in Specimen
DOPamine [Mass/volume] in Plasma --supine
EPINEPHrine [Mass/volume] in Plasma --standing
DOPamine [Mass/volume] in Plasma --standing
Catecholamines supine and standing panel - Plasma
Chlorobenzene [Mass/volume] in Serum or Plasma
C little e Ab [Presence] in Serum or Plasma from Donor
ADRB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q deletion in Bone marrow by FISH
Chromosome 9 and 11 and 15 aneuploidy in Bone marrow by FISH
Chromosome region 14q32 rearrangements in Bone marrow by FISH
1,3 beta glucan [Mass/volume] in Cerebral spinal fluid
Histoplasma capsulatum Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay
Bacteria [Presence] in Bronchoalveolar lavage by Light microscopy
Cannabidiol/Tetrahydrocannabinol [Ratio] in Urine by Confirmatory method
C peptide [Mass/volume] in Serum or Plasma --15 min post meal
Glucagon [Mass/volume] in Serum or Plasma --5 hours post meal
Glucose [Mass/volume] in Serum or Plasma --15 min post meal
Insulin [Units/volume] in Serum or Plasma --15 min post meal
C peptide post fasting and meal stimulation panel - Serum or Plasma
C peptide [Mass/volume] in Serum or Plasma --1.5 hours post meal
C peptide [Mass/volume] in Serum or Plasma --1 hour post meal
C peptide [Mass/volume] in Serum or Plasma --2.5 hours post meal
C peptide [Mass/volume] in Serum or Plasma --2 hours post meal
C peptide [Mass/volume] in Serum or Plasma --3.5 hours post meal
C peptide [Mass/volume] in Serum or Plasma --30 min post meal
C peptide [Mass/volume] in Serum or Plasma --3 hours post meal
C peptide [Mass/volume] in Serum or Plasma --4.5 hours post meal
C peptide [Mass/volume] in Serum or Plasma --4 hours post meal
C peptide [Mass/volume] in Serum or Plasma --5 hours post meal
Glucagon post fasting and meal stimulation panel - Serum or Plasma
Glucagon [Mass/volume] in Serum or Plasma --1.5 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --1 hour post meal
Glucagon [Mass/volume] in Serum or Plasma --2.5 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --2 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --3.5 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --30 min post meal
Glucagon [Mass/volume] in Serum or Plasma --3 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --4.5 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --4 hours post meal
Glucagon [Mass/volume] in Serum or Plasma --fasting
Glucose post fasting and meal stimulation panel - Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --2.5 hours post meal
Glucose [Mass/volume] in Serum or Plasma --3.5 hours post meal
Glucose [Mass/volume] in Serum or Plasma --30 min post meal
Glucose [Mass/volume] in Serum or Plasma --3 hours post meal
Glucose [Mass/volume] in Serum or Plasma --4.5 hours post meal
Glucose [Mass/volume] in Serum or Plasma --4 hours post meal
Glucose [Mass/volume] in Serum or Plasma --5 hours post meal
Insulin post fasting and meal stimulation panel - Serum or Plasma
Insulin [Units/volume] in Serum or Plasma --1.5 hours post meal
Insulin [Units/volume] in Serum or Plasma --1 hour post meal
Insulin [Units/volume] in Serum or Plasma --2.5 hours post meal
Insulin [Units/volume] in Serum or Plasma --2 hours post meal
Insulin [Units/volume] in Serum or Plasma --3.5 hours post meal
Insulin [Units/volume] in Serum or Plasma --30 min post meal
Insulin [Units/volume] in Serum or Plasma --3 hours post meal
Insulin [Units/volume] in Serum or Plasma --4.5 hours post meal
Insulin [Units/volume] in Serum or Plasma --4 hours post meal
Insulin [Units/volume] in Serum or Plasma --5 hours post meal
Coagulation factor VIII activity and inhibitor panel - Platelet poor plasma by Chromogenic method
Coagulation factor VIII inhibitor [Interpretation] in Platelet poor plasma by Chromogenic method
Gene fusion transcript details in Blood or Tissue by Molecular genetics method Narrative
Sarcoma targeted gene fusion transcript analysis in Tissue by Sequencing
SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
Lipid and glucose panel - Serum or Plasma
Mycobacterium tuberculosis lipoarabinomannan Ag [Presence] in Urine by Rapid immunoassay
Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method
Dense fine speckled 70 protein IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Aggressive prostate cancer risk [Score] by Calculated by ExoDx
Cytomegalovirus Ab [Titer] in Serum by Complement fixation
Cytomegalovirus DNA panel - Amniotic fluid by NAA with probe detection
Parvovirus B19 DNA panel - Amniotic fluid by NAA with probe detection
Epstein Barr virus DNA panel - Amniotic fluid by NAA with probe detection
Varicella zoster virus DNA panel - Amniotic fluid by NAA with probe detection
C little e Ab [Presence] in Serum or Plasma
Herpes simplex virus 1 and 2 DNA panel - Amniotic fluid by NAA with probe detection
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation
UGT1A1 gene TA repeats [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Hepatitis D virus RNA panel - Serum or Plasma
Hepatitis B virus core Ab panel - Serum or Plasma
Hepatitis B virus core IgM panel - Serum or Plasma
Hepatitis B virus DNA panel - Serum or Plasma
Hepatitis B virus surface Ag and Hepatitis B virus e Ab and Ag panel - Serum or Plasma
Hepatitis B virus surface Ag panel - Serum or Plasma
Avian infectious laryngotracheitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Infectious bronchitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection
Mycoplasma synoviae DNA [#/volume] in Specimen by NAA with probe detection
Ornithobacterium rhinotracheale RNA [#/volume] in Specimen by NAA with probe detection
PRRSV ORF5 gene sequence homology to Prime Pac in Isolate by Sequencing
PRRSV ORF5 gene sequence homology to Prevacent in Isolate by Sequencing
Hepatitis E virus RNA [Presence] in Specimen by NAA with probe detection
Salmonella gallinarum+Salmonella pullorum Ab [Presence] in Serum, Plasma or Blood by Agglutination
Diclofenac [Mass/volume] in Serum or Plasma
Avian encephalomyelitis virus Ab/Positive control in Serum by Immunoassay
Avian metapneumovirus Ab/Positive control in Serum by Immunoassay
Avian paramyxovirus 1 Ab/Positive control in Serum by Immunoassay
Avian reovirus Ab/Positive control in Serum by Immunoassay
Bordetella avium Ab/Positive control in Serum by Immunoassay
Infectious bronchitis virus Ab/Positive control in Serum by Immunoassay
Infectious bursal disease virus Ab/Positive control in Serum by Immunoassay
Mycoplasma gallisepticum Ab/Positive control in Serum by Immunoassay
Echovirus 11 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Mycoplasma synoviae Ab/Positive control in Serum by Immunoassay
Ornithobacterium rhinotracheale Ab/Positive control in Serum by Immunoassay
Avian infectious laryngotracheitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Infectious bronchitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma gallisepticum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma synoviae DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma iowae DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Mycoplasma meleagridis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
Echovirus 18 Ab [Titer] in Serum by Complement fixation
Ornithobacterium rhinotracheale RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Avian encephalomyelitis virus Ab [Titer] in Serum by Immunoassay
Avian metapneumovirus Ab [Titer] in Serum by Immunoassay
Avian reovirus Ab [Titer] in Serum by Immunoassay
Bordetella avium Ab [Titer] in Serum by Immunoassay
Infectious bursal disease virus Ab [Titer] in Serum by Immunoassay
Mycoplasma gallisepticum Ab [Titer] in Serum by Immunoassay
Mycoplasma synoviae Ab [Titer] in Serum by Immunoassay
Echovirus 30 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Ornithobacterium rhinotracheale Ab [Titer] in Serum by Immunoassay
Clostridioides difficile toxin and BI-NAP1-027 strain DNA panel - Stool by NAA with probe detection
Cytomegalovirus T-cell immunodeficiency panel - Blood by Flow cytometry (FC)
HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CD107a+b expressing CMV-specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CD107a+b expressing HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CD107a+b expressing HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CD107a+b expressing HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Echovirus 4 Ab [Titer] in Cerebral spinal fluid by Complement fixation
CD107a+b expressing HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CD107a+b expressing HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
Interferon-gamma producing HLA-A1 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
CMV-specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
HLA-B35 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
HLA-B8 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
HLA-B7 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
HLA-A2 CMV specific CD8 cells [#/volume] in Blood by Flow cytometry (FC)
PMA+ionomycin stimulated CD107a+b expressing CD8 cells/100 CD3+CD8+ cells in Blood by Flow cytometry (FC)
PMA+ionomycin stimulated gamma interferon producing CD8 Cells/100 CD3+CD8+ cells in Blood by Flow cytometry (FC)
Hepatitis B virus surface Ab panel - Serum or Plasma
Hepatitis C virus Ab panel - Serum or Plasma
Hepatitis E virus RNA panel - Serum or Plasma
Echovirus 9 Ab [Titer] in Cerebral spinal fluid by Complement fixation
SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay
Anaplasma marginale Ab/Negative control in Serum by Immunoassay
Bluetongue virus Ag/Negative control in Serum by Immunoassay
Neospora caninum Ab/Negative control in Serum by Immunoassay
Basophils/100 leukocytes in Stem cell product by Manual count
Blasts/100 leukocytes in Stem cell product by Manual count
CBC W Differential panel - Stem cell product
Entamoeba histolytica IgA Ab [Units/volume] in Serum by Immunoassay
Eosinophils/100 leukocytes in Stem cell product by Manual count
Nucleated erythrocytes/100 leukocytes in Stem cell product by Manual count
Leukocytes [#/volume] in Stem cell product
Variant lymphocytes/100 leukocytes in Stem cell product by Manual count
C little e Ag [Presence] on Red Blood Cells from Blood product unit
Lymphocytes/100 leukocytes in Stem cell product by Manual count
Metamyelocytes/100 leukocytes in Stem cell product by Manual count
Monocytes/100 leukocytes in Stem cell product by Manual count
Mononuclear cells/100 leukocytes in Stem cell product by Manual count
Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay
Myelocytes/100 leukocytes in Stem cell product by Manual count
Band form neutrophils/100 leukocytes in Stem cell product by Manual count
Segmented neutrophils/100 leukocytes in Stem cell product by Manual count
Other cells/100 leukocytes in Stem cell product by Manual count
Promyelocytes/100 leukocytes in Stem cell product by Manual count
Biliary tract neoplasm chromosome analysis in Tissue
Biliary tract neoplasm chromosome aneuploidy and cytology analysis in Tissue
Chromosome aneuploidy details in Blood or Tissue by Molecular genetics method Narrative
Entamoeba histolytica IgM Ab [Units/volume] in Serum by Immunoassay
Microalbumin [Presence] in Urine by Test strip
Microalbumin/Creatinine Qualitative in Urine by Test strip
Hepatitis B virus surface Ag [Interpretation] in Serum or Plasma
Hepatitis B virus Ab [Interpretation] in Serum or Plasma
Hepatitis B virus DNA [Interpretation] in Serum or Plasma
Hepatitis C virus Ab [Interpretation] in Serum or Plasma
Hepatitis D virus Ab [Interpretation] in Serum or Plasma
Giardia lamblia Ab [Titer] in Serum by Immunofluorescence
Hepatitis E virus Ab [Interpretation] in Serum or Plasma
Platelet aggregation ADP induced in Platelet rich plasma --0.6 umol/L
Platelet aggregation ADP induced in Platelet rich plasma --1.2 umol/L
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --0.5 umol/L
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --1 umol/L
Platelet aggregation ristocetin induced in Platelet rich plasma --375 ug/mL
Hepatitis D virus IgM Ab [Units/volume] in Serum
Vitamin B6 and metabolites panel - Serum or Plasma
Connective tissue autoimmune IgG panel - Serum or Plasma
HLA-A+B+C (class I) Ab [Presence] in Serum or Plasma by Immunoassay
Platelet and HLA glycoprotein antibody panel - Blood
Bicarbonate [Moles/volume] in Body fluid --post secretin
Aquaporin 4 water channel IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Hexacarboxylporphyrin [Mass/time] in 24 hour Urine
Aquaporin 4 water channel IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
DNM2 gene full mutation analysis in Blood or Tissue by Sequencing
FGD4 gene full mutation analysis in Blood or Tissue by Sequencing
GARS gene full mutation analysis in Blood or Tissue by Sequencing
GJB1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
HSPB1 gene full mutation analysis in Blood or Tissue by Sequencing
HSPB8 gene full mutation analysis in Blood or Tissue by Sequencing
MTMR2 gene full mutation analysis in Blood or Tissue by Sequencing
Histoplasma capsulatum IgA Ab [Units/volume] in Serum by Immunoassay
NDRG1 gene full mutation analysis in Blood or Tissue by Sequencing
PARK2 gene deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method
PARK7 gene deletion in Blood or Tissue by Molecular genetics method
PINK1 gene deletion in Blood or Tissue by Molecular genetics method
RAB7A gene full mutation analysis in Blood or Tissue by Sequencing
SBF2 gene full mutation analysis in Blood or Tissue by Sequencing
TRPV4 gene full mutation analysis in Blood or Tissue by Sequencing
YARS gene full mutation analysis in Blood or Tissue by Sequencing
Histoplasma capsulatum IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
C little e Ag [Presence] on Red Blood Cells from Donor
Histoplasma capsulatum IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Influenza virus A Ab [Titer] in Cerebral spinal fluid
Influenza virus A IgG Ab [Titer] in Serum
Influenza virus A IgM Ab [Titer] in Serum
Influenza virus B Ab [Titer] in Cerebral spinal fluid
Influenza virus B IgG Ab [Titer] in Serum
Rabbit hemorrhagic disease virus RNA panel - Specimen by NAA with probe detection
Rabbit hemorrhagic disease virus type 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Rabbit hemorrhagic disease virus type 2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection
Pancreatic exocrine function panel - Body fluid
Bicarbonate post secretin stimulation panel - Body fluid
Influenza virus B IgM Ab [Titer] in Serum
Date of first positive specimen collection
Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA)
La Crosse virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
Legionella pneumophila 1 IgG Ab [Titer] in Serum by Immunofluorescence
SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
Legionella pneumophila 1 IgM Ab [Titer] in Serum by Immunofluorescence
Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory system specimen by NAA with probe detection
Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by Sequencing
SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Legionella pneumophila 1 Ag [Presence] in Urine by Radioimmunoassay (RIA)
Legionella pneumophila 2 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 2 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 3 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 3 IgM Ab [Titer] in Serum by Immunofluorescence
C little e Ag [Presence] on Red Blood Cells
Legionella pneumophila 4 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 4 IgM Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 5 IgG Ab [Titer] in Serum by Immunofluorescence
Legionella pneumophila 5 IgM Ab [Titer] in Serum by Immunofluorescence
Angiotensin II (1-8) and angiotensin (1-7) panel - Plasma
Angiotensin (1-7) [Mass/volume] in Plasma
Legionella pneumophila 6 IgG Ab [Titer] in Serum by Immunofluorescence
SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory system specimen by NAA with probe detection
HIV 1 and 2 Ab panel - Serum or Plasma by Immunoassay
HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Immunoassay
Chromium and cobalt panel [Mass/volume] - Synovial fluid
Chromium [Mass/volume] in Synovial fluid
Cytomegalovirus IgG Ab [Presence] in Saliva (oral fluid) by Immunoassay
Human papilloma virus high-risk genotypes panel - Cervix by NAA with probe detection
Human papilloma virus 56+59+66 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 52 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 51 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 45 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 35+39+68 DNA [Presence] in Cervix by NAA with probe detection
Human papilloma virus 33+58 DNA [Presence] in Cervix by NAA with probe detection
Legionella pneumophila 6 IgM Ab [Titer] in Serum by Immunofluorescence
Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection
Carbapenem resistance blaIMP+blaVIM genes [Presence] by Molecular method
SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Aspergillus terreus IgG Ab [Presence] in Serum
HTLV I DNA [#/volume] in Specimen by NAA with probe detection
Loprazolam [Mass/volume] in Serum by Confirmatory method
C sup(w) Ab [Presence] in Serum or Plasma from Blood product unit
ABL1 gene c.944C>T [Presence] in Blood or Marrow by Molecular genetics method
Chromosome region 17p11.2 deletion in Blood or Tissue by FISH
4p16.3 chromosome deletion in Blood or Tissue by FISH
5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH
Pancreatic exocrine cell Ab [Presence] in Serum by Immunofluorescence
F7 gene p.Arg353Gln [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Adrenal cancer risk assessment and urine steroid fractions panel
Evidence of adrenal cortical hormone excess [Presence] in 24 hour Urine
Etiocholanolone [Z-score] in 24 hour Urine
Dehydroepiandrosterone (DHEA) [Z-score] in 24 hour Urine
16-Alpha hydroxydehydroepiandrosterone [Mass/time] in 24 hour Urine
16-Alpha hydroxydehydroepiandrosterone [Z-score] in 24 hour Urine
5-Pregnenetriol [Mass/time] in 24 hour Urine
5-Pregnenetriol [Z-score] in 24 hour Urine
5-Pregnenediol [Mass/time] in 24 hour Urine
5-Pregnenediol [Z-score] in 24 hour Urine
Tetrahydro-11-corticosterone [Mass/time] in 24 hour Urine
Tetrahydro-11-corticosterone [Z-score] in 24 hour Urine
11-Deoxytetrahydrocorticosterone [Mass/time] in 24 hour Urine
11-Deoxytetrahydrocorticosterone [Z-score] in 24 hour Urine
17 Alpha-hydroxypregnanolone [Mass/time] in 24 hour Urine
17 Alpha-hydroxypregnanolone [Z-score] in 24 hour Urine
Pregnanetriol [Z-score] in 24 hour Urine
Pregnanetriolone [Z-score] in 24 hour Urine
Tetrahydrodeoxycortisol [Z-score] in 24 hour Urine
6-Beta-Hydroxycortisol [Z-score] in 24 hour Urine
Tetrahydrocortisol [Z-score] in 24 hour Urine
5-Alpha tetrahydrocortisol [Z-score] in 24 hour Urine
11-Hydroxyandrosterone [Z-score] in 24 hour Urine
11-Hydroxyetiocholanolone [Z-score] in 24 hour Urine
Tetrahydrocortisone [Z-score] in 24 hour Urine
Alpha cortolone [Z-score] in 24 hour Urine
Beta cortolone [Mass/time] in 24 hour Urine
Beta cortolone [Z-score] in 24 hour Urine
11-Ketoetiocholanolone [Z-score] in 24 hour Urine
25-hydroxyvitamin D2 [Mass/volume] in Capillary blood
25-hydroxyvitamin D3 [Mass/volume] in Capillary blood
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Capillary blood
PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Line blot
Gelatinous bodies [Presence] in Semen by Microscopy
Mucus strands [Presence] in Semen by Microscopy
Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Contactin-associated protein 2 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Serum by Cell binding immunofluorescent assay
GABABR Ab [Titer] in Serum by Cell binding immunofluorescent assay
AMPAR2 Ab [Titer] in Serum by Cell binding immunofluorescent assay
AMPAR1 Ab [Titer] in Serum by Cell binding immunofluorescent assay
NMDAR subunit 1 Ab [Titer] in Serum by Cell binding immunofluorescent assay
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection
SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by Sequencing
C sup(w) Ab [Presence] in Serum or Plasma from Donor
Jamestown canyon virus neutralizing antibody [Titer] in Specimen by Neutralization test
California encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Cache valley virus neutralizing antibody [Titer] in Specimen by Neutralization test
Colorado tick fever virus neutralizing antibody [Titer] in Specimen by Neutralization test
Barmah forest virus neutralizing antibody [Titer] in Specimen by Neutralization test
Snowshoe hare virus neutralizing antibody [Titer] in Specimen by Neutralization test
Tahyna virus neutralizing antibody [Titer] in Specimen by Neutralization test
Japanese encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Murray Valley encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Ross River virus neutralizing antibody [Titer] in Specimen by Neutralization test
Powassan virus neutralizing antibody [Titer] in Specimen by Neutralization test
Sindbis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Chikungunya virus neutralizing antibody [Titer] in Specimen by Neutralization test
Mayaro virus neutralizing antibody [Titer] in Specimen by Neutralization test
Yellow fever virus neutralizing antibody [Titer] in Specimen by Neutralization test
Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Measles virus Ab [Titer] in Cerebral spinal fluid by Complement fixation
La Crosse virus neutralizing antibody [Titer] in Specimen by Neutralization test
Eastern equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Western equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Flavivirus identified in Specimen by Neutralization test
Influenza virus A H7 Eurasia RNA [Presence] in Specimen by NAA with probe detection
Adenovirus RNA [Presence] in Specimen by NAA with probe detection
Eastern equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Barmah forest virus IgG Ab [Presence] in Specimen by Immunoassay
Japanese encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
Zika virus IgG Ab [Presence] in Specimen by Immunoassay
Jamestown canyon virus IgG Ab [Presence] in Specimen by Immunoassay
Snowshoe hare virus IgG Ab [Presence] in Specimen by Immunoassay
Tahyna virus IgG Ab [Presence] in Specimen by Immunoassay
Japanese encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Highlands J virus IgG Ab [Presence] in Specimen by Immunoassay
Murray Valley encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Ross River virus IgG Ab [Presence] in Specimen by Immunoassay
Sindbis virus IgG Ab [Presence] in Specimen by Immunoassay
Chikungunya virus IgG Ab [Presence] in Specimen by Immunoassay
Dengue virus 1+2+3+4 IgG Ab [Presence] in Specimen by Immunoassay
Mayaro virus IgG Ab [Presence] in Specimen by Immunoassay
Yellow fever virus IgG Ab [Presence] in Specimen by Immunoassay
Venezuelan equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Saint Louis encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Western equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Mumps virus Ab [Titer] in Cerebral spinal fluid by Complement fixation
Barmah forest virus IgM Ab [Presence] in Specimen by Immunoassay
Snowshoe hare virus IgM Ab [Presence] in Specimen by Immunoassay
Tahyna virus IgM Ab [Presence] in Specimen by Immunoassay
Japanese encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Highlands J virus IgM Ab [Presence] in Specimen by Immunoassay
Murray Valley encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Ross River virus IgM Ab [Presence] in Specimen by Immunoassay
Sindbis virus IgM Ab [Presence] in Specimen by Immunoassay
Chikungunya virus IgM Ab [Presence] in Specimen by Immunoassay
Dengue virus 1+2+3+4 IgM Ab [Presence] in Specimen by Immunoassay
Mayaro virus IgM Ab [Presence] in Specimen by Immunoassay
Yellow fever virus IgM Ab [Presence] in Specimen by Immunoassay
Venezuelan equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Saint Louis encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Western equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Cache valley virus IgA Ab [Presence] in Specimen by Immunoassay
Nocardia sp IgG Ab [Units/volume] in Serum
Colorado tick fever virus IgA Ab [Presence] in Specimen by Immunoassay
Barmah forest virus IgA Ab [Presence] in Specimen by Immunoassay
Snowshoe hare virus IgA Ab [Presence] in Specimen by Immunoassay
Tahyna virus IgA Ab [Presence] in Specimen by Immunoassay
Highlands J virus IgA Ab [Presence] in Specimen by Immunoassay
Murray Valley encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
Ross River virus IgA Ab [Presence] in Specimen by Immunoassay
Powassan virus IgA Ab [Presence] in Specimen by Immunoassay
Para aminobenzoate [Mass/volume] in 6 hour Urine --6 hours post 500 mg bentiromide PO
West Nile virus IgA Ab [Presence] in Specimen by Immunoassay
Sindbis virus IgA Ab [Presence] in Specimen by Immunoassay
Chikungunya virus IgA Ab [Presence] in Specimen by Immunoassay
Dengue virus IgA Ab [Presence] in Specimen by Immunoassay
Mayaro virus IgA Ab [Presence] in Specimen by Immunoassay
Yellow fever virus IgA Ab [Presence] in Specimen by Immunoassay
Venezuelan equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
C sup(w) Ab [Presence] in Serum or Plasma
La Crosse virus IgA Ab [Presence] in Specimen by Immunoassay
Parvovirus B19 DNA [Presence] in Specimen by NAA with probe detection
Saint Louis encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
Eastern equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
Western equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay
Varicella zoster virus IgG Ab [Units/volume] in Specimen by Immunoassay
17 alpha-Hydroxylase Ab [Titer] in Serum by Immunofluorescence
Barmah forest virus Ab [Presence] in Serum by Immunoassay
Flavivirus Ab [Presence] in Serum or Plasma
Glycine receptor Ab [Titer] in Serum or Plasma by Immunoassay
Glycine receptor Ab [Titer] in Cerebral spinal fluid by Immunoassay
Glycine receptor Ab [Presence] in Serum or Plasma by Immunoassay
Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunoassay
Glycine receptor Ab [Presence] in Serum or Plasma by Immunofluorescence
Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum or Plasma by Immunoassay
Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence
Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence
Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Candida auris DNA [Presence] in Urine by NAA with non-probe detection
Candida auris DNA [Presence] in Specimen by NAA with non-probe detection
Candida auris DNA [Presence] in Blood by NAA with non-probe detection
Cefiderocol [Susceptibility] by Disk diffusion (KB)
Parathyrin.1-84 [Moles/volume] in Serum or Plasma by Immunoassay
BMPR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
GATA2 gene full mutation analysis in Blood or Tissue by Sequencing
IDH1 and IDH2 genes targeted mutation analysis in Blood or Tissue by Molecular genetics method
ACADM gene full mutation analysis in Blood or Tissue by Sequencing
MSH6 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
HGSNAT gene full mutation analysis in Blood or Tissue by Sequencing
GNS gene full mutation analysis in Blood or Tissue by Sequencing
ACADS gene full mutation analysis in Blood or Tissue by Sequencing
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
TERT gene promotor region targeted mutation analysis in Tissue by Molecular genetics method
TFE3 gene rearrangements in Tissue by FISH
TFEB gene rearrangements in Tissue by FISH
ATP7B gene full mutation analysis in Blood or Tissue by Sequencing
ABCD1 gene full mutation analysis in Blood or Tissue by Sequencing
ETV6 gene rearrangements in Blood or Marrow by FISH
FGFR2 gene rearrangements in Tissue by FISH
FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence
Gene XXX mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Tetrahydrocorticosterone [Mass/time] in 24 hour Urine
HBG1 and HBG2 genes full mutation analysis in Blood or Tissue by Sequencing
Norfentanyl [Presence] in Urine by Screen method
Normeperidine [Presence] in Urine by Screen method
O-nortramadol [Presence] in Urine by Screen method
Immunoglobulin light chains.free panel - Urine
Immunoglobulin light chains.free and IFE panel - Urine
Thyroxine (T4) Ab [Units/volume] in Serum
Cholesterol and triglyceride and chylomicrons panel - Urine
Carbapenem resistance genes [Presence] by Molecular method
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence
SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
Viable CD3 cells/100 CD3 cells in Blood product unit
Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence
T cell product characterization panel - Blood product unit by Flow cytometry (FC)
Viable CD45 cells/100 CD45 cells in Blood product unit
Hematopoietic progenitor cell product characterization panel - Blood product unit by Flow cytometry (FC)
Lymphocyte dose in hematopoietic progenitor cell transfusion [#/mass]
CD3 dose in hematopoietic progenitor cell transfusion [#/mass]
Nucleated cells [#] in Blood product unit
Mononuclear cells [#] in Blood product unit
Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence
Mononuclear cell dose in hematopoietic progenitor cell transfusion [#/mass]
Nucleated cells.recovered/Nucleated cells.total
Mononuclear cells.recovered/Mononuclear cells.total
Microscopic exam [Interpretation] in Sputum by Microscopy Narrative
Monocytes+Macrophages/100 leukocytes in Sputum by Manual count
Lymphocytes/100 leukocytes in Sputum by Manual count
Neutrophils/100 leukocytes in Sputum by Manual count
Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence
Epithelial cells.squamous [#/volume] in Sputum by Manual count
Nucleated cells [#/volume] in Sputum by Manual count
Cell count and Differential panel - Sputum by Manual count
Somatotropin [Mass/volume] in Serum by Immunoassay --90 minutes post dose macimorelin
Somatotropin [Mass/volume] in Serum by Immunoassay --60 minutes post dose macimorelin
Somatotropin [Mass/volume] in Serum by Immunoassay --45 minutes post dose macimorelin
Somatotropin [Mass/volume] in Serum by Immunoassay --30 minutes post dose macimorelin
Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence
Somatotropin post macimorelin stimulation panel - Serum by Immunoassay
Borrelia burgdorferi Ab [Interpretation] in Serum
Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot
C sup(w) Ag [Presence] on Red Blood Cells from Blood product unit
Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot
Pneumocystis jiroveci DNA [Presence] in Tissue by NAA with probe detection
Coccidioides sp DNA [Presence] in Tissue by NAA with probe detection
Blastomyces sp DNA [Presence] in Tissue by NAA with probe detection
Coccidioides sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Blastomyces sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Histoplasma capsulatum DNA [Presence] in Lower respiratory specimen by NAA with probe detection
Fungal pathogens panel - Tissue by NAA with probe detection
Borrelia burgdorferi 30kD IgG Ab [Presence] in Serum by Immunoblot
Fungal pathogens panel - Lower respiratory specimen by NAA with probe detection
Galantamine [Mass/volume] in Serum, Plasma or Blood
Hydroxychloroquine [Mass/volume] in Blood
Borrelia burgdorferi 39kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 41kD IgG Ab [Presence] in Serum by Immunoblot
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
Borrelia burgdorferi 45kD IgG Ab [Presence] in Serum by Immunoblot
Alcuronium IgE Ab [Units/volume] in Serum
Aloe vera IgE Ab [Units/volume] in Serum
Glucan 1,4 alpha glucosidase IgE Ab [Units/volume] in Serum
Borrelia burgdorferi 58kD IgG Ab [Presence] in Serum by Immunoblot
Arnica montana IgE Ab [Units/volume] in Serum
Azalea spp IgE Ab [Units/volume] in Serum
Azorubine IgE Ab [Units/volume] in Serum
Aminoglycoside Mix (Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin) IgE Ab [Units/volume] in Serum
Stone pine IgE Ab [Units/volume] in Serum
Butylparaben IgE Ab [Units/volume] in Serum
Lemon grass IgE Ab [Units/volume] in Serum
Italian chicory Radicchio IgE Ab [Units/volume] in Serum
Black salsify IgE Ab [Units/volume] in Serum
Tetrachlorophthalic anhydride IgE Ab [Units/volume] in Serum
House dust Japan IgE Ab [Units/volume] in Serum
Tree Allergen Oak Mix (White oak+Red oak+Black Oak) IgE Ab [Units/volume] in Serum
European gooseberry IgE Ab [Units/volume] in Serum
Ethylparaben IgE Ab [Units/volume] in Serum
Aspergillus glaucus IgE Ab [Units/volume] in Serum
Freesia spp IgE Ab [Units/volume] in Serum
Borrelia burgdorferi 66kD IgG Ab [Presence] in Serum by Immunoblot
Gerbera spp IgE Ab [Units/volume] in Serum
C sup(w) Ag [Presence] on Red Blood Cells from Donor
SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
SARS-CoV-2 stimulated gamma interferon [Presence] in Blood
SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
SARS-CoV-2 stimulated gamma interferon panel - Blood
Borrelia burgdorferi 93kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 23kD IgM Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi 39kD IgM Ab [Presence] in Serum by Immunoblot
Taenia solium larva Ab [Presence] in Serum by Immunoblot
Taenia solium larva 13kD Ab [Presence] in Serum by Immunoblot
Taenia solium larva 14kD Ab [Presence] in Serum by Immunoblot
Taenia solium larva 18kD Ab [Presence] in Serum by Immunoblot
Microscopic observation [Identifier] in Tissue by Alcian blue stain.with hyaluronidase
Taenia solium larva 21kD Ab [Presence] in Serum by Immunoblot
Human epididymis protein 4 [Mass/volume] in Serum or Plasma
Osmotic fragility of Red Blood Cells--10% glucose 48 hour 37 degree C incubation
B and T cell crossmatch panel - Patient serum and Donor blood by Flow cytometry (FC)
T cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC)
T cell median channel shift in Patient serum and Donor blood by Flow cytometry (FC)
B cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC)
C sup(w) Ag [Presence] on Red Blood Cells
B cell median channel shift in Patient serum and Donor blood by Flow cytometry (FC)
Borrelia sp DNA [Presence] in Blood by NAA with probe detection
Taenia solium larva 24kD Ab [Presence] in Serum by Immunoblot
Interferon beta IgG Ab [Presence] in Serum
Mitragynine [Presence] in Urine by Screen method
Mitragynine [Mass/volume] in Urine by Screen method
Taenia solium larva 39-42kD Ab [Presence] in Serum by Immunoblot
Taenia solium larva 50kD Ab [Presence] in Serum by Immunoblot
Hepatitis C virus 100-3 Ab [Presence] in Serum by Immunoblot
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory system specimen by NAA with probe detection
Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot
Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot
Bedaquiline [Susceptibility] by Genotype method
Clofazimine [Susceptibility] by Genotype method
Delamanid [Susceptibility] by Genotype method
Ethionamide [Susceptibility] by Genotype method
Linezolid [Susceptibility] by Genotype method
Moxifloxacin [Susceptibility] by Genotype method
Rifabutin [Susceptibility] by Genotype method
Streptomycin [Susceptibility] by Genotype method
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay
Level of tumor invasion [Type] in Colorectal cancer specimen by Haggitt
Anterior surgical resection [Type] in Lower GI tract
Resection adequacy of non-malignant polyp in Specimen Qualitative
SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
Cortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
C sup(x) Ab [Presence] in Serum or Plasma from Blood product unit
Cortisol [Mass/volume] in Serum or Plasma --2 hours post 250 ug corticotropin IM
Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 250 ug corticotropin IM
17-Hydroxyprogesterone [Mass/time] in 24 hour Urine
Chylomicrons [Mass/volume] in Pleural fluid
Cholesterol [Mass/volume] in Pleural fluid
Indoor respiratory allergen IgE panel - Serum
Dermatology autoimmune Ab panel - Serum or Plasma
Triglyceride [Mass/volume] in Pleural fluid
Lipoprotein.beta [Mass/volume] in Pleural fluid
C sup(x) Ab [Presence] in Serum or Plasma from Donor
Lipoprotein.pre-beta [Mass/volume] in Pleural fluid
Phytonadione [Mass/volume] in Serum or Plasma
Vanillylmandelate [Mass/volume] in Urine
Artifact [#/area] in Urine by Computer assisted method
Arsenic.inorganic+methylated [Mass/volume] in Urine
Arsenic.inorganic+methylated [Mass/volume] in 24 hour Urine
Arsenic.methylated [Mass/volume] in 24 hour Urine
Saint Louis encephalitis virus IgG and IgM panel - Cerebral spinal fluid
Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma
Saint Louis encephalitis virus IgG and IgM panel - Serum
Copper free [Moles/volume] in Serum or Plasma
Copper free [Mass/volume] in Serum or Plasma
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Calculated by Martin-Hopkins
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Calculated by Martin-Hopkins
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma
Delta aPTT W excess hexagonal phospholipid [Time] in Platelet poor plasma by Coagulation assay
Monocytes.PD-L1/100 Monocytes in Blood by Flow cytometry (FC)
Cyclin-dependent kinase 4 [Presence] in Cancer specimen by Immune stain
Imipramine+Desipramine [Mass/volume] in Serum or Plasma
DNA mismatch repair protein Msh3 [Presence] in Cancer specimen by Immune stain
DNA mismatch repair protein Mlh3 [Presence] in Cancer specimen by Immune stain
HIV 1 RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection
American Beech wood dust IgE Ab [Units/volume] in Serum
Ammonium persulfate IgE Ab [Units/volume] in Serum
Blackcurrant IgE Ab [Units/volume] in Serum
carBAMazepine IgE Ab [Units/volume] in Serum
Dermatophagoides pteronyssinus recombinant (rDer p) 23 IgE Ab [Units/volume] in Serum
European silver fir wood dust IgE Ab [Units/volume] in Serum
European Ash wood dust IgE Ab [Units/volume] in Serum
European pigeon tick IgE Ab [Units/volume] in Serum
Coagulation factor XII inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Indomethacin IgE Ab [Units/volume] in Serum
Ketoprofen IgE Ab [Units/volume] in Serum
Macrolide Mix (Amphotericin B+Erythromycin+Nystatin+Spiramycin) IgE Ab [Units/volume] in Serum
Methylene blue IgE Ab [Units/volume] in Serum
O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma
predniSONE IgE Ab [Units/volume] in Serum
Pregnenolone sulfate [Mass/volume] in Serum or Plasma
Quinoline IgE Ab [Units/volume] in Serum
Sodium nitrite IgE Ab [Units/volume] in Serum
Straw dust IgE Ab [Units/volume] in Serum
Streptomycin IgE Ab [Units/volume] in Serum
Thuja spp IgE Ab [Units/volume] in Serum
TOLAZamide [Mass/volume] in Serum or Plasma
Cobalamin (Vitamin B12) IgE Ab [Units/volume] in Serum
Cell growth [Presence] of Fibroblast in Tissue culture
Bacteroides fragilis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Candida auris DNA [Presence] by NAA with non-probe detection in Positive blood culture
Cryptococcus gattii+neoformans DNA [Presence] by NAA with non-probe detection in Positive blood culture
Enterococcus faecalis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Venlafaxine [Mass/volume] in Serum or Plasma
Enterococcus faecium DNA [Presence] by NAA with non-probe detection in Positive blood culture
Enterobacterales DNA [Presence] by NAA with non-probe detection in Positive blood culture
Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture
Klebsiella aerogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture
Methicillin resistance mecA+mecC genes+SCCmec+OrfX junction [Presence] by Molecular method
Staphylococcus epidermidis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Staphylococcus lugdunensis DNA [Presence] by NAA with non-probe detection in Positive blood culture
Stenotrophomonas maltophilia DNA [Presence] by NAA with non-probe detection in Positive blood culture
Salmonella sp DNA [Presence] by NAA with non-probe detection in Positive blood culture
AMPAR1+AMPAR2 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Enterobacter cloacae complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Escherichia coli DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Streptococcus agalactiae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Aspergillus fumigatus Ab [Presence] in Serum
Haemophilus influenzae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Klebsiella oxytoca DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Klebsiella aerogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Moraxella catarrhalis DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Pseudomonas aeruginosa DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Proteus sp DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Staphylococcus aureus DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Serratia marcescens DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Streptococcus pneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Streptococcus pyogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection
Epstein Barr virus capsid IgA Ab [Titer] in Serum by Immunofluorescence
Saint Louis encephalitis virus IgG Ab [Titer] in Specimen
Saint Louis encephalitis virus IgM Ab [Titer] in Specimen
Platelets Large [#/volume] in Blood by Automated count
Equine herpesvirus 1 [Presence] in Specimen by Organism specific culture
Equine herpesvirus 3 [Presence] in Specimen by Organism specific culture
Equine herpesvirus 4 [Presence] in Specimen by Organism specific culture
Bovine parainfluenza virus 3 [Presence] in Specimen by Organism specific culture
7-Aminoclonazepam [Presence] in Saliva (oral fluid) by Confirmatory method
Dextromethorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Dextromethorphan [Presence] in Saliva (oral fluid) by Confirmatory method
Varicella zoster virus Ab [Presence] in Cerebral spinal fluid
Dextrorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Dextrorphan+Levorphanol [Presence] in Saliva (oral fluid) by Confirmatory method
Gabapentin [Presence] in Saliva (oral fluid) by Confirmatory method
Naltrexol [Presence] in Saliva (oral fluid) by Confirmatory method
Naltrexone [Presence] in Saliva (oral fluid) by Confirmatory method
Pregabalin [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Pregabalin [Presence] in Saliva (oral fluid) by Confirmatory method
Sertraline [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Sertraline [Presence] in Saliva (oral fluid) by Confirmatory method
Tapentadol [Presence] in Saliva (oral fluid) by Confirmatory method
C sup(x) Ab [Presence] in Serum or Plasma
18-Hydroxycorticosterone [Mass/time] in 24 hour Urine
Cytomegalovirus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection
Retinol binding protein panel - 24 hour Urine
Retinol binding protein/Creatinine [Mass Ratio] in 24 hour Urine
Retinol binding protein/Creatinine [Mass Ratio] in Urine
Renal clearance and Renal plasma flow panel - Urine and Serum or Plasma
Androstanediol [Mass/volume] in Serum or Plasma
Para aminohippurate renal clearance/1.73 sq M in Urine and Serum or Plasma
Filtration Fraction in Urine and Serum or Plasma
Retinol binding protein [Mass/volume] in 24 hour Urine
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --30M post sham feeding
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --25M post sham feeding
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --20M post sham feeding
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --15M post sham feeding
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --10M post sham feeding
Catecholamines/Creatinine [Mass Ratio] in Urine
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --5M post sham feeding
Pancreatic polypeptide [Mass/volume] in Serum or Plasma --fasting
Pancreatic polypeptide sham feeding panel - Serum or Plasma
DOCK8 expression panel - Blood by Flow cytometry (FC)
Cells.CD3+CD14-CD45+DOCK8+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
Cells.CD3-CD14-CD19+CD45+DOCK8+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
Cells.CD3-CD14-CD45+CD56+DOCK8+/100 Cells.CD3-CD14-CD45+CD56+ in Blood by Flow cytometry (FC)
Cells.CD3-CD14+CD45+DOCK8+/100 Cells.CD3-CD14+CD45+ in Blood by Flow cytometry (FC)
Creatine kinase.BB/Creatine kinase.total in Serum or Plasma
Daratumumab [Presence] in Serum by Immunofixation
Testosterone/Cortisol [Mass Ratio] in DBS
Borrelia burgdorferi IgM Ab [Presence] in Specimen
Borrelia burgdorferi IgA Ab [Presence] in Specimen
Borrelia burgdorferi G39/40 IgG bands [Identifier] in Specimen by Immunoblot
Borrelia burgdorferi G39/40 IgG bands [#] in Specimen by Immunoblot
Borrelia burgdorferi 49736 IgG bands [Identifier] in Specimen by Immunoblot
Borrelia burgdorferi 49736 IgG bands [#] in Specimen by Immunoblot
Creatine kinase.MM/Creatine kinase.total in Serum or Plasma
SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
Cell growth [Presence] of Tumor in Tissue culture
Hepatotocellular carcinoma risk [Score] GALAD
Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma
Hepatocellular carcinoma risk panel - Serum or Plasma
Metanephrine/Creatinine [Mass Ratio] in Urine
Coagulation factor XI activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Coagulation factor II inhibitor [Presence] in Platelet poor plasma by Coagulation assay
Coagulation factor II activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Coagulation factor VIII activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Coagulation factor X activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Coagulation factor V activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Coagulation factor IX activity and inhibitor panel - Platelet poor plasma by Coagulation assay
Thyroglobulin [Mass/volume] in Serum or Plasma by Immunoassay --post thyroglobulin antibody neutralization
Gastrin releasing polypeptide prohormone [Mass/volume] in Serum or Plasma by Immunoassay
Sirolimus [Moles/volume] in Blood by Immunoassay
Copper free/Total copper in Serum or Plasma by calculation
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Immunofluorescence
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Immunofluorescence
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
C sup(x) Ag [Presence] on Red Blood Cells from Blood product unit
Rho GTPase-activating protein 26 IgG Ab [Titer] in Serum by Immunofluorescence
Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Immunofluorescence
Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Rho GTPase-activating protein 26 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
IgLON5 IgG Ab [Presence] in Serum by Immunofluorescence
IgLON5 IgG Ab [Titer] in Serum by Immunofluorescence
IgLON5 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Alpha-internexin IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Alpha-internexin IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Neuronal intermediate filament heavy chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Neuronal intermediate filament light chain IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Neuronal intermediate filament IgG Ab [Presence] in Serum by Immunofluorescence
Neuronal intermediate filament IgG Ab [Titer] in Serum by Immunofluorescence
Neuronal intermediate filament heavy chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Neuronal intermediate filament light chain IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Neuronal intermediate filament IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Neuronal intermediate filament IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
CD3+CD8+CD27+CD45RO+CD62L+ cells [#/volume] in Blood
T-cell naive and memory and activated subsets panel - Blood
ABL1 and ABL2 and PDGFRB gene rearrangements in Blood or Tissue by FISH
Hydroflumethiazide [Mass/volume] in Urine
ABL2 gene rearrangements in Blood or Tissue by FISH
Glycine receptor alpha-1 subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Glycine receptor alpha-1 subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
La Crosse virus Ab.IgG and IgM panel - Cerebral spinal fluid
La Crosse virus Ab.IgG and IgM panel - Serum
TIF1-gamma Ab [Units/volume] in Serum by Immunoassay
Adenovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection
Colorado tick fever virus IgM Ab [Presence] in Specimen by Immunoassay
Oropouche virus IgG Ab [Presence] in Specimen by Immunoassay
California encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Bunyamwera virus IgG Ab [Presence] in Specimen by Immunoassay
Tick-borne encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay
Heartland banyangvirus IgG Ab [Presence] in Specimen by Immunoassay
Bwamba virus IgG Ab [Presence] in Specimen by Immunoassay
Rift valley fever virus IgG Ab [Presence] in Specimen by Immunoassay
Sandfly fever Naples virus IgG Ab [Presence] in Specimen by Immunoassay
Cache valley virus IgM Ab [Presence] in Specimen by Immunoassay
Sandfly fever Sicilian virus IgG Ab [Presence] in Specimen by Immunoassay
Toscana virus IgG Ab [Presence] in Specimen by Immunoassay
Bourbon virus IgG Ab [Presence] in Specimen by Immunoassay
Onyong-nyong virus IgG Ab [Presence] in Specimen by Immunoassay
Semliki Forest virus IgG Ab [Presence] in Specimen by Immunoassay
Ilheus virus IgG Ab [Presence] in Specimen by Immunoassay
Cache valley virus IgG Ab [Presence] in Specimen by Immunoassay
Colorado tick fever virus IgG Ab [Presence] in Specimen by Immunoassay
Ilheus virus IgM Ab [Presence] in Specimen by Immunoassay
Rocio virus IgM Ab [Presence] in Specimen by Immunoassay
Semliki Forest virus IgM Ab [Presence] in Specimen by Immunoassay
Onyong-nyong virus IgM Ab [Presence] in Specimen by Immunoassay
Bourbon virus IgM Ab [Presence] in Specimen by Immunoassay
Toscana virus IgM Ab [Presence] in Specimen by Immunoassay
N-desalkylflurazepam [Mass/volume] in Serum or Plasma
Sandfly fever Sicilian virus IgM Ab [Presence] in Specimen by Immunoassay
Sandfly fever Naples virus IgM Ab [Presence] in Specimen by Immunoassay
Oropouche virus IgM Ab [Presence] in Specimen by Immunoassay
Rift valley fever virus IgM Ab [Presence] in Specimen by Immunoassay
Bwamba virus IgM Ab [Presence] in Specimen by Immunoassay
Heartland banyangvirus IgM Ab [Presence] in Specimen by Immunoassay
Tick-borne encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Bunyamwera virus IgM Ab [Presence] in Specimen by Immunoassay
Trichlormethiazide [Mass/volume] in Urine
California encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay
Rocio virus IgG Ab [Presence] in Specimen by Immunoassay
C sup(x) Ag [Presence] on Red Blood Cells from Donor
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
Campylobacter jejuni Ab [Titer] in Serum
Eutylone [Mass/volume] in Serum or Plasma
HIV 1 and 2 RNA [Identifier] in Serum or Plasma by NAA with probe detection
HIV 1 and 2 RNA panel - Serum or Plasma by NAA with probe detection
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoassay
Nuclear pore protein gp210 Ab [Units/volume] in Serum by Immunoassay
Citrullinated alpha enolase peptide 1 Ab [Units/volume] in Serum by Immunoassay
Cytosolic 5'-nucleotidase 1A Ab [Units/volume] in Serum by Immunoassay
Inner ear 68kD IgG Ab [Units/volume] in Serum by Immunoassay
Inner ear Ab [Units/volume] in Serum by Immunoassay
sp100 Ab [Units/volume] in Serum by Immunoassay
Cabotegravir [Susceptibility] by Genotype method
Toxocara sp IgG Ab [Presence] in Ocular fluid by Immunoassay
Toxocara sp IgG Ab [Presence] in Serum by Immunoassay
Echinococcus sp IgM Ab [Units/volume] in Serum by Immunoassay
Giardia lamblia IgA Ab [Units/volume] in Serum
Alanine aminotransferase [Enzymatic activity/volume] in DBS
Aspartate aminotransferase [Enzymatic activity/volume] in DBS
Cholesterol.total/Cholesterol in HDL [Mass Ratio] in DBS
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in DBS
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in DBS
Gamma glutamyl transferase [Enzymatic activity/volume] in DBS
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Cholesterol in LDL [Mass/volume] in DBS by Direct assay
Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection
Retinol and Alpha tocopherol panel - Serum or Plasma
Bacilliform bacteria [Presence] in Skin by Light microscopy
HIV 1 gp160 Ab [Presence] in Serum by Immunoblot
Methadone and EDDP panel - Serum or Plasma
SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT
Acrylic fiber IgE Ab [Units/volume] in Serum
Sugar cane pollen IgE Ab [Units/volume] in Serum
Treated sheep wool IgE Ab [Units/volume] in Serum
HIV 1 gp120 Ab [Presence] in Serum by Immunoblot
Treponema pallidum and Haemophilus ducreyi and Herpes simplex virus DNA panel - Specimen by NAA with probe detection
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Specimen by NAA with probe detection
HLA-A [Type] in Donor by High resolution
HLA-A and B and C (class I) typing panel - Blood or Tissue from Donor by High resolution
HLA-A and B and C (class I) typing panel - Blood or Tissue by High resolution
HLA-A unresolved alleles [Type] in Donor by High resolution
HLA-A unresolved alleles [Type] by High resolution
HLA-B [Type] in Donor by High resolution
HLA-B unresolved alleles [Type] in Donor by High resolution
C sup(x) Ag [Presence] on Red Blood Cells
HLA-B unresolved alleles [Type] by High resolution
HLA-C [Type] in Donor by High resolution
HLA-C unresolved alleles [Type] in Donor by High resolution
HLA-C unresolved alleles [Type] by High resolution
Donor HLA typing comment [Interpretation] Narrative
HLA typing comment [Interpretation] Narrative
HIV 1 gp41 Ab [Presence] in Serum by Immunoblot
HLA-A and B and C (class I) typing panel - Blood or Tissue from Donor by Low resolution
HLA-A and B and C (class I) typing panel - Blood or Tissue by Low resolution
HIV 1 p17 Ab [Presence] in Serum by Immunoblot
HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue by High resolution
HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue from Donor by Low resolution
HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue from Donor by High resolution
HLA-DP and DQ and DR (class II) typing panel - Blood or Tissue by Low resolution
HLA-DPA1 [Type] in Donor by High resolution
HLA-DPA1 [Type] in Donor by Low resolution
HIV 1 p24 Ab [Presence] in Serum by Immunoblot
HLA-DPA1 unresolved alleles [Type] in Donor by High resolution
HLA-DPA1 unresolved alleles [Type] by High resolution
HLA-DPB1 [Type] in Donor by High resolution
HLA-DPB1 [Type] in Donor by Low resolution
HLA-DPB1 T-cell epitope match [Type] in Donor+Patient by High resolution
HLA-DPB1 unresolved alleles [Type] in Donor by High resolution
HLA-DPB1 unresolved alleles [Type] by High resolution
HLA-DQA1 [Type] in Donor by High resolution
HLA-DQA1 [Type] in Donor by Low resolution
HLA-DQA1 unresolved alleles [Type] in Donor by High resolution
HLA-DQA1 unresolved alleles [Type] by High resolution
HLA-DQB1 [Type] in Donor by High resolution
HLA-DQB1 [Type] in Donor by Low resolution
HLA-DQB1 unresolved alleles [Type] in Donor by High resolution
HLA-DQB1 unresolved alleles [Type] by High resolution
HLA-DRB1 [Type] in Donor by High resolution
HLA-DRB1 [Type] in Donor by Low resolution
HLA-DRB1 unresolved alleles [Type] in Donor by High resolution
HLA-DRB1 unresolved alleles [Type] by High resolution
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by High resolution
HIV 1 p31 Ab [Presence] in Serum by Immunoblot
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by Low resolution
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by High resolution
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by Low resolution
HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type]
HLA-DRB3 and HLA-DRB4 and HLA DRB5 unresolved alleles [Type] in Donor by High resolution
HLA-DRB3 and HLA-DRB4 and HLA DRB5 unresolved alleles [Type] by High resolution
HIV 1 p51 Ab [Presence] in Serum by Immunoblot
Activated clotting time.diatomaceous earth induced of Blood by Microviscometry
Activated clotting time.diatomaceous earth+clay induced of Blood by Microviscometry
Activated clotting time.glass bead induced of Blood by Microviscometry
Activated clotting time.glass bead induced of Blood by Microviscometry --post heparin neutralization
Activated clotting time.kaolin induced of Blood by Microviscometry
HIV 1 p55 Ab [Presence] in Serum by Immunoblot
Clot formation and Platelet function.glass bead induced post heparin neutralization panel - Blood by Microviscometry
Clot formation and Platelet function.glass bead induced panel - Blood by Microviscometry
Clot formation.diatomaceous earth induced panel - Blood by Microviscometry
Clot formation.diatomaceous earth+clay induced panel - Blood by Microviscometry
Clot formation.glass bead induced panel - Blood by Microviscometry
Clot formation.kaolin induced panel - Blood by Microviscometry
Coagulation viscoelastic tracing in Blood Document
Platelet-induced clot retraction.glass bead induced in Blood by Microviscometry
HIV 1 p66 Ab [Presence] in Serum by Immunoblot
Platelet-induced clot retraction.glass bead induced in Blood by Microviscometry --post heparin neutralization
Rate of fibrin formation.diatomaceous earth induced [Units] in Blood by Microviscometry
Rate of fibrin formation.diatomaceous earth+clay induced [Units] in Blood by Microviscometry
Rate of fibrin formation.glass bead induced [Units] in Blood by Microviscometry
Rate of fibrin formation.glass bead induced [Units] in Blood by Microviscometry --post heparin neutralization
Rate of fibrin formation.kaolin induced [Units] in Blood by Microviscometry
Plasmodium malariae IgG Ab [Units/volume] in Serum
Clot initiation.kaolin induced [Time] in Blood by US
Clot initiation.kaolin induced/Clot initiation.kaolin induced post heparin neutralization [Time Ratio] in Blood by calculation
Clot initiation.kaolin induced [Time] in Blood by US --post heparin neutralization
Clot stiffness reduction percent due to fibrinolysis in Blood by calculation
Clot stiffness.platelet contribution (elasticity) in Blood by calculation
Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited (elasticity) in Blood by US --post heparin neutralization
Clot stiffness.tissue factor induced (elasticity) in Blood by US --post heparin neutralization
Clot [Presence] of Body fluid Qualitative
Erythrocytes [#/area] in Body fluid by Light microscopy
Leukocytes [#/area] in Body fluid by Light microscopy
Microscopic observation [Identifier] in Body fluid by Light microscopy
Epithelial cells.squamous [#/volume] in Bronchial specimen by Manual count
Leukocytes [#/area] in Prostatic fluid by Light microscopy
Plasmodium malariae IgM Ab [Units/volume] in Serum
Erythrocytes [#/area] in Prostatic fluid by Light microscopy
Epithelial cells [#/area] in Prostatic fluid by Light microscopy
Macrophages [#/area] in Prostatic fluid by Light microscopy
Amyloid bodies [#/area] in Prostatic fluid by Light microscopy
Alveolar macrophages [#/volume] in Lower respiratory specimen by Manual count
Xanthoma cells [#/volume] in Lower respiratory specimen by Manual count
Epithelial cells.ciliated [#/volume] in Lower respiratory specimen by Manual count
Salmonella sp IgA Ab [Units/volume] in Serum
Erythrocytes [#/volume] in Lower respiratory specimen by Manual count
Elastic fibers [#/volume] in Lower respiratory specimen by Manual count
Coral fibers [#/volume] in Lower respiratory specimen by Manual count
Calcified elastic fibers [#/volume] in Lower respiratory specimen by Manual count
Curschmann's spirals and crystals [type] in Lower respiratory specimen by Light microscopy
Spermine [Presence] in Semen by Light microscopy
Connective tissue [Presence] in Stool by Light microscopy
Fatty acid salts [Presence] in Stool by Light microscopy
Salmonella sp IgG Ab [Units/volume] in Serum
Lipoprotein.beta.subparticle.medium [Moles/volume] in Serum
SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing
SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay
Salmonella sp IgM Ab [Units/volume] in Serum
SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method
Mycobacterium tuberculosis stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative
SARS-CoV-2 (COVID-19) S gene codon N501= [Presence] in Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) S gene codon N501Y [Presence] in Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection
Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
Softwood Mix (Beech+Pine+Red cedar+Silver fir) IgE Ab [Units/volume] in Serum by Multidisk
Hardwood Mix (Oak+Mahogany+West Red Cedar+Abachi) IgE Ab [Units/volume] in Serum by Multidisk
Hexacarboxylporphyrins [Moles/volume] in Urine
SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection
Cortisol, glucose, and somatotropin post arginine stimulation panel - Serum or Plasma
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine
Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose arginine
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine
24 hour predicted protein [Mass/time] based on random Urine by calculation
24 hour predicted protein [Mass/time range] based on random Urine by calculation
Cobalamin (Vitamin B12) and folate panel - Serum
Vancomycin IgE Ab [Units/volume] in Serum
Cyanocobalamin IgE Ab [Units/volume] in Serum
White willow IgE Ab [Units/volume] in Serum
Goat milk cheese IgE Ab [Units/volume] in Serum
Sheep milk cheese IgE Ab [Units/volume] in Serum
Piper gurnard IgE Ab [Units/volume] in Serum
Tetracaine IgE Ab [Units/volume] in Serum
Thermoactinomyces candidus IgE Ab [Units/volume] in Serum
1-Naphthol [Mass/volume] in Serum or Plasma
English yew IgE Ab [Units/volume] in Serum
Roxithromycin IgE Ab [Units/volume] in Serum
Propylparaben IgE Ab [Units/volume] in Serum
SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection
2-Methyl-2-Propanol [Mass/volume] in Specimen
Bendiocarb [Mass/volume] in Serum or Plasma
Cadmium [Mass/volume] in Cerebral spinal fluid
Carbaryl [Mass/volume] in Serum or Plasma
Carbofuran [Mass/volume] in Serum or Plasma
SARS-CoV-2 (COVID-19) sequencing and identification panel - Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method
SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection
SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection
Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method
Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel - Specimen
Delta aminolevulinate and porphobilinogen panel - Serum or Plasma
Fodrin alpha subunit IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
Homogenous nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Nucleolar nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Speckled nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Spindle fibers nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Smooth nuclear envelope nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Intercellular bridge nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Nuclear dots nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
PCNA extractable nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Centrosomal nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
Fodrin alpha subunit IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Mercury [Mass/volume] in Cerebral spinal fluid
Propoxur [Mass/volume] in Serum or Plasma
SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine
SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
Cholesterol.in LDL.small dense [Moles/volume] in Serum or Plasma
Varicella zoster virus IgM Ab index [Units/volume] in Serum and CSF
Varicella zoster virus IgG Ab index [Units/volume] in Serum and CSF
Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with probe detection
Grimontia holisae and Vibrio fluvialis and Vibrio harveyi DNA [Identifier] in Specimen by NAA with probe detection
EZH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CARD11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8-Hydroxyloxapine [Mass/volume] in Serum or Plasma
CD79A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CD79B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
MYD88 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
TP53 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
STK11 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PTEN gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
CDH1 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PALB2 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Trisomy 13, trisomy 18 or triploidy risk [Interpretation] in Plasma cell-free+WBC DNA Qualitative by calculation
Comment on overall fetal aneuploidy risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Trisomy 13, trisomy 18 or triploidy risk [Likelihood] in Plasma cell-free+WBC DNA by calculation
Chromosome analysis in Products of Conception by Microarray
Sex [Type] in Products of Conception by Molecular genetics method
SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
PARoxetine [Mass/volume] in Serum or Plasma
Insulin type [Identifier] in Serum or Plasma by LC/MS/MS
Maximum amplitude kaolin+tissue factor induced [Length] in Blood by Resonance TEG
Procaine [Mass/volume] in Serum or Plasma
Maximum amplitude kaolin+tissue factor induced [Length] in Blood
Clot initiation.kaolin induced [Time] in Blood by Resonance TEG --post heparin neutralization
Clot initiation.kaolin+tissue factor induced [Time] in Blood
Activated clotting time.kaolin+tissue factor induced of Blood by calculation
Clot formation kaolin+tissue factor induced [Time] in Blood
Clot angle kaolin+tissue factor induced in Blood
Reduction in kaolin+tissue factor induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude
Reduction in kaolin induced clot strength [Length fraction] in Blood by Resonance TEG --30 minutes post maximum clot amplitude
sulfiSOXAZOLE [Mass/volume] in Serum or Plasma
Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood by Resonance TEG
Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited [Length] in Blood
Fibrinogen [Mass/volume] in Blood by calculation
Maximum amplitude kaolin induced [Length] in Blood --after addition of heparinase
Maximum amplitude activator F induced [Length] in Blood
Maximum amplitude ADP induced [Length] in Blood
Maximum amplitude arachidonate induced [Length] in Blood
Reduction in kaolin induced clot strength [Length fraction] in Blood --30 minutes post maximum clot amplitude
Terbutaline [Mass/volume] in Serum or Plasma
Clot strength arachidonate inhibited [Length fraction] in Blood by calculation
aPTT mixing study panel - Platelet poor plasma
BRAF gene V600 mutations [Identifier] in Tissue by Molecular genetics method Nominal
Phosphatidylserine-prothrombin complex IgG and IgM panel - Serum or Plasma
Trihexyphenidyl [Mass/volume] in Serum or Plasma
Weak D Ag [Presence] on Red Blood Cells from Blood product unit
p53 Ab [Mass/volume] in Serum or Plasma by Immunoassay
Acinetobacter calcoaceticus-baumannii complex DNA [Presence] by NAA with non-probe detection in Positive blood culture
Interferon beta [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 2 [Mass/volume] in Serum or Plasma
Macrophage inflammatory protein 1 alpha [Mass/volume] in Serum or Plasma
Granulocyte macrophage colony stimulating factor [Mass/volume] in Serum or Plasma
Coccidioides immitis IgA Ab [Units/volume] in Serum
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum
SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid
Zygosity [Type] in Fetuses by Molecular genetics method
SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum
Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay
Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay
Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum
Weak D Ag [Presence] on Red Blood Cells from Donor
Shigella boydii Ab [Titer] in Serum by Complement fixation
Shigella dysenteriae Ab [Titer] in Serum by Complement fixation
Shigella flexneri Ab [Titer] in Serum by Complement fixation
Guanidinoacetate [Moles/volume] in Urine
proPSA isoform 2 [Mass/volume] in Serum or Plasma by Immunoassay
Prostate health index in Serum or Plasma by calculation
Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection
HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay
Primidone [Presence] in Urine by Confirmatory method
Shigella sonnei Ab [Titer] in Serum by Complement fixation
Ecgonine methyl ester [Presence] in Urine by Confirmatory method
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification
Cytokeratin 8 Ag [Presence] in Tissue by Immune stain
2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method
Norclobazam [Mass/volume] in Urine by Confirmatory method
Amphetamines panel - Urine by Confirmatory method
Streptococcal hyaluronidase Ab [Titer] in Serum
Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot
Theophylline [Mass/volume] in Serum or Plasma --peak
Triiodothyronine (T3) [Mass/time] in 24 hour Urine
Triiodothyronine (T3) [Moles/time] in 24 hour Urine
Thyroxine (T4) [Mass/time] in 24 hour Urine
Thyroxine (T4) [Moles/time] in 24 hour Urine
Vasopressin [Mass/time] in 24 hour Urine
Vasopressin [Moles/time] in 24 hour Urine
Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay
Adalimumab [Mass/volume] in Serum or Plasma --trough
Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine
Yersinia outer protein Ab panel - Serum by Line blot
Yersinia outer protein M Ab [Presence] in Serum by Line blot
Yersinia outer protein H Ab [Presence] in Serum by Line blot
Yersinia LcrV protein Ab [Presence] in Serum by Line blot
Yersinia outer protein D Ab [Presence] in Serum by Line blot
Yersinia outer protein N Ab [Presence] in Serum by Line blot
Yersinia outer protein P Ab [Presence] in Serum by Line blot
Yersinia outer protein E Ab [Presence] in Serum by Line blot
Yersinia outer protein Ab band pattern [Interpretation] in Serum by Line blot
Muscle relaxants [Presence] in Saliva (oral fluid) by Confirmatory method
Carnitine free and total and acylcarnitine panel - Serum or Plasma
Mephobarbital and PHENobarbital panel - Serum or Plasma
West Nile virus RNA [Presence] in Urine by NAA with probe detection
Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Toxocara canis IgG Ab [Units/volume] in Serum by Immunoassay
Ryanodine receptor Ab [Presence] in Serum by Immunoblot
Alpha-2-Macroglobulin [Mass/volume] in Urine
carBAMazepine [Mass/volume] in Serum or Plasma --peak
carBAMazepine [Moles/volume] in Serum or Plasma --peak
carBAMazepine [Moles/volume] in Serum or Plasma --trough
Phenytoin [Mass/volume] in Serum or Plasma --peak
Phenytoin [Moles/volume] in Serum or Plasma --peak
Phenytoin [Moles/volume] in Serum or Plasma --trough
Toxocara canis IgM Ab [Units/volume] in Serum by Immunoassay
quiNIDine [Moles/volume] in Serum or Plasma --peak
quiNIDine [Moles/volume] in Serum or Plasma --trough
Hemolysis interference index of Cerebral spinal fluid
Icteric interference index of Cerebral spinal fluid
Lipemic interference index of Cerebral spinal fluid
Tropheryma whipplei DNA [Presence] in Blood by NAA with non-probe detection
Tropheryma whipplei DNA [Presence] in Specimen by NAA with non-probe detection
6-monoacetylmorphine free [Presence] in Cord tissue by Screen method
6-monoacetylmorphine free [Presence] in Cord tissue by Confirmatory method
7-Aminoclonazepam [Presence] in Cord tissue by Screen method
7-Aminoclonazepam [Presence] in Cord tissue by Confirmatory method
Acetyl fentanyl [Presence] in Cord tissue by Screen method
Acetyl fentanyl [Presence] in Cord tissue by Confirmatory method
Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Screen method
Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Confirmatory method
ALPRAZolam [Presence] in Cord tissue by Screen method
ALPRAZolam [Presence] in Cord tissue by Confirmatory method
Smith extractable nuclear Ab [Titer] in Serum
Amphetamine [Presence] in Cord tissue by Screen method
Amphetamine [Presence] in Cord tissue by Confirmatory method
Benzoylecgonine [Presence] in Cord tissue by Screen method
Benzoylecgonine [Presence] in Cord tissue by Confirmatory method
Butalbital [Presence] in Cord tissue by Screen method
Butalbital [Presence] in Cord tissue by Confirmatory method
Carisoprodol [Presence] in Cord tissue by Screen method
Carisoprodol [Presence] in Cord tissue by Confirmatory method
chlordiazePOXIDE [Presence] in Cord tissue by Screen method
chlordiazePOXIDE [Presence] in Cord tissue by Confirmatory method
clonazePAM [Presence] in Cord tissue by Screen method
clonazePAM [Presence] in Cord tissue by Confirmatory method
Cocaethylene [Presence] in Cord tissue by Screen method
Cocaethylene [Presence] in Cord tissue by Confirmatory method
Cocaine [Presence] in Cord tissue by Screen method
Cocaine [Presence] in Cord tissue by Confirmatory method
Codeine Free [Presence] in Cord tissue by Screen method
Codeine Free [Presence] in Cord tissue by Confirmatory method
Spermatozoa IgA Ab [Units/volume] in Serum
N-desalkylflurazepam [Presence] in Cord tissue by Screen method
N-desalkylflurazepam [Presence] in Cord tissue by Confirmatory method
diazePAM [Presence] in Cord tissue by Screen method
diazePAM [Presence] in Cord tissue by Confirmatory method
Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Screen method
Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Confirmatory method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Screen method
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Confirmatory method
Spermatozoa IgG Ab [Units/volume] in Serum
Ethylone [Presence] in Cord tissue by Screen method
Ethylone [Presence] in Cord tissue by Confirmatory method
fentaNYL [Presence] in Cord tissue by Screen method
fentaNYL [Presence] in Cord tissue by Confirmatory method
Flunitrazepam [Presence] in Cord tissue by Screen method
Flunitrazepam [Presence] in Cord tissue by Confirmatory method
Flurazepam [Presence] in Cord tissue by Screen method
Spermatozoa IgM Ab [Units/volume] in Serum
Flurazepam [Presence] in Cord tissue by Confirmatory method
HYDROcodone Free [Presence] in Cord tissue by Screen method
HYDROcodone Free [Presence] in Cord tissue by Confirmatory method
HYDROmorphone Free [Presence] in Cord tissue by Screen method
HYDROmorphone Free [Presence] in Cord tissue by Confirmatory method
Hydroxytriazolam [Presence] in Cord tissue by Screen method
Hydroxytriazolam [Presence] in Cord tissue by Confirmatory method
LORazepam [Presence] in Cord tissue by Screen method
LORazepam [Presence] in Cord tissue by Confirmatory method
Methylenedioxyamphetamine [Presence] in Cord tissue by Screen method
Methylenedioxyamphetamine [Presence] in Cord tissue by Confirmatory method
Methylenedioxyethylamphetamine [Presence] in Cord tissue by Screen method
Methylenedioxyethylamphetamine [Presence] in Cord tissue by Confirmatory method
Methylenedioxymethamphetamine [Presence] in Cord tissue by Screen method
Methylenedioxymethamphetamine [Presence] in Cord tissue by Confirmatory method
Meperidine [Presence] in Cord tissue by Screen method
Meperidine [Presence] in Cord tissue by Confirmatory method
Meprobamate [Presence] in Cord tissue by Screen method
Meprobamate [Presence] in Cord tissue by Confirmatory method
Methadone [Presence] in Cord tissue by Screen method
Methadone [Presence] in Cord tissue by Confirmatory method
Methamphetamine [Presence] in Cord tissue by Screen method
Methamphetamine [Presence] in Cord tissue by Confirmatory method
Methylone [Presence] in Cord tissue by Screen method
Methylone [Presence] in Cord tissue by Confirmatory method
Midazolam [Presence] in Cord tissue by Screen method
Eosinophils/100 leukocytes in Nose by Manual count
Midazolam [Presence] in Cord tissue by Confirmatory method
Morphine Free [Presence] in Cord tissue by Screen method
Morphine Free [Presence] in Cord tissue by Confirmatory method
Nordiazepam [Presence] in Cord tissue by Screen method
Nordiazepam [Presence] in Cord tissue by Confirmatory method
Norfentanyl [Presence] in Cord tissue by Screen method
Norfentanyl [Presence] in Cord tissue by Confirmatory method
Norhydrocodone [Presence] in Cord tissue by Screen method
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
Norhydrocodone [Presence] in Cord tissue by Confirmatory method
Normeperidine [Presence] in Cord tissue by Screen method
Normeperidine [Presence] in Cord tissue by Confirmatory method
Noroxycodone [Presence] in Cord tissue by Screen method
Noroxycodone [Presence] in Cord tissue by Confirmatory method
O-nortramadol [Presence] in Cord tissue by Screen method
O-nortramadol [Presence] in Cord tissue by Confirmatory method
Oxazepam [Presence] in Cord tissue by Confirmatory method
Canary serum proteins IgE Ab [Units/volume] in Serum
oxyCODONE Free [Presence] in Cord tissue by Screen method
oxyMORphone Free [Presence] in Cord tissue by Screen method
oxyMORphone Free [Presence] in Cord tissue by Confirmatory method
Phencyclidine [Presence] in Cord tissue by Screen method
Phencyclidine [Presence] in Cord tissue by Confirmatory method
PHENobarbital [Presence] in Cord tissue by Screen method
PHENobarbital [Presence] in Cord tissue by Confirmatory method
Tapentadol [Presence] in Cord tissue by Screen method
Pentacarboxylporphyrins [Mass/time] in 24 hour Urine
Tapentadol [Presence] in Cord tissue by Confirmatory method
Temazepam [Presence] in Cord tissue by Screen method
Temazepam [Presence] in Cord tissue by Confirmatory method
traMADol [Presence] in Cord tissue by Screen method
traMADol [Presence] in Cord tissue by Confirmatory method
Triazolam [Presence] in Cord tissue by Screen method
Triazolam [Presence] in Cord tissue by Confirmatory method
Zolpidem [Presence] in Cord tissue by Screen method
Phosphoethanolamine [Mass/time] in 24 hour Urine
Zolpidem [Presence] in Cord tissue by Confirmatory method
Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with probe detection
Salmonella sp DNA [Presence] in Stool by NAA with probe detection
Vibrio cholerae DNA [Presence] in Stool by NAA with probe detection
Vibrio parahaemolyticus DNA [Presence] in Stool by NAA with probe detection
Vibrio vulnificus DNA [Presence] in Stool by NAA with probe detection
Escherichia coli enteroaggregative DNA [Presence] in Stool by NAA with probe detection
Escherichia coli enteropathogenic DNA [Presence] in Stool by NAA with probe detection
Escherichia coli enterotoxigenic DNA [Presence] in Stool by NAA with probe detection
Escherichia coli O157 DNA [Presence] in Stool by NAA with probe detection
Cyclospora cayetanensis DNA [Presence] in Stool by NAA with probe detection
Oxazepam [Presence] in Cord tissue by Screen method
oxyCODONE Free [Presence] in Cord tissue by Confirmatory method
Carbapenem resistant bacteria identification and resistance panel by Molecular genetics method
Staphylococcus aureus VNTR pattern [Type] in Isolate or Specimen by Molecular genetics method
Staphylococcus aureus identification and resistance panel by Molecular genetics method
Phosphoserine [Mass/time] in 24 hour Urine
Alpha 1 globulin [Mass/volume] in Urine by Electrophoresis
Uroporphyrin/Porphyrins.total in 24 hour Stool
Allopurinol [Mass/volume] in Serum or Plasma
Propoxyphene [Mass/volume] in Gastric fluid
D Ab [Presence] in Serum or Plasma from Blood product unit
Gabapentin [Mass/volume] in Serum, Plasma or Blood
Neopterin [Moles/volume] in Serum or Plasma
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
Isoleucine [Mass/volume] in Cerebral spinal fluid
Beta globulin [Mass/volume] in Urine by Electrophoresis
Gamma globulin [Mass/volume] in Urine by Electrophoresis
D Ab [Presence] in Serum or Plasma from Donor
Dantrolene [Mass/volume] in Serum or Plasma
Dapsone [Mass/volume] in Serum or Plasma
Hemoglobin F [Units/volume] in Blood by Electrophoresis
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation
Prion disease biomarker panel - Cerebral spinal fluid
Abnormal Prion Protein [Presence] in Cerebral spinal fluid
Average glucose [Mass/volume] in Interstitial fluid during Reporting Period
Glucose measurements in range out of Total glucose measurements during reporting period
Fungal Ab panel - Specimen by Immune diffusion (ID)
Rabies virus IgM Ab [Presence] in Specimen by Immunofluorescence
Campylobacter sp [Presence] in Specimen by Organism specific culture
Entamoeba moshkovskii DNA [Presence] in Specimen by NAA with probe detection
Entamoeba bangladeshi DNA [Presence] in Specimen by NAA with probe detection
Acanthamoeba sp Ab [Presence] in Specimen by Immunofluorescence
Rabies virus IgG Ab [Presence] in Specimen by Immunofluorescence
Paracoccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID)
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Blastomyces sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID)
Histoplasma capsulatum mycelial phase Ab band pattern [Identifier] in Specimen by Immune diffusion (ID)
Coccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID)
Giardia sp [Presence] in Water by Immunofluorescence
Hepatitis A virus RNA [Presence] in Specimen by NAA with probe detection
Cryptosporidium sp [Presence] in Water by Immunofluorescence
Norovirus genogroup I RNA [Presence] in Specimen by NAA with probe detection
Balamuthia mandrillaris Ag [Presence] in Specimen by Immunofluorescence
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Acanthamoeba sp Ag [Presence] in Specimen by Immunofluorescence
Naegleria fowleri Ag [Presence] in Specimen by Immunofluorescence
Naegleria fowleri [Presence] in Specimen by Organism specific culture
Naegleria fowleri Ab [Presence] in Specimen by Immunofluorescence
Balamuthia mandrillaris Ab [Presence] in Specimen by Immunofluorescence
Norovirus genogroup II RNA [Presence] in Specimen by NAA with probe detection
Somatotropin post glucose stimulation panel - Serum or Plasma
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post dose glucose
Coxsackievirus A2 Ab [Titer] in Serum by Complement fixation
pH of Central venous blood adjusted to patient's actual temperature
Carbon dioxide [Partial pressure] in Central venous blood
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Central venous blood
Oxygen [Partial pressure] in Central venous blood
Oxygen [Partial pressure] adjusted to patient's actual temperature in Central venous blood
Coxsackievirus A4 Ab [Titer] in Serum by Complement fixation
Bicarbonate [Moles/volume] in Central venous blood
Bicarbonate [Moles/volume] standard in Central venous blood
Carbon dioxide, total [Moles/volume] in Central venous blood
Base excess in Central venous blood by calculation
Base excess standard in Central venous blood
Oxygen saturation in Central venous blood
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation
Hemoglobin [Mass/volume] in Central venous blood by calculation
Carboxyhemoglobin/Hemoglobin.total in Central venous blood
Fractional oxyhemoglobin in Central venous blood
Deoxyhemoglobin/Hemoglobin.total in Central venous blood
Methemoglobin/Hemoglobin.total in Central venous blood
Hemoglobin [Mass/volume] in Central venous blood by Oximetry
Hemoglobin [Mass/volume] in Capillary blood by Oximetry
Gastrointestinal dysmotility autoimmune Ab panel - Serum
Acetylcholine receptor binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
Acetylcholine receptor ganglionic neuronal IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
Voltage-gated potassium channel IgG+IgM Ab [Moles/volume] in Serum by Immunoassay
Necrotizing myopathy autoimmune Ab panel - Serum
Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Signal Recognition Particle (SRP) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
B-cell primary immunodeficiency multigene analysis in Blood or Tissue by Molecular genetics method
Myasthenia gravis and Lambert-Eaton syndrome autoimmune Ab panel - Serum
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation
Buprenorphine free [Presence] in Cord tissue by Screen method
Buprenorphine free [Presence] in Cord tissue by Confirmatory method
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Screen method
Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method
Tetrahydrocannabinol [Presence] in Cord tissue by Screen method
Tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method
Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Screen method
Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Confirmatory method
Norbuprenorphine free [Presence] in Cord tissue by Screen method
Norbuprenorphine free [Presence] in Cord tissue by Confirmatory method
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Lower respiratory specimen by Flow cytometry (FC)
CD3 cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
CD3+CD4+ (T4 helper) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
CD3+CD8+ (T8 suppressor) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
CD19 cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
CD3-CD16+CD56+ (Natural killer) cells/100 lymphocytes in Lower respiratory specimen by Flow cytometry (FC)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Lower respiratory specimen by Flow cytometry (FC)
Cefonicid [Susceptibility] by Disk diffusion (KB)
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid by Complement fixation
CD45 (Lymphs) cells [#/volume] in Lower respiratory specimen by Flow cytometry (FC)
Microorganism of interest sequence [Presence] in Specimen
Glial fibrillary acidic protein and Ubiquitin carboxyl-terminal hydrolase-L1 panel - Plasma
Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1 [Interpretation] in Plasma Qualitative
Glial fibrillary acidic protein [Mass/volume] in Plasma by Immunoassay
Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Plasma by Immunoassay
Joint pathogens panel - Synovial fluid by NAA with non-probe detection
Anaerococcus prevotii+vaginalis DNA [Presence] in Synovial fluid by NAA with non-probe detection
D Ag [Presence] on Red Blood Cells from Blood product unit
Bacteroides fragilis DNA [Presence] in Synovial fluid by NAA with non-probe detection
Candida albicans DNA [Presence] in Synovial fluid by NAA with non-probe detection
Candida sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Citrobacter sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Clostridium perfringens [Presence] in Synovial fluid by NAA with non-probe detection
Cutibacterium avidum+granulosum DNA [Presence] in Synovial fluid by NAA with non-probe detection
Enterobacter cloacae complex DNA [Presence] in Synovial fluid by NAA with non-probe detection
Enterococcus faecalis DNA [Presence] in Synovial fluid by NAA with non-probe detection
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Enterococcus faecium DNA [Presence] in Synovial fluid by NAA with non-probe detection
Escherichia coli DNA [Presence] in Synovial fluid by NAA with non-probe detection
Finegoldia magna DNA [Presence] in Synovial fluid by NAA with non-probe detection
Haemophilus influenzae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Kingella kingae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Klebsiella aerogenes DNA [Presence] in Synovial fluid by NAA with non-probe detection
Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Morganella morganii DNA [Presence] in Synovial fluid by NAA with non-probe detection
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Neisseria gonorrhoeae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Parvimonas micra DNA [Presence] in Synovial fluid by NAA with non-probe detection
Peptoniphilus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Peptostreptococcus anaerobius DNA [Presence] in Synovial fluid by NAA with non-probe detection
Proteus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Pseudomonas aeruginosa DNA [Presence] in Synovial fluid by NAA with non-probe detection
Salmonella sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Serratia marcescens DNA [Presence] in Synovial fluid by NAA with non-probe detection
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid by Complement fixation
Staphylococcus aureus DNA [Presence] in Synovial fluid by NAA with non-probe detection
Staphylococcus lugdunensis DNA [Presence] in Synovial fluid by NAA with non-probe detection
Streptococcus agalactiae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Streptococcus pneumoniae DNA [Presence] in Synovial fluid by NAA with non-probe detection
Streptococcus pyogenes DNA [Presence] in Synovial fluid by NAA with non-probe detection
Streptococcus sp DNA [Presence] in Synovial fluid by NAA with non-probe detection
Thyroglobulin [Moles/volume] in Tissue fine needle aspirate
dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay --post DOAC neutralization
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid by Complement fixation
dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay
Barmah forest virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
Barmah forest virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Parainfluenza virus 1+2+3+4 RNA [Presence] in Specimen by NAA with probe detection
Lassa virus RNA [Presence] in Specimen by NAA with probe detection
Asenapine [Presence] in Urine by Confirmatory method
Iloperidone [Presence] in Urine by Confirmatory method
2-Amino-5-chloropyridine [Presence] in Urine by Confirmatory method
Desmethylcyclobenzaprine [Presence] in Urine by Confirmatory method
Pigeon serum IgG Ab [Mass/volume] in Serum
Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Mass/volume] in Serum by Multidisk
Asian Hornet IgE Ab [Units/volume] in Serum
SMN2 gene copy number in Blood or Tissue by Molecular genetics method
Hereditary breast and gynecologic cancer multigene analysis in Blood or Tissue by Molecular genetics method
Hereditary cancer multigene analysis in Blood or Tissue by Molecular genetics method
Vancomycin [Mass/volume] in Serum or Plasma --2 hours post dose
2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in Urine
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunofluorescence
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunofluorescence
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
CD5+CD20+ cells [#/volume] in Leukocytes
Xylose [Mass/volume] in Blood --1 hour post 25 g xylose PO
Enterovirus VP1 gene [Nucleotide sequence] in Isolate by Sequencing
Ergotamine [Mass/volume] in Serum or Plasma
Influenza virus types A and B and subtypes RNA panel - Specimen by NAA with probe detection
Metoclopramide [Mass/volume] in Serum or Plasma
Estradiol (E2) [Moles/volume] in Aspirate
Estradiol (E2) [Mass/volume] in Aspirate
Cancer Ag 125 [Units/volume] in Aspirate
Enolase.neuron specific [Mass/volume] in Aspirate
Alpha-1-Fetoprotein [Units/volume] in Aspirate
Alpha-1-Fetoprotein [Mass/volume] in Aspirate
Carcinoembryonic Ag [Mass/volume] in Aspirate
Cytokeratin 19 [Mass/volume] in Aspirate
Cancer Ag 15-3 [Units/volume] in Aspirate
Cancer Ag 19-9 [Units/volume] in Aspirate
Amiodarone+Desethylamiodarone [Moles/volume] in Serum or Plasma
Herpes virus 6 DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
Androstenedione [Mass/volume] in Body fluid
Androstenedione [Moles/volume] in Body fluid
Moricizine [Mass/volume] in Serum or Plasma
Fungus and Mycobacterium sp identified in Blood by Organism specific culture
Magnesium and phosphate and lactate panel - Serum or Plasma
MLH1 gene methylation analysis in Blood by Molecular genetics method
MLH1 gene methylation analysis in Tumor by Molecular genetics method
Parathyrin.intact [Moles/volume] in Body fluid
Beta 2 globulin/Protein.total in 24 hour Urine by Electrophoresis
Beta 1 globulin/Protein.total in 24 hour Urine by Electrophoresis
Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone PO overnight
Norchlordiazepoxide [Mass/volume] in Serum or Plasma
IgG subclass 2 [Mass/volume] in Body fluid
IgG subclass 4 [Mass/volume] in Body fluid
Artifact [#/area] in Urine sediment by Light microscopy
Nucleated erythrocytes [#/volume] in Cord blood
Bilirubin.total [Moles/volume] in Capillary blood
Protein.monoclonal band 1 [Mass/volume] in 24 hour Urine by Electrophoresis
Protein.monoclonal band 1 [Mass/volume] in Urine by Electrophoresis
Base excess standard in Arterial cord blood by calculation
Base excess standard in Venous cord blood by calculation
Base excess standard in Cord blood by calculation
Urea [Moles/volume] in Dialysis fluid --1 hour specimen
Creatinine [Moles/volume] in Dialysis fluid --1 hour specimen
Glucose [Moles/volume] in Dialysis fluid --1 hour specimen
Sodium [Moles/volume] in Dialysis fluid --1 hour specimen
Sodium [Moles/volume] in Dialysis fluid --2 hour specimen
Sodium [Moles/volume] in Dialysis fluid --4 hour specimen
Phenelzine [Mass/volume] in Serum or Plasma
D Ag [Presence] on Red Blood Cells from Donor
quiNIDine Free [Mass/volume] in Serum or Plasma
Acanthamoeba sp identified in Specimen by Organism specific culture
Adenovirus sp identified in Specimen by Organism specific culture
Ehrlichia chaffeensis IgG Ab [Titer] in Serum
Ehrlichia chaffeensis IgM Ab [Titer] in Serum
Anticomplementary activity [Titer] in Specimen by Complement fixation
Paracoccidioides sp Ab [Titer] in Specimen by Complement fixation
Blastomyces sp Ab [Titer] in Specimen by Complement fixation
Histoplasma capsulatum yeast phase Ab [Titer] in Specimen by Complement fixation
Histoplasma capsulatum mycelial phase Ab [Titer] in Specimen by Complement fixation
Coccidioides sp Ab [Titer] in Specimen by Complement fixation
Fungal Ab panel - Specimen by Complement fixation
HIV 1 Ab panel - Serum or Plasma by Immunoblot
HIV 2 Ab panel - Serum or Plasma by Immunoblot
Herpes virus 8 IgG and IgM panel - Serum or Plasma
Herpes virus 8 IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
Parainfluenza virus 1 and 2 and 3 Ab panel - Serum or Plasma
Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain
Chikungunya virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Chikungunya virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
Yellow fever virus Ab panel - Serum or Plasma
Zika virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
Hantavirus IgG and IgM panel - Serum or Plasma
Sarcoptes scabiei identified in Skin by Light microscopy
Herpes virus 8 IgM Ab [Presence] in Serum or Plasma
Carbamate pesticides [Type] in Serum or Plasma
Methyl bromide [Mass/volume] in Serum or Plasma
Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method
Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method --after addition of factor VIII Ab
Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic method
Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic method --after addition of factor VIII Ab
Time to thrombin peak in Platelet poor plasma by Chromogenic method
Organochlorine pesticides [Type] in Serum or Plasma
Thrombin generation test panel - Platelet poor plasma
Coccidioides sp DNA [Presence] in Specimen by NAA with probe detection
Oropouche virus RNA [Presence] in Specimen by NAA with probe detection
Rift valley fever virus RNA [Presence] in Specimen by NAA with probe detection
Bwamba virus RNA [Presence] in Specimen by NAA with probe detection
Tick-borne encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Bunyamwera virus RNA [Presence] in Specimen by NAA with probe detection
California encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Organophosphate pesticides [Identifier] in Blood
Sandfly fever Naples virus RNA [Presence] in Specimen by NAA with probe detection
Jamestown canyon virus RNA [Presence] in Specimen by NAA with probe detection
Barmah forest virus RNA [Presence] in Specimen by NAA with probe detection
Snowshoe hare virus RNA [Presence] in Specimen by NAA with probe detection
Tahyna virus RNA [Presence] in Specimen by NAA with probe detection
Highlands J virus RNA [Presence] in Specimen by NAA with probe detection
Ross River virus RNA [Presence] in Specimen by NAA with probe detection
Sindbis virus RNA [Presence] in Specimen by NAA with probe detection
Trichloroethylene [Mass/volume] in Urine
Mayaro virus RNA [Presence] in Specimen by NAA with probe detection
Colorado tick fever virus RNA [Presence] in Specimen by NAA with probe detection
Sandfly fever Sicilian virus RNA [Presence] in Specimen by NAA with probe detection
Toscana virus RNA [Presence] in Specimen by NAA with probe detection
Bourbon virus RNA [Presence] in Specimen by NAA with probe detection
Candida auris DNA [Presence] in Specimen by NAA with probe detection
Color.reverse pigment [Type] in Isolate by Culture
Medium induced in vitro yeast conversion [Identifier] in Isolate by Culture
Cryptococcus sp [Presence] in Isolate by Organism specific culture
Cycloheximide [Susceptibility] in Isolate Qualitative
Texture.yeast colony [Type] in Isolate by Culture
Color.yeast colony [Type] in Isolate by Culture
Color.yeast colony [Type] in Isolate by Culture--with canavanine glycine+bromothymol blue
Color.mold colony [Type] in Isolate by Culture
Color.fungal colony [Type] in Isolate by Culture--with Chromogenic agar
Rocio virus RNA [Presence] in Specimen by NAA with probe detection
Ilheus virus RNA [Presence] in Specimen by NAA with probe detection
Semliki Forest virus RNA [Presence] in Specimen by NAA with probe detection
Di sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Onyong-nyong virus RNA [Presence] in Specimen by NAA with probe detection
Venezuelan equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection
Rhinovirus+Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAA with probe detection
European Hornet IgG4 Ab [Mass/volume] in Serum
London Plane IgG4 Ab [Mass/volume] in Serum
Silver Birch recombinant (rBet v) 1 IgG4 Ab [Mass/volume] in Serum
Olive pollen native (nOle e) 1 IgG4 Ab [Mass/volume] in Serum
European Ash IgG4 Ab [Mass/volume] in Serum
Grey Alder IgG4 Ab [Mass/volume] in Serum
Silver Birch IgG4 Ab [Mass/volume] in Serum
Pellitory (Parietaria judaica) IgG4 Ab [Mass/volume] in Serum
Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgG4 Ab [Mass/volume] in Serum
European house dust mite recombinant (rDer p) 2 IgG4 Ab [Mass/volume] in Serum
Chicken droppings IgG4 Ab [Mass/volume] in Serum
Ovalbumin IgG4 Ab [Mass/volume] in Serum
Ovomucoid IgG4 Ab [Mass/volume] in Serum
Turkey meat IgG4 Ab [Mass/volume] in Serum
Conalbumin IgG4 Ab [Mass/volume] in Serum
Peanut recombinant (rAra h) 8 IgG4 Ab [Mass/volume] in Serum
Peanut recombinant (rAra h) 1 IgG4 Ab [Mass/volume] in Serum
Peanut recombinant (rAra h) 2 IgG4 Ab [Mass/volume] in Serum
Peanut recombinant (rAra h) 3 IgG4 Ab [Mass/volume] in Serum
Codfish recombinant (rGad c) 1 IgG4 Ab [Mass/volume] in Serum
Peanut recombinant (rAra h) 9 IgG4 Ab [Mass/volume] in Serum
Apple recombinant (rMal d) 1 IgG4 Ab [Mass/volume] in Serum
Apple recombinant (rMal d) 3 IgG4 Ab [Mass/volume] in Serum
Hazelnut recombinant (rCor a) 14 IgG4 Ab [Mass/volume] in Serum
Hazelnut recombinant (rCor a) 9 IgG4 Ab [Mass/volume] in Serum
Cultivated Corn IgG4 Ab [Mass/volume] in Serum
Timothy recombinant (rPhl p) 1 IgG4 Ab [Mass/volume] in Serum
Timothy recombinant (rPhl p) 1 + 5b IgG4 Ab [Mass/volume] in Serum
Honey bee phospholipase A2 recombinant (rApi m) 1 IgG4 Ab [Mass/volume] in Serum
Common wasp recombinant (rVes v) 5 IgG4 Ab [Mass/volume] in Serum
Honey bee recombinant (rApi m) 10 IgG4 Ab [Mass/volume] in Serum
Chicken meat IgG4 Ab [Mass/volume] in Serum
Culex mosquito IgG4 Ab [Mass/volume] in Serum
von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Immunoassay
Herpes virus 6 IgG Ab [Units/volume] in Serum by Immunofluorescence
Herpes virus 6 IgM Ab [Presence] in Serum by Immunofluorescence
Epstein Barr virus early IgM Ab [Titer] in Serum by Immunofluorescence
Platelets Large/Platelets in Blood by Automated count.optical
Platelets [#/volume] in Blood by Automated count.optical
Myeloperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
HPA and HLA Ab [Interpretation] in Serum, Plasma or Blood Narrative
HLA-DP and DQ and DR (class II) IgG donor specific [Identifier] in Serum or Plasma
HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by High resolution
HLA-DP and DQ and DR (class II) [Type] by Low resolution
HLA-A and B and C (class I) [Type] by Low resolution
HLA-A and B and C (class I) IgG donor specific [Identifier] in Serum or Plasma
HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type]
HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by Low resolution
HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) Ab [Identifier] in Serum or Plasma
B cell+T cell crossmatch [Interpretation] Narrative
Plasma cell proliferation analysis in Bone marrow by FISH
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge
Fat [#/area] in Urine sediment by Microscopy high power field
Megakaryocytes [#/volume] in Bone marrow by Manual count
Megakaryoblasts/100 cells in Bone marrow by Manual count
Promegakaryocytes/100 cells in Bone marrow by Manual count
Leukocytes [#/volume] in Lower respiratory specimen by Manual count
Abnormal lymphocytes [Presence] in Body fluid by Manual count
Epithelial cells [#/area] in Cervical or vaginal smear or scraping by Light microscopy
Lecithin [#/area] in Prostatic fluid by Manual count
Fungus [Identifier] in Prostatic fluid by Fungus stain
Parasite identified in Prostatic fluid by Light microscopy
Lecithin [Presence] in Semen by Light microscopy
Crystals [type] in Semen by Light microscopy
Crystals [type] in Stool by Light microscopy
Di sup(a) Ab [Presence] in Serum or Plasma from Donor
Natural killer cell cytotoxicity.IL-2 stimulated panel - Blood mononuclear cells by Flow cytometry (FC)
Jewish descent preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method
CFTR and FMR1 (CGG repeat) and SMN1 gene mutation analysis in Blood or Tissue by Molecular genetics method
Preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method
Cortisone IgE Ab [Units/volume] in Serum
Chanterelles IgE Ab [Units/volume] in Serum
5-Aminosalicylate IgE Ab [Units/volume] in Serum
Lincomycin IgE Ab [Units/volume] in Serum
Lipoxygenase IgE Ab [Units/volume] in Serum
Levothyroxine IgE Ab [Units/volume] in Serum
European roe venison IgE Ab [Units/volume] in Serum
Microsporum canis IgE Ab [Units/volume] in Serum
Minocycline IgE Ab [Units/volume] in Serum
Mouse droppings IgE Ab [Units/volume] in Serum
Oxacillin IgE Ab [Units/volume] in Serum
Penicillium digitatum IgE Ab [Units/volume] in Serum
Penicillium expansum IgE Ab [Units/volume] in Serum
Gilt-head bream IgE Ab [Units/volume] in Serum
Penicillamine IgE Ab [Units/volume] in Serum
2,4-Dichlorophenoxyacetate [Mass/volume] in Urine
Wild garlic (Allium ursinum) IgE Ab [Units/volume] in Serum
Beta-lactam resistance ESBL blaCTX-M-15 gene [Presence] by Molecular method
Beta-lactam resistance ESBL blaCTX-M-14 gene [Presence] by Molecular method
Carbapenem resistance blaOXA-143 gene [Presence] by Molecular method
Colistin resistance mcr-3+mcr-4+mcr-5 genes [Presence] by Molecular method
SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay
Natural killer and natural killer T cell subsets panel - Blood
Chlordane [Mass/volume] in Serum or Plasma
SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection
Cytomegalovirus DNA [#/volume] (viral load) in Saliva (oral fluid) by NAA with probe detection
Phenothiazines [Presence] in Gastric fluid
Propoxyphene [Presence] in Gastric fluid
Interleukin 33 [Mass/volume] in Serum or Plasma
Thymic stromal lymphopoietin [Mass/volume] in Serum or Plasma
Interleukin 17F [Mass/volume] in Serum or Plasma
Interleukin 21 [Mass/volume] in Serum or Plasma
Interleukin 22 [Mass/volume] in Serum or Plasma
Interleukin 23 [Mass/volume] in Serum or Plasma
Chemokine (C-X-C motif) ligand 10 [Mass/volume] in Serum, Plasma or Blood
Interleukin 9 [Mass/volume] in Serum or Plasma
Interleukin 15 [Mass/volume] in Serum or Plasma
Interleukin 16 [Mass/volume] in Serum or Plasma
Brain-derived neurotrophic factor [Mass/volume] in Serum or Plasma
Macrophage colony-stimulating factor [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 11 [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 8 [Mass/volume] in Serum or Plasma
Di sup(a) Ab [Presence] in Serum or Plasma
Chemokine (C-C motif) ligand 7 [Mass/volume] in Serum or Plasma
Chromogranin A [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 4 [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 20 [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 5 [Mass/volume] in Serum or Plasma
Chemokine (C-X3-C motif) ligand 1 [Mass/volume] in Serum or Plasma
Chemokine (C-X-C motif) ligand 9 [Mass/volume] in Serum or Plasma
Chemokine (C-C motif) ligand 27 [Mass/volume] in Serum or Plasma
Fibroblast growth factor 2 [Mass/volume] in Serum or Plasma
Vascular endothelial growth factor C [Mass/volume] in Serum or Plasma
Angiopoietin receptor 2 [Mass/volume] in Serum or Plasma
Intercellular adhesion molecule 1 [Mass/volume] in Serum or Plasma
Protein/Creatinine Qualitative in Urine by Test strip
Neutrophil.fMLP and PMA stimulated DHR panel by Flow cytometry (FC)
Neutrophil.fMLP stimulated DHR panel by Flow cytometry (FC)
Neutrophil.PMA stimulated DHR panel by Flow cytometry (FC)
Intravascular coagulation and fibrinolysis panel
Zimnitsky urine concentration panel - Urine
Normoblasts oxyphilic+polychromatophilic/Normoblasts.total in Bone marrow by Manual count
Neutrophils.immature/Neutrophils.segmented [Ratio] in Bone marrow by Manual count
Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen
SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory system specimen by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory system specimen by NAA with probe detection
Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen
Dextroamphetamine [Mass/volume] in Serum or Plasma
Lithium [Mass/volume] in Red Blood Cells
Actinomyces sp identified in Specimen by Organism specific culture
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay
Thyroxine (T4) free [Moles/volume] in Cord blood
Wild boar dander IgE Ab [Units/volume] in Serum
Acetylcysteine IgE Ab [Units/volume] in Serum
Cryptococcus sp Ag [Titer] in Serum by Immunoassay
Aspartame IgE Ab [Units/volume] in Serum
Aspergillus repens IgE Ab [Units/volume] in Serum
Bacampicillin IgE Ab [Units/volume] in Serum
Benzocaine IgE Ab [Units/volume] in Serum
Bromhexine IgE Ab [Units/volume] in Serum
Azlocillin IgE Ab [Units/volume] in Serum
Cephalothin IgE Ab [Units/volume] in Serum
Wax begonia IgE Ab [Units/volume] in Serum
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination
Hibiscus tea IgE Ab [Units/volume] in Serum
Diatrizoate IgE Ab [Units/volume] in Serum
Echinacea IgE Ab [Units/volume] in Serum
EPINEPHrine IgE Ab [Units/volume] in Serum
Erythrosine B IgE Ab [Units/volume] in Serum
Phenacetin IgE Ab [Units/volume] in Serum
Paraphenylenediamine IgE Ab [Units/volume] in Serum
Fuchsia spp IgE Ab [Units/volume] in Serum
Cryptococcus sp Ag [Titer] in Serum by Latex agglutination
Borrelia burgdorferi IgG and IgM bands panel - Serum by Immunoblot
Borrelia burgdorferi IgG and IgM and total panel - Serum by Immunoassay
Borrelia burgdorferi 21kD IgG Ab [Presence] in Serum by Immunoblot
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoassay
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
Legionella pneumophila IgG and IgM panel - Serum
Legionella pneumophila IgM Ab [Presence] in Serum by Immunoassay
Salmonella species antibody panel - Serum by Agglutination
Reagin Ab and Treponema pallidum IgG and IgM and total panel - Serum
Treponema pallidum IgG and IgM and bands panel - Serum by Immunoblot
Reagin Ab and Treponema pallidum IgG and IgM and total panel - Cerebral spinal fluid
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunoassay
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Treponema pallidum IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Treponema pallidum IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Treponema pallidum IgG and IgM and bands panel - Cerebral spinal fluid by Immunoblot
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
Treponema pallidum IgG bands [Identifier] in Serum by Immunoblot
Treponema pallidum IgG bands [Identifier] in Cerebral spinal fluid by Immunoblot
Treponema pallidum IgM bands [Identifier] in Serum by Immunoblot
Treponema pallidum IgM bands [Identifier] in Cerebral spinal fluid by Immunoblot
Piperacillin IgE Ab [Units/volume] in Serum
prednisoLONE IgE Ab [Units/volume] in Serum
Prilocaine IgE Ab [Units/volume] in Serum
Bacteria identified in Dialysis fluid by Culture
Ofloxacin IgE Ab [Units/volume] in Serum
Corn starch IgE Ab [Units/volume] in Serum
Sorbic acid IgE Ab [Units/volume] in Serum
St. John's wort IgE Ab [Units/volume] in Serum
Cape gooseberry IgE Ab [Units/volume] in Serum
Quail meat IgE Ab [Units/volume] in Serum
Wild boar meat IgE Ab [Units/volume] in Serum
Mycobacterium sp identified in Bronchial specimen by Organism specific culture
Norfloxacin IgE Ab [Units/volume] in Serum
Chemokine (C-X-C motif) ligand 1 [Mass/volume] in Serum or Plasma
Platelet-derived growth factor B+BB [Mass/volume] in Serum or Plasma
CD154 expression and function panel - T cells by Flow cytometry (FC)
CD154 function (binding to CD40) [Presence] in T cells
Spermatozoa Motile [#/volume] in Urine by Light microscopy --post ejaculation
Spermatozoa [#/volume] in Urine by Light microscopy --post ejaculation
Mycobacterium sp identified in Gastric fluid by Organism specific culture
Spermatozoa Motile/100 spermatozoa in Urine by Light microscopy --post ejaculation
Spermatozoa motility [Score] in Urine Qualitative by Light microscopy --post ejaculation
Spermatozoa Motile [#] in Urine by Light microscopy --post ejaculation
Spermatozoa Agglutinated [Presence] in Urine --post ejaculation
Primary or recurrent or distant metastasis [Type] in Tumor
Cancer pathology panel - Endometrial cancer specimen
Stage [Type] in Endometrial cancer specimen by FIGO
Histologic grade in Endometrial cancer specimen Qualitative
Myometrial invasion [Presence] in Endometrial cancer specimen
Depth of myometrial invasion [Length] in Endometrial cancer specimen
Depth of myometrial invasion/Myometrial thickness [Length fraction] in Endometrial cancer specimen
Extent of myometrial invasion in Endometrial cancer specimen Qualitative
MELF invasion pattern [Presence] in Endometrial cancer specimen
Distance of myoinvasive tumor from serosa [Length] in Endometrial cancer specimen
Vessels involved in lymphovascular invasion [#] in Cancer specimen
Lymphovascular invasion extent in Cancer specimen Qualitative
Stromal invasion [Presence] in Endometrial cancer specimen
Distance of tumor from cervical resection margins [Length] in Endometrial cancer specimen
Vaginal involvement [Presence] in Endometrial cancer specimen
Omental involvement [Presence] in Endometrial cancer specimen
Involvement of peritoneal biopsy specimen [Presence] in Endometrial cancer specimen
Uterine serosa involvement [Presence] in Endometrial cancer specimen
Parametrial involvement [Presence] in Endometrial cancer specimen
Adnexal involvement [Presence] in Endometrial cancer specimen
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Site of adnexal involvement [Anatomy] in Endometrial cancer specimen
Background endometrium findings in Endometrial cancer specimen
Cyclic hormonal phase of endometrium [Type] in Endometrial cancer specimen
Left pelvic lymph nodes examined [#] in Specimen
Left pelvic lymph nodes positive [#] in Specimen
Right pelvic lymph nodes examined [#] in Specimen
Right pelvic lymph nodes positive [#] in Specimen
Para-aortic lymph nodes examined [#] in Specimen
Para-aortic lymph nodes positive [#] in Specimen
Protocol used for examination of sentinel lymph nodes
DNA mismatch repair in Cancer specimen by Immune stain Narrative
Optimal tissue block [Identifier] in Cancer specimen
House dust Greer IgE Ab [Units/volume] in Serum
Di sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Beta globulin [Mass/time] in 24 hour Urine
Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
Gamma globulin [Mass/time] in 24 hour Urine
Cholesterol in HDL 2 [Mass/volume] in Serum or Plasma
Cholesterol in HDL 3 [Mass/volume] in Serum or Plasma
HIV proviral DNA [Presence] in Blood by Probe with amplification
Di sup(a) Ag [Presence] on Red Blood Cells from Donor
HIV 1 proviral DNA [Presence] in Blood by Probe with amplification
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
Depth of stromal invasion/Cervical thickness [Length fraction] in Endometrial cancer specimen
Percent epithelial component of carcinosarcoma
Percent sarcomatous component of carcinosarcoma
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immune diffusion (ID)
Sarcomatous pattern [Type] in carcinosarcoma
Candida sp [Identifier] in Isolate by Sequencing
Candida sp [Identifier] in Isolate by MS.MALDI-TOF
Color.candida colony [Type] in Isolate by Culture
Aspergillus sp CYP51 gene [Identifier] in Isolate by Sequencing
Color.aspergillus colony [Type] in Isolate by Culture
Fungus identified in Isolate by NAA with probe detection
Fungus identified in Isolate by MS.MALDI-TOF
Cefonicid [Susceptibility] by Serum bactericidal titer
CD11+CD20+ cells [#/volume] in Leukocytes
Fungus identified in Isolate by Sequencing
Yeast [Morphology] in Isolate by Light microscopy
Mold [Morphology] in Isolate by Light microscopy
Yeast identified in Isolate by MS.MALDI-TOF
Mold identified in Isolate by MS.MALDI-TOF
Malassezia sp identified in Isolate by MS.MALDI-TOF
Color.yeast colony [Type] in Isolate by Culture--with Sabouraud Dextrose Agar
Conidia morphology [Interpretation] in Isolate by Light microscopy
Yeast identified in Isolate by NAA with probe detection
Mold identified in Isolate by NAA with probe detection
Cryptococcus molecular type in Isolate by Sequencing
Cryptosporidium sp [Identifier] in Isolate by RFLP.rRNA
Retrograde ejaculation evaluation panel - Urine
lamoTRIgine [Mass/volume] in Urine by Confirmatory method
lamoTRIgine [Presence] in Urine by Confirmatory method
Sertraline/Creatinine [Mass Ratio] in Urine by Confirmatory method
traZODone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Eutylone/Creatinine [Mass Ratio] in Urine by Confirmatory method
Casts [#/area] in Urine sediment by Microscopy low power field
Di sup(a) Ag [Presence] on Red Blood Cells
Apolipoprotein E phenotype [Identifier] in Cerebral spinal fluid
Apolipoprotein E phenotype [Interpretation] in Cerebral spinal fluid Narrative
Amyloid beta 42 peptide/Amyloid beta 40 peptide [Mass Ratio] in Cerebral spinal fluid
Apolipoprotein E [Mass/volume] in Cerebral spinal fluid
Alzheimer's disease risk [Score] in Cerebral spinal fluid by calculation
Liver fibrosis score in Serum Calculated by FIB4
FLT3 gene internal tandem duplication length [#] in Blood or Tissue by Molecular genetics method
FLT3 gene.p.Asp835+Ile836 mutations/Normal in Blood or Tissue by Molecular genetics method
Liver fibrosis score panel by Calculated by FIB4
Apolipoprotein E and beta amyloid Alzheimer's risk panel - Cerebral spinal fluid
SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection
SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection
Di sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
Di sup(b) Ab [Presence] in Serum or Plasma from Donor
SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay
Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay
Di sup(b) Ab [Presence] in Serum or Plasma
SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay
SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay
Di sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
Transforming growth factor beta free [Mass/volume] in Serum or Plasma
Transforming growth factor beta [Mass/volume] in Serum or Plasma
Methemoglobin and sulfhemoglobin panel - Blood
Osmotic fragility panel of Red Blood Cells
Red blood cell membrane evaluation panel - Red Blood Cells
Band 3 [Presence] in Red Blood Cells by Flow cytometry (FC)
Di sup(b) Ag [Presence] on Red Blood Cells from Donor
KCNN4 gene full mutation analysis in Blood or Tissue by Sequencing
Burkholderia pseudomallei Ab [Titer] in Specimen by Hemagglutination inhibition
Coccidioides immitis IgM Ab [Units/volume] in Specimen by Immunoassay
Coccidioides immitis IgG Ab [Units/volume] in Specimen by Immunoassay
Periostin [Moles/volume] in Serum or Plasma by Immunoassay
Aspergillus fumigatus [Presence] in Isolate by MS.MALDI-TOF
Dehydroaripiprazole [Presence] in Urine by Confirmatory method
Lurasidone [Presence] in Urine by Confirmatory method
Cariprazine [Presence] in Urine by Confirmatory method
Cariprazine [Mass/volume] in Urine by Confirmatory method
Brexpiprazole [Presence] in Urine by Confirmatory method
Brexpiprazole [Mass/volume] in Urine by Confirmatory method
Antipsychotics drug panel - Urine by Confirmatory method
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021)
6-Hydroxybuspirone [Mass/volume] in Urine by Confirmatory method
Methocarbamol [Mass/volume] in Urine by Confirmatory method
OXcarbazepine [Mass/volume] in Urine by Confirmatory method
10-Hydroxycarbazepine [Mass/volume] in Urine by Confirmatory method
Chloride/Creatinine [Molar ratio] in 24 hour Urine
C reactive protein [Units/volume] in Body fluid
Prolactin [Moles/volume] in Serum or Plasma --45 minutes post dose TRH IV
Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count
Methotrexate [Moles/volume] in Serum or Plasma --18 hour post dose
Methotrexate [Moles/volume] in Serum or Plasma --5 minutes post dose
Alpha-1-acid glycoprotein/Protein.total in Serum or Plasma by Electrophoresis
Alpha 1 antitrypsin/Protein.total in Serum or Plasma by Electrophoresis
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Electrophoresis
Transferrin/Protein.total in Serum or Plasma by Electrophoresis
Transferrin [Mass/volume] in Serum or Plasma by Electrophoresis
Haptoglobin/Protein.total in Serum or Plasma by Electrophoresis
Hematocrit [Pure volume fraction] of Cord blood by Automated count
Nucleated cells [#/volume] in Synovial fluid by Automated count
Dysautonomia autoimmune Ab panel - Serum
Leptospira weilii sv Celledoni Ab [Titer] in Serum by Agglutination
Leptospira santarosai sv Alexi Ab [Titer] in Serum by Agglutination
Leptospira santarosai sv Georgia Ab [Titer] in Serum by Agglutination
Leptospira santarosai sv Borincana Ab [Titer] in Serum by Agglutination
Leptospira kirschneri sv Cynopteri Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Wolffi Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Mankarso Ab [Titer] in Serum by Agglutination
Leptospira interrogans sv Djasiman Ab [Titer] in Serum by Agglutination
Leptospira borgpetersenii sv Javanica Ab [Titer] in Serum by Agglutination
Leptospira sp Ab panel - Serum by Agglutination
Urinary tract pathogens panel - Urine by NAA with probe detection
Acinetobacter baumannii DNA [Presence] in Urine by NAA with probe detection
Citrobacter freundii DNA [Presence] in Urine by NAA with probe detection
Citrobacter koseri DNA [Presence] in Urine by NAA with probe detection
Enterobacter cloacae complex DNA [Presence] in Urine by NAA with probe detection
Enterococcus faecalis DNA [Presence] in Urine by NAA with probe detection
Enterococcus faecium DNA [Presence] in Urine by NAA with probe detection
Escherichia coli DNA [Presence] in Urine by NAA with probe detection
Di sup(b) Ag [Presence] on Red Blood Cells
Klebsiella aerogenes DNA [Presence] in Urine by NAA with probe detection
Klebsiella oxytoca DNA [Presence] in Urine by NAA with probe detection
Klebsiella pneumoniae DNA [Presence] in Urine by NAA with probe detection
Morganella morganii DNA [Presence] in Urine by NAA with probe detection
Proteus sp DNA [Presence] in Urine by NAA with probe detection
Providencia rettgeri DNA [Presence] in Urine by NAA with probe detection
Providencia stuartii DNA [Presence] in Urine by NAA with probe detection
Pseudomonas aeruginosa DNA [Presence] in Urine by NAA with probe detection
Serratia marcescens DNA [Presence] in Urine by NAA with probe detection
Staphylococcus aureus DNA [Presence] in Urine by NAA with probe detection
Staphylococcus epidermidis DNA [Presence] in Urine by NAA with probe detection
Staphylococcus saprophyticus DNA [Presence] in Urine by NAA with probe detection
Streptococcus agalactiae DNA [Presence] in Urine by NAA with probe detection
Candida albicans DNA [Presence] in Urine by NAA with probe detection
Trimethoprim resistance dfrA1 gene [Presence] by Molecular method
Trimethoprim resistance dfrA5 gene [Presence] by Molecular method
Trimethoprim resistance dfrA7+dfrA17 genes [Presence] by Molecular method
Trimethoprim dfrA12 gene [Presence] by Molecular method
Metanephrine Free [Moles/time] in 24 hour Urine
Metanephrine Free [Moles/volume] in Urine
Acidity.titratable [Moles/volume] in 24 hour Urine
Erythrocytes [#/volume] in Bronchoalveolar lavage by Manual count
Leukocytes [#/volume] in Bronchoalveolar lavage by Manual count
Epithelial cells [Presence] in Bronchoalveolar lavage by Light microscopy
Cells Counted Total [#] in Bronchoalveolar lavage
Manual differential comment [Interpretation] in Bronchoalveolar lavage Narrative
SLC12A1 gene full mutation analysis in Blood by Molecular genetics method
DHCR7 gene full mutation analysis in Blood or Tissue by Sequencing
N-acetylglycine/Creatinine [Mass Ratio] in Urine
Cerebroventricular lining cells/100 leukocytes in Cerebral spinal fluid
Cholesterol.esterified actual/normal in Fibroblast
Acetylcholine receptor modulation Ab [Presence] in Serum by Flow cytometry (FC)
Free water Clearance in Urine and Serum or Plasma
Ej Ab [Units/volume] in Serum by Line blot
PL-12 Ab [Units/volume] in Serum by Line blot
PL-7 Ab [Units/volume] in Serum by Line blot
Ku Ab [Units/volume] in Serum by Line blot
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Line blot
Kelch-like protein 11 IgG Ab [Titer] in Serum by Immunofluorescence
Kelch-like protein 11 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Calcium/Creatinine [Mass Ratio] in Urine from Fetus
Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine
Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine
Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay
Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay
Acrylfentanyl [Presence] in Urine by Confirmatory method
O-nortramadol [Presence] in Urine by Confirmatory method
Furanylfentanyl [Presence] in Urine by Confirmatory method
Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay
Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay
Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay
Napsin A Ag [Presence] in Tissue by Immune stain
p40 Ag [Presence] in Tissue by Immune stain
Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with probe detection
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay
Procalcitonin [Moles/volume] in Serum or Plasma
Do sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
Norepinephrine [Mass/volume] in Serum or Plasma
Cancer Ag 242 [Units/volume] in Serum or Plasma
Gastrin releasing polypeptide [Units/volume] in Serum or Plasma
Tumor necrosis factor.alpha [Units/volume] in Serum or Plasma
Choriogonadotropin [Mass/volume] in Urine
Chlamydia trachomatis Ag [Presence] in Serum or Plasma by Immunoassay
Stimulants drug panel - Urine by Screen method
ePHEDrine [Presence] in Urine by Screen method
Pseudoephedrine [Presence] in Urine by Screen method
Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine by Screen method
Dengue virus neutralizing antibody [Titer] in Specimen by Neutralization test
Rocio virus neutralizing antibody [Titer] in Specimen by Neutralization test
Ilheus virus neutralizing antibody [Titer] in Specimen by Neutralization test
Semliki Forest virus neutralizing antibody [Titer] in Specimen by Neutralization test
Onyong-nyong virus neutralizing antibody [Titer] in Specimen by Neutralization test
Bourbon virus neutralizing antibody [Titer] in Specimen by Neutralization test
Toscana virus neutralizing antibody [Titer] in Specimen by Neutralization test
Sandfly fever Sicilian virus neutralizing antibody [Titer] in Specimen by Neutralization test
Sandfly fever Naples virus neutralizing antibody [Titer] in Specimen by Neutralization test
Oropouche virus neutralizing antibody [Titer] in Specimen by Neutralization test
Rift valley fever virus neutralizing antibody [Titer] in Specimen by Neutralization test
Bwamba virus neutralizing antibody [Titer] in Specimen by Neutralization test
Heartland banyangvirus neutralizing antibody [Titer] in Specimen by Neutralization test
Tick-borne encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test
Bunyamwera virus neutralizing antibody [Titer] in Specimen by Neutralization test
NOTCH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
BIRC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
PLCG2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
SF3B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Rabies virus IgM Ab [Titer] in Specimen by Immunofluorescence
Rabies virus IgG Ab [Titer] in Specimen by Immunofluorescence
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Line blot
Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC)
Designer benzodiazepines [Presence] in Urine by Confirmatory method
Delorazepam [Mass/volume] in Urine by Confirmatory method
Etizolam [Mass/volume] in Urine by Confirmatory method
Alpha hydroxyetizolam [Mass/volume] in Urine by Confirmatory method
Deschloroetizolam [Mass/volume] in Urine by Confirmatory method
Nifoxipam [Mass/volume] in Urine by Confirmatory method
Diclazepam [Mass/volume] in Urine by Confirmatory method
Clonazolam [Mass/volume] in Urine by Confirmatory method
8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method
Flualprazolam [Mass/volume] in Urine by Confirmatory method
Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method
Meclonazepam [Mass/volume] in Urine by Confirmatory method
Flubromazepam [Mass/volume] in Urine by Confirmatory method
Phenazepam [Mass/volume] in Urine by Confirmatory method
3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method
Pyrazolam [Mass/volume] in Urine by Confirmatory method
Flubromazolam [Mass/volume] in Urine by Confirmatory method
Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method
Do sup(a) Ab [Presence] in Serum or Plasma from Donor
Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum
Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot
SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
Do sup(a) Ab [Presence] in Serum or Plasma
Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum
Horse hair+Horse dander IgG Ab [Mass/volume] in Serum
Euroglyphus maynei IgG Ab [Mass/volume] in Serum
Sheep milk IgG Ab [Mass/volume] in Serum
Chicken meat IgG Ab [Mass/volume] in Serum
Culex mosquito IgG Ab [Mass/volume] in Serum
London Plane IgG Ab [Mass/volume] in Serum
Grey Alder IgG Ab [Mass/volume] in Serum
Silver Birch IgG Ab [Mass/volume] in Serum
Hazelnut Pollen IgG Ab [Mass/volume] in Serum
Olive Pollen IgG Ab [Mass/volume] in Serum
Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum
Mercury [Moles/volume] in Cerebral spinal fluid
Mercury [Moles/volume] in Dialysis fluid
Cancer Ag 50 [Units/volume] in Body fluid
Hepatitis B virus surface Ag [log units/volume] in Serum or Plasma by Immunoassay
Adenovirus DNA [Log #/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection
Choriogonadotropin.tumor marker [Units/volume] in Aspirate
Choriogonadotropin.tumor marker [Units/volume] in Pleural fluid
Progesterone [Moles/volume] in Ovarian aspirate
Progesterone [Mass/volume] in Ovarian aspirate
Siderocytes panel - Blood or Marrow by Prussian blue stain
Siderocytes [Presence] in Blood or Marrow by Prussian blue stain
Siderocytes/100 Erythroblasts in Blood or Marrow by Prussian blue stain
Siderocytes.Type 1/100 Erythroblasts in Blood or Marrow by Prussian blue stain
Siderocytes.Type 2/100 Erythroblasts in Blood or Marrow by Prussian blue stain
Siderocytes.Type 3/100 Erythroblasts in Blood or Marrow by Prussian blue stain
CD19+CD23+ cells/100 cells in Bone marrow
Cells.CD19+FMC7+/100 cells in Bone marrow
Cells.CD19+CD79b+/100 cells in Bone marrow
Cells.CD19+CD22+/100 cells in Bone marrow
CD19+CD38+ cells/100 cells in Bone marrow
Myeloperoxidase [Mass/volume] in Serum by Immunoassay
Matrix metallopeptidase 9 [Mass/volume] in Serum by Immunoassay
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma by LC/MS/MS
Italian Cypress IgG Ab [Mass/volume] in Serum
Voltage-gated calcium channel Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay
Beta globulin [Mass/volume] in Serum or Plasma by Immunofixation
Gamma globulin [Mass/volume] in Serum or Plasma by Immunofixation
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Immunofixation
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Immunofixation
Penicillin G IgG4 Ab [Mass/volume] in Serum
Penicillin V IgG4 Ab [Mass/volume] in Serum
Amoxicillin IgG4 Ab [Mass/volume] in Serum
Blomia tropicalis IgG4 Ab [Mass/volume] in Serum
Dermatophagoides microceras IgG4 Ab [Mass/volume] in Serum
Tyrophagus putrescentiae IgG4 Ab [Mass/volume] in Serum
Euroglyphus maynei IgG4 Ab [Mass/volume] in Serum
Goat epithelium IgG4 Ab [Mass/volume] in Serum
Cat recombinant (rFel d) 1 IgG4 Ab [Mass/volume] in Serum
Sugar Beet Seed (Beta vulgaris seed) IgG4 Ab [Mass/volume] in Serum
Cyprinus carpio recombinant (rCyp c) 1 IgG4 Ab [Mass/volume] in Serum
Peach recombinant (rPru p) 3 IgG4 Ab [Mass/volume] in Serum
English walnut recombinant (rJug r) 1 IgG4 Ab [Mass/volume] in Serum
English walnut recombinant (rJug r) 3 IgG4 Ab [Mass/volume] in Serum
Cashew nut recombinant (rAna o) 3 IgG4 Ab [Mass/volume] in Serum
Do sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
Peanut recombinant (rAra h) 6 IgG4 Ab [Mass/volume] in Serum
Barley Pollen IgG4 Ab [Mass/volume] in Serum
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG4 Ab [Mass/volume] in Serum
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgG4 Ab [Mass/volume] in Serum
Bumble Bee IgG4 Ab [Mass/volume] in Serum
Paper wasp recombinant (rPol d) 5 IgG4 Ab [Mass/volume] in Serum
Common wasp recombinant (rVes v) 1 IgG4 Ab [Mass/volume] in Serum
Green Nimitti IgG4 Ab [Mass/volume] in Serum
European paper wasp IgG4 Ab [Mass/volume] in Serum
Botrytis cinerea IgG4 Ab [Mass/volume] in Serum
Horn beam IgG4 Ab [Mass/volume] in Serum
Silver Birch recombinant (rBet v) 2 IgG4 Ab [Mass/volume] in Serum
Penicillin V IgG Ab [Mass/volume] in Serum
Clostridium tetani toxoid IgG Ab [Mass/volume] in Serum
Amoxicillin IgG Ab [Mass/volume] in Serum
Blomia tropicalis IgG Ab [Mass/volume] in Serum
Tyrophagus putrescentiae IgG Ab [Mass/volume] in Serum
Rabbit urine proteins IgG Ab [Mass/volume] in Serum
Budgerigar droppings IgG Ab [Mass/volume] in Serum
Rabbit epithelium IgG Ab [Mass/volume] in Serum
Rat epithelium, serum proteins + urine proteins IgG Ab [Mass/volume] in Serum
Sugar Beet Seed (Beta vulgaris seed) IgG Ab [Mass/volume] in Serum
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum
Sweet Vernal grass IgG Ab [Mass/volume] in Serum
Velvet grass IgG Ab [Mass/volume] in Serum
Oat pollen IgG Ab [Mass/volume] in Serum
Cultivated Corn IgG Ab [Mass/volume] in Serum
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG Ab [Mass/volume] in Serum
Horse Bot Fly IgG Ab [Mass/volume] in Serum
Paper wasp recombinant (rPol d) 5 IgG Ab [Mass/volume] in Serum
Common wasp recombinant (rVes v) 1 IgG Ab [Mass/volume] in Serum
Red Imported Fire Ant IgG Ab [Mass/volume] in Serum
Penicillium frequentans IgG Ab [Mass/volume] in Serum
Aspergillus flavus IgG Ab [Mass/volume] in Serum
Sheep Sorrel IgG Ab [Mass/volume] in Serum
Cefiderocol [Susceptibility] by Minimum inhibitory concentration (MIC)
Glucose [Mass/volume] in Interstitial fluid
Do sup(a) Ag [Presence] on Red Blood Cells from Donor
Circumference [Length] of Pulmonary valve
Thickness [Length] of Interventricular septum
Stenosis degree [Length fraction] in Left main coronary artery by Autopsy
Stenosis degree [Length fraction] in Proximal left anterior descending artery by Autopsy
Stenosis degree [Length fraction] in Mid left anterior descending artery by Autopsy
Stenosis degree [Length fraction] in Distal left anterior descending artery by Autopsy
Stenosis degree [Length fraction] in Proximal left circumflex artery by Autopsy
Stenosis degree [Length fraction] in Middle left circumflex artery by Autopsy
Stenosis degree [Length fraction] in Distal left circumflex artery by Autopsy
Stenosis degree [Length fraction] in Proximal right coronary artery by Autopsy
Stenosis degree [Length fraction] in Mid right coronary artery by Autopsy
Circumference [Length] of Lower extremity
Stenosis degree [Length fraction] in Distal right coronary artery by Autopsy
Gas and electrolytes panel - Arterial blood
SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay
Erythrocytes.dysmorphic/100 erythrocytes in Urine by Automated count
Protein.monoclonal band 1/Protein.total in Urine by Electrophoresis
Beta 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis
Beta 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis
Glucose/Creatinine [Molar ratio] in 24 hour Urine
Band form neutrophils/100 leukocytes in Peritoneal fluid by Manual count
Band form neutrophils/100 leukocytes in Pleural fluid by Manual count
Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay
Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in RBC.lysate
Saturated fatty acids [Moles/volume] in RBC.lysate
Monounsaturated fatty acids [Moles/volume] in RBC.lysate
Polyunsaturated fatty acids [Moles/volume] in RBC.lysate
Omega 3 fatty acids (w3) [Moles/volume] in RBC.lysate
Omega 6 fatty acids (w6) [Moles/volume] in RBC.lysate
Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection
Japanese encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
PCA-2 Ab [Presence] in Serum by Line blot
PCA-2 Ab [Presence] in Cerebral spinal fluid by Line blot
Do sup(a) Ag [Presence] on Red Blood Cells
Hepatocellular carcinoma screening [Interpretation] based on clinical and lab data
Clot initiation.kaolin induced [Time] in Blood by Resonance TEG
Clot angle.kaolin induced in Blood by Resonance TEG
Clot formation.kaolin induced [Time] in Blood by Resonance TEG
Interferon gamma [Mass/volume] in Cerebral spinal fluid
Interleukin 12 [Mass/volume] in Cerebral spinal fluid
Interleukin 17 [Mass/volume] in Cerebral spinal fluid
Interleukin 1 beta [Mass/volume] in Cerebral spinal fluid
Interleukin 2 Receptor Soluble [Mass/volume] in Cerebral spinal fluid
Interleukin 8 [Mass/volume] in Cerebral spinal fluid
DBG Ag [Presence] on Red Blood Cells from Blood product unit
Tumor necrosis factor.alpha [Mass/volume] in Cerebral spinal fluid
SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood
SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative
SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood
SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood
Leukocytes [#/volume] in Peritoneal dialysis fluid by Automated count
Leukocytes [#/volume] in Bronchoalveolar lavage by Automated count
Erythrocytes [#/volume] in Bronchoalveolar lavage by Automated count
Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by NAA with probe detection
Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by NAA with probe detection
Multidrug resistant gram-negative organism classification [Type]
Adalimumab and Adalimumab Ab panel - Serum or Plasma by Immunoassay
Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post cardiac transplant
Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post lung transplant
Cell-free DNA.donor/Cell-free DNA.total in Plasma cell-free DNA --post kidney transplant
DBG Ag [Presence] on Red Blood Cells from Donor
Erythrocytes.non-dysmorphic [Presence] in Urine sediment by Computer assisted method
Erythrocytes.non-dysmorphic [#/area] in Urine sediment by Computer assisted method
Erythrocytes.non-dysmorphic [#/volume] in Urine sediment by Computer assisted method
Erythrocytes.dysmorphic [#/area] in Urine sediment by Computer assisted method
Erythrocytes.dysmorphic [Presence] in Urine sediment by Computer assisted method
Erythrocytes.dysmorphic [#/volume] in Urine sediment by Computer assisted method
Acanthocytes [Presence] in Urine sediment by Computer assisted method
Acanthocytes/100 erythrocytes in Urine sediment by Computer assisted method
Acanthocytes [#/area] in Urine sediment by Computer assisted method
Acanthocytes [#/volume] in Urine sediment by Computer assisted method
Erythrocytes.ghost cells [Presence] in Urine sediment by Computer assisted method
Erythrocytes.ghost cells [#/area] in Urine sediment by Computer assisted method
Erythrocytes.ghost cells [#/volume] in Urine sediment by Computer assisted method
Superficial transitional cells [Presence] in Urine sediment by Computer assisted method
Superficial transitional cells [#/area] in Urine sediment by Computer assisted method
Superficial transitional cells [#/volume] in Urine sediment by Computer assisted method
Deep transitional cells [Presence] in Urine sediment by Computer assisted method
Deep transitional cells [#/area] in Urine sediment by Computer assisted method
Deep transitional cells [#/volume] in Urine sediment by Computer assisted method
Lipids [Presence] in Urine sediment by Computer assisted method
Lipids [#/area] in Urine sediment by Computer assisted method
Lipids [#/volume] in Urine sediment by Computer assisted method
Free lipid droplets [Presence] in Urine sediment by Computer assisted method
Free lipid droplets [#/area] in Urine sediment by Computer assisted method
Free lipid droplets [#/volume] in Urine sediment by Computer assisted method
Cholesterol crystals [#/volume] in Urine sediment by Computer assisted method
Hyaline-granular casts [Presence] in Urine sediment by Computer assisted method
Hyaline-granular casts [#/area] in Urine sediment by Computer assisted method
Hyaline-granular casts [#/volume] in Urine sediment by Computer assisted method
Crystal casts [Presence] in Urine sediment by Computer assisted method
Crystal casts [#/area] in Urine sediment by Computer assisted method
Crystal casts [#/volume] in Urine sediment by Computer assisted method
Microorganism casts [Presence] in Urine sediment by Computer assisted method
Microorganism casts [#/area] in Urine sediment by Computer assisted method
Microorganism casts [#/volume] in Urine sediment by Computer assisted method
Calcium oxalate monohydrate crystals [Presence] in Urine sediment by Computer assisted method
Calcium oxalate monohydrate crystals [#/area] in Urine sediment by Computer assisted method
Calcium oxalate monohydrate crystals [#/volume] in Urine sediment by Computer assisted method
Calcium oxalate dihydrate crystals [Presence] in Urine sediment by Computer assisted method
Calcium oxalate dihydrate crystals [#/area] in Urine sediment by Computer assisted method
Calcium oxalate dihydrate crystals [#/volume] in Urine sediment by Computer assisted method
Triple phosphate crystals [Presence] in Urine sediment by Computer assisted method
Triple phosphate crystals [#/area] in Urine sediment by Computer assisted method
Triple phosphate crystals [#/volume] in Urine sediment by Computer assisted method
Urate crystals [Presence] in Urine sediment by Computer assisted method
Urate crystals [#/area] in Urine sediment by Computer assisted method
Urate crystals [#/volume] in Urine sediment by Computer assisted method
Urate crystals amorphous [#/area] in Urine sediment by Computer assisted method
Urate crystals amorphous [#/volume] in Urine sediment by Computer assisted method
Phosphate crystals amorphous [#/volume] in Urine sediment by Computer assisted method
Atypical crystals [Presence] in Urine sediment by Computer assisted method
Atypical crystals [#/area] in Urine sediment by Computer assisted method
Atypical crystals [#/volume] in Urine sediment by Computer assisted method
Bacilliform bacteria [Presence] in Urine sediment by Automated
Bacilliform bacteria [#/area] in Urine sediment by Automated count
Bacilliform bacteria [#/volume] in Urine sediment by Automated count
Cocci bacteria [Presence] in Urine sediment by Automated
Cocci bacteria [#/area] in Urine sediment by Automated count
Cocci bacteria [#/volume] in Urine sediment by Automated count
Amorphous sediment [Presence] in Urine sediment by Automated
Amorphous sediment [#/area] in Urine sediment by Automated count
Amorphous sediment [#/volume] in Urine sediment by Automated count
Schistosoma haematobium [Presence] in Urine sediment by Computer assisted method
Schistosoma haematobium [#/area] in Urine sediment by Computer assisted method
Schistosoma haematobium [#/volume] in Urine sediment by Computer assisted method
Artifact [Presence] in Urine sediment by Computer assisted method
Artifact [#/volume] in Urine sediment by Computer assisted method
Erythrocytes [Presence] in Body fluid by Automated
Erythrocytes [#/area] in Body fluid by Automated count
Leukocytes [Presence] in Body fluid by Automated
Leukocytes [#/area] in Body fluid by Automated count
Nucleated cells [Presence] in Body fluid by Automated
Nucleated cells [#/area] in Body fluid by Automated count
Bacteria [Presence] in Body fluid by Automated
Leukocyte clumps [Presence] in Body fluid by Automated
Urothelial carcinoma gene expression score in Urine by Molecular genetics method
ADAMTS13 gene full mutation analysis in Blood or Tissue by Sequencing
Myeloproliferative neoplasm multigene analysis in Blood or Tissue by Molecular genetics method
JAK2 gene exon 12 full mutation analysis in Blood or Tissue by Sequencing
JAK2 gene exon 14 full mutation analysis in Blood or Tissue by Sequencing
MPL gene exon 10 full mutation analysis in Blood or Tissue by Sequencing
ASXL1 gene exon 13 full mutation analysis in Blood or Tissue by Sequencing
KIT gene exon 17 full mutation analysis in Blood or Tissue by Sequencing
Atypical hemolytic uremic syndrome multigene analysis in Blood or Tissue by Molecular genetics method
Thrombotic microangiopathy multigene analysis in Blood or Tissue by Molecular genetics method
PLG gene full mutation analysis in Blood or Tissue by Sequencing
Hereditary thrombocytopenia multigene analysis in Blood or Tissue by Molecular genetics method
Hemophagocytic lymphohistiocytosis multigene analysis in Blood or Tissue by Molecular genetics method
Hearing loss multigene analysis in Blood or Tissue by Molecular genetics method